PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Keaver, L; Webber, L; Dee, A; Shiely, F; Marsh, T; Balanda, K; Perry, I				Keaver, Laura; Webber, Laura; Dee, Anne; Shiely, Frances; Marsh, Tim; Balanda, Kevin; Perry, Ivan			Application of the UK Foresight Obesity Model in Ireland: The Health and Economic Consequences of Projected Obesity Trends in Ireland	PLOS ONE			English	Article								Background: Given the scale of the current obesity epidemic and associated health consequences there has been increasing concern about the economic burden placed on society in terms of direct healthcare costs and indirect societal costs. In the Republic of Ireland these costs were estimated at (sic)1.13 billion for 2009. The total direct healthcare costs for six major obesity related conditions (coronary heart disease & stroke, cancer, hypertension, type 2 diabetes and knee osteoarthritis) in the same year were estimated at (sic)2.55 billion. The aim of this research is to project disease burden and direct healthcare costs for these conditions in Ireland to 2030 using the established model developed by the Health Forum (UK) for the Foresight: Tackling Obesities project. Methodology: Routine data sources were used to derive incidence, prevalence, mortality and survival for six conditions as inputs for the model. The model utilises a two stage modelling process to predict future BMI rates, disease prevalence and costs. Stage 1 employs a non-linear multivariate regression model to project BMI trends; stage 2 employs a microsimulation approach to produce longitudinal projections and test the impact of interventions upon future incidence of obesity-related disease. Results: Overweight and obesity are projected to reach levels of 89% and 85% in males and females respectively by 2030. This will result in an increase in the obesity related prevalence of CHD & stroke by 97%, cancers by 61% and type 2 diabetes by 21%. The direct healthcare costs associated with these increases will amount to (sic)5.4 billion by 2030. A 5% reduction in population BMI levels by 2030 is projected to result in (sic) 495 million less being spent in obesity-related direct healthcare costs over twenty years. Discussion: These findings have significant implications for policy, highlighting the need for effective strategies to prevent this avoidable health and economic burden.	[Keaver, Laura; Shiely, Frances; Perry, Ivan] Natl Univ Ireland Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Ireland; [Webber, Laura; Marsh, Tim] UK Hlth Forum, London, England; [Dee, Anne] Hlth Serv Execut Dept Publ Hlth, Limerick, Ireland; [Balanda, Kevin] Inst Publ Hlth Ireland, Dublin, Ireland	University College Cork	Perry, I (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Ireland.	i.perry@ucc.ie	Dee, Anne/AAE-5880-2022	Balanda, Kevin/0000-0002-6780-8536; Perry, Ivan/0000-0002-4965-9792; Dee, Anne/0000-0003-3168-3732	Irish Health Research Board [HRC/2007/13]	Irish Health Research Board	This research was supported by the Irish Health Research Board funding (reference: HRC/2007/13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buckley CM, 2013, DIABETIC MED, V30, P1198, DOI 10.1111/dme.12226; Dee A, 2012, XECUTIVE SUMMARY COS; Department of Health and Children, 2008, URV LIF ATT NUTR IR; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Friel S, 1998, NATL HLTH LIFESTYLE; Health Atlas Ireland, 2009, DIR HEALTHC COSTS; Health Survey for England, 2010, REND TABL HYP PREV; HSE, 2008, HSE FRAM ACT OB 2008; Institute of Public Health, 2012, MUSC COND BRIEF SEPT; International Association for the Study of Obesity, 2010, WORKP 7 OV OB REP DA; IUNA, 2010, AT AD NUTR SURV FOOD; IUNA (Irish Universities Nutrition Alliance), 2012, NAT PRESCH NUTR SURV; Jeffords JM, 2010, HE OVERALL COSTS OBE; Kelleher C, 2003, REGIONAL RESULTS SLA; Kelly PJ, 2012, STROKE, V43, P2042, DOI 10.1161/STROKEAHA.111.645721; Kopelman P, 2007, OBES REV, V8, P13, DOI 10.1111/j.1467-789X.2007.00311.x; Layte R, 2011, 2 DEP CHILDR YOUTH A; Leach, 2010, DATA DOCUMENTATION D; McPherson K, 2007, TACKLING OBESITIES F; Morgan K, 2008, SLAN 2007 SURVEY LIF; Murrin CM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-81; National Adult Nutrition Survey, 2011, SUMM REP; National Cancer Registry, 2012, INC MORT TREATM SURV; Nichols M, 2012, UROPEAN CARDIOVASCUL; RTVELADZE K, 2012, SCIRES, V4, P1471; Shrivastava A, 2012, PUBLIC HEALTH NUTR, V13, P1, DOI DOI 10.1017/S1368980012003667; South North Ireland Food Consumption Survey, 2001, IR U NUTR ALL SUMM R; TILDA, 2011, 50 PLUS IR 1 RES IR; United Nations Population Prospects, 2010, POP 5 YEAR AG GROUP; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Webber L, 2012, OBES REV, V13, P744, DOI 10.1111/j.1467-789X.2012.00999.x; Webber L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039589; Wolfe CDA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001033; World Health Organization, 2012, CONTR GLOB OB EP; World Health Organization, 2001, NAT BURD DIS STUD PR	35	56	59	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79827	10.1371/journal.pone.0079827	http://dx.doi.org/10.1371/journal.pone.0079827			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236162	Green Submitted, Green Published, gold			2022-12-27	WOS:000327254700162
J	Weng, TP; Huang, SC; Chuang, YF; Wang, JS				Weng, Tzu-Pin; Huang, Shu-Chun; Chuang, Yu-Fen; Wang, Jong-Shyan			Effects of Interval and Continuous Exercise Training on CD4 Lymphocyte Apoptotic and Autophagic Responses to Hypoxic Stress in Sedentary Men	PLOS ONE			English	Article							T-CELL-ACTIVATION; OXIDATIVE STRESS; HEART-FAILURE; IMMUNE FUNCTION; PROTECTS; HEMODYNAMICS; AGGREGATION; INTENSITY; PLATELET; CAPACITY	Exercise is linked with the type/intensity-dependent adaptive immune responses, whereas hypoxic stress facilitates the programmed death of CD4 lymphocytes. This study investigated how high intensity-interval (HIT) and moderate intensity-continuous (MCT) exercise training influence hypoxia-induced apoptosis and autophagy of CD4 lymphocytes in sedentary men. Thirty healthy sedentary males were randomized to engage either HIT (3-minute intervals at 40% and 80% VO2max, n=10) or MCT (sustained 60% VO2max, n=10) for 30 minutes/day, 5 days/week for 5 weeks, or to a control group that did not received exercise intervention (CTL, n=10). CD4 lymphocyte apoptotic and autophagic responses to hypoxic exercise (HE, 100W under 12%O-2 for 30 minutes) were determined before and after various regimens. The results demonstrated that HIT exhibited higher enhancements of pulmonary ventilation, cardiac output, and VO2 at ventilatory threshold and peak performance than MCT did. Before the intervention, HE significantly down-regulated autophagy by decreased beclin-1, Atg-1, LC3-II, Atg-12, and LAMP-2 expressions and acridine orange staining, and simultaneously enhanced apoptosis by increased phospho-Bcl-2 and active caspase-9/-3 levels and phosphotidylserine exposure in CD4 lymphocytes. However, five weeks of HIT and MCT, but not CTL, reduced the extents of declined autophagy and potentiated apoptosis in CD4 lymphocytes caused by HE. Furthermore, both HIT and MCT regimens manifestly lowered plasma myeloperoxidase and interleukin-4 levels and elevated the ratio of interleukin-4 to interferon-gamma at rest and following HE. Therefore, we conclude that HIT is superior to MCT for enhancing aerobic fitness. Moreover, either HIT or MCT effectively depresses apoptosis and promotes autophagy in CD4 lymphocytes and is accompanied by increased interleukin-4/interferon-gamma ratio and decreased peroxide production during HE.	[Weng, Tzu-Pin; Chuang, Yu-Fen; Wang, Jong-Shyan] Chang Gung Univ, Grad Inst Rehabil Sci, Healthy Aging Res Ctr, Tao Yuan, Taiwan; [Huang, Shu-Chun] Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Tao Yuan, Taiwan; [Weng, Tzu-Pin] Jen Teh Jr Coll Med Nursing & Management, Dept Rehabil Sci, Miaoli, Taiwan	Chang Gung University; Chang Gung Memorial Hospital	Wang, JS (corresponding author), Chang Gung Univ, Grad Inst Rehabil Sci, Healthy Aging Res Ctr, Tao Yuan, Taiwan.	s5492@mail.cgu.edu.tw		chuang, yufen/0000-0002-4797-625X	National Science Council of Taiwan (NSC) [100-2314-B-182-004-MY3]; Chang Gung Medical Research Program (CMRPG) [280241]; Healthy Aging Research Center, Chang Gung University [EMRPD1A0841]	National Science Council of Taiwan (NSC)(Ministry of Science and Technology, Taiwan); Chang Gung Medical Research Program (CMRPG); Healthy Aging Research Center, Chang Gung University	This work was supported by the National Science Council of Taiwan (grant number NSC 100-2314-B-182-004-MY3), Chang Gung Medical Research Program (grant number CMRPG 280241) and the Healthy Aging Research Center, Chang Gung University (grant number EMRPD1A0841). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brennan ML, 2003, CURR OPIN LIPIDOL, V14, P353, DOI 10.1097/00041433-200308000-00003; Dutta D, 2013, AUTOPHAGY, V9, P328, DOI 10.4161/auto.22971; Feng CG, 2009, AUTOPHAGY, V5, P232, DOI 10.4161/auto.5.2.7445; Frasier CR, 2011, J APPL PHYSIOL, V111, P905, DOI 10.1152/japplphysiol.00004.2011; Fu TC, 2013, INT J CARDIOL, V167, P41, DOI 10.1016/j.ijcard.2011.11.086; Fu TC, 2011, AM J PHYSIOL-HEART C, V300, pH1545, DOI 10.1152/ajpheart.00867.2010; Glanemann M, 2003, J HEPATOL, V38, P59, DOI 10.1016/S0168-8278(02)00327-6; Harris J, 2007, IMMUNITY, V27, P505, DOI 10.1016/j.immuni.2007.07.022; Higgins GC, 2011, CELL MOL LIFE SCI, V68, P3725, DOI 10.1007/s00018-011-0667-9; Hsieh YC, 2009, TRENDS MOL MED, V15, P129, DOI 10.1016/j.molmed.2009.01.002; Hubbard VM, 2010, J IMMUNOL, V185, P7349, DOI 10.4049/jimmunol.1000576; Kontogianni K, 2007, ENVIRON MOL MUTAGEN, V48, P722, DOI 10.1002/em.20351; Larbi A, 2007, EXP GERONTOL, V42, P852, DOI 10.1016/j.exger.2007.05.004; Li CY, 2006, J IMMUNOL, V177, P5163, DOI 10.4049/jimmunol.177.8.5163; Mazzeo RS, 2005, EXERC IMMUNOL REV, V11, P6; Paraskevaidis IA, 2005, INT J CARDIOL, V98, P221, DOI 10.1016/j.ijcard.2003.10.040; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pedersen BK, 2000, PHYSIOL REV, V80, P1055, DOI 10.1152/physrev.2000.80.3.1055; Ravikumar B, 2006, HUM MOL GENET, V15, P1209, DOI 10.1093/hmg/ddl036; Swain DP, 2006, AM J CARDIOL, V97, P141, DOI 10.1016/j.amjcard.2005.07.130; Thompson W.R., 2010, ACSMS GUID EX TEST P, P152; van Baarle D, 2005, IMMUNOL LETT, V97, P19, DOI 10.1016/j.imlet.2004.10.003; Wang JS, 2007, J APPL PHYSIOL, V103, P305, DOI 10.1152/japplphysiol.00226.2007; Wang JS, 2013, INT J CARDIOL, V168, P1243, DOI 10.1016/j.ijcard.2012.11.053; Wang JS, 2011, BRAIN BEHAV IMMUN, V25, P270, DOI 10.1016/j.bbi.2010.09.018; Wang JS, 2010, EUR J APPL PHYSIOL, V108, P371, DOI 10.1007/s00421-009-1231-2; Wang JS, 2009, STROKE, V40, P656, DOI 10.1161/STROKEAHA.108.517995; Wang JS, 2006, THROMB HAEMOSTASIS, V95, P490, DOI 10.1160/TH05-09-0646; Wang JS, 2005, EUR J APPL PHYSIOL, V95, P290, DOI 10.1007/s00421-005-0005-8; Wisloff U, 2007, CIRCULATION, V115, P3086, DOI 10.1161/CIRCULATIONAHA.106.675041; Woods JA, 1999, MED SCI SPORT EXER, V31, P57, DOI 10.1097/00005768-199901000-00011; Yan WJ, 2013, ACTA PHARMACOL SIN, V34, P636, DOI 10.1038/aps.2013.18	32	38	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80248	10.1371/journal.pone.0080248	http://dx.doi.org/10.1371/journal.pone.0080248			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236174	gold, Green Submitted, Green Published			2022-12-27	WOS:000327254700175
J	Augis, V; Airiau, K; Josselin, M; Turcq, B; Mahon, FX; Belloc, F				Augis, Vanessa; Airiau, Kelly; Josselin, Marina; Turcq, Beatrice; Mahon, Francois-Xavier; Belloc, Francis			A Single Nucleotide Polymorphism in cBIM Is Associated with a Slower Achievement of Major Molecular Response in Chronic Myeloid Leukaemia Treated with Imatinib	PLOS ONE			English	Article							TYROSINE KINASE INHIBITORS; DOWN-REGULATION; BIM; RESISTANCE; APOPTOSIS; MUTATIONS; SUPPRESSOR; GENES; CELLS; BCL-2	Purpose: BIM is essential for the response to tyrosine-kinase inhibitors (TKI) in chronic myeloid leukaemia (CML) patients. Recently, a deletion polymorphism in intron 2 of the BIM gene was demonstrated to confer an intrinsic TKI resistance in Asian patients. The present study aimed at identifying mutations in the BIM sequence that could lead to imatinib resistance independently of BCR-ABL mutations. Experimental Design: BIM coding sequence analysis was performed in 72 imatinib-treated CML patients from a French population of our centre and in 29 healthy controls (reference population) as a case-control study. Real-time quantitative PCR (RT qPCR) was performed to assess Bim expression in our reference population. Results: No mutation with amino-acid change was found in the BIM coding sequence. However, we observed a silent single nucleotide polymorphism (SNP) c465C>T (rs724710). A strong statistical link was found between the presence of the T allele and the high Sokal risk group (p = 0.0065). T allele frequency was higher in non responsive patients than in the reference population (p = 0.0049). Similarly, this T allele was associated with the mutation frequency on the tyrosine kinase domain of BCR-ABL (p<0.001) and the presence of the T allele significantly lengthened the time to achieve a major molecular response (MMR). Finally, the presence of the T allele was related to a decreased basal expression of the Bim mRNA in the circulating mononuclear cells of healthy controls. Conclusion: These results suggest that the analysis of the c465C>T SNP of BIM could be useful for predicting the outcome of imatinib-treated CML patients.	[Augis, Vanessa; Airiau, Kelly; Josselin, Marina; Turcq, Beatrice; Mahon, Francois-Xavier; Belloc, Francis] Univ Bordeaux Segalen, Bordeaux, France; [Augis, Vanessa; Airiau, Kelly; Josselin, Marina; Turcq, Beatrice; Mahon, Francois-Xavier; Belloc, Francis] INSERM U1035 Bordeaux, Bordeaux, France; [Augis, Vanessa; Mahon, Francois-Xavier; Belloc, Francis] Ctr Hosp Univ Bordeaux, Hematol Lab, Bordeaux, France; [Mahon, Francois-Xavier] Ctr Hosp Univ Bordeaux, Serv Malad Sang, Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Bordeaux; CHU Bordeaux	Augis, V (corresponding author), Univ Bordeaux Segalen, Bordeaux, France.	vanessa.augis@chu-bordeaux.fr		Turcq, Beatrice/0000-0003-2235-8540	La Ligue contre le Cancer Aquitaine	La Ligue contre le Cancer Aquitaine	La Ligue contre le Cancer Aquitaine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airiau K, 2012, EXP HEMATOL, V40, P367, DOI 10.1016/j.exphem.2012.01.004; Baccarani M, 2009, J CLIN ONCOL, V27, P6041, DOI 10.1200/JCO.2009.25.0779; BARAN Y, 2007, HEMATOLOGY; Belloc F, 2007, CANCER BIOL THER, V6, P912, DOI 10.4161/cbt.6.6.4101; Bermano G, 2007, GENES NUTR, V2, P225, DOI 10.1007/s12263-007-0052-3; Branford S, 2006, METH MOLEC MED, V125, P93; Deininger MWN, 1997, BLOOD, V90, P3691, DOI 10.1182/blood.V90.9.3691; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Dulucq S, 2008, BLOOD, V112, P2024, DOI 10.1182/blood-2008-03-147744; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Hughes T, 2006, BLOOD, V108, P28, DOI 10.1182/blood-2006-01-0092; Kelly JL, 2010, CANCER EPIDEM BIOMAR, V19, P2847, DOI 10.1158/1055-9965.EPI-10-0581; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kuribara R, 2004, MOL CELL BIOL, V24, P6172, DOI 10.1128/MCB.24.14.6172-6183.2004; Lahaye T, 2005, CANCER-AM CANCER SOC, V103, P1659, DOI 10.1002/cncr.20922; Mahon FX, 2000, BLOOD, V96, P1070, DOI 10.1182/blood.V96.3.1070.015k17_1070_1079; Mestre-Escorihuela C, 2007, BLOOD, V109, P271, DOI 10.1182/blood-2006-06-026500; Miao J, 2007, APOPTOSIS, V12, P1691, DOI 10.1007/s10495-007-0093-5; Miyashita MUT, 2001, FEBS LETT, V509, P135, DOI 10.1016/S0014-5793(01)03145-3; Ng KP, 2012, NAT MED, V18, P521, DOI 10.1038/nm.2713; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Sauna ZE, 2007, CANCER RES, V67, P9609, DOI 10.1158/0008-5472.CAN-07-2377; Shinjyo T, 2001, MOL CELL BIOL, V21, P854, DOI 10.1128/MCB.21.3.854-864.2001; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575	25	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78582	10.1371/journal.pone.0078582	http://dx.doi.org/10.1371/journal.pone.0078582			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223824	gold, Green Published, Green Submitted			2022-12-27	WOS:000326597400033
J	Khanna, S; Santos, MJ; Ustin, SL; Koltunov, A; Kokaly, RF; Roberts, DA				Khanna, Shruti; Santos, Maria J.; Ustin, Susan L.; Koltunov, Alexander; Kokaly, Raymond F.; Roberts, Dar A.			Detection of Salt Marsh Vegetation Stress and Recovery after the Deepwater Horizon Oil Spill in Barataria Bay, Gulf of Mexico Using AVIRIS Data	PLOS ONE			English	Article							LOUISIANA CRUDE-OIL; SPECTRAL REFLECTANCE; HYDROCARBON POLLUTION; REMOTE ESTIMATION; SAUDI-ARABIA; BRACKISH; IMPACT; COAST; CLASSIFICATION; SPECTROSCOPY	The British Petroleum Deepwater Horizon Oil Spill in the Gulf of Mexico was the biggest oil spill in US history. To assess the impact of the oil spill on the saltmarsh plant community, we examined Advanced Visible Infrared Imaging Spectrometer (AVIRIS) data flown over Barataria Bay, Louisiana in September 2010 and August 2011. Oil contamination was mapped using oil absorption features in pixel spectra and used to examine impact of oil along the oiled shorelines. Results showed that vegetation stress was restricted to the tidal zone extending 14 m inland from the shoreline in September 2010. Four indexes of plant stress and three indexes of canopy water content all consistently showed that stress was highest in pixels next to the shoreline and decreased with increasing distance from the shoreline. Index values along the oiled shoreline were significantly lower than those along the oil-free shoreline. Regression of index values with respect to distance from oil showed that in 2011, index values were no longer correlated with proximity to oil suggesting that the marsh was on its way to recovery. Change detection between the two dates showed that areas denuded of vegetation after the oil impact experienced varying degrees of re-vegetation in the following year. This recovery was poorest in the first three pixels adjacent to the shoreline. This study illustrates the usefulness of high spatial resolution airborne imaging spectroscopy to map actual locations where oil from the spill reached the shore and then to assess its impacts on the plant community. We demonstrate that post-oiling trends in terms of plant health and mortality could be detected and monitored, including recovery of these saltmarsh meadows one year after the oil spill.	[Khanna, Shruti; Ustin, Susan L.; Koltunov, Alexander] Univ Calif Davis, Ctr Spatial Technol & Remote Sensing, Dept Land Air & Water Resources, Davis, CA 95616 USA; [Santos, Maria J.] Stanford Univ, Ctr Spatial & Textual Anal CESTA, Stanford, CA 94305 USA; [Kokaly, Raymond F.] US Geol Survey, Denver, CO 80225 USA; [Roberts, Dar A.] Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93106 USA	University of California System; University of California Davis; Stanford University; United States Department of the Interior; United States Geological Survey; University of California System; University of California Santa Barbara	Khanna, S (corresponding author), Univ Calif Davis, Ctr Spatial Technol & Remote Sensing, Dept Land Air & Water Resources, Davis, CA 95616 USA.	shrkhanna@ucdavis.edu	Kokaly, Raymond/A-6817-2017; Khanna, Shruti/AAI-5171-2020; Santos, Maria Joao/M-5034-2013	Kokaly, Raymond/0000-0003-0276-7101; Khanna, Shruti/0000-0003-1724-248X; Santos, Maria Joao/0000-0002-6558-7477; Ustin, Susan/0000-0001-8551-0461	NSF [1058134]; Chevron Corp. [201118134]; Chevron	NSF(National Science Foundation (NSF)); Chevron Corp.; Chevron	This work has been partially funded by an NSF Macroecosystems program for a Rapid grant (#1058134) and Chevron Corp. (#201118134). The authors project for Chevron is primarily to provide advice on when to use different types of remote sensing data, mostly to identify land cover types using different types of statistical classification methods. The objective of their funding from Chevron has been to identify cost effective data types and methods of analysis that can be applied under a range of environmental conditions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENDOR E, 1990, APPL SPECTROSC, V44, P1064, DOI 10.1366/0003702904086821; BenDor E, 1997, REMOTE SENS ENVIRON, V61, P1, DOI 10.1016/S0034-4257(96)00120-4; Bianchi R, 1995, P SOC PHOTO-OPT INS, V2585, P352, DOI 10.1117/12.227199; Brekke C, 2005, REMOTE SENS ENVIRON, V95, P1, DOI 10.1016/j.rse.2004.11.015; Carter GA, 2001, AM J BOT, V88, P677, DOI 10.2307/2657068; CLARK RN, 1984, J GEOPHYS RES, V89, P6329, DOI 10.1029/JB089iB07p06329; CLOUTIS EA, 1989, SCIENCE, V245, P165, DOI 10.1126/science.245.4914.165; CROSS AM, 1992, INT J REMOTE SENS, V13, P781, DOI 10.1080/01431169208904152; Dale MRT, 2002, ECOSCIENCE, V9, P162, DOI 10.1080/11956860.2002.11682702; DEDOMENICO L, 1994, MAR POLLUT BULL, V28, P587, DOI 10.1016/0025-326X(94)90359-X; DeLaune RD, 2011, SOIL SCI SOC AM J, V75, P1602, DOI 10.2136/sssaj2011.0168; DELAUNE RD, 1984, ENVIRON POLLUT A, V36, P207, DOI 10.1016/0143-1471(84)90003-5; Fingas MF, 1997, SPILL SCI TECHNOL B, V4, P199, DOI 10.1016/S1353-2561(98)00023-1; Gaffey S.J., 1993, REMOTE GEOCHEMICAL A, P43; GAFFEY SJ, 1986, AM MINERAL, V71, P151; Gerrard A.J., 1981, SOILS LANDFORMS INTE; GITELSON A, 1994, J PLANT PHYSIOL, V143, P286, DOI 10.1016/S0176-1617(11)81633-0; Gitelson AA, 1997, INT J REMOTE SENS, V18, P2691, DOI 10.1080/014311697217558; GOODMAN R, 1994, SPILL SCI TECHNOL B, V1, P11, DOI 10.1016/1353-2561(94)90004-3; GUNDLACH ER, 1978, MAR TECHNOL SOC J, V12, P18; HARDISKY MA, 1983, PHOTOGRAMM ENG REM S, V49, P77; Hester MW, 2000, MAR ENVIRON RES, V49, P233, DOI 10.1016/S0141-1136(99)00071-9; Horig B, 2001, INT J REMOTE SENS, V22, P1413, DOI 10.1080/01431160010013450; HORLER DNH, 1983, INT J REMOTE SENS, V4, P273, DOI 10.1080/01431168308948546; Houborg R, 2007, REMOTE SENS ENVIRON, V106, P39, DOI 10.1016/j.rse.2006.07.016; Howari FM, 2004, J COASTAL RES, V20, P1089, DOI 10.2112/03-0023R.1; Hu CM, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047184; HUNT ER, 1989, REMOTE SENS ENVIRON, V30, P43, DOI 10.1016/0034-4257(89)90046-1; Irani M, 2002, INT J COMPUT VISION, V48, P173, DOI 10.1023/A:1016372015744; JACKSON JBC, 1989, SCIENCE, V243, P37, DOI 10.1126/science.243.4887.37; Jurgens C, 1997, INT J REMOTE SENS, V18, P3583, DOI 10.1080/014311697216810; KENWORTHY WJ, 1993, MAR POLLUT BULL, V27, P213, DOI 10.1016/0025-326X(93)90027-H; Khanna S, 2007, REMOTE SENS ENVIRON, V109, P154, DOI 10.1016/j.rse.2006.12.018; Khanna S, 2011, INT J REMOTE SENS, V32, P1067, DOI 10.1080/01431160903505328; Ko JY, 2004, OCEAN COAST MANAGE, V47, P597, DOI 10.1016/j.ocecoaman.2004.12.004; Kokaly R. F., 2011, SHORELINE SURVEYS OI; Kokaly RF, 2013, REMOTE SENS ENVIRON, V129, P210, DOI 10.1016/j.rse.2012.10.028; Kokaly RF, 2009, REMOTE SENS ENVIRON, V113, pS78, DOI 10.1016/j.rse.2008.10.018; Koltunov A, 2009, INT J REMOTE SENS, V30, P57, DOI 10.1080/01431160802220193; Koltunov A., 2012, P ASPRS ANN C SACR C; Leifer I, 2012, REMOTE SENS ENVIRON, V124, P185, DOI 10.1016/j.rse.2012.03.024; Li L, 2005, REMOTE SENS ENVIRON, V94, P1, DOI 10.1016/j.rse.2004.08.010; Lin B, 2004, LECT NOTES COMPUT SC, V3173, P977; Lin QX, 1996, MAR POLLUT BULL, V32, P202, DOI 10.1016/0025-326X(95)00118-7; Liu P, 2011, MAR POLLUT BULL, V62, P2611, DOI 10.1016/j.marpolbul.2011.09.036; Liu Y, 2011, COMBINING NUMERICAL; MENDELSSOHN IA, 1990, OIL CHEM POLLUT, V7, P1, DOI 10.1016/S0269-8579(05)80031-0; Merton R, 1998, MONITORING COMMUNITY; MILTON NM, 1991, REMOTE SENS ENVIRON, V36, P121, DOI 10.1016/0034-4257(91)90034-4; Mishra DR, 2012, REMOTE SENS ENVIRON, V118, P176, DOI 10.1016/j.rse.2011.11.007; Moss L, 2010, 13 LARGEST OIL SPILL; Nagler PL, 2000, REMOTE SENS ENVIRON, V71, P207, DOI 10.1016/S0034-4257(99)00082-6; PENUELAS J, 1993, REMOTE SENS ENVIRON, V46, P110, DOI 10.1016/0034-4257(93)90088-F; Pezeshki SR, 2000, ENVIRON POLLUT, V108, P129, DOI 10.1016/S0269-7491(99)00244-4; Ramsey E, 2011, REMOTE SENS-BASEL, V3, P2630, DOI 10.3390/rs3122630; ROSENFIELD GH, 1986, PHOTOGRAMM ENG REM S, V52, P223; SMITH CJ, 1981, ENVIRON POLLUT A, V26, P297, DOI 10.1016/0143-1471(81)90051-9; STORY M, 1986, PHOTOGRAMM ENG REM S, V52, P397; Svejkovsky J, 2012, PHOTOGRAMME IN PRESS; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; Ustin SL, 2009, REMOTE SENS ENVIRON, V113, pS67, DOI 10.1016/j.rse.2008.10.019; van der Meer F, 2002, TERRA NOVA, V14, P1, DOI 10.1046/j.1365-3121.2002.00390.x; Volckaert FAM, 2000, MAR POLLUT BULL, V40, P1051, DOI 10.1016/S0025-326X(00)00056-4; Yang H, 1998, TERRA NOVA, V10, P231; Zar J.H., 1999, ZAR KUHR 5 2019, V4th; Zarco-Tejada PJ, 2003, REMOTE SENS ENVIRON, V85, P109, DOI 10.1016/S0034-4257(02)00197-9	66	52	54	2	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78989	10.1371/journal.pone.0078989	http://dx.doi.org/10.1371/journal.pone.0078989			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223872	Green Published, Green Submitted, gold			2022-12-27	WOS:000326597400044
J	Namdar, M; Biaggi, P; Stahli, B; Butler, B; Casado-Arroyo, R; Ricciardi, D; Rodriguez-Manero, M; Steffel, J; Hurlimann, D; Schmied, C; de Asmundis, C; Chierchia, GB; Sarkozy, A; Luscher, TF; Jenni, R; Duru, F; Paulus, WJ; Brugada, P				Namdar, Mehdi; Biaggi, Patric; Staehli, Barbara; Buetler, Bernhard; Casado-Arroyo, Ruben; Ricciardi, Danilo; Rodriguez-Manero, Moises; Steffel, Jan; Huerlimann, David; Schmied, Christian; de Asmundis, Carlo; Chierchia, Gian-Battista; Sarkozy, Andrea; Luescher, Thomas F.; Jenni, Rolf; Duru, Firat; Paulus, Walter J.; Brugada, Pedro			A Novel Electrocardiographic Index for the Diagnosis of Diastolic Dysfunction	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; WALL-MOTION ABNORMALITY; HEART-FAILURE; NATRIURETIC PEPTIDE; EJECTION FRACTION; DOPPLER-ECHOCARDIOGRAPHY; HYPERTENSIVE PATIENTS; QT DISPERSION; HIGH-RISK; T-WAVE	Background: Although the assessment of diastolic dysfunction (DD) is an integral part of routine cardiologic examinations, little is known about associated electrocardiographic (ECG) changes. Our aim was to investigate a potential role of ECG indices for the recognition of patients with DD. Methods and Results: ECG parameters correlating with echocardiographic findings of DD were retrospectively assessed in a derivation group of 172 individuals (83 controls with normal diastolic function, 89 patients with DD) and their diagnostic performance was tested in a validation group of 50 controls and 50 patients. The patient group with a DD Grade 1 and 2 showed longer QTc (422 +/- 24ms and 434 +/- 32ms vs. 409 +/- 25ms, p<0.0005) and shorter Tend-P and Tend-Q intervals, reflecting the electrical and mechanical diastole (240 +/- 78ms and 276 +/- 108ms vs. 373 +/- 110ms, p<0.0001; 409 +/- 85ms and 447 +/- 115ms vs. 526 +/- 119ms, p<0.0001). The PQ-interval was significantly longer in the patient group (169 +/- 28ms and 171 +/- 38ms vs. 153 +/- 22ms, p<0.005). After adjusting for possible confounders, a novel index (Tend-P/[PQxAge]) showed a high performance for the recognition of DD, stayed robust in the validation group (sensitivity 82%, specificity 93%, positive predictive value 93%, negative predictive value 82%, accuracy 88%) and proved a substantial added value when combined with the indexed left atrial volume (LAESVI, sensitivity 90%, specificity 92%, positive predictive value 95%, negative predictive value 86%, accuracy 91%). Conclusions: A novel electrocardiographic index Tend-P/(PQxAge) demonstrates a high diagnostic accuracy for the diagnosis of DD and yields a substantial added value when combined with the LAESVI.	[Namdar, Mehdi; Casado-Arroyo, Ruben; Ricciardi, Danilo; Rodriguez-Manero, Moises; de Asmundis, Carlo; Chierchia, Gian-Battista; Sarkozy, Andrea; Brugada, Pedro] VUB, UZ Brussel, Heart Rhythm Management Ctr, Div Cardiovasc, Brussels, Belgium; [Namdar, Mehdi; Biaggi, Patric; Staehli, Barbara; Buetler, Bernhard; Steffel, Jan; Huerlimann, David; Schmied, Christian; Luescher, Thomas F.; Jenni, Rolf; Duru, Firat] Univ Zurich Hosp, Ctr Cardiovasc, CH-8091 Zurich, Switzerland; [Paulus, Walter J.] Vrije Univ Amsterdam, Med Ctr, Dept Physiol, Amsterdam, Netherlands; [Namdar, Mehdi] Hop Univ Geneve, Serv Cardiol, Geneva, Switzerland	University Hospital Brussels; Vrije Universiteit Brussel; University of Zurich; University Zurich Hospital; Vrije Universiteit Amsterdam; University of Geneva	Namdar, M (corresponding author), VUB, UZ Brussel, Heart Rhythm Management Ctr, Div Cardiovasc, Brussels, Belgium.	mehdi.namdar@hcuge.ch	Rodríguez-Mañero, Moisés/R-6110-2019; Sarkozy, Andrea/C-4939-2017; rolf jenni, MSEE/B-2334-2015; Arroyo, Ruben Casado/L-7726-2019	Rodríguez-Mañero, Moisés/0000-0001-7566-9321; Sarkozy, Andrea/0000-0001-6327-0487; Arroyo, Ruben Casado/0000-0002-3876-6074; de Asmundis, Carlo/0000-0001-9351-0760; Duru, Firat/0000-0002-4748-0158; Namdar, Mehdi/0000-0002-5779-7431; Jenni, Rolf/0000-0002-2609-6915				Abhayaratna WP, 2006, J AM COLL CARDIOL, V47, P2357, DOI 10.1016/j.jacc.2006.02.048; Agarwal YK, 2003, AM J CARDIOL, V91, P882, DOI 10.1016/S0002-9149(03)00027-4; [Anonymous], [No title captured]; Antzelevitch C, 1997, J ELECTROCARDIOL, V30, P168; Antzelevitch C, 2007, AM J PHYSIOL-HEART C, V293, pH2024, DOI 10.1152/ajpheart.00355.2007; Antzelevitch C, 2007, HEART RHYTHM, V4, P1114, DOI 10.1016/j.hrthm.2007.05.028; Bombardini T, 2008, CARDIOVASC ULTRASOUN, V6, DOI 10.1186/1476-7120-6-15; Cheng S, 2009, JAMA-J AM MED ASSOC, V301, P2571, DOI 10.1001/jama.2009.888; Chiladakis J, 2009, PACING CLIN ELECTROP, V33, P553, DOI DOI 10.1111/J.1540-8159.2009.02657.X.PUBMED:20025715; Darbar D, 2002, PACE, V25, P1447, DOI 10.1046/j.1460-9592.2002.01447.x; DEFERRARI GM, 1994, CIRCULATION, V89, P2126, DOI 10.1161/01.CIR.89.5.2126; Dilaveris PE, 1998, AM HEART J, V135, P733, DOI 10.1016/S0002-8703(98)70030-4; Engel G, 2004, CURR PROB CARDIOLOGY, V29, P365, DOI 10.1016/j.cpcardiol.2004.02.007; FLEG JL, 1990, J GERONTOL, V45, pM95, DOI 10.1093/geronj/45.3.M95; FREEDMAN RA, 1986, J AM COLL CARDIOL, V7, P595, DOI 10.1016/S0735-1097(86)80470-3; Grewal J, 2008, AM J CARDIOL, V102, P733, DOI 10.1016/j.amjcard.2008.04.048; Haugaa KH, 2009, EUR HEART J, V30, P330, DOI 10.1093/eurheartj/ehn466; Hnatkova K, 2010, J ELECTROCARDIOL, V43, P588, DOI 10.1016/j.jelectrocard.2010.06.003; Hummel YM, 2011, EUR J HEART FAIL, V13, P698, DOI 10.1093/eurjhf/hfr061; Janssen PML, 2010, AM J PHYSIOL-HEART C, V299, pH1741, DOI 10.1152/ajpheart.00759.2010; Kitzman DW, 2002, JAMA-J AM MED ASSOC, V288, P2144, DOI 10.1001/jama.288.17.2144; LAKATTA EG, 1975, CIRC RES, V36, P262, DOI 10.1161/01.RES.36.2.262; Ledwidge M, 2013, JAMA-J AM MED ASSOC, V310, P66, DOI 10.1001/jama.2013.7588; Lester SJ, 2008, J AM COLL CARDIOL, V51, P679, DOI 10.1016/j.jacc.2007.09.061; LEV M, 1964, AM J MED, V37, P742, DOI 10.1016/0002-9343(64)90022-1; Mayet J, 1996, HYPERTENSION, V28, P791, DOI 10.1161/01.HYP.28.5.791; McGrady M, 2013, EUR J HEART FAIL, V15, P573, DOI 10.1093/eurjhf/hft001; Muntinga HJ, 1997, NUCL MED COMMUN, V18, P642, DOI 10.1097/00006231-199707000-00008; NADOR F, 1991, CIRCULATION, V84, P1530, DOI 10.1161/01.CIR.84.4.1530; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Nakayama K, 1998, HEART, V80, P245, DOI 10.1136/hrt.80.3.245; Nussinovitch U, 2012, ANN NONINVAS ELECTRO, V17, P28, DOI 10.1111/j.1542-474X.2011.00478.x; Oikarinen L, 2001, J HYPERTENS, V19, P1883, DOI 10.1097/00004872-200110000-00025; Okin PM, 2001, J AM COLL CARDIOL, V38, P514, DOI 10.1016/S0735-1097(01)01378-X; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Savoye C, 2003, Eur J Echocardiogr, V4, P209, DOI 10.1016/S1525-2167(03)00011-8; SCHNITTGER I, 1988, J AM COLL CARDIOL, V11, P83, DOI 10.1016/0735-1097(88)90170-2; Shuai XX, 2011, EUR J HEART FAIL, V13, P737, DOI 10.1093/eurjhf/hfr053; SIMPSON RJ, 1982, AM J CARDIOL, V50, P1331, DOI 10.1016/0002-9149(82)90471-4; Truong QA, 2011, J ELECTROCARDIOL, V44, P257, DOI 10.1016/j.jelectrocard.2010.04.011; Truong QA, 2011, INT J CARDIOL, V146, P171, DOI 10.1016/j.ijcard.2009.06.029; Tsao CW, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-7; Tschope C, 2009, CIRCULATION, V120, P810, DOI 10.1161/CIRCULATIONAHA.109.869628; Vaidean GD, 2005, J ELECTROCARDIOL, V38, P139, DOI 10.1016/j.jelectrocard.2004.09.020; van Heerebeek L, 2006, CIRCULATION, V113, P1966, DOI 10.1161/CIRCULATIONAHA.105.587519; Vyas H, 2008, J AM SOC ECHOCARDIOG, V21, DOI 10.1016/j.echo.2007.08.001; Wilcox JE, 2011, AM J CARDIOL, V108, P1760, DOI 10.1016/j.amjcard.2011.07.050; Yamada T, 1999, EUR HEART J, V20, P211, DOI 10.1053/euhj.1998.1281; Yan GX, 1998, CIRCULATION, V98, P1928, DOI 10.1161/01.CIR.98.18.1928; YIN FCP, 1979, MECH AGEING DEV, V10, P17, DOI 10.1016/0047-6374(79)90067-8; Zile MR, 2001, CIRCULATION, V104, P779, DOI 10.1161/hc3201.094226	51	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79152	10.1371/journal.pone.0079152	http://dx.doi.org/10.1371/journal.pone.0079152			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223898	Green Published, gold, Green Submitted			2022-12-27	WOS:000326597400048
J	Van Doornik, DM; Berejikian, BA; Campbell, LA				Van Doornik, Donald M.; Berejikian, Barry A.; Campbell, Lance A.			Gene Flow between Sympatric Life History Forms of Oncorhynchus mykiss Located above and below Migratory Barriers	PLOS ONE			English	Article							CROSS-SPECIES AMPLIFICATION; RESIDENT RAINBOW-TROUT; FRESH-WATER; POPULATION-STRUCTURE; MICROSATELLITE LOCI; ANADROMOUS STEELHEAD; MATING SYSTEM; CONSERVATION; DIFFERENTIATION; RIVER	Oncorhynchus mykiss have a diverse array of life history types, and understanding the relationship among types is important for management of the species. Patterns of gene flow between sympatric freshwater resident O. mykiss, commonly known as rainbow trout, and anadromous O. mykiss, commonly known as steelhead, populations are complex and poorly understood. In this study, we attempt to determine the occurrence and pathways of gene flow and the degree of genetic similarity between sympatric resident and anadromous O. mykiss in three river systems, and investigate whether resident O. mykiss are producing anadromous offspring in these rivers, two of which have complete barriers to upstream migration. We found that the population structure of the O. mykiss in these rivers appears to be influenced more by the presence of a barrier to upstream migration than by life history type. The sex ratio of resident O. mykiss located above a barrier, and smolts captured in screw traps was significantly skewed in favor of females, whereas the reverse was true below the barriers, suggesting that male resident O. mykiss readily migrate downstream over the barrier, and that precocious male maturation may be occurring in the anadromous populations. Through paternity analyses, we also provide direct confirmation that resident O. mykiss can produce offspring that become anadromous. Most (89%) of the resident O. mykiss that produced anadromous offspring were males. Our results add to the growing body of evidence that shows that gene flow does readily occur between sympatric resident and anadromous O. mykiss life history types, and indicates that resident O. mykiss populations may be a potential repository of genes for the anadromous life history type.	[Van Doornik, Donald M.; Berejikian, Barry A.] NOAA, NW Fisheries Sci Ctr, Natl Marine Fisheries Serv, Manchester, WA 98353 USA; [Campbell, Lance A.] Washington Dept Fish & Wildlife, Olympia, WA USA	National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; Washington Department of Fish & Wildlife (WDFW)	Van Doornik, DM (corresponding author), NOAA, NW Fisheries Sci Ctr, Natl Marine Fisheries Serv, Manchester, WA 98353 USA.	don.vandoornik@noaa.gov		Berejikian, Barry/0000-0003-2933-7806	National Oceanic and Atmospheric Administration; Hood Canal Salmon Enhancement Group, Long Live the Kings; Skokomish Tribal Nation; U.S. Fish and Wildlife Service; Washington Department of Fish and Wildlife	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); Hood Canal Salmon Enhancement Group, Long Live the Kings; Skokomish Tribal Nation; U.S. Fish and Wildlife Service(US Fish & Wildlife Service); Washington Department of Fish and Wildlife	Primary funding for this work was provided by the National Oceanic and Atmospheric Administration. Additional support was provided by the Hood Canal Salmon Enhancement Group, Long Live the Kings, the Skokomish Tribal Nation, the U.S. Fish and Wildlife Service, and the Washington Department of Fish and Wildlife. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf F., 2007, CONSERVATION GENETIC; [Anonymous], 2002, FSTAT VERSION 2 9 3; Araki H, 2007, MOL ECOL, V16, P953, DOI 10.1111/j.1365-294X.2006.03206.x; Araki H, 2007, CONSERV BIOL, V21, P181, DOI 10.1111/j.1523-1739.2006.00564.x; Banks MA, 1999, J HERED, V90, P281, DOI 10.1093/jhered/90.2.281; Beechie T, 2006, BIOL CONSERV, V130, P560, DOI 10.1016/j.biocon.2006.01.019; Behnke RJ, 2002, TROUT SALMON N AM; Berejikian BA, 2008, CAN J FISH AQUAT SCI, V65, P754, DOI 10.1139/F08-014; Berejikian BA, 2013, CAN J FISH AQUAT SCI, V70, P756, DOI 10.1139/cjfas-2012-0491; Berejikian BA, 2012, ENVIRON BIOL FISH, V94, P29, DOI 10.1007/s10641-011-9788-0; Brunelli JP, 2008, GENOME, V51, P739, DOI 10.1139/G08-060; Buchholz W., 1999, 991 US FISH WILDL SE; BUSBY PJ, 1996, NMFSNWFSC27 NAT OC A; Cairney M, 2000, MOL ECOL, V9, P2175, DOI 10.1046/j.1365-294X.2000.105312.x; Christie MR, 2011, MOL ECOL, V20, P1263, DOI 10.1111/j.1365-294X.2010.04994.x; Clemento AJ, 2009, CONSERV GENET, V10, P1321, DOI 10.1007/s10592-008-9712-0; Condrey MJ, 1998, MOL ECOL, V7, P787; CURRENS KP, 1990, COPEIA, P730; Docker MF, 2003, CONSERV GENET, V4, P227, DOI 10.1023/A:1023355114612; Donohoe CJ, 2008, CAN J FISH AQUAT SCI, V65, P1060, DOI 10.1139/F08-029; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FOOTE CJ, 1988, BEHAVIOUR, V106, P43, DOI 10.1163/156853988X00089; Good TP, 2005, NMFSNWFSC66 NAT OC A; Greene CM, 2010, BIOL LETTERS, V6, P382, DOI 10.1098/rsbl.2009.0780; GROSS MR, 1988, SCIENCE, V239, P1291, DOI 10.1126/science.239.4845.1291; Hayes SA, 2012, N AM J FISH MANAGE, V32, P772, DOI 10.1080/02755947.2012.686953; Heath DD, 2008, T AM FISH SOC, V137, P1268, DOI 10.1577/T05-278.1; Hecht BC, 2013, MOL ECOL, V22, P3061, DOI 10.1111/mec.12082; Hendry Andrew P., 2004, P92; Holecek DE, 2012, T AM FISH SOC, V141, P68, DOI 10.1080/00028487.2011.651550; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kuligowski DR, 2005, T AM FISH SOC, V134, P1202, DOI 10.1577/T04-187.1; MAEKAWA K, 1994, ENVIRON BIOL FISH, V39, P109, DOI 10.1007/BF00004927; McConnell S, 1995, AQUACULTURE, V137, P19, DOI 10.1016/0044-8486(95)01111-0; McMillan JR, 2007, T AM FISH SOC, V136, P736, DOI 10.1577/T06-016.1; McPhee MV, 2007, ECOL FRESHW FISH, V16, P539, DOI 10.1111/j.1600-0633.2007.00248.x; Meka JM, 2003, T AM FISH SOC, V132, P717, DOI 10.1577/T01-166; Moore M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049645; Morris DB, 1996, CAN J FISH AQUAT SCI, V53, P120, DOI 10.1139/cjfas-53-1-120; Narum SR, 2004, J FISH BIOL, V65, P471, DOI 10.1111/j.0022-1112.2004.00461.x; Nelson RJ, 1999, ANIM GENET, V30, P228, DOI 10.1046/j.1365-2052.1999.00404-4.x; Nichols KM, 2008, GENETICS, V179, P1559, DOI 10.1534/genetics.107.084251; OConnell M, 1997, CAN J FISH AQUAT SCI, V54, P1391, DOI 10.1139/cjfas-54-6-1391; Olsen JB, 1998, MOL ECOL, V7, P1087; Olsen JB, 2006, CONSERV GENET, V7, P613, DOI 10.1007/s10592-005-9099-0; Pascual M, 2001, T AM FISH SOC, V130, P53, DOI 10.1577/1548-8659(2001)130<0053:FDCOAI>2.0.CO;2; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pearse DE, 2009, J HERED, V100, P515, DOI 10.1093/jhered/esp040; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pritchard JK, 2000, GENETICS, V155, P945; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Rundio DE, 2012, ECOL FRESHW FISH, V21, P293, DOI 10.1111/j.1600-0633.2011.00547.x; Scribner KT, 1996, CAN J FISH AQUAT SCI, V53, P833, DOI 10.1139/cjfas-53-4-833; Seamons TR, 2007, EVOL ECOL RES, V9, P409; Seamons TR, 2004, ENVIRON BIOL FISH, V69, P333, DOI 10.1023/B:EBFI.0000022893.88086.8f; Smith CT, 1998, MOL ECOL, V7, P1614; Spies IB, 2005, MOL ECOL NOTES, V5, P278, DOI 10.1111/j.1471-8286.2005.00900.x; Thibault I, 2010, ECOL FRESHW FISH, V19, P348, DOI 10.1111/j.1600-0633.2010.00417.x; Thrower F, 2004, ENVIRON BIOL FISH, V69, P111, DOI 10.1023/B:EBFI.0000022880.52256.92; Thrower FP, 2004, J FISH BIOL, V65, P286, DOI 10.1111/j.0022-1112.2004.00551.x; Thrower FP, 2009, CONSERV GENET, V10, P1299, DOI 10.1007/s10592-008-9709-8; Van Doornik DM, 2010, CAN J FISH AQUAT SCI, V67, P1449, DOI 10.1139/F10-073; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; WDFW (Washington Department of Fish and Wildlife), 2012, SPAWN GROUND SURV DA; Winans GA, 2008, NORTHWEST SCI, V82, P128, DOI 10.3955/0029-344X-82.S.I.128; Zimmerman CE, 2000, CAN J FISH AQUAT SCI, V57, P2152, DOI 10.1139/cjfas-57-10-2152; Zimmerman CE, 2009, T AM FISH SOC, V138, P280, DOI 10.1577/T08-044.1	69	13	13	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79931	10.1371/journal.pone.0079931	http://dx.doi.org/10.1371/journal.pone.0079931			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224023	gold, Green Published, Green Submitted			2022-12-27	WOS:000326597400096
J	Ma, YH; Kang, WJ; Bao, YX; Jiao, FB; Ma, YR				Ma, Yinghuan; Kang, Wanjun; Bao, Yongxin; Jiao, Fubin; Ma, Yiran			Clinical Significance of Ischemia-Modified Albumin in the Diagnosis of Doxorubicin-Induced Myocardial Injury in Breast Cancer Patients	PLOS ONE			English	Article							COBALT-BINDING TEST; ADRIAMYCIN NSC-123127; CARDIOTOXICITY; BIOMARKERS; MARKER; CARDIOMYOPATHY; MECHANISMS; MANAGEMENT	Background: Ischemia-modified albumin is an altered serum albumin that forms under conditions of oxidative stress, a state also associated with doxorubicin-induced myocardial injury. Objective: The aim of this study was to better assess diagnostic and prognostic significance of ischemia-modified albumin in patients with breast cancer undergoing doxorubicin chemotherapy. Methods: Blood samples were collected from 152 breast cancer patients before and after each cycle of doxorubicin chemotherapy to measure the serum levels of ischemia-modified albumin, cardiac troponin T and creatine kinase-MB. We also monitored cardiac function during a 12 month follow-up. Results: There was a significant difference in ischemia-modified albumin levels before and after each cycle of chemotherapy and the ischemia-modified albumin concentration positively correlated with the cumulative dose of doxorubicin (r = 0.212, P < 0.05). The combination of ischemia-modified albumin with cardiac troponin T and creatine kinase-MB increased the sensitivity to 0.920 and the specificity to 0.830 in the diagnosis of doxorubicin-induced myocardial injury. The optimal cutoff for ischemia-modified albumin concentration was 112.09 U/ml. The rate of change for ischemia-modified albumin levels correlated negatively with the rate of change for left ventricular ejection fraction at one year (r = -0.221, P < 0.05). Conclusion: Ischemia-modified albumin may be a clinically potential new marker for diagnosing doxorubicin-induced myocardial injury, and is helpful to predict long-term impairment of cardiac function.	[Ma, Yinghuan; Kang, Wanjun; Bao, Yongxin] 463rd Hosp Chinese PLA, Dept Canc, Shenyang, Liaoning, Peoples R China; [Jiao, Fubin] Gen Advisor Off Chinese PLA, Bur Guard, Div Hlth, Beijing, Peoples R China; [Ma, Yiran] China Med Univ, Hosp 1, Dept Transfus, Shenyang, Liaoning, Peoples R China	China Medical University	Ma, YR (corresponding author), China Med Univ, Hosp 1, Dept Transfus, Shenyang, Liaoning, Peoples R China.	yiransmile@hotmail.com			Shenyang Science and Technology Project [F11-264-1-12]; 463rd Hospital of the Chinese PLA Medical Research Project [070106]; First hospital of China Medical University; 463rd Hospital of the Chinese PLA	Shenyang Science and Technology Project; 463rd Hospital of the Chinese PLA Medical Research Project; First hospital of China Medical University; 463rd Hospital of the Chinese PLA	This work was supported by research grants from Shenyang Science and Technology Project (No. F11-264-1-12) and the 463rd Hospital of the Chinese PLA Medical Research Project (No. 070106). The authors wish to thank the First hospital of China Medical University and the 463rd Hospital of the Chinese PLA for their research grants.	Apple FS, 2002, CLIN CHEM, V48, P1097; ARCAMONE F, 1969, BIOTECHNOL BIOENG, V11, P1101, DOI 10.1002/bit.260110607; Bar-Or D, 2001, EUR J BIOCHEM, V268, P42, DOI 10.1046/j.1432-1327.2001.01846.x; Barry E, 2007, EXPERT OPIN PHARMACO, V8, P1039, DOI 10.1517/14656566.8.8.1039; Berthiaume JM, 2007, CELL BIOL TOXICOL, V23, P15, DOI 10.1007/s10565-006-0140-y; Biskup Piotr, 2006, Pol Arch Med Wewn, V115, P551; BONADONNA G, 1970, CANCER RES, V30, P2572; Christenson RH, 2001, CLIN CHEM, V47, P464; Collinson PO, 2005, SCAND J CLIN LAB INV, V65, P86, DOI 10.1080/00365510500236002; Dawie Jelal, 2011, Ethiop Med J, V49, P25; DIMARCO A, 1969, CANCER CHEMOTH REP 1, V53, P33; Dominguez-Rodriguez A, 2008, CLIN CHIM ACTA, V388, P196, DOI 10.1016/j.cca.2007.10.030; Dong Shi-Yong, 2012, Asian Cardiovasc Thorac Ann, V20, P252, DOI 10.1177/0218492311434947; Ellis P, 2009, LANCET, V373, P1681, DOI 10.1016/S0140-6736(09)60740-6; GOORMAGHTIGH E, 1980, BIOCHEM PHARMACOL, V29, P3003, DOI 10.1016/0006-2952(80)90050-7; Govender R, 2008, CARDIOVASC J AFR, V19, P141; Gunduz A, 2008, AM J EMERG MED, V26, P874, DOI 10.1016/j.ajem.2007.11.023; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HAQ MM, 1985, CANCER-AM CANCER SOC, V56, P1361, DOI 10.1002/1097-0142(19850915)56:6<1361::AID-CNCR2820560624>3.0.CO;2-S; Hjortshoj S, 2009, CLIN CHIM ACTA, V403, P114, DOI 10.1016/j.cca.2009.01.033; Kalyanaraman B, 2002, MOL CELL BIOCHEM, V234, P119, DOI 10.1023/A:1015976430790; Kehl DW, 2012, TRANSL RES, V159, P252, DOI 10.1016/j.trsl.2011.11.002; Khattry N, 2009, MED PEDIATR ONCOL, V30, P9, DOI [10.4103/0971-5851.56329, DOI 10.4103/0971-5851.56329]; Mentese A, 2008, EMERG MED J, V25, P811, DOI 10.1136/emj.2007.056614; Montagnana M, 2006, CLIN BIOCHEM, V39, P913, DOI 10.1016/j.clinbiochem.2006.03.016; Octavia Y, 2012, J MOL CELL CARDIOL, V52, P1213, DOI 10.1016/j.yjmcc.2012.03.006; Quiles JL, 2002, TOXICOLOGY, V180, P79, DOI 10.1016/S0300-483X(02)00383-9; Rathe M, 2010, PEDIATR BLOOD CANCER, V54, P444, DOI 10.1002/pbc.22302; Roy D, 2006, HEART, V92, P113, DOI 10.1136/hrt.2004.049643; Sbarouni E, 2011, CLIN CHEM LAB MED, V49, P177, DOI 10.1515/CCLM.2011.037; Sinha MK, 2004, EMERG MED J, V21, P29, DOI 10.1136/emj.2003.006007; Sliwinska J, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/890826; Stoodley PW, 2011, HEART LUNG CIRC, V20, P3, DOI 10.1016/j.hlc.2010.09.007; Takemura G, 2007, PROG CARDIOVASC DIS, V49, P330, DOI 10.1016/j.pcad.2006.10.002; Talwalkar SS, 2008, ANN CLIN LAB SCI, V38, P132; Turedi S, 2009, AM J EMERG MED, V27, P635, DOI 10.1016/j.ajem.2008.05.002; Ukinc K, 2009, ENDOCRINE, V36, P425, DOI 10.1007/s12020-009-9236-5; Zapico-Muniz E, 2004, CLIN CHEM, V50, P1063, DOI 10.1373/clinchem.2003.027789; Zhang YW, 2009, ARCH IMMUNOL THER EX, V57, P435, DOI 10.1007/s00005-009-0051-8; Zhou SY, 2001, CANCER RES, V61, P771	40	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79426	10.1371/journal.pone.0079426	http://dx.doi.org/10.1371/journal.pone.0079426			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223946	Green Published, gold, Green Submitted			2022-12-27	WOS:000326503400113
J	Vondenhoff, GH; Pugach, K; Gadakh, B; Carlier, L; Rozenski, J; Froeyen, M; Severinov, K; Van Aerschot, A				Vondenhoff, Gaston H.; Pugach, Ksenia; Gadakh, Bharat; Carlier, Laurence; Rozenski, Jef; Froeyen, Mathy; Severinov, Konstantin; Van Aerschot, Arthur			N-Alkylated Aminoacyl sulfamoyladenosines as Potential Inhibitors of Aminoacylation Reactions and Microcin C Analogues Containing D-Amino Acids	PLOS ONE			English	Article							D-TYR-TRNA(TYR) DEACYLASE; RESISTANCE; BIOSYNTHESIS; RECOGNITION; MECHANISM; PEPTIDE; COLI; CELL; FORM	Microcin C analogues were recently envisaged as important compounds for the development of novel antibiotics. Two issues that may pose problems to these potential antibiotics are possible acquisition of resistance through acetylation and in vivo instability of the peptide chain. N-methylated aminoacyl sulfamoyladenosines were synthesized to investigate their potential as aminoacyl tRNA synthetase inhibitors and to establish whether these N-alkylated analogues would escape the natural inactivation mechanism via acetylation of the alpha amine. It was shown however, that these compounds are not able to effectively inhibit their respective aminoacyl tRNA synthetase. In addition, we showed that (D)-aspartyl-sulfamoyladenosine (i.e. with a (D)-configuration for the aspartyl moiety), is a potent inhibitor of aspartyl tRNA synthetase. However, we also showed that the inhibitory effect of (D)-aspartyl-sulfamoyladenosine is relatively short-lasting. Microcin C analogues with (D)-amino acids throughout from positions two to six proved inactive. They were shown to be resistant against metabolism by the different peptidases and therefore not able to release the active moiety. This observation could not be reversed by incorporation of (L)-amino acids at position six, showing that none of the available peptidases exhibit endopeptidase activity.	[Vondenhoff, Gaston H.; Pugach, Ksenia; Gadakh, Bharat; Carlier, Laurence; Rozenski, Jef; Froeyen, Mathy; Van Aerschot, Arthur] Catholic Univ Louvain, Rega Inst Med Res, Med Chem Lab, B-3000 Louvain, Belgium; [Severinov, Konstantin] Rutgers State Univ, Waksman Inst, Dept Mol Biol & Biochem, Piscataway, NJ USA; [Severinov, Konstantin] Russian Acad Sci, Inst Gene Biol, Moscow, Russia	KU Leuven; Universite Catholique Louvain; Rutgers State University New Brunswick; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences	Van Aerschot, A (corresponding author), Catholic Univ Louvain, Rega Inst Med Res, Med Chem Lab, Minderbroedersstr 10, B-3000 Louvain, Belgium.	Arthur.VanAerschot@rega.kuleuven.be	Severinov, Konstantin/C-8545-2016; Gadakh, Bharat K./F-9886-2014; Froeyen, Mathy MC/I-1665-2014	Gadakh, Bharat K./0000-0001-6814-4818; Froeyen, Mathy MC/0000-0002-8675-6540; Rozenski, Jef/0000-0001-9624-5536; Van Aerschot, Arthur/0000-0003-3528-8588	Belgian IWT fellowship [SB81117]; Hercules Foundation of the Flemish Government [20100225-7]; Russian Academy of Sciences; Erasmus Mundus External Cooperation Window lot 13 fellowship	Belgian IWT fellowship; Hercules Foundation of the Flemish Government; Russian Academy of Sciences(Russian Academy of Sciences); Erasmus Mundus External Cooperation Window lot 13 fellowship	GV was recipient of a Belgian IWT fellowship (SB81117). MS was made possible by the Hercules Foundation of the Flemish Government (grant 20100225-7). KS was supported by a Russian Academy of Sciences Presidium Nanotechnology Program grant. Bharat Gadakh received an Erasmus Mundus External Cooperation Window lot 13 fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banik SD, 2010, J PHYS CHEM B, V114, P2301, DOI 10.1021/jp910730s; Banik SD, 2013, TOP CURR CHEM, V333, P255, DOI 10.1007/128_2012_369; Banik SD, 2012, J BIOMOL STRUCT DYN, V30, P701, DOI 10.1080/07391102.2012.689701; Beautement K, 1999, N ALPHA AMINOACYL 5, P288; BENZ G, 1984, LIEBIGS ANN CHEM, P1408, DOI 10.1002/jlac.198419840803; Chacon O, 2009, MICROBIOL-SGM, V155, P1440, DOI 10.1099/mic.0.024901-0; Guo M, 2009, NATURE, V462, P808, DOI 10.1038/nature08612; Kazakov T, 2008, J BACTERIOL, V190, P2607, DOI 10.1128/JB.01956-07; Malde AK, 2009, J AM CHEM SOC, V131, P3848, DOI 10.1021/ja9002124; Nakama T, 2001, J BIOL CHEM, V276, P47387, DOI 10.1074/jbc.M109089200; Novikova M, 2010, J BIOL CHEM, V285, P12662, DOI 10.1074/jbc.M109.080192; Palencia A, 2012, NAT STRUCT MOL BIOL, V19, P677, DOI 10.1038/nsmb.2317; Rink R, J PHARMACOL TOX MET, V61, P210, DOI [10.1016/j.vascn.2010.02.010, DOI 10.1016/J.VASCN.2010.02.010.PUBMED:20176117]; Soutourina J, 2000, J BIOL CHEM, V275, P32535, DOI 10.1074/jbc.M005166200; Thompson D, 2007, J BIOL CHEM, V282, P30856, DOI 10.1074/jbc.M704788200; Tikhonov A, 2010, J BIOL CHEM, V285, P37944, DOI 10.1074/jbc.M110.179135; Van de Vijver P, 2009, BIOORGAN MED CHEM, V17, P260, DOI 10.1016/j.bmc.2008.11.054; Van de Vijver P, 2009, J BACTERIOL, V191, P6273, DOI 10.1128/JB.00829-09; Vondenhoff GHM, 2011, EUR J MED CHEM, V46, P5227, DOI 10.1016/j.ejmech.2011.08.049; Vondenhoff GHM, 2011, NUCLEOS NUCLEOT NUCL, V30, P465, DOI 10.1080/15257770.2011.583972; Vondenhoff GHM, 2011, BIOORGAN MED CHEM, V19, P5462, DOI 10.1016/j.bmc.2011.07.052; Vondenhoff GHM, 2011, J BACTERIOL, V193, P3618, DOI 10.1128/JB.00172-11; Werle M, 2006, AMINO ACIDS, V30, P351, DOI 10.1007/s00726-005-0289-3; Wydau S, 2009, J BIOL CHEM, V284, P14096, DOI 10.1074/jbc.M808173200; Yang HB, 2003, FEBS LETT, V552, P95, DOI 10.1016/S0014-5793(03)00858-5; Zheng G, 2009, BIOCHEM J, V417, P85, DOI 10.1042/BJ20080617	26	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79234	10.1371/journal.pone.0079234	http://dx.doi.org/10.1371/journal.pone.0079234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223911	Green Submitted, Green Published, gold			2022-12-27	WOS:000326503400104
J	Attar, A; Liu, TY; Chan, WTC; Hayes, J; Nejad, M; Lei, KC; Bitan, G				Attar, Aida; Liu, Tingyu; Chan, Wai-Ting Coco; Hayes, Jane; Nejad, Mona; Lei, KaiChyuan; Bitan, Gal			A Shortened Barnes Maze Protocol Reveals Memory Deficits at 4-Months of Age in the Triple-Transgenic Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							REDUCES A-BETA; WATER-MAZE; COGNITIVE IMPAIRMENT; AMYLOID-BETA; 3XTG-AD MICE; ALPHA-SYNUCLEIN; SPATIAL MEMORY; PATHOLOGY; TAU; DEPOSITION	Alzheimer's disease is a progressive neurodegenerative disease that manifests as memory loss, cognitive dysfunction, and dementia. Animal models of Alzheimer's disease have been instrumental in understanding the underlying pathological mechanism and in evaluation of potential therapies. The triple transgenic (3xTg) mouse model of AD is unique because it recapitulates both pathologic hallmarks of Alzheimer's disease - amyloid plaques and neurofibrillary tangles. The earliest cognitive deficits in this model have been shown at 6-m of age by most groups, necessitating aging of the mice to this age before initiating evaluation of the cognitive effects of therapies. To assess cognitive deficits in the 3xTg mice, originally we employed a typical Barnes maze protocol of 15 training trials, but found no significant deficits in aged mice. Therefore, we shortened the protocol to include only 5 training trials to increase difficulty. We found cognitive deficits using this protocol using mainly measures from the probe day, rather than the training trials. This also decreased the effort involved with data analysis. We compared 3xTg and wild-type mice at 4-m- and 15-m of age using both the original, long training, and the short training paradigms. We found that differences in learning between 3xTg and wild-type mice disappeared after the 4th training trial. Measures of learning and memory on the probe day showed significant differences between 3xTg and wild-type mice following the short, 5-training trial protocol but not the long, 15-training trial protocol. Importantly, we detected cognitive dysfunction already at 4-m of age in 3xTg mice using the short Barnes-maze protocol. The ability to test learning and memory in 4-m old 3xTg mice using a shortened Barnes maze protocol offers considerable time and cost savings and provides support for the utilization of this model at pre-pathology stages for therapeutic studies.	[Attar, Aida; Liu, Tingyu; Chan, Wai-Ting Coco; Hayes, Jane; Nejad, Mona; Lei, KaiChyuan; Bitan, Gal] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Attar, Aida; Bitan, Gal] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Bitan, Gal] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Bitan, G (corresponding author), Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA.	gbitan@mednet.ucla.edu	liu, ting/GZM-3326-2022; Bitan, Gal/U-2204-2019	Bitan, Gal/0000-0001-7046-3754	University of California-Los Angeles Jim Easton Consortium for Alzheimer's Drug Discovery and Biomarker Development; RJG Foundation [20095024]; Cure Alzheimer's Fund grant; Individual Pre-doctoral National Research Service Award [1F31AG037283]; NATIONAL INSTITUTE ON AGING [F31AG037283] Funding Source: NIH RePORTER	University of California-Los Angeles Jim Easton Consortium for Alzheimer's Drug Discovery and Biomarker Development; RJG Foundation; Cure Alzheimer's Fund grant; Individual Pre-doctoral National Research Service Award; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by University of California-Los Angeles Jim Easton Consortium for Alzheimer's Drug Discovery and Biomarker Development (G. B.); RJG Foundation grant 20095024 (G. B.); a Cure Alzheimer's Fund grant (G. B.); and an Individual Pre-doctoral National Research Service Award 1F31AG037283 (A. A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambree O, 2009, NEUROBIOL AGING, V30, P1192, DOI 10.1016/j.neurobiolaging.2007.11.010; Attar A, 2012, BRAIN, V135, P3735, DOI 10.1093/brain/aws289; Banaceur S, 2013, BEHAV BRAIN RES, V240, P197, DOI 10.1016/j.bbr.2012.11.021; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106; Chen YX, 2013, MOL NEUROBIOL, V47, P711, DOI 10.1007/s12035-012-8375-5; Clinton LK, 2007, NEUROBIOL DIS, V28, P76, DOI 10.1016/j.nbd.2007.06.013; Clinton LK, 2010, J NEUROSCI, V30, P7281, DOI 10.1523/JNEUROSCI.0490-10.2010; Das P, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-39; Davis KE, 2013, J ALZHEIMERS DIS, V33, P681, DOI 10.3233/JAD-2012-121543; Filali M, 2012, BEHAV BRAIN RES, V234, P334, DOI 10.1016/j.bbr.2012.07.004; Fleisher AS, 2012, LANCET NEUROL, V11, P1057, DOI 10.1016/S1474-4422(12)70227-2; Frazer ME, 2008, MOL THER, V16, P845, DOI 10.1038/mt.2008.39; Golde TE, 2013, J CLIN INVEST, V123, P1847, DOI 10.1172/JCI66029; Gulinello M, 2009, BEHAV BRAIN RES, V196, P220, DOI 10.1016/j.bbr.2008.09.002; Guzman-Ramos K, 2012, LEARN MEMORY, V19, P453, DOI 10.1101/lm.026070.112; Hebda-Bauer EK, 2013, J ALZHEIMERS DIS, V33, P407, DOI 10.3233/JAD-2012-121438; Hirata-Fukae C, 2008, BRAIN RES, V1216, P92, DOI 10.1016/j.brainres.2008.03.079; Holscher C, 1999, BEHAV BRAIN RES, V100, P225, DOI 10.1016/S0166-4328(98)00134-X; INGRAM DK, 1994, LIFE SCI, V55, P2037, DOI 10.1016/0024-3205(94)00384-X; Kraemer PJ, 1996, BRAIN RES BULL, V39, P17, DOI 10.1016/0361-9230(95)02028-4; Larson ME, 2012, J NEUROSCI, V32, P10253, DOI 10.1523/JNEUROSCI.0581-12.2012; Mckee AC, 2008, BRAIN RES, V1207, P225, DOI 10.1016/j.brainres.2008.01.095; Medina DX, 2011, BRAIN PATHOL, V21, P140, DOI 10.1111/j.1750-3639.2010.00430.x; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Moscovitch M, 2005, J ANAT, V207, P35, DOI 10.1111/j.1469-7580.2005.00421.x; O'Leary TP, 2009, BEHAV BRAIN RES, V201, P120, DOI 10.1016/j.bbr.2009.01.039; Oddo S, 2006, J BIOL CHEM, V281, P1599, DOI 10.1074/jbc.M507892200; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2006, AM J PATHOL, V168, P184, DOI 10.2353/ajpath.2006.050593; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Peng Y, 2010, J NEUROSCI, V30, P8180, DOI 10.1523/JNEUROSCI.0340-10.2010; Pompl PN, 1999, J NEUROSCI METH, V87, P87, DOI 10.1016/S0165-0270(98)00169-1; Reiman EM, 2012, LANCET NEUROL, V11, P1048, DOI 10.1016/S1474-4422(12)70228-4; Rodriguez GA, 2013, LEARN MEMORY, V20, P256, DOI 10.1101/lm.030031.112; Rojanathammanee L, 2013, J NUTR, V143, P597, DOI 10.3945/jn.112.169516; Schulz D, 2007, NEUROBIOL LEARN MEM, V87, P309, DOI 10.1016/j.nlm.2006.09.006; Sterniczuk R, 2010, BRAIN RES, V1348, P149, DOI 10.1016/j.brainres.2010.06.011; Sun MK, 2004, NEUROSCIENCE, V129, P129, DOI 10.1016/j.neuroscience.2004.07.041; Sunyer B., 2007, NAT PROTOC, P390; Torres-Lista V, 2013, BEHAV BRAIN RES, V247, P153, DOI 10.1016/j.bbr.2013.03.021; Walker JM, 2011, BEHAV BRAIN RES, V222, P169, DOI 10.1016/j.bbr.2011.03.049	43	74	75	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80355	10.1371/journal.pone.0080355	http://dx.doi.org/10.1371/journal.pone.0080355			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236177	Green Published, gold			2022-12-27	WOS:000327254700178
J	Fu, SN; Chin, WY; Wong, CKH; Yeung, VTF; Yiu, MP; Tsui, HY; Chan, KH				Fu, Sau Nga; Chin, Weng Yee; Wong, Carlos King Ho; Yeung, Vincent Tok Fai; Yiu, Ming Pong; Tsui, Hoi Yee; Chan, Ka Hung			Development and Validation of the Chinese Attitudes to Starting Insulin Questionnaire (Ch-ASIQ) for Primary Care Patients with Type 2 Diabetes	PLOS ONE			English	Article							PSYCHOLOGICAL RESISTANCE; GLYCEMIC CONTROL; ORAL-AGENTS; THERAPY; BARRIERS; PREVALENCE; ACCEPTANCE; MANAGEMENT; INITIATION; MELLITUS	Objectives: To develop and evaluate the psychometric properties of a Chinese questionnaire which assesses the barriers and enablers to commencing insulin in primary care patients with poorly controlled Type 2 diabetes. Research Design and Method: Questionnaire items were identified using literature review. Content validation was performed and items were further refined using an expert panel. Following translation, back translation and cognitive debriefing, the translated Chinese questionnaire was piloted on target patients. Exploratory factor analysis and item-scale correlations were performed to test the construct validity of the subscales and items. Internal reliability was tested by Cronbach's alpha. Results: Twenty-seven identified items underwent content validation, translation and cognitive debriefing. The translated questionnaire was piloted on 303 insulin naive (never taken insulin) Type 2 diabetes patients recruited from 10 government-funded primary care clinics across Hong Kong. Sufficient variability in the dataset for factor analysis was confirmed by Bartlett's Test of Sphericity (P<0.001). Using exploratory factor analysis with varimax rotation, 10 factors were generated onto which 26 items loaded with loading scores > 0.4 and Eigenvalues >1. Total variance for the 10 factors was 66.22%. Kaiser-Meyer-Olkin measure was 0.725. Cronbach's alpha coefficients for the first four factors were >= 0.6 identifying four subscales to which 13 items correlated. Remaining sub-scales and items with poor internal reliability were deleted. The final 13-item instrument had a four scale structure addressing: 'Self-image and stigmatization'; 'Factors promoting self-efficacy; 'Fear of pain or needles'; and 'Time and family support'. Conclusion: The Chinese Attitudes to Starting Insulin Questionnaire (Ch-ASIQ) appears to be a reliable and valid measure for assessing barriers to starting insulin. This short instrument is easy to administer and may be used by healthcare providers and researchers as an assessment tool for Chinese diabetic primary care patients, including the elderly, who are unwilling to start insulin.	[Fu, Sau Nga; Yiu, Ming Pong; Tsui, Hoi Yee; Chan, Ka Hung] Hosp Author, Kowloon West Cluster, Dept Family Med & Primary Hlth Care, Hong Kong, Hong Kong, Peoples R China; [Chin, Weng Yee; Wong, Carlos King Ho] Univ Hong Kong, Li Ka Shing Fac Med, Dept Family Med & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Yeung, Vincent Tok Fai] Our Lady Maryknoll Hosp, Dept Med & Geriatr, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Fu, SN (corresponding author), Hosp Author, Kowloon West Cluster, Dept Family Med & Primary Hlth Care, Hong Kong, Hong Kong, Peoples R China.	fsn299@ha.org.hk	Wong, Carlos King Ho/B-4322-2011	Wong, Carlos King Ho/0000-0002-6895-6071; Fu, Sau Nga/0000-0002-6491-654X	Food and Health Bureau, the government of Hong Kong S.A.R. [10112261]	Food and Health Bureau, the government of Hong Kong S.A.R.	The project is funded by the Health and Medical Research Fund, Food and Health Bureau, the government of Hong Kong S.A.R. (Reference number 10112261)since Oct 2012. URL: "http://fhbgrants.netsoft.net/english/funded_search/funded_search_result.php?fund=&ref_no=10112261&keywords=&keysearch=and&RAC=&HC=&investigator=&investsearch=and&status=". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Benroubi M, 2011, DIABETES RES CLIN PR, V93, pS97, DOI 10.1016/S0168-8227(11)70021-3; Bogatean MP, 2004, PRACT DIABETES INT, V21, P247, DOI DOI 10.1002/PDI.670; Caballero AE, 2006, ETHNIC DIS, V16, P559; Chan J. C. N., 2000, Hong Kong Medical Journal, V6, P77; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Chen CC, 2011, DIABETES METAB, V37, P389, DOI 10.1016/j.diabet.2010.12.008; Dodd AH, 2009, CURR MED RES OPIN, V25, P1605, DOI 10.1185/03007990902973300; Guisasola FA, 2008, DIABETES OBES METAB, V10, P8, DOI 10.1111/j.1463-1326.2008.00881.x; Ho EY, 2006, CAN J DIABETES, V30, P390, DOI DOI 10.1016/S1499-2671(06)04004-4; Hunt LM, 1997, DIABETES CARE, V20, P292, DOI 10.2337/diacare.20.3.292; Karter AJ, 2010, DIABETES CARE, V33, P733, DOI 10.2337/dc09-1184; Kim MS, 1999, HEALTH COMMUN, V11, P249, DOI 10.1207/S15327027HC110307; Larkin ME, 2008, DIABETES EDUCATOR, V34, P511, DOI 10.1177/0145721708317869; Lau Y. K., 2012, INT EMPLOYMENT RELAT, V18, P82; Levine RV, 1999, J CROSS CULT PSYCHOL, V30, P178, DOI 10.1177/0022022199030002003; Luna B, 2001, AM FAM PHYSICIAN, V63, P1747; LYNN MR, 1986, NURS RES, V35, P382; Martin Leslie R, 2005, Ther Clin Risk Manag, V1, P189; Martinez L, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-53; Meece J, 2006, DIABETES EDUCATOR, V32, p9S, DOI 10.1177/0145721705285638; Mishali M, 2007, FAM PRACT, V24, P610, DOI 10.1093/fampra/cmm057; Nam S, 2010, DIABETES CARE, V33, P1747, DOI 10.2337/dc10-0099; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Oliveria SA, 2007, CURR MED RES OPIN, V23, P3105, DOI 10.1185/030079907X242638; Petrak F, 2007, DIABETES CARE, V30, P2199, DOI 10.2337/dc06-2042; Peyrot M, 2005, DIABETES CARE, V28, P2673, DOI 10.2337/diacare.28.11.2673; Polonsky WH, 2005, DIABETES CARE, V28, P2543, DOI 10.2337/diacare.28.10.2543; Polonsky WH, 2011, CURR MED RES OPIN, V27, P1169, DOI 10.1185/03007995.2011.573623; Roglic G, 2005, DIABETES CARE, V28, P2130, DOI 10.2337/diacare.28.9.2130; Skyler JS, 2009, J AM COLL CARDIOL, V53, P298, DOI [10.1016/j.jacc.2008.10.008, 10.2337/dc08-9026]; Snoek FJ, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-69; Swinnen SG, 2009, DIABETES CARE, V32, pS253, DOI 10.2337/dc09-S318; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vinik A, 2007, CLIN THER, V29, P1236, DOI 10.1016/j.clinthera.2007.07.005; Wang HF, 2012, J ADV NURS, V68, P743, DOI 10.1111/j.1365-2648.2011.05853.x; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Wong S, 2011, DIABETIC MED, V28, P206, DOI 10.1111/j.1464-5491.2010.03195.x; Woudenberg YJC, 2012, DIABETIC MED, V29, P796, DOI 10.1111/j.1464-5491.2011.03552.x; Wu S, 2006, J EVIDENCE BASED NUR, V2, P14, DOI DOI 10.6225/JEBN.2.1.14; Xiaolian Jiang, 2002, Nurs Health Sci, V4, P41, DOI 10.1046/j.1442-2018.2002.00100.x; Yam HK, 2009, HEALTH POLICY, V91, P229, DOI 10.1016/j.healthpol.2008.12.012; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yiu MP, 2010, QUESTIONNAIRE STUDY	44	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78933	10.1371/journal.pone.0078933	http://dx.doi.org/10.1371/journal.pone.0078933			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236071	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700068
J	Gabriel, FC; Szucs, D; Content, A				Gabriel, Florence C.; Szucs, Denes; Content, Alain			The Development of the Mental Representations of the Magnitude of Fractions	PLOS ONE			English	Article							WHOLE NUMBER; JUDGMENTS; ORIGINS; REAL	We investigated the development of the mental representation of the magnitude of fractions during the initial stages of fraction learning in grade 5, 6 and 7 children as well as in adults. We examined the activation of global fraction magnitude in a numerical comparison task and a matching task. There were global distance effects in the comparison task, but not in the matching task. This suggests that the activation of the global magnitude representation of fractions is not automatic in all tasks involving magnitude judgments. The slope of the global distance effect increased during early fraction learning and declined by adulthood, demonstrating that the development of the fraction global distance effect differs from that of the integer distance effect.	[Gabriel, Florence C.; Szucs, Denes] Univ Cambridge, Dept Expt Psychol, Ctr Neuroscience Educ, Cambridge CB2 3EB, England; [Gabriel, Florence C.; Content, Alain] Univ Libre Bruxelles, Fac Sci Psychol & Educ, Lab Cognit Langage & Dev, Brussels, Belgium	University of Cambridge; Universite Libre de Bruxelles	Gabriel, FC (corresponding author), Univ Cambridge, Dept Expt Psychol, Ctr Neuroscience Educ, Downing St, Cambridge CB2 3EB, England.	fcg25@cam.ac.uk; ds377@cam.ac.uk	Gabriel, Florence/AAE-7977-2020	Gabriel, Florence/0000-0001-9721-5312; Content, Alain/0000-0003-4170-463X; Szucs, Denes/0000-0002-9477-0801	Wiener-Anspach Foundation; Belgian National Fund; Medical Research Council [G90951]; Medical Research Council [G1000183B, G0001354B, G0001354] Funding Source: researchfish	Wiener-Anspach Foundation; Belgian National Fund(Fonds de la Recherche Scientifique - FNRS); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by grants to F. G. from the Wiener-Anspach Foundation (http://fwa.ulb.ac.be/) and from the Belgian National Fund for Scientific Research (http://www.frs-fnrs.be/) and grant G90951 from the Medical Research Council (http://www.mrc.ac.uk/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball D.L., 1993, RATIONAL NUMBERS INT, P157; Behr M.J., 1986, ESTIMATION MENTAL CO, P103; Bonato M, 2007, J EXP PSYCHOL HUMAN, V33, P1410, DOI 10.1037/0096-1523.33.6.1410; BRIGHT GW, 1988, J RES MATH EDUC, V19, P215, DOI 10.2307/749066; Charalambous C.Y., 2007, EDUC STUD MATH, V64, P293; Christ SE, 2001, DEV NEUROPSYCHOL, V20, P653, DOI 10.1207/875656401753549852; Cohen DJ, 2009, PSYCHON B REV, V16, P332, DOI 10.3758/PBR.16.2.332; De Smedt B, 2009, J EXP CHILD PSYCHOL, V103, P469, DOI 10.1016/j.jecp.2009.01.010; Gabriel F, 2012, MIND BRAIN EDUC, V6, P137, DOI 10.1111/j.1751-228X.2012.01149.x; Gallistel CR, 2000, TRENDS COGN SCI, V4, P59, DOI 10.1016/S1364-6613(99)01424-2; Holloway ID, 2008, DEVELOPMENTAL SCI, V11, P644, DOI 10.1111/j.1467-7687.2008.00712.x; Holloway ID, 2009, J EXP CHILD PSYCHOL, V103, P17, DOI 10.1016/j.jecp.2008.04.001; Ischebeck A, 2009, NEUROIMAGE, V47, P403, DOI 10.1016/j.neuroimage.2009.03.041; Iuculano T, 2011, Q J EXP PSYCHOL, V64, P2088, DOI 10.1080/17470218.2011.604785; Jacob SN, 2009, J NEUROSCI, V29, P4652, DOI 10.1523/JNEUROSCI.0651-09.2009; Kallai AY, 2009, J EXP PSYCHOL HUMAN, V35, P1845, DOI 10.1037/a0016892; Lonnemann J, 2011, J NEUROLINGUIST, V24, P583, DOI 10.1016/j.jneuroling.2011.02.004; LORCH RF, 1990, J EXP PSYCHOL LEARN, V16, P149, DOI 10.1037/0278-7393.16.1.149; Mamede E, 2005, P 29 C INT GROUP PSY, V3, P281; Mazzocco MMM, 2008, DEVELOPMENTAL SCI, V11, P681, DOI 10.1111/j.1467-7687.2008.00717.x; McCrink K, 2007, PSYCHOL SCI, V18, P740, DOI 10.1111/j.1467-9280.2007.01969.x; Meert G, 2010, ACTA PSYCHOL, V135, P284, DOI 10.1016/j.actpsy.2010.07.014; Meert G, 2010, J EXP CHILD PSYCHOL, V107, P244, DOI 10.1016/j.jecp.2010.04.008; Meert G, 2009, Q J EXP PSYCHOL, V62, P1598, DOI 10.1080/17470210802511162; Mix KS, 1999, DEV PSYCHOL, V35, P164, DOI 10.1037/0012-1649.35.1.164; MOYER RS, 1967, NATURE, V215, P1519, DOI 10.1038/2151519a0; Ni YJ, 2005, EDUC PSYCHOL-US, V40, P27, DOI 10.1207/s15326985ep4001_3; Nunes T., 1996, CHILDREN DOING MATH; Pitkethly A, 1996, EDUC STUD MATH, V30, P5, DOI [10.1007/BF00163751, DOI 10.1007/BF00163751]; Rubinsten O, 2002, J EXP CHILD PSYCHOL, V81, P74, DOI 10.1006/jecp.2001.2645; Sasanguie D, 2011, ACTA PSYCHOL, V136, P73, DOI 10.1016/j.actpsy.2010.10.004; Schneider M, 2010, J EXP PSYCHOL HUMAN, V36, P1227, DOI 10.1037/a0018170; SEKULER R, 1977, CHILD DEV, V48, P630, DOI 10.1111/j.1467-8624.1977.tb01208.x; Siegler RS, 2013, TRENDS COGN SCI, V17, P13, DOI 10.1016/j.tics.2012.11.004; Siegler RS, 2011, COGNITIVE PSYCHOL, V62, P273, DOI 10.1016/j.cogpsych.2011.03.001; Szucs D, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-23; Vallentin D, 2008, CURR BIOL, V18, P1420, DOI 10.1016/j.cub.2008.08.042; van Opstal F, 2011, J COGN PSYCHOL, V23, P112, DOI 10.1080/20445911.2011.466796; Verguts T, 2004, J COGNITIVE NEUROSCI, V16, P1493, DOI 10.1162/0898929042568497; White SLJ, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2011.00392	40	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80016	10.1371/journal.pone.0080016	http://dx.doi.org/10.1371/journal.pone.0080016			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236169	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700170
J	Kreidenweiss, A; Hopkins, AV; Mordmuller, B				Kreidenweiss, Andrea; Hopkins, Annika V.; Mordmueller, Benjamin			2A and the Auxin-Based Degron System Facilitate Control of Protein Levels in Plasmodium falciparum	PLOS ONE			English	Article							MALARIA PARASITES; EXPRESSION	Analysis of gene function in Plasmodium falciparum, the most important human malaria parasite, is restricted by the lack of robust and simple reverse genetic tools. Approaches to manipulate protein levels post-translationally are powerful tools to study protein-off effects especially in the haploid malaria parasite where genetic knockouts of essential genes are lethal. We investigated if the auxin-inducible degron system is functional in P. falciparum and found that degron-tagged yellow fluorescent protein levels were efficiently reduced upon addition of auxin which otherwise had no effect on parasite viability. The genetic components required in this conditional approach were co-expressed in P. falciparum by applying the small peptide 2A. 2A is a self-processing peptide from Foot-And-Mouth Disease virus that allows the whole conditional system to be accommodated on a single plasmid vector and ensures stoichiometric expression levels.	[Kreidenweiss, Andrea; Hopkins, Annika V.; Mordmueller, Benjamin] Univ Tubingen, Inst Trop Med, Tubingen, Germany	Eberhard Karls University of Tubingen	Kreidenweiss, A (corresponding author), Univ Tubingen, Inst Trop Med, Tubingen, Germany.	andrea.kreidenweiss@uni-tuebingen.de	Mordmüller, Benjamin/A-5749-2010	Mordmüller, Benjamin/0000-0001-9101-2768; Kreidenweiss, Andrea/0000-0002-5025-7221	Institute of Tropical Medicine, University Tubingen, Wilhelmstrasse 27, D-72074 Tubingen, Germany; Deutsche Forschungsgemeinschaft; Tubingen University	Institute of Tropical Medicine, University Tubingen, Wilhelmstrasse 27, D-72074 Tubingen, Germany; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tubingen University	This work was supported by the scientific budget of the Institute of Tropical Medicine, University Tubingen, Wilhelmstrasse 27, D-72074 Tubingen, Germany. The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tubingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong CM, 2007, NAT METHODS, V4, P1007, DOI 10.1038/nmeth1132; de Felipe Pablo, 2004, Genet Vaccines Ther, V2, P13, DOI 10.1186/1479-0556-2-13; Deitsch KW, 2001, NUCLEIC ACIDS RES, V29, P850, DOI 10.1093/nar/29.3.850; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; DUSSURGET O, 1994, APPL ENVIRON MICROB, V60, P953, DOI 10.1128/AEM.60.3.953-959.1994; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Kreidenweiss A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-187; Meissner M, 2005, P NATL ACAD SCI USA, V102, P2980, DOI 10.1073/pnas.0500112102; Muralidharan V, 2011, P NATL ACAD SCI USA, V108, P4411, DOI 10.1073/pnas.1018449108; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Nkrumah LJ, 2006, NAT METHODS, V3, P615, DOI 10.1038/NMETH904; Noedl H, 2004, ANTIMICROB AGENTS CH, V48, P4485, DOI 10.1128/AAC.48.11.4485-4487.2004; Straimer J, 2012, NAT METHODS, V9, P993, DOI [10.1038/NMETH.2143, 10.1038/nmeth.2143]; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	16	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78661	10.1371/journal.pone.0078661	http://dx.doi.org/10.1371/journal.pone.0078661			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236031	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700028
J	Li, ZT; Zou, XF; Xie, LX; Dong, HM; Chen, YP; Liu, Q; Wu, X; Zhou, D; Tan, DF; Zhang, H				Li, Zongtai; Zou, Xiaofang; Xie, Liangxi; Dong, Hongmei; Chen, Yuping; Liu, Qing; Wu, Xiao; Zhou, David; Tan, Dongfeng; Zhang, Hao			Prognostic Importance and Therapeutic Implications of PAK1, a Drugable Protein Kinase, in Gastroesophageal Junction Adenocarcinoma	PLOS ONE			English	Article							GASTRIC-CANCER CELLS; ESOPHAGOGASTRIC JUNCTION; P21-ACTIVATED KINASES; DOWN-REGULATION; EXPRESSION; ESOPHAGEAL; GROWTH; RESISTANCE; PHOSPHORYLATION; ACTIVATION	Gastroesophageal junction (GEJ) adenocarcinoma is a lethal cancer with rising incidence, yet the molecular biomarkers that have strong prognostic impact and also hold great therapeutic promise remain elusive. We used a data mining approach and identified the p21 protein-activated kinase 1 (PAK1), an oncogene and drugable protein kinase, to be among the most promising targets for GEJ adenocarcinoma. Immunoblot analysis and data mining demonstrated that PAK1 protein and mRNA were upregulated in cancer tissues compared to the noncancerous tissues. Immunohistochemistry revealed PAK1 overexpression in 72.6% of primary GEJ adenocarcinomas (n = 113). A step-wise increase in PAK1 levels was noted from paired normal epithelium, to atypical hyperplasia and adenocarcinoma. PAK1 overexpression in tumor was associated with lymph node (LN) metastasis (P < 0.001), advanced tumor stage (P < 0.001), large tumor size (P = 0.006), residual surgical margin (P = 0.033), and unfavorable overall survival (P < 0.001). Multivariate analysis showed PAK1 overexpression is an independent high-risk prognostic predictor (P < 0.001). Collectively, PAK1 is overexpressed during tumorigenic progression and its upregulation correlates with malignant properties mainly relevant to invasion and metastasis. PAK1 expression could serve as a prognostic predictor that holds therapeutic promise for GEJ adenocarcinoma.	[Li, Zongtai; Zou, Xiaofang; Liu, Qing; Zhang, Hao] Shantou Univ, Coll Med, Affiliated Canc Hosp, Dept Integrat Oncol, Shantou, Peoples R China; [Li, Zongtai; Zou, Xiaofang; Dong, Hongmei; Liu, Qing; Zhang, Hao] Shantou Univ, Coll Med, Canc Res Ctr, Shantou, Peoples R China; [Xie, Liangxi] Shantou Univ, Coll Med, Affiliated Canc Hosp, Dept Radiat Oncol, Shantou, Peoples R China; [Chen, Yuping] Shantou Univ, Coll Med, Affiliated Canc Hosp, Dept Thorac Surg, Shantou, Peoples R China; [Wu, Xiao] Shantou Univ, Coll Med, Affiliated Canc Hosp, Dept Pathol, Shantou, Peoples R China; [Wu, Xiao; Zhang, Hao] Shantou Univ, Coll Med, Affiliated Canc Hosp, Tumor Tissue Bank, Shantou, Peoples R China; [Zhou, David] Univ Rochester, Med Ctr, Dept Pathol, Rochester, NY 14642 USA; [Tan, Dongfeng] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	Shantou University; Shantou University; Shantou University; Shantou University; Shantou University; Shantou University; University of Rochester; University of Texas System; UTMD Anderson Cancer Center	Zhang, H (corresponding author), Shantou Univ, Coll Med, Affiliated Canc Hosp, Dept Integrat Oncol, Shantou, Peoples R China.	haozhang@stu.edu.cn			National Natural Science Foundation of China [81071736, 30973508, 81171994]; Cancer Center Support Grant from National Institutes of Health [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Cancer Center Support Grant from National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Natural Science Foundation of China grants 81071736 and 30973508 (H. Zhang), and 81171994 (L. Xie). The University of Texas MD Anderson Cancer Center is supported in part by a Cancer Center Support Grant (CA016672) from National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam L, 1998, J BIOL CHEM, V273, P28238, DOI 10.1074/jbc.273.43.28238; Almhanna K, 2012, ADV PHARMACOL, V65, P437, DOI 10.1016/B978-0-12-397927-8.00014-2; Arias-Romero LE, 2010, ONCOGENE, V29, P5839, DOI 10.1038/onc.2010.318; Badgwell B, 2008, ANN SURG ONCOL, V15, P2684, DOI 10.1245/s10434-008-0055-3; Bagheri-Yarmand R, 2000, J BIOL CHEM, V275, P39451, DOI 10.1074/jbc.M006150200; Bain GH, 2010, ONCOLOGIST, V15, P270, DOI 10.1634/theoncologist.2009-0293; Bang YJ, 2010, LANCET, V376, P1302; Bostner J, 2010, CLIN CANCER RES, V16, P1624, DOI 10.1158/1078-0432.CCR-09-1733; Cai XZ, 2009, CANCER BIOL THER, V8, P1360, DOI 10.4161/cbt.8.14.8720; Carter JH, 2004, CLIN CANCER RES, V10, P3448, DOI 10.1158/1078-0432.CCR-03-0210; Ching YP, 2007, CANCER RES, V67, P3601, DOI 10.1158/0008-5472.CAN-06-3994; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eswaran J, 2012, CLIN CANCER RES, V18, P3743, DOI 10.1158/1078-0432.CCR-11-1952; Faber AC, 2010, CELL CYCLE, V9, P851, DOI 10.4161/cc.9.5.11096; Fan YJ, 2008, WORLD J SURG, V32, P1980, DOI 10.1007/s00268-008-9674-x; Feith M, 2006, SURG ONCOL CLIN N AM, V15, P751, DOI 10.1016/j.soc.2006.07.015; Field Jeffrey, 2012, Cell Logist, V2, P54; Fiszman GL, 2011, INT J BREAST CANCER, V2011, DOI 10.4061/2011/352182; Gaxiola RA, 2001, P NATL ACAD SCI USA, V98, P11444, DOI 10.1073/pnas.191389398; Hasegawa S, 2013, ANN SURG ONCOL, V20, P773, DOI 10.1245/s10434-012-2780-x; Hayashi ML, 2007, P NATL ACAD SCI USA, V104, P11489, DOI 10.1073/pnas.0705003104; He H, 2013, BBA-MOL CELL RES, V1833, P33, DOI 10.1016/j.bbamcr.2012.10.015; Hicks DG, 2011, APPL IMMUNOHISTO M M, V19, P1506, DOI 10.1097/PAI.0b013e31822c3a0f; Huang B, 2011, HUM PATHOL, V42, P808, DOI 10.1016/j.humpath.2010.04.022; Huang Q, 2011, MODERN PATHOL, V24, P138, DOI 10.1038/modpathol.2010.183; Isinger-Ekstrand A, 2010, CANCER GENET CYTOGEN, V200, P120, DOI 10.1016/j.cancergencyto.2010.03.013; Kichina JV, 2010, EXPERT OPIN THER TAR, V14, P703, DOI 10.1517/14728222.2010.492779; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Kusano C, 2008, J GASTROEN HEPATOL, V23, P1662, DOI 10.1111/j.1440-1746.2008.05572.x; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Li LH, 2012, ONCOL REP, V27, P1435, DOI 10.3892/or.2012.1664; Li LH, 2010, INT J ONCOL, V37, P951, DOI 10.3892/ijo_00000746; Liu FN, 2009, INT J CANCER, V125, P2511, DOI 10.1002/ijc.24588; Moehler M, 2008, WORLD J GASTROENTERO, V14, P3773, DOI 10.3748/wjg.14.3773; Morgan S, 2009, EXP CELL RES, V315, P572, DOI 10.1016/j.yexcr.2008.08.009; Mukherjee K, 2010, DIGEST DIS SCI, V55, P3304, DOI 10.1007/s10620-010-1187-4; Narumiya S, 1997, FEBS LETT, V410, P68, DOI 10.1016/S0014-5793(97)00317-7; Ohshiro K, 2012, INT J BIOL MARKER, V27, pE305, DOI 10.5301/JBM.2012.10437; Ong CC, 2011, P NATL ACAD SCI USA, V108, P7177, DOI 10.1073/pnas.1103350108; Oshima T, 2012, SURG TODAY, V42, P313, DOI 10.1007/s00595-011-0065-9; Pohl H, 2005, ROLE OVERDIAGNOSIS R; Rexer BN, 2009, CELL CYCLE, V8, P18, DOI 10.4161/cc.8.1.7324; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Rizk NP, 2009, J THORAC ONCOL, V4, P875, DOI 10.1097/JTO.0b013e3181a8cebf; Shah MA, 2006, J CLIN ONCOL, V24, P5201, DOI 10.1200/JCO.2006.08.0887; Shrestha Y, 2012, ONCOGENE, V31, P3397, DOI 10.1038/onc.2011.515; Singhal R, 2012, ONCOTARGET, V3, P700, DOI 10.18632/oncotarget.587; Stein HJ, 2000, SURG ONCOL, V9, P35, DOI 10.1016/S0960-7404(00)00021-9; Su AI, 2001, CANCER RES, V61, P7388; Su M, 2007, EUR J EPIDEMIOL, V22, P43, DOI 10.1007/s10654-006-9086-x; Tada M, 2010, CANCER SCI, V101, P1261, DOI 10.1111/j.1349-7006.2010.01500.x; Vu T, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00062; Ueda Y, 2004, J BIOL CHEM, V279, P24505, DOI 10.1074/jbc.M400081200; VAUGHAN TL, 1995, CANCER EPIDEM BIOMAR, V4, P85; Wang RA, 2006, ONCOGENE, V25, P2931, DOI 10.1038/sj.onc.1209309; Wang SZE, 2006, CANCER RES, V66, P9591, DOI 10.1158/0008-5472.CAN-06-2071; Xu JJ, 2012, GASTROENTEROLOGY, V143, P199, DOI 10.1053/j.gastro.2012.03.053; Yang ZB, 2005, CANCER RES, V65, P3179, DOI 10.1158/0008-5472.CAN-04-3480; Yang ZB, 2004, CLIN CANCER RES, V10, P658, DOI 10.1158/1078-0432.CCR-0382-03; Ye Diana Zi, 2012, Cell Logist, V2, P105; Ying JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039797; Yokoyama H, 2006, BRIT J CANCER, V95, P1504, DOI 10.1038/sj.bjc.6603459; Zhang GH, 2008, CANCER INVEST, V26, P296, DOI 10.1080/07357900701683901; Zhao X., 2012, ONCOGENE	65	8	9	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80665	10.1371/journal.pone.0080665	http://dx.doi.org/10.1371/journal.pone.0080665			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236193	Green Submitted, gold, Green Published			2022-12-27	WOS:000327254700196
J	Lin, N; Ho, A; Charoenvimolphan, N; Frerichs, KU; Day, AL; Du, R				Lin, Ning; Ho, Allen; Charoenvimolphan, Nareerat; Frerichs, Kai U.; Day, Arthur L.; Du, Rose			Analysis of Morphological Parameters to Differentiate Rupture Status in Anterior Communicating Artery Aneurysms	PLOS ONE			English	Article							UNRUPTURED INTRACRANIAL ANEURYSMS; CEREBRAL ANEURYSMS; RISK; RATIO; PREVALENCE	In contrast to size, the association of morphological characteristics of intracranial aneurysms with rupture has not been established in a systematic manner. We present an analysis of the morphological variables that are associated with rupture in anterior communicating artery aneurysms to determine site-specific risk variables. One hundred and twenty-four anterior communicating artery aneurysms were treated in a single institution from 2005 to 2010, and CT angiograms (CTAs) or rotational angiography from 79 patients (42 ruptured, 37 unruptured) were analyzed. Vascular imaging was evaluated with 3D Slicer (c) to generate models of the aneurysms and surrounding vasculature. Morphological parameters were examined using univariate and multivariate analysis and included aneurysm volume, aspect ratio, size ratio, distance to bifurcation, aneurysm angle, vessel angle, flow angle, and parent-daughter angle. Multivariate logistic regression revealed that size ratio, flow angle, and parent-daughter angle were associated with aneurysm rupture after adjustment for age, sex, smoking history, and other clinical risk factors. Simple morphological parameters such as size ratio, flow angle, and parent-daughter angle may thus aid in the evaluation of rupture risk of anterior communicating artery aneurysms.	[Lin, Ning; Charoenvimolphan, Nareerat; Frerichs, Kai U.; Du, Rose] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Lin, Ning; Ho, Allen; Frerichs, Kai U.; Du, Rose] Harvard Univ, Sch Med, Boston, MA USA; [Day, Arthur L.] Univ Texas Houston, Sch Med, Dept Neurosurg, Houston, TX USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Texas System; University of Texas Health Science Center Houston	Du, R (corresponding author), Brigham & Womens Hosp, Dept Neurosurg, 75 Francis St, Boston, MA 02115 USA.	rdu@partners.org	Lin, Ning/AAP-7745-2020; Du, Rose/AAJ-2873-2020; Du, Rose/I-5402-2012	Lin, Ning/0000-0002-3638-4814; Du, Rose/0000-0003-2641-6496	Daniel E. Ponton Fund	Daniel E. Ponton Fund	This work was supported by the Daniel E. Ponton Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baharoglu MI, 2010, STROKE, V41, P1423, DOI 10.1161/STROKEAHA.109.570770; Baharoglu MI, 2012, J NEUROSURGERY; Castro M A, 2009, AJNR Am J Neuroradiol, V30, P297, DOI 10.3174/ajnr.A1323; Cebral JR, 2011, AM J NEURORADIOL, V32, P145, DOI 10.3174/ajnr.A2419; Cebral JR, 2005, AM J NEURORADIOL, V26, P2550; Chien AC, 2011, NEUROSURGERY, V69, P349, DOI 10.1227/NEU.0b013e31821661c3; Dhar S, 2008, NEUROSURGERY, V63, P185, DOI 10.1227/01.NEU.0000316847.64140.81; Ecker Robert D, 2004, Neurosurg Focus, V17, pE4; Elsharkawy A, 2013, NEUROSURGERY; Fukazawa K, 2013, WORLD NEUROSURGERY; Komotar RJ, 2008, NEUROSURGERY, V62, P183, DOI 10.1227/01.NEU.0000311076.64109.2E; Lin N, 2012, J NEUROSURG, V117, P913, DOI 10.3171/2012.7.JNS111766; Macdonald RL, 2012, J NEUROSURGERY; Matsukawa H, 2012, J NEUROSURGERY; Matsukawa H, 2013, J NEUROSURG, V118, P978, DOI 10.3171/2012.11.JNS121210; Miura Y, 2013, STROKE, V44, P519, DOI 10.1161/STROKEAHA.112.675306; Mocco J, 2004, Neurosurg Focus, V17, pE3; Morita A, 2012, NEW ENGL J MED, V366, P2474, DOI 10.1056/NEJMoa1113260; PERLMUTTER D, 1976, J NEUROSURG, V45, P259, DOI 10.3171/jns.1976.45.3.0259; Raghavan ML, 2005, J NEUROSURG, V102, P355, DOI 10.3171/jns.2005.102.2.0355; Rahman M, 2010, STROKE, V41, P916, DOI 10.1161/STROKEAHA.109.574244; Rinkel GJE, 2008, REV NEUROL-FRANCE, V164, P781, DOI 10.1016/j.neurol.2008.07.012; Rinkel GJE, 1998, STROKE, V29, P251, DOI 10.1161/01.STR.29.1.251; Ujiie H, 2001, NEUROSURGERY, V48, P495, DOI 10.1097/00006123-200103000-00007; Vlak MHM, 2011, LANCET NEUROL, V10, P626, DOI 10.1016/S1474-4422(11)70109-0; Weir B, 2002, J NEUROSURG, V96, P3, DOI 10.3171/jns.2002.96.1.0003; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Xiang JP, 2011, STROKE, V42, P144, DOI 10.1161/STROKEAHA.110.592923; Yasuda R, 2011, NEUROSURGERY, V68, P310, DOI 10.1227/NEU.0b013e3182010ed0	29	45	54	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79635	10.1371/journal.pone.0079635	http://dx.doi.org/10.1371/journal.pone.0079635			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236149	Green Submitted, Green Published, gold			2022-12-27	WOS:000327254700148
J	Mackin, KE; Carter, GP; Howarth, P; Rood, JI; Lyras, D				Mackin, Kate E.; Carter, Glen P.; Howarth, Pauline; Rood, Julian I.; Lyras, Dena			Spo0A Differentially Regulates Toxin Production in Evolutionarily Diverse Strains of Clostridium difficile	PLOS ONE			English	Article							TETRACYCLINE RESISTANCE; HYPERVIRULENT STRAIN; EMERGING STRAIN; ALPHA-TOXIN; SPORULATION; GENE; PERFRINGENS; TRANSCRIPTION; HUMANS; IDENTIFICATION	Clostridium difficile is an important pathogen of humans and animals, representing a significant global healthcare problem. The last decade has seen the emergence of epidemic BI/NAP1/027 and ribotype 078 isolates, associated with the onset of more severe disease and higher rates of morbidity and mortality. However, little is known about these isolates at the molecular level, partly due to difficulties in the genetic manipulation of these strains. Here we report the development of an optimised Tn916-mediated plasmid transfer system, and the use of this system to construct and complement spo0A mutants in a number of different C. difficile strain backgrounds. Spo0A is a global regulator known to control sporulation, but may also be involved in the regulation of potential virulence factors and other phenotypes. Recent studies have failed to elucidate the role of Spo0A in toxin A and toxin B production by C. difficile, with conflicting data published to date. In this study, we aimed to clarify the role of Spo0A in production of the major toxins by C. difficile. Through the construction and complementation of spo0A mutants in two ribotype 027 isolates, we demonstrate that Spo0A acts as a negative regulator of toxin A and toxin B production in this strain background. In addition, spo0A was disrupted and subsequently complemented in strain 630 Delta erm and, for the first time, in a ribotype 078 isolate, JGS6133. In contrast to the ribotype 027 strains, Spo0A does not appear to regulate toxin production in strain 630Derm. In strain JGS6133, Spo0A appears to negatively regulate toxin production during early stationary phase, but has little effect on toxin expression during late stationary phase. These data suggest that Spo0A may differentially regulate toxin production in phylogenetically distinct C. difficile strain types. In addition, Spo0A may be involved in regulating some aspects of C. difficile motility.	[Mackin, Kate E.; Carter, Glen P.; Howarth, Pauline; Rood, Julian I.; Lyras, Dena] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia	Monash University	Lyras, D (corresponding author), Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia.	dena.lyras@monash.edu	Rood, Julian I/A-4858-2008	Rood, Julian I/0000-0003-2126-7209; Carter, Glen/0000-0002-7306-9362; Lyras, Dena/0000-0003-2345-9271	Australian National Health and Medical Research Council; Australian Research Council	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by funding from the Australian National Health and Medical Research Council and the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktories K, 2011, NAT REV MICROBIOL, V9, P487, DOI 10.1038/nrmicro2592; ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741, DOI 10.1128/JB.81.5.741-746.1961; Awad MM, 1997, MICROB PATHOGENESIS, V22, P275, DOI 10.1006/mpat.1996.0115; BALLARD J, 1992, INFECT IMMUN, V60, P784, DOI 10.1128/IAI.60.3.784-790.1992; Bauer MP, 2011, LANCET, V377, P63, DOI 10.1016/S0140-6736(10)61266-4; Borriello SP, 1998, J ANTIMICROB CHEMOTH, V41, P13, DOI 10.1093/jac/41.suppl_3.13; Burns DA, 2011, J MICROBIOL METH, V87, P133, DOI 10.1016/j.mimet.2011.07.017; Carter GP, 2007, J BACTERIOL, V189, P7290, DOI 10.1128/JB.00731-07; Carter GP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002317; Carter GP, 2011, INFECT IMMUN, V79, P1025, DOI 10.1128/IAI.00968-10; Dawson LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050527; Deakin LJ, 2012, INFECT IMMUN, V80, P2704, DOI 10.1128/IAI.00147-12; Dingle KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019993; Dupuy B, 1998, MOL MICROBIOL, V27, P107, DOI 10.1046/j.1365-2958.1998.00663.x; Fawcett P, 2000, P NATL ACAD SCI USA, V97, P8063, DOI 10.1073/pnas.140209597; Freeman J, 2010, CLIN MICROBIOL REV, V23, P529, DOI 10.1128/CMR.00082-09; Gerding DN, 2008, CLIN INFECT DIS, V46, pS43, DOI 10.1086/521861; Goorhuis A, 2008, CLIN INFECT DIS, V47, P1162, DOI 10.1086/592257; Goorhuis A, 2008, J CLIN MICROBIOL, V46, P1157, DOI 10.1128/JCM.01536-07; Hall IC, 1931, J BACTERIOL, V22, P375, DOI 10.1128/JB.22.6.375-385.1931; Hammitt MC, 2008, VET MICROBIOL, V127, P343, DOI 10.1016/j.vetmic.2007.09.002; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Huang IH, 2004, FEMS MICROBIOL LETT, V233, P233, DOI [10.1016/j.femsle.2004.02.014, 10.1111/j.1574-6968.2004.tb09487.x]; Hussain HA, 2005, J MED MICROBIOL, V54, P137, DOI 10.1099/jmm.0.45790-0; Janvilisri T, 2009, J BACTERIOL, V191, P3881, DOI 10.1128/JB.00222-09; Jhung MA, 2008, EMERG INFECT DIS, V14, P1039, DOI 10.3201/eid1407.071641; Keel K, 2007, J CLIN MICROBIOL, V45, P1963, DOI 10.1128/JCM.00224-07; Keel MK, 2006, VET PATHOL, V43, P225, DOI 10.1354/vp.43-3-225; Keessen EC, 2011, VET MICROBIOL, V153, P205, DOI 10.1016/j.vetmic.2011.03.020; Lopez D, 2009, FEMS MICROBIOL REV, V33, P152, DOI 10.1111/j.1574-6976.2008.00148.x; LYERLY DM, 1992, INFECT IMMUN, V60, P4633, DOI 10.1128/IAI.60.11.4633-4639.1992; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; MULLANY P, 1990, J GEN MICROBIOL, V136, P1343, DOI 10.1099/00221287-136-7-1343; Nakano MM, 1998, ANNU REV MICROBIOL, V52, P165, DOI 10.1146/annurev.micro.52.1.165; O'Connor JR, 2006, MOL MICROBIOL, V61, P1335, DOI 10.1111/j.1365-2958.2006.05315.x; Paredes CJ, 2005, NAT REV MICROBIOL, V3, P969, DOI 10.1038/nrmicro1288; Paredes-Sabja D, 2011, MICROB PATHOGENESIS, V51, P384, DOI 10.1016/j.micpath.2011.05.006; Pepin J, 2005, CAN MED ASSOC J, V173, P1037, DOI 10.1503/cmaj.050978; Perelle S, 1997, INFECT IMMUN, V65, P1402, DOI 10.1128/IAI.65.4.1402-1407.1997; Poncet S, 1997, MICROBIOL-UK, V143, P2743, DOI 10.1099/00221287-143-8-2743; POSPIECH A, 1995, TRENDS GENET, V11, P217, DOI 10.1016/S0168-9525(00)89052-6; Reynolds CB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002024; Roberts AP, 2003, J MICROBIOL METH, V55, P617, DOI 10.1016/S0167-7012(03)00200-8; ROOD JI, 1983, CAN J MICROBIOL, V29, P1241, DOI 10.1139/m83-193; Rosenbusch KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048608; Sambrook J., 2001, MOL CLONING LAB MANU; Saujet L, 2011, J BACTERIOL, V193, P3186, DOI 10.1128/JB.00272-11; Scaria J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015147; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Stabler RA, 2006, J BACTERIOL, V188, P7297, DOI 10.1128/JB.00664-06; Stabler RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031559; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Underwood S, 2009, J BACTERIOL, V191, P7296, DOI 10.1128/JB.00882-09; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; Zhao YL, 1998, J BACTERIOL, V180, P136, DOI 10.1128/JB.180.1.136-142.1998	59	53	57	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79666	10.1371/journal.pone.0079666	http://dx.doi.org/10.1371/journal.pone.0079666			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236153	Green Published, gold			2022-12-27	WOS:000327254700152
J	Ruiz-Ranwez, V; Posadas, DM; Estein, SM; Abdian, PL; Martin, FA; Zorreguieta, A				Ruiz-Ranwez, Veronica; Posadas, Diana M.; Estein, Silvia M.; Abdian, Patricia L.; Martin, Fernando A.; Zorreguieta, Angeles			The BtaF Trimeric Autotransporter of Brucella suis Is Involved in Attachment to Various Surfaces, Resistance to Serum and Virulence	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; PROTEIN SECRETION; MORAXELLA-CATARRHALIS; BACTERIAL ADHESION; ABORTUS; CLONING; PATHWAY; COMPLEMENT; ACTIVATION; PREDICTION	The adhesion of bacterial pathogens to host cells is an event that determines infection, and ultimately invasion and intracellular multiplication. Several evidences have recently shown that this rule is also truth for the intracellular pathogen Brucella. Brucella suis displays the unipolar BmaC and BtaE adhesins, which belong to the monomeric and trimeric autotransporter (TA) families, respectively. It was previously shown that these adhesins are involved in bacterial adhesion to host cells and components of the extracellular matrix (ECM). In this work we describe the role of a new member of the TA family of B. suis (named BtaF) in the adhesive properties of the bacterial surface. BtaF conferred the bacteria that carried it a promiscuous adhesiveness to various ECM components and the ability to attach to an abiotic surface. Furthermore, BtaF was found to participate in bacterial adhesion to epithelial cells and was required for full virulence in mice. Similar to BmaC and BtaE, the BtaF adhesin was expressed in a small subpopulation of bacteria, and in all cases, it was detected at the new pole generated after cell division. Interestingly, BtaF was also implicated in the resistance of B. suis to porcine serum. Our findings emphasize the impact of TAs in the Brucella lifecycle.	[Ruiz-Ranwez, Veronica; Posadas, Diana M.; Abdian, Patricia L.; Martin, Fernando A.; Zorreguieta, Angeles] Fdn Inst Leloir, Buenos Aires, DF, Argentina; [Ruiz-Ranwez, Veronica; Posadas, Diana M.; Abdian, Patricia L.; Martin, Fernando A.; Zorreguieta, Angeles] Consejo Nacl Invest Cient & Tecn, IIBBA, RA-1033 Buenos Aires, DF, Argentina; [Posadas, Diana M.; Martin, Fernando A.; Zorreguieta, Angeles] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina; [Estein, Silvia M.] Univ Nacl Cent Provincia Buenos Aires, Ctr Invest Vet Tandil CIVETAN, Fac Ciencias Vet, Lab Inmunol, Tandil, Buenos Aires, Argentina	Leloir Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Zorreguieta, A (corresponding author), Fdn Inst Leloir, Buenos Aires, DF, Argentina.	azorreguieta@leloir.org.ar	Abdian, Patricia/AAW-2420-2020; Martin, Fernando Ariel/AAA-6941-2021; martin, Fernando Ariel/GYV-1866-2022	Abdian, Patricia/0000-0002-8366-8115; ESTEIN, SILVIA/0000-0002-9533-0680	University of Buenos Aires [UBACyT, X-245, X-997]; CONICET [PIP 545]	University of Buenos Aires(University of Buenos Aires); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by grants from University of Buenos Aires (UBACyT, X-245 and X-997) and from CONICET (PIP 545) to AZ. VRR, DMP, and FAM were supported by fellowships from CONICET, Argentina. AZ and PLA are research fellows of CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acha PN, 1980, ZOONOSES COMMUNICABL, Vxv; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atluri VL, 2011, ANNU REV MICROBIOL, V65, P523, DOI 10.1146/annurev-micro-090110-102905; Attia AS, 2005, INFECT IMMUN, V73, P2400, DOI 10.1128/IAI.73.4.2400-2410.2005; Barquero-Calvo E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000631; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Brown PJB, 2012, P NATL ACAD SCI USA, V109, P1697, DOI 10.1073/pnas.1114476109; Bujnicki JM, 2001, BIOINFORMATICS, V17, P750, DOI 10.1093/bioinformatics/17.8.750; Castaneda-Roldan EI, 2004, CELL MICROBIOL, V6, P435, DOI 10.1111/j.1462-5822.2004.00372.x; Castaneda-Roldan EI, 2006, CELL MICROBIOL, V8, P1877, DOI 10.1111/j.1462-5822.2006.00754.x; Celli J, 2004, CURR OPIN MICROBIOL, V7, P93, DOI 10.1016/j.mib.2003.11.001; Cheng HP, 1998, J BACTERIOL, V180, P5183, DOI 10.1128/JB.180.19.5183-5191.1998; Conde-Alvarez R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002675; Conners R, 2008, EMBO J, V27, P1779, DOI 10.1038/emboj.2008.101; Cotter SE, 2005, TRENDS MICROBIOL, V13, P199, DOI 10.1016/j.tim.2005.03.004; Czibener C, 2012, MICROBES INFECT, V14, P79, DOI 10.1016/j.micinf.2011.08.012; Dautin N, 2007, ANNU REV MICROBIOL, V61, P89, DOI 10.1146/annurev.micro.61.080706.093233; Delpino MV, 2007, INFECT IMMUN, V75, P299, DOI 10.1128/IAI.00952-06; Dotreppe D, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-257; FERNANDEZ RC, 1994, INFECT IMMUN, V62, P4727, DOI 10.1128/IAI.62.11.4727-4738.1994; Fernandez-Prada CM, 2001, INFECT IMMUN, V69, P4407, DOI 10.1128/IAI.69.7.4407-4416.2001; FINE DP, 1974, J IMMUNOL, V112, P763; Godefroid M, 2010, FEMS IMMUNOL MED MIC, V59, P364, DOI 10.1111/j.1574-695X.2010.00689.x; Hallez R, 2007, EMBO J, V26, P1444, DOI 10.1038/sj.emboj.7601577; Hallstrom T, 2011, J IMMUNOL, V186, P3120, DOI 10.4049/jimmunol.1002621; HEESEMANN J, 1983, J INFECT DIS, V147, P107, DOI 10.1093/infdis/147.1.107; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Henderson IR, 1998, TRENDS MICROBIOL, V6, P370, DOI 10.1016/S0966-842X(98)01318-3; Hernandez-Castro R, 2008, MICROB PATHOGENESIS, V44, P28, DOI 10.1016/j.micpath.2007.08.008; HOFFMANN EM, 1983, VET IMMUNOL IMMUNOP, V5, P65, DOI 10.1016/0165-2427(83)90032-6; Hoiczyk E, 2000, EMBO J, V19, P5989, DOI 10.1093/emboj/19.22.5989; Jacob-Dubuisson F, 2004, BBA-MOL CELL RES, V1694, P235, DOI 10.1016/j.bbamcr.2004.03.008; Kaiser PO, 2012, CELL MICROBIOL, V14, P198, DOI 10.1111/j.1462-5822.2011.01711.x; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kurowski MA, 2003, NUCLEIC ACIDS RES, V31, P3305, DOI 10.1093/nar/gkg557; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Marr N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020585; Martirosyan A, 2011, IMMUNOL REV, V240, P211, DOI 10.1111/j.1600-065X.2010.00982.x; MORENO E, 1981, INFECT IMMUN, V31, P362, DOI 10.1128/IAI.31.1.362-370.1981; Newman CL, 2004, CRIT REV MICROBIOL, V30, P275, DOI 10.1080/10408410490499872; Nordstrom T, 2004, J IMMUNOL, V173, P4598, DOI 10.4049/jimmunol.173.7.4598; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; Paixao TA, 2009, INFECT IMMUN, V77, P4197, DOI 10.1128/IAI.00417-09; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Paulsen IT, 2002, P NATL ACAD SCI USA, V99, P13148, DOI 10.1073/pnas.192319099; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P5711; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P2387; Pizarro-Cerda J, 1999, BRUCELLA ABORTUS INV; Posadas DM, 2012, CELL MICROBIOL, V14, P965, DOI 10.1111/j.1462-5822.2012.01771.x; Roop RM, 2009, MED MICROBIOL IMMUN, V198, P221, DOI 10.1007/s00430-009-0123-8; Ruiz-Ranwez V, 2013, INFECT IMMUN, V81, P996, DOI 10.1128/IAI.01241-12; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Seleem MN, 2010, VET MICROBIOL, V140, P392, DOI 10.1016/j.vetmic.2009.06.021; Serruto D, 2009, CELL MICROBIOL, V11, P1044, DOI 10.1111/j.1462-5822.2009.01306.x; Skerker JM, 2004, NAT REV MICROBIOL, V2, P325, DOI 10.1038/nrmicro864; Szczesny P, 2008, BIOINFORMATICS, V24, P1251, DOI 10.1093/bioinformatics/btn118; Thorne E. Tom, 2001, P372, DOI 10.1002/9780470344880.ch22; Tomlinson AD, 2009, CURR OPIN MICROBIOL, V12, P708, DOI 10.1016/j.mib.2009.09.014; Van der Henst C, 2012, J BACTERIOL, V194, P5305, DOI 10.1128/JB.00699-12; VERGER JM, 1985, INT J SYST BACTERIOL, V35, P292, DOI 10.1099/00207713-35-3-292	64	19	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79770	10.1371/journal.pone.0079770	http://dx.doi.org/10.1371/journal.pone.0079770			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236157	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700157
J	Ambosta, AH; Reichert, JF; Kelly, DM				Ambosta, Althea H.; Reichert, James F.; Kelly, Debbie M.			Reorienting in Virtual 3D Environments: Do Adult Humans Use Principal Axes, Medial Axes or Local Geometry?	PLOS ONE			English	Article							INFORMATION-CONTENT; ORIENTATION; IMAGES; NAVIGATION; PIGEONS; MODULE; CUES	Studies have shown that animals, including humans, use the geometric properties of environments to orient. It has been proposed that orientation is accomplished primarily by encoding the principal axes (i.e., global geometry) of an environment. However, recent research has shown that animals use local information such as wall length and corner angles as well as local shape parameters (i.e., medial axes) to orient. The goal of the current study was to determine whether adult humans reorient according to global geometry based on principal axes or whether reliance is on local geometry such as wall length and sense information or medial axes. Using a virtual environment task, participants were trained to select a response box located at one of two geometrically identical corners within a featureless rectangular-shaped environment. Participants were subsequently tested in a transformed L-shaped environment that allowed for a dissociation of strategies based on principal axes, medial axes and local geometry. Results showed that participants relied primarily on a medial axes strategy to reorient in the L-shaped test environment. Importantly, the search behaviour of participants could not be explained by a principal axes-based strategy.	[Ambosta, Althea H.; Reichert, James F.; Kelly, Debbie M.] Univ Manitoba, Dept Psychol, Winnipeg, MB R3T 2N2, Canada	University of Manitoba	Kelly, DM (corresponding author), Univ Manitoba, Dept Psychol, Winnipeg, MB R3T 2N2, Canada.	Debbie.Kelly@umanitoba.ca			Natural Sciences and Engineering Research Council of Canada [214113]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Natural Sciences and Engineering Research Council of Canada, grant#214113, http://www.nserc-crsng.gc.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodily KD, 2011, ANIM COGN, V14, P665, DOI 10.1007/s10071-011-0401-x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cheng K, 2005, PSYCHON B REV, V12, P1, DOI 10.3758/BF03196346; Cheng K, 2005, J EXP PSYCHOL-ANIM B, V31, P254, DOI 10.1037/0097-7403.31.2.254; CHENG K, 1986, COGNITION, V23, P149, DOI 10.1016/0010-0277(86)90041-7; Cheng K, 2005, CONNECT SCI, V17, P5, DOI 10.1080/09540090500138077; Cheung A, 2008, J EXP PSYCHOL ANIM B, V34, P15, DOI 10.1037/0097-7403.34.1.15; Epstein RA, 2008, TRENDS COGN SCI, V12, P388, DOI 10.1016/j.tics.2008.07.004; Gallistel C. R., 1990, ORG LEARNING; Graham P, 2009, CURR BIOL, V19, pR935, DOI 10.1016/j.cub.2009.08.015; Kelly Debbie M., 2011, Communicative & Integrative Biology, V4, P710; Kelly DM, 2011, BIOL LETTERS, V7, P372, DOI 10.1098/rsbl.2010.1024; Kelly DM, 2005, J EXP PSYCHOL HUMAN, V31, P1391, DOI 10.1037/0096-1523.31.6.1391; Kelly DM, 2001, J EXP PSYCHOL-ANIM B, V27, P417, DOI 10.1037//0097-7403.27.4.417; Lent DD, 2013, CURR BIOL, V23, P684, DOI 10.1016/j.cub.2013.03.016; Lubyk DM, 2012, PSYCHON B REV, V19, P436, DOI 10.3758/s13423-012-0232-z; Lubyk DM, 2012, ANIM COGN, V15, P305, DOI 10.1007/s10071-011-0454-x; McGregor A, 2006, J EXP PSYCHOL-ANIM B, V32, P314, DOI 10.1037/0097-7403.32.3.314; Parsons TD, 2004, NEUROPSYCHOLOGIA, V42, P555, DOI 10.1016/j.neuropsychologia.2003.08.014; Pearce JM, 2004, J EXP PSYCHOL ANIM B, V30, P135, DOI 10.1037/0097-7403.30.2.135; Pecchia T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022657; Pecchia T, 2010, J EXP BIOL, V213, P2987, DOI 10.1242/jeb.043315; Sandstrom NJ, 1998, COGNITIVE BRAIN RES, V6, P351, DOI 10.1016/S0926-6410(98)00002-0; Spetch ML, 1997, J COMP PSYCHOL, V111, P14, DOI 10.1037/0735-7036.111.1.14; Sturzl W, 2008, J EXP PSYCHOL ANIM B, V34, P1, DOI 10.1037/0097-7403.34.1.1; Sturz BR, 2012, PSYCHON B REV, V19, P270, DOI 10.3758/s13423-011-0195-5; Sturz BR, 2011, PSYCHON B REV, V18, P848, DOI 10.3758/s13423-011-0111-z; Sturz BR, 2011, J EXP PSYCHOL-ANIM B, V37, P246, DOI 10.1037/a0021215; Tommasi L, 2004, ANIM COGN, V7, P53, DOI 10.1007/s10071-003-0182-y; VANDENBERG SG, 1978, PERCEPT MOTOR SKILL, V47, P599, DOI 10.2466/pms.1978.47.2.599; Wystrach A, 2012, ANIM BEHAV, V84, P13, DOI 10.1016/j.anbehav.2012.04.017; Wystrach A, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-21; Zeil J, 2012, CURR OPIN NEUROBIOL, V22, P285, DOI 10.1016/j.conb.2011.12.008	33	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78985	10.1371/journal.pone.0078985	http://dx.doi.org/10.1371/journal.pone.0078985			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	247EE	24223869	Green Published, Green Submitted, gold			2022-12-27	WOS:000326597400043
J	Ito, G; Okamoto, R; Murano, T; Shimizu, H; Fujii, S; Nakata, T; Mizutani, T; Yui, S; Akiyama-Morio, J; Nemoto, Y; Okada, E; Araki, A; Ohtsuka, K; Tsuchiya, K; Nakamura, T; Watanabe, M				Ito, Go; Okamoto, Ryuichi; Murano, Tatsuro; Shimizu, Hiromichi; Fujii, Satoru; Nakata, Toru; Mizutani, Tomohiro; Yui, Shiro; Akiyama-Morio, Junko; Nemoto, Yasuhiro; Okada, Eriko; Araki, Akihiro; Ohtsuka, Kazuo; Tsuchiya, Kiichiro; Nakamura, Tetsuya; Watanabe, Mamoru			Lineage-Specific Expression of Bestrophin-2 and Bestrophin-4 in Human Intestinal Epithelial Cells	PLOS ONE			English	Article							BICARBONATE SECRETION; CYSTIC-FIBROSIS; ULCERATIVE-COLITIS; MACULAR DYSTROPHY; GENE-EXPRESSION; ION-TRANSPORT; HUMAN COLON; FAMILY; DIFFERENTIATION; IDENTIFICATION	Intestinal epithelial cells (IECs) regulate the absorption and secretion of anions, such as HCO3(-) or Cl-. Bestrophin genes represent a newly identified group of calcium-activated Cl- channels (CaCCs). Studies have suggested that, among the four human bestrophin-family genes, bestrophin-2 (BEST2) and bestrophin-4 (BEST4) might be expressed within the intestinal tissue. Consistently, a study showed that BEST2 is expressed by human colonic goblet cells. However, their precise expression pattern along the gastrointestinal tract, or the lineage specificity of the cells expressing these genes, remains largely unknown. Here, we show that BEST2 and BEST4 are expressed in vivo, each in a distinct, lineage-specific manner, in human IECs. While BEST2 was expressed exclusively in colonic goblet cells, BEST4 was expressed in the absorptive cells of both the small intestine and the colon. In addition, we found that BEST2 expression is significantly down-regulated in the active lesions of ulcerative colitis, where goblet cells were depleted, suggesting that BEST2 expression is restricted to goblet cells under both normal and pathologic conditions. Consistently, the induction of goblet cell differentiation by a Notch inhibitor, LY411575, significantly up-regulated the expression of not BEST4 but BEST2 in MUC2-positive HT-29 cells. Conversely, the induction of absorptive cell differentiation up-regulated the expression of BEST4 in villin-positive Caco-2 cells. In addition, we found that the up- or down-regulation of Notch activity leads to the preferential expression of either BEST4 or BEST2, respectively, in LS174T cells. These results collectively confirmed that BEST2 and BEST4 could be added to the lineage-specific genes of humans IECs due to their abilities to clearly identify goblet cells of colonic origin and a distinct subset of absorptive cells, respectively.	[Ito, Go; Okamoto, Ryuichi; Murano, Tatsuro; Shimizu, Hiromichi; Fujii, Satoru; Nakata, Toru; Mizutani, Tomohiro; Yui, Shiro; Akiyama-Morio, Junko; Nemoto, Yasuhiro; Okada, Eriko; Araki, Akihiro; Ohtsuka, Kazuo; Tsuchiya, Kiichiro; Nakamura, Tetsuya; Watanabe, Mamoru] Tokyo Med & Dent Univ, Grad Sch, Dept Gastroenterol & Hepatol, Tokyo, Japan; [Okamoto, Ryuichi; Tsuchiya, Kiichiro; Nakamura, Tetsuya] Tokyo Med & Dent Univ, Grad Sch, Dept Adv GI Therapeut, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Okamoto, R (corresponding author), Tokyo Med & Dent Univ, Grad Sch, Dept Gastroenterol & Hepatol, Tokyo, Japan.	rokamoto.gast@tmd.ac.jp	Tsuchiya, Kiichiro/AAB-1769-2020; Okamoto, Ryuichi/I-1130-2019; Watanabe, Mamoru/AHE-0489-2022; Mizutani, Tomohiro/AAX-5650-2021	Tsuchiya, Kiichiro/0000-0002-1977-8707; Okamoto, Ryuichi/0000-0002-7047-571X; Mizutani, Tomohiro/0000-0002-8373-7969; Yui, Shiro/0000-0003-4268-647X	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan; Grants-in-Aid for Scientific Research [25293170, 25460945] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid for Young Scientists (B) (to RO and JA-M), Scientific Research (C) (to KI), Scientific Research (B) (to TN), Scientific Research (S) (to MW), Exploratory Research (to MW) and Scientific Research on Innovative Areas "Chemical Biology of Natural Products" (to RO and TN) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Health and Labor Sciences Research Grant (to RO and MW) from the Ministry of Health, Labor and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama J, 2010, BIOCHEM BIOPH RES CO, V393, P662, DOI 10.1016/j.bbrc.2010.02.048; Barrett KE, 2000, ANNU REV PHYSIOL, V62, P535, DOI 10.1146/annurev.physiol.62.1.535; Binder HJ, 2005, J CLIN GASTROENTEROL, V39, pS53, DOI 10.1097/01.mcg.0000155521.81382.3a; Caldwell GM, 1999, GENOMICS, V58, P98, DOI 10.1006/geno.1999.5808; CARPENTER CC, 1972, J INFECT DIS, V126, P551, DOI 10.1093/infdis/126.5.551; Danese S, 2011, NEW ENGL J MED, V365, P1713, DOI 10.1056/NEJMra1102942; De Lisle RC, 2009, J CLIN INVEST, V119, P2535, DOI 10.1172/JCI40598; Farkas K, 2011, INFLAMM BOWEL DIS, V17, P884, DOI 10.1002/ibd.21432; Field M, 2003, J CLIN INVEST, V111, P931, DOI 10.1172/JCI200318326; Garcia MAS, 2009, J CLIN INVEST, V119, P2613, DOI 10.1172/JCI38662; Greger R, 2000, ANNU REV PHYSIOL, V62, P467, DOI 10.1146/annurev.physiol.62.1.467; Gruber AD, 1998, GENOMICS, V54, P200, DOI 10.1006/geno.1998.5562; Gustafsson JK, 2012, J EXP MED, V209, P1263, DOI 10.1084/jem.20120562; Hartzell HC, 2008, PHYSIOL REV, V88, P639, DOI 10.1152/physrev.00022.2007; Hino K, 2008, RNA, V14, P1433, DOI 10.1261/rna.810208; Ito T, 2000, DEVELOPMENT, V127, P3913; Iwasaki M, 2011, J GASTROENTEROL, V46, P191, DOI 10.1007/s00535-010-0346-x; Jacob P, 2002, GASTROENTEROLOGY, V122, P709, DOI 10.1053/gast.2002.31875; Komiya T, 1999, BIOCHEM BIOPH RES CO, V255, P347, DOI 10.1006/bbrc.1999.0168; Laubitz D, 2008, AM J PHYSIOL-GASTR L, V295, pG63, DOI 10.1152/ajpgi.90207.2008; Martinez-Augustin O, 2009, INFLAMM BOWEL DIS, V15, P114, DOI 10.1002/ibd.20579; Murayama M, 2009, J GASTROENTEROL, V44, P173, DOI 10.1007/s00535-008-2284-4; Nakamura T, 2007, J GASTROENTEROL, V42, P705, DOI 10.1007/s00535-007-2087-z; Nemeth ZH, 2002, AM J PHYSIOL-GASTR L, V283, pG122, DOI 10.1152/ajpgi.00015.2002; Okada S, 2003, FEBS LETT, V540, P157, DOI 10.1016/S0014-5793(03)00256-4; Okamoto R, 2002, NAT MED, V8, P1011, DOI 10.1038/nm755; Okamoto R, 2009, AM J PHYSIOL-GASTR L, V296, pG23, DOI 10.1152/ajpgi.90225.2008; Oshima S, 2004, MOL CELL BIOL, V24, P6298, DOI 10.1128/MCB.24.14.6298-6310.2004; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; Quinton PM, 2008, LANCET, V372, P415, DOI 10.1016/S0140-6736(08)61162-9; Stohr H, 2002, EUR J HUM GENET, V10, P281, DOI 10.1038/sj.ejhg.5200796; Tsuchiya K, 2007, GASTROENTEROLOGY, V132, P208, DOI 10.1053/j.gastro.2006.10.031; Tsunenari T, 2003, J BIOL CHEM, V278, P41114, DOI 10.1074/jbc.M306150200; Yu K, 2010, J CLIN INVEST, V120, P1722, DOI 10.1172/JCI41129; Zheng X, 2011, INFLAMM BOWEL DIS, V17, P2251, DOI 10.1002/ibd.21611	35	24	24	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79693	10.1371/journal.pone.0079693	http://dx.doi.org/10.1371/journal.pone.0079693			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223998	gold, Green Submitted, Green Published			2022-12-27	WOS:000326597400082
J	Ferrando, M; Wan, XH; Meiss, R; Yang, J; De Siervi, A; Navone, N; Vazquez, E				Ferrando, Mercedes; Wan, Xinhai; Meiss, Roberto; Yang, Jun; De Siervi, Adriana; Navone, Nora; Vazquez, Elba			Heme Oxygenase-1 (HO-1) Expression in Prostate Cancer Cells Modulates the Oxidative Response in Bone Cells	PLOS ONE			English	Article							OSTEOBLAST DIFFERENTIATION; UP-REGULATION; BETA-CATENIN; OSTEOCLASTOGENESIS; STRESS; ACTIVATION; GROWTH	Prostate cancer (PCa) is a leading cause of death among males. It is currently estimated that inflammatory responses are linked to 15-20% of all deaths from cancer worldwide. PCa is dominated by complications arising from metastasis to the bone where the tumor cells interact with the bone microenvironment impairing the balance between bone formation and degradation. However, the molecular nature of this interaction is not completely understood. Heme oxygenase-1 (HO-1) counteracts oxidative damage and inflammation. Previous studies from our laboratory showed that HO-1 is implicated in PCa, demonstrating that endogenous HO-1 inhibits bone derived-prostate cancer cells proliferation, invasion and migration and decreases tumor growth and angiogenesis in vivo. The aim of this work was to analyze the impact of HO-1 modulated PCa cells on osteoblasts proliferation in vitro and on bone remodeling in vivo. Using a co-culture system of PC3 cells with primary mice osteoblasts (PMOs), we demonstrated that HO-1 pharmacological induction (hemin treatment) abrogated the diminution of PMOs proliferation induced by PCa cells and decreased the expression of osteoclast-modulating factors in osteoblasts. No changes were detected in the expression of genes involved in osteoblasts differentiation. However, co-culture of hemin pre-treated PC3 cells (PC3 Hem) with PMOs provoked an oxidative status and activated FoxO signaling in osteoblasts. The percentage of active osteoblasts positive for HO-1 increased in calvarias explants co-cultured with PC3 Hem cells. Nuclear HO-1 expression was detected in tumors generated by in vivo bone injection of HO-1 stable transfected PC3 (PC3HO-1) cells in the femur of SCID mice. These results suggest that HO-1 has the potential to modify the bone microenvironment impacting on PCa bone metastasis.	[Ferrando, Mercedes; De Siervi, Adriana; Vazquez, Elba] Univ Buenos Aires, Dept Biol Chem, Sch Sci, IQUIBICEN CONICET, Buenos Aires, DF, Argentina; [Wan, Xinhai; Yang, Jun; Navone, Nora] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Meiss, Roberto] Natl Acad Med Buenos Aires, Inst Oncol Studies, Dept Pathol, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Texas System; UTMD Anderson Cancer Center; Buenos Aires National Academy of Medicine	Vazquez, E (corresponding author), Univ Buenos Aires, Dept Biol Chem, Sch Sci, IQUIBICEN CONICET, Buenos Aires, DF, Argentina.	elba@qb.fcen.uba.ar	De Siervi, Adriana/AAC-7177-2020; Vazquez, Elba/D-5134-2019	De Siervi, Adriana/0000-0002-1524-8063; Vazquez, Elba/0000-0002-0460-0236	University of Buenos Aires, Argentina; UBACyT [20020100100179]; ANPCYT [PICT RAICES 2010-0431]; CONICET; UICC International Cancer Technology Transfer Fellowship; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	University of Buenos Aires, Argentina(University of Buenos Aires); UBACyT; ANPCYT(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); UICC International Cancer Technology Transfer Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the University of Buenos Aires, Argentina, UBACyT (20020100100179) and ANPCYT (PICT RAICES 2010-0431). M. F. held fellowships from CONICET and UICC International Cancer Technology Transfer Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida M, 2007, J BIOL CHEM, V282, P27298, DOI 10.1074/jbc.M702811200; Almeida M, 2011, BONE, V49, P319, DOI 10.1016/j.bone.2011.05.023; Bai XC, 2004, BIOCHEM BIOPH RES CO, V314, P197, DOI 10.1016/j.bbrc.2003.12.073; Barbagallo I, 2010, J BONE MINER METAB, V28, P276, DOI 10.1007/s00774-009-0134-y; Battisti V, 2011, BIOMED PHARMACOTHER, V65, P516, DOI 10.1016/j.biopha.2011.06.003; Clerigues V, 2012, BIOCHEM PHARMACOL, V83, P395, DOI 10.1016/j.bcp.2011.11.024; Darash-Yahana M, 2004, FASEB J, V18, P1240, DOI 10.1096/fj.03-0935fje; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Elguero B, 2012, NEOPLASIA, V14, P1043, DOI 10.1593/neo.121358; Feller L, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-24; Ferrando M, 2011, ANGIOGENESIS, V14, P467, DOI 10.1007/s10456-011-9230-4; Fizazi K, 2003, CLIN CANCER RES, V9, P2587; Freshney RI, 1994, CULTURE ANIMAL CELLS; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Glass DA, 2007, ENDOCRINOLOGY, V148, P2630, DOI 10.1210/en.2006-1372; Goldring SR, 2002, J RHEUMATOL, V29, P44; Graves DT, 2011, J DENT RES, V90, P143, DOI 10.1177/0022034510385236; Grochot-Przeczek A, 2012, CLIN SCI, V122, P93, DOI 10.1042/CS20110147; Gueron G, 2009, MOL CANCER RES, V7, P1745, DOI 10.1158/1541-7786.MCR-08-0325; Guise TA, 2006, CLIN CANCER RES, V12, p6213S, DOI 10.1158/1078-0432.CCR-06-1007; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Kido J, 1997, J CELL BIOCHEM, V67, P248; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Lahusen T, 2003, MOL CARCINOGEN, V36, P183, DOI 10.1002/mc.10114; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Lin TH, 2010, J CELL PHYSIOL, V222, P757, DOI 10.1002/jcp.22008; Logothetis CJ, 2005, NAT REV CANCER, V5, P21, DOI 10.1038/nrc1528; Martinez J, 1996, J CELL BIOCHEM, V61, P18, DOI 10.1002/(SICI)1097-4644(19960401)61:1<18::AID-JCB3>3.0.CO;2-5; Pratap J, 2003, CANCER RES, V63, P5357; Sacca P, 2007, BRIT J CANCER, V97, P1683, DOI 10.1038/sj.bjc.6604081; Sakai E, 2013, J PHARMACOL SCI, V121, P288, DOI 10.1254/jphs.12243FP; Vanella L, 2010, BONE, V46, P236, DOI 10.1016/j.bone.2009.10.012; Wauquier F, 2009, TRENDS MOL MED, V15, P468, DOI 10.1016/j.molmed.2009.08.004; Yang J, 2001, CANCER RES, V61, P5652; Zwerina J, 2005, FASEB J, V19, P2011, DOI 10.1096/fj.05-4278fje	37	16	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e80315	10.1371/journal.pone.0080315	http://dx.doi.org/10.1371/journal.pone.0080315			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24224047	gold, Green Published			2022-12-27	WOS:000326503400153
J	Kida, T; Kakigi, R				Kida, Tetsuo; Kakigi, Ryusuke			Task-Related Changes in Functional Properties of the Human Brain Network Underlying Attentional Control	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; SPATIAL ATTENTION; PREPARATORY STATES; CONNECTIVITY; EVENT; STIMULUS; LINKS; DESYNCHRONIZATION; SYNCHRONIZATION; MODULATION	Previous studies have demonstrated task-related changes in brain activation and inter-regional connectivity but the temporal dynamics of functional properties of the brain during task execution is still unclear. In the present study, we investigated task-related changes in functional properties of the human brain network by applying graph-theoretical analysis to magnetoencephalography (MEG). Subjects performed a cue-target attention task in which a visual cue informed them of the direction of focus for incoming auditory or tactile target stimuli, but not the sensory modality. We analyzed the MEG signal in the cue-target interval to examine network properties during attentional control. Cluster-based non-parametric permutation tests with the Monte-Carlo method showed that in the cue-target interval, beta activity was desynchronized in the sensori-motor region including premotor and posterior parietal regions in the hemisphere contralateral to the attended side. Graph-theoretical analysis revealed that, in beta frequency, global hubs were found around the sensori-motor and prefrontal regions, and functional segregation over the entire network was decreased during attentional control compared to the baseline. Thus, network measures revealed task-related temporal changes in functional properties of the human brain network, leading to the understanding of how the brain dynamically responds to task execution as a network.	[Kida, Tetsuo] Waseda Univ, Waseda Inst Adv Study, Tokyo, Japan; [Kida, Tetsuo; Kakigi, Ryusuke] Natl Inst Physiol Sci, Dept Integrat Physiol, Okazaki, Aichi 444, Japan	Waseda University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Kida, T (corresponding author), Waseda Univ, Waseda Inst Adv Study, Tokyo, Japan.	tkida@aoni.waseda.jp	Kida, Tetsuo/GSD-8744-2022	Kida, Tetsuo/0000-0003-3499-0762	Waseda University [2012A-935]; Japan Society for the Promotion of Science (JSPS) [25705021]; National Institute for Physiological Sciences	Waseda University; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institute for Physiological Sciences(National Institutes of Natural Sciences (NINS) - JapanNational Institute for Physiological Sciences (NIPS))	This study was supported by a Waseda University Grant for Special Research Projects (No. 2012A-935) and Grants-in-Aid for Young Scientists(A)(No. 25705021) from the Japan Society for the Promotion of Science (JSPS) to T.K., and the Cooperative Study Program of National Institute for Physiological Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2012, P NATL ACAD SCI USA, V109, P20608, DOI 10.1073/pnas.1208933109; Akaishi R, 2010, J NEUROSCI, V30, P4295, DOI 10.1523/JNEUROSCI.6198-09.2010; Anderson KL, 2011, NEUROSCIENCE, V180, P165, DOI 10.1016/j.neuroscience.2011.02.004; Bastiaansen MCM, 2001, CLIN NEUROPHYSIOL, V112, P393, DOI 10.1016/S1388-2457(00)00537-X; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chambers CD, 2004, NEURON, V44, P925, DOI 10.1016/j.neuron.2004.12.009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; de Bie HMA, 2012, HUM BRAIN MAPP, V33, P1189, DOI 10.1002/hbm.21280; de Haan W, 2012, NEUROIMAGE, V59, P3085, DOI 10.1016/j.neuroimage.2011.11.055; de Pasquale F, 2013, NEUROIMAGE, V69, P51, DOI 10.1016/j.neuroimage.2012.11.051; Dodel S, 2002, NEUROCOMPUTING, V44, P1065, DOI 10.1016/S0925-2312(02)00416-2; Eimer M, 2002, J COGNITIVE NEUROSCI, V14, P254, DOI 10.1162/089892902317236885; Fuggetta G, 2006, J NEUROPHYSIOL, V95, P3277, DOI 10.1152/jn.01273.2005; Gherri E, 2008, CLIN NEUROPHYSIOL, V119, P2587, DOI 10.1016/j.clinph.2008.07.214; Gili T, 2013, J NEUROSCI, V33, P4024, DOI 10.1523/JNEUROSCI.3480-12.2013; Hillebrand A, 2012, NEUROIMAGE, V59, P3909, DOI 10.1016/j.neuroimage.2011.11.005; Hinrichs H, 2008, HUM BRAIN MAPP, V29, P193, DOI 10.1002/hbm.20382; Hipp JF, 2012, NAT NEUROSCI, V15, P884, DOI 10.1038/nn.3101; Jones SR, 2010, J NEUROSCI, V30, P13760, DOI 10.1523/JNEUROSCI.2969-10.2010; Kida T, 2007, J NEUROPHYSIOL, V97, P3585, DOI 10.1152/jn.00007.2007; Kida T, 2011, J NEUROPHYSIOL, V105, P674, DOI 10.1152/jn.00807.2009; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lahnakoski JM, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00233; Macaluso E, 2003, EXP BRAIN RES, V149, P62, DOI 10.1007/s00221-002-1335-y; Macaluso E, 2002, J COGNITIVE NEUROSCI, V14, P389, DOI 10.1162/089892902317361912; Macaluso E, 2001, EXP BRAIN RES, V137, P445, DOI 10.1007/s002210000656; Morishima Y, 2009, NAT NEUROSCI, V12, P85, DOI 10.1038/nn.2237; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rushworth MFS, 2003, NEUROIMAGE, V20, pS89, DOI 10.1016/j.neuroimage.2003.09.011; Rushworth MFS, 2001, NAT NEUROSCI, V4, P656, DOI 10.1038/88492; Sakai K, 2003, NAT NEUROSCI, V6, P75, DOI 10.1038/nn987; Sakai K, 2002, NAT NEUROSCI, V5, P479, DOI 10.1038/nn846; Seiss E, 2009, CLIN NEUROPHYSIOL, V120, P1087, DOI 10.1016/j.clinph.2009.03.016; Siegel M, 2008, NEURON, V60, P709, DOI 10.1016/j.neuron.2008.09.010; Spence C, 1996, J EXP PSYCHOL HUMAN, V22, P1005, DOI 10.1037/0096-1523.22.4.1005; Stam CJ, 2012, NEUROIMAGE, V62, P1415, DOI 10.1016/j.neuroimage.2012.05.050; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Stam CJ, 2004, NEUROSCI LETT, V355, P25, DOI 10.1016/j.neulet.2003.10.063; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Supp GG, 2011, CURR BIOL, V21, P1988, DOI 10.1016/j.cub.2011.10.017; van den Heuvel MP, 2010, J NEUROSCI, V30, P15915, DOI 10.1523/JNEUROSCI.2874-10.2010; van Ede F, 2011, J NEUROSCI, V31, P2016, DOI 10.1523/JNEUROSCI.5630-10.2011; van Ede F, 2010, NEUROIMAGE, V51, P867, DOI 10.1016/j.neuroimage.2010.02.053	45	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79023	10.1371/journal.pone.0079023	http://dx.doi.org/10.1371/journal.pone.0079023			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223876	Green Published, Green Submitted, gold			2022-12-27	WOS:000326503400096
J	Sanjurjo, L; Amezaga, N; Vilaplana, C; Caceres, N; Marzo, E; Valeri, M; Cardona, PJ; Sarrias, MR				Sanjurjo, Lucia; Amezaga, Nuria; Vilaplana, Cristina; Caceres, Neus; Marzo, Elena; Valeri, Marta; Cardona, Pere-Joan; Sarrias, Maria-Rosa			The Scavenger Protein Apoptosis Inhibitor of Macrophages (AIM) Potentiates the Antimicrobial Response against Mycobacterium tuberculosis by Enhancing Autophagy	PLOS ONE			English	Article							CELL-BINDING CHARACTERISTICS; LIVER-X-RECEPTORS; VITAMIN-D; SP-ALPHA; MOLECULAR-CLONING; NITRIC-OXIDE; SURVIVAL; MURINE; EXPRESSION; DOMAIN	Apoptosis inhibitor of macrophages (AIM), a scavenger protein secreted by tissue macrophages, is transcriptionally regulated by the nuclear receptor Liver X Receptor (LXR) and Retinoid X Receptor (RXR) heterodimer. Given that LXR exerts a protective immune response against M. tuberculosis, here we analyzed whether AIM is involved in this response. In an experimental murine model of tuberculosis, AIM serum levels peaked dramatically early after infection with M. tuberculosis, providing an in vivo biological link to the disease. We therefore studied the participation of AIM in macrophage response to M. tuberculosis in vitro. For this purpose, we used the H37Rv strain to infect THP-1 macrophages transfected to stably express AIM, thereby increasing infected macrophage survival. Furthermore, the expression of this protein enlarged foam cell formation by enhancing intracellular lipid content. Phagocytosis assays with FITC-labeled M. tuberculosis bacilli indicated that this protein was not involved in bacterial uptake; however, AIM expression decreased the number of intracellular cfus by up to 70% in bacterial killing assays, suggesting that AIM enhances macrophage mycobactericidal activity. Accordingly, M. tuberculosis-infected AIM-expressing cells upregulated the production of reactive oxygen species. Moreover, real-time PCR analysis showed increased mRNA levels of the antimicrobial peptides cathelicidin and defensin 4B. These increases were concomitant with greater cellular concentrations of the autophagy-related molecules Beclin 1 and LC3II, as well as enhanced acidification of mycobacterial phagosomes and LC3 co-localization. In summary, our data support the notion that AIM contributes to key macrophage responses to M. tuberculosis.	[Sanjurjo, Lucia; Amezaga, Nuria; Sarrias, Maria-Rosa] Fundacio Inst Invest Ciencies Salut Germans Trias, Innate Immun Grp, Badalona, Spain; [Vilaplana, Cristina; Caceres, Neus; Marzo, Elena; Cardona, Pere-Joan] Fundacio Inst Invest Ciencies Salut Germans Trias, UTE, Badalona, Spain; [Vilaplana, Cristina; Caceres, Neus; Marzo, Elena; Cardona, Pere-Joan] Univ Autonoma Barcelona, Bellaterra, Spain; [Vilaplana, Cristina; Caceres, Neus; Marzo, Elena; Cardona, Pere-Joan] Inst Carlos III, Ctr Invest Biomed Red Enfermedades Resp CIBERES, Palma de Mallorca, Spain; [Valeri, Marta] Vall Hebron Res Inst VHIR, Barcelona, Spain; [Sarrias, Maria-Rosa] Inst Carlos III, Ctr Invest Biomed Red Enfermedades Hepaticas & Di, Barcelona, Spain	Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Sarrias, MR (corresponding author), Fundacio Inst Invest Ciencies Salut Germans Trias, Innate Immun Grp, Badalona, Spain.	mrsarrias@igtp.cat	sarrias, maria rosa/D-6205-2014; Cardona, Pere-Joan/A-5258-2011; Vilaplana, Cristina/K-7216-2012; Marzo, Elena/AAG-7662-2020; Sanjurjo, Lucía/K-9221-2015	sarrias, maria rosa/0000-0001-6929-8069; Cardona, Pere-Joan/0000-0001-5623-7873; Vilaplana, Cristina/0000-0002-2808-7270; Sanjurjo, Lucía/0000-0003-4006-8010	Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III [FIS PI10/1565, FIS CP08/124]; Fundacio Marato de TV3 [MTV308932]; Spanish Ministry of Science and Innovation; Miguel Servet Research Program [CP08/124]	Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III(Instituto de Salud Carlos III); Fundacio Marato de TV3; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Miguel Servet Research Program	This work was supported by grants from the Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, FIS PI10/1565 and FIS CP08/124 as well as Fundacio Marato de TV3, MTV308932. CV is supported by the program CIBER Enfermedades Respiratorias from the Spanish Ministry of Science and Innovation. MRS is supported by Miguel Servet Research Program (CP08/124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Arai S, 2005, CELL METAB, V1, P201, DOI 10.1016/j.cmet.2005.02.002; ARMSTRONG JA, 1975, J EXP MED, V142, P1, DOI 10.1084/jem.142.1.1; Bikker FJ, 2002, J BIOL CHEM, V277, P32109, DOI 10.1074/jbc.M203788200; Bowdish DME, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-47; Bowdish DME, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000474; Caceres N, 2009, TUBERCULOSIS, V89, P175, DOI 10.1016/j.tube.2008.11.001; Campbell GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002689; Cannizzo ES, 2012, CELL REP, V2, P136, DOI 10.1016/j.celrep.2012.06.005; Cardona PJ, 2005, VACCINE, V23, P1393, DOI 10.1016/j.vaccine.2004.09.008; Cardona PJ, 2003, INFECT IMMUN, V71, P5845, DOI 10.1128/IAI.71.10.5845-5854.2003; Chan ED, 2001, AM J RESP CELL MOL, V25, P606, DOI 10.1165/ajrcmb.25.5.4487; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; ELOMAA O, 1995, CELL, V80, P603, DOI 10.1016/0092-8674(95)90514-6; Fabri M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003045; Fabriek BO, 2009, BLOOD, V113, P887, DOI 10.1182/blood-2008-07-167064; Gangadharan B, 2007, CLIN CHEM, V53, P1792, DOI 10.1373/clinchem.2007.089144; Gebe JA, 1997, J BIOL CHEM, V272, P6151, DOI 10.1074/jbc.272.10.6151; Gebe JA, 2000, IMMUNOLOGY, V99, P78, DOI 10.1046/j.1365-2567.2000.00903.x; Gray J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-271; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; HART P D, 1974, Infection and Immunity, V10, P742; Haruta I, 2001, J BIOL CHEM, V276, P22910, DOI 10.1074/jbc.M100324200; Iwamura Y, 2012, BIOCHEM BIOPH RES CO, V422, P476, DOI 10.1016/j.bbrc.2012.05.018; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Karim AF, 2011, J BIOL CHEM, V286, P40307, DOI 10.1074/jbc.M111.266239; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; Kim JW, 2004, HEPATOLOGY, V39, P518, DOI 10.1002/hep.20053; Kim WK, 2008, EXP MOL MED, V40, P677, DOI 10.3858/emm.2008.40.6.677; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Klug-Micu GM, 2013, IMMUNOLOGY, V139, P121, DOI 10.1111/imm.12062; Knudsen TB, 2005, CLIN MICROBIOL INFEC, V11, P730, DOI 10.1111/j.1469-0691.2005.01229.x; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; Korf H, 2009, J CLIN INVEST, V119, P1626, DOI 10.1172/JCI35288; Krutzik SR, 2008, J IMMUNOL, V181, P7115, DOI 10.4049/jimmunol.181.10.7115; Kurokawa J, 2011, P NATL ACAD SCI USA, V108, P12072, DOI 10.1073/pnas.1101841108; Kurokawa J, 2010, CELL METAB, V11, P479, DOI 10.1016/j.cmet.2010.04.013; Kuwata K, 2003, AM J PATHOL, V162, P837, DOI 10.1016/S0002-9440(10)63880-1; Li Y, 2011, CANCER RES, V71, P5488, DOI 10.1158/0008-5472.CAN-10-4225; Liu PT, 2007, J IMMUNOL, V179, P2060, DOI 10.4049/jimmunol.179.4.2060; Liu PT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005810; Martineau AR, 2012, P NUTR SOC, V71, P84, DOI 10.1017/S0029665111003326; Melo RCN, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002729; Miller J, 2010, NY TIMES BK REV, P6; Miyazaki T, 1999, J EXP MED, V189, P413, DOI 10.1084/jem.189.2.413; Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006; Qu P, 2009, J IMMUNOL, V182, P1648, DOI 10.4049/jimmunol.182.3.1648; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Reggiori F, 2002, EUKARYOT CELL, V1, P11, DOI 10.1128/EC.01.1.11-21.2002; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Sanjuan MA, 2009, IMMUNOL REV, V227, P203, DOI 10.1111/j.1600-065X.2008.00732.x; Sarrias MR, 2007, P NATL ACAD SCI USA, V104, P11724, DOI 10.1073/pnas.0702815104; Sarrias MR, 2004, CRIT REV IMMUNOL, V24, P1; Sarrias MR, 2005, J BIOL CHEM, V280, P35391, DOI 10.1074/jbc.M505042200; Sarrias MR, 2004, TISSUE ANTIGENS, V63, P335, DOI 10.1111/j.0001-2815.2004.00193.x; Sever-Chroneos Z, 2011, TUBERCULOSIS, V91, pS69, DOI 10.1016/j.tube.2011.10.014; Shin DM, 2010, CELL MICROBIOL, V12, P1648, DOI 10.1111/j.1462-5822.2010.01497.x; Sonawane A, 2011, CELL MICROBIOL, V13, P1601, DOI 10.1111/j.1462-5822.2011.01644.x; Steinberg BE, 2008, J CLIN INVEST, V118, P2002, DOI 10.1172/JCI35433; Theus SA, 2004, INFECT IMMUN, V72, P1169, DOI 10.1128/IAI.72.2.1169-1173.2004; Tissot JD, 2002, ELECTROPHORESIS, V23, P1203, DOI 10.1002/1522-2683(200204)23:7/8<1203::AID-ELPS1203>3.0.CO;2-1; Torrado E, 2011, TRENDS IMMUNOL, V32, P66, DOI 10.1016/j.it.2010.12.001; Valledor AF, 2004, P NATL ACAD SCI USA, V101, P17813, DOI 10.1073/pnas.0407749101; WEINBERG JB, 1995, BLOOD, V86, P1184; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yang Chul-Su, 2009, Immune Netw, V9, P46, DOI 10.4110/in.2009.9.2.46; Yu HR, 2009, PEDIAT ALLERG IMM-UK, V20, P699, DOI 10.1111/j.1399-3038.2008.00844.x; Yuk JM, 2009, CELL HOST MICROBE, V6, P231, DOI 10.1016/j.chom.2009.08.004; Yusa S, 1999, EUR J IMMUNOL, V29, P1086, DOI 10.1002/(SICI)1521-4141(199904)29:04<1086::AID-IMMU1086>3.3.CO;2-O; Zou T, 2011, INFECT IMMUN, V79, P1526, DOI 10.1128/IAI.01195-10	72	34	40	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79670	10.1371/journal.pone.0079670	http://dx.doi.org/10.1371/journal.pone.0079670			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223991	Green Published, gold, Green Submitted			2022-12-27	WOS:000326503400136
J	Sreeramareddy, CT; Kumar, HNH; Sathian, B				Sreeramareddy, Chandrashekhar T.; Kumar, H. N. Harsha; Sathian, Brijesh			Time Trends and Inequalities of Under-Five Mortality in Nepal: A Secondary Data Analysis of Four Demographic and Health Surveys between 1996 and 2011	PLOS ONE			English	Article							CHILDHOOD MORTALITY; MIDDLE-INCOME; COUNTDOWN; SURVIVAL; NEWBORN; DETERMINANTS; CONFLICT; INFANT; COUNTRIES; FRAMEWORK	Background: Inequalities in progress towards achievement of Millennium Development Goal four (MDG-4) reflect unequal access to child health services. Objective: To examine the time trends, socio-economic and regional inequalities of under-five mortality rate (U5MR) in Nepal. Methods: We analyzed the data from complete birth histories of four Nepal Demographic and Health Surveys (NDHS) done in the years 1996, 2001, 2006 and 2011. For each livebirth, we computed survival period from birth until either fifth birthday or the survey date. Using direct methods i.e. by constructing life tables, we calculated yearly U5MRs from 1991 to 2010. Projections were made for the years 2011 to 2015. For each NDHS, U5MRs were calculated according to child's sex, mother's education, household wealth index, rural/urban residence, development regions and ecological zones. Inequalities were calculated as rate difference, rate ratio, population attributable risk and hazard ratio. Results: Yearly U5MR (per 1000 live births) had decreased from 157.3 (95% CIs 178.0-138.9) in 1991 to 43.2 (95% CIs 59.1-31.5) in 2010 i.e. 114.1 reduction in absolute risk. Projected U5MR for the year 2015 was 54.33. U5MRs had decreased in absolute terms in all sub groups but relative inequalities had reduced for gender and rural/urban residence only. Wide inequalities existed by wealth and education and increased between 1996 and 2011. For lowest wealth quintile (as compared to highest quintile) hazard ratio (HR) increased from 1.37 (95% CIs 1.27, 1.49) to 2.54 (95% CIs 2.25, 2.86) and for mothers having no education (as compared to higher education) HR increased from 2.55 (95% CIs 1.95, 3.33) to 3.75 (95% CIs 3.17, 4.44). Changes in regional inequities were marginal and irregular. Conclusions: Nepal is most likely to achieve MDG-4 but eductional and wealth inequalities may widen further. National health policies should address to reduce inequalities in U5MR through "inclusive policies'.	[Sreeramareddy, Chandrashekhar T.] Univ Tunku Abdul Rahman, Fac Med & Hlth Sci, Dept Populat Med, Bandar Sungai Long, Selangor, Malaysia; [Kumar, H. N. Harsha] Kasturba Med Coll & Hosp, Dept Community Med, Mangalore, Karnataka, India; [Sathian, Brijesh] Manipal Coll Med Sci, Dept Community Med, Pokhara, Western Develop, Nepal	Universiti Tunku Abdul Rahman (UTAR); Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Mangalore	Sreeramareddy, CT (corresponding author), Univ Tunku Abdul Rahman, Fac Med & Hlth Sci, Dept Populat Med, Bandar Sungai Long, Selangor, Malaysia.	chandrashekharats@yahoo.com	Sathian, Brijesh/B-1035-2015; Sreeramareddy, Chandrashekhar/C-5433-2014; CT, Sreeramareddy/I-1203-2019; Sathian, Brijesh/G-7576-2014	Sathian, Brijesh/0000-0003-0851-4762; Sreeramareddy, Chandrashekhar/0000-0002-5693-7631; CT, Sreeramareddy/0000-0002-5693-7631; Sathian, Brijesh/0000-0003-0851-4762				[Anonymous], TECHNICAL REPORT; Ayiko Rogers, 2009, East Afr J Public Health, V6, P136; Barros AJD, 2012, LANCET, V379, P1225, DOI 10.1016/S0140-6736(12)60113-5; Bauze AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037861; Behl AS, 2013, INDIAN PEDIATR, V50, P143, DOI 10.1007/s13312-013-0028-x; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Bohara AK, 2006, J CONFLICT RESOLUT, V50, P108, DOI 10.1177/0022002705282872; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Chin B, 2011, HEALTH PLACE, V17, P929, DOI 10.1016/j.healthplace.2011.04.006; Dawson P, 2008, B WORLD HEALTH ORGAN, V86, P339, DOI 10.2471/BLT.07.047688; Department of Health, 2013, ANN REP; Devkota Bhimsen, 2010, Confl Health, V4, P20, DOI 10.1186/1752-1505-4-20; Do QT, 2010, J PEACE RES, V47, P735, DOI 10.1177/0022343310386175; Fikree FF, 2004, BMJ-BRIT MED J, V328, P823, DOI 10.1136/bmj.328.7443.823; Gautam KC, 2010, J NEPAL MED ASSOC, V49, P174; Gill R, 2011, WOMEN HEALTH ISS, V21, P12, DOI 10.1016/j.whi.2010.10.003; Gostin LO, 2012, JAMA-J AM MED ASSOC, V307, P2087, DOI 10.1001/jama.2012.4395; Hill PS, 2010, B WORLD HEALTH ORGAN, V88, P562, DOI 10.2471/BLT.09.071365; Houweling TAJ, 2006, J EPIDEMIOL COMMUN H, V60, P62, DOI 10.1136/jech.2005.036079; Houweling TAJ, 2005, INT J EPIDEMIOL, V34, P1257, DOI 10.1093/ije/dyi190; Houweling TAJ, 2007, INDIAN J MED RES, V126, P239; Houweling TAJ, 2010, BRIT MED BULL, V93, P7, DOI 10.1093/bmb/ldp048; Houweling Tanja Aj, 2007, Int J Equity Health, V6, P15, DOI 10.1186/1475-9276-6-15; Katti V., 1987, INT STUDIES, V24, P209, DOI [10.1177/0020881787024003002, DOI 10.1177/0020881787024003002]; Nguyen KH, 2013, J EPIDEMIOL COMMUN H, V67, P311, DOI 10.1136/jech-2012-201503; King NB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5774; Korenromp EL, 2004, INT J EPIDEMIOL, V33, P1293, DOI 10.1093/ije/dyh182; Kraft AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053696; Lawn JE, 2007, ARCH DIS CHILD, V92, P551, DOI 10.1136/adc.2006.099291; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Macassa Gloria, 2006, Afr J Health Sci, V13, P139; Malla DS, 2011, BJOG-INT J OBSTET GY, V118, P60, DOI 10.1111/j.1471-0528.2011.03113.x; Malqvist Mats, 2008, BMC Int Health Hum Rights, V8, P4, DOI 10.1186/1472-698X-8-4; Ministry of Health and Population [.Nepal] New ERA MII, 2011, NEW ERA MII; Mosley WH, 2003, B WORLD HEALTH ORGAN, V81, P140; Murray CJL, 2007, LANCET, V370, P1040, DOI 10.1016/S0140-6736(07)61478-0; Nannan N, 2007, J BIOSOC SCI, V39, P613, DOI 10.1017/S0021932006001702; NPC, 2011, CLIM RES PLANN; Paalman M., 2004, MACROECONOMICS HLTH; Peters DH, 2008, ANN NY ACAD SCI, V1136, P161, DOI 10.1196/annals.1425.011; Pradhan A, 2007, TRENDS DEMOGRAPHIC H; Pradhan YV, 2012, HEALTH POLICY PLANN, V27, P57, DOI 10.1093/heapol/czs052; Rajaratnam JK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000253; Rosenberg D, 1998, ANAL METHODS MATERNA; Rutstein Shea Oscar, 2004, DEMOGRAPHIC HLTH SUR; Schell CO, 2007, SCAND J PUBLIC HEALT, V35, P288, DOI 10.1080/14034940600979171; Schneider Maria Cristina, 2005, Epidemiol Bull, V26, P7; Shrestha Sarala, 2003, Educ Health (Abingdon), V16, P318, DOI 10.1080/1357628031000701607668; Singh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026856; Stuckler D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000241; Thapa S, 2008, J TROP PEDIATRICS, V54, P265, DOI 10.1093/tropej/fmn011; Thomas D, 2005, EVALUATION INCREASIN; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; World B, 2006, 34834 NP WORLD B POV	55	18	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79818	10.1371/journal.pone.0079818	http://dx.doi.org/10.1371/journal.pone.0079818			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	245ZC	24224010	gold, Green Published, Green Submitted			2022-12-27	WOS:000326503400144
J	Visser, K; Mortimer, M; Louw, A				Visser, Koch; Mortimer, Morne; Louw, Ann			Cyclopia Extracts Act as ER alpha Antagonists and ER beta Agonists, In Vitro and In Vivo	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-BETA; NF-KAPPA-B; HUMAN-BREAST-CANCER; INTERLEUKIN-6 GENE-EXPRESSION; BONE-MINERAL DENSITY; POSTMENOPAUSAL WOMEN; SELECTIVE LIGANDS; HONEYBUSH TEA; ASPALATHUS-LINEARIS; ANIMAL-MODELS	Hormone replacement therapy associated risks, and the concomitant reluctance of usage, has instigated the search for new generations of estrogen analogues that would maintain estrogen benefits without associated risks. Furthermore, if these analogues display chemo-preventative properties in breast and endometrial tissues it would be of great value. Both the selective estrogen receptor modulators as well as the selective estrogen receptor subtype modulators have been proposed as estrogen analogues with improved risk profiles. Phytoestrogen containing extracts of Cyclopia, an indigenous South African fynbos plant used to prepare Honeybush tea may serve as a source of new estrogen analogues. In this study three extracts, P104, SM6Met, and cup-of-tea, from two species of Cyclopia, C. genistoides and C. subternata, were evaluated for ER subtype specific agonism and antagonism both in transactivation and transrepression. For transactivation, the Cyclopia extracts displayed ER alpha antagonism and ER beta agonism when ER subtypes were expressed separately, however, when co-expressed only agonism was uniformly observed. In contrast, for transrepression, this uniform behavior was lost, with some extracts (P104) displaying uniform agonism, while others (SM6Met) displayed antagonism when subtypes were expressed separately and agonism when co-expressed. In addition, breast cancer cell proliferation assays indicate that extracts antagonize cell proliferation in the presence of estrogen at lower concentrations than that required for proliferation. Furthermore, lack of uterine growth and delayed vaginal opening in an immature rat uterotrophic model validates the ERa antagonism of extracts observed in vitro and supports the potential of the Cyclopia extracts as a source of estrogen analogues with a reduced risk profile.	[Visser, Koch; Mortimer, Morne; Louw, Ann] Univ Stellenbosch, Dept Biochem, ZA-7600 Stellenbosch, South Africa	Stellenbosch University	Louw, A (corresponding author), Univ Stellenbosch, Dept Biochem, ZA-7600 Stellenbosch, South Africa.	al@sun.ac.za	Louw, Ann/A-7620-2012	Louw, Ann/0000-0002-1021-6732	Medical Research Council (MRC); Cancer Association of South Africa (CANSA)	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Association of South Africa (CANSA)	The authors would like to thank the Medical Research Council (MRC) and the Cancer Association of South Africa (CANSA) for financial support to A.L. (grant for projects entitled "Cyclopia Phytoestrogens" and "Cyclopia and breast cancer") and for financial support to K. V. and M. M. the National Research Foundation (NRF) and the Harry Crossley foundation is acknowledged. Any opinion, findings and conclusions or recommendations expressed in this material are those of the author(s) and therefore the funders do not accept any liability in regard thereto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2000, J MAMMARY GLAND BIOL, V5, P271, DOI 10.1023/A:1009594727358; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; ARONICA SM, 1994, P NATL ACAD SCI USA, V91, P8517, DOI 10.1073/pnas.91.18.8517; Ball LJ, 2009, MOL CELL ENDOCRINOL, V299, P204, DOI 10.1016/j.mce.2008.10.050; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brzezinski A, 1999, EUR J OBSTET GYN R B, V85, P47, DOI 10.1016/S0301-2115(98)00281-4; Burger HG, 2008, MENOPAUSE, V15, P603, DOI 10.1097/gme.0b013e318174ea4d; Cacquevel M, 2004, CURR DRUG TARGETS, V5, P529, DOI 10.2174/1389450043345308; Cao YX, 2003, J MAMMARY GLAND BIOL, V8, P215, DOI 10.1023/A:1025905008934; Chang EC, 2006, ENDOCRINOLOGY, V147, P4831, DOI 10.1210/en.2006-0563; Chen XW, 2003, J NUTR BIOCHEM, V14, P342, DOI 10.1016/S0955-2863(03)00056-1; Choi EM, 2012, INT IMMUNOPHARMACOL, V12, P139, DOI 10.1016/j.intimp.2011.11.003; Collins-Burow BM, 2000, NUTR CANCER, V38, P229, DOI 10.1207/S15327914NC382_13; Cranney A, 2005, DRUG SAFETY, V28, P721, DOI 10.2165/00002018-200528080-00006; Cvoro A, 2006, MOL CELL, V21, P555, DOI 10.1016/j.molcel.2006.01.014; Cvoro A, 2008, J IMMUNOL, V180, P630, DOI 10.4049/jimmunol.180.1.630; Cvoro A, 2007, ENDOCRINOLOGY, V148, P538, DOI 10.1210/en.2006-0803; D'Amelio P, 2013, EXPERT OPIN PHARMACO, V14, P949, DOI 10.1517/14656566.2013.782002; de Beer D, 2012, MOLECULES, V17, P14602, DOI 10.3390/molecules171214602; DELIMA, 2008, PHYTOMEDICINE, V15, P31, DOI DOI 10.1016/J.PHYMED.2007.06.006; Delmas PD, 1997, NEW ENGL J MED, V337, P1641, DOI 10.1056/NEJM199712043372301; Denger S, 2001, MOL CELL ENDOCRINOL, V178, P155, DOI 10.1016/S0303-7207(01)00417-8; Dennerstein L, 2000, OBSTET GYNECOL, V96, P351, DOI 10.1016/S0029-7844(00)00930-3; du Toit J, 1998, J SUSTAIN AGR, V12, P67, DOI 10.1300/J064v12n02_06; Duncan AM, 2003, BEST PRACT RES CL EN, V17, P253, DOI 10.1016/S1521-690X(02)00103-3; Enmark E, 1999, J INTERN MED, V246, P133, DOI 10.1046/j.1365-2796.1999.00545.x; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; FELSON DT, 1993, NEW ENGL J MED, V329, P1141, DOI 10.1056/NEJM199310143291601; Flototto T, 2004, J STEROID BIOCHEM, V88, P131, DOI 10.1016/j.jsbmb.2003.11.004; Flouriot G, 2000, EMBO J, V19, P4688, DOI 10.1093/emboj/19.17.4688; Fong CJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-151; Fong CJ, 2010, J MOL ENDOCRINOL, V45, P161, DOI 10.1677/JME-09-0158; Frasor J, 2009, CANCER RES, V69, P8918, DOI 10.1158/0008-5472.CAN-09-2608; FRIEND DR, 1984, J MED CHEM, V27, P261, DOI 10.1021/jm00369a005; Galien R, 1997, NUCLEIC ACIDS RES, V25, P2424, DOI 10.1093/nar/25.12.2424; Ghisletti S, 2005, MOL CELL BIOL, V25, P2957, DOI 10.1128/MCB.25.8.2957-2968.2005; Glazier MG, 2001, ARCH INTERN MED, V161, P1161, DOI 10.1001/archinte.161.9.1161; Gosselin D, 2011, CELL, V145, P495, DOI 10.1016/j.cell.2011.04.018; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Gruber CJ, 2004, TRENDS ENDOCRIN MET, V15, P73, DOI 10.1016/j.tem.2004.01.008; HABEL LA, 1993, EPIDEMIOL REV, V15, P209, DOI 10.1093/oxfordjournals.epirev.a036107; HALL J, 2008, MENOPAUSAL MED, P16; Hall JM, 2002, MOL ENDOCRINOL, V16, P469, DOI 10.1210/me.16.3.469; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Han DH, 2002, BIOSCI BIOTECH BIOCH, V66, P1479, DOI 10.1271/bbb.66.1479; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harnish DC, 2000, ENDOCRINOLOGY, V141, P3403, DOI 10.1210/en.141.9.3403; Harrington WR, 2003, MOL CELL ENDOCRINOL, V206, P13, DOI 10.1016/S0303-7207(03)00255-7; Harris HA, 2003, ENDOCRINOLOGY, V144, P4241, DOI 10.1210/en.2003-0550; Harris HA, 2002, ENDOCRINOLOGY, V143, P4172, DOI 10.1210/en.2002-220403; Harris HA, 2007, MOL ENDOCRINOL, V21, P1, DOI 10.1210/me.2005-0459; Helguero LA, 2005, ONCOGENE, V24, P6605, DOI 10.1038/sj.onc.1208807; Hertrampf T, 2008, BRIT J PHARMACOL, V153, P1432, DOI 10.1038/sj.bjp.0707664; Hillisch A, 2004, MOL ENDOCRINOL, V18, P1599, DOI 10.1210/me.2004-0050; Hiremath SP, 2000, EUR J PHARMACOL, V391, P193, DOI 10.1016/S0014-2999(99)00723-2; Hiroi H, 1999, ENDOCR J, V46, P773, DOI 10.1507/endocrj.46.773; Jordan VC, 2007, J CLIN ONCOL, V25, P5815, DOI 10.1200/JCO.2007.11.3886; Jordan VC, 2007, NAT REV CANCER, V7, P46, DOI 10.1038/nrc2048; JORDAN VC, 1988, CANCER INVEST, V6, P589, DOI 10.3109/07357908809082124; Joubert E, 2008, J ETHNOPHARMACOL, V119, P376, DOI 10.1016/j.jep.2008.06.014; Kamara BI, 2004, J AGR FOOD CHEM, V52, P5391, DOI 10.1021/jf040097z; Kamara BI, 2003, J AGR FOOD CHEM, V51, P3874, DOI 10.1021/jf0210730; Kanno J, 2001, ENVIRON HEALTH PERSP, V109, P785, DOI 10.2307/3454820; KIES P., 1951, BOTHALIA, V6, P161; KNABBE C, 1987, CELL, V48, P417, DOI 10.1016/0092-8674(87)90193-0; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Kulling SE, 2002, J CHROMATOGR B, V777, P211, DOI 10.1016/S1570-0232(02)00215-5; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Lattrich C, 2013, STEROIDS, V78, P195, DOI 10.1016/j.steroids.2012.10.014; Lazennec G, 2001, ENDOCRINOLOGY, V142, P4120, DOI 10.1210/en.142.9.4120; Lee SO, 2005, CANCER RES, V65, P3487, DOI 10.1158/0008-5472.CAN-04-3267; LERNER LJ, 1990, CANCER RES, V50, P4177; LI H, 2013, TOXICOL APPL PHARM; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Lindsay R, 1996, OBSTET GYNECOL, V87, pS16, DOI 10.1016/0029-7844(95)00430-0; Louw A, 2013, PLANTA MED, V79, P580, DOI 10.1055/s-0032-1328463; LOVE RR, 1992, NEW ENGL J MED, V326, P852, DOI 10.1056/NEJM199203263261302; MacGregor JI, 1998, PHARMACOL REV, V50, P151; Malamas MS, 2004, J MED CHEM, V47, P5021, DOI 10.1021/jm049719y; Maximov PY, 2013, CURR CLIN PHARMACOL, V8, P135, DOI 10.2174/1574884711308020006; Mersereau JE, 2008, MOL CELL ENDOCRINOL, V283, P49, DOI 10.1016/j.mce.2007.11.020; Meyers MJ, 2001, J MED CHEM, V44, P4230, DOI 10.1021/jm010254a; Mfenyana C, 2008, J STEROID BIOCHEM, V112, P74, DOI 10.1016/j.jsbmb.2008.08.005; Monroe DG, 2003, J CELL BIOCHEM, V90, P315, DOI 10.1002/jcb.10633; Murkies AL, 1998, J CLIN ENDOCR METAB, V83, P297, DOI 10.1210/jc.83.2.297; Nand SL, 1998, OBSTET GYNECOL, V91, P678, DOI 10.1016/S0029-7844(98)00038-6; Nemeth K, 2003, EUR J NUTR, V42, P29, DOI 10.1007/s00394-003-0397-3; Nettles KW, 2008, MOL ENDOCRINOL, V22, P263, DOI 10.1210/me.2007-0324; Nettles KW, 2005, ANNU REV PHYSIOL, V67, P309, DOI 10.1146/annurev.physiol.66.032802.154710; Nicholson RI, 1999, ENDOCR-RELAT CANCER, V6, P373, DOI 10.1677/erc.0.0060373; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; O'Regan RM, 2002, LANCET ONCOL, V3, P207, DOI 10.1016/S1470-2045(02)00711-8; Odum J, 1997, REGUL TOXICOL PHARM, V25, P176, DOI 10.1006/rtph.1997.1100; Oseni T, 2008, PLANTA MED, V74, P1656, DOI 10.1055/s-0028-1088304; Pacifici R, 1996, J BONE MINER RES, V11, P1043; Palmieri C, 2002, ENDOCR-RELAT CANCER, V9, P1, DOI 10.1677/erc.0.0090001; Paruthiyil S, 2004, CANCER RES, V64, P423, DOI 10.1158/0008-5472.CAN-03-2446; Paruthiyil S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006271; Plaisance S, 1997, MOL CELL BIOL, V17, P3733, DOI 10.1128/MCB.17.7.3733; Powell E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030993; Powell E, 2008, P NATL ACAD SCI USA, V105, P19012, DOI 10.1073/pnas.0807274105; Primiano T, 2001, PHARM BIOL, V39, P83, DOI 10.1076/phbi.39.2.83.6256; Ray P, 1997, FEBS LETT, V409, P79, DOI 10.1016/S0014-5793(97)00487-0; Riggs BL, 2003, NEW ENGL J MED, V348, P618, DOI 10.1056/NEJMra022219; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; Romas E, 1997, OSTEOPOROSIS INT, V7, P47, DOI 10.1007/BF03194342; Ross RK, 2000, JNCI-J NATL CANCER I, V92, P328, DOI 10.1093/jnci/92.4.328; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Rymer J, 2003, BRIT MED J, V326, P322, DOI 10.1136/bmj.326.7384.322; Safe S, 2008, J MOL ENDOCRINOL, V41, P263, DOI 10.1677/JME-08-0103; Saji S, 2000, P NATL ACAD SCI USA, V97, P337, DOI 10.1073/pnas.97.1.337; Scafonas A, 2008, J STEROID BIOCHEM, V110, P197, DOI 10.1016/j.jsbmb.2007.10.013; Schmidt C, 2010, J NATL CANCER I, V102, P1690, DOI 10.1093/jnci/djq477; Schreurs R, 2002, ARCH TOXICOL, V76, P257, DOI 10.1007/s00204-002-0348-4; Setchell KDR, 2002, AM J CLIN NUTR, V76, P447, DOI 10.1093/ajcn/76.2.447; Shaaban AM, 2003, AM J SURG PATHOL, V27, P1502, DOI 10.1097/00000478-200312000-00002; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; SHIRAKAWA F, 1989, MOL CELL BIOL, V9, P2424, DOI 10.1128/MCB.9.6.2424; Slavin JL, 1998, AM J CLIN NUTR, V68, p1492S, DOI 10.1093/ajcn/68.6.1492S; Snijman PW, 2007, MUTAT RES-GEN TOX EN, V631, P111, DOI 10.1016/j.mrgentox.2007.03.009; Stossi F, 2004, ENDOCRINOLOGY, V145, P3473, DOI 10.1210/en.2003-1682; Stroheker T, 2003, REPROD TOXICOL, V17, P421, DOI 10.1016/S0890-6238(03)00044-3; Strom A, 2004, P NATL ACAD SCI USA, V101, P1566, DOI 10.1073/pnas.0308319100; Sun J, 2002, ENDOCRINOLOGY, V143, P941, DOI 10.1210/en.143.3.941; Tee MK, 2004, MOL BIOL CELL, V15, P1262, DOI 10.1091/mbc.E03-06-0360; Tikkanen MJ, 2000, BIOCHEM PHARMACOL, V60, P1, DOI 10.1016/S0006-2952(99)00409-8; Tremblay A, 1999, MOL CELL, V3, P513, DOI 10.1016/S1097-2765(00)80479-7; Trock BJ, 2006, JNCI-J NATL CANCER I, V98, P459, DOI 10.1093/jnci/djj102; Tu SH, 2013, FOOD CHEM, V141, P1553, DOI 10.1016/j.foodchem.2013.04.077; Verhoog NJD, 2007, S AFR J SCI, V103, P13; Verhoog NJD, 2007, J AGR FOOD CHEM, V55, P4371, DOI 10.1021/jf063588n; VILLALOBOS M, 1995, ENVIRON HEALTH PERSP, V103, P844, DOI 10.2307/3432398; Vogel VG, 2006, JAMA-J AM MED ASSOC, V295, P2727, DOI 10.1001/jama.295.23.joc60074; Vosse M, 2002, EUR J OBSTET GYN R B, V101, P58, DOI 10.1016/S0301-2115(01)00516-4; Wardell SE, 2013, CLIN CANCER RES, V19, P2420, DOI 10.1158/1078-0432.CCR-12-3771; Weiderpass E, 1999, J NATL CANCER I, V91, P1131, DOI 10.1093/jnci/91.13.1131; Williams C, 2008, ONCOGENE, V27, P1019, DOI 10.1038/sj.onc.1210712; Yeh WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060889; Zhu JTT, 2007, J AGR FOOD CHEM, V55, P2438, DOI 10.1021/jf063299z	143	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79223	10.1371/journal.pone.0079223	http://dx.doi.org/10.1371/journal.pone.0079223			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223909	Green Published, Green Submitted, gold			2022-12-27	WOS:000326503400103
J	Li, JZ; Chen, X; Gong, XL; Hu, HY; Shi, D; Lu, YM; Qiu, L; Lu, F; Hu, ZL; Zhang, JP				Li, Jian-Zhong; Chen, Xia; Gong, Xue-Lian; Hu, Hong-Yuan; Shi, Duo; Lu, Yi-Ming; Qiu, Lei; Lu, Fa; Hu, Zhen-Lin; Zhang, Jun-Ping			Identification of a Functional Nuclear Localization Signal Mediating Nuclear Import of the Zinc Finger Transcription Factor ZNF24	PLOS ONE			English	Article							DNA-BINDING; NUCLEOCYTOPLASMIC TRANSPORT; CELL-PROLIFERATION; DOMAIN; PROTEINS; GENE; REPRESSION; SEQUENCE	ZNF24 is a member of the SCAN domain family of Kruppel-like zinc finger (ZF) transcription factors, which plays a critical role in cell proliferation and differentiation. However, how ZNF24 enters the nucleus in order to exert its function remains unclear since its nuclear localization signal(s) (NLS) has not been identified. Here, we generated a series of GFP-tagged deletion and point mutants and assessed their subcellular localization. Our results delimit the NLS to ZF1-2. Deletion of ZF1-2 caused cytoplasmic accumulation of ZNF24. Fusion of the ZF1-2 to green fluorescent protein (GFP) targeted GFP to the nucleus, demonstrating that the ZF1-2 is both necessary and sufficient for nuclear localization. ZNF24 containing histidine to leucine mutations that disrupt the structure of ZF1 or/and ZF2 retains appropriate nuclear localization, indicating that neither the tertiary structure of the zinc fingers nor specific DNA binding are necessary for nuclear localization. K286A and R290A mutation led to partial cytoplasmic accumulation. Co-immunoprecipitation demonstrated that ZNF24 interacted with importin-beta and this interaction required the ZF motifs. The beta-Catenin (CTNNB1) luciferase assays showed that the ZNF24 mutants defective in nuclear localization could not promote CTNNB1promoter activation as the wild-type ZNF24 did. Taken together, these results suggest that consecutive ZF1-2 is critical for the regulation of ZNF24 nuclear localization and its transactivation function.	[Li, Jian-Zhong; Gong, Xue-Lian; Hu, Hong-Yuan; Shi, Duo; Lu, Yi-Ming; Qiu, Lei; Lu, Fa; Hu, Zhen-Lin; Zhang, Jun-Ping] Second Mil Med Univ, Dept Biochem Pharm, Shanghai, Peoples R China; [Chen, Xia] Second Mil Med Univ, Inst Canc, Shanghai, Peoples R China; [Gong, Xue-Lian] Second Mil Med Univ, Dept Hlth Toxicol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University	Li, JZ (corresponding author), Second Mil Med Univ, Dept Biochem Pharm, Shanghai, Peoples R China.	466186272@qq.com; jpzhang08@hotmail.com			National Natural Science Foundation of China [30871353, 30901322]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 30871353 and No. 30901322). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese V, 2001, HUM MOL GENET, V10, P1785, DOI 10.1093/hmg/10.17.1785; Corbi N, 2004, BIOCHEM CELL BIOL, V82, P428, DOI 10.1139/O04-047; Dono R, 1998, ONCOGENE, V16, P2151, DOI 10.1038/sj.onc.1201746; Edelstein LC, 2005, GENE, V359, P1, DOI 10.1016/j.gene.2005.06.022; Han ZG, 1999, J BIOL CHEM, V274, P35741, DOI 10.1074/jbc.274.50.35741; Harper J, 2007, CANCER RES, V67, P8736, DOI 10.1158/0008-5472.CAN-07-1617; Hatayama M, 2008, HUM MOL GENET, V17, P3459, DOI 10.1093/hmg/ddn239; Howng SYB, 2010, GENE DEV, V24, P301, DOI 10.1101/gad.1864510; Ishidate T, 1997, FEBS LETT, V409, P237, DOI 10.1016/S0014-5793(97)00455-9; Khalfallah O, 2009, STEM CELLS, V27, P1643, DOI 10.1002/stem.88; KLUG A, 1995, FASEB J, V9, P597, DOI 10.1096/fasebj.9.8.7768350; Kuwahara J, 2000, Nucleic Acids Symp Ser, P265; LACASSE EC, 1995, NUCLEIC ACIDS RES, V23, P1647, DOI 10.1093/nar/23.10.1647; Li J, J CELL BIOCH; Li JZ, 2006, EXP CELL RES, V312, P3990, DOI 10.1016/j.yexcr.2006.08.020; Li JZ, 2010, BIOCHEM BIOPH RES CO, V397, P318, DOI 10.1016/j.bbrc.2010.05.110; Li JZ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-241; Liu GY, 2012, HEPATOLOGY, V55, P1830, DOI 10.1002/hep.25564; MATHENY C, 1994, J BIOL CHEM, V269, P8176; Mehta TS, 2009, CELL RES, V19, P1098, DOI 10.1038/cr.2009.64; Michael WM, 1997, EMBO J, V16, P3587, DOI 10.1093/emboj/16.12.3587; MICHALOWSKI CB, 1990, MOL GEN GENET, V224, P222, DOI 10.1007/BF00271555; Nam K, 2004, PROTEINS, V56, P685, DOI 10.1002/prot.20170; NEDVED ML, 1994, NUCLEIC ACIDS RES, V22, P4705, DOI 10.1093/nar/22.22.4705; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Pandya K, 2002, J BIOL CHEM, V277, P16304, DOI 10.1074/jbc.M200866200; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Quadrini KJ, 2002, J BIOL CHEM, V277, P32243, DOI 10.1074/jbc.M205677200; ROUSSEAUMERCK MF, 1991, GENOMICS, V9, P154, DOI 10.1016/0888-7543(91)90233-5; Sachdev S, 1998, MOL CELL BIOL, V18, P2524, DOI 10.1128/MCB.18.5.2524; SANDER G, 1976, EUR J BIOCHEM, V61, P317, DOI 10.1111/j.1432-1033.1976.tb10024.x; Schumacher C, 2000, J BIOL CHEM, V275, P17173, DOI 10.1074/jbc.M000119200; Shi S L, 1998, Shi Yan Sheng Wu Xue Bao, V31, P21; Sorokin AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1439, DOI 10.1134/S0006297907130032; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Takei Y, 1999, FEBS LETT, V447, P292, DOI 10.1016/S0014-5793(99)00306-3; Wagstaff KM, 2012, BIOCHEM J, V443, P851, DOI 10.1042/BJ20120150; Wali A, 2007, ANN HUM GENET, V71, P570, DOI 10.1111/j.1469-1809.2007.00362.x; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Zhao J, 2007, CELL MOL LIFE SCI, V64, P3017, DOI 10.1007/s00018-007-7137-4	40	7	8	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79910	10.1371/journal.pone.0079910	http://dx.doi.org/10.1371/journal.pone.0079910			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24224020	Green Submitted, Green Published, gold			2022-12-27	WOS:000326499300096
J	Wang, M; Wang, F; Wang, YN; Ma, XN; Zhao, M; Zhao, CJ				Wang, Miao; Wang, Fei; Wang, Yinan; Ma, Xiaonan; Zhao, Min; Zhao, Chunjie			Metabonomics Study of the Therapeutic Mechanism of Gynostemma pentaphyllum and Atorvastatin for Hyperlipidemia in Rats	PLOS ONE			English	Article							TRADITIONAL CHINESE MEDICINE; DIET-INDUCED HYPERLIPIDEMIA; NMR-SPECTROSCOPY; METABOLOMICS; URINE; SERUM; BERBERINE; SAPONINS	Gynostemma pentaphyllum (GP) is widely used for the treatment of diseases such as hyperlipidemia, fatty liver and obesity in China, and atorvastatin is broadly used as an anti-hyperlipidemia drug. This research focuses on the plasma and liver metabolites in the following four groups of rats: control, a hyperlipidemia model, a hyperlipidemia model treated with GP and a hyperlipidemia model treated with atorvastatin. Using H-1-NMR-based metabonomics, we elucidated the therapeutic mechanisms of GP and atorvastatin. Orthogonal Partial Least Squares-Discriminant analysis (OPLS-DA) plotting of the metabolic state and analysis of potential biomarkers in the plasma and liver correlated well with the results of biochemical assays. GP can effectively affect lipid metabolism, and it exerts its anti-hyperlipidemia effect by elevating the level of phosphatidylcholine and decreasing the level of trimethylamine N-oxide (TMAO). In contrast, atorvastatin affects hyperlipidemia mainly during lipid metabolism and protein metabolism in vivo.	[Wang, Miao; Wang, Yinan; Zhao, Min; Zhao, Chunjie] Shenyang Pharmaceut Univ, Sch Pharm, Shenyang, Peoples R China; [Wang, Fei] Northeastern Univ, Coll Informat Sci & Eng, Shenyang, Peoples R China; [Wang, Miao; Ma, Xiaonan] Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, Shenyang, Peoples R China	Shenyang Pharmaceutical University; Northeastern University - China; Shenyang Pharmaceutical University	Zhao, CJ (corresponding author), Shenyang Pharmaceut Univ, Sch Pharm, Shenyang, Peoples R China.	zcjjljj@sina.com						Azmi J, 2005, BIOMARKERS, V10, P401, DOI 10.1080/13547500500309259; BALES JR, 1984, CLIN CHEM, V30, P426; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Bollard ME, 2000, MAGNET RESON MED, V44, P201, DOI 10.1002/1522-2594(200008)44:2<201::AID-MRM6>3.0.CO;2-5; CHEN HZ, 2004, J CHINESE INTEG 0302, V2, P81; DONALD V, 2000, FUNDAMENTALS BIOCH; Fan WMT, 1996, PROG NUCL MAG RES SP, V28, P161, DOI 10.1016/0079-6565(95)01017-3; Gavaghan CL, 2002, FEBS LETT, V530, P191, DOI 10.1016/S0014-5793(02)03476-2; Gibellini F, 2010, IUBMB LIFE, V62, P414, DOI 10.1002/iub.337; Gu Y, 2010, TALANTA, V81, P766, DOI 10.1016/j.talanta.2010.01.015; He QH, 2012, J NUTR BIOCHEM, V23, P133, DOI 10.1016/j.jnutbio.2010.11.007; Hollywood K, 2006, PROTEOMICS, V6, P4716, DOI 10.1002/pmic.200600106; Huyen VTT, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/452313; JEAN CM, 2009, ATHEROSCLEROSIS, V206, P127, DOI DOI 10.1016/J.ATHEROSCLEROSIS.2009.01.040; Kao TH, 2008, ANAL CHIM ACTA, V626, P200, DOI 10.1016/j.aca.2008.07.049; LACOUR B, 1995, J ETHNOPHARMACOL, V46, P125, DOI 10.1016/0378-8741(95)01234-5; Li N, 2012, EUR J MED CHEM, V50, P173, DOI 10.1016/j.ejmech.2012.01.052; Liang SX, 2002, SPECTROSC SPECT ANAL, V22, P847; Liang XP, 2011, J PROTEOME RES, V10, P790, DOI 10.1021/pr1009299; Lindon JC, 2004, EXPERT REV MOL DIAGN, V4, P189, DOI 10.1586/14737159.4.2.189; Liu F, 2012, ANAL BIOANAL CHEM, V403, P847, DOI 10.1007/s00216-012-5923-9; Naoumova RP, 1997, J LIPID RES, V38, P1496; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Qin RA, 2012, ARCH PHARM RES, V35, P1241, DOI 10.1007/s12272-012-0715-5; Sun Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032115, 10.1371/journal.pone.0047003]; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Watkins SM, 2002, CURR OPIN MOL THER, V4, P224; Wei L, 2008, TOXICOL APPL PHARM, V227, P417, DOI 10.1016/j.taap.2007.11.015; Wishart DS, 2008, J CHROMATOGR B, V871, P164, DOI 10.1016/j.jchromb.2008.05.001; Wishart DS, 2007, BRIEF BIOINFORM, V8, P279, DOI 10.1093/bib/bbm030; Yang XB, 2008, J AGR FOOD CHEM, V56, P6905, DOI 10.1021/jf801101u; Zha WB, 2009, BIOMARKERS, V14, P372, DOI 10.1080/13547500903026401; Zhang AH, 2012, PHARMAZIE, V67, P667, DOI 10.1691/ph.2012.2511; Zhang Q, 2010, BIOMARKERS, V15, P205, DOI 10.3109/13547500903419049; Zhang Q, 2009, ACTA PHARMACOL SIN, V30, P1674, DOI 10.1038/aps.2009.173	36	17	22	5	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78731	10.1371/journal.pone.0078731	http://dx.doi.org/10.1371/journal.pone.0078731			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223845	Green Submitted, Green Published, gold			2022-12-27	WOS:000326499300032
J	Yam, PT; Pincus, Z; Gupta, GD; Bashkurov, M; Charron, F; Pelletier, L; Colman, DR				Yam, Patricia T.; Pincus, Zachary; Gupta, Gagan D.; Bashkurov, Mikhail; Charron, Frederic; Pelletier, Laurence; Colman, David R.			N-Cadherin Relocalizes from the Periphery to the Center of the Synapse after Transient Synaptic Stimulation in Hippocampal Neurons	PLOS ONE			English	Article							AMPA RECEPTOR TRAFFICKING; BETA-CATENIN; CELL; ADHESION; ORGANIZATION; SYNAPTOGENESIS; PLASTICITY; MICROSCOPY; JUNCTIONS; COMPLEX	N-cadherin is a cell adhesion molecule which is enriched at synapses. Binding of N-cadherin molecules to each other across the synaptic cleft has been postulated to stabilize adhesion between the presynaptic bouton and the postsynaptic terminal. N-cadherin is also required for activity-induced changes at synapses, including hippocampal long term potentiation and activity-induced spine expansion and stabilization. We hypothesized that these activity-dependent changes might involve changes in N-cadherin localization within synapses. To determine whether synaptic activity changes the localization of N-cadherin, we used structured illumination microscopy, a superresolution approach which overcomes the conventional resolution limits of light microscopy, to visualize the localization of N-cadherin within synapses of hippocampal neurons. We found that synaptic N-cadherin exhibits a spectrum of localization patterns, ranging from puncta at the periphery of the synapse adjacent to the active zone to an even distribution along the synaptic cleft. Furthermore, the N-cadherin localization pattern within synapses changes during KCl depolarization and after transient synaptic stimulation. During KCl depolarization, N-cadherin relocalizes away from the central region of the synaptic cleft to the periphery of the synapse. In contrast, after transient synaptic stimulation with KCl followed by a period of rest in normal media, fewer synapses have N-cadherin present as puncta at the periphery and more synapses have N-cadherin present more centrally and uniformly along the synapse compared to unstimulated cells. This indicates that transient synaptic stimulation modulates N-cadherin localization within the synapse. These results bring new information to the structural organization and activity-induced changes occurring at synapses, and suggest that N-cadherin relocalization may contribute to activity dependent changes at synapses.	[Yam, Patricia T.; Colman, David R.] McGill Univ, Dept Neurol & Neurosurg, Montreal Neurol Inst & Hosp, Montreal, PQ, Canada; [Yam, Patricia T.; Charron, Frederic; Colman, David R.] McGill Univ, Program Neuroengn, Montreal, PQ, Canada; [Pincus, Zachary] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT USA; [Gupta, Gagan D.; Bashkurov, Mikhail; Pelletier, Laurence] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Charron, Frederic] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Charron, Frederic] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Charron, Frederic] McGill Univ, Dept Biol, Dept Anat & Cell Biol, Div Expt Med, Montreal, PQ H3A 1B1, Canada; [Pelletier, Laurence] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	McGill University; McGill University; Yale University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; McGill University; University of Toronto	Yam, PT (corresponding author), Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada.	patricia.yam@gmail.com	Charron, Frederic/D-2140-2009; Charron, Frederic/O-8017-2019; Pelletier, Laurence/F-8858-2013	Charron, Frederic/0000-0003-3483-8672; Charron, Frederic/0000-0003-3483-8672; Gupta, Gagan/0000-0002-1089-965X; Yam, Patricia/0000-0002-3631-3151; Pincus, Zachary/0000-0001-9785-5977	Regenerative Medicine and Nanomedicine Initiative of the Canadian Institutes of Health Research (CIHR); McGill Program in Neuroengineering; NSERC; CIHR; Rio Tinto Alcan; Molson Foundation; Ontario Research Fund GL2; Canadian Cancer Society; NIH [1K99AG042487]; NATIONAL INSTITUTE ON AGING [R00AG042487, K99AG042487] Funding Source: NIH RePORTER	Regenerative Medicine and Nanomedicine Initiative of the Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); McGill Program in Neuroengineering; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR)); Rio Tinto Alcan; Molson Foundation; Ontario Research Fund GL2; Canadian Cancer Society(Canadian Cancer Society (CCS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by a grant from the Regenerative Medicine and Nanomedicine Initiative of the Canadian Institutes of Health Research (CIHR) to D. R. C., by grants obtained via the McGill Program in Neuroengineering, which is supported by NSERC, CIHR, Rio Tinto Alcan and the Molson Foundation, grants from the Ontario Research Fund GL2 and the Canadian Cancer Society to L. P., a grant from CIHR to F. C. and NIH 1K99AG042487 grant to Z.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arikkath J, 2008, TRENDS NEUROSCI, V31, P487, DOI 10.1016/j.tins.2008.07.001; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Benson DL, 1998, J NEUROSCI, V18, P6892; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; Bozdagi O, 2004, MOL CELL NEUROSCI, V27, P509, DOI 10.1016/j.mcn.2004.08.008; Bozdagi O, 2010, J NEUROSCI, V30, P9984, DOI 10.1523/JNEUROSCI.1223-10.2010; Brasch J, 2012, TRENDS CELL BIOL, V22, P299, DOI 10.1016/j.tcb.2012.03.004; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Chen XB, 2008, P NATL ACAD SCI USA, V105, P4453, DOI 10.1073/pnas.0800897105; Colman DR, 1997, MOL CELL NEUROSCI, V10, P1, DOI 10.1006/mcne.1997.0648; Dani A, 2010, NEURON, V68, P843, DOI 10.1016/j.neuron.2010.11.021; Dustin ML, 2002, SCIENCE, V298, P785, DOI 10.1126/science.1076386; Elste AM, 2006, J COMP NEUROL, V495, P324, DOI 10.1002/cne.20876; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Jontes JD, 2004, J NEUROSCI, V24, P9027, DOI 10.1523/JNEUROSCI.5399-04.2004; Jungling K, 2006, J NEUROSCI, V26, P6968, DOI 10.1523/JNEUROSCI.1013-06.2006; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kharazia VN, 1997, NEUROSCI LETT, V238, P41, DOI 10.1016/S0304-3940(97)00846-X; Latefi NS, 2009, DEV NEUROBIOL, V69, P518, DOI 10.1002/dneu.20718; Lawo S, 2012, NAT CELL BIOL, V14, P1148, DOI 10.1038/ncb2591; MacGillavry HD, 2011, MOL CELL NEUROSCI, V48, P321, DOI 10.1016/j.mcn.2011.09.001; Mendez P, 2010, J CELL BIOL, V189, P589, DOI 10.1083/jcb.201003007; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Nuriya M, 2006, J NEUROCHEM, V97, P652, DOI 10.1111/j.1471-4159.2006.03740.x; Okamura K, 2004, J CELL BIOL, V167, P961, DOI 10.1083/jcb.200406030; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Pincus Z, 2007, J MICROSC-OXFORD, V227, P140, DOI 10.1111/j.1365-2818.2007.01799.x; Redies C, 2000, PROG NEUROBIOL, V61, P611, DOI 10.1016/S0301-0082(99)00070-2; Rubio ME, 2005, MOL CELL NEUROSCI, V30, P118, DOI 10.1016/j.mcn.2005.06.005; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; SANTAMARIA F, PLOS COMPUT BIOL, V6, P780, DOI DOI 10.1371/J0URNAL.PCBI.1000780.PUBMED:20485563; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Sigrist SJ, 2012, CURR OPIN NEUROBIOL, V22, P86, DOI 10.1016/j.conb.2011.10.014; Siksou L, 2007, J NEUROSCI, V27, P6868, DOI 10.1523/JNEUROSCI.1773-07.2007; Silverman JB, 2007, J NEUROSCI, V27, P8505, DOI 10.1523/JNEUROSCI.1395-07.2007; Spacek J, 1998, J COMP NEUROL, V393, P58, DOI 10.1002/(SICI)1096-9861(19980330)393:1<58::AID-CNE6>3.0.CO;2-P; Stan A, 2010, P NATL ACAD SCI USA, V107, P11116, DOI 10.1073/pnas.0914233107; Tai CY, 2007, NEURON, V54, P771, DOI 10.1016/j.neuron.2007.05.013; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; TRILLER A, 1985, J NEUROCYTOL, V14, P177, DOI 10.1007/BF01258446; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; Vitureira N, 2012, NAT NEUROSCI, V15, P81, DOI 10.1038/nn.2995; Xie Z, 2008, J NEUROSCI, V28, P6079, DOI 10.1523/JNEUROSCI.1170-08.2008; Yasuda S, 2007, NEURON, V56, P456, DOI 10.1016/j.neuron.2007.08.020; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001	52	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79679	10.1371/journal.pone.0079679	http://dx.doi.org/10.1371/journal.pone.0079679			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223993	Green Published, gold, Green Submitted			2022-12-27	WOS:000326499300093
J	Fagan, RL; Wu, M; Chedin, F; Brenner, C				Fagan, Rebecca L.; Wu, Meng; Chedin, Frederic; Brenner, Charles			An Ultrasensitive High Throughput Screen for DNA Methyltransferase 1-Targeted Molecular Probes	PLOS ONE			English	Article							DIFFERENTIAL SCANNING FLUOROMETRY; EPIGENETIC REGULATION; METHYLATION; INHIBITORS; CANCER; IDENTIFICATION; FUTURE; CELLS; TUMORIGENESIS; EXPRESSION	DNA methyltransferase 1 (DNMT1) is the enzyme most responsible for epigenetic modification of human DNA and the intended target of approved cancer drugs such as 5-aza-cytidine and 5-aza-2'-deoxycytidine. 5-aza nucleosides have complex mechanisms of action that require incorporation into DNA, and covalent trapping and proteolysis of DNMT isozymes. Direct DNMT inhibitors are needed to refine understanding of the role of specific DNMT isozymes in cancer etiology and, potentially, to improve cancer prevention and treatment. Here, we developed a high throughput pipeline for identification of direct DNMT1 inhibitors. The components of this screen include an activated form of DNMT1, a restriction enzyme-coupled fluorigenic assay performed in 384 well plates with a z-factor of 0.66, a counter screen against the restriction enzyme, a screen to eliminate DNA intercalators, and a differential scanning fluorimetry assay to validate direct binders. Using the Microsource Spectrum collection of 2320 compounds, this screen identified nine compounds with dose responses ranging from 300 nM to 11 mu M, representing at least two different pharmacophores with DNMT1 inhibitory activity. Seven of nine inhibitors identified exhibited two to four-fold selectivity for DNMT1 versus DNMT3A.	[Fagan, Rebecca L.; Wu, Meng; Brenner, Charles] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA; [Chedin, Frederic] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Chedin, Frederic] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA	University of Iowa; University of California System; University of California Davis; University of California System; University of California Davis	Brenner, C (corresponding author), Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA.	charles-brenner@uiowa.edu	Wu, Meng/F-3958-2010; Brenner, Charles/D-6339-2014	Brenner, Charles/0000-0002-4955-3226; Wu, Meng/0000-0003-2222-0736; Chedin, Frederic/0000-0002-1306-5335; Switzer, Rebecca/0000-0003-0591-2538	National Cancer Institute [HHSN261200433000C, R01CA75954]; National Institutes of Health [GM094299]; American Cancer Society; NATIONAL CANCER INSTITUTE [R01CA075954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094299] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work was supported by contract HHSN261200433000C and grant R01CA75954 from the National Cancer Institute and a generous gift from the Roy J. Carver Foundation to CB, grant GM094299 from the National Institutes of Health to FC and an American Cancer Society postdoctoral fellowship to RLF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaning K, 2013, BIOORG MED CHEM LETT, V23, P3620, DOI 10.1016/j.bmcl.2013.04.003; Azad N, 2013, NAT REV CLIN ONCOL, V10, P256, DOI 10.1038/nrclinonc.2013.42; Bigey P, 2000, GENE, V242, P407, DOI 10.1016/S0378-1119(99)00501-6; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Ceccaldi A, 2013, ACS CHEM BIOL, V8, P543, DOI 10.1021/cb300565z; Ceccaldi A, 2011, CHEMBIOCHEM, V12, P1337, DOI 10.1002/cbic.201100130; Daniel FI, 2011, CANCER-AM CANCER SOC, V117, P677, DOI 10.1002/cncr.25482; Datta J, 2009, CANCER RES, V69, P4277, DOI 10.1158/0008-5472.CAN-08-3669; Detich N, 2001, J BIOL CHEM, V276, P24881, DOI 10.1074/jbc.M103056200; Eads CA, 2002, CANCER RES, V62, P1296; Eglen RM, 2011, J BIOMOL SCREEN, V16, P1137, DOI 10.1177/1087057111417871; Fagan RL, 2013, J BIOL CHEM, V288, P23858, DOI 10.1074/jbc.M113.480517; Feng BY, 2006, NAT PROTOC, V1, P550, DOI 10.1038/nprot.2006.77; Gavin DP, 2010, NEUROSCI BIOBEHAV R, V34, P882, DOI 10.1016/j.neubiorev.2009.10.010; Goyal R, 2006, NUCLEIC ACIDS RES, V34, P1182, DOI 10.1093/nar/gkl002; Gros C, 2012, BIOCHIMIE, V94, P2280, DOI 10.1016/j.biochi.2012.07.025; Hortobagyi GN, 1997, DRUGS, V54, P1, DOI 10.2165/00003495-199700544-00003; Huang J, 2013, ONCOGENE IN PRESS; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; Kareta MS, 2006, J BIOL CHEM, V281, P25893, DOI 10.1074/jbc.M603140200; Karouzakis E, 2009, NAT REV RHEUMATOL, V5, P266, DOI 10.1038/nrrheum.2009.55; Kilgore JA, 2013, J BIOL CHEM, V288, P19673, DOI 10.1074/jbc.M112.443895; Klein CJ, 2011, NAT GENET, V43, P595, DOI 10.1038/ng.830; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Ma HM, 2013, CHEMOSPHERE, V90, P1023, DOI 10.1016/j.chemosphere.2012.07.063; MACLEOD AR, 1995, J BIOL CHEM, V270, P11327, DOI 10.1074/jbc.270.19.11327; MACLEOD AR, 1995, J BIOL CHEM, V270, P8037, DOI 10.1074/jbc.270.14.8037; Mishra N, 2001, P NATL ACAD SCI USA, V98, P2628, DOI 10.1073/pnas.051507098; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Ramchandani S, 1997, P NATL ACAD SCI USA, V94, P684, DOI 10.1073/pnas.94.2.684; Slack A, 1999, J BIOL CHEM, V274, P10105, DOI 10.1074/jbc.274.15.10105; Stresemann C, 2008, INT J CANCER, V123, P8, DOI 10.1002/ijc.23607; Syeda F, 2011, J BIOL CHEM, V286, P15344, DOI 10.1074/jbc.M110.209882; SZYF M, 1994, TRENDS PHARMACOL SCI, V15, P233, DOI 10.1016/0165-6147(94)90317-4; Taberlay PC, 2011, PROG DRUG RES, V67, P1, DOI 10.1007/978-3-7643-8989-5_1; Teodoridis JM, 2008, CANCER LETT, V268, P177, DOI 10.1016/j.canlet.2008.03.022; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Wan KF, 2009, CELL CYCLE, V8, P3943, DOI 10.4161/cc.8.23.10114; Yoder JA, 1997, J MOL BIOL, V270, P385, DOI 10.1006/jmbi.1997.1125; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	41	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78752	10.1371/journal.pone.0078752	http://dx.doi.org/10.1371/journal.pone.0078752			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236046	gold, Green Submitted, Green Published			2022-12-27	WOS:000327254700043
J	He, N; Duan, S; Ding, YY; Rou, KM; McGoogan, JM; Jia, MH; Yang, YC; Wang, JB; Montaner, JSG; Wu, ZY				He, Na; Duan, Song; Ding, Yingying; Rou, Keming; McGoogan, Jennifer M.; Jia, Manhong; Yang, Yuecheng; Wang, Jibao; Montaner, Julio S. G.; Wu, Zunyou		China Natl HIV Prevention Study Gr	Antiretroviral Therapy Reduces HIV Transmission in Discordant Couples in Rural Yunnan, China	PLOS ONE			English	Article							HORMONAL CONTRACEPTIVES; SERODISCORDANT COUPLES; RESISTANCE MUTATIONS; HETEROSEXUAL RISK; HEPATITIS-B; PREVENTION; PREVALENCE; INFECTION; INITIATION; SYPHILIS	Background: Although HIV treatment as prevention (TasP) via early antiretroviral therapy (ART) has proven to reduce transmissions among HIV-serodiscordant couples, its full implementation in developing countries remains a challenge. In this study, we determine whether China's current HIV treatment program prevents new HIV infections among discordant couples in rural China. Methods: A prospective, longitudinal cohort study was conducted from June 2009 to March 2011, in rural Yunnan. A total of 1,618 HIV-discordant couples were eligible, 1,101 were enrolled, and 813 were followed for an average of 1.4 person-years (PY). Routine ART was prescribed to HIV-positive spouses according to eligibility (CD4<350 cells/mu l). Seroconversion was used to determine HIV incidence. Results: A total of 17 seroconversions were documented within 1,127 PY of follow-up, for an overall incidence of 1.5 per 100 PY. Epidemiological and genetic evidence confirmed that all 17 seroconverters were infected via marital secondary sexual transmission. Having an ART-experienced HIV-positive partner was associated with a lower rate of seroconvertion compared with having an ART-naive HIV-positive partner (0.8 per 100 PY vs. 2.4 per 100 PY, HR = 0.34, 95% CI = 0.12-0.97, p = 0.0436). While we found that ART successfully suppressed plasma viral load to <400 copies/ml in the majority of cases (85.0% vs. 19.5%, p<0.0001 at baseline), we did document five seroconversions among ART-experienced subgroup. Conclusions: ART is associated with a 66% reduction in HIV incidence among discordant couples in our sample, demonstrating the effectiveness of China's HIV treatment program at preventing new infections, and providing support for earlier ART initiation and TasP implementation in this region.	[He, Na; Ding, Yingying] Fudan Univ, Dept Epidemiol, Sch Publ Hlth, Minist Educ, Shanghai 200433, Peoples R China; Fudan Univ, Minist Educ, Key Lab Publ Hlth Safety, Shanghai 200433, Peoples R China; [Duan, Song; Yang, Yuecheng; Wang, Jibao] Dehong Prefecture Ctr Dis Control & Prevent, Mangshi, Yunnan Province, Peoples R China; [Rou, Keming; McGoogan, Jennifer M.; Wu, Zunyou] Chinese Ctr Dis Control & Prevent China CDC, Natl Ctr AIDS STD Control & Prevent NCAIDS, Beijing, Peoples R China; [Jia, Manhong] Yunnan Prov Ctr Dis Control & Prevent, Kunming, Yunnan Province, Peoples R China	Fudan University; Fudan University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Wu, ZY (corresponding author), Chinese Ctr Dis Control & Prevent China CDC, Natl Ctr AIDS STD Control & Prevent NCAIDS, Beijing, Peoples R China.	wuzy@263.net	ding, yy/HHS-9589-2022	Liu, Enwu/0000-0003-2580-3523	Chinese Ministry of Health [2008ZX10001-016]	Chinese Ministry of Health	The study was supported by the National Science and Technology Major Project on Prevention and Treatment of Major Infectious Diseases including AIDS and Viral Hepatitis from the Chinese Ministry of Health (Grant No. 2008ZX10001-016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], COCHRANE DATABASE SY; Arora P, 2011, SEX TRANSM INFECT, V87, P516, DOI 10.1136/sextrans-2011-050203; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cohen MS, 2011, JAIDS-J ACQ IMM DEF, V56, pE101, DOI 10.1097/QAI.0b013e3182041968; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Del Romero J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2205; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Duan S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-180; El-Sadr WM, 2011, AIDS, V25, P2295, DOI 10.1097/QAD.0b013e32834c4c22; Granich R, 2011, CURR HIV RES, V9, P355, DOI 10.2174/157016211798038551; Guthrie BL, 2011, JAIDS-J ACQ IMM DEF, V58, pE87, DOI 10.1097/QAI.0b013e31822f064e; Han J, 2009, INT J STD AIDS, V20, P249, DOI 10.1258/ijsa.2008.008480; Han XX, 2007, AIDS RES HUM RETROV, V23, P357, DOI 10.1089/aid.2006.0094; Heffron R, 2012, LANCET INFECT DIS, V12, P19, DOI 10.1016/S1473-3099(11)70247-X; Jia YJ, 2008, INT J EPIDEMIOL, V37, P1287, DOI 10.1093/ije/dyn196; Kennedy CE, 2010, B WORLD HEALTH ORGAN, V88, P615, DOI 10.2471/BLT.09.068213; Kumarasamy N, 2010, HIV MED, V11, P178, DOI 10.1111/j.1468-1293.2009.00760.x; Lingappa JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001411; Melo MG, 2008, SEX TRANSM DIS, V35, P912, DOI 10.1097/OLQ.0b013e31817e2491; Ministry of Health in People's Republic of China Joint United Nations Programme on HIV/AIDS World Health Organization, 2011, 2011 EST HIV AIDS EP; Montaner J, 2011, JAIDS-J ACQ IMM DEF, V56, pE101, DOI 10.1097/QAI.0b013e318202e41d; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Polis CB, 2013, LANCET INFECT DIS, V13, P797, DOI 10.1016/S1473-3099(13)70155-5; Reynolds SJ, 2011, AIDS, V25, P473, DOI 10.1097/QAD.0b013e3283437c2b; Ruan YH, 2007, AIDS, V21, pS39, DOI 10.1097/01.aids.0000304695.54884.4f; Ruan YH, 2009, JAIDS-J ACQ IMM DEF, V52, P604, DOI 10.1097/QAI.0b013e3181b31f5c; Ruzagira E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024037; Tu YQ, 2009, TRANSFUSION, V49, P1865, DOI 10.1111/j.1537-2995.2009.02219.x; Wang L, 2010, JAIDS-J ACQ IMM DEF, V55, P232, DOI 10.1097/QAI.0b013e3181e9b6b7; Zang CP, 2011, CHINESE MED J-PEKING, V124, P1890, DOI 10.3760/cma.j.issn.0366-6999.2011.12.022; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4	33	47	64	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e77981	10.1371/journal.pone.0077981	http://dx.doi.org/10.1371/journal.pone.0077981			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236010	gold, Green Submitted, Green Published			2022-12-27	WOS:000327254700007
J	Peng, LY; Xu, LW; Ouyang, W				Peng, Linying; Xu, Liwei; Ouyang, Wen			Role of Peripheral Inflammatory Markers in Postoperative Cognitive Dysfunction (POCD): A Meta-Analysis	PLOS ONE			English	Article							NEURON-SPECIFIC ENOLASE; CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; ELDERLY-PATIENTS; CEREBRAL-DAMAGE; CARDIAC-SURGERY; S-100 PROTEIN; BRAIN; NEUROINFLAMMATION; DECLINE	Background: Postoperative cognitive dysfunction (POCD) is common following cardiac and non-cardiac surgery, but the pathogenic mechanisms remain unknown. Many studies suggest that an inflammatory response is a key contributor to POCD. The current meta-analysis shows that the levels of peripheral inflammatory markers are associated with POCD. Methods: An online search was performed to identify peer-reviewed studies without language restriction that measured peripheral inflammatory markers of patients with and without POCD, using PubMed, ScienceDirect, SinoMed and the National Knowledge Infrastructure database. Extracted data were analyzed with STATA (version 12). The standardized mean difference (SMD) and the 95% confidence interval (95% CI) were calculated for each outcome using a random effect model. Tests of heterogeneity assessment of bias, and meta-regression were performed in the meta-analysis. Results: A total of 13 studies that measured the concentrations of peripheral inflammatory markers were included. The current meta-analysis found significantly higher concentrations of S-100 beta(SMD[95% CI]) (1.377 [0.423, 2.331], p-value < 0.001, N [POCD/non-POCD] = 178/391, 7 studies), and interleukin(IL)-6 (SMD[95% CI]) (1.614 [0.603, 2.624], p-value <0.001, N[POCD/non-POCD] = 91/99, 5 studies), but not of neuron specific enolase, interleukin-1 beta, or tumor necrosis factor-alpha, in POCD compared with patients without POCD. In meta-regression analyses, a significant positive association was found between the SMD and the preoperative interleukin-6 peripheral blood concentration in patients with POCD (Coef. = 0.0587, p-value = 0.038, 5 studies). Conclusions: This study shows that POCD is indeed correlated with the concentrations of peripheral inflammatory markers, particularly interleukin-6 and S-100 beta.	[Peng, Linying; Ouyang, Wen] Cent South Univ, Xiangya Hosp 3, Dept Anesthesiol, Changsha, Hunan, Peoples R China; [Xu, Liwei] Cent South Univ, Xiangya Hosp 1, Dept Gastrointestinal Surg, Changsha, Hunan, Peoples R China	Central South University; Central South University	Ouyang, W (corresponding author), Cent South Univ, Xiangya Hosp 3, Dept Anesthesiol, Changsha, Hunan, Peoples R China.	ouyangwen_123@163.com			National Natural Science Foundation of China [30871306]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (Grant No. 30871306). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker LD, 2010, ARCH NEUROL-CHICAGO, V67, P71, DOI 10.1001/archneurol.2009.307; Banks WA, 2002, NEUROIMMUNOMODULAT, V10, P319, DOI 10.1159/000071472; Barrientos RM, 2012, J NEUROSCI, V32, P14641, DOI 10.1523/JNEUROSCI.2173-12.2012; Barrientos RM, 2009, BRAIN BEHAV IMMUN, V23, P46, DOI 10.1016/j.bbi.2008.07.002; Basile AM, 2001, EUR NEUROL, V45, P151, DOI 10.1159/000052114; Belarbi K, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-23; Beloosesky Y, 2007, J GERONTOL A-BIOL, V62, P420, DOI 10.1093/gerona/62.4.420; Bianchi R, 2007, J LEUKOCYTE BIOL, V81, P108, DOI 10.1189/jlb.0306198; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Brown GC, 2010, MOL NEUROBIOL, V41, P242, DOI 10.1007/s12035-010-8105-9; Buvanendran A, 2006, ANESTHESIOLOGY, V104, P403, DOI 10.1097/00000542-200603000-00005; Cai YM, 2012, ANESTHESIOLOGY, V116, P84, DOI 10.1097/ALN.0b013e31823da7a2; CHEN MH, 2009, MED HLTH, V25, P867; Choi DK, 2011, MOLECULES, V16, P1021, DOI 10.3390/molecules16021021; Cibelli M, 2010, ANN NEUROL, V68, P360, DOI 10.1002/ana.22082; Clemens JA, 1997, MOL BRAIN RES, V48, P187, DOI 10.1016/S0169-328X(97)00092-2; Fidalgo AR, 2011, NEUROSCI LETT, V498, P63, DOI 10.1016/j.neulet.2011.04.063; Goncalves CA, 2008, CLIN BIOCHEM, V41, P755, DOI 10.1016/j.clinbiochem.2008.04.003; Hattori H, 2011, GERIATR GERONTOL INT, V11, P431, DOI 10.1111/j.1447-0594.2011.00698.x; He HJ, 2012, CNS NEUROSCI THER, V18, P994, DOI 10.1111/cns.12018; Higgins JPT, 2008, STAT MED, V27, P6072, DOI 10.1002/sim.3427; [洪涛 Hong Tao], 2006, [临床麻醉学杂志, The Journal of Clinical Anesthestology], V22, P571; Horsburgh K, 2000, NEUROBIOL AGING, V21, P245, DOI 10.1016/S0197-4580(00)00097-X; Hozo SP., 2005, BMC MED RES METHODOL, V5, P1, DOI [10.1186/1471-2288-5-13, DOI 10.1186/1471-2288-5-13]; LI RL, 2013, J SURG RES; Li YC, 2012, ACTA ANAESTH SCAND, V56, P595, DOI 10.1111/j.1399-6576.2011.02616.x; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Linstedt U, 2002, ACTA ANAESTH SCAND, V46, P384, DOI 10.1034/j.1399-6576.2002.460409.x; Ma CX, 2009, CHINESE MED J-PEKING, V122, P1575, DOI 10.3760/cma.j.issn.0366-6999.2009.13.019; Maier SF, 2003, BRAIN BEHAV IMMUN, V17, P69, DOI 10.1016/S0889-1591(03)00032-1; McDonagh DL, 2010, ANESTHESIOLOGY, V112, P852, DOI 10.1097/ALN.0b013e3181d31fd7; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Peng M, 2012, J SURG RES, V178, pE1, DOI 10.1016/j.jss.2012.08.030; Peng Y., 2010, J NANCHANG U MED SCI, V50, P21; Pressley JC, 2003, J CLIN EPIDEMIOL, V56, P896, DOI 10.1016/S0895-4356(03)00133-1; Price CC, 2008, ANESTHESIOLOGY, V108, P8, DOI 10.1097/01.anes.0000296072.02527.18; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Rasmussen LS, 2000, BRIT J ANAESTH, V84, P242, DOI 10.1093/oxfordjournals.bja.a013410; Rivest S, 2000, P SOC EXP BIOL MED, V223, P22, DOI 10.1046/j.1525-1373.2000.22304.x; Rosczyk HA, 2008, EXP GERONTOL, V43, P840, DOI 10.1016/j.exger.2008.06.004; [施丽燕 Shi Liyan], 2012, [上海医学, Shanghai Medical Journal], V35, P115; Silbert B, 2011, BEST PRACT RES-CLIN, V25, P379, DOI 10.1016/j.bpa.2011.05.001; Skinner RA, 2009, BRIT J PHARMACOL, V156, P1115, DOI 10.1111/j.1476-5381.2008.00129.x; Slater JP, 2009, ANN THORAC SURG, V87, P36, DOI 10.1016/j.athoracsur.2008.08.070; Spath-Schwalbe E, 1998, J CLIN ENDOCR METAB, V83, P1573, DOI 10.1210/jc.83.5.1573; Steinmetz J, 2009, ANESTHESIOLOGY, V110, P548, DOI 10.1097/ALN.0b013e318195b569; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Terrando N, 2011, ANN NEUROL, V70, P986, DOI 10.1002/ana.22664; Terrando N, 2010, P NATL ACAD SCI USA, V107, P20518, DOI 10.1073/pnas.1014557107; TIAN HZ, 2012, CHINA PRACT MED, V7, P134; Tilvis RS, 2004, J GERONTOL A-BIOL, V59, P268; van Harten AE, 2012, ANAESTHESIA, V67, P280, DOI 10.1111/j.1365-2044.2011.07008.x; van Munster BC, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-21; Wan YJ, 2007, ANESTHESIOLOGY, V106, P436, DOI 10.1097/00000542-200703000-00007; Wan YJ, 2010, CRIT CARE MED, V38, P2190, DOI 10.1097/CCM.0b013e3181f17bcb; Wells GA, 2011, NEWCASTLE OTTAWA SCA; Witte AV, 2009, P NATL ACAD SCI USA, V106, P1255, DOI 10.1073/pnas.0808587106; WU MD, 2013, BRAIN BEHAV IMMUN; WU WC, 2012, CLIN MED ENG, V19, P1699; [杨泽勇 Yang Zeyong], 2010, [临床麻醉学杂志, The Journal of Clinical Anesthestology], V26, P764; Ye SM, 1999, J NEUROIMMUNOL, V93, P139, DOI 10.1016/S0165-5728(98)00217-3; 徐莹华, 2010, [中国老年学杂志, Chinese Journal of Gerontology], V30, P3158	64	38	52	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79624	10.1371/journal.pone.0079624	http://dx.doi.org/10.1371/journal.pone.0079624			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236147	gold, Green Published, Green Submitted			2022-12-27	WOS:000327254700146
J	Scicluna, BP; van ' t Veer, C; Nieuwdorp, M; Felsmann, K; Wlotzka, B; Stroes, ESG; van der Poll, T				Scicluna, Brendon P.; van ' t Veer, Cornelis; Nieuwdorp, Max; Felsmann, Karen; Wlotzka, Britta; Stroes, Erik S. G.; van der Poll, Tom			Role of Tumor Necrosis Factor-alpha in the Human Systemic Endotoxin-Induced Transcriptome	PLOS ONE			English	Article							INFLAMMATORY RESPONSES; INTRAVENOUS ENDOTOXIN; GENE-EXPRESSION; IRAK-M; RECEPTOR; TOLERANCE; MODELS; INFECTIONS; INDUCTION; NETWORKS	TNF alpha has been implicated in the pathogenesis of various inflammatory diseases. Different strategies to inhibit TNF alpha in patients with sepsis and chronic inflammatory conditions have shown contrasting outcomes. Although TNF alpha inhibitors are widely used in clinical practice, the impact of TNF alpha antagonism on white blood cell gene expression profiles during acute inflammation in humans in vivo has not been assessed. We here leveraged the established model of human endotoxemia to examine the effect of the TNF alpha antagonist, etanercept, on the genome-wide transcriptional responses in circulating leukocytes induced by intravenous LPS administration in male subjects. Etanercept pre-treatment resulted in a markedly dampened transcriptional response to LPS. Gene co-expression network analysis revealed this LPS-induced transcriptome can be categorized as TNF alpha responsive and non-responsive modules. Highly significant TNF alpha responsive modules include NF-kB signaling, antiviral responses and T-cell mediated responses. Within these TNF alpha responsive modules we delineate fundamental genes involved in epigenetic modifications, transcriptional initiation and elongation. Thus, we provide comprehensive information about molecular pathways that might be targeted by therapeutic interventions that seek to inhibit TNF alpha activity during human inflammatory diseases.	[Scicluna, Brendon P.; van ' t Veer, Cornelis; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Expt Mol Med, NL-1105 AZ Amsterdam, Netherlands; [Scicluna, Brendon P.; van ' t Veer, Cornelis; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun, NL-1105 AZ Amsterdam, Netherlands; [Nieuwdorp, Max; Stroes, Erik S. G.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Nieuwdorp, Max] Univ Amsterdam, Acad Med Ctr, Dept Endocrinol & Metab, NL-1105 AZ Amsterdam, Netherlands; [van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Div Infect Dis, NL-1105 AZ Amsterdam, Netherlands; [Felsmann, Karen; Wlotzka, Britta] SIRS Lab GmbH, Jena, Germany	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Scicluna, BP (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Expt Mol Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	b.scicluna@amc.uva.nl	Scicluna, Brendon/T-8112-2018	Scicluna, Brendon/0000-0003-2826-0341	CTMM Netherlands	CTMM Netherlands	This work was supported by CTMM Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Brealey David, 2002, Lancet (North American Edition), V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Broad A, 2006, CURR MED CHEM, V13, P2487, DOI 10.2174/092986706778201675; Buness A, 2005, BIOINFORMATICS, V21, P554, DOI 10.1093/bioinformatics/bti052; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GRIMM S, 1993, BIOCHEM J, V290, P297, DOI 10.1042/bj2900297; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Kadonaga JT, 2004, CELL, V116, P247, DOI 10.1016/S0092-8674(03)01078-X; Khor CC, 2010, NEW ENGL J MED, V362, P2092, DOI 10.1056/NEJMoa0905606; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lorente JA, 2005, SHOCK, V24, P107, DOI 10.1097/01.shk.0000191343.21228.78; MAEKAWA T, 1989, J BIOL CHEM, V264, P14591; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Nieuwdorp A, 2009, ATHEROSCLEROSIS, V202, P296, DOI 10.1016/j.atherosclerosis.2008.03.024; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Reinhart K, 2001, CRIT CARE MED, V29, pS121, DOI 10.1097/00003246-200107001-00037; Sarrias MR, 2007, P NATL ACAD SCI USA, V104, P11724, DOI 10.1073/pnas.0702815104; Sarrias MR, 2004, CRIT REV IMMUNOL, V24, P1; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stearns-Kurosawa DJ, 2011, ANNU REV PATHOL-MECH, V6, P19, DOI 10.1146/annurev-pathol-011110-130327; SUFFREDINI AF, 1995, J IMMUNOL, V155, P5038; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; van der Poll T, 2008, LANCET INFECT DIS, V8, P32, DOI 10.1016/S1473-3099(07)70265-7; van 't Veer C, 2007, J IMMUNOL, V179, P7110, DOI 10.4049/jimmunol.179.10.7110; vanderPoll T, 1997, BLOOD, V89, P3727; Winthrop KL, 2006, NAT CLIN PRACT RHEUM, V2, P602, DOI 10.1038/ncprheum0336; Wirtz S, 2006, J EXP MED, V203, P1875, DOI 10.1084/jem.20060471; Wong HR, 2012, CRIT CARE, V16, DOI 10.1186/cc11847; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Yoza BK, 2006, J IMMUNOL, V177, P4080, DOI 10.4049/jimmunol.177.6.4080; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhao W, 2010, J BIOPHARM STAT, V20, P281, DOI 10.1080/10543400903572753	50	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79051	10.1371/journal.pone.0079051	http://dx.doi.org/10.1371/journal.pone.0079051			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236088	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700086
J	Cui, YX; Xia, XY; Zhou, Y; Gao, L; Shang, XJ; Ni, T; Wang, WP; Fan, XB; Yin, HL; Jiang, SJ; Yao, B; Hu, YA; Wang, G; Li, XJ				Cui, Ying-Xia; Xia, Xin-Yi; Zhou, Yang; Gao, Lin; Shang, Xue-Jun; Ni, Tong; Wang, Wei-Ping; Fan, Xiao-Buo; Yin, Hong-Lin; Jiang, Shao-Jun; Yao, Bing; Hu, Yu-An; Wang, Gang; Li, Xiao-Jun			Novel Mutations of ABCB6 Associated with Autosomal Dominant Dyschromatosis Universalis Hereditaria	PLOS ONE			English	Article							TRANSPORTER; IDENTIFICATION	Objective: Dyschromatosis universalis hereditaria (DUH) is a rare heterogeneous pigmentary genodermatosis, which was first described in 1933. The genetic cause has recently been discovered by the discovery of mutations in ABCB6. Here we investigated a Chinese family with typical features of autosomal dominant DUH and 3 unrelated patients with sporadic DUH. Methods: Skin tissues were obtained from the proband, of this family and the 3 sporadic patients. Histopathological examination and immunohistochemical analysis of ABCB6 were performed. Peripheral blood DNA samples were obtained from 21 affected, 14 unaffected, 11 spouses in the family and the 3 sporadic patients. A genome-wide linkage scan for the family was carried out to localize the causative gene. Exome sequencing was performed from 3 affected and 1 unaffected in the family. Sanger sequencing of ABCB6 was further used to identify the causative gene for all samples obtained from available family members, the 3 sporadic patients and a panel of 455 ethnically-matched normal Chinese individuals. Results: Histopathological analysis showed melanocytes in normal control's skin tissue and the hyperpigmented area contained more melanized, mature melanosomes than those within the hypopigmented areas. Empty immature melanosomes were found in the hypopigmented melanocytes. Parametric multipoint linkage analysis produced a HLOD score of 4.68, with markers on chromosome 2q35-q37.2. A missense mutation (c.1663 C>A, p.Gln555Lys) in ABCB6 was identified in this family by exome and Sanger sequencing. The mutation perfectly cosegregated with the skin phenotype. An additional mutation (g. 776 delC, c. 459 delC) in ABCB6 was found in an unrelated sporadic patient. No mutation in ABCB6 was discovered in the other two sporadic patients. Neither of the two mutations was present in the 455 controls. Melanocytes showed positive immunoreactivity to ABCB6. Conclusion: Our data add new variants to the repertoire of ABCB6 mutations with DUH.	[Cui, Ying-Xia; Xia, Xin-Yi; Zhou, Yang; Shang, Xue-Jun; Wang, Wei-Ping; Fan, Xiao-Buo; Yao, Bing; Hu, Yu-An; Li, Xiao-Jun] Nanjing Univ, Sch Med, Jinling Hosp, Inst Lab Med, Nanjing 210008, Jiangsu, Peoples R China; [Gao, Lin; Wang, Gang] Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, Xian 710032, Peoples R China; [Ni, Tong] Nanjing Univ, Sch Med, Jinling Hosp, Dept Dermatol, Nanjing 210008, Jiangsu, Peoples R China; [Yin, Hong-Lin; Jiang, Shao-Jun] Nanjing Univ, Sch Med, Jinling Hosp, Dept Pathol, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Air Force Military Medical University; Nanjing University; Nanjing University	Li, XJ (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Inst Lab Med, Nanjing 210008, Jiangsu, Peoples R China.	Lixiaojun1962@gmail.com	Xia, Xin-Yi/C-3744-2014; Wang, Gang/H-6710-2019	Wang, Gang/0000-0002-5842-8080	National Natural Science Foundation of China [30901652, 81071419]; Natural Science Foundation of Jiangsu Province [BK2011660]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This sdudy is supported in part by the National Natural Science Foundation of China (30901652,81071419) and the Natural Science Foundation of Jiangsu Province (BK2011660). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Hawsawi K, 2002, PEDIATR DERMATOL, V19, P523, DOI 10.1046/j.1525-1470.2002.00225.x; Andolfo I, 2013, AM J HEMATOL, V88, P66, DOI 10.1002/ajh.23357; Baker KE, 2004, CURR OPIN CELL BIOL, V16, P293, DOI 10.1016/j.ceb.2004.03.003; Bukhari IA, 2006, J EUR ACAD DERMATOL, V20, P628, DOI 10.1111/j.1468-3083.2006.01522.x; Helias V, 2012, NAT GENET, V44, P170, DOI 10.1038/ng.1069; Helmerl S, 2007, MELANOMA RES, V17, P265, DOI 10.1097/CMR.0b013e3282a7e0b9; Ichigawa T, 1933, JAPANESE J DERMATOLO, V34, P360; Kenani N, 2008, Dermatol Online J, V14, P16; Kiss K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037378; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; Mitsuhashi N, 2000, J BIOL CHEM, V275, P17536, DOI 10.1074/jbc.275.23.17536; Nuber UA, 2004, AM J MED GENET A, V125A, P261, DOI 10.1002/ajmg.a.20519; Reddy Shruthi Geedipalley, 2011, Dermatol Online J, V17, P3; Sethuraman G, 2002, CLIN EXP DERMATOL, V27, P477, DOI 10.1046/j.1365-2230.2002.01129.x; Steel KP, 1998, NAT GENET, V20, P319, DOI 10.1038/3781; Sturm RA, 2001, GENE, V277, P49, DOI 10.1016/S0378-1119(01)00694-1; SUENAGA M, 1952, Tohoku J Exp Med, V55, P373; Tsuchida M, 2008, BIOCHEM BIOPH RES CO, V369, P369, DOI 10.1016/j.bbrc.2008.02.027; Udayashankar Carounanidy, 2011, Dermatol Online J, V17, P2; Wang LJ, 2012, AM J HUM GENET, V90, P40, DOI 10.1016/j.ajhg.2011.11.026; Xing QH, 2003, AM J HUM GENET, V73, P377, DOI 10.1086/377007; Yusuf SM, 2009, INT J DERMATOL, V48, P749, DOI 10.1111/j.1365-4632.2009.03290.x; Zhang CE, 2013, J INVEST DERMATOL, V133, P2221, DOI 10.1038/jid.2013.145	23	18	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79808	10.1371/journal.pone.0079808	http://dx.doi.org/10.1371/journal.pone.0079808			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224009	gold, Green Published, Green Submitted			2022-12-27	WOS:000326597400090
J	Dohms, KM; Burg, TM				Dohms, Kimberly M.; Burg, Theresa M.			Molecular Markers Reveal Limited Population Genetic Structure in a North American Corvid, Clark's Nutcracker (Nucifraga columbiana)	PLOS ONE			English	Article							MICROSATELLITE LOCI; MITOCHONDRIAL-DNA; PHYLOGEOGRAPHIC STRUCTURE; POSTGLACIAL COLONIZATION; PINE; DISPERSAL; PATTERNS; DIVERSITY; SEQUENCES; SOFTWARE	The genetic impact of barriers and Pleistocene glaciations on high latitude resident species has not been widely investigated. The Clark's nutcracker is an endemic North American corvid closely associated with Pinus-dominated forests. The nutcracker's encompasses known barriers to dispersal for other species, and glaciated and unglaciated areas. Clark's nutcrackers also irruptively disperse long distances in search of pine seed crops, creating the potential for gene flow among populations. Using the highly variable mitochondrial DNA control region, seven microsatellite loci, and species distribution modeling, we examined the effects of glaciations and dispersal barriers on population genetic patterns and population structure of nutcrackers. We sequenced 900 bp of mitochondrial control region for 169 individuals from 15 populations and analysed seven polymorphic microsatellite loci for 13 populations across the Clark's nutcracker range. We used species distribution modeling and a range of phylogeographic analyses to examine evolutionary history. Clark's nutcracker populations are not highly differentiated throughout their range, suggesting high levels of gene flow among populations, though we did find some evidence of isolation by distance and peripheral isolation. Our analyses suggested expansion from a single refugium after the last glacial maximum, but patterns of genetic diversity and paleodistribution modeling of suitable habitat were inconclusive as to the location of this refugium. Potential barriers to dispersal (e. g. mountain ranges) do not appear to restrict gene flow in Clark's nutcracker, and postglacial expansion likely occurred quickly from a single refugium located south of the ice sheets.	[Dohms, Kimberly M.; Burg, Theresa M.] Univ Lethbridge, Lethbridge, AB T1K 3M4, Canada	University of Lethbridge	Dohms, KM (corresponding author), Univ Lethbridge, Lethbridge, AB T1K 3M4, Canada.	kim.dohms@uleth.ca			Natural Science and Engineering Research Council (NSERC); Alberta Innovates (AI)	Natural Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates (AI)	The work was supported by the following: Natural Science and Engineering Research Council (NSERC) Discovery Grant (TMB) and Post-Graduate Scholarship D (KMD), http://www.nserc-crsng.gc.ca/; Alberta Innovates (AI) New Faculty Award (TMB) and Graduate Scholarship (KMD), http://www.albertatechfutures.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2010, J BIOGEOGR, V37, P1378, DOI 10.1111/j.1365-2699.2010.02290.x; Avise J.C., 2004, MOL MARKERS NATURAL, P684; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barrowclough GF, 2004, MOL ECOL, V13, P1911, DOI 10.1111/j.1365-294X.2004.02215.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brunsfeld S., 2001, INTEGRATING ECOLOGY, V14, P319; Burg TM, 2006, MOL ECOL, V15, P2409, DOI 10.1111/j.1365-294X.2006.02957.x; Burg TM, 2005, MOL ECOL, V14, P3745, DOI 10.1111/j.1365-294X.2005.02710.x; Burg TM, 2003, P ROY SOC B-BIOL SCI, V270, P979, DOI 10.1098/rspb.2002.2322; Burg TM, 2001, MOL ECOL, V10, P2647, DOI 10.1046/j.0962-1083.2001.01392.x; Cheng L, 2013, MOL BIOL EVOL, V30, P1224, DOI 10.1093/molbev/mst028; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Dynesius M, 2000, P NATL ACAD SCI USA, V97, P9115, DOI 10.1073/pnas.97.16.9115; EARL DA, 2012, CONSERV GENET RESOUR, V4, P1, DOI DOI 10.1007/S12686-011-9460-1; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Ernest HB, 2008, MOL ECOL RESOUR, V8, P196, DOI 10.1111/j.1471-8286.2007.01921.x; Ersts P, 2011, GEOGRAPHIC DISTANCE; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Galbreath KE, 2010, J BIOGEOGR, V37, P344, DOI 10.1111/j.1365-2699.2009.02201.x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Graham BA, 2012, J AVIAN BIOL, V43, P198, DOI 10.1111/j.1600-048X.2012.05604.x; Haring E, 2007, MOL PHYLOGENET EVOL, V45, P840, DOI 10.1016/j.ympev.2007.06.016; Hasumi H., 2004, 1 U TOK CTR CLIM SYS; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hutchison DW, 1999, EVOLUTION, V53, P1898, DOI 10.1111/j.1558-5646.1999.tb04571.x; Jaramillo-Correa JP, 2009, CAN J FOREST RES, V39, P286, DOI 10.1139/X08-181; Johansen AD, 2003, MOL ECOL, V12, P293, DOI 10.1046/j.1365-294X.2003.01723.x; Jorgensen S, 2002, AM J BOT, V89, P792, DOI 10.3732/ajb.89.5.792; Keyghobadi N, 2007, CAN J ZOOL, V85, P1049, DOI 10.1139/Z07-095; Kim MS, 2011, TREE GENET GENOMES, V7, P11, DOI 10.1007/s11295-010-0311-0; Klicka J, 2011, AUK, V128, P346, DOI 10.1525/auk.2011.10264; Koopman ME, 2007, AUK, V124, P690, DOI 10.1642/0004-8038(2007)124[690:HCAMGS]2.0.CO;2; Lait LA, 2012, J AVIAN BIOL, V43, P541, DOI 10.1111/j.1600-048X.2012.05761.x; Latch EK, 2006, CONSERV GENET, V7, P295, DOI 10.1007/s10592-005-9098-1; Latta RG, 1999, EVOLUTION, V53, P769, DOI 10.2307/2640717; Lorenz TJ, 2010, J FIELD ORNITHOL, V81, P430, DOI 10.1111/j.1557-9263.2010.00299.x; Lorenz TJ, 2009, CONDOR, V111, P326, DOI 10.1525/cond.2009.080070; Marthinsen G, 2008, MOL PHYLOGENET EVOL, V47, P1005, DOI 10.1016/j.ympev.2008.03.027; MCKINNEY ST, 2011, FUTURE HIGH ELEVATIO, P376; Mila B, 2000, P ROY SOC B-BIOL SCI, V267, P1033, DOI 10.1098/rspb.2000.1107; Milot E, 2000, MOL ECOL, V9, P667, DOI 10.1046/j.1365-294x.2000.00897.x; Mitton JB, 2000, MOL ECOL, V9, P91, DOI 10.1046/j.1365-294x.2000.00840.x; Moritz C, 2002, SYST BIOL, V51, P238, DOI 10.1080/10635150252899752; Newton I, 2006, ARDEA, V94, P433; Oyler-McCance SJ, 2013, CONSERV GENET RESOUR, V5, P303, DOI 10.1007/s12686-012-9789-0; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pielou EC, 1991, ICE AGE RETURN LIFE; Piertney SB, 2001, P ROY SOC B-BIOL SCI, V268, P1511, DOI 10.1098/rspb.2001.1015; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Pritchard JK, 2000, GENETICS, V155, P945; Pulgarin-R PC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040412; Pyle P, 1997, IDENTIFICATION GUIDE; Richardson BA, 2002, MOL ECOL, V11, P215, DOI 10.1046/j.1365-294X.2002.01435.x; Ridgely R. S, 2007, DIGITAL DISTRIBUTION; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Saunders MA, 2000, J MOL EVOL, V51, P97, DOI 10.1007/s002390010070; SLATKIN M, 1991, GENETICS, V129, P555; Spellman GM, 2007, MOL ECOL, V16, P1729, DOI 10.1111/j.1365-294X.2007.03237.x; Spellman GM, 2006, P ROY SOC B-BIOL SCI, V273, P3057, DOI 10.1098/rspb.2006.3682; Stenzler LM, 2009, CONDOR, V111, P470, DOI 10.1525/cond.2009.080052; Stenzler LM, 2002, MOL ECOL NOTES, V2, P547, DOI 10.1046/j.1471-8286.2002.00312.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TOMBACK DF, 1982, J ANIM ECOL, V51, P451, DOI 10.2307/3976; TOMBACK DF, 1998, BIRDS N AM, V24; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Weir JT, 2004, P ROY SOC B-BIOL SCI, V271, P1881, DOI 10.1098/rspb.2004.2803; Williams JW, 2003, GLOBAL PLANET CHANGE, V35, P1, DOI 10.1016/S0921-8181(02)00088-7; Wright S., 1978, EVOLUTION GENETIC PO; Zink RM, 1996, EVOLUTION, V50, P308, DOI 10.1111/j.1558-5646.1996.tb04494.x; Zink Robert M., 1997, P301, DOI 10.1016/B978-012498315-1/50017-0	78	9	9	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79621	10.1371/journal.pone.0079621	http://dx.doi.org/10.1371/journal.pone.0079621			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223982	Green Published, gold			2022-12-27	WOS:000326503400132
J	Iwajomo, OH; Finn, A; Ogunniyi, AD; Williams, NA; Heyderman, RS				Iwajomo, Oluwadamilola H.; Finn, Adam; Ogunniyi, Abiodun D.; Williams, Neil A.; Heyderman, Robert S.			Impairment of Pneumococcal Antigen Specific Isotype-Switched Igg Memory B-Cell Immunity in HIV Infected Malawian Adults	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; AFRICAN CHILDREN; RESPONSES; DISEASE; IMMUNIZATION; INDIVIDUALS; PROTEIN; PNEUMOLYSIN; EXPRESSION; PROTECTION	Pneumococcal disease is associated with a particularly high morbidity and mortality amongst adults in HIV endemic countries. Our previous findings implicating a B-cell defect in HIV-infected children from the same population led us to comprehensively characterize B-cell subsets in minimally symptomatic HIV-infected Malawian adults and investigate the isotype-switched IgG memory B-cell immune response to the pneumococcus. We show that similar to vertically acquired HIV-infected Malawian children, horizontally acquired HIV infection in these adults is associated with IgM memory B-cell (CD19(+) CD27(+) IgM(+) IgD(+)) depletion, B-cell activation and impairment of specific IgG B-cell memory to a range of pneumococcal proteins. Our data suggest that HIV infection affects both T-cell independent and T-cell dependent B-cell maturation, potentially leading to impairment of humoral responses to extracellular pathogens such as the pneumococcus, and thus leaving this population susceptible to invasive disease.	[Iwajomo, Oluwadamilola H.; Finn, Adam; Williams, Neil A.; Heyderman, Robert S.] Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England; [Iwajomo, Oluwadamilola H.; Heyderman, Robert S.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Ogunniyi, Abiodun D.] Univ Adelaide, Sch Mol & Biomed Sci, Res Ctr Infect Dis, Adelaide, SA, Australia	University of Bristol; University of Malawi; University of Adelaide	Iwajomo, OH (corresponding author), Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England.	damilola.iwajomo@gmail.com		Finn, Adam/0000-0003-1756-5668; Heyderman, Robert/0000-0003-4573-449X; Ogunniyi, Abiodun/0000-0001-9308-5629	Joan Franklin-Adams Trust; David Baum Memorial Appeal; Wellcome Trust MLW core grant; Wellcome Trust project grant	Joan Franklin-Adams Trust; David Baum Memorial Appeal; Wellcome Trust MLW core grant; Wellcome Trust project grant(Wellcome Trust)	This work was supported by the Joan Franklin-Adams Trust (scholarship to OHI), David Baum Memorial Appeal (grant to AF and RSH), Wellcome Trust MLW core grant (funding to RSH) and a Wellcome Trust project grant (funding to RSH and NAW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clarke ET, 2013, MUCOSAL IMMUNOL, V6, P288, DOI 10.1038/mi.2012.70; Crotty S, 2004, J IMMUNOL METHODS, V286, P111, DOI 10.1016/j.jim.2003.12.015; Glennie SJ, 2013, CLIN INFECT DIS, V56, P291, DOI 10.1093/cid/cis842; Glennie SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025610; Gordon MA, 2001, J INFECTION, V42, P44, DOI 10.1053/jinf.2000.0779; Gordon SB, 2000, CLIN INFECT DIS, V31, P53, DOI 10.1086/313910; Gordon SB, 2002, AIDS, V16, P1409, DOI 10.1097/00002030-200207050-00013; Hart M, 2007, J IMMUNOL, V178, P8212, DOI 10.4049/jimmunol.178.12.8212; Ho J, 2006, P NATL ACAD SCI USA, V103, P19436, DOI 10.1073/pnas.0609515103; Iwajomo OH, 2011, J INFECT DIS, V204, P534, DOI 10.1093/infdis/jir316; Jacobson MA, 2002, JAIDS, V31, P472, DOI 10.1097/00126334-200212150-00003; Kruetzmann S, 2003, J EXP MED, V197, P939, DOI 10.1084/jem.20022020; Lindqvist M, 2012, J CLIN INVEST, V122, P3271, DOI 10.1172/JCI64314; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; Madhi SA, 2000, PEDIATR INFECT DIS J, V19, P1141, DOI 10.1097/00006454-200012000-00004; Malaspina A, 2006, P NATL ACAD SCI USA, V103, P2262, DOI 10.1073/pnas.0511094103; Malley R, 2010, J MOL MED, V88, P135, DOI 10.1007/s00109-009-0579-4; Moir S, 2001, P NATL ACAD SCI USA, V98, P10362, DOI 10.1073/pnas.181347898; Moir S, 2004, J EXP MED, V200, P587, DOI 10.1084/jem.20032236; O'Brien KL, 2001, J CLIN MICROBIOL, V39, P1021, DOI 10.1128/JCM.39.3.1021-1024.2001; Ogunniyi AD, 2008, VACCINE, V26, P4676, DOI 10.1016/j.vaccine.2008.06.099; Ogunniyi AD, 2000, INFECT IMMUN, V68, P3028, DOI 10.1128/IAI.68.5.3028-3033.2000; Ogunniyi AD, 2001, INFECT IMMUN, V69, P5997, DOI 10.1128/IAI.69.10.5997-6003.2001; Pilling PA, 1998, ACTA CRYSTALLOGR D, V54, P1464, DOI 10.1107/S0907444998005812; Shi YH, 2005, J IMMUNOL, V175, P3262, DOI 10.4049/jimmunol.175.5.3262; Smith KGC, 1996, EUR J IMMUNOL, V26, P444, DOI 10.1002/eji.1830260226; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; World Health Organization, 2009, RAP ADV ANT THER HIV; Xu WF, 2009, NAT IMMUNOL, V10, P1008, DOI 10.1038/ni.1753; Zhang QB, 2006, EUR J IMMUNOL, V36, P46, DOI 10.1002/eji.200535101; Zhang QB, 2007, J INFECT DIS, V195, P1194, DOI 10.1086/512617	31	11	11	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78592	10.1371/journal.pone.0078592	http://dx.doi.org/10.1371/journal.pone.0078592			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223825	Green Published, gold, Green Submitted			2022-12-27	WOS:000326503400074
J	Kshirsagar, AV; Freburger, JK; Ellis, AR; Wang, L; Winkelmayer, WC; Brookhart, MA				Kshirsagar, Abhijit V.; Freburger, Janet K.; Ellis, Alan R.; Wang, Lily; Winkelmayer, Wolfgang C.; Brookhart, M. Alan			Intravenous Iron Supplementation Practices and Short-Term Risk of Cardiovascular Events in Hemodialysis Patients	PLOS ONE			English	Article							ANEMIA MANAGEMENT; MORTALITY; THERAPY; PRODUCTS; PATTERNS; OUTCOMES; DISEASE; ALPHA	Background & Objectives: Intravenous iron supplementation is widespread in the hemodialysis population, but there is uncertainty about the safest dosing strategy. We compared the safety of different intravenous iron dosing practices on the risk of adverse cardiovascular outcomes in a large population of hemodialysis patients. Design settings, participants, & measurements: A retrospective cohort was created from the clinical database of a large dialysis provider (years 2004-2008) merged with administrative data from the United States Renal Data System. Dosing comparisons were (1) bolus (consecutive doses >= 100 mg exceeding 600 mg during one month) versus maintenance (all other iron doses during the month); and (2) high (> 200 mg over 1 month) versus low dose (<= 200 mg over 1 month). We established a 6-month baseline period (to identify potential confounders and effect modifiers), a one-month iron exposure period, and a three-month follow-up period. Outcomes were myocardial infarction, stroke, and death from cardiovascular disease. Results: 117,050 patients contributed 776,203 unique iron exposure/follow-up periods. After adjustment, we found no significant associations of bolus dose versus maintenance, hazards ratio for composite outcome, 1.03 (95% C. I. 0.99, 1.07), or high dose versus low dose intravenous iron, hazards ratio for composite outcome, 0.99 (95% C. I. 0.96, 1.03). There were no consistent associations of either high or bolus dose versus low or maintenance respectively among pre-specified subgroups. Conclusions: Strategies favoring large doses of intravenous iron were not associated with increased short-term cardiovascular morbidity and mortality. Investigation of the long-term safety of the various intravenous iron supplementation strategies may still be warranted.	[Kshirsagar, Abhijit V.] Univ N Carolina, Sch Med, Kidney Ctr, Chapel Hill, NC 27515 USA; [Freburger, Janet K.; Ellis, Alan R.; Wang, Lily] Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC USA; [Winkelmayer, Wolfgang C.] Stanford Univ, Sch Med, Dept Med, Div Nephrol, Palo Alto, CA 94304 USA; [Brookhart, M. Alan] UNC, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; Stanford University; University of North Carolina; University of North Carolina Chapel Hill	Kshirsagar, AV (corresponding author), Univ N Carolina, Sch Med, Kidney Ctr, Chapel Hill, NC 27515 USA.	sagar@med.unc.edu			Agency for Healthcare Research and Quality (AHRQ), United States Department of Health and Human Services (DHHS) as part of the Developing Evidence to Inform Decisions about Effectiveness (DECIDE) program [HHSA290200500401]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090181] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality (AHRQ), United States Department of Health and Human Services (DHHS) as part of the Developing Evidence to Inform Decisions about Effectiveness (DECIDE) program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was funded under contract number HHSA290200500401 from the Agency for Healthcare Research and Quality (AHRQ), United States Department of Health and Human Services (DHHS) as part of the Developing Evidence to Inform Decisions about Effectiveness (DECIDE) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akizawa T, 2008, NEPHROL DIAL TRANSPL, V23, P3643, DOI 10.1093/ndt/gfn346; Berliner JA, 1996, FREE RADICAL BIO MED, V20, P707, DOI 10.1016/0891-5849(95)02173-6; BIEMOND P, 1988, FREE RADICAL BIO MED, V4, P185, DOI 10.1016/0891-5849(88)90026-3; Brewster UC, 2006, SEMIN DIALYSIS, V19, P285, DOI 10.1111/j.1525-139X.2006.00174.x; *CTR MED MED SERV, 2012, FED REGISTER, V77, P133; *CTR MED MED SERV, 2011, FED REGISTER, V76, P218; de Jager DJ, 2009, JAMA-J AM MED ASSOC, V302, P1782, DOI 10.1001/jama.2009.1488; Drueke T, 2002, CIRCULATION, V106, P2212, DOI 10.1161/01.CIR.0000035250.66458.67; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; *FDA, 2011, DRUG SAF COMM MOD DO; Feldman HI, 2004, J AM SOC NEPHROL, V15, P1623, DOI 10.1097/01.ASN.0000128009.69594.BE; Fishbane S, 1999, AM J KIDNEY DIS, V34, pS47, DOI 10.1053/ajkd.1999.v34.aajkd0344b0047; Freburger JK, 2012, AM J MED, V125, P906, DOI 10.1016/j.amjmed.2012.03.011; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; Himmelfarb J, 2002, KIDNEY INT, V62, P1524, DOI 10.1046/j.1523-1755.2002.00600.x; Hoen B, 1998, J AM SOC NEPHROL, V9, P869; Kalantar-Zadeh K, 2005, J AM SOC NEPHROL, V16, P3070, DOI 10.1681/ASN.2005040423; KSHIRSAGAR AV, 2013, AM J MED IN PRESS, P97800; LIN DY, 1994, BIOMETRIKA, V81, P61, DOI 10.1093/biomet/81.1.61; *NAT I HLTH, 2011, RES GUID USRDS DAT 2; Parkkinen J, 2000, NEPHROL DIAL TRANSPL, V15, P1827, DOI 10.1093/ndt/15.11.1827; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Pisoni RL, 2004, AM J KIDNEY DIS, V44, P94, DOI 10.1053/j.ajkd.2004.03.023; Reis KA, 2005, INT HEART J, V46, P255, DOI 10.1536/ihj.46.255; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; SEVANIAN A, 1985, ANNU REV NUTR, V5, P365, DOI 10.1146/annurev.nu.05.070185.002053; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Singh N, 2012, CLIN NEPHROL, V77, P188, DOI 10.5414/CN107266; Spiegel DM, 2009, CLIN J AM SOC NEPHRO, V4, P1009, DOI 10.2215/CJN.00270109; Thakuria M, 2011, SEMIN DIALYSIS, V24, P597, DOI 10.1111/j.1525-139X.2011.00975.x; Vaziri ND, 2012, AM J MED, V125, P951, DOI 10.1016/j.amjmed.2012.02.009; Yong K, 2010, NEPHROLOGY, V15, P288, DOI 10.1111/j.1440-1797.2009.01184.x; Zanen AL, 1996, NEPHROL DIAL TRANSPL, V11, P820, DOI 10.1093/oxfordjournals.ndt.a027405	34	54	56	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78930	10.1371/journal.pone.0078930	http://dx.doi.org/10.1371/journal.pone.0078930			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223866	Green Published, gold, Green Submitted			2022-12-27	WOS:000326499300043
J	Meuwese, JDI; van Loon, AM; Scholte, HS; Lirk, PB; Vulink, NCC; Hollmann, MW; Lamme, VAF				Meuwese, Julia D. I.; van Loon, Anouk M.; Scholte, H. Steven; Lirk, Philipp B.; Vulink, Nienke C. C.; Hollmann, Markus W.; Lamme, Victor A. F.			NMDA Receptor Antagonist Ketamine Impairs Feature Integration in Visual Perception	PLOS ONE			English	Article							FIGURE-GROUND SEGREGATION; LOW-DOSE KETAMINE; ACETYLCHOLINE-RELEASE; WORKING-MEMORY; CORTICOCORTICAL CONNECTIONS; SUBANESTHETIC KETAMINE; CELLULAR MECHANISMS; ANALOG SCALES; CORTEX; FEEDFORWARD	Recurrent interactions between neurons in the visual cortex are crucial for the integration of image elements into coherent objects, such as in figure-ground segregation of textured images. Blocking N-methyl-D-aspartate (NMDA) receptors in monkeys can abolish neural signals related to figure-ground segregation and feature integration. However, it is unknown whether this also affects perceptual integration itself. Therefore, we tested whether ketamine, a non-competitive NMDA receptor antagonist, reduces feature integration in humans. We administered a subanesthetic dose of ketamine to healthy subjects who performed a texture discrimination task in a placebo-controlled double blind within-subject design. We found that ketamine significantly impaired performance on the texture discrimination task compared to the placebo condition, while performance on a control fixation task was much less impaired. This effect is not merely due to task difficulty or a difference in sedation levels. We are the first to show a behavioral effect on feature integration by manipulating the NMDA receptor in humans.	[Meuwese, Julia D. I.; van Loon, Anouk M.; Scholte, H. Steven; Lamme, Victor A. F.] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Meuwese, Julia D. I.; van Loon, Anouk M.; Scholte, H. Steven; Lamme, Victor A. F.] Univ Amsterdam, Cognit Sci Ctr Amsterdam, Amsterdam, Netherlands; [Lirk, Philipp B.; Hollmann, Markus W.] Univ Amsterdam, Acad Med Ctr, Dept Anesthesiol, NL-1105 AZ Amsterdam, Netherlands; [Vulink, Nienke C. C.] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Meuwese, JDI (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.	j.d.i.meuwese@uva.nl	Scholte, H.Steven/ABD-1737-2020	Vulink, Nienke/0000-0001-8991-9627; van Loon, Anouk/0000-0002-9015-7647; Scholte, H.Steven/0000-0002-9839-1788	European Research Council (ERC) [230355]	European Research Council (ERC)(European Research Council (ERC))	This work is supported by funding from the Advanced Investigator Grant from the European Research Council (ERC) to V.A.F. Lamme (grant number 230355). Eurocept BV (Ankeveen, The Netherlands) supported this work by providing S-ketamine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel KM, 2003, NEUROPHARMACOLOGY, V44, P729, DOI 10.1016/S0028-3908(03)00073-X; Abel KM, 2003, NEUROREPORT, V14, P387, DOI 10.1097/01.wnr.0000058031.29600.31; Adler CM, 1998, BIOL PSYCHIAT, V43, P811, DOI 10.1016/S0006-3223(97)00556-8; Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; Angelucci A, 2003, J PHYSIOL-PARIS, V97, P141, DOI 10.1016/j.jphysparis.2003.09.001; Angelucci A, 2002, J NEUROSCI, V22, P8633; Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Boehler CN, 2008, P NATL ACAD SCI USA, V105, P8742, DOI 10.1073/pnas.0801999105; BOND A, 1974, BRIT J MED PSYCHOL, V47, P211, DOI 10.1111/j.2044-8341.1974.tb02285.x; Boyer JL, 2005, P NATL ACAD SCI USA, V102, P16875, DOI 10.1073/pnas.0505332102; Chizh BA, 2007, J PSYCHOPHARMACOL, V21, P259, DOI 10.1177/0269881105062484; Chou YC, 1999, BRAIN RES, V821, P516, DOI 10.1016/S0006-8993(99)01125-7; COLLINGRIDGE GL, 1987, TRENDS NEUROSCI, V10, P288, DOI 10.1016/0166-2236(87)90175-5; DANION JM, 1989, PSYCHOPHARMACOLOGY, V99, P238, DOI 10.1007/BF00442815; Dehaene S, 2003, P NATL ACAD SCI USA, V100, P8520, DOI 10.1073/pnas.1332574100; Duman RS, 2012, NEUROPHARMACOLOGY, V62, P35, DOI 10.1016/j.neuropharm.2011.08.044; Durstewitz D, 2009, NEURAL NETWORKS, V22, P1189, DOI 10.1016/j.neunet.2009.07.016; Enns JT, 2000, TRENDS COGN SCI, V4, P345, DOI 10.1016/S1364-6613(00)01520-5; Fahrenfort JJ, 2007, J COGNITIVE NEUROSCI, V19, P1488, DOI 10.1162/jocn.2007.19.9.1488; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FOX K, 1989, J NEUROSCI, V9, P2443; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; Fukuda M, 1998, NEUROSCI RES, V31, P9, DOI 10.1016/S0168-0102(98)00018-2; GIFT AG, 1989, NURS RES, V38, P286; GILBERT CD, 1989, J NEUROSCI, V9, P2432; Gilbert CD, 1996, CURR OPIN NEUROBIOL, V6, P269, DOI 10.1016/S0959-4388(96)80083-3; Harborne GC, 1996, J PSYCHOPHARMACOL, V10, P134, DOI 10.1177/026988119601000208; Hemmings HC, 2005, TRENDS PHARMACOL SCI, V26, P503, DOI 10.1016/j.tips.2005.08.006; Herrero JL, 2008, NATURE, V454, P1110, DOI 10.1038/nature07141; Hess RF, 2003, J PHYSIOL-PARIS, V97, P105, DOI 10.1016/j.jphysparis.2003.09.013; Honey RAE, 2004, NEUROPSYCHOPHARMACOL, V29, P1203, DOI 10.1038/sj.npp.1300438; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Hupe JM, 1998, NATURE, V394, P784, DOI 10.1038/29537; Johnson RR, 1996, J COMP NEUROL, V368, P335, DOI 10.1002/(SICI)1096-9861(19960506)368:3<335::AID-CNE2>3.0.CO;2-6; JOYCE CRB, 1975, EUR J CLIN PHARMACOL, V8, P415, DOI 10.1007/BF00562315; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; Kavalaii ET, 2012, AM J PSYCHIAT, V169, P1150, DOI 10.1176/appi.ajp.2012.12040531; Kikuchi T, 1997, BRIT J ANAESTH, V79, P128, DOI 10.1093/bja/79.1.128; Kocsis B, 2013, CNS NEUROSCI THER, V19, P437, DOI 10.1111/cns.12081; Kotermanski SE, 2013, PHARMACOL BIOCHEM BE, V109, P67, DOI 10.1016/j.pbb.2013.05.005; Krystal JH, 1999, PSYCHOPHARMACOLOGY, V145, P193, DOI 10.1007/s002130051049; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Krystal JH, 2005, PSYCHOPHARMACOLOGY, V179, P303, DOI 10.1007/s00213-004-1982-8; Kurylo DD, 2008, PHYSIOL BEHAV, V95, P152, DOI 10.1016/j.physbeh.2008.05.012; Lamme V.A.F., 2000, BRAIN MIND, V1, P385, DOI [10.1023/A:1011569019782, DOI 10.1023/A:1011569019782]; LAMME VAF, 1995, J NEUROSCI, V15, P1605; Lamme VAF, 1998, P NATL ACAD SCI USA, V95, P3263, DOI 10.1073/pnas.95.6.3263; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Li W, 2008, NEURON, V57, P442, DOI 10.1016/j.neuron.2007.12.011; LODGE D, 1990, TRENDS PHARMACOL SCI, V11, P81, DOI 10.1016/0165-6147(90)90323-Z; LUBY ED, 1959, ARCH NEURO PSYCHIATR, V81, P363, DOI 10.1001/archneurpsyc.1959.02340150095011; Lumer ED, 1997, CEREB CORTEX, V7, P207, DOI 10.1093/cercor/7.3.207; LURIA RE, 1975, J PSYCHIATR RES, V12, P51, DOI 10.1016/0022-3956(75)90020-5; Maeng S, 2008, BIOL PSYCHIAT, V63, P349, DOI 10.1016/j.biopsych.2007.05.028; Malhotra AK, 1996, NEUROPSYCHOPHARMACOL, V14, P301, DOI 10.1016/0893-133X(95)00137-3; Mathew SJ, 2012, CNS DRUGS, V26, P189, DOI 10.2165/11599770-000000000-00000; Moghaddam B, 1997, J NEUROSCI, V17, P2921; Morgan CJA, 2006, PSYCHOPHARMACOLOGY, V188, P408, DOI 10.1007/s00213-006-0572-3; Muller CP, 2011, J NEUROCHEM, V119, P419, DOI 10.1111/j.1471-4159.2011.07445.x; Nelson CL, 2002, PSYCHOPHARMACOLOGY, V161, P168, DOI 10.1007/s00213-002-1004-7; Newcomer JW, 1999, NEUROPSYCHOPHARMACOL, V20, P106, DOI 10.1016/S0893-133X(98)00067-0; Newcomer JW, 2001, HIPPOCAMPUS, V11, P529, DOI 10.1002/hipo.1069.abs; Nikiforuk A, 2010, EUR NEUROPSYCHOPHARM, V20, P37, DOI 10.1016/j.euroneuro.2009.08.001; Oranje B, 2000, NEUROPSYCHOPHARMACOL, V22, P293, DOI 10.1016/S0893-133X(99)00118-9; OYE I, 1992, J PHARMACOL EXP THER, V260, P1209; Passie T, 2005, NEUROPSYCHOBIOLOGY, V51, P226, DOI 10.1159/000085724; Pourtois G, 2008, VISION RES, V48, P55, DOI 10.1016/j.visres.2007.10.027; Roelfsema PR, 2005, NEURAL COMPUT, V17, P2176, DOI 10.1162/0899766054615699; Roelfsema PR, 2002, J COGNITIVE NEUROSCI, V14, P525, DOI 10.1162/08989290260045756; ROSIER AM, 1993, J COMP NEUROL, V335, P369, DOI 10.1002/cne.903350307; Rowland LM, 2005, AVIAT SPACE ENVIR MD, V76, pC52; SALIN PA, 1995, PHYSIOL REV, V75, P107, DOI 10.1152/physrev.1995.75.1.107; Sato K, 1996, BRIT J ANAESTH, V77, P381, DOI 10.1093/bja/77.3.381; Scholte HS, 2008, J COGNITIVE NEUROSCI, V20, P2097, DOI 10.1162/jocn.2008.20142; Schwartz S, 2002, P NATL ACAD SCI USA, V99, P17137, DOI 10.1073/pnas.242414599; Self MW, 2012, P NATL ACAD SCI USA, V109, P11031, DOI 10.1073/pnas.1119527109; Snyder GL, 2007, NEUROPHARMACOLOGY, V53, P619, DOI 10.1016/j.neuropharm.2007.07.008; SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521; Szewczyk B, 2012, EXPERT OPIN INV DRUG, V21, P91, DOI 10.1517/13543784.2012.638916; Taffe MA, 2002, DRUG ALCOHOL DEPEN, V68, P175, DOI 10.1016/S0376-8716(02)00194-1; Umbricht D, 2000, ARCH GEN PSYCHIAT, V57, P35; van Loon AM, 2012, J COGNITIVE NEUROSCI, V24, P965, DOI 10.1162/jocn_a_00197; Wokke ME, 2012, BRAIN BEHAV, V2, P763, DOI 10.1002/brb3.91; Wyatte D, 2012, J COGNITIVE NEUROSCI, V24, P2248, DOI 10.1162/jocn_a_00282; Yotsumoto Y, 2008, PLOS BIOL, V6, P1623, DOI 10.1371/journal.pbio.0060221; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856; Zipser K, 1996, J NEUROSCI, V16, P7376	89	16	16	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79326	10.1371/journal.pone.0079326	http://dx.doi.org/10.1371/journal.pone.0079326			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223927	Green Submitted, Green Published, gold			2022-12-27	WOS:000326499300074
J	Schofield, DJ; Callander, EJ; Shrestha, RN; Passey, ME; Percival, R; Kelly, SJ				Schofield, Deborah J.; Callander, Emily J.; Shrestha, Rupendra N.; Passey, Megan E.; Percival, Richard; Kelly, Simon J.			Multiple Chronic Health Conditions and Their Link with Labour Force Participation and Economic Status	PLOS ONE			English	Article							QUALITY-OF-LIFE; CHRONIC DISEASES; INCOME; COMORBIDITY; ILLNESS; IMPACT; WORKERS; BURDEN; COSTS	Aims: To assess the labour force participation and quantify the economic status of older Australian workers with multiple health conditions. Background: Many older people suffer from multiple health conditions. While multiple morbidities have been highlighted as an important research topic, there has been limited research in this area to date, particularly on the economic status of those with multiple morbidities. Methods: Cross sectional analysis of Health&WealthMOD, a microsimulation model of Australians aged 45 to 64 years. Results: People with one chronic health condition had 0.59 times the odds of being employed compared to those with no condition (OR 0.59, 95% CI: 0.49, 0.71), and those with four or more conditions had 0.14 times the odds of being employed compared to those with no condition (OR 0.14, 95% CI: 0.11, 0.18). People with one condition received a weekly income 32% lower than those with no health condition, paid 49 % less tax, and received 37% more in government transfer payments; those with four or more conditions received a weekly income 94% lower, paid 97% less in tax and received over 2,000% more in government transfer payments per week than those with no condition. Conclusion: While having a chronic health condition is associated with lower labour force participation and poorer economic status, having multiple conditions compounds the affect - with these people being far less likely to be employed and having drastically lower incomes.	[Schofield, Deborah J.; Callander, Emily J.; Shrestha, Rupendra N.] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW 2006, Australia; [Schofield, Deborah J.] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; [Passey, Megan E.] Univ Sydney, Univ Ctr Rural Hlth North Coast, Lismore, NSW, Australia; [Percival, Richard; Kelly, Simon J.] Univ Canberra, Natl Ctr Social & Econ Modelling, Canberra, ACT 2601, Australia	University of Sydney; University of Sydney; University of Sydney; University of Canberra	Callander, EJ (corresponding author), Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW 2006, Australia.	emily.callander@ctc.usyd.edu.au	Passey, Megan/AAC-7062-2019; Kelly, Simon/X-7282-2018; Callander, Emily/M-5679-2017	Passey, Megan/0000-0001-5766-0235; Kelly, Simon/0000-0002-8245-0181; Callander, Emily/0000-0001-7233-6804; Shrestha, Rupendra/0000-0001-5455-0735; Schofield, Deborah/0000-0002-1658-494X	Australian Research Council [LP07749193]; Pfizer Australia	Australian Research Council(Australian Research Council); Pfizer Australia(PfizerPfizer Australia)	This work was supported by the Australian Research Council (under grant LP07749193), and Pfizer Australia is a partner to the grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, PRODUCTIVITY COMMISS; Apouey B, 2009, WINNING BIG FEELING; Australian Bureau of Statistics, 2004, SURV DIS AG CAR 2003; BARTLEY M, 1999, SOCIAL DETERMINANTS; Baumeister H, 2005, J CLIN EPIDEMIOL, V58, P1090, DOI 10.1016/j.jclinepi.2005.03.011; Bayliss EA, 2004, HLTH QUAL LIFE OUTCO, V2; Begg S., 2007, BURDEN DIS INJURY AU; Buddelmeyer H, 2009, INTERRELATED DYNAMIC; Centrelink, 2011, DIS SUPP PENS; Commonwealth of Australia, 2010, AUSTR 2050 FUT CHALL; Commonwealth of Australia, 2007, INT REP 2007 08; Contoyannis P, 2004, J APPL ECONOMET, V19, P473, DOI 10.1002/jae.755; COVINSKY KE, 1994, JAMA-J AM MED ASSOC, V272, P1839, DOI 10.1001/jama.272.23.1839; Department for Work and Pensions, 2011, EMPL SUPP ALL; Dunlop DD, 2003, ARTHRIT RHEUM-ARTHR, V49, P101, DOI 10.1002/art.10913; Fischer JAV, 2009, HEALTH ECON, V18, P71, DOI 10.1002/hec.1341; Fortin M, 2007, BMJ-BRIT MED J, V334, P1016, DOI 10.1136/bmj.39201.463819.2C; Frijters P, 2005, J HEALTH ECON, V24, P997, DOI 10.1016/j.jhealeco.2005.01.004; Frijters P, 2008, J HEALTH ECON, V27, P1626, DOI 10.1016/j.jhealeco.2008.06.003; Gijsen R, 2001, J CLIN EPIDEMIOL, V54, P661, DOI 10.1016/S0895-4356(00)00363-2; Gunasekara FI, 2012, J EPIDEMIOL COMMUNIT, V66, P1, DOI [DOI 10.1136/JECH-2012-201753.002.PUBMED:21875869, 10.1136/jech-2012-201753.002]; Halliday TJ, 2012, EARNINGS GROWTH MOVE; Halliday TJ, 2007, 3234 IZA I STUD LAB; Iverson D, 2010, J OCCUP ENVIRON MED, V52, P1206, DOI 10.1097/JOM.0b013e3181fd276a; Jones AM, 2008, J HEALTH ECON, V27, P308, DOI 10.1016/j.jhealeco.2007.05.007; Kelly S., 2009, DONT STOP THINKING T; Kriegsman DMW, 2004, J CLIN EPIDEMIOL, V57, P55, DOI 10.1016/S0895-4356(03)00258-0; Lambert S, 1994, 1 NATSEM STINMOD; Leal J, 2006, EUR HEART J, V27, P1610, DOI 10.1093/eurheartj/ehi733; Lorgelly PK, 2008, HEALTH ECON, V17, P249, DOI 10.1002/hec.1254; Mcdonough P, 2003, J HEALTH SOC BEHAV, V44, P198, DOI 10.2307/1519808; OECD, 2006, LIV LONG WORK LONG S; Organisation for Economic Co-operation and Development, 2007, LAB FORC STAT, P1986; Organisation for Economic Co-operation and Development, 2008, AG SOC; Organisation for Economic Co-operation and Development, 2007, SICKN DIS WORK BREAK; Organisation for Economic Co-operation and Development, 2004, LAB FORC PART OLD WO; Organisation for Economic Co-operation and Development Media Relations, 2007, OECD 18 DEC 2007 SAY; Percival R, 2007, MODELLING OUR FUTURE; Rassler S., 2002, STAT MATCHING FREQUE; Rijken M, 2005, QUAL LIFE RES, V14, P45, DOI 10.1007/s11136-004-0616-2; Roberts J, 2008, EARLY RETIREMENT INE; Saunders P, 2005, 145 SPRC U NEW S WAL; Schofield D, INT J CARDI IN PRESS; Schofield D, AGING MENT IN PRESS, V15, P654; Schofield D., 2011, INT J MICROSIMULATIO, V4, P32; Schofield D, 2010, INT J MICRO IN PRESS; Schofield D.J., 2010, BR J DIABETES VASC D, V10, P300, DOI [10.1177/1474651410385864, DOI 10.1177/1474651410385864]; Schofield D, 2011, INT J CARDIOL, V146, P125, DOI 10.1016/j.ijcard.2010.09.092; Schofield DJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-418; Schofield DJ, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-72; Schofield DJ, 2011, BRIT J PSYCHIAT, V198, P123, DOI 10.1192/bjp.bp.110.081679; Schofield DJ, 2008, MED J AUSTRALIA, V189, P447, DOI 10.5694/j.1326-5377.2008.tb02119.x; Schofield DJ, 2012, INT J CARDIOL; Schofield DJ, 2011, EUR SPINE J; Social Security Online, 2011, UPPL SEC INC; Swoboda SM, 2002, AM J CRIT CARE, V11, P459, DOI 10.4037/ajcc2002.11.5.459; Valdmanis V, 2001, AM J PUBLIC HEALTH, V91, P129, DOI 10.2105/AJPH.91.1.129; Waghorn G, 2008, PSYCHIATR REHABIL J, V31, P243, DOI 10.2975/31.3.2008.243.246; Walker AE, 2007, CHRONIC ILLN, V3, P202, DOI 10.1177/1742395307081504	59	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79108	10.1371/journal.pone.0079108	http://dx.doi.org/10.1371/journal.pone.0079108			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	245XZ	24223887	Green Published, Green Accepted, gold			2022-12-27	WOS:000326499300056
J	Woon, AP; Tohidpour, A; Alonso, H; Saijo-Hamano, Y; Kwok, T; Roujeinikova, A				Woon, Amanda P.; Tohidpour, Abolghasem; Alonso, Hernan; Saijo-Hamano, Yumiko; Kwok, Terry; Roujeinikova, Anna			Conformational Analysis of Isolated Domains of Helicobacter pylori CagA	PLOS ONE			English	Article							CIRCULAR-DICHROISM SPECTRA; IV SECRETION; SECONDARY STRUCTURE; GAB FAMILY; PROTEIN; PHOSPHORYLATION; POLYPROLINE; VIRULENCE; ONCOPROTEIN; PREDICTION	The CagA protein of Helicobacter pylori is associated with increased virulence and gastric cancer risk. CagA is translocated into the host cell by a H. pylori type IV secretion system via mechanisms that are poorly understood. Translocated CagA interacts with numerous host factors, altering a variety of host signalling pathways. The recently determined crystal structure of C-terminally-truncated CagA indicated the presence of two domains: the smaller, flexible N-terminal domain and the larger, middle domain. In this study, we have investigated the conformation, oligomeric state and stability of the N-terminal, middle and glutamate-proline-isoleucine-tyrosine-alanine (EPIYA)-repeats domains. All three domains are monomeric, suggesting that the multimerisation of CagA observed in infected cells is likely to be mediated not by CagA itself but by its interacting partners. The middle and the C-terminal domains, but not the N-terminal domain, are capable of refolding spontaneously upon heat denaturation, lending support to the hypothesis that unfolded CagA is threaded C-terminus first through the type IV secretion channel with its N-terminal domain, which likely requires interactions with other domains to refold, being threaded last. Our findings also revealed that the C-terminal EPIYA-repeats domain of CagA exists in an intrinsically disordered premolten globule state with regions in PPII conformation - a feature that is shared by many scaffold proteins that bind multiple protein components of signalling pathways. Taken together, these results provide a deeper understanding of the physicochemical properties of CagA that underpin its complex cellular and oncogenic functions.	[Woon, Amanda P.; Kwok, Terry; Roujeinikova, Anna] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Tohidpour, Abolghasem; Alonso, Hernan; Kwok, Terry; Roujeinikova, Anna] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia; [Saijo-Hamano, Yumiko] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan	Monash University; Monash University; Osaka University	Roujeinikova, A (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia.	Anna.Roujeinikova@monash.edu		Woon, Amanda/0000-0002-4781-0356; Kwok, Terry/0000-0002-5905-3233; Roujeinikova, Anna/0000-0001-8478-4751	Monash University Strategic Grant Scheme	Monash University Strategic Grant Scheme(Monash University)	This work was supported by the Monash University Strategic Grant Scheme, www.monash.edu. AR is an Australian Research Council Research Fellow (DP1094619), http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei AA, 2013, J MOL BIOL, V425, P2100, DOI 10.1016/j.jmb.2013.03.018; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Backert S, 2004, INFECT IMMUN, V72, P1043, DOI 10.1128/IAI.72.2.1043-1056.2004; Backert S, 2008, CELL MICROBIOL, V10, P1573, DOI 10.1111/j.1462-5822.2008.01156.x; Backert S, 2010, HELICOBACTER, V15, P163, DOI 10.1111/j.1523-5378.2010.00759.x; Berisio R, 2012, CURR PROTEIN PEPT SC, V13, P855, DOI 10.2174/138920312804871157; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Christie PJ, 2004, BBA-MOL CELL RES, V1694, P219, DOI 10.1016/j.bbamcr.2004.02.013; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; COVACCI A, 1993, P NATL ACAD SCI USA, V90, P5791, DOI 10.1073/pnas.90.12.5791; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Harkiolaki M, 2009, STRUCTURE, V17, P809, DOI 10.1016/j.str.2009.03.017; Hatakeyama M, 2003, MICROBES INFECT, V5, P143, DOI 10.1016/S1286-4579(02)00085-0; Hayashi T, 2013, CELL MICROBIOL, V15, P377, DOI 10.1111/cmi.12040; Hayashi T, 2012, CELL HOST MICROBE, V12, P20, DOI 10.1016/j.chom.2012.05.010; Higashi H, 2005, J BIOL CHEM, V280, P23130, DOI 10.1074/jbc.M503583200; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Jones KR, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00115; Kabanov VA, 2004, J PHYS CHEM B, V108, P1485, DOI 10.1021/jp035821f; Kaplan-Turkoz B, 2012, P NATL ACAD SCI USA, V109, P14640, DOI 10.1073/pnas.1206098109; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Lai CH, 2011, FEMS MICROBIOL LETT, V323, P155, DOI 10.1111/j.1574-6968.2011.02372.x; MAKAROV AA, 1994, BIOPOLYMERS, V34, P1123, DOI 10.1002/bip.360340816; MARSHALL BJ, 1984, LANCET, V1, P1311; Murata-Kamiya N, 2011, MICROBES INFECT, V13, P799, DOI 10.1016/j.micinf.2011.03.011; Murata-Kamiya N, 2010, CELL HOST MICROBE, V7, P399, DOI 10.1016/j.chom.2010.04.005; Nagase L, 2011, J BIOL CHEM, V286, P33622, DOI 10.1074/jbc.M111.258673; Nesic D, 2010, NAT STRUCT MOL BIOL, V17, P130, DOI 10.1038/nsmb.1705; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Ogura K, 2000, J EXP MED, V192, P1601, DOI 10.1084/jem.192.11.1601; Ohnishi N, 2008, P NATL ACAD SCI USA, V105, P1003, DOI 10.1073/pnas.0711183105; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Pattis I, 2007, MICROBIOL-SGM, V153, P2896, DOI 10.1099/mic.0.2007/007385-0; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Pellicena P, 2001, J BIOL CHEM, V276, P28190, DOI 10.1074/jbc.M100055200; Pelz C, 2011, J BIOL CHEM, V286, P8999, DOI 10.1074/jbc.M110.166504; Race PR, 2007, BIOPHYS J, V93, P586, DOI 10.1529/biophysj.106.101766; Ranjbar B, 2009, CHEM BIOL DRUG DES, V74, P101, DOI 10.1111/j.1747-0285.2009.00847.x; Ren SM, 2006, J BIOL CHEM, V281, P32344, DOI 10.1074/jbc.M606172200; Rucker AL, 2002, PROTEIN SCI, V11, P980, DOI 10.1110/ps.4550102; Saadat I, 2007, NATURE, V447, P330, DOI 10.1038/nature05765; Selbach M, 2002, J BIOL CHEM, V277, P6775, DOI 10.1074/jbc.C100754200; Simister PC, 2012, MOL BIOSYST, V8, P33, DOI 10.1039/c1mb05272a; Stein M, 2002, MOL MICROBIOL, V43, P971, DOI 10.1046/j.1365-2958.2002.02781.x; Suzuki M, 2009, CELL HOST MICROBE, V5, P23, DOI 10.1016/j.chom.2008.11.010; Tompa P, 2010, STRUCTURE AND FUNCTI, P43; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Zafra-Ruano A, 2012, FEBS LETT, V586, P2619, DOI 10.1016/j.febslet.2012.04.057	54	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79367	10.1371/journal.pone.0079367	http://dx.doi.org/10.1371/journal.pone.0079367			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223932	Green Submitted, Green Published, gold			2022-12-27	WOS:000326499300077
J	Chauzat, MP; Cauquil, L; Roy, L; Franco, S; Hendrikx, P; Ribiere-Chabert, M				Chauzat, Marie-Pierre; Cauquil, Laura; Roy, Lise; Franco, Stephanie; Hendrikx, Pascal; Ribiere-Chabert, Magali			Demographics of the European Apicultural Industry	PLOS ONE			English	Article							BEE COLONY LOSSES; NATIONAL-SURVEY; UNITED-STATES; EXPOSURE; APIS; US	Over the last few years, many European and North American countries have reported a high rate of disorders (mortality, dwindling and disappearance) affecting honeybee colonies (Apis mellifera). Although beekeeping has become an increasingly professional activity in recent years, the beekeeping industry remains poorly documented in Europe. The European Union Reference Laboratory for Honeybee Health sent a detailed questionnaire to each Member State, in addition to Kosovo and Norway, to determine the demographics and state of their beekeeping industries. Based on data supplied by the National Reference Laboratory for honeybee diseases in each European country, a European database was created to describe the beekeeping industry including the number and types of beekeepers, operation size, industry production, and health (notifiable diseases, mortalities). The total number of beekeepers in Europe was estimated at 620 000. European honey production was evaluated at around 220 000 tons in 2010. The price of honey varied from 1.5 to 40 (sic)/kg depending on the country and on the distribution network. The estimated colony winter mortality varied from 7 to 28% depending on the country and the origin of the data (institutional survey or beekeeping associations). This survey documents the high heterogeneity of the apicultural industry within the European Union. The high proportion of non-professional beekeepers and the small mean number of colonies per beekeeper were the only common characteristics at European level. The tremendous variation in European apicultural industries has implication for any comprehensive epidemiological or economic analysis of the industry. This variability needs to be taken into account for such analysis as well as for future policy development. The industry would be served if beekeeping registration was uniformly implemented across member states. Better information on the package bee and queen production would help in understanding the ability of the industry to replace lost honey bee stocks.	[Chauzat, Marie-Pierre; Cauquil, Laura; Franco, Stephanie; Ribiere-Chabert, Magali] French Agcy Food Environm & Occupat Hlth & Safety, Honeybee Pathol Unit, European Union & Natl Reference Lab Honeybee Hlth, Sophia Antipolis, France; [Roy, Lise] French Agcy Food Environm & Occupat Hlth & Safety, Epidemiol Unit, Lyon, France; [Chauzat, Marie-Pierre; Hendrikx, Pascal] French Agcy Food Environm & Occupat Hlth & Safety, Sci Affairs Dept Labs, Epidemiol Surveillance Unit, Maisons Alfort, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA)	Chauzat, MP (corresponding author), French Agcy Food Environm & Occupat Hlth & Safety, Honeybee Pathol Unit, European Union & Natl Reference Lab Honeybee Hlth, Sophia Antipolis, France.	marie-pierre.chauzat@anses.fr	, Roy/G-5648-2017	, Roy/0000-0001-8833-1717	European Union; ANSES	European Union(European Commission); ANSES	The EURL for bee health was supported by the European Union and by ANSES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.154r; Bacon SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047689; Boncristiani H, 2012, J INSECT PHYSIOL, V58, P613, DOI 10.1016/j.jinsphys.2011.12.011; Brown MA, 2002, BEE WORLD, V83, P151, DOI 10.1080/0005772X.2002.11099558; Calderone, 2000, BEE CULT, V128, P1, DOI DOI 10.3896/IBRA.1.49.1.01; Chauzat MP, 2013, BEE WORLD        MAR, P11; Crane E, 2004, BEE WORLD, V85, P6, DOI 10.1080/0005772X.2004.11099604; Currie RW, 2010, J APICULT RES, V49, P104, DOI 10.3896/IBRA.1.49.1.18; Daberkow S, 2009, J ECON ENTOMOL, V102, P868, DOI 10.1603/029.102.0304; Deforce K, 2010, J ARCHAEOL SCI, V37, P337, DOI 10.1016/j.jas.2009.09.045; Deguines N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045822; European Commission, 1997, OFFICIAL J; European Commission, 2010, COMM COMM EUR PARL C; European Commission, 2004, OFFICIAL J; Fries I, 2001, APIDOLOGIE, V32, P199, DOI 10.1051/apido:2001122; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Haubruge Eric, 2006, Notes Fauniques de Gembloux, V59, P3; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Lebuhn G, 2013, CONSERV BIOL, V27, P113, DOI 10.1111/j.1523-1739.2012.01962.x; Lindstrom A, 2008, APIDOLOGIE, V39, P515, DOI 10.1051/apido:2008032; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Maxim L, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/014006; Maxim L, 2007, SCI TOTAL ENVIRON, V376, P1, DOI 10.1016/j.scitotenv.2006.12.052; MURILHAS A M, 2004, EURBEE NEWSLETTER, V2, P7; Nguyen BK, 2010, J APICULT RES, V49, P337, DOI 10.3896/IBRA.1.49.4.07; Nguyen BK, 2010, J APICULT RES, V49, P97, DOI 10.3896/IBRA.1.49.1.15; Osborne JL, 2012, NATURE, V491, P43, DOI 10.1038/nature11637; Palmer MJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2648; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; PHAMDELEGUE MH, 1987, BIOCHIMIE, V69, P661, DOI 10.1016/0300-9084(87)90186-6; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Spleen AM, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.2.07; The European Commission, 2011, COMMISSION REGULATIO, V15, P1; van der Zee R, 2012, J APICULT RES, V51, P91, DOI 10.3896/IBRA.1.51.1.12; Vanengelsdorp D, 2013, J APICULT RES, V52; VANENGELSDORP D, 2011, HONEY BEE COLONY HLT, P237; Vanengelsdorp D, 2012, J APICULT RES, V51, P115, DOI 10.3896/IBRA.1.51.1.14; vanEngelsdorp D, 2010, J APICULT RES, V49, P7, DOI 10.3896/IBRA.1.49.1.03; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; Vannier P, 1997, VET MICROBIOL, V55, P167, DOI 10.1016/S0378-1135(96)01298-9; Vidau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021550; Williamson SM, 2013, J EXP BIOL, V216, P1799, DOI 10.1242/jeb.083931	43	75	78	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79018	10.1371/journal.pone.0079018	http://dx.doi.org/10.1371/journal.pone.0079018			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236084	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700082
J	Elliott, SJ; Wilf, P; Walter, RC; Merritts, DJ				Elliott, Sara J.; Wilf, Peter; Walter, Robert C.; Merritts, Dorothy J.			Subfossil Leaves Reveal a New Upland Hardwood Component of the Pre-European Piedmont Landscape, Lancaster County, Pennsylvania	PLOS ONE			English	Article							FOLIAR SURFACE-FEATURES; CHESAPEAKE BAY; WOODY-PLANTS; RIPARIAN VEGETATION; MID-ATLANTIC; RESTORATION; EROSION; FOREST; SEDIMENTATION; DISTURBANCE	Widespread deforestation, agriculture, and construction of milldams by European settlers greatly influenced valley-bottom stream morphology and riparian vegetation in the northeastern USA. The former broad, tussock-sedge wetlands with small, anastomosing channels were converted into today's incised, meandering streams with unstable banks that support mostly weedy, invasive vegetation. Vast accumulations of fine-grained "legacy" sediments that blanket the regional valley-bottom Piedmont landscape now are being reworked from stream banks, significantly impairing the ecological health of downstream water bodies, most notably the Chesapeake Bay. However, potential restoration is impaired by lack of direct knowledge of the pre-settlement riparian and upslope floral ecosystems. We studied the subfossil leaf flora of Denlingers Mill, an obsolete (breached) milldam site in southeastern Pennsylvania that exhibits a modern secondary forest growing atop thin soils, above bedrock outcrops immediately adjacent to a modified, incised stream channel. Presumably, an overhanging old-growth forest also existed on this substrate until the early 1700s and was responsible for depositing exceptionally preserved, minimally transported subfossil leaves into hydric soil strata, which immediately underlie post-European settlement legacy sediments. We interpret the eleven identified species of the subfossil assemblage to primarily represent a previously unknown, upland Red Oak-American Beech mixed hardwood forest. Some elements also appear to belong to a valley-margin Red Maple-Black Ash swamp forest, consistent with preliminary data from a nearby site. Thus, our results add significantly to a more complete understanding of the pre-European settlement landscape, especially of the hardwood tree flora. Compared with the modern forest, it is apparent that both lowland and upslope forests in the region have been modified significantly by historical activities. Our study underscores that generally overlooked subfossil leaves can provide important, local, temporally constrained paleoecological data, with much potential value in this case for stream and wetland restoration decisions in the mid-Atlantic region.	[Elliott, Sara J.; Wilf, Peter] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Walter, Robert C.; Merritts, Dorothy J.] Franklin & Marshall Coll, Dept Earth & Environm, Lancaster, PA 17604 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Franklin & Marshall College	Wilf, P (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16802 USA.	pwilf@psu.edu	Walter, Robert/AAD-7642-2020	Walter, Robert/0000-0001-8761-5355; Wilf, Peter/0000-0001-6813-1937	Geological Society of America [9590-11]; Pennsylvania State University Department of Geosciences; David and Lucile Packard Fellowship; NSF [EAR-0844253]	Geological Society of America; Pennsylvania State University Department of Geosciences; David and Lucile Packard Fellowship(The David & Lucile Packard Foundation); NSF(National Science Foundation (NSF))	This study was supported by a Geological Society of America Student Research Grant (number 9590-11, www.geosociety.org) and the P.D. Krynine Memorial Fund, Pennsylvania State University Department of Geosciences (SJE); a David and Lucile Packard Fellowship (PW, www.packard.org); and NSF EAR-0844253 to RW Graham (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], SUSTAIN; [Anonymous], 1950, GRAYS MANUAL BOT; Argus G.W., 2006, GUIDE IDENTIFICATION; Asch Sidell N., 2008, NEW YORK STATE B MUS, V512, P29; BAKER R G, 1990, Journal of the Iowa Academy of Science, V97, P167; Baker R.G., 1993, Holocene, V3, P314, DOI 10.1177/095968369300300403; Banks W.S.L., 2009, SOURCES TRANSPORT ST; Barclay R.S., 2012, CUTICLE DATABASE PRO; Behrensmeyer AK, 2000, PALEOBIOLOGY, V26, P103, DOI 10.1666/0094-8373(2000)26[103:TAP]2.0.CO;2; Bennion H, 2011, J PALEOLIMNOL, V45, P533, DOI 10.1007/s10933-010-9419-3; BILBY RE, 1980, ECOLOGY, V61, P1107, DOI 10.2307/1936830; Birks HH, 2000, J BIOGEOGR, V27, P31, DOI 10.1046/j.1365-2699.2000.00375.x; BIRKS HH, 1978, NEW PHYTOL, V80, P455, DOI 10.1111/j.1469-8137.1978.tb01579.x; Black BA, 2006, CAN J FOREST RES, V36, P1266, DOI 10.1139/X06-027; Boesch DF, 2001, J ENVIRON QUAL, V30, P303, DOI 10.2134/jeq2001.302303x; BURNHAM RJ, 1992, PALEOBIOLOGY, V18, P30, DOI 10.1017/S0094837300012203; BURNHAM RJ, 1993, PALAIOS, V8, P376, DOI 10.2307/3515267; Carpenter RJ, 2005, INT J PLANT SCI, V166, P843, DOI 10.1086/431806; Chumbley CA, 1989, THESIS U IOWA; Cogbill CV, 2000, RHODORA, V102, P250; Coladonato M., 1991, FIRE EFFECTS INFORM; COSTA JE, 1975, GEOL SOC AM BULL, V86, P1281, DOI 10.1130/0016-7606(1975)86&lt;1281:EOAOEA&gt;2.0.CO;2; Danzeglocke U, 2011, CALPAL 2007ONLINE; Davies-Vollum KS, 1998, PALAIOS, V13, P28, DOI 10.2307/3515279; DENEVAN WM, 1992, ANN ASSOC AM GEOGR, V82, P369, DOI 10.1111/j.1467-8306.1992.tb01965.x; Douglass I., 1991, EARTH TRANSFORMED HU, P215; Doyle MW, 2005, GEOMORPHOLOGY, V71, P227, DOI 10.1016/j.geomorph.2004.04.011; eFloras, 2008, MISS BOT GARD; Ellis D, 2009, MANUAL LEAF ARCHITEC; Fenneman N.M., 1938, PHYSIOGRAPHY E US; FERGUSON DK, 1985, REV PALAEOBOT PALYNO, V46, P117, DOI 10.1016/0034-6667(85)90041-7; Fike J, 1999, TERRESTRIAL PALUSTRI; FISRWG (Federal Interagency Stream Research Working Group), 2008, STREAM CORR REST PRI; Fleming GP, 1999, BANISTERIA, V13, P67; Foster DR, 1998, ECOSYSTEMS, V1, P96, DOI 10.1007/s100219900008; Gleason H.A., 1963, MANUAL VASCULAR PLAN; Gottschalk LC, 1945, GEOGR REV, V35, P219, DOI 10.2307/211476; Gutshall M, 2004, BACK FUTURE STREAM C; HARDIN JW, 1986, BRITTONIA, V38, P133, DOI 10.2307/2807266; HARDIN JW, 1985, B TORREY BOT CLUB, V112, P11, DOI 10.2307/2996100; HARDIN JW, 1979, B TORREY BOT CLUB, V106, P313, DOI 10.2307/2560358; Hartranft J.L., 2011, SUSTAIN, V24, P24; HICKEY LJ, 1975, ANN MO BOT GARD, V62, P538, DOI 10.2307/2395267; Hilgartner W, 2010, EC SOC AM ANN M PITT; Hilgartner WB, 2006, HOLOCENE, V16, P479, DOI 10.1191/0959683606hl938rp; Johnson PS, 1992, SILVICS N AM, P1219; Keeton WS, 2007, ECOL APPL, V17, P852, DOI 10.1890/06-1172; KELLER EA, 1979, EARTH SURF PROC LAND, V4, P361, DOI 10.1002/esp.3290040406; Kemp WM, 2005, MAR ECOL PROG SER, V303, P1, DOI 10.3354/meps303001; Kenney MA, 2012, J AM WATER RESOUR AS, V48, P603, DOI 10.1111/j.1752-1688.2011.00635.x; Lemon James T., 2002, BEST POOR MANS COUNT; Little E. L., 1988, AUDUBON SOC FIELD GU; LORIMER CG, 1994, J FOREST, V92, P33; Mann M.E., 2002, ENCYCLOP GLOB ENV CH, V1, P504; McQuilkin RA, 1992, SILVICS N AM, V2, P1366; Merritts D., 2010, SEDIMENT NUTR LOADS; Merritts D, 2003, COLONIAL MILL PONDS; Merritts D, 2010, WATER POWERED MILLIN; Merritts D, 2013, REV ENG GEOL, V21, P183, DOI 10.1130/2013.4121(14); Merritts D, 2011, PHILOS T R SOC A, V369, P976, DOI 10.1098/rsta.2010.0335; Middleton A.P., 1953, TOBACCO COAST MARITI; MILLER BB, 1994, QUATERNARY RES, V41, P350, DOI 10.1006/qres.1994.1040; Miller CL, 2011, THESIS PENNSYVANIA S; Miller CL, 2010, GEOL SOC AM ANN M DE, V42, P606; MOSS JH, 1978, J GEOL, V86, P1, DOI 10.1086/649652; Niemitz J, 2013, GEOLOGY, V41, P47, DOI 10.1130/G33547.1; Orr CH, 2002, THESIS U WISCONSIN; ORTH RJ, 1983, SCIENCE, V222, P51, DOI 10.1126/science.222.4619.51; Palmer MA, 2005, J APPL ECOL, V42, P208, DOI 10.1111/j.1365-2664.2005.01004.x; Palmer M, 2007, RESTOR ECOL, V15, P472, DOI 10.1111/j.1526-100X.2007.00243.x; PENNOCK JR, 1994, CHANGES IN FLUXES IN ESTUARIES: IMPLICATIONS FROM SCIENCE TO MANAGEMENT, P139; Pizzuto J, 2009, GEOLOGY, V37, P19, DOI 10.1130/G25207A.1; Rhoads A.F., 2007, PLANTS PENNSYLVANIA; Rhoads AF, 2005, TREES OF PENNSYLVANIA: A COMPLETE REFERENCE GUIDE, P1; Richardson DM, 2007, DIVERS DISTRIB, V13, P126, DOI 10.1111/j.1366-9516.2006.00314.x; Sander IL, 1990, AGR HDB, V2, P1401; Schenk ER, 2009, J AM WATER RESOUR AS, V45, P597, DOI 10.1111/j.1752-1688.2009.00308.x; Shafroth PB, 2002, ECOL APPL, V12, P107, DOI 10.1890/1051-0761(2002)012[0107:RVRTAD]2.0.CO;2; Sibley D.A., 2009, SIBLEY GUIDE TREES; SIMON A, 1989, WATER RESOUR BULL, V25, P1177; SPICER RA, 1989, ADV BOT RES, V16, P95; Springer GS, 2010, HOLOCENE, V20, P275, DOI 10.1177/0959683609350395; Stanley EH, 2003, FRONT ECOL ENVIRON, V1, P15, DOI 10.1890/1540-9295(2003)001[0015:TOTEEO]2.0.CO;2; Stanley EH, 2002, BIOSCIENCE, V52, P693, DOI 10.1641/0006-3568(2002)052[0693:AGPONR]2.0.CO;2; Stinchcomb GE, 2011, GEOLOGY, V39, P363, DOI 10.1130/G31596.1; United States Department of Agriculture Natural Resources Conservation Service, 2011, PLANTS DAT; Virginia Tech Forest Resources and Environmental Conservation Tree ID Database, 2010, BLACKSB VIRG TECH DE; Voli M., 2009, WATER RES IMPACT, V11, P11; Walter R., 2007, ESTIMATING VOLUME NU; Walter RC, 2008, SCIENCE, V319, P299, DOI 10.1126/science.1151716; Waters T. F., 1995, SEDIMENT STREAMS SOU; WESTERVELT K, 2006, GUIDE NATURAL COMMUN; Wilf P, 1997, PALEOBIOLOGY, V23, P373, DOI 10.1017/S0094837300019746; Wing SL, 1995, PALAIOS, V10, P551, DOI 10.2307/3515094; Work PT, 2005, PALAEOGEOGR PALAEOCL, V223, P204, DOI 10.1016/j.palaeo.2005.04.005; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	96	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79317	10.1371/journal.pone.0079317	http://dx.doi.org/10.1371/journal.pone.0079317			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236120	Green Submitted, gold, Green Published			2022-12-27	WOS:000327254700119
J	Jurdak, R				Jurdak, Raja			The Impact of Cost and Network Topology on Urban Mobility: A Study of Public Bicycle Usage in 2 US Cities	PLOS ONE			English	Article							HUMAN TRAVEL; MIGRATION; PATTERNS; MODEL; LAWS	Understanding the drivers of urban mobility is vital for epidemiology, urban planning, and communication networks. Human movements have so far been studied by observing people's positions in a given space and time, though most recent models only implicitly account for expected costs and returns for movements. This paper explores the explicit impact of cost and network topology on mobility dynamics, using data from 2 city-wide public bicycle share systems in the USA. User mobility is characterized through the distribution of trip durations, while network topology is characterized through the pairwise distances between stations and the popularity of stations and routes. Despite significant differences in station density and physical layout between the 2 cities, trip durations follow remarkably similar distributions that exhibit cost sensitive trends around pricing point boundaries, particularly with long-term users of the system. Based on the results, recommendations for dynamic pricing and incentive schemes are provided to positively influence mobility patterns and guide improved planning and management of public bicycle systems to increase uptake.	[Jurdak, Raja] Commonwealth Sci Ind & Res Org, Brisbane, Qld, Australia; [Jurdak, Raja] Univ Queensland, Brisbane, Qld, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland	Jurdak, R (corresponding author), Commonwealth Sci Ind & Res Org, Brisbane, Qld, Australia.	rjurdak@ieee.org	Jurdak, Raja/B-7637-2011	Jurdak, Raja/0000-0001-7517-0782	Commonwealth Scientific Industrial and Research Organisation (CSIRO), Australia	Commonwealth Scientific Industrial and Research Organisation (CSIRO), Australia	The work of Jurdak is funded by the Commonwealth Scientific Industrial and Research Organisation (CSIRO), Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MTI1126; [Anonymous], 2012, SUMMARY LONG TERM BI; [Anonymous], 2013, BOST DAT VIS CHALL H; BORJAS GJ, 1994, J ECON LIT, V32, P1667; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Buck D, 2013, ARE BIKESHARE USERS; Carrington WJ, 1996, AM ECON REV, V86, P909; DeMaio P., 2009, J PUBLIC TRANSPORT, V12, P41, DOI https://doi.org/10.5038/2375-0901.12.4.3; Fishman E, 2013, TRANSPORT REV, V33, P148, DOI 10.1080/01441647.2013.775612; Froehlich J, 2009, 21ST INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI-09), PROCEEDINGS, P1420; Gaker D, 2011, P WORLD C TRANSP RES; Gilbert R, 2007, ENERG POLICY, V35, P3053, DOI 10.1016/j.enpol.2006.11.002; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Kaltenbrunner A, 2010, PERVASIVE MOB COMPUT, V6, P455, DOI 10.1016/j.pmcj.2010.07.002; Kolbl R, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/348; MASSEY DS, 1993, POPUL DEV REV, V19, P431, DOI 10.2307/2938462; Matyas L, 1997, WORLD ECON, V20, P363, DOI 10.1111/1467-9701.00074; Nair R, 2013, INT J SUSTAIN TRANSP, V7, P85, DOI 10.1080/15568318.2012.660115; Noulas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037027; Padgham M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037754; Rhee I, 2011, IEEE ACM T NETWORK, V19, P630, DOI 10.1109/TNET.2011.2120618; Shaheen SA, 2010, TRANSPORT RES REC, P159, DOI 10.3141/2143-20; Shaheen SA, 2009, TRANSPORT RES REC, P35, DOI 10.3141/2110-05; Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856; SJAASTAD LA, 1962, J POLIT ECON, V70, P80, DOI 10.1086/258726; Ward G., 2000, TOURISM GEOGR, V2, P87, DOI [10.1080/146166800363466, DOI 10.1080/146166800363466]; Zipf GK, 1946, AM SOCIOL REV, V11, P677, DOI 10.2307/2087063	27	23	23	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79396	10.1371/journal.pone.0079396	http://dx.doi.org/10.1371/journal.pone.0079396			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236127	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700126
J	Wang, YH; Sun, YP; Li, D; Zhang, L; Wang, KM; Zuo, Y; Gartner, TK; Liu, JL				Wang, Yanhua; Sun, Yueping; Li, Ding; Zhang, Lin; Wang, Kemin; Zuo, Yong; Gartner, T. Kent; Liu, Junling			Platelet P2Y12 Is Involved in Murine Pulmonary Metastasis	PLOS ONE			English	Article							THROMBUS FORMATION; CELL INVASIVENESS; TUMOR-GROWTH; IN-VIVO; IDENTIFICATION; ANGIOGENESIS; PROGRESSION; RECEPTOR; ADENOCARCINOMA; AGGREGATION	The involvement of platelets in tumor progression is well recognized. The depletion of circulating platelets or pharmacologic inhibitors of platelet activation decreases the metastatic potential of circulating tumor cells in metastasis mouse models. The platelet ADP receptor P2Y12 amplifies the initial hemostatic responses activated by a variety of platelet agonists and stabilizes platelet aggregation, playing a crucial role in granule secretion, integrin activation and thrombus formation. However, the relationship between P2Y12 and tumor progression is not clear. In our study, the Lewis Lung Carcinoma (LLC) spontaneous metastatic mouse model was used to evaluate the role of P2Y12 in metastasis. The results demonstrated that P2Y12 deficiency significantly reduced pulmonary metastasis. Further studies indicated that P2Y12 deficiency diminished the ability of LLC cells to induce platelet shape change and release of active TGF beta 1 by a non-contact dependent mechanism resulting in a diminished, platelet-induced EMT-like transformation of the LLC cells, and that transformation probably is a prerequisite of LLC cell metastasis. Immunohistochemical analyses indicated an obvious P2Y12 deficiency related attenuation of recruitment of VEGFR1+ bone marrow derived cell clusters, and extracellular matrix fibronectin deposition in lungs, which presumably are required for pre-metastatic niche formation. In contrast to the LLC cells, non-epithelial melanoma B16 cells induced platelet aggregation in a cell number and P2Y12-dependent manner. Also, a platelet induced EMT-like transformation of B16 cells is dependent on P2Y12. In agreement with the LLC cell model, platelet P2Y12 deficiency also results in significantly less lung metastasis in the B16 melanoma experimental metastasis model. These results demonstrate that P2Y12 is a safe drug target for anti-thrombotic therapy, and that P2Y12 may serve as a new target for inhibition of tumor metastasis.	[Wang, Yanhua; Sun, Yueping; Li, Ding; Zhang, Lin; Wang, Kemin; Zuo, Yong; Liu, Junling] Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Cell Biol, Shanghai Key Lab Tumor Microenvironm & Inflammat, Shanghai 200030, Peoples R China; [Gartner, T. Kent] Univ Memphis, Dept Biol, Memphis, TN 38152 USA	Shanghai Jiao Tong University; University of Memphis	Liu, JL (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Cell Biol, Shanghai Key Lab Tumor Microenvironm & Inflammat, Shanghai 200030, Peoples R China.	liujl@shsmu.edu.cn			National Natural Science Foundation of China [81030039]; Program for New Century Excellent Talents in University [NCET-08-0351]; Shanghai Municipal Education Commission; Shanghai Education Development Foundation; Shanghai Committee of Science and Technology [11DZ2260200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Shanghai Education Development Foundation; Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	This work was supported, in part, by Program of National Natural Science Foundation of China (81030039 to J. Liu), the Program for New Century Excellent Talents in University (NCET-08-0351 to J. Liu), Shanghai Municipal Education Commission and Shanghai Education Development Foundation, Shanghai Committee of Science and Technology (11DZ2260200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre P, 2003, J CLIN INVEST, V112, P398, DOI 10.1172/JCI200317864; ASSOIAN RK, 1983, J BIOL CHEM, V258, P7155; Bakewell SJ, 2003, P NATL ACAD SCI USA, V100, P14205, DOI 10.1073/pnas.2234372100; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Boucharaba A, 2004, J CLIN INVEST, V114, P1714, DOI 10.1172/JCI200422123; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Cui W, 1996, CELL, V86, P531, DOI 10.1016/S0092-8674(00)80127-0; Dangelmaier C, 2001, THROMB HAEMOSTASIS, V85, P341, DOI 10.1055/s-0037-1615690; Dorsam RT, 2004, J CLIN INVEST, V113, P340, DOI 10.1172/JCI200420986; Dorsam RT, 2002, J BIOL CHEM, V277, P47588, DOI 10.1074/jbc.M208778200; Feng WY, 2011, BLOOD, V117, P3893, DOI 10.1182/blood-2010-08-304808; GASIC GJ, 1973, INT J CANCER, V11, P704, DOI 10.1002/ijc.2910110322; GASIC GJ, 1968, P NATL ACAD SCI USA, V61, P46, DOI 10.1073/pnas.61.1.46; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Hollopeter G, 2001, NATURE, V409, P202, DOI 10.1038/35051599; HONN KV, 1982, SCIENCE, V217, P540, DOI 10.1126/science.7046053; HYNES RO, 1982, J CELL BIOL, V95, P369, DOI 10.1083/jcb.95.2.369; Jain S, 2007, P NATL ACAD SCI USA, V104, P9024, DOI 10.1073/pnas.0700625104; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Karpatkin S, 1981, Ann N Y Acad Sci, V370, P101, DOI 10.1111/j.1749-6632.1981.tb29726.x; Kato Y, 1997, CANCER RES, V57, P3040; Kaul Sanjay, 2010, Arch Intern Med, V170, P1010, DOI 10.1001/archinternmed.2010.139; Kim YJ, 1998, P NATL ACAD SCI USA, V95, P9325, DOI 10.1073/pnas.95.16.9325; Labelle M, 2011, CANCER CELL, V20, P576, DOI 10.1016/j.ccr.2011.09.009; Liu JL, 2006, BLOOD, V108, P2596, DOI 10.1182/blood-2006-01-011817; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Massberg S, 2006, J EXP MED, V203, P1221, DOI 10.1084/jem.20051772; Niu HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047356; Oft M, 1998, CURR BIOL, V8, P1243, DOI 10.1016/S0960-9822(07)00533-7; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Rickles FR, 2001, THROMB RES, V102, pV215, DOI 10.1016/S0049-3848(01)00285-7; Rickles FR, 1998, HAEMOSTASIS, V28, P43; Savi P, 2000, THROMB HAEMOSTASIS, V84, P891, DOI 10.1055/s-0037-1614133; Serebruany V, 2010, AM J THER; Serebruany VL, 2009, AM J MED, V122, P407, DOI 10.1016/j.amjmed.2008.11.023; Sierko E, 2004, SEMIN THROMB HEMOST, V30, P95; Struyf S, 2007, CANCER RES, V67, P5940, DOI 10.1158/0008-5472.CAN-06-4682; TERRANOVA VP, 1986, P NATL ACAD SCI USA, V83, P465, DOI 10.1073/pnas.83.2.465; Terraube V, 2006, J THROMB HAEMOST, V4, P519, DOI 10.1111/j.1538-7836.2005.01770.x; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; TZANAKAKIS GN, 1991, J SURG ONCOL, V48, P45, DOI 10.1002/jso.2930480109; van Gestel MA, 2003, ARTERIOSCL THROM VAS, V23, P518, DOI 10.1161/01.ATV.0000057809.32354.22	43	63	69	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80780	10.1371/journal.pone.0080780	http://dx.doi.org/10.1371/journal.pone.0080780			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236201	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700204
J	Cheng, CX; Xu, XZ; Singer, SD; Li, J; Zhang, HJ; Gao, M; Wang, L; Song, JY; Wang, XP				Cheng, Chenxia; Xu, Xiaozhao; Singer, Stacy D.; Li, Jun; Zhang, Hongjing; Gao, Min; Wang, Li; Song, Junyang; Wang, Xiping			Effect of GA(3) Treatment on Seed Development and Seed-Related Gene Expression in Grape	PLOS ONE			English	Article							POLLEN-TUBE GROWTH; GIBBERELLIC-ACID; LIPID-PEROXIDATION; OVULE DEVELOPMENT; MATERNAL CONTROL; FERTILIZATION; STRESS; MEDEA; FRUIT; ELONGATION	Background: The phytohormone gibberellic acid (GA(3)) is widely used in the table grape industry to induce seedlessness in seeded varieties. However, there is a paucity of information concerning the mechanisms by which GAs induce seedlessness in grapes. Methodology/Principal Findings: In an effort to systematically analyze the cause of this GA(3)-induced seed abortion, we conducted an in depth characterization of two seeded grape cultivars ('Kyoho' and 'Red Globe'), along with a seedless cultivar (Thompson Seedless'), following treatment with GA(3). In a similar fashion to the seedless control, which exhibited GA(3)-induced abortion of the seeds 9 days after full bloom (DAF), both 'Kyoho' and 'Red Globe' seeded varieties exhibited complete abortion of the seeds 15 DAF when treated with GA(3). Morphological analyses indicated that while fertilization appeared to occur normally following GA(3) treatment, as well as in the untreated seedless control cultivar, seed growth eventually ceased. In addition, we found that GA(3) application had an effect on redox homeostasis, which could potentially cause cell damage and subsequent seed abortion. Furthermore, we carried out an analysis of antioxidant enzyme activities, as well as transcript levels from various genes believed to be involved in seed development, and found several differences between GA(3)-treated and untreated controls. Conclusion: Therefore, it seems that the mechanisms driving GA(3)-induced seedlessness are similar in both seeded and seedless cultivars, and that the observed abortion of seeds may result at least in part from a GA(3)-induced increase in cell damage caused by reactive oxygen species, a decrease in antioxidant enzymatic activities, and an alteration of the expression of genes related to seed development.	[Cheng, Chenxia; Xu, Xiaozhao; Li, Jun; Zhang, Hongjing; Gao, Min; Wang, Li; Song, Junyang; Wang, Xiping] Northwest A&F Univ, Coll Hort, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Cheng, Chenxia; Xu, Xiaozhao; Li, Jun; Zhang, Hongjing; Gao, Min; Wang, Li; Song, Junyang; Wang, Xiping] Northwest A&F Univ, Minist Agr, Key Lab Hort Plant Biol & Germplasm Innovat North, Yangling, Shaanxi, Peoples R China; [Singer, Stacy D.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; University of Alberta	Wang, XP (corresponding author), Northwest A&F Univ, Coll Hort, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	wangxiping@nwsuaf.edu.cn	程, 晨霞/HDO-7321-2022; 宋, 军阳/A-3567-2017	宋, 军阳/0000-0002-3529-8113; Li, Jun/0000-0003-2845-2351	National Natural Science Foundation of China [31071782]; Ministry of Agriculture of China [2012-S12]; Chinese Universities Scientific Fund [QN2011056]; Program for Innovative Research Team of Grape Germplasm Resources and Breeding [2013KCT-25]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); Chinese Universities Scientific Fund; Program for Innovative Research Team of Grape Germplasm Resources and Breeding	This work was supported by the National Natural Science Foundation of China (31071782), 948 Project from Ministry of Agriculture of China (2012-S12), Chinese Universities Scientific Fund (QN2011056), as well as the Program for Innovative Research Team of Grape Germplasm Resources and Breeding (2013KCT-25). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Aguero C, 2000, PLANT GROWTH REGUL, V30, P9, DOI 10.1023/A:1006207614388; Aubert D, 1998, PLANT MOL BIOL, V36, P871, DOI 10.1023/A:1005938624418; Beppu K, 2001, J JPN SOC HORTIC SCI, V70, P157, DOI 10.2503/jjshs.70.157; Bolwell GP, 1999, CURR OPIN PLANT BIOL, V2, P287, DOI 10.1016/S1369-5266(99)80051-X; Brambilla V, 2007, PLANT CELL, V19, P2544, DOI 10.1105/tpc.107.051797; CHANCE B, 1955, METHOD ENZYMOL, V2, P764, DOI 10.1016/S0076-6879(55)02300-8; Chaudhury AM, 1997, P NATL ACAD SCI USA, V94, P4223, DOI 10.1073/pnas.94.8.4223; Colombo L, 2008, TRENDS PLANT SCI, V13, P444, DOI 10.1016/j.tplants.2008.04.011; COOMBE BG, 1960, PLANT PHYSIOL, V35, P241, DOI 10.1104/pp.35.2.241; Dat J, 2000, CELL MOL LIFE SCI, V57, P779, DOI 10.1007/s000180050041; Day RC, 2008, PLANT PHYSIOL, V148, P1964, DOI 10.1104/pp.108.128108; Dreni L, 2013, MOL PLANT, V6, P650, DOI 10.1093/mp/sst019; Fath A, 2001, PLANT PHYSIOL, V126, P156, DOI 10.1104/pp.126.1.156; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; Gapper C, 2006, PLANT PHYSIOL, V141, P341, DOI 10.1104/pp.106.079079; Garcia D, 2005, PLANT CELL, V17, P52, DOI 10.1105/tpc.104.027136; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; Grossniklaus U, 1998, SCIENCE, V280, P446, DOI 10.1126/science.280.5362.446; Hanania U, 2009, PLANT CELL REP, V28, P1033, DOI 10.1007/s00299-009-0715-1; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Ishibashi Y, 2012, PLANT PHYSIOL, V158, P1705, DOI 10.1104/pp.111.192740; IWAHORI S, 1968, PLANT PHYSIOL, V43, P333, DOI 10.1104/pp.43.3.333; JANERO DR, 1990, FREE RADICAL BIO MED, V9, P515, DOI 10.1016/0891-5849(90)90131-2; Jofuku KD, 2005, P NATL ACAD SCI USA, V102, P3117, DOI 10.1073/pnas.0409893102; Kimura PH, 1996, AM J ENOL VITICULT, V47, P152; Kiyosue T, 1999, P NATL ACAD SCI USA, V96, P4186, DOI 10.1073/pnas.96.7.4186; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; LANGRIDGE J, 1957, NATURE, V180, P36, DOI 10.1038/180036a0; Liszkay A, 2004, PLANT PHYSIOL, V136, P3114, DOI 10.1104/pp.104.044784; Lotan T, 1998, CELL, V93, P1195, DOI 10.1016/S0092-8674(00)81463-4; Mesejo C, 2008, PLANT SCI, V175, P267, DOI 10.1016/j.plantsci.2008.04.008; Ohto M, 2005, P NATL ACAD SCI USA, V102, P3123, DOI 10.1073/pnas.0409858102; Okamoto G, 2005, VITIS, V44, P157; PHARIS RP, 1985, ANNU REV PLANT PHYS, V36, P517, DOI 10.1146/annurev.pp.36.060185.002505; Ross JJ, 1997, PHYSIOL PLANTARUM, V100, P550, DOI 10.1034/j.1399-3054.1997.1000317.x; Roxrud I, 2007, PLANT CELL PHYSIOL, V48, P471, DOI 10.1093/pcp/pcm016; Schopfer P, 2002, PLANTA, V214, P821, DOI 10.1007/s00425-001-0699-8; Schwechheimer C, 2009, CURR OPIN PLANT BIOL, V12, P57, DOI 10.1016/j.pbi.2008.09.004; Singh DP, 2002, PLANT CELL, V14, P3133, DOI 10.1105/tpc.003046; Stout AB, 1936, SEEDLESSNESS GRAPES, P1; SUGIURA A., 1966, Engei Gakkai Zasshi = Journal of the Japanese Society of Horticultural Science, V35, P233; Suzuki M, 2008, CURR OPIN PLANT BIOL, V11, P548, DOI 10.1016/j.pbi.2008.06.015; Swain SM, 1997, PLANT J, V12, P1329, DOI 10.1046/j.1365-313x.1997.12061329.x; Tang DM, 2009, SCI HORTIC-AMSTERDAM, V120, P51, DOI 10.1016/j.scienta.2008.09.018; Tian SF, 2011, ACTA PHYSIOL PLANT, V33, P2467, DOI 10.1007/s11738-011-0791-z; Varoquaux F, 2000, TRENDS BIOTECHNOL, V18, P233, DOI 10.1016/S0167-7799(00)01448-7; Vergara R, 2012, J EXP BOT, V63, P4123, DOI 10.1093/jxb/ers094; Vielle-Calzada JP, 1999, GENE DEV, V13, P2971, DOI 10.1101/gad.13.22.2971; Wang Z, 2012, PROTEOMICS, V12, P86, DOI 10.1002/pmic.201000668; Xu XZ, 2013, PLANT CELL TISS ORG, V114, P187, DOI 10.1007/s11240-013-0314-2; Yamaguchi S, 1998, PLANT CELL, V10, P2115, DOI 10.1105/tpc.10.12.2115; Yamamoto A, 2009, PLANT J, V58, P843, DOI 10.1111/j.1365-313X.2009.03817.x; Ye WJ, 2009, PLANT SCI, V177, P19, DOI 10.1016/j.plantsci.2009.03.005; Yu H, 2004, P NATL ACAD SCI USA, V101, P7827, DOI 10.1073/pnas.0402377101; Zhou BY, 2006, PLANT GROWTH REGUL, V49, P113, DOI 10.1007/s10725-006-9000-2	56	44	55	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80044	10.1371/journal.pone.0080044	http://dx.doi.org/10.1371/journal.pone.0080044			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224035	Green Published, Green Submitted, gold			2022-12-27	WOS:000326597400107
J	Dixit, S; Upadhyay, SK; Singh, H; Sidhu, OP; Verma, PC; Chandrashekar, K				Dixit, Sameer; Upadhyay, Santosh Kumar; Singh, Harpal; Sidhu, Om Prakash; Verma, Praveen Chandra; Chandrashekar, K.			Enhanced Methanol Production in Plants Provides Broad Spectrum Insect Resistance	PLOS ONE			English	Article							PECTIN METHYLESTERASE; BACILLUS-THURINGIENSIS; DROUGHT-RESISTANCE; BEMISIA-TABACI; BT COTTON; EXPRESSION; TOBACCO; WHITEFLIES; MOVEMENT; EMISSION	Plants naturally emit methanol as volatile organic compound. Methanol is toxic to insect pests; but the quantity produced by most of the plants is not enough to protect them against invading insect pests. In the present study, we demonstrated that the over-expression of pectin methylesterase, derived from Arabidopsis thaliana and Aspergillus niger, in transgenic tobacco plants enhances methanol production and resistance to polyphagous insect pests. Methanol content in the leaves of transgenic plants was measured using proton nuclear spectroscopy (1H NMR) and spectra showed up to 16 fold higher methanol as compared to control wild type (WT) plants. A maximum of 100 and 85% mortality in chewing insects Helicoverpa armigera and Spodoptera litura larvae was observed, respectively when fed on transgenic plants leaves. The surviving larvae showed less feeding, severe growth retardation and could not develop into pupae. In-planta bioassay on transgenic lines showed up to 99 and 75% reduction in the population multiplication of plant sap sucking pests Myzus persicae (aphid) and Bemisia tabaci (whitefly), respectively. Most of the phenotypic characters of transgenic plants were similar to WT plants. Confocal microscopy showed no deformities in cellular integrity, structure and density of stomata and trichomes of transgenic plants compared to WT. Pollen germination and tube formation was also not affected in transgenic plants. Cell wall enzyme transcript levels were comparable with WT. This study demonstrated for the first time that methanol emission can be utilized for imparting broad range insect resistance in plants.	[Dixit, Sameer; Upadhyay, Santosh Kumar; Singh, Harpal; Sidhu, Om Prakash; Verma, Praveen Chandra; Chandrashekar, K.] CSIR, Natl Bot Res Inst, Lucknow, Uttar Pradesh, India; [Dixit, Sameer] Acad Sci & Innovat Res AcSIR, New Delhi, India; [Upadhyay, Santosh Kumar] Natl Agrifood Biotechnol Inst, Dept Biotechnol, Minist Sci & Technol, Mohali, Punjab, India; [Chandrashekar, K.] Indian Agr Res Inst, Pune, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI); Academy of Scientific & Innovative Research (AcSIR); Department of Biotechnology (DBT) India; National Agri Food Biotechnology Institute (NABI); Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute	Verma, PC (corresponding author), CSIR, Natl Bot Res Inst, Lucknow, Uttar Pradesh, India.	praveencverma@nbri.res.in; kc_shekar2001@yahoo.com	Upadhyay, Santosh/ABD-2302-2020; Chadrashekar, K/AAX-4996-2021; Verma, Praveen C/F-9709-2010	Upadhyay, Santosh/0000-0001-6991-0502; Verma, Praveen C/0000-0002-3732-0564	CSIR, INDIA	CSIR, INDIA(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by CSIR, INDIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abro G. H., 2004, Biotechnology, V3, P75; Aktar M.S., 2009, INTERDISCIPLINARY TO, V2, P1; Anthon GE, 2004, J AGR FOOD CHEM, V52, P3749, DOI 10.1021/jf035284w; Baldwin IT, 2001, CURR OPIN PLANT BIOL, V4, P351, DOI 10.1016/S1369-5266(00)00184-9; Bharti SK, 2011, MAGN RESON CHEM, V49, P659, DOI 10.1002/mrc.2817; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; Carvalho AB, 2009, INT J FOOD SCI NUTR, V60, P255, DOI 10.1080/09637480701752244; Chen MH, 2000, EMBO J, V19, P913, DOI 10.1093/emboj/19.5.913; Chen MH, 2003, PLANT J, V35, P386, DOI 10.1046/j.1365-313X.2003.01818.x; de Maagd RA, 1999, TRENDS PLANT SCI, V4, P9, DOI 10.1016/S1360-1385(98)01356-9; Dorokhov YL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002640; Dutt U., 2007, MEALY BUG INFESTATIO; Fall R, 1996, TRENDS PLANT SCI, V1, P296, DOI 10.1016/S1360-1385(96)88175-0; FLEMING R, 1985, J ECON ENTOMOL, V78, P1179, DOI 10.1093/jee/78.6.1179; Frenkel C, 1998, J BIOL CHEM, V273, P4293, DOI 10.1074/jbc.273.8.4293; GUENTHER A, 1995, J GEOPHYS RES-ATMOS, V100, P8873, DOI 10.1029/94JD02950; Hasunuma T, 2004, J BIOTECHNOL, V111, P241, DOI 10.1016/j.jbiotec.2004.04.015; Hasunuma T, 2003, J BIOTECHNOL, V106, P45, DOI 10.1016/j.jbiotec.2003.07.008; HORSCH RB, 1984, SCIENCE, V223, P496, DOI 10.1126/science.223.4635.496; Huang JK, 2003, AGR ECON, V29, P55, DOI 10.1016/S0169-5150(03)00044-6; Huve K, 2007, J EXP BOT, V58, P1783, DOI 10.1093/jxb/erm038; Jin SX, 2012, PLANT BIOTECHNOL J, V10, P313, DOI 10.1111/j.1467-7652.2011.00663.x; Jirschitzka J, 2012, CURRENT OPINION BIOT, V24, P1; Korner E, 2009, J EXP BOT, V60, P2631, DOI 10.1093/jxb/erp106; Lionetti V, 2007, PLANT PHYSIOL, V143, P1871, DOI 10.1104/pp.106.090803; Liu XH, 2003, J EXP BIOL, V206, P2221, DOI 10.1242/jeb.00420; Mangos TJ, 1997, ANAL BIOCHEM, V244, P357, DOI 10.1006/abio.1996.9908; Marty P, 1997, PHYTOCHEMISTRY, V44, P1435, DOI 10.1016/S0031-9422(96)00766-2; Micheli F, 2001, TRENDS PLANT SCI, V6, P414, DOI 10.1016/S1360-1385(01)02045-3; Misra P, 2010, PLANT PHYSIOL, V152, P2258, DOI 10.1104/pp.109.150979; Navakoudis E, 2007, BBA-BIOENERGETICS, V1767, P948, DOI 10.1016/j.bbabio.2007.05.003; NEMECEKMARSHALL M, 1995, PLANT PHYSIOL, V108, P1359, DOI 10.1104/pp.108.4.1359; NONOMURA AM, 1992, P NATL ACAD SCI USA, V89, P9794, DOI 10.1073/pnas.89.20.9794; Pelloux J, 2007, TRENDS PLANT SCI, V12, P267, DOI 10.1016/j.tplants.2007.04.001; Pimentel David, 2009, P83, DOI 10.1007/978-1-4020-8992-3_3; Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x; Singh SP, 2010, PLANT BIOTECHNOL J, V8, P1005, DOI 10.1111/j.1467-7652.2010.00527.x; Tian GW, 2006, DEV BIOL, V294, P83, DOI 10.1016/j.ydbio.2006.02.026; Upadhyay SK, 2011, J BIOSCIENCES, V36, P153, DOI 10.1007/s12038-011-9009-1; Virla EG, 2010, CROP PROT, V29, P635, DOI 10.1016/j.cropro.2009.12.019; Xiao BZ, 2007, THEOR APPL GENET, V115, P35, DOI 10.1007/s00122-007-0538-9; Xu Wen-hua, 2008, Journal of Ecology and Rural Environment, V24, P32; Yarasi B, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-102; Zhang JT, 2011, J PROTEOME RES, V10, P1904, DOI 10.1021/pr101140n; Zhao HW, 2000, ACTA BOT SIN, V42, P616	45	30	32	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79664	10.1371/journal.pone.0079664	http://dx.doi.org/10.1371/journal.pone.0079664			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223989	gold, Green Published, Green Submitted			2022-12-27	WOS:000326597400080
J	Haagensen, AMJ; Klein, AB; Ettrup, A; Matthews, LR; Sorensen, DB				Haagensen, Annika Maria Juul; Klein, Anders Bue; Ettrup, Anders; Matthews, Lindsay R.; Sorensen, Dorte Bratbo			Cognitive Performance of Gottingen Minipigs Is Affected by Diet in a Spatial Hole-Board Discrimination Test	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; HIGH-ENERGY DIET; NEUROTROPHIC FACTOR; HIGH-FAT; ALZHEIMERS-DISEASE; METABOLIC SYNDROME; SATURATED FAT; MEMORY; SUCROSE; OBESITY	Consumption of a high energy diet, containing high amounts of saturated fat and refined sugar has been associated with impairment of cognitive function in rodents and humans. We sought to contrast the effect of a high fat/cholesterol, low carbohydrate diet and a low fat, high carbohydrate/sucrose diet, relative to a standard low fat, high carbohydrate minipig diet on spatial cognition with regards to working memory and reference memory in 24 male Gottingen minipigs performing in a spatial hole-board discrimination test. We found that both working memory and reference memory were impaired by both diets relative to a standard minipig diet high in carbohydrate, low in fat and sugar. The different diets did not impact levels of brain-derived neurotrophic factor in brain tissue and neither did they affect circulatory inflammation measured by concentrations of C-reactive protein and haptoglobin in serum. However, higher levels of triglycerides were observed for minipigs fed the diets with high fat/cholesterol, low carbohydrate and low fat, high carbohydrate/sucrose compared to minipigs fed a standard minipig diet. This might explain the observed impairments in spatial cognition. These findings suggest that high dietary intake of both fat and sugar may impair spatial cognition which could be relevant for mental functioning in humans.	[Haagensen, Annika Maria Juul; Sorensen, Dorte Bratbo] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Sect Expt Anim Models, Frederiksberg, Denmark; [Klein, Anders Bue] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Frederiksberg, Denmark; [Ettrup, Anders] Copenhagen Univ Hosp, Rigshosp, Neurobiol Res Unit, Copenhagen, Denmark; [Matthews, Lindsay R.] Lindsay R Matthews & Associates Res Int, Scerne Di Pineto, Italy; [Matthews, Lindsay R.] Univ Auckland, Dept Psychol, Auckland, New Zealand	University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Auckland	Haagensen, AMJ (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Sect Expt Anim Models, Frederiksberg, Denmark.	amjh@sund.ku.dk		Sorensen, Dorte Bratbo/0000-0002-6144-1710; Ettrup, Anders/0000-0002-8926-3012; Klein, Anders Bue/0000-0002-0236-3089	Centre for Applied Laboratory Animal Research; Danish Council for Strategic Research [2101-06-0034]	Centre for Applied Laboratory Animal Research; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This study was supported by the Centre for Applied Laboratory Animal Research and the Danish Council for Strategic Research (Grant Number: 2101-06-0034). The funders had no role in study design, data collection and analysis, decision to publish, or preperation of the manuscript.	Abargouei AS, 2012, PUBLIC HEALTH NUTR, V15, P1925, DOI 10.1017/S1368980011003302; Acuna E, 2004, ST CLASS DAT ANAL, P639; Agrawal R, 2012, J PHYSIOL-LONDON, V590, P2485, DOI 10.1113/jphysiol.2012.230078; Arts JWM, 2009, BEHAV BRAIN RES, V205, P303, DOI 10.1016/j.bbr.2009.06.014; Banks WA, 2004, DIABETES, V53, P1253, DOI 10.2337/diabetes.53.5.1253; Bollen PJA, 2002, 32 SCAND LAS S GARD; Brown LA, 2013, FOOD FUNCT, V4, P770, DOI 10.1039/c3fo30243a; Bruggeman EC, 2011, PHARMACOL BIOCHEM BE, V99, P356, DOI 10.1016/j.pbb.2011.05.014; Cao DF, 2007, J BIOL CHEM, V282, P36275, DOI 10.1074/jbc.M703561200; Carvalho C, 2012, DIABETES, V61, P1234, DOI 10.2337/db11-1186; Chepulis LM, 2009, PHYSIOL BEHAV, V97, P359, DOI 10.1016/j.physbeh.2009.03.001; Cserjesi R, 2009, APPETITE, V52, P535, DOI 10.1016/j.appet.2009.01.003; Eagan Danielle E, 2012, Cardiovasc Psychiatry Neurol, V2012, P120540, DOI 10.1155/2012/120540; Elias MF, 2005, NEUROBIOL AGING, V26, pS11, DOI 10.1016/j.neurobiolaging.2005.08.019; Farr SA, 2008, ENDOCRINOLOGY, V149, P2628, DOI 10.1210/en.2007-1722; Fergenbaum JH, 2009, OBESITY, V17, P1957, DOI 10.1038/oby.2009.161; Gieling ET, 2012, PEDIATR RES, V71, P71, DOI 10.1038/pr.2011.5; Granholm AC, 2008, J ALZHEIMERS DIS, V14, P133; Haagensen AMJ, 2013, BEHAV PHARMACOL, V24, P172, DOI 10.1097/FBP.0b013e32836104fd; HEILMAN KM, 1974, ARCH NEUROL-CHICAGO, V31, P67, DOI 10.1001/archneur.1974.00490370093018; Holloway CJ, 2011, AM J CLIN NUTR, V93, P748, DOI 10.3945/ajcn.110.002758; Jarrard LE, 1995, BEHAV BRAIN RES, V71, P1, DOI 10.1016/0166-4328(95)00034-8; Jurdak N, 2008, NUTR NEUROSCI, V11, P48, DOI 10.1179/147683008X301333; Kanoski SE, 2007, BEHAV BRAIN RES, V182, P57, DOI 10.1016/j.bbr.2007.05.004; Kanoski SE, 2010, J ALZHEIMERS DIS, V21, P207, DOI 10.3233/JAD-2010-091414; Kanoski SE, 2010, J EXP PSYCHOL-ANIM B, V36, P313, DOI 10.1037/a0017228; Karczewska-Kupczewska M, 2012, DIABETES CARE, V35, P358, DOI 10.2337/dc11-1295; Kesslak JP, 1998, BEHAV NEUROSCI, V112, P1012, DOI 10.1037/0735-7044.112.4.1012; Khabour OF, 2010, HIPPOCAMPUS, V20, P637, DOI 10.1002/hipo.20657; Klein AB, 2011, INT J NEUROPSYCHOPH, V14, P347, DOI 10.1017/S1461145710000738; Kornum BR, 2011, NEUROSCI BIOBEHAV R, V35, P437, DOI 10.1016/j.neubiorev.2010.05.004; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; Liu SM, 2002, AM J CLIN NUTR, V75, P492, DOI 10.1093/ajcn/75.3.492; Manton J, 2010, REPROD TOXICOL, V30, P233; MATHEW NT, 1976, EUR NEUROL, V14, P370, DOI 10.1159/000114761; Molteni R, 2004, NEUROSCIENCE, V123, P429, DOI 10.1016/j.neuroscience.2003.09.020; Molteni R, 2002, NEUROSCIENCE, V112, P803, DOI 10.1016/S0306-4522(02)00123-9; Northstone K, 2012, J EPIDEMIOL COMMUN H, V66, P624, DOI 10.1136/jech.2010.111955; OADES RD, 1978, BEHAV BIOL, V24, P327, DOI 10.1016/S0091-6773(79)90184-6; Park HR, 2010, NEUROSCI LETT, V482, P235, DOI 10.1016/j.neulet.2010.07.046; Pasinetti GM, 2008, J NEUROCHEM, V106, P1503, DOI 10.1111/j.1471-4159.2008.05454.x; Perlmuter L C, 1988, J Diabet Complications, V2, P210, DOI 10.1016/S0891-6632(88)80011-4; Pistell PJ, 2010, J NEUROIMMUNOL, V219, P25, DOI 10.1016/j.jneuroim.2009.11.010; Ross AP, 2009, NEUROBIOL LEARN MEM, V92, P410, DOI 10.1016/j.nlm.2009.05.007; Schuitemaker A, 2009, NEUROBIOL AGING, V30, P1885, DOI 10.1016/j.neurobiolaging.2008.01.014; Sorensen LB, 2005, AM J CLIN NUTR, V82, P421, DOI 10.1093/ajcn/82.2.421; Svendsen O, 2006, EXP TOXICOL PATHOL, V57, P335, DOI 10.1016/j.etp.2006.03.003; Teunissen CE, 2003, J NEUROIMMUNOL, V134, P142, DOI 10.1016/S0165-5728(02)00398-3; van der Borght K, 2011, REGUL PEPTIDES, V167, P26, DOI 10.1016/j.regpep.2010.11.002; Wang B, 2007, AM J CLIN NUTR, V85, P561, DOI 10.1093/ajcn/85.2.561; WOLRAICH ML, 1994, NEW ENGL J MED, V330, P301, DOI 10.1056/NEJM199402033300501; Wu AG, 2004, EUR J NEUROSCI, V19, P1699, DOI 10.1111/j.1460-9568.2004.03246.x; Yamada K, 2002, LIFE SCI, V70, P735, DOI 10.1016/S0024-3205(01)01461-8; Yamada-Goto N, 2012, J NEUROENDOCRINOL, V24, P1120, DOI 10.1111/j.1365-2826.2012.02327.x; Yu HL, 2010, INT J DEV NEUROSCI, V28, P271, DOI 10.1016/j.ijdevneu.2009.12.001	55	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79429	10.1371/journal.pone.0079429	http://dx.doi.org/10.1371/journal.pone.0079429			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223947	gold, Green Submitted, Green Published			2022-12-27	WOS:000326597400065
J	Hisatomi, Y; Asakura, K; Kugino, K; Kurokawa, M; Asakura, T; Nakata, K				Hisatomi, Yuko; Asakura, Kyo; Kugino, Kenji; Kurokawa, Mamoru; Asakura, Tomiko; Nakata, Keiko			Changes in Brain Tissue and Behavior Patterns Induced by Single Short-Term Fasting in Mice	PLOS ONE			English	Article							OREXIN NEURONS; APPARATUS; AROUSAL	In humans, emaciation from long-term dietary deficiencies, such as anorexia, reportedly increases physical activity and brain atrophy. However, the effects of single short-term fasting on brain tissue or behavioral activity patterns remain unclear. To clarify the impact of malnutrition on brain function, we conducted a single short-term fasting study as an anorexia model using male adult mice and determined if changes occurred in migratory behavior as an expression of brain function and in brain tissue structure. Sixteen-week-old C57BL/6J male mice were divided into either the fasted group or the control group. Experiments were conducted in a fixed indoor environment. We examined the effects of fasting on the number of nerve cells, structural changes in the myelin and axon density, and brain atrophy. For behavior observation, the amount of food and water consumed, ingestion time, and the pattern of movement were measured using a time-recording system. The fasted mice showed a significant increase in physical activity and their rhythm of movement was disturbed. Since the brain was in an abnormal state after fasting, mice that were normally active during the night became active regardless of day or night and performed strenuous exercise at a high frequency. The brain weight did not change by a fast, and brain atrophy was not observed. Although no textural change was apparent by fasting, the neuronal neogenesis in the subventricular zone and hippocampus was inhibited, causing disorder of the brain function. A clear association between the suppression of encephalic neuropoiesis and overactivity was not established. However, it is interesting that the results of this study suggest that single short-term fasting has an effect on encephalic neuropoiesis.	[Hisatomi, Yuko; Nakata, Keiko] Nishikyushu Univ, Fac Hlth & Social Welf Sci, Dept Hlth & Nutr Sci, Kanzaki, Saga, Japan; [Asakura, Kyo] Special Nursing Home Aged Social Welf Jurid Perso, Dietary Dept, Bungo Ono, Ooita, Japan; [Kugino, Kenji] Nagasaki Univ, Grad Sch Human Hlth Sci, Div Nutr Sci, Nagasaki 852, Japan; [Kurokawa, Mamoru] Nagasaki Univ, Grad Sch Biomed Sci, Dept Med & Dent Sci, Nagasaki 852, Japan; [Asakura, Tomiko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo, Japan	Nagasaki University; Nagasaki University; University of Tokyo	Kugino, K (corresponding author), Nagasaki Univ, Grad Sch Human Hlth Sci, Div Nutr Sci, Nagasaki 852, Japan.	kugino@mxa.cncm.ne.jp						ARTMANN H, 1985, NEURORADIOLOGY, V27, P304, DOI 10.1007/BF00339562; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144; Hagan JJ, 1999, P NATL ACAD SCI USA, V96, P10911, DOI 10.1073/pnas.96.19.10911; Hanada R, 2004, NAT MED, V10, P1067, DOI 10.1038/nm1106; HEINZ ER, 1977, J COMPUT ASSIST TOMO, V1, P415, DOI 10.1097/00004728-197710000-00006; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; Ida T, 2000, BIOCHEM BIOPH RES CO, V270, P318, DOI 10.1006/bbrc.2000.2412; Kurokawa M, 2000, PHYSIOL BEHAV, V70, P105, DOI 10.1016/S0031-9384(00)00226-2; Kurokawa M, 2003, CELL MOL NEUROBIOL, V23, P121, DOI 10.1023/A:1022956403708; Kurokawa M, 2005, COLOR ATLAS MOUSE IL, P169; Matsuda Motoko, 2000, Congenital Anomalies, V40, P14, DOI 10.1111/j.1741-4520.2000.tb00904.x; Mukai M, 2008, NIPPON TOSEKI IGAKKA, V41, P421, DOI 10.4009/jsdt.41.421; Nagai J, 2007, J PHARMACOL EXP THER, V321, P195, DOI 10.1124/jpet.106.115121; Nakamura T, 2000, BRAIN RES, V873, P181, DOI 10.1016/S0006-8993(00)02555-5; Nambu T, 1999, BRAIN RES, V827, P243, DOI 10.1016/S0006-8993(99)01336-0; NUSSBAUM M, 1980, J PEDIATR-US, V96, P867, DOI 10.1016/S0022-3476(80)80561-0; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Watanabe Seiji, 2009, No To Hattatsu, V41, P43; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3	20	2	2	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80085	10.1371/journal.pone.0080085	http://dx.doi.org/10.1371/journal.pone.0080085			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224039	Green Submitted, Green Published, gold			2022-12-27	WOS:000326597400111
J	Yang, HX; Chu, JM				Yang, Hongxiao; Chu, Jianmin			Persistence of Coastal Vegetation in Supratidal Zones of Northern China	PLOS ONE			English	Article							STORM-SURGE; SEED-DISPERSAL; ECOSYSTEMS; COMMUNITY; RESERVE; PLANTS; IMPACT	Coastal vegetation comprises a number of coastal specialists and terrestrial generalists. It remains unclear how they persist on disturbed and undisturbed coastal conditions. We tested the hypothesis that coastal specialists may be superior to terrestrial generalists on supratidal zones of coasts, but their superiority can be influenced by human disturbances. Eight separate sandy coasts of the Shandong Peninsula were sampled, representing for disturbed and undisturbed sandy coasts. Plants growing on their supratidal zones were surveyed. On this basis, we compared the relative dominances, niche widths, and commonness of all species, and also analyzed species diversities of the coasts. Coastal specialists were found to be more common and widespread on supratidal zones of the sandy coasts than terrestrial generalists haphazardly invading from hinterlands. Coastal specialists exhibited lower Sorensen dissimilarities than terrestrial generalists among the coasts. Tourist trampling seemed more detrimental than pond fishery to coastal vegetation. Relative to terrestrial generalists, coastal specialists responded to human disturbances more deterministically, with steady decreases in species diversities. These evidences verify that coastal specialists are intrinsically superior to terrestrial generalists on supratidal zones of coasts, especially of undisturbed coasts, because their dispersal among coasts adapts well to local storm surge regime. They also validate that human disturbances can depress the superiority of coastal specialists, partly by inducing invasion of terrestrial generalists.	[Yang, Hongxiao] Qingdao Agr Univ, Coll Resources & Environm, Qingdao, Shandong, Peoples R China; [Chu, Jianmin] State Forestry Adm, Key Lab Tree Breeding & Cultivat, Beijing, Peoples R China; [Chu, Jianmin] Chinese Acad Forestry, Res Inst Forestry, Beijing, Peoples R China	Qingdao Agricultural University; Chinese Academy of Forestry; Research Institute of Forestry, CAF	Chu, JM (corresponding author), State Forestry Adm, Key Lab Tree Breeding & Cultivat, Beijing, Peoples R China.	cjmcaf@163.com			Qingdao Agricultural University	Qingdao Agricultural University	This work was supported by the funds of Qingdao Agricultural University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta A, 2005, APPL VEG SCI, V8, P133, DOI 10.1111/j.1654-109X.2005.tb00638.x; Acosta A, 2007, J COASTAL RES, V23, P1518, DOI 10.2112/05-0589.1; Ai D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046164; Barbier EB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058715; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Bird E.C., 2011, COASTAL GEOMORPHOLOG; Blaber SJM, 2000, ICES J MAR SCI, V57, P590, DOI 10.1006/jmsc.2000.0723; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Breitbach N, 2012, J ECOL, V100, P1349, DOI 10.1111/1365-2745.12001; Chen Hanbin, 1990, FLORA SHANDONG; Christenhusz MJM, 2013, BOT J LINN SOC, V171, P277, DOI 10.1111/j.1095-8339.2012.01301.x; de Juan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065575; Fan SJ, 2003, FLORA LAOSHAN; Guimaraes JTF, 2013, EARTH SURF PROC LAND, V38, P1535, DOI 10.1002/esp.3396; Fenner M., 2005, ECOLOGY SEEDS; Foxcroft LC, 2011, PERSPECT PLANT ECOL, V13, P89, DOI 10.1016/j.ppees.2011.03.004; Gormsem E., 1997, GeoJournal, V42, P39, DOI 10.1023/A:1006840622450; GREENE DF, 1995, CAN J BOT, V73, P1036, DOI 10.1139/b95-113; Guja LK, 2010, FUNCT PLANT BIOL, V37, P1175, DOI 10.1071/FP10166; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; HAYDEN BP, 1995, GEOMORPHOLOGY, V13, P283, DOI 10.1016/0169-555X(95)00032-Z; Kreitler J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056670; Lee TL, 2009, ADV ENG SOFTW, V40, P1200, DOI 10.1016/j.advengsoft.2007.06.005; Leithead M, 2012, J VEG SCI, V23, P339, DOI 10.1111/j.1654-1103.2011.01351.x; LEVINS RICHARD, 1968; Li PS, 1994, MARINE FORECASTS, V11, P47; Mather P. M., 1976, COMPUTATIONAL METHOD; McCune B., 2006, PC ORD MULTIVARIATE; Nilsson C, 2010, BIOL REV, V85, P837, DOI 10.1111/j.1469-185X.2010.00129.x; Rodgers JC, 2009, ESTUAR COAST, V32, P496, DOI 10.1007/s12237-009-9138-z; Rosner B., 2011, FUNDAMENTALS BIOSTAT, V7th ed; Savage C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042708; Shannon C. E., 1949, MATH THEORY COMMUNIC; Shepard CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027374; Tate AS, 2013, J VEG SCI, V24, P46, DOI 10.1111/j.1654-1103.2012.01447.x; Thrush SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011899; VELLINGA P, 1982, COAST ENG, V6, P361, DOI 10.1016/0378-3839(82)90007-2; Wamsley TV, 2010, OCEAN ENG, V37, P59, DOI 10.1016/j.oceaneng.2009.07.018; Wilson JB, 2012, J VEG SCI, V23, P1013, DOI 10.1111/j.1654-1103.2012.01430.x; Yang HX, 2012, FLORA, V207, P701, DOI 10.1016/j.flora.2012.08.001; Yang HongXiao, 2010, Acta Prataculturae Sinica, V19, P228; Yang HX, 2011, CHIN B BOT, V46, P50, DOI [10.3724/SP.J.1259.2011.00050, DOI 10.3724/SP.J.1259.2011.00050]	42	2	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79964	10.1371/journal.pone.0079964	http://dx.doi.org/10.1371/journal.pone.0079964			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224026	Green Published, gold, Green Submitted			2022-12-27	WOS:000326597400100
J	Zawistowski, JS; Sabouri-Ghomi, M; Danuser, G; Hahn, KM; Hodgson, L				Zawistowski, Jon S.; Sabouri-Ghomi, Mohsen; Danuser, Gaudenz; Hahn, Klaus M.; Hodgson, Louis			A RhoC Biosensor Reveals Differences in the Activation Kinetics of RhoA and RhoC in Migrating Cells	PLOS ONE			English	Article							BREAST-CANCER CELLS; GTPASE ACTIVITIES; EXCHANGE FACTOR; STRESS FIBERS; INVASION; DOWNSTREAM; MOTILITY; METASTASIS; DYNAMICS; DRIVES	RhoA and RhoC GTPases share 92% amino acid sequence identity, yet play different roles in regulating cell motility and morphology. To understand these differences, we developed and validated a biosensor of RhoC activation (RhoC FLARE). This was used together with a RhoA biosensor to compare the spatio-temporal dynamics of RhoA and RhoC activity during cell protrusion/retraction and macropinocytosis. Both GTPases were activated similarly at the cell edge, but in regions more distal from the edge RhoC showed higher activation during protrusion. The two isoforms differed markedly in the kinetics of activation. RhoC was activated concomitantly with RhoA at the cell edge, but distally, RhoC activation preceded RhoA activation, occurring before edge protrusion. During macropinocytosis, differences were observed during vesicle closure and in the area surrounding vesicle formation.	[Zawistowski, Jon S.; Hahn, Klaus M.; Hodgson, Louis] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27515 USA; [Zawistowski, Jon S.; Hahn, Klaus M.; Hodgson, Louis] Univ N Carolina, Sch Med, Lineberger Canc Ctr, Chapel Hill, NC USA; [Sabouri-Ghomi, Mohsen; Danuser, Gaudenz] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Scripps Research Institute	Hahn, KM (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27515 USA.	khahn@med.unc.edu; louis.hodgson@einstein.yu.edu		Hahn, Klaus/0000-0002-1970-7562; Hodgson, Louis/0000-0001-9188-7580; Danuser, Gaudenz/0000-0001-8583-2014	American Cancer Society/The Josephine Peiser Charitable Foundation Postdoctoral Fellowship [PF-07-102-01-TBE]; The Sinsheimer Foundation Young Investigator Award; NIH [RO1 GM090317, RO1 GM093121]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090317, R01GM093121] Funding Source: NIH RePORTER	American Cancer Society/The Josephine Peiser Charitable Foundation Postdoctoral Fellowship; The Sinsheimer Foundation Young Investigator Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by the following: American Cancer Society/The Josephine Peiser Charitable Foundation Postdoctoral Fellowship #PF-07-102-01-TBE (J.S.Z.); The Sinsheimer Foundation Young Investigator Award (L.H.); NIH RO1 GM090317 (G. D. and K. M. H.); and NIH RO1 GM093121 (L.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur WT, 2002, J BIOL CHEM, V277, P42964, DOI 10.1074/jbc.M207401200; Bellovin DI, 2006, ONCOGENE, V25, P6959, DOI 10.1038/sj.onc.1209682; Bravo-Cordero JJ, 2013, J CELL SCI, V126, P3356, DOI 10.1242/jcs.123547; Bravo-Cordero JJ, 2011, CURR BIOL, V21, P635, DOI 10.1016/j.cub.2011.03.039; Chang KW, 2013, ORAL ONCOL, V49, P27, DOI 10.1016/j.oraloncology.2012.07.003; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Danuser G, 1999, J MICROSC-OXFORD, V193, P62, DOI 10.1046/j.1365-2818.1999.00425.x; Dietrich KA, 2009, BIOL CHEM, V390, P1063, DOI 10.1515/BC.2009.110; Efron B., 1993, INTRO BOOTSTRAP, Vxvi; Fritz RD, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004135; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Kitzing TM, 2010, ONCOGENE, V29, P2441, DOI 10.1038/onc.2009.515; Korkina O, 2013, J BIOL CHEM, V288, P5364, DOI 10.1074/jbc.M112.414060; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Lim JI, 2010, EXP CELL RES, V316, P2027, DOI 10.1016/j.yexcr.2010.04.011; Liu M, 2011, CANCER LETT, V301, P151, DOI 10.1016/j.canlet.2010.11.009; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Melendez J, 2011, J BIOL CHEM, V286, P15132, DOI 10.1074/jbc.C111.229336; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Nagai T, 2004, BIOCHEM BIOPH RES CO, V319, P72, DOI 10.1016/j.bbrc.2004.04.147; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Pille JY, 2005, MOL THER, V11, P267, DOI 10.1016/j.ymthe.2004.08.029; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rosenthal DT, 2011, CANCER RES, V71, P6338, DOI 10.1158/0008-5472.CAN-11-1291; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Ruth MC, 2006, J INVEST DERMATOL, V126, P862, DOI 10.1038/sj.jid.5700211; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ncb796; Simpson KJ, 2004, CANCER RES, V64, P8694, DOI 10.1158/0008-5472.CAN-04-2247; Spiering D, 2012, METHODS MOL BIOL, V827, P215, DOI 10.1007/978-1-61779-442-1_15; Unsal-Kacmaz K, 2012, MOL ONCOL, V6, P284, DOI 10.1016/j.molonc.2011.12.001; Vega FM, 2011, J CELL BIOL, V193, P655, DOI 10.1083/jcb.201011038; Vilela M, 2013, METHOD ENZYMOL, V519, P253, DOI 10.1016/B978-0-12-405539-1.00009-9; Wallace SW, 2011, MOL CELL BIOL, V31, P81, DOI 10.1128/MCB.01001-10; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; WHITLOW M, 1993, PROTEIN ENG, V6, P989, DOI 10.1093/protein/6.8.989; Wilson CA, 2010, NATURE, V465, P373, DOI 10.1038/nature08994; Wu D, 2009, ONCOGENE, V28, P2219, DOI 10.1038/onc.2009.96; Wu M, 2010, CANCER-AM CANCER SOC, V116, P2768, DOI 10.1002/cncr.25181; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934	41	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79877	10.1371/journal.pone.0079877	http://dx.doi.org/10.1371/journal.pone.0079877			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224016	Green Published, gold, Green Submitted			2022-12-27	WOS:000326597400093
J	de Groot, GA; During, H				de Groot, G. Arjen; During, Heinjo			Fern Spore Longevity in Saline Water: Can Sea Bottom Sediments Maintain a Viable Spore Bank?	PLOS ONE			English	Article							GENETIC DIVERSITY; DIASPORE BANK; COLONIZATION; POPULATIONS; GERMINATION; DISPERSAL; NACL	Freshwater and marine sediments often harbor reservoirs of plant diaspores, from which germination and establishment may occur whenever the sediment falls dry. Therewith, they form valuable records of historical inter- and intraspecific diversity, and are increasingly exploited to facilitate diversity establishment in new or restored nature areas. Yet, while ferns may constitute a considerable part of a vegetation's diversity and sediments are known to contain fern spores, little is known about their longevity, which may suffer from inundation and - in sea bottoms - salt stress. We tested the potential of ferns to establish from a sea or lake bottom, using experimental studies on spore survival and gametophyte formation, as well as a spore bank analysis on sediments from a former Dutch inland sea. Our experimental results revealed clear differences among species. For Asplenium scolopendrium and Gymnocarpium dryopteris, spore germination was not affected by inundated storage alone, but decreased with rising salt concentrations. In contrast, for Asplenium trichomanes subsp. quadrivalens germination decreased following inundation, but not in response to salt. Germination rates decreased with time of storage in saline water. Smaller and less viable gametophytes were produced when saline storage lasted for a year. Effects on germination and gametophyte development clearly differed among genotypes of A. scolopendrium. Spore bank analyses detected no viable spores in marine sediment layers. Only two very small gametophytes (identified as Thelypteris palustris via DNA barcoding) emerged from freshwater sediments. Both died before maturation. We conclude that marine, and likely even freshwater sediments, will generally be of little value for long-term storage of fern diversity. The development of any fern vegetation on a former sea floor will depend heavily on the deposition of spores onto the drained land by natural or artificial means of dispersal.	[de Groot, G. Arjen] Alterra Wageningen UR, Wageningen, Netherlands; [de Groot, G. Arjen; During, Heinjo] Univ Utrecht, Inst Environm Biol, Utrecht, Netherlands	Wageningen University & Research; Utrecht University	de Groot, GA (corresponding author), Alterra Wageningen UR, Wageningen, Netherlands.	g.a.degroot@wur.nl						Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Ballesteros D, 2011, WORKING WITH FERNS: ISSUES AND APPLICATIONS, P165, DOI 10.1007/978-1-4419-7162-3_12; Bogdanovic M, 2011, AUST J BOT, V59, P734, DOI 10.1071/BT11059; Brederveld RJ, 2011, J APPL ECOL, V48, P1241, DOI 10.1111/j.1365-2664.2011.02026.x; Bremer P., 2007, The colonisation of a former sea-floor by ferns; Chen ShaSha, 2012, African Journal of Biotechnology, V11, P9572, DOI 10.5897/AJB12.320; Cremer H, 2006, 2006UR0133B TNO BOUW; Cremer H, 2009, HYDROBIOLOGIA, V631, P279, DOI 10.1007/s10750-009-9816-7; Dalen Linda, 1999, Lindbergia, V24, P49; de Groot GA, 2008, GORTERIA, V33, P59; De Groot GA, 2012, ANN BOT-LONDON, V109, P965, DOI 10.1093/aob/mcs013; de Groot GA, 2012, AM J BOT, V99, P1375, DOI 10.3732/ajb.1100482; de Groot GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016371; De Groot GA, 2011, THESIS UTRECHT U UTR, P197; During Heinjo J., 2007, LINDBERGIA, V32, P55; During HJ, 1997, ADV BRYOLOG, V6, P103; During HJ, 2001, BRYOLOGIST, V104, P92, DOI 10.1639/0007-2745(2001)104[0092:DB]2.0.CO;2; Dyer A. F., 1979, EXPT BIOL FERNS, P253; DYER AF, 1994, BIODIVERS CONSERV, V3, P160, DOI 10.1007/BF02291886; DYER AF, 1992, AM FERN J, V82, P89, DOI 10.2307/1547792; Erkkila HMJB, 1998, CAN J BOT, V76, P1188, DOI 10.1139/cjb-76-7-1188; Furness SB, 1981, BRID J BRYOL, V4, P733; Guan B, 2009, J ARID ENVIRON, V73, P135, DOI 10.1016/j.jaridenv.2008.08.009; HAIRSTON NG, 1995, ECOLOGY, V76, P1706, DOI 10.2307/1940704; Hairston NG, 1996, LIMNOL OCEANOGR, V41, P1087, DOI 10.4319/lo.1996.41.5.1087; Hock Z, 2008, AM J BOT, V95, P542, DOI 10.3732/ajb.2007283; Hock Z, 2006, PLANT ECOL, V187, P289, DOI 10.1007/s11258-006-9142-3; Hopfensperger KN, 2007, OIKOS, V116, P1438, DOI [10.1111/j.2007.0030-1299.15818.x, 10.1111/j.0030-1299.2007.15818.x]; Jansen AJM, 2004, APPL VEG SCI, V7, P243, DOI 10.1111/j.1654-109X.2004.tb00616.x; Johansson ME, 1996, J VEG SCI, V7, P593, DOI 10.2307/3236309; Khan MA, 1998, SEED SCI TECHNOL, V26, P107; Klekowski EJ, 1969, BOT J LINN SOC, V62; Kochanek J, 2009, AUST J BOT, V57, P123, DOI 10.1071/BT09023; Lindsay Stuart, 1992, P285; LLOYD R M, 1986, Fern Gazette, V13, P97; Nishihiro J, 2007, ENVIRON RES, V11, P171, DOI [10.1007/s11355-006-0005-9, DOI 10.1007/S11355-006-0005-9]; ONR, 2013, OC WAT SAL OFF NAV R; Pangua E, 2009, FLORA, V204, P673, DOI 10.1016/j.flora.2008.09.007; Quintanilla LG, 2002, ANN BOT-LONDON, V90, P461, DOI 10.1093/aob/mcf224; Stuurman RJ, 2007, 2007UR0225B TNO BOUW; Sun WQ, 1999, PHYSIOL PLANTARUM, V105, P51, DOI 10.1034/j.1399-3054.1999.105109.x; Ungar I.A., 1995, SEED DEV GERMINATION, P529; Ungar Irwin A., 2001, Wetlands Ecology and Management, V9, P499, DOI 10.1023/A:1012236829474; Urrego LE, 2009, REV PALAEOBOT PALYNO, V156, P358, DOI 10.1016/j.revpalbo.2009.04.004; WARNE TR, 1995, INT J PLANT SCI, V156, P374, DOI 10.1086/297259; WEINBERG ES, 1969, P NATL ACAD SCI USA, V64, P835, DOI 10.1073/pnas.64.3.835; Wilmshurst JM, 2005, J PALEOLIMNOL, V34, P503, DOI 10.1007/s10933-005-5476-4; Wubs ERJ, 2010, ANN BOT-LONDON, V106, P583, DOI 10.1093/aob/mcq157	48	1	2	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79470	10.1371/journal.pone.0079470	http://dx.doi.org/10.1371/journal.pone.0079470			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223951	Green Published, Green Submitted, gold			2022-12-27	WOS:000326503400116
J	Yang, CC; Lin, CY; Wang, HS; Lyu, SR				Yang, Chih-Chang; Lin, Cheng-Yu; Wang, Hwai-Shi; Lyu, Shaw-Ruey			Matrix Metalloproteases and Tissue Inhibitors of Metalloproteinases in Medial Plica and Pannus-like Tissue Contribute to Knee Osteoarthritis Progression	PLOS ONE			English	Article							HUMAN ARTICULAR-CARTILAGE; RHEUMATOID-ARTHRITIS; CELL-MIGRATION; FOLLOW-UP; DEGRADATION; COMPARTMENT; EXPRESSION; ANGIOGENESIS; INFLAMMATION; DESTRUCTION	Osteoarthritis (OA) is characterized by degradation of the cartilage matrix, leading to pathologic changes in the joints. However, the pathogenic effects of synovial tissue inflammation on OA knees are not clear. To investigate whether the inflammation caused by the medial plica is involved in the pathogenesis of osteoarthritis, we examined the expression of matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs), interleukin (IL)-1 beta, and tumor necrosis factor (TNF)-alpha in the medial plica and pannus-like tissue in the knees of patients with medial compartment OA who underwent either arthroscopic medial release (stage II; 15 knee joints from 15 patients) or total knee replacement (stage IV; 18 knee joints from 18 patients). MMP-2, MMP-3, MMP-9, IL-1 beta, and TNF-alpha mRNA and protein levels measured, respectively, by quantitative real-time PCR and Quantibody human MMP arrays, were highly expressed in extracts of medial plica and pannus-like tissue from stage IV knee joints. Immunohistochemical staining also demonstrated high expression of MMP-2, MMP-3, and MMP-9 in plica and pannus-like tissue of stage IV OA knees and not in normal cartilage. Some TIMP/MMP ratios decreased significantly in both medial plica and pannus-like tissue as disease progressed from stage II to stage IV. Furthermore, the migration of cells from the pannus-like tissue was enhanced by IL-1 beta, while plica cell migration was enhanced by TNF-alpha. The results suggest that medial plica and pannus-like tissue may be involved in the process of cartilage degradation in medial compartment OA of the knee.	[Yang, Chih-Chang; Lin, Cheng-Yu; Wang, Hwai-Shi] Natl Yang Ming Univ, Dept Anat, Taipei, Taiwan; [Lyu, Shaw-Ruey] Tzu Chi Dalin Gen Hosp, Joint Ctr, Chiayi, Taiwan; [Lyu, Shaw-Ruey] Tzu Chi Univ, Hualien, Taiwan	National Yang Ming Chiao Tung University; Buddhist Tzu Chi General Hospital; Tzu Chi University	Wang, HS (corresponding author), Natl Yang Ming Univ, Dept Anat, Taipei, Taiwan.	hswang@ym.edu.tw; srlyu@seed.net.tw	Lyu, Shaw-Ruey/AAC-5480-2022; Lyu, Shaw-Ruey/AAD-9397-2022	Lyu, Shaw-Ruey/0000-0003-3797-4848; Lin, Cheng-Yu/0000-0001-9959-140X	Tzu-Chi Dalin General Hospital, Chiayi, Taiwan; National Science Council, Taiwan [NSC100-2320-B-010-013]; Ministry of Education, Taiwan, Aim for the Top University Plan	Tzu-Chi Dalin General Hospital, Chiayi, Taiwan; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan, Aim for the Top University Plan	Supported by the Tzu-Chi Dalin General Hospital, Chiayi, Taiwan (S.-R. Lyu) and by a grant from the National Science Council, Taiwan (NSC100-2320-B-010-013) to H.-S. Wang, and a grant from the Ministry of Education, Taiwan, Aim for the Top University Plan (H.-S. Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainola MM, 2005, CLIN EXP RHEUMATOL, V23, P644; Akhavani MA, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2689; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Ayral X, 2005, OSTEOARTHR CARTILAGE, V13, P361, DOI 10.1016/j.joca.2005.01.005; Becher N, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-45; Benito MJ, 2005, ANN RHEUM DIS, V64, P1263, DOI 10.1136/ard.2004.025270; Blom AB, 2007, ARTHRITIS RHEUM, V56, P147, DOI 10.1002/art.22337; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; BROOM MJ, 1986, ORTHOP CLIN N AM, V17, P279; DANDY D J, 1990, Arthroscopy, V6, P79, DOI 10.1016/0749-8063(90)90002-U; DEAN DD, 1989, J CLIN INVEST, V84, P678, DOI 10.1172/JCI114215; DEAN DD, 1987, J RHEUMATOL, V14, P43; DEAN DD, 1984, BIOCHEM J, V218, P277, DOI 10.1042/bj2180277; Duerr S, 2004, CLIN EXP RHEUMATOL, V22, P603; Dupont JY, 1997, CLIN SPORT MED, V16, P87, DOI 10.1016/S0278-5919(05)70009-0; Engel CK, 2005, CHEM BIOL, V12, P181, DOI 10.1016/j.chembiol.2004.11.014; Fassbender HG, 1975, PATHOLOGY RHEUMATIC, P279; FLANAGAN JP, 1994, ACTA ORTHOP SCAND, V65, P408, DOI 10.3109/17453679408995480; Haywood L, 2003, ARTHRITIS RHEUM, V48, P2173, DOI 10.1002/art.11094; Hulejova H, 2007, CYTOKINE, V38, P151, DOI 10.1016/j.cyto.2007.06.001; Hunter DJ, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2314; Ikeuchi M, 2005, ARTHROSCOPY, V21, P1457, DOI 10.1016/j.arthro.2005.09.011; JACKSON RW, 1982, ORTHOP CLIN N AM, V13, P307; Katerinaki E, 2003, BRIT J CANCER, V89, P1123, DOI 10.1038/sj.bjc.6601257; KLEIN W, 1983, ARCH ORTHOP TRAUM SU, V102, P67, DOI 10.1007/BF02498717; Kobayashi M, 2005, ARTHRITIS RHEUM-US, V52, P128, DOI 10.1002/art.20776; Kontogiorgis CA, 2005, CURR MED CHEM, V12, P339, DOI 10.2174/0929867053363243; Lin CC, 2009, CELL SIGNAL, V21, P1652, DOI 10.1016/j.cellsig.2009.07.002; Lyu SR, 2008, J BONE JOINT SURG BR, V90B, P1186, DOI 10.1302/0301-620X.90B9.20584; Lyu SR, 2007, CLIN BIOMECH, V22, P1013, DOI 10.1016/j.clinbiomech.2007.08.001; Lyu SR, 2006, CLIN BIOMECH, V21, P860, DOI 10.1016/j.clinbiomech.2006.03.010; Lyu SR, 2010, KNEE SURG SPORT TR A, V18, P769, DOI 10.1007/s00167-009-0946-2; Lyu SR, 2006, ARTHROSCOPY, V22, P17, DOI 10.1016/j.arthro.2005.08.039; MEACHIM G, 1970, J PATHOL, V102, P1, DOI 10.1002/path.1711020102; Mitchell MD, 2007, AM J PHYSIOL-HEART C, V292, pH1139, DOI 10.1152/ajpheart.00881.2005; Mountain DJH, 2007, AM J PHYSIOL-CELL PH, V292, pC867, DOI 10.1152/ajpcell.00161.2006; Murphy G, 2008, NAT CLIN PRACT RHEUM, V4, P128, DOI 10.1038/ncprheum0727; Nakata K, 1986, Nihon Seikeigeka Gakkai Zasshi, V60, P763; NOTTAGE WM, 1983, AM J SPORT MED, V11, P211, DOI 10.1177/036354658301100405; OGATA S, 1990, Arthroscopy, V6, P315, DOI 10.1016/0749-8063(90)90063-J; OKADA Y, 1992, LAB INVEST, V66, P680; Patwari P, 2003, ARTHRITIS RHEUM-US, V48, P1292, DOI 10.1002/art.10892; Sakata K, 2000, INT J ONCOL, V17, P673; SCHULITZ KP, 1983, ARCH ORTHOP TRAUM SU, V102, P37, DOI 10.1007/BF00443037; Shibakawa A, 2003, OSTEOARTHR CARTILAGE, V11, P133, DOI 10.1053/joca.2002.0871; Squires GR, 2003, ARTHRITIS RHEUM-US, V48, P1261, DOI 10.1002/art.10976; TASKER T, 1982, J BONE JOINT SURG BR, V64, P486, DOI 10.1302/0301-620X.64B4.7096428; Verma RP, 2007, BIOORGAN MED CHEM, V15, P2223, DOI 10.1016/j.bmc.2007.01.011; Wang HS, 2011, HISTOPATHOLOGY, V58, P593, DOI 10.1111/j.1365-2559.2011.03783.x; Yuan GH, 2004, OSTEOARTHR CARTILAGE, V12, P38, DOI 10.1016/j.joca.2003.08.004	50	49	53	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79662	10.1371/journal.pone.0079662	http://dx.doi.org/10.1371/journal.pone.0079662			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223987	Green Submitted, gold, Green Published			2022-12-27	WOS:000326503400133
J	Helms, N; Kowalski, M; Illes, P; Riedel, T				Helms, Nick; Kowalski, Maria; Illes, Peter; Riedel, Thomas			Agonist Antagonist Interactions at the Rapidly Desensitizing P2X3 Receptor	PLOS ONE			English	Article							P2X(2/3) RECEPTORS; P2X(3) RECEPTORS; ION-CHANNEL; PURINERGIC RECEPTORS; SENSORY NEURONS; ATP; PAIN; RAT; SUBUNITS; KINETICS	P2X3 receptors (P2XRs), as members of the purine receptor family, are deeply involved in chronic pain sensation and therefore, specific, competitive antagonists are of great interest for perspective pain management. Heretofore, Schild plot analysis has been commonly used for studying the interaction of competitive antagonists and the corresponding receptor. Unfortunately, the steady-state between antagonist and agonist, as a precondition for this kind of analysis, cannot be reached at fast desensitizing receptors like P2X3R making Schild plot analysis inappropriate. The aim of this study was to establish a new method to analyze the interaction of antagonists with their binding sites at the rapidly desensitizing human P2X3R. The patch-clamp technique was used to investigate the structurally divergent, preferential antagonists A317491, TNP-ATP and PPADS. The P2X1,3-selective alpha,beta-methylene ATP (alpha,beta-meATP) was used as an agonist to induce current responses at the wild-type (wt) P2X3R and several agonist binding site mutants. Afterwards a Markov model combining sequential transitions of the receptor from the closed to the open and desensitized mode in the presence or absence of associated antagonist molecules was developed according to the measured data. The P2X3R-induced currents could be fitted correctly with the help of this Markov model allowing identification of amino acids within the binding site which are important for antagonist binding. In conclusion, Markov models are suitable to simulate agonist antagonist interactions at fast desensitizing receptors such as the P2X3R. Among the antagonists investigated, TNP-ATP and A317491 acted in a competitive manner, while PPADS was identified as a (pseudo) irreversible blocker.	[Helms, Nick; Kowalski, Maria; Illes, Peter; Riedel, Thomas] Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, D-04109 Leipzig, Germany	Leipzig University	Riedel, T (corresponding author), Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, D-04109 Leipzig, Germany.	Thomas.Riedel@medizin.uni-leipzig.de		Kowalski-Jahn, Maria/0000-0003-1442-3656	Deutsche Forschungsgemeinschaft [FOR748, RI 2092/1-2, IL 20/18-2]; University of Leipzig	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Leipzig	This work was supported by the Deutsche Forschungsgemeinschaft, http://www.dfg.de/ (FOR748; RI 2092/1-2 and IL 20/18-2) and the University of Leipzig, http://www.uniklinikum-leipzig.de/r-promotionsfoerderung-a-768.html (Promotionsforderung). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsopp RC, 2011, J BIOL CHEM, V286, P29207, DOI 10.1074/jbc.M111.260364; Bodnar M, 2011, J BIOL CHEM, V286, P2739, DOI 10.1074/jbc.M110.167437; Brown SG, 2001, DRUG DEVELOP RES, V53, P281, DOI 10.1002/ddr.1197; Browne L.E., 2012, WIRES MEMBR TRANSP S, V1, P56, DOI DOI 10.1002/WMTS.24; Buell G, 1996, EMBO J, V15, P55, DOI 10.1002/j.1460-2075.1996.tb00333.x; Burgard EC, 2000, MOL PHARMACOL, V58, P1502, DOI 10.1124/mol.58.6.1502; Burnstock G, 2011, PROG NEUROBIOL; Burnstock G, 2009, CURR PHARM DESIGN, V15, P1717, DOI 10.2174/138161209788186335; CHEN CC, 1995, NATURE, V377, P428, DOI 10.1038/377428a0; Chizh BA, 2001, PHARMACOL REV, V53, P553; Egan TM, 2004, J NEUROSCI, V24, P3413, DOI 10.1523/JNEUROSCI.5429-03.2004; El-Ajouz S, 2012, BRIT J PHARMACOL, V165, P390, DOI 10.1111/j.1476-5381.2011.01534.x; Hattori M, 2012, NATURE, DOI DOI 10.HTML#/SUPPLEMENTARY-INF0RMATI0N.ACCESSED; Hausmann R, 2006, MOL PHARMACOL, V69, P2058, DOI 10.1124/mol.106.022665; Jarvis MF, 2002, P NATL ACAD SCI USA, V99, P17179, DOI 10.1073/pnas.252537299; Jarvis MF, 2009, NEUROPHARMACOLOGY, V56, P208, DOI 10.1016/j.neuropharm.2008.06.067; Karoly R, 2008, MOL PHARMACOL, V73, P224, DOI 10.1124/mol.107.038901; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Kennedy C, 2003, J PHYSIOL-LONDON, V553, P683, DOI 10.1113/jphysiol.2003.049114; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Khakh BS, 2001, PHARMACOL REV, V53, P107; Koles L, 2008, N-S ARCH PHARMACOL, V377, P1, DOI 10.1007/s00210-007-0222-2; LEWIS C, 1995, NATURE, V377, P432, DOI 10.1038/377432a0; Michel AD, 2008, BRIT J PHARMACOL, V155, P738, DOI 10.1038/bjp.2008.306; Michel AD, 2009, BRIT J PHARMACOL, V156, P1312, DOI 10.1111/j.1476-5381.2009.00135.x; Milescu LS, 2005, BIOPHYS J, V88, P2494, DOI 10.1529/biophysj.104.053256; Neelands TR, 2003, BRIT J PHARMACOL, V140, P202, DOI 10.1038/sj.bjp.0705411; Newbolt A, 1998, J BIOL CHEM, V273, P15177, DOI 10.1074/jbc.273.24.15177; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Riedel T, 2012, MOL PHARM; Sokolova E, 2006, MOL PHARMACOL, V70, P373, DOI 10.1124/mol.106.023564; Spelta V, 2002, BRIT J PHARMACOL, V135, P1524, DOI 10.1038/sj.bjp.0704591; Syed N.I., 2012, WILEY INTERDISCIPLIN, V1, P16, DOI DOI 10.1002/WMTS.1; Virginio C, 1998, MOL PHARMACOL, V53, P969; Wirkner K, 2007, MOL NEUROBIOL, V36, P165, DOI 10.1007/s12035-007-0033-y; Wolf C, 2011, MOL PHARMACOL, V79, P649, DOI 10.1124/mol.110.068700	36	3	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79213	10.1371/journal.pone.0079213	http://dx.doi.org/10.1371/journal.pone.0079213			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223907	Green Published, Green Submitted, gold			2022-12-27	WOS:000326499300066
J	Mehlhorn, J; Steinocher, H; Beck, S; Kennis, JTM; Hegemann, P; Mathes, T				Mehlhorn, Jennifer; Steinocher, Helena; Beck, Sebastian; Kennis, John T. M.; Hegemann, Peter; Mathes, Tilo			A Set of Engineered Escherichia coli Expression Strains for Selective Isotope and Reactivity Labeling of Amino Acid Side Chains and Flavin Cofactors	PLOS ONE			English	Article							INDUCED STRUCTURAL-CHANGES; COUPLED ELECTRON-TRANSFER; BLUE-LIGHT PHOTORECEPTOR; INFRARED-SPECTROSCOPY; CRYSTAL-STRUCTURES; FAD BLUF; APPA; PROTEIN; DOMAIN; SIGNAL	Biological reactions are facilitated by delicate molecular interactions between proteins, cofactors and substrates. To study and understand their dynamic interactions researchers have to take great care not to influence or distort the object of study. As a non-invasive alternative to a site-directed mutagenesis approach, selective isotope labeling in combination with vibrational spectroscopy may be employed to directly identify structural transitions in wild type proteins. Here we present a set of customized Escherichia coli expression strains, suitable for replacing both the flavin cofactor and/or selective amino acids with isotope enriched or chemically modified substrates. For flavin labeling we report optimized auxotrophic strains with significantly enhanced flavin uptake properties. Labeled protein biosynthesis using these strains was achieved in optimized cultivation procedures using high cell density fermentation. Finally, we demonstrate how this approach is used for a clear assignment of vibrational spectroscopic difference signals of apoprotein and cofactor of a flavin containing photoreceptor of the BLUF (Blue Light receptors Using FAD) family.	[Mehlhorn, Jennifer; Steinocher, Helena; Hegemann, Peter; Mathes, Tilo] Humboldt Univ, Inst Biol Expt Biophys, D-10099 Berlin, Germany; [Beck, Sebastian] Humboldt Univ, Inst Chem, D-10099 Berlin, Germany; [Kennis, John T. M.; Mathes, Tilo] Vrije Univ Amsterdam, Fac Sci, Dept Phys & Astron, Biophys Grp, Amsterdam, Netherlands	Humboldt University of Berlin; Humboldt University of Berlin; Vrije Universiteit Amsterdam	Mathes, T (corresponding author), Humboldt Univ, Inst Biol Expt Biophys, D-10099 Berlin, Germany.	mathes@vu.nl	Beck, Sebastian/C-8159-2017; Mathes, Tilo/C-5715-2011	Beck, Sebastian/0000-0001-6440-693X; Mathes, Tilo/0000-0002-9694-748X	German Research Organisation (DFG) [HE3824/24-1]; Netherlands Organization for Scientific Research (NWO)-DFG [HE3824/25-1]; NWO-Chemical Sciences Section (CW); NWO	German Research Organisation (DFG)(German Research Foundation (DFG)); Netherlands Organization for Scientific Research (NWO)-DFG(Netherlands Organization for Scientific Research (NWO)); NWO-Chemical Sciences Section (CW); NWO(Netherlands Organization for Scientific Research (NWO))	The research presented here was funded by the German Research Organisation (DFG) (HE3824/24-1) and the Netherlands Organization for Scientific Research (NWO)-DFG Bilateral Cooperation program (HE3824/25-1). JTM Kennis was supported by the NWO-Chemical Sciences Section (CW) through a VICI and Echo grant. Funding for open access publication was from NWO through the Incentive Fund Open Access publications. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson S, 2005, BIOCHEMISTRY-US, V44, P7998, DOI 10.1021/bi0502691; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BANDRIN SV, 1979, GENETIKA+, V15, P2063; Barth A, 2000, PROG BIOPHYS MOL BIO, V74, P141, DOI 10.1016/S0079-6107(00)00021-3; Bauer S, 2003, J MOL BIOL, V326, P1463, DOI 10.1016/S0022-2836(03)00059-7; Bonetti C, 2008, BIOPHYS J, V95, P4790, DOI 10.1529/biophysj.108.139246; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; Domratcheva T, 2008, BIOPHYS J, V94, P3872, DOI 10.1529/biophysj.107.124172; Dragnea V, 2009, BIOCHEMISTRY-US, V48, P9969, DOI 10.1021/bi9009067; Eberhardt S, 1997, J BACTERIOL, V179, P2938, DOI 10.1128/jb.179.9.2938-2943.1997; Fiedler S, 2007, GENET ENG BIOTECHN, V27, P54; Gauden M, 2005, BIOCHEMISTRY-US, V44, P3653, DOI 10.1021/bi047359a; Gauden M, 2006, P NATL ACAD SCI USA, V103, P10895, DOI 10.1073/pnas.0600720103; Goldbourt A, 2007, J MAGN RESON, V189, P157, DOI 10.1016/j.jmr.2007.07.011; Gomelsky M, 2002, TRENDS BIOCHEM SCI, V27, P497, DOI 10.1016/S0968-0004(02)02181-3; Gomelsky M, 2011, TRENDS MICROBIOL, V19, P441, DOI 10.1016/j.tim.2011.05.002; Grage SL, 2007, ANNU REP NMR SPECTRO, V60, P191, DOI 10.1016/S0066-4103(06)60005-7; Grinstead JS, 2006, CHEMBIOCHEM, V7, P187, DOI 10.1002/cbic.200500270; Hamm P, 2008, ANNU REV PHYS CHEM, V59, P291, DOI 10.1146/annurev.physchem.59.032607.093757; Hashimoto S, 2002, BIOCHEMISTRY-US, V41, P6495, DOI 10.1021/bi012190b; Hefti MH, 2003, EUR J BIOCHEM, V270, P4227, DOI 10.1046/j.1432-1033.2003.03802.x; Hertwig S, 2003, J MOL BIOL, V331, P605, DOI 10.1016/S0022-2836(03)00763-0; Hong M, 1999, J BIOMOL NMR, V14, P71, DOI 10.1023/A:1008334930603; Husain M, 1978, Methods Enzymol, V53, P429; Ishima R, 2000, NAT STRUCT BIOL, V7, P740, DOI 10.1038/78963; Jung A, 2005, P NATL ACAD SCI USA, V102, P12350, DOI 10.1073/pnas.0500722102; Jung A, 2006, J MOL BIOL, V362, P717, DOI 10.1016/j.jmb.2006.07.024; Khrenova MG, 2013, J PHYS CHEM B, V117, P2369, DOI 10.1021/jp312775x; Kita A, 2005, J MOL BIOL, V349, P1, DOI 10.1016/j.jmb.2005.03.067; Kotting C, 2005, CHEMPHYSCHEM, V6, P881, DOI 10.1002/cphc.200400504; Kraft BJ, 2003, BIOCHEMISTRY-US, V42, P6726, DOI 10.1021/bi030055o; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LeMaster DM, 1996, J AM CHEM SOC, V118, P9255, DOI 10.1021/ja960877r; Lin MT, 2011, METHODS, V55, P370, DOI 10.1016/j.ymeth.2011.08.019; Majerus T, 2007, CHEMPHYSCHEM, V8, P1787, DOI 10.1002/cphc.200700248; Masuda S, 2005, PLANT CELL PHYSIOL, V46, P1894, DOI 10.1093/pcp/pci208; Masuda S, 2005, BIOCHEMISTRY-US, V44, P1215, DOI 10.1021/bi047876t; Masuda S, 2004, BIOCHEMISTRY-US, V43, P5304, DOI 10.1021/bi049836v; Masuda S, 2002, CELL, V110, P613, DOI 10.1016/S0092-8674(02)00876-0; Masuda S, 2008, PLANT CELL PHYSIOL, V49, P1600, DOI 10.1093/pcp/pcn132; Mathes T, 2012, J BIOL CHEM, V287, P31725, DOI 10.1074/jbc.M112.391896; Mathes T, 2012, J PHYS CHEM LETT, V3, P203, DOI 10.1021/jz201579y; Mathes T, 2011, J PHYS CHEM B, V115, P7963, DOI 10.1021/jp201296m; Mathes T, 2009, J MOL BIOL, V385, P1511, DOI 10.1016/j.jmb.2008.11.001; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; O'Grady C, 2012, ANAL BIOCHEM, V426, P126, DOI 10.1016/j.ab.2012.04.019; Rathod R, 2012, PROTEIN EXPRES PURIF, V85, P125, DOI 10.1016/j.pep.2012.06.011; Sadeghian K, 2008, J AM CHEM SOC, V130, P12501, DOI 10.1021/ja803726a; Sharan SK, 2009, NAT PROTOC, V4, P206, DOI 10.1038/nprot.2008.227; Spehr V, 1999, BIOCHEMISTRY-US, V38, P16261, DOI 10.1021/bi9919605; Stelling AL, 2007, J AM CHEM SOC, V129, P15556, DOI 10.1021/ja074074n; Takahashi R, 2007, BIOCHEMISTRY-US, V46, P6459, DOI 10.1021/bi7004653; Toh KC, 2008, BIOPHYS J, V95, P312, DOI 10.1529/biophysj.107.117788; Tong KI, 2008, J BIOMOL NMR, V42, P59, DOI 10.1007/s10858-008-9264-0; Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101; Tyagi A, 2010, J PHOTOCH PHOTOBIO B, V101, P76, DOI 10.1016/j.jphotobiol.2010.06.014; Uchida T, 2004, J BIOL CHEM, V279, P53613, DOI 10.1074/jbc.M409719200; Udvarhelyi A, 2013, J PHYS CHEM B, V117, P2888, DOI 10.1021/jp400437x; Unno M, 2005, J PHYS CHEM B, V109, P12620, DOI 10.1021/jp0522664; Unno M, 2010, BIOPHYS J, V98, P1949, DOI 10.1016/j.bpj.2010.01.007; Vogel R, 2000, CURR OPIN CHEM BIOL, V4, P518, DOI 10.1016/S1367-5931(00)00125-3; Vogl C, 2007, J BACTERIOL, V189, P7367, DOI 10.1128/JB.00590-07; Warscheid B, 2008, VIB SPECTROSC, V48, P28, DOI 10.1016/j.vibspec.2007.11.003; Yuan H, 2006, BIOCHEMISTRY-US, V45, P12687, DOI 10.1021/bi061435n; Yuan H, 2011, BIOCHEMISTRY-US, V50, P6365, DOI 10.1021/bi200701d; Zirak P, 2009, J PHOTOCH PHOTOBIO B, V97, P61, DOI 10.1016/j.jphotobiol.2009.08.002; Zscherp C, 2001, BIOCHEMISTRY-US, V40, P1875, DOI 10.1021/bi002567y	68	13	13	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79006	10.1371/journal.pone.0079006	http://dx.doi.org/10.1371/journal.pone.0079006			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223875	Green Published, gold, Green Submitted			2022-12-27	WOS:000326499300047
J	Chen, SX; Shen, XQ; Cheng, SQ; Li, PP; Du, JN; Chang, YX; Meng, HW				Chen, Shuxia; Shen, Xiaoqing; Cheng, Siqiong; Li, Panpan; Du, Junna; Chang, Yanxia; Meng, Huanwen			Evaluation of Garlic Cultivars for Polyphenolic Content and Antioxidant Properties	PLOS ONE			English	Article							ALLIUM-SATIVUM L.; IN-VITRO ANTIOXIDANT; INFRARED-SPECTROSCOPY; LIPID-PEROXIDATION; ENDOTHELIAL-CELLS; CAPACITY; ONION; FLAVONOIDS; VIVO	Two phenolic compound parameters (total phenolic and flavonoid contents) and 5 antioxidant parameters (DPPH [2, 2diphenyl- 1-picrylhydrazyl] radical scavenging activity, HRSC (hydroxyl radical scavenging capacity), FRAP (ferric ion reducing antioxidant power), CUPRAC (cupric ion reducing antioxidant capacity), and MCA (metal chelating activity) were measured in bulbs and bolts of 43 garlic cultivars. The bulbs of cultivar '74-x' had the highest phenolic content (total phenolic, flavonoids) and the strongest antioxidant capacity (DPPH, FRAP, and CUPRAC), followed by bulbs of cultivar 'Hanzhong purple'; the bulbs of cultivar 'Gailiang' had the lowest phenolic content and antioxidant capacity (FRAP, CUPRAC, MCA). The bolts of 'Hanzhong purple' also had higher phenolic content. Principal components analysis (PCA) separated the cultivars into 3 groups according to phenolic and flavonoid contents and strength of antioxidant activity. The first group had higher HRSC, FRAP, and flavonoid content; the second group had higher total phenolic content and MCA; some cultivars in the third group had higher HRSC and FRAP. All 8 test garlic bulb extracts successfully prevented Human Vascular Endothelial Cell death and significantly prevented reactive-oxygen species (ROS) formation in oxidative stress model, in which cultivar '74-x' had highest protection capability, following by cultivar 'Hanzhong purple', and the bulbs of cultivar 'No. 105 from Korea' had the lower protection capability against cell death and ROS formation. The protection capability in vivo of these garlic cultivars was consistent with their phenolic content and antioxidant capacity.	[Chen, Shuxia; Shen, Xiaoqing; Cheng, Siqiong; Du, Junna; Chang, Yanxia; Meng, Huanwen] Northwest A&F Univ, Coll Hort, Key Lab Hort Plant Germplasm Resources Utilizat N, Yangling, Peoples R China; [Li, Panpan] Northwest A&F Univ, Coll Vet Med, Yangling, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Chen, SX (corresponding author), Northwest A&F Univ, Coll Hort, Key Lab Hort Plant Germplasm Resources Utilizat N, Yangling, Peoples R China.	shuxiachen@nwsuaf.edu.cn			National Natural Science Foundation of China [31071813]; National public welfare sectors (Agriculture) special research [200903018-7]; Northwest AF University [QN2011088]; Yulin City Science and Technology Bureau Project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National public welfare sectors (Agriculture) special research; Northwest AF University; Yulin City Science and Technology Bureau Project	This work was supported by National Natural Science Foundation of China (No. 31071813), the National public welfare sectors (Agriculture) special research (200903018-7), Basic Scientific Research Fund from Northwest A&F University (No. QN2011088), and Yulin City Science and Technology Bureau Project. The founders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjali Bhatt, 2013, Free Radicals and Antioxidants, V3, P30, DOI 10.1016/j.fra.2013.03.003; Apak R, 2008, MICROCHIM ACTA, V160, P413, DOI 10.1007/s00604-007-0777-0; Batcioglu K, 2012, EUR REV MED PHARMACO, V16, P47; Corzo-Martinez M, 2007, TRENDS FOOD SCI TECH, V18, P609, DOI 10.1016/j.tifs.2007.07.011; Dong QA, 2010, CHEM-BIOL INTERACT, V188, P31, DOI 10.1016/j.cbi.2010.06.006; Fenercioglu AK, 2010, J ENDOCRINOL INVEST, V33, P118, DOI 10.3275/6564; Ide N, 1997, J PHARM PHARMACOL, V49, P908, DOI 10.1111/j.2042-7158.1997.tb06134.x; Jastrzebski Z, 2007, FOOD CHEM TOXICOL, V45, P1626, DOI 10.1016/j.fct.2007.02.028; Kamenetsky R., 2007, Horticultural Reviews, V33, P123, DOI 10.1002/9780470168011.ch2; Khar A, 2011, FOOD CHEM, V128, P988, DOI 10.1016/j.foodchem.2011.04.004; Kim JS, 2013, J FUNCT FOODS, V5, P80, DOI 10.1016/j.jff.2012.08.006; Lanzotti V, 2006, J CHROMATOGR A, V1112, P3, DOI 10.1016/j.chroma.2005.12.016; LAWSON LD, 1996, GARLIC SCI THERAPEUT, P37; LU GY, 2001, RELATIONSHIP ECOTYPE, V29, P55; Lu GY, 1994, J CHANGJIANG VEGETAB, V2, P33; Lu XN, 2011, J AGR FOOD CHEM, V59, P5215, DOI 10.1021/jf201254f; Beato VM, 2011, PLANT FOOD HUM NUTR, V66, P218, DOI 10.1007/s11130-011-0236-2; Morihara N, 2011, PLANT FOOD HUM NUTR, V66, P17, DOI 10.1007/s11130-011-0216-6; Morihara N, 2010, PHYTOTHER RES, V24, P602, DOI 10.1002/ptr.3008; Nencini C, 2011, PLANT FOOD HUM NUTR, V66, P11, DOI 10.1007/s11130-010-0204-2; Nuutila AM, 2003, FOOD CHEM, V81, P485, DOI 10.1016/S0308-8146(02)00476-4; Pardo JE, 2007, J FOOD QUALITY, V30, P609, DOI 10.1111/j.1745-4557.2007.00146.x; Park JH, 2009, PLANT FOOD HUM NUTR, V64, P244, DOI 10.1007/s11130-009-0132-1; Prakash D, 2007, FOOD CHEM, V102, P1389, DOI 10.1016/j.foodchem.2006.06.063; Prasad K, 1996, MOL CELL BIOCHEM, V154, P55, DOI 10.1007/BF00248461; Queiroz YS, 2009, FOOD CHEM, V115, P371, DOI 10.1016/j.foodchem.2008.11.105; Sellappan S, 2002, J AGR FOOD CHEM, V50, P5338, DOI 10.1021/jf020333a; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Sterling SJ, 1997, ACTA HORTIC, V555, P63; Volk GM, 2009, HORTSCIENCE, V44, P1238, DOI 10.21273/HORTSCI.44.5.1238; WATERER D, 1994, CAN J PLANT SCI, V74, P611, DOI 10.4141/cjps94-110; Weiss N, 2013, J ETHNOPHARMACOL, V145, P162, DOI 10.1016/j.jep.2012.10.045; Xu BM, 2009, MODERN AGR SCI TECHN, V1, P19; Yiannakopoulou EC, 2012, J CARDIOVASC PHARM T, V17, P366, DOI 10.1177/1074248412447109; Yin MC, 1998, J AGR FOOD CHEM, V46, P4097, DOI 10.1021/jf980344x; Zhang CY, 2008, J AGR FOOD CHEM, V56, P8268, DOI 10.1021/jf801830z	36	66	69	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79730	10.1371/journal.pone.0079730	http://dx.doi.org/10.1371/journal.pone.0079730			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24232741	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700156
J	Clerc, P; Young, CA; Bordt, EA; Grigore, AM; Fiskum, G; Polster, BM				Clerc, Pascaline; Young, Christina A.; Bordt, Evan A.; Grigore, Alina M.; Fiskum, Gary; Polster, Brian M.			Magnesium Sulfate Protects Against the Bioenergetic Consequences of Chronic Glutamate Receptor Stimulation	PLOS ONE			English	Article							SPARE RESPIRATORY CAPACITY; TRAUMATIC BRAIN-INJURY; NEURONAL CULTURES; OXIDATIVE STRESS; EXCITOTOXICITY; CALCIUM; DEATH; ACTIVATION; APOPTOSIS; MITOCHONDRIA	Extracellular glutamate is elevated following brain ischemia or trauma and contributes to neuronal injury. We tested the hypothesis that magnesium sulfate (MgSO4, 3 mM) protects against metabolic failure caused by excitotoxic glutamate exposure. Rat cortical neuron preparations treated in medium already containing a physiological concentration of Mg2+ (1 mM) could be segregated based on their response to glutamate (100 mu M). Type I preparations responded with a decrease or small transient increase in oxygen consumption rate (OCR). Type II neurons responded with >50% stimulation in OCR, indicating a robust response to increased energy demand without immediate toxicity. Pre-treatment with MgSO4 improved the initial bioenergetic response to glutamate and ameliorated subsequent loss of spare respiratory capacity, measured following addition of the uncoupler FCCP, in Type I but not Type II neurons. Spare respiratory capacity in Type I neurons was also improved by incubation with MgSO4 or NMDA receptor antagonist MK801 in the absence of glutamate treatment. This finding indicates that the major difference between Type I and Type II preparations is the amount of endogenous glutamate receptor activity. Incubation of Type II neurons with 5 mM glutamate prior to excitotoxic (100 mM) glutamate exposure recapitulated a Type I phenotype. MgSO4 protected against an excitotoxic glutamate-induced drop in neuronal ATP both with and without prior 5 mu M glutamate exposure. Results indicate that MgSO4 protects against chronic moderate glutamate receptor stimulation and preserves cellular ATP following treatment with excitotoxic glutamate.	[Polster, Brian M.] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Ctr Shock Trauma & Anesthesiol Res STAR, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Polster, BM (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA.	bpolster@anes.umm.edu		Polster, Brian/0000-0003-2571-7510	National Institute of Neurological Disorders and Stroke; National Institutes of Health [R01NS064978, P01HD016596]; National Institute of Child Health and Human Development/; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD016596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064978] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Child Health and Human Development/(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the National Institute of Neurological Disorders and Stroke/the National Institutes of Health (www.nih.gov, grant number R01NS064978) and by the National Institute of Child Health and Human Development/the National Institutes of Health (www.nih.gov, grant number P01HD016596). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2008, BBA-BIOENERGETICS, V1777, P953, DOI 10.1016/j.bbabio.2008.04.017; Almeida A, 2001, J NEUROCHEM, V77, P676, DOI 10.1046/j.1471-4159.2001.00276.x; Altura BT, 1997, NEUROSCI LETT, V230, P37, DOI 10.1016/S0304-3940(97)00471-0; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Blitzblau R, 1996, EUR J NEUROSCI, V8, P1840, DOI 10.1111/j.1460-9568.1996.tb01328.x; Castilho RF, 1998, J NEUROSCI, V18, P10277; Chen YC, 2008, J NEUROSCI METH, V171, P239, DOI 10.1016/j.jneumeth.2008.03.013; Clerc P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034465; Deshpande LS, 2008, EUR J PHARMACOL, V583, P73, DOI 10.1016/j.ejphar.2008.01.025; Gerencser AA, 2009, J NEUROCHEM, V110, P990, DOI 10.1111/j.1471-4159.2009.06194.x; Gleichmann M, 2009, J NEUROCHEM, V109, P644, DOI 10.1111/j.1471-4159.2009.05997.x; Greene MF, 2003, NEW ENGL J MED, V348, P275, DOI 10.1056/NEJMp020166; Hallak M, 1998, MAGNESIUM RES, V11, P117; Heath DL, 1999, J PHARMACOL EXP THER, V288, P1311; Jekabsons MB, 2004, J BIOL CHEM, V279, P32989, DOI 10.1074/jbc.M401540200; Kovac S, 2012, J CELL SCI, V125, P1796, DOI 10.1242/jcs.099176; Lampl Y, 1998, J NEUROL, V245, P584, DOI 10.1007/s004150050249; McKee JA, 2005, NEUROCRIT CARE, V2, P342, DOI 10.1385/NCC:2:3:342; Memon ZI, 1995, SCAND J CLIN LAB INV, V55, P671, DOI 10.3109/00365519509075397; Nicholls DG, 2009, BIOCHEM SOC T, V37, P1385, DOI 10.1042/BST0371385; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Panov A, 1996, BIOCHEMISTRY-US, V35, P427, DOI 10.1021/bi952101t; Rodriguez-Zavala JS, 1998, J BIOL CHEM, V273, P7850, DOI 10.1074/jbc.273.14.7850; Stoica BA, 2005, MOL CELL NEUROSCI, V29, P355, DOI 10.1016/j.mcn.2005.02.009; Stout AK, 1998, NAT NEUROSCI, V1, P366, DOI 10.1038/1577; van den Bergh WM, 2003, NEUROSURGERY, V52, P276, DOI 10.1227/01.NEU.0000043984.42487.0E; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Xu Minhui, 2002, Chin J Traumatol, V5, P361; Yadava N, 2007, J NEUROSCI, V27, P7310, DOI 10.1523/JNEUROSCI.0212-07.2007; Yakovlev AG, 2001, J NEUROSCI, V21, P7439, DOI 10.1523/JNEUROSCI.21-19-07439.2001; Zhu HD, 2005, EXP NEUROL, V193, P361, DOI 10.1016/j.expneurol.2005.01.022	31	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79982	10.1371/journal.pone.0079982	http://dx.doi.org/10.1371/journal.pone.0079982			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236167	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700168
J	Cui, X; Chopp, M; Zacharek, A; Ning, RZ; Ding, XS; Roberts, C; Chen, JL				Cui, Xu; Chopp, Michael; Zacharek, Alex; Ning, Ruizhuo; Ding, Xiaoshuang; Roberts, Cynthia; Chen, Jieli			Endothelial Nitric Oxide Synthase Regulates White Matter Changes via the BDNF/TrkB Pathway after Stroke in Mice	PLOS ONE			English	Article							NEUROTROPHIC FACTOR EXPRESSION; GROWTH-FACTOR; UP-REGULATION; FACTOR BDNF; BRAIN; CELLS; ASTROCYTES; ISCHEMIA; OLIGODENDROCYTES; ACTIVATION	Stroke induced white matter (WM) damage is associated with neurological functional deficits, but the underlying mechanisms are not well understood. In this study, we investigate whether endothelial nitric oxide synthase (eNOS) affects WM-damage post-stroke. Adult male wild-type (WT) and eNOS knockout (eNOS(-/-)) mice were subjected to middle cerebral artery occlusion. Functional evaluation, infarct volume measurement, immunostaining and primary cortical cell culture were performed. To obtain insight into the mechanisms underlying the effects of eNOS(-/-) on WM-damage, measurement of eNOS, brain-derived neurotrophic factor (BDNF) and its receptor TrkB in vivo and in vitro were also performed. No significant differences were detected in the infarction volume, myelin density in the ipsilateral striatal WM-bundles and myelin-based protein expression in the cerebral ischemic border between WT and eNOS(-/-) mice. However, eNOS(-/-) mice showed significantly: 1) decreased functional outcome, concurrent with decreases of total axon density and phosphorylated high-molecular weight neurofilament density in the ipsilateral striatal WM-bundles. Correlation analysis showed that axon density is significantly positive correlated with neurological functional outcome; 2) decreased numbers of oligodendrocytes / oligodendrocyte progenitor cells in the ipsilateral striatum; 3) decreased synaptophysin, BDNF and TrkB expression in the ischemic border compared with WT mice after stroke (n = 12/group, p < 0.05). Primary cortical cell culture confirmed that the decrease of neuronal neurite outgrowth in the neurons derived from eNOS(-/-) mice is mediated by the reduction of BDNF/TrkB (n = 6/group, p < 0.05). Our data show that eNOS plays a critical role in WM-damage after stroke, and eNOS(-/-)-induced decreases in the BDNF/TrkB pathway may contribute to increased WM-damage, and thereby decrease functional outcome.	[Cui, Xu; Chopp, Michael; Zacharek, Alex; Ning, Ruizhuo; Ding, Xiaoshuang; Roberts, Cynthia; Chen, Jieli] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA	Henry Ford Health System; Henry Ford Hospital; Oakland University	Chen, JL (corresponding author), Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA.	jieli@neuro.hfh.edu		Cui, Xu/0000-0002-6937-6191	National Institute on Aging [RO1 AG031811, RO1 AG037506, 1R41NS064708]; American Heart Association [09GRNT2300151]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R41NS064708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031811, R01AG037506] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institute on Aging RO1 AG031811 (JC) (http://www.nia.nih.gov/), National Institute on Aging RO1 AG037506 (M. C.) and 1R41NS064708 (JC) (http://www.ninds.nih.gov/), and American Heart Association grant 09GRNT2300151 (JC) (http://www.heart.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix JJP, 2006, EUR NEUROL, V56, P74, DOI 10.1159/000095543; Alix JJP, 2011, NEUROLOGY, V76, P397, DOI 10.1212/WNL.0b013e3182088273; Amin-Hanjani S, 2001, STROKE, V32, P980, DOI 10.1161/01.STR.32.4.980; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Bakiri Y, 2011, J PHYSIOL-LONDON, V589, P559, DOI 10.1113/jphysiol.2010.201376; Barna M, 1996, VIROLOGY, V223, P331, DOI 10.1006/viro.1996.0484; Ben Achour S, 2012, NEUROCHEM RES, V37, P2464, DOI 10.1007/s11064-012-0807-0; Bergami M, 2008, J CELL BIOL, V183, P213, DOI 10.1083/jcb.200806137; Bouloumie A, 1999, CARDIOVASC RES, V41, P773, DOI 10.1016/S0008-6363(98)00228-4; Calhoun ME, 1996, J NEUROCYTOL, V25, P821, DOI 10.1007/BF02284844; Chen JL, 2009, STROKE, V40, P2532, DOI 10.1161/STROKEAHA.108.545095; Chen JL, 2005, J NEUROSCI, V25, P2366, DOI 10.1523/JNEUROSCI.5071-04.2005; Chen MJ, 2006, BRAIN RES BULL, V68, P257, DOI 10.1016/j.brainresbull.2005.08.013; Cui X, 2009, NEUROSCIENCE, V159, P744, DOI 10.1016/j.neuroscience.2008.12.055; Cui X, 2012, CELL TRANSPLANT; DINERMAN JL, 1994, P NATL ACAD SCI USA, V91, P4214, DOI 10.1073/pnas.91.10.4214; Djalali S, 2005, J NEUROCHEM, V92, P616, DOI 10.1111/j.1471-4159.2004.02911.x; Du YZ, 2006, J NEUROSCI RES, V84, P1692, DOI 10.1002/jnr.21080; Du YZ, 2003, DEV NEUROSCI-BASEL, V25, P116, DOI 10.1159/000072261; Dugas JC, 2006, J NEUROSCI, V26, P10967, DOI 10.1523/JNEUROSCI.2572-06.2006; Dziewulska D, 2004, FOLIA NEUROPATHOL, V42, P75; Endres M, 2004, TRENDS NEUROSCI, V27, P283, DOI 10.1016/j.tins.2004.03.009; Endres M, 1998, P NATL ACAD SCI USA, V95, P8880, DOI 10.1073/pnas.95.15.8880; Farr TD, 2002, STROKE, V33, P1869, DOI 10.1161/01.STR.0000020714.48349.4E; FRISEN J, 1993, P NATL ACAD SCI USA, V90, P4971, DOI 10.1073/pnas.90.11.4971; Gabbott PLA, 1996, BRAIN RES, V714, P135, DOI 10.1016/0006-8993(95)01509-4; Gertz K, 2006, CIRC RES, V99, P1132, DOI 10.1161/01.RES.0000250175.14861.77; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Halassa MM, 2007, TRENDS MOL MED, V13, P54, DOI 10.1016/j.molmed.2006.12.005; Hernandez R, 2004, NEUROSCIENCE, V126, P879, DOI 10.1016/j.neuroscience.2004.04.010; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Johnston MV, 2009, DEV DISABIL RES REV, V15, P94, DOI 10.1002/ddrr.64; Juric DM, 2006, BRAIN RES, V1108, P54, DOI 10.1016/j.brainres.2006.06.008; Kim H, 2004, J BIOL CHEM, V279, P33538, DOI 10.1074/jbc.M404115200; Kovalchuk Y, 2004, CURR OPIN NEUROBIOL, V14, P558, DOI 10.1016/j.conb.2004.08.014; Laufs U, 2000, J CLIN INVEST, V106, P15, DOI 10.1172/JCI9639; Linares D, 2006, J NEUROSCI, V26, P12672, DOI 10.1523/JNEUROSCI.0294-06.2006; Liu HS, 2011, NEUROIMAGE, V56, P280, DOI 10.1016/j.neuroimage.2011.02.049; Liu ZW, 2011, STROKE, V42, P740, DOI 10.1161/STROKEAHA.110.607226; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Madinier A, 2013, NEUROSCIENCE, V231, P169, DOI 10.1016/j.neuroscience.2012.11.054; Matthias GKaE, 2008, ENOS STROKE PREVENTI, P537; McIver SR, 2010, NEUROSCIENCE, V169, P1364, DOI 10.1016/j.neuroscience.2010.04.070; Medina DL, 2004, EMBO J, V23, P3803, DOI 10.1038/sj.emboj.7600399; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Pantoni L, 1996, STROKE, V27, P1641, DOI 10.1161/01.STR.27.9.1641; PERSSON LA, 1981, J NEUROCYTOL, V10, P169, DOI 10.1007/BF01257965; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; RUDGE JS, 1995, J NEUROSCI, V15, P6856; Runyan SA, 2009, EXP NEUROL, V216, P95, DOI 10.1016/j.expneurol.2008.11.015; Shi XZ, 2010, BRAIN RES, V1317, P257, DOI 10.1016/j.brainres.2009.12.061; Sozmen EG, 2009, J NEUROSCI METH, V180, P261, DOI 10.1016/j.jneumeth.2009.03.017; Theodosis DT, 2008, PHYSIOL REV, V88, P983, DOI 10.1152/physrev.00036.2007; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wang H, 2006, EUR J NEUROSCI, V23, P1665, DOI 10.1111/j.1460-9568.2006.04682.x; Wiencken AE, 1999, GLIA, V26, P280; Xiao JH, 2010, NEUROSIGNALS, V18, P186, DOI 10.1159/000323170; Yuhanna IS, 1999, AM J RESP CELL MOL, V21, P629, DOI 10.1165/ajrcmb.21.5.3749; Zheng J, 1999, ENDOCRINOLOGY, V140, P1399, DOI 10.1210/en.140.3.1399	60	30	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80358	10.1371/journal.pone.0080358	http://dx.doi.org/10.1371/journal.pone.0080358			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236179	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700180
J	Gaertner, C; Bucci, MP; Obeid, R; Wiener-Vacher, S				Gaertner, Chrystal; Bucci, Maria Pia; Obeid, Rima; Wiener-Vacher, Sylvette			Subjective Visual Vertical and Postural Performance in Healthy Children	PLOS ONE			English	Article							BALANCE CONTROL; DUAL-TASK; PERCEPTION; MODELS	Introduction: Verticality is essential in our life, especially for postural stability. Subjective vertical as well as postural stability depends on different sensorial information: visual, vestibular and somesthesic. They help to build the spatial referentials and create a central representation of verticality. Children are more visuo-dependant than adults; however, we did not find any study focusing on how children develop their sense of verticality. Methods: We studied two groups of subjects: 10 children (from 6 to 8 years) and 12 young adults. We recorded postural stability with a Techno Concept plateform and perception of subjective visual vertical in the following conditions: while adjusting the vertical in the dark or with visual perturbation, while fixating the vertical bar, and with eyes closed. Results: Children are more instable than adults in terms of postural parameters, and also while performing a double task, especially when no visual references are present. They also present a higher variability and lower accuracy than adults in reporting their perception of true vertical reference. Discussion: Children might have limited attentional resources, and focus their attention on the more demanding task, corresponding to the U-shaped non-linear model.	[Gaertner, Chrystal] Univ Paris 06, Paris, France; [Gaertner, Chrystal; Wiener-Vacher, Sylvette] Robert Debre Paediat Hosp, Children balance Evaluat Ctr, Paris, France; [Bucci, Maria Pia; Obeid, Rima; Wiener-Vacher, Sylvette] Univ Paris, Hop Robert Debre, INSERM, UMR 676, F-75252 Paris, France	UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Wiener-Vacher, S (corresponding author), Robert Debre Paediat Hosp, Children balance Evaluat Ctr, Paris, France.	sylvette.wiener@gmail.com	Obeid, Rima/AAR-9906-2020					Andersen R A, 1993, Curr Opin Neurobiol, V3, P171, DOI 10.1016/0959-4388(93)90206-E; Assaiante C, 1998, NEUROSCI BIOBEHAV R, V22, P527, DOI 10.1016/S0149-7634(97)00040-7; ASSAIANTE C, 1995, HUM MOVEMENT SCI, V14, P13, DOI 10.1016/0167-9457(94)00048-J; Barra J, 2010, BRAIN, V133, P3552, DOI 10.1093/brain/awq311; Berthoz A, 1991, BRAIN SPACE, P82; BRANDT T, 1988, INT CONGR SER, V812, P127; BRANDT T, 1981, ANN NY ACAD SCI, V374, P636, DOI 10.1111/j.1749-6632.1981.tb30907.x; BRANDT T, 1996, DISORDERS VESTIBULAR, P126; Chiari L, 2002, CLIN BIOMECH, V17, P666, DOI 10.1016/S0268-0033(02)00107-9; DICHGANS J, 1972, SCIENCE, V178, P1217, DOI 10.1126/science.178.4066.1217; Gagey P.M., 1999, POSTUROLOGIE REGULAT; GEURTS ACH, 1993, ARCH PHYS MED REHAB, V74, P1144; Guerraz M, 1998, PERCEPT PSYCHOPHYS, V60, P287, DOI 10.3758/BF03206037; HUGHES PC, 1972, PERCEPT PSYCHOPHYS, V11, P135, DOI 10.3758/BF03210359; Isableu B, 1997, EXP BRAIN RES, V114, P584, DOI 10.1007/PL00005667; Isableu B, 1998, HUM MOVEMENT SCI, V17, P367, DOI 10.1016/S0167-9457(98)00005-0; Jacot E, 2009, INT J PEDIATR OTORHI, V73, P209, DOI 10.1016/j.ijporl.2008.10.024; Kirshenbaum N, 2001, EXP BRAIN RES, V140, P420, DOI 10.1007/s002210100835; Lacour M, 2008, NEUROPHYSIOL CLIN, V38, P411, DOI 10.1016/j.neucli.2008.09.005; LEE DN, 1974, PERCEPT PSYCHOPHYS, V15, P529, DOI 10.3758/BF03199297; Lopez C, 2011, NEUROSCIENCE, V181, P134, DOI 10.1016/j.neuroscience.2011.02.009; Lopez C., 2005, BIPEDIE CONTROLE POS, P35; LOPEZ C, 2003, POSTURE EQUILIBRE PH, P103; Lopez C, 2007, NEUROPSYCHOLOGIA, V45, P2025, DOI 10.1016/j.neuropsychologia.2007.02.004; MAKI BE, 1990, J AM GERIATR SOC, V38, P1, DOI 10.1111/j.1532-5415.1990.tb01588.x; MITTELSTAEDT H, 1983, NATURWISSENSCHAFTEN, V70, P272, DOI 10.1007/BF00404833; OHLMANN T, 2001, NOUVEAUTES 2001 CONC, P15; Olivier I, 2007, NEUROREPORT, V18, P817, DOI 10.1097/WNR.0b013e3280e129e1; Olivier I, 2010, GAIT POSTURE, V32, P494, DOI 10.1016/j.gaitpost.2010.07.008; Palluel E, 2010, BRAIN RES, V1358, P151, DOI 10.1016/j.brainres.2010.08.051; Perennou DA, 2008, BRAIN, V131, P2401, DOI 10.1093/brain/awn170; Poulain I, 2008, GAIT POSTURE, V27, P1, DOI 10.1016/j.gaitpost.2007.02.007; Rival C, 2005, NEUROSCI LETT, V376, P133, DOI 10.1016/j.neulet.2004.11.042; Wiener-Vacher SR, 2012, J PEDIATR-US, V161, P246, DOI 10.1016/j.jpeds.2012.02.009; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9; WITKIN HA, 1948, J EXP PSYCHOL, V38, P762, DOI 10.1037/h0053671	36	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79623	10.1371/journal.pone.0079623	http://dx.doi.org/10.1371/journal.pone.0079623			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236146	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700145
J	Laguerre, M; Sabi, E; Daly, M; Stockley, J; Nurden, P; Pillois, X; Nurden, AT				Laguerre, Michel; Sabi, Essa; Daly, Martina; Stockley, Jacqueline; Nurden, Paquita; Pillois, Xavier; Nurden, Alan T.			Molecular Dynamics Analysis of a Novel beta 3 Pro189Ser Mutation in a Patient with Glanzmann Thrombasthenia Differentially Affecting alpha IIb beta 3 and alpha v beta 3 Expression	PLOS ONE			English	Article							INTEGRIN BETA(3) GENE; GLYCOPROTEIN-IIIA; ALPHA-IIB; EXTRACELLULAR SEGMENT; MISSENSE MUTATIONS; CRYSTAL-STRUCTURE; COMPLEX; SUBUNIT; PLATELETS; RECEPTOR	Mutations in ITGA2B and ITGB3 cause Glanzmann thrombasthenia, an inherited bleeding disorder in which platelets fail to aggregate when stimulated. Whereas an absence of expression or qualitative defects of alpha IIb beta 3 mainly affect platelets and megakaryocytes, alpha v beta 3 has a widespread tissue distribution. Little is known of how amino acid substitutions of beta 3 comparatively affect the expression and structure of both integrins. We now report computer modelling including molecular dynamics simulations of extracellular head domains of alpha IIb beta 3 and alpha v beta 3 to determine the role of a novel b3 Pro189Ser (P163S in the mature protein) substitution that abrogates alpha IIb beta 3 expression in platelets while allowing synthesis of alpha v beta 3. Transfection of wild-type and mutated integrins in CHO cells confirmed that only alpha v beta 3 surface expression was maintained. Modeling initially confirmed that replacement of alpha II beta by alpha v in the dimer results in a significant decrease in surface contacts at the subunit interface. For alpha IIb beta 3, the presence of beta 3S163 specifically displaces an alpha-helix starting at position 259 and interacting with beta 3R261 while there is a moderate 11% increase in intra-subunit H-bonds and a very weak decrease in the global H-bond network. In contrast, for alpha v beta 3, S163 has different effects with b3R261 coming deeper into the propeller with a 43% increase in intra-subunit H-bonds but with little effect on the global H-bond network. Compared to the WT integrins, the P163S mutation induces a small increase in the inter-subunit fluctuations for alpha IIb beta 3 but a more rigid structure for alpha v beta 3. Overall, this mutation stabilizes alpha v beta 3 despite preventing alpha IIb beta 3 expression.	[Laguerre, Michel] Inst Europeen Chim & Biol, Pessac, France; [Sabi, Essa; Daly, Martina; Stockley, Jacqueline] Univ Sheffield, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England; [Nurden, Paquita; Nurden, Alan T.] Hop Xavier Arnozan, Plateforme Technol & Innovat Biomed, Pessac, France; [Nurden, Paquita] Hop La Timone, Ctr Hosp Univ Marseille, Marseille, France; [Pillois, Xavier] Hop Haut Leveque, INSERM, U1034, Pessac, France	University of Sheffield; CHU Bordeaux; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Nurden, AT (corresponding author), Hop Xavier Arnozan, Plateforme Technol & Innovat Biomed, Pessac, France.	Nurdenat@gmail.com		Stockley, Jacqueline/0000-0001-6601-5107	Genoscope d'Evry [Nu AP07/08.42]; INSERM [ANR-08-GENO-028-03]	Genoscope d'Evry; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This study was financed by contract Nu AP07/08.42 with the Genoscope d'Evry and from INSERM (ANR-08-GENO-028-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambo H, 1998, BIOCHEM BIOPH RES CO, V251, P763, DOI 10.1006/bbrc.1998.9526; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Calvete J, 1999, BIOCHEM J, V74, P63; COLLER BS, 1991, BLOOD, V78, P2603; DARDEN TA, 1993, ENVIRON HEALTH PERSP, V101, P410, DOI 10.2307/3431897; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; DJAFFAR I, 1993, HUM MOL GENET, V2, P2183, DOI 10.1093/hmg/2.12.2183; Filizola M, 2004, J BIOL CHEM, V279, P24624, DOI 10.1074/jbc.M400243200; Fiore M, 2012, HAEMOPHILIA, V18, pe201, DOI 10.1111/j.1365-2516.2011.02744.x; GEORGE JN, 1990, BLOOD, V75, P1383; Gerold G, 2008, NAT IMMUNOL, V9, P761, DOI 10.1038/ni.1618; Hauschner H, 2010, BLOOD, V115, P4542, DOI 10.1182/blood-2009-10-251066; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jackson DE, 1998, THROMB HAEMOSTASIS, V80, P42, DOI 10.1055/s-0037-1615136; Jacquelin B, 2003, J THROMB HAEMOST, V1, P573, DOI 10.1046/j.1538-7836.2003.00107.x; Jallu V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047304; Kamata T, 2004, BIOCHEM J, V378, P1079, DOI 10.1042/BJ20031701; Mansour W, 2011, J THROMB HAEMOST, V9, P192, DOI 10.1111/j.1538-7836.2010.04087.x; Mor-Cohen R, 2007, THROMB HAEMOSTASIS, V98, P1257, DOI 10.1160/TH07-04-0248; Mor-Cohen R, 2012, J BIOL CHEM, V287, P8879, DOI 10.1074/jbc.M111.311043; Morel-Kopp MC, 2001, THROMB HAEMOSTASIS, V86, P1425; Nelson EJR, 2005, J THROMB HAEMOST, V3, P2773, DOI 10.1111/j.1538-7836.2005.01593.x; Nurden AT, 2013, SEMIN THROMB HEMOST, V39, P642, DOI 10.1055/s-0033-1353393; Nurden AT, 2012, EXPERT REV HEMATOL, V5, P487, DOI [10.1586/EHM.12.46, 10.1586/ehm.12.46]; Nurden AT, 2011, BLOOD, V118, P5996, DOI 10.1182/blood-2011-07-365635; Nurden AT, 2002, PLATELETS, V13, P101, DOI 10.1080/09537100220122466; NURDEN AT, 1985, BLOOD, V65, P1021; NURDEN P, 1995, J CLIN INVEST, V95, P1612, DOI 10.1172/JCI117835; Nurden P, 2004, BLOOD, V104, P107, DOI 10.1182/blood-2003-11-3842; Poujol C, 1997, BRIT J HAEMATOL, V96, P823, DOI 10.1046/j.1365-2141.1997.d01-2109.x; Tadokoro S, 2002, BLOOD, V99, P931, DOI 10.1182/blood.V99.3.931; Thon Jonathan N, 2012, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-29423-5_1; Van Gunsteren WF, 1987, GROMOS 87 MANUAL; Ward CM, 2000, BLOOD, V96, P161, DOI 10.1182/blood.V96.1.161.013k50_161_169; Wilhide CC, 1997, BLOOD, V90, P3951, DOI 10.1182/blood.V90.10.3951; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018; Zhu JQ, 2010, BLOOD, V116, P5050, DOI 10.1182/blood-2010-04-281154	40	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78683	10.1371/journal.pone.0078683	http://dx.doi.org/10.1371/journal.pone.0078683			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236036	gold, Green Published, Green Submitted			2022-12-27	WOS:000327254700033
J	Liang, P; Feng, B; Zhou, XG; Gao, XW				Liang, Pei; Feng, Bing; Zhou, Xuguo; Gao, Xiwu			Identification and Developmental Profiling of microRNAs in Diamondback Moth, Plutellaxylostella (L.)	PLOS ONE			English	Article							REVEALS; TRANSCRIPTOME; PREDICTION; MANAGEMENT; INSIGHTS; RNAS	MicroRNAs (miRNAs) are a group of small RNAs involved in various biological processes through negative regulation of mRNAs at the post-transcriptional level. Although miRNA profiles have been documented in over two dozen insect species, few are agricultural pests. In this study, both conserved and novel miRNAs in the diamondback moth, Plutella xylostella L., a devastating insect pest of cruciferous crops worldwide, were documented. High-throughput sequencing of a small RNA library constructed from a mixed life stages of P. xylostella, including eggs, 1st to 4th (last) instar larvae, pupae and adults, identified 384 miRNAs, of which 174 were P. xylostella specific. In addition, temporal expressions of 234 miRNAs at various developmental stages were investigated using a customized microarray analysis. Among the 91 differentially expressed miRNAs, qRT-PCR analysis was used to validate highly expressed miRNAs at each stage. The combined results not only systematically document miRNA profiles in an agriculturally important insect pest, but also provide molecular targets for future functional analysis and, ultimately, genetic-based pest control practice.	[Liang, Pei; Feng, Bing; Gao, Xiwu] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China; [Zhou, Xuguo] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA	China Agricultural University; University of Kentucky	Zhou, XG (corresponding author), Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA.	xuguozhou@uky.edu; gaoxiwu@263.net.cn	Liang, Pei/S-7748-2019	Liang, Pei/0000-0002-3083-8918	National Basic Research Programme of China [2012CB114103]; National Natural Science Foundation of China [30671389, 30971941, 31171873]	National Basic Research Programme of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Programme of China (2012CB114103), and the National Natural Science Foundation of China (30671389, 30971941, 31171873). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asgari S, 2013, INSECT BIOCHEM MOLEC, V43, P388, DOI 10.1016/j.ibmb.2012.10.005; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cayirlioglu P, 2008, SCIENCE, V319, P1256, DOI 10.1126/science.1149483; Chawla G, 2011, INT REV CEL MOL BIO, V286, P1, DOI 10.1016/B978-0-12-385859-7.00001-X; Cristino AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019350; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Etebari K, 2013, INSECT BIOCHEM MOLEC, V43, P309, DOI 10.1016/j.ibmb.2013.01.004; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Furlong MJ, 2013, ANNU REV ENTOMOL, V58, P517, DOI 10.1146/annurev-ento-120811-153605; Gao XL, 2004, BIOPOLYMERS, V73, P579, DOI 10.1002/bip.20005; He PA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-248; He WY, 2012, GENOMICS, V99, P169, DOI 10.1016/j.ygeno.2011.12.009; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Jagadeeswaran G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-52; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Leaman D, 2005, CELL, V121, P1097, DOI 10.1016/j.cell.2005.04.016; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Legeai F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-281; Liu SP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-85; Lucas K, 2013, INSECT BIOCHEM MOLEC, V43, P24, DOI 10.1016/j.ibmb.2012.10.009; Luo QB, 2008, J GENET GENOMICS, V35, P349, DOI 10.1016/S1673-8527(08)60051-X; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sathyamurthy G, 2010, INT J INSECT SCI, V2, P1; Singh J, 2008, INSECT MOL BIOL, V17, P427, DOI 10.1111/j.1365-2583.2008.00816.x; Skalsky RL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-119; Smibert P, 2010, SEMIN CELL DEV BIOL, V21, P745, DOI 10.1016/j.semcdb.2010.03.001; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Stark A, 2007, GENOME RES, V17, P1865, DOI 10.1101/gr.6593807; Sun W, 2010, ANNU REV BIOMED ENG, V12, P1, DOI 10.1146/annurev-bioeng-070909-105314; Tang BZ, 2011, PESTIC BIOCHEM PHYS, V101, P80, DOI 10.1016/j.pestbp.2011.08.003; Weaver DB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r97; Wei YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r6; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Winter F, 2007, NUCLEIC ACIDS RES, V35, P6953, DOI 10.1093/nar/gkm686; Xie W, 2012, INT J BIOL SCI, V8, P1142, DOI 10.7150/ijbs.4588; You MS, 2013, NAT GENET, V45, P220, DOI 10.1038/ng.2524; Zalucki MP, 2012, J ECON ENTOMOL, V105, P1115, DOI 10.1603/EC12107; Zhang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004677; Zhu Qi, 2007, V382, P287, DOI 10.1007/978-1-59745-304-2_19	41	28	33	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78787	10.1371/journal.pone.0078787	http://dx.doi.org/10.1371/journal.pone.0078787			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236051	gold, Green Published, Green Submitted			2022-12-27	WOS:000327254700048
J	Narva, E; Pursiheimo, JP; Laiho, A; Rahkonen, N; Emani, MR; Viitala, M; Laurila, K; Sahla, R; Lund, R; Lahdesmaki, H; Jaakkola, P; Lahesmaa, R				Narva, Elisa; Pursiheimo, Juha-Pekka; Laiho, Asta; Rahkonen, Nelly; Emani, Maheswara Reddy; Viitala, Miro; Laurila, Kirsti; Sahla, Roosa; Lund, Riikka; Lahdesmaki, Harri; Jaakkola, Panu; Lahesmaa, Riitta			Continuous Hypoxic Culturing of Human Embryonic Stem Cells Enhances SSEA-3 and MYC Levels	PLOS ONE			English	Article							INDUCIBLE FACTOR; SELF-RENEWAL; C-MYC; TUMOR-SUPPRESSOR; HIF-ALPHA; PROLYL HYDROXYLATION; PROTEIN STABILITY; HUMAN FIBROBLASTS; SURFACE-ANTIGENS; DIFFERENTIATION	Low oxygen tension (hypoxia) contributes critically to pluripotency of human embryonic stem cells (hESCs) by preventing spontaneous differentiation and supporting self-renewal. However, it is not well understood how hESCs respond to reduced oxygen availability and what are the molecular mechanisms maintaining pluripotency in these conditions. In this study we characterized the transcriptional and molecular responses of three hESC lines (H9, HS401 and HS360) on short (2 hours), intermediate (24 hours) and prolonged (7 days) exposure to low oxygen conditions (4% O-2). In response to prolonged hypoxia the expression of pluripotency surface marker SSEA-3 was increased. Furthermore, the genome wide gene-expression analysis revealed that a substantial proportion (12%) of all hypoxia-regulated genes in hESCs, were directly linked to the mechanisms controlling pluripotency or differentiation. Moreover, transcription of MYC oncogene was induced in response to continuous hypoxia. At the protein level MYC was stabilized through phosphorylation already in response to a short hypoxic exposure. Total MYC protein levels remained elevated throughout all the time points studied. Further, MYC protein expression in hypoxia was affected by silencing HIF2 alpha, but not HIF1 alpha. Since MYC has a crucial role in regulating pluripotency we propose that induction of sustained MYC expression in hypoxia contributes to activation of transcriptional programs critical for hESC self-renewal and maintenance of enhanced pluripotent state.	[Narva, Elisa; Pursiheimo, Juha-Pekka; Laiho, Asta; Rahkonen, Nelly; Emani, Maheswara Reddy; Viitala, Miro; Laurila, Kirsti; Sahla, Roosa; Lund, Riikka; Lahdesmaki, Harri; Jaakkola, Panu; Lahesmaa, Riitta] Turku Univ, Turku Ctr Biotechnol, Turku, Finland; [Narva, Elisa; Pursiheimo, Juha-Pekka; Laiho, Asta; Rahkonen, Nelly; Emani, Maheswara Reddy; Viitala, Miro; Laurila, Kirsti; Sahla, Roosa; Lund, Riikka; Lahdesmaki, Harri; Jaakkola, Panu; Lahesmaa, Riitta] Abo Akad Univ, Turku, Finland; [Jaakkola, Panu] Turku Univ Hosp, Dept Radiotherapy & Oncol, FIN-20520 Turku, Finland; [Laurila, Kirsti; Sahla, Roosa; Lahdesmaki, Harri] Aalto Univ, Sch Sci, Dept Informat & Comp Sci, Espoo, Finland	University of Turku; Abo Akademi University; University of Turku; Aalto University	Lahesmaa, R (corresponding author), Turku Univ, Turku Ctr Biotechnol, Turku, Finland.	riitta.lahesmaa@btk.fi	Kallionpää, Roosa/AAY-4816-2020; Närvä, Elisa Maarit/AAA-4885-2022; Emani, Maheswara Reddy/AAM-3500-2020; Jaakkola, Panu M/B-4355-2012; Lund, Riikka J/F-7320-2014; Lund, Riikka/K-2441-2019; Lund, Riikka/AAW-7853-2020	Kallionpää, Roosa/0000-0003-0146-0060; Närvä, Elisa Maarit/0000-0003-0517-9436; Lund, Riikka/0000-0002-1068-5918; Jaakkola, Panu/0000-0002-2365-4985; Maheswara Reddy, Emani/0000-0002-3455-1818	ESTOOLS consortium under the Sixth Research Framework Programme of the European Union; JDRF; Academy of Finland [116713]; Academy of Finland Centre of Excellence in Molecular Systems Immunology and Physiology Research [250114]; Finnish Cancer Organizations; Turku Graduate School of Biomedical Sciences; Ida Montin Foundation; Orion-Farmos Research Foundation; Finnish Cultural Foundation	ESTOOLS consortium under the Sixth Research Framework Programme of the European Union; JDRF(Juvenile Diabetes Research Foundation); Academy of Finland(Academy of Finland); Academy of Finland Centre of Excellence in Molecular Systems Immunology and Physiology Research; Finnish Cancer Organizations; Turku Graduate School of Biomedical Sciences; Ida Montin Foundation; Orion-Farmos Research Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	This study was supported by ESTOOLS consortium under the Sixth Research Framework Programme of the European Union (www.estools.eu), JDRF (jdrf.org), The Academy of Finland (116713), the Academy of Finland Centre of Excellence in Molecular Systems Immunology and Physiology Research, 2012-2017, Decision 250114 (http://www.aka.fi/eng), The Finnish Cancer Organizations (https://cancer-fi.directo.fi), Turku Graduate School of Biomedical Sciences (http://www.tubs.utu.fi), Ida Montin Foundation (www.idamontininsaatio.fi), Orion-Farmos Research Foundation (http://www.orion.fi/Tutkimus-ja-tuotekehitys/Orion-Farmos-Tutkimussaatio), and Finnish Cultural Foundation (http://www.skr.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS PW, 1982, INT J CANCER, V29, P523, DOI 10.1002/ijc.2910290507; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Bae D, 2011, STEM CELLS DEV; Becker KA, 2006, J CELL PHYSIOL, V209, P883, DOI 10.1002/jcp.20776; Behbahan IS, 2011, STEM CELL REV REP, V7, P748, DOI 10.1007/s12015-010-9216-4; Benassi B, 2006, MOL CELL, V21, P509, DOI 10.1016/j.molcel.2006.01.009; Besser D, 2004, J BIOL CHEM, V279, P45076, DOI 10.1074/jbc.M404979200; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Cameron CM, 2008, EXP BIOL MED, V233, P1044, DOI 10.3181/0709-RM-263; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chen HF, 2009, HUM REPROD, V24, P71, DOI 10.1093/humrep/den345; Chen YG, 2012, CELL STEM CELL, V10, P231, DOI 10.1016/j.stem.2012.02.008; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Draper JS, 2002, J ANAT, V200, P249, DOI 10.1046/j.1469-7580.2002.00030.x; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Florczyk U, 2011, FREE RADICAL BIO MED, V51, P1882, DOI 10.1016/j.freeradbiomed.2011.08.023; Fong HL, 2008, STEM CELLS, V26, P1931, DOI 10.1634/stemcells.2007-1002; Forristal CE, 2010, REPRODUCTION, V139, P85, DOI 10.1530/REP-09-0300; Forsyth NR, 2008, REGEN MED, V3, P817, DOI 10.2217/17460751.3.6.817; Forsyth NR, 2006, CLONING STEM CELLS, V8, P16, DOI 10.1089/clo.2006.8.16; Fu J, 2007, J BIOL CHEM, V282, P12410, DOI 10.1074/jbc.M608748200; Fu J, 2010, J BIOL CHEM, V285, P8927, DOI 10.1074/jbc.M109.078600; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gonzalez R, 2011, ANGEW CHEM INT EDIT, V50, P11181, DOI 10.1002/anie.201103909; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Hogel H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027112; Hsieh D, 2010, BIOCHEM BIOPH RES CO, V397, P367, DOI 10.1016/j.bbrc.2010.05.145; Huang LE, 2008, CELL DEATH DIFFER, V15, P672, DOI 10.1038/sj.cdd.4402302; Inzunza J, 2005, STEM CELLS, V23, P544, DOI 10.1634/stemcells.2004-0201; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jauniaux E, 1999, HUM REPROD, V14, P2901, DOI 10.1093/humrep/14.11.2901; Jokilehto T, 2010, J CELL MOL MED, V14, P758, DOI 10.1111/j.1582-4934.2010.01030.x; Katoh M, 2007, INT J ONCOL, V31, P461; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Loboda A, 2010, MOL CELLS, V29, P435, DOI 10.1007/s10059-010-0067-2; Matin MM, 2004, STEM CELLS, V22, P659, DOI 10.1634/stemcells.22-5-659; Minchenko OH, 2005, ACTA BIOCHIM POL, V52, P881; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Mutoh T, 2012, STEM CELLS, V30, P561, DOI 10.1002/stem.1019; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Narva E, 2010, NAT BIOTECHNOL; Nguyen AD, 2007, J BIOL CHEM, V282, P27436, DOI 10.1074/jbc.M704976200; Qi JL, 2009, CELL CYCLE, V8, P3729, DOI 10.4161/cc.8.22.10033; R Core Team, 2018, R LANG ENV STAT COMP; RODESCH F, 1992, OBSTET GYNECOL, V80, P283; Ross HH, 2012, EXP NEUROL; Salvagiotto G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017829; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Studer L, 2000, J NEUROSCI, V20, P7377; Sumi T, 2007, ONCOGENE, V26, P5564, DOI 10.1038/sj.onc.1210353; Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561; Utting JC, 2006, EXP CELL RES, V312, P1693, DOI 10.1016/j.yexcr.2006.02.007; Varlakhanova N, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-20; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Westfall SD, 2008, STEM CELLS DEV, V17, P869, DOI 10.1089/scd.2007.0240; Wykoff CC, 2000, ONCOGENE, V19, P6297, DOI 10.1038/sj.onc.1204012; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yoon BS, 2010, STEM CELLS, V28, P874, DOI 10.1002/stem.412; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Zhang XQ, 2010, CELL STEM CELL, V7, P90, DOI 10.1016/j.stem.2010.04.017; Zuo CQ, 2009, INT J MOL MED, V23, P811, DOI 10.3892/ijmm_00000197	72	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78847	10.1371/journal.pone.0078847	http://dx.doi.org/10.1371/journal.pone.0078847			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236059	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700056
J	Phillips, CM; Kearney, PM; McCarthy, VJ; Harrington, JM; Fitzgerald, AP; Perry, IJ				Phillips, Catherine M.; Kearney, Patricia M.; McCarthy, Vera J.; Harrington, Janas M.; Fitzgerald, Anthony P.; Perry, Ivan J.			Comparison of Diabetes Risk Score Estimates and Cardiometabolic Risk Profiles in a Middle-Aged Irish Population	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; LIFE-STYLE INTERVENTION; CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; DIETARY PATTERNS; MEAT INTAKE; TYPE-2; MELLITUS	Background: To compare diabetes risk assessment tools in estimating risk of developing type 2 diabetes (T2DM) and to evaluate cardiometabolic risk profiles in a middle-aged Irish population. Methods: Future risk of developing T2DM was estimated using 7 risk scores, including clinical measures with or without anthropometric, biological and lifestyle data, in the cross-sectional Mitchelstown cohort of 2,047 middle-aged men and women. Cardiometabolic phenotypes including markers of glucose metabolism, inflammatory and lipid profiles were determined. Results: Estimates of subjects at risk for developing T2DM varied considerably according to the risk assessment tool used (0.3% to 20%), with higher proportions of males at risk (0-29.2% vs. 0.1-13.4%, for men and women, respectively). Extrapolated to the Irish population of similar age, the overall number of adults at high risk of developing T2DM ranges from 3,378 to 236,632. Numbers of non-optimal metabolic features were generally greater among those at high risk of developing T2DM. However, cardiometabolic profile characterisation revealed that only those classified at high risk by the Griffin (UK Cambridge) score displayed a more pro-inflammatory, obese, hypertensive, dysglycaemic and insulin resistant metabolic phenotype. Conclusions: Most diabetes risk scores examined offer limited ability to identify subjects with metabolic abnormalities and at risk of developing T2DM. Our results highlight the need to validate diabetes risk scoring tools for each population studied and the potential for developing an Irish diabetes risk score, which may help to promote self awareness and identify high risk individuals and diabetes hot spots for targeted public health interventions.	[Phillips, Catherine M.; Kearney, Patricia M.; McCarthy, Vera J.; Harrington, Janas M.; Fitzgerald, Anthony P.; Perry, Ivan J.] Natl Univ Ireland Univ Coll Cork, HRB Ctr Diet & Hlth Res, Dept Epidemiol & Publ Hlth, Cork, Ireland; [Fitzgerald, Anthony P.] Natl Univ Ireland Univ Coll Cork, Dept Stat, Cork, Ireland	Health Research Board - Ireland; University College Cork; University College Cork	Phillips, CM (corresponding author), Natl Univ Ireland Univ Coll Cork, HRB Ctr Diet & Hlth Res, Dept Epidemiol & Publ Hlth, Cork, Ireland.	c.phillips@ucc.ie	Harrington, Janas/AAV-8123-2021; Kearney, Patricia M/AAE-8501-2020; Fitzgerald, Tony/AAB-5331-2020	Harrington, Janas/0000-0002-6238-7031; Kearney, Patricia/0000-0001-9599-3540; Perry, Ivan/0000-0002-4965-9792; Fitzgerald, Tony/0000-0001-6437-5686; Phillips, Catherine/0000-0003-4916-4463	Irish Health Research Board [HRC/2007/13]	Irish Health Research Board	This work was supported by a research grant from the Irish Health Research Board (reference HRC/2007/13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Anderson JW, 2003, J AM COLL NUTR, V22, P331, DOI 10.1080/07315724.2003.10719316; Balkau B, 2008, DIABETES CARE, V31, P2056, DOI 10.2337/dc08-0368; Bassuk SS, 2005, J APPL PHYSIOL, V99, P1193, DOI 10.1152/japplphysiol.00160.2005; Bertoni AG, 2010, DIABETES CARE, V33, P804, DOI 10.2337/dc09-1679; Carlsson S, 2005, DIABETOLOGIA, V48, P1051, DOI 10.1007/s00125-005-1768-5; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Creagh D, 2002, Ir Med J, V95, P298; Festa A, 2002, DIABETES, V51, P1131, DOI 10.2337/diabetes.51.4.1131; Fung TT, 2004, ARCH INTERN MED, V164, P2235, DOI 10.1001/archinte.164.20.2235; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Glumer C, 2006, DIABETES CARE, V29, P410, DOI 10.2337/diacare.29.02.06.dc05-0945; Greenland P, 2003, JAMA-J AM MED ASSOC, V290, P891, DOI 10.1001/jama.290.7.891; Griffin SJ, 2000, DIABETES-METAB RES, V16, P164, DOI 10.1002/1520-7560(200005/06)16:3<164::AID-DMRR103>3.0.CO;2-R; Grundy SM, 1999, CIRCULATION, V100, P1134, DOI 10.1161/01.CIR.100.10.1134; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Harrington J, 2007, PSYCHOL REPORTS DEP, V6; Institute of Public Health in Ireland, 2012, DIAB BRIEF TECHN DOC; Kahn HS, 2009, ANN INTERN MED, V150, P741, DOI 10.7326/0003-4819-150-11-200906020-00002; Kearney PM, 2013, INT J EPIDEMIOL, V42, P1253, DOI 10.1093/ije/dys131; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lee CC, 2009, DIABETOLOGIA, V52, P1040, DOI 10.1007/s00125-009-1338-3; Lindstrom J, 2003, J AM SOC NEPHROL, V14, pS108, DOI 10.1097/01.ASN.0000070157.96264.13; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Mann DM, 2010, AM J EPIDEMIOL, V171, P980, DOI 10.1093/aje/kwq030; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Montonen J, 2003, AM J CLIN NUTR, V77, P622, DOI 10.1093/ajcn/77.3.622; Nolan J J, 2006, Ir Med J, V99, P307; O'Connor JW, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0083188, 10.1371/journal.pone.0080504]; Perry IJ, 2001, INT J EPIDEMIOL, V30, P554, DOI 10.1093/ije/30.3.554; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Saaristo Timo, 2005, Diab Vasc Dis Res, V2, P67, DOI 10.3132/dvdr.2005.011; Schmid R, 2011, DIABETES CARE, V34, P1863, DOI 10.2337/dc11-0206; Schulze MB, 2007, DIABETES CARE, V30, P510, DOI 10.2337/dc06-2089; Schwarz PEH, 2007, PUBLIC HEALTH REP, V122, P258, DOI 10.1177/003335490712200216; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Unwin N, 2002, DIABETIC MED, V19, P708, DOI 10.1046/j.1464-5491.2002.00835.x; van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97; van Dam RM, 2002, DIABETES CARE, V25, P417, DOI 10.2337/diacare.25.3.417; Villegas R, 2004, Ir Med J, V97, P300; Villegas R, 2004, PUBLIC HEALTH NUTR, V7, P1017, DOI 10.1079/PHN2004638; Wannamethee SG, 2011, DIABETIC MED, V28, P23, DOI 10.1111/j.1464-5491.2010.03171.x; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068	46	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78950	10.1371/journal.pone.0078950	http://dx.doi.org/10.1371/journal.pone.0078950			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236074	Green Submitted, Green Published, gold			2022-12-27	WOS:000327254700071
J	Shehadeh, LA; Sharma, S; Pessanha, M; Wei, JQ; Liu, J; Yuan, HJ; Rodrigues, CO; Scherr, M; Tsinoremas, NF; Bishopric, NH				Shehadeh, Lina A.; Sharma, Salil; Pessanha, Monica; Wei, Jian Qin; Liu, Jing; Yuan, Huijun; Rodrigues, Claudia O.; Scherr, Michaela; Tsinoremas, Nicholas F.; Bishopric, Nanette H.			MicroRNA-20a Constrains p300-Driven Myocardial Angiogenic Transcription by Direct Targeting of p300	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CARDIAC-HYPERTROPHY; VASCULAR INTEGRITY; PRESSURE-OVERLOAD; HEART-FAILURE; EXPRESSION; INHIBITION; CLUSTER; HYPOXIA; CELL	Objective: To characterize downstream effectors of p300 acetyltransferase in the myocardium. Background: Acetyltransferase p300 is a central driver of the hypertrophic response to increased workload, but its biological targets and downstream effectors are incompletely known. Methods and Results: Mice expressing a myocyte-restricted transgene encoding acetyltransferase p300, previously shown to develop spontaneous hypertrophy, were observed to undergo robust compensatory blood vessel growth together with increased angiogenic gene expression. Chromatin immunoprecipitation demonstrated binding of p300 to the enhancers of the angiogenic regulators Angpt1 and Egln3. Interestingly, p300 overexpression in vivo was also associated with relative upregulation of several members of the anti-angiogenic miR-17 similar to 92 cluster in vivo. Confirming this finding, both miR-17-3p and miR-20a were upregulated in neonatal rat ventricular myocytes following adenoviral transduction of p300. Relative expression of most members of the 17,92 cluster was similar in all 4 cardiac chambers and in other organs, however, significant downregulation of miR-17-3p and miR-20a occurred between 1 and 8 months of age in both wt and tg mice. The decline in expression of these microRNAs was associated with increased expression of VEGFA, a validated miR-20a target. In addition, miR-20a was demonstrated to directly repress p300 expression through a consensus binding site in the p300 3'UTR. In vivo transduction of p300 resulted in repression both of p300 and of p300-induced angiogenic transcripts. Conclusion: p300 drives an angiogenic transcription program during hypertrophy that is fine-tuned in part through direct repression of p300 by miR-20a.	[Shehadeh, Lina A.; Wei, Jian Qin; Liu, Jing; Bishopric, Nanette H.] Univ Miami, Miller Sch Med, Dept Med, Div Cardiol, Miami, FL 33136 USA; [Sharma, Salil; Pessanha, Monica; Yuan, Huijun; Rodrigues, Claudia O.; Bishopric, Nanette H.] Univ Miami, Miller Sch Med, Dept Mol Pharmacol, Miami, FL 33136 USA; [Sharma, Salil; Pessanha, Monica; Yuan, Huijun; Rodrigues, Claudia O.; Bishopric, Nanette H.] Univ Miami, Miller Sch Med, Dept Cellular Pharmacol, Miami, FL 33136 USA; [Bishopric, Nanette H.] Univ Miami, Miller Sch Med, Dept Pediat, Miami, FL 33136 USA; [Tsinoremas, Nicholas F.] Univ Miami, Miller Sch Med, Ctr Computat Sci, Miami, FL 33136 USA; [Scherr, Michaela] Hannover Med Sch, Dept Hematol Hemostasis & Oncol, Hannover, Germany	University of Miami; University of Miami; University of Miami; University of Miami; University of Miami; Hannover Medical School	Bishopric, NH (corresponding author), Univ Miami, Miller Sch Med, Dept Med, Div Cardiol, Miami, FL 33136 USA.	n.bishopric@miami.edu			National Institutes of Health (NIH) [R-01-HL71094]; Florida Heart Research Institute (NHB); Fondation Leducq Transatlantic Network of Excellence [05-CVD-02]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071094, F32HL083673] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Heart Research Institute (NHB); Fondation Leducq Transatlantic Network of Excellence(Leducq Foundation); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health (NIH) (R-01-HL71094 to NHB), the Florida Heart Research Institute (NHB), and the Fondation Leducq Transatlantic Network of Excellence 05-CVD-02 (NHB), as well as a Predoctoral Fellowship (SS) and a Scientist Development Grant (LS) from the American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANVERSA P, 1985, AM J PHYSIOL, V248, pH883, DOI 10.1152/ajpheart.1985.248.6.H883; ANVERSA P, 1979, LAB INVEST, V40, P341; Bearzi C, 2009, P NATL ACAD SCI USA, V106, P15885, DOI 10.1073/pnas.0907622106; BISHOPRIC NH, 1991, P NATL ACAD SCI USA, V88, P2132, DOI 10.1073/pnas.88.6.2132; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chen JH, 2013, CIRC RES, V112, P1557, DOI 10.1161/CIRCRESAHA.112.300658; Choi YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004042; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Frank D, 2012, J MOL CELL CARDIOL, V52, P711, DOI 10.1016/j.yjmcc.2011.12.001; Giordano FJ, 2001, P NATL ACAD SCI USA, V98, P5780, DOI 10.1073/pnas.091415198; Hilfiker-Kleiner D, 2004, CIRC RES, V95, P187, DOI 10.1161/01.RES.0000134921.50377.61; Hossain A, 2006, MOL CELL BIOL, V26, P8191, DOI 10.1128/MCB.00242-06; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; HUDLICKA O, 1992, PHYSIOL REV, V72, P369, DOI 10.1152/physrev.1992.72.2.369; Kienstra KA, 2007, J AM ASSOC LAB ANIM, V46, P50; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; MARCUS ML, 1987, CIRCULATION, V75, P19; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Morimoto T, 2008, J CLIN INVEST, V118, P868, DOI 10.1172/JCI33160; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Pessanha MG, 2000, VIRCHOWS ARCH, V437, P667; RAKUSAN K, 1992, CIRCULATION, V86, P38, DOI 10.1161/01.CIR.86.1.38; Rodrigues CO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024013; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Scherr M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm971; Sharma S, 2012, EMBO MOL MED, V4, P617, DOI 10.1002/emmm.201200234; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Shyu KG, 2005, J BIOMED SCI, V12, P409, DOI 10.1007/s11373-005-3008-x; Slepak TI, 2001, J BIOL CHEM, V276, P7575, DOI 10.1074/jbc.M004625200; Suarez Y, 2008, P NATL ACAD SCI USA, V105, P14082, DOI 10.1073/pnas.0804597105; Sylvestre Y, 2007, J BIOL CHEM, V282, P2135, DOI 10.1074/jbc.M608939200; Taguchi A, 2008, CANCER RES, V68, P5540, DOI 10.1158/0008-5472.CAN-07-6460; Tillmanns J, 2008, P NATL ACAD SCI USA, V105, P1668, DOI 10.1073/pnas.0706315105; TOMANEK RJ, 1990, J AM COLL CARDIOL, V15, P528, DOI 10.1016/0735-1097(90)90620-5; Urbich C, BLOOD, V115, P4944; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Wei JQ, 2008, CIRCULATION, V118, P934, DOI 10.1161/CIRCULATIONAHA.107.760488; Woods K, 2007, J BIOL CHEM, V282, P2130, DOI 10.1074/jbc.C600252200; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Yoon YS, 2005, CIRCULATION, V111, P2073, DOI 10.1161/01.CIR.0000162472.52990.36; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103	49	11	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79133	10.1371/journal.pone.0079133	http://dx.doi.org/10.1371/journal.pone.0079133			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236097	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700095
J	Yu, C; Smith, LB				Yu, Chen; Smith, Linda B.			Joint Attention without Gaze Following: Human Infants and Their Parents Coordinate Visual Attention to Objects through Eye-Hand Coordination	PLOS ONE			English	Article							FINE-GRAINED SENSITIVITY; HEAD; MOVEMENTS; COGNITION; DIRECTION; VIEW; CONVERSATION; EXPERIENCE; DYNAMICS; TRACKING	The coordination of visual attention among social partners is central to many components of human behavior and human development. Previous research has focused on one pathway to the coordination of looking behavior by social partners, gaze following. The extant evidence shows that even very young infants follow the direction of another's gaze but they do so only in highly constrained spatial contexts because gaze direction is not a spatially precise cue as to the visual target and not easily used in spatially complex social interactions. Our findings, derived from the moment-to-moment tracking of eye gaze of one-year-olds and their parents as they actively played with toys, provide evidence for an alternative pathway, through the coordination of hands and eyes in goal-directed action. In goal-directed actions, the hands and eyes of the actor are tightly coordinated both temporally and spatially, and thus, in contexts including manual engagement with objects, hand movements and eye movements provide redundant information about where the eyes are looking. Our findings show that one-year-olds rarely look to the parent's face and eyes in these contexts but rather infants and parents coordinate looking behavior without gaze following by attending to objects held by the self or the social partner. This pathway, through eye-hand coupling, leads to coordinated joint switches in visual attention and to an overall high rate of looking at the same object at the same time, and may be the dominant pathway through which physically active toddlers align their looking behavior with a social partner.	[Yu, Chen; Smith, Linda B.] Indiana Univ, Dept Psychol & Brain Sci, Cognit Sci Program, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Yu, C (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Cognit Sci Program, Bloomington, IN 47405 USA.	chenyu@indiana.edu			National Science Foundation [BCS 0924248]; National Institutes of Health [R01HD074601, R21 EY017843]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD074601] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R21EY017843] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by National Science Foundation Grant BCS 0924248 and by National Institutes of Health Grant R01HD074601 and R21 EY017843. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibali MW, 2001, J MEM LANG, V44, P169, DOI 10.1006/jmla.2000.2752; Allopenna PD, 1998, J MEM LANG, V38, P419, DOI 10.1006/jmla.1997.2558; Angus D, 2012, IEEE T VIS COMPUT GR, V18, P988, DOI 10.1109/TVCG.2011.100; Aslin RN, 2009, OPTOMETRY VISION SCI, V86, P561, DOI 10.1097/OPX.0b013e3181a76e96; Ballard DH, 1997, BEHAV BRAIN SCI, V20, P723, DOI 10.1017/S0140525X97001611; Baron-Cohen S., 1997, MALADAPTED MIND CLAS, P207; Brooks R, 2005, DEVELOPMENTAL SCI, V8, P535, DOI 10.1111/j.1467-7687.2005.00445.x; Carpenter M, 1998, AUTISM RES; Clark HH, 2004, J MEM LANG, V50, P62, DOI 10.1016/j.jml.2003.08.004; Corkum V, 1998, DEV PSYCHOL, V34, P28, DOI 10.1037/0012-1649.34.1.28; Dale R, 2011, FRONTIERS COGNITION, V2; Deckner DF, 2003, INFANCY, V4, P201, DOI 10.1207/S15327078IN0402_03; Doherty MJ, 2009, J EXP CHILD PSYCHOL, V104, P296, DOI 10.1016/j.jecp.2009.06.004; Farroni T, 2004, INFANCY, V5, P39, DOI 10.1207/s15327078in0501_2; Farroni T, 2000, VIS COGN, V7, P705, DOI 10.1080/13506280050144399; Feldman R, 2007, CURR DIR PSYCHOL SCI, V16, P340, DOI 10.1111/j.1467-8721.2007.00532.x; Franchak JM, 2011, CHILD DEV, V82, P1738, DOI 10.1111/j.1467-8624.2011.01670.x; Frank M, 2012, MEASURING CHILDRENS; Garrod S., 2007, OXFORD HDB PSYCHOLIN, P443; Horstmann A, 2005, EXP BRAIN RES, V167, P187, DOI 10.1007/s00221-005-0038-6; Johansson RS, 2001, J NEUROSCI, V21, P6917, DOI 10.1523/JNEUROSCI.21-17-06917.2001; Jones SS, 2005, INFANT BEHAV DEV, V28, P194, DOI 10.1016/j.infbeh.2005.02.003; Kannass KN, 2006, J COGN DEV, V7, P381, DOI 10.1207/s15327647jcd0703_8; Kraut RE, 2003, HUM-COMPUT INTERACT, V18, P13, DOI 10.1207/S15327051HCI1812_2; Land MF, 2001, VISION RES, V41, P3559, DOI 10.1016/S0042-6989(01)00102-X; Langton SRH, 2000, TRENDS COGN SCI, V4, P50, DOI 10.1016/S1364-6613(99)01436-9; Loomis JM, 2008, PERCEPTION, V37, P1443, DOI 10.1068/p5896; Meltzoff AN, 2007, GAZE FOLLOWING ITS D; Mundy P, 2007, CURR DIR PSYCHOL SCI, V16, P269, DOI 10.1111/j.1467-8721.2007.00518.x; Olofson EL, 2011, COGNITION, V118, P258, DOI 10.1016/j.cognition.2010.11.012; Pelz J, 2001, EXP BRAIN RES, V139, P266, DOI 10.1007/s002210100745; Sebanz N, 2009, TOP COGN SCI, V1, P353, DOI 10.1111/j.1756-8765.2009.01024.x; Shockley K, 2003, J EXP PSYCHOL HUMAN, V29, P326, DOI 10.1037/0096-1523.29.2.326; Shockley K, 2009, TOP COGN SCI, V1, P305, DOI 10.1111/j.1756-8765.2009.01021.x; Smith LB, 2011, DEVELOPMENTAL SCI, V14, P9, DOI 10.1111/j.1467-7687.2009.00947.x; Stavropoulos KK, 2013, J CHILD PSYCHOL PSYC; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; Ullman S, 2012, P NATL ACAD SCI USA, V109, P18215, DOI 10.1073/pnas.1207690109; Vecera S. P., 1995, Visual Cognition, V2, P59, DOI 10.1080/13506289508401722; Vida M., 2012, J VISION, V12, P634, DOI DOI 10.1167/12.9.634; Vida MD, 2012, J EXP CHILD PSYCHOL, V112, P243, DOI 10.1016/j.jecp.2012.02.002; Vida MD, 2012, J EXP CHILD PSYCHOL, V111, P299, DOI 10.1016/j.jecp.2011.08.009; WEST MJ, 1987, DEV PSYCHOBIOL, V20, P549, DOI 10.1002/dev.420200508; Yoshida H, 2008, INFANCY, V13, P229, DOI 10.1080/15250000802004437	44	95	95	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79659	10.1371/journal.pone.0079659	http://dx.doi.org/10.1371/journal.pone.0079659			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236151	gold, Green Submitted, Green Published			2022-12-27	WOS:000327254700150
J	Lee, EJ; Kamli, MR; Pokharel, S; Malik, A; Tareq, KMA; Bhat, AR; Park, HB; Lee, YS; Kim, SH; Yang, B; Chung, KY; Choi, I				Lee, Eun Ju; Kamli, Majid Rasool; Pokharel, Smritee; Malik, Adeel; Tareq, K. M. A.; Bhat, Abdul Roouf; Park, Hee-Bok; Lee, Yong Seok; Kim, SangHoon; Yang, Bohsuk; Chung, Ki Young; Choi, Inho			Expressed Sequence Tags for Bovine Muscle Satellite Cells, Myotube Formed-Cells and Adipocyte-Like Cells	PLOS ONE			English	Article							SKELETAL-MUSCLE; NITRIC-OXIDE; BINDING PROTEIN; DIFFERENTIATION; GROWTH; TRANSDIFFERENTIATION; FAMILY; PROFILES; S100A4; THROMBOSPONDIN-1	Background: Muscle satellite cells (MSCs) represent a devoted stem cell population that is responsible for postnatal muscle growth and skeletal muscle regeneration. An important characteristic of MSCs is that they encompass multi potential mesenchymal stem cell activity and are able to differentiate into myocytes and adipocytes. To achieve a global view of the genes differentially expressed in MSCs, myotube formed-cells (MFCs) and adipocyte-like cells (ALCs), we performed large-scale EST sequencing of normalized cDNA libraries developed from bovine MSCs. Results: A total of 24,192 clones were assembled into 3,333 clusters, 5,517 singletons and 3,842contigs. Functional annotation of these unigenes revealed that a large portion of the differentially expressed genes are involved in cellular and signaling processes. Database for Annotation, Visualization and Integrated Discovery (DAVID) functional analysis of three subsets of highly expressed gene lists (MSC233, MFC258, and ALC248) highlighted some common and unique biological processes among MSC, MFC and ALC. Additionally, genes that may be specific to MSC, MFC and ALC are reported here, and the role of dimethylarginine dimethylaminohydrolase2 (DDAH2) during myogenesis and hemoglobin subunit alpha2 (HBA2) during transdifferentiation in C2C12 were assayed as a case study. DDAH2 was up-regulated during myognesis and knockdown of DDAH2 by siRNA significantly decreased myogenin (MYOG) expression corresponding with the slight change in cell morphology. In contrast, HBA2 was up-regulated during ALC formation and resulted in decreased intracellular lipid accumulation and CD36 mRNA expression upon knockdown assay. Conclusion: In this study, a large number of EST sequences were generated from the MSC, MFC and ALC. Overall, the collection of ESTs generated in this study provides a starting point for the identification of novel genes involved in MFC and ALC formation, which in turn offers a fundamental resource to enable better understanding of the mechanism of muscle differentiation and transdifferentiation.	[Lee, Eun Ju; Kamli, Majid Rasool; Pokharel, Smritee; Malik, Adeel; Tareq, K. M. A.; Bhat, Abdul Roouf; Choi, Inho] Yeungnam Univ, Sch Biotechnol, Gyongsan, South Korea; [Lee, Eun Ju; Lee, Yong Seok; Choi, Inho] Yeungnam Univ, Bovine Genome Resources Bank, Gyongsan, South Korea; [Park, Hee-Bok] Gyeongsang Natl Univ, Inst Agr & Life Sci, Jinju, South Korea; [Lee, Yong Seok] Soonchunhyang Univ, Coll Nat Sci, Dept Life Sci & Biotechnol, Asan, South Korea; [Kim, SangHoon] Kyung Hee Univ, Dept Biol, Seoul, South Korea; [Yang, Bohsuk; Chung, Ki Young] Natl Inst Anim Sci, Hanwoo Expt Stn, RDA, Seoul, South Korea	Yeungnam University; Yeungnam University; Gyeongsang National University; Soonchunhyang University; Kyung Hee University; National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea	Chung, KY (corresponding author), Natl Inst Anim Sci, Hanwoo Expt Stn, RDA, Seoul, South Korea.	cky95@korea.kr; inhochoi@ynu.ac.kr	Kamli, Majid Rasool/AAN-6151-2020; Malik, Adeel/ABD-4831-2020; kamli, majid/AFS-7216-2022; Kim, Sang Hoon/AAJ-7334-2020; LEE, YONGSEOK/AAF-3965-2020	Kamli, Majid Rasool/0000-0003-0553-0046; Malik, Adeel/0000-0002-3453-6001; Lee, Yongseok/0000-0002-8687-589X; Kim, Sanghoon/0000-0002-4078-6269	BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ907099]; Republic of Korea; National Research Foundation of Korea (MEST) [2008-0060480]; Yeungnam University	BioGreen 21 Program, Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); Republic of Korea; National Research Foundation of Korea (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); Yeungnam University	This work was supported by a grant from the BioGreen 21 Program (project no. PJ907099), Rural Development Administration, Republic of Korea, as well as a grant from the Republic of Korea and National Research Foundation of Korea (MEST) (grant no. 2008-0060480). This study was supported by the 2011 Yeungnam University research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abderrahim-Ferkoune A, 2003, J LIPID RES, V44, P994, DOI 10.1194/jlr.M200382-JLR200; Adams JC, 1997, INT J BIOCHEM CELL B, V29, P861, DOI 10.1016/S1357-2725(96)00171-9; ALLEN RE, 1987, J CELL PHYSIOL, V133, P567, DOI 10.1002/jcp.1041330319; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Aragones G, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-72; Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; Bentzinger CF, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt27; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749; Bracha AL, 2010, NAT CHEM BIOL, V6, P202, DOI 10.1038/NCHEMBIO.301; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandan E, 1996, EUR J CELL BIOL, V71, P170; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Burattini S, 2004, EUR J HISTOCHEM, V48, P223; Chmurzynska A, 2006, J APPL GENET, V47, P39, DOI 10.1007/BF03194597; Csete M, 2005, ANN NY ACAD SCI, V1049, P1, DOI 10.1196/annals.1334.001; De Coppi P, 2006, DIABETOLOGIA, V49, P1962, DOI 10.1007/s00125-006-0304-6; De Palma C, 2012, MOL NEUROBIOL, V46, P682, DOI 10.1007/s12035-012-8311-8; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Esemuede N, 2004, J SURG RES, V122, P135, DOI 10.1016/j.jss.2004.05.015; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fruhbeck G, 2009, TRENDS CELL BIOL, V19, P141, DOI 10.1016/j.tcb.2009.01.007; FURST DO, 1989, J CELL BIOL, V109, P517, DOI 10.1083/jcb.109.2.517; Gao Y, 2007, MEAT SCI, V77, P36, DOI 10.1016/j.meatsci.2007.03.026; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; Guerin Colleen M, 2009, Commun Integr Biol, V2, P452; Gupta S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-72; Gutierrez J, 2010, MOL CELL BIOL, V30, P1634, DOI 10.1128/MCB.01164-09; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; HIGGS DR, 1989, BLOOD, V73, P1081; Hirsch DS, 2001, J BIOL CHEM, V276, P875, DOI 10.1074/jbc.M007039200; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; HU ED, 1995, P NATL ACAD SCI USA, V92, P9856, DOI 10.1073/pnas.92.21.9856; Huang JL, 2012, TRANSGENIC RES, V21, P1311, DOI 10.1007/s11248-012-9615-1; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; HUEHNS E R, 1965, J Med Genet, V2, P48, DOI 10.1136/jmg.2.1.48; Isenberg JS, 2007, J BIOL CHEM, V282, P15404, DOI 10.1074/jbc.M701638200; Kelley JM, 1999, NUCLEIC ACIDS RES, V27, P1539, DOI 10.1093/nar/27.6.1539; Kunes P, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/920517; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; Lee DM, 2012, GENES GENOM, V34, P125, DOI 10.1007/s13258-011-0075-4; Lee DM, 2011, IN VITRO CELL DEV-AN, V47, P438, DOI 10.1007/s11626-011-9427-2; Lee EJ, 2010, ASIAN AUSTRAL J ANIM, V23, P649, DOI 10.5713/ajas.2010.90227; Lee EJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063617, DOI 10.1371/J0URNAL.P0NE.0063617.PUBMED:23717454]; Lee EJ, 2012, GENOMICS, V100, P195, DOI 10.1016/j.ygeno.2012.06.005; Lee EJ, 2012, GENES GENOM, V34, P133, DOI 10.1007/s13258-011-0096-z; LEE KH, 1994, J BIOL CHEM, V269, P14371; Leiper JM, 1999, BIOCHEM J, V343, P209, DOI 10.1042/0264-6021:3430209; Liang F, 2000, NUCLEIC ACIDS RES, V28, P3657, DOI 10.1093/nar/28.18.3657; Maile LA, 2010, EXP DIABETES RES, DOI 10.1155/2010/617052; Mirko V, 2010, J BIOMED BIOTECHNOL; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Nagaraj SH, 2007, BRIEF BIOINFORM, V8, P6, DOI 10.1093/bib/bbl015; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; OLSON EN, 1990, GENE DEV, V4, P1454, DOI 10.1101/gad.4.9.1454; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pope AJ, 2009, PHARMACOL RES, V60, P461, DOI 10.1016/j.phrs.2009.07.016; Raymond F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-125; Reeves MA, 2010, ANTIOXID REDOX SIGN, V12, P809, DOI 10.1089/ars.2009.2883; Ryan DG, 2003, INVEST OPHTH VIS SCI, V44, P4255, DOI 10.1167/iovs.03-0578; SANTERRE RF, 1993, MOL CELL BIOL, V13, P6044, DOI 10.1128/MCB.13.10.6044; Schmidt A, 1998, ANNU REV CELL DEV BI, V14, P305, DOI 10.1146/annurev.cellbio.14.1.305; Schneider M, 2007, CARDIOVASC RES, V75, P40, DOI 10.1016/j.cardiores.2007.03.027; Sherbet GV, 1998, ANTICANCER RES, V18, P2415; Singh NK, 2007, J ANIM SCI, V85, P1126, DOI 10.2527/jas.2006-524; SOARES MB, 1994, P NATL ACAD SCI USA, V91, P9228, DOI 10.1073/pnas.91.20.9228; Sterrenburg E, 2004, NEUROMUSCULAR DISORD, V14, P507, DOI 10.1016/j.nmd.2004.03.008; Straub AC, 2012, NATURE, V491, P473, DOI 10.1038/nature11626; Su Y, 2010, ELECTROPHORESIS, V31, P2913, DOI 10.1002/elps.201000034; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Velleman SG, 2013, COMP BIOCHEM PHYS A, V164, P36, DOI 10.1016/j.cbpa.2012.10.007; Wride MA, 2003, MOL VIS, V9, P360; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; Zhang HN, 2011, J PROTEOME RES, V10, P4757, DOI 10.1021/pr200553c	77	12	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79780	10.1371/journal.pone.0079780	http://dx.doi.org/10.1371/journal.pone.0079780			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224006	Green Submitted, gold, Green Published			2022-12-27	WOS:000326597400087
J	Wu, LJ; Tang, ZH; Sun, XH; Feng, XY; Qian, W; Wang, J; Jin, LX				Wu, Lingjie; Tang, Zuohua; Sun, Xinghuai; Feng, Xiaoyuan; Qian, Wen; Wang, Jie; Jin, Lixin			Metabolic Changes in the Visual Cortex of Binocular Blindness Macaque Monkeys: A Proton Magnetic Resonance Spectroscopy Study	PLOS ONE			English	Article							CROSS-MODAL PLASTICITY; IN-VIVO; RAT-BRAIN; MONOCULAR ENUCLEATION; N-ACETYLASPARTATE; MRS; NMR	Purpose: To evaluate proton magnetic resonance spectroscopy (H-1-MRS) in a study of cross-modal plasticity in the visual cortex of binocular blindness macaque monkeys. Materials and Methods: Four healthy neonatal macaque monkeys were randomly divided into 2 groups, with 2 in each group. Optic nerve transection was performed in both monkeys in the experimental group (group B) to obtain binocular blindness. Two healthy macaque monkeys served as a control group (group A). After sixteen months post-procedure, H-1-MRS was performed in the visual cortex of all monkeys. We compared the peak areas of NAA, Cr, Cho, Glx and Ins and the ratios of NAA/Cr, Cho/Cr, Glx/Cr and Ins/Cr of each monkey in group B with group A. Results: The peak area of NAA and the NAA/Cr ratio in the visual cortex of monkey 4 in group B were found to be dramatically decreased, the peak area of NAA slightly decreased and the NAA/Cr ratio clearly decreased in visual cortex of monkey 3 in group B than those in group A. The peak area of Ins and the Ins/Cr ratio in the visual cortex of monkey 4 in group B slightly increased. The peak area of Cho and the Cho/Cr ratio in the visual cortex of all monkeys in group B dramatically increased compared with group A. The peak area of Glx in the visual cortex of all monkeys in group B slightly increased compared with group A. Conclusions: 1H-MRS could detect biochemical and metabolic changes in the visual cortex and therefore this technique can be used to provide valuable information for investigating the mechanisms of cross-modal plasticity of binocular blindness in a macaque monkey model.	[Wu, Lingjie; Tang, Zuohua; Qian, Wen; Wang, Jie] Fudan Univ, Shanghai Med Sch, Eye & ENT Hosp, Dept Radiol, Shanghai 200433, Peoples R China; [Sun, Xinghuai] Fudan Univ, Inst Brain Sci, State Key Lab Med Neurobiol, Eye & ENT Hosp,Dept Ophthalmol, Shanghai 200433, Peoples R China; [Feng, Xiaoyuan] Fudan Univ, Shanghai Med Sch, Huashan Hosp, Dept Radiol, Shanghai 200433, Peoples R China; [Jin, Lixin] Siemens Ltd, Healthcare Sect, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University; Siemens AG	Tang, ZH (corresponding author), Fudan Univ, Shanghai Med Sch, Eye & ENT Hosp, Dept Radiol, Shanghai 200433, Peoples R China.	tzh518sunny@163.com; xhsun@shmu.edu.cn			Grant of Science and Technology Commission of Shanghai Municipality [09ZR1405600]; Funds for International Cooperation and Exchange of the National Natural Science Foundation of China [81020108017]	Grant of Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Funds for International Cooperation and Exchange of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The Grant of Science and Technology Commission of Shanghai Municipality (No. 09ZR1405600), http://www.stcsm.gov.cn/; The Funds for International Cooperation and Exchange of the National Natural Science Foundation of China (Grant No. 81020108017), http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Bernabeu A, 2009, NEUROIMAGE, V47, P1172, DOI 10.1016/j.neuroimage.2009.04.080; BRAND A, 1993, DEV NEUROSCI-BASEL, V15, P289, DOI 10.1159/000111347; Chan KC, 2009, EXP EYE RES, V88, P61, DOI 10.1016/j.exer.2008.10.002; Choi JK, 2007, NMR BIOMED, V20, P216, DOI 10.1002/nbm.1145; Chow AM, 2011, INT J DEV NEUROSCI, V29, P25, DOI 10.1016/j.ijdevneu.2010.10.002; Desgent S, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/590725; Dowling C, 2001, AM J NEURORADIOL, V22, P604; FONT C, 1982, REV ESP FISIOL, V38, P317; Fournier GN, 2004, NEUROSCIENCE, V126, P257, DOI 10.1016/j.neuroscience.2004.04.002; Gujar SK, 2005, J NEURO-OPHTHALMOL, V25, P217, DOI 10.1097/01.wno.0000177307.21081.81; HOWE FA, 1993, MAGN RESON QUART, V9, P31; Karlen SJ, 2009, CEREB CORTEX, V19, P1360, DOI 10.1093/cercor/bhn176; Larvaron P, 2006, NMR BIOMED, V19, P180, DOI 10.1002/nbm.997; Merabet LB, 2010, NAT REV NEUROSCI, V11, P44, DOI 10.1038/nrn2758; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; MOFFETT JR, 1993, J HISTOCHEM CYTOCHEM, V41, P559, DOI 10.1177/41.4.8450195; Mountford C, 2006, J MAGN RESON IMAGING, V24, P459, DOI 10.1002/jmri.20668; Mountford CE, 2010, CHEM REV, V110, P3060, DOI 10.1021/cr900250y; Newton JR, 2002, EXP BRAIN RES, V144, P423, DOI 10.1007/s00221-002-1087-8; Pajonk FG, 2010, ARCH GEN PSYCHIAT, V67, P133, DOI 10.1001/archgenpsychiatry.2009.193; RAUSCHECKER JP, 1995, TRENDS NEUROSCI, V18, P36, DOI 10.1016/0166-2236(95)93948-W; RIBAK CE, 1986, EXP BRAIN RES, V62, P203; Ross B, 2001, ANAT RECORD, V265, P54, DOI 10.1002/ar.1058; Schroeder CE, 2003, INT J PSYCHOPHYSIOL, V50, P5, DOI 10.1016/S0167-8760(03)00120-X; Shen J, 1999, P NATL ACAD SCI USA, V96, P8235, DOI 10.1073/pnas.96.14.8235; SIMMONS ML, 1991, NEUROSCIENCE, V45, P37, DOI 10.1016/0306-4522(91)90101-S; Steen RG, 2005, NEUROPSYCHOPHARMACOL, V30, P1949, DOI 10.1038/sj.npp.1300850; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Tkac I, 2003, MAGN RESON MED, V50, P24, DOI 10.1002/mrm.10497; VIZUETE ML, 1992, BRAIN RES, V575, P231, DOI 10.1016/0006-8993(92)90084-M; Xu S, 2005, NEUROIMAGE, V28, P401, DOI 10.1016/j.neuroimage.2005.06.016; You YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052061; Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073197	34	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80073	10.1371/journal.pone.0080073	http://dx.doi.org/10.1371/journal.pone.0080073			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224037	Green Published, gold, Green Submitted			2022-12-27	WOS:000326597400109
J	Hsu, YL; Shi, SF; Wu, WL; Ho, LJ; Lai, JH				Hsu, Yu-Lin; Shi, Shao-Fu; Wu, Wan-Lin; Ho, Ling-Jun; Lai, Jenn-Haung			Protective Roles of Interferon-Induced Protein with Tetratricopeptide Repeats 3 (IFIT3) in Dengue Virus Infection of Human Lung Epithelial Cells	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; STIMULATED GENES; ANTIVIRAL RESPONSE; IDENTIFICATION; EXPRESSION; EFFECTORS; FAMILY; ALPHA; INHIBITION; INFLUENZA	Interferons (IFNs) are critical cytokines that regulate immune response against virus infections. Dengue virus (DV) infections are a major public health concern worldwide, and especially in Asia. In the present study, we investigated the effects and mechanisms of action of IFN-induced protein with tetratricopeptide repeats 3 (IFIT3) in human lung epithelial cells. The results demonstrated that DV infection induced expression of several IFITs, including IFIT1, IFIT2, IFIT3, and IFIT5 in A549 cells. Induction of IFIT3 by DV infection was also observed in human dendritic cells. In a knockdown study, we showed that a signal transducer and activator of transcription 2 (STAT2), but not STAT1 or STAT3, regulated DV-induced IFIT3 production. By using several different methods to evaluate cell death, we demonstrated that knockdown of IFIT3 led to cellular apoptosis. Furthermore, knockdown of IFIT3 induced the expression of several apoptotic regulators such as caspase 3, caspase 8, caspase 9, and Bcl-2-associated X protein (BAX). Such apoptotic effects and mechanisms were synergistically enhanced after DV infection. Moreover, under conditions of IFIT3 deficiency, viral production increased, suggesting an anti-viral effect of IFIT3. Interestingly, DV could suppress IFN-alpha-induced but not IFN-gamma-induced IFIT3 expression, a phenomenon similar to the regulation of STATs by DV. In conclusion, this study revealed some mechanisms of IFIT3 induction, and also demonstrated the protective roles of IFIT3 following IFN-alpha production in DV infection of human lung epithelial cells.	[Hsu, Yu-Lin; Lai, Jenn-Haung] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Shi, Shao-Fu] Natl Def Med Ctr, Grad Inst Microbiol & Immunol, Taipei, Taiwan; [Wu, Wan-Lin; Ho, Ling-Jun] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan; [Ho, Ling-Jun] China Med Univ, PhD Program Aging, Grad Inst Basic Med Sci, Taichung, Taiwan; [Lai, Jenn-Haung] Chang Gung Univ, Chang Gung Mem Hosp, Dept Internal Med, Div Rheumatol Allergy & Immunol, Tao Yuan, Taiwan	National Defense Medical Center; National Defense Medical Center; National Health Research Institutes - Taiwan; China Medical University Taiwan; Chang Gung Memorial Hospital; Chang Gung University	Lai, JH (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.	laiandho@gmail.com	Ho, Ling-Jun/B-1087-2010	Ho, Ling-Jun/0000-0003-3453-2913	Chang Gung Memorial Hospital [CMRPG3B1751E]; National Science Council, Taiwan. R.O.C.	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Science Council, Taiwan. R.O.C.(Ministry of Science and Technology, Taiwan)	The study was supported by a research grant from Chang Gung Memorial Hospital (CMRPG3B1751E) and National Science Council, Taiwan. R.O.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta EG, 2009, CELL MICROBIOL, V11, P1533, DOI 10.1111/j.1462-5822.2009.01345.x; Bordignon J, 2008, VIROLOGY, V377, P319, DOI 10.1016/j.virol.2008.04.033; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Clemens MJ, 2003, J INTERF CYTOK RES, V23, P277, DOI 10.1089/107999003766628124; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; de Veer MJ, 1998, GENOMICS, V54, P267, DOI 10.1006/geno.1998.5555; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Despres P, 1996, J VIROL, V70, P4090; Fensterl V, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002712; Fensterl V, 2011, J INTERF CYTOK RES, V31, P71, DOI 10.1089/jir.2010.0101; Guzman MG, 2003, J CLIN VIROL, V27, P1, DOI 10.1016/S1386-6532(03)00010-6; Hertzog P, 2011, J INTERF CYTOK RES, V31, P5, DOI 10.1089/jir.2010.0126; Ho LJ, 2005, J IMMUNOL, V174, P8163, DOI 10.4049/jimmunol.174.12.8163; Ho LJ, 2001, J IMMUNOL, V166, P1499, DOI 10.4049/jimmunol.166.3.1499; Kumar D, 2010, CELL, V140, P731, DOI 10.1016/j.cell.2010.02.012; Laughlin CA, 2012, J INFECT DIS, V206, P1121, DOI 10.1093/infdis/jis351; Lee YR, 2007, VIRUS RES, V126, P216, DOI 10.1016/j.virusres.2007.03.003; Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104; Li Y, 2009, P NATL ACAD SCI USA, V106, P7945, DOI 10.1073/pnas.0900818106; Liu XY, 2011, J IMMUNOL, V187, P2559, DOI 10.4049/jimmunol.1100963; Lou YJ, 2009, CANCER RES, V69, P3673, DOI 10.1158/0008-5472.CAN-08-4922; MacMicking JD, 2012, NAT REV IMMUNOL, V12, P367, DOI 10.1038/nri3210; Metz P, 2012, HEPATOLOGY, V56, P2082, DOI 10.1002/hep.25908; Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005; Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; Rothwell C, 2009, VIROLOGY, V389, P8, DOI 10.1016/j.virol.2009.03.025; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Schmeisser H, 2010, J VIROL, V84, P10671, DOI 10.1128/JVI.00818-10; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Stawowczyk M, 2011, J BIOL CHEM, V286, P7257, DOI 10.1074/jbc.M110.207068; Stein DA, 2008, J ANTIMICROB CHEMOTH, V62, P555, DOI 10.1093/jac/dkn221; Umareddy I, 2008, J GEN VIROL, V89, P3052, DOI 10.1099/vir.0.2008/001594-0; Wacher C, 2007, J VIROL, V81, P860, DOI 10.1128/JVI.01167-06; Xiao S, 2006, P NATL ACAD SCI USA, V103, P16448, DOI 10.1073/pnas.0607830103	36	45	47	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79518	10.1371/journal.pone.0079518	http://dx.doi.org/10.1371/journal.pone.0079518			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223959	gold, Green Submitted, Green Published			2022-12-27	WOS:000326503400120
J	Nelson, RM; Pettersson, ME; Li, XD; Carlborg, O				Nelson, Ronald M.; Pettersson, Mats E.; Li, Xidan; Carlborg, Orjan			Variance Heterogeneity in Saccharomyces cerevisiae Expression Data: Trans-Regulation and Epistasis	PLOS ONE			English	Article							GENE-EXPRESSION; PROTEIN; TRANSCRIPTION; PATHWAY; TRAITS; ARCHITECTURE; VARIABILITY; DISSECTION; LANDSCAPE; RIM101	Here, we describe the results from the first variance heterogeneity Genome Wide Association Study (VGWAS) on yeast expression data. Using this forward genetics approach, we show that the genetic regulation of gene-expression in the budding yeast, Saccharomyces cerevisiae, includes mechanisms that can lead to variance heterogeneity in the expression between genotypes. Additionally, we performed a mean effect association study (GWAS). Comparing the mean and variance heterogeneity analyses, we find that the mean expression level is under genetic regulation from a larger absolute number of loci but that a higher proportion of the variance controlling loci were trans-regulated. Both mean and variance regulating loci cluster in regulatory hotspots that affect a large number of phenotypes; a single variance-controlling locus, mapping close to DIA2, was found to be involved in more than 10% of the significant associations. It has been suggested in the literature that variance-heterogeneity between the genotypes might be due to genetic interactions. We therefore screened the multi-locus genotype-phenotype maps for several traits where multiple associations were found, for indications of epistasis. Several examples of two and three locus genetic interactions were found to involve variance-controlling loci, with reports from the literature corroborating the functional connections between the loci. By using a new analytical approach to re-analyze a powerful existing dataset, we are thus able to both provide novel insights to the genetic mechanisms involved in the regulation of gene-expression in budding yeast and experimentally validate epistasis as an important mechanism underlying genetic variance-heterogeneity between genotypes.	[Nelson, Ronald M.; Pettersson, Mats E.; Li, Xidan; Carlborg, Orjan] Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden	Swedish University of Agricultural Sciences	Nelson, RM (corresponding author), Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden.	ronnie.nelson@slu.se	Pettersson, Mats E/E-4523-2011	Pettersson, Mats/0000-0002-7372-9076; Carlborg, Orjan/0000-0002-2722-5264	Swedish Foundation for Strategic Research; Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning (FORMAS); EURYI	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning (FORMAS)(Swedish Research Council Formas); EURYI(European Science Foundation (ESF))	This study was funded by the Swedish Foundation for Strategic Research; by Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning (FORMAS); and by a EURYI Award to OC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansel J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000049; Bao MZ, 2004, CELL, V119, P991, DOI 10.1016/j.cell.2004.11.052; Barwell KJ, 2005, EUKARYOT CELL, V4, P890, DOI 10.1128/EC.4.5.890-899.2005; Blake D, 2006, GENETICS, V174, P1709, DOI 10.1534/genetics.106.057836; BLOOM JS, 2013, NATURE; Boysen JH, 2006, MOL BIOL CELL, V17, P1344, DOI 10.1091/mbc.e05-10-0949; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Ehrenreich IM, 2010, NATURE, V464, P1039, DOI 10.1038/nature08923; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Fichtner L, 2007, MOL MICROBIOL, V66, P1276, DOI 10.1111/j.1365-2958.2007.06014.x; Flint J, 2009, GENOME RES, V19, P723, DOI 10.1101/gr.086660.108; Flynn PJ, 1999, MOL CELL BIOL, V19, P882; Fraser HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008635; Hiltunen JK, 2003, FEMS MICROBIOL REV, V27, P35, DOI 10.1016/S0168-6445(03)00017-2; Huang W, 2012, P NATL ACAD SCI USA, V109, P15553, DOI 10.1073/pnas.1213423109; Hulse AM, 2013, GENETICS, V193, P95, DOI 10.1534/genetics.112.146779; Jamieson DJ, 1998, YEAST, V14, P1511, DOI 10.1002/(SICI)1097-0061(199812)14:16<1511::AID-YEA356>3.3.CO;2-J; Jimenez-Gomez JM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002295; Kobayashi O, 1996, MOL GEN GENET, V251, P707, DOI 10.1007/s004380050220; Kus BM, 2004, PROTEINS, V54, P455, DOI 10.1002/prot.10620; Le Rouzic A, 2008, TRENDS ECOL EVOL, V23, P33, DOI 10.1016/j.tree.2007.09.014; Liti G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002912; Odorizzi G, 2003, J CELL SCI, V116, P1893, DOI 10.1242/jcs.00395; Pai AA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003000; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Pettersson M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002180; Reece RJ, 2000, CELL MOL LIFE SCI, V57, P1161, DOI 10.1007/PL00000756; Ronnegard L, 2011, GENETICS, V188, P435, DOI 10.1534/genetics.111.127068; Rothfels K, 2005, MOL CELL BIOL, V25, P6772, DOI 10.1128/MCB.25.15.6772-6788.2005; ROY A, 1990, MOL CELL BIOL, V10, P5257, DOI 10.1128/MCB.10.10.5257; Shen X, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002839; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Sorensen D, 2003, GENET RES, V82, P207, DOI 10.1017/S0016672303006426; Storey JD, 2005, PLOS BIOL, V3, P1380, DOI 10.1371/journal.pbio.0030267; Struchalin MV, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-92; Teo H, 2004, DEV CELL, V7, P559, DOI 10.1016/j.devcel.2004.09.003; TEUNISSEN AWRH, 1995, YEAST, V11, P1001, DOI 10.1002/yea.320111102; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	41	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79507	10.1371/journal.pone.0079507	http://dx.doi.org/10.1371/journal.pone.0079507			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223957	Green Submitted, gold, Green Published			2022-12-27	WOS:000326503400119
J	Pelchovich, G; Omer-Bendori, S; Gophna, U				Pelchovich, Gidi; Omer-Bendori, Shira; Gophna, Uri			Menaquinone and Iron Are Essential for Complex Colony Development in Bacillus subtilis	PLOS ONE			English	Article							FRUITING BODY FORMATION; VITAMIN-K MENAQUINONE; STREPTOMYCES-COELICOLOR; BACTERIAL COLONIES; MYXOCOCCUS-XANTHUS; SELF-ORGANIZATION; AERIAL HYPHAE; COOPERATIVE ORGANIZATION; ISOCHORISMATE SYNTHASE; CAROTENOID SYNTHESIS	Cells of undomesticated species of Bacillus subtilis frequently form complex colonies during spreading on agar surfaces. Given that menaquinone is involved in another form of coordinated behavior, namely, sporulation, we looked for a possible role for menaquinone in complex colony development (CCD) in the B. subtilis strain NCIB 3610. Here we show that inhibition of menaquinone biosynthesis in B. subtilis indeed abolished its ability to develop complex colonies. Additionally some mutations of B. subtilis which confer defective CCD could be suppressed by menaquinone derivatives. Several such mutants mapped to the dhb operon encoding the genes responsible for the biosynthesis of the iron siderophore, bacillibactin. Our results demonstrate that both menaquinone and iron are essential for CCD in B. subtilis.	[Pelchovich, Gidi; Omer-Bendori, Shira; Gophna, Uri] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel	Tel Aviv University	Pelchovich, G (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.	gidi78@gmail.com	Gophna, Uri/AAS-8376-2020	Gophna, Uri/0000-0001-5129-5652	Tauber Fund at Tel-Aviv University; DIP grant from the Deutsche Forschungsgemeinschaft	Tauber Fund at Tel-Aviv University; DIP grant from the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The research was supported in large part by a grant from the Tauber Fund at Tel-Aviv University. UG is supported by a DIP grant from the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABULHAJJ YJ, 1978, J BIOL CHEM, V253, P2356; Banin E, 2005, P NATL ACAD SCI USA, V102, P11076, DOI 10.1073/pnas.0504266102; Ben-Jacob E, 1998, ANNU REV MICROBIOL, V52, P779, DOI 10.1146/annurev.micro.52.1.779; Ben-Jacob E, 2003, PHILOS T R SOC A, V361, P1283, DOI 10.1098/rsta.2003.1199; Ben-Jacob E, 2000, PHYSICA A, V282, P247, DOI 10.1016/S0378-4371(00)00093-5; Ben-Jacob E, 2000, ADV PHYS, V49, P395, DOI 10.1080/000187300405228; Ben-Jacob E, 2009, ANN NY ACAD SCI, V1178, P78, DOI 10.1111/j.1749-6632.2009.05022.x; BENJACOB E, 1995, PHYS REV LETT, V75, P2899, DOI 10.1103/PhysRevLett.75.2899; BENJACOB E, 1992, PHYSICA A, V187, P378, DOI 10.1016/0378-4371(92)90002-8; BenJacob E, 1997, CONTEMP PHYS, V38, P205, DOI 10.1080/001075197182405; BENJACOB E, 1994, NATURE, V368, P46, DOI 10.1038/368046a0; BENTLEY R, 1982, MICROBIOL REV, V46, P241, DOI 10.1128/MMBR.46.3.241-280.1982; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Branda SS, 2004, J BACTERIOL, V186, P3970, DOI 10.1128/JB.186.12.3970-3979.2004; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; BUDRENE EO, 1995, NATURE, V376, P49, DOI 10.1038/376049a0; BUDRENE EO, 1991, NATURE, V349, P630, DOI 10.1038/349630a0; Carpentier W, 2005, J BACTERIOL, V187, P3293, DOI 10.1128/JB.187.10.3293-3301.2005; Chater KF, 2001, CURR OPIN MICROBIOL, V4, P667, DOI 10.1016/S1369-5274(01)00267-3; Claessen D, 2003, GENE DEV, V17, P1714, DOI 10.1101/gad.264303; Claessen D, 2006, TRENDS MICROBIOL, V14, P313, DOI 10.1016/j.tim.2006.05.008; Cloud KA, 2004, J BACTERIOL, V186, P7811, DOI 10.1128/JB.186.22.7811-7814.2004; Curtis PD, 2007, J BACTERIOL, V189, P9126, DOI 10.1128/JB.01008-07; Czirok A, 1996, PHYS REV E, V54, P1791, DOI 10.1103/PhysRevE.54.1791; DAHL MK, 1992, J BIOL CHEM, V267, P14509; Daruwala R, 1996, FEMS MICROBIOL LETT, V140, P159, DOI 10.1016/0378-1097(96)00173-5; Degering C, 2010, APPL ENVIRON MICROB, V76, P6370, DOI 10.1128/AEM.01146-10; DOY CH, 1965, BIOCHIM BIOPHYS ACTA, V104, P377, DOI 10.1016/0304-4165(65)90343-0; EMMONS GT, 1985, BIOCHEM BIOPH RES CO, V131, P956, DOI 10.1016/0006-291X(85)91332-4; Fall R, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-31; FARRAND SK, 1974, J BACTERIOL, V117, P324, DOI 10.1128/JB.117.1.324-326.1974; FARRAND SK, 1973, J BACTERIOL, V115, P1035, DOI 10.1128/JB.115.3.1035-1044.1973; Ferland G, 2012, ANN NUTR METAB, V61, P213, DOI 10.1159/000343108; Fu QS, 2009, BIODEGRADATION, V20, P109, DOI 10.1007/s10532-008-9204-4; FUJIKAWA H, 1989, J PHYS SOC JPN, V58, P3875, DOI 10.1143/JPSJ.58.3875; FUJIKAWA H, 1994, FEMS MICROBIOL ECOL, V13, P159, DOI 10.1111/j.1574-6941.1994.tb00062.x; HAMMOND RK, 1970, J BACTERIOL, V103, P611, DOI 10.1128/JB.103.3.611-615.1970; Hamoen LW, 2003, MICROBIOL-SGM, V149, P9, DOI 10.1099/mic.0.26003-0; Hamon MA, 2001, MOL MICROBIOL, V42, P1199, DOI 10.1046/j.1365-2958.2001.02709.x; Hamze K, 2011, MICROBIOL-SGM, V157, P2456, DOI 10.1099/mic.0.047159-0; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; Hoffmann T, 2002, J BACTERIOL, V184, P718, DOI 10.1128/JB.184.3.718-727.2002; HUANG L, 1974, J BIOL CHEM, V249, P4467; HUANG L, 1974, J BIOL CHEM, V249, P4473; IKEDA H, 1990, EUR J BIOCHEM, V192, P219, DOI 10.1111/j.1432-1033.1990.tb19218.x; Ingham CJ, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-36; KAKUTANI Y, 1967, J BIOCHEM-TOKYO, V61, P193, DOI 10.1093/oxfordjournals.jbchem.a128531; Kaplan HB, 2003, CURR OPIN MICROBIOL, V6, P572, DOI 10.1016/j.mib.2003.10.006; Kearns DB, 2010, NAT REV MICROBIOL, V8, P634, DOI 10.1038/nrmicro2405; Kearns DB, 2004, MOL MICROBIOL, V52, P357, DOI 10.1111/j.1365-2958.2004.03996.x; Kearns DB, 2003, MOL MICROBIOL, V49, P581, DOI 10.1046/j.1365-2958.2003.03584.x; Kelemen GH, 1996, MOL MICROBIOL, V21, P593, DOI 10.1111/j.1365-2958.1996.tb02567.x; Kinsinger RF, 2005, J BACTERIOL, V187, P8462, DOI 10.1128/JB.187.24.8462-8469.2005; KOCH GLE, 1971, BIOCHIM BIOPHYS ACTA, V229, P795, DOI 10.1016/0005-2795(71)90298-4; KoikeTakeshita A, 1997, J BIOL CHEM, V272, P12380, DOI 10.1074/jbc.272.19.12380; Kolappan S, 2007, BIOCHEMISTRY-US, V46, P946, DOI 10.1021/bi0608515; KUNER JM, 1982, J BACTERIOL, V151, P458, DOI 10.1128/JB.151.1.458-461.1982; Le Breton Y, 2006, APPL ENVIRON MICROB, V72, P327, DOI 10.1128/AEM.72.1.327-333.2006; Lies DP, 2005, APPL ENVIRON MICROB, V71, P4414, DOI 10.1128/AEM.71.8.4414-4426.2005; MATSUSHITA M, 1990, PHYSICA A, V168, P498, DOI 10.1016/0378-4371(90)90402-E; MAY BK, 1968, BIOCHIM BIOPHYS ACTA, V157, P607, DOI 10.1016/0005-2787(68)90158-5; May JJ, 2002, P NATL ACAD SCI USA, V99, P12120, DOI 10.1073/pnas.182156699; May JJ, 2001, J BIOL CHEM, V276, P7209, DOI 10.1074/jbc.M009140200; MCCANDLISS RJ, 1978, P NATL ACAD SCI USA, V75, P4810, DOI 10.1073/pnas.75.10.4810; Meganathan R, 2001, VITAM HORM, V61, P173; Mendelson NH, 1996, J BACTERIOL, V178, P1980, DOI 10.1128/jb.178.7.1980-1989.1996; Miethke M, 2006, MOL MICROBIOL, V61, P1413, DOI 10.1111/j.1365-2958.2006.05321.x; NAKANO MM, 1992, MOL GEN GENET, V232, P313, DOI 10.1007/BF00280011; Piggot PJ, 2004, CURR OPIN MICROBIOL, V7, P579, DOI 10.1016/j.mib.2004.10.001; POPP JL, 1989, ANAL BIOCHEM, V178, P306, DOI 10.1016/0003-2697(89)90643-X; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; Rowland BM, 1996, GENE, V178, P119, DOI 10.1016/0378-1119(96)00349-6; SCHOLES PB, 1965, BIOCHEM J, V97, P766, DOI 10.1042/bj0970766; Schwedock J, 1997, MOL MICROBIOL, V25, P847, DOI 10.1111/j.1365-2958.1997.mmi507.x; Seminara A, 2012, P NATL ACAD SCI USA, V109, P1116, DOI 10.1073/pnas.1109261108; Shapiro JA, 1998, ANNU REV MICROBIOL, V52, P81, DOI 10.1146/annurev.micro.52.1.81; SLECHTA L, 1958, NATURE, V181, P268, DOI 10.1038/181268b0; Sliusarenko O, 2007, J BACTERIOL, V189, P611, DOI 10.1128/JB.01206-06; Sogaard-Andersen L, 2003, MOL MICROBIOL, V48, P1, DOI 10.1046/j.1365-2958.2003.03399.x; STEINMETZ M, 1994, J BACTERIOL, V176, P1761, DOI 10.1128/jb.176.6.1761-1763.1994; Sun H, 2000, CURR BIOL, V10, P1143, DOI 10.1016/S0960-9822(00)00705-3; TABER HW, 1981, J BACTERIOL, V145, P321, DOI 10.1128/JB.145.1.321-327.1981; Tcherpakov M, 1999, INT J SYST BACTERIOL, V49, P239, DOI 10.1099/00207713-49-1-239; VICSEK T, 1994, FRACTALS, V2, P15, DOI DOI 10.1142/S0218348X9400003X; Vlamakis H, 2008, GENE DEV, V22, P945, DOI 10.1101/gad.1645008; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Wallin R, 2004, TRENDS MOL MED, V10, P299, DOI 10.1016/j.molmed.2004.05.003; Wallin R, 2008, VITAM HORM, V78, P227, DOI 10.1016/S0083-6729(07)00011-8; Yamamoto Y, 2006, BIOMETALS, V19, P205, DOI 10.1007/s10534-005-5419-6; Yepes A, 2012, MOL MICROBIOL, V86, P457, DOI 10.1111/j.1365-2958.2012.08205.x; YOUNG IG, 1975, BIOCHEMISTRY-US, V14, P399, DOI 10.1021/bi00673a029	91	16	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79488	10.1371/journal.pone.0079488	http://dx.doi.org/10.1371/journal.pone.0079488			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223955	Green Published, Green Submitted, gold			2022-12-27	WOS:000326503400118
J	Sin, YY; Ballantyne, LL; Mukherjee, K; Amand, TS; Kyriakopoulou, L; Schulze, A; Funk, CD				Sin, Yuan Yan; Ballantyne, Laurel L.; Mukherjee, Kamalika; Amand, Tim St.; Kyriakopoulou, Lianna; Schulze, Andreas; Funk, Colin D.			Inducible Arginase 1 Deficiency in Mice Leads to Hyperargininemia and Altered Amino Acid Metabolism	PLOS ONE			English	Article							HUMAN-LIVER ARGINASE; GUANIDINO COMPOUNDS; GENE-THERAPY; MOUSE MODEL; BRAIN; EXPRESSION; CLONING; ARGININEMIA; SEQUENCE; PROLINE	Arginase deficiency is a rare autosomal recessive disorder resulting from a loss of the liver arginase isoform, arginase 1 (ARG1), which is the final step in the urea cycle for detoxifying ammonia. ARG1 deficiency leads to hyperargininemia, characterized by progressive neurological impairment, persistent growth retardation and infrequent episodes of hyperammonemia. Using the Cre/loxP-directed conditional gene knockout system, we generated an inducible Arg1-deficient mouse model by crossing "floxed'' Arg1 mice with CreER(T2) mice. The resulting mice (Arg-Cre) die about two weeks after tamoxifen administration regardless of the starting age of inducing the knockout. These treated mice were nearly devoid of Arg1 mRNA, protein and liver arginase activity, and exhibited symptoms of hyperammonemia. Plasma amino acid analysis revealed pronounced hyperargininemia and significant alterations in amino acid and guanidino compound metabolism, including increased citrulline and guanidinoacetic acid. Despite no alteration in ornithine levels, concentrations of other amino acids such as proline and the branched-chain amino acids were reduced. In summary, we have generated and characterized an inducible Arg1-deficient mouse model exhibiting several pathologic manifestations of hyperargininemia. This model should prove useful for exploring potential treatment options of ARG1 deficiency.	[Sin, Yuan Yan; Ballantyne, Laurel L.; Mukherjee, Kamalika; Amand, Tim St.; Funk, Colin D.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Kyriakopoulou, Lianna; Schulze, Andreas] Univ Toronto, Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Kyriakopoulou, Lianna; Schulze, Andreas] Univ Toronto, Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada	Queens University - Canada; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Funk, CD (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	funkc@queensu.ca	Schulze, Andreas/I-5706-2019; Mukherjee, Kamalika/O-5148-2019	Schulze, Andreas/0000-0001-8491-1095; Sin, Yuan Yan/0000-0001-6537-5266; Funk, Colin/0000-0001-7029-4233	Heart and Stroke Foundation of Ontario	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	CDF holds a Tier I Canada Research Chair in Molecular, Cellular, and Physiological Medicine and is recipient of a Career Investigator Award from the Heart and Stroke Foundation of Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batshaw ML, 2001, J PEDIATR-US, V138, pS46, DOI 10.1067/mpd.2001.111836; Berthoud HR, 2002, NEUROSCI BIOBEHAV R, V26, P393, DOI 10.1016/S0149-7634(02)00014-3; Crombez EA, 2005, MOL GENET METAB, V84, P243, DOI 10.1016/j.ymgme.2004.11.004; Deignan JL, 2008, MOL GENET METAB, V93, P172, DOI 10.1016/j.ymgme.2007.09.016; Deignan JL, 2010, MOL GENET METAB, V100, pS31, DOI 10.1016/j.ymgme.2010.01.012; DIZIKES GJ, 1986, SOMAT CELL MOLEC GEN, V12, P375, DOI 10.1007/BF01570732; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; FEIL S, 2009, METHOD MOL BIOL, V530, P1; FELDMAN JM, 1971, AM J PHYSIOL, V221, P1027, DOI 10.1152/ajplegacy.1971.221.4.1027; Fernandez I, 2010, J AM ASSOC LAB ANIM, V49, P202; Gau CL, 2009, MOL THER, V17, P1155, DOI 10.1038/mt.2009.65; GRODY WW, 1993, HUM GENET, V91, P1; HARAGUCHI Y, 1987, P NATL ACAD SCI USA, V84, P412, DOI 10.1073/pnas.84.2.412; HARPER AE, 1989, J NUTR, V119, P677, DOI 10.1093/jn/119.5.677; Holecek M, 2011, AMINO ACIDS, V40, P575, DOI 10.1007/s00726-010-0679-z; Huh WJ, 2012, GASTROENTEROLOGY, V142, P21, DOI 10.1053/j.gastro.2011.09.050; Iyer R, 1998, J INHERIT METAB DIS, V21, P86, DOI 10.1023/A:1005313809037; Iyer RK, 2002, MOL CELL BIOL, V22, P4491, DOI 10.1128/MCB.22.13.4491-4498.2002; Jobgen WJ, 2009, J NUTR, V139, P230, DOI 10.3945/jn.108.096362; Kasten J, 2013, MOL GENET METAB, V110, P222, DOI 10.1016/j.ymgme.2013.06.020; KLAUNIG JE, 1981, IN VITRO CELL DEV B, V17, P913; Krishnan N, 2008, FREE RADICAL BIO MED, V44, P671, DOI 10.1016/j.freeradbiomed.2007.10.054; Lee EK, 2013, GENE THER, V20, P785, DOI 10.1038/gt.2012.99; Lee EK, 2012, MOL THER, V20, P1844, DOI 10.1038/mt.2012.129; Louin G, 2007, NITRIC OXIDE-BIOL CH, V17, P91, DOI 10.1016/j.niox.2007.05.006; Luiking YC, 2010, CURR OPIN CLIN NUTR, V13, P97, DOI 10.1097/MCO.0b013e328332f99d; MARESCAU B, 1992, METABOLISM, V41, P526, DOI 10.1016/0026-0495(92)90213-T; MELLINKOFF SM, 1956, J APPL PHYSIOL, V8, P535, DOI 10.1152/jappl.1956.8.5.535; MIZUTANI N, 1987, TOHOKU J EXP MED, V153, P197, DOI 10.1620/tjem.153.197; Morris SM, 1997, GENE, V193, P157, DOI 10.1016/S0378-1119(97)00099-1; Prasad AN, 1997, J CHILD NEUROL, V12, P301, DOI 10.1177/088307389701200502; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SPARKES RS, 1986, AM J HUM GENET, V39, P186; TAKIGUCHI M, 1988, NUCLEIC ACIDS RES, V16, P8789, DOI 10.1093/nar/16.18.8789; Vockley JG, 1996, GENOMICS, V38, P118, DOI 10.1006/geno.1996.0606	35	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e80001	10.1371/journal.pone.0080001	http://dx.doi.org/10.1371/journal.pone.0080001			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24224027	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000326503400149
J	Zehender, G; Ebranati, E; Shkjezi, R; Papa, A; Luzzago, C; Gabanelli, E; Lo Presti, A; Lai, A; Rezza, G; Galli, M; Bino, S; Ciccozzi, M				Zehender, Gianguglielmo; Ebranati, Erika; Shkjezi, Renata; Papa, Anna; Luzzago, Camilla; Gabanelli, Elena; Lo Presti, Alessandra; Lai, Alessia; Rezza, Giovanni; Galli, Massimo; Bino, Silvia; Ciccozzi, Massimo			Bayesian Phylogeography of Crimean-Congo Hemorrhagic Fever Virus in Europe	PLOS ONE			English	Article							CLINICAL-FEATURES; SPREAD; EPIDEMIOLOGY; TRANSMISSION; INFERENCE; DYNAMICS; OUTBREAK; PATTERNS; DISEASES; STRAINS	Crimean-Congo hemorrhagic fever (CCHF) is a zoonosis mainly transmitted by ticks that causes severe hemorrhagic fever and has a mortality rate of 5-60%. The first outbreak of CCHF occurred in the Crimean peninsula in 1944-45 and it has recently emerged in the Balkans and eastern Mediterranean. In order to reconstruct the origin and pathway of the worldwide dispersion of the virus at global and regional (eastern European) level, we investigated the phylogeography of the infection by analysing 121 publicly available CCHFV S gene sequences including two recently characterised Albanian isolates. The spatial and temporal phylogeny was reconstructed using a Bayesian Markov chain Monte Carlo approach, which estimated a mean evolutionary rate of 2.96 x 10(-4) (95% HPD=1.6 and 4.7 x 10(-4)) substitutions/site/year for the analysed fragment. All of the isolates segregated into seven highly significant clades that correspond to the known geographical clades: in particular the two new isolates from northern Albania clustered significantly within the Europe 1 clade. Our phylogeographical reconstruction suggests that the global CCHFV clades originated about one thousand years ago from a common ancestor probably located in Africa. The virus then spread to Asia in the XV century and entered Europe on at least two occasions: the first in the early 1800s, when a still circulating but less or non-pathogenic virus emerged in Greece and Turkey, and the second in the early 1900s, when a pathogenic CCHFV strain began to spread in eastern Europe. The most probable location for the origin of this European clade 1 was Russia, but Turkey played a central role in spreading the virus throughout Europe. Given the close proximity of the infected areas, our data suggest that the movement of wild and domestic ungulates from endemic areas was probably the main cause of the dissemination of the virus in eastern Europe.	[Zehender, Gianguglielmo; Ebranati, Erika; Gabanelli, Elena; Lai, Alessia; Galli, Massimo] Univ Milan, Dept Clin Sci Luigi Sacco, Infect Dis Sect, Milan, Italy; [Shkjezi, Renata] Catholic Univ Our Lady Good Council, Fac Med, Tirana, Albania; [Papa, Anna] Aristotle Univ Thessaloniki, Sch Med, Dept Microbiol, Thessaloniki, Greece; [Luzzago, Camilla] Univ Milan, Dept Vet Sci & Publ Hlth, Milan, Italy; [Lo Presti, Alessandra; Rezza, Giovanni; Ciccozzi, Massimo] Ist Super Sanita, Dept Infect Parasit & Immunomediate Dis, Epidemiol Unit, Rome, Italy; [Bino, Silvia] Natl Inst Hlth, Control Infect Dis Dept, Tirana, Albania	University of Milan; Luigi Sacco Hospital; Aristotle University of Thessaloniki; University of Milan; Istituto Superiore di Sanita (ISS)	Zehender, G (corresponding author), Univ Milan, Dept Clin Sci Luigi Sacco, Infect Dis Sect, Milan, Italy.	gianguglielmo.zehender@unimi.it	CICCOZZI, MASSIMO/C-6484-2016; Lo Presti, Alessandra/K-1451-2016; Luzzago, Camilla/G-2829-2011; rezza, giovanni/D-4393-2016; Ciccozzi, Massimo/AAC-3271-2022; LAI, ALESSIA/AAR-1300-2021; GALLI, MASSIMO/L-7282-2017	CICCOZZI, MASSIMO/0000-0003-3866-9239; Lo Presti, Alessandra/0000-0001-7611-5021; Luzzago, Camilla/0000-0001-9236-2049; rezza, giovanni/0000-0003-0268-6790; Ciccozzi, Massimo/0000-0003-3866-9239; LAI, ALESSIA/0000-0002-3174-5721; GALLI, MASSIMO/0000-0001-8887-6215	European Commission [260427]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was supported by grants from the European Commission under the Health Cooperation Work Programme of the 7th Framework Programme (Grant agreement no 260427). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostou V, 2009, INFECT GENET EVOL, V9, P948, DOI 10.1016/j.meegid.2009.06.018; [Anonymous], 2012, EFSA J, V10, P2635; Aradaib IE, 2010, EMERG INFECT DIS, V16, P837, DOI 10.3201/eid1605.091815; Bakir M, 2005, J MED MICROBIOL, V54, P385, DOI 10.1099/jmm.0.45865-0; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Carroll SA, 2010, MOL PHYLOGENET EVOL, V55, P1103, DOI 10.1016/j.ympev.2010.01.006; Chinikar S, 2010, J CLIN VIROL, V47, P110, DOI 10.1016/j.jcv.2009.10.014; Chumakov M. P., 1945, MEDITSINSKA PARAZITOLOGI[IMAGE] I PARAZITARNYE BOLEZNI [MED PARASITOL AND PARASITIC DIS], V14, P18; Ciccozzi M, 2013, INFECT GENET EVOL, V17, P46, DOI 10.1016/j.meegid.2013.03.034; Deyde VM, 2006, J VIROL, V80, P8834, DOI 10.1128/JVI.00752-06; Di Nardo A, 2011, REV SCI TECH OIE, V30, P63; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; EFSA, 2010, EFSA J, V8, P1703; Ergonul O, 2006, LANCET INFECT DIS, V6, P203, DOI 10.1016/S1473-3099(06)70435-2; Estrada-Pena A, 2012, EMERG INFECT DIS, V18, P179, DOI 10.3201/eid1801.111040; Gargili A, 2011, VECTOR-BORNE ZOONOT, V11, P747, DOI 10.1089/vbz.2010.0030; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Han Na, 2011, Virologica Sinica, V26, P229, DOI 10.1007/s12250-011-3211-z; Hewson R, 2004, VIRUS RES, V102, P185, DOI 10.1016/j.virusres.2003.12.035; HOOGSTRAAL H, 1981, ANNU REV ENTOMOL, V26, P75, DOI 10.1146/annurev.en.26.010181.000451; Hubalek Z, 2012, PARASITOL RES, V111, P9, DOI 10.1007/s00436-012-2910-1; Jameson LJ, 2012, VECTOR-BORNE ZOONOT, V12, P753, DOI 10.1089/vbz.2011.0773; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; KONDRATENKO V F, 1976, Parazitologiya (St. Petersburg), V10, P297; Kovalev SY, 2009, J GEN VIROL, V90, P2884, DOI 10.1099/vir.0.012419-0; Kunchev A, 2008, EUROSURVEILLANCE, V13; Leblebicioglu H, 2010, INT J ANTIMICROB AG, V36, pS43, DOI 10.1016/j.ijantimicag.2010.06.020; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Mahzounieh M, 2012, VECTOR-BORNE ZOONOT, V12, P782, DOI 10.1089/vbz.2011.0928; Midilli K, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-54; Mild M, 2010, J GEN VIROL, V91, P199, DOI 10.1099/vir.0.014878-0; Nabeth P, 2007, EMERGING VIRUSES HUM, VS0168-7069, P16012; Ozkaya E, 2010, VIRUS RES, V149, P64, DOI 10.1016/j.virusres.2009.12.014; Papa A, 2008, EUROSURVEILLANCE, V13; Papa A, 2011, EMERG INFECT DIS, V17, P141, DOI 10.3201/eid1701.100073; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Roeder PL, 2006, RINDERPEST 20 21 CEN; Schmaljohn C.S., 2001, FIELDS VIROLOGY; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SHEPHERD AJ, 1987, T ROY SOC TROP MED H, V81, P1004, DOI 10.1016/0035-9203(87)90379-8; Sherman DM, 2011, REV SCI TECH OIE, V30, P207; SLATKIN M, 1989, GENETICS, V123, P603; Slingenbergh J, 2004, REV SCI TECH OIE, V23, P467, DOI 10.20506/rst.23.2.1492; SWANEPOEL R, 1987, AM J TROP MED HYG, V36, P120, DOI 10.4269/ajtmh.1987.36.120; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANDEWAL BW, 1985, S AFR MED J, V68, P729; Whitehouse CA, 2004, ANTIVIR RES, V64, P145, DOI 10.1016/j.antiviral.2004.08.001; Zehender G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037198; Zehender G, 2011, INFECT GENET EVOL, V11, P646, DOI 10.1016/j.meegid.2011.02.003	50	20	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79663	10.1371/journal.pone.0079663	http://dx.doi.org/10.1371/journal.pone.0079663			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223988	Green Published, Green Submitted, gold			2022-12-27	WOS:000326503400134
J	Berg, A; Zelano, J; Pekna, M; Wilhelmsson, U; Pekny, M; Cullheim, S				Berg, Alexander; Zelano, Johan; Pekna, Marcela; Wilhelmsson, Ulrika; Pekny, Milos; Cullheim, Staffan			Axonal Regeneration after Sciatic Nerve Lesion Is Delayed but Complete in GFAP- and Vimentin-Deficient Mice	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; INTERMEDIATE-FILAMENTS; SPINAL MOTONEURONS; ASTROCYTE ACTIVATION; SYNAPTIC TERMINALS; NEUROMUSCULAR-JUNCTION; FUNCTIONAL RECOVERY; CELL-PROLIFERATION; SCHWANN-CELLS; GLIAL-CELLS	Peripheral axotomy of motoneurons triggers Wallerian degeneration of injured axons distal to the lesion, followed by axon regeneration. Centrally, axotomy induces loss of synapses (synaptic stripping) from the surface of lesioned motoneurons in the spinal cord. At the lesion site, reactive Schwann cells provide trophic support and guidance for outgrowing axons. The mechanisms of synaptic stripping remain elusive, but reactive astrocytes and microglia appear to be important in this process. We studied axonal regeneration and synaptic stripping of motoneurons after a sciatic nerve lesion in mice lacking the intermediate filament (nanofilament) proteins glial fibrillary acidic protein (GFAP) and vimentin, which are upregulated in reactive astrocytes and Schwann cells. Seven days after sciatic nerve transection, ultrastructural analysis of synaptic density on the somata of injured motoneurons revealed more remaining boutons covering injured somata in GFAP(-/-)Vim(-/-) mice. After sciatic nerve crush in GFAP(-/-)Vim(-/-) mice, the fraction of reinnervated motor endplates on muscle fibers of the gastrocnemius muscle was reduced 13 days after the injury, and axonal regeneration and functional recovery were delayed but complete. Thus, the absence of GFAP and vimentin in glial cells does not seem to affect the outcome after peripheral motoneuron injury but may have an important effect on the response dynamics.	[Berg, Alexander; Cullheim, Staffan] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Zelano, Johan] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Pekna, Marcela; Wilhelmsson, Ulrika; Pekny, Milos] Univ Gothenburg, Ctr Brain Repair & Rehabil, Dept Clin Neurosci & Rehabil, Inst Neurosci & Physiol, Gothenburg, Sweden; [Pekna, Marcela; Pekny, Milos] Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia	Karolinska Institutet; Uppsala University; University of Gothenburg; Florey Institute of Neuroscience & Mental Health	Berg, A (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.	alexander.berg@ki.se	Pekna, Marcela/AAM-3261-2021; Pekna, Marcela/AAM-3249-2021; Zelano, Johan/AAF-1708-2021	Pekna, Marcela/0000-0003-2734-8237; Pekna, Marcela/0000-0003-2734-8237; Zelano, Johan/0000-0001-9445-4545; Wilhelmsson, Ulrika/0000-0003-3227-2687	Swedish Medical Research Council; AFA Research Foundation; ALF Goteborg [11392]; Sten A. Olsson Foundation for Research and Culture; Soderberg Foundations; Hjarnfonden; Hagstromer's Foundation Millennium; Swedish Stroke Foundation; Swedish Society for Medical Research; Free Mason Foundation; Amlov's Foundation; E. Jacobson's Donation Fund; NanoNet COST Action [BM1002]; EU [237956, 279017]	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); AFA Research Foundation; ALF Goteborg; Sten A. Olsson Foundation for Research and Culture; Soderberg Foundations; Hjarnfonden; Hagstromer's Foundation Millennium; Swedish Stroke Foundation; Swedish Society for Medical Research; Free Mason Foundation; Amlov's Foundation; E. Jacobson's Donation Fund; NanoNet COST Action(European Cooperation in Science and Technology (COST)); EU(European Commission)	This work was supported by the Swedish Medical Research Council, AFA Research Foundation, ALF Goteborg (project 11392), Sten A. Olsson Foundation for Research and Culture, Soderberg Foundations, Hjarnfonden, Hagstromer's Foundation Millennium, the Swedish Stroke Foundation, the Swedish Society for Medical Research, the Free Mason Foundation, Amlov's Foundation, E. Jacobson's Donation Fund, NanoNet COST Action (BM1002), the EU FP 7 Program EduGlia (237956), and the EU FP 7 Program TargetBraIn (279017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldskogius H, 1999, J NEUROSCI RES, V58, P33, DOI 10.1002/(SICI)1097-4547(19991001)58:1<33::AID-JNR5>3.3.CO;2-D; Alvarez FJ, 2011, J NEUROPHYSIOL; Barron K, 1983, SPINAL CORD RECONSTR, P7; Berg A, 2012, EXP NEUROL, V237, P8, DOI 10.1016/j.expneurol.2012.06.008; BLINZING.K, 1968, Z ZELLFORSCH MIK ANA, V85, P145, DOI 10.1007/BF00325030; Carlstedt T, 2000, Prog Brain Res, V127, P501; CHEN DH, 1978, J COMP NEUROL, V177, P635, DOI 10.1002/cne.901770407; Cho KS, 2005, J CELL SCI, V118, P863, DOI 10.1242/jcs.01658; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; COPE TC, 1994, J NEUROPHYSIOL, V71, P817, DOI 10.1152/jn.1994.71.2.817; de Pablo Y, 2013, HISTOCHEM CELL BIOL, V140, P81, DOI 10.1007/s00418-013-1110-0; Ding M, 1998, MOL BRAIN RES, V62, P77, DOI 10.1016/S0169-328X(98)00240-X; Ekmark-Lewen S, 2010, RESTOR NEUROL NEUROS, V28, P311, DOI 10.3233/RNN-2010-0529; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43; Feng Z, 2008, ANN NY ACAD SCI, V1132, P19, DOI 10.1196/annals.1405.016; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; JESSEN KR, 1990, DEVELOPMENT, V109, P91; Kinouchi R, 2003, NAT NEUROSCI, V6, P863, DOI 10.1038/nn1088; Koirala S, 2000, J NEUROBIOL, V44, P343, DOI 10.1002/1097-4695(20000905)44:3<343::AID-NEU5>3.0.CO;2-O; Kraft AW, 2013, FASEB J, V27, P187, DOI 10.1096/fj.12-208660; Lago N, 2006, J NEUROTRAUM, V23, P227, DOI 10.1089/neu.2006.23.227; Larsson A, 2004, NEUROCHEM RES, V29, P2069, DOI 10.1007/s11064-004-6880-2; Lepekhin EA, 2001, J NEUROCHEM, V79, P617, DOI 10.1046/j.1471-4159.2001.00595.x; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; Linda H, 2000, J COMP NEUROL, V425, P10; Lu YB, 2011, FASEB J, V25, P624, DOI 10.1096/fj.10-163790; Ludwin S K, 1988, Adv Neurol, V47, P215; Macauley SL, 2011, J NEUROSCI, V31, P15575, DOI 10.1523/JNEUROSCI.3579-11.2011; Madduri S, 2010, J PERIPHER NERV SYST, V15, P93, DOI 10.1111/j.1529-8027.2010.00257.x; Menet V, 2003, P NATL ACAD SCI USA, V100, P8999, DOI 10.1073/pnas.1533187100; Mor D, 2010, NEUROSCIENCE, V166, P1167, DOI 10.1016/j.neuroscience.2010.01.045; Oliveira ALR, 2004, P NATL ACAD SCI USA, V101, P17843, DOI 10.1073/pnas.0408154101; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; PEKNY M, 1995, EMBO J, V14, P1590, DOI 10.1002/j.1460-2075.1995.tb07147.x; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; Potokar M, 2007, TRAFFIC, V8, P12, DOI 10.1111/j.1600-0854.2006.00509.x; Potokar M, 2010, GLIA, V58, P1208, DOI 10.1002/glia.21000; STEFANSSON K, 1982, BRAIN RES, V234, P309, DOI 10.1016/0006-8993(82)90871-X; SUGIMURA K, 1989, MUSCLE NERVE, V12, P929, DOI 10.1002/mus.880121109; Sulaiman OAR, 2009, NEUROSURGERY, V65, pA105, DOI 10.1227/01.NEU.0000358537.30354.63; SUMNER BEH, 1975, EXP NEUROL, V49, P406, DOI 10.1016/0014-4886(75)90097-7; SVENSSON M, 1993, BRAIN RES BULL, V30, P499, DOI 10.1016/0361-9230(93)90284-I; Triolo D, 2006, J CELL SCI, V119, P3981, DOI 10.1242/jcs.03168; Vardjan N, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-144; Waller A., 1850, PHIL T R SOC, V140, P423, DOI DOI 10.1098/RSTL.1850.0021; Widestrand A, 2007, STEM CELLS, V25, P2619, DOI 10.1634/stemcells.2007-0122; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Wilhelmsson U, 2012, STEM CELLS, V30, P2320, DOI 10.1002/stem.1196; Zelano J, 2009, J COMP NEUROL, V517, P670, DOI 10.1002/cne.22186	51	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79395	10.1371/journal.pone.0079395	http://dx.doi.org/10.1371/journal.pone.0079395			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223940	Green Published, Green Submitted, gold			2022-12-27	WOS:000326499300080
J	Seliger, C; Leukel, P; Moeckel, S; Jachnik, B; Lottaz, C; Kreutz, M; Brawanski, A; Proescholdt, M; Bogdahn, U; Bosserhoff, AK; Vollmann-Zwerenz, A; Hau, P				Seliger, Corinna; Leukel, Petra; Moeckel, Sylvia; Jachnik, Birgit; Lottaz, Claudio; Kreutz, Marina; Brawanski, Alexander; Proescholdt, Martin; Bogdahn, Ulrich; Bosserhoff, Anja-Katrin; Vollmann-Zwerenz, Arabel; Hau, Peter			Lactate-Modulated Induction of THBS-1 Activates Transforming Growth Factor (TGF)-beta2 and Migration of Glioma Cells In Vitro	PLOS ONE			English	Article							CANCER STEM-CELLS; LATENT TGF-BETA; MATRIX METALLOPROTEINASE-2; THROMBOSPONDIN-1; EXPRESSION; GLIOBLASTOMA; MALIGNANCY; PROTEINS; MOTILITY; BINDING	Background: An important phenomenon observed in glioma metabolism is increased aerobic glycolysis in tumor cells, which is generally referred to as the Warburg effect. Transforming growth factor (TGF)-beta2, which we previously showed to be induced by lactic acid, is a key pathophysiological factor in glioblastoma, leading to increased invasion and severe local immunosuppression after proteolytic cleavage from its latency associated peptide. In this study we tested the hypothesis, that lactate regulates TGF-beta2 expression and glioma cell migration via induction of Thrombospondin-1 (THBS-1), a TGF-beta activating protein. Methods: Lactate levels were reduced by knockdown of LDH-A using specific small interfering RNA (siRNA) and competitive inhibition of LDH-A by sodium oxamate. Knockdown of THBS-1 was performed using specific siRNA. Western Blot, qRT-PCR, and ELISA were used to investigate expression levels of LDH-A, LDH-B, TGF-beta2 and THBS-1. Migration of cells was examined by Spheroid, Scratch and Boyden Chamber assays. Results: Knockdown of LDH-A with subsequent decrease of lactate concentration leads to reduced levels of THBS-1 and TGF-beta2 in glioma cells. Lactate addition increases THBS-1 protein, leading to increased activation of TGF-beta2. Inhibition of THBS-1 reduces TGF-beta2 protein and migration of glioma cells. Addition of synthetic THBS-1 can rescue reduced TGF-beta2 protein levels and glioma cell migration in siLDH-A treated cells. Conclusion: We define a regulatory cascade between lactate, THBS-1 and TGF-beta2, leading to enhanced migration of glioma cells. Our results demonstrate a specific interaction between tumor metabolism and migration and provide a better understanding of the mechanisms underlying glioma cell invasion.	[Seliger, Corinna; Leukel, Petra; Moeckel, Sylvia; Jachnik, Birgit; Bogdahn, Ulrich; Vollmann-Zwerenz, Arabel; Hau, Peter] Univ Hosp Regensburg, Dept Neurol, Regensburg, Germany; [Seliger, Corinna; Leukel, Petra; Moeckel, Sylvia; Jachnik, Birgit; Bogdahn, Ulrich; Vollmann-Zwerenz, Arabel; Hau, Peter] Univ Hosp Regensburg, Wilhelm Sander NeuroOncol Unit, Regensburg, Germany; [Bosserhoff, Anja-Katrin] Univ Regensburg, Inst Pathol, D-93053 Regensburg, Germany; [Kreutz, Marina] Univ Regensburg, Dept Hematol & Oncol, D-93053 Regensburg, Germany; [Brawanski, Alexander; Proescholdt, Martin] Univ Regensburg, Sch Med, Dept Neurosurg, D-93053 Regensburg, Germany; [Lottaz, Claudio] Inst Funct Genom, Regensburg, Germany	University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg	Hau, P (corresponding author), Univ Hosp Regensburg, Dept Neurol, Regensburg, Germany.	Peter.Hau@ukr.de		Hau, Peter/0000-0003-3894-5053; Lottaz, Claudio/0000-0003-0781-4827; Bosserhoff, Anja/0000-0001-8147-394X	University Hospital Regensburg (ReForM-C)	University Hospital Regensburg (ReForM-C)	Part of the work was funded by an internal grant of the University Hospital Regensburg (ReForM-C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adams J, 2004, INT J BIOCHEM CELL B, V36, P960, DOI 10.1016/j.biocel.2004.02.009; Adams JC, 2001, ANNU REV CELL DEV BI, V17, P25, DOI 10.1146/annurev.cellbio.17.1.25; Amagasaki K, 2001, INT J CANCER, V94, P508, DOI 10.1002/ijc.1497; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Arslan F, 2007, BRIT J CANCER, V96, P1560, DOI 10.1038/sj.bjc.6603766; Baumann F, 2009, NEURO-ONCOLOGY, V11, P368, DOI 10.1215/15228517-2008-106; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; BORNSTEIN P, 1995, J CELL BIOL, V130, P503, DOI 10.1083/jcb.130.3.503; Bouche M, 2000, FASEB J, V14, P1147, DOI 10.1096/fasebj.14.9.1147; Czekay RP, 2001, MOL BIOL CELL, V12, P1467, DOI 10.1091/mbc.12.5.1467; Das S, 2008, NAT CLIN PRACT NEURO, V4, P427, DOI 10.1038/ncpneuro0862; DERDA DF, 1980, J BIOL CHEM, V255, P1112; Formby B, 2003, BIOCHEM BIOPH RES CO, V305, P203, DOI 10.1016/S0006-291X(03)00723-X; Friese MA, 2004, CANCER RES, V64, P7596, DOI 10.1158/0008-5472.CAN-04-1627; FULHAM MJ, 1992, RADIOLOGY, V185, P675, DOI 10.1148/radiology.185.3.1438744; GRIFFITHS JR, 1991, BRIT J CANCER, V64, P425, DOI 10.1038/bjc.1991.326; Hau P, 2007, OLIGONUCLEOTIDES, V17, P201, DOI 10.1089/oli.2006.0053; HAWKINS RA, 1992, J NUCL MED, V33, P339; Hoffmann A, 2001, J CELL PHYSIOL, V188, P33, DOI 10.1002/jcp.1092; Kawataki T, 2000, NEUROPATHOLOGY, V20, P161, DOI 10.1046/j.1440-1789.2000.00327.x; Kim SA, 2001, MOL CELL BIOCHEM, V216, P21, DOI 10.1023/A:1011022822077; Kjellman C, 2000, INT J CANCER, V89, P251, DOI 10.1002/1097-0215(20000520)89:3<251::AID-IJC7>3.0.CO;2-5; LAWLER J, 1986, J CELL BIOL, V103, P1635, DOI 10.1083/jcb.103.5.1635; Lee T, 2003, J VASC SURG, V38, P147, DOI 10.1016/S0741-5214(02)75468-2; Murphy-Ullrich JE, 2000, CYTOKINE GROWTH F R, V11, P59, DOI 10.1016/S1359-6101(99)00029-5; Nickl-Jockschat T, 2007, INT J ONCOL, V30, P499; Ramm P, 2011, STEM CELLS DEV, V20, P2189, DOI 10.1089/scd.2010.0567; Ribeiro SMF, 1999, J BIOL CHEM, V274, P13586, DOI 10.1074/jbc.274.19.13586; Roberts DD, 1996, FASEB J, V10, P1183, DOI 10.1096/fasebj.10.10.8751720; Rofstad EK, 2006, CANCER RES, V66, P6699, DOI 10.1158/0008-5472.CAN-06-0983; Sasaki A, 2001, NEUROL MED-CHIR, V41, P253, DOI 10.2176/nmc.41.253; Schlingensiepen KH, 2006, CYTOKINE GROWTH F R, V17, P129, DOI 10.1016/j.cytogfr.2005.09.002; SCHULTZCHERRY S, 1995, J BIOL CHEM, V270, P7304, DOI 10.1074/jbc.270.13.7304; SILVERSTEIN RL, 1986, J BIOL CHEM, V261, P9959; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Stiles JD, 1997, J NEUROPATH EXP NEUR, V56, P435, DOI 10.1097/00005072-199704000-00012; STUBBS M, 1994, CANCER RES, V54, P4011; Sullivan DE, 2009, J CELL MOL MED, V13, P1866, DOI 10.1111/j.1582-4934.2009.00647.x; Theriault BL, 2011, CANCER LETT, V313, P108, DOI 10.1016/j.canlet.2011.08.033; Tuszynski GP, 1996, BIOESSAYS, V18, P71, DOI 10.1002/bies.950180113; Walenta S, 2004, SEMIN RADIAT ONCOL, V14, P267, DOI 10.1016/j.semradonc.2004.04.004; WARBURG O, 1956, SCIENCE, V124, P269; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wick W, 2006, CURR PHARM DESIGN, V12, P341, DOI 10.2174/138161206775201901; Wick W, 2001, J NEUROSCI, V21, P3360, DOI 10.1523/JNEUROSCI.21-10-03360.2001; Zhang H, 2003, BLOOD, V101, P2253, DOI 10.1182/blood-2002-02-0629	46	58	60	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78935	10.1371/journal.pone.0078935	http://dx.doi.org/10.1371/journal.pone.0078935			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223867	Green Submitted, Green Published, gold			2022-12-27	WOS:000326499300044
J	Bom, RJM; van der Helm, JJ; Bruisten, SM; Grunberg, AW; Sabajo, LOA; van der Loeff, MFS; de Vries, HJC				Bom, Reinier J. M.; van der Helm, Jannie J.; Bruisten, Sylvia M.; Gruenberg, Antoon W.; Sabajo, Leslie O. A.; van der Loeff, Maarten F. Schim; de Vries, Henry J. C.			The Role of Surinamese Migrants in the Transmission of Chlamydia trachomatis between Paramaribo, Suriname and Amsterdam, The Netherlands	PLOS ONE			English	Article							DISPARITIES; INFECTIONS; PATTERNS; HIV	The large Surinamese migrant population in the Netherlands is a major risk group for urogenital Chlamydia trachomatis infection. Suriname, a former Dutch colony, also has a high prevalence of C. trachomatis. Surinamese migrants travel extensively between the Netherlands and Suriname. Our objective was to assess whether the Surinamese migrants in the Netherlands form a bridge population facilitating transmission of C. trachomatis between Suriname and the Netherlands. If so, joint prevention campaigns involving both countries might be required. Between March 2008 and July 2010, participants were recruited at clinics in Paramaribo, Suriname and in Amsterdam, the Netherlands. Participants were grouped as native Surinamese, native Dutch, Surinamese migrant, Dutch migrant, or Other, based on country of residence and country of birth of the participant and of their parents. Risk behavior, such as sexual mixing between ethnic groups, was recorded and C. trachomatis positive samples were typed through multilocus sequence typing (MLST). A minimum spanning tree of samples from 426 participants showed four MLST clusters. The MLST strain distribution of Surinamese migrants differed significantly from both the native Surinamese and Dutch populations, but was not an intermediate state between these two populations. Sexual mixing between the Surinamese migrants and the Dutch and Surinamese natives occurred frequently. Yet, the MLST cluster distribution did not differ significantly between participants who mixed and those who did not. Sexual mixing occurred between Surinamese migrants in Amsterdam and the native populations of Suriname and the Netherlands. These migrants, however, did not seem to form an effective bridge population for C. trachomatis transmission between the native populations. Although our data do not seem to justify the need for joint campaigns to reduce the transmission of C. trachomatis strains between both countries, intensified preventive campaigns to decrease the C. trachomatis burden are required, both in Suriname and in the Netherlands.	[Bom, Reinier J. M.; Bruisten, Sylvia M.] Publ Hlth Serv Amsterdam, Publ Hlth Lab, Amsterdam, Netherlands; [van der Helm, Jannie J.; van der Loeff, Maarten F. Schim] Publ Hlth Serv Amsterdam, Dept Res, Amsterdam, Netherlands; [van der Helm, Jannie J.; de Vries, Henry J. C.] Publ Hlth Serv Amsterdam, STI Outpatient Clin, Amsterdam, Netherlands; [Bruisten, Sylvia M.] Univ Amsterdam, Acad Med Ctr, Dept Expt Virol, NL-1105 AZ Amsterdam, Netherlands; [Gruenberg, Antoon W.] Lobi Fdn, Paramaribo, Suriname; [Sabajo, Leslie O. A.] Minist Hlth, Dermatol Serv, Paramaribo, Suriname, Suriname; [de Vries, Henry J. C.] Univ Amsterdam, Acad Med Ctr, Dept Dermatol, NL-1105 AZ Amsterdam, Netherlands; [van der Loeff, Maarten F. Schim; de Vries, Henry J. C.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [de Vries, Henry J. C.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands	Public Health Service Amsterdam; Public Health Service Amsterdam; Public Health Service Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Netherlands National Institute for Public Health & the Environment	de Vries, HJC (corresponding author), Publ Hlth Serv Amsterdam, Publ Hlth Lab, Amsterdam, Netherlands.	h.j.devries@amc.nl	de Vries, Henry/K-5963-2012	de Vries, Henry/0000-0001-9784-547X; van der Helm, Jannie/0000-0002-4288-9544	Public Health Service of Amsterdam (GGD Amsterdam) [RD 2369]; AGIS healthcare insurance (RWZ), The Netherlands [1417000]	Public Health Service of Amsterdam (GGD Amsterdam); AGIS healthcare insurance (RWZ), The Netherlands(Netherlands Government)	This work was supported by the Public Health Service of Amsterdam (GGD Amsterdam, grant nr R&D 2369), and AGIS healthcare insurance (RWZ grant nr 1417000), The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimora AA, 2005, J INFECT DIS, V191, pS115, DOI 10.1086/425280; Aral SO, 2008, LANCET, V372, P337, DOI 10.1016/S0140-6736(08)61118-6; Aral SO, 2000, SEX TRANSM INFECT, V76, P415, DOI 10.1136/sti.76.6.415; Bom RJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053869; Bom RJM, 2011, J CLIN MICROBIOL, V49, P2844, DOI 10.1128/JCM.00128-11; Fenton K, 1997, BRIT MED J, V314, P1703, DOI 10.1136/bmj.314.7096.1703; Ford K, 2002, SEX TRANSM DIS, V29, P13, DOI 10.1097/00007435-200201000-00003; Heijman TLJ, 2007, SEX TRANSM DIS, V34, P508, DOI 10.1097/01.olq.0000251209.52901.c3; Kramer MA, 2008, SEX TRANSM INFECT, V84, P554, DOI 10.1136/sti.2008.032094; Pedersen LN, 2009, FEMS IMMUNOL MED MIC, V55, P120, DOI 10.1111/j.1574-695X.2008.00526.x; Quint KD, 2010, MOL CELL PROBE, V24, P266, DOI 10.1016/j.mcp.2010.04.007; Quint KD, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-63; The World Bank, SUR; Trienekens SC, 2012, 2010510012012 RIVM N; van der Helm JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032122; van Veen MG, 2009, AIDS CARE, V21, P683, DOI 10.1080/09540120802511984; van Veen MG, 2010, SEX TRANSM DIS, V37, P416, DOI 10.1097/OLQ.0b013e3181cfcb34	17	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e77977	10.1371/journal.pone.0077977	http://dx.doi.org/10.1371/journal.pone.0077977			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236009	gold, Green Submitted, Green Published			2022-12-27	WOS:000327254700006
J	Cai, XL; Han, XY; Luo, YY; Ji, LN				Cai, Xiaoling; Han, Xueyao; Luo, Yingying; Ji, Linong			Comparisons of the Efficacy of Alpha Glucosidase Inhibitors on Type 2 Diabetes Patients between Asian and Caucasian	PLOS ONE			English	Article							IMPROVES GLYCEMIC CONTROL; INTIMA-MEDIA THICKNESS; DOUBLE-BLIND; METABOLIC-CONTROL; NIDDM PATIENTS; ACARBOSE MONOTHERAPY; COMBINATION THERAPY; INSULIN SENSITIVITY; 24-WEEK MONOTHERAPY; JAPANESE PATIENTS	Background: To compare the efficacy of glycemic control and insulin secretion of alpha glucosidase inhibitors (AGI) on type 2 diabetes patients between Asian and Caucasian. Methodology/Principal Findings: The MEDLINE (R), EMBASE (R), CENTRAL were searched and qualified studies in Asian and Caucasian population comparing AGI treatment with placebo or other oral anti-diabetic drugs in type 2 diabetic patients were included. Totally 58 qualified studies were included. When AGI treatment was compared with placebo, a significant difference in HbA1c decline from baseline favoring AGI treatment was found in Asian (weighted mean difference (WMD), -0.50%; 95% CI, -0.66% to -0.34%) and in Caucasian a significant difference in HbA1c decline favoring AGI treatment was also found (WMD, -0.68%; 95% CI, -0.76% to -0.60%). In Asian, fasting plasma glucose was reduced with AGI treatment compared with placebo (WMD, -0.53 mmol/L; 95% CI, -0.91 to -0.14 mmol/L) and in Caucasian there was also a significant difference in FPG changes favoring AGI therapy (WMD, -0.88 mmol/L; 95% CI, -1.00 to -0.77 mmol/L). Studies in Asian showed a significant difference in fasting insulin changes favoring AGI treatment (WMD, -0.78 uU/ml; 95% CI, -0.96 to -0.59 uU/ml). While in Caucasian fasting insulin was decreased without significance with AGI treatment (WMD-1.24 uU/ml; 95% CI, -2.51 to 0.04 uU/ml). Body weight was decreased with AGI treatment in Asian (WMD, -1.00 kg; 95% CI, -1.69 to -0.31 kg) and was also decreased with AGI treatment in Caucasian (WMD, -0.73 kg; 95% CI, -1.13 to -0.33 kg). Conclusions/Significance: According to results from this meta-analysis, the efficacy in glucose lowering, body weight reduction and insulin secretion decreasing of AGI treatment in Asian were comparable with those in Caucasian.	[Cai, Xiaoling; Han, Xueyao; Luo, Yingying; Ji, Linong] Peking Univ, Peoples Hosp, Dept Endocrinol & Metab, Beijing 100871, Peoples R China	Peking University	Ji, LN (corresponding author), Peking Univ, Peoples Hosp, Dept Endocrinol & Metab, Beijing 100871, Peoples R China.	prof_jilinong@aliyun.com	Linong, Ji/AAB-6543-2020	Cai, Xiaoling/0000-0002-7881-0543	National Natural Science Foundation of China (NSFC) [81000334]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This meta-analysis was supported by National Natural Science Foundation of China (NSFC) 81000334. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann W, 2003, CLIN DRUG INVEST, V23, P679, DOI 10.2165/00044011-200323100-00007; Bao YQ, 2010, CLIN EXP PHARMACOL P, V37, P564, DOI 10.1111/j.1440-1681.2010.05361.x; Bayraktar M, 1996, DIABETES CARE, V19, P252, DOI 10.2337/diacare.19.3.252; CallePascual A, 1996, DIABETES METAB, V22, P201; Chan JCN, 1998, DIABETES CARE, V21, P1058, DOI 10.2337/diacare.21.7.1058; CHIASSON JL, 1994, ANN INTERN MED, V121, P928, DOI 10.7326/0003-4819-121-12-199412150-00004; Chiasson JL, 2001, DIABETES CARE, V24, P989, DOI 10.2337/diacare.24.6.989; Delgado H, 2002, DIABETES METAB, V28, P195; Derosa G, 2010, J CLIN PHARM THER, V35, P565, DOI 10.1111/j.1365-2710.2009.01132.x; Derosa G, 2012, CLIN THER, V34, P1221, DOI 10.1016/j.clinthera.2012.04.012; Derosa G, 2011, J DIABETES COMPLICAT, V25, P258, DOI 10.1016/j.jdiacomp.2011.01.003; Derosa Giuseppe, 2009, BIOMEDICINE PHARMACO, V63; Duran C, 2009, J ENDOCRINOL INVEST, V32, P69, DOI 10.1007/BF03345682; Feinbock C, 2003, DIABETES NUTR METAB, V16, P214; Fischer S, 2003, DIABETES OBES METAB, V5, P38, DOI 10.1046/j.1463-1326.2003.00239.x; Food and Agriculture Organization of the United Nations, 2013, DIM NEED STAPL FOODS; Gentile S, 2001, DIABETES OBES METAB, V3, P33, DOI 10.1046/j.1463-1326.2001.00103.x; Goke Burkhard, 2002, Treat Endocrinol, V1, P329; Guvener N, 1999, ACTA DIABETOL, V36, P93, DOI 10.1007/s005920050151; Halimi S, 2000, DIABETES RES CLIN PR, V50, P49, DOI 10.1016/S0168-8227(00)00163-7; Hanefeld M, 2002, DIABETES RES CLIN PR, V55, P221, DOI 10.1016/S0168-8227(01)00347-3; Hanefeld M, 2009, HORM METAB RES, V41, P132, DOI 10.1055/s-0028-1119407; Hasche H, 1999, DIABETES NUTR METAB, V12, P277; Hoffmann J, 1997, AM J MED, V103, P483, DOI 10.1016/S0002-9343(97)00252-0; HOFFMANN J, 1994, DIABETES CARE, V17, P561, DOI 10.2337/diacare.17.6.561; HOTTA N, 1993, DIABETIC MED, V10, P134, DOI 10.1111/j.1464-5491.1993.tb00030.x; Hsieh SH, 2011, ACTA DIABETOL, V48, P71, DOI 10.1007/s00592-010-0220-6; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Hwu CM, 2003, DIABETES RES CLIN PR, V60, P111, DOI 10.1016/S0168-8227(03)00015-9; Iwamoto Y, 2010, DIABETES OBES METAB, V12, P613, DOI 10.1111/j.1463-1326.2010.01197.x; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jayaram S, 2010, J ASSOC PHYSICIAN I, V58, P12; Johnston PS, 1998, DIABETES CARE, V21, P416, DOI 10.2337/diacare.21.3.416; Johnston PS, 1998, DIABETES CARE, V21, P409, DOI 10.2337/diacare.21.3.409; JOSSE RG, 1995, DIABETES RES CLIN PR, V28, pS167, DOI 10.1016/0168-8227(95)01081-N; Josse RG, 2003, DIABETES RES CLIN PR, V59, P37, DOI 10.1016/S0168-8227(02)00176-6; Kato T, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-12; Kawamori R, 2012, DIABETES OBES METAB, V14, P348, DOI 10.1111/j.1463-1326.2011.01545.x; Kelley DE, 1998, DIABETES CARE, V21, P2056, DOI 10.2337/diacare.21.12.2056; Kirkman MS, 2006, DIABETES CARE, V29, P2095, DOI 10.2337/dc06-0061; Koyasu M, 2010, CLIN THER, V32, P1610, DOI 10.1016/j.clinthera.2010.07.015; Lam KSL, 1998, DIABETES CARE, V21, P1154, DOI 10.2337/diacare.21.7.1154; Laube H, 2002, CLIN DRUG INVEST, V22, P141, DOI 10.2165/00044011-200222030-00001; Lebovitz HE, 1998, DIABETES REV, V6, P132; Lin BJ, 2003, J DIABETES COMPLICAT, V17, P179, DOI 10.1016/S1056-8727(02)00258-1; Lin SD, 2011, J DIABETES COMPLICAT, V25, P332, DOI 10.1016/j.jdiacomp.2011.06.004; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; Meneilly GS, 2000, DIABETES CARE, V23, P1162, DOI 10.2337/diacare.23.8.1162; Mitrakou A, 1998, DIABETIC MED, V15, P657, DOI 10.1002/(SICI)1096-9136(199808)15:8<657::AID-DIA652>3.3.CO;2-Z; Nemoto M, 2011, ACTA DIABETOL, V48, P15, DOI 10.1007/s00592-010-0206-4; Oyama T, 2008, J ATHEROSCLER THROMB, V15, P154, DOI 10.5551/jat.E549; Pan C, 2008, DIABETIC MED, V25, P435, DOI 10.1111/j.1464-5491.2008.02391.x; Phillips P, 2003, DIABETES CARE, V26, P269, DOI 10.2337/diacare.26.2.269; Rosenbaum P, 2002, BRAZ J MED BIOL RES, V35, P877, DOI 10.1590/S0100-879X2002000800004; Rosenstock J, 1998, DIABETES CARE, V21, P2050, DOI 10.2337/diacare.21.12.2050; Salman S, 2001, CURR MED RES OPIN, V16, P296, DOI 10.1185/030079901750120231; Schnell O, 2007, DIABETES OBES METAB, V9, P853, DOI 10.1111/j.1463-1326.2006.00666.x; Scott R, 1999, DIABETES RES CLIN PR, V43, P179, DOI 10.1016/S0168-8227(99)00009-1; Segal P, 1997, DIABETES CARE, V20, P687, DOI 10.2337/diacare.20.5.687; Standl E, 2001, DIABETES RES CLIN PR, V51, P205, DOI 10.1016/S0168-8227(00)00231-X; Standl E, 1999, DIABETES OBES METAB, V1, P215, DOI 10.1046/j.1463-1326.1999.00021.x; Takami K, 2002, DIABETES CARE, V25, P658, DOI 10.2337/diacare.25.4.658; van de Laar FA, 2005, DIABETES CARE, V28, P154, DOI 10.2337/diacare.28.1.154; Van Gaal L, 2001, DIABETES OBES METAB, V3, P326, DOI 10.1046/j.1463-1326.2001.00141.x; Wagner H, 2006, DIABETES CARE, V29, P1471, DOI 10.2337/dc05-2513; Wang JS, 2011, CLIN THER, V33, P1932, DOI 10.1016/j.clinthera.2011.10.014; Willms B, 1999, DIABETIC MED, V16, P755, DOI 10.1046/j.1464-5491.1999.00149.x; Yilmaz H, 2007, ACTA DIABETOL, V44, P187, DOI 10.1007/s00592-007-0004-9; Yokoyama H, 2007, METABOLISM, V56, P1458, DOI 10.1016/j.metabol.2007.06.010; Zhu QB, 2013, CLIN THER, V35, P880, DOI 10.1016/j.clinthera.2013.03.020	70	22	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79421	10.1371/journal.pone.0079421	http://dx.doi.org/10.1371/journal.pone.0079421			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236131	gold, Green Submitted, Green Published			2022-12-27	WOS:000327254700130
J	Dehnhard, N; Ludynia, K; Poisbleau, M; Demongin, L; Quillfeldt, P				Dehnhard, Nina; Ludynia, Katrin; Poisbleau, Maud; Demongin, Laurent; Quillfeldt, Petra			Good Days, Bad Days: Wind as a Driver of Foraging Success in a Flightless Seabird, the Southern Rockhopper Penguin	PLOS ONE			English	Article							EUDYPTES-CHRYSOCOME-CHRYSOCOME; BREEDING SUCCESS; POPULATION TRENDS; DIET COMPOSITION; C.-CHRYSOCOME; KING PENGUINS; EL-NINO; ISLAND; PRODUCTIVITY; SURVIVAL	Due to their restricted foraging range, flightless seabirds are ideal models to study the short-term variability in foraging success in response to environmentally driven food availability. Wind can be a driver of upwelling and food abundance in marine ecosystems such as the Southern Ocean, where wind regime changes due to global warming may have important ecological consequences. Southern rockhopper penguins (Eudyptes chrysocome) have undergone a dramatic population decline in the past decades, potentially due to changing environmental conditions. We used a weighbridge system to record daily foraging mass gain (the difference in mean mass of adults leaving the colony in the morning and returning to the colony in the evening) of adult penguins during the chick rearing in two breeding seasons. We related the day-to-day variability in foraging mass gain to ocean wind conditions (wind direction and wind speed) and tested for a relationship between wind speed and sea surface temperature anomaly (SSTA). Foraging mass gain was highly variable among days, but did not differ between breeding seasons, chick rearing stages (guard and creche) and sexes. It was strongly correlated between males and females, indicating synchronous changes among days. There was a significant interaction of wind direction and wind speed on daily foraging mass gain. Foraging mass gain was highest under moderate to strong winds from westerly directions and under weak winds from easterly directions, while decreasing under stronger easterly winds and storm conditions. Ocean wind speed showed a negative correlation with daily SSTA, suggesting that winds particularly from westerly directions might enhance upwelling and consequently the prey availability in the penguins' foraging areas. Our data emphasize the importance of small-scale, wind-induced patterns in prey availability on foraging success, a widely neglected aspect in seabird foraging studies, which might become more important with increasing changes in climatic variability.	[Dehnhard, Nina; Ludynia, Katrin; Poisbleau, Maud; Demongin, Laurent; Quillfeldt, Petra] Max Planck Inst Ornithol, Vogelwarte Radolfzell, Radolfzell am Bodensee, Germany; [Ludynia, Katrin] Univ Cape Town, Anim Demog Unit, ZA-7925 Cape Town, South Africa; [Poisbleau, Maud; Demongin, Laurent] Univ Antwerp, Dept Biol Ethol, Antwerp, Belgium; [Quillfeldt, Petra] Univ Giessen, Behav Ecol & Ecophysiol Grp, D-35390 Giessen, Germany	Max Planck Society; University of Cape Town; University of Antwerp; Justus Liebig University Giessen	Dehnhard, N (corresponding author), Max Planck Inst Ornithol, Vogelwarte Radolfzell, Radolfzell am Bodensee, Germany.	dehnhard@orn.mpg.de	Dehnhard, Nina/H-6160-2016; Poisbleau, Maud/B-9968-2014; Quillfeldt, Petra/A-9549-2009	Dehnhard, Nina/0000-0002-4182-2698; Poisbleau, Maud/0000-0002-0729-3251; Quillfeldt, Petra/0000-0002-4450-8688; Ludynia, Katrin/0000-0002-0353-1929; Chiaradia, Andre/0000-0002-6178-4211	Deutsche Forschungsgemeinschaft (DFG) [Qu 148/1-ff]; Overseas Territories Environment Programme (OTEP) [FAL 603]; Environmental Studies Budget grant from the Falkland Islands Government	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Overseas Territories Environment Programme (OTEP); Environmental Studies Budget grant from the Falkland Islands Government	This study was funded by a grant provided by the Deutsche Forschungsgemeinschaft (DFG, Qu 148/1-ff), Overseas Territories Environment Programme (OTEP, FAL 603) and an Environmental Studies Budget grant from the Falkland Islands Government. The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	Acha EM, 2004, J MARINE SYST, V44, P83, DOI 10.1016/j.jmarsys.2003.09.005; Ahrens C. D., 2011, ESSENTIALS METEOROLO; Arkhipkin A, 2010, FISH RES, V105, P156, DOI 10.1016/j.fishres.2010.03.022; Auth TD, 2011, FISH OCEANOGR, V20, P314, DOI 10.1111/j.1365-2419.2011.00586.x; Ballard G, 2010, MAR ECOL PROG SER, V405, P287, DOI 10.3354/meps08514; Baylis AMM, 2013, POLAR BIOL, V36, P1007, DOI 10.1007/s00300-013-1324-6; Birdlife International, 2010, P INT WORKSH ED 3 5; Boersma PD, 2008, BIOSCIENCE, V58, P597, DOI 10.1641/B580707; Boersma PD, 1998, CONDOR, V100, P245, DOI 10.2307/1370265; Bost CA, 2009, J MARINE SYST, V78, P363, DOI 10.1016/j.jmarsys.2008.11.022; Clarke JR, 2001, POLAR BIOL, V24, P16, DOI 10.1007/s003000000168; Clausen AP, 2002, AQUAT CONSERV, V12, P51, DOI 10.1002/aqc.476; Croxall J. P., 1999, Marine Ornithology, V27, P1; CROXALL JP, 1985, J ZOOL, V206, P485; Croxall JP, 1999, MAR ECOL PROG SER, V177, P115, DOI 10.3354/meps177115; CUNNINGHAM DM, 1994, EMU, V94, P27, DOI 10.1071/MU9940027; Davies RG, 2010, GLOBAL ECOL BIOGEOGR, V19, P98, DOI 10.1111/j.1466-8238.2009.00498.x; Dehnhard N, 2013, AQUAT CONSERV, V23, P777, DOI 10.1002/aqc.2331; Erwin CA, 2007, MAR ECOL PROG SER, V331, P255, DOI 10.3354/meps331255; Frederiksen M, 2007, MAR ECOL PROG SER, V350, P137, DOI 10.3354/meps07126; Furness RW, 1997, ICES J MAR SCI, V54, P726, DOI 10.1006/jmsc.1997.0243; Fyfe JC, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025332; HEATH RGM, 1985, J ZOOL, V205, P91; Lagadeuc Y, 1997, J PLANKTON RES, V19, P1183, DOI 10.1093/plankt/19.9.1183; Lescroel A, 2010, ECOLOGY, V91, P2044, DOI 10.1890/09-0766.1; Ludynia K, 2013, ANIM BEHAV, V85, P255, DOI 10.1016/j.anbehav.2012.11.001; Ludynia K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050429; Masello JF, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00103.1; Matley JK, 2012, MAR ECOL PROG SER, V450, P219, DOI 10.3354/meps09561; MONTEVECCHI WA, 1995, MAR ECOL PROG SER, V117, P1, DOI 10.3354/meps117001; Morrison KW, 2009, CONDOR, V111, P433, DOI 10.1525/cond.2009.080099; Nicolaus M, 2008, ARDEA, V96, P286, DOI 10.5253/078.096.0215; Peron C, 2012, P ROY SOC B-BIOL SCI, V279, P2515, DOI 10.1098/rspb.2011.2705; PIEROTTI R, 1990, BIOSCIENCE, V40, P568, DOI 10.2307/1311297; Poisbleau M, 2008, POLAR BIOL, V31, P925, DOI 10.1007/s00300-008-0431-2; Poisbleau M, 2010, ARDEA, V98, P217, DOI 10.5253/078.098.0212; Putz K, 2003, WATERBIRDS, V26, P169, DOI 10.1675/1524-4695(2003)026[0169:ROHRPP]2.0.CO;2; Putz K, 2001, POLAR BIOL, V24, P793, DOI 10.1007/s003000100293; Quilifeldt P, 2007, J AVIAN BIOL, V38, P298, DOI 10.1111/j.2007.0908-8857.03846.x; Quillfeldt P, 2001, ANTARCT SCI, V13, P400, DOI 10.1017/S0954102001000566; *R DEV COR TEAM, 2013, R LANG ENV STAT COMP; Rey AR, 2007, IBIS, V149, P826; Rey AR, 2005, POLAR BIOL, V28, P132, DOI 10.1007/s00300-004-0668-3; Ropert-Coudert Y, 2009, P ROY SOC B-BIOL SCI, V276, P4105, DOI 10.1098/rspb.2009.1399; Saether BE, 2004, AM NAT, V164, P793, DOI 10.1086/425371; Saraux C, 2011, ECOLOGY, V92, P1909, DOI 10.1890/11-0407.1; Saraux C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020407; Saraux C, 2011, NATURE, V469, P203, DOI 10.1038/nature09630; Scheffer A, 2012, MAR ECOL PROG SER, V465, P281, DOI 10.3354/meps09884; Spear LB, 1997, IBIS, V139, P221, DOI 10.1111/j.1474-919X.1997.tb04620.x; Stearns S.C., 1992, pi; STRANGE I J, 1982, Gerfaut, V72, P137; Suryan RM, 2002, MAR ECOL PROG SER, V236, P273, DOI 10.3354/meps236273; THOMPSON KR, 1994, ANTARCT SCI, V6, P269, DOI 10.1017/S0954102094000404; Upton J, 2002, AQUAT CONSERV, V12, P15, DOI 10.1002/aqc.496; Vargas FH, 2006, BIOL CONSERV, V127, P107, DOI 10.1016/j.biocon.2005.08.001; Weimerskirch H, 2012, SCIENCE, V335, P211, DOI 10.1126/science.1210270; Williams T.D., 1995, PENGUINS; Wilson Rory P., 1999, Marine Ornithology, V27, P85; Wood S, 2013, PACKAGE MGCV R PACKA; YDENBERG RC, 1994, BEHAV ECOL, V5, P28, DOI 10.1093/beheco/5.1.28; Zuur Alain F., 2009, P1	62	32	32	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79487	10.1371/journal.pone.0079487	http://dx.doi.org/10.1371/journal.pone.0079487			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236139	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700138
J	Eren, MI; Jennings, TA; Smallwood, AM				Eren, Metin I.; Jennings, Thomas A.; Smallwood, Ashley M.			Paleoindian Unifacial Stone Tool 'Spurs': Intended Accessories or Incidental Accidents?	PLOS ONE			English	Article							SHERIDEN CAVE; END SCRAPERS; TECHNOLOGY; REDUCTION; POINT; BIFACE; SITE; AGE; ORGANIZATION; VARIABILITY	Paleoindian unifacial stone tools frequently exhibit distinct, sharp projections, known as "spurs". During the last two decades, a theoretically and empirically informed interpretation-based on individual artifact analysis, use-wear, tool-production techniques, and studies of resharpening-suggested that spurs were sometimes created intentionally via retouch, and other times created incidentally via resharpening or knapping accidents. However, more recently Weedman strongly criticized the inference that Paleoindian spurs were ever intentionally produced or served a functional purpose, and asserted that ethnographic research "demonstrates that the presence of so called 'graver' spurs does not have a functional significance." While ethnographic data cannot serve as a direct test of the archaeological record, we used Weedman's ethnographic observations to create two quantitative predictions of the Paleoindian archaeological record in order to directly examine the hypothesis that Paleoindian spurs were predominantly accidents occurring incidentally via resharpening and reshaping. The first prediction is that the frequency of spurs should increase as tool reduction proceeds. The second prediction is that the frequency of spurs should increase as tool breakage increases. An examination of 563 unbroken tools and 629 tool fragments from the Clovis archaeological record of the North American Lower Great Lakes region showed that neither prediction was consistent with the notion that spurs were predominately accidents. Instead, our results support the prevailing viewpoint that spurs were sometimes created intentionally via retouch, and other times, created incidentally via resharpening or knapping accidents. Behaviorally, this result is consistent with the notion that unifacial stone tools were multifunctional implements that enhanced the mobile lifestyle of Pleistocene hunter-gatherers.	[Eren, Metin I.] Univ Kent, Dept Anthropol, Canterbury, Kent, England; [Eren, Metin I.] Cleveland Museum Nat Hist, Dept Archaeol, Cleveland, OH USA; [Jennings, Thomas A.; Smallwood, Ashley M.] Univ West Georgia, Dept Anthropol, Carrollton, GA USA	University of Kent; Cleveland Museum of Natural History; University System of Georgia; University of West Georgia	Eren, MI (corresponding author), Univ Kent, Dept Anthropol, Marlowe Bldg, Canterbury, Kent, England.	metin.i.eren@gmail.com		Smallwood, Ashley/0000-0003-2945-9061	Leverhulme Trust Early Career Fellowship Program	Leverhulme Trust Early Career Fellowship Program	MIE is grateful to The Leverhulme Trust Early Career Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson David G., 1990, EARLY PALEOINDIAN EC, V5, P163; [Anonymous], 1986, ARCHAEOL E N AM; [Anonymous], 1989, E PALEOINDIAN LITHIC; [Anonymous], 2005, PEOPLES FLUTE STUDY; [Anonymous], 2012, J OHIO ARCHAEOLOGY; [Anonymous], 1 DISCOVERY AM ARCHA; Bamforth DB, 2009, J ANTHROPOL ARCHAEOL, V28, P142, DOI 10.1016/j.jaa.2009.01.002; BINFORD LR, 1979, J ANTHROPOL RES, V35, P255, DOI 10.1086/jar.35.3.3629902; Blades BS, 2003, AM ANTIQUITY, V68, P141, DOI 10.2307/3557037; BLEED P, 1986, AM ANTIQUITY, V51, P737, DOI 10.2307/280862; Buchanan B, 2006, J ARCHAEOL SCI, V33, P185, DOI 10.1016/j.jas.2005.07.008; Buchanan B, 2012, PLOS ONE, V7, P1; Buchanan B, 2007, J ANTHROPOL ARCHAEOL, V26, P366, DOI 10.1016/j.jaa.2007.02.005; Buchanan B, 2011, J ARCHAEOL SCI, V38, P852, DOI 10.1016/j.jas.2010.11.007; Buchanan B, 2010, NEW PERSPECTIVES ON OLD STONES: ANALYTICAL APPROACHES TO PALEOLITHIC TECHNOLOGIES, P255, DOI 10.1007/978-1-4419-6861-6_11; Buchanan B, 2010, J ARCHAEOL SCI, V37, P350, DOI 10.1016/j.jas.2009.09.047; Buchanan B, 2009, AM ANTIQUITY, V74, P279, DOI 10.1017/S0002731600048605; Callahan E, 1990, BASICS BIFACE KNAPPI; Cannon MD, 2008, QUATERN INT, V191, P5, DOI 10.1016/j.quaint.2008.03.002; Clark J. D., 1981, MODERN MAT CULTURE A, P303; Collins M. B., 1999, CLOVIS BLADE TECHNOL; Deller D, 2011, CROWFIELD AFHJ 31 UN; Deller D, 1992, THEDFORD 2 PALEO IND; Deller DB, 2009, AM ANTIQUITY, V74, P371, DOI 10.1017/S0002731600048642; ELLIS C, 1995, J FIELD ARCHAEOL, V22, P459, DOI 10.1179/009346995791974143; Ellis C, 1998, QUATERN INT, V50, P151; Ellis C, 2002, CARADOC SITE LATE PA; Ellis C, 1997, ARCHAEOLOGY E N AM, V25, P1; Ellis C, 1988, MIDCONTINENTAL J ARC, V13, P111; Ellis C, 2000, 159 CAN MUS CIV ARCH, V159; Ellis C, 2008, J ANTHROPOL ARCHAEOL, V27, P298, DOI 10.1016/j.jaa.2008.05.002; Ellis C, 2011, J ANTHROPOL ARCHAEOL, V30, P385, DOI 10.1016/j.jaa.2011.05.001; Ellis CJ, 2011, QUATERN INT, V242, P534, DOI 10.1016/j.quaint.2011.02.038; Eren M. I., 2011, OPEN ANTHR J, V4, P40, DOI [10.2174/1874912701104010040, DOI 10.2174/1874912701104010040]; Eren MI, 2013, J ARCHAEOL SCI, V40, P2934, DOI 10.1016/j.jas.2013.02.031; Eren MI, 2013, J ARCHAEOL SCI, V40, P2101, DOI 10.1016/j.jas.2012.12.013; Eren MI, 2013, AM ANTIQUITY, V78, P166, DOI 10.7183/0002-7316.78.1.166; Eren MI, 2011, MIDCONT J ARCHAEOL, V36, P173, DOI 10.1179/mca.2011.009; Eren MI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034179; Eren MI, 2005, CURRENT RES PLEISTOC, V22, P43; FRISON GC, 1989, AM ANTIQUITY, V54, P766, DOI 10.2307/280681; Gould R. A., 1969, YIWARA FORAGERS AUST; Graf KE, 2010, J ARCHAEOL SCI, V37, P210, DOI 10.1016/j.jas.2009.09.034; Grimes J, 1985, ARCHAEOLOGY E N AM, V13, P35; GRIMES JR, 1984, ARCHAEOLOGY E N AM, V12, P159; Hamilton MJ, 2009, J ANTHROPOL ARCHAEOL, V28, P55, DOI 10.1016/j.jaa.2008.10.005; Hardy B, 2009, MANUAL CARDIOVASCULA, V18, P109; Iovita R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029029; Iovita R, 2010, NEW PERSPECTIVES ON OLD STONES: ANALYTICAL APPROACHES TO PALEOLITHIC TECHNOLOGIES, P235, DOI 10.1007/978-1-4419-6861-6_10; IRWIN HT, 1970, AM ANTIQUITY, V35, P24, DOI 10.2307/278175; Jackson L.J., 1998, SANDY RIDGE HALSTEAD; Jennings TA, 2013, J ARCHAEOL SCI, V40, P649, DOI 10.1016/j.jas.2012.07.016; Jennings TA, 2010, J ARCHAEOL SCI, V37, P2155, DOI 10.1016/j.jas.2010.02.020; Kelly R., 2003, COLONIZATION UNFAMIL, P44; KELLY RL, 1988, AM ANTIQUITY, V53, P231, DOI 10.2307/281017; Kraft H.C., 1973, ARCHAEOL E N AM, V1, P56; KUHN SL, 1994, AM ANTIQUITY, V59, P426, DOI 10.2307/282456; Loebel T. J., 2013, E FLUTED POINT TRADI, P315; Loebel TJ, 2012, J ARCHAEOL SCI, V39, P1205, DOI 10.1016/j.jas.2011.12.012; Lothrop J, 1988, THESIS STATE U NEW Y; Lothrop J., 1989, E PALEOINDIAN LITHIC, P99; Lycett SJ, 2006, J ARCHAEOL SCI, V33, P847, DOI 10.1016/j.jas.2005.10.014; Lycett SJ, 2010, NEW PERSPECTIVES ON OLD STONES: ANALYTICAL APPROACHES TO PALEOLITHIC TECHNOLOGIES, P1, DOI 10.1007/978-1-4419-6861-6_1; MacDonald GF, 1968, DEBERT PALAEO INDIAN; McCall GS, 2012, J ARCHAEOL RES, V20, P157, DOI 10.1007/s10814-011-9056-z; Meltzer D. J., 1993, KOSTENKI CLOVIS, P293; Meltzer D. J., 2009, 1 PEOPLES NEW WORLD; Meltzer D.J., 2002, 1 AM PLEISTOCENE COL, P27; Meltzer DJ, 2004, SETTLEMENT OF THE AMERICAN CONTINENTS, P123; Meltzer DJ., 1981, J FIELD ARCHAEOL, V8, P313; Meltzer DJ, 2003, COLONIZATION UNFAMIL; Miller GL, 2013, LITHIC TECHNOLOGY; MORRIS EA, 1987, AM ANTIQUITY, V52, P830, DOI 10.2307/281391; Morrow JE, 1999, AM ANTIQUITY, V64, P215, DOI 10.2307/2694275; Morrow JE., 1997, LITHIC TECHNOL, V22, P70, DOI [10.1080/01977261.1997.11754534, DOI 10.1080/01977261.1997.11754534]; Nelson M.C., 1991, ARCHAEOLOGICAL METHO, P57, DOI DOI 10.2307/20170213; Nissen K., 1974, TEBIWA, V17, P67; Patten RJ, 2002, SPECIAL PUBLICATION, P299; Prasciunas MM, 2007, AM ANTIQUITY, V72, P334, DOI 10.2307/40035817; Redmond BG, 2005, AM ANTIQUITY, V70, P503, DOI 10.2307/40035311; ROGERS RA, 1986, AM ANTIQUITY, V51, P338, DOI 10.2307/279945; Rule P, 1985, SHAWNEE MINISINK STR, P211, DOI DOI 10.1016/B978-0-12-485971-5.50014; Sellet F, 2004, J ARCHAEOL SCI, V31, P1553, DOI 10.1016/j.jas.2004.03.016; Sellet F, 2006, ARCHAEOLOGY ETHNOARC, P221; SHOTT M, 1986, J ANTHROPOL RES, V42, P15, DOI 10.1086/jar.42.1.3630378; Shott M, 1989, E PALEOINDIAN LITHIC, P221; Shott M, 1993, MEMOIRS U MICHIGAN M, V25; Shott M.J., 1995, LITHIC TECHNOL, V20, P53; Shott MJ, 2007, J ARCHAEOL SCI, V34, P1016, DOI 10.1016/j.jas.2006.09.009; Shott MJ, 2007, AM ANTIQUITY, V72, P153, DOI 10.2307/40035302; Shott MJ, 2010, NEW PERSPECTIVES ON OLD STONES: ANALYTICAL APPROACHES TO PALEOLITHIC TECHNOLOGIES, P275, DOI 10.1007/978-1-4419-6861-6_12; Simons Donald B., 1997, CARIBOU REINDEER HUN, P105; Smallwood AM, 2012, AM ANTIQUITY, V77, P689, DOI 10.7183/0002-7316.77.4.689; Smallwood AM, 2010, J ARCHAEOL SCI, V37, P2413, DOI 10.1016/j.jas.2010.05.002; Storck P. L., 1997, FISHER SITE ARCHAEOL; STORCK PL, 1994, AM ANTIQUITY, V59, P121, DOI 10.2307/3085506; Surovell T., 2009, BEHAV ECOLOGY LITHIC; Tankersley K, 1990, RES EC ANTHR S5, P259; TANKERSLEY KB, 1994, AM ANTIQUITY, V59, P498, DOI 10.2307/282462; Tomenchuk J, 1997, AM ANTIQUITY, V62, P508, DOI 10.2307/282168; Torrence R, 2001, BIOSOCIAL S, V13, P73; Torrence R, 1983, TIME ENERGY STONE TO, P1; Vaughan P.C., 1985, USE WEAR ANAL FLAKED; Waters M.R., 2011, CLOVIS LITHIC TECHNO; Waters MR, 2009, AM ANTIQUITY, V74, P107, DOI 10.2307/25470540; Weedman KJ, 2002, AM ANTIQUITY, V67, P731, DOI 10.2307/1593801; Wiederhold J, 2004, THESIS TEXAS A M U C; Wilmsen E. N., 1974, LINDENMEIER PLEISTOC; Yellen J. E, 1976, KALAHARI HUNTER GATH, P47, DOI DOI 10.4159/HARVARD.9780674430600; [No title captured]	111	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78419	10.1371/journal.pone.0078419	http://dx.doi.org/10.1371/journal.pone.0078419			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	255QK	24236017	gold, Green Published, Green Submitted			2022-12-27	WOS:000327254700014
J	Cano, ARG; Fernandez, MH; Alvarez-Sierra, MA				Gomez Cano, Ana Rosa; Hernandez Fernandez, Manuel; Angeles Alvarez-Sierra, M.			Dietary Ecology of Murinae (Muridae, Rodentia): A Geometric Morphometric Approach	PLOS ONE			English	Article							EVOLUTIONARY HISTORY; PHYLOGENY; SHAPE; PATTERNS; CLIMATE; TRENDS; DIVERSIFICATION; REGION	Murine rodents represent a highly diverse group, which displays great ecological versatility. In the present paper we analyse the relationship between dental morphology, on one hand, using geometric morphometrics based upon the outline of first upper molar and the dietary preference of extant murine genera, on the other. This ecomorphological study of extant murine rodents demonstrates that dietary groups can be distinguished with the use of a quantitative geometric morphometric approach based on first upper molar outline. A discriminant analysis of the geometric morphometric variables of the first upper molars enables us to infer the dietary preferences of extinct murine genera from the Iberian Peninsula. Most of the extinct genera were omnivore; only Stephanomys showed a pattern of dental morphology alike that of the herbivore genera.	[Gomez Cano, Ana Rosa; Hernandez Fernandez, Manuel; Angeles Alvarez-Sierra, M.] Univ Complutense Madrid, Fac Ciencias Geol, Dept Paleontol, Madrid, Spain; [Hernandez Fernandez, Manuel; Angeles Alvarez-Sierra, M.] UCM, CSIC, Inst Geociencias, Dept Geol Sedimentaria & Cambio Medioambiental, Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UCM - Instituto de Geociencias (IGEO)	Cano, ARG (corresponding author), Univ Complutense Madrid, Fac Ciencias Geol, Dept Paleontol, Madrid, Spain.	argomez@ucm.es	Gómez Cano, Ana Rosa/G-9332-2014; Fernández, Manuel Hernández/I-5012-2013	Gómez Cano, Ana Rosa/0000-0001-5351-4185; Fernández, Manuel Hernández/0000-0001-5640-9647; ALVAREZ SIERRA, MARIA DE LOS ANGELES/0000-0002-2649-5887	Spanish Ministry of Tecnology and Science [CGL2006-01773/BTE, CGL-2008-05813-C02-01/BTE, CGL-2010-19116/BOS, CGL-2011-28877/BTE]; Spanish Ministry of Education in the program of Formacion de Profesorado Universitario	Spanish Ministry of Tecnology and Science; Spanish Ministry of Education in the program of Formacion de Profesorado Universitario(German Research Foundation (DFG))	This research was supported by projects of the Spanish Ministry of Tecnology and Science CGL2006-01773/BTE, CGL-2008-05813-C02-01/BTE, CGL-2010-19116/BOS and CGL-2011-28877/BTE, as well as by a predoctoral contract of the Spanish Ministry of Education in the program of Formacion de Profesorado Universitario to A. R. G. C. During this study, M. H. F. availed of a UCM contract from the Ramon y Cajal Program, belonging to the Spanish Ministry of Education and Science. This research is a contribution by the research group UCM-910607 on Evolution of Cenozoic Mammals and Continental Palaeoenvironments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Auffray Jean-Christophe, 2009, Kasetsart Journal Natural Sciences, V43, P83; Blois JL, 2009, ANNU REV EARTH PL SC, V37, P181, DOI 10.1146/annurev.earth.031208.100055; Bohme M, 2011, PALAEOGEOGR PALAEOCL, V304, P212, DOI 10.1016/j.palaeo.2010.09.028; Bohme M, 2008, EARTH PLANET SC LETT, V275, P393, DOI 10.1016/j.epsl.2008.09.011; Boyer DM, 2010, AM J PHYS ANTHROPOL, V142, P194, DOI 10.1002/ajpa.21211; Carrion JS, 2010, J ARID ENVIRON, V74, P731, DOI 10.1016/j.jaridenv.2008.11.014; Carrion JS, 2010, REV PALAEOBOT PALYNO, V162, P227, DOI 10.1016/j.revpalbo.2010.07.002; Casanovas-Vilar I, 2011, J HUM EVOL, V61, P42, DOI 10.1016/j.jhevol.2011.01.003; Collen B, 2011, PHILOS T R SOC B, V366, P2611, DOI 10.1098/rstb.2011.0109; Costeur L, 2007, GEOBIOS-LYON, V40, P775, DOI 10.1016/j.geobios.2007.07.001; Cox PG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036299; Cucchi T, 2006, ZOOTAXA, P1; Dam JA Van, 1997, GEOLOGICA ULTRAIECTI, V156; Deffontaine V, 2009, MOL ECOL, V18, P2489, DOI 10.1111/j.1365-294X.2009.04162.x; Fabre PH, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-88; FERSON S, 1985, SYST ZOOL, V34, P59, DOI 10.2307/2413345; Garcia-Alix A, 2008, PALAEOGEOGR PALAEOCL, V265, P214, DOI 10.1016/j.palaeo.2008.04.005; Cano ARG, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-94; Cano ARG, 2011, PALAEOGEOGR PALAEOCL, V307, P193, DOI 10.1016/j.palaeo.2011.05.014; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P78; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hautier L, 2012, J MORPHOL, V273, P1319, DOI 10.1002/jmor.20061; Hernandez Fernandez M, 2005, ANALISIS PALEOCLIMAT; Huchon D, 2007, P NATL ACAD SCI USA, V104, P7495, DOI 10.1073/pnas.0701289104; HUNTER JP, 1995, P NATL ACAD SCI USA, V92, P10718, DOI 10.1073/pnas.92.23.10718; Jansa SA, 2004, MOL PHYLOGENET EVOL, V31, P256, DOI 10.1016/j.ympev.2003.07.002; Kavanagh KD, 2007, NATURE, V449, P427, DOI 10.1038/nature06153; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; Ledevin R, 2010, BIOL J LINN SOC, V100, P681, DOI 10.1111/j.1095-8312.2010.01445.x; Lopez-Martinez N., 1998, Journal of Mammalian Evolution, V5, P185, DOI 10.1023/A:1020508428859; Martin SA., 2010, DENT ADAPTATION MURI; Matthews T, 2011, PALAEOGEOGR PALAEOCL, V302, P230, DOI 10.1016/j.palaeo.2011.02.003; McGuire J, 2009, QUATERN INT, P1; Mein P, 2009, SCRIPTA GEOLOGICA, V103, P41; Michaux J, 2007, J ZOOL SYST EVOL RES, V45, P263, DOI 10.1111/j.1439-0469.2006.00390.x; Michaux J, 2001, MOL BIOL EVOL, V18, P2017, DOI 10.1093/oxfordjournals.molbev.a003743; Miljutin Andrei, 2011, Acta Zoologica Lituanica, V21, P192, DOI 10.2478/v10043-011-0024-0; Misonne X, 1969, BELGUIQUE ANN SERIE, V8, P1; Musser GG, 2005, MAMMAL SPECIES WORLD, P1; Renaud S, 2005, P ROY SOC B-BIOL SCI, V272, P609, DOI 10.1098/rspb.2004.2992; Renaud S, 2004, ZOOL J LINN SOC-LOND, V142, P555, DOI 10.1111/j.1096-3642.2004.00140.x; Renaud S, 2003, J BIOGEOGR, V30, P1617, DOI 10.1046/j.1365-2699.2003.00932.x; Renaud S, 1996, PALEOBIOLOGY, V22, P255, DOI 10.1017/S0094837300016201; Renaud S, 1999, J BIOGEOGRAPHY; Renaud S, 2007, ZOOL SCR, V36, P525, DOI 10.1111/j.1463-6409.2007.00297.x; Renvoise E, 2009, EVOLUTION, V63, P1327, DOI 10.1111/j.1558-5646.2009.00639.x; ROHLF FJ, 1984, SYST ZOOL, V33, P302, DOI 10.2307/2413076; Rohlf FJ, 2010, TPSDIG2 THIN PLATE S; Samuels JX, 2009, ZOOL J LINN SOC-LOND, V156, P864, DOI 10.1111/j.1096-3642.2009.00502.x; Sanz de Siria Catalan A., 1994, ACTA GEOL HISP, V29, P169; Schaub S., 1938, Abhandlungen der Schweizerischen Palaeontologischen Gesellschaft Geneve, V61, P1; Sese C., 2006, Estudios Geologicos (Madrid), V62, P429; Swiderski Donald L., 2000, Hystrix, V11, P49; Ungar P.S., 2010, MAMMAL TEETH ORIGIN; Van Bocxlaer B, 2010, PALEOBIOLOGY, V36, P497, DOI 10.1666/08068.1; van Dam JA, 1999, PALAEOGEOGR PALAEOCL, V151, P267, DOI 10.1016/S0031-0182(99)00015-2; van de Weerd A, 1976, UTRECHT MICROPALEONT, V2; van Zon L, 2011, SEASONALITY SURVAIVA; Vrba ES, 1987, EVOL ECOL, V1, P283, DOI 10.1007/BF02071554; VRBA ES, 1980, S AFR J SCI, V76, P61; Williams Susan H., 2001, Journal of Mammalian Evolution, V8, P207, DOI 10.1023/A:1012231829141	62	22	22	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79080	10.1371/journal.pone.0079080	http://dx.doi.org/10.1371/journal.pone.0079080			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236090	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000327254700088
J	Montefusco, S; Esposito, R; D'Andrea, L; Monti, MC; Dunne, C; Dolan, B; Tosco, A; Marzullo, L; Clyne, M				Montefusco, Sandro; Esposito, Roberta; D'Andrea, Luca; Monti, Maria Chiara; Dunne, Ciara; Dolan, Brendan; Tosco, Alessandra; Marzullo, Liberato; Clyne, Marguerite			Copper Promotes TFF1-Mediated Helicobacter pylori Colonization	PLOS ONE			English	Article							TREFOIL PROTEIN TFF1; GASTRIC-CANCER; SIGNALING PATHWAYS; MUCOSA; MUTATIONS; INTERACTS; INVASION; MUC5AC; CELLS	The trefoil peptides (TFF1, TFF2 and TFF3) are a family of small highly conserved proteins that play an essential role in epithelial regeneration within the gastrointestinal tract, where they are mainly expressed. TFF1 expression is strongly induced after mucosal injury and it has been proposed that tff1 functions as a gastric tumor suppressor gene. Several studies confirm that tff1 expression is frequently lost in gastric cancer because of deletions, mutations or methylation of the tff1 promoter. Infection by Helicobacter pylori (H. pylori) results in chronic gastritis and it can lead to the development of gastric or duodenal ulcers. Moreover, it is known that there is a strong link to the development of gastric cancer. It has been shown that H. pylori interacts with the dimeric form of TFF1 and that the rough form of lipopolysaccharide mediates this interaction. We have previously reported that the carboxy-terminus of TFF1 is able to specifically bind copper ions (Cu) and that Cu binding favours the homodimerization of the peptide, thus enhancing its motogenic activity. Here, we report that the Cu-TFF1 cuprocomplex promotes adherence of H. pylori to epithelial cells. Adherence of H. pylori to gastric adenocarcinoma cells, AGS AC1 cells, induced to hyper-express TFF1 was enhanced compared to noninduced cells. Copper further promoted this interaction. A H. pylori mutant unable to bind TFF1 did not show enhanced infection of induced cells. Cu treatment induced a thickening of the mucus layer produced by the colorectal adenocarcinoma mucus secreting, goblet cells, HT29-E12 and promoted H. pylori colonisation. Finally, SPR analysis shows that the C-terminus of TFF1, involved in the binding of copper, is also able to selectively bind H. pylori RF-LPS.	[Montefusco, Sandro; Esposito, Roberta; Tosco, Alessandra; Marzullo, Liberato] Univ Salerno, Dept Pharm, Div Biomed Arturo Leone, Fisciano, SA, Italy; [D'Andrea, Luca] CNR, Inst Biostruct & Bioimaging, I-80125 Naples, Italy; [Monti, Maria Chiara] Univ Salerno, Dept Pharm, Div Chem & Chem Technol Luigi Gomez Paloma, Fisciano, SA, Italy; [Dunne, Ciara; Dolan, Brendan; Clyne, Marguerite] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland	University of Salerno; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Salerno; University College Dublin	Marzullo, L (corresponding author), Univ Salerno, Dept Pharm, Div Biomed Arturo Leone, Fisciano, SA, Italy.	marzullo@unisa.it	Dolan, Brendan/AAE-6544-2022; Marzullo, Liberato/C-4408-2008; Clyne, Marguerite M/H-4179-2012; Dolan, Brendan/AAK-6817-2021; Tosco, Alessandra/F-6773-2011	Dolan, Brendan/0000-0001-9062-3882; Marzullo, Liberato/0000-0001-6133-4483; Clyne, Marguerite M/0000-0003-2547-9129; Dolan, Brendan/0000-0001-9062-3882; Tosco, Alessandra/0000-0002-5443-1565; D'ANDREA, LUCA DOMENICO/0000-0002-2589-216X	University of Salerno Intramural funds FARB; Project NUME-MiPAAF; MIUR	University of Salerno Intramural funds FARB; Project NUME-MiPAAF; MIUR(Ministry of Education, Universities and Research (MIUR))	This work was supported by the following grants: University of Salerno Intramural funds FARB, Project NUME-MiPAAF, and MIUR PRIN 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrens I, 2001, PHARM RES-DORDR, V18, P1138, DOI 10.1023/A:1010974909998; Chandan V, 2007, BIOCHEM CELL BIOL, V85, P582, DOI 10.1139/O07-056; Clyne M, 2004, P NATL ACAD SCI USA, V101, P7409, DOI 10.1073/pnas.0308489101; Correa P, 1996, CANCER EPIDEM BIOMAR, V5, P477; Cottet S, 2002, J BIOL CHEM, V277, P33978, DOI 10.1074/jbc.M201726200; Dolan B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047300; Everhart JE, 2000, GASTROENTEROL CLIN N, V29, P559, DOI 10.1016/S0889-8553(05)70130-8; Forman D, 2006, BEST PRACT RES CL GA, V20, P633, DOI 10.1016/j.bpg.2006.04.008; Keely S, 2008, PHARM RES-DORDR, V25, P1193, DOI 10.1007/s11095-007-9501-3; Lefebvre O, 1996, SCIENCE, V274, P259, DOI 10.1126/science.274.5285.259; Longman RJ, 2000, GUT, V47, P792, DOI 10.1136/gut.47.6.792; Moese S, 2004, INFECT IMMUN, V72, P3646, DOI 10.1128/IAI.72.6.3646-3649.2004; Park WS, 2000, GASTROENTEROLOGY, V119, P691, DOI 10.1053/gast.2000.16483; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Reeves EP, 2008, GASTROENTEROLOGY, V135, P2043, DOI 10.1053/j.gastro.2008.08.049; Ruchaud-Sparagano MH, 2004, CELL MOL LIFE SCI, V61, P1946, DOI 10.1007/s00018-004-4124-x; Selbach M, 2002, INFECT IMMUN, V70, P665, DOI 10.1128/IAI.70.2.665-671.2002; Siu LS, 2004, PEPTIDES, V25, P745, DOI 10.1016/j.peptides.2004.01.024; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; Thim L, 2005, CELL MOL LIFE SCI, V62, P2956, DOI 10.1007/s00018-005-5484-6; Thim L, 2002, EUR J CLIN INVEST, V32, P519, DOI 10.1046/j.1365-2362.2002.01014.x; Tosco A, 2010, CELL MOL LIFE SCI, V67, P1943, DOI 10.1007/s00018-010-0309-7; Tosco A, 2010, GENES NUTR, V5, P1, DOI 10.1007/s12263-009-0153-2; Tosco A, 2007, PEPTIDES, V28, P1461, DOI 10.1016/j.peptides.2007.06.004; Toyonaga Atsushi, 2000, Kurume Medical Journal, V47, P25, DOI 10.2739/kurumemedj.47.25; Van de Bovenkamp JHB, 2003, HELICOBACTER, V8, P521, DOI 10.1046/j.1523-5378.2003.00173.x; Vestergaard EM, 2010, INT J CANCER, V127, P1857, DOI 10.1002/ijc.25209; Waidner B, 2005, J BACTERIOL, V187, P4683, DOI 10.1128/JB.187.13.4683-4688.2005; Wen SC, 2009, CANCER LETT, V282, P1, DOI 10.1016/j.canlet.2008.11.016; Westley BR, 2005, BIOCHEMISTRY-US, V44, P7967, DOI 10.1021/bi047287n; Yio X, 2006, GASTROENTEROLOGY, V130, P1696, DOI 10.1053/j.gastro.2006.01.040	31	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79455	10.1371/journal.pone.0079455	http://dx.doi.org/10.1371/journal.pone.0079455			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236136	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700135
J	Park, SJ; Choi, NK; Park, KH; Woo, SJ				Park, Sang Jun; Choi, Nam-Kyoung; Park, Kyu Hyung; Woo, Se Joon			Five Year Nationwide Incidence of Rhegmatogenous Retinal Detachment Requiring Surgery in Korea	PLOS ONE			English	Article							POSTERIOR VITREOUS DETACHMENT; EPIDEMIOLOGIC CHARACTERISTICS; POPULATION; MYOPIA; PREVALENCE; MINNESOTA; SCOTLAND; CHINA; AGE	Purpose: To define the incidence and demographic characteristics of rhegmatogenous retinal detachment (RRD) requiring surgery in Korea. Design: Nationwide population-based retrospective study. Methods: Patients who underwent surgery for RRD from 2007 to 2011 were retrospectively identified using the diagnostic code for RRD and the surgical codes for retinal detachment surgeries in the national claim database. The average incidence rate of RRD during the 5-year period was estimated using the population data of the 2010 Census in Korea. Results: A total of 24,928 surgically treated RRD cases were identified. The average incidence of surgery requiring RRD was 10.39 cases per 100,000 person-years [95% confidence interval (CI), 10.26-10.52). The incidence in men (11.32 cases per 100,000 person-years; 95% CI:11.13-11.51) was significantly higher than that in women (9.47 cases per 100,000 person-years; 95% CI:9.29-9.64) (p<0.001). The incidence of surgery requiring RRD showed a bimodal distribution across age groups, with one peak (28.55 cases per 100,000 person-years; 95% CI:27.46-29.67)representing patients between 65 and 69 years of age and the second peak (approximately 8.5 per 100,000 person-years) representing patients between 20 and 29 years of age. The male-to-female ratio was approximately 1.0 for the peak-incidence age groups, whereas the ratio was higher for the other age groups. Conclusions: The incidence of RRD in the Korean population was similar to that reported previously, with the peak incidence being lower than that in the Caucasian population. The age-specific RRD incidence pattern in Korea followed a bimodal distribution.	[Park, Sang Jun; Park, Kyu Hyung; Woo, Se Joon] Seoul Natl Univ, Bundang Hosp, Seoul Natl Univ Coll Med, Dept Ophthalmol, Songnam, South Korea; [Choi, Nam-Kyoung] Seoul Natl Univ Hosp, Med Res Collaborating Ctr, Seoul 110744, South Korea; [Choi, Nam-Kyoung] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Choi, Nam-Kyoung] Seoul Natl Univ, Med Res Ctr, Inst Environm Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Woo, SJ (corresponding author), Seoul Natl Univ, Bundang Hosp, Seoul Natl Univ Coll Med, Dept Ophthalmol, Songnam, South Korea.	sejoon1@snu.ac.kr	Park, Sang Jun/C-3234-2015	Park, Sang Jun/0000-0003-0542-2758	Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Kore [A111161]; Korean government (MEST) [2012R1A2A2A02012821]	Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Kore; Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This study was supported by grants from the Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (Grant No. A111161), and the National Research Foundation of Korea (NRF), which is funded by the Korean government (MEST, No. 2012R1A2A2A02012821). The grant did not have any specific role in design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	AKIBA J, 1993, OPHTHALMOLOGY, V100, P1384; Anton A, 2009, OPHTHAL EPIDEMIOL, V16, P231, DOI [10.1080/09286580903000476, 10.3109/09286580903000476]; CAMBIAGGI A, 1964, AM J OPHTHALMOL, V58, P642, DOI 10.1016/0002-9394(64)91383-2; FOOS RY, 1982, OPHTHALMOLOGY, V89, P1502; Ghazi NG, 2002, EYE, V16, P411, DOI 10.1038/sj.eye.6700197; HAIMANN MH, 1982, ARCH OPHTHALMOL-CHIC, V100, P289; Jung SK, 2012, INVEST OPHTH VIS SCI, V53, P5579, DOI 10.1167/iovs.12-10106; LAATIKAINEN L, 1985, ACTA OPHTHALMOL, V63, P59; Lee YK, 2013, OSTEOPOROSIS INT, V24, P707, DOI 10.1007/s00198-012-2016-8; Lee YK, 2012, OSTEOPOROSIS INT, V23, P1859, DOI 10.1007/s00198-011-1833-5; Li XX, 2003, OPHTHALMOLOGY, V110, P2413, DOI 10.1016/S0161-6420(03)00867-4; Liang YB, 2009, OPHTHALMOLOGY, V116, P2119, DOI 10.1016/j.ophtha.2009.04.040; Limeira-Soares PH, 2007, EYE, V21, P348, DOI 10.1038/sj.eye.6702202; Los LI, 2012, OPHTHALMOLOGY; Mitry D, 2010, BRIT J OPHTHALMOL, V94, P678, DOI 10.1136/bjo.2009.157727; Mitry D, 2011, OPHTHALMOLOGY, V118, P1429, DOI 10.1016/j.ophtha.2010.11.031; Mitry D, 2011, BRIT J OPHTHALMOL, V95, P365, DOI 10.1136/bjo.2009.172296; Mitry D, 2010, INVEST OPHTH VIS SCI, V51, P4963, DOI 10.1167/iovs.10-5400; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Pan CW, 2011, INVEST OPHTH VIS SCI, V52, P3166, DOI 10.1167/iovs.10-6210; Polkinghorne PJ, 2004, CLIN EXP OPHTHALMOL, V32, P159, DOI 10.1111/j.1442-9071.2004.00003.x; Rowe JA, 1999, OPHTHALMOLOGY, V106, P154, DOI 10.1016/S0161-6420(99)90018-0; SASAKI K, 1995, GRAEF ARCH CLIN EXP, V233, P772; SCHEPENS CL, 1961, ARCH OPHTHALMOL-CHIC, V66, P631, DOI 10.1001/archopht.1961.00960010633006; TORNQUIST R, 1987, ACTA OPHTHALMOL, V65, P213; WILKES SR, 1982, AM J OPHTHALMOL, V94, P670, DOI 10.1016/0002-9394(82)90013-7; Wong TY, 1999, ARCH OPHTHALMOL-CHIC, V117, P379, DOI 10.1001/archopht.117.3.379; YONEMOTO J, 1994, GRAEF ARCH CLIN EXP, V232, P67, DOI 10.1007/BF00171665; Yoon Kyung-Chul, 2011, Korean J Ophthalmol, V25, P421, DOI 10.3341/kjo.2011.25.6.421; Zou H, 2002, RETINA-J RET VIT DIS, V22, P294, DOI 10.1097/00006982-200206000-00007	30	51	51	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80174	10.1371/journal.pone.0080174	http://dx.doi.org/10.1371/journal.pone.0080174			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236173	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700174
J	Sanchez-Vidaurre, S; Cruz, MJ; Gomez-Olles, S; Morell, F; Munoz, X				Sanchez-Vidaurre, Sara; Cruz, Maria-Jesus; Gomez-Olles, Susana; Morell, Ferran; Munoz, Xavier			Sputum Inflammatory Profile Before and After Specific Inhalation Challenge in Individuals with Suspected Occupational Asthma	PLOS ONE			English	Article							ISOCYANATE-INDUCED ASTHMA; WORK-RELATED ASTHMA; AIRWAY INFLAMMATION; TOLUENE DIISOCYANATE; CELL COUNTS; AGENTS; EXPOSURE; LEUKOTRIENES; EOSINOPHILIA; STATEMENT	Background: The aim of this study was to establish the sputum inflammatory profile and changes in levels of leukotriene B-4 (LTB4) and a panel of Th1/Th2 cytokines in subjects with suspected occupational asthma (OA) following specific inhalation challenge (SIC) to high-molecular-weight (HMW) and low-molecular-weight (LMW) agents. Material and Methods: Fifty-one consecutive subjects undergoing SIC for suspected OA were enrolled. Sputum induction was performed the day before and 24 h after exposure to the offending agent. Total and differential cell counts were assessed. LTB4 and a 10 Th1/Th2 cytokines were measured in sputum supernatant. Results: Thirty-four patients tested positive to SIC and were diagnosed with OA (in 10 due to HMW agents and in 24 to LMW agents). SIC was negative in 17 subjects. As compared to baseline an increase was found in the percentage of sputum eosinophils and neutrophils, and in IL-10 concentration after SIC (p = 0.0078, p = 0.0195, and p = 0.046, respectively), and a decrease was seen in LTB4 level (p = 0.0078) in patients with OA due to HMW agents. An increase in the percentage of sputum neutrophils after SIC (p = 0.0040) was observed in subjects without OA exposed to LMW agents. IL-8 levels after SIC were higher in patients without OA compared with patients with OA (p = 0.0146). Conclusion: When conducting airway inflammation studies in OA, patients should be divided according to the causal agent (HMW or LMW). In OA patients exposed to HMW agents, an increase in the number of neutrophils can be found in parallel to the increase of eosinophils, although this does not contradict an IgE-mediated mechanism. Exposure to LMW agents can result in increased neutrophilic inflammation in patients with airway diseases unrelated to OA. There is variability in the responses observed in patients with OA exposed to LMW agents.	[Sanchez-Vidaurre, Sara; Cruz, Maria-Jesus; Gomez-Olles, Susana; Morell, Ferran; Munoz, Xavier] Hosp Univ Vall Hebron, Serv Pneumol, Barcelona, Spain; [Sanchez-Vidaurre, Sara; Cruz, Maria-Jesus; Gomez-Olles, Susana; Morell, Ferran; Munoz, Xavier] CIBER Enfermedades Resp Ciberes, Barcelona, Spain; [Sanchez-Vidaurre, Sara] Univ Autonoma Barcelona, Dept Med, E-08193 Barcelona, Spain; [Munoz, Xavier] Univ Autonoma Barcelona, Dept Biol Cellular Fisiol Immunol, E-08193 Barcelona, Spain	Hospital Universitari Vall d'Hebron; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Autonomous University of Barcelona; Autonomous University of Barcelona	Cruz, MJ (corresponding author), Hosp Univ Vall Hebron, Serv Pneumol, Barcelona, Spain.	mj.cruz@vhir.org	Cruz, Maria Jesus/I-9073-2014; Muñoz, Xavier/I-9009-2014	Cruz, Maria Jesus/0000-0001-9759-5466; Munoz, Xavier/0000-0002-8693-022X; Morell Brotad, Ferran/0000-0002-7206-4543	Miguel Servet programme from Instituto de Salud Carlos III [CP12/03101]; FIS [PI05100]; Sociedad Espanola de Patologia Respiratoria (SEPAR); Fundacio Catalana de Pneumologia (FUCAP); Societat Catalana de Pneumologia (SOCAP)	Miguel Servet programme from Instituto de Salud Carlos III(Instituto de Salud Carlos III); FIS(Instituto de Salud Carlos III); Sociedad Espanola de Patologia Respiratoria (SEPAR); Fundacio Catalana de Pneumologia (FUCAP); Societat Catalana de Pneumologia (SOCAP)	MJC is a researcher supported by the Miguel Servet programme from Instituto de Salud Carlos III (CP12/03101). This project was supported by the FIS PI05100 (Instituto de Salud Carlos III), the Sociedad Espanola de Patologia Respiratoria (SEPAR), the Fundacio Catalana de Pneumologia (FUCAP), and the Societat Catalana de Pneumologia (SOCAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks DE, 2007, CURR OPIN PULM MED, V13, P131, DOI 10.1097/MCP.0b013e32802c7d0f; BERNSTEIN IL, 1999, ASTHMA WORKPLACE, P1; Besnard AG, 2012, J MOL CELL BIOL, V4, P3, DOI 10.1093/jmcb/mjr042; Bettiol J, 2002, ALLERGY, V57, P1145, DOI 10.1034/j.1398-9995.2002.23586.x; Bohle B, 2007, J ALLERGY CLIN IMMUN, V120, P707, DOI 10.1016/j.jaci.2007.06.013; Burge PS, 2012, OCCUP MED-OXFORD, V62, P129, DOI 10.1093/occmed/kqr211; Cruz MJ, 2012, CURR OPIN ALLERGY CL, V12, P119, DOI 10.1097/ACI.0b013e328351137c; Di Franco A, 1998, RESP MED, V92, P550; Dudek W, 2009, INT J OCCUP MED ENV, V22, P293, DOI 10.2478/v10001-009-0022-7; FAHY JV, 1995, J ALLERGY CLIN IMMUN, V95, P843, DOI 10.1016/S0091-6749(95)70128-1; Fernandez-Nieto M, 2009, CHEST, V136, P1308, DOI 10.1378/chest.09-0103; Girard F, 2004, AM J RESP CRIT CARE, V170, P845, DOI 10.1164/rccm.200403-380OC; Hallstrand TS, 2010, CURR OPIN ALLERGY CL, V10, P60, DOI 10.1097/ACI.0b013e32833489c3; Henneberger PK, 2011, AM J RESP CRIT CARE, V184, P368, DOI 10.1164/rccm.812011ST; Lemiere C, 2004, CLIN EXP ALLERGY, V34, P1684, DOI 10.1111/j.1365-2222.2004.02102.x; Lemiere C, 2002, J ALLERGY CLIN IMMUN, V110, P641, DOI 10.1067/mai.2002.128806; Lemiere C, 2001, J ALLERGY CLIN IMMUN, V107, P1063, DOI 10.1067/mai.2001.115486; Lemiere C, 2000, J ALLERGY CLIN IMMUN, V106, P1163; Lemiere C, 2010, CHEST, V137, P617, DOI 10.1378/chest.09-2081; MAESTRELLI P, 1994, CLIN EXP ALLERGY, V24, P29, DOI 10.1111/j.1365-2222.1994.tb00913.x; Mapp CE, 2009, CLIN EXP ALLERGY, V39, P812, DOI 10.1111/j.1365-2222.2009.03215.x; Mapp CE, 2005, AM J RESP CRIT CARE, V172, P280, DOI 10.1164/rccm.200311-1575SO; Morell F, 2002, MED CLIN-BARCELONA, V3, P23; Munoz X, 2004, OCCUP ENVIRON MED, V61, P861, DOI 10.1136/oem.2004.013177; Munoz X, 2009, RESPIRATION, V78, P455, DOI 10.1159/000235817; Pala G, 2011, CLIN TOXICOL, V49, P506, DOI 10.3109/15563650.2011.590141; Park HS, 1999, CLIN EXP ALLERGY, V29, P1395; PEPYS J, 1975, AM REV RESPIR DIS, V112, P829; Pizzichini E, 1996, AM J RESP CRIT CARE, V154, P308, DOI 10.1164/ajrccm.154.2.8756799; Prince P, 2012, CHEST, V141, P1522, DOI 10.1378/chest.11-1134; Quirce S, 2008, ALLERGY, V63, P137, DOI 10.1111/j.1398-9995.2007.01525.x; SAMPSON AP, 1995, ARCH DIS CHILD, V73, P221, DOI 10.1136/adc.73.3.221; Sanchez-Vidaurre S, 2012, ANN ALLERG ASTHMA IM, V108, P151, DOI 10.1016/j.anai.2011.12.010; Sastre J, 2003, EUR RESPIR J, V22, P364, DOI 10.1183/09031936.03.00045103; STERK PJ, 1993, EUR RESPIR J, V6, P53, DOI 10.1183/09041950.053s1693; Vandenplas O, 2009, ALLERGY, V64, P754, DOI 10.1111/j.1398-9995.2008.01896.x; Vandenplas O, 2011, ALLERGY ASTHMA IMMUN, V3, P157, DOI 10.4168/aair.2011.3.3.157; ZOCCA E, 1990, J APPL PHYSIOL, V68, P1576, DOI 10.1152/jappl.1990.68.4.1576	38	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78304	10.1371/journal.pone.0078304	http://dx.doi.org/10.1371/journal.pone.0078304			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236015	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700012
J	Zhan, T; Zhang, K; Chen, YY; Lin, YJ; Wu, GB; Zhang, LL; Yao, P; Shao, ZZ; Liu, ZD				Zhan, Tao; Zhang, Kai; Chen, Yangyan; Lin, Yongjun; Wu, Gaobing; Zhang, Lili; Yao, Pei; Shao, Zongze; Liu, Ziduo			Improving Glyphosate Oxidation Activity of Glycine Oxidase from Bacillus cereus by Directed Evolution	PLOS ONE			English	Article							HERBICIDE GLYPHOSATE; FLUORESCENS ESTERASE; TOLERANCE; MUTATIONS; ENANTIOSELECTIVITY; PREDICTION; RESISTANCE; SUBTILIS; SYNTHASE	Glyphosate, a broad spectrum herbicide widely used in agriculture all over the world, inhibits 5-enolpyruvylshikimate-3-phosphate synthase in the shikimate pathway, and glycine oxidase (GO) has been reported to be able to catalyze the oxidative deamination of various amines and cleave the C-N bond in glyphosate. Here, in an effort to improve the catalytic activity of the glycine oxidase that was cloned from a glyphosate-degrading marine strain of Bacillus cereus (BceGO), we used a bacteriophage T7 lysis-based method for high-throughput screening of oxidase activity and engineered the gene encoding BceGO by directed evolution. Six mutants exhibiting enhanced activity toward glyphosate were screened from two rounds of error-prone PCR combined with site directed mutagenesis, and the beneficial mutations of the six evolved variants were recombined by DNA shuffling. Four recombinants were generated and, when compared with the wild-type BceGO, the most active mutant B3S1 showed the highest activity, exhibiting a 160-fold increase in substrate affinity, a 326-fold enhancement in catalytic efficiency against glyphosate, with little difference between their pH and temperature stabilities. The role of these mutations was explored through structure modeling and molecular docking, revealing that the Arg(51) mutation is near the active site and could be an important residue contributing to the stabilization of glyphosate binding, while the role of the remaining mutations is unclear. These results provide insight into the application of directed evolution in optimizing glycine oxidase function and have laid a foundation for the development of glyphosate-tolerant crops.	[Zhan, Tao; Zhang, Kai; Chen, Yangyan; Lin, Yongjun; Wu, Gaobing; Yao, Pei; Liu, Ziduo] Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China; [Zhang, Lili] Tarim Univ, Coll Life Sci, Key Lab Protect & Utilizat Biol Resources Tarim B, Alar, Xinjiang, Peoples R China; [Shao, Zongze] State Ocean Adm, Inst Oceanog 3, Key Lab Marine Biogenet Resources, Xiamen, Fujian, Peoples R China	Huazhong Agricultural University; Tarim University; State Oceanic Administration	Liu, ZD (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China.	lzd@mail.hzau.edu.cn			National Natural Science Foundation of China [u1170303]; Genetically Modified Organisms Breeding Major Projects of China [2011zx08001-001]; Key Laboratory of Protection and Utilization of Biological Resources in Tarim Basin of Xinjiang Production & Construction Corps [BRZD1101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Genetically Modified Organisms Breeding Major Projects of China; Key Laboratory of Protection and Utilization of Biological Resources in Tarim Basin of Xinjiang Production & Construction Corps	This work was supported by grants from the National Natural Science Foundation of China (number u1170303), the Genetically Modified Organisms Breeding Major Projects of China (2011zx08001-001), and the opening project of the Key Laboratory of Protection and Utilization of Biological Resources in Tarim Basin of Xinjiang Production & Construction Corps (number BRZD1101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-51; Barry G.F., 1995, U.S. Patent, Patent No. [5-463,175, 5463175]; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; Castle LA, 2004, SCIENCE, V304, P1151, DOI 10.1126/science.1096770; Duke SO, 2008, PEST MANAG SCI, V64, P319, DOI 10.1002/ps.1518; ELSNER HI, 1989, DNA-J MOLEC CELL BIO, V8, P697, DOI 10.1089/dna.1989.8.697; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; Franz JE, 1997, AM CHEM SOC MONOGRAP, V189; GOLDSBROUGH PB, 1990, PLANT SCI, V72, P53, DOI 10.1016/0168-9452(90)90186-R; Harrison LA, 1996, J NUTR, V126, P728, DOI 10.1093/jn/126.3.728; Horsman GP, 2003, CHEM-EUR J, V9, P1933, DOI 10.1002/chem.200204551; Job V, 2002, J BIOL CHEM, V277, P6985, DOI 10.1074/jbc.M111095200; Job V, 2002, EUR J BIOCHEM, V269, P1456, DOI 10.1046/j.1432-1033.2002.02790.x; Joern JM, 2002, J MOL BIOL, V316, P643, DOI 10.1006/jmbi.2001.5349; Larguinho M, 2010, TALANTA, V81, P881, DOI 10.1016/j.talanta.2010.01.032; Martinez-Martinez I, 2008, PROTEINS, V70, P1429, DOI 10.1002/prot.21690; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Meilan R, 2002, CAN J FOREST RES, V32, P967, DOI 10.1139/X02-015; Morley KL, 2005, TRENDS BIOTECHNOL, V23, P231, DOI 10.1016/j.tibtech.2005.03.005; Mortl M, 2004, J BIOL CHEM, V279, P29718, DOI 10.1074/jbc.M401224200; Nandula VK, 2007, J AGR FOOD CHEM, V55, P3540, DOI 10.1021/jf063568l; Nishiya Y, 1998, FEBS LETT, V438, P263, DOI 10.1016/S0014-5793(98)01313-1; PADGETTE SR, 1995, CROP SCI, V35, P1451, DOI 10.2135/cropsci1995.0011183X003500050032x; Park S, 2005, CHEM BIOL, V12, P45, DOI 10.1016/j.chembiol.2004.10.012; Pedotti M, 2009, J BIOL CHEM, V284, P36415, DOI 10.1074/jbc.M109.051631; Pollegioni L, 2011, FEBS J, V278, P2753, DOI 10.1111/j.1742-4658.2011.08214.x; ROST B, 1994, PROTEINS, V20, P216, DOI 10.1002/prot.340200303; Schonbrunn E, 2001, P NATL ACAD SCI USA, V98, P1376, DOI 10.1073/pnas.98.4.1376; Settembre EC, 2003, BIOCHEMISTRY-US, V42, P2971, DOI 10.1021/bi026916v; SHAH DM, 1986, SCIENCE, V233, P478, DOI 10.1126/science.233.4762.478; Siehl DL, 2005, PEST MANAG SCI, V61, P235, DOI 10.1002/ps.1014; STEINRUCKEN HC, 1980, BIOCHEM BIOPH RES CO, V94, P1207, DOI 10.1016/0006-291X(80)90547-1; STEINRUCKEN HC, 1986, ARCH BIOCHEM BIOPHYS, V244, P169, DOI 10.1016/0003-9861(86)90106-2; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Stierand K, 2011, MOL INFORM, V30, P12, DOI 10.1002/minf.201000167; TARAHOVSKY YS, 1994, FEMS MICROBIOL LETT, V122, P195, DOI 10.1111/j.1574-6968.1994.tb07164.x; Tian YS, 2011, APPL ENVIRON MICROB, V77, P8409, DOI 10.1128/AEM.05271-11; Weiner M, 1994, GENOME RES, V4, P131, DOI [10.1101/gr.4.3.S131, DOI 10.1101/GR.4.3.S131]; Zhao HM, 1997, CURR OPIN STRUC BIOL, V7, P480, DOI 10.1016/S0959-440X(97)80110-8	41	20	23	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79175	10.1371/journal.pone.0079175	http://dx.doi.org/10.1371/journal.pone.0079175			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223901	Green Submitted, Green Published, gold			2022-12-27	WOS:000326597400051
J	Goodwin, L; Ben-Zion, I; Fear, NT; Hotopf, M; Stansfeld, SA; Wessely, S				Goodwin, Laura; Ben-Zion, Ilan; Fear, Nicola T.; Hotopf, Matthew; Stansfeld, Stephen A.; Wessely, Simon			Are Reports of Psychological Stress Higher in Occupational Studies? A Systematic Review across Occupational and Population Based Studies	PLOS ONE			English	Review							MINOR PSYCHIATRIC-DISORDER; COMMON MENTAL-DISORDERS; HOUSEHOLD PANEL SURVEY; HOSPITAL CONSULTANTS; JOB-SATISFACTION; GENERAL-PRACTITIONERS; COPING STRATEGIES; NORTHERN-IRELAND; COHORT PROFILE; SOCIAL-WORKERS	Objectives: The general health questionnaire (GHQ) is commonly used to assess symptoms of common mental disorder (CMD). Prevalence estimates for CMD caseness from UK population studies are thought to be in the range of 14-17%, and the UK occupational studies of which we are aware indicate a higher prevalence. This review will synthesise the existing research using the GHQ from both population and occupational studies and will compare the weighted prevalence estimates between them. Methods: We conducted a systematic review and meta-analysis to examine the prevalence of CMD, as assessed by the GHQ, in all UK occupational and population studies conducted from 1990 onwards. Results: The search revealed 65 occupational papers which met the search criteria and 15 relevant papers for UK population studies. The weighted prevalence estimate for CMD across all occupational studies which used the same version and cut-off for the GHQ was 29.6% (95% confidence intervals (CIs) 27.3-31.9%) and for comparable population studies was significantly lower at 19.1% (95% CIs 17.3-20.8%). This difference was reduced after restricting the studies by response rate and sampling method (23.9% (95% CIs 20.5%-27.4%) vs. 19.2% (95 CIs 17.1%-21.3%)). Conclusions: Counter intuitively, the prevalence of CMD is higher in occupational studies, compared to population studies (which include individuals not in employment), although this difference narrowed after accounting for measures of study quality, including response rate and sampling method. This finding is inconsistent with the healthy worker effect, which would presume lower levels of psychological symptoms in individuals in employment. One explanation is that the GHQ is sensitive to contextual factors, and it seems possible that symptoms of CMD are over reported when participants know that they have been recruited to a study on the basis that they belong to a specific occupational group, as in nearly all "stress" surveys.	[Goodwin, Laura; Ben-Zion, Ilan; Fear, Nicola T.; Wessely, Simon] Kings Coll London, Inst Psychiat, Dept Psychol Med, Kings Ctr Mil Hlth Res, London WC2R 2LS, England; [Hotopf, Matthew] Kings Coll London, Inst Psychiat, Dept Psychol Med, London WC2R 2LS, England; [Stansfeld, Stephen A.] Queen Mary Univ London, Ctr Psychiat, London, England	University of London; King's College London; University of London; King's College London; University of London; Queen Mary University London	Goodwin, L (corresponding author), Kings Coll London, Inst Psychiat, Dept Psychol Med, Kings Ctr Mil Hlth Res, London WC2R 2LS, England.	laura.goodwin@kcl.ac.uk	GOODWIN, LAURA/F-3173-2012; Hotopf, Matthew/E-4971-2010; Wessely, Simon C/A-8713-2008	Fear, Nicola/0000-0002-5792-2925; Hotopf, Matthew/0000-0002-3980-4466; Wessely, Simon Charles/0000-0002-6743-9929; Goodwin, Laura/0000-0002-0354-7787	UK Ministry of Defence (MoD)	UK Ministry of Defence (MoD)	This study was funded by the UK Ministry of Defence (MoD). The author's work was independent of the funders and the paper was disclosed to the MoD at the point of submission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DA, 2001, BRIT J PSYCHIAT, V178, P76, DOI 10.1192/bjp.178.1.76; Appleton K, 1998, BRIT J GEN PRACT, V48, P1059; Avery AJ, 1998, PUBLIC HEALTH, V112, P169, DOI 10.1016/S0033-3506(98)00223-6; Baldwin PJ, 1997, SOC SCI MED, V45, P41, DOI 10.1016/S0277-9536(96)00307-3; Balmer NJ, 2010, HEALTH SOC CARE COMM, V18, P588, DOI 10.1111/j.1365-2524.2010.00927.x; Bamber M, 2008, CLIN PSYCHOL PSYCHOT, V15, P96, DOI 10.1002/cpp.564; Bara AC, 2009, SCAND J WORK ENV HEA, V35, P361, DOI 10.5271/sjweh.1344; Benzeval M, 2009, INT J EPIDEMIOL, V38, P1215, DOI 10.1093/ije/dyn213; Berman R, 2007, CLIN MED, V7, P235, DOI 10.7861/clinmedicine.7-3-235; Biggam FH, 1997, STRESS MEDICINE, V13, P109, DOI 10.1002/(SICI)1099-1700(199704)13:2<109::AID-SMI724>3.0.CO;2-H; Bogaerts K, 2005, J PSYCHOSOM RES, V58, P537, DOI 10.1016/j.jpsychores.2004.12.005; Booker CL, 2011, J EPIDEMIOLOGY COMMU; Booth NJ, 2000, INT J SOC PSYCHIATR, V46, P67, DOI 10.1177/002076400004600108; Bowling A, 1999, J PUBLIC HEALTH MED, V21, P255, DOI 10.1093/pubmed/21.3.255; Bridger RS, 2007, OCCUP MED-OXFORD, V57, P92, DOI [10.1093/occmed.kql124, 10.1093/occmed/kql124]; Bridger RS, 2008, OCCUP MED-OXFORD, V58, P534, DOI 10.1093/occmed/kqn136; Brown J, 1999, WORK STRESS, V13, P312, DOI 10.1080/02678379950019770; Burbeck R, 2002, EMERG MED J, V19, P234, DOI 10.1136/emj.19.3.234; Butterworth T, 1999, STRESS MEDICINE, V15, P27; Calnan M, 2001, SOC SCI MED, V52, P499, DOI 10.1016/S0277-9536(00)00155-6; CAPLAN RP, 1994, BRIT MED J, V309, P1261, DOI 10.1136/bmj.309.6964.1261; Catt S, 2005, BRIT J CANCER, V93, P1092, DOI 10.1038/sj.bjc.6602816; Coffey M, 2004, BRIT J SOC WORK, V34, P735, DOI 10.1093/bjsw/bch088; Coomber S, 2002, BRIT J ANAESTH, V89, P873, DOI 10.1093/bja/aef273; Craig R, 2009, HLTH SURVEY ENGLAND; CUSHWAY D, 1994, STRESS MEDICINE, V10, P35, DOI 10.1002/smi.2460100107; CUSHWAY D, 1992, BRIT J CLIN PSYCHOL, V31, P169, DOI 10.1111/j.2044-8260.1992.tb00981.x; Donaldson-Feilder EJ, 2004, BRIT J GUID COUNS, V32, P187, DOI 10.1080/08069880410001692210; Dong W., 1995, SCOTLANDS HLTH SCOTT; Dundas R, 2006, INT J EPIDEMIOL, V35, P458, DOI 10.1093/ije/dyi239; Edwards D, 2000, J Psychiatr Ment Health Nurs, V7, P7, DOI 10.1046/j.1365-2850.2000.00258.x; Eich E, 2000, PSYCHOL SCI, V11, P244, DOI 10.1111/1467-9280.00249; Emslie C, 2002, SOC SCI MED, V54, P621, DOI 10.1016/S0277-9536(01)00056-9; Emslie C, 1999, SOC SCI MED, V48, P33, DOI 10.1016/S0277-9536(98)00287-1; Evans S, 2006, BRIT J PSYCHIAT, V188, P75, DOI 10.1192/bjp.188.1.75; FAGIN L, 1995, J ADV NURS, V22, P347, DOI 10.1046/j.1365-2648.1995.22020347.x; Ford E, 2010, PUBLIC HEALTH, V124, P675, DOI 10.1016/j.puhe.2010.08.019; Glozier N, 2006, INT J SOC PSYCHIATR, V52, P525, DOI 10.1177/0020764006066843; Goldberg DP., 1972, DETECTION PSYCHIAT I; Gorter RC, 2011, COMMUNITY DENT ORAL, V39, P87, DOI 10.1111/j.1600-0528.2010.00568.x; Guppy A, 1997, WORK STRESS, V11, P58, DOI 10.1080/02678379708256822; Guthrie E., 1999, PSYCHIAT B, V23, P207, DOI [10.1192/pb.23.4.207, DOI 10.1192/PB.23.4.207]; Hardy GE, 1999, PSYCHOL ASSESSMENT, V11, P159, DOI 10.1037/1040-3590.11.2.159; Hatch SL, 2009, J AFFECT DISORDERS, V119, P66, DOI 10.1016/j.jad.2009.03.021; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2008, INT J EPIDEMIOL, V37, P1158, DOI 10.1093/ije/dyn204; Hotopf M, 2006, LANCET, V367, P1731, DOI 10.1016/S0140-6736(06)68662-5; Hughes EL, 2007, WORK STRESS, V21, P264, DOI 10.1080/02678370701667242; Hussain T, 2004, OCCUP MED-OXFORD, V54, P506, DOI 10.1093/occmed/kqh087; Jones M, 2006, OCCUP MED-OXFORD, V56, P322, DOI 10.1093/occmed/kql023; Kinman G., 2008, INT J STRESS MANAGE, V15, P381, DOI [10.1037/a0013213, DOI 10.1037/A0013213]; Kinman G, 2011, BRIT J SOC WORK, V41, P261, DOI 10.1093/bjsw/bcq088; Kinman G, 2008, EDUC PSYCHOL-UK, V28, P823, DOI 10.1080/01443410802366298; Kumary A, 2008, COUNS PSYCHOL Q, V21, P19, DOI 10.1080/09515070801895626; LAGUARDIA RL, 1983, AM J ORTHOPSYCHIAT, V53, P18, DOI 10.1111/j.1939-0025.1983.tb03345.x; LEWIS G, 1993, J EPIDEMIOL COMMUN H, V47, P358, DOI 10.1136/jech.47.5.358; Li CY, 1999, OCCUP MED-OXFORD, V49, P225, DOI 10.1093/occmed/49.4.225; Loretto W, 2010, BRIT J MANAGE, V21, P526, DOI 10.1111/j.1467-8551.2009.00658.x; Macleod J, 2002, BMJ-BRIT MED J, V324, P1247, DOI 10.1136/bmj.324.7348.1247; MACPHERSON R, 1994, INT J GERIATR PSYCH, V9, P381, DOI 10.1002/gps.930090506; McClenahan CA, 2007, WORK STRESS, V21, P85, DOI 10.1080/02678370701264552; McKinstry B, 2004, ED PRIMARY CARE, V15, P231; McManus IC, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-29; McManus IC, 2003, BRIT MED J, V327, P139, DOI 10.1136/bmj.327.7407.139; McManus IC, 1999, LANCET, V354, P1358, DOI 10.1016/S0140-6736(99)02112-1; McManus IC, 2002, MED EDUC, V36, P35, DOI 10.1046/j.1365-2923.2002.01123.x; McManus IC, 2000, QUAL HEALTH CARE, V9, P14, DOI 10.1136/qhc.9.1.14; Miller GVF, 2005, INT REV PSYCHIATR, V17, P317, DOI 10.1080/09540260500238470; Murphy H, 2007, INT J SOC PSYCHIATR, V53, P397, DOI 10.1177/0020764007078340; O'Reilly D, 2003, J EPIDEMIOL COMMUN H, V57, P488, DOI 10.1136/jech.57.7.488; Oyefeso A, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-39; Paice E, 2002, MED EDUC, V36, P56, DOI 10.1046/j.1365-2923.2002.01101.x; Patterson I D, 2000, Health Bull (Edinb), V58, P403; Pembroke TPI, 2006, J EPIDEMIOL COMMUN H, V60, P789, DOI 10.1136/jech.2005.042150; PENNEBAKER JW, 1980, J PERS SOC PSYCHOL, V39, P165, DOI 10.1037/0022-3514.39.1.165; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; PRESCOTTCLARKE P, 1997, HLTH SURVEY ENGLAND; RAMIREZ AJ, 1995, BRIT J CANCER, V71, P1263, DOI 10.1038/bjc.1995.244; Ramirez AJ, 1996, LANCET, V347, P724, DOI 10.1016/S0140-6736(96)90077-X; Riley RD, 2011, BMJ, V342; Roelen CAM, 2009, EUR J PUBLIC HEALTH, V19, P625, DOI 10.1093/eurpub/ckp090; Sharma A, 2008, PSYCHO-ONCOLOGY, V17, P570, DOI 10.1002/pon.1269; Sharma A, 2008, COLORECTAL DIS, V10, P397, DOI 10.1111/j.1463-1318.2007.01338.x; Sheikh A, 2000, BRIT J GEN PRACT, V50, P203; Stansfeld S, 2002, BRIT J PSYCHIAT, V181, P96; Stansfeld S, 2003, OCCUPATION MENTAL HL; STANSFELD SA, 1992, PSYCHOL MED, V22, P739, DOI 10.1017/S0033291700038186; Stansfeld SA, 2002, INT J EPIDEMIOL, V31, P248, DOI 10.1093/ije/31.1.248; StataCorp, 2021, STATA STAT SOFTWARE; Taylor C, 2005, LANCET, V366, P742, DOI 10.1016/S0140-6736(05)67178-4; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; TYLER PA, 1991, INT J NURS STUD, V28, P125, DOI 10.1016/0020-7489(91)90002-K; Unwin C, 1999, LANCET, V353, P169, DOI 10.1016/S0140-6736(98)11338-7; Waddell G., 2006, IS WORK GOOD YOUR HL; Wadsworth EJK, 2008, OCCUP MED-OXFORD, V58, P198, DOI 10.1093/occmed/kqn008; Wall TD, 1997, BRIT J PSYCHIAT, V171, P519, DOI 10.1192/bjp.171.6.519; Weich S, 2001, BRIT J PSYCHIAT, V178, P222, DOI 10.1192/bjp.178.3.222; Williams ML, 2004, PALLIATIVE MED, V18, P638, DOI 10.1191/0269216304pm929oa; Wray J, 2009, INT J NURS STUD, V46, P977, DOI 10.1016/j.ijnurstu.2008.07.008	99	73	73	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78693	10.1371/journal.pone.0078693	http://dx.doi.org/10.1371/journal.pone.0078693			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	245ZC	24223840	Green Submitted, Green Published, gold			2022-12-27	WOS:000326503400083
J	Kinouchi, K; Ichihara, A; Sano, M; Sun-Wada, GH; Wada, Y; Ochi, H; Fukuda, T; Bokuda, K; Kurosawa, H; Yoshida, N; Takeda, S; Fukuda, K; Itoh, H				Kinouchi, Kenichiro; Ichihara, Atsuhiro; Sano, Motoaki; Sun-Wada, Ge-Hong; Wada, Yoh; Ochi, Hiroki; Fukuda, Toru; Bokuda, Kanako; Kurosawa, Hideaki; Yoshida, Naohiro; Takeda, Shu; Fukuda, Keiichi; Itoh, Hiroshi			The Role of Individual Domains and the Significance of Shedding of ATP6AP2/(pro)renin Receptor in Vacuolar H+-ATPase Biogenesis	PLOS ONE			English	Article							PRO RENIN RECEPTOR; ENDOPLASMIC-RETICULUM; PRORENIN RECEPTOR; (PRO)RENIN RECEPTOR; ANGIOTENSIN-II; V-ATPASE; OSTEOCLAST DIFFERENTIATION; NONPROTEOLYTIC ACTIVATION; SACCHAROMYCES-CEREVISIAE; MEMBRANE SECTOR	The ATPase 6 accessory protein 2 (ATP6AP2)/(pro)renin receptor (PRR) is essential for the biogenesis of active vacuolar H+-ATPase (V-ATPase). Genetic deletion of ATP6AP2/PRR causes V-ATPase dysfunction and compromises vesicular acidification. Here, we characterized the domains of ATP6AP2/PRR involved in active V-ATPase biogenesis. Three forms of ATP6AP2/PRR were found intracellularly: full-length protein and the N- and C-terminal fragments of furin cleavage products, with the N-terminal fragment secreted extracellularly. Genetic deletion of ATP6AP2/PRR did not affect the protein stability of V-ATPase subunits. The extracellular domain (ECD) and transmembrane domain (TM) of ATP6AP2/PRR were indispensable for the biogenesis of active V-ATPase. A deletion mutant of ATP6AP2/PRR, which lacks exon 4-encoded amino acids inside the ECD (Delta 4M) and causes X-linked mental retardation Hedera type (MRXSH) and X-linked parkinsonism with spasticity (XPDS) in humans, was defective as a V-ATPase-associated protein. Prorenin had no effect on the biogenesis of active V-ATPase. The cleavage of ATP6AP2/PRR by furin seemed also dispensable for the biogenesis of active V-ATPase. We conclude that the N-terminal ECD of ATP6AP2/PRR, which is also involved in binding to prorenin or renin, is required for the biogenesis of active V-ATPase. The V-ATPase assembly occurs prior to its delivery to the trans-Golgi network and hence shedding of ATP6AP2/PRR would not affect the biogenesis of active V-ATPase.	[Kinouchi, Kenichiro; Ochi, Hiroki; Fukuda, Toru; Bokuda, Kanako; Kurosawa, Hideaki; Takeda, Shu; Itoh, Hiroshi] Keio Univ, Sch Med, Dept Internal Med, Div Endocrinol Metab & Nephrol, Tokyo, Japan; [Ichihara, Atsuhiro; Yoshida, Naohiro] Tokyo Womens Med Univ, Dept Endocrinol & Hypertens, Tokyo, Japan; [Sano, Motoaki; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan; [Sun-Wada, Ge-Hong] Doshisha Womens Coll, Fac Pharmaceut Sci, Dept Biochem, Kyoto, Japan; [Wada, Yoh] Osaka Univ, Inst Sci & Ind Res, Div Biol Sci, Osaka, Japan	Keio University; Tokyo Women's Medical University; Keio University; Osaka University	Ichihara, A (corresponding author), Tokyo Womens Med Univ, Dept Endocrinol & Hypertens, Tokyo, Japan.	atzichi@endm.twmu.ac.jp	Sano, Motoaki/L-3405-2013; Kinouchi, Kenichiro/AAW-8471-2021; Fukuda, Keiichi/L-3777-2013	Kinouchi, Kenichiro/0000-0003-4743-2583; 	JSPS KAKENHI [25293198]; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Grants-in-Aid for Scientific Research [25650066, 25293198] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a JSPS KAKENHI Grant Number 25293198 (to A.I.), a Grant-in-Aid for JSPS fellows (to K. K.), notable awards for research achievements in science and technology (Takeda Science Foundation), and the Mochida Memorial Foundation for Medical and Pharmaceutical Research (to M. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUERLE C, 1993, J BIOL CHEM, V268, P12749; Burckle C, 2006, HYPERTENSION, V48, P549, DOI 10.1161/01.HYP.0000241132.48495.df; Contrepas A, 2009, AM J PHYSIOL-REG I, V297, pR250, DOI 10.1152/ajpregu.90832.2008; Cousin C, 2009, HYPERTENSION, V53, P1077, DOI 10.1161/HYPERTENSIONAHA.108.127258; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gonzalez AA, 2011, HYPERTENSION, V57, P859, DOI 10.1161/HYPERTENSIONAHA.110.167957; Graham LA, 1998, J CELL BIOL, V142, P39, DOI 10.1083/jcb.142.1.39; HILL KJ, 1995, J BIOL CHEM, V270, P22329, DOI 10.1074/jbc.270.38.22329; HILL KJ, 1994, MOL BIOL CELL, V5, P1039, DOI 10.1091/mbc.5.9.1039; HIRATA R, 1993, J BIOL CHEM, V268, P961; Ichihara A, 2006, HYPERTENSION, V47, P894, DOI 10.1161/01.HYP.0000215838.48170.0b; Ichihara A, 2004, J CLIN INVEST, V114, P1128, DOI 10.1172/JCI200421398; Ichihara A, 2006, J AM SOC NEPHROL, V17, P2495, DOI 10.1681/ASN.2005121278; Ichihara A, 2006, J AM SOC NEPHROL, V17, P1950, DOI 10.1681/ASN.2006010029; Jackson DD, 1997, J BIOL CHEM, V272, P25928, DOI 10.1074/jbc.272.41.25928; Jansen EJR, 1998, J CELL SCI, V111, P2999; Jansen EJR, 2012, CURR PROTEIN PEPT SC, V13, P124; KANE PM, 1992, J BIOL CHEM, V267, P447; Kinouchi K, 2011, FRONT BIOSCI-LANDMRK, V16, P3216, DOI 10.2741/3907; Kinouchi K, 2010, CIRC RES, V107, P30, DOI 10.1161/CIRCRESAHA.110.224667; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Korvatska O, 2013, HUM MOL GENET; Louagie E, 2008, P NATL ACAD SCI USA, V105, P12319, DOI 10.1073/pnas.0800340105; Ludwig J, 1998, J BIOL CHEM, V273, P10939, DOI 10.1074/jbc.273.18.10939; Malkus P, 2004, MOL BIOL CELL, V15, P5075, DOI 10.1091/mbc.E04-06-0514; Nakamura N, 2000, J BIOL CHEM, V275, P6523, DOI 10.1074/jbc.275.9.6523; Nakamura N, 2001, J BIOCHEM-TOKYO, V130, P765, DOI 10.1093/oxfordjournals.jbchem.a003047; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; Oluwatosin YE, 1998, MOL CELL BIOL, V18, P1534, DOI 10.1128/MCB.18.3.1534; Oshima Y, 2011, J AM SOC NEPHROL, V22, P2203, DOI 10.1681/ASN.2011020202; Ramser J, 2005, HUM MOL GENET, V14, P1019, DOI 10.1093/hmg/ddi094; Riediger F, 2011, J AM SOC NEPHROL, V22, P2193, DOI 10.1681/ASN.2011020200; Saris JJ, 2006, HYPERTENSION, V48, P564, DOI 10.1161/01.HYP.0000240064.19301.1b; Sun-Wada GH, 2003, CELL STRUCT FUNCT, V28, P455, DOI 10.1247/csf.28.455; Sun-Wada GH, 2002, J BIOL CHEM, V277, P18098, DOI 10.1074/jbc.M111567200; Takahashi H, 2007, J AM SOC NEPHROL, V18, P2054, DOI 10.1681/ASN.2006080820; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Toyomura T, 2000, J BIOL CHEM, V275, P8760, DOI 10.1074/jbc.275.12.8760; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; Yoshikawa A, 2011, HYPERTENS RES, V34, P599, DOI 10.1038/hr.2010.284	42	27	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78603	10.1371/journal.pone.0078603	http://dx.doi.org/10.1371/journal.pone.0078603			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223829	Green Submitted, Green Published, gold			2022-12-27	WOS:000326503400077
J	Tajiri, N; Kellogg, SL; Shimizu, T; Arendash, GW; Borlongan, CV				Tajiri, Naoki; Kellogg, S. Leilani; Shimizu, Toru; Arendash, Gary W.; Borlongan, Cesar V.			Traumatic Brain Injury Precipitates Cognitive Impairment and Extracellular A beta Aggregation in Alzheimer's Disease Transgenic Mice	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; FOOTBALL-LEAGUE PLAYER; HEAD-INJURY; OLDER-ADULTS; RISK; ENCEPHALOPATHY; DAMAGE; ABNORMALITIES; HIPPOCAMPUS; PERFORMANCE	Traumatic brain injury (TBI) has become a signature wound of the wars in Iraq and Afghanistan. Many American soldiers, even those undiagnosed but likely suffering from mild TBI, display Alzheimer's disease (AD)-like cognitive impairments, suggesting a pathological overlap between TBI and AD. This study examined the cognitive and neurohistological effects of TBI in presymptomatic APP/PS1 AD-transgenic mice. AD mice and non-transgenic (NT) mice received an experimental TBI on the right parietal cortex using the controlled cortical impact model. Animals were trained in a water maze task for spatial memory before TBI, and then reevaluated in the same task at two and six weeks post-TBI. The results showed that AD mice with TBI made significantly more errors in the task than AD mice without TBI and NT mice regardless of TBI. A separate group of AD mice and NT mice were evaluated neurohistologically at six weeks after TBI. The number of extracellular beta-amyloid (A beta)-deposits significantly increased by at least one fold in the cortex of AD mice that received TBI compared to the NT mice that received TBI or the AD and NT mice that underwent sham surgery. A significant decrease in MAP2 positive cells, indicating neuronal loss, was observed in the cortex of both the AD and NT mice that received TBI compared to the AD and NT mice subjected to sham surgery. Similar changes in extracellular A beta deposits and MAP2 positive cells were also seen in the hippocampus. These results demonstrate for the first time that TBI precipitates cognitive impairment in presymptomatic AD mice, while also confirming extracellular A beta deposits following TBI. The recognition of this pathological link between TBI and AD should aid in developing novel treatments directed at abrogating cellular injury and extracellular A beta deposition in the brain.	[Tajiri, Naoki; Borlongan, Cesar V.] Univ S Florida, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Morsani Coll Med, Tampa, FL 33620 USA; [Kellogg, S. Leilani; Shimizu, Toru] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Arendash, Gary W.] NeuroEM Therapeut Inc, Scottsdale, AZ USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Borlongan, CV (corresponding author), Univ S Florida, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Morsani Coll Med, Tampa, FL 33620 USA.	cborlong@health.usf.edu	Tajiri, Naoki/K-1230-2012; Borlongan, Cesar/I-5696-2012	Tajiri, Naoki/0000-0003-2189-662X; Borlongan, Cesar/0000-0002-2966-9782	University of South Florida Department of Neurosurgery; Brain Repair funds; James and Esther King Biomedical Research Foundation [1KG01-33966, NIH 5U01NS055914-04, NIH 1R01NS071956-01A1]; SanBio Inc.; Celgene Cellular Therapeutics; KMPHC; NeuralStem Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071956] Funding Source: NIH RePORTER	University of South Florida Department of Neurosurgery; Brain Repair funds; James and Esther King Biomedical Research Foundation; SanBio Inc.; Celgene Cellular Therapeutics(Bristol-Myers SquibbCelgene Corporation); KMPHC; NeuralStem Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Financial support for this study was through the University of South Florida Department of Neurosurgery and Brain Repair funds. CVB is funded by the James and Esther King Biomedical Research Foundation 1KG01-33966, NIH 5U01NS055914-04 and NIH 1R01NS071956-01A1, SanBio Inc., Celgene Cellular Therapeutics, KMPHC and NeuralStem Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliev G, 2003, NEUROL RES, V25, P665, DOI 10.1179/016164103101201977; Arendash GW, 2004, BRAIN RES, V1012, P29, DOI 10.1016/j.brainres.2004.02.081; Baldauf K, 2005, BRAIN RES, V1056, P158, DOI 10.1016/j.brainres.2005.07.035; Borroni B, 2002, J NEUROL SCI, V203, P189, DOI 10.1016/S0022-510X(02)00289-7; Bryan C, 2012, J HEAD TRAUMA REHAB, V27, P45, DOI 10.1097/HTR.0b013e318238f146; DALE GE, 1991, J NEUROL NEUROSUR PS, V54, P116, DOI 10.1136/jnnp.54.2.116; Davies TA, 2000, AMYLOID, V7, P153, DOI 10.3109/13506120009146830; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Feng JF, 2012, J NEUROTRAUM, V29, P1167, DOI 10.1089/neu.2011.1867; Forbes ML, 1998, J NEUROSURG, V88, P549, DOI 10.3171/jns.1998.88.3.0549; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Jantaratnotai Nattinee, 2011, Int J Alzheimers Dis, V2011, P918280, DOI 10.4061/2011/918280; Jellinger K A, 2001, BMC Neurol, V1, P3, DOI 10.1186/1471-2377-1-3; Kline RP, 2012, ANESTHESIOLOGY, V116, P603, DOI 10.1097/ALN.0b013e318246ec0b; Matsuda H, 2012, AM J NEURORADIOL, V33, P1109, DOI 10.3174/ajnr.A2935; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Miller G, 2011, SCIENCE, V333, P517, DOI 10.1126/science.333.6042.517; Mlekusch R, 2009, NEUROSCI LETT, V466, P135, DOI 10.1016/j.neulet.2009.09.043; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; OMeara ES, 1997, AM J EPIDEMIOL, V146, P373, DOI 10.1093/oxfordjournals.aje.a009290; Palmer JC, 2010, NEUROPATH APPL NEURO, V36, P487, DOI 10.1111/j.1365-2990.2010.01084.x; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Salib E, 1997, INT J GERIATR PSYCH, V12, P363, DOI 10.1002/(SICI)1099-1166(199703)12:3<363::AID-GPS515>3.0.CO;2-F; Sarmiento K, 2008, J HEAD TRAUMA REHAB, V23, P164, DOI 10.1097/01.HTR.0000319933.22709.61; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Shetty AK, 2009, J CELL MOL MED, V13, P2408, DOI 10.1111/j.1582-4934.2009.00675.x; Thomas KE, 2008, J SAFETY RES, V39, P269, DOI 10.1016/j.jsr.2008.05.001; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Walker DG, 2008, MICROVASC RES, V75, P411, DOI 10.1016/j.mvr.2007.10.004; Yesil Y, 2012, ARCH GERONTOL GERIAT, V55, P257, DOI 10.1016/j.archger.2011.09.016; You ZR, 2007, J CEREBR BLOOD F MET, V27, P1954, DOI 10.1038/sj.jcbfm.9600497; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	37	50	51	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78851	10.1371/journal.pone.0078851	http://dx.doi.org/10.1371/journal.pone.0078851			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223856	Green Submitted, gold, Green Published			2022-12-27	WOS:000326503400091
J	Gautam, S; Kirschnek, S; Wiesmeier, M; Vier, J; Hacker, G				Gautam, Sanjivan; Kirschnek, Susanne; Wiesmeier, Michael; Vier, Juliane; Haecker, Georg			Roscovitine-induced Apoptosis in Neutrophils and Neutrophil Progenitors Is Regulated by the Bcl-2-Family Members Bim, Puma, Noxa and Mcl-1	PLOS ONE			English	Article							DEPENDENT KINASE INHIBITOR; BCL-2 PROTEIN FAMILY; R-ROSCOVITINE; CANCER THERAPEUTICS; SELICICLIB CYC202; BH3-ONLY PROTEINS; MULTIPLE-MYELOMA; DOWN-REGULATION; BH3 DOMAINS; CELL-DEATH	Neutrophil granulocyte (neutrophil) apoptosis plays a key role in determining inflammation in infectious and noninfectious settings. Recent work has shown that inhibitors of cyclin-dependent kinases (cdk) such as roscovitine can potently induce neutrophil apoptosis and reduce inflammation. Using a conditional Hoxb8-expression system we tested the participation of Bcl-2-family proteins to roscovitine-induced apoptosis in mouse neutrophils and in neutrophil progenitor cells. Bcl-2 strongly protected against roscovitine-induced apoptosis in neutrophils. The isolated loss of either Bim or noxa provided significant, partial protection while protection through combined loss of Bim and noxa or Bim and Puma was only slightly greater than this individual loss. The only substantial change in protein levels observed was the loss of Mcl-1, which was not transcriptional and was inhibited by proteasome blockade. In progenitor cells there was no protection by the loss of Bim alone but substantial protection by the loss of both Bim and Puma; surprisingly, strongest protection was seen by the isolated loss of noxa. The pattern of protein expression and Mcl-1-regulation in progenitor cells was very similar to the one observed in differentiated neutrophils. In addition, roscovitine strongly inhibited proliferation in progenitor cells, associated with an accumulation of cells in G2/M-phase.	[Gautam, Sanjivan; Kirschnek, Susanne; Wiesmeier, Michael; Vier, Juliane; Haecker, Georg] Univ Med Ctr, Inst Med Microbiol & Hyg, Freiburg, Germany	University of Freiburg	Hacker, G (corresponding author), Univ Med Ctr, Inst Med Microbiol & Hyg, Freiburg, Germany.	georg.haecker@uniklinik-freiburg.de			Deutsche Forschungsgemeinschaft (DFG) [SFB 620, TP A12]; Spemann Graduate School, Excellence Initiative of German Government; MOTI-VATE Promotionskolleg der Medizinischen Fakultat Freiburg; Else Kroner Fresenius-Stiftung	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Spemann Graduate School, Excellence Initiative of German Government; MOTI-VATE Promotionskolleg der Medizinischen Fakultat Freiburg; Else Kroner Fresenius-Stiftung	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) (SFB 620, TP A12), grant to GH, S. G was supported by Spemann Graduate School, Excellence Initiative of German Government and M. W was supported by MOTI-VATE Promotionskolleg der Medizinischen Fakultat Freiburg funded by Else Kroner Fresenius-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Craxton A, 2012, CELL DEATH DIFFER, V19, P1424, DOI 10.1038/cdd.2012.16; Czabotar PE, 2013, CELL, V152, P519, DOI 10.1016/j.cell.2012.12.031; Dey A, 2008, NAT REV DRUG DISCOV, V7, P1031, DOI 10.1038/nrd2759; Hoogendijk AJ, 2012, MOL MED, V18, P1086, DOI 10.2119/molmed.2012.00033; Huntington ND, 2007, NAT IMMUNOL, V8, P856, DOI 10.1038/ni1487; Kirschnek S, 2011, CELL DEATH DIFFER, V18, P1805, DOI 10.1038/cdd.2011.69; Koedel U, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000461; Leitch AE, 2012, CELL DEATH DIFFER, V19, P1950, DOI 10.1038/cdd.2012.80; Leitch AE, 2010, EUR J IMMUNOL, V40, P1127, DOI 10.1002/eji.200939664; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Llambi F, 2011, MOL CELL, V44, P517, DOI 10.1016/j.molcel.2011.10.001; MacCallum DE, 2005, CANCER RES, V65, P5399, DOI 10.1158/0008-5472.CAN-05-0233; McDonald JU, 2011, FASEB J, V25, P1972, DOI 10.1096/fj.10-178517; McGrath EE, 2011, J LEUKOCYTE BIOL, V90, P855, DOI 10.1189/jlb.0211062; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Pillay J, 2010, BLOOD, V116, P625, DOI 10.1182/blood-2010-01-259028; Ploner C, 2008, ONCOGENE, V27, pS84, DOI 10.1038/onc.2009.46; Raje N, 2005, BLOOD, V106, P1042, DOI 10.1182/blood-2005-01-0320; Ren Y, 2008, J IMMUNOL, V180, P4978, DOI 10.4049/jimmunol.180.7.4978; Rossi AG, 2006, NAT MED, V12, P1056, DOI 10.1038/nm1468; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Steimer DA, 2009, BLOOD, V113, P2805, DOI 10.1182/blood-2008-05-159145; Stewart DP, 2010, MOL CELL BIOL, V30, P3099, DOI 10.1128/MCB.01266-09; Theilgaard-Monch K, 2005, BLOOD, V105, P1785, DOI 10.1182/blood-2004-08-3346; Tofts PS, 2011, BLOOD, V117, P6050, DOI 10.1182/blood-2010-10-310532; Turner SM, 2011, BLOOD, V117, P6052, DOI 10.1182/blood-2010-12-322271; Wang GG, 2006, NAT METHODS, V3, P287, DOI 10.1038/NMETH865; Wertz IE, 2011, NATURE, V471, P110, DOI 10.1038/nature09779; Wilfling F, 2012, CELL DEATH DIFFER, V19, P1328, DOI 10.1038/cdd.2012.9; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	34	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79352	10.1371/journal.pone.0079352	http://dx.doi.org/10.1371/journal.pone.0079352			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223929	Green Submitted, Green Published, gold			2022-12-27	WOS:000326499300076
J	Anwar, T; Gourinath, S				Anwar, Tamanna; Gourinath, Samudrala			Analysis of the Protein Phosphotome of Entamoeba histolytica Reveals an Intricate Phosphorylation Network	PLOS ONE			English	Article							TYROSINE PHOSPHATASES; SUPERFAMILY; TARGETS; PREDICTION; INTERPRO; KINASES; FAMILY; WEB	Phosphorylation is the most common mechanism for the propagation of intracellular signals. Protein phosphatases and protein kinases play a dynamic antagonistic role in protein phosphorylation. Protein phosphatases make up a significant fraction of eukaryotic proteome. In this article, we report the identification and analysis of protein phosphatases in the intracellular parasite Entamoeba histolytica. Based on an in silico analysis, we classified 250 non-redundant protein phosphatases in E. histolytica. The phosphotome of E. histolytica is 3.1% of its proteome and 1.3 times of the human phosphotome. In this extensive study, we identified 42 new putative phosphatases (39 hypothetical proteins and 3 pseudophosphatases). The presence of pseudophosphatases may have an important role in virulence of E. histolytica. A comprehensive phosphotome analysis of E. histolytica shows spectacular low similarity to human phosphatases, making them potent candidates for drug target.	[Anwar, Tamanna; Gourinath, Samudrala] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Gourinath, S (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	sgourinath@mail.jnu.ac.in			University Grants Commission (Government of India)	University Grants Commission (Government of India)(University Grants Commission, India)	The authors are thankful to University Grants Commission (Government of India) for providing the funds for this project under Dr. D. S. Kothari postdoctoral fellowship scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Altman A, 2002, CURR DIR AUTOIMMUN, P186; Anamika K, 2008, PROTEINS, V71, P995, DOI 10.1002/prot.21790; Andreeva AV, 2008, INT J PARASITOL, V38, P1279, DOI 10.1016/j.ijpara.2008.04.003; Barr AJ, 2006, TRENDS PHARMACOL SCI, V27, P525, DOI 10.1016/j.tips.2006.08.005; Beresford NJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-457; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; Brenchley R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-434; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; CHEN J, 1990, J BACTERIOL, V172, P5686, DOI 10.1128/jb.172.10.5686-5689.1990; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Cohen PTW, 2004, TOP CURR GENET, V5, P1; Denu JM, 1998, CURR OPIN CHEM BIOL, V2, P633, DOI 10.1016/S1367-5931(98)80095-1; Dlakic M, 2000, TRENDS BIOCHEM SCI, V25, P272, DOI 10.1016/S0968-0004(00)01582-6; Easty D, 2006, CURR CANCER DRUG TAR, V6, P519, DOI 10.2174/156800906778194603; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Gee CE, 2005, CELL MOL LIFE SCI, V62, P1120, DOI 10.1007/s00018-005-5008-4; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Kedzierski L, 2004, ARCH IMMUNOL THER EX, V52, P104; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kellosalo J, 2012, SCIENCE, V337, P473, DOI 10.1126/science.1222505; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; Kutuzov MA, 2008, MOL BIOCHEM PARASIT, V161, P81, DOI 10.1016/j.molbiopara.2008.06.008; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liberti S, 2013, FEBS J, V280, P379, DOI 10.1111/j.1742-4658.2012.08712.x; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Lotter H, 2006, ARCH MED RES, V37, P292, DOI 10.1016/j.arcmed.2005.09.004; Luan S, 2003, ANNU REV PLANT BIOL, V54, P63, DOI 10.1146/annurev.arplant.54.031902.134743; LUNDIN M, 1991, J BIOL CHEM, V266, P12168; Majerus PW, 1999, J BIOL CHEM, V274, P10669, DOI 10.1074/jbc.274.16.10669; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Mulder NJ, 2008, MOL BIOTECHNOL, V38, P165, DOI 10.1007/s12033-007-9003-x; Mustelin Tomas, 2007, V365, P9; Rigden DJ, 2008, BIOCHEM J, V409, P333, DOI 10.1042/BJ20071097; Stauffer W, 2003, CURR OPIN INFECT DIS, V16, P479, DOI 10.1097/00001432-200310000-00016; Szoor B, 2010, MOL BIOCHEM PARASIT, V173, P53, DOI 10.1016/j.molbiopara.2010.05.017; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tautz L, 2006, EXPERT OPIN THER TAR, V10, P157, DOI 10.1517/14728222.10.1.157; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2009, CELL, V139, P464, DOI 10.1016/j.cell.2009.10.008; Veeramani S, 2009, TRENDS BIOCHEM SCI, V34, P273, DOI 10.1016/j.tibs.2009.03.002; Wilkes JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-412	46	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78714	10.1371/journal.pone.0078714	http://dx.doi.org/10.1371/journal.pone.0078714			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236039	Green Submitted, Green Published, gold			2022-12-27	WOS:000327254700036
J	Lee, CH; Shieh, YS; Tsai, CS; Hung, YJ; Tsai, YT; Lin, CY				Lee, Chien-Hsing; Shieh, Yi-Shing; Tsai, Chien-Sung; Hung, Yi-Jen; Tsai, Yi-Ting; Lin, Chih-Yuan			Plasma Concentrations Predict Aortic Expression of Growth-Arrest-Specific Protein 6 in Patients Undergoing Coronary Artery Bypass Grafting	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; KINASE RECEPTOR AXL; PHOSPHATE-INDUCED CALCIFICATION; SYSTEMIC-LUPUS-ERYTHEMATOSUS; TYROSINE KINASE; ENDOTHELIAL-CELLS; TYRO-3 FAMILY; SOLUBLE FORM; GAS6; INFLAMMATION	Aims: The tyrosine kinase receptor Axl is expressed in the vasculature, and growth arrest-specific protein 6 (Gas6) is its ligand. Plasma Gas6 levels have been shown to be associated with endothelial dysfunction markers and cardiovascular events. We set out to determine the plasma Gas6 levels in patients undergoing coronary artery bypass grafting (CABG) and investigate the expression of Gas6 and Axl in the aorta. Methods and Results: Immunoassays were used to investigate plasma Gas6 levels in CABG patients (n = 19) and control subjects (n = 20). The expression of Gas6 and Axl in the injured aorta were examined by reverse transcription-polymerase chain reactions, real-time reverse transcription-polymerase chain reactions, western blotting, and immunohistochemical staining. Plasma Gas6 levels were significantly lower in CABG patients than in matched control subjects. In CABG patients, plasma Gas6 levels were negatively correlated with fasting glucose, E-selectin, and vascular cell adhesion molecule-1 levels. The levels predicted the operative mortality rate and were positively correlated with plasma soluble Axl (sAxl) levels and Gas6 expression in the aorta. Moreover, Gas6 expression was positively correlated with Axl expression in the aorta. Conclusion: We concluded that plasma Gas6 is associated with fasting glucose, endothelial dysfunction markers, sAxl values, and vascular Gas6 expression in CABG patients, and it predicts the operative mortality of these patients. These findings suggest that the Gas6/Axl system is crucial in vascular biology.	[Lee, Chien-Hsing; Hung, Yi-Jen] Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Endocrinol & Metab, Taipei, Taiwan; [Shieh, Yi-Shing] Natl Def Med Ctr, Triserv Gen Hosp, Dept Oral Diag & Pathol, Taipei, Taiwan; [Tsai, Chien-Sung; Tsai, Yi-Ting; Lin, Chih-Yuan] Natl Def Med Ctr, Triserv Gen Hosp, Dept Surg, Div Cardiovasc Surg, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital	Lin, CY (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Surg, Div Cardiovasc Surg, Taipei, Taiwan.	linrock@ms26.hinet.net			National Science Council [NSC 98-2314-B016-013, NSC 99-2314-B-016-011-MY2, NSC 100-2314-B-016 -026 -MY3]; Tri-Service General Hospital in Taiwan [TSGH-C100-012-S02, TSGH-C101-035, TSGH-C101-007-012-S02]	National Science Council(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital in Taiwan	This work was supported by the National Science Council (NSC 98-2314-B016-013, NSC 99-2314-B-016-011-MY2, NSC 100-2314-B-016 -026 -MY3) and Tri-Service General Hospital (TSGH-C100-012-S02, TSGH-C101-035, TSGH-C101-007-012-S02) in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Oufella H, 2008, ARTERIOSCL THROM VAS, V28, P1429, DOI 10.1161/ATVBAHA.108.169078; Alciato F, 2010, J LEUKOCYTE BIOL, V87, P869, DOI 10.1189/jlb.0909610; Avanzi GC, 1998, BLOOD, V91, P2334, DOI 10.1182/blood.V91.7.2334.2334_2334_2340; Cavet ME, 2008, ARTERIOSCL THROM VAS, V28, P886, DOI 10.1161/ATVBAHA.108.162693; Clauser S, 2012, THROMB HAEMOSTASIS, V107, P140, DOI 10.1160/TH11-05-0368; D'Arcangelo D, 2002, CIRC RES, V91, pE4, DOI 10.1161/01.RES.0000036753.50601.E9; Ekman C, 2010, J THROMB HAEMOST, V8, P838, DOI 10.1111/j.1538-7836.2010.03752.x; Ekman C, 2010, CLIN BIOCHEM, V43, P873, DOI 10.1016/j.clinbiochem.2010.04.006; Ekman C, 2010, CLIN BIOCHEM, V43, P110, DOI 10.1016/j.clinbiochem.2009.07.025; Fernandez-Fernandez L, 2008, THROMB HAEMOSTASIS, V100, P604, DOI 10.1160/TH08-04-0253; Fridell YWC, 1998, J BIOL CHEM, V273, P7123, DOI 10.1074/jbc.273.12.7123; Gheita TA, 2012, J CLIN IMMUNOL, V32, P1279, DOI 10.1007/s10875-012-9743-7; Gibot S, 2007, CRIT CARE, V11, DOI 10.1186/cc5158; Hafizi S, 2006, FEBS J, V273, P5231, DOI 10.1111/j.1742-4658.2006.05529.x; Hsiao FC, 2013, J CLIN ENDOCR METAB, V98, pE267, DOI 10.1210/jc.2012-3179; Hung YJ, 2010, DIABETES CARE, V33, P1840, DOI 10.2337/dc09-1073; Hurtado B, 2011, THROMB HAEMOSTASIS, V105, P873, DOI 10.1160/TH10-10-0630; Jiang L, 2009, AM J CLIN PATHOL, V131, P738, DOI 10.1309/AJCP3CX3AUVRBHCF; Kim HA, 2013, J CLIN IMMUNOL, V33, P143, DOI 10.1007/s10875-012-9765-1; Kim H, 2012, J CELL MOL MED, V16, P273, DOI 10.1111/j.1582-4934.2011.01294.x; Kobayashi KJ, 2009, J CARDIAC SURG, V24, P637, DOI 10.1111/j.1540-8191.2009.00906.x; Konishi A, 2004, J BIOL CHEM, V279, P28766, DOI 10.1074/jbc.M401977200; Korshunov VA, 2006, CIRC RES, V98, P1446, DOI 10.1161/01.RES.0000223322.16149.9a; Korshunov VA, 2007, HYPERTENSION, V50, P1057, DOI 10.1161/HYPERTENSIONAHA.107.096289; Lemke G, 2003, CURR OPIN IMMUNOL, V15, P31, DOI 10.1016/S0952-7915(02)00016-X; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Lutgens E, 2008, J PATHOL, V216, P55, DOI 10.1002/path.2381; Malarstig A, 2006, ARTERIOSCL THROM VAS, V26, P1667, DOI 10.1161/01.ATV.0000222908.78873.36; Melaragno MG, 1998, CIRC RES, V83, P697, DOI 10.1161/01.RES.83.7.697; Metzler B, 2012, THROMB HAEMOSTASIS, V108, P1065, DOI 10.1160/TH11-06-0399; Nakano T, 1996, FEBS LETT, V387, P78, DOI 10.1016/0014-5793(96)00395-X; Nyberg P, 1997, EUR J BIOCHEM, V246, P147, DOI 10.1111/j.1432-1033.1997.t01-2-00147.x; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; Sheetz MJ, 2002, JAMA-J AM MED ASSOC, V288, P2579, DOI 10.1001/jama.288.20.2579; Son BK, 2006, CIRC RES, V98, P1024, DOI 10.1161/01.RES.0000218859.90970.8d; Son BK, 2007, EUR J PHARMACOL, V556, P1, DOI 10.1016/j.ejphar.2006.09.070; STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0; Taggart DP, 2005, BMJ-BRIT MED J, V330, P785, DOI 10.1136/bmj.330.7494.785; Thorp E, 2008, ARTERIOSCL THROM VAS, V28, P1421, DOI 10.1161/ATVBAHA.108.167197; Tjwa M, 2008, BLOOD, V111, P4096, DOI 10.1182/blood-2007-05-089565	40	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79452	10.1371/journal.pone.0079452	http://dx.doi.org/10.1371/journal.pone.0079452			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236135	Green Submitted, gold, Green Published			2022-12-27	WOS:000327254700134
J	Marietta, EV; Gomez, AM; Yeoman, C; Tilahun, AY; Clark, CR; Luckey, DH; Murray, JA; White, BA; Kudva, YC; Rajagopalan, G				Marietta, Eric V.; Gomez, Andres M.; Yeoman, Carl; Tilahun, Ashenafi Y.; Clark, Chad R.; Luckey, David H.; Murray, Joseph A.; White, Bryan A.; Kudva, Yogish C.; Rajagopalan, Govindarajan			Low Incidence of Spontaneous Type 1 Diabetes in NonObese Diabetic Mice Raised on Gluten-Free Diets Is Associated with Changes in the Intestinal Microbiome	PLOS ONE			English	Article							CELIAC-DISEASE; EXPOSURE; RISK; TRIGGER; WHEAT	Human and animal studies strongly suggest that dietary gluten could play a causal role in the etiopathogenesis of type 1 diabetes (T1D). However, the mechanisms have not been elucidated. Recent reports indicate that the intestinal microbiome has a major influence on the incidence of T1D. Since diet is known to shape the composition of the intestinal microbiome, we investigated using non-obese diabetic (NOD) mice whether changes in the intestinal microbiome could be attributed to the pro-and anti-diabetogenic effects of gluten-containing and gluten-free diets, respectively. NOD mice were raised on gluten-containing chows (GCC) or gluten-free chows (GFC). The incidence of diabetes was determined by monitoring blood glucose levels biweekly using a glucometer. Intestinal microbiome composition was analyzed by sequencing 16S rRNA amplicons derived from fecal samples. First of all, GCC-fed NOD mice had the expected high incidence of hyperglycemia whereas NOD mice fed with a GFC had significantly reduced incidence of hyperglycemia. Secondly, when the fecal microbiomes were compared, Bifidobacterium, Tannerella, and Barnesiella species were increased (p = 0.03, 0.02, and 0.02, respectively) in the microbiome of GCC mice, where as Akkermansia species was increased (p = 0.02) in the intestinal microbiomes of NOD mice fed GFC. Thirdly, both of the gluten-free chows that were evaluated, either egg white based (EW-GFC) or casein based (C-GFC), significantly reduced the incidence of hyperglycemia. Interestingly, the gut microbiome from EW-GFC mice was similar to C-GFC mice. Finally, adding back gluten to the gluten-free diet reversed its anti-diabetogenic effect, reduced Akkermansia species and increased Bifidobacterium, Tannerella, and Barnesiella suggesting that the presence of gluten is directly responsible for the pro-diabetogenic effects of diets and it determines the gut microflora. Our novel study thus suggests that dietary gluten could modulate the incidence of T1D by changing the gut microbiome.	[Marietta, Eric V.; Tilahun, Ashenafi Y.; Clark, Chad R.; Luckey, David H.; Rajagopalan, Govindarajan] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA; [Marietta, Eric V.] Mayo Clin, Dept Dermatol, Rochester, MN USA; [Marietta, Eric V.; Murray, Joseph A.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA; [Gomez, Andres M.; White, Bryan A.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Yeoman, Carl] Montana State Univ, Coll Agr, Dept Anim & Range Sci, Bozeman, MT 59717 USA; [Kudva, Yogish C.] Mayo Clin, Div Endocrinol Diabet Metab & Nutr, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Illinois System; University of Illinois Urbana-Champaign; Montana State University System; Montana State University Bozeman; Mayo Clinic	Marietta, EV (corresponding author), Mayo Clin, Dept Immunol, Rochester, MN 55905 USA.	marietta.eric@mayo.edu; rajagopalan.govindarajan@Mayo.edu	Yeoman, Carl/ABA-1906-2021	Yeoman, Carl/0000-0002-8775-7879	Iacocca Foundation; NIH R01 grant [DK071003]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071003] Funding Source: NIH RePORTER; Office Of The Director [1443108] Funding Source: National Science Foundation	Iacocca Foundation; NIH R01 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This study was funded by grants from the Iacocca Foundation (GR) and NIH R01 grant (DK071003) (JAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barera G, 2002, PEDIATRICS, V109, P833, DOI 10.1542/peds.109.5.833; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; BOTTAZZO GF, 1978, BRIT MED J, V2, P165, DOI 10.1136/bmj.2.6131.165; de Goffau MC, 2012, FECAL MICROBIOTA COM; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; ELLIOTT RB, 1984, DIABETOLOGIA, V26, P297, DOI 10.1007/BF00283653; Erb-Downward JR, 2012, SCI REP-UK, V2, DOI 10.1038/srep00774; Gomez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036095; Hansen CHF, 2012, DIABETOLOGIA, V55, P2285, DOI 10.1007/s00125-012-2564-7; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Kashyap PC, 2013, GASTROENTEROLOGY, V144, P967, DOI 10.1053/j.gastro.2013.01.047; Kriegel MA, 2011, P NATL ACAD SCI USA, V108, P11548, DOI 10.1073/pnas.1108924108; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Ludvigsson JF, 2006, DIABETES CARE, V29, P2483, DOI 10.2337/dc06-0794; MAKI M, 1984, ARCH DIS CHILD, V59, P739, DOI 10.1136/adc.59.8.739; Maurano F, 2005, DIABETOLOGIA, V48, P931, DOI 10.1007/s00125-005-1718-2; Neu J, 2010, ENDOCRIN METAB CLIN, V39, P563, DOI 10.1016/j.ecl.2010.05.008; Norris JM, 2003, JAMA-J AM MED ASSOC, V290, P1713, DOI 10.1001/jama.290.13.1713; Schmid S, 2004, DIABETOLOGIA, V47, P1130; Schmid S, 2004, CLIN IMMUNOL, V111, P108, DOI 10.1016/j.clim.2003.09.012; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Van Belle TL, 2012, J AUTOIMMUNITY; Ventura A, 1999, GASTROENTEROLOGY, V117, P297, DOI 10.1053/gast.1999.0029900297; Yildirim S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013963; Yoon Ji-Won, 2005, Am J Ther, V12, P580, DOI 10.1097/01.mjt.0000178767.67857.63	26	87	93	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78687	10.1371/journal.pone.0078687	http://dx.doi.org/10.1371/journal.pone.0078687			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236037	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700034
J	Negandhi, K; Laurion, I; Whiticar, MJ; Galand, PE; Xu, XM; Lovejoy, C				Negandhi, Karita; Laurion, Isabelle; Whiticar, Michael J.; Galand, Pierre E.; Xu, Xiaomei; Lovejoy, Connie			Small Thaw Ponds: An Unaccounted Source of Methane in the Canadian High Arctic	PLOS ONE			English	Article							ION-SOURCE DEVELOPMENT; ORGANIC-CARBON; ARCHAEAL COMMUNITIES; NORTHERN LAKES; LENA DELTA; PERMAFROST; CO2; EMISSIONS; PATHWAYS; SEQUENCE	Thawing permafrost in the Canadian Arctic tundra leads to peat erosion and slumping in narrow and shallow runnel ponds that surround more commonly studied polygonal ponds. Here we compared the methane production between runnel and polygonal ponds using stable isotope ratios, C-14 signatures, and investigated potential methanogenic communities through high-throughput sequencing archaeal 16S rRNA genes. We found that runnel ponds had significantly higher methane and carbon dioxide emissions, produced from a slightly larger fraction of old carbon, compared to polygonal ponds. The methane stable isotopic signature indicated production through acetoclastic methanogenesis, but gene signatures from acetoclastic and hydrogenotrophic methanogenic Archaea were detected in both polygonal and runnel ponds. We conclude that runnel ponds represent a source of methane from potentially older C, and that they contain methanogenic communities able to use diverse sources of carbon, increasing the risk of augmented methane release under a warmer climate.	[Negandhi, Karita; Laurion, Isabelle] Ctr Northern Studies CEN, Quebec City, PQ, Canada; [Whiticar, Michael J.] Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC, Canada; [Galand, Pierre E.] Univ Paris 06, LECOB, Observat Oceanol, UMR 8222, Banyuls Sur Mer, France; [Galand, Pierre E.] CNRS, LECOB, Observat Oceanol, UMR 8222, Banyuls Sur Mer, France; [Xu, Xiaomei] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA USA; [Lovejoy, Connie] Univ Laval, Dept Biol, Inst Biol Integrat & Syst, Quebec City, PQ G1K 7P4, Canada; [Lovejoy, Connie] Takuvik, CNRS, UMI 3376, Quebec City, PQ, Canada	University of Victoria; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); University of California System; University of California Irvine; Laval University	Lovejoy, C (corresponding author), Univ Laval, Dept Biol, Inst Biol Integrat & Syst, Quebec City, PQ G1K 7P4, Canada.	connie.lovejoy@bio.ulaval.ca	Lovejoy, Connie/A-3756-2008; Galand, Pierre/A-1429-2014	Lovejoy, Connie/0000-0001-8027-2281; Galand, Pierre/0000-0002-2238-3247; Negandhi, Karita/0000-0002-2463-3414; Laurion, Isabelle/0000-0001-8694-3330	National Research and Engineering Council (NSERC) Canada; ArcticNet; Canadian International Polar Year (IPY); Keck Carbon Cycle AMS Facility	National Research and Engineering Council (NSERC) Canada; ArcticNet; Canadian International Polar Year (IPY); Keck Carbon Cycle AMS Facility	Funding for the study was primarily from the National Research and Engineering Council (NSERC) Canada, including grants to LL, CL, and MJW. Additional support was from ArcticNet, the Canadian International Polar Year (IPY). Parks Canada and The Polar Continental Shelf Project provided logistic support. XX had support from the Keck Carbon Cycle AMS Facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnizova A, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004237; Anthony KMW, 2010, LIMNOL OCEANOGR-METH, V8, P592, DOI 10.4319/lom.2010.8.0592; Barber RD, 2011, J BACTERIOL, V193, P3668, DOI 10.1128/JB.05031-11; Barbier BA, 2012, FEMS MICROBIOL ECOL, V82, P287, DOI 10.1111/j.1574-6941.2012.01332.x; Bastviken D, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002238; Berggren M, 2010, ECOL LETT, V13, P870, DOI 10.1111/j.1461-0248.2010.01483.x; Borrel G, 2012, INT J SYST EVOL MICR, V62, P1625, DOI 10.1099/ijs.0.034538-0; Borrel G, 2011, RES MICROBIOL, V162, P832, DOI 10.1016/j.resmic.2011.06.004; Breton J, 2009, CAN J FISH AQUAT SCI, V66, P1635, DOI 10.1139/F09-108; Brosius LS, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001810; Chappaz A, 2008, GEOCHIM COSMOCHIM AC, V72, P170, DOI 10.1016/j.gca.2007.10.014; Cole JJ, 1998, LIMNOL OCEANOGR, V43, P647, DOI 10.4319/lo.1998.43.4.0647; Comeau AM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00604; Comeau AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027492; Deppenmeier U, 2002, J MOL MICROB BIOTECH, V4, P453; Fortier D, 2004, CAN J EARTH SCI, V41, P997, DOI 10.1139/E04-031; Galand PE, 2006, AQUAT MICROB ECOL, V44, P115, DOI 10.3354/ame044115; Grosse G, 2011, J GEOPHYS RES, V116, P2005; Grosse G., 2008, 9 INT CONFERENCNCE P, P551; Guillemette F, 2011, LIMNOL OCEANOGR, V56, P734, DOI 10.4319/lo.2011.56.2.0734; HAMILTON JD, 1994, J GEOPHYS RES-ATMOS, V99, P1495, DOI 10.1029/93JD03020; HESSLEIN RH, 1991, AIR-WATER MASS TRANSFER, P413; Hoj L, 2005, FEMS MICROBIOL ECOL, V53, P89, DOI 10.1016/j.femsec.2005.01.004; Hoj L, 2008, ISME J, V2, P37, DOI 10.1038/ismej.2007.84; Hornibrook ERC, 1997, GEOCHIM COSMOCHIM AC, V61, P745, DOI 10.1016/S0016-7037(96)00368-7; Juottonen H., 2008, THESIS; Karadagli F, 2007, BIODEGRADATION, V18, P453, DOI 10.1007/s10532-006-9078-2; Kobabe S, 2004, FEMS MICROBIOL ECOL, V50, P13, DOI 10.1016/j.femsec.2004.05.003; Laurion I, 2010, LIMNOL OCEANOGR, V55, P115, DOI 10.4319/lo.2010.55.1.0115; MacIntyre S, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044164; Metje M, 2007, ENVIRON MICROBIOL, V9, P954, DOI 10.1111/j.1462-2920.2006.01217.x; Michmerhuizen CM, 1996, LIMNOL OCEANOGR, V41, P985, DOI 10.4319/lo.1996.41.5.0985; Muster S, 2012, TELLUS B, V64, DOI 10.3402/tellusb.v64i0.17301; Penning H, 2007, ORG GEOCHEM, V38, P2058, DOI 10.1016/j.orggeochem.2007.08.004; Pouliot J, 2009, ENVIRON MICROBIOL, V11, P687, DOI 10.1111/j.1462-2920.2008.01846.x; Roehm CL, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000863; Rowland J., 2010, EOS T AM GEOPHYS UNI, V91, P229, DOI [10.1029/2010EO260001, DOI 10.1029/2010E0260001]; Sachs T, 2008, J GEOPHYS RES, V113, P2005; Sakai S, 2009, APPL ENVIRON MICROB, V75, P4892, DOI 10.1128/AEM.02835-08; Schloss PD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008230; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schuur EAG, 2008, BIOSCIENCE, V58, P701, DOI 10.1641/B580807; Shirokova LS, 2013, BIOGEOCHEMISTRY, V113, P573, DOI 10.1007/s10533-012-9790-4; Smith LC, 2007, PERMAFROST PERIGLAC, V18, P201, DOI 10.1002/ppp.581; Southon J, 2007, NUCL INSTRUM METH B, V259, P88, DOI 10.1016/j.nimb.2007.01.147; Southon JR, 2004, RADIOCARBON, V46, P33, DOI 10.1017/S0033822200039321; STAINTON MP, 1977, CAN FISH MAR SERV MI, V25; Tank SE, 2009, ECOSYSTEMS, V12, P144, DOI 10.1007/s10021-008-9213-5; Tranvik LJ, 2009, LIMNOL OCEANOGR, V54, P2298, DOI 10.4319/lo.2009.54.6_part_2.2298; Wagner D, 2005, ENVIRON MICROBIOL, V7, P1582, DOI 10.1111/j.1462-2920.2005.00849.x; Wagner D, 2007, GLOBAL CHANGE BIOL, V13, P1089, DOI 10.1111/j.1365-2486.2007.01331.x; Walter KM, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000569; Walter KM, 2007, PHILOS T R SOC A, V365, P1657, DOI 10.1098/rsta.2007.2036; Xu X, 2012, 21 RAD C PAR; Xu XM, 2007, NUCL INSTRUM METH B, V259, P320, DOI 10.1016/j.nimb.2007.01.175; Zimov S. A, 2001, NATO SCI SERIES, V76, P511, DOI [10.1007/978-94-010-0684-2_35., DOI 10.1007/978-94-010-0684-2_]; Zimov SA, 1997, SCIENCE, V277, P800, DOI 10.1126/science.277.5327.800; Zimov SA, 2006, SCIENCE, V312, P1612, DOI 10.1126/science.1128908; Zona D, 2008, AGU FALL M	59	54	55	7	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78204	10.1371/journal.pone.0078204	http://dx.doi.org/10.1371/journal.pone.0078204			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236014	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000327254700011
J	Rathleff, CR; Baird, WN; Olesen, JL; Roos, EM; Rasmussen, S; Rathleff, MS				Rathleff, Camilla Rams; Baird, William Neill; Olesen, Jens Lykkegaard; Roos, Ewa Maria; Rasmussen, Sten; Rathleff, Michael Skovdal			Hip and Knee Strength Is Not Affected in 12-16 Year Old Adolescents with Patellofemoral Pain - A Cross-Sectional Population-Based Study	PLOS ONE			English	Article							FOOT ORTHOSES EFFICACY; INDIVIDUALS; INSTRUMENT; LIGAMENT; INJURY	Background: One of the rationales behind using strength training in the treatment of adolescents with Patellofemoral Pain (PFP) is that reduced strength of the lower extremity is a risk factor for PFP and a common deficit. This rationale is based on research conducted on adolescents >15 years of age but has never been investigated among young adolescents with PFP. Objectives: To compare isometric muscle strength of the lower extremity among adolescents with PFP compared to age- and gender-matched pain-free adolescents. Methods: In 2011 a population-based cohort (APA2011-cohort) consisting of 768 adolescents aged 12-15 years from 8 local schools was formed. In September 2012, all adolescents who reported knee pain in September 2011 were offered a clinical examination if they still had knee pain. From these, 20 adolescents (16 females) were diagnosed with PFP. Pain-free adolescents from the APA2011-cohort (n = 20) were recruited on random basis as age-and gender-matched pairs. Primary outcome was isometric knee extension strength normalized to body weight (%BW) and blinded towards subject information. Secondary outcomes included knee flexion, hip abduction/adduction and hip internal/external rotation strength. Demographic data included Knee Injury and Osteoarthritis Outcome Score (KOOS) and symptom duration. Results: Adolescents with PFP reported long symptom duration and significantly worse KOOS scores compared to pain-free adolescents. There were no significant differences in isometric knee extension strength (Delta 0.3% BW, p = 0.97), isometric knee flexion strength (Delta 0.4% BW, p = 0.84) or different measures of hip strength (Delta 0.4 to 1.1% BW, p>0.35). Conclusion: Young symptomatic adolescents with PFP between 12 and 16 years of age did not have decreased isometric muscle strength of the knee and hip. These results question the rationale of targeting strength deficits in the treatment of adolescents with PFP. However, strength training may still be an effective treatment for those individuals with PFP suffering from strength deficits.	[Rathleff, Camilla Rams; Rasmussen, Sten; Rathleff, Michael Skovdal] Aalborg Univ Hosp, Orthopaed Surg Res Unit, Aalborg, Denmark; [Baird, William Neill; Olesen, Jens Lykkegaard] Aalborg Univ Hosp, Dept Rheumatol, Aalborg, Denmark; [Roos, Ewa Maria] Univ Southern Denmark, Inst Sports Sci & Clin Biomech, Res Unit Musculoskeletal Funct & Physiotherapy, Odense, Denmark; [Rathleff, Michael Skovdal] Aarhus Univ, HEALTH, Aarhus, Denmark	Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; University of Southern Denmark; Aarhus University	Rathleff, MS (corresponding author), Aalborg Univ Hosp, Orthopaed Surg Res Unit, Aalborg, Denmark.	misr@rn.dk	Rasmussen, Sten/N-3916-2013; Roos, Ewa M/A-5416-2012	Rasmussen, Sten/0000-0002-8664-352X; Roos, Ewa M/0000-0001-5425-2199; Olesen, Jes/0000-0002-6712-2702; Rathleff, Michael Skovdal/0000-0003-1173-0335	Obelske Family Foundation; Association of Danish Physiotherapists Research Fund; Danish Rheumatism Association	Obelske Family Foundation; Association of Danish Physiotherapists Research Fund; Danish Rheumatism Association	Obelske Family Foundation, The Association of Danish Physiotherapists Research Fund, Danish Rheumatism Association are acknowledged for their funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aadahl M, 2003, MED SCI SPORT EXER, V35, P1196, DOI 10.1249/01.MSS.0000074446.02192.14; Barton CJ, 2011, BRIT J SPORT MED, V45, P697, DOI 10.1136/bjsm.2010.077644; Barton CJ, 2011, MED SCI SPORT EXER, V43, P1603, DOI 10.1249/MSS.0b013e318211c45d; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Blond L, 1998, Acta Orthop Belg, V64, P393; Boling MC, 2009, AM J SPORT MED, V37, P2108, DOI 10.1177/0363546509337934; Burstrom K, 2011, EUR J PUBLIC HEALTH, V21, P171, DOI 10.1093/eurpub/ckq037; Carry PM, 2010, ORTHOPEDICS, V33, P498, DOI 10.3928/01477447-20100526-16; Cichanowski HR, 2007, MED SCI SPORT EXER, V39, P1227, DOI 10.1249/mss.0b013e3180601109; Collins N, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1735; Collins NJ, 2013, BRIT J SPORT MED, V47, P227, DOI 10.1136/bjsports-2012-091696; Collins NJ, 2012, SPORTS MED, V42, P31, DOI 10.2165/11594460-000000000-00000; Cowan SM, 2002, MED SCI SPORT EXER, V34, P1879, DOI 10.1097/00005768-200212000-00004; Devereaux M D, 1984, Br J Sports Med, V18, P18; Duvigneaud N, 2008, ISOKINET EXERC SCI, V16, P213, DOI 10.3233/IES-2008-0311; ENG JJ, 1993, PHYS THER, V73, P62, DOI 10.1093/ptj/73.2.62; FAIRBANK JCT, 1984, J BONE JOINT SURG BR, V66, P685, DOI 10.1302/0301-620X.66B5.6501361; Ireland ML, 2003, J ORTHOP SPORT PHYS, V33, P671, DOI 10.2519/jospt.2003.33.11.671; Janz KF, 2000, MED SCI SPORT EXER, V32, P1250, DOI 10.1097/00005768-200007000-00011; Lankhorst NE, 2013, BRIT J SPORT MED, V47, P193, DOI 10.1136/bjsports-2011-090369; Lind M, 2009, KNEE SURG SPORT TR A, V17, P117, DOI 10.1007/s00167-008-0654-3; Luhmann SJ, 2008, J CHILD ORTHOP, V2, P269, DOI 10.1007/s11832-008-0104-2; Magalhaes E, 2010, J ORTHOP SPORT PHYS, V40, P641, DOI 10.2519/jospt.2010.3120; Molgaard C, 2011, J AM PODIAT MED ASSN, V101, P215, DOI 10.7547/1010215; Piva SR, 2005, J ORTHOP SPORT PHYS, V35, P793, DOI 10.2519/jospt.2005.35.12.793; Rathleff MS, 2013, MED SCI SPORT EXER, V45, P1730, DOI 10.1249/MSS.0b013e318292be30; Rathleff MS, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-225; Rathleff MS, 2013, J ORTHOP SPORT PHYS, V43, P414, DOI 10.2519/jospt.2013.4383; Rathleff MS, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-9; Roos EM, 1998, J ORTHOP SPORT PHYS, V28, P88, DOI 10.2519/jospt.1998.28.2.88; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Thomee R, 1999, SPORTS MED, V28, P245, DOI 10.2165/00007256-199928040-00003; Uziel Yosef, 2007, Pediatr Rheumatol Online J, V5, P5, DOI 10.1186/1546-0096-5-5; van Linschoten R, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4074; VANLINSCHOTEN R, 2009, BMJ-BRIT MED J, V339, DOI DOI 10.1136/BMJ.B4074; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; WHITELAW GP, 1989, CLIN ORTHOP RELAT R, P234; Willson JD, 2008, AM J SPORT MED, V36, P1587, DOI 10.1177/0363546508315592	38	52	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79153	10.1371/journal.pone.0079153	http://dx.doi.org/10.1371/journal.pone.0079153			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236101	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700099
J	van der Meijden, A; Coelho, PL; Sousa, P; Herrel, A				van der Meijden, Arie; Coelho, Pedro Lobo; Sousa, Pedro; Herrel, Anthony			Choose Your Weapon: Defensive Behavior Is Associated with Morphology and Performance in Scorpions	PLOS ONE			English	Article							ANTIPREDATOR BEHAVIOR; CONFIDENCE-INTERVALS; BITE PERFORMANCE; EVOLUTION; VENOM; BUTHIDAE; PHYLOGENY; ARACHNIDA; PATTERNS; LIZARDS	Morphology can be adaptive through its effect on performance of an organism. The effect of performance may, however, be modulated by behavior; an organism may choose a behavioral option that does not fully utilize its maximum performance. Behavior may therefore be decoupled from morphology and performance. To gain insight into the relationships between these levels of organization, we combined morphological data on defensive structures with measures of defensive performance, and their utilization in defensive behavior. Scorpion species show significant variation in the morphology and performance of their main defensive structures; their chelae (pincers) and the metasoma ("tail") carrying the stinger. Our data show that size-corrected pinch force varies to almost two orders of magnitude among species, and is correlated with chela morphology. Chela and metasoma morphology are also correlated to the LD50 of the venom, corroborating the anecdotal rule that dangerously venomous scorpions can be recognized by their chelae and metasoma. Analyses of phylogenetic independent contrasts show that correlations between several aspects of chela and metasoma morphology, performance and behavior are present. These correlations suggest co-evolution of behavior with morphology and performance. Path analysis found a performance variable (pinch force) to partially mediate the relationship between morphology (chela aspect ratio) and behavior (defensive stinger usage). We also found a correlation between two aspects of morphology: pincer finger length correlates with the relative "thickness" (aspect ratio) of the metasoma. This suggests scorpions show a trade-off between their two main weapon complexes: the metasoma carrying the stinger, and the pedipalps carrying the chelae.	[van der Meijden, Arie; Coelho, Pedro Lobo; Sousa, Pedro] CIBIO, Ctr Invest Biodiversidade & Recursos Genet, Vairao, Portugal; [Herrel, Anthony] Museum Natl Hist Nat, Dept Ecol & Gest Biodiversite, UMR 7179, F-75231 Paris, France	Universidade do Porto; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN)	van der Meijden, A (corresponding author), CIBIO, Ctr Invest Biodiversidade & Recursos Genet, Campus Agr Vairao, Vairao, Portugal.	mail@arievandermeijden.nl	Herrel, Anthony/C-3712-2013; Lobo-Coelho, Pedro/D-5277-2014; van der Meijden, Arie/AAD-5199-2019; Sousa, Pedro/N-3015-2013	Herrel, Anthony/0000-0003-0991-4434; Lobo-Coelho, Pedro/0000-0001-5889-8579; Sousa, Pedro/0000-0002-5859-9656; van der Meijden, Arie/0000-0002-1317-5382	FCT [PTDC/BIA-BEC/104644/2008, PTDC/BIA-EVF/2687/2012, SFRH/BPD/48042/2008]	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by FCT I&D grants to AvdM (PTDC/BIA-BEC/104644/2008 and PTDC/BIA-EVF/2687/2012). AvdM has been supported by FCT postdoctoral fellowship SFRH/BPD/48042/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts P, 2000, NETH J ZOOL, V50, P261, DOI 10.1163/156854200505865; ALEXANDER RM, 1985, J EXP BIOL, V115, P231; Alfaro ME, 2005, AM NAT, V165, pE140, DOI 10.1086/429564; ARNOLD SJ, 1983, AM ZOOL, V23, P347, DOI 10.1093/icb/23.2.347; Blomberg S, 2003, EVOLUTION; BRODIE ED, 1993, EVOLUTION, V47, P844, DOI 10.1111/j.1558-5646.1993.tb01238.x; Bruford Michael W., 1992, P225; Carlson BE, 2009, J ARACHNOL, V37, P321, DOI 10.1636/Hi09-06.1; Cox RM, 2010, EVOLUTION, V64, P1321, DOI 10.1111/j.1558-5646.2009.00906.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fet Elizabeth V., 2003, Revista Iberica de Aracnologia, V8, P69; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fry BG, 2006, NATURE, V439, P584, DOI 10.1038/nature04328; Fry BG, 2008, MOL CELL PROTEOMICS, V7, P215, DOI 10.1074/mcp.M700094-MCP200; Gantenbein B, 2000, REV SUISSE ZOOL, V107, P213, DOI 10.5962/bhl.part.80126; Garland T, 1999, ANIM BEHAV, V58, P77, DOI 10.1006/anbe.1999.1132; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; Garland T, 1999, AM ZOOL, V39, P374; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; Garland Theodore Jr., 1994, P240; Ghalambor CK, 2004, AM NAT, V164, P38, DOI 10.1086/421412; GWEE MCE, 1993, TOXICON, V31, P1305, DOI 10.1016/0041-0101(93)90403-6; Haag CR, 2005, P ROY SOC B-BIOL SCI, V272, P2449, DOI 10.1098/rspb.2005.3235; Habermehl G. G., 1994, GIFT TIERE IHRE WAFF; Herrel A, 1999, FUNCT ECOL, V13, P289, DOI 10.1046/j.1365-2435.1999.00305.x; Herrel A, 2009, PHYSIOL BIOCHEM ZOOL, V82, P680, DOI 10.1086/605935; Holderied M, 2011, J COMP PHYSIOL A, V197, P425, DOI 10.1007/s00359-010-0608-3; Huey RB, 2003, AM NAT, V161, P357, DOI 10.1086/346135; Irschick DJ, 2005, EVOLUTION, V59, P1579; ISMAIL M, 1974, TOXICON, V12, P75, DOI 10.1016/0041-0101(74)90102-0; Kleber J. J., 1999, DTSCH ARZTEBLATT, V96, pA1711; Kovarik F., 2009, ILLUSTRATED CATALOG; LAMORAL B H, 1979, Annals of the Natal Museum, V23, P497; Leeming J, 2003, SCORPIONS SO AFRICA; Londei T, 1998, BEHAV BRAIN RES, V94, P249, DOI 10.1016/S0166-4328(97)00162-9; Lourenco Wilson R., 2004, Entomologische Mitteilungen aus dem Zoologischen Museum Hamburg, V14, P165; Lourenco WR, 2005, REV SUISSE ZOOL, V112, P145, DOI 10.5962/bhl.part.80291; Lourenco WR, 2003, REV SUISSE ZOOL, V110, P875, DOI 10.5962/bhl.part.80218; Maddison WP, 2009, MESQUITE MODULAR SYS; NEWLANDS G, 1985, Koedoe, P35; NEWLANDS G, 1969, African Wildlife, V23, P147; Nisani Z, 2012, TOXICON, V147, P509; Nisani Z, 2007, COMP BIOCHEM PHYS A, V147, P509, DOI 10.1016/j.cbpa.2007.01.027; PALKA J, 1967, Z VERGL PHYSIOL, V55, P286; Polis G.A., 1990, P247; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prendini L, 2005, CLADISTICS, V21, P446, DOI 10.1111/j.1096-0031.2005.00073.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Santana SE, 2009, J EVOLUTION BIOL, V22, P2131, DOI 10.1111/j.1420-9101.2009.01827.x; Sells PG, 2003, TOXICON, V42, P115, DOI 10.1016/S0041-0101(03)00125-9; Shulov A., 1960, Arch Inst Pasteur Alger, V38, P117; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Sobel M. E., 1982, SOCIOLOGICAL METHODO; Soleglad Michael E., 2011, Euscorpius, V112, P1; Soper D. S., 2013, SOBEL TEST CALCULATO; Sousa P, 2012, J ZOOL, V288, P66, DOI 10.1111/j.1469-7998.2012.00925.x; Sousa P, 2011, AFR INVERTEBR, V52, P135, DOI 10.5733/afin.052.0106; Tallarovic SK, 2000, J INSECT BEHAV, V13, P827, DOI 10.1023/A:1007858400402; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; VACHON M, 1968, Monitore Zoologico Italiano, V2, P81; Vachon M., 1952, ETUDES SCORPIONS; van der Meijden A, 2010, J ZOOL, V280, P319, DOI 10.1111/j.1469-7998.2009.00628.x; van der Meijden A, 2012, J EXP BIOL, V215, P3411, DOI 10.1242/jeb.072926; van der Meijden A, 2012, J ANAT, V220, P423, DOI 10.1111/j.1469-7580.2012.01485.x; Vanhooydonck B, 2003, FUNCT ECOL, V17, P160, DOI 10.1046/j.1365-2435.2003.00716.x; Vonk FJ, 2008, NATURE, V454, P630, DOI 10.1038/nature07178; Warburg MR, 1998, J ETHOL, V16, P115, DOI 10.1007/BF02769290; Young BA, 2007, J EXP ZOOL PART A, V307A, P18, DOI 10.1002/jez.a.341; ZLOTKIN E, 1971, TOXICON, V9, P1, DOI 10.1016/0041-0101(71)90037-7; Zlotkin E., 1978, NEUROTOXIC ACTION PE, P227	70	31	33	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78955	10.1371/journal.pone.0078955	http://dx.doi.org/10.1371/journal.pone.0078955			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236075	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700072
J	Walenta, E; Pessentheiner, AR; Pelzmann, HJ; Deutsch, A; Goeritzer, M; Kratky, D; Hackl, H; Oh, DY; Prokesch, A; Bogner-Strauss, JG				Walenta, Evelyn; Pessentheiner, Ariane R.; Pelzmann, Helmut J.; Deutsch, Alexander; Goeritzer, Madeleine; Kratky, Dagmar; Hackl, Hubert; Oh, Da Young; Prokesch, Andreas; Bogner-Strauss, Juliane G.			alpha/beta-Hydrolase Domain Containing Protein 15 (ABHD15) - an Adipogenic Protein Protecting from Apoptosis	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; PPAR-GAMMA; ADIPOCYTE DIFFERENTIATION; INSULIN-RESISTANCE; OBESITY; MICE; PREADIPOCYTES; REVEALS; PATHWAY; GLUCOSE	Our knowledge about adipocyte metabolism and development is steadily growing, yet many players are still undefined. Here, we show that alpha/beta-hydrolase domain containing protein 15 (Abhd15) is a direct and functional target gene of peroxisome proliferator-activated receptor gamma (PPAR gamma), the master regulator of adipogenesis. In line, Abhd15 is mainly expressed in brown and white adipose tissue and strongly upregulated during adipogenesis in various murine and human cell lines. Stable knockdown of Abhd15 in 3T3-L1 cells evokes a striking differentiation defect, as evidenced by low lipid accumulation and decreased expression of adipocyte marker genes. In preconfluent cells, knockdown of Abhd15 leads to impaired proliferation, which is caused by apoptosis, as we see an increased SubG1 peak, caspase 3/7 activity, and BAX protein expression as well as a reduction in anti-apoptotic BCL-2 protein. Furthermore, apoptosis-inducing amounts of palmitic acid evoke a massive increase of Abhd15 expression, proposing an apoptosis-protecting role for ABHD15. On the other hand, in mature adipocytes physiological (i.e. non-apoptotic) concentrations of palmitic acid down-regulate Abhd15 expression. Accordingly, we found that the expression of Abhd15 in adipose tissue is reduced in physiological situations with high free fatty acid levels, like high-fat diet, fasting, and aging as well as in genetically obese mice. Collectively, our results position ABHD15 as an essential component in the development of adipocytes as well as in apoptosis, thereby connecting two substantial factors in the regulation of adipocyte number and size. Together with its intricate regulation by free fatty acids, ABHD15 might be an intriguing new target in obesity and diabetes research.	[Walenta, Evelyn; Pessentheiner, Ariane R.; Pelzmann, Helmut J.; Prokesch, Andreas; Bogner-Strauss, Juliane G.] Graz Univ Technol, Inst Genom & Bioinformat, A-8010 Graz, Austria; [Pessentheiner, Ariane R.; Pelzmann, Helmut J.; Prokesch, Andreas; Bogner-Strauss, Juliane G.] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria; [Deutsch, Alexander] Med Univ Graz, Div Hematol, Graz, Austria; [Goeritzer, Madeleine; Kratky, Dagmar] Med Univ Graz, Inst Mol Biol & Biochem, Graz, Austria; [Hackl, Hubert] Med Univ Innsbruck, Bioctr, Div Bioinformat, A-6020 Innsbruck, Austria; [Oh, Da Young] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA	Graz University of Technology; Graz University of Technology; Medical University of Graz; Medical University of Graz; Medical University of Innsbruck; University of California System; University of California San Diego	Bogner-Strauss, JG (corresponding author), Graz Univ Technol, Inst Genom & Bioinformat, A-8010 Graz, Austria.	juliane.bogner-strauss@tugraz.at	Kratky, Dagmar/ABF-5699-2021; Deutsch, Alexander AJ/F-2168-2010; Hackl, Hubert/B-3168-2018; PROKESCH, ANDREAS/B-6786-2019	Deutsch, Alexander AJ/0000-0003-0914-2809; Hackl, Hubert/0000-0003-4055-3841; Bogner-Strauss, Juliane/0000-0003-2459-0124; Pessentheiner, Ariane/0000-0002-5010-9528; PROKESCH, ANDREAS/0000-0002-8487-7103; Kratky, Dagmar/0000-0003-1357-7573	Austrian Science Fund FWF [W1226, P24143]; Austrian Science Fund (FWF) [P 24143, F 3004] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund FWF (DK-MCD W1226 and P24143). http://www.fwf.ac.at/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay LR, 2013, NUTR REV, V71, P168, DOI 10.1111/j.1753-4887.2012.00533.x; Ahren B, 1998, EUR J ENDOCRINOL, V139, P461, DOI 10.1530/eje.0.1390461; Alkhouri N, 2010, J BIOL CHEM, V285, P3428, DOI 10.1074/jbc.M109.074252; Bogner-Strauss JG, 2010, CELL MOL LIFE SCI, V67, P4049, DOI 10.1007/s00018-010-0424-5; Capurso C, 2012, VASC PHARMACOL, V57, P91, DOI 10.1016/j.vph.2012.05.003; Chavez JA, 2006, BIOCHEM BIOPH RES CO, V342, P1218, DOI 10.1016/j.bbrc.2006.02.091; Degerman E, 2011, CURR OPIN PHARMACOL, V11, P676, DOI 10.1016/j.coph.2011.09.015; Essayan DM, 2001, J ALLERGY CLIN IMMUN, V108, P671, DOI 10.1067/mai.2001.119555; Gridley S, 2005, CELL SIGNAL, V17, P59, DOI 10.1016/j.cellsig.2004.05.013; Guo W, 2007, AM J PHYSIOL-ENDOC M, V293, pE576, DOI 10.1152/ajpendo.00523.2006; Hakim-Weber Robab, 2011, BMC Res Notes, V4, P157, DOI 10.1186/1756-0500-4-157; Hammond RA, 2010, DIABETES METAB SYNDR, V3, P285, DOI [10.2147/DMSOTT.S7384, 10.2147/DMSO.S7384]; Hansen JB, 1999, J BIOL CHEM, V274, P2386, DOI 10.1074/jbc.274.4.2386; Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134; Insel PA, 2012, ACTA PHYSIOL, V204, P277, DOI 10.1111/j.1748-1716.2011.02273.x; Kanda T, 2009, J CLIN INVEST, V119, P110, DOI 10.1172/JCI36233; Kim HK, 2006, J NUTR, V136, P2965, DOI 10.1093/jn/136.12.2965; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Li PP, 2011, CELL, V147, P815, DOI 10.1016/j.cell.2011.09.050; Mandrup S, 1997, J BIOL CHEM, V272, P5367, DOI 10.1074/jbc.272.9.5367; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Pabinger S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-268; Prokesch A, 2011, NUCLEIC ACIDS RES, V39, P3224, DOI 10.1093/nar/gkq1289; Prokesch A, 2009, CURR MED CHEM, V16, P2952, DOI 10.2174/092986709788803132; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Rodriguez D, 2011, BBA-MOL CELL RES, V1813, P564, DOI 10.1016/j.bbamcr.2010.11.012; Rohana A, 2011, WORLD ACAD SCI ENG T, P1; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; SAGER G, 1985, BIOCHEM PHARMACOL, V34, P2812, DOI 10.1016/0006-2952(85)90584-2; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schaeffler A, 2009, IMMUNOLOGY, V126, P233, DOI 10.1111/j.1365-2567.2008.02892.x; Sloan C, 2011, DIABETES, V60, P1424, DOI 10.2337/db10-1106; Sorisky A, 2000, INT J OBESITY, V24, pS3, DOI 10.1038/sj.ijo.0801491; Soukas A, 2001, J BIOL CHEM, V276, P34167, DOI 10.1074/jbc.M104421200; Spiegelman BM, 1997, BIOCHIMIE, V79, P111, DOI 10.1016/S0300-9084(97)81500-3; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100; TONTONOZ P, 1995, CURR OPIN GENET DEV, V5, P571, DOI 10.1016/0959-437X(95)80025-5; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Withrow D, 2011, OBES REV, V12, P131, DOI 10.1111/j.1467-789X.2009.00712.x	45	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79134	10.1371/journal.pone.0079134	http://dx.doi.org/10.1371/journal.pone.0079134			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236098	Green Submitted, gold, Green Published			2022-12-27	WOS:000327254700096
J	Yoshida, N; Oda, M; Kuroda, Y; Katayama, Y; Okikawa, Y; Masunari, T; Fujiwara, M; Nishisaka, T; Sasaki, N; Sadahira, Y; Mihara, K; Asaoku, H; Matsui, H; Seto, M; Kimura, A; Arihiro, K; Sakai, A				Yoshida, Noriaki; Oda, Miyo; Kuroda, Yoshiaki; Katayama, Yuta; Okikawa, Yoshiko; Masunari, Taro; Fujiwara, Megumu; Nishisaka, Takashi; Sasaki, Naomi; Sadahira, Yoshito; Mihara, Keichiro; Asaoku, Hideki; Matsui, Hirotaka; Seto, Masao; Kimura, Akiro; Arihiro, Koji; Sakai, Akira			Clinical Significance of sIL-2R Levels in B-Cell Lymphomas	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; SOLUBLE INTERLEUKIN-2-RECEPTOR; PROGNOSTIC INDEX; HODGKIN LYMPHOMA; LEUKEMIA; MATRIX-METALLOPROTEINASE-9; ANGIOGENESIS; PROGRESSION; EXPRESSION; RITUXIMAB	Elevated soluble interleukin-2 receptor (sIL-2R) in sera is observed in patients with malignant lymphoma (ML). Therefore, sIL-2R is commonly used as a diagnostic and prognostic marker for ML, but the mechanisms responsible for the increase in sIL-2R levels in patients with B-cell lymphomas have not yet been elucidated. We first hypothesized that lymphoma cells expressing IL-2R and some proteinases such as matrix metalloproteinases (MMPs) in the tumor microenvironment can give rise to increased sIL-2R in sera. However, flow cytometric studies revealed that few lymphoma cells expressed IL-2R a chain (CD25) in diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL), and most CD25-expressing cells in the tumor were T-cells. Distinct correlations between CD25 expression on B-lymphoma cells and sIL-2R levels were not observed. We then confirmed that MMP-9 plays an important role in producing sIL-2R in functional studies. Immunohistochemical (IHC) analysis also revealed that MMP-9 is mainly derived from tumor-associated macrophages (TAMs). We therefore evaluated the number of CD68 and CD163 positive macrophages in the tumor microenvironment using IHC analysis. A positive correlation between the levels of sIL-2R in sera and the numbers of CD68 positive macrophages in the tumor microenvironment was confirmed in FL and extranodal DLBCL. These results may be useful in understanding the pathophysiology of B-cell lymphomas.	[Yoshida, Noriaki; Kuroda, Yoshiaki; Mihara, Keichiro; Kimura, Akiro; Sakai, Akira] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Hematol & Oncol, Hiroshima, Japan; [Yoshida, Noriaki; Seto, Masao] Aichi Canc Ctr, Res Inst, Div Mol Med, Nagoya, Aichi 464, Japan; [Yoshida, Noriaki; Seto, Masao] Nagoya Univ, Grad Sch Med, Aichi Canc Ctr, Res Inst,Dept Canc Genet, Nagoya, Aichi 4648601, Japan; [Oda, Miyo; Arihiro, Koji] Hiroshima Univ, Dept Anat Pathol, Hiroshima, Japan; [Katayama, Yuta; Asaoku, Hideki] Hiroshima Red Cross Hosp, Dept Internal Med, Hiroshima, Japan; [Katayama, Yuta; Fujiwara, Megumu; Asaoku, Hideki] Atom Bomb Survivors Hosp, Hiroshima, Japan; [Okikawa, Yoshiko] Natl Hosp Org Kure Med Ctr, Dept Hematol, Kure, Japan; [Masunari, Taro] Chugoku Cent Hosp, Dept Hematol, Fukuyama, Hiroshima, Japan; [Fujiwara, Megumu] Hiroshima Red Cross Hosp, Dept Pathol, Hiroshima, Japan; [Nishisaka, Takashi] Hiroshima Prefecture Hosp, Dept Lab Pathol, Hiroshima, Japan; [Sasaki, Naomi] Kure Kyosai Hosp, Dept Pathol, Kure, Japan; [Sadahira, Yoshito] Kawasaki Med Sch, Dept Pathol, Kurashiki, Okayama, Japan; [Matsui, Hirotaka] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Mol Oncol, Hiroshima, Japan; [Matsui, Hirotaka] Hiroshima Univ, Res Inst Radiat Biol & Med, Leukemia Program Project, Hiroshima, Japan; [Kimura, Akiro] Kure Kyosai Hosp, Dept Lab Med, Kure, Japan; [Sakai, Akira] Fukushima Med Univ, Dept Radiat Life Sci, Fukushima, Japan	Hiroshima University; Aichi Cancer Center; Aichi Cancer Center; Nagoya University; Hiroshima University; Kawasaki Medical School; Hiroshima University; Hiroshima University; Fukushima Medical University	Yoshida, N (corresponding author), Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Hematol & Oncol, Hiroshima, Japan.	nyoshida@aichi-cc.jp; sakira@fmu.ac.jp	Matsui, Hirotaka/AED-6669-2022; Mihara, Keichiro/L-5167-2019; Katayama, Yuta/AAB-7409-2022	Matsui, Hirotaka/0000-0002-6266-3227; Katayama, Yuta/0000-0001-5054-9104	Hiroshima Lymphoma Study Group; Grants-in-Aid for Scientific Research [24591397] Funding Source: KAKEN	Hiroshima Lymphoma Study Group; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding was provided by Hiroshima Lymphoma Study Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agueznay NEH, 2007, CLIN EXP IMMUNOL, V150, P114, DOI 10.1111/j.1365-2249.2007.03464.x; Ahn GO, 2008, CANCER CELL, V13, P193, DOI 10.1016/j.ccr.2007.11.032; AMBROSETTI A, 1993, INT J CLIN LAB RES, V23, P34, DOI 10.1007/BF02592278; Arcaini L, 2010, BRIT J HAEMATOL, V149, P455, DOI 10.1111/j.1365-2141.2009.08065.x; Barros MHM, 2012, CLIN CANCER RES, V18, P3762, DOI 10.1158/1078-0432.CCR-12-0129; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Canioni D, 2008, J CLIN ONCOL, V26, P440, DOI 10.1200/JCO.2007.12.8298; De Paiva CS, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-31; Ennishi D, 2009, ANN ONCOL, V20, P526, DOI 10.1093/annonc/mdn677; Federico Massimo, 2009, Curr Hematol Malig Rep, V4, P202, DOI 10.1007/s11899-009-0027-0; Federico M, 2009, J CLIN ONCOL, V27, P4555, DOI 10.1200/JCO.2008.21.3991; Giraudo E, 2004, J CLIN INVEST, V114, P623, DOI 10.1172/JCI200422087; Goto H, 2005, J CANCER RES CLIN, V131, P73, DOI 10.1007/s00432-004-0600-9; Goto N, 2012, ANN HEMATOL, V91, P705, DOI 10.1007/s00277-011-1363-4; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Hayashibara T, 2002, BRIT J HAEMATOL, V116, P94, DOI 10.1046/j.1365-2141.2002.03255.x; KAMIHIRA S, 1994, CANCER, V73, P2753, DOI 10.1002/1097-0142(19940601)73:11<2753::AID-CNCR2820731117>3.0.CO;2-X; Kang TB, 2001, J BIOL CHEM, V276, P21960, DOI 10.1074/jbc.M007997200; Katsuya H, 2012, J CLIN ONCOL, V30, P1635, DOI 10.1200/JCO.2011.38.2101; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Liu D, 2012, PLOS ONE, V7; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mori N, 2002, BLOOD, V99, P1341, DOI 10.1182/blood.V99.4.1341; Morito T, 2009, CANCER SCI, V100, P1255, DOI 10.1111/j.1349-7006.2009.01167.x; Murakami S, 2004, FRONT BIOSCI-LANDMRK, V9, P3085, DOI 10.2741/1461; Niino D, 2010, PATHOL INT, V60, P278, DOI 10.1111/j.1440-1827.2010.02514.x; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; POPOVIC M, 1983, SCIENCE, V219, P856, DOI 10.1126/science.6600519; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; RUBIN L A, 1990, Cytokine, V2, P330, DOI 10.1016/1043-4666(90)90062-X; RUBIN LA, 1985, J IMMUNOL, V135, P3172; Sehn LH, 2007, BLOOD, V109, P1857, DOI 10.1182/blood-2006-08-038257; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Solinas G, 2010, J IMMUNOL, V185, P642, DOI 10.4049/jimmunol.1000413; Tan KL, 2012, BLOOD, V120, P3280, DOI 10.1182/blood-2012-04-421057; YASUDA N, 1988, BLOOD, V71, P1021	38	31	32	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78730	10.1371/journal.pone.0078730	http://dx.doi.org/10.1371/journal.pone.0078730			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236041	gold, Green Submitted, Green Published			2022-12-27	WOS:000327254700038
J	Cruaud, A; Underhill, JG; Huguin, M; Genson, G; Jabbour-Zahab, R; Tolley, KA; Rasplus, JY; van Noort, S				Cruaud, Astrid; Underhill, Jenny G.; Huguin, Mailis; Genson, Gwenaelle; Jabbour-Zahab, Roula; Tolley, Krystal A.; Rasplus, Jean-Yves; van Noort, Simon			A Multilocus Phylogeny of the World Sycoecinae Fig Wasps (Chalcidoidea: Pteromalidae)	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; HYMENOPTERA CHALCIDOIDEA; AGAONIDAE; SYSTEMATICS; FICUS; EVOLUTION; GENE; TREE; INFORMATIVENESS; NUCLEAR	The Sycoecinae is one of five chalcid subfamilies of fig wasps that are mostly dependent on Ficus inflorescences for reproduction. Here, we analysed two mitochondrial (COI, Cytb) and four nuclear genes (ITS2, EF-1 alpha, RpL27a, mago nashi) from a worldwide sample of 56 sycoecine species. Various alignment and partitioning strategies were used to test the stability of major clades. All topologies estimated using maximum likelihood and Bayesian methods were similar and well resolved but did not support the existing classification. A high degree of morphological convergence was highlighted and several species appeared best described as species complexes. We therefore proposed a new classification for the subfamily. Our analyses revealed several cases of probable speciation on the same host trees (up to 8 closely related species on one single tree of F. sumatrana), which raises the question of how resource partitioning occurs to avoid competitive exclusion. Comparisons of our results with fig phylogenies showed that, despite sycoecines being internally ovipositing wasps host-switches are common incidents in their evolutionary history. Finally, by studying the evolutionary properties of the markers we used and profiling their phylogenetic informativeness, we predicted their utility for resolving phylogenetic relationships of Chalcidoidea at various taxonomic levels.	[Cruaud, Astrid; Huguin, Mailis; Genson, Gwenaelle; Jabbour-Zahab, Roula; Rasplus, Jean-Yves] INRA, CBGP, UMR1062, Montferrier Sur Lez, France; [Underhill, Jenny G.; Tolley, Krystal A.] South African Natl Biodivers Inst, Kirstenbosch Res Ctr, Cape Town, South Africa; [van Noort, Simon] Iziko Museums Cape Town, S African Museum, Nat Hist Div, Cape Town, South Africa; [Tolley, Krystal A.; van Noort, Simon] Univ Cape Town, Dept Zool, ZA-7700 Rondebosch, South Africa	INRAE; Institut de Recherche pour le Developpement (IRD); South African National Biodiversity Institute; University of Cape Town	Cruaud, A (corresponding author), INRA, CBGP, UMR1062, Montferrier Sur Lez, France.	cruaud@supagro.inra.fr	van Noort, Simon/C-4006-2017; Rasplus, Jean-Yves/O-2873-2017	van Noort, Simon/0000-0001-6930-9741; Rasplus, Jean-Yves/0000-0001-8614-6665; Tolley, Krystal/0000-0002-7778-1963	South African National Research Foundation [GUN 61497]; French National Research Agency (ANR); South African National Biodiversity Institute; network Bibliotheque du Vivant; CNRS; Museum National d'Histoire Naturelle; INRA; CEA (Genoscope)	South African National Research Foundation(National Research Foundation - South Africa); French National Research Agency (ANR)(French National Research Agency (ANR)); South African National Biodiversity Institute; network Bibliotheque du Vivant; CNRS(Centre National de la Recherche Scientifique (CNRS)); Museum National d'Histoire Naturelle; INRA; CEA (Genoscope)	This work is based upon financial support received from the South African National Research Foundation grant GUN 61497 to SvN and from the French National Research Agency (ANR) grant that supports the "BioFigs" project. This research was also supported by the South African National Biodiversity Institute. Sequencing was supported by the network Bibliotheque du Vivant founded by the CNRS, the Museum National d'Histoire Naturelle, the INRA and the CEA (Genoscope). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Auger-Rozenberg MA, 2006, SYST ENTOMOL, V31, P47, DOI 10.1111/j.1365-3113.2005.00310.x; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Belshaw R, 1997, MOL PHYLOGENET EVOL, V7, P281, DOI 10.1006/mpev.1996.0400; Berg C. C., 2005, FLORA MALESIANA 1; Boucek Z., 1988, P1; Britton T, 2007, SYSTEMATIC BIOL, V56, P741, DOI 10.1080/10635150701613783; Burks RA, 2011, CLADISTICS, V27, P581, DOI 10.1111/j.1096-0031.2011.00358.x; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chen Y, 2004, MOL PHYLOGENET EVOL, V31, P300, DOI 10.1016/S1055-7903(03)00282-3; CHO SW, 1995, MOL BIOL EVOL, V12, P650; Cognato AI, 2001, SYST BIOL, V50, P758, DOI 10.1080/106351501753462803; Compton S.G., 1994, PARASITOID COMMUNITY, P323; Compton SG, 2000, BIOTROPICA, V32, P515, DOI 10.1111/j.1744-7429.2000.tb00497.x; Cook JM, 2010, ECOL ENTOMOL, V35, P54, DOI 10.1111/j.1365-2311.2009.01148.x; Cook JM, 2003, TRENDS ECOL EVOL, V18, P241, DOI 10.1016/S0169-5347(03)00062-4; Corner E. J. H., 1978, Philosophical Transactions of the Royal Society of London, B, V281, P347, DOI 10.1098/rstb.1978.0002; Cruaud A, 2012, SYST BIOL, V61, P1029, DOI 10.1093/sysbio/sys068; Cruaud A, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-178; Cruaud A, 2011, J BIOGEOGR, V38, P209, DOI 10.1111/j.1365-2699.2010.02429.x; Cruaud A, 2010, CLADISTICS, V26, P359, DOI 10.1111/j.1096-0031.2009.00291.x; Danforth BN, 2002, P NATL ACAD SCI USA, V99, P286, DOI 10.1073/pnas.012387999; Drummond AJ, 2010, ENEIOUS V5 5; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fong JJ, 2011, MOL PHYLOGENET EVOL, V61, P300, DOI 10.1016/j.ympev.2011.06.016; GALIL J, 1977, NEW PHYTOL, V79, P163, DOI 10.1111/j.1469-8137.1977.tb02192.x; GARDINER A J, 1987, Tijdschrift voor Entomologie, V130, P129; Gauthier N, 2000, SYST ENTOMOL, V25, P521, DOI 10.1046/j.1365-3113.2000.00134.x; Gibson GAP, 1999, ZOOL SCR, V28, P87, DOI 10.1046/j.1463-6409.1999.00016.x; Harrison RD, 2006, J TROP ECOL, V22, P631, DOI 10.1017/S0266467406003488; Heraty John, 2009, P445, DOI 10.1002/9781444308211.ch19; Heraty JM, 2013, CLADISTICS, V29, P466, DOI 10.1111/cla.12006; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jackson AP, 2004, BIOL REV, V79, P751, DOI 10.1017/S1464793104006463; JANZEN DH, 1979, ANNU REV ECOL SYST, V10, P13, DOI 10.1146/annurev.es.10.110179.000305; Jiang ZF, 2006, J EVOLUTION BIOL, V19, P1157, DOI 10.1111/j.1420-9101.2006.01087.x; Jousselin E, 2001, OIKOS, V94, P287, DOI 10.1034/j.1600-0706.2001.940209.x; Jousselin E, 2008, EVOLUTION, V62, P1777, DOI 10.1111/j.1558-5646.2008.00406.x; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kerdelhue C, 1996, OIKOS, V75, P3, DOI 10.2307/3546315; KJELLBERG F, 1988, P K NED AKAD C BIOL, V91, P117; Kjellberg Finn, 2005, P539; Klopfstein S, 2010, SYST BIOL, V59, P226, DOI 10.1093/sysbio/syp105; Lin CP, 2004, MOL PHYLOGENET EVOL, V30, P686, DOI 10.1016/S1055-7903(03)00241-0; Lohse K, 2011, MOL ECOL RESOUR, V11, P521, DOI 10.1111/j.1755-0998.2010.02956.x; Lohse K, 2010, EVOLUTION, V64, P2664, DOI 10.1111/j.1558-5646.2010.01024.x; Lopez-Giraldez F, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-152; Lopez-Vaamonde C, 2001, MOL PHYLOGENET EVOL, V21, P55, DOI 10.1006/mpev.2001.0993; Marussich WA, 2007, MOL ECOL, V16, P1925, DOI 10.1111/j.1365-294X.2007.03278.x; Micklem DR, 1997, CURR BIOL, V7, P468, DOI 10.1016/S0960-9822(06)00218-1; Miller M.A., 2010, P GAT COMP ENV WORKS; Munro JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027023; Nylander J.A.A., 2004, MRAIC PL; Owen AK, 2007, SYST ENTOMOL, V32, P227, DOI 10.1111/j.1365-3113.2006.00361.x; Pagel M, 2005, MATHEMATICS OF EVOLUTION AND PHYLOGENY, P121; Rasplus JY, 1998, CR ACAD SCI III-VIE, V321, P517, DOI 10.1016/S0764-4469(98)80784-1; Renoult JP, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-248; Rokas A, 2002, MOL PHYLOGENET EVOL, V22, P206, DOI 10.1006/mpev.2001.1032; Ronsted N, 2007, MOL PHYLOGENET EVOL, V43, P190, DOI 10.1016/j.ympev.2006.12.010; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Schmidt S, 2007, SYST ENTOMOL, V32, P81, DOI 10.1111/j.1365-3113.2006.00364.x; Schulte JA, 2008, MOL PHYLOGENET EVOL, V47, P700, DOI 10.1016/j.ympev.2008.01.010; Segar ST, 2012, MOL PHYLOGENET EVOL, V65, P116, DOI 10.1016/j.ympev.2012.05.030; Sharanowski BJ, 2010, MOL PHYLOGENET EVOL, V57, P101, DOI 10.1016/j.ympev.2010.07.006; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Silvieus SI, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P225; Stamatakis A., 2006, P 20 IEEE INT PAR DI, P8, DOI DOI 10.1109/IPDPS.2006.1639535; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Townsend JP, 2008, J MOL EVOL, V67, P437, DOI 10.1007/s00239-008-9142-0; Townsend JP, 2007, SYSTEMATIC BIOL, V56, P222, DOI 10.1080/10635150701311362; Townsend JP, 2011, SYST BIOL, V60, P358, DOI 10.1093/sysbio/syq097; Van Noort S, 2005, ZOOTAXA, P1; van Noort S, 1992, THESIS RHODES U GRAH; Van Noort S, 2006, ZOOTAXA, P39, DOI 10.11646/zootaxa.1337.1.2; vanNoort S, 1996, J BIOGEOGR, V23, P415, DOI 10.1111/j.1365-2699.1996.tb00003.x; VANNOORT S, 1993, P K NED AKAD WETENSC, V96, P233; VANNOORT S, 1994, P K NED AKAD WETENSC, V97, P341; VANNOORT S, 1993, P K NED AKAD WETENSC, V96, P449; VANNOORT S, 1994, P K NED AKAD WETENSC, V97, P311; VANNOORT S, 1994, P K NED AKAD WETENSC, V97, P83; VERKERKE W, 1989, EXPERIENTIA, V45, P612, DOI 10.1007/BF01975678; Warren M, 2010, ECOGRAPHY, V33, P148, DOI 10.1111/j.1600-0587.2009.06041.x; Weiblen GD, 2002, ANNU REV ENTOMOL, V47, P299, DOI 10.1146/annurev.ento.47.091201.145213; WIEBES J T, 1977, Zoologische Mededelingen (Leiden), V52, P137; WIEBES JT, 1974, P K NED AKAD C BIOL, V77, P295; WIEBES JT, 1968, P K NED AKAD C BIOL, V71, P346; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Zhang FP, 2009, NATURWISSENSCHAFTEN, V96, P543, DOI 10.1007/s00114-008-0502-9	93	5	6	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79291	10.1371/journal.pone.0079291	http://dx.doi.org/10.1371/journal.pone.0079291			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223925	Green Submitted, Green Published, gold			2022-12-27	WOS:000326597400061
J	Lidster, K; Jackson, SJ; Ahmed, Z; Munro, P; Coffey, P; Giovannoni, G; Baker, MD; Baker, D				Lidster, Katie; Jackson, Samuel J.; Ahmed, Zubair; Munro, Peter; Coffey, Pete; Giovannoni, Gavin; Baker, Mark D.; Baker, David			Neuroprotection in a Novel Mouse Model of Multiple Sclerosis	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; TRANSGENIC MICE; NEUROMYELITIS-OPTICA; SODIUM-CHANNELS; VISUAL-ACUITY; ANIMAL-MODELS; ANTIBODIES; DISEASE; MECHANISMS	Multiple sclerosis is an immune-mediated, demyelinating and neurodegenerative disease that currently lacks any neuroprotective treatments. Innovative neuroprotective trial designs are required to hasten the translational process of drug development. An ideal target to monitor the efficacy of strategies aimed at treating multiple sclerosis is the visual system, which is the most accessible part of the human central nervous system. A novel C57BL/6 mouse line was generated that expressed transgenes for a myelin oligodendrocyte glycoprotein-specific T cell receptor and a retinal ganglion cell restricted-Thy1 promoter-controlled cyan fluorescent protein. This model develops spontaneous or induced optic neuritis, in the absence of paralytic disease normally associated with most rodent autoimmune models of multiple sclerosis. Demyelination and neurodegeneration could be monitored longitudinally in the living animal using electrophysiology, visual sensitivity, confocal scanning laser ophthalmoscopy and optical coherence tomography all of which are relevant to human trials. This model offers many advantages, from a 3Rs, economic and scientific perspective, over classical experimental autoimmune encephalomyelitis models that are associated with substantial suffering of animals. Optic neuritis in this model led to inflammatory damage of axons in the optic nerve and subsequent loss of retinal ganglion cells in the retina. This was inhibited by the systemic administration of a sodium channel blocker (oxcarbazepine) or intraocular treatment with siRNA targeting caspase-2. These novel approaches have relevance to the future treatment of neurodegeneration of MS, which has so far evaded treatment.	[Lidster, Katie; Jackson, Samuel J.; Giovannoni, Gavin; Baker, Mark D.; Baker, David] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England; [Ahmed, Zubair] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Munro, Peter; Coffey, Pete] UCL, Inst Ophthalmol, London, England	University of London; Queen Mary University London; University of Birmingham; University of London; University College London	Lidster, K (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England.	katie.lidster@nc3rs.org.uk		Coffey, Peter/0000-0002-5427-2939	Barts and the London Charity; Multiple Sclerosis Society of Great Britain and Northern Ireland; National Multiple Sclerosis Society, USA; National Centre for the Replacement, Refinement & Reduction of Animals in Research; Wellcome Trust [092539]; National Centre for the Replacement [G1000094/1] Funding Source: researchfish	Barts and the London Charity; Multiple Sclerosis Society of Great Britain and Northern Ireland; National Multiple Sclerosis Society, USA(National Multiple Sclerosis Society); National Centre for the Replacement, Refinement & Reduction of Animals in Research(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); Wellcome Trust(Wellcome TrustEuropean Commission); National Centre for the Replacement	The authors acknowledge the support of the Barts and the London Charity, the Multiple Sclerosis Society of Great Britain and Northern Ireland, the National Multiple Sclerosis Society, USA, notably the National Centre for the Replacement, Refinement & Reduction of Animals in Research, and the Wellcome Trust (grant no. 092539 to ZA). The siRNA was provided by Quark Pharmaceuticals. The funders and Quark Pharmaceuticals had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2002, AM J PATHOL, V161, P1577, DOI 10.1016/S0002-9440(10)64436-7; Al-Izki S, 2011, MULT SCLER J, V17, pS209; Al-Izki S, 2012, MULT SCLER RELAT DIS, V1, P29, DOI 10.1016/j.msard.2011.09.001; Al-Izki S, 2011, MULT SCLER J, V17, P939, DOI 10.1177/1352458511400476; Baker D, 2011, MULT SCLER J, V17, P647, DOI 10.1177/1352458511398885; Bechtold DA, 2006, J NEUROL, V253, P1542, DOI 10.1007/s00415-006-0204-1; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bettelli E, 2006, J CLIN INVEST, V116, P2393, DOI 10.1172/JCI28334; Bjartmar C, 2003, J NEUROL SCI, V206, P165, DOI 10.1016/S0022-510X(02)00069-2; Black JA, 2012, EXP NEUROL, V234, P302, DOI 10.1016/j.expneurol.2011.09.030; Cohen JA, 2012, LANCET NEUROL, V11, P467, DOI 10.1016/S1474-4422(12)70059-5; Coles AJ, 1999, ANN NEUROL, V46, P296, DOI 10.1002/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO;2-#; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Coquet JM, 2013, IMMUNITY, V38, P53, DOI 10.1016/j.immuni.2012.09.009; Dutta R, 2011, PROG NEUROBIOL, V93, P1, DOI 10.1016/j.pneurobio.2010.09.005; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fernandes DB, 2012, J NEURO-OPHTHALMOL, V32, P102, DOI 10.1097/WNO.0b013e31823a9ebc; Galetta KM, 2011, NEUROTHERAPEUTICS, V8, P117, DOI 10.1007/s13311-010-0005-1; Gnanapavan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070019; GOVERMAN J, 1993, CELL, V72, P551, DOI 10.1016/0092-8674(93)90074-Z; Guan YT, 2006, J NEUROIMMUNOL, V178, P40, DOI 10.1016/j.jneuroim.2006.05.019; Hafezi F, 2000, BRIT J OPHTHALMOL, V84, P922, DOI 10.1136/bjo.84.8.922; Hampton DW, 2008, J NEUROIMMUNOL, V201, P200, DOI 10.1016/j.jneuroim.2008.05.034; Hayton T, 2011, J NEUROL, V258, P1; Kapoor R, 2003, ANN NEUROL, V53, P174, DOI 10.1002/ana.10443; Kapoor R, 2010, LANCET NEUROL, V9, P681, DOI 10.1016/S1474-4422(10)70131-9; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Leung CKS, 2009, BRIT J OPHTHALMOL, V93, P964, DOI 10.1136/bjo.2008.150482; Mader S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-184; Morris-Downes MM, 2002, J NEUROIMMUNOL, V125, P114, DOI 10.1016/S0165-5728(02)00040-1; O'Neill JK, 1998, J NEUROIMMUNOL, V82, P210, DOI 10.1016/S0165-5728(97)00203-8; Oh J, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/460825; PIDDLESDEN SJ, 1993, AM J PATHOL, V143, P555; Pryce G, 2005, J NEUROIMMUNOL, V165, P41, DOI 10.1016/j.jneuroim.2005.04.009; Steinman L, 2006, ANN NEUROL, V60, P12, DOI 10.1002/ana.20913; Svingen T, 2009, SEX DEV, V3, P194, DOI 10.1159/000228720; Talman LS, 2010, ANN NEUROL, V67, P749, DOI 10.1002/ana.22005; Thomas BB, 2004, J NEUROSCI METH, V138, P7, DOI 10.1016/j.jneumeth.2004.03.007; Wang X, 2010, NEUROSCI LETT, V468, P110, DOI 10.1016/j.neulet.2009.10.077; Waxman SG, 2008, NAT CLIN PRACT NEURO, V4, P159, DOI 10.1038/ncpneuro0735	40	28	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79188	10.1371/journal.pone.0079188	http://dx.doi.org/10.1371/journal.pone.0079188			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223903	gold, Green Published, Green Submitted			2022-12-27	WOS:000326503400101
J	Dietz, P; Ulrich, R; Dalaker, R; Striegel, H; Franke, AG; Lieb, K; Simon, P				Dietz, Pavel; Ulrich, Rolf; Dalaker, Robert; Striegel, Heiko; Franke, Andreas G.; Lieb, Klaus; Simon, Perikles			Associations between Physical and Cognitive Doping - A Cross-Sectional Study in 2.997 Triathletes	PLOS ONE			English	Article							ANABOLIC-STEROID USE; RANDOMIZED-RESPONSE; NUTRITIONAL SUPPLEMENTS; DRUG-USE; FITNESS-SPORTS; CAFFEINE; PREVALENCE; ENHANCEMENT; ILLICIT; PERFORMANCE	Purpose: This study assessed, for the first time, prevalence estimates for physical and cognitive doping within a single collective of athletes using the randomized response technique (RRT). Furthermore, associations between the use of legal and freely available substances to improve physical and cognitive performance (enhancement) and illicit or banned substances to improve physical and cognitive performance (doping) were examined. Methods: An anonymous questionnaire using the unrelated question RRT was used to survey 2,997 recreational triathletes in three sports events (Frankfurt, Regensburg, and Wiesbaden) in Germany. Prior to the survey, statistical power analyses were performed to determine sample size. Logistic regression was used to predict physical and cognitive enhancement and the bootstrap method was used to evaluate differences between the estimated prevalences of physical and cognitive doping. Results: 2,987 questionnaires were returned (99.7%). 12-month prevalences for physical and cognitive doping were 13.0% and 15.1%, respectively. The prevalence estimate for physical doping was significantly higher in athletes who also used physical enhancers, as well as in athletes who took part in the European Championship in Frankfurt compared to those who did not. The prevalence estimate for cognitive doping was significantly higher in athletes who also used physical and cognitive enhancers. Moreover, the use of physical and cognitive enhancers were significantly associated and also the use of physical and cognitive doping. Discussion: The use of substances to improve physical and cognitive performance was associated on both levels of legality (enhancement vs. doping) suggesting that athletes do not use substances for a specific goal but may have a general propensity to enhance. This finding is important for understanding why people use such substances. Consequently, more effective prevention programs against substance abuse and doping could be developed.	[Dietz, Pavel; Dalaker, Robert; Simon, Perikles] Johannes Gutenberg Univ Mainz, Dept Sports Med Rehabil & Dis Prevent, D-55122 Mainz, Germany; [Striegel, Heiko] Univ Tubingen, Dept Sports Med, Tubingen, Germany; [Franke, Andreas G.; Lieb, Klaus] Univ Med Ctr, Dept Psychiat & Psychotherapy, Mainz, Germany; [Ulrich, Rolf] Univ Tubingen, Dept Psychol, Tubingen, Germany	Johannes Gutenberg University of Mainz; Eberhard Karls University of Tubingen; Johannes Gutenberg University of Mainz; Eberhard Karls University of Tubingen	Simon, P (corresponding author), Johannes Gutenberg Univ Mainz, Dept Sports Med Rehabil & Dis Prevent, D-55122 Mainz, Germany.	simonpe@uni-mainz.de	Simon, Perikles D/B-2293-2013; Ulrich, Rolf/A-9372-2012	Simon, Perikles D/0000-0002-7996-4034; Ulrich, Rolf/0000-0001-8443-2705; Dietz, Pavel/0000-0002-8390-0594	World Anti-Doping Agency (WADA) [09M5]; Initiative PRO Humanities and Social Sciences (Initiative PRO Geistes- und Sozialwissenschaften) of the Johannes Gutenberg University Mainz, Germany	World Anti-Doping Agency (WADA); Initiative PRO Humanities and Social Sciences (Initiative PRO Geistes- und Sozialwissenschaften) of the Johannes Gutenberg University Mainz, Germany	This project has been carried out with the support of the World Anti-Doping Agency (WADA) (grant number: 09M5) and the Initiative PRO Humanities and Social Sciences 2015 (Initiative PRO Geistes- und Sozialwissenschaften) of the Johannes Gutenberg University Mainz, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, STAGES PATHWAYS DRUG, DOI [DOI 10.1017/CBO9780511499777.003, 10.1017/CBO9780511499777]; Arvary D, 2000, NEW ENGL J MED, V342, P1532, DOI 10.1056/NEJM200005183422018; Backhouse SH, 2013, SCAND J MED SCI SPOR, V23, P244, DOI 10.1111/j.1600-0838.2011.01374.x; Braun H, 2009, INT J SPORT NUTR EXE, V19, P97, DOI 10.1123/ijsnem.19.1.97; BUCKLEY WE, 1988, JAMA-J AM MED ASSOC, V260, P3441; Burns NR, 2006, HUM PSYCHOPHARM CLIN, V21, P27, DOI 10.1002/hup.739; Castaldi S, 2012, J ADDICT MED, V6, P112, DOI 10.1097/ADM.0b013e3182479584; Deutsche Angestellten Krankenkasse (DAK), 2009, GES 2009 AN ARB SCHW; Dietz P, 2013, PHARMACOTHERAPY, V33, P44, DOI 10.1002/phar.1166; DURANT RH, 1993, NEW ENGL J MED, V328, P922, DOI 10.1056/NEJM199304013281304; EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844; Franke AG, 2011, PHARMACOPSYCHIATRY, V44, P331, DOI 10.1055/s-0031-1286347; Franke AG, 2011, PHARMACOPSYCHIATRY, V44, P60, DOI 10.1055/s-0030-1268417; Franke AG, 2010, BUNDESGESUNDHEITSBLA, V53, P853, DOI 10.1007/s00103-010-1105-0; Franke AG, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-102; Geyer H, 2008, J MASS SPECTROM, V43, P892, DOI 10.1002/jms.1452; GREENBERG BG, 1969, J AM STAT ASSOC, V64, P520, DOI 10.2307/2283636; HUGHES JR, 1992, AM J PSYCHIAT, V149, P33; International Triathlon Union (ITU), 2012, ANT; Kanayama G, 2001, PSYCHOTHER PSYCHOSOM, V70, P137, DOI 10.1159/000056238; Killgore WDS, 2009, SLEEP, V32, P205, DOI 10.1093/sleep/32.2.205; Klaber M, 2010, DOPING FITNESS STUDI; Knez WL, 2010, INT J SPORT NUTR EXE, V20, P507, DOI 10.1123/ijsnem.20.6.507; Kohler M, 2010, DRUG TEST ANAL, V2, P533, DOI 10.1002/dta.186; Korkia P, 1997, INT J SPORTS MED, V18, P557, DOI 10.1055/s-2007-972681; Lensvelt-Mulders GJLM, 2005, SOCIOL METHOD RES, V33, P319, DOI 10.1177/0049124104268664; Lentillon-Kaestner V, 2010, SCAND J MED SCI SPOR, V20, P336, DOI 10.1111/j.1600-0838.2009.00885.x; Lieberman HR, 2001, NUTR REV, V59, P91, DOI 10.1111/j.1753-4887.2001.tb06995.x; LITTLE RJA, 1982, J AM STAT ASSOC, V77, P237, DOI 10.2307/2287227; Maher B, 2008, NATURE, V452, P674, DOI 10.1038/452674a; Maughan RJ, 2007, J SPORT SCI, V25, pS103, DOI 10.1080/02640410701607395; Mayet A, 2012, ADDICT BEHAV, V37, P160, DOI 10.1016/j.addbeh.2011.09.012; Nehlig A, 2010, J ALZHEIMERS DIS, V20, pS85, DOI 10.3233/JAD-2010-091315; Niess A M, 2007, Ther Umsch, V64, P181, DOI 10.1024/0040-5930.64.3.181; Papadopoulos FC, 2006, EUR J EPIDEMIOL, V21, P307, DOI 10.1007/s10654-006-0018-6; Paulhus D.L., 1991, MEASURES PERSONALITY, P17, DOI [DOI 10.1016/B978-0-12-590241-0.50006-X, 10.1016/B978-0-12-590241-0.50006-X]; Repantis D., 2009, POIESIS PRAXIS, V6, P139, DOI [DOI 10.1007/S10202-008-0060-4, 10.1007/s10202-008-0060-4]; Repantis D, 2010, PHARMACOL RES, V62, P187, DOI 10.1016/j.phrs.2010.04.002; Simon P, 2006, ADDICTION, V101, P1640, DOI 10.1111/j.1360-0443.2006.01568.x; Solomon PR, 2002, JAMA-J AM MED ASSOC, V288, P835, DOI 10.1001/jama.288.7.835; Striegel H, 2006, INT J SPORTS MED, V27, P236, DOI 10.1055/s-2005-865648; Striegel H, 2006, DRUG ALCOHOL DEPEN, V81, P11, DOI 10.1016/j.drugalcdep.2005.05.013; Striegel H, 2010, DRUG ALCOHOL DEPEN, V106, P230, DOI 10.1016/j.drugalcdep.2009.07.026; Teter CJ, 2006, PHARMACOTHERAPY, V26, P1501, DOI 10.1592/phco.26.10.1501; Tscholl P, 2010, AM J SPORT MED, V38, P133, DOI 10.1177/0363546509344071; Ulrich R, 2012, PSYCHOL METHODS, V17, P623, DOI 10.1037/a0029314; WARNER SL, 1965, J AM STAT ASSOC, V60, P63, DOI 10.2307/2283137; Wesensten NJ, 2005, J SLEEP RES, V14, P255, DOI 10.1111/j.1365-2869.2005.00468.x; Wilens TE, 2008, J AM ACAD CHILD PSY, V47, P21, DOI 10.1097/chi.0b013e31815a56f1; World Anti-Doping Agency (WADA), 2012, PROH LIST 2013; World Triathlon Corporation (WTC), 2012, WORLD TRIATHL CORP L	51	37	37	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78702	10.1371/journal.pone.0078702	http://dx.doi.org/10.1371/journal.pone.0078702			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236038	Green Submitted, Green Published, gold			2022-12-27	WOS:000327254700035
J	Han, L; Tang, MX; Ti, Y; Wang, ZH; Wang, J; Ding, WY; Wang, H; Zhang, Y; Zhang, W; Zhong, M				Han, Lu; Tang, Meng-Xiong; Ti, Yun; Wang, Zhi-Hao; Wang, Jia; Ding, Wen-Yuan; Wang, Hua; Zhang, Yun; Zhang, Wei; Zhong, Ming			Overexpressing STAMP2 Improves Insulin Resistance in Diabetic ApoE(-/-)/LDLR-/- Mice via Macrophage Polarization Shift in Adipose Tissues	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; BROWN ADIPOCYTES; TNF-ALPHA; OBESITY; INFLAMMATION; ADIPOGENESIS; EXPRESSION	STAMP2 is a counterregulator of inflammation and insulin resistance. The aim of this study is to investigate whether activation of STAMP2 improves insulin resistance by regulating macrophage polarization in adipose tissues. The diabetic ApoE(-/-)/LDLR-/- mouse model was induced by high-fat diet and low-dose streptozotocin. Samples were obtained from epididymal, subcutaneous and brown adipose tissues. Infiltration of M1/M2 macrophages and inflammatory cytokines were investigated by immunohistochemistry. We then used gene overexpression to investigate the effect of STAMP2 on macrophages infiltration and polarization and inflammatory cytokines expression. Our results showed that infiltration of macrophages, the ratio of M1/M2 macrophages and the expression of pro-inflammatory cytokines were enhanced and STAMP2 was downregulated in adipose tissues of diabetic ApoE(-/-)/LDLR-/- mice compared with control mice. STAMP2 gene overexpression could significantly reduce macrophages infiltration, the ratio of M1/M2 macrophages and the expression of pro-inflammatory cytokines in epididymal and brown adipose tissues, improving insulin resistance. Our results suggested that STAMP2 gene overexpression may improve insulin resistance via regulating macrophage polarization in visceral and brown adipose tissues.	[Han, Lu; Tang, Meng-Xiong; Ti, Yun; Wang, Zhi-Hao; Wang, Jia; Ding, Wen-Yuan; Wang, Hua; Zhang, Yun; Zhang, Wei; Zhong, Ming] Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Jinan, Peoples R China; [Han, Lu; Tang, Meng-Xiong; Ti, Yun; Wang, Zhi-Hao; Wang, Jia; Ding, Wen-Yuan; Wang, Hua; Zhang, Yun; Zhang, Wei; Zhong, Ming] Chinese Minist Publ Hlth, Jinan, Peoples R China; [Han, Lu; Ti, Yun; Wang, Jia; Ding, Wen-Yuan; Wang, Hua; Zhang, Yun; Zhang, Wei; Zhong, Ming] Shandong Univ, Qilu Hosp, Dept Cardiol, Jinan 250100, Peoples R China; [Tang, Meng-Xiong] Shandong Univ, Qilu Hosp, Dept Emergency, Jinan 250100, Peoples R China; [Wang, Zhi-Hao] Shandong Univ, Qilu Hosp, Dept Geriatr Med, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong University	Zhong, M (corresponding author), Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Jinan, Peoples R China.	zhongmingzm@gmail.com			Key Technologies R & D Program of Shandong Province [2010G0020262]; Independent Innovation Foundation of Shandong University [2012JC034]; Natural Science Foundation of Shandong Province [ZR2009CM022, ZR2009CM025]; National Natural Science Foundation of China [30971215, 81070192, 81070141, 81100605, 81270352, 81270287]; National Basic Research Program of China (973 Program) [2012CB722406]	Key Technologies R & D Program of Shandong Province; Independent Innovation Foundation of Shandong University; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the research grants from Key Technologies R & D Program of Shandong Province (2010G0020262), the Independent Innovation Foundation of Shandong University (2012JC034), the Natural Science Foundation of Shandong Province (ZR2009CM022, ZR2009CM025), the National Natural Science Foundation of China (30971215, 81070192, 81070141, 81100605, 81270352 and 81270287) and the National Basic Research Program of China (973 Program, Grant No.: 2012CB722406). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergman RN, 2007, AM J MED, V120, pS3, DOI 10.1016/j.amjmed.2006.11.012; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Danforth E, 2000, NAT GENET, V26, P13, DOI 10.1038/79111; EVANS DJ, 1984, METABOLISM, V33, P68, DOI 10.1016/0026-0495(84)90164-1; Guerra C, 2001, J CLIN INVEST, V108, P1205, DOI 10.1172/JCI200113103; Hammarstedt A, 2007, BIOCHEM BIOPH RES CO, V357, P700, DOI 10.1016/j.bbrc.2007.03.202; HEIBRONN L, 2004, INT J OBES RELAT S4, V28, pS12; Heilbronn LK, 2008, CURR PHARM DESIGN, V14, P1225, DOI 10.2174/138161208784246153; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hotamisligil GS, 2000, INT J OBESITY, V24, pS23, DOI 10.1038/sj.ijo.0801497; KAHN CR, 1994, DIABETES, V43, P1066, DOI 10.2337/diab.43.8.1066; Lyon CJ, 2003, ENDOCRINOLOGY, V144, P2195, DOI 10.1210/en.2003-0285; Matsuzawa Y, 1999, ANN NY ACAD SCI, V892, P146, DOI 10.1111/j.1749-6632.1999.tb07793.x; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mu J, 2006, DIABETES, V55, P1695, DOI 10.2337/db05-1602; Nakae J, 2008, DIABETES, V57, P563, DOI 10.2337/db07-0698; Nisoli E, 1997, CELL DEATH DIFFER, V4, P771, DOI 10.1038/sj.cdd.4400292; Preis SR, 2010, OBESITY, V18, P2191, DOI 10.1038/oby.2010.59; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Sun M, 2007, CIRCULATION, V115, P1398, DOI 10.1161/CIRCULATIONAHA.106.643585; Valladares A, 2001, FEBS LETT, V493, P6, DOI 10.1016/S0014-5793(01)02264-5; Valverde AM, 1998, ENDOCRINOLOGY, V139, P1229, DOI 10.1210/en.139.3.1229; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2007, CELL, V129, P537, DOI 10.1016/j.cell.2007.02.049; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	25	26	26	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78903	10.1371/journal.pone.0078903	http://dx.doi.org/10.1371/journal.pone.0078903			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236066	gold, Green Submitted, Green Published			2022-12-27	WOS:000327254700063
J	Padmashali, R; You, H; Karnik, N; Lei, P; Andreadis, ST				Padmashali, Roshan; You, Hui; Karnik, Nikhila; Lei, Pedro; Andreadis, Stelios T.			Adherens Junction Formation Inhibits Lentivirus Entry and Gene Transfer	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; VESICULAR STOMATITIS-VIRUS; HUMAN EPIDERMAL-KERATINOCYTES; POLARIZED EPITHELIAL-CELLS; STEM-CELLS; ALPHA-CATENIN; IN-VIVO; RHINOVIRUS INFECTION; AIRWAY EPITHELIUM; CADHERIN	Although cellular signaling pathways that affect lentivirus infection have been investigated, the role of cell-cell interactions in lentiviral gene delivery remains elusive. In the course of our studies we observed that lentiviral gene transfer was a strong function of the position of epithelial cells within colonies. While peripheral cells were transduced efficiently, cells in the center of colonies were resistant to gene transfer. In addition, gene delivery was enhanced significantly under culture conditions that disrupted adherens junctions (AJ) but decreased upon AJ formation. In agreement, gene knockdown and gain-of-function approaches showed that a-catenin, a key component of the AJ complex prevented lentivirus gene transfer. Using a doxycycline regulatable system we showed that expression of dominant negative E-cadherin enhanced gene transfer in a dose-dependent manner. In addition, dissolution of AJ by doxycycline increased entry of lentiviral particles into the cell cytoplasm in a dose-dependent manner. Taken together our results demonstrate that AJ formation renders cells non-permissive to lentiviral gene transfer and may facilitate development of simple means to enhance gene delivery or combat virus infection.	[Padmashali, Roshan; You, Hui; Karnik, Nikhila; Lei, Pedro; Andreadis, Stelios T.] SUNY Buffalo, Dept Chem & Biol Engn, Bioengn Lab, Amherst, NY 14260 USA; [Andreadis, Stelios T.] SUNY Buffalo, Dept Biomed Engn, Amherst, NY USA; [Andreadis, Stelios T.] Ctr Excellence Bioinformat & Life Sci, Buffalo, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Andreadis, ST (corresponding author), SUNY Buffalo, Dept Chem & Biol Engn, Bioengn Lab, Amherst, NY 14260 USA.	sandread@buffalo.edu	Lei, Pedro/U-1027-2019		National Science Foundation [CBET-0853993]	National Science Foundation(National Science Foundation (NSF))	Funding came from the National Science Foundation (CBET-0853993). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SC, 2002, INVEST OPHTH VIS SCI, V43, P978; Bajaj BG, 2005, MOL THER, V11, P969, DOI 10.1016/j.ymthe.2004.10.023; Bajpai S, 2008, P NATL ACAD SCI USA, V105, P18331, DOI 10.1073/pnas.0806783105; Bomsel M, 2003, NAT REV MOL CELL BIO, V4, P57, DOI 10.1038/nrm1005; Bonazzi M, 2011, J CELL BIOL, V195, P348, DOI 10.1083/jcb.201106011; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Capaldo CT, 2007, MOL BIOL CELL, V18, P189, DOI 10.1091/mbc.E06-05-0471; Castellani S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/103976; Cheng SL, 1998, J BONE MINER RES, V13, P633, DOI 10.1359/jbmr.1998.13.4.633; Clement C, 2006, J CELL BIOL, V174, P1009, DOI 10.1083/jcb.200509155; Cmielewski P, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-84; Cockrell AS, 2007, MOL BIOTECHNOL, V36, P184, DOI 10.1007/s12033-007-0010-8; Coyne CB, 2006, CELL, V124, P119, DOI 10.1016/j.cell.2005.10.035; Dahl U, 1996, DEVELOPMENT, V122, P2895; Delorme-Axford E, 2011, VIRUSES-BASEL, V3, P2462, DOI 10.3390/v3122462; Etienne-Manneville Sandrine, 2012, Subcell Biochem, V60, P225, DOI 10.1007/978-94-007-4186-7_10; Fu JD, 2008, STEM CELLS DEV, V17, P315, DOI 10.1089/scd.2007.0114; HODIVALA KJ, 1994, J CELL BIOL, V124, P589, DOI 10.1083/jcb.124.4.589; Holgate Stephen T, 2009, Proc Am Thorac Soc, V6, P655, DOI 10.1513/pats.200907-072DP; Jakiela B, 2008, AM J RESP CELL MOL, V38, P517, DOI 10.1165/rcmb.2007-0050OC; Johannsdottir HK, 2009, J VIROL, V83, P440, DOI 10.1128/JVI.01864-08; Kafri Tal, 2004, Methods Mol Biol, V246, P367; Knudsen KA, 1998, J CELL BIOCHEM, P168; Kremer KL, 2007, J GENE MED, V9, P362, DOI 10.1002/jgm.1025; Krishnan S, 2012, CELL MICROBIOL, V14, P1415, DOI 10.1111/j.1462-5822.2012.01805.x; Lee MH, 2011, FASEB J, V25, P613, DOI 10.1096/fj.10-161380; Lee MH, 2011, J VIROL, V85, P2657, DOI 10.1128/JVI.01765-10; Lee MH, 2009, FASEB J, V23, P3874, DOI 10.1096/fj.08-117804; Levayer R, 2011, NAT CELL BIOL, V13, P529, DOI 10.1038/ncb2224; Limberis M, 2002, HUM GENE THER, V13, P1961, DOI 10.1089/10430340260355365; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Man Y, 2000, AM J RESP CELL MOL, V23, P610, DOI 10.1165/ajrcmb.23.5.4046; Naldini L, 1999, THROMB HAEMOSTASIS, V82, P552; Nelson WJ, 1996, TRENDS CELL BIOL, V6, P325, DOI 10.1016/0962-8924(96)30040-8; Nieman MT, 1999, J CELL SCI, V112, P1621; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Orlichenko L, 2009, MOL BIOL CELL, V20, P4140, DOI 10.1091/mbc.E08-10-1043; Petermann P, 2009, J VIROL, V83, P9759, DOI 10.1128/JVI.00835-09; Qian LW, 2008, J VIROL, V82, P11902, DOI 10.1128/JVI.01042-08; Quinn K, 2009, J VIROL, V83, P10176, DOI 10.1128/JVI.00422-09; Redfield A, 1997, J CELL BIOL, V138, P1323, DOI 10.1083/jcb.138.6.1323; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Ruetze M, 2010, INTEGR BIOL-UK, V2, P241, DOI 10.1039/b926147h; Samarin SN, 2007, MOL BIOL CELL, V18, P3429, DOI 10.1091/mbc.E07-04-0315; Schelhaas M, 2003, J GEN VIROL, V84, P2473, DOI 10.1099/vir.0.19226-0; Smith AL, 2012, MOL BIOL CELL, V23, P99, DOI 10.1091/mbc.E11-06-0497; Sousa S, 2005, CURR OPIN CELL BIOL, V17, P489, DOI 10.1016/j.ceb.2005.08.013; Spear PG, 2002, DEV CELL, V3, P462, DOI 10.1016/S1534-5807(02)00298-8; Strauss R, 2009, CANCER RES, V69, P5115, DOI 10.1158/0008-5472.CAN-09-0645; SUPERTI F, 1987, J GEN VIROL, V68, P387, DOI 10.1099/0022-1317-68-2-387; TEMMGROVE CJ, 1994, J CELL SCI, V107, P2951; Theard D, 2007, MOL BIOL CELL, V18, P2313, DOI 10.1091/mbc.E06-11-1040; Tian J, 2009, GENE THER, V16, P874, DOI 10.1038/gt.2009.46; Tomei AA, 2008, AM J PHYSIOL-LUNG C, V294, pL79, DOI 10.1152/ajplung.00062.2007; Tudor D, 2007, CELL PROLIFERAT, V40, P706, DOI 10.1111/j.1365-2184.2007.00467.x; Van den Broeke C, 2011, VIRUSES-BASEL, V3, P278, DOI 10.3390/v3040278; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Vogelmann R, 2004, CURR OPIN CELL BIOL, V16, P86, DOI 10.1016/j.ceb.2003.12.002; Yeo NK, 2010, LARYNGOSCOPE, V120, P346, DOI 10.1002/lary.20764; Yoon M, 2002, J VIROL, V76, P7203, DOI 10.1128/JVI.76.14.7203-7208.2002	61	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79265	10.1371/journal.pone.0079265	http://dx.doi.org/10.1371/journal.pone.0079265			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236116	Green Submitted, gold, Green Published			2022-12-27	WOS:000327254700115
J	Rito, T; Richards, MB; Fernandes, V; Alshamali, F; Cerny, V; Pereira, L; Soares, P				Rito, Teresa; Richards, Martin B.; Fernandes, Veronica; Alshamali, Farida; Cerny, Viktor; Pereira, Luisa; Soares, Pedro			The First Modern Human Dispersals across Africa	PLOS ONE			English	Article							MIDDLE STONE-AGE; BAYESIAN COALESCENT INFERENCE; PLEISTOCENE HOMO-SAPIENS; MTDNA VARIATION; SHELL BEADS; GENETIC PREHISTORY; PHYLOGENETIC TREE; NO EVIDENCE; ANCIENT; EVOLUTION	The emergence of more refined chronologies for climate change and archaeology in prehistoric Africa, and for the evolution of human mitochondrial DNA (mtDNA), now make it feasible to test more sophisticated models of early modern human dispersals suggested by mtDNA distributions. Here we have generated 42 novel whole-mtDNA genomes belonging to haplogroup L0, the most divergent clade in the maternal line of descent, and analysed them alongside the growing database of African lineages belonging to L0's sister clade, L1'6. We propose that the last common ancestor of modern human mtDNAs (carried by "mitochondrial Eve") possibly arose in central Africa similar to 180 ka, at a time of low population size. By similar to 130 ka two distinct groups of anatomically modern humans co-existed in Africa: broadly, the ancestors of many modern-day Khoe and San populations in the south and a second central/eastern African group that includes the ancestors of most extant worldwide populations. Early modern human dispersals correlate with climate changes, particularly the tropical African "megadroughts" of MIS 5 (marine isotope stage 5, 135-75 ka) which paradoxically may have facilitated expansions in central and eastern Africa, ultimately triggering the dispersal out of Africa of people carrying haplogroup L3 similar to 60 ka. Two south to east migrations are discernible within haplogroup LO. One, between 120 and 75 ka, represents the first unambiguous long-range modern human dispersal detected by mtDNA and might have allowed the dispersal of several markers of modernity. A second one, within the last 20 ka signalled by L0d, may have been responsible for the spread of southern click-consonant languages to eastern Africa, contrary to the view that these eastern examples constitute relicts of an ancient, much wider distribution.	[Rito, Teresa; Fernandes, Veronica; Pereira, Luisa; Soares, Pedro] Univ Porto, IPATIMUP Inst Patol & Imunol Mol, P-4100 Oporto, Portugal; [Richards, Martin B.] Univ Huddersfield, Sch Appl Sci, Huddersfield HD1 3DH, W Yorkshire, England; [Fernandes, Veronica] Univ Leeds, Fac Biol Sci, Inst Integrat & Comparat Biol, Leeds, W Yorkshire, England; [Alshamali, Farida] Dubai Police GHQ Gen Dept Forens Sci & Criminol, Dubai, U Arab Emirates; [Cerny, Viktor] Charles Univ Prague, Fac Sci, Dept Anthropol & Human Genet, Prague, Czech Republic; [Cerny, Viktor] Inst Adv Study, Paris, France; [Pereira, Luisa] Univ Porto, Fac Med, P-4100 Oporto, Portugal	Universidade do Porto; University of Huddersfield; University of Leeds; Charles University Prague; Universidade do Porto	Soares, P (corresponding author), Univ Porto, IPATIMUP Inst Patol & Imunol Mol, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	pedroa@ipatimup.pt	Alshamali, Farida/N-1119-2013; Rito, Teresa/O-7726-2014; Rito, Teresa/AAC-9041-2019; Soares, Pedro A/G-9422-2011; Cerny, Viktor/G-7842-2014; Pereira, Luisa/H-3050-2011; Fernandes, Vernonica/AAC-6824-2022	Rito, Teresa/0000-0002-8374-6347; Rito, Teresa/0000-0002-8374-6347; Soares, Pedro A/0000-0002-2807-690X; Pereira, Luisa/0000-0002-4271-1527; RICHARDS, MARTIN/0000-0003-3118-0967; fernandes, veronica/0000-0002-3873-2034	FCT, the Portuguese Foundation for Science and Technology [PTDC/CS-ANT/113832/2009, SFRH/BPD/64233/2009, SFRH/BD/61342/2009]; FCT; Fundação para a Ciência e a Tecnologia [PTDC/CS-ANT/113832/2009] Funding Source: FCT	FCT, the Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	This work was supported by FCT, the Portuguese Foundation for Science and Technology, through the project PTDC/CS-ANT/113832/2009 and personal grants to P. S. (SFRH/BPD/64233/2009) and V. F. (SFRH/BD/61342/2009). IPATIMUP is an Associate Laboratory of the Portuguese Ministry of Science, Technology, and Higher Education and is partially supported by FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Abri A, 2012, AM J PHYS ANTHROPOL, V149, P291, DOI 10.1002/ajpa.22131; Ashford RW, 2000, J MED MICROBIOL, V49, P771, DOI 10.1099/0022-1317-49-9-771; Atkinson QD, 2009, P ROY SOC B-BIOL SCI, V276, P367, DOI 10.1098/rspb.2008.0785; BANDELT HJ, 1995, GENETICS, V141, P743; Barbieri C, 2013, EUR J HUM GENET, V21, P430, DOI 10.1038/ejhg.2012.192; Barbieri C, 2013, AM J HUM GENET, V92, P285, DOI 10.1016/j.ajhg.2012.12.010; Barham L., 2008, 1 AFRICANS AFRICAN A; Basell LS, 2008, QUATERNARY SCI REV, V27, P2484, DOI 10.1016/j.quascirev.2008.09.010; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Blome MW, 2012, J HUM EVOL, V62, P563, DOI 10.1016/j.jhevol.2012.01.011; Blum MGB, 2011, MOL BIOL EVOL, V28, P889, DOI 10.1093/molbev/msq265; Bouzouggar A, 2007, P NATL ACAD SCI USA, V104, P9964, DOI 10.1073/pnas.0703877104; Brown KS, 2012, NATURE, V491, P590, DOI 10.1038/nature11660; Cerny V, 2011, MOL BIOL EVOL, V28, P2491, DOI 10.1093/molbev/msr067; Chen YS, 2000, AM J HUM GENET, V66, P1362, DOI 10.1086/302848; CHEN YS, 1995, AM J HUM GENET, V57, P133; Clark JD, 2003, NATURE, V423, P747, DOI 10.1038/nature01670; Compton JS, 2011, QUATERNARY SCI REV, V30, P506, DOI 10.1016/j.quascirev.2010.12.012; Cruciani F, 2011, AM J HUM GENET, V88, P814, DOI 10.1016/j.ajhg.2011.05.002; d'Errico F, 2012, J ARCHAEOL SCI, V39, P942, DOI 10.1016/j.jas.2011.10.032; d'Errico F, 2009, P NATL ACAD SCI USA, V106, P16051, DOI 10.1073/pnas.0903532106; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Fernandes V, 2012, AM J HUM GENET, V90, P347, DOI 10.1016/j.ajhg.2011.12.010; Forster P, 1996, AM J HUM GENET, V59, P935; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; Gamble C, 2007, ORIGINS AND REVOLUTIONS: HUMAN IDENTITY IN EARLIEST PREHISTORY, P1, DOI 10.1017/CBO9780511618598; Gliganic LA, 2012, J HUM EVOL, V62, P533, DOI 10.1016/j.jhevol.2012.02.004; Gonder MK, 2007, MOL BIOL EVOL, V24, P757, DOI 10.1093/molbev/msl209; Gronau I, 2011, NAT GENET, V43, P1031, DOI 10.1038/ng.937; Guldemann T, 2008, ANNU REV ANTHROPOL, V37, P93, DOI 10.1146/annurev.anthro.37.081407.085109; Hall TA, NUCL ACIDS S SER, V41, P95; Harding RM, 2004, CURR OPIN GENET DEV, V14, P667, DOI 10.1016/j.gde.2004.08.010; Heller D, 2002, J ORGAN BEHAV, V23, P815, DOI 10.1002/job.168; Henn BM, 2008, P NATL ACAD SCI USA, V105, P10693, DOI 10.1073/pnas.0801184105; Henn BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002397; Henn BM, 2011, P NATL ACAD SCI USA, V108, P5154, DOI 10.1073/pnas.1017511108; Henshilwood C, 2004, SCIENCE, V304, P404, DOI 10.1126/science.1095905; Henshilwood CS, 2009, J HUM EVOL, V57, P27, DOI 10.1016/j.jhevol.2009.01.005; Jacobs Z, 2008, SCIENCE, V322, P733, DOI 10.1126/science.1162219; Klein RG, 1989, HUMAN CAREER HUMAN B; Lahr MM, 1998, YEARB PHYS ANTHROPOL, V41, P137; Lieberman DE, 2008, EVOL ANTHROPOL, V17, P55, DOI 10.1002/evan.20154; Lieberman DE, 2002, P NATL ACAD SCI USA, V99, P1134, DOI 10.1073/pnas.022440799; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Marean CW, 2007, NATURE, V449, P905, DOI 10.1038/nature06204; Mayer DEBY, 2009, J HUM EVOL, V56, P307, DOI 10.1016/j.jhevol.2008.10.005; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; McBrearty S, 2007, NATURE, V449, P793, DOI 10.1038/449793a; McDougall I, 2005, NATURE, V433, P733, DOI 10.1038/nature03258; MELLARS P, 2005, SINGLESPECIES MODELS, V14, P12, DOI DOI 10.1002/EVAN.20037; Mellars P, 2013, P NATL ACAD SCI USA, V110, P10699, DOI 10.1073/pnas.1306043110; Mendez FL, 2013, AM J HUM GENET, V92, P454, DOI 10.1016/j.ajhg.2013.02.002; Millard AR, 2008, J HUM EVOL, V54, P848, DOI 10.1016/j.jhevol.2007.11.002; Mitchell P, 2010, J ANTHROPOL SCI, V88, P73; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Pereira L, 2001, ANN HUM GENET, V65, P439, DOI 10.1017/S0003480001008855; Pereira L, 2007, MOL BIOL EVOL, V24, P868, DOI 10.1093/molbev/msm004; Pereira L, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-390; Pereira L, 2009, AM J HUM GENET, V84, P628, DOI 10.1016/j.ajhg.2009.04.013; PHILLIPSON DW, 2005, AFRICAN ARCHAEOLOGY; Pickrell JK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2140; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards M, 2003, AM J HUM GENET, V72, P1058, DOI 10.1086/374384; Rightmire GP, 2006, J HUM EVOL, V50, P96, DOI 10.1016/j.jhevol.2005.08.010; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Schlebusch CM, 2012, SCIENCE, V338, P374, DOI 10.1126/science.1227721; Scholz CA, 2007, P NATL ACAD SCI USA, V104, P16416, DOI 10.1073/pnas.0703874104; Shea J.J., 2007, RETHINKING HUMAN EVO, P219; Sjodin P, 2012, MOL BIOL EVOL, V29, P1851, DOI 10.1093/molbev/mss061; Smith TM, 2007, P NATL ACAD SCI USA, V104, P6128, DOI 10.1073/pnas.0700747104; Soares P, AFRICA MIS 6 2 POPUL; Soares P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058993; Soares P, 2012, MOL BIOL EVOL, V29, P915, DOI 10.1093/molbev/msr245; Soares P, 2011, AM J HUM GENET, V88, P239, DOI 10.1016/j.ajhg.2011.01.009; Soares P, 2010, CURR BIOL, V20, pR174, DOI 10.1016/j.cub.2009.11.054; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Soodyall H, 1993, MITOCHONDRIAL DNA PO; Soodyall H, 2008, SOUTH AFR HUMANIT, V20, P37; Stringer C, 2011, ORIGIN OUR SPECIES; Tishkoff SA, 2007, MOL BIOL EVOL, V24, P2180, DOI 10.1093/molbev/msm155; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Vanhaeren M, 2006, SCIENCE, V312, P1785, DOI 10.1126/science.1128139; Veeramah KR, 2012, MOL BIOL EVOL, V29, P617, DOI 10.1093/molbev/msr212; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503; White TD, 2003, NATURE, V423, P742, DOI 10.1038/nature01669; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	92	63	63	2	126	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80031	10.1371/journal.pone.0080031	http://dx.doi.org/10.1371/journal.pone.0080031			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	255QK	24236171	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000327254700172
J	Uma, D; Durkee, C; Herzner, G; Weiss, M				Uma, Divya; Durkee, Caitlin; Herzner, Gudrun; Weiss, Martha			Double Deception: Ant-Mimicking Spiders Elude Both Visually- and Chemically-Oriented Predators	PLOS ONE			English	Article							CUTICULAR HYDROCARBONS; PREY RECOGNITION; DIGGER WASP; JUMPING SPIDERS; INNATE AVERSION; MIMICRY; HYMENOPTERA; ARANEAE; CUES; MYRMECOMORPHY	Biological mimicry is often multimodal, in that a mimic reinforces its resemblance to another organism via different kinds of signals that can be perceived by a specific target audience. In this paper we describe a novel scenario, in which a mimic deceives at least two distinct audiences, each of which relies primarily on a different sensory modality for decision-making. We have previously shown that Peckhamia picata, a myrmecomorphic spider that morphologically and behaviorally resembles the ant Camponotus nearcticus, experiences reduced predation by visually-oriented jumping spiders. Here we report that Peckhamia also faces reduced aggression from spider-hunting sphecid wasps as well as from its model ant, both of which use chemical cues to identify prey. We also report that Peckhamia does not chemically resemble its model ants, and that its total cuticular hydrocarbons are significantly lower than those of the ants and non-mimic spiders. Although further studies are needed to clarify the basis of Peckhamia's chemically-mediated protection, to our knowledge, such 'double deception,' in which a single organism sends misleading visual cues to one set of predators while chemically misleading another set, has not been reported; however, it is likely to be common among what have until now been considered purely visual mimics.	[Uma, Divya; Durkee, Caitlin; Weiss, Martha] Georgetown Univ, Dept Biol, Washington, DC 20057 USA; [Uma, Divya] Indian Inst Sci Educ & Res, Sch Biol, Trivandrum, Kerala, India; [Herzner, Gudrun] Univ Regensburg, Dept Zool, D-93053 Regensburg, Germany	Georgetown University; Indian Institute of Science Education & Research (IISER) - Thiruvananthapuram; University of Regensburg	Uma, D (corresponding author), Georgetown Univ, Dept Biol, Washington, DC 20057 USA.	dbuorama@gmail.com			Washington Biologists' Field Club; Arachnological Society of America; Sigma Xi; Animal Behavior Society; American Museum of Natural History; NSF (Doctoral Dissertation Improvement Grant); Georgetown University's Department of Biology and Graduate School	Washington Biologists' Field Club; Arachnological Society of America; Sigma Xi; Animal Behavior Society; American Museum of Natural History; NSF (Doctoral Dissertation Improvement Grant)(National Science Foundation (NSF)); Georgetown University's Department of Biology and Graduate School	The Washington Biologists' Field Club, the Arachnological Society of America, Sigma Xi, the Animal Behavior Society, the American Museum of Natural History, and NSF (Doctoral Dissertation Improvement Grant) provided financial assistance, as did Georgetown University's Department of Biology and Graduate School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton S, 1998, J INSECT BEHAV, V11, P671, DOI 10.1023/A:1022346825811; Bohart RM, 1976, SHPECID WASPS WORLD; Carlson DA, 1998, J CHEM ECOL, V24, P1845, DOI 10.1023/A:1022311701355; Cini A, 2009, BIOL LETTERS, V5, P459, DOI 10.1098/rsbl.2009.0140; CLARKE KR, 1988, MAR ECOL PROG SER, V46, P213, DOI 10.3354/meps046213; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Coville R.E., 1987, P309; Cushing P. E., 2012, PSYCHE-J ENTOMOL, V2012, P1, DOI DOI 10.1155/2012/151989; Cushing PE, 1997, FLA ENTOMOL, V80, P165, DOI 10.2307/3495552; CUTLER B, 1991, J INSECT BEHAV, V4, P401, DOI 10.1007/BF01048287; Durkee CA, 2011, ENVIRON ENTOMOL, V40, P1223, DOI 10.1603/EN11057; Edmunds Malcolm, 1993, Memoirs of the Queensland Museum, V33, P507; Gnatzy W, 2001, ZOOL-ANAL COMPLEX SY, V103, P125; Greene MJ, 2003, NATURE, V423, P32, DOI 10.1038/423032a; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hebets EA, 2005, BEHAV ECOL SOCIOBIOL, V57, P197, DOI 10.1007/s00265-004-0865-7; Hebets EA, 2006, ETHOLOGY, V112, P1062, DOI 10.1111/j.1439-0310.2006.01274.x; Herzner G, 2005, ANIM BEHAV, V70, P1411, DOI 10.1016/j.anbehav.2005.03.032; Holldobler B., 1990, pi; Huang JN, 2011, P ROY SOC B-BIOL SCI, V278, P1356, DOI 10.1098/rspb.2010.1896; JOCQUE R, 1988, BR ARACHNOL SOC NEWS, V51, P7; Johnson CA, 2008, ANIM BEHAV, V76, P1965, DOI 10.1016/j.anbehav.2008.09.003; Kroiss J, 2009, ENTOMOL SCI, V12, P9, DOI 10.1111/j.1479-8298.2009.00300.x; Lahav S, 1999, NATURWISSENSCHAFTEN, V86, P246, DOI 10.1007/s001140050609; Lambardi D, 2007, BEHAV ECOL SOCIOBIOL, V61, P843, DOI 10.1007/s00265-006-0313-y; Legendre P., 2012, NUMERICAL ECOLOGY; Lenoir A, 2001, ANNU REV ENTOMOL, V46, P573, DOI 10.1146/annurev.ento.46.1.573; Lorenzi MC, 2002, PARASITOLOGY, V125, P507, DOI 10.1017/S003118200200238X; MCIVER JD, 1993, ANNU REV ENTOMOL, V38, P351, DOI 10.1146/annurev.en.38.010193.002031; Nelson XJ, 2006, BEHAV ECOL, V17, P676, DOI 10.1093/beheco/ark017; Nelson XJ, 2006, BIOL J LINN SOC, V88, P23, DOI 10.1111/j.1095-8312.2006.00598.x; Nelson XJ, 2005, J ARACHNOL, V33, P813, DOI 10.1636/S04-12.1; Nelson XJ, 2004, NEW ZEAL J ZOOL, V31, P45, DOI 10.1080/03014223.2004.9518358; OLIVEIRA PS, 1988, BIOL J LINN SOC, V33, P1, DOI 10.1111/j.1095-8312.1988.tb00443.x; OLIVEIRA PS, 1986, B SOC ZOOL FR, V111, P297; Ozaki M, 2005, SCIENCE, V309, P311, DOI 10.1126/science.1105244; Pekar S, 2011, ANIM BEHAV, V82, P1193, DOI 10.1016/j.anbehav.2011.09.007; Punzo F, 2006, J ENTOMOL SCI, V41, P202, DOI 10.18474/0749-8004-41.3.202; Punzo F, 2005, J INSECT BEHAV, V18, P757, DOI 10.1007/s10905-005-8738-0; REISKIND J, 1977, BIOTROPICA, V9, P1, DOI 10.2307/2387854; Rowe C, 1999, EVOL ECOL, V13, P655, DOI 10.1023/A:1011021630244; Ruxton GD, 2004, OXFORD BIOL; Uetz GW, 2002, BRAIN BEHAV EVOLUT, V59, P222, DOI 10.1159/000064909; Uma DB, 2010, THESIS GEORGETOWN U; Uma DB, 2010, ETHOLOGY, V116, P85, DOI 10.1111/j.1439-0310.2009.01715.x; VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X	46	18	18	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79660	10.1371/journal.pone.0079660	http://dx.doi.org/10.1371/journal.pone.0079660			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236152	Green Published, gold			2022-12-27	WOS:000327254700151
J	Zhang, DD; Ding, HY; Liu, LL; Hou, XL; Sun, GY; Li, L; Liu, YZ; Zhou, CL; Gu, RL; Luo, YJ				Zhang, Dandan; Ding, Haiyan; Liu, Lili; Hou, Xinlin; Sun, Guoyu; Li, Lei; Liu, Yunzhe; Zhou, Congle; Gu, Ruolei; Luo, Yuejia			The Prognostic Value of Amplitude-Integrated EEG in Full-Term Neonates with Seizures	PLOS ONE			English	Article							HYPOXIC-ISCHEMIC ENCEPHALOPATHY; PREDICTIVE-VALUE; PRETERM INFANTS; NEUROLOGIC EXAMINATION; BIRTH ASPHYXIA; ELECTROENCEPHALOGRAPHY; AEEG; HYPOTHERMIA; NEWBORN; BORN	Neonatal seizures pose a high risk for adverse outcome in survived infants. While the prognostic value of amplitude-integrated electroencephalogram (aEEG) is well established in neonates with encephalopathy and asphyxia, neonatal seizure studies focusing on the direct correlation between early aEEG measurement and subsequent neurologic outcome are scarce. In this study, the prognostic value of aEEG features was systematically analyzed in 143 full-term neonates to identify prognostic indicators of neurodevelopmental outcome. Neonatal aEEG features of background pattern, cyclicity, and seizure activity, as well as the etiology of neonatal seizures, were significantly associated with neurodevelopmental outcome at one year of age. aEEG background pattern was highly associated with neurologic outcomes (chi(2) = 116.9), followed by aEEG cyclicity (chi(2) = 87.2) and seizure etiology (chi(2) = 79.3). Multiple linear regression showed that the four predictors explained 71.2% of the variation in neurological outcome, with standardized beta coefficients of 0.44, 0.24, 0.22, and 0.14 for the predictors of aEEG background pattern, cyclicity, etiology, and aEEG seizure activity, respectively. This clinically applicable scoring system based on etiology and three aEEG indices would allow pediatricians to assess the risk for neurodevelopmental impairment and facilitate an early intervention in newborns developing seizures.	[Zhang, Dandan; Liu, Yunzhe; Luo, Yuejia] Shenzhen Univ, Inst Affect & Social Neurosci, Shenzhen, Peoples R China; [Ding, Haiyan] Tsinghua Univ, Dept Biomed Engn, Beijing 100084, Peoples R China; [Liu, Lili; Hou, Xinlin; Sun, Guoyu; Zhou, Congle] Peking Univ, Hosp 1, Dept Pediat, Beijing 100871, Peoples R China; [Li, Lei] Chinese Acad Sci, Tech Inst Phys & Chem, Key Lab Cryogen, Beijing, Peoples R China; [Gu, Ruolei] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China	Shenzhen University; Tsinghua University; Peking University; Chinese Academy of Sciences; Technical Institute of Physics & Chemistry, CAS; Chinese Academy of Sciences; Institute of Psychology, CAS	Hou, XL (corresponding author), Peking Univ, Hosp 1, Dept Pediat, Beijing 100871, Peoples R China.	houxinlin@gmail.com	Gu, Ruolei/H-6946-2019	Gu, Ruolei/0000-0001-8722-2172; ?, ?/0000-0003-0859-1880	National Natural Science Foundation of China [31300867, 31300847, 91132704]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China (31300867; 31300847; 91132704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	al Naqeeb N, 1999, PEDIATRICS, V103, P1263, DOI 10.1542/peds.103.6.1263; Bowen JR, 2010, PEDIATR RES, V67, P538, DOI 10.1203/PDR.0b013e3181d4ecda; Dlugos D, 2007, NEUROLOGY, V69, P1812, DOI 10.1212/01.wnl.0000279344.82107.7b; EKEN P, 1995, ARCH DIS CHILD-FETAL, V73, pF75, DOI 10.1136/fn.73.2.F75; El-Dib M, 2009, PEDIATR NEUROL, V41, P315, DOI 10.1016/j.pediatrneurol.2009.05.002; Garfinkle J, 2011, EUR J PAEDIATR NEURO, V15, P222, DOI 10.1016/j.ejpn.2010.11.002; Gesell A, 1940, 1 5 YEARS LIFE PRESC; Glass HC, 2012, PEDIATR NEUROL, V46, P111, DOI 10.1016/j.pediatrneurol.2011.11.006; Glass HC, 2009, CURR TREAT OPTION NE, V11, P405, DOI 10.1007/s11940-009-0045-1; Hellstrom-Westas L., 2008, ATLAS AMPLITUDE INTE, V2nd; Hellstrom-Westas L., 2006, NEOREVIEWS, DOI [DOI 10.1542/NEO.7-2-E76, 10.1542/neo.7-2-e76]; HELLSTROMWESTAS L, 1995, ARCH DIS CHILD-FETAL, V72, pF34, DOI 10.1136/fn.72.1.F34; Kidokoro H, 2010, NEUROPEDIATRICS, V41, DOI 10.1055/s-0030-1270479; Klebermass K, 2011, PEDIATR RES, V70, P102, DOI 10.1203/PDR.0b013e31821ba200; Malik Bushra Abdul, 2005, J Coll Physicians Surg Pak, V15, P786; Massaro AN, 2012, NEONATOLOGY, V102, P197, DOI 10.1159/000339570; Murray DM, 2008, ARCH DIS CHILD-FETAL, V93, pF187, DOI 10.1136/adc.2005.086314; Okumura A, 2009, BRAIN DEV-JPN, V31, P766, DOI 10.1016/j.braindev.2008.11.009; Osredkar D, 2005, PEDIATRICS, V115, P327, DOI 10.1542/peds.2004-0863; Pisani F, 2012, PEDIATR RES, V72, P186, DOI 10.1038/pr.2012.66; Pisani F, 2009, PEDIATRICS, V124, pE580, DOI 10.1542/peds.2008-2087; Shah DK, 2012, ARCH DIS CHILD-FETAL, V97, pF65, DOI 10.1136/adc.2009.169508; Shalak LF, 2003, PEDIATRICS, V111, P351, DOI 10.1542/peds.111.2.351; Shankaran S, 2011, PEDIATRICS, V128, pE112, DOI 10.1542/peds.2010-2036; Spitzmiller RE, 2007, J CHILD NEUROL, V22, P1069, DOI 10.1177/0883073807306258; Tekgul H, 2006, PEDIATRICS, V117, P1270, DOI 10.1542/peds.2005-1178; ter Horst H, 2004, PEDIATR RES, V55, P1026, DOI 10.1203/01.pdr.0000127019.52562.8c; ter Horst HJ, 2010, ACTA PAEDIATR, V99, P194, DOI 10.1111/j.1651-2227.2009.01567.x; Thoresen M, 2010, PEDIATRICS, V126, pE131, DOI 10.1542/peds.2009-2938; Toet MC, 1999, ARCH DIS CHILD-FETAL, V81, pF19, DOI 10.1136/fn.81.1.F19; Toet MC, 2006, PEDIATRICS, V117, P333, DOI 10.1542/peds.2005-0987; Udani V, 2008, INDIAN PEDIATR, V45, P739; van der Heide MJ, 2012, EARLY HUM DEV, V88, P33, DOI 10.1016/j.earlhumdev.2011.06.012; van Rooij LGM, 2005, ARCH DIS CHILD-FETAL, V90, P245, DOI 10.1136/adc.2004.064964; Vasiljevic B, 2012, VOJNOSANIT PREGL, V69, P492; Volpe J.J., 2008, NEUROLOGY NEWBORN; Zhang DD, 2011, PEDIATRICS, V127, pE1280, DOI 10.1542/peds.2010-2833	37	11	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78960	10.1371/journal.pone.0078960	http://dx.doi.org/10.1371/journal.pone.0078960			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236076	gold, Green Published, Green Submitted			2022-12-27	WOS:000327254700073
J	Xu, KF; Liu, XY; Yang, F; Cui, D; Shi, Y; Shen, C; Tang, W; Yang, T				Xu, Kuanfeng; Liu, Xiaoyun; Yang, Fan; Cui, Dai; Shi, Yun; Shen, Chong; Tang, Wei; Yang, Tao			PAI-1-675 4G/5G Polymorphism in Association with Diabetes and Diabetic Complications Susceptibility: a Meta-Analysis Study	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; ANGIOTENSIN-CONVERTING ENZYME; GENE POLYMORPHISMS; PROMOTER POLYMORPHISM; CARDIOVASCULAR RISK; INSULIN-RESISTANCE; METABOLIC SYNDROME; RETINOPATHY; GENOTYPE; DISEASE	A meta-analysis was performed to assess the association between the PAI-1 -675 4G/5G polymorphism and susceptibility to diabetes mellitus (DM), diabetic nephropathy (DN), diabetic retinopathy (DR) and diabetic coronary artery disease (CAD). A literature-based search was conducted to identify all relevant studies. The fixed or random effect pooled measure was calculated mainly at the allele level to determine heterogeneity bias among studies. Further stratified analyses and sensitivity analyses were also performed. Publication bias was examined by the modified Begg's and Egger's test. Twenty published articles with twenty-seven outcomes were included in the meta-analysis: 6 studies with a total of 1,333 cases and 3,011 controls were analyzed for the PAI-1 -675 4G/5G polymorphism with diabetes risk, 7 studies with 1,060 cases and 1,139 controls for DN risk, 10 studies with 1,327 cases and 1,557 controls for DR and 4 studies with 610 cases and 1,042 controls for diabetic CAD risk respectively. Using allelic comparison (4G vs. 5G), the PAI-1 -675 4G/5G polymorphism was observed to have no significant association with diabetes (REM OR 1.07, 95% CI 0.96, 1.20), DN (REM OR 1.10, 95% CI 0.98, 1.25), DR (REM OR 1.09, 95% CI 0.97, 1.22) or diabetic CAD risk (REM OR 1.07, 95% CI 0.81, 1.42), and similar results were obtained in the dominant, recessive and co-dominant models. Our meta-analyses suggest that the PAI-1 -675 4G/5G polymorphism might not be a risk factor for DM, DN, DR or diabetic CAD risk in the populations investigated. This conclusion warrants confirmation by further studies.	[Xu, Kuanfeng; Liu, Xiaoyun; Yang, Fan; Cui, Dai; Shi, Yun; Yang, Tao] Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China; [Shen, Chong] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Tang, Wei] Jiangyin Peoples Hosp, Dept Endocrinol, Wuxi, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Tang, W (corresponding author), Jiangyin Peoples Hosp, Dept Endocrinol, Wuxi, Jiangsu, Peoples R China.	drtangwei@aliyun.com; yangt@njmu.edu.cn	Cui, Dai/ABD-7918-2021	Cui, Dai/0000-0001-5534-9558	Natural Science Foundation of Jiangsu province [BK2012486]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Natural Science Foundation of Jiangsu province(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	The study was supported by grants from the Natural Science Foundation of Jiangsu province (number BK2012486). A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hamodi Z, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/234937; Brazionis L, 2008, ARTERIOSCL THROM VAS, V28, P786, DOI 10.1161/ATVBAHA.107.160168; Broch M, 1998, DIABETES CARE, V21, P463, DOI 10.2337/diacare.21.3.463a; De Cosmo S, 1999, DIABETES-METAB RES, V15, P247, DOI 10.1002/(SICI)1520-7560(199907/08)15:4<247::AID-DMRR41>3.0.CO;2-P; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; ERIKSSON P, 1995, P NATL ACAD SCI USA, V92, P1851, DOI 10.1073/pnas.92.6.1851; Ezzidi I, 2009, DIABETES METAB, V35, P214, DOI 10.1016/j.diabet.2008.12.002; Festa A, 2002, DIABETES, V51, P1131, DOI 10.2337/diabetes.51.4.1131; Festa A, 2006, CIRCULATION, V113, P1753, DOI 10.1161/CIRCULATIONAHA.106.616177; Globocnik-Petrovic M, 2003, OPHTHALMOLOGICA, V217, P219, DOI 10.1159/000068975; Gori AM, 2004, THROMB HAEMOSTASIS, V92, P54, DOI 10.1160/th03-08-0509; Ioannidis JPA, 2003, LANCET, V361, P567, DOI 10.1016/S0140-6736(03)12516-0; Kimura H, 1998, KIDNEY INT, V54, P1659, DOI 10.1046/j.1523-1755.1998.00139.x; Lassila M, 2007, DIABETOLOGIA, V50, P1315, DOI 10.1007/s00125-007-0652-x; Liu Shi-qun, 2004, Di Yi Jun Yi Da Xue Xue Bao, V24, P904; Lopes C, 2003, DIABETOLOGIA, V46, P1284, DOI 10.1007/s00125-003-1170-0; MANSFIELD MW, 1995, THROMB HAEMOSTASIS, V74, P842; Martin RJL, 2007, DIABETIC MED, V24, P259, DOI 10.1111/j.1464-5491.2007.02087.x; Meigs JB, 2006, OBESITY, V14, P753, DOI 10.1038/oby.2006.85; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Munafo MR, 2004, TRENDS GENET, V20, P439, DOI 10.1016/j.tig.2004.06.014; Murata M, 2004, DIABETIC MED, V21, P837, DOI 10.1111/j.1464-5491.2004.01252.x; Nagi DK, 1997, DIABETES CARE, V20, P1304, DOI 10.2337/diacare.20.8.1304; Naran NH, 2008, ATHEROSCLEROSIS, V196, P155, DOI 10.1016/j.atherosclerosis.2007.03.024; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Patsopoulos NA, 2008, INT J EPIDEMIOL, V37, P1148, DOI 10.1093/ije/dyn065; Petrovic D, 2003, CARDIOLOGY, V100, P157, DOI 10.1159/000073935; Prasad P, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-52; Saely CH, 2008, CLIN CHIM ACTA, V396, P18, DOI 10.1016/j.cca.2008.06.015; Santos KG, 2003, DIABETES RES CLIN PR, V61, P133, DOI 10.1016/S0168-8227(03)00112-8; Seo JY, 2009, AM J NEPHROL, V30, P481, DOI 10.1159/000242477; Steinberger J, 2003, CIRCULATION, V107, P1448, DOI 10.1161/01.CIR.0000060923.07573.F2; Tarnow L, 2000, NEPHROL DIAL TRANSPL, V15, P625, DOI 10.1093/ndt/15.5.625; VASSALLI JD, 1991, J CLIN INVEST, V88, P1067, DOI 10.1172/JCI115405; Wiklund PG, 2005, STROKE, V36, P1661, DOI 10.1161/01.STR.0000174485.10277.24; Wong TYH, 2000, KIDNEY INT, V57, P632; Zietz B, 2004, ENDOCR RES, V30, P443, DOI 10.1081/ERC-200035728	37	19	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79150	10.1371/journal.pone.0079150	http://dx.doi.org/10.1371/journal.pone.0079150			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223897	Green Published, gold, Green Submitted			2022-12-27	WOS:000326597400047
J	Inoshita, H; Kim, BG; Yamashita, M; Choi, SH; Tomino, Y; Letterio, JJ; Emancipator, SN				Inoshita, Hiroyuki; Kim, Byung-Gyu; Yamashita, Michifumi; Choi, Sung Hee; Tomino, Yasuhiko; Letterio, John J.; Emancipator, Steven N.			Disruption of Smad4 Expression in T Cells Leads to IgA Nephropathy-Like Manifestations	PLOS ONE			English	Article							MURINE B-CELLS; TGF-BETA; IMMUNE-COMPLEXES; O-GLYCOSYLATION; KNOCKOUT MICE; RENAL-DISEASE; GLOMERULONEPHRITIS; COMPLEMENT; ACTIVATION; DIFFERENTIATION	The link between glomerular IgA nephropathy (IgAN) and T helper 2 (Th2) response has been implicated, however, the mechanisms are poorly defined because of the lack of an appropriate model. Here we report a novel murine model characterized by lineage-restricted deletion of the gene encoding MAD homologue 4 (Smad4) in T cells (Smad4(co/co;Lck-cre)). Loss of Smad4 expression in T cells results in overproduction of Th2 cytokines and high serum IgA levels. We found that Smad4(co/co;Lck-cre) mice exhibited massive glomerular IgA deposition, increased albumin creatinine ratio, aberrant glycosylated IgA, IgA complexed with IgG1 and IgG2a, and polymeric IgA, all known features of IgAN in humans. Furthermore, we examined the beta 1, 4-galactosyltransferases (beta 4GalT) enzyme which is involved in the synthesis of glycosylated murine IgA, and we found reduced beta 4GalT2 and beta 4GalT4 mRNA levels in B cells. These findings indicate that Smad4(co/co;Lck-cre) mice could be a useful model for studying the mechanisms between IgAN and Th2 response, and further, disruption of Smad4-dependent signaling in T cells may play an important role in the pathogenesis of human IgAN and contributing to a Th2 T cell phenotype.	[Inoshita, Hiroyuki; Yamashita, Michifumi; Emancipator, Steven N.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Kim, Byung-Gyu; Choi, Sung Hee; Letterio, John J.] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Inoshita, Hiroyuki; Tomino, Yasuhiko] Juntendo Univ, Fac Med, Dept Internal Med, Div Nephrol,Bunkyo Ku, Tokyo, Japan; [Emancipator, Steven N.] Louis Stokes Dept Vet Affairs, Med Ctr, Pathol & Lab Med Serv, Cleveland, OH USA; Univ Hosp Cleveland, Case Med Ctr, Dept Pathol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Juntendo University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; University Hospitals of Cleveland	Inoshita, H (corresponding author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.	inoshitahiroyuki@gmail.com	YAMASHITA, Michifumi/AFT-3479-2022	Kim, Byung-Gyu/0000-0002-8921-5061; Yamashita, Michifumi/0000-0001-6221-8900	Department of Veteran Affairs [BLRD-5I01 BX000376-04]	Department of Veteran Affairs(US Department of Veterans Affairs)	This research was supported by a Merit grant from the Department of Veteran Affairs (BLRD-5I01 BX000376-04). Dr. Letterio is endowed as the Jane and Lee Seidman Chair in Pediatric Cancer Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano M, 1997, EMBO J, V16, P1850, DOI 10.1093/emboj/16.8.1850; Barratt J, 2007, SEMIN IMMUNOPATHOL, V29, P427, DOI 10.1007/s00281-007-0089-9; Chintalacharuvu SR, 2008, CLIN EXP IMMUNOL, V153, P456, DOI 10.1111/j.1365-2249.2008.03703.x; Chintalacharuvu SR, 1997, J IMMUNOL, V159, P2327; Chintalacharuvu SR, 2000, CYTOKINE, V12, P1182, DOI 10.1006/cyto.2000.0699; Chintalacharuvu SR, 2001, CLIN EXP IMMUNOL, V126, P326, DOI 10.1046/j.1365-2249.2001.01678.x; Couser WG, 1999, LANCET, V353, P1509, DOI 10.1016/S0140-6736(98)06195-9; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; EMANCIPATOR SN, 1990, KIDNEY INT, V38, P1216, DOI 10.1038/ki.1990.337; EMANCIPATOR SN, 1987, LAB INVEST, V57, P269; Emancipator SN, 2007, HEPTINSTALLS PATHOLO; FRIEDBERG M, 1978, LANCET, V1, P498; Gharavi AG, 2011, NAT GENET, V43, P321, DOI 10.1038/ng.787; Gorelik L, 2002, NAT REV IMMUNOL, V2, P46, DOI 10.1038/nri704; Hennet T, 2002, CELL MOL LIFE SCI, V59, P1081, DOI 10.1007/s00018-002-8489-4; Hiki Y, 2001, KIDNEY INT, V59, P1077, DOI 10.1046/j.1523-1755.2001.00591.x; HOGG R J, 1982, Kidney International, V22, P643; HUBERT D, 1984, PRESSE MED, V13, P1083; Johnson RJ, 2003, AM J KIDNEY DIS, V42, P575, DOI 10.1016/S0272-6386(03)00801-1; Kim BG, 2006, NATURE, V441, P1015, DOI 10.1038/nature04846; Kotani N, 2001, BIOCHEM J, V357, P827, DOI 10.1042/0264-6021:3570827; Kusaba G, 2012, MED MOL MORPHOL, V45, P29, DOI 10.1007/s00795-011-0538-3; LAI KN, 1994, CLIN EXP IMMUNOL, V96, P116; LEE HS, 1989, KIDNEY INT, V35, P880, DOI 10.1038/ki.1989.68; LEE SMK, 1982, HUM PATHOL, V13, P314, DOI 10.1016/S0046-8177(82)80221-9; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Mantel PY, 2007, PLOS BIOL, V5, P2847, DOI 10.1371/journal.pbio.0050329; NAKAZAWA K, 1988, J BIOCHEM-TOKYO, V104, P165, DOI 10.1093/oxfordjournals.jbchem.a122434; Nishie T, 2007, AM J PATHOL, V170, P447, DOI 10.2353/ajpath.2007.060559; Nolting J, 2009, J EXP MED, V206, P2131, DOI 10.1084/jem.20090639; Roos A, 2006, J AM SOC NEPHROL, V17, P1724, DOI 10.1681/ASN.2005090923; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; SCIVITTARO V, 1994, CLIN NEPHROL, V42, P1; Sharmin S, 2004, J NEPHROL, V17, P504; Suzuki H, 2007, KIDNEY INT, V72, P319, DOI 10.1038/sj.ki.5002300; Suzuki Y, 2008, SEMIN NEPHROL, V28, P66, DOI 10.1016/j.semnephrol.2007.10.008; VANES LA, 1988, AM J KIDNEY DIS, V12, P397, DOI 10.1016/S0272-6386(88)80033-7; Wang J, 2004, J CLIN INVEST, V113, P826, DOI 10.1172/JCI200420096; Yamada K, 2010, NEPHROL DIAL TRANSPL, V25, P3890, DOI 10.1093/ndt/gfq325; Yang X, 2002, GENESIS, V32, P80, DOI 10.1002/gene.10029; YOSHIKAWA N, 1990, CLIN NEPHROL, V33, P160; YOSHIMURA M, 1987, AM J KIDNEY DIS, V9, P404, DOI 10.1016/S0272-6386(87)80143-9; ZHANG W, 1994, IMMUNOLOGY, V81, P137; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2003, IMMUNITY, V19, P739, DOI 10.1016/S1074-7613(03)00292-9	45	8	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78736	10.1371/journal.pone.0078736	http://dx.doi.org/10.1371/journal.pone.0078736			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223846	Green Published, gold, Green Submitted			2022-12-27	WOS:000326503400086
J	Taina, M; Vanninen, R; Hedman, M; Jakala, P; Karkkainen, S; Tapiola, T; Sipola, P				Taina, Mikko; Vanninen, Ritva; Hedman, Marja; Jakala, Pekka; Karkkainen, Satu; Tapiola, Tero; Sipola, Petri			Left Atrial Appendage Volume Increased in More Than Half of Patients with Cryptogenic Stroke	PLOS ONE			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; ISCHEMIC-STROKE; CARDIAC CT; FIBRILLATION; RISK; ECHOCARDIOGRAPHY; MORPHOLOGY; TELEMETRY; FORMS	Background: Ischemic strokes without a well-defined etiology are labeled as cryptogenic, and account for 30-40% of strokes in stroke registries. The left atrial appendage (LAA) is the most typical origin for intracardiac thrombus formation when associated with atrial fibrillation. Here, we examined whether increased LAA volume detected with cardiac computed tomography (cCT) constitutes a risk factor in cryptogenic stroke patients. Methods: This study included 82 stroke/TIA patients (57 males; mean age, 58 years) with a diagnosis of cryptogenic stroke after extensive radiological and cardiological investigations. Cases were classified using the TOAST criteria modified by European Association of Echocardiography recommendations for defining cardiac sources of embolism. Forty age- and gender-matched control subjects without cardiovascular diseases were selected for pair-wise comparisons (21 males; mean age, 54 years). LAA volume adjusted for body surface area was measured three dimensionally by tracing the LAA borders on electrocardiogram-gated CT slices. Results: In control subjects, mean LAA volume was 3.4 +/- 1.1 mL/m(2). Mean+2SD, which was considered the upper limit for normal LAA volume was 5.6 mL/m(2). In paired Student t-test between the patient group and matched controls, LAA volume was 67% larger in cryptogenic stroke/TIA patients (5.7 +/- 2.0 mL/m(2) vs. 3.4 +/- 1.1 mL/m(2); P<0.001). Forty-five (55%) patients with cryptogenic stroke/TIA had enlarged LAA. Conclusion: LAA is significantly enlarged in more than half of patients with cryptogenic stroke/TIA. LAA thrombosis may contribute to the pathogenesis of stroke in patients considered to have cryptogenic stroke after conventional evaluation.	[Taina, Mikko; Vanninen, Ritva; Hedman, Marja; Sipola, Petri] Kuopio Univ Hosp, Dept Clin Radiol, SF-70210 Kuopio, Finland; [Taina, Mikko; Vanninen, Ritva; Sipola, Petri] Univ Eastern Finland, Radiol Unit, Inst Clin Med, Kuopio, Finland; [Hedman, Marja; Karkkainen, Satu] Kuopio Univ Hosp, Ctr Heart, SF-70210 Kuopio, Finland; [Jakala, Pekka] Kuopio Univ Hosp, NeuroCtr, SF-70210 Kuopio, Finland; [Jakala, Pekka] Univ Eastern Finland, Neurol Unit, Inst Clin Med, Kuopio, Finland; [Tapiola, Tero] North Kymi Hosp, Dept Neurol, Kouvola, Finland	Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland	Taina, M (corresponding author), Kuopio Univ Hosp, Dept Clin Radiol, SF-70210 Kuopio, Finland.	Mikko.Taina@kuh.fi			Kuopio University Hospital [5063519]	Kuopio University Hospital	This study was supported by the Kuopio University Hospital (grant number 5063519). Kuopio University Hospital web site: www.kuh.fi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Amarenco P, 2009, CEREBROVASC DIS, V27, P97, DOI 10.1159/000200446; Anselmino M, 2011, J CARDIOVASC ELECTR, V22, P1, DOI 10.1111/j.1540-8167.2010.01853.x; Bang OY, 2003, ANN NEUROL, V54, P227, DOI 10.1002/ana.10644; Beinart R, 2011, J CARDIOVASC ELECTR, V22, P10, DOI 10.1111/j.1540-8167.2010.01854.x; Blackshear JL, 1996, ANN THORAC SURG, V61, P755, DOI 10.1016/0003-4975(95)00887-X; BONITA R, 1992, LANCET, V339, P342, DOI 10.1016/0140-6736(92)91658-U; Bouzas-Mosquera A, 2011, CAN MED ASSOC J, V183, pE657, DOI 10.1503/cmaj.091688; BURRELL LD, 2013, AM J CARDIOL; Christiaens L, 2010, INT J CARDIOL, V140, P189, DOI 10.1016/j.ijcard.2008.11.055; Di Biase L, 2012, J AM COLL CARDIOL, V60, P531, DOI 10.1016/j.jacc.2012.04.032; Di Tullio MR, 1999, STROKE, V30, P2019, DOI 10.1161/01.STR.30.10.2019; Dion F, 2010, J INTERV CARD ELECTR, V28, P101, DOI 10.1007/s10840-010-9485-5; DOLHABERRIAGUE L, 1989, STROKE, V20, P1648, DOI 10.1161/01.STR.20.12.1648; ERNST G, 1995, ANAT REC, V242, P553, DOI 10.1002/ar.1092420411; Etgen T, 2013, STROKE, V44, P2007, DOI 10.1161/STROKEAHA.113.001340; Ferro JM, 2003, LANCET NEUROL, V2, P177, DOI 10.1016/S1474-4422(03)00324-7; Flint AC, 2012, STROKE, V43, P2788, DOI 10.1161/STROKEAHA.112.665844; Gladstone DJ, 2008, STROKE, V39, pE78, DOI 10.1161/STROKEAHA.107.513002; GRAHAM TP, 1973, CIRCULATION, V47, P144, DOI 10.1161/01.CIR.47.1.144; Healey JS, 2012, NEW ENGL J MED, V366, P120, DOI 10.1056/NEJMoa1105575; Heist EK, 2006, HEART RHYTHM, V3, P1313, DOI 10.1016/j.hrthm.2006.07.022; Hur J, 2009, RADIOLOGY, V251, P683, DOI 10.1148/radiol.2513090794; Jickling GC, 2012, STROKE, V43, P2036, DOI 10.1161/STROKEAHA.111.648725; Knebel F, 2009, CARDIOVASC ULTRASOUN, V7, DOI 10.1186/1476-7120-7-15; Lacomis JM, 2007, EUROPACE, V9, P1134, DOI 10.1093/europace/eum227; Leschka S, 2006, EUR RADIOL, V16, P1964, DOI 10.1007/s00330-006-0262-x; MANINA G, 2012, INTERN EMERG MED; Miller DJ, 2013, J NEUROL SCI, V324, P57, DOI 10.1016/j.jns.2012.10.001; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098, DOI 10.1056/nejm198710223171717; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Nakajima H, 2010, AM J CARDIOL, V106, P885, DOI 10.1016/j.amjcard.2010.05.014; Nedios S, 2011, J INTERV CARD ELECTR, V32, P87, DOI 10.1007/s10840-011-9591-z; Okuyama H, 2006, CIRC J, V70, P971, DOI 10.1253/circj.70.971; Pan NH, 2009, J CARDIOVASC ELECTR, V20, P153, DOI 10.1111/j.1540-8167.2008.01290.x; Pepi M, 2010, EUR J ECHOCARDIOGR, V11, P461, DOI 10.1093/ejechocard/jeq045; Rizos T, 2012, STROKE, V43, P2689, DOI 10.1161/STROKEAHA.112.654954; Sipola P, 2013, CEREBROVASC DIS, V35, P521, DOI 10.1159/000350734; Tayal AH, 2008, NEUROLOGY, V71, P1696, DOI 10.1212/01.wnl.0000325059.86313.31; Walker DT, 2012, J INTERV CARD ELECTR, V34, P173, DOI 10.1007/s10840-011-9638-1; Whisenant BK, 2013, J AM COLL CARDIOL, V61, pE279, DOI 10.1016/S0735-1097(13)60279-X; Wolber Thomas, 2007, J Stroke Cerebrovasc Dis, V16, P1, DOI 10.1016/j.jstrokecerebrovasdis.2006.07.002; Yip PK, 1997, STROKE, V28, P2507, DOI 10.1161/01.STR.28.12.2507	43	26	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79519	10.1371/journal.pone.0079519	http://dx.doi.org/10.1371/journal.pone.0079519			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223960	gold, Green Published, Green Submitted			2022-12-27	WOS:000326503400121
J	Dvorak, J; Mancikova, V; Pizl, V; Elhottova, D; Silerova, M; Roubalova, R; Skanta, F; Prochazkova, P; Bilej, M				Dvorak, Jiri; Mancikova, Veronika; Pizl, Vaclav; Elhottova, Dana; Silerova, Marcela; Roubalova, Radka; Skanta, Frantisek; Prochazkova, Petra; Bilej, Martin			Microbial Environment Affects Innate Immunity in Two Closely Related Earthworm Species Eisenia andrei and Eisenia fetida	PLOS ONE			English	Article							CELOMIC FLUID; TRANSPLANTATION IMMUNITY; LUMBRICUS-TERRESTRIS; PROTEIN; IDENTIFICATION; LYSOZYME; DNA; CLONING; RECOGNITION; EXPRESSION	Survival of earthworms in the environment depends on their ability to recognize and eliminate potential pathogens. This work is aimed to compare the innate defense mechanisms of two closely related earthworm species, Eisenia andrei and Eisenia fetida, that inhabit substantially different ecological niches. While E. andrei lives in a compost and manure, E. fetida can be found in the litter layer in forests. Therefore, the influence of environment-specific microbiota on the immune response of both species was followed. Firstly, a reliable method to discern between E. andrei and E. fetida based on species-specific primers for cytochrome c oxidase I (COI) and stringent PCR conditions was developed. Secondly, to analyze the immunological profile in both earthworm species, the activity and expression of lysozyme, pattern recognition protein CCF, and antimicrobial proteins with hemolytic function, fetidin and lysenins, have been assessed. Whereas, CCF and lysozyme showed only slight differences in the expression and activity, fetidin/lysenins expression as well as the hemolytic activity was considerably higher in E. andrei as compared to E. fetida. The expression of fetidin/lysenins in E. fetida was not affected upon the challenge with compost microbiota, suggesting more substantial changes in the regulation of the gene expression. Genomic DNA analyses revealed significantly higher level of fetidin/lysenins (determined using universal primer pairs) in E. andrei compared to E. fetida. It can be hypothesized that E. andrei colonizing compost as a new habitat acquired an evolutionary selection advantage resulting in a higher expression of antimicrobial proteins.	[Dvorak, Jiri; Mancikova, Veronika; Silerova, Marcela; Roubalova, Radka; Skanta, Frantisek; Prochazkova, Petra; Bilej, Martin] Acad Sci Czech Republ, Inst Microbiol, Lab Cellular & Mol Immunol, VVI, Prague, Czech Republic; [Pizl, Vaclav; Elhottova, Dana] Acad Sci Czech Republ, Inst Soil Biol, Ctr Biol, Dept Soil Zool & Soil Microstruct,VVI, CR-37005 Ceske Budejovice, Czech Republic	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Bilej, M (corresponding author), Acad Sci Czech Republ, Inst Microbiol, Lab Cellular & Mol Immunol, VVI, Prague, Czech Republic.	mbilej@biomed.cas.cz	Roubalová, Radka/H-2501-2014; Dvořák, Jiří/I-1145-2014; Bilej, Martin/I-4564-2014; Prochazkova, Petra/H-2529-2014; Pizl, Vaclav/B-2636-2009; Škanta, František/H-7931-2014; Elhottová, Dana/G-1168-2014	Roubalová, Radka/0000-0002-9298-4734; Dvořák, Jiří/0000-0002-3714-7781; Pizl, Vaclav/0000-0003-2216-3137	Ministry of Education, Youth and Sports [CZ.1.07/2.3.00/20.0055, CZ.1.07/2.3.00/30.0003]; Institutional Research Concepts [RVO 61388971, RVO 60077344]	Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); Institutional Research Concepts	This research was supported by the Ministry of Education, Youth and Sports (CZ.1.07/2.3.00/20.0055 for PP and CZ.1.07/2.3.00/30.0003 for RR), and the Institutional Research Concepts RVO 61388971 and RVO 60077344. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 1963, B BIOL FR BELG, V97, P1; BAILEY S, 1971, IMMUNOLOGY, V21, P81; Beschin A, 1998, J BIOL CHEM, V273, P24948, DOI 10.1074/jbc.273.38.24948; Beschin A, 2001, CELL MOL LIFE SCI, V58, P801, DOI 10.1007/PL00000901; BILEJ M, 1995, IMMUNOL LETT, V45, P123, DOI 10.1016/0165-2478(94)00248-P; Bouche MB, 1972, I N R A PUBL ANN ZOO, V72; BRUCE KD, 1992, APPL ENVIRON MICROB, V58, P3413, DOI 10.1128/AEM.58.10.3413-3416.1992; Chun J, 2007, INT J SYST EVOL MICR, V57, P2259, DOI 10.1099/ijs.0.64915-0; COOPER EL, 1968, TRANSPLANTATION, V6, P322, DOI 10.1097/00007890-196805000-00002; COTUK A, 1984, COMP BIOCHEM PHYS A, V78, P469, DOI 10.1016/0300-9629(84)90580-2; Dominguez J, 2005, PEDOBIOLOGIA, V49; DUPASQUI.L, 1968, CR ACAD SCI D NAT, V266, P538; Gregory TR, 2002, CAN J ZOOL, V80, P1485, DOI 10.1139/Z02-145; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Jolles P, 1996, EXS, V75, P3; Joskova R, 2009, DEV COMP IMMUNOL, V33, P932, DOI 10.1016/j.dci.2009.03.002; Kauschke E, 1997, COMP BIOCHEM PHYS B, V116, P235, DOI 10.1016/S0305-0491(96)00248-9; Kohlerova P, 2004, DEV COMP IMMUNOL, V28, P701, DOI 10.1016/j.dci.2004.01.001; Kyselkova M, 2012, MICROBES ENVIRON, V27, P413, DOI 10.1264/jsme2.ME12028; Lassegues M, 1997, EUR J BIOCHEM, V246, P756, DOI 10.1111/j.1432-1033.1997.00756.x; LAVELLE P, 1988, BIOL FERT SOILS, V6, P237, DOI 10.1007/BF00260820; LIE O, 1986, ACTA VET SCAND, V27, P23; Milochau A, 1997, BBA-PROTEIN STRUCT M, V1337, P123, DOI 10.1016/S0167-4838(96)00160-4; MURRAY V, 1989, NUCLEIC ACIDS RES, V17, P8889, DOI 10.1093/nar/17.21.8889; Perez-Losada M, 2005, PEDOBIOLOGIA, V49, P317, DOI 10.1016/j.pedobi.2005.02.004; Pil V, 2002, SBORNIK PRIRODOVED S, V9, P1; Prochazkova P, 2006, DEV COMP IMMUNOL, V30, P381, DOI 10.1016/j.dci.2005.06.014; Prochazkova P, 2013, J INVERTEBR PATHOL, V114, P217, DOI 10.1016/j.jip.2013.08.003; ROCH P, 1991, DEV COMP IMMUNOL, V15, P27, DOI 10.1016/0145-305X(91)90044-Y; ROCH P, 1981, COMP BIOCHEM PHYS B, V69, P829, DOI 10.1016/0305-0491(81)90390-4; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sekizawa Y, 1997, GENE, V191, P97, DOI 10.1016/S0378-1119(97)00047-4; Silerova M, 2006, DEV COMP IMMUNOL, V30, P765, DOI 10.1016/j.dci.2005.11.002; Valembois P., 1986, P74; Vitturi R, 2000, HEREDITY, V85, P203, DOI 10.1046/j.1365-2540.2000.00709.x	35	18	18	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79257	10.1371/journal.pone.0079257	http://dx.doi.org/10.1371/journal.pone.0079257			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223917	Green Published, Green Submitted, gold			2022-12-27	WOS:000326499300071
J	Lallemand, M; Login, FH; Guschinskaya, N; Pineau, C; Effantin, G; Robert, X; Shevchik, VE				Lallemand, Mathilde; Login, Frederic H.; Guschinskaya, Natalia; Pineau, Camille; Effantin, Geraldine; Robert, Xavier; Shevchik, Vladimir E.			Dynamic Interplay between the Periplasmic and Transmembrane Domains of GspL and GspM in the Type II Secretion System	PLOS ONE			English	Article							VIBRIO-CHOLERAE; PSEUDOMONAS-AERUGINOSA; ERWINIA-CHRYSANTHEMI; MEMBRANE-PROTEIN; MULTIPLE INTERACTIONS; SCANNING MUTAGENESIS; INTERACTION NETWORK; CYTOPLASMIC DOMAIN; CROSS-LINKING; COMPLEX	The type II secretion system (T2SS) is a multiprotein nanomachine that transports folded proteins across the outer membrane of gram-negative bacteria. The molecular mechanisms that govern the secretion process remain poorly understood. The inner membrane components GspC, GspL and GspM possess a single transmembrane segment (TMS) and a large periplasmic region and they are thought to form a platform of unknown function. Here, using two-hybrid and pull-down assays we performed a systematic mapping of the GspC/GspL/GspM interaction regions in the plant pathogen Dickeya dadantii. We found that the TMS of these components interact with each other, implying a complex interaction network within the inner membrane. We also showed that the periplasmic, ferredoxin-like, domains of GspL and GspM drive homo- and heterodimerizations of these proteins. Disulfide bonding analyses revealed that the respective domain interfaces include the equivalent secondary-structure elements, suggesting alternating interactions of the periplasmic domains, L/L and M/M versus L/M. Finally, we found that displacements of the periplasmic GspM domain mediate coordinated shifts or rotations of the cognate TMS. These data suggest a plausible mechanism for signal transmission between the periplasmic and the cytoplasmic portions of the T2SS machine.	[Login, Frederic H.; Guschinskaya, Natalia; Robert, Xavier; Shevchik, Vladimir E.] Univ Lyon 1, F-69365 Lyon, France; [Lallemand, Mathilde; Pineau, Camille; Shevchik, Vladimir E.] INSA Lyon, Villeurbanne, France; [Lallemand, Mathilde; Login, Frederic H.; Guschinskaya, Natalia; Pineau, Camille; Effantin, Geraldine; Shevchik, Vladimir E.] CNRS, UMR5240, Lyon, France; [Robert, Xavier] CNRS, Lab Biocrystallog & Struct Biol Therapeut Targets, UMR5086, Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National des Sciences Appliquees de Lyon - INSA Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Shevchik, VE (corresponding author), Univ Lyon 1, F-69365 Lyon, France.	vladimir.shevchik@insa-lyon.fr	ROBERT, Xavier/C-3879-2015	ROBERT, Xavier/0000-0002-6174-8595; Shevchik, Vladimir/0000-0002-8031-8638; Effantin, Geraldine/0000-0002-7296-0831	Centre National de la Recherche Scientifique; Agence Nationale de la Recherche [ANR-2010-BLANC-1531]; LyonBioPole	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); LyonBioPole	This work was supported by the Centre National de la Recherche Scientifique, by a grant from the Agence Nationale de la Recherche (ANR-2010-BLANC-1531) and a grant from LyonBioPole to V. E. S. C. P. was supported by the ANR-2010-BLANC-1531 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abendroth J, 2005, J MOL BIOL, V348, P845, DOI 10.1016/j.jmb.2005.02.061; Abendroth J, 2004, J MOL BIOL, V344, P619, DOI 10.1016/j.jmb.2004.09.062; Abendroth J, 2004, J MOL BIOL, V338, P585, DOI 10.1016/j.jmb.2004.01.064; Abendroth J, 2009, J STRUCT BIOL, V168, P313, DOI 10.1016/j.jsb.2009.07.022; Arts J, 2007, MICROBIOL-SGM, V153, P1582, DOI 10.1099/mic.0.2006/002840-0; Ayers M, 2009, J MOL BIOL, V394, P128, DOI 10.1016/j.jmb.2009.09.034; Bouley J, 2001, J MOL BIOL, V308, P205, DOI 10.1006/jmbi.2001.4594; Camberg JL, 2007, EMBO J, V26, P19, DOI 10.1038/sj.emboj.7601481; Chami M., 2005, J BIOL CHEM, V280, P2703; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; Cisneros DA, 2012, EMBO J, V31, P1041, DOI 10.1038/emboj.2011.454; DeLano WL, 2005, ABSTR PAP AM CHEM S, V230, pU1371; Douet V, 2004, RES MICROBIOL, V155, P71, DOI 10.1016/j.resmic.2003.10.001; Douzi B, 2011, J BIOL CHEM, V286, P40792, DOI 10.1074/jbc.M111.294843; Douzi B, 2009, J BIOL CHEM, V284, P34580, DOI 10.1074/jbc.M109.042366; Dunstan RA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003117; FALKE JJ, 1987, SCIENCE, V237, P1596, DOI 10.1126/science.2820061; Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Georgiadou M, 2012, MOL MICROBIOL, V84, P857, DOI 10.1111/j.1365-2958.2012.08062.x; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Gouet P, 2002, BIOINFORMATICS, V18, P767, DOI 10.1093/bioinformatics/18.5.767; Gray MD, 2011, MOL MICROBIOL, V79, P786, DOI 10.1111/j.1365-2958.2010.07487.x; Gu S, 2012, J BIOL CHEM, V287, P9072, DOI 10.1074/jbc.M111.300624; Gu S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002531; Johnson TL, 2007, J BACTERIOL, V189, P9082, DOI 10.1128/JB.01256-07; Karimova G, 2005, J BACTERIOL, V187, P2233, DOI 10.1128/JB.187.7.2233-2243.2005; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Karuppiah V, 2011, J BIOL CHEM, V286, P24434, DOI 10.1074/jbc.M111.243535; Korotkov KV, 2008, NAT STRUCT MOL BIOL, V15, P462, DOI 10.1038/nsmb.1426; Korotkov KV, 2006, J MOL BIOL, V363, P311, DOI 10.1016/j.jmb.2006.08.037; Korotkov KV, 2012, NAT REV MICROBIOL, V10, P336, DOI 10.1038/nrmicro2762; Korotkov KV, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002228; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lai WC, 2007, METHOD ENZYMOL, V423, P299, DOI 10.1016/S0076-6879(07)23013-7; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE GF, 1995, P NATL ACAD SCI USA, V92, P5416, DOI 10.1073/pnas.92.12.5416; Login FH, 2006, J BIOL CHEM, V281, P33152, DOI 10.1074/jbc.M606245200; Login FH, 2010, MOL MICROBIOL, V76, P944, DOI 10.1111/j.1365-2958.2010.07149.x; Michel G, 1998, MICROBIOL-SGM, V144, P3379, DOI 10.1099/00221287-144-12-3379; Miller JH., 1972, EXPT MOL GENETICS; Possot OM, 2000, J BACTERIOL, V182, P2142, DOI 10.1128/JB.182.8.2142-2152.2000; Py B, 1999, J MOL BIOL, V289, P659, DOI 10.1006/jmbi.1999.2803; Py B, 2001, EMBO REP, V2, P244, DOI 10.1093/embo-reports/kve042; Reichow SL, 2011, CHANNELS, V5, P215, DOI 10.4161/chan.5.3.15268; Reichow SL, 2010, NAT STRUCT MOL BIOL, V17, P1226, DOI 10.1038/nsmb.1910; Robert V, 2002, J BACTERIOL, V184, P1779, DOI 10.1128/JB.184.6.1779-1782.2002; Sal-Man N, 2007, J BIOL CHEM, V282, P19753, DOI 10.1074/jbc.M610368200; Sampaleanu LM, 2009, J MOL BIOL, V394, P143, DOI 10.1016/j.jmb.2009.09.037; Sandkvist M, 1999, J BACTERIOL, V181, P3129, DOI 10.1128/JB.181.10.3129-3135.1999; Sandkvist M, 2000, J BACTERIOL, V182, P742, DOI 10.1128/JB.182.3.742-748.2000; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Seeger MA, 2008, NAT STRUCT MOL BIOL, V15, P199, DOI 10.1038/nsmb.1379; Shevchik VE, 1998, MICROBIOL-UK, V144, P3219, DOI 10.1099/00221287-144-11-3219; Shevchik VE, 1997, EMBO J, V16, P3007, DOI 10.1093/emboj/16.11.3007; Tammam S, 2011, MOL MICROBIOL, V82, P1496, DOI 10.1111/j.1365-2958.2011.07903.x; Tammam S, 2013, J BACTERIOL, V195, P2126, DOI 10.1128/JB.00032-13; Tosi T, 2011, MOL MICROBIOL, V82, P1422, DOI 10.1111/j.1365-2958.2011.07896.x; Tsai RT, 2002, BIOCHEM J, V367, P865, DOI 10.1042/BJ20020909; Wang XH, 2012, J BIOL CHEM, V287, P19082, DOI 10.1074/jbc.M112.346338; Zhang XYZ, 2011, J BIOL CHEM, V286, P11756, DOI 10.1074/jbc.M110.192773	62	22	23	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79562	10.1371/journal.pone.0079562	http://dx.doi.org/10.1371/journal.pone.0079562			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223969	Green Published, gold, Green Submitted			2022-12-27	WOS:000326499300089
J	Borgella, S; Fievet, N; Huynh, BT; Ibitokou, S; Hounguevou, G; Affedjou, J; Sagbo, JC; Houngbegnon, P; Guezo-Mevo, B; Massougbodji, A; Luty, AJF; Cot, M; Deloron, P				Borgella, Sophie; Fievet, Nadine; Bich-Tram Huynh; Ibitokou, Samad; Hounguevou, Gbetognon; Affedjou, Jacqueline; Sagbo, Jean-Claude; Houngbegnon, Parfait; Guezo-Mevo, Blaise; Massougbodji, Achille; Luty, Adrian J. F.; Cot, Michel; Deloron, Philippe			Impact of Pregnancy-Associated Malaria on Infant Malaria Infection in Southern Benin	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; BIRTH-WEIGHT; PLACENTAL INFECTION; WOMEN; INFLAMMATION; RESPONSES; EXPOSURE; RISK	Background: Infants of mothers with placental Plasmodium falciparum infections at delivery are themselves more susceptible to malaria attacks or to infection in early life. Methodology/Principal Findings: To assess the impact of either the timing or the number of pregnancy-associated malaria (PAM) infections on the incidence of parasitemia or malaria attacks in infancy, we followed 218 mothers through pregnancy (monthly visits) up to delivery and their infants from birth to 12 months of age (fortnightly visits), collecting detailed clinical and parasitological data. After adjustment on location, mother's age, birth season, bed net use, and placental malaria, infants born to a mother with PAM during the third trimester of pregnancy had a significantly increased risk of infection (OR [95% CI]: 4.2 [1.6; 10.5], p = 0.003) or of malaria attack (4.6 [1.7; 12.5], p = 0.003). PAM during the first and second trimesters had no such impact. Similarly significant results were found for the effect of the overall number of PAM episodes on the time to first parasitemia and first malaria attack (HR [95% CI]: 2.95 [1.58; 5.50], p = 0.001 and 3.19 [1.59; 6.38], p = 0.001) respectively. Conclusions/Significance: This study highlights the importance of protecting newborns by preventing repeated episodes of PAM in their mothers.	[Borgella, Sophie; Fievet, Nadine] Univ Abomey Calavi, Fac Sci Sante, Ctr Etud & Rech Paludisme Associe Grossesse & Enf, Cotonou, Benin; [Borgella, Sophie; Fievet, Nadine; Bich-Tram Huynh; Luty, Adrian J. F.; Cot, Michel; Deloron, Philippe] Inst Rech Dev, UMR 216, Paris, France; [Borgella, Sophie; Fievet, Nadine; Bich-Tram Huynh; Ibitokou, Samad; Hounguevou, Gbetognon; Affedjou, Jacqueline; Sagbo, Jean-Claude; Houngbegnon, Parfait; Guezo-Mevo, Blaise; Massougbodji, Achille; Luty, Adrian J. F.; Cot, Michel; Deloron, Philippe] Univ Paris 05, Fac Pharm, Sorbonne Paris Cite, PRES, Paris, France	University of Abomey Calavi; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Fievet, N (corresponding author), Univ Abomey Calavi, Fac Sci Sante, Ctr Etud & Rech Paludisme Associe Grossesse & Enf, Cotonou, Benin.	fievet@ird.fr	Deloron, Philippe/G-6305-2010; Luty, Adrian/CAH-2547-2022; Cot, Michel/E-7633-2011	Deloron, Philippe/0000-0003-4705-2484; Cot, Michel/0000-0003-3014-4294; Luty, Adrian John Frederick/0000-0001-8830-3425; Huynh, Bich-Tram/0000-0001-6340-9557; Fievet, Nadine/0000-0003-2272-9794	European 7th Framework Programme [200889]	European 7th Framework Programme(European Commission)	This paper describes work undertaken in the context of the STOPPAM project, 'Strategies To Prevent Pregnancy Associated Malaria'. STOPPAM is a Small & Medium Scale Collaborative Project supported by the European 7th Framework Programme, contract number: 200889. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, STRATEGIC FRAMEWORK; Baiz N, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-87; Bardaji A, 2011, J INFECT DIS, V203, P691, DOI 10.1093/infdis/jiq049; Huynh BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035342; Huynh BT, 2011, AM J TROP MED HYG, V85, P214, DOI 10.4269/ajtmh.2011.11-0103; Huynh BT, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-72; Boeuf P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003153; Cottrell G, 2005, AM J TROP MED HYG, V73, P1112, DOI 10.4269/ajtmh.2005.73.1112; Cottrell G, 2009, REV EPIDEMIOL SANTE, V57, P361, DOI 10.1016/j.respe.2009.04.011; Cottrell G, 2007, AM J TROP MED HYG, V76, P849, DOI 10.4269/ajtmh.2007.76.849; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Dent A, 2006, J IMMUNOL, V177, P7139, DOI 10.4049/jimmunol.177.10.7139; Diouf I, 2007, J REPROD IMMUNOL, V74, P152, DOI 10.1016/j.jri.2006.10.001; Djenontin A, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-83; Doritchamou J, 2012, J INFECT DIS, V206, P1911, DOI 10.1093/infdis/jis629; Faris PD, 2002, J CLIN EPIDEMIOL, V55, P184, DOI 10.1016/S0895-4356(01)00433-4; Fievet N, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-251; Gbedande K, 2013, INFECT IMMUN, V81, P2686, DOI 10.1128/IAI.00237-13; Guyatt HL, 2004, CLIN MICROBIOL REV, V17, P760, DOI 10.1128/CMR.17.4.760-769.2004; Hviid L, 2011, EXPERT REV VACCINES, V10, P1405, DOI [10.1586/ERV.11.113, 10.1586/erv.11.113]; Jusko TA, 2012, ENVIRON HEALTH PERSP, V120, P595, DOI 10.1289/ehp.1104229; Le Port A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027516; Le Port A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000342; LeHesran JY, 1997, AM J EPIDEMIOL, V146, P826, DOI 10.1093/oxfordjournals.aje.a009200; Malhotra I, 2005, INFECT IMMUN, V73, P3462, DOI 10.1128/IAI.73.6.3462-3470.2005; Malhotra I, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000116; Mens PF, 2010, EUR J OBSTET GYN R B, V152, P126, DOI 10.1016/j.ejogrb.2010.05.013; Moore SE, 2005, NESTLE NUTR WORKS SE, V55, P153; Moore SE, 1999, INT J EPIDEMIOL, V28, P1088, DOI 10.1093/ije/28.6.1088; Muehlenbachs A, 2006, PLOS MED, V3, P2124, DOI 10.1371/journal.pmed.0030446; Mutabingwa TK, 2005, PLOS MED, V2, P1260, DOI 10.1371/journal.pmed.0020407; Rijken MJ, 2011, BJOG-INT J OBSTET GY, V118, P671, DOI 10.1111/j.1471-0528.2010.02880.x; Salomon LJ, 2010, ULTRASOUND OBST GYN, V35, P385, DOI 10.1002/uog.7623; Schonland SO, 2003, BLOOD, V102, P1428, DOI 10.1182/blood-2002-11-3591; Schwarz NG, 2008, CLIN INFECT DIS, V47, P1017, DOI 10.1086/591968; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; Suguitan AL, 2003, J INFECT DIS, V188, P1074, DOI 10.1086/378500; Umbers AJ, 2011, TRENDS PARASITOL, V27, P168, DOI 10.1016/j.pt.2011.01.007; Umbers AJ, 2011, J INFECT DIS, V203, P561, DOI 10.1093/infdis/jiq080; van den Biggelaar AHJ, 2010, CLIN EXP IMMUNOL, V160, P42, DOI 10.1111/j.1365-2249.2010.04137.x; World Health Organization, 2011, IR DEF AN ASS PREV C	41	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80624	10.1371/journal.pone.0080624	http://dx.doi.org/10.1371/journal.pone.0080624			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236190	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700193
J	Chen, J; Wei, DY; Zhao, YR; Liu, XY; Zhang, J				Chen, Jie; Wei, Deying; Zhao, Yueran; Liu, Xiaoyan; Zhang, Jie			Overexpression of EFEMP1 Correlates with Tumor Progression and Poor Prognosis in Human Ovarian Carcinoma	PLOS ONE			English	Article							BREAST-CANCER; PROMOTER HYPERMETHYLATION; FIBULIN 1; EXPRESSION; GROWTH; INVASION; METHYLATION; INDUCTION; PROTEIN; ROLES	Objective: This study was to explore the role of EFEMP1 in ovarian tumor progression and its relationship with prognosis of ovarian carcinoma. Methods: EFEMP1 mRNA and protein expressions in normal ovarian tissue, ovarian tumor, high invasive subclones and low invasive subclones were evaluated by immunohistochemistry and real time RT-PCR. Serum EFEMP1 levels in patients with ovarian tumor were measured by ELISA assay. To assess the angiogenic properties of EFEMP1, VEGF and tumor microvessel density were analyzed in ovarian carcinoma by immunohistochemistry. Results: EFEMP1 expression was up-regulated in ovarian carcinoma, positively correlated with MVD and VEGF, and its overexpression and high serum levels were significantly associated with high stage, low differentiation, lymph node metastasis and poor prognosis of ovarian cancer. EFEMP1 expression was also found to be over-expressed in the highly invasive subclones compared with the low invasive subclones. Conclusion: EFEMP1 is a newly identified gene over-expressed in ovarian cancer, associated with poor clinicopathologic features and promotes angiogenesis. This study shows that EFEMP1 may serve as a new prognostic factor and a therapeutic target for patients with ovarian cancer in the future.	[Chen, Jie] Shandong Univ, Sch Publ Hlth, Dept Maternal & Child Hlth Care, Jinan 250100, Peoples R China; [Wei, Deying] Shandong Univ, Shandong Prov Hosp, Dept Obstet & Gynecol, Jinan 250100, Peoples R China; [Liu, Xiaoyan] Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, Jinan 250100, Peoples R China; [Zhao, Yueran; Zhang, Jie] Shandong Univ, Shandong Prov Hosp, Cent Lab, Jinan 250100, Peoples R China	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Wei, DY (corresponding author), Shandong Univ, Shandong Prov Hosp, Dept Obstet & Gynecol, Jinan 250100, Peoples R China.	hl922@163.com; zhangjie19630711@163.com			Shandong University [2012TS088]; National Nature Science Foundation of China [81202056]	Shandong University; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant-in-aid for scientific research from Shandong University (2012TS088) and National Nature Science Foundation of China (81202056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albig AR, 2006, CANCER RES, V66, P2621, DOI 10.1158/0008-5472.CAN-04-4096; Bardin A, 2005, ENDOCRINOLOGY, V146, P760, DOI 10.1210/en.2004-1239; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Brun JL, 2000, GYNECOL ONCOL, V78, P21, DOI 10.1006/gyno.2000.5805; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chen J, 2012, J CELL PHYSIOL, V227, P3629, DOI 10.1002/jcp.24069; Chen J, 2009, J CANCER RES CLIN, V135, P909, DOI 10.1007/s00432-008-0526-8; Chen LX, 2009, ONCOL REP, V21, P917, DOI 10.3892/or_00000304; Cheng YY, 2008, BRIT J CANCER, V99, P2083, DOI 10.1038/sj.bjc.6604760; Cho KR, 2009, ANNU REV PATHOL-MECH, V4, P287, DOI 10.1146/annurev.pathol.4.110807.092246; Coticchia Christine M, 2008, J Natl Compr Canc Netw, V6, P795; de Vega S, 2009, CELL MOL LIFE SCI, V66, P1890, DOI 10.1007/s00018-009-8632-6; Gallagher WM, 2005, TRENDS MOL MED, V11, P336, DOI 10.1016/j.molmed.2005.06.001; Greene LM, 2003, BRIT J CANCER, V88, P871, DOI 10.1038/sj.bjc.6600802; Hu B, 2009, MOL CANCER RES, V7, P1756, DOI 10.1158/1541-7786.MCR-09-0207; Hu YJ, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-123; Hu Z, 2011, UROL ONCOL-SEMIN ORI, V29, P430, DOI 10.1016/j.urolonc.2009.06.004; Hwang CF, 2010, J PATHOL, V222, P367, DOI 10.1002/path.2776; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kanda M, 2011, MOL CARCINOGEN, V50, P571, DOI 10.1002/mc.20735; Kim EJ, 2012, INT J ONCOL, V40, P402, DOI 10.3892/ijo.2011.1191; Law EWL, 2012, ONCOGENE, V31, P728, DOI 10.1038/onc.2011.272; Moll F, 2002, ONCOGENE, V21, P1097, DOI 10.1038/sj.onc.1205171; Omasu F, 2005, ELECTROPHORESIS, V26, P1163, DOI 10.1002/elps.200410182; Pass HI, 2012, NEW ENGL J MED, V367, P1417, DOI 10.1056/NEJMoa1115050; Sadr-Nabavi A, 2009, INT J CANCER, V124, P1727, DOI 10.1002/ijc.24108; Schluterman MK, 2010, DIS MODEL MECH, V3, P333, DOI 10.1242/dmm.003707; Seeliger H, 2009, MOL CANCER RES, V7, P189, DOI 10.1158/1541-7786.MCR-08-0132; Song EL, 2011, GYNECOL ONCOL, V121, P174, DOI 10.1016/j.ygyno.2010.11.004; Song EL, 2010, GYNECOL ONCOL, V117, P417, DOI 10.1016/j.ygyno.2009.12.016; WEIDNER N, 1992, JNCI-J NATL CANCER I, V84, P1875, DOI 10.1093/jnci/84.24.1875; Wlazlinski A, 2007, PROSTATE, V67, P1770, DOI 10.1002/pros.20667; Xie L, 2008, EXP BIOL MED, V233, P155, DOI 10.3181/0706-RM-167; Yi CH, 2007, AM J PATHOL, V170, P1535, DOI 10.2353/ajpath.2007.060478; Yue W, 2009, CANCER RES, V69, P6339, DOI 10.1158/0008-5472.CAN-09-0398	35	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78783	10.1371/journal.pone.0078783	http://dx.doi.org/10.1371/journal.pone.0078783			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236050	gold, Green Submitted, Green Published			2022-12-27	WOS:000327254700047
J	Gunther, ALB; Walz, H; Kroke, A; Wudy, SA; Riedel, C; von Kries, R; Joslowski, G; Remer, T; Cheng, G; Buyken, AE				Guenther, Anke L. B.; Walz, Helena; Kroke, Anja; Wudy, Stefan A.; Riedel, Christina; von Kries, Ruediger; Joslowski, Gesa; Remer, Thomas; Cheng, Guo; Buyken, Anette E.			Breastfeeding and Its Prospective Association with Components of the GH-IGF-Axis, Insulin Resistance and Body Adiposity Measures in Young Adulthood - Insights from Linear and Quantile Regression Analysis	PLOS ONE			English	Article							GROWTH-FACTOR-I; FORMULA-FED INFANTS; CHILDHOOD OBESITY; ANTHROPOMETRIC MEASUREMENTS; BLOOD-PRESSURE; PROTEIN-INTAKE; RISK-FACTORS; DISEASE; HEALTH; LIFE	Background: Breastfeeding may lower chronic disease risk by long-term effects on hormonal status and adiposity, but the relations remain uncertain. Objective: To prospectively investigate the association of breastfeeding with the growth hormone-(GH) insulin-like growth factor- (IGF) axis, insulin sensitivity, body composition and body fat distribution in younger adulthood (18-37 years). Design: Data from 233 (54% female) participants of a German cohort, the Dortmund Nutritional and Anthropometric Longitudinally Designed (DONALD) Study, with prospective data on infant feeding were analyzed. Multivariable linear as well as quantile regression were performed with full breastfeeding (not: <= 2, short: 3-17, long: >17 weeks) as exposure and adult IGF-I, IGF binding proteins (IGFBP) -1, -2, -3, homeostasis model assessment of insulin resistance (HOMA-IR), fat mass index, fat-free mass index, and waist circumference as outcomes. Results: After adjustment for early life and socio-economic factors, women who had been breastfed longer displayed higher adult IGFBP-2 (p(trend) = 0.02) and lower values of HOMA-IR (p(trend) = 0.004). Furthermore, in women breastfeeding duration was associated with a lower mean fat mass index (p(trend) = 0.01), fat-free mass index (ptrend = 0.02) and waist circumference (p(trend) = 0.004) in young adulthood. However, there was no relation to IGF-I, IGFBP-1 and IGFBP-3 (all p(trend) >0.05). Associations for IGFBP-2 and fat mass index were more pronounced at higher, for waist circumference at very low or high percentiles of the distribution. In men, there was no consistent relation of breastfeeding with any outcome. Conclusions: Our data suggest that breastfeeding may have long-term, favorable effects on extremes of adiposity and insulin metabolism in women, but not in men. In both sexes, breastfeeding does not seem to induce programming of the GH-IGF-axis.	[Guenther, Anke L. B.; Walz, Helena; Kroke, Anja; Cheng, Guo] Fulda Univ Appl Sci, Dept Nutr Food & Consumer Sci, Fulda, Germany; [Wudy, Stefan A.] Univ Giessen, Ctr Child & Adolescent Med, Lab Translat Hormone Analyt Pediat Endocrinol, Peptide Hormone Res Unit, D-35390 Giessen, Germany; [Riedel, Christina; von Kries, Ruediger] Univ Munich, Inst Social Paediat & Adolescent Med, Munich, Germany; [Joslowski, Gesa; Remer, Thomas; Buyken, Anette E.] Univ Bonn, DONALD Study Res Inst Child Nutr, IEL Nutr Epidemiol, Bonn, Germany; [Cheng, Guo] West China Sch Publ Hlth, Chengdu, Peoples R China	Justus Liebig University Giessen; University of Munich; University of Bonn	Gunther, ALB (corresponding author), Fulda Univ Appl Sci, Dept Nutr Food & Consumer Sci, Fulda, Germany.	anke.guenther@he.hs-fulda.de	Wudy, Stefan/ABC-7173-2020	Sobotzki, Christina/0000-0002-0956-0050; Cheng, Guo/0000-0002-0945-5728	Wereld Kanker Onderzoek Fonds (WCRF NL) as part of the WCRF International grant programme [2010/248]; Kompetenznetz Adipositas (Competence Network Obesity); Federal Ministry of Education and Research, Germany [FKZ: 01GI1121A]; Ministry of Science and Research of North Rhine Westphalia, Germany	Wereld Kanker Onderzoek Fonds (WCRF NL) as part of the WCRF International grant programme; Kompetenznetz Adipositas (Competence Network Obesity); Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF)); Ministry of Science and Research of North Rhine Westphalia, Germany	This analysis was funded by the Wereld Kanker Onderzoek Fonds (WCRF NL), grant no. 2010/248, as part of the WCRF International grant programme (www.wcrf-nl.org). The quantile regression analysis was supported by the Kompetenznetz Adipositas (Competence Network Obesity) funded by the Federal Ministry of Education and Research, Germany, FKZ: 01GI1121A (www.kompetenznetz-adipositas.de). The DONALD Study is supported by the Ministry of Science and Research of North Rhine Westphalia, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair LS, 2009, J NUTR, V139, p408S, DOI 10.3945/jn.108.097808; Arenz S, 2004, INT J OBESITY, V28, P1247, DOI 10.1038/sj.ijo.0802758; Ascaso JF, 2003, DIABETES CARE, V26, P3320, DOI 10.2337/diacare.26.12.3320; Beyerlein A, 2008, OBESITY, V16, P2730, DOI 10.1038/oby.2008.432; Beyerlein A, 2011, AM J CLIN NUTR, V94, p1772S, DOI 10.3945/ajcn.110.000547; BLUM WF, 1986, ACTA ENDOCRINOL-COP, V111, P271, DOI 10.1530/acta.0.1110271; Burgers AMG, 2011, J CLIN ENDOCR METAB, V96, P2912, DOI 10.1210/jc.2011-1377; Buyken AE, 2012, BUNDESGESUNDHEITSBLA, V55, P875, DOI 10.1007/s00103-012-1503-6; Buyken AE, 2008, AM J CLIN NUTR, V87, P1964, DOI 10.1093/ajcn/87.6.1964; Chellakooty M, 2006, J CLIN ENDOCR METAB, V91, P820, DOI 10.1210/jc.2005-0950; Closa-Monasterolo R, 2011, AM J CLIN NUTR, V94, p1920S, DOI 10.3945/ajcn.110.001123; Cole TJ, 2008, AM J CLIN NUTR, V87, P1959, DOI 10.1093/ajcn/87.6.1959; Cope MB, 2008, OBES REV, V9, P594, DOI 10.1111/j.1467-789X.2008.00504.x; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; FERRARIO M, 1995, INT J OBESITY, V19, P449; Fewtrell MS, 2011, P NUTR SOC, V70, P472, DOI 10.1017/S0029665111000589; Fogelholm M, 1997, EUR J CLIN NUTR, V51, P495, DOI 10.1038/sj.ejcn.1600448; GoodmanGruen D, 1997, AM J EPIDEMIOL, V145, P970, DOI 10.1093/oxfordjournals.aje.a009065; Harder T, 2005, AM J EPIDEMIOL, V162, P397, DOI 10.1093/aje/kwi222; Horta BL, 2007, EVIDENCE LONG TERM E; Joslowski G, 2013, J NUTR, V143, P1147, DOI 10.3945/jn.113.175877; KlipsteinGrobusch K, 1997, INT J EPIDEMIOL, V26, pS174, DOI 10.1093/ije/26.suppl_1.S174; Koletzko B, 2009, AM J CLIN NUTR, V89, pS1502, DOI 10.3945/ajcn.2009.27113D; Krajcik RA, 2002, CANCER EPIDEM BIOMAR, V11, P1566; Kramer MS, 2007, AM J CLIN NUTR, V86, P1717; Kroke A, 2004, EUR J NUTR, V43, P45, DOI 10.1007/s00394-004-0445-7; Larnkjaer A, 2012, CURR OPIN CLIN NUTR, V15, P285, DOI 10.1097/MCO.0b013e328351c472; Larnkjaer A, 2009, GROWTH HORM IGF RES, V19, P82, DOI 10.1016/j.ghir.2008.06.003; Lawlor DA, 2005, ARCH DIS CHILD, V90, P582, DOI 10.1136/adc.2004.055335; Lohmann TG, 1988, ANTHROPOMETRIC STAND; LUCAS A, 1980, LANCET, V1, P1267; Madsen AL, 2011, GROWTH HORM IGF RES, V21, P199, DOI 10.1016/j.ghir.2011.05.003; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Manco M, 2011, J AM COLL NUTR, V30, P29, DOI 10.1080/07315724.2011.10719941; MARKS GC, 1989, AM J EPIDEMIOL, V130, P578, DOI 10.1093/oxfordjournals.aje.a115372; Martin RM, 2013, JAMA-J AM MED ASSOC, V309, P1005, DOI 10.1001/jama.2013.167; Martin RM, 2011, NESTLE NUTR WORKS SE, V67, P79, DOI 10.1159/000325577; Martin RM, 2005, CLIN ENDOCRINOL, V62, P728, DOI 10.1111/j.1365-2265.2005.02287.x; Martin RM, 2005, J EPIDEMIOL COMMUN H, V59, P121, DOI 10.1136/jech.2003.018952; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Murphy MJ, 2004, PEDIATRICS, V113, P82, DOI 10.1542/peds.113.1.82; Nelson MC, 2005, EPIDEMIOLOGY, V16, P247, DOI 10.1097/01.ede.0000152900.81355.00; Ong KK, 2009, AM J CLIN NUTR, V90, P156, DOI 10.3945/ajcn.2008.27408; Owen CG, 2005, AM J CLIN NUTR, V82, P1298, DOI 10.1093/ajcn/82.6.1298; Owen CG, 2005, PEDIATRICS, V115, P1367, DOI 10.1542/peds.2004-1176; Owen CG, 2011, P NUTR SOC, V70, P478, DOI 10.1017/S0029665111000590; Ravelli ACJ, 2000, ARCH DIS CHILD, V82, P248, DOI 10.1136/adc.82.3.248; Savino F, 2005, ACTA PAEDIATR, V94, P531, DOI 10.1080/08035250510027642; Socha P, 2005, ADV EXP MED BIOL, V569, P159; Socha P, 2011, AM J CLIN NUTR, V94, p1776S, DOI 10.3945/ajcn.110.000596; Thomas EL, 1998, J APPL PHYSIOL, V85, P1778, DOI 10.1152/jappl.1998.85.5.1778; Voigt M, 2010, Z GEBURTSH NEONATOL, V214, P24, DOI 10.1055/s-0029-1241833; Wheatcroft SB, 2009, TRENDS ENDOCRIN MET, V20, P153, DOI 10.1016/j.tem.2009.01.002	53	8	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79436	10.1371/journal.pone.0079436	http://dx.doi.org/10.1371/journal.pone.0079436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236134	Green Submitted, Green Published, gold			2022-12-27	WOS:000327254700133
J	Kukimoto, I; Maehama, T; Sekizuka, T; Ogasawara, Y; Kondo, K; Kusumoto-Matsuo, R; Mori, S; Ishii, Y; Takeuchi, T; Yamaji, T; Takeuchi, F; Hanada, K; Kuroda, M				Kukimoto, Iwao; Maehama, Tomohiko; Sekizuka, Tsuyoshi; Ogasawara, Yumiko; Kondo, Kazunari; Kusumoto-Matsuo, Rika; Mori, Seiichiro; Ishii, Yoshiyuki; Takeuchi, Takamasa; Yamaji, Toshiyuki; Takeuchi, Fumihiko; Hanada, Kentaro; Kuroda, Makoto			Genetic Variation of Human Papillomavirus Type 16 in Individual Clinical Specimens Revealed by Deep Sequencing	PLOS ONE			English	Article							LONG CONTROL REGION; NEXT-GENERATION; CERVICAL-CANCER; DNA; INTEGRATION; DIVERSITY; VARIANTS; E6	Viral genetic diversity within infected cells or tissues, called viral quasispecies, has been mostly studied for RNA viruses, but has also been described among DNA viruses, including human papillomavirus type 16 (HPV16) present in cervical precancerous lesions. However, the extent of HPV genetic variation in cervical specimens, and its involvement in HPV-induced carcinogenesis, remains unclear. Here, we employ deep sequencing to comprehensively analyze genetic variation in the HPV16 genome isolated from individual clinical specimens. Through overlapping full-circle PCR, approximately 8-kb DNA fragments covering the whole HPV16 genome were amplified from HPV16-positive cervical exfoliated cells collected from patients with either low-grade squamous intraepithelial lesion (LSIL) or invasive cervical cancer (ICC). Deep sequencing of the amplified HPV16 DNA enabled de novo assembly of the full-length HPV16 genome sequence for each of 7 specimens (5 LSIL and 2 ICC samples). Subsequent alignment of read sequences to the assembled HPV16 sequence revealed that 2 LSILs and 1 ICC contained nucleotide variations within E6, E1 and the non-coding region between E5 and L2 with mutation frequencies of 0.60% to 5.42%. In transient replication assays, a novel E1 mutant found in ICC, E1 Q381E, showed reduced ability to support HPV16 origin-dependent replication. In addition, partially deleted E2 genes were detected in 1 LSIL sample in a mixed state with the intact E2 gene. Thus, the methods used in this study provide a fundamental framework for investigating the influence of HPV somatic genetic variation on cervical carcinogenesis.	[Kukimoto, Iwao; Sekizuka, Tsuyoshi; Ogasawara, Yumiko; Kusumoto-Matsuo, Rika; Mori, Seiichiro; Ishii, Yoshiyuki; Takeuchi, Takamasa; Takeuchi, Fumihiko; Kuroda, Makoto] Natl Inst Infect Dis, Pathogen Genom Ctr, Tokyo, Japan; [Maehama, Tomohiko; Yamaji, Toshiyuki; Hanada, Kentaro] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Tokyo, Japan; [Kondo, Kazunari] NTT Med Ctr Tokyo, Tokyo, Japan	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); Kanto Medical Center NTT EC	Kukimoto, I (corresponding author), Natl Inst Infect Dis, Pathogen Genom Ctr, Tokyo, Japan.	ikuki@niid.go.jp	Maehama, Tomohiko/AAX-8926-2020; Kukimoto, I/I-3995-2019; kondo, kazunari/AGE-0558-2022; Maehama, Tomohiko/HGB-4896-2022	Kukimoto, I/0000-0001-9080-1642; kondo, kazunari/0000-0002-2662-4626; Maehama, Tomohiko/0000-0002-9685-2317; Sekizuka, Tsuyoshi/0000-0002-1302-5472; Hanada, Kentaro/0000-0003-1383-2781	Japanese Ministry of Education, Culture, Sports, and Science; Ministry of Health, Labor, Welfare, and Technology; Mitsubishi Foundation	Japanese Ministry of Education, Culture, Sports, and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, Welfare, and Technology(Ministry of Health, Labour and Welfare, Japan); Mitsubishi Foundation	This work was supported by Grants-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, and Science; by Grants-in-Aid for Scientific Research from the Ministry of Health, Labor, Welfare, and Technology; and by a grant from the Mitsubishi Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amador-Molina A, 2013, J GEN VIROL, V94, P393, DOI 10.1099/vir.0.045807-0; Arad U, 1998, BIOTECHNIQUES, V24, P760, DOI 10.2144/98245bm14; Arias-Pulido H, 2006, J CLIN MICROBIOL, V44, P1755, DOI 10.1128/JCM.44.5.1755-1762.2006; Beerenwinkel N, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00329; Bodily J, 2011, TRENDS MICROBIOL, V19, P33, DOI 10.1016/j.tim.2010.10.002; Burk RD, 2013, VIROLOGY, V445, P232, DOI 10.1016/j.virol.2013.07.018; Cornet I, 2013, BRIT J CANCER, V108, P240, DOI 10.1038/bjc.2012.508; Cornet I, 2012, J VIROL, V86, P6855, DOI 10.1128/JVI.00483-12; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; Ekstrom J, 2011, INT J CANCER, V129, P2643, DOI 10.1002/ijc.26204; Estrade C, 2011, J CLIN MICROBIOL, V49, P3474, DOI 10.1128/JCM.05039-11; Foulongne V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038499; Fradet-Turcotte A, 2010, VIROLOGY, V399, P65, DOI 10.1016/j.virol.2009.12.026; Fu LP, 2004, J INFECT DIS, V190, P1303, DOI 10.1086/423855; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Hebner CM, 2006, REV MED VIROL, V16, P83, DOI 10.1002/rmv.488; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; JEON S, 1995, J VIROL, V69, P2989, DOI 10.1128/JVI.69.5.2989-2997.1995; Kajitani N, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00152; KANDA T, 1987, JPN J CANCER RES, V78, P103; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Kondo Kazunari, 2012, Open Virol J, V6, P277, DOI 10.2174/1874357901206010277; Kwok H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036939; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin QQ, 1998, INT J CANCER, V75, P484, DOI 10.1002/(SICI)1097-0215(19980130)75:3<484::AID-IJC25>3.0.CO;2-7; Matsumoto K, 2000, CANCER LETT, V156, P159, DOI 10.1016/S0304-3835(00)00457-2; McBride AA, 2008, ADV VIRUS RES, V72, P155, DOI 10.1016/S0065-3527(08)00404-1; Meiring TL, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-164; Meissner JD, 1999, J GEN VIROL, V80, P1725, DOI 10.1099/0022-1317-80-7-1725; MELENDY T, 1995, J VIROL, V69, P7857, DOI 10.1128/JVI.69.12.7857-7867.1995; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Miura S, 2006, INT J CANCER, V119, P2713, DOI 10.1002/ijc.22195; Pande S, 2008, J CLIN MICROBIOL, V46, P1060, DOI 10.1128/JCM.02202-07; Pett M, 2007, J PATHOL, V212, P356, DOI 10.1002/path.2192; Sichero L, 2012, VIROLOGY, V432, P127, DOI 10.1016/j.virol.2012.06.011; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Smith B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021375; STANLEY MA, 1989, INT J CANCER, V43, P672, DOI 10.1002/ijc.2910430422; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Titolo S, 2000, J VIROL, V74, P7349, DOI 10.1128/JVI.74.16.7349-7361.2000; van Velzen M, 2012, J INFECT DIS, V205, P1539, DOI 10.1093/infdis/jis237; Vartanian JP, 2008, SCIENCE, V320, P230, DOI 10.1126/science.1153201; *WHO, 2009, WNOIVB1012 WHO; Xu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066693; YEE C, 1985, AM J PATHOL, V119, P361; Zou NX, 2000, J VIROL, V74, P3761, DOI 10.1128/JVI.74.8.3761-3770.2000; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	51	24	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80583	10.1371/journal.pone.0080583	http://dx.doi.org/10.1371/journal.pone.0080583			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236186	Green Published, gold			2022-12-27	WOS:000327254700187
J	Li, F; Zhang, XM; Hu, RB; Wu, FQ; Ma, JH; Meng, Y; Fu, YF				Li, Fang; Zhang, Xiaomei; Hu, Ruibo; Wu, Faqiang; Ma, Jinhua; Meng, Ying; Fu, YongFu			Identification and Molecular Characterization of FKF1 and GI Homologous Genes in Soybean	PLOS ONE			English	Article							F-BOX PROTEINS; ARABIDOPSIS CIRCADIAN CLOCK; FLOWERING-LOCUS-T; MAP-BASED CLONING; GIGANTEA GENE; CONFORMATIONAL-CHANGES; GROWTH HABIT; EXPRESSION; CONSTANS; THALIANA	In Arabidopsis, FKF1 (FLAVIN BINDING, KELCH REPEAT, F-BOX1) and GI (GIGANTEA) play important roles in flowering pathway through regulating daytime CO (CONSTANS) expression, and such a function is conserved across plants studied. But related reports are limited for soybean. In this study, we cloned FKF1 and GI homologs in soybean, and named as GmFKF1, GmFKF2, GmGI1, GmGI2, and GmGI3, respectively. GmGI1 had two alternative splicing forms, GmGI1 alpha and GmGI1 beta. GmFKF1/2 transcripts were diurnally regulated, with a peak at zeitgeber time 12 (ZT12) in long days and at ZT10 in short days. The diurnal phases between GmGIs transcript levels greatly differed. GmGI2 expression was regulated by both the circadian clock and photoperiod. But the rhythmic phases of GmGI1 and GmGI3 expression levels were mainly conferred by long days. GmFKFs shared similar spatio-temporal expression profiles with GmGIs in all of the tissue/organs in different developmental stages in both LD and SD. Both GmFKF and GmGI proteins were targeted to the nucleus. Yeast two hybrid assays showed GmFKF1/GmFKF2 interacted with GmGI1/GmGI2/GmCDF1 (CYCLING DOF FACTOR CDF1 homolog in soybean); and the LOV (Light, Oxygen, or Voltage) domain in GmFKF1/GmFKF2 played an important role in these interactions. N-terminus of GmGI2 was sufficient to mediate its interaction with GmCDF1. Interestingly, N-terminus not full of GmGI3 interacted with GmFKF1/GmFKF2/GmCDF1. Ectopic over-expression of the GmFKF1 or GmFKF2 in Arabidopsis enhanced flowering in SD. Collectively, GmFKF and GmGI in soybean had conserved functional domains at DNA sequence level, but specific characters at function level with their homologs in other plants.	[Li, Fang; Zhang, Xiaomei; Wu, Faqiang; Ma, Jinhua; Meng, Ying; Fu, YongFu] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resource & Genet Improve, MOA Key Lab Soybean Biol Beijing, Beijing 100193, Peoples R China; [Hu, Ruibo] Chinese Acad Sci, Qingdao Inst BioEnergy & BioProc Technol, CAS Key Lab Biofuels, Shandong Prov Key Lab Energy Genet, Qingdao, Shandong, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS	Fu, YF (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resource & Genet Improve, MOA Key Lab Soybean Biol Beijing, Beijing 100193, Peoples R China.	fufu19cn@163.com	Hu, Ruibo/P-3471-2018	Hu, Ruibo/0000-0001-6299-5320	973 Program [2010CB125906]; Transgenic program [2011ZX08009-001, 2011ZX08004-005]; 863 program [2013AA102602]; National Natural Science Founds [31000681]	973 Program(National Basic Research Program of China); Transgenic program; 863 program(National High Technology Research and Development Program of China); National Natural Science Founds	This work was partly supported by 973 Program (2010CB125906), Transgenic program (2011ZX08009-001 and 2011ZX08004-005), 863 program (2013AA102602), and the National Natural Science Founds (31000681). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe J, 2003, THEOR APPL GENET, V106, P445, DOI 10.1007/s00122-002-1073-3; Andrade MA, 2001, PLANT MOL BIOL, V46, P603, DOI 10.1023/A:1010650809272; Andres F, 2012, NAT REV GENET, V13, P627, DOI 10.1038/nrg3291; Baudry A, 2010, PLANT CELL, V22, P606, DOI 10.1105/tpc.109.072843; Bendix C, 2013, PLANT CELL ENVIRON, V36, P1379, DOI 10.1111/pce.12067; Black MM, 2011, PROTEIN EXPRES PURIF, V76, P197, DOI 10.1016/j.pep.2010.11.009; Cao SQ, 2005, PLANT CELL REP, V24, P683, DOI 10.1007/s00299-005-0061-x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; D'Aloia M, 2011, PLANT J, V65, P972, DOI 10.1111/j.1365-313X.2011.04482.x; Dalchau N, 2011, P NATL ACAD SCI USA, V108, P5104, DOI 10.1073/pnas.1015452108; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Dunford RP, 2005, THEOR APPL GENET, V110, P925, DOI 10.1007/s00122-004-1912-5; Edwards J, 2010, PLANT J, V63, P651, DOI 10.1111/j.1365-313X.2010.04269.x; Eitoku T, 2007, J MOL BIOL, V371, P1290, DOI 10.1016/j.jmb.2007.06.035; Fornara F, 2010, CELL, V141, DOI 10.1016/j.cell.2010.04.024; Fornara F, 2009, DEV CELL, V17, P75, DOI 10.1016/j.devcel.2009.06.015; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Fowler S, 1999, EMBO J, V18, P4679, DOI 10.1093/emboj/18.17.4679; Fujiwara S, 2008, J BIOL CHEM, V283, P23073, DOI 10.1074/jbc.M803471200; Green RM, 2002, PLANT PHYSIOL, V129, P576, DOI 10.1104/pp.004374; Harmer SL, 2009, ANNU REV PLANT BIOL, V60, P357, DOI 10.1146/annurev.arplant.043008.092054; Hayama R, 2003, NATURE, V422, P719, DOI 10.1038/nature01549; Hecht V, 2005, PLANT PHYSIOL, V137, P1420, DOI 10.1104/pp.104.057018; Hecht V, 2007, PLANT PHYSIOL, V144, P648, DOI 10.1104/pp.107.096818; Higuchi Y, 2011, PLANT CELL PHYSIOL, V52, P638, DOI 10.1093/pcp/pcr023; Hong SY, 2010, PLANT MOL BIOL, V72, P485, DOI 10.1007/s11103-009-9586-7; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Huq E, 2000, P NATL ACAD SCI USA, V97, P9789, DOI 10.1073/pnas.170283997; Imaizumi T, 2005, SCIENCE, V309, P293, DOI 10.1126/science.1110586; Imaizumi T, 2003, NATURE, V426, P302, DOI 10.1038/nature02090; Ito S, 2012, MOL PLANT, V5, P573, DOI 10.1093/mp/sss013; Jackson SD, 2009, NEW PHYTOL, V181, P517, DOI 10.1111/j.1469-8137.2008.02681.x; Jung JH, 2007, PLANT CELL, V19, P2736, DOI 10.1105/tpc.107.054528; Kim MY, 2012, J BIOSCIENCES, V37, P857, DOI 10.1007/s12038-012-9252-0; Kim WY, 2007, NATURE, V449, P356, DOI 10.1038/nature06132; Kobayashi Y, 2007, GENE DEV, V21, P2371, DOI 10.1101/gad.1589007; Kong FJ, 2010, PLANT PHYSIOL, V154, P1220, DOI 10.1104/pp.110.160796; Liu BH, 2010, PLANT PHYSIOL, V153, P198, DOI 10.1104/pp.109.150607; Liu H, 2009, J PLANT PHYSIOL, V166, P278, DOI 10.1016/j.jplph.2008.06.003; Lu Q, 2010, PLANT J, V61, P259, DOI 10.1111/j.1365-313X.2009.04048.x; Massiah MA, 2007, J MOL BIOL, V369, P1, DOI 10.1016/j.jmb.2007.03.017; Mizoguchi T, 2005, PLANT CELL, V17, P2255, DOI 10.1105/tpc.105.033464; Nakasone Y, 2010, BIOPHYS J, V99, P3831, DOI 10.1016/j.bpj.2010.10.005; Nelson DC, 2000, CELL, V101, P331, DOI 10.1016/S0092-8674(00)80842-9; Paltiel J, 2006, PLANTA, V224, P1255, DOI 10.1007/s00425-006-0305-1; Park DH, 1999, SCIENCE, V285, P1579, DOI 10.1126/science.285.5433.1579; Penfield S, 2009, PLANT CELL, V21, P1722, DOI 10.1105/tpc.108.064022; Pineiro M, 2013, PLANT SCI, V198, P98, DOI [10.1016/j.plantsci.2012.10.005, 10.1016/j.pla]; Salomon M, 2004, FEBS LETT, V572, P8, DOI 10.1016/j.febslet.2004.06.081; Sawa M, 2007, SCIENCE, V318, P261, DOI 10.1126/science.1146994; Sawa M, 2011, P NATL ACAD SCI USA, V108, P11698, DOI 10.1073/pnas.1106771108; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schultz TF, 2001, PLANT CELL, V13, P2659, DOI 10.1105/tpc.13.12.2659; Serikawa M, 2008, PLANT PHYSIOL, V146, P1952, DOI 10.1104/pp.107.114611; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Song YH, 2012, SCIENCE, V336, P1045, DOI 10.1126/science.1219644; Song YH, 2010, CURR OPIN PLANT BIOL, V13, P594, DOI 10.1016/j.pbi.2010.05.004; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Sun HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029238; Sung S, 2006, J EXP BOT, V57, P3369, DOI 10.1093/jxb/erl105; Takase T, 2011, PLANT J, V67, P608, DOI 10.1111/j.1365-313X.2011.04618.x; Taylor A, 2010, PLANT CELL PHYSIOL, V51, P1638, DOI 10.1093/pcp/pcq120; Thakare D, 2011, PLANTA, V234, P933, DOI 10.1007/s00425-011-1450-8; Thakare D, 2010, PLANTA, V231, P951, DOI 10.1007/s00425-010-1100-6; Tian ZX, 2010, P NATL ACAD SCI USA, V107, P8563, DOI 10.1073/pnas.1000088107; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Wang L, 2010, EMBO J, V29, P1903, DOI 10.1038/emboj.2010.76; Watanabe S, 2011, BREEDING SCI, V61, P531, DOI 10.1270/jsbbs.61.531; Watanabe S, 2011, GENETICS, V188, P395, DOI 10.1534/genetics.110.125062; Watanabe S, 2009, GENETICS, V182, P1251, DOI 10.1534/genetics.108.098772; Wu FQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027737; Xia ZJ, 2012, P NATL ACAD SCI USA, V109, pE2155, DOI 10.1073/pnas.1117982109; Xiao CW, 2009, PLANT MOL BIOL, V71, P39, DOI 10.1007/s11103-009-9507-9; Xue ZG, 2012, MOL BIOL REP, V39, P1411, DOI 10.1007/s11033-011-0875-2; Yamaguchi A, 2005, PLANT CELL PHYSIOL, V46, P1175, DOI 10.1093/pcp/pci151; Yan OY, 1998, P NATL ACAD SCI USA, V95, P8660, DOI 10.1073/pnas.95.15.8660; Yasuhara M, 2004, J EXP BOT, V55, P2015, DOI 10.1093/jxb/erh226; Yon F, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-172; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang QZ, 2008, P NATL ACAD SCI USA, V105, P21028, DOI 10.1073/pnas.0810585105; Zhao XY, 2005, PLANT MOL BIOL, V58, P53, DOI 10.1007/s11103-005-4162-2	82	16	25	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79036	10.1371/journal.pone.0079036	http://dx.doi.org/10.1371/journal.pone.0079036			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236086	gold, Green Published, Green Submitted			2022-12-27	WOS:000327254700084
J	Peng, CFJ; Wikramanayake, AH				Peng, ChiehFu Jeff; Wikramanayake, Athula H.			Differential Regulation of Disheveled in a Novel Vegetal Cortical Domain in Sea Urchin Eggs and Embryos: Implications for the Localized Activation of Canonical Wnt Signaling	PLOS ONE			English	Article							NUCLEAR BETA-CATENIN; STICHOPUS-CALIFORNICUS ECHINODERMATA; SYNAPTULA HYDRIFORMIS HOLOTHUROIDEA; NEMATOSTELLA-VECTENSIS; DEVELOPMENTAL BIOLOGY; UNFERTILIZED EGG; BASAL BODIES; CELL FATE; POLARITY; AXIS	Pattern formation along the animal-vegetal (AV) axis in sea urchin embryos is initiated when canonical Wnt (cWnt) signaling is activated in vegetal blastomeres. The mechanisms that restrict cWnt signaling to vegetal blastomeres are not well understood, but there is increasing evidence that the egg's vegetal cortex plays a critical role in this process by mediating localized "activation" of Disheveled (Dsh). To investigate how Dsh activity is regulated along the AV axis, sea urchin-specific Dsh antibodies were used to examine expression, subcellular localization, and post-translational modification of Dsh during development. Dsh is broadly expressed during early sea urchin development, but immunolocalization studies revealed that this protein is enriched in a punctate pattern in a novel vegetal cortical domain (VCD) in the egg. Vegetal blastomeres inherit this VCD during embryogenesis, and at the 60-cell stage Dsh puncta are seen in all cells that display nuclear beta-catenin. Analysis of Dsh post-translational modification using two-dimensional Western blot analysis revealed that compared to Dsh pools in the bulk cytoplasm, this protein is differentially modified in the VCD and in the 16-cell stage micromeres that partially inherit this domain. Dsh localization to the VCD is not directly affected by disruption of microfilaments and microtubules, but unexpectedly, microfilament disruption led to degradation of all the Dsh pools in unfertilized eggs over a period of incubation suggesting that microfilament integrity is required for maintaining Dsh stability. These results demonstrate that a pool of differentially modified Dsh in the VCD is selectively inherited by the vegetal blastomeres that activate cWnt signaling in early embryos, and suggests that this domain functions as a scaffold for localized Dsh activation. Localized cWnt activation regulates AV axis patterning in many metazoan embryos. Hence, it is possible that the VCD is an evolutionarily conserved cytoarchitectural domain that specifies the AV axis in metazoan ova.	[Peng, ChiehFu Jeff; Wikramanayake, Athula H.] Univ Miami, Dept Biol, Coral Gables, FL 33124 USA	University of Miami	Wikramanayake, AH (corresponding author), Univ Miami, Dept Biol, Coral Gables, FL 33124 USA.	athula@miami.edu			National Science Foundation	National Science Foundation(National Science Foundation (NSF))	This work was funded by the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angerer LM, 2000, DEV BIOL, V218, P1, DOI 10.1006/dbio.1999.9553; Angerer LM, 2011, DEVELOPMENT, V138, P3613, DOI 10.1242/dev.058172; Asano Y, 2001, CELL MOTIL CYTOSKEL, V48, P245, DOI 10.1002/cm.1013; BAER K. E. v., 1834, ARCH ANAT PHYSL, V1, P481; Bernatik O, 2011, J BIOL CHEM, V286, P10396, DOI 10.1074/jbc.M110.169870; Bince Joanna M., 2008, V469, P201, DOI 10.1007/978-1-60327-469-2_15; Bince Joanna M., 2008, V469, P213, DOI 10.1007/978-1-60327-469-2_16; Boveri T., 1901, ZOOLOGISCHE JB UCHER, V14, P630; Boveri T., 1901, VERHANDLUNGEN PHYSIK, V34, P145; BOYLE JA, 1989, DEV BIOL, V134, P72, DOI 10.1016/0012-1606(89)90079-1; Byrum C.A., 2004, P33; Capelluto DGS, 2002, NATURE, V419, P726, DOI 10.1038/nature01056; Croce J, 2011, DEVELOPMENT, V138, P3297, DOI 10.1242/dev.058792; Croce JC, 2006, SEMIN CELL DEV BIOL, V17, P168, DOI 10.1016/j.semcdb.2006.04.004; Croce JC, 2006, DEV BIOL, V300, P121, DOI 10.1016/j.ydbio.2006.08.045; Croce Jenifer C., 2008, V469, P3, DOI 10.1007/978-1-60327-469-2_1; Darras S, 2011, DEVELOPMENT, V138, P959, DOI 10.1242/dev.059493; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; DiCarlo M, 1996, BIOCHEM BIOPH RES CO, V229, P511; Egana AL, 2007, MOL REPROD DEV, V74, P76, DOI 10.1002/mrd.20511; Emily-Fenouil F, 1998, DEVELOPMENT, V125, P2489; Foissner I, 2007, PLANT CELL PHYSIOL, V48, P585, DOI 10.1093/pcp/pcm030; Frick JE, 1996, BIOL BULL-US, V191, P168, DOI 10.2307/1542920; Frick JE, 1996, INVERTEBR BIOL, V115, P46, DOI 10.2307/3226941; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Henry JQ, 2008, DEV BIOL, V317, P368, DOI 10.1016/j.ydbio.2008.02.042; Henry JQ, 2010, INTEGR COMP BIOL, V50, P707, DOI 10.1093/icb/icq076; Hirota Y, 2010, DEVELOPMENT, V137, P3037, DOI 10.1242/dev.050120; HORSTADIUS S, 1950, EXP CELL RES, V1, P188, DOI 10.1016/0014-4827(50)90031-0; Imai K, 2000, DEVELOPMENT, V127, P3009; KUMBUREGAMA S, 2007, SIGNAL TRANSDUCT, V7, P164, DOI DOI 10.1002/SITA.200600127; Kumburegama S, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-2; KURAISHI R, 1994, DEVELOPMENT, V120, P2619; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee PN, 2007, DEV BIOL, V310, P169, DOI 10.1016/j.ydbio.2007.05.040; Leonard JD, 2007, DEV BIOL, V306, P50, DOI 10.1016/j.ydbio.2007.02.041; Lhomond G, 2012, DEVELOPMENT, V139, P816, DOI 10.1242/dev.072215; Lillie FR, 1909, BIOL BULL-US, V16, P54, DOI 10.2307/1536026; Logan CY, 1999, DEVELOPMENT, V126, P345; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; MARK EL, 1881, B MUS COMP ZOOL HARV, V9, P173; Martindale Mark Q., 2013, Biological Theory, V8, P253; Martindale MQ, 2009, DEV CELL, V17, P162, DOI 10.1016/j.devcel.2009.07.024; Martindale MQ, 2005, NAT REV GENET, V6, P917, DOI 10.1038/nrg1725; MARUYAMA YK, 1985, J EXP ZOOL, V236, P155, DOI 10.1002/jez.1402360206; McClay DR, 2011, DEVELOPMENT, V138, P2639, DOI 10.1242/dev.048967; Mitchell B, 2009, CURR BIOL, V19, P924, DOI 10.1016/j.cub.2009.04.018; Miyawaki K, 2003, DEV GROWTH DIFFER, V45, P121; Momose T, 2008, DEVELOPMENT, V135, P2105, DOI 10.1242/dev.021543; Nakamura K, 2005, GENE DEV, V19, P1749, DOI 10.1101/gad.1323705; Niehrs C, 2010, DEVELOPMENT, V137, P845, DOI 10.1242/dev.039651; Oliveri P, 2004, CURR OPIN GENET DEV, V14, P351, DOI 10.1016/j.gde.2004.06.004; Oliveri P, 2008, P NATL ACAD SCI USA, V105, P5955, DOI 10.1073/pnas.0711220105; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Peter IS, 2011, NATURE, V474, P635, DOI 10.1038/nature10100; Petersen CP, 2009, CELL, V139, P1056, DOI 10.1016/j.cell.2009.11.035; SCHROEDER TE, 1991, DEV BIOL, V144, P240, DOI 10.1016/0012-1606(91)90418-3; SCHROEDER TE, 1985, DEV GROWTH DIFFER, V27, P311; SCHROEDER TE, 1980, DEV BIOL, V79, P428, DOI 10.1016/0012-1606(80)90128-1; SCHROEDER TE, 1980, EXP CELL RES, V128, P490, DOI 10.1016/0014-4827(80)90088-9; SMILEY S, 1985, BIOL BULL, V169, P342, DOI 10.2307/1541487; SMILEY S, 1988, BIOL BULL, V175, P79, DOI 10.2307/1541895; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Stack C, 2006, DEV DYNAM, V235, P1042, DOI 10.1002/dvdy.20695; Stamateris RE, 2010, GENE EXPR PATTERNS, V10, P60, DOI 10.1016/j.gep.2009.10.004; Torres MA, 2000, J CELL BIOL, V149, P1433, DOI 10.1083/jcb.149.7.1433; VACQUIER VD, 1975, DEV BIOL, V43, P62, DOI 10.1016/0012-1606(75)90131-1; Vonica A, 2000, DEV BIOL, V217, P230, DOI 10.1006/dbio.1999.9551; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Weitzel HE, 2004, DEVELOPMENT, V131, P2947, DOI 10.1242/dev.01152; Wessel GM, 1999, BIOESSAYS, V21, P459, DOI 10.1002/(SICI)1521-1878(199906)21:6<459::AID-BIES3>3.0.CO;2-Y; Wikramanayake AH, 1998, P NATL ACAD SCI USA, V95, P9343, DOI 10.1073/pnas.95.16.9343; Wikramanayake AH, 2004, GENESIS, V39, P194, DOI 10.1002/gene.20045; Wikramanayake AH, 2003, NATURE, V426, P446, DOI 10.1038/nature02113; WIKRAMANAYAKE AH, 1995, DEVELOPMENT, V121, P1497; Wilson EB., 1925, CELL DEV HEREDITY, V3rd edition; Wilt FH, 2004, METHOD CELL BIOL, V74, P273; Wong GK, 1997, CELL MOTIL CYTOSKEL, V36, P30, DOI 10.1002/(SICI)1097-0169(1997)36:1<30::AID-CM3>3.0.CO;2-L; Wourms JP., 1987, REPRODUCTION MARINE, P50	80	34	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80693	10.1371/journal.pone.0080693	http://dx.doi.org/10.1371/journal.pone.0080693			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236196	gold, Green Submitted, Green Published			2022-12-27	WOS:000327254700199
J	Srinivasan, M; Wang, Y; Sheets, A				Srinivasan, Manoj; Wang, Yang; Sheets, Alison			People Bouncing on Trampolines: Dramatic Energy Transfer, a Table-Top Demonstration, Complex Dynamics and a Zero Sum Game	PLOS ONE			English	Article							WALKING; MODEL; OPTIMIZATION	Jumping on trampolines is a popular backyard recreation. In some trampoline games (e. g., "seat drop war"), when two people land on the trampoline with only a small time-lag, one person bounces much higher than the other, as if energy has been transferred from one to the other. First, we illustrate this energy-transfer in a table-top demonstration, consisting of two balls dropped onto a mini-trampoline, landing almost simultaneously, sometimes resulting in one ball bouncing much higher than the other. Next, using a simple mathematical model of two masses bouncing passively on a massless trampoline with no dissipation, we show that with specific landing conditions, it is possible to transfer all the kinetic energy of one mass to the other through the trampoline - in a single bounce. For human-like parameters, starting with equal energy, the energy transfer is maximal when one person lands approximately when the other is at the bottom of her bounce. The energy transfer persists even for very stiff surfaces. The energy-conservative mathematical model exhibits complex non-periodic long-term motions. To complement this passive bouncing model, we also performed a game-theoretic analysis, appropriate when both players are acting strategically to steal the other player's energy. We consider a zero-sum game in which each player's goal is to gain the other player's kinetic energy during a single bounce, by extending her leg during flight. For high initial energy and a symmetric situation, the best strategy for both subjects (minimax strategy and Nash equilibrium) is to use the shortest available leg length and not extend their legs. On the other hand, an asymmetry in initial heights allows the player with more energy to gain even more energy in the next bounce. Thus synchronous bouncing unstable is unstable both for passive bouncing and when leg lengths are controlled as in game-theoretic equilibria.	[Srinivasan, Manoj; Wang, Yang; Sheets, Alison] Ohio State Univ, Columbus, OH 43210 USA	Ohio State University	Srinivasan, M (corresponding author), Ohio State Univ, Columbus, OH 43210 USA.	srinivasan.88@osu.edu	Srinivasan, Manoj/E-8751-2011	Srinivasan, Manoj/0000-0002-7811-3617				Berry MV, 1981, EUROPEAN J PHYS, V2; Black GB, 2003, CAN J SURG, V46, P199; Blajer W, 2003, MULTIBODY SYST DYN, V10, P289, DOI 10.1023/A:1025991618087; Bryson A.E., 2018, APPL OPTIMAL CONTROL, P90, DOI 10.1201/9781315137667-3; Chatterjee A, 1999, NONLINEAR DYNAM, V20, P159, DOI 10.1023/A:1008397905242; Chatterjee A, 1997, THESIS CORNELL U; Chiappori PA, 2002, AM ECON REV, V92, P1138, DOI 10.1257/00028280260344678; Chvatal V., 1983, LINEAR PROGRAMMING; Cross R, 2007, AM J PHYS, V75, P1009, DOI 10.1119/1.2772286; Davis Morton D., 2012, GAME THEORY NONTECHN; Dublin University Trampoline Club, 2011, SEAT DROP WARS DUBL; Esposito PW, 2009, CURR SPORT MED REP, V8, P273, DOI 10.1249/JSR.0b013e3181b8f60a; Fax JA, 2004, IEEE T AUTOMAT CONTR, V49, P1465, DOI 10.1109/TAC.2004.834433; Ferguson TS, 2013, GAME THEORY; Garcia M, 1998, J BIOMECH ENG-T ASME, V120, P281, DOI 10.1115/1.2798313; Gilet T, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.014501; Gilet T, 2009, J FLUID MECH, V625, P167, DOI 10.1017/S0022112008005442; Goldstein H., 2002, CLASSICAL MECH, Vthird; Guckenheimer J, 2013, APPL MATH SCI, V42; Hairer E., 2006, GEOMETRIC NUMERICAL, V31; Isaacs R., 1999, DIFFERENTIAL GAMES M; Ivanov AP, 1995, PMM-J APPL MATH MEC+, V59, P887, DOI 10.1016/0021-8928(95)00122-0; MEISS JD, 1992, REV MOD PHYS, V64, P795, DOI 10.1103/RevModPhys.64.795; Nash JF, 1950, ECONOMETRICA, V18, P155, DOI 10.2307/1907266; Pattar U, 2002, RESONANCE, V7, P67; Poundstone W., 1992, PHYS TODAY, V45, P73; Raghavan T., 1994, HDB GAME THEORY EC A, V2, P735; Ruina A, 2005, J THEOR BIOL, V237, P170, DOI 10.1016/j.jtbi.2005.04.004; Sheets AL, 2009, J BIOMECH, V42, P1685, DOI 10.1016/j.jbiomech.2009.04.014; Smith J.M., 1993, EVOLUTION THEORY GAM; Srinivasan M, 2006, NATURE, V439, P72, DOI 10.1038/nature04113; Srinivasan M, 2011, J R SOC INTERFACE, V8, P74, DOI 10.1098/rsif.2009.0544; Srinivasan M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.066609; TUFILLARO NB, 1992, EXPT APPROACH NONLIN; USTA, 2004, US TUMBL TRAMP ASS S; von Neumann J., 1947, THEORY GAMES EC BEHA, V2nd ed; Walker M, 2001, AM ECON REV, V91, P1521, DOI 10.1257/aer.91.5.1521; Wong KKL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010331; WOODWARD GA, 1992, PEDIATRICS, V89, P849	40	1	1	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78645	10.1371/journal.pone.0078645	http://dx.doi.org/10.1371/journal.pone.0078645			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236029	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700026
J	Tanneeru, K; Guruprasad, L				Tanneeru, Karunakar; Guruprasad, Lalitha			Ponatinib Is a Pan-BCR-ABL Kinase Inhibitor: MD Simulations and SIE Study	PLOS ONE			English	Article							SOLVATED INTERACTION ENERGY; CHRONIC MYELOID-LEUKEMIA; LIGAND-BINDING AFFINITIES; BOUNDARY-ELEMENT METHOD; PARTICLE MESH EWALD; CLINICAL RESISTANCE; TYROSINE KINASE; IMATINIB RESISTANCE; P-LOOP; MUTATIONS	BCR-ABL kinase domain inhibition can be used to treat chronic myeloid leukemia. The inhibitors such as imatinib, dasatinib and nilotinib are effective drugs but are resistant to some BCR-ABL mutations. The pan-BCR-ABL kinase inhibitor ponatinib exhibits potent activity against native, T315I, and all other clinically relevant mutants, and showed better inhibition than the previously known inhibitors. We have studied the molecular dynamics simulations and calculated solvated interaction energies of native and fourteen mutant BCR-ABL kinases (M244V, G250E, Q252H, Y253F, Y253H, E255K, E255V, T315A, T315I, F317L, F317V, M351T, F359V and H396P) complexed with ponatinib. These studies revealed that the interactions between ponatinib and individual residues in BCR-ABL kinase are also affected due to the remote residue mutations. We report that some residues, Met244, Lys245, Gln252, Gly254, Leu370 and Leu298 do not undergo any conformational changes, while the fluctuations in residues from P-loop, beta 3-, beta 5-strands and alpha C-helix are mainly responsible for ponatinib binding to native and all mutant BCR-ABL kinases. Our work provides the molecular mechanisms of native and mutant BCR-ABL kinases inhibition by ponatinib at atomic level that has not been studied before.	[Tanneeru, Karunakar; Guruprasad, Lalitha] Univ Hyderabad, Sch Chem, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad	Guruprasad, L (corresponding author), Univ Hyderabad, Sch Chem, Hyderabad 500134, Andhra Pradesh, India.	lgpsc@uohyd.ernet.in	Tanneeru, Karunakar/C-8200-2019; Tanneeru, Karunakar/C-8946-2016	Tanneeru, PhD, FICS, Dr. Karunakar/0000-0002-9250-6476	CSIR, Government of India [02(0036)/11/EMR-II]	CSIR, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by CSIR, Government of India, No. 02(0036)/11/EMR-II. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN PB, 1992, BAILLIERE CLIN HAEM, V5, P897, DOI 10.1016/S0950-3536(11)80051-X; Aqvist J, 2002, ACCOUNTS CHEM RES, V35, P358, DOI 10.1021/ar010014p; Branford S, 2003, BLOOD, V102, P276, DOI 10.1182/blood-2002-09-2896; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Carter TA, 2005, P NATL ACAD SCI USA, V102, P11011, DOI 10.1073/pnas.0504952102; Chan WW, 2011, CANCER CELL, V19, P556, DOI 10.1016/j.ccr.2011.03.003; Chen W, 2004, BIOPHYS J, V87, P3035, DOI 10.1529/biophysj.104.049494; Cui QZ, 2008, J MOL BIOL, V379, P787, DOI 10.1016/j.jmb.2008.04.035; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; DALEY GQ, 1991, ADV CANCER RES, V57, P151; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; Deininger MWN, 2000, BLOOD, V96, P3343, DOI 10.1182/blood.V96.10.3343; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Druker Brian J, 2002, Hematology Am Soc Hematol Educ Program, P111; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Faderl S, 1999, NEW ENGL J MED, V341, P164, DOI 10.1056/NEJM199907153410306; Gohlke H, 2004, J COMPUT CHEM, V25, P238, DOI 10.1022/jcc.10379; Goldman JM, 2001, BLOOD, V98, P2039, DOI 10.1182/blood.V98.7.2039; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Kantarjian H, 2006, NEW ENGL J MED, V354, P2542, DOI 10.1056/NEJMoa055104; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kuhn B, 2005, J MED CHEM, V48, P4040, DOI 10.1021/jm049081q; KURZROCK R, 1988, NEW ENGL J MED, V319, P990; Lee TS, 2008, CANCER-AM CANCER SOC, V112, P1744, DOI 10.1002/cncr.23355; Lill MA, 2011, J CHEM INF MODEL, V51, P2680, DOI 10.1021/ci200191m; Melo JV, 1996, BLOOD, V88, P2375, DOI 10.1182/blood.V88.7.2375.bloodjournal8872375; Modugno M, 2007, CANCER RES, V67, P7987, DOI 10.1158/0008-5472.CAN-07-1825; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Naim M, 2007, J CHEM INF MODEL, V47, P122, DOI 10.1021/ci600406v; Ottmann OG, 2002, BLOOD, V100, P1965, DOI 10.1182/blood-2001-12-0181; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pendergast A M, 1987, Baillieres Clin Haematol, V1, P1001, DOI 10.1016/S0950-3536(87)80036-7; PURISIMA EO, 1995, J COMPUT CHEM, V16, P681, DOI 10.1002/jcc.540160604; Purisima EO, 1998, J COMPUT CHEM, V19, P1494, DOI 10.1002/(SICI)1096-987X(199810)19:13<1494::AID-JCC6>3.0.CO;2-L; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Roche-Lestienne C, 2002, BLOOD, V100, P1014, DOI 10.1182/blood.V100.3.1014; Roumiantsev S, 2002, P NATL ACAD SCI USA, V99, P10700, DOI 10.1073/pnas.162140299; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Sousa da Silva Alan W, 2012, BMC Res Notes, V5, P367, DOI 10.1186/1756-0500-5-367; Sulea T, 2011, J CHEM INF MODEL, V51, P2066, DOI 10.1021/ci2000242; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Weisberg E, 2007, NAT REV CANCER, V7, P345, DOI 10.1038/nrc2126; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675; Zhou TJ, 2011, CHEM BIOL DRUG DES, V77, P1, DOI 10.1111/j.1747-0285.2010.01054.x; Zou XQ, 1999, J AM CHEM SOC, V121, P8033, DOI 10.1021/ja984102p	52	18	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78556	10.1371/journal.pone.0078556	http://dx.doi.org/10.1371/journal.pone.0078556			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236021	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700018
J	Reisberg, EE; Hildebrandt, U; Riederer, M; Hentschel, U				Reisberg, Eva E.; Hildebrandt, Ulrich; Riederer, Markus; Hentschel, Ute			Distinct Phyllosphere Bacterial Communities on Arabidopsis Wax Mutant Leaves	PLOS ONE			English	Article							TRANSPIRATION BARRIER PROPERTIES; PLANT-MICROBE INTERACTIONS; CUTICULAR WAXES; PSEUDOMONAS-SYRINGAE; ECERIFERUM MUTANTS; EPICUTICULAR WAXES; LEAF; COLONIZATION; DIVERSITY; TOMATO	The phyllosphere of plants is inhabited by diverse microorganisms, however, the factors shaping their community composition are not fully elucidated. The plant cuticle represents the initial contact surface between microorganisms and the plant. We thus aimed to investigate whether mutations in the cuticular wax biosynthesis would affect the diversity of the phyllosphere microbiota. A set of four Arabidopsis thaliana eceriferum mutants (cer1, cer6, cer9, cer16) and their respective wild type (Landsberg erecta) were subjected to an outdoor growth period and analysed towards this purpose. The chemical distinctness of the mutant wax phenotypes was confirmed by gas chromatographic measurements. Next generation amplicon pyrosequencing of the bacterial communities showed distinct community patterns. This observation was supported by denaturing gradient gel electrophoresis experiments. Microbial community analyses revealed bacterial phylotypes that were ubiquitously present on all plant lines (termed "core" community) while others were positively or negatively affected by the wax mutant phenotype (termed "plant line-specific" community). We conclude from this study that plant cuticular wax composition can affect the community composition of phyllosphere bacteria.	[Reisberg, Eva E.; Hildebrandt, Ulrich; Riederer, Markus; Hentschel, Ute] Univ Wurzburg, Dept Bot 2, Julius von Sachs Inst Biol Sci, D-97070 Wurzburg, Germany	University of Wurzburg	Hentschel, U (corresponding author), Univ Wurzburg, Dept Bot 2, Julius von Sachs Inst Biol Sci, D-97070 Wurzburg, Germany.	ute.hentschel@uni-wuerzburg.de	Riederer, Markus/B-5540-2008; Hentschel, Ute/ABD-6624-2021; Hentschel, Ute/H-8343-2013	Riederer, Markus/0000-0001-7081-1456; Hentschel, Ute/0000-0003-0596-790X; Hentschel, Ute/0000-0003-0596-790X	DFG Graduiertenkolleg 1342 "Lipid Signalling" [TP A8]; German Research Foundation (DFG); University of Wuerzburg	DFG Graduiertenkolleg 1342 "Lipid Signalling"; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This project was financially supported by the DFG Graduiertenkolleg 1342 "Lipid Signalling" (TP A8) to U. Hentschel/M. Riederer. URLs: http://www.dfg.de/en/; http://www.gk-1342.uni-wuerzburg.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. (The publication fee will be funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing.) URL: http://www.bibliothek.uni-wuerzburg.de/en/homepage/.	Bashan Y, 2002, APPL ENVIRON MICROB, V68, P2637, DOI 10.1128/AEM.68.6.2637-2643.2002; Beattie GA, 1999, PHYTOPATHOLOGY, V89, P353, DOI 10.1094/PHYTO.1999.89.5.353; Beattie GA, 2002, PHYLLOSPHERE MICROBIOLOGY, P3; Beattie GA, 2011, ANNU REV PHYTOPATHOL, V49, P533, DOI 10.1146/annurev-phyto-073009-114436; Bernard A, 2013, PROG LIPID RES, V52, P110, DOI 10.1016/j.plipres.2012.10.002; Bodenhausen N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056329; Bourdenx B, 2011, PLANT PHYSIOL, V156, P29, DOI 10.1104/pp.111.172320; Brandl MT, 1998, APPL ENVIRON MICROB, V64, P3256; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Burch AY, 2013, APPL ENVIRON MICROB, V79, P845, DOI 10.1128/AEM.02791-12; Burch AY, 2011, ENVIRON MICROBIOL, V13, P2681, DOI 10.1111/j.1462-2920.2011.02534.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; CURSTEDT T, 1974, BIOCHIM BIOPHYS ACTA, V360, P12, DOI 10.1016/0005-2760(74)90176-3; Delmotte N, 2009, P NATL ACAD SCI USA, V106, P16428, DOI 10.1073/pnas.0905240106; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ensikat HJ, 2011, BEILSTEIN J NANOTECH, V2, P152, DOI 10.3762/bjnano.2.19; Finkel OM, 2012, APPL ENVIRON MICROB, V78, P6187, DOI 10.1128/AEM.00888-12; Finkel OM, 2011, APPL ENVIRON MICROB, V77, P7647, DOI 10.1128/AEM.05565-11; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HANKIN L, 1968, J GEN MICROBIOL, V51, P457, DOI 10.1099/00221287-51-3-457; Hansjakob A, 2010, NEW PHYTOL, V188, P1039, DOI 10.1111/j.1469-8137.2010.03419.x; Hartmann A, 2012, J CHEM ECOL, V38, P704, DOI 10.1007/s10886-012-0141-7; Huang TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042124; Hunter PJ, 2010, APPL ENVIRON MICROB, V76, P8117, DOI 10.1128/AEM.01321-10; Innerebner G, 2011, APPL ENVIRON MICROB, V77, P3202, DOI 10.1128/AEM.00133-11; JENKS MA, 1995, PLANT PHYSIOL, V108, P369, DOI 10.1104/pp.108.1.369; Jenks MA, 1996, PHYTOCHEMISTRY, V42, P29, DOI 10.1016/0031-9422(95)00898-5; Jenks MA, 2002, ARABIDOPSIS BOOK, V1, pe0016; Jetter R, 2006, ANNU PLANT REV, V23, P145; Kadivar H, 2003, MICROBIAL ECOL, V45, P353, DOI 10.1007/s00248-002-1065-5; Kim M, 2012, MICROB ECOL, V63, P674, DOI 10.1007/s00248-011-9953-1; Knief C, 2010, MICROB ECOL, V60, P440, DOI 10.1007/s00248-010-9725-3; Knief C, 2010, ISME J, V4, P719, DOI 10.1038/ismej.2010.9; Knoll D, 2000, MICROB ECOL, V40, P33, DOI 10.1007/s002480000012; KOORNNEEF M, 1989, J HERED, V80, P118, DOI 10.1093/oxfordjournals.jhered.a110808; Krimm U, 2005, FEMS MICROBIOL ECOL, V53, P483, DOI 10.1016/j.femsec.2005.02.004; Larkin MJ, 2005, CURR OPIN BIOTECH, V16, P282, DOI 10.1016/j.copbio.2005.04.007; Lee CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044224; Leide J, 2007, PLANT PHYSIOL, V144, P1667, DOI 10.1104/pp.107.099481; Leveau JHJ, 2006, ANNU PLANT REV, V23, P334; Li YH, 2007, PLANT PHYSIOL, V144, P1267, DOI 10.1104/pp.107.099432; Lindow SE, 2003, APPL ENVIRON MICROB, V69, P1875, DOI 10.1128/AEM.69.4.1875-1883.2003; Lopez-Velasco G, 2011, J APPL MICROBIOL, V110, P1203, DOI 10.1111/j.1365-2672.2011.04969.x; Lu SY, 2012, PLANT PHYSIOL, V159, P930, DOI 10.1104/pp.112.198697; Marcell LM, 2002, MOL PLANT MICROBE IN, V15, P1236, DOI 10.1094/MPMI.2002.15.12.1236; MINTON KW, 1994, MOL MICROBIOL, V13, P9, DOI 10.1111/j.1365-2958.1994.tb00397.x; Monier JM, 2005, APPL ENVIRON MICROB, V71, P5484, DOI 10.1128/AEM.71.9.5484-5493.2005; Monier JM, 2003, P NATL ACAD SCI USA, V100, P15977, DOI 10.1073/pnas.2436560100; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; Muyzer G., 1998, MOL MICROBIAL ECOLOG, P1; Neinhuis C, 1998, NEW PHYTOL, V138, P91, DOI 10.1046/j.1469-8137.1998.00882.x; OBRIEN RD, 1989, PHYTOPATHOLOGY, V79, P619, DOI 10.1094/Phyto-79-619; Okamura K, 2009, J GEN APPL MICROBIOL, V55, P43, DOI 10.2323/jgam.55.43; Oksanen JF, 2012, PACKAGE VEGAN; PODILA GK, 1993, PLANT PHYSIOL, V103, P267, DOI 10.1104/pp.103.1.267; Prosser JI, 2010, ENVIRON MICROBIOL, V12, P1806, DOI 10.1111/j.1462-2920.2010.02201.x; Rashotte AM, 2001, PHYTOCHEMISTRY, V57, P115, DOI 10.1016/S0031-9422(00)00513-6; Rastogi G, 2012, ISME J, V6, P1812, DOI 10.1038/ismej.2012.32; Redford AJ, 2010, ENVIRON MICROBIOL, V12, P2885, DOI 10.1111/j.1462-2920.2010.02258.x; Reisberg EE, 2012, ANTON LEEUW INT J G, V101, P551, DOI 10.1007/s10482-011-9669-8; Remus-Emsermann MNP, 2012, ISME J, V6, P756, DOI 10.1038/ismej.2011.209; Riederer M, 2001, J EXP BOT, V52, P2023, DOI 10.1093/jexbot/52.363.2023; Riederer M, 2006, ANNU PLANT REV, V23, P1; Ryan MP, 2007, J APPL MICROBIOL, V103, P754, DOI 10.1111/j.1365-2672.2007.03361.x; Schreiber L, 2005, NEW PHYTOL, V166, P589, DOI 10.1111/j.1469-8137.2005.01343.x; Schreiber L, 2010, TRENDS PLANT SCI, V15, P546, DOI 10.1016/j.tplants.2010.06.004; Schulz S, 2012, ISME J, V6, P1763, DOI 10.1038/ismej.2012.17; Shanker KS, 2007, PHYTOCHEM ANALYSIS, V18, P7, DOI 10.1002/pca.942; Shepherd T, 1997, PHYTOCHEMISTRY, V46, P83, DOI 10.1016/S0031-9422(97)00272-0; SHEPHERD T, 1995, PHYTOCHEMISTRY, V40, P407, DOI 10.1016/0031-9422(95)00281-B; Shepherd T, 2006, NEW PHYTOL, V171, P469, DOI 10.1111/j.1469-8137.2006.01826.x; Shin DH, 2012, J MICROBIOL BIOTECHN, V22, P448, DOI 10.4014/jmb.1108.08087; Truyens S, 2012, PLANT BIOL IN PRESS; Tsuba M, 2002, PHYSIOL MOL PLANT P, V60, P51, DOI 10.1006/pmpp.2002.0376; Vogg G, 2004, J EXP BOT, V55, P1401, DOI 10.1093/jxb/erh149; Vorholt JA, 2012, NAT REV MICROBIOL, V10, P828, DOI 10.1038/nrmicro2910; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Warnes G., 2012, PACKAGE GPLOTS	81	58	62	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78613	10.1371/journal.pone.0078613	http://dx.doi.org/10.1371/journal.pone.0078613			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223831	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000326597400035
J	Fujita, A; Koinuma, S; Yasuda, S; Nagai, H; Kamiguchi, H; Wada, N; Nakamura, T				Fujita, Akane; Koinuma, Shingo; Yasuda, Sayaka; Nagai, Hiroyuki; Kamiguchi, Hiroyuki; Wada, Naoyuki; Nakamura, Takeshi			GTP Hydrolysis of TC10 Promotes Neurite Outgrowth through Exocytic Fusion of Rab11-and L1-Containing Vesicles by Releasing Exocyst Component Exo70	PLOS ONE			English	Article							AXONAL GROWTH CONES; PLASMA-MEMBRANE; PC12 CELLS; RHO FAMILY; N-WASP; MAMMALIAN-CELLS; SMALL GTPASES; T-SNARE; PROTEIN; COMPLEX	The use of exocytosis for membrane expansion at nerve growth cones is critical for neurite outgrowth. TC10 is a Rho family GTPase that is essential for specific types of vesicular trafficking to the plasma membrane. Recent studies have shown that TC10 and its effector Exo70, a component of the exocyst tethering complex, contribute to neurite outgrowth. However, the molecular mechanisms of the neuritogenesis-promoting functions of TC10 remain to be established. Here, we propose that GTP hydrolysis of vesicular TC10 near the plasma membrane promotes neurite outgrowth by accelerating vesicle fusion by releasing Exo70. Using Forster resonance energy transfer (FRET)-based biosensors, we show that TC10 activity at the plasma membrane decreased at extending growth cones in hippocampal neurons and nerve growth factor (NGF)-treated PC12 cells. In neuronal cells, TC10 activity at vesicles was higher than its activity at the plasma membrane, and TC10-positive vesicles were found to fuse to the plasma membrane in NGF-treated PC12 cells. Therefore, activity of TC10 at vesicles is presumed to be inactivated near the plasma membrane during neuronal exocytosis. Our model is supported by functional evidence that constitutively active TC10 could not rescue decrease in NGF-induced neurite outgrowth induced by TC10 depletion. Furthermore, TC10 knockdown experiments and colocalization analyses confirmed the involvement of Exo70 in TC10-mediated trafficking in neuronal cells. TC10 frequently resided on vesicles containing Rab11, which is a key regulator of recycling pathways and implicated in neurite outgrowth. In growth cones, most of the vesicles containing the cell adhesion molecule L1 had TC10. Exocytosis of Rab11- and L1-positive vesicles may play a central role in TC10-mediated neurite outgrowth. The combination of this study and our previous work on the role of TC10 in EGF-induced exocytosis in HeLa cells suggests that the signaling machinery containing TC10 proposed here may be broadly used for exocytosis.	[Fujita, Akane; Koinuma, Shingo; Yasuda, Sayaka; Nagai, Hiroyuki; Nakamura, Takeshi] Tokyo Univ Sci, Res Inst Biomed Sci, Div Biosignaling, Noda, Chiba 278, Japan; [Nagai, Hiroyuki] RIKEN, Brain Sci Inst, Lab Neuronal Growth Mech, Wako, Saitama, Japan; [Wada, Naoyuki] Tokyo Univ Sci, Dept Appl Biol Sci, Noda, Chiba 278, Japan	Tokyo University of Science; RIKEN; Tokyo University of Science	Nakamura, T (corresponding author), Tokyo Univ Sci, Res Inst Biomed Sci, Div Biosignaling, Noda, Chiba 278, Japan.	tnakamr@rs.noda.tus.ac.jp	Kamiguchi, Hiroyuki/N-5409-2015	Kamiguchi, Hiroyuki/0000-0003-1802-6324; Koinuma, Shingo/0000-0001-8653-0501	Japan Society for the Promotion of Science [23300134, 24657094]; Yamada Science Foundation; Grants-in-Aid for Scientific Research [24657094] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Yamada Science Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (23300134 and 24657094) from Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html) and the Yamada Science Foundation (http://www.yamadazaidan.jp/english.html) to TN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2003, J CELL SCI, V116, P155, DOI 10.1242/jcs.00208; Alberts P, 2006, MOL BIOL CELL, V17, P1194, DOI 10.1091/mbc.E05-07-0643; Aoki K, 2004, J BIOL CHEM, V279, P713, DOI 10.1074/jbc.M306382200; Aoki K, 2007, J CELL BIOL, V177, P817, DOI 10.1083/jcb.200609017; Bhuin T, 2009, CELL TISSUE RES, V335, P349, DOI 10.1007/s00441-008-0711-8; Bodrikov V, 2011, J NEUROSCI, V31, P18013, DOI 10.1523/JNEUROSCI.4729-11.2011; Boyd C, 2004, J CELL BIOL, V167, P889, DOI 10.1083/jcb.200408124; Bridges D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042451; Brocker C, 2010, CURR BIOL, V20, pR943, DOI 10.1016/j.cub.2010.09.015; Cheng J, 2005, J BIOL CHEM, V280, P3731, DOI 10.1074/jbc.M410026200; Chiang SH, 2001, NATURE, V410, P944, DOI 10.1038/35073608; CRAIG AM, 1995, NATURE, V375, P592, DOI 10.1038/375592a0; Cuadra AE, 2004, J NEUROSCI, V24, P7491, DOI 10.1523/JNEUROSCI.1255-04.2004; Dupraz S, 2009, J NEUROSCI, V29, P13292, DOI 10.1523/JNEUROSCI.3907-09.2009; Eva R, 2010, J NEUROSCI, V30, P11654, DOI 10.1523/JNEUROSCI.2425-10.2010; Futerman AH, 1996, TRENDS NEUROSCI, V19, P144, DOI 10.1016/S0166-2236(96)80025-7; Gonzalez-Billault C, 2012, CYTOSKELETON, V69, P464, DOI 10.1002/cm.21034; Goslin K., 1998, CULTURING NERVE CELL, P339; Goto A, 2011, MOL BIOL CELL, V22, P1780, DOI 10.1091/mbc.E10-09-0783; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; Gupton SL, 2010, DEV CELL, V18, P725, DOI [10.1016/j.devcel.2010.02.017, 10.1016/j.devce1.2010.02.017]; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; Hazuka CD, 1999, J NEUROSCI, V19, P1324; He B, 2007, EMBO J, V26, P4053, DOI 10.1038/sj.emboj.7601834; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Heider MR, 2012, TRAFFIC, V13, P898, DOI 10.1111/j.1600-0854.2012.01353.x; HIGASHIDA H, 1983, BRAIN RES, V279, P363, DOI 10.1016/0006-8993(83)90211-1; Igarashi M, 1996, J CELL BIOL, V134, P205, DOI 10.1083/jcb.134.1.205; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; Kamiguchi H, 2000, J NEUROSCI, V20, P3676, DOI 10.1523/JNEUROSCI.20-10-03676.2000; Kanzaki M, 2002, MOL BIOL CELL, V13, P2334, DOI 10.1091/mbc.01-10-0490; Kawase K, 2006, DEV CELL, V11, P411, DOI 10.1016/j.devcel.2006.07.008; Liu JL, 2007, MOL BIOL CELL, V18, P4483, DOI 10.1091/mbc.E07-05-0461; Mehta SQ, 2005, NEURON, V46, P219, DOI 10.1016/j.neuron.2005.02.029; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Mohammadi S, 2013, J CELL BIOL, V200, P81, DOI 10.1083/jcb.201204090; Moskalenko S, 2003, J BIOL CHEM, V278, P51743, DOI 10.1074/jbc.M308702200; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Nakamura T, 2002, MOL CELL BIOL, V22, P8721, DOI 10.1128/MCB.22.24.8721-8734.2002; Nakamura T, 1999, J BIOL CHEM, V274, P13322, DOI 10.1074/jbc.274.19.13322; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Nishimura K, 2003, J CELL BIOL, V163, P1077, DOI 10.1083/jcb.200303060; Ory S, 2011, SEMIN CELL DEV BIOL, V22, P27, DOI 10.1016/j.semcdb.2010.12.002; Pfenninger KH, 2009, NAT REV NEUROSCI, V10, P251, DOI 10.1038/nrn2593; PFENNINGER KH, 1993, DEV BRAIN RES, V71, P181, DOI 10.1016/0165-3806(93)90170-F; PFENNINGER KH, 1981, J CELL BIOL, V89, P547, DOI 10.1083/jcb.89.3.547; Pommereit D, 2007, J CELL SCI, V120, P2694, DOI 10.1242/jcs.03475; Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3; Sann S, 2009, TRENDS CELL BIOL, V19, P317, DOI 10.1016/j.tcb.2009.05.001; Sivaram MVS, 2005, BIOCHEMISTRY-US, V44, P6302, DOI 10.1021/bi048008z; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Stuermer CAO, 2010, TRENDS CELL BIOL, V20, P6, DOI 10.1016/j.tcb.2009.10.003; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sugihara K, 2002, NAT CELL BIOL, V4, P73, DOI 10.1038/ncb720; Takahashi S, 2012, J CELL SCI, V125, P4049, DOI 10.1242/jcs.102913; Takano T, 2012, J NEUROSCI, V32, P6587, DOI 10.1523/JNEUROSCI.5317-11.2012; Tanabe K, 2000, J NEUROSCI, V20, P4138; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Tojima T, 2007, NAT NEUROSCI, V10, P58, DOI 10.1038/nn1814; Tojima T, 2010, NEURON, V66, P370, DOI 10.1016/j.neuron.2010.04.007; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; van IJzendoorn SCD, 2006, J CELL SCI, V119, P1679, DOI 10.1242/jcs.02948; Walsh FS, 1997, SOC GEN PHY, V52, P221; Wiederkehr A, 2004, J CELL BIOL, V167, P875, DOI 10.1083/jcb.200408001; Wu H, 2008, TRENDS CELL BIOL, V18, P397, DOI 10.1016/j.tcb.2008.06.007; Zhang XM, 2004, J BIOL CHEM, V279, P43027, DOI 10.1074/jbc.M402264200; ZHENG JQ, 1994, J CELL BIOL, V127, P1693, DOI 10.1083/jcb.127.6.1693	68	38	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79689	10.1371/journal.pone.0079689	http://dx.doi.org/10.1371/journal.pone.0079689			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223996	Green Submitted, Green Published, gold			2022-12-27	WOS:000326503400139
J	Laycock, I; Cresswell, JE				Laycock, Ian; Cresswell, James E.			Repression and Recuperation of Brood Production in Bombus terrestris Bumble Bees Exposed to a Pulse of the Neonicotinoid Pesticide Imidacloprid	PLOS ONE			English	Article							DECREASES FORAGING SUCCESS; APIS-MELLIFERA; LEARNING PERFORMANCES; COLONY GROWTH; HONEY-BEES; SURVIVAL; INSECTICIDES; ABUNDANCE; DECLINES; QUEENS	Currently, there is concern about declining bee populations and some blame the residues of neonicotinoid pesticides in the nectar and pollen of treated crops. Bumble bees are important wild pollinators that are widely exposed to dietary neonicotinoids by foraging in agricultural environments. In the laboratory, we tested the effect of a pulsed exposure (14 days 'on dose' followed by 14 days 'off dose') to a common neonicotinoid, imidacloprid, on the amount of brood (number of eggs and larvae) produced by Bombus terrestris L. bumble bees in small, standardised experimental colonies (a queen and four adult workers). During the initial 'on dose' period we observed a dose-dependent repression of brood production in colonies, with productivity decreasing as dosage increased up to 98 mu g kg(-1) dietary imidacloprid. During the following 'off dose' period, colonies showed a dose-dependent recuperation such that total brood production during the 28-day pulsed exposure was not correlated with imidacloprid up to 98 mu g kg(-1). Our findings raise further concern about the threat to wild bumble bees from neonicotinoids, but they also indicate some resilience to a pulsed exposure, such as that arising from the transient bloom of a treated mass-flowering crop.	[Laycock, Ian; Cresswell, James E.] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England; [Cresswell, James E.] Univ Calcutta, Ctr Pollinat Studies, Kolkata, India	University of Exeter; University of Calcutta	Laycock, I (corresponding author), Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England.	il219@exeter.ac.uk			Natural Environment Research Council	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	IL was supported by a studentship from the Natural Environment Research Council (http://www.nerc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acreage, 2012, ACR; Ak?akaya H.R., 2008, DEMOGRAPHIC TOXICITY, P3; Amin MR, 2012, J INSECT BEHAV, V25, P362, DOI 10.1007/s10905-011-9306-4; [Anonymous], LATE LESSONS EARLY W; Azevedo-Pereira HMVS, 2011, WATER AIR SOIL POLL, V219, P215, DOI 10.1007/s11270-010-0700-x; Beekman M, 1998, ENTOMOL EXP APPL, V89, P207, DOI 10.1023/A:1003595306816; Brown MJF, 2003, J ANIM ECOL, V72, P994, DOI 10.1046/j.1365-2656.2003.00770.x; Burkle LA, 2013, SCIENCE, V339, P1611, DOI 10.1126/science.1232728; Cresswell JE, 2014, PEST MANAG SCI, V70, P332, DOI 10.1002/ps.3569; Cresswell JE, 2012, ZOOLOGY, V115, P365, DOI 10.1016/j.zool.2012.05.003; Cresswell JE, 2012, SCIENCE, V337, DOI 10.1126/science.1224618; Cresswell JE, 2012, PEST MANAG SCI, V68, P819, DOI 10.1002/ps.3290; Cresswell JE, 2011, ECOTOXICOLOGY, V20, P149, DOI 10.1007/s10646-010-0566-0; Decourtye A, 2003, PEST MANAG SCI, V59, P269, DOI 10.1002/ps.631; Decourtye A, 2010, ADV EXP MED BIOL, V683, P85; DEFRA, 2012, AGR UK 2011; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2752; European Food Safety Authority, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3295; FERA, 2013, PEST US SURV; Genersch E, 2006, J INVERTEBR PATHOL, V91, P61, DOI 10.1016/j.jip.2005.10.002; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Goulson D, 2004, APIDOLOGIE, V35, P55, DOI 10.1051/apido:2003062; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; He YX, 2012, ECOTOXICOLOGY, V21, P1291, DOI 10.1007/s10646-012-0883-6; He YX, 2011, J ECON ENTOMOL, V104, P833, DOI 10.1603/EC10281; Heinrich B, 2004, BUMBLEBEE EC, P7; Henry M, 2012, SCIENCE, V337, DOI 10.1126/science.1224930; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Hoyle M, 2007, ECOL APPL, V17, P2123, DOI 10.1890/06-1972.1; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; Laycock I, 2012, ECOTOXICOLOGY, V21, P1937, DOI 10.1007/s10646-012-0927-y; Lopez-Vaamonde C, 2004, NATURE, V430, P557, DOI 10.1038/nature02769; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Mommaerts V, 2010, ECOTOXICOLOGY, V19, P207, DOI 10.1007/s10646-009-0406-2; Moncharmont FXD, 2003, ENVIRON TOXICOL CHEM, V22, P3088, DOI 10.1897/02-578; MULLER CB, 1992, ECOL ENTOMOL, V17, P343, DOI 10.1111/j.1365-2311.1992.tb01068.x; NAUEN R, 1995, PESTIC SCI, V44, P145, DOI 10.1002/ps.2780440207; OWEN RE, 1980, BEHAV ECOL SOCIOBIOL, V7, P287, DOI 10.1007/BF00300669; PLOWRIGHT RC, 1968, INSECT SOC, V15, P171, DOI 10.1007/BF02223465; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Pyke GH, 2011, ECOL ENTOMOL, V36, P511, DOI 10.1111/j.1365-2311.2011.01295.x; Ramirez-Romero R, 2005, APIDOLOGIE, V36, P601, DOI 10.1051/apido:2005039; Rennich K., 2012, 2011 2012 NATL HONEY; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Shardlow M, 2012, REV RECENT RES RELAT; Statistics Canada, 2012, 2011 CENS AGR; Stelzer RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009559; Suchail S, 2004, PEST MANAG SCI, V60, P1056, DOI 10.1002/ps.895; Tasei JN, 2000, PEST MANAG SCI, V56, P784, DOI 10.1002/1526-4998(200009)56:9<784::AID-PS208>3.0.CO;2-T; Tomizawa M, 2003, ANNU REV ENTOMOL, V48, P339, DOI 10.1146/annurev.ento.48.091801.112731; Vogt FD, 1998, CAN J ZOOL, V76, P2026, DOI 10.1139/cjz-76-11-2026; Westphal C, 2009, J APPL ECOL, V46, P187, DOI 10.1111/j.1365-2664.2008.01580.x; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Williams PH, 2009, APIDOLOGIE, V40, P367, DOI 10.1051/apido/2009025	56	36	36	2	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79872	10.1371/journal.pone.0079872	http://dx.doi.org/10.1371/journal.pone.0079872			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24224015	Green Submitted, Green Published, gold			2022-12-27	WOS:000326503400146
J	Ouyang, JQ; Zheng, H; Kong, FB; Liu, TM				Ouyang, Jianquan; Zheng, Hao; Kong, Fanbin; Liu, Tianming			Visual Exploratory Search of Relationship Graphs on Smartphones	PLOS ONE			English	Article							INFORMATION EXPLORATION	This paper presents a novel framework for Visual Exploratory Search of Relationship Graphs on Smartphones (VESRGS) that is composed of three major components: inference and representation of semantic relationship graphs on the Web via meta-search, visual exploratory search of relationship graphs through both querying and browsing strategies, and human-computer interactions via the multi-touch interface and mobile Internet on smartphones. In comparison with traditional lookup search methodologies, the proposed VESRGS system is characterized with the following perceived advantages. 1) It infers rich semantic relationships between the querying keywords and other related concepts from large-scale meta-search results from Google, Yahoo! and Bing search engines, and represents semantic relationships via graphs; 2) the exploratory search approach empowers users to naturally and effectively explore, adventure and discover knowledge in a rich information world of interlinked relationship graphs in a personalized fashion; 3) it effectively takes the advantages of smartphones' user-friendly interfaces and ubiquitous Internet connection and portability. Our extensive experimental results have demonstrated that the VESRGS framework can significantly improve the users' capability of seeking the most relevant relationship information to their own specific needs. We envision that the VESRGS framework can be a starting point for future exploration of novel, effective search strategies in the mobile Internet era.	[Ouyang, Jianquan; Zheng, Hao] Xiangtan Univ, Coll Informat Engn, Xiangtan, Hunan, Peoples R China; [Kong, Fanbin] Univ Georgia, Dept Food Sci, Athens, GA 30602 USA; [Liu, Tianming] Univ Georgia, Dept Comp Sci, Athens, GA 30602 USA	Xiangtan University; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Liu, TM (corresponding author), Univ Georgia, Dept Comp Sci, Athens, GA 30602 USA.	tliu@cs.uga.edu	ouyang, jian-quan/A-2159-2011; Liu, Tianming/AAA-4602-2022	kong, fanbin/0000-0002-7477-9948				ACM, 2007, SIGCHI WORKSH EPXL S; Albaham AT, 2013, LECT NOTES COMPUT SC, V7802, P325; Alonso O, 2007, SIGCHI 2007 WORKSH E; [Anonymous], 2010, NOTES EXPLORING FUTU; Aslam J. A., 2001, SIGIR Forum, P276; Bizer C, 2009, INT J SEMANT WEB INF, V5, P1, DOI 10.4018/jswis.2009081901; BRACHMAN RJ, 1977, INT J MAN MACH STUD, V9, P127, DOI 10.1016/S0020-7373(77)80017-5; Cimiano P, 2004, P 4 INT C LANG RES E; Dork M, 2008, IEEE T VIS COMPUT GR, V14, P1205, DOI 10.1109/TVCG.2008.175; Donaldson JJ, 2008, 19 ACM C HYP HYP; Egusa Y, 2010, P 3 ACM S INF INT CO; Faure D, 1998, LREC WORKSH AD LEX C; Fellbaum Christiane, 2005, ENCY LANGUAGE LINGUI, P665; Gersh J, 2006, COMMUN ACM, V49, P63, DOI 10.1145/1121949.1121984; Guinney J, 2010, JSM P AM STAT ASS VA, P4887; Hahn U, 1998, FIFTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE (AAAI-98) AND TENTH CONFERENCE ON INNOVATIVE APPLICATIONS OF ARTIFICAL INTELLIGENCE (IAAI-98) - PROCEEDINGS, P524; Hearst M. A., 2009, SEARCH USER INTERFAC; HEARST MA, 1998, WORDNET ELECT LEXICA, P132; Hearst MA, 1992, P COLING 92 NANT FRA; Heimonen T., 2007, P 9 INT C HUMAN COMP, V309, P397; Hu XT, 2012, IEEE T MULTIMEDIA, V14, P314, DOI 10.1109/TMM.2011.2172201; Huh SY, 2010, J AM DIET ASSOC, V110, P563, DOI 10.1016/j.jada.2009.12.025; Karlson A. K., 2006, Conference on Human Factors in Computing Systems. CHI2006, P711; Landauer TK, 1998, DISCOURSE PROCESS, V25, P259, DOI 10.1080/01638539809545028; Lee L, 1997, TR1197 HARV U; Li X, 2011, IPAD BIOIMAGE INFORM; Marchionini G, 2006, COMMUN ACM, V49, P41, DOI 10.1145/1121949.1121979; Marchionini G, 2003, J DIGIT INF, V4; Melnik S, 2002, P 18 INT C DAT ENG; Meng WY, 2002, ACM COMPUT SURV, V34, P48, DOI 10.1145/505282.505284; Miller G., 1990, INT J LEXICOGR, V3, P235, DOI DOI 10.1093/IJL/3.4.235; Mu XM, 2011, J BIOMED INFORM, V44, P576, DOI 10.1016/j.jbi.2011.01.008; Nolan M, 2008, B AM SOC INFORM SCI, V34, P38; Pujol JP, 2009, P WWW 09; Richardson S.-D., 1998, ACL, P1098, DOI DOI 10.3115/980691; Ruiz-Casado M, 2005, LECT NOTES COMPUT SC, V3513, P67; Shami N. S., 2011, P ACM 2011 C COMP SU; Shastri L, 1988, SEMANTIC NETWORKS EV; Shneiderman B., 2005, DESIGNING USER INTER; Sowa JF, 1991, PRINCIPLES SEMANTIC; Tunkelang D, 2009, ACETED SEARCH SYNTHE; Tvarozek M, 2008, P HYP 2008 WORKSH CO, P29; Wagner Andreas, 2011, Database and Expert Systems Applications. Proceedings 22nd International Conference, DEXA 2011, P303, DOI 10.1007/978-3-642-23088-2_22; Westlund O, 2011, BEHAV INFORM TECHNOL, V30, P691, DOI 10.1080/0144929X.2010.516020; White RW, 2006, COMMUN ACM, V49, P37; Yee K.P., 2003, P SIGCHI C HUM FACT, P401, DOI DOI 10.1145/642611.642681; Zhu H., 2002, P 15 INT FLOR ART IN, P450; Zinman GE, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-134	48	0	0	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79379	10.1371/journal.pone.0079379	http://dx.doi.org/10.1371/journal.pone.0079379			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223936	Green Published, Green Submitted, gold			2022-12-27	WOS:000326503400109
J	Retana, C; Sanchez, EI; Gonzalez, S; Perez-Lopez, A; Cruz, A; Lagunas-Munoz, J; Alfaro-Cruz, C; Vital-Flores, S; Reyes, JL				Retana, Carmen; Sanchez, Elsa I.; Gonzalez, Sirenia; Perez-Lopez, Alejandro; Cruz, Armando; Lagunas-Munoz, Jesus; Alfaro-Cruz, Carmen; Vital-Flores, Socorro; Reyes, Jose L.			Retinoic Acid Improves Morphology of Cultured Peritoneal Mesothelial Cells from Patients Undergoing Dialysis	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; HIGH GLUCOSE; MESENCHYMAL TRANSITION; FACTOR-BETA; SURFACE; EXPRESSION; SINUS; DIFFERENTIATION; MICROVILLI; INDUCTION	Patients undergoing continuous ambulatory peritoneal dialysis are classified according to their peritoneal permeability as low transporter (low solute permeability) or High transporter (high solute permeability). Factors that determine the differences in permeability between them have not been fully disclosed. We investigated morphological features of cultured human peritoneal mesothelial cells from low or high transporter patients and its response to All trans retinoic Acid (ATRA, vitamin A active metabolite), as compared to non-uremic human peritoneal mesothelial cells. Control cells were isolated from human omentum. High or low transporter cells were obtained from dialysis effluents. Cells were cultured in media containing ATRA (0, 50, 100 or 200 nM). We studied length and distribution of microvilli and cilia (scanning electron microscopy), epithelial (cytokeratin, claudin-1, ZO-1 and occludin) and mesenchymal (vimentin and alpha-smooth muscle actin) transition markers by immunofluorescence and Western blot, and transforming growth factor beta 1 expression by Western blot. Low and high transporter exhibited hypertrophic cells, reduction in claudin-1, occludin and ZO-1 expression, cytokeratin and vimentin disorganization and positive alpha-smooth muscle actin label. Vimentin, alpha-smooth muscle actin and transforming growth factor- beta 1 were overexpressed in low transporter. Ciliated cells were diminished in low and high transporters. Microvilli number and length were severely reduced in high transporter. ATRA reduced hypertrophic cells number in low transporter. It also improved cytokeratin and vimentin organization, decreased vimentin and alpha-smooth muscle actin expression, and increased claudin 1, occludin and ZO-1 expression, in low and high transporter. In low transporter, ATRA reduced transforming growth factor-beta 1 expression. ATRA augmented percentage of ciliated cells in low and high transporter. It also augmented cilia length in high transporter. Alterations in structure, epithelial mesenchymal markers and transforming growth factor-beta 1expression were differential between low and high transporter. Beneficial effects of ATRA were improved human peritoneal mesothelial cells morphology tending to normalize structures.	[Retana, Carmen] Natl Polytech Inst, Ctr Res & Adv Studies, Dept Pharmacol, Mexico City, DF, Mexico; [Sanchez, Elsa I.; Reyes, Jose L.] Natl Polytech Inst, Ctr Res & Adv Studies, Physiol Biophys & Neurosci Dept, Mexico City, DF, Mexico; [Gonzalez, Sirenia] Natl Polytech Inst, Ctr Res & Adv Studies, Cent Labs, Mexico City, DF, Mexico; [Perez-Lopez, Alejandro] Hosp Cent Norte Petr Mexicanos, Dept Nephrol, Mexico City, DF, Mexico; [Cruz, Armando; Lagunas-Munoz, Jesus] Hosp Gen Raza, Inst Mexicano Seguro Social, Dept Nephrol, Unidad Med Alta Especialidad, Mexico City, DF, Mexico; [Cruz, Armando; Lagunas-Munoz, Jesus] Hosp Gen Raza, Inst Mexicano Seguro Social, Dept Gynecol, Unidad Med Alta Especialidad, Mexico City, DF, Mexico; [Alfaro-Cruz, Carmen] Hosp Reg 1, Inst Mexicano Seguro Social, Dept Nephrol, Mexico City, DF, Mexico; [Vital-Flores, Socorro] Hosp Juarez Mexico, Dept Nephrol, Mexico City, DF, Mexico	Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico; Instituto Mexicano del Seguro Social; Instituto Mexicano del Seguro Social; Instituto Mexicano del Seguro Social	Reyes, JL (corresponding author), Natl Polytech Inst, Ctr Res & Adv Studies, Physiol Biophys & Neurosci Dept, Mexico City, DF, Mexico.	jreyes@fisio.cinvestav.mx	Retana Contreras, Maria del Carmen/Q-8946-2018	Retana Contreras, Maria del Carmen/0000-0003-0457-8478	Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico [0179870];  [CONACYT 176602]	Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); 	Study partially supported by Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico (Grant 0179870). Carmen Retana had a postgraduate fellowship (CONACYT 176602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bird SD, 2004, CELL BIOL INT, V28, P79, DOI 10.1016/j.cellbi.2003.11.014; BOMAN BM, 1983, LAB INVEST, V48, P199; BORNSTEIN MB, 1958, LAB INVEST, V7, P134; Cardenas-Rodriguez M, 2009, AM J MED GENET C, V151C, P263, DOI 10.1002/ajmg.c.30227; Chan TM, 2003, NEPHROL DIAL TRANSPL, V18, P1086, DOI 10.1093/ndt/gfg096; Clagett-Dame M, 2011, NUTRIENTS, V3, P385, DOI 10.3390/nu3040385; COHEN PS, 1995, CANCER RES, V55, P2380; Correa-Rotter R, 2001, PERITON DIALYSIS INT, V21, pS75; Danielpour D, 1996, J CELL PHYSIOL, V166, P231, DOI 10.1002/(SICI)1097-4652(199601)166:1<231::AID-JCP24>3.0.CO;2-G; Diaz C, 1998, ADV PERIT D, V14, P19; Erickson VR, 2008, AM J RHINOL, V22, P334, DOI 10.2500/ajr.2008.22.3176; Fang W, 2004, CHINESE MED J-PEKING, V117, P862; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; GOTLOIB L, 1989, NEPHRON, V51, P77, DOI 10.1159/000185247; GuerreroBarrera AL, 1996, MICROBIOL-SGM, V142, P1133, DOI 10.1099/13500872-142-5-1133; Hill EM, 1998, AM J RESP CELL MOL, V18, P662, DOI 10.1165/ajrcmb.18.5.2985; Hills CE, 2012, DIABETOLOGIA, V55, P812, DOI 10.1007/s00125-011-2409-9; HONG WK, 1994, LEUKEMIA, V8, pS33; Hwang PH, 2006, LARYNGOSCOPE, V116, P1080, DOI 10.1097/01.mlg.0000224352.50256.99; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kang DH, 1999, PERITON DIALYSIS INT, V19, P221; KIM KH, 1987, J CELL BIOL, V105, P3039, DOI 10.1083/jcb.105.6.3039; Ksiazek K, 2007, LAB INVEST, V87, P345, DOI 10.1038/labinvest.3700519; Kultti A, 2006, J BIOL CHEM, V281, P15821, DOI 10.1074/jbc.M512840200; Lange K, 2001, AM J PHYSIOL-CELL PH, V281, pC369, DOI 10.1152/ajpcell.2001.281.2.C369; Lange K, 2011, J CELL PHYSIOL, V226, P896, DOI 10.1002/jcp.22302; Lee EA, 2001, PERITON DIALYSIS INT, V21, P245; Lee HB, 2007, J KOREAN MED SCI, V22, P943, DOI 10.3346/jkms.2007.22.6.943; Lee YM, 2008, J BIOL CHEM, V283, P33969, DOI 10.1074/jbc.M804469200; Leung MK, 2007, AM J RHINOL, V21, P271, DOI 10.2500/ajr.2007.21.3035; Liu QH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032009; Lopez-Cabrera M, 2006, PERITON DIALYSIS INT, V26, P26; Million K, 2001, AM J RESP CELL MOL, V25, P744, DOI 10.1165/ajrcmb.25.6.4549; Mutsaers SE, 2002, RESPIROLOGY, V7, P171, DOI 10.1046/j.1440-1843.2002.00404.x; Mutsaers SE, 2004, INT J BIOCHEM CELL B, V36, P9, DOI 10.1016/S1357-2725(03)00242-5; Mutsaers SE, 1996, J PATHOL, V180, P333; Pasonen-Seppanen SM, 2008, J INVEST DERMATOL, V128, P797, DOI 10.1038/sj.jid.5701098; Piskunov A, 2012, ONCOGENE, V31, P3333, DOI 10.1038/onc.2011.499; Rohatgi R, 2010, CURR OPIN CELL BIOL, V22, P541, DOI 10.1016/j.ceb.2010.03.010; Saavalainen K, 2005, J BIOL CHEM, V280, P14636, DOI 10.1074/jbc.M500206200; Singh B, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-82; Strippoli R, 2010, J CELL SCI, V123, P4321, DOI 10.1242/jcs.071647; Wang Gui-hua, 2008, Sichuan Da Xue Xue Bao Yi Xue Ban, V39, P575; Wang T, 1998, NEPHROL DIAL TRANSPL, V13, P1242, DOI 10.1093/ndt/13.5.1242; Witowski J, 2008, NEPHRON EXP NEPHROL, V108, pE69, DOI 10.1159/000126920; Wolf G, 2001, AM J PATHOL, V158, P1091, DOI 10.1016/S0002-9440(10)64056-4; YANEZ MM, 2003, N ENGL MED, P403; Yang AH, 2003, KIDNEY INT, V63, P1530, DOI 10.1046/j.1523-1755.2003.00861.x; Yung S, 2006, PERITON DIALYSIS INT, V26, P162; Yung S, 2007, PERITON DIALYSIS INT, V27, pS110; Yung S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/484167; Zhong H, 2009, INT J HEMATOL, V89, P438, DOI 10.1007/s12185-009-0293-6	52	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79678	10.1371/journal.pone.0079678	http://dx.doi.org/10.1371/journal.pone.0079678			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223992	Green Submitted, Green Published, gold			2022-12-27	WOS:000326503400137
J	Rajayer, SR; Jacob, A; Yang, WL; Zhou, MA; Chaung, WN; Wang, P				Rajayer, Salil R.; Jacob, Asha; Yang, Weng-Lang; Zhou, Mian; Chaung, Wayne; Wang, Ping			Cold-Inducible RNA-Binding Protein Is an Important Mediator of Alcohol-Induced Brain Inflammation	PLOS ONE			English	Article							NF-KAPPA-B; GENE-EXPRESSION; MICROGLIAL CELLS; BINGE DRINKING; ETHANOL; NEUROINFLAMMATION; CONSUMPTION; ACTIVATION; SENSOR; CIRP	Binge drinking has been associated with cerebral dysfunction. Ethanol induced microglial activation initiates an inflammatory process that causes upregulation of proinflammatory cytokines which in turn creates neuronal inflammation and damage. However, the molecular mechanism is not fully understood. We postulate that cold-inducible RNA-binding protein (CIRP), a novel proinflammatory molecule, can contribute to alcohol-induced neuroinflammation. To test this theory male wild-type (WT) mice were exposed to alcohol at concentrations consistent to binge drinking and blood and brain tissues were collected. At 5 h after alcohol, a significant increase of 53% in the brain of CIRP mRNA was observed and its expression remained elevated at 10 h and 15 h. Brain CIRP protein levels were increased by 184% at 10 h and remained high at 15 h. We then exposed male WT and CIRP knockout (CIRP-/-) mice to alcohol, and blood and brain tissues were collected at 15 h post-alcohol infusion. Serum levels of tissue injury markers (AST, ALT and LDH) were significantly elevated in alcohol-exposed WT mice while they were less increased in the CIRP-/- mice. Brain TNF-alpha mRNA and protein expressions along with IL-1 beta protein levels were significantly increased in WT mice, which was not seen in the CIRP-/- mice. In cultured BV2 cells (mouse microglia), ethanol at 100 mM showed an increase of CIRP mRNA by 274% and 408% at 24 h and 48 h respectively. Corresponding increases in TNF-alpha and IL-1 beta were also observed. CIRP protein levels were markedly increased in the medium, suggesting that CIRP was secreted by the BV2 cells. From this we conclude that alcohol exposure activates microglia to produce and secrete CIRP and possibly induce pro-inflammatory response and thereby causing neuroinflammation. CIRP could be a novel mediator of alcohol-induced brain inflammation.	[Rajayer, Salil R.; Jacob, Asha; Yang, Weng-Lang; Zhou, Mian; Chaung, Wayne; Wang, Ping] Hofstra North Shore LIJ Sch Med, Dept Surg, Manhasset, NY USA; [Jacob, Asha; Yang, Weng-Lang; Zhou, Mian; Chaung, Wayne; Wang, Ping] Feinstein Inst Med Res, Ctr Translat Res, Manhasset, NY USA	Hofstra University; Northwell Health; Northwell Health	Wang, P (corresponding author), Hofstra North Shore LIJ Sch Med, Dept Surg, Manhasset, NY USA.	pwang@nshs.edu	Varghese, Asha/AAK-4922-2021	Wang, Ping/0000-0002-1557-0394	National Institutes of Health (NIH) [R21 AA021496]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA021496] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported in part by National Institutes of Health (NIH) grant, R21 AA021496 to P. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ADACHI J, 1991, J STUD ALCOHOL, V52, P448, DOI 10.15288/jsa.1991.52.448; Alfonso-Loeches S, 2010, J NEUROSCI, V30, P8285, DOI 10.1523/JNEUROSCI.0976-10.2010; Anderson ML, 2012, NEUROSCIENCE, V224, P202, DOI 10.1016/j.neuroscience.2012.08.018; Appel S H, 2011, Acta Myol, V30, P4; Archie S, 2012, ALCOHOL, V46, P165, DOI 10.1016/j.alcohol.2011.07.001; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Bleich S, 2003, NEUROSCI LETT, V335, P179, DOI 10.1016/S0304-3940(02)01194-1; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; Boscia F, 2009, STROKE, V40, P3608, DOI 10.1161/STROKEAHA.109.557439; Bouchery EE, 2011, AM J PREV MED, V41, P516, DOI 10.1016/j.amepre.2011.06.045; Carson EJ, 1996, ALCOHOL CLIN EXP RES, V20, P132, DOI 10.1111/j.1530-0277.1996.tb01055.x; Cheyuo C, 2012, NEUROPHARMACOLOGY, V62, P890, DOI 10.1016/j.neuropharm.2011.09.018; Chung YC, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/370526; Climent E, 2002, J NEUROSCI RES, V68, P213, DOI 10.1002/jnr.10208; Crews F, 2006, ALCOHOL CLIN EXP RES, V30, P1938, DOI 10.1111/j.1530-0277.2006.00239.x; Dodd PR, 2000, NEUROCHEM INT, V37, P509, DOI 10.1016/S0197-0186(00)00061-9; Fernandez-Lizarbe S, 2009, J IMMUNOL, V183, P4733, DOI 10.4049/jimmunol.0803590; GEHRMANN J, 1995, BRAIN RES REV, V20, P269, DOI 10.1016/0165-0173(94)00015-H; Gualerzi CO, 2003, J MOL BIOL, V331, P527, DOI 10.1016/S0022-2836(03)00732-0; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Harper C, 2005, CURR OPIN PHARMACOL, V5, P73, DOI 10.1016/j.coph.2004.06.011; Jack C, 2005, J NEUROSCI RES, V81, P363, DOI 10.1002/jnr.20482; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Mayfield J, 2013, CURR OPIN NEUROBIOL, V23, P513, DOI 10.1016/j.conb.2013.01.024; Morf J, 2012, SCIENCE, V338, P379, DOI 10.1126/science.1217726; Nakajima K, 2001, J BIOCHEM-TOKYO, V130, P169, DOI 10.1093/oxfordjournals.jbchem.a002969; Niemela O, 2001, FREE RADICAL BIO MED, V31, P1533, DOI 10.1016/S0891-5849(01)00744-4; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nishiyama H, 1997, J CELL BIOL, V137, P899, DOI 10.1083/jcb.137.4.899; Qiang XL, 2013, NAT MED, V19, P1489, DOI 10.1038/nm.3368; Saito M, 2002, NEUROCHEM RES, V27, P1221, DOI 10.1023/A:1020937728506; Schiller Jeannine S, 2012, Vital Health Stat 10, P1; Sheikh MS, 1997, J BIOL CHEM, V272, P26720, DOI 10.1074/jbc.272.42.26720; Spear L, 2011, ALCOHOL DEV BRAIN; Stoll G, 1999, PROG NEUROBIOL, V58, P233, DOI 10.1016/S0301-0082(98)00083-5; Streit WJ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-14; Theoharides TC, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-46; Tremblay Marie-Eve, 2011, Commun Integr Biol, V4, P220, DOI 10.4161/cib.4.2.14506; Weitz Tara M, 2012, Int J Alzheimers Dis, V2012, P314185, DOI 10.1155/2012/314185; Wellmann S, 2004, J CELL SCI, V117, P1785, DOI 10.1242/jcs.01026; Wilcock DM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-84; Xue JH, 1999, FREE RADICAL BIO MED, V27, P1238, DOI 10.1016/S0891-5849(99)00158-6; Yang I, 2010, J CLIN NEUROSCI, V17, P6, DOI 10.1016/j.jocn.2009.05.006; Zou J, 2010, ALCOHOL CLIN EXP RES, V34, P777, DOI 10.1111/j.1530-0277.2010.01150.x	44	34	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79430	10.1371/journal.pone.0079430	http://dx.doi.org/10.1371/journal.pone.0079430			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223948	Green Published, gold, Green Submitted			2022-12-27	WOS:000326499300084
J	Carpenter, RL; Han, W; Paw, I; Lo, HW				Carpenter, Richard L.; Han, Woody; Paw, Ivy; Lo, Hui-Wen			HER2 Phosphorylates and Destabilizes Pro-Apoptotic PUMA, Leading to Antagonized Apoptosis in Cancer Cells	PLOS ONE			English	Article							HUMAN-BREAST-CANCER; BCL-X-L; SURVIVAL SIGNALS; COLON-CANCER; P53; EXPRESSION; GENE; ONCOGENE; DEATH; IDENTIFICATION	HER2 is overexpressed in 15-20% of breast cancers. HER2 overexpression is known to reduce apoptosis but the underlying mechanisms for this association remain unclear. To elucidate the mechanisms for HER2-mediated survival, we investigated the relationship between HER2 and p53 upregulated modulator of apoptosis (PUMA), a potent apoptosis inducer. Our results showed that HER2 interacts with PUMA, which was independent of HER2 activation. In addition, we observed that HER2 interacted with PUMA in both mitochondrial and non-mitochondrial compartments. We next examined whether HER2 phosphorylates PUMA. Notably, PUMA tyrosine phosphorylation has never been reported. Using an intracellular assay, we found PUMA to be phosphorylated in breast cancer cells with activated HER2. Via cell-free HER2 kinase assay, we observed that PUMA was directly phosphorylated by HER2. Activation of HER2 decreased PUMA protein half-life. To identify which of the three tyrosines within PUMA are targeted by HER2, we generated three PUMA non-phosphorylation mutants each with a single Tyr -> Phe substitution. Results indicated that each PUMA single mutant had lost some, but not all phosphorylation by HER2 indicating that HER2 targets all three tyrosines. Consequently, we created an additional PUMA mutant with all three tyrosines mutated (TM-PUMA) that could not be phosphorylated by HER2. Importantly, TM-PUMA was found to have a longer half-life than PUMA. An inverse association was observed between HER2 and PUMA in 93 invasive breast carcinoma samples. We further found that TM-PUMA suppressed growth of breast cancer cells to a greater degree than PUMA. Also, TM-PUMA had a stronger propensity to induce apoptosis than PUMA. Together, our results demonstrate, for the first time, that PUMA can be tyrosine phosphorylated and that HER2-mediated phosphorylation destabilizes PUMA protein. The HER2-PUMA interplay represents a novel mechanism by which PUMA is regulated and a new molecular basis for HER2-mediated growth and survival of cancer cells.	[Carpenter, Richard L.; Han, Woody; Paw, Ivy; Lo, Hui-Wen] Duke Univ, Sch Med, Dept Surg, Div Surg Sci, Durham, NC 27710 USA; [Lo, Hui-Wen] Duke Univ, Sch Med, Duke Canc Inst, Durham, NC USA; [Lo, Hui-Wen] Duke Univ, Sch Med, Duke Ctr RNA Biol, Durham, NC USA	Duke University; Duke University; Duke University	Lo, HW (corresponding author), Duke Univ, Sch Med, Dept Surg, Div Surg Sci, Durham, NC 27710 USA.	huiwen.lo@duke.edu		Carpenter, Richard/0000-0001-9986-6493	National Institutes of Health [K01-CA118423]; United States Department of Defense [W81XWH-11-1-0600]; Pediatric Brain Tumor Foundation; Beez Foundation; Intramural Division of Surgical Sciences; NATIONAL CANCER INSTITUTE [K01CA118423] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense(United States Department of Defense); Pediatric Brain Tumor Foundation; Beez Foundation; Intramural Division of Surgical Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Institutes of Health grant K01-CA118423, and W81XWH-11-1-0600 from the United States Department of Defense, the Pediatric Brain Tumor Foundation, the Beez Foundation and the Intramural Division of Surgical Sciences Dani P. Bolognesi, Ph.D. Award and Clarence Gardner, Ph.D. Award (to H-WL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arisan ED, 2010, BREAST CANCER RES TR, V119, P271, DOI 10.1007/s10549-009-0343-z; Bean GR, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003483; Cao XY, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-26; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Ding Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2236; Faris M, 1998, J IMMUNOL, V160, P134; Fricker M, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.38; Goh AM, 2011, J PATHOL, V223, P116, DOI 10.1002/path.2784; Han JW, 2001, P NATL ACAD SCI USA, V98, P11318, DOI 10.1073/pnas.201208798; Henson ES, 2006, CLIN CANCER RES, V12, P845, DOI 10.1158/1078-0432.CCR-05-0754; Hernandez-Vargas H, 2006, INT J CANCER, V119, P1164, DOI 10.1002/ijc.21938; Hoque MO, 2003, CANCER LETT, V199, P75, DOI 10.1016/S0304-3835(03)00344-6; Ji ZY, 2007, J BIOL CHEM, V282, P14048, DOI 10.1074/jbc.M611089200; Kumar R, 1996, CLIN CANCER RES, V2, P1215; Lakhter AJ, 2013, J INVEST DERMATOL, V133, P2247, DOI 10.1038/jid.2013.56; Liu YJ, 2009, MOL THER, V17, P1509, DOI 10.1038/mt.2009.43; Lo HW, 2009, CANCER RES, V69, P6790, DOI 10.1158/0008-5472.CAN-09-0886; Luo X, 2005, CELL DEATH DIFFER, V12, P1310, DOI 10.1038/sj.cdd.4401659; Middelburg R, 2005, CLIN CANCER RES, V11, P1863, DOI 10.1158/1078-0432.CCR-04-1372; Ming LH, 2008, CARCINOGENESIS, V29, P1878, DOI 10.1093/carcin/bgn150; Ming L, 2006, J BIOL CHEM, V281, P16034, DOI 10.1074/jbc.M513587200; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Oakes SR, 2012, P NATL ACAD SCI USA, V109, P2766, DOI 10.1073/pnas.1104778108; Roberts CG, 2011, ONCOGENE, V30, P3186, DOI 10.1038/onc.2011.36; Sandow JJ, 2012, CELL DEATH DIFFER, V19, P633, DOI 10.1038/cdd.2011.131; Siddiqa A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-129; Siziopikou KP, 2005, APPL IMMUNOHISTO M M, V13, P14, DOI 10.1097/00129039-200503000-00003; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Society A.C., 2013, CANC FACTS FIG 2013; Tuna M, 2005, ONCOGENE, V24, P1648, DOI 10.1038/sj.onc.1208345; WALLASCH C, 1995, EMBO J, V14, P4267, DOI 10.1002/j.1460-2075.1995.tb00101.x; Wang R, 2009, BREAST CANCER RES TR, V117, P45, DOI 10.1007/s10549-008-0163-6; Wu B, 2007, GUT, V56, P645, DOI 10.1136/gut.2006.101683; Xia WL, 2002, ONCOGENE, V21, P6255, DOI 10.1038/sj.onc.1205794; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yee KS, 2008, APOPTOSIS, V13, P87, DOI 10.1007/s10495-007-0140-2; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Yu J, 2006, CLIN CANCER RES, V12, P2928, DOI 10.1158/1078-0432.CCR-05-2429; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100; Zhu H, 2010, CANCER LETT, V294, P101, DOI 10.1016/j.canlet.2010.01.028	43	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78836	10.1371/journal.pone.0078836	http://dx.doi.org/10.1371/journal.pone.0078836			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236056	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700053
J	Guo, SQ; Cui, YL; He, LS; Zhang, L; Cao, Z; Zhang, W; Zhang, R; Tan, GY; Wang, BM; Cui, LW				Guo, Suqin; Cui, Yongliang; He, Lishan; Zhang, Liang; Cao, Zhen; Zhang, Wei; Zhang, Rui; Tan, Guiyu; Wang, Baomin; Cui, Liwang			Development of a Specific Monoclonal Antibody-Based ELISA to Measure the Artemether Content of Antimalarial Drugs	PLOS ONE			English	Article							MICROBIAL TRANSFORMATION; ARTEMISININ; MALARIA; ACID	Artemether is one of the artemisinin derivatives that are active ingredients in antimalarial drugs. Counterfeit and substandard antimalarial drugs have become a serious problem, which demands reliable analytical tools and implementation of strict regulation of drug quality. Structural similarity among artemisinin analogs is a challenge to develop immunoassays that are specific to artemisinin derivatives. To produce specific antibodies to artemether, we used microbial fermentation of artemether to obtain 9-hydroxyartemether, which was subsequently used to prepare a 9-O-succinylartemether hapten for conjugation with ovalbumin as the immunogen. A monoclonal antibody (mAb), designated as 2G12E1, was produced with high specificity to artemether. 2G12E1 showed low cross reactivities to dihydroartemisinin, artemisinin, artesunate and other major antimalarial drugs. An indirect competitive enzyme linked immunosorbent assay (icELISA) developed showed a concentration causing 50% of inhibition for artemether as 3.7 ng mL(-1) and a working range of 0.7-19 ng mL(-1). The icELISA was applied for determination of artemether content in different commercial drugs and the results were comparable to those determined by high-performance liquid chromatography analysis. In comparison with reported broad cross activity of anti-artemisinin mAbs, the most notable advantage of the 2G12E1-based ELISA is its high specificity to artemether only.	[Guo, Suqin; Cui, Yongliang; He, Lishan; Zhang, Liang; Cao, Zhen; Zhang, Wei; Zhang, Rui; Tan, Guiyu; Wang, Baomin] China Agr Univ, Coll Agron & Biotechnol, Beijing 100094, Peoples R China; [Cui, Liwang] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA	China Agricultural University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Wang, BM (corresponding author), China Agr Univ, Coll Agron & Biotechnol, Beijing 100094, Peoples R China.	wbaomin@263.net; luc2@psu.edu		Cao, Zhen/0000-0003-1259-6107	United States National Institutes of Allergy and Infectious Diseases, National Institutes of Health [U19AI089672]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089672] Funding Source: NIH RePORTER	United States National Institutes of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the United States National Institutes of Allergy and Infectious Diseases, National Institutes of Health (U19AI089672). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abourashed EA, 1996, J NAT PROD, V59, P251, DOI 10.1021/np960060b; [Anonymous], 1986, CHIN J PHARM ANAL; Bosman A, 2007, AM J TROP MED HYG, V77, P193, DOI 10.4269/ajtmh.2007.77.193; Diawara HZ, 2011, J PHARMACEUT BIOMED, V56, P7, DOI 10.1016/j.jpba.2011.04.012; Duthaler U, 2011, J MASS SPECTROM, V46, P172, DOI 10.1002/jms.1883; Eggelte TA, 1999, AM J TROP MED HYG, V61, P449, DOI 10.4269/ajtmh.1999.61.449; Ferreira JFS, 1996, PHYTOCHEMISTRY, V41, P97, DOI 10.1016/0031-9422(95)00542-0; He SP, 2009, ANAL BIOANAL CHEM, V393, P1297, DOI 10.1007/s00216-008-2527-5; HUFFORD CD, 1995, J NAT PRODUCTS, V58, P751, DOI 10.1021/np50119a016; Ioset JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007270; JAZIRI M, 1993, PHYTOCHEMISTRY, V33, P821, DOI 10.1016/0031-9422(93)85282-V; Kokwaro G, 2007, EXPERT OPIN PHARMACO, V8, P75, DOI 10.1517/14656566.8.1.75; Lamalle Caroline, 2012, Electrophoresis, V33, P1669, DOI 10.1002/elps.201100621; Mohamed SS, 1999, J CHROMATOGR B, V731, P251, DOI 10.1016/S0378-4347(99)00232-7; PERATA P, 1990, J PLANT GROWTH REGUL, V9, P1, DOI 10.1007/BF02041934; Song Z-Y, 1985, ACTA PHARMACOL SIN, V20, P610; Tanaka H, 2007, PLANTA MED, V73, P1127, DOI 10.1055/s-2007-981560; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Zhang Y, 1982, ACTA PHARMACOL SIN, V3, P9; Zhang Y, 2011, J CRYST GROWTH, V314, P185, DOI 10.1016/j.jcrysgro.2010.10.165; Zhao J, 2006, ANAL BIOANAL CHEM, V386, P1735, DOI 10.1007/s00216-006-0780-z	21	11	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79154	10.1371/journal.pone.0079154	http://dx.doi.org/10.1371/journal.pone.0079154			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236102	gold, Green Published, Green Submitted			2022-12-27	WOS:000327254700100
J	Kingma, JG; Simard, D; Voisine, P; Rouleau, JR				Kingma, John G.; Simard, Denys; Voisine, Pierre; Rouleau, Jacques R.			Influence of Cardiac Decentralization on Cardioprotection	PLOS ONE			English	Article							CORONARY ENDOTHELIAL DYSFUNCTION; MYOCARDIAL-PERFUSION RESERVE; ISCHEMIC-HEART-DISEASE; NEURONAL-ACTIVITY; INFARCT SIZE; BLOOD-FLOW; SYMPATHETIC INNERVATION; ANESTHETIZED DOGS; COLLATERAL FLOW; CONSCIOUS DOG	The role of cardiac nerves on development of myocardial tissue injury after acute coronary occlusion remains controversial. We investigated whether acute cardiac decentralization (surgical) modulates coronary flow reserve and myocardial protection in preconditioned dogs subject to ischemia-reperfusion. Experiments were conducted on four groups of anesthetised, open-chest dogs (n = 32): 1-controls (CTR, intact cardiac nerves), 2-ischemic preconditioning (PC; 4 cycles of 5-min IR), 3-cardiac decentralization (CD) and 4-CD+ PC; all dogs underwent 60-min coronary occlusion and 180-min reperfusion. Coronary blood flow and reactive hyperemic responses were assessed using a blood volume flow probe. Infarct size (tetrazolium staining) was related to anatomic area at risk and coronary collateral blood flow (microspheres) in the anatomic area at risk. Post-ischemic reactive hyperemia and repayment-to-debt ratio responses were significantly reduced for all experimental groups; however, arterial perfusion pressure was not affected. Infarct size was reduced in CD dogs (18.6 +/- 4.3; p = 0.001, data are mean +/- SD) compared to 25.265.5% in CTR dogs and was less in PC dogs as expected (13.5 +/- 3.2 vs. 25.2 +/- 5.5%; p = 0.001); after acute CD, PC protection was conserved (11.6 +/- 3.4 vs. 18.6 +/- 4.3%; p = 0.02). In conclusion, our findings provide strong evidence that myocardial protection against ischemic injury can be preserved independent of extrinsic cardiac nerve inputs.	[Kingma, John G.; Rouleau, Jacques R.] Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada; [Simard, Denys] Inst Univ Cardiol & Pneumol Quebec, Res Ctr, Quebec City, PQ, Canada; [Voisine, Pierre] Univ Laval, Dept Chirurg, Quebec City, PQ, Canada	Laval University; Laval University	Kingma, JG (corresponding author), Univ Laval, Dept Med, Pavillon Ferdinand Vandry,1050 Ave Med, Quebec City, PQ G1K 7P4, Canada.	john.kingma@fmed.ulaval.ca						Ardell JL, 2009, AM J PHYSIOL-REG I, V297, pR470, DOI 10.1152/ajpregu.90821.2008; Armour JA, 2008, EXP PHYSIOL, V93, P165, DOI 10.1113/expphysiol.2007.041178; Armour JA, 1998, AM J PHYSIOL-REG I, V274, pR939, DOI 10.1152/ajpregu.1998.274.4.R939; ARMOUR JA, 1986, CAN J PHYSIOL PHARM, V64, P1038, DOI 10.1139/y86-177; ARMOUR JA, 1991, REFLEX CONTROL CIRCU, P1; Arora, 2000, Curr Interv Cardiol Rep, V2, P188; BARBER MJ, 1983, CIRCULATION, V67, P787, DOI 10.1161/01.CIR.67.4.787; Bulow HP, 2003, NUCL MED COMMUN, V24, P233, DOI 10.1097/01.mnm.0000061044.24401.6d; Canty JM, 2003, CIRC RES, V93, P796, DOI 10.1161/01.RES.0000100845.27406.FB; Cardinal R, 2009, AUTON NEUROSCI-BASIC, V145, P55, DOI 10.1016/j.autneu.2008.11.007; DAE MW, 1991, J AM COLL CARDIOL, V17, P1416, DOI 10.1016/S0735-1097(10)80156-1; Juarez-Orozco LE, 2013, EUR J NUCL MED MOL I, V40, P1148, DOI 10.1007/s00259-013-2394-y; Fallavollita JA, 2010, J NUCL CARDIOL, V17, P1107, DOI 10.1007/s12350-010-9292-5; Hausenloy DJ, 2009, ATHEROSCLEROSIS, V204, P334, DOI 10.1016/j.atherosclerosis.2008.10.029; Huang CH, 2003, CIRC RES, V93, P866, DOI 10.1161/01.RES.0000097762.64561.D2; HUANG MH, 1993, AM J PHYSIOL, V265, pR659, DOI 10.1152/ajpregu.1993.265.3.R659; HUANG MH, 1994, CARDIOVASC RES, V28, P636, DOI 10.1093/cvr/28.5.636; Huang Ming-He, 1993, Integrative Physiological and Behavioral Science, V28, P5, DOI 10.1007/BF02691196; JONES CE, 1978, AM HEART J, V95, P738, DOI 10.1016/0002-8703(78)90504-5; JONES CE, 1978, AM J PHYSIOL, V235, pH429, DOI 10.1152/ajpheart.1978.235.4.H429; JUGDUTT BI, 1979, CIRCULATION, V60, P1141, DOI 10.1161/01.CIR.60.5.1141; Kaeffer N, 1996, AM J PHYSIOL-HEART C, V271, pH842, DOI 10.1152/ajpheart.1996.271.3.H842; Kember G, 2013, PHYSIOL GENOMICS, V45, P638, DOI 10.1152/physiolgenomics.00027.2013; Kingma JG, 2005, J THROMB THROMBOLYS, V19, P201, DOI 10.1007/s11239-005-1201-4; Kingma JG, 2011, CARDIOVASC RES, V89, P384, DOI 10.1093/cvr/cvq306; Kudej RK, 2006, CIRC RES, V99, P1270, DOI 10.1161/01.RES.0000251282.79411.44; Laude K, 2002, CARDIOVASC RES, V55, P466, DOI 10.1016/S0008-6363(02)00277-8; LAVALLEE M, 1985, CIRC RES, V57, P383, DOI 10.1161/01.RES.57.3.383; Mentzer RM, 1999, ANN SURG, V229, P643, DOI 10.1097/00000658-199905000-00006; MIURA T, 1989, JPN HEART J, V30, P695; Murphy DA, 2000, ANN THORAC SURG, V69, P1769, DOI 10.1016/S0003-4975(00)01240-6; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; OLSSON RA, 1975, CIRC RES, V37, P263, DOI 10.1161/01.RES.37.3.263; Reffelmann T, 2002, AM J PHYSIOL-HEART C, V283, pH1099, DOI 10.1152/ajpheart.00270.2002; Reffelmann T, 2002, AM J PHYSL HEART CIR; REIMER KA, 1979, CIRCULATION, V60, P866, DOI 10.1161/01.CIR.60.4.866; REIMER KA, 1985, CIRC RES, V56, P651, DOI 10.1161/01.RES.56.5.651; RICHARD V, 1994, CIRCULATION, V89, P1254, DOI 10.1161/01.CIR.89.3.1254; Rouleau JR, 2002, AUTON NEUROSCI-BASIC, V97, P12, DOI 10.1016/S1566-0702(02)00002-4; Shen YT, 2000, ARTERIOSCL THROM VAS, V20, P2309, DOI 10.1161/01.ATV.20.10.2309; Smith FM, 2001, AM J PHYSIOL-HEART C, V281, pH1919, DOI 10.1152/ajpheart.2001.281.5.H1919; Tio RA, 2009, J NUCL MED, V50, P214, DOI 10.2967/jnumed.108.054395	42	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79190	10.1371/journal.pone.0079190	http://dx.doi.org/10.1371/journal.pone.0079190			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236106	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700104
J	Luo, XY; Gao, ZH; Shi, T; Cheng, ZM; Zhang, Z; Ni, ZJ				Luo, Xiaoyan; Gao, Zhihong; Shi, Ting; Cheng, Zongming; Zhang, Zhen; Ni, Zhaojun			Identification of miRNAs and Their Target Genes in Peach (Prunus persica L.) Using High-Throughput Sequencing and Degradome Analysis	PLOS ONE			English	Article							STRESS-RESPONSIVE MICRORNAS; SMALL RNAS; REGULATED MICRORNAS; PARALLEL ANALYSIS; SIRNA BIOGENESIS; PLANT MICRORNAS; ARABIDOPSIS; EXPRESSION; PREDICTION; POPULUS	MicroRNAs play critical roles in various biological and metabolic processes. The function of miRNAs has been widely studied in model plants such as Arabidopsis and rice. However, the number of identified miRNAs and related miRNA targets in peach (Prunus persica) is limited. To understand further the relationship between miRNAs and their target genes during tissue development in peach, a small RNA library and three degradome libraries were constructed from three tissues for deep sequencing. We identified 117 conserved miRNAs and 186 novel miRNA candidates in peach by deep sequencing and 19 conserved miRNAs and 13 novel miRNAs were further evaluated for their expression by RT-qPCR. The number of gene targets that were identified for 26 conserved miRNA families and 38 novel miRNA candidates, were 172 and 87, respectively. Some of the identified miRNA targets were abundantly represented as conserved miRNA targets in plant. However, some of them were first identified and showed important roles in peach development. Our study provides information concerning the regulatory network of miRNAs in peach and advances our understanding of miRNA functions during tissue development.	[Luo, Xiaoyan; Gao, Zhihong; Shi, Ting; Cheng, Zongming; Zhang, Zhen; Ni, Zhaojun] Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Gao, ZH (corresponding author), Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China.	gaozhihong@njau.edu.cn		Shi, Ting/0000-0002-0955-016X	National Science Foundation of China [31101526]; project of 948; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); project of 948; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	The authors gratefully acknowledge the National Science Foundation of China (31101526) and the project of 948 and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) for funding part of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Addo-Quaye C, 2009, BIOINFORMATICS, V25, P130, DOI 10.1093/bioinformatics/btn604; An FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018937; Arazi T, 2005, PLANT J, V43, P837, DOI 10.1111/j.1365-313X.2005.02499.x; Barakat A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-481; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chen HM, 2010, P NATL ACAD SCI USA, V107, P15269, DOI 10.1073/pnas.1001738107; Cuperus JT, 2010, NAT STRUCT MOL BIOL, V17, P997, DOI 10.1038/nsmb.1866; Eldem V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050298; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Gao ZH, 2012, MOL CELLS, V34, P239, DOI 10.1007/s10059-012-0004-7; Gao ZH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-371; Gebelin V, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-18; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; German MA, 2009, NAT PROTOC, V4, P356, DOI 10.1038/nprot.2009.8; Jeong DH, 2011, PLANT CELL, V23, P4185, DOI 10.1105/tpc.111.089045; Joshi T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S14; Kulcheski FR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-307; Lenz Dorina, 2011, BMC Res Notes, V4, P483, DOI 10.1186/1756-0500-4-483; Li BS, 2011, J EXP BOT, V62, P3765, DOI 10.1093/jxb/err051; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lu SF, 2005, PLANT CELL, V17, P2186, DOI 10.1105/tpc.105.033456; Lu SF, 2008, PLANT J, V55, P131, DOI 10.1111/j.1365-313X.2008.03497.x; Ma ZR, 2010, PLANT CELL, V22, P1090, DOI 10.1105/tpc.110.073882; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Naqvi AR, 2012, J CELL PHYSIOL, V227, P3163, DOI 10.1002/jcp.24052; Pang MX, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r122; Pantaleo V, 2010, PLANT J; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Shulaev V, 2008, PLANT PHYSIOL, V147, P985, DOI 10.1104/pp.107.115618; Song CNA, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-431, 10.1186/1471-2164-11-261]; Song QX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-5; Subramanian S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-160; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Wang JF, 2004, NUCLEIC ACIDS RES, V32, P1688, DOI 10.1093/nar/gkh332; Wang LW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-154; Wang XW, 2010, MOL BIOTECHNOL, V44, P61, DOI 10.1007/s12033-009-9204-6; Wu L, 2010, MOL CELL, V38, P465, DOI 10.1016/j.molcel.2010.03.008; Xu Q, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-246; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Zhang YP, 2012, MOL BIOL REP, V39, P1975, DOI 10.1007/s11033-011-0944-6; Zhou M., 2010, FRONT BIOL, V5, P67, DOI [DOI 10.1007/S11515-010-0007-8, 10.1007/s11515-010-0007-8]; Zhu H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-149; Zhu JK, 2008, P NATL ACAD SCI USA, V105, P9851, DOI 10.1073/pnas.0805207105; Zhu JK, 2008, CLONING CHARACTERIZA; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	51	24	27	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79090	10.1371/journal.pone.0079090	http://dx.doi.org/10.1371/journal.pone.0079090			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236092	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700090
J	Maier, LJ; Liechti, ME; Herzig, F; Schaub, MP				Maier, Larissa J.; Liechti, Matthias E.; Herzig, Fiona; Schaub, Michael P.			To Dope or Not to Dope: Neuroenhancement with Prescription Drugs and Drugs of Abuse among Swiss University Students	PLOS ONE			English	Article							COLLEGE-STUDENTS; NONMEDICAL USE; PHARMACOLOGICAL NEUROENHANCEMENT; COGNITIVE ENHANCEMENT; ADHD MEDICATIONS; ILLICIT USE; STIMULANTS; HEALTHY; PREVALENCE; METHYLPHENIDATE	Background: Neuroenhancement is the use of substances by healthy subjects to enhance mood or cognitive function. The prevalence of neuroenhancement among Swiss university students is unknown. Investigating the prevalence of neuroenhancement among students is important to monitor problematic use and evaluate the necessity of prevention programs. Study aim: To describe the prevalence of the use of prescription medications and drugs of abuse for neuroenhancement among Swiss university students. Method: In this cross-sectional study, students at the University of Zurich, University of Basel, and Swiss Federal Institute of Technology Zurich were invited via e-mail to participate in an online survey. Results: A total of 28,118 students were contacted, and 6,275 students completed the survey. Across all of the institutions, 13.8% of the respondents indicated that they had used prescription drugs (7.6%) or drugs of abuse including alcohol (7.8%) at least once specifically for neuroenhancement. The most frequently used prescription drugs for neuroenhancement were methylphenidate (4.1%), sedatives (2.7%), and beta-blockers (1.2%). Alcohol was used for this purpose by 5.6% of the participants, followed by cannabis (2.5%), amphetamines (0.4%), and cocaine (0.2%). Arguments for neuroenhancement included increased learning (66.2%), relaxation or sleep improvement (51.2%), reduced nervousness (39.1%), coping with performance pressure (34.9%), increased performance (32.2%), and experimentation (20%). Neuroenhancement was significantly more prevalent among more senior students, students who reported higher levels of stress, and students who had previously used illicit drugs. Although "soft enhancers", including coffee, energy drinks, vitamins, and tonics, were used daily in the month prior to an exam, prescription drugs or drugs of abuse were used much less frequently. Conclusions: A significant proportion of Swiss university students across most academic disciplines reported neuroenhancement with prescription drugs and drugs of abuse. However, these substances are rarely used on a daily basis and more sporadically used prior to exams.	[Maier, Larissa J.; Schaub, Michael P.] Univ Zurich, Associated Inst, Swiss Res Inst Publ Hlth & Addict, Zurich, Switzerland; [Maier, Larissa J.; Schaub, Michael P.] WHO Collaborating Ctr, Zurich, Switzerland; [Liechti, Matthias E.] Univ Basel Hosp, Div Clin Pharmacol & Toxicol, Dept Biomed, CH-4031 Basel, Switzerland; [Liechti, Matthias E.] Univ Basel Hosp, Dept Internal Med, CH-4031 Basel, Switzerland; [Liechti, Matthias E.] Univ Basel, Basel, Switzerland; [Herzig, Fiona] Univ Zurich, Div Psychopathol & Clin Intervent, Zurich, Switzerland	University of Zurich; World Health Organization; University of Basel; University of Basel; University of Basel; University of Zurich	Maier, LJ (corresponding author), Univ Zurich, Associated Inst, Swiss Res Inst Publ Hlth & Addict, Zurich, Switzerland.	larissa.maier@isgf.uzh.ch	Maier, Larissa/P-8669-2014; Schaub, Michael P./ABF-9468-2021; Maier, Larissa J/C-2922-2017	Maier, Larissa/0000-0002-4302-0488; Schaub, Michael P./0000-0002-8375-4005; Maier, Larissa J/0000-0002-4302-0488				Arria AM, 2008, PHARMACOTHERAPY, V28, P156, DOI 10.1592/phco.28.2.156; Banjo OC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014322; Bell S, 2013, NEUROETHICS-NETH, V6, P197, DOI 10.1007/s12152-012-9153-9; BRUGGISSER M, 2012, SCHWEIZ RUNDSCH MED, V101, P299; Bruggisser M, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13267; Cakic V, 2009, J MED ETHICS, V35, P611, DOI 10.1136/jme.2009.030882; DeSantis AD, 2008, J AM COLL HEALTH, V56, P315, DOI 10.3200/JACH.57.3.315-324; Dietz P, 2013, PHARMACOTHERAPY, V33, P44, DOI 10.1002/phar.1166; Eckhardt A, 2011, HUMAN ENHANCEMENT, DOI [10.3218/3404-2., DOI 10.3218/3404-2]; Eickenhorst P, 2012, J PSYCHOACTIVE DRUGS, V44, P418, DOI 10.1080/02791072.2012.736845; Elliott R, 1997, PSYCHOPHARMACOLOGY, V131, P196, DOI 10.1007/s002130050284; Forstl H, 2009, NERVENARZT, V80, P840, DOI 10.1007/s00115-009-2801-6; Franke AG, 2011, PHARMACOPSYCHIATRY, V44, P60, DOI 10.1055/s-0030-1268417; Franke AG, 2010, BUNDESGESUNDHEITSBLA, V53, P853, DOI 10.1007/s00103-010-1105-0; Franke AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040047; Franke AG, 2012, PSYCHIAT PRAX, V39, P174, DOI 10.1055/s-0031-1298900; Gmel G., 2012, SUCHTMONITORING SCHW; Grebner S, 2010, STRESS BEI SCHWEIZER; Greely H, 2008, NATURE, V456, P702, DOI 10.1038/456702a; Hildt E, 2011, NERVENHEILKUNDE, V30, P833; Ilieva I, 2013, NEUROPHARMACOLOGY, V64, P496, DOI 10.1016/j.neuropharm.2012.07.021; Kaloyanides KB, 2007, PHARMACOTHERAPY, V27, P666, DOI 10.1592/phco.27.5.666; Kordt M, 2009, DAK GESUNDHEITSREPOR; Kuhne R., 2011, SCHWEIZERISCHE ARZTE, V92, P1295; Mache S, 2012, WIEN MED WOCHENSCHR, V162, P262, DOI [10.1007/s10354-012-0115-y, 10.1007/s10354-012-0144-6]; Maher B, 2008, NATURE, V452, P674, DOI 10.1038/452674a; McCabe SE, 2005, ADDICTION, V100, P96, DOI 10.1111/j.1360-0443.2005.00944.x; Middendorff E., 2012, HOCHSCHUL INF SYST E, P11; Normann C, 2008, EUR ARCH PSY CLIN N, V258, P110, DOI 10.1007/s00406-008-5022-2; Novak SP, 2007, SUBST ABUSE TREAT PR, V2, DOI 10.1186/1747-597X-2-32; Ott R, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13707; Partridge B, 2013, DRUG ALCOHOL REV, V32, P295, DOI 10.1111/dar.12005; Quednow B.B, 2010, SUCHTMAGAZIN, V36, P19; Quednow BB, 2010, BIOSOCIETIES, V5, P153, DOI 10.1057/biosoc.2009.13; Repantis D, 2011, PSYCHOPHARMAKOLOGISC; Repantis D, 2009, VERBESSERUNG MENSCHE, P63; Repantis D, 2010, PHARMACOL RES, V62, P187, DOI 10.1016/j.phrs.2010.04.002; Sahakian B, 2007, NATURE, V450, P1157, DOI 10.1038/4501157a; Sucht Schweiz, 2012, DOP ALLT; Sussman S, 2006, SUBST ABUSE TREAT PR, V1, DOI 10.1186/1747-597X-1-15; Turner DC, 2003, PSYCHOPHARMACOLOGY, V165, P260, DOI 10.1007/s00213-002-1250-8; Wilens TE, 2008, J AM ACAD CHILD PSY, V47, P21, DOI 10.1097/chi.0b013e31815a56f1; Wulf MA, 2012, ETHIK MED, V24, P29, DOI 10.1007/s00481-011-0137-9	43	116	120	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e77967	10.1371/journal.pone.0077967	http://dx.doi.org/10.1371/journal.pone.0077967			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236008	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000327254700005
J	Nakano, S; Morizane, Y; Makisaka, N; Suzuki, T; Togawa, T; Tsukimura, T; Kawashima, I; Sakuraba, H; Shibasaki, F				Nakano, Sachie; Morizane, Yoshihito; Makisaka, Noriko; Suzuki, Toshihiro; Togawa, Tadayasu; Tsukimura, Takahiro; Kawashima, Ikuo; Sakuraba, Hitoshi; Shibasaki, Futoshi			Development of a Highly Sensitive Immuno-PCR Assay for the Measurement of alpha-Galactosidase A Protein Levels in Serum and Plasma	PLOS ONE			English	Article							ENZYME REPLACEMENT THERAPY; POLYMERASE-CHAIN-REACTION; FABRY-DISEASE; ANTIBODY-FORMATION; ANTIGEN-DETECTION; AGALSIDASE-ALPHA; GENE; MUTATIONS; AMPLIFICATION; EXPRESSION	Fabry disease is an X-linked genetic disorder caused by defects in the a-galactosidase A (GLA) gene, and heterogeneous mutations lead to quantitative and/or qualitative defects in GLA protein in male patients with Fabry disease. Random X-chromosomal inactivation modifies the clinical and biochemical features of female patients with Fabry disease. Functional polymorphisms have been frequently reported in recent times, and these increase the difficulty of understanding the pathogenetic basis of the disease. To date, GLA protein level has been measured using an enzyme-linked immunosorbent assay (ELISA). However, ELISA is not highly sensitive due to the high background noise. In this paper, we introduce a novel application of the immuno-polymerase chain reaction (PCR) method (termed Multiple Simultaneous Tag [MUSTag]) for measurement of the GLA protein level in blood samples. We compared the sensitivities of the MUSTag method with plates or magnetic beads with those of ELISA for recombinant human GLA and found that the apparent maximal sensitivity was higher for the former than for the latter. We then measured the GLA concentrations in serum and plasma from male patients with classic Fabry disease (Male Fabry), females with Fabry disease (Female Fabry), male subjects harboring the functional polymorphism p. E66Q (E66Q), and control (Control) subjects. Our results revealed that compared to the MUSTag plate and ELISA, the MUSTag beads assay afforded a clearer estimation of the GLA protein levels in the serum and plasma with minimal or no background noise, although all the methods could differentiate between the Male Fabry, E66Q, and Control groups. The Female Fabry group showed characteristic heterogeneity, which was consistent with the X-linked inheritance. This novel method is expected to be useful for the sensitive determination of GLA level in blood and elucidation of the pathogenetic basis of Fabry disease.	[Nakano, Sachie; Morizane, Yoshihito; Makisaka, Noriko; Kawashima, Ikuo; Shibasaki, Futoshi] Tokyo Metropolitan Inst Med Sci, Dept Mol Med Res, Tokyo 113, Japan; [Nakano, Sachie; Morizane, Yoshihito; Makisaka, Noriko] Synthera Technol Co Ltd, Tokyo, Japan; [Suzuki, Toshihiro; Sakuraba, Hitoshi] Meiji Pharmaceut Univ, Dept Analyt Biochem, Tokyo, Japan; [Togawa, Tadayasu; Tsukimura, Takahiro] Meiji Pharmaceut Univ, Dept Funct Bioanal, Tokyo, Japan; [Sakuraba, Hitoshi] Meiji Pharmaceut Univ, Dept Clin Genet, Tokyo, Japan	Tokyo Metropolitan Institute of Medical Science; Meiji Pharmaceutical University; Meiji Pharmaceutical University; Meiji Pharmaceutical University	Shibasaki, F (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Mol Med Res, Tokyo 113, Japan.	shibasaki-ft@igakuken.or.jp			Program for Research on Intractable Diseases of Health and Labor Science Research; Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovat ion [09-15]; Japan Society for the Promotion of Science (JSPS ID) [23659527]; Special Foundation of Tokyo Metropolitan Government;  [07831860];  [09811230];  [10868930];  [11930174]	Program for Research on Intractable Diseases of Health and Labor Science Research; Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovat ion(National Institute of Biomedical Innovation); Japan Society for the Promotion of Science (JSPS ID); Special Foundation of Tokyo Metropolitan Government; ; ; ; 	This work was supported by the Program for Research on Intractable Diseases of Health and Labor Science Research (HS); the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovat ion (ID: 09-15, HS); the Japan Society for the Promotion of Science (JSPS ID: 23659527, HS); the Grant-in-Aid for Exploratory Research (ID: 07831860, 09811230, 10868930, 11930174, FS); and a Special Foundation of Tokyo Metropolitan Government (FS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler M, 2003, BIOCHEM BIOPH RES CO, V308, P240, DOI 10.1016/S0006-291X(03)01364-0; Benichou B, 2009, MOL GENET METAB, V96, P4, DOI 10.1016/j.ymgme.2008.10.004; Chen L, 2010, CIRCULATION, V122, P910, DOI 10.1161/CIRCULATIONAHA.109.931931; Deegan PB, 2012, J INHERIT METAB DIS, V35, P227, DOI 10.1007/s10545-011-9400-y; Desnick R, 2001, ALPHA GALACTOSIDASE; Doi K, 2012, J HUM GENET, V57, P575, DOI 10.1038/jhg.2012.68; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Fervenza FC, 2008, BIOL-TARGETS THER, V2, P823; Fuller M, 2004, CLIN CHEM, V50, P1979, DOI 10.1373/clinchem.2004.037937; HENDRICKSON ER, 1995, NUCLEIC ACIDS RES, V23, P522, DOI 10.1093/nar/23.3.522; ISHII S, 1994, BBA-PROTEIN STRUCT M, V1204, P265, DOI 10.1016/0167-4838(94)90017-5; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kim NH, 2010, BIOCHEM BIOPH RES CO, V391, P1500, DOI 10.1016/j.bbrc.2009.12.101; Kitagawa T, 2008, PEDIATR NEPHROL, V23, P1461, DOI 10.1007/s00467-008-0846-6; Lee BH, 2010, J HUM GENET, V55, P512, DOI 10.1038/jhg.2010.58; Linthorst GE, 2004, KIDNEY INT, V66, P1589, DOI 10.1111/j.1523-1755.2004.00924.x; Niemeyer CM, 2005, TRENDS BIOTECHNOL, V23, P208, DOI 10.1016/j.tibtech.2005.02.006; Niemeyer CM, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng090; Ohashi T, 2008, MOL GENET METAB, V94, P313, DOI 10.1016/j.ymgme.2008.03.008; Ohashi T, 2007, MOL GENET METAB, V92, P271, DOI 10.1016/j.ymgme.2007.06.013; OKUMIYA T, 1995, HUM GENET, V95, P557; Rombach SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047805; RUZICKA V, 1993, SCIENCE, V260, P698, DOI 10.1126/science.8480182; RYCHLIK W, 1990, NUCLEIC ACIDS RES, V18, P6409, DOI 10.1093/nar/18.21.6409; SANO T, 1992, SCIENCE, V258, P120, DOI 10.1126/science.1439758; Schiffmann R, 2000, P NATL ACAD SCI USA, V97, P365, DOI 10.1073/pnas.97.1.365; Schiffmann R, 2006, NEPHROL DIAL TRANSPL, V21, P345, DOI 10.1093/ndt/gfi152; Sims PW, 2000, ANAL BIOCHEM, V281, P230, DOI 10.1006/abio.2000.4578; Sugawara K, 2008, J HUM GENET, V53, P812, DOI 10.1007/s10038-008-0316-9; Togawa T, 2012, MOL GENET METAB, V105, P615, DOI 10.1016/j.ymgme.2012.01.010; Vedder AC, 2008, MOL GENET METAB, V94, P319, DOI 10.1016/j.ymgme.2008.03.003; Weidemann F, 2009, CIRCULATION, V119, P524, DOI 10.1161/CIRCULATIONAHA.108.794529; Yasuda M, 2003, HUM MUTAT, V22, P486, DOI 10.1002/humu.10275; ZHOU H, 1993, NUCLEIC ACIDS RES, V21, P6038, DOI 10.1093/nar/21.25.6038	34	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78588	10.1371/journal.pone.0078588	http://dx.doi.org/10.1371/journal.pone.0078588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236025	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700022
J	Rauhut, H				Rauhut, Heiko			Beliefs about Lying and Spreading of Dishonesty: Undetected Lies and Their Constructive and Destructive Social Dynamics in Dice Experiments	PLOS ONE			English	Article								Field experiments have shown that observing other people littering, stealing or lying can trigger own misconduct, leading to a decay of social order. However, a large extent of norm violations goes undetected. Hence, the direction of the dynamics crucially depends on actors' beliefs regarding undetected transgressions. Because undetected transgressions are hardly measureable in the field, a laboratory experiment was developed, where the complete prevalence of norm violations, subjective beliefs about them, and their behavioral dynamics is measurable. In the experiment, subjects could lie about their monetary payoffs, estimate the extent of liars in their group and make subsequent lies contingent on information about other people's lies. Results show that informed people who underestimate others' lying increase own lying more than twice and those who overestimate, decrease it by more than half compared to people without information about others' lies. This substantial interaction puts previous results into perspective, showing that information about others' transgressions can trigger dynamics in both directions: the spreading of normative decay and restoring of norm adherence.	[Rauhut, Heiko] Univ Zurich, Inst Sociol, Zurich, Switzerland; [Rauhut, Heiko] ETH, Swiss Fed Inst Technol, Dept Humanities Social & Polit Sci, Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Rauhut, H (corresponding author), Univ Zurich, Inst Sociol, Zurich, Switzerland.	heiko.rauhut@uzh.ch	Rauhut, Heiko/F-6409-2012	Rauhut, Heiko/0000-0002-1181-5534	ETH Zurich, Swiss Federal Institute of Technology	ETH Zurich, Swiss Federal Institute of Technology(ETH Zurich)	This work was supported by ETH Zurich, Swiss Federal Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babcock L, 1997, J ECON PERSPECT, V11, P109, DOI 10.1257/jep.11.1.109; Bullough VL, 1998, J SEX RES, V35, P127, DOI 10.1080/00224499809551925; CIALDINI RB, 1990, J PERS SOC PSYCHOL, V58, P1015, DOI 10.1037/0022-3514.58.6.1015; CIALDINI RB, 1991, ADV EXP SOC PSYCHOL, V24, P201; Croson R, 2013, EXPLORING RELA UNPUB; Diekmann A, 2011, NUFFIELD CTR EXPT SO; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; Fischbacher U, 2008, RES PAPER SERIES THU, V40, P1; Gachter Simon., 2007, EC PSYCHOL PROMISING, P19; Gachter S, 2010, EXP ECON, V13, P364, DOI 10.1007/s10683-010-9246-4; Gino F, 2009, PSYCHOL SCI, V20, P393, DOI 10.1111/j.1467-9280.2009.02306.x; Groeber P, 2010, COMPUT MATH ORGAN TH, V16, P1, DOI 10.1007/s10588-009-9061-7; Keizer K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065137; Keizer K, 2008, SCIENCE, V322, P1681, DOI 10.1126/science.1161405; Kinsey A, 1948, SEXUAL BEHAV HUMAN M, DOI 10.1037/t17515-000; Kroher M, 2013, SOCIAL CONTROL CHEAT; MARKS G, 1987, PSYCHOL BULL, V102, P72, DOI 10.1037/0033-2909.102.1.72; MESSE LA, 1979, J PERS SOC PSYCHOL, V37, P602, DOI 10.1037/0022-3514.37.4.602; Murphy RO, 2010, OPERATIONAL RULES DE; Opp K.-D., 2012, SOCIOLOGY UNINTENDED, P257; Palfrey TR, 2009, J ECON BEHAV ORGAN, V71, P98, DOI 10.1016/j.jebo.2009.03.025; Payton ME, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.34; Piff PK, 2012, P NATL ACAD SCI USA, V109, P4086, DOI 10.1073/pnas.1118373109; Popitz H., 1968, PRAVENTIVWIRKUNG NIC; ROSS L, 1977, J EXP SOC PSYCHOL, V13, P279, DOI 10.1016/0022-1031(77)90049-X; Schenker N, 2001, AM STAT, V55, P182, DOI 10.1198/000313001317097960; Schultz PW, 2007, PSYCHOL SCI, V18, P429, DOI 10.1111/j.1467-9280.2007.01917.x; Shalvi S, 2011, ORGAN BEHAV HUM DEC, V115, P181, DOI 10.1016/j.obhdp.2011.02.001; Thoni C., 2012, 6277 IZA	30	35	35	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e77878	10.1371/journal.pone.0077878	http://dx.doi.org/10.1371/journal.pone.0077878			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236007	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000327254700004
J	Santos, KS; Stephano, MA; Marcelino, JR; Ferreira, VMR; Rocha, T; Caricati, C; Higashi, HG; Moro, AM; Kalil, JE; Malaspina, O; Castro, FFM; Palma, MS				Santos, Keity Souza; Stephano, Marco Antonio; Marcelino, Jose Roberto; Resende Ferreira, Virginia Maria; Rocha, Thalita; Caricati, Celso; Higashi, Hisako Gondo; Moro, Ana Maria; Kalil, Jorge Elias; Malaspina, Osmar; Morato Castro, Fabio Fernandes; Palma, Mario Sergio			Production of the First Effective Hyperimmune Equine Serum Antivenom against Africanized Bees	PLOS ONE			English	Article							APIS-MELLIFERA VENOM; PHOSPHOLIPASE A(2); LETHALITY; MELITTIN	Victims of massive bee attacks become extremely ill, presenting symptoms ranging from dizziness and headache to acute renal failure and multiple organ failure that can lead to death. Previous attempts to develop specific antivenom to treat these victims have been unsuccessful. We herein report a F(ab)'(2)-based antivenom raised in horse as a potential new treatment for victims of multiple bee stings. The final product contains high specific IgG titers and is effective in neutralizing toxic effects, such as hemolysis, cytotoxicity and myotoxicity. The assessment of neutralization was revised and hemolysis, the primary toxic effect of these stings, was fully neutralized in vivo for the first time.	[Santos, Keity Souza; Resende Ferreira, Virginia Maria; Kalil, Jorge Elias; Morato Castro, Fabio Fernandes] Univ Sao Paulo, Sch Med, FMUSP, Div Clin Immunol & Allergy, Sao Paulo, Brazil; [Santos, Keity Souza; Resende Ferreira, Virginia Maria; Moro, Ana Maria; Kalil, Jorge Elias; Malaspina, Osmar; Morato Castro, Fabio Fernandes; Palma, Mario Sergio] Inst Invest Immunol INCT, Sao Paulo, Brazil; [Stephano, Marco Antonio] Univ Sao Paulo, Fac Ciencias Farmaceut, Sao Paulo, Brazil; [Marcelino, Jose Roberto] Butantan Inst, Div Hyperimmune Plasmas, Sao Paulo, Brazil; [Rocha, Thalita] Univ Sao Francisco, Sch Med, BR-12900000 Braganca Paulista, SP, Brazil; [Caricati, Celso] Butantan Inst, Special Pilot Lab Res & Dev Vet Immunobiol, Sao Paulo, Brazil; [Higashi, Hisako Gondo] Inst Technol Parana, Curitiba, Parana, Brazil; [Moro, Ana Maria] Butantan Inst, Lab Biopharmaceut Anim Cells, Sao Paulo, Brazil; [Santos, Keity Souza; Kalil, Jorge Elias; Morato Castro, Fabio Fernandes] Univ Sao Paulo, Sch Med, Heart Inst InCor, LIM 19, Sao Paulo, Brazil; [Malaspina, Osmar; Palma, Mario Sergio] Univ Sao Paulo State UNESP, Ctr Study Social Insects, Inst Biosci, Dept Biol, Rio Claro, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Instituto Butantan; Universidade Sao Francisco; Instituto Butantan; Instituto Butantan; Universidade de Sao Paulo; Universidade Estadual Paulista	Palma, MS (corresponding author), Inst Invest Immunol INCT, Sao Paulo, Brazil.	mspalma@rc.unesp.br	Rocha, Thalita/T-6408-2019; Palma, Mario Sergio/E-7800-2012; Santos, Keity/M-9401-2015; Souza, Keity/AEX-0817-2022; Fapesp, Biota/F-8655-2017; Rocha, Thalita/I-4729-2014; Castro, Fabio FM/C-1082-2017; Palma, Mario/N-3903-2019; Moro, Ana Maria/A-5134-2012; Santos, Keity Souza/Q-5704-2019; Castro, Fabio/AAP-5433-2020; Stephano, Marco/H-3980-2013; Malaspina, Osmar/AAL-9167-2021; KALIL, JORGE/C-8029-2012	Rocha, Thalita/0000-0002-2731-9586; Palma, Mario Sergio/0000-0002-7363-8211; Souza, Keity/0000-0001-5271-4011; Fapesp, Biota/0000-0002-9887-8449; Rocha, Thalita/0000-0002-2731-9586; Castro, Fabio FM/0000-0002-6211-5773; Moro, Ana Maria/0000-0002-0650-7764; Santos, Keity Souza/0000-0001-5271-4011; Stephano, Marco/0000-0003-2927-0584; Malaspina, Osmar/0000-0002-1650-257X; KALIL, JORGE/0000-0001-8415-4274	FAPESP/BIOprospecTA [2011/51684-1]; CNPq (INCT-III); FINEP (CT-BIOTEC-Anticorpos -MCTFINEP); National Research Council of Brazil-CNPq; Butantan Institute; CAPES	FAPESP/BIOprospecTA(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (INCT-III)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FINEP (CT-BIOTEC-Anticorpos -MCTFINEP); National Research Council of Brazil-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Butantan Institute; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from FAPESP/BIOprospecTA (2011/51684-1), CNPq (INCT-iii) and FINEP (CT-BIOTEC-Anticorpos -MCTFINEP 01/2003). JEK, OM and MSP were awarded a research grant from the National Research Council of Brazil-CNPq. KSS was awarded PhD fellowship from Butantan Institute, and VMRF has a PhD student fellowship from CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Christensen P. A., 1968, P437; COVELL DG, 1986, CANCER RES, V46, P3969; de Oliveira F A, 2000, Rev Soc Bras Med Trop, V33, P403, DOI 10.1590/S0037-86822000000400012; de Roodt Adolfo R, 2005, Gac Med Mex, V141, P215; Delori P, 1977, B I PASTEUR, V74, P6; Ewan PW, 1998, BRIT MED J, V316, P1442, DOI 10.1136/bmj.316.7142.1442; Ferreira RS, 2010, TOXICON, V56, P355, DOI 10.1016/j.toxicon.2010.03.023; Fitzgerald KT, 2006, CLIN TECH SMALL AN P, V21, P194, DOI 10.1053/j.ctsap.2006.10.002; FRANCA FOS, 1994, Q J MED, V87, P269; Ismail M, 1996, TOXICON, V34, P1011, DOI 10.1016/0041-0101(96)00055-4; Jones RGA, 1999, AM J TROP MED HYG, V61, P361, DOI 10.4269/ajtmh.1999.61.361; Kerr W.E., 1967, S AFR BEE J, V39, P3; Kolecki P, 1999, ANN EMERG MED, V33, P114, DOI 10.1016/S0196-0644(99)70428-2; Lee YJ, 2007, CHEM-BIOL INTERACT, V169, P189, DOI 10.1016/j.cbi.2007.06.036; Leon G, 1997, TOXICON, V35, P1627, DOI 10.1016/S0041-0101(97)00034-2; LONGROWE KO, 1994, TOXICON, V32, P165, DOI 10.1016/0041-0101(94)90105-8; MCKENNA WR, 1992, PEDIATR ASTHMA ALLER, V6, P275, DOI 10.1089/pai.1992.6.275; Mejia-Velez G, 2010, NEFROLOGIA, V30, P531, DOI 10.3265/Nefrologia.pre2010.May.10269; OCONNOR R, 1980, J CHEM EDUC, V57, P206, DOI 10.1021/ed057p206; Ownby CL, 1997, TOXICON, V35, P67, DOI 10.1016/S0041-0101(96)00078-5; Patterson M K Jr, 1979, Methods Enzymol, V58, P141; Pope CG, 1939, BRIT J EXP PATHOL, V20, P132; Prado M, 2009, REV PANAM SALUD PUBL, V25, P389, DOI 10.1590/S1020-49892009000500002; Robertson ML, 1998, EMERGEN MED, V10, P5; Rocha T, 2007, TOXICON, V50, P589, DOI 10.1016/j.toxicon.2007.05.003; SCHUMACHER MJ, 1990, AM J TROP MED HYG, V43, P79, DOI 10.4269/ajtmh.1990.43.79; SCHUMACHER MJ, 1995, ARCH INTERN MED, V155, P2038, DOI 10.1001/archinte.155.19.2038; Schumacher MJ, 1996, AM J TROP MED HYG, V55, P197, DOI 10.4269/ajtmh.1996.55.197; Souza BM, 2005, PEPTIDES, V26, P2157, DOI 10.1016/j.peptides.2005.04.026; SPIVAK M, 1991, AFRICAN HONEYBEE; Winston M. L., 1992, KILLER BEES AFRICANI; WINSTON ML, 1994, Q J MED, V87, P263	32	15	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79971	10.1371/journal.pone.0079971	http://dx.doi.org/10.1371/journal.pone.0079971			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236166	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700167
J	Troeung, L; Egan, SJ; Gasson, N				Troeung, Lakkhina; Egan, Sarah J.; Gasson, Natalie			A Meta-Analysis of Randomised Placebo-Controlled Treatment Trials for Depression and Anxiety in Parkinson's Disease	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; COGNITIVE-BEHAVIORAL THERAPY; DOUBLE-BLIND; SERTRALINE; ANTIDEPRESSANTS; MULTICENTER; PRAMIPEXOLE; EFFICACY; AMITRIPTYLINE; SYMPTOMS	Background: Psychopharmacotherapy currently constitutes the first-line treatment for depression and anxiety in Parkinson's disease (PD) however the efficacy of antidepressant treatments in PD is unclear. Several alternative treatments have been suggested as potentially more viable alternatives including dopamine agonists, repetitive transcranial magnetic stimulation, and cognitive behavioural therapy (CBT). Method: A meta-analysis of randomised placebo-controlled trials for depression and/or anxiety in PD was conducted to systematically examine the efficacy of current treatments for depression and anxiety in PD. Results: Nine trials were included. There was only sufficient data to calculate a pooled effect for antidepressant therapies. The pooled effect of antidepressants for depression in PD was moderate but non-significant (d = .71, 95% CI = 21.33 to 3.08). The secondary effect of antidepressants on anxiety in PD was large but also non-significant (d = 1.13, 95% CI = 2.67 to 2.94). Two single-trials of non-pharmacological treatments for depression in PD resulted in significant large effects; Omega-3 supplementation (d = .92, 95% CI = .15 to 1.69) and CBT (d = 1.57, 95% CI = 1.06 to 2.07), and warrant further exploration. Conclusions: There remains a lack of controlled trials for both pharmacological and non-pharmacological treatments for depression and anxiety in PD which limits the conclusions which can be drawn. While the pooled effects of antidepressant therapies in PD were non-significant, the moderate to large magnitude of each pooled effect is promising. Non-pharmacological approaches show potential for depression in PD however more research is required.	[Troeung, Lakkhina; Egan, Sarah J.; Gasson, Natalie] Curtin Univ, Sch Psychol & Speech Pathol, Perth, WA 6845, Australia	Curtin University	Troeung, L (corresponding author), Curtin Univ, Sch Psychol & Speech Pathol, Perth, WA 6845, Australia.	l.troeung@curtin.edu.au		Gasson, Natalie/0000-0001-6265-9095; Egan, Sarah/0000-0002-3715-4009				Akca A, 2011, NOROPSIKIYATRI ARS, V48, P201, DOI 10.4274/Npa.Y5711; ANDERSEN J, 1980, ACTA NEUROL SCAND, V62, P210; [Anonymous], 2008, COCHRANE HDB SYSTEMA; Antonini A, 2006, MOVEMENT DISORD, V21, P1119, DOI 10.1002/mds.20895; Barone P, 2006, J NEUROL, V253, P601, DOI 10.1007/s00415-006-0067-5; Barone P, 2010, LANCET NEUROL, V9, P573, DOI 10.1016/S1474-4422(10)70106-X; Black KJ, 2011, AM J PSYCHIAT, V168, P1015, DOI 10.1176/appi.ajp.2011.11071124; Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12; Carod-Artal FJ, 2008, PARKINSONISM RELAT D, V14, P102, DOI 10.1016/j.parkreldis.2007.06.011; Chen P, 2007, J GERIATR PSYCH NEUR, V20, P161, DOI 10.1177/0891988707301866; Chen R, 2010, MOVEMENT DISORD, V25, P2272, DOI 10.1002/mds.23266; Cole K, 2005, PARKINSONISM RELAT D, V11, P269, DOI 10.1016/j.parkreldis.2005.03.002; da Silva TM, 2008, J AFFECT DISORDERS, V111, P351, DOI 10.1016/j.jad.2008.03.008; de Lau LML, 2005, NEUROLOGY, V64, P2040, DOI 10.1212/01.WNL.0000166038.67153.9F; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; Devos D, 2008, MOVEMENT DISORD, V23, P850, DOI 10.1002/mds.21966; Djokic G, 2010, EUR PSYCHIAT, V25, P249; Dobkin RD, 2006, PSYCHOSOMATICS, V47, P259, DOI 10.1176/appi.psy.47.3.259; Dobkin RD, 2011, J GERIATR PSYCH NEUR, V24, P206, DOI 10.1177/0891988711422529; Dobkin RD, 2011, AM J PSYCHIAT, V168, P1066, DOI 10.1176/appi.ajp.2011.10111669; Dobkin RD, 2007, MOVEMENT DISORD, V22, P946, DOI 10.1002/mds.21455; Werneck ALD, 2009, ARQ NEURO-PSIQUIAT, V67, P407, DOI 10.1590/S0004-282X2009000300007; Dragasevic N, 2002, MOVEMENT DISORD, V17, P528, DOI 10.1002/mds.10109; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Epstein CM, 2007, CLIN NEUROPHYSIOL, V118, P2189, DOI 10.1016/j.clinph.2007.07.010; Farabaugh A, 2010, PSYCHOSOMATICS, V51, P124, DOI 10.1176/appi.psy.51.2.124; Feeney F., 2005, CLIN PSYCHOL-UK, V9, P31, DOI DOI 10.1080/13284200500048240; Fregni F, 2004, J NEUROL NEUROSUR PS, V75, P1171, DOI 10.1136/jnnp.2003.027060; Frisina PG, 2008, INT J NEUROSCI, V118, P667, DOI 10.1080/00207450701239418; Frisina Pasquale G, 2008, Neuropsychiatr Dis Treat, V4, P81; Gupta R., 2000, CLIN GERONTOL, V22, p87 ; Hauser RA, 1997, MOVEMENT DISORD, V12, P756, DOI 10.1002/mds.870120522; Hedges LV, 1998, PSYCHOL METHODS, V3, P486, DOI 10.1037/1082-989X.3.4.486; Hedges LV, 2014, STAT METHODS META AN; Heinrichs N, 2001, COGN BEHAV PRACT, V8, P328, DOI 10.1016/S1077-7229(01)80005-5; Hely MA, 2005, MOVEMENT DISORD, V20, P190, DOI 10.1002/mds.20324; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Kano Osamu, 2008, Neuropsychiatr Dis Treat, V4, P707; KLAASSEN T, 1995, J NEUROPSYCH CLIN N, V7, P281; Kormos TC, 2007, MOVEMENT DISORD, V22, P1836, DOI 10.1002/mds.21613; Kulisevsky J, 2008, EUR J NEUROL, V15, P953, DOI 10.1111/j.1468-1331.2008.02218.x; Laidlaw K., 2003, COGNITIVE BEHAV THER; Laidlaw K., 2008, HDB EMOTIONAL DISORD; Leentjens AFG, 2003, INT J GERIATR PSYCH, V18, P552, DOI 10.1002/gps.865; Leentjens AFG, 2009, CLIN THER, V31, P89, DOI 10.1016/j.clinthera.2009.01.012; Matthias RL, 2006, J NEUROL SCI, V248, P266, DOI 10.1016/j.jns.2006.05.024; Lemke MR, 2005, J NEUROPSYCH CLIN N, V17, P214, DOI 10.1176/appi.neuropsych.17.2.214; Marin-Martinez F, 2009, ELECT ENG RES REPORT, V1, P1; Marino L, 2013, INT J NEUROSCI, V123, P70, DOI 10.3109/00207454.2012.726300; Marsh L, 2000, INT REV PSYCHIATR, V12, P307, DOI 10.1080/09540260020002532; Menza M, 2004, J NEUROPSYCH CLIN N, V16, P315, DOI 10.1176/appi.neuropsych.16.3.315; Menza M, 2009, NEUROLOGY, V72, P886, DOI 10.1212/01.wnl.0000336340.89821.b3; MOHER D, 2009, PLOS MED, V6, P1; Mohlman Jan, 2010, Clin Case Stud, V9, P74; Muller Thomas, 2002, Expert Opin Pharmacother, V3, P381, DOI 10.1517/14656566.3.4.381; National Institute for Health and Clinical Excellence, 2010, DEPR NICE GUID TREAT; Negre-Pages L, 2010, MOVEMENT DISORD, V25, P157, DOI 10.1002/mds.22760; Pal E, 2010, MOVEMENT DISORD, V25, P2311, DOI 10.1002/mds.23270; Pinquart M, 2007, AGING MENT HEALTH, V11, P645, DOI 10.1080/13607860701529635; Rektorova I, 2003, EUR J NEUROL, V10, P399, DOI 10.1046/j.1468-1331.2003.00612.x; Richard I, 2012, NEUROLOGY, V78, P1314; Rocha FL, 2013, J PSYCHOPHARMACOL, V27, P417, DOI 10.1177/0269881113478282; Rohit V., 2012, DELHI PSYCHIATR SOC, V15, P57; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Samadi P, 2006, ANN NEUROL, V59, P282, DOI 10.1002/ana.20738; Serrano-Duenas M, 2002, REV NEUROLOGIA, V35, P1010, DOI 10.33588/rn.3511.2001044; Skapinakis P, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-49; Tesei S, 2001, MOVEMENT DISORD, V15, P986; Thornton A, 2000, J CLIN EPIDEMIOL, V53, P207, DOI 10.1016/S0895-4356(99)00161-4; Vajda FJE, 2005, J CLIN NEUROSCI, V12, P739, DOI 10.1016/j.jocn.2005.03.008; Veazey C, 2009, J CLIN PSYCHOL MED S, V16, P243, DOI 10.1007/s10880-009-9167-6; Weintraub D, 2010, NEUROLOGY, V75, P448, DOI 10.1212/WNL.0b013e3181ebdd79; Weintraub D, 2005, MOVEMENT DISORD, V20, P111; Weintraub D, 2006, J NEUROPSYCH CLIN N, V18, P377, DOI 10.1176/appi.neuropsych.18.3.377; Weintraub D, 2011, MOVEMENT DISORD, V26, P1022, DOI 10.1002/mds.23664; Wermuth L, 1998, NORD J PSYCHIAT, V52, P163, DOI 10.1080/08039489850139049; Xia Yi, 2012, Zhongguo Zhen Jiu, V32, P1071	79	76	78	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79510	10.1371/journal.pone.0079510	http://dx.doi.org/10.1371/journal.pone.0079510			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236141	Green Submitted, Green Published, gold			2022-12-27	WOS:000327254700140
J	Alves, CCD; Collison, A; Hatchwell, L; Plank, M; Morten, M; Foster, PS; Johnston, SL; da Costa, CF; de Almeida, MV; Teixeira, HC; Ferreira, AP; Mattes, J				de Souza Alves, Caio Cesar; Collison, Adam; Hatchwell, Luke; Plank, Maximilian; Morten, Matthew; Foster, Paul S.; Johnston, Sebastian L.; da Costa, Cristiane Franca; de Almeida, Mauro Vieira; Teixeira, Henrique Couto; Ferreira, Ana Paula; Mattes, Joerg			Inhibiting AKT Phosphorylation Employing Non-Cytotoxic Anthraquinones Ameliorates T(H)2 Mediated Allergic Airways Disease and Rhinovirus Exacerbation	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; EPITHELIAL-CELLS; SEVERE ASTHMA; PHOSPHATIDYLINOSITOL 3-KINASE; MULTIPLE-SCLEROSIS; TOPOISOMERASE-II; ANTI-IGE; INFLAMMATION; MITOXANTRONE; ACTIVATION	Background: Severe asthma is associated with T helper (T-H) 2 and 17 cell activation, airway neutrophilia and phosphoinositide-3-kinase (PI3K) activation. Asthma exacerbations are commonly caused by rhinovirus (RV) and also associated with PI3K-driven inflammation. Anthraquinone derivatives have been shown to reduce PI3K-mediated AKT phosphorylation in-vitro. Objective: To determine the anti-inflammatory potential of anthraquinones in-vivo. Methods: BALB/c mice were sensitized and challenged with crude house dust mite extract to induce allergic airways disease and treated with mitoxantrone and a novel non-cytotoxic anthraquinone derivative. Allergic mice were also infected with RV1B to induce an exacerbation. Results: Anthraquinone treatment reduced AKT phosphorylation, hypoxia-inducible factor-1 alpha and vascular endothelial growth factor expression, and ameliorated allergen-and RV-induced airways hyprereactivity, neutrophilic and eosinophilic inflammation, cytokine/chemokine expression, mucus hypersecretion, and expression of T(H)2 proteins in the airways. Anthraquinones also boosted type 1 interferon responses and limited RV replication in the lung. Conclusion: Non-cytotoxic anthraquinone derivatives may be of therapeutic benefit for the treatment of severe and RV-induced asthma by blocking pro-inflammatory pathways regulated by PI3K/AKT.	[de Souza Alves, Caio Cesar; Teixeira, Henrique Couto; Ferreira, Ana Paula] Univ Fed Juiz de Fora, Inst Biol Sci, Dept Parasitol Microbiol & Immunol, Sao Pedro, MG, Brazil; [de Souza Alves, Caio Cesar; Collison, Adam; Hatchwell, Luke; Morten, Matthew; Mattes, Joerg] Univ Newcastle, Experimental& Translat Resp Grp, Newcastle, NSW 2300, Australia; [de Souza Alves, Caio Cesar; Collison, Adam; Hatchwell, Luke; Plank, Maximilian; Morten, Matthew; Foster, Paul S.; Mattes, Joerg] Hunter Med Res Inst, Newcastle, NSW, Australia; [de Souza Alves, Caio Cesar; Collison, Adam; Hatchwell, Luke; Plank, Maximilian; Morten, Matthew; Foster, Paul S.; Mattes, Joerg] Univ Newcastle, Prior Res Ctr Asthma & Resp Dis, Newcastle, NSW 2300, Australia; [Johnston, Sebastian L.] Univ London Imperial Coll Sci Technol & Med, MRC, Airway Dis Infect Sect, Natl Heart & Lung Inst, London, England; [Johnston, Sebastian L.] Univ London Imperial Coll Sci Technol & Med, Asthma UK Ctr Allerg Mech Asthma, London, England; [da Costa, Cristiane Franca; de Almeida, Mauro Vieira] Univ Fed Juiz de Fora, Dept Chem, Sao Pedro, MG, Brazil; [Mattes, Joerg] Newcastle Childrens Hosp, Paediat Resp & Sleep Med Unit, Newcastle, NSW, Australia	University of Newcastle; Hunter Medical Research Institute; University of Newcastle; University of Newcastle; Imperial College London; Imperial College London; University of London; King's College London	Ferreira, AP (corresponding author), Univ Fed Juiz de Fora, Inst Biol Sci, Dept Parasitol Microbiol & Immunol, Sao Pedro, MG, Brazil.	ana.paula@ufjf.edu.br; Joerg.mattes@newcastle.edu.au	Johnston, Sebastian Lennox/I-2423-2012; Da Costa, Cristiane F/C-3710-2016; Foster, Paul/G-5057-2013; Teixeira, Henrique C/R-2133-2019; Almeida, Mauro/U-8931-2019; Ferreira, Ana Paula/C-5259-2013; De Souza Alves, Caio Cesar/B-9428-2013; MATTES, JOERG/M-5179-2019	Johnston, Sebastian Lennox/0000-0003-3009-9200; Teixeira, Henrique C/0000-0002-0172-9720; De Souza Alves, Caio Cesar/0000-0001-9765-8527; 	National Health Medical Research Council (NHMRC); Hunter Medical Research Institute; Hunter Children's Research Foundation; NH&MRC Health Professional Research Fellowship; CAPES; CNPq; FAPEMIG; Asthma UK [CH1155]; MRC Centre grant [G1000758]; ERC [233015]; Medical Research Council [G1000758] Funding Source: researchfish	National Health Medical Research Council (NHMRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)National Health and Medical Research Council (NHMRC) of Australia); Hunter Medical Research Institute; Hunter Children's Research Foundation; NH&MRC Health Professional Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Asthma UK; MRC Centre grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ERC(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the National Health Medical Research Council (NH&MRC) (J.M., P. F.), the Hunter Medical Research Institute (J.M., P. F.), the Hunter Children's Research Foundation (J.M., P. F.) and an NH&MRC Health Professional Research Fellowship (J.M.). C. C. S. A., C. F. C., H. C. T., M. V. A. and A. P. F. were supported by CAPES, CNPq and FAPEMIG grants. S.L.J. was supported by a Chair from Asthma UK (CH1155). This work was supported in part by MRC Centre grant G1000758 and ERC FP7 Advanced Grant 233015 (to S.L.J). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTS DS, 1985, INVEST NEW DRUG, V3, P101; ALRAMLI W, 2009, J ALLERGY CLIN IMMUN, V123; Barnes PJ, 2012, J ALLERGY CLIN IMMUN, V129, P48, DOI 10.1016/j.jaci.2011.11.006; Bauerfeld CP, 2012, J IMMUNOL, V188, P2847, DOI 10.4049/jimmunol.1102157; BOCHNER BS, 1994, ANNU REV IMMUNOL, V12, P295; Broide DH, 2008, J ALLERGY CLIN IMMUN, V121, P560, DOI 10.1016/j.jaci.2008.01.031; Busse W, 2001, J ALLERGY CLIN IMMUN, V108, P184, DOI 10.1067/mai.2001.117880; Busse WW, 2011, NEW ENGL J MED, V364, P1005, DOI 10.1056/NEJMoa1009705; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; CORREN J, 2011, NEW ENGL J MED, V3, P3; Corrigan CJ, 2011, P NATL ACAD SCI USA, V108, P1579, DOI 10.1073/pnas.1014241108; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Dunn JJ, 2004, J CLIN MICROBIOL, V42, P79, DOI 10.1128/JCM.42.1.79-82.2004; FAULDS D, 1991, DRUGS, V41, P400, DOI 10.2165/00003495-199141030-00007; Fitzpatrick AM, 2010, J ALLERGY CLIN IMMUN, V125, P851, DOI 10.1016/j.jaci.2010.01.048; Fox EJ, 2006, CLIN THER, V28, P461, DOI 10.1016/j.clinthera.2006.04.013; Friedlander SL, 2005, J ALLERGY CLIN IMMUN, V116, P267, DOI 10.1016/j.jaci.2005.06.003; Grunberg K, 2001, AM J RESP CRIT CARE, V164, P1816; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Hastie AT, 2010, J ALLERGY CLIN IMMUN, V125, P1028, DOI 10.1016/j.jaci.2010.02.008; Holgate Stephen T, 2009, Proc Am Thorac Soc, V6, P655, DOI 10.1513/pats.200907-072DP; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Kambayashi T, 2007, J ALLERGY CLIN IMMUN, V119, P544, DOI 10.1016/j.jaci.2007.01.017; Kay AB, 2005, TRENDS MOL MED, V11, P148, DOI 10.1016/j.molmed.2005.02.002; Kim JH, 2008, BIOCHEM BIOPH RES CO, V377, P195, DOI 10.1016/j.bbrc.2008.09.095; Kim SR, 2010, EUR J IMMUNOL, V40, P2858, DOI 10.1002/eji.200939948; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Kwak YG, 2003, J CLIN INVEST, V111, P1083, DOI 10.1172/JCI200316440; Lajoie S, 2010, NAT IMMUNOL, V11, P928, DOI 10.1038/ni.1926; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; Lanier B, 2009, J ALLERGY CLIN IMMUN, V124, P1210, DOI 10.1016/j.jaci.2009.09.021; Lau C, 2008, J IMMUNOL, V180, P870, DOI 10.4049/jimmunol.180.2.870; Lee CG, 2004, NAT MED, V10, P1095, DOI 10.1038/nm1105; Lee Chun Geun, 2011, Proc Am Thorac Soc, V8, P512, DOI 10.1513/pats.201102-018MW; Lee Chung-Tien, 2006, Birth Defects Research, V78, P129, DOI 10.1002/bdrc.20072; Lee KS, 2006, J ALLERGY CLIN IMMUN, V118, P403, DOI 10.1016/j.jaci.2006.04.041; Leung DYM, 1998, PEDIATR ALLERGY IMMU, V9, P3, DOI 10.1111/j.1399-3038.1998.tb00293.x; Leung DYM, 1997, CLIN CHEST MED, V18, P611, DOI 10.1016/S0272-5231(05)70405-6; Lloyd C, 2002, IMMUNOLOGY, V105, P144, DOI 10.1046/j.1365-2567.2002.01344.x; Lu Y, 2012, MOL CELL BIOCHEM, V365, P333, DOI 10.1007/s11010-012-1273-3; Lu Y, 2011, BIOCHEM PHARMACOL, V82, P1700, DOI 10.1016/j.bcp.2011.08.022; Mattes J, 2001, J IMMUNOL, V167, P1683, DOI 10.4049/jimmunol.167.3.1683; Message SD, 2008, P NATL ACAD SCI USA, V105, P13562, DOI 10.1073/pnas.0804181105; Miller EK, 2010, IMMUNOL ALLERGY CLIN, V30, P541, DOI 10.1016/j.iac.2010.08.007; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; Neuhaus O, 2004, J NEUROL SCI, V223, P25, DOI 10.1016/j.jns.2004.04.015; Newcomb DC, 2008, AM J RESP CRIT CARE, V177, P1111, DOI 10.1164/rccm.200708-1243OC; Newcomb DC, 2005, J BIOL CHEM, V280, P36952, DOI 10.1074/jbc.M502449200; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Papadopoulos NG, 2002, THORAX, V57, P328, DOI 10.1136/thorax.57.4.328; Rommel C, 2007, NAT REV IMMUNOL, V7, P191, DOI 10.1038/nri2036; Sears MR, 2008, J ALLERGY CLIN IMMUN, V122, P662, DOI 10.1016/j.jaci.2008.08.003; Shi JB, 2010, ORL-J OTO-RHIN-LARYN, V72, P256, DOI 10.1159/000312687; Shiraishi Y, 2009, J ALLERGY CLIN IMMUN, V123, pS56, DOI 10.1016/j.jaci.2008.11.047; Simoes DCM, 2009, AM J RESP CRIT CARE, V179, P894, DOI 10.1164/rccm.200807-1081OC; Simpson JL, 2006, RESPIROLOGY, V11, P54, DOI 10.1111/j.1440-1843.2006.00784.x; SMITH IE, 1983, CANCER TREAT REV, V10, P103, DOI 10.1016/0305-7372(83)90008-7; Thomson NC, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-102; To Y, 2010, AM J RESP CRIT CARE, V182, P897, DOI 10.1164/rccm.200906-0937OC; Toh YM, 2011, CLIN CANCER RES, V17, P5026, DOI 10.1158/1078-0432.CCR-11-0235; Wang Q, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002070; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Weckmann M, 2007, NAT MED, V13, P1308, DOI 10.1038/nm1660; Wenzel SE, 1997, AM J RESP CRIT CARE, V156, P737, DOI 10.1164/ajrccm.156.3.9610046; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258	65	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79565	10.1371/journal.pone.0079565	http://dx.doi.org/10.1371/journal.pone.0079565			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223970	Green Published, gold, Green Submitted			2022-12-27	WOS:000326597400073
J	Zhang, HB; Sachdev, PS; Wen, W; Kochan, NA; Crawford, JD; Brodaty, H; Slavin, MJ; Reppermund, S; Kang, K; Trollor, JN				Zhang, Haobo; Sachdev, Perminder S.; Wen, Wei; Kochan, Nicole A.; Crawford, John D.; Brodaty, Henry; Slavin, Melissa J.; Reppermund, Simone; Kang, Kristan; Trollor, Julian N.			Grey Matter Correlates of Three Language Tests in Non-demented Older Adults	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; MINI-MENTAL-STATE; VERBAL FLUENCY; SEMANTIC MEMORY; WORKING-MEMORY; ALZHEIMERS-DISEASE; PHONEMIC FLUENCY; FUNCTIONAL MRI; WORD RETRIEVAL; BRAIN	Language has been extensively investigated by functional neuroimaging studies. However, only a limited number of structural neuroimaging studies have examined the relationship between language performance and brain structure in healthy adults, and the number is even less in older adults. The present study sought to investigate correlations between grey matter volumes and three standardized language tests in late life. The participants were 344 non-demented, community-dwelling adults aged 70-90 years, who were drawn from the population-based Sydney Memory and Ageing Study. The three language tests included the Controlled Oral Word Association Task (COWAT), Category Fluency (CF), and Boston Naming Test (BNT). Correlation analyses between voxel-wise GM volumes and language tests showed distinctive GM correlation patterns for each language test. The GM correlates were located in the right frontal and left temporal lobes for COWAT, in the left frontal and temporal lobes for CF, and in bilateral temporal lobes for BNT. Our findings largely corresponded to the neural substrates of language tasks revealed in fMRI studies, and we also observed a less hemispheric asymmetry in the GM correlates of the language tests. Furthermore, we divided the participants into two age groups (70-79 and 80-90 years old), and then examined the correlations between structural laterality indices and language performance for each group. A trend toward significant difference in the correlations was found between the two age groups, with stronger correlations in the group of 70-79 years old than those in the group of 80-90 years old. This difference might suggest a further decline of language lateralization in different stages of late life.	[Zhang, Haobo; Sachdev, Perminder S.; Wen, Wei; Kochan, Nicole A.; Crawford, John D.; Reppermund, Simone; Kang, Kristan; Trollor, Julian N.] Univ New S Wales, Sch Psychiat, Brain & Ageing Res Program, Sydney, NSW, Australia; [Sachdev, Perminder S.; Wen, Wei; Kochan, Nicole A.] Prince Wales Hosp, Inst Neuropsychiat, Randwick, NSW 2031, Australia; [Brodaty, Henry] Prince Wales Hosp, Acad Dept Old Age Psychiat, Randwick, NSW 2031, Australia; [Brodaty, Henry; Slavin, Melissa J.] Univ New S Wales, Sch Psychiat, Dementia Collaborat Res Ctr, Sydney, NSW, Australia; [Trollor, Julian N.] Univ New S Wales, Sch Psychiat, Dept Dev Disabil Neuropsychiat, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Trollor, JN (corresponding author), Univ New S Wales, Sch Psychiat, Brain & Ageing Res Program, Sydney, NSW, Australia.	J.Trollor@unsw.edu.au	Sachdev, Perminder/ABC-1137-2020	Sachdev, Perminder/0000-0002-9595-3220; Trollor, Julian/0000-0002-7685-2977; Zhang, Haobo/0000-0002-7220-8957	National Health and Medical Research Council of Australia Program Grant [350833]; Project Grant [ID 510175]; Australian Research Council Discovery Grant [ID DP0774213]	National Health and Medical Research Council of Australia Program Grant(National Health and Medical Research Council (NHMRC) of Australia); Project Grant(Wellcome Trust); Australian Research Council Discovery Grant(Australian Research Council)	The current study was financially supported by the National Health and Medical Research Council of Australia Program Grant (ID 350833) and Project Grant (ID 510175) (http://www.nhmrc.gov.au/grants), as well as by an Australian Research Council Discovery Grant (ID DP0774213) (http://www.arc.gov.au/ncgp/dp/dp_default.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams S, 2003, HUM BRAIN MAPP, V20, P29, DOI 10.1002/hbm.10126; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Anderson TM, 2007, AM J GERIAT PSYCHIAT, V15, P467, DOI 10.1097/JGP.0b013e3180547053; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Benton A.L., 1967, CORTEX, V3, P32, DOI [10.1016/s0010-9452(67)80005-4, DOI 10.1016/S0010-9452(67)80005-4, 10.1016/S0010-9452(67)80005-4]; Bernard FA, 2004, NEUROIMAGE, V22, P1704, DOI 10.1016/j.neuroimage.2004.03.036; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; Birn RM, 2010, NEUROIMAGE, V49, P1099, DOI 10.1016/j.neuroimage.2009.07.036; Blaizot X, 2010, CEREB CORTEX, V20, P2198, DOI 10.1093/cercor/bhp289; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; Brown S, 2009, BRAIN COGNITION, V70, P31, DOI 10.1016/j.bandc.2008.12.006; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Cardenas VA, 2011, NEUROBIOL AGING, V32, P572, DOI 10.1016/j.neurobiolaging.2009.04.011; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; Chee MWL, 2009, NEUROIMAGE, V46, P257, DOI 10.1016/j.neuroimage.2009.01.036; Chee MWL, 2002, NEUROIMAGE, V16, P259, DOI 10.1006/nimg.2002.1061; Chen ZJ, 2011, NEUROIMAGE, V56, P235, DOI 10.1016/j.neuroimage.2011.01.010; Corbett F, 2009, BRAIN, V132, P2593, DOI 10.1093/brain/awp146; Costafreda SG, 2006, HUM BRAIN MAPP, V27, P799, DOI 10.1002/hbm.20221; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Damasio H, 2004, COGNITION, V92, P179, DOI 10.1016/j.cognition.2002.07.001; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Fisher R. A., 1921, METRON             4, V1, P3, DOI DOI 10.1093/BIOMET/9.1-2.22; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Foundas AL, 1996, P NATL ACAD SCI USA, V93, P719, DOI 10.1073/pnas.93.2.719; Frenck-Mestre C, 2005, NEUROREPORT, V16, P761, DOI 10.1097/00001756-200505120-00021; Gauger LM, 1997, J SPEECH LANG HEAR R, V40, P1272, DOI 10.1044/jslhr.4006.1272; Gerlach C, 2007, J COGNITIVE NEUROSCI, V19, P296, DOI 10.1162/jocn.2007.19.2.296; Gourovitch ML, 2000, NEUROPSYCHOLOGY, V14, P353, DOI 10.1037//0894-4105.14.3.353; Grogan A, 2009, CEREB CORTEX, V19, P2690, DOI 10.1093/cercor/bhp023; Haist F, 2001, NAT NEUROSCI, V4, P1139, DOI 10.1038/nn739; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284; Hirshorn EA, 2006, NEUROPSYCHOLOGIA, V44, P2547, DOI 10.1016/j.neuropsychologia.2006.03.035; HODGES JR, 1992, NEUROPSYCHOLOGIA, V30, P301, DOI 10.1016/0028-3932(92)90104-T; Hoeppner J, 2009, EUR ARCH PSY CLIN N, V259, P92, DOI 10.1007/s00406-008-0840-9; Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001; Indefrey P, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00255; Jefferies E, 2007, NEUROPSYCHOLOGIA, V45, P1065, DOI 10.1016/j.neuropsychologia.2006.09.009; Josse G, 2003, COGNITIVE BRAIN RES, V18, P1, DOI 10.1016/j.cogbrainres.2003.08.007; Josse G, 2009, J NEUROSCI, V29, P13516, DOI 10.1523/JNEUROSCI.1680-09.2009; Kaplan E, 2001, BOSTON NAMING TEST; Kennedy KM, 2009, NEUROBIOL AGING, V30, P1657, DOI 10.1016/j.neurobiolaging.2007.12.020; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Knaus TA, 2010, BRAIN LANG, V112, P113, DOI 10.1016/j.bandl.2009.11.005; Koelsch S, 2009, HUM BRAIN MAPP, V30, P859, DOI 10.1002/hbm.20550; Leskela M, 1999, EUR J NEUROL, V6, P653, DOI 10.1046/j.1468-1331.1999.660653.x; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Martin A, 2001, CURR OPIN NEUROBIOL, V11, P194, DOI 10.1016/S0959-4388(00)00196-3; McGeown WJ, 2009, PSYCHIAT RES-NEUROIM, V173, P218, DOI 10.1016/j.pscychresns.2008.10.005; Meinzer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033631; Meinzer M, 2009, J COGNITIVE NEUROSCI, V21, P2007, DOI 10.1162/jocn.2009.21219; Melrose RJ, 2009, INT J GERIATR PSYCH, V24, P885, DOI 10.1002/gps.2229; MILLER BL, 1991, NEUROLOGY, V41, P1374, DOI 10.1212/WNL.41.9.1374; Moser D, 2009, NEUROIMAGE, V46, P549, DOI 10.1016/j.neuroimage.2009.01.015; Nadel L, 2000, HIPPOCAMPUS, V10, P352, DOI 10.1002/1098-1063(2000)10:4<352::AID-HIPO2>3.3.CO;2-4; Newman LM, 2007, BRAIN IMAGING BEHAV, V1, P3, DOI 10.1007/s11682-007-9000-5; NICHOLAS M, 1985, CORTEX, V21, P595, DOI 10.1016/S0010-9452(58)80007-6; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Noppeney U, 2004, NEUROIMAGE, V22, P164, DOI 10.1016/j.neuroimage.2003.12.010; Nyberg L, 2003, NEUROPSYCHOLOGIA, V41, P371, DOI 10.1016/S0028-3932(02)00168-9; Obler LK, 2010, BRAIN LANG, V113, P113, DOI [10.1016/j.band1.2010.03.001, 10.1016/j.bandl.2010.03.001]; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Park DC, 2002, PSYCHOL AGING, V17, P299, DOI 10.1037//0882-7974.17.2.299; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; Phelps EA, 1997, NEUROREPORT, V8, P561, DOI 10.1097/00001756-199701200-00036; Pihlajamaki M, 2000, ANN NEUROL, V47, P470, DOI 10.1002/1531-8249(200004)47:4<470::AID-ANA10>3.3.CO;2-D; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Pujol J, 1999, NEUROLOGY, V52, P1038, DOI 10.1212/WNL.52.5.1038; Reuter-Lorenz PA, 2000, J COGNITIVE NEUROSCI, V12, P174, DOI 10.1162/089892900561814; Reuter-Lorenz PA, 2008, CURR DIR PSYCHOL SCI, V17, P177, DOI 10.1111/j.1467-8721.2008.00570.x; Richardson FM, 2009, BRAIN STRUCT FUNCT, V213, P511, DOI 10.1007/s00429-009-0211-y; Ryan L, 2008, NEUROPSYCHOLOGIA, V46, P2109, DOI 10.1016/j.neuropsychologia.2008.02.030; Sachdev PS, 2010, INT PSYCHOGERIATR, V22, P1248, DOI 10.1017/S1041610210001067; Schmolck H, 2002, HIPPOCAMPUS, V12, P520, DOI 10.1002/hipo.10039; Schneider P, 2005, NAT NEUROSCI, V8, P1241, DOI 10.1038/nn1530; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Shafto MA, 2007, J COGNITIVE NEUROSCI, V19, P2060, DOI 10.1162/jocn.2007.19.12.2060; Sharp DJ, 2010, HUM BRAIN MAPP, V31, P365, DOI 10.1002/hbm.20871; Somers M, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00031; Spreen O., 1969, NEUROSENSORY CTR COM; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Szaflarski JP, 2006, HUM BRAIN MAPP, V27, P202, DOI 10.1002/hbm.20177; Thompson-Schill SL, 2003, NEUROPSYCHOLOGIA, V41, P280, DOI 10.1016/S0028-3932(02)00161-6; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Venneri A, 2008, NEUROPSYCHOLOGIA, V46, P497, DOI 10.1016/j.neuropsychologia.2007.08.026; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Whitney C, 2011, CEREB CORTEX, V21, P1066, DOI 10.1093/cercor/bhq180; Whitney C, 2011, CEREB CORTEX, V21, P831, DOI 10.1093/cercor/bhq148; Wierenga CE, 2008, NEUROBIOL AGING, V29, P436, DOI 10.1016/j.neurobiolaging.2006.10.024; Wildgruber D, 2001, NEUROIMAGE, V13, P101, DOI 10.1006/nimg.2000.0672; Worsley KJ, 1999, HUM BRAIN MAPP, V8, P98, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<98::AID-HBM5>3.3.CO;2-6; Zhang HB, 2011, DEMENT GERIATR COGN, V32, P216, DOI 10.1159/000333372; Zheng ZZ, 2010, J COGNITIVE NEUROSCI, V22, P1770, DOI 10.1162/jocn.2009.21324; Ziegler DA, 2010, NEUROBIOL AGING, V31, P1912, DOI 10.1016/j.neurobiolaging.2008.10.015	98	15	16	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80215	10.1371/journal.pone.0080215	http://dx.doi.org/10.1371/journal.pone.0080215			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	247EE	24224044	Green Published, gold			2022-12-27	WOS:000326597400114
J	Fenske, N; Burns, J; Hothorn, T; Rehfuess, EA				Fenske, Nora; Burns, Jacob; Hothorn, Torsten; Rehfuess, Eva A.			Understanding Child Stunting in India: A Comprehensive Analysis of Socio-Economic, Nutritional and Environmental Determinants Using Additive Quantile Regression	PLOS ONE			English	Article							COMPLEMENTARY FEEDING PRACTICES; RISK-FACTORS; MULTISECTOR INTERVENTION; ACCELERATE REDUCTIONS; RESPIRATORY MORBIDITY; DEVELOPING-COUNTRIES; SYSTEMATIC ANALYSIS; PRESCHOOL-CHILDREN; DIETARY DIVERSITY; POPULATION HEALTH	Background: Most attempts to address undernutrition, responsible for one third of global child deaths, have fallen behind expectations. This suggests that the assumptions underlying current modelling and intervention practices should be revisited. Objective: We undertook a comprehensive analysis of the determinants of child stunting in India, and explored whether the established focus on linear effects of single risks is appropriate. Design: Using cross-sectional data for children aged 0-24 months from the Indian National Family Health Survey for 2005/2006, we populated an evidence-based diagram of immediate, intermediate and underlying determinants of stunting. We modelled linear, non-linear, spatial and age-varying effects of these determinants using additive quantile regression for four quantiles of the Z-score of standardized height-for-age and logistic regression for stunting and severe stunting. Results: At least one variable within each of eleven groups of determinants was significantly associated with height-for-age in the 35% Z-score quantile regression. The non-modifiable risk factors child age and sex, and the protective factors household wealth, maternal education and BMI showed the largest effects. Being a twin or multiple birth was associated with dramatically decreased height-for-age. Maternal age, maternal BMI, birth order and number of antenatal visits influenced child stunting in non-linear ways. Findings across the four quantile and two logistic regression models were largely comparable. Conclusions: Our analysis confirms the multifactorial nature of child stunting. It emphasizes the need to pursue a systems-based approach and to consider non-linear effects, and suggests that differential effects across the height-for-age distribution do not play a major role.	[Fenske, Nora; Hothorn, Torsten] Univ Munich, Inst Stat, Munich, Germany; [Burns, Jacob; Rehfuess, Eva A.] Univ Munich, Inst Med Informationsverarbeitung Biometrie & Epi, Munich, Germany	University of Munich; University of Munich	Fenske, N (corresponding author), Univ Munich, Inst Stat, Munich, Germany.	nora.fenske@stat.uni-muenchen.de	Rehfuess, Eva Annette/ABD-8167-2021		Munich Center of Health Sciences (MC-Health)	Munich Center of Health Sciences (MC-Health)	This work was supported by the Munich Center of Health Sciences (MC-Health). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair LS, 1997, J NUTR, V127, P314, DOI 10.1093/jn/127.2.314; Agee MD, 2010, SOC SCI MED, V71, P1973, DOI 10.1016/j.socscimed.2010.09.020; Anekwe TD, 2012, J PUBLIC HEALTH-UK, V34, P489, DOI 10.1093/pubmed/fds032; ANGELES IT, 1993, AM J CLIN NUTR, V58, P339, DOI 10.1093/ajcn/58.3.339; [Anonymous], 2008, LANCET, DOI DOI 10.1016/S0140-6736(07)61693-6; Arimond M, 2004, J NUTR, V134, P2579, DOI 10.1093/jn/134.10.2579; Best CM, 2007, NUTRITION, V23, P731, DOI 10.1016/j.nut.2007.06.014; Bhandari N, 2008, MATERN CHILD NUTR, V4, P5, DOI 10.1111/j.1740-8709.2007.00126.x; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Buhlmann P, 2007, STAT SCI, V22, P477, DOI 10.1214/07-STS242; Casapia M, 2007, BRIT J NUTR, V98, P1259, DOI 10.1017/S0007114507795272; Caulfield LE, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P551; Checkley W, 2008, INT J EPIDEMIOL, V37, P816, DOI 10.1093/ije/dyn099; Clemens MA, 2012, AM J CLIN NUTR, V95, P774, DOI 10.3945/ajcn.111.031278; Conde-Agudelo A, 2007, AM J OBSTET GYNECOL, V196, P297, DOI 10.1016/j.ajog.2006.05.055; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; De-Regil LM, 2011, COCHRANE DB SYST REV, V9; Dekker LH, 2010, FOOD NUTR BULL, V31, P242, DOI 10.1177/156482651003100207; Delpeuch F, 2000, PUBLIC HEALTH NUTR, V3, P39, DOI 10.1017/S1368980000000069; Dewey KG, 2008, MATERN CHILD NUTR, V4, P24, DOI 10.1111/j.1740-8709.2007.00124.x; Dewey KG, 2011, MATERN CHILD NUTR, V7, P129, DOI 10.1111/j.1740-8709.2011.00357.x; Dewey KG, 2011, MATERN CHILD NUTR, V7, P5, DOI 10.1111/j.1740-8709.2011.00349.x; Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655; Fenske N, 2011, J AM STAT ASSOC, V106, P494, DOI 10.1198/jasa.2011.ap09272; Fink G, 2011, INT J EPIDEMIOL, V40, P1196, DOI 10.1093/ije/dyr102; Galea S, 2010, INT J EPIDEMIOL, V39, P97, DOI 10.1093/ije/dyp296; Garg A, 2009, J HEALTH POPUL NUTR, V27, P763; Ghosh R, 2011, ARCH PEDIAT ADOL MED, V165, P492, DOI 10.1001/archpediatrics.2010.294; Gwatkin D R, 2007, Niger J Clin Pract, V10, P272; Habicht JP, 2004, ADV EXP MED BIOL, V554, P79; Haddad L, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6687; Hall A, 2008, MATERN CHILD NUTR, V4, P118, DOI 10.1111/j.1740-8709.2007.00127.x; Hien Nguyen Ngoc, 2008, J Prev Med Public Health, V41, P232, DOI 10.3961/jpmph.2008.41.4.232; Hofner B, 2011, J COMPUT GRAPH STAT, V20, P956, DOI 10.1198/jcgs.2011.09220; Hothorn T, 2013, MBOOST MODEL BASED B; Hothorn T, 2010, J MACH LEARN RES, V11, P2109; Huy ND, 2009, FOOD NUTR BULL, V30, pS506, DOI 10.1177/15648265090304S405; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S25; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S22; International Institute for Population Sciences, 2013, NAT FAM HLTH SURV; International Institute for Population Sciences and Macro International, 2007, NAT FAM HLTH SURV NF, P517; Jayasinghe S, 2011, EMERG THEMES EPIDEMI, V8, DOI 10.1186/1742-7622-8-2; Joffe M, 2012, EMERG THEMES EPIDEMI, V9, DOI 10.1186/1742-7622-9-1; Jones AD, 2012, SOC SCI MED, V75, P1673, DOI 10.1016/j.socscimed.2012.06.025; Kandala NB, 2009, POPUL SPACE PLACE, V15, P461, DOI 10.1002/psp.524; Kimani-Murage EW, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-23; Kneib T, 2009, BIOMETRICS, V65, P626, DOI 10.1111/j.1541-0420.2008.01112.x; KRIEGER N, 1994, SOC SCI MED, V39, P887, DOI 10.1016/0277-9536(94)90202-X; Kyu HH, 2009, INT J EPIDEMIOL, V38, P1342, DOI 10.1093/ije/dyp253; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lloyd SJ, 2011, ENVIRON HEALTH PERSP, V119, P1817, DOI 10.1289/ehp.1003311; Lutter CK, 2011, PEDIATRICS, V128, pE1418, DOI 10.1542/peds.2011-1392; Magadi MA, 2011, SOC SCI MED, V73, P436, DOI 10.1016/j.socscimed.2011.05.042; Markovitz AR, 2012, INT J EPIDEMIOL, V41, P504, DOI 10.1093/ije/dyr194; MARTORELL R, 1994, EUR J CLIN NUTR, V48, pS45; Martorell R, 2012, PAEDIATR PERINAT EP, V26, P302, DOI 10.1111/j.1365-3016.2012.01298.x; Masset E, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8222; McMichael AJ, 2001, P NUTR SOC, V60, P195, DOI 10.1079/PNS200090; Medhin G, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-27; Mishra V, 2007, INT J EPIDEMIOL, V36, P117, DOI 10.1093/ije/dyl234; Monteiro CA, 2010, B WORLD HEALTH ORGAN, V88, P305, DOI 10.2471/BLT.09.069195; Moursi MM, 2008, J NUTR, V138, P2448, DOI 10.3945/jn.108.093971; Muller O, 2005, CAN MED ASSOC J, V173, P279, DOI 10.1503/cmaj.050342; Nalwoga A, 2010, TROP MED INT HEALTH, V15, P414, DOI 10.1111/j.1365-3156.2010.02476.x; Osei A, 2010, FOOD NUTR BULL, V31, P221, DOI 10.1177/156482651003100205; Patel A, 2012, MATERN CHILD NUTR, V8, P28, DOI 10.1111/j.1740-8709.2011.00385.x; Paul KH, 2011, FOOD NUTR BULL, V32, P244, DOI 10.1177/156482651103200308; Pearce N, 2011, INT J EPIDEMIOL, V40, P503, DOI 10.1093/ije/dyq257; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rahman A, 2008, TROP MED INT HEALTH, V13, P579, DOI 10.1111/j.1365-3156.2008.02036.x; Ramakrishnan U, 2009, AM J CLIN NUTR, V89, P191, DOI 10.3945/ajcn.2008.26862; Reddy KS, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7188; Remans R, 2011, AM J CLIN NUTR, V94, P1632, DOI 10.3945/ajcn.111.020099; Rosado JL, 1999, J NUTR, V129, p531S, DOI 10.1093/jn/129.2.531S; ROWLAND MGM, 1988, AM J CLIN NUTR, V47, P134, DOI 10.1093/ajcn/47.1.134; RUE H., 2005, GAUSSIAN MARKOV RAND; Ruel MT, 2002, J NUTR, V132, P1180, DOI 10.1093/jn/132.6.1180; Ruel MT, 2002, 143 INT FOOD POL RES, P53; Semba RD, 2008, AM J CLIN NUTR, V87, P438, DOI 10.1093/ajcn/87.2.438; Semba RD, 2008, LANCET, V371, P322, DOI 10.1016/S0140-6736(08)60169-5; Semba RD, 2010, J NUTR, V140, p208S, DOI 10.3945/jn.109.110700; Sguassero Y., 2012, COCHRANE DB SYST REV, V6; Shroff MR, 2011, SOC SCI MED, V73, P447, DOI 10.1016/j.socscimed.2011.05.040; Smith GD, 2001, J CLIN EPIDEMIOL, V54, P325, DOI 10.1016/S0895-4356(00)00334-6; Smith LC, 2003, 131 IFPRI, P163; Stevens GA, 2012, LANCET, V380, P824, DOI 10.1016/S0140-6736(12)60647-3; Subramanian SV, 2010, PEDIATRICS, V126, pE663, DOI 10.1542/peds.2010-0222; Subramanyam MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011392; Surkan PJ, 2011, B WORLD HEALTH ORGAN, V89, P607, DOI 10.2471/BLT.11.088187; Svedberg P, 2006, INT J EPIDEMIOL, V35, P1336, DOI 10.1093/ije/dyl157; Tielsch JM, 2009, INT J EPIDEMIOL, V38, P1351, DOI 10.1093/ije/dyp286; UNICEF, 1998, STAT WORLDS CHILDR 1; UNICEF WHO The World Bank and United Nations DESA/Population Division, 2011, LEV TRENDS CHILD MOR, P19; Van De Poel E, 2008, B WORLD HEALTH ORGAN, V86, P282, DOI 10.2471/BLT.07.044800; Varela-Silva MI, 2009, AM J HUM BIOL, V21, P657, DOI 10.1002/ajhb.20883; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; Vitolo MR, 2008, J PEDIAT-BRAZIL, V84, P251, DOI [10.2223/JPED.1776, 10.1590/S0021-75572008000300011]; WHO, 2003, INF YOUNG CHILD FEED, P140; WHO Multicentre Growth Reference Study Group, 2006, WHO GUID DRINK WAT Q, P138; WHO UNICEF, 2005, HDB INT MAN CHILDH I, P163; World Health Organization, GLOB DAT CHILD GROWT; Zottarelli L. K., 2007, Eastern Mediterranean Health Journal, V13, P1330	102	108	109	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78692	10.1371/journal.pone.0078692	http://dx.doi.org/10.1371/journal.pone.0078692			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	245ZC	24223839	Green Published, Green Submitted, gold			2022-12-27	WOS:000326503400082
J	Kolahdooz, F; Barr, A; Roache, C; Sheehy, T; Corriveau, A; Sharma, S				Kolahdooz, Fariba; Barr, Alison; Roache, Cindy; Sheehy, Tony; Corriveau, Andre; Sharma, Sangita			Dietary Adequacy of Vitamin D and Calcium among Inuit and Inuvialuit Women of Child-Bearing Age in Arctic Canada: A Growing Concern	PLOS ONE			English	Article							D DEFICIENCY; LIFE-STYLE; NUTRITION TRANSITION; RAPID TRANSITION; FOOD INSECURITY; POPULATION; HEALTH; RISK; DISEASE; DETERMINANTS	Background: Arctic populations are at an increased risk of vitamin D inadequacy due to geographic latitude and a nutrition transition. This study aimed to assess the adequacy of dietary vitamin D and calcium among women of child-bearing age in Arctic Canada. Methods: This study collected data from 203 randomly selected women of child-bearing age (19-44 years) in Nunavut and the Northwest Territories of Arctic Canada. Cross-sectional surveys using a validated quantitative food frequency questionnaire were analysed to determine the dietary adequacy of vitamin D and calcium and summarize the top foods contributing to vitamin D and calcium intake among traditional food eaters (TFE) and non-traditional food eaters (NTFE). Results: The response rate was between 69-93% depending on the community sampled. Mean BMIs for both TFE and NTFE were above the normal range. Traditional food eaters had a significantly higher median vitamin D intake compared with non-traditional eaters (TFE = 5.13 +/- 5.34 mu g/day; NTFE = 3.5 +/- 3.22 mu g/day, p = 0.004). The majority of women (87%) were below the Estimated Average Requirements (EAR) for vitamin D. Despite adequate median daily calcium intake in both TFE (1299 +/- 798 mg/day) and NTFE (992 +/- 704 mg/day; p = 0.0005), 27% of the study population fell below the EAR for calcium. Dairy products contributed the most to intake of vitamin D (TFE = 30.7%; NTFE = 39.1%) and calcium (TFE = 25.5%; NTFE = 34.5%). Conclusions: Inadequate dietary vitamin D intake is evident among Inuit and Inuvialuit women of child-bearing age in Arctic Canada. Promotion of nutrient-rich sources of traditional foods, supplementation protocols and/or expanded food fortification should be considered to address this nutrition concern.	[Kolahdooz, Fariba; Barr, Alison; Roache, Cindy; Sharma, Sangita] Univ Alberta, Dept Med, Aboriginal & Global Hlth Res Grp, Edmonton, AB, Canada; [Sheehy, Tony] Natl Univ Ireland Univ Coll Cork, Dept Food & Nutr Sci, Cork, Ireland; [Corriveau, Andre] Govt Northwest Territories, Dept Hlth & Social Serv, Yellowknife, NT, Canada	University of Alberta; University College Cork	Sharma, S (corresponding author), Univ Alberta, Dept Med, Aboriginal & Global Hlth Res Grp, Edmonton, AB, Canada.	gita.sharma@ualberta.ca		Sharma, Sangita/0000-0002-4995-0010	American Diabetes Association Clinical Research award [1-08-CR-57]	American Diabetes Association Clinical Research award(American Diabetes Association)	This project was supported by the American Diabetes Association Clinical Research award 1-08-CR-57. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegboye ARA, 2010, J NUTR, V140, P1864, DOI 10.3945/jn.109.117770; Berti PR, 2008, INT J CIRCUMPOL HEAL, V67, P349, DOI 10.3402/ijch.v67i4.18340; Brenner DR, 2011, CLIN INVEST MED, V34, pE377; Buppasiri P, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007079.pub2; Calvo MS, 2004, AM J CLIN NUTR, V80, p1710S, DOI 10.1093/ajcn/80.6.1710S; Cashman KD, 2012, SCAND J CLIN LAB INV, V72, P136, DOI 10.3109/00365513.2012.682891; Egeland GM, 2011, J NUTR, V141, P1746, DOI 10.3945/jn.111.139006; Erber E, 2010, J HUM NUTR DIET, V23, P35, DOI 10.1111/j.1365-277X.2010.01098.x; Gittelsohn J, 2006, J NUTR EDUC BEHAV, V38, P163, DOI 10.1016/j.jneb.2005.12.004; Glendenning P, 2012, PATHOLOGY, V44, P160, DOI 10.1097/PAT.0b013e32834e8df6; Holick MF, 2008, NUTR REV, V66, pS182, DOI 10.1111/j.1753-4887.2008.00104.x; Hopping BN, 2010, J HUM NUTR DIET, V23, P27, DOI 10.1111/j.1365-277X.2010.01099.x; Kuhnlein HV, 2007, J NUTR, V137, P1110, DOI 10.1093/jn/137.4.1110; Kuhnlein HV, 2004, J NUTR, V134, P1447, DOI 10.1093/jn/134.6.1447; Kull M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-22; Lewis S, 2010, MOL NUTR FOOD RES, V54, P1092, DOI 10.1002/mnfr.201000044; Lucas RM, 2008, NUTR REV, V66, P710, DOI 10.1111/j.1753-4887.2008.00126.x; Macdonald HM, 2008, BONE, V42, P996, DOI 10.1016/j.bone.2008.01.011; Mason RS, 2011, EUR J CLIN NUTR, V65, P986, DOI 10.1038/ejcn.2011.105; McGrath J, 2001, MED HYPOTHESES, V56, P367, DOI 10.1054/mehy.2000.1226; Mitri J, 2011, EUR J CLIN NUTR, V65, P1005, DOI 10.1038/ejcn.2011.118; Morabia A, 2000, EUR J CLIN NUTR, V54, P684, DOI 10.1038/sj.ejcn.1601074; Norman AW, 2011, PUBLIC HEALTH NUTR, V14, P744, DOI 10.1017/S1368980011000280; Nwosu BU, 2011, J PEDIATR ENDOCR MET, V24, P619, DOI 10.1515/JPEM.2011.300; Pakseresht M, 2010, J HUM NUTR DIET, V23, P67, DOI 10.1111/j.1365-277X.2010.01104.x; Seligman HK, 2010, J NUTR, V140, P304, DOI 10.3945/jn.109.112573; Sharma S, 2010, J HUM NUTR DIET, V23, P5, DOI 10.1111/j.1365-277X.2010.01093.x; Sharma S, 2011, NUTR REV, V69, P468, DOI 10.1111/j.1753-4887.2011.00406.x; Sharma S, 2010, BRIT J NUTR, V103, P749, DOI 10.1017/S0007114509992224; Sharma S, 2009, CAN J PUBLIC HEALTH, V100, P442, DOI 10.1007/BF03404341; Souberbielle JC, 2010, AUTOIMMUN REV, V9, P709, DOI 10.1016/j.autrev.2010.06.009; Vanga SR, 2010, AM J CARDIOL, V106, P798, DOI 10.1016/j.amjcard.2010.04.042; Vieth R, 2001, EUR J CLIN NUTR, V55, P1091, DOI 10.1038/sj.ejcn.1601275; Webb AR, 2006, PROG BIOPHYS MOL BIO, V92, P17, DOI 10.1016/j.pbiomolbio.2006.02.004; Weiler HA, 2007, J NUTR, V137, P461, DOI 10.1093/jn/137.2.461; Willows ND, 2005, CAN J PUBLIC HEALTH, V96, pS32, DOI 10.1007/BF03405199	36	14	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78987	10.1371/journal.pone.0078987	http://dx.doi.org/10.1371/journal.pone.0078987			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223871	gold, Green Published			2022-12-27	WOS:000326503400095
J	Marciniak, A; Selck, C; Friedrich, B; Speier, S				Marciniak, Anja; Selck, Claudia; Friedrich, Betty; Speier, Stephan			Mouse Pancreas Tissue Slice Culture Facilitates Long-Term Studies of Exocrine and Endocrine Cell Physiology in situ	PLOS ONE			English	Article							ACINAR-CELLS; ANIMAL-MODELS; AMYLASE RELEASE; DUCT CELLS; BETA-CELLS; INSULIN; ACTIVATION; ADULT; HETEROGENEITY; EXPRESSION	Studies on pancreatic cell physiology rely on the investigation of exocrine and endocrine cells in vitro. Particularly, in the case of the exocrine tissue these studies have suffered from a reduced functional viability of acinar cells in culture. As a result not only investigations on dispersed acinar cells and isolated acini were limited in their potential, but also prolonged studies on pancreatic exocrine and endocrine cells in an intact pancreatic tissue environment were unfeasible. To overcome these limitations, we aimed to establish a pancreas tissue slice culture platform to allow long-term studies on exocrine and endocrine cells in the intact pancreatic environment. Mouse pancreas tissue slice morphology was assessed to determine optimal long-term culture settings for intact pancreatic tissue. Utilizing optimized culture conditions, cell specificity and function of exocrine acinar cells and endocrine beta cells were characterized over a culture period of 7 days. We found pancreas tissue slices cultured under optimized conditions to have intact tissue specific morphology for the entire culture period. Amylase positive intact acini were present at all time points of culture and acinar cells displayed a typical strong cell polarity. Amylase release from pancreas tissue slices decreased during culture, but maintained the characteristic bell-shaped dose-response curve to increasing caerulein concentrations and a ca. 4-fold maximal over basal release. Additionally, endocrine beta cell viability and function was well preserved until the end of the observation period. Our results show that the tissue slice culture platform provides unprecedented maintenance of pancreatic tissue specific morphology and function over a culture period for at least 4 days and in part even up to 1 week. This analytical advancement now allows mid-to long-term studies on the cell biology of pancreatic disorder pathogenesis and therapy in an intact surrounding in situ.	[Marciniak, Anja; Selck, Claudia; Friedrich, Betty; Speier, Stephan] Tech Univ Dresden, CRTD DFG Res Ctr Regenerat Therapies Dresden, D-01062 Dresden, Germany; [Marciniak, Anja; Selck, Claudia; Friedrich, Betty; Speier, Stephan] German Ctr Diabet Res DZD, Paul Langerhans Inst Dresden, Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden	Speier, S (corresponding author), Tech Univ Dresden, CRTD DFG Res Ctr Regenerat Therapies Dresden, D-01062 Dresden, Germany.	stephan.speier@crt-dresden.de	Speier, Stephan/E-8525-2010	Speier, Stephan/0000-0002-4561-7085; Selck, Claudia/0000-0002-1831-752X	Emmy Noether Program of the German Research Foundation (DFG); CRTD - DFG Research Center for Regenerative Therapies Dresden, Cluster of Excellence; German Ministry for Education and Research (BMBF); Network of Competence for Diabetes (KKNDm)	Emmy Noether Program of the German Research Foundation (DFG)(German Research Foundation (DFG)); CRTD - DFG Research Center for Regenerative Therapies Dresden, Cluster of Excellence; German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Network of Competence for Diabetes (KKNDm)	This work was supported with funds from the Emmy Noether Program of the German Research Foundation (DFG; www.dfg.de), the CRTD - DFG Research Center for Regenerative Therapies Dresden, Cluster of Excellence (www.crt-dresden.de), and the German Ministry for Education and Research (BMBF; www.bmbf.de) to the German Centre for Diabetes Research (DZD-e.v.) and the Network of Competence for Diabetes (KKNDm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghdassi AA, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-26; Ahn YB, 2007, DIABETOLOGIA, V50, P334, DOI 10.1007/s00125-006-0536-5; AMSTERDA.A, 1974, J CELL BIOL, V63, P1037, DOI 10.1083/jcb.63.3.1037; Bensellam M, 2012, MOL CELL ENDOCRINOL, V364, P1, DOI 10.1016/j.mce.2012.08.003; Bhagat L, 2000, J CLIN INVEST, V106, P81, DOI 10.1172/JCI8706; Blinman TA, 2000, AM J PHYSIOL-CELL PH, V279, pC1993, DOI 10.1152/ajpcell.2000.279.6.C1993; BOSCO D, 1994, J CELL PHYSIOL, V160, P378, DOI 10.1002/jcp.1041600219; Chan YC, 2007, PANCREAS, V34, P1, DOI 10.1097/01.mpa.0000246658.38375.04; Chen N, 2011, J CLIN GASTROENTEROL, V45, P850, DOI 10.1097/MCG.0b013e31822a2ae5; Criscimanna A, 2011, GASTROENTEROLOGY, V141, P1451, DOI 10.1053/j.gastro.2011.07.003; Esni F, 2005, METH MOLEC MED, V103, P259; Gier B, 2012, DIABETES, V61, P1250, DOI 10.2337/db11-1109; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; Houbracken I, 2011, GASTROENTEROLOGY, V141, P731, DOI 10.1053/j.gastro.2011.04.050; Huang YC, 2013, DIABETES, V62, P519, DOI 10.2337/db11-0786; Huang YC, 2011, J PHYSIOL-LONDON, V589, P395, DOI 10.1113/jphysiol.2010.200345; Irving-Rodgers HF, 2012, CELL TRANSPLANT; King AJF, 2012, BRIT J PHARMACOL, V166, P877, DOI 10.1111/j.1476-5381.2012.01911.x; LOGSDON CD, 1986, AM J PHYSIOL, V250, pG440, DOI 10.1152/ajpgi.1986.250.4.G440; LOGSDON CD, 1983, AM J PHYSIOL, V244, pG675, DOI 10.1152/ajpgi.1983.244.6.G675; MALHOTRA R, 1992, REGUL PEPTIDES, V41, P149, DOI 10.1016/0167-0115(92)90044-U; Meisterfeld R, 2008, EXP CLIN ENDOCR DIAB, V116, pS7, DOI 10.1055/s-2008-1080918; Negi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030415; OLIVER C, 1980, IN VITRO CELL DEV B, V16, P297; Paraskevas S, 1999, FEBS LETT, V455, P203, DOI 10.1016/S0014-5793(99)00882-0; Perez-Mancera PA, 2012, GASTROENTEROLOGY, V142, P1079, DOI 10.1053/j.gastro.2012.03.002; PIPELEERS D, 1982, P NATL ACAD SCI-BIOL, V79, P7322, DOI 10.1073/pnas.79.23.7322; do Amaral ASR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055288; Rose T, 2007, J GEN PHYSIOL, V129, P493, DOI 10.1085/jgp.200609604; Speier S, 2005, MOL CELL ENDOCRINOL, V230, P51, DOI 10.1016/j.mce.2004.11.002; Speier S, 2003, PFLUG ARCH EUR J PHY, V446, P553, DOI 10.1007/s00424-003-1097-9; Speier S, 2007, DIABETES, V56, P1078, DOI 10.2337/db06-0232; Stozer A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054638; Tatarkiewicz K, 2010, AM J PHYSIOL-ENDOC M, V299, pE1076, DOI 10.1152/ajpendo.00479.2010; UNGER RH, 1985, DIABETOLOGIA, V28, P119; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	36	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78706	10.1371/journal.pone.0078706	http://dx.doi.org/10.1371/journal.pone.0078706			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223842	Green Submitted, Green Published, gold			2022-12-27	WOS:000326503400084
J	Bontell, I; Sarker, MS; Rahman, M; Afrad, MH; Sonnerborg, A; Azim, T				Bontell, Irene; Sarker, Md. Safiullah; Rahman, Mustafizur; Afrad, Mokibul Hassan; Sonnerborg, Anders; Azim, Tasnim			Molecular Dating of HIV-1 Subtype C from Bangladesh	PLOS ONE			English	Article							PREVALENCE; SYPHILIS	Bangladesh has an overall low HIV prevalence of <0.1% in the general population and <1% among key affected populations, but it is one of few Asian countries that has yet to reverse the epidemic. In order to do this, it is important to understand the transmission dynamics in this country. The aim of this study was to investigate the phylogenetic relationships of HIV-1 subtype C strains from Bangladesh and related strains from other countries, and thereby clarify when and from where subtype C was introduced in the country and how it subsequently spread within Bangladesh. The phylogenetic analysis included 118 Bangladeshi gag sequences and 128 sequences from other countries and was performed using the BEAST package. Our analysis revealed that the vast majority of Bangladeshi sequences (97/118, 82%) fall into a large regional cluster of samples from Bangladesh, India, China and Myanmar, which dates back to the early 1960's. Following its establishment in the region, this strain has entered Bangladesh multiple times from around 1975 and onwards, but extensive in-country transmission could only be detected among drug users and not through sexual transmission. In addition, there have been multiple (at least ten) introductions of subtype C to Bangladesh from outside this region, but no extensive spread could be detected for any of these. Since many HIV-infections remain undetected while asymptomatic, the true extent of the transmission of each strain remains unknown, especially among hard to reach groups such as clients of sex workers and returning migrants with families.	[Bontell, Irene; Sonnerborg, Anders] Karolinska Inst, Dept Med Huddinge, Infect Dis Unit, Solna, Sweden; [Sarker, Md. Safiullah; Rahman, Mustafizur; Afrad, Mokibul Hassan; Azim, Tasnim] Icddr B, Virol Lab, Dhaka, Bangladesh; [Sonnerborg, Anders] Karolinska Inst, Dept Lab Med, Div Microbiol, Solna, Sweden	Karolinska Institutet; International Centre for Diarrhoeal Disease Research (ICDDR); Karolinska Institutet	Bontell, I (corresponding author), Karolinska Inst, Dept Med Huddinge, Infect Dis Unit, Solna, Sweden.	irene.bontell@ki.se	rahman, mustafizur/E-6918-2010; Afrad, Mokibul/C-4149-2011; Sarker, Safiullah/E-7587-2010; Sönnerborg, Anders/W-2011-2019; Sarker, Safiullah/N-3014-2019; Afrad, Mokibul Hassan/H-6904-2012	Afrad, Mokibul/0000-0002-9627-7877; Sönnerborg, Anders/0000-0001-8928-3374; Afrad, Mokibul Hassan/0000-0002-9627-7877; Sarker, Md. Safiullah/0000-0002-5320-1274	UNAIDS; Department of International Development (DfID), UK [BGH 9800 552/582/002]; Govt. of Bangladesh/DfID/IDA [3441 BD]; World Health Organization (WHO) [SE/01/257693]; Family Health International; icddr, b; EU [246599]; Centre's research efforts: Australian International Development Agency (AusAID), Government of Bangladesh; Canadian International Development Agency CIDA), Government of Japa; Government of the Netherlands; Swedish International Development Cooperative Agency (SIDA); Swiss Development Cooperation (SDC); Department for International Development, UK (DFID)	UNAIDS; Department of International Development (DfID), UK; Govt. of Bangladesh/DfID/IDA; World Health Organization (WHO)(World Health Organization); Family Health International; icddr, b; EU(European Commission); Centre's research efforts: Australian International Development Agency (AusAID), Government of Bangladesh; Canadian International Development Agency CIDA), Government of Japa; Government of the Netherlands(Netherlands Government); Swedish International Development Cooperative Agency (SIDA); Swiss Development Cooperation (SDC); Department for International Development, UK (DFID)	This surveillance was conducted by icddr,b on behalf of the Govt. of Bangladesh, with support of grants from UNAIDS, from the Department of International Development (DfID), UK grant number BGH 9800 552/582/002 and Govt. of Bangladesh/DfID/IDA, credit number 3441 BD. The VCT Unit was supported by UNAIDS, Family Health International, and icddr, b. The HIV survey on tuberculosis patients was supported by World Health Organization (WHO), grant number SE/01/257693. The icddr, b acknowledges with gratitude the commitment of the different development partners to the Centre's research efforts. The icddr, b also gratefully acknowledges those donors who provide unrestricted support to the Centre's research efforts: Australian International Development Agency (AusAID), Government of Bangladesh, Canadian International Development Agency CIDA), Government of Japan, Government of the Netherlands, Swedish International Development Cooperative Agency (SIDA), Swiss Development Cooperation (SDC) and Department for International Development, UK (DFID). IB is thankful for funding from the EU FP7 program Marie Curie ERG (#246599). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis AB, 2009, J VIROL, V83, P12917, DOI 10.1128/JVI.01022-09; [Anonymous], MOL EV PHYL EP; Azim T, 2000, AIDS, V14, P210, DOI 10.1097/00002030-200001280-00022; Badreddine S, 2007, AIDS RES HUM RETROV, V23, P667, DOI 10.1089/aid.2007.0185; Commision on AIDS in Asia, 2008, RED AIDS AS CRAFT EF; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Foss AM, 2007, ADDICTION, V102, P114, DOI 10.1111/j.1360-0443.2006.01637.x; Ghys PD, 2001, AIDS, V15, pS91, DOI 10.1097/00002030-200100005-00012; Government of Bangladesh IEDCR and icddrb, 2011, AT HIV SER SURV 2011; Nepal B, 2007, J HEALTH POPUL NUTR, V25, P267; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rich JD, 1997, AIDS, V11, P703; Sarker MS, 2008, VIRUS RES, V135, P89, DOI 10.1016/j.virusres.2008.02.010; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; UNAIDS, 2012, LOB REP UNAIDS REP G; Zaidi A, 2004, 15 INT AIDS C BANGK	16	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79193	10.1371/journal.pone.0079193	http://dx.doi.org/10.1371/journal.pone.0079193			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223905	Green Published, gold, Green Submitted			2022-12-27	WOS:000326499300065
J	Fusinatto, LA; Alexandrino, J; Haddad, CFB; Brunes, TO; Rocha, CFD; Sequeira, F				Fusinatto, Luciana A.; Alexandrino, Joao; Haddad, Celio F. B.; Brunes, Tuliana O.; Rocha, Carlos F. D.; Sequeira, Fernando			Cryptic Genetic Diversity Is Paramount in Small-Bodied Amphibians of the Genus Euparkerella (Anura: Craugastoridae) Endemic to the Brazilian Atlantic Forest	PLOS ONE			English	Article							BAYESIAN SPECIES DELIMITATION; PHYLOGENETIC-RELATIONSHIPS; MAXIMUM-LIKELIHOOD; RELATIVE RATES; BODY-SIZE; FROGS; INFERENCE; TREES; DIVERSIFICATION; UNDERESTIMATION	Morphological similarity associated to restricted distributions and low dispersal abilities make the direct developing "Terrarana" frogs of the genus Euparkerella a good model for examining diversification processes. We here infer phylogenetic relationships within the genus Euparkerella, using DNA sequence data from one mitochondrial and four nuclear genes coupled with traditional Bayesian phylogenetic reconstruction approaches and more recent coalescent methods of species tree inference. We also used Bayesian clustering analysis and a recent Bayesian coalescent-based approach specifically to infer species delimitation. The analysis of 39 individuals from the four known Euparkerella species uncovered high levels of genetic diversity, especially within the two previously morphologically-defined E. cochranae and E. brasiliensis. Within these species, the gene trees at five independent loci and trees from combined data (concatenated dataset and the species tree) uncovered six deeply diverged and geographically coherent evolutionary units, which may have diverged between the Miocene and the Pleistocene. These six units were also uncovered in the Bayesian clustering analysis, and supported by the Bayesian coalescent-based species delimitation (BPP), and Genealogical Sorting Index (GSI), providing thus strong evidence for underestimation of the current levels of diversity within Euparkerella. The cryptic diversity now uncovered opens new opportunities to examine the origins and maintenance of microendemism in the context of spatial heterogeneity and/or human induced fragmentation of the highly threatened Brazilian Atlantic forest hotspot.	[Fusinatto, Luciana A.; Rocha, Carlos F. D.] Univ Estado Rio de Janeiro, Inst Biol Roberto Alcantara Gomes, Dept Ecol, BR-20550011 Rio De Janeiro, Brazil; [Alexandrino, Joao] UNIFESP Univ Fed Sao Paulo, Dept Ciencias Biol, Sao Paulo, Brazil; [Alexandrino, Joao; Haddad, Celio F. B.] Univ Estadual Paulista, Inst Biociencias, Dept Zool, Sao Paulo, Brazil; [Brunes, Tuliana O.; Sequeira, Fernando] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, CIBIO UP, Vairao, Portugal; [Brunes, Tuliana O.] Univ Porto, Fac Ciencias, Dept Biol, P-4100 Oporto, Portugal	Universidade do Estado do Rio de Janeiro; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade do Porto; Universidade do Porto	Fusinatto, LA (corresponding author), Univ Estado Rio de Janeiro, Inst Biol Roberto Alcantara Gomes, Dept Ecol, BR-20550011 Rio De Janeiro, Brazil.	lufusinatto@gmail.com	Brunes, Tuliana O./L-7916-2013; Sequeira, Fernando/C-3119-2012; Haddad, Célio F. B./C-4267-2012; Rocha, Carlos Frederico D/A-6225-2013; Alexandrino, João/B-7603-2012; Fusinatto, Luciana A/K-3517-2013	Brunes, Tuliana O./0000-0002-3665-030X; Sequeira, Fernando/0000-0003-0740-7981; Haddad, Célio F. B./0000-0002-7044-5764; Rocha, Carlos Frederico D/0000-0003-3000-1242; Alexandrino, João/0000-0003-2427-0964; Fusinatto, Luciana A/0000-0001-9354-1698	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes) [proc. 0378/11-9]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [proc. 142823/2009-0]; "Productivity in Research" grant; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [proc. 2005/52727-5, proc. 2006/56938-3]; CFBH [proc. 2008/50928-1]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [proc. E-26/102.404765-2012]; Fundacao Para a Ciencia e a Tecnologia (FCT) [SFRH/BPD/87721/2012];  [304791/2010-5];  [472287/2012-5]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); "Productivity in Research" grant; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CFBH; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao Para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); ; 	This research was founded by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes) as sandwich doctorate grant to LAF (proc. 0378/11-9); by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) as doctorate grant (proc. 142823/2009-0) to LAF, "Productivity in Research" grant to CFBH, and grants (proc. 304791/2010-5 and 472287/2012-5) to CFDR; by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) as grants to JA (proc. 2005/52727-5 and proc. 2006/56938-3) and CFBH (proc. 2008/50928-1); by Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) as grants to CFDR (proc. E-26/102.404765-2012); and by Fundacao Para a Ciencia e a Tecnologia (FCT) as postdoctoral grant to FS (SFRH/BPD/87721/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Alonso R, 2012, J BIOGEOGR, V39, P434, DOI 10.1111/j.1365-2699.2011.02594.x; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Belfiore NM, 2008, SYST BIOL, V57, P294, DOI 10.1080/10635150802044011; Bossuyt F, 2000, P NATL ACAD SCI USA, V97, P6585, DOI 10.1073/pnas.97.12.6585; Brumfield RT, 2008, SYST BIOL, V57, P719, DOI 10.1080/10635150802422290; Brunes TO, 2010, MOL PHYLOGENET EVOL, V57, P1120, DOI 10.1016/j.ympev.2010.08.026; Campbell JA, 2000, HERPETOL MONOGR, V14, P186, DOI 10.2307/1467048; Canedo C, 2012, MOL PHYLOGENET EVOL, V65, P610, DOI 10.1016/j.ympev.2012.07.016; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Carstens BC, 2013, BIOL J LINN SOC, V109, P737, DOI 10.1111/bij.12093; CHERRY LM, 1977, AM ZOOL, V17, P910; Chiari Y, 2004, MOL ECOL, V13, P3763, DOI 10.1111/j.1365-294X.2004.02367.x; Clemente-Carvalho RBG, 2011, MOL PHYLOGENET EVOL, V61, P79, DOI 10.1016/j.ympev.2011.05.017; Crawford AJ, 2003, J MOL EVOL, V57, P636, DOI 10.1007/s00239-003-2513-7; Cummings MP, 2008, EVOLUTION, V62, P2411, DOI 10.1111/j.1558-5646.2008.00442.x; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; DELARIVA I, 2007, HERPETOL MONOGR, P241, DOI DOI 10.1655/07-011.1; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Edwards SV, 2000, EVOLUTION, V54, P1839; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Faivovich J, 2005, B AM MUS NAT HIST, P6, DOI 10.1206/0003-0090(2005)294[0001:SROTFF]2.0.CO;2; Fouquet A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001109; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Frost DR, 2013, AMPHIBIAN SPECIES WO; Ghalambor CK, 2006, INTEGR COMP BIOL, V46, P5, DOI 10.1093/icb/icj003; Glaw F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031314; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HANKEN J, 1994, COPEIA, P573; HANKEN J, 1993, ANNU REV ECOL SYST, V24, P501, DOI 10.1146/annurev.es.24.110193.002441; Hanken J, 2001, HERPETOLOGICA, V57, P515; Harvey MB, 2013, ZOOTAXA, V3635, P1, DOI 10.11646/zootaxa.3635.1.1; Hedges S.B., 1989, P305; Hedges SB, 2008, ZOOTAXA, P1; Heinicke MP, 2007, P NATL ACAD SCI USA, V104, P10092, DOI 10.1073/pnas.0611051104; Heinicke MP, 2009, ZOOTAXA, P1; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; IZECKSOHN E, 1988, Revista Brasileira de Biologia, V48, P59; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kieswetter CM, 2013, MOL PHYLOGENET EVOL, V69, P417, DOI 10.1016/j.ympev.2013.08.007; Kohler J, 2005, BIOSCIENCE, V55, P693, DOI 10.1641/0006-3568(2005)055[0693:NAAGCA]2.0.CO;2; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Leache AD, 2010, P ROY SOC B-BIOL SCI, V277, P3071, DOI 10.1098/rspb.2010.0662; Leache AD, 2010, MOL PHYLOGENET EVOL, V54, P162, DOI 10.1016/j.ympev.2009.09.006; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lynch JD, 1976, SPECIES GROUPS S AM, P1; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Miralles A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068242; Moritz C, 2000, ANNU REV ECOL SYST, V31, P533, DOI 10.1146/annurev.ecolsys.31.1.533; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Pabijan M, 2012, J EVOLUTION BIOL, V25, P2310, DOI 10.1111/j.1420-9101.2012.02613.x; Pasachnik SA, 2010, CONSERV GENET, V11, P1767, DOI 10.1007/s10592-010-0070-3; Pritchard JK, 2000, GENETICS, V155, P945; Pulquerio MJF, 2007, TRENDS ECOL EVOL, V22, P180, DOI 10.1016/j.tree.2006.11.013; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Rambaut A., 2007, TRACER V1 4; Rittmeyer EN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029797; Rodriguez A, 2010, MOL PHYLOGENET EVOL, V54, P179, DOI 10.1016/j.ympev.2009.08.023; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sakalidis ML, 2011, MOL PHYLOGENET EVOL, V60, P333, DOI 10.1016/j.ympev.2011.04.026; Savage J.M., 1987, FIELDIANA ZOOL, V33, P1; Sequeira F, 2006, AMPHIBIA-REPTILIA, V27, P409, DOI 10.1163/156853806778190114; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Smith MA, 2008, MOL ECOL RESOUR, V8, P235, DOI 10.1111/j.1471-8286.2007.01964.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stuart BL, 2008, MOL PHYLOGENET EVOL, V46, P49, DOI 10.1016/j.ympev.2007.09.016; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thome MTC, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-242; Townsend TM, 2011, MOL PHYLOGENET EVOL, V61, P363, DOI 10.1016/j.ympev.2011.07.008; Veloso H. M. P., 1991, CLASSIFICACAO VEGETA; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Weisrock DW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009883; Welton LJ, 2013, MOL ECOL, V22, P3495, DOI 10.1111/mec.12324; Wiens JJ, 2008, BIOSCIENCE, V58, P297, DOI 10.1641/B580405; Wiens JJ, 2010, BIOL J LINN SOC, V99, P445, DOI 10.1111/j.1095-8312.2009.01342.x; Wilson E. O., 2003, FUTURE LIFE; Wollenberg KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-217; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107	83	28	29	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79504	10.1371/journal.pone.0079504	http://dx.doi.org/10.1371/journal.pone.0079504			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223956	Green Submitted, Green Published, gold			2022-12-27	WOS:000326499300087
J	Hazra, S; Stepps, V; Bhatwadekar, AD; Caballero, S; Boulton, ME; Higgins, PJ; Nikonova, EV; Pepine, CJ; Thut, C; Finney, EM; Stone, DJ; Bartelmez, SH; Grant, MB				Hazra, Sugata; Stepps, Valerie; Bhatwadekar, Ashay D.; Caballero, Sergio; Boulton, Michael E.; Higgins, Paul J.; Nikonova, Elena V.; Pepine, Carl J.; Thut, Catherine; Finney, Eva M.; Stone, David J.; Bartelmez, Stephen H.; Grant, Maria B.			Enhancing the Function of CD34(+) Cells by Targeting Plasminogen Activator Inhibitor-1	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; NITRIC-OXIDE SYNTHASE; MOBILIZATION; EXPRESSION; TYPE-1; GENE; OVEREXPRESSION; ANGIOGENESIS; RECEPTOR; STEM	Previously, we showed that transient inhibition of TGF-beta 1 resulted in correction of key aspects of diabetes-induced CD34(+) cell dysfunction. In this report, we examine the effect of transient inhibition of plasminogen activator inhibitor-1 (PAI-1), a major gene target of TGF-beta 1 activation. Using gene array studies, we examined CD34(+) cells isolated from a cohort of longstanding diabetic individuals, free of microvascular complications despite suboptimal glycemic control, and found that the cells exhibited reduced transcripts of both TGF-beta 1 and PAI-1 compared to age, sex, and degree of glycemic control-matched diabetic individuals with microvascular complications. CD34(+) cells from diabetic subjects with microvascular complications consistently exhibited higher PAI-1 mRNA than age-matched non-diabetic controls. TGF-beta 1 phosphorodiamidate morpholino oligo (PMO) reduced PAI-1 mRNA in diabetic (p<0.01) and non-diabetic (p=0.05) CD34(+) cells. To reduce PAI-1 in human CD34(+) cells, we utilized PAI-1 siRNA, lentivirus expressing PAI-1 shRNA or PAI-1 PMO. We found that inhibition of PAI-1 promoted CD34(+) cell proliferation and migration in vitro, likely through increased PI3(K) activity and increased cGMP production. Using a retinal ischemia reperfusion injury model in mice, we observed that recruitment of diabetic CD34(+) cells to injured acellular retinal capillaries was greater after PAI-1-PMO treatment compared with control PMO-treated cells. Targeting PAI-1 offers a promising therapeutic strategy for restoring vascular reparative function in defective diabetic progenitors.	[Hazra, Sugata; Bhatwadekar, Ashay D.; Caballero, Sergio; Grant, Maria B.] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA; [Stepps, Valerie; Bartelmez, Stephen H.] BetaStem Therapeut Inc, San Francisco, CA USA; [Boulton, Michael E.] Univ Florida, Dept Anat & Cell Biol, Gainesville, FL USA; [Higgins, Paul J.] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA; [Nikonova, Elena V.; Thut, Catherine; Finney, Eva M.; Stone, David J.] Merck & Co Inc, Merck Res Labs, Exploratory & Translat Sci, West Point, PA USA; [Pepine, Carl J.] Univ Florida, Dept Med, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Albany Medical College; Merck & Company; State University System of Florida; University of Florida	Grant, MB (corresponding author), Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA.	grantma@ufl.edu	Bhatwadekar, Ashay/AAT-5933-2020	Pepine, Carl/0000-0002-6011-681X	NIH [EY007739, EY012601, U01 HL087366, DK090730, 1R43HL093955, DK48708]; AVIBiopharma Inc, Corvallis, OR (Sarepta, Boston, MA); Center for Cancer Research, National Cancer Institute, NIH; FWR [GM057242]; NATIONAL EYE INSTITUTE [R01EY007739, R01EY012601, R44EY028070, R29EY007739] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL087366, R43HL093955] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048708, R01DK090730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057242] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AVIBiopharma Inc, Corvallis, OR (Sarepta, Boston, MA); Center for Cancer Research, National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); FWR; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH grants EY007739, EY012601, U01 HL087366, DK090730 to MBG, 1R43HL093955 to SB and MBG, DK48708 (SB), and AVIBiopharma Inc, Corvallis, OR (Sarepta, Boston, MA). This research was also supported in part by the Intramural Research Program, Center for Cancer Research, National Cancer Institute, NIH and GM057242 and GM057242 (FWR). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Basu A, 2009, INVEST OPHTH VIS SCI, V50, P4974, DOI 10.1167/iovs.09-3619; Bhatwadekar AD, 2010, DIABETES, V59, P2010, DOI 10.2337/db10-0287; Binder BR, 2002, NEWS PHYSIOL SCI, V17, P56, DOI 10.1152/nips.01369.2001; Busik JV, 2009, J EXP MED, V206, P2897, DOI 10.1084/jem.20090889; Caballero S, 2007, DIABETES, V56, P960, DOI 10.2337/db06-1254; Calzi SL, 2008, DIABETES, V57, P2488, DOI 10.2337/db08-0381; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chen YH, 2007, DIABETES, V56, P1559, DOI 10.2337/db06-1103; Czekay Ralf-Peter, 2011, Int J Cell Biol, V2011, P562481, DOI 10.1155/2011/562481; Das A, 1999, INVEST OPHTH VIS SCI, V40, P809; Degryse B, 2004, J BIOL CHEM, V279, P22595, DOI 10.1074/jbc.M313004200; Fadini GP, 2006, EUR HEART J, V27, P2247, DOI 10.1093/eurheartj/ehl198; Fadini GP, 2013, DIABETES CARE, V36, P943, DOI 10.2337/dc12-1084; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; Glowinska B, 2003, ATHEROSCLEROSIS, V167, P275, DOI 10.1016/S0021-9150(03)00003-0; Grant MB, 1996, EXP EYE RES, V63, P233, DOI 10.1006/exer.1996.0112; Grant MB, 2000, INVEST OPHTH VIS SCI, V41, P2296; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jarajapu YPR, 2013, DIABETES, V62, P1258, DOI 10.2337/db12-0808; Jarajapu YPR, 2011, INVEST OPHTH VIS SCI, V52, P5093, DOI 10.1167/iovs.10-70911; JARAJAPU YP, 2010, FASEB J, V24, P571; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loomans CJM, 2004, DIABETES, V53, P195, DOI 10.2337/diabetes.53.1.195; Losordo DW, 2011, CIRC RES, V109, P428, DOI 10.1161/CIRCRESAHA.111.245993; Mukai Y, 2007, AM J PHYSIOL-HEART C, V292, pH1937, DOI 10.1152/ajpheart.00868.2006; Nagi DK, 1997, DIABETES CARE, V20, P1304, DOI 10.2337/diacare.20.8.1304; Pandolfi A, 2001, ACTA DIABETOL, V38, P71, DOI 10.1007/s005920170016; Rosso A, 2006, J BIOL CHEM, V281, P4339, DOI 10.1074/jbc.M509293200; Rufaihah AJ, 2010, REGEN MED, V5, P231, DOI 10.2217/RME.09.83; Segal MS, 2006, DIABETES, V55, P102, DOI 10.2337/diabetes.55.1.102; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Thum T, 2007, DIABETES, V56, P666, DOI 10.2337/db06-0699; Uchiyama T, 2000, ARTERIOSCL THROM VAS, V20, P1155, DOI 10.1161/01.ATV.20.4.1155; Xiang GS, 2004, J EXP MED, V200, P1657, DOI 10.1084/jem.20040221; Zampetaki A, 2008, CARDIOVASC RES, V78, P413, DOI 10.1093/cvr/cvn081; Zheng L, 2007, INVEST OPHTH VIS SCI, V48, P361, DOI 10.1167/iovs.06-0510	39	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79067	10.1371/journal.pone.0079067	http://dx.doi.org/10.1371/journal.pone.0079067			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223881	Green Published, Green Submitted, gold			2022-12-27	WOS:000326499300051
J	Xu, Y; Lin, H; Zhu, P; Zhou, WY; Han, Y; Zheng, YH; Zhang, ZG				Xu, Yue; Lin, Han; Zhu, Ping; Zhou, Wenyan; Han, Yi; Zheng, Youhua; Zhang, Zhiguang			A Comparative Study between Use of Arthroscopic Lavage and Arthrocentesis of Temporomandibular Joint Based on Computational Fluid Dynamics Analysis	PLOS ONE			English	Article							CLOSED LOCK; DISC DISPLACEMENT; SURGERY; LYSIS; MANAGEMENT; DISORDERS; REDUCTION; THERAPY	Arthroscopic lavage and arthrocentesis, performed with different inner-diameter lavage needles, are the current minimally invasive techniques used in temporomandibular joint disc displacement (TMJ-DD) for pain reduction and functional improvement. In the current study, we aimed to explore the biomechanical influence and explain the diverse clinical outcomes of these two approaches with computational fluid dynamics. Data was retrospectively analyzed from 78 cases that had undergone arthroscopic lavage or arthrocentesis for TMJ-DD from 2002 to 2010. Four types of finite volume models, featuring irrigation needles of different diameters, were constructed based on computed tomography images. We investigated the flow pattern and pressure distribution of lavage fluid secondary to caliber-varying needles. Our results demonstrated that the size of outflow portal was the critical factor in determining irrigated flow rate, with a larger inflow portal and a smaller outflow portal leading to higher intra-articular pressure. This was consistent with clinical data suggesting that increasing the mouth opening and maximal contralateral movement led to better outcomes following arthroscopic lavage. The findings of this study could be useful for choosing the lavage apparatus according to the main complaint of pain, or limited mouth opening, and examination of joint movements.	[Xu, Yue; Lin, Han; Zhu, Ping; Zheng, Youhua; Zhang, Zhiguang] Sun Yat Sen Univ, Guanghua Sch Stomatol, Guangzhou 510275, Guangdong, Peoples R China; [Han, Yi] Sun Yat Sen Univ, Dept Appl Mech & Engn, Guangzhou 510275, Guangdong, Peoples R China; [Zhou, Wenyan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Shanghai 200030, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Shanghai Jiao Tong University	Zheng, YH (corresponding author), Sun Yat Sen Univ, Guanghua Sch Stomatol, Guangzhou 510275, Guangdong, Peoples R China.	dr-zheng@hotmail.com	Xu, yue/HGE-1737-2022		National Natural Science Foundation of China [81271115]; Sun Yat-Sen University [2007050]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sun Yat-Sen University	This study was supported by the National Natural Science Foundation of China (81271115) (http://www.nsfc.gov.cn/Portal0/default152.htm); and Sun Yat-Sen University Clinical Research 5010 Program (2007050) (http://mso.sysu.edu.cn/Plan5010/Index.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan A, 2007, EUR J DENT, V1, P179; Barkin S, 2000, J Can Dent Assoc, V66, P199; Batchelor G.K., 2000, INTRO FLUID DYNAMICS, DOI DOI 10.1017/CBO9780511800955; Adachi PLDG, 2008, BRIT J ORAL MAX SURG, V46, P320, DOI 10.1016/j.bjoms.2007.07.208; DOLWICK MF, 1994, BRIT J ORAL MAX SURG, V32, P307, DOI 10.1016/0266-4356(94)90052-3; Dworkin Samuel F., 1992, Journal of Craniomandibular Disorders, V6, P301; Fridrich KL, 1996, J ORAL MAXIL SURG, V54, P816, DOI 10.1016/S0278-2391(96)90526-1; Gonzalez-Garcia R, 2011, J ORAL MAXIL SURG, V69, P2513, DOI 10.1016/j.joms.2011.05.027; Goudot P, 2000, J CRANIO MAXILL SURG, V28, P39, DOI 10.1054/jcms.1999.0103; Guarda-Nardini L, 2010, ORAL MAXILLOFAC SURG, V14, P29, DOI 10.1007/s10006-009-0179-z; Hobeich JB, 2007, SAUDI MED J, V28, P1541; Hosaka H, 1996, ORAL SURG ORAL MED O, V82, P501, DOI 10.1016/S1079-2104(96)80193-4; Kaneyama K, 2004, J ORAL MAXIL SURG, V62, P657, DOI 10.1016/j.joms.2003.08.031; Kropmans TJB, 1999, J ORAL REHABIL, V26, P357, DOI 10.1046/j.1365-2842.1999.00417.x; Leibur E, 2010, J CRANIO MAXILL SURG, V38, P615, DOI 10.1016/j.jcms.2010.02.003; Machon V, 2011, J CRANIO MAXILL SURG, V39, P127, DOI 10.1016/j.jcms.2010.04.010; Monje-Gil F, 2012, MED ORAL PATOL ORAL, V17, pE575, DOI 10.4317/medoral.17670; Morey-Mas MA, 2010, J ORAL MAXIL SURG, V68, P1069, DOI 10.1016/j.joms.2009.09.039; MURAKAMI K, 1995, ORAL SURG ORAL MED O, V80, P253, DOI 10.1016/S1079-2104(05)80379-8; Nitzan Dorrit W, 2006, Oral Maxillofac Surg Clin North Am, V18, P311, DOI 10.1016/j.coms.2006.03.005; OHNISHI M, 1990, REV STOMATOL CHIR, V91, P143; Rehman KU, 2009, BRIT J ORAL MAX SURG, V47, P403, DOI 10.1016/j.bjoms.2008.09.014; Sakamoto I, 2000, CRANIO, V18, P264, DOI 10.1080/08869634.2000.11746140; Sanroman JF, 2004, INT J ORAL MAX SURG, V33, P344, DOI 10.1016/j.ijom.2003.10.005; van Oosterhout M, 2006, ARTHRIT RHEUM-ARTHR, V55, P964, DOI 10.1002/art.22340; Xu Y, 2012, J ORAL REHABIL, V39, P719, DOI 10.1111/j.1365-2842.2012.02307.x; Xu Y, 2012, J FORMOSAN MED, V112, P346; Zhu YM, 2012, BRIT J ORAL MAX SURG, V50, P144, DOI 10.1016/j.bjoms.2011.02.004	28	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78953	10.1371/journal.pone.0078953	http://dx.doi.org/10.1371/journal.pone.0078953			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223868	Green Published, gold, Green Submitted			2022-12-27	WOS:000326499300045
J	Kahana-Edwin, S; Stark, M; Kassir, Y				Kahana-Edwin, Smadar; Stark, Michal; Kassir, Yona			Multiple MAPK Cascades Regulate the Transcription of IME1, the Master Transcriptional Activator of Meiosis Saccharomyces cerevisiae	PLOS ONE			English	Article							KINASE SIGNALING SPECIFICITY; ZINC-FINGER PROTEIN; BUDDING YEAST; OSMOTIC-STRESS; PSEUDOHYPHAL DIFFERENTIATION; BIDIRECTIONAL PROMOTERS; NEGATIVE REGULATORS; POSITIVE REGULATOR; GENE ENCODES; HOG1 KINASE	The choice between alternative developmental pathways is primarily controlled at the level of transcription. Induction of meiosis in budding yeasts in response to nutrient levels provides a system to investigate the molecular basis of cellular decision-making. In Saccharomyces cerevisiae, entry into meiosis depends on multiple signals converging upon IME1, the master transcriptional activator of meiosis. Here we studied the regulation of the cis-acting regulatory element Upstream Activation Signal (UAS)ru, which resides within the IME1 promoter. Guided by our previous data acquired using a powerful high-throughput screening system, here we provide evidence that UASru is regulated by multiple stimuli that trigger distinct signal transduction pathways as follows: (i) The glucose signal inhibited UASru activity through the cyclic AMP (cAMP/protein kinase A (PKA) pathway, targeting the transcription factors (TFs), Com2 and Sko1; (ii) high osmolarity activated UASru through the Hog1/mitogen-activated protein kinase (MAPK) pathway and its corresponding TF Sko1; (iii) elevated temperature increased the activity of UASru through the cell wall integrity pathway and the TFs Swi4/Mpk1 and Swi4/Mlp1; (iv) the nitrogen source repressed UASru activity through Sum1; and (v) the absence of a nitrogen source was detected and transmitted to UASru by the Kss1 and Fus3 MAPK pathways through their respective downstream TFs, Ste12/Tec1 and Ste12/Ste12 as well as by their regulators Dig1/2. These signaling events were specific to UASru; they did not affect the mating and filamentation response elements that are regulated by MAPK pathways. The complex regulation of UASru through all the known vegetative MAPK pathways is unique to S. cerevisiae and is specific for IME1, likely because it is the master regulator of gametogenesis.	[Kahana-Edwin, Smadar; Stark, Michal; Kassir, Yona] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel	Technion Israel Institute of Technology	Kassir, Y (corresponding author), Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel.	ykassir@tx.technion.ac.il	Stark, Michal/AFL-9651-2022; Stark, Michal/AAH-1763-2022	Stark, Michal/0000-0002-4712-7696; Stark, Michal/0000-0002-4712-7696; Kahana-Edwin, Smadar/0000-0002-2869-4310	ISF - Israel Science Foundation	ISF - Israel Science Foundation(Israel Science Foundation)	This study was funded by the ISF - Israel Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed NT, 2009, MOL CELL BIOL, V29, P4352, DOI 10.1128/MCB.00305-09; Bao MZ, 2004, CELL, V119, P991, DOI 10.1016/j.cell.2004.11.052; Bodenmiller B, 2008, NAT BIOTECHNOL, V26, P1339, DOI 10.1038/nbt1208-1339; Breeden LL, 2003, CURR BIOL, V13, pR31, DOI 10.1016/S0960-9822(02)01386-6; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Chou S, 2006, MOL CELL BIOL, V26, P4794, DOI 10.1128/MCB.02053-05; Chou S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.47; Collart M A, 2001, Curr Protoc Mol Biol, VChapter 13, DOI 10.1002/0471142727.mb1312s23; Cook JG, 1996, GENE DEV, V10, P2831, DOI 10.1101/gad.10.22.2831; COVITZ PA, 1991, GENE DEV, V5, P1982, DOI 10.1101/gad.5.11.1982; COVITZ PA, 1993, GENE DEV, V7, P1598, DOI 10.1101/gad.7.8.1598; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; FIELDS S, 1987, MOL CELL BIOL, V7, P3818, DOI 10.1128/MCB.7.10.3818; Gancedo JM, 2008, FEMS MICROBIOL REV, V32, P673, DOI 10.1111/j.1574-6976.2008.00117.x; Gerke J, 2009, SCIENCE, V323, P498, DOI 10.1126/science.1166426; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; Gurevich V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011005; Honigberg SM, 2003, J CELL SCI, V116, P2137, DOI 10.1242/jcs.00460; Houser JR, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.18; Kahana S, 2010, GENETICS, V186, P829, DOI 10.1534/genetics.110.122200; Kainth P, 2009, METHODS, V48, P258, DOI 10.1016/j.ymeth.2009.02.015; Kassir Y, 2003, INT REV CYTOL, V224, P111, DOI 10.1016/S0074-7696(05)24004-4; KASSIR Y, 1976, GENETICS, V82, P187; KASSIR Y, 1988, CELL, V52, P853, DOI 10.1016/0092-8674(88)90427-8; KASSIR Y, 1991, METHOD ENZYMOL, V194, P94; Kim KY, 2008, MOL CELL BIOL, V28, P2579, DOI 10.1128/MCB.01795-07; KRISAK L, 1994, GENE DEV, V8, P2151, DOI 10.1101/gad.8.18.2151; Kupiec M., 1997, MOL CELLULAR BIOL YE, P889; Leza MA, 1999, GENETICS, V151, P531; Liang YJ, 2012, J BIOL CHEM, V287, P33533, DOI 10.1074/jbc.M112.392332; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; Miller J.H., 1972, EXPT MOL GENETICS; Mintzer KA, 1999, CELL SIGNAL, V11, P127, DOI 10.1016/S0898-6568(98)00044-8; MITCHELL AP, 1986, NATURE, V319, P738, DOI 10.1038/319738a0; NEHLIN JO, 1992, NUCLEIC ACIDS RES, V20, P5271, DOI 10.1093/nar/20.20.5271; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Neiman AM, 2011, GENETICS, V189, P737, DOI 10.1534/genetics.111.127126; Pan XW, 2002, MOL CELL BIOL, V22, P3981, DOI 10.1128/MCB.22.12.3981-3993.2002; Pan XW, 1999, MOL CELL BIOL, V19, P4874; Pascual-Ahuir A, 2001, J BIOL CHEM, V276, P37373, DOI 10.1074/jbc.M105755200; Pijnappel WWMP, 2001, GENE DEV, V15, P2991, DOI 10.1101/gad.207401; Pnueli L, 2004, MOL CELL BIOL, V24, P5197, DOI 10.1128/MCB.24.12.5197-5208.2004; Proft M, 2002, MOL CELL, V9, P1307, DOI 10.1016/S1097-2765(02)00557-9; Proft M, 2001, EMBO J, V20, P1123, DOI 10.1093/emboj/20.5.1123; Proft M, 2006, MOL CELL, V23, P241, DOI 10.1016/j.molcel.2006.05.031; Robertson LS, 1998, P NATL ACAD SCI USA, V95, P13783, DOI 10.1073/pnas.95.23.13783; Rubinstein A, 2007, P NATL ACAD SCI USA, V104, P6241, DOI 10.1073/pnas.0611168104; Sagee S, 1998, MOL CELL BIOL, V18, P1985, DOI 10.1128/MCB.18.4.1985; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Schwartz MA, 2004, ANNU REV GENET, V38, P725, DOI 10.1146/annurev.genet.39.073003.112634; Shenhar G, 2001, MOL CELL BIOL, V21, P1603, DOI 10.1128/MCB.21.5.1603-1612.2001; SHERMAN A, 1993, MOL GEN GENET, V237, P375, DOI 10.1007/BF00279441; Shin ME, 2010, MOL CELL BIOL, V30, P2996, DOI 10.1128/MCB.01682-09; Shock TR, 2009, EUKARYOT CELL, V8, P606, DOI 10.1128/EC.00005-09; THEVELEIN JM, 1994, YEAST, V10, P1753, DOI 10.1002/yea.320101308; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; van Werven FJ, 2012, CELL, V150, P1170, DOI 10.1016/j.cell.2012.06.049; Versele M, 1999, EMBO J, V18, P5577, DOI 10.1093/emboj/18.20.5577; Versele M, 2001, EMBO REP, V2, P574, DOI 10.1093/embo-reports/kve132; Xie JX, 1999, EMBO J, V18, P6448, DOI 10.1093/emboj/18.22.6448; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Yassour M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r87; Zeller CE, 2007, J BIOL CHEM, V282, P25168, DOI 10.1074/jbc.M702569200	65	7	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78920	10.1371/journal.pone.0078920	http://dx.doi.org/10.1371/journal.pone.0078920			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236068	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700065
J	Mesri, M; Birse, C; Heidbrink, J; McKinnon, K; Brand, E; Bermingham, CL; Feild, B; FitzHugh, W; He, T; Ruben, S; Moore, PA				Mesri, Mehdi; Birse, Charlie; Heidbrink, Jenny; McKinnon, Kathy; Brand, Erin; Bermingham, Candy Lee; Feild, Brian; FitzHugh, William; He, Tao; Ruben, Steve; Moore, Paul A.			Identification and Characterization of Angiogenesis Targets through Proteomic Profiling of Endothelial Cells in Human Cancer Tissues	PLOS ONE			English	Article							TUMOR ANGIOGENESIS; THY-1 CD90; GENES; VASCULATURE; ADHESION; VESSELS; B7-H3; CD146	Genomic and proteomic analysis of normal and cancer tissues has yielded abundant molecular information for potential biomarker and therapeutic targets. Considering potential advantages in accessibility to pharmacological intervention, identification of targets resident on the vascular endothelium within tumors is particularly attractive. By employing mass spectrometry (MS) as a tool to identify proteins that are over-expressed in tumor-associated endothelium relative to normal cells, we aimed to discover targets that could be utilized in tumor angiogenesis cancer therapy. We developed proteomic methods that allowed us to focus our studies on the discovery of cell surface/secreted proteins, as they represent key antibody therapeutic and biomarker opportunities. First, we isolated endothelial cells (ECs) from human normal and kidney cancer tissues by FACS using CD146 as a marker. Additionally, dispersed human colon and lung cancer tissues and their corresponding normal tissues were cultured ex-vivo and their endothelial content were preferentially expanded, isolated and passaged. Cell surface proteins were then preferentially captured, digested with trypsin and subjected to MS-based proteomic analysis. Peptides were first quantified, and then the sequences of differentially expressed peptides were resolved by MS analysis. A total of 127 unique non-overlapped (157 total) tumor endothelial cell over-expressed proteins identified from directly isolated kidney-associated ECs and those identified from ex-vivo cultured lung and colon tissues including known EC markers such as CD146, CD31, and VWF. The expression analyses of a panel of the identified targets were confirmed by immunohistochemistry (IHC) including CD146, B7H3, Thy-1 and ATP1B3. To determine if the proteins identified mediate any functional role, we performed siRNA studies which led to previously unidentified functional dependency for B7H3 and ATP1B3.	[Mesri, Mehdi; Birse, Charlie; Heidbrink, Jenny; McKinnon, Kathy; Brand, Erin; Bermingham, Candy Lee; Feild, Brian; FitzHugh, William; He, Tao; Ruben, Steve; Moore, Paul A.] Celera, Alameda, CA USA		Birse, C (corresponding author), Celera, Alameda, CA USA.	mesrim@mail.nih.gov			Celera	Celera	The authors have the following interests. This study was funded by and performed at Celera, the employer of all authors during the course of these studies. Celera has 3 issued US patents to declare: 7,582,441, 8,110,373, and 8,334,106, describing associations of Na-K ATPase beta3 protein in various malignant states. There are no products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Ahlskog J, 2006, Q J NUCL MED MOL IM, V50, P296; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; BOBBITT JM, 1956, ADV CARBOHYD CHEM, V11, P1; Castronovo V, 2006, MOL CELL PROTEOMICS, V5, P2083, DOI 10.1074/mcp.M600164-MCP200; Chapoval AI, 2001, NAT IMMUNOL, V2, P269, DOI 10.1038/85339; CLARKE MSF, 1991, ELECTROPHORESIS, V12, P500, DOI 10.1002/elps.1150120708; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; He J, 2011, MOL CELL PROTEOMICS; Huminiecki L, 2000, GENOME RES, V10, P1796, DOI 10.1101/gr.150700; Jouve N, 2013, J BIOL CHEM, V288, P2571, DOI 10.1074/jbc.M112.418848; Jurisic G, 2010, EXP CELL RES, V316, P2982, DOI 10.1016/j.yexcr.2010.06.013; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Langenkamp E, 2009, CELL TISSUE RES, V335, P205, DOI 10.1007/s00441-008-0642-4; Lee WS, 1998, CIRC RES, V82, P845; Loo D, 2012, CLIN CANCER RES, V18, P3834, DOI 10.1158/1078-0432.CCR-12-0715; Neri D, 2005, NAT REV CANCER, V5, P436, DOI 10.1038/nrc1627; Ohga N, 2012, AM J PATHOL; Ouhtit A, 2009, BBA-REV CANCER, V1795, P130, DOI 10.1016/j.bbcan.2009.01.002; Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0; Rybak JN, 2005, NAT METHODS, V2, P291, DOI 10.1038/NMETH745; Saalbach A, 2002, MICROVASC RES, V64, P86, DOI 10.1006/mvre.2002.2401; SASAKI K, 1991, CELL TISSUE RES, V265, P503, DOI 10.1007/BF00340873; Seaman S, 2007, CANCER CELL, V11, P539, DOI 10.1016/j.ccr.2007.04.017; Semenza GL, 2008, NEW ENGL J MED, V358, P2066, DOI 10.1056/NEJMcibr0800272; Solovey A, 1997, NEW ENGL J MED, V337, P1584, DOI 10.1056/NEJM199711273372203; St Croix B, 2000, SCIENCE, V289, P1197; Tuzmen Sukru, 2007, Methods Mol Biol, V353, P177; Wandel E, 2012, J IMMUNOL, V188, P1442, DOI 10.4049/jimmunol.1003944; Wetzel A, 2004, J IMMUNOL, V172, P3850, DOI 10.4049/jimmunol.172.6.3850; Yoshimura SH, 2008, J CELL SCI, V121, P2159, DOI 10.1242/jcs.022905; Zang XX, 2010, MODERN PATHOL, V23, P1104, DOI 10.1038/modpathol.2010.95; Zhang H, 2003, NAT BIOTECHNOL, V21, P660, DOI 10.1038/nbt827	34	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78885	10.1371/journal.pone.0078885	http://dx.doi.org/10.1371/journal.pone.0078885			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236063	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700060
J	Polman, E; Pollmann, MMH; Poehlman, TA				Polman, Evan; Pollmann, Monique M. H.; Poehlman, T. Andrew			The Name-Letter-Effect in Groups: Sharing Initials with Group Members Increases the Quality of Group Work	PLOS ONE			English	Article							GROUP DECISION-MAKING; IMPLICIT SELF-ESTEEM; RELATIONAL DEMOGRAPHY; INCIDENTAL SIMILARITY; LETTER PREFERENCES; EGOTISM; PERFORMANCE; DIVERSITY; INFORMATION; CONFLICT	Although the name-letter-effect has been demonstrated reliably in choice contexts, recent research has called into question the existence of the name-letter-effect-the tendency among people to make choices that bear remarkable similarity with the letters in their own name. In this paper, we propose a connection between the name-letter-effect and interpersonal, group-level behavior that has not been previously captured in the literature. Specifically, we suggest that sharing initials with other group members promotes positive feelings toward those group members that in turn affect group outcomes. Using both field and laboratory studies, we found that sharing initials with group members cause groups to perform better by demonstrating greater performance, collective efficacy, adaptive conflict, and accuracy (on a hidden-profile task). Although many studies have investigated the effects of member similarity on various outcomes, our research demonstrates how minimal a degree of similarity among members is sufficient to influence quality of group outcomes.	[Polman, Evan] Univ Wisconsin, Wisconsin Sch Business, Madison, WI 53706 USA; [Pollmann, Monique M. H.] Tilburg Univ, Dept Commun & Informat Sci, NL-5000 LE Tilburg, Netherlands; [Poehlman, T. Andrew] So Methodist Univ, Edwin L Cox Sch Business, Dallas, TX 75275 USA	University of Wisconsin System; University of Wisconsin Madison; Tilburg University; Southern Methodist University	Polman, E (corresponding author), Univ Wisconsin, Wisconsin Sch Business, Madison, WI 53706 USA.	epolman@bus.wisc.edu	Pollmann, Monique Maria Henriette/C-6508-2011	Pollmann, Monique Maria Henriette/0000-0003-3918-0646; Peng, Lingyun/0000-0003-0884-3072				ANCONA DG, 1992, ADMIN SCI QUART, V37, P634, DOI 10.2307/2393475; Anseel F, 2008, PSYCHOL SCI, V19, P1059, DOI 10.1111/j.1467-9280.2008.02199.x; Ayub N, 2011, CURRENT TOPICS MANAG, P13; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Barsade SG, 2002, ADMIN SCI QUART, V47, P644, DOI 10.2307/3094912; Barsade SG, 2000, ADMIN SCI QUART, V45, P802, DOI 10.2307/2667020; Bazerman MH, 2000, ANNU REV PSYCHOL, V51, P279, DOI 10.1146/annurev.psych.51.1.279; Bekkers R, 2010, INT J NONPROFIT VOLU, V15, P172, DOI 10.1002/nvsm.381; Blau P., 1977, INEQUALITY HETEROGEN; Brendl CM, 2005, J CONSUM RES, V32, P405, DOI 10.1086/497552; Burger JM, 2004, PERS SOC PSYCHOL B, V30, P35, DOI 10.1177/0146167203258838; BUSS DM, 1985, AM SCI, V73, P47; Chandler J, 2008, JUDGM DECIS MAK, V3, P404; COX TH, 1991, ACAD MANAGE J, V34, P827, DOI 10.2307/256391; DeHart T, 2004, SOC COGNITION, V22, P126, DOI 10.1521/soco.22.1.126.30986; Dovidio JF., 2006, SOCIAL PSYCHOL PROSO; Dunbar K., 1995, NATURE INSIGHT, P365, DOI DOI 10.1016/S0193-3973(99)00050-7; FINCH JF, 1989, PERS SOC PSYCHOL B, V15, P222, DOI 10.1177/0146167289152009; Forbes, 2013, FORBES; Galinsky AD, 2005, GROUP PROCESS INTERG, V8, P109, DOI 10.1177/1368430205051060; Garner R, 2005, J CONSUM PSYCHOL, V15, P108; GEORGE JM, 1990, J APPL PSYCHOL, V75, P107, DOI 10.1037/0021-9010.75.2.107; Goncalo JA, 2010, ORGAN BEHAV HUM DEC, V113, P13, DOI 10.1016/j.obhdp.2010.05.001; GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037/0033-295X.102.1.4; Greer LL, 2007, RES MANAG GROUP TEAM, V10, P21, DOI 10.1016/S1534-0856(07)10002-5; Harrison DA, 1998, ACAD MANAGE J, V41, P96, DOI 10.2307/256901; Hatfield E., 1994, REV PERSONALITY SOCI; Heider F., 1958, PSYCHOL INTERPERSONA, DOI DOI 10.1037/14200-000; Hodson G, 2005, PERS SOC PSYCHOL B, V31, P1099, DOI 10.1177/0146167205274895; Holland RW, 2009, SOC COGNITION, V27, P579, DOI 10.1521/soco.2009.27.4.579; HOORENS V, 1988, EUR J SOC PSYCHOL, V18, P365, DOI 10.1002/ejsp.2420180406; Howard DJ, 2011, J EXP SOC PSYCHOL, V47, P63, DOI 10.1016/j.jesp.2010.08.008; Jehn KA, 1999, ADMIN SCI QUART, V44, P741, DOI 10.2307/2667054; Jehn KA, 2003, RES ORGAN BEHAV, V25, P187, DOI 10.1016/s0191-3085(03)25005-X; Jehn KA, 2001, ACAD MANAGE J, V44, P238, DOI 10.2307/3069453; Jiang L, 2010, J CON RES, V36, P156; Jones JT, 2002, J EXP SOC PSYCHOL, V38, P170, DOI 10.1006/jesp.2001.1497; Jones JT, 2004, J PERS SOC PSYCHOL, V87, P665, DOI 10.1037/0022-3514.87.5.665; Kelly JR, 2001, ORGAN BEHAV HUM DEC, V86, P99, DOI 10.1006/obhd.2001.2974; Kitayama S, 1997, PERS SOC PSYCHOL B, V23, P736, DOI 10.1177/0146167297237006; Knewtson HS, 2010, J BUS RES, V63, P1324, DOI 10.1016/j.jbusres.2009.12.003; Koole SL, 2001, J PERS SOC PSYCHOL, V80, P669, DOI 10.1037//0022-3514.80.4.669; Kray LJ, 2001, J PERS SOC PSYCHOL, V80, P942, DOI 10.1037/0022-3514.80.6.942; Lebel EP, 2009, J EXP SOC PSYCHOL, V45, P1291, DOI 10.1016/j.jesp.2009.07.003; Maxwell S, 1999, PSYCHOL MARKET, V16, P545, DOI 10.1002/(SICI)1520-6793(199910)16:7<545::AID-MAR1>3.0.CO;2-I; Mesmer-Magnus JR, 2009, J APPL PSYCHOL, V94, P535, DOI 10.1037/a0013773; Miller DT, 1998, EUR J SOC PSYCHOL, V28, P475, DOI 10.1002/(SICI)1099-0992(199805/06)28:3<475::AID-EJSP881>3.0.CO;2-M; Moreland RL, 2010, SMALL GR RES, V41, P251, DOI 10.1177/1046496409358618; Nelson LD, 2007, PSYCHOL SCI, V18, P1106, DOI 10.1111/j.1467-9280.2007.02032.x; NUTTIN JM, 1987, EUR J SOC PSYCHOL, V17, P381, DOI 10.1002/ejsp.2420170402; NUTTIN JM, 1985, EUR J SOC PSYCHOL, V15, P353, DOI 10.1002/ejsp.2420150309; Pelham B, 2011, J PERS SOC PSYCHOL, V101, P25, DOI 10.1037/a0023526; Pelham BW, 2005, CURR DIR PSYCHOL SCI, V14, P106, DOI 10.1111/j.0963-7214.2005.00344.x; Pelham BW, 2002, J PERS SOC PSYCHOL, V82, P469, DOI 10.1037//0022-3514.82.4.469; Pinter B, 2004, GROUP PROCESS INTERG, V7, P283, DOI 10.1177/1368430204046112; Pinter B, 2011, GROUP PROCESS INTERG, V14, P81, DOI 10.1177/1368430210375251; Sherif M., 1961, INTERGROUP CONFLICT; Simonsohn U, 2011, PSYCHOL SCI, V22, P1087, DOI 10.1177/0956797611413937; Simonsohn U, 2011, J PERS SOC PSYCHOL, V101, P1, DOI 10.1037/a0021990; Sommers SR, 2006, J PERS SOC PSYCHOL, V90, P597, DOI 10.1037/0022-3514.90.4.597; STASSER G, 1985, J PERS SOC PSYCHOL, V48, P1467, DOI 10.1037/0022-3514.48.6.1467; STASSER G, 1992, J PERS SOC PSYCHOL, V63, P426, DOI 10.1037/0022-3514.63.3.426; STEWART DD, 1995, J PERS SOC PSYCHOL, V69, P619, DOI 10.1037/0022-3514.69.4.619; Stieger S, 2012, SOC PSYCHOL-GERMANY, V43, P7, DOI 10.1027/1864-9335/a000075; Tasa K, 2007, J APPL PSYCHOL, V92, P17, DOI 10.1037/0021-9010.92.1.17; Tindale R.S., 2000, GROUP PROCESS INTERG, V3, P123, DOI [10.1177/1368430200003002002, DOI 10.1177/1368430200003002002]; TOLBERT PS, 1991, SOCIOL EDUC, V64, P305, DOI 10.2307/2112710; TSUI AS, 1989, ACAD MANAGE J, V32, P402, DOI 10.2307/256368; TSUI AS, 1992, ADMIN SCI QUART, V37, P549, DOI 10.2307/2393472; Tyran KL, 2008, GROUP ORGAN MANAGE, V33, P46, DOI 10.1177/1059601106287111; TZINER A, 1985, J APPL PSYCHOL, V70, P85, DOI 10.1037/0021-9010.70.1.85; WATSON WE, 1993, ACAD MANAGE J, V36, P590, DOI 10.2307/256593; Wittenbaum G. M., 1996, WHATS SOCIAL SOCIAL, DOI DOI 10.4135/9781483327648.N1	73	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79039	10.1371/journal.pone.0079039	http://dx.doi.org/10.1371/journal.pone.0079039			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236087	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700085
J	Rao, M; Vogelzang, A; Kaiser, P; Schuerer, S; Kaufmann, SHE; Gengenbacher, M				Rao, Martin; Vogelzang, Alexis; Kaiser, Peggy; Schuerer, Stefanie; Kaufmann, Stefan H. E.; Gengenbacher, Martin			The Tuberculosis Vaccine Candidate Bacillus Calmette-Guerin Delta ureC::hly Coexpressing Human Interleukin-7 or-18 Enhances Antigen-Specific T Cell Responses in Mice	PLOS ONE			English	Article							GAMMA-INTERFERON PRODUCTION; MYCOBACTERIUM-TUBERCULOSIS; PROTECTIVE IMMUNITY; RATIONAL DESIGN; BCG; INFECTION; BIOLOGY; LYMPHOCYTES; EXPRESSION; STRATEGIES	Bacillus Calmette-Guerin (BCG), the only approved tuberculosis vaccine, provides only limited protection. Previously, we generated a recombinant derivative (BCG Delta ureC::hly), which secretes the pore-forming toxin listeriolysin O (LLO) of Listeria monocytogenes. This vaccine shows superior protection against tuberculosis in preclinical models and is safe in humans. Here we describe two new vaccine strains which express human interleukin-7 (hIL)-7 or hIL-18 in the genetic background of BCG Delta ureC::hly to modulate specific T cell immunity. Both strains exhibited an uncompromised in vitro growth pattern, while inducing a proinflammatory cytokine profile in human dendritic cells (DCs). Human DCs harbouring either strain efficiently promoted secretion of IL-2 by autologous T cells in a coculture system, suggesting superior immunogenicity. BALB/c mice vaccinated with BCG Delta ureC::hly, BCG Delta ureC::hly_hIL7 or BCG Delta ureC::hly_hIL18 developed a more robust Th1 response than after vaccination with parental BCG. Both strains provided significantly better protection than BCG in a murine Mycobacterium tuberculosis challenge model but efficacy remained comparable to that afforded by BCG Delta ureC::hly. We conclude that expression of hIL-7 or hIL-18 enhanced specific T cell responses but failed to improve protection over BCG Delta ureC:: hly in mice.	[Rao, Martin; Vogelzang, Alexis; Kaiser, Peggy; Schuerer, Stefanie; Kaufmann, Stefan H. E.; Gengenbacher, Martin] Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany	Max Planck Society	Kaufmann, SHE (corresponding author), Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany.	kaufmann@mpiib-berlin.mpg.de; gengenbacher@mpiib-berlin.mpg.de	Vogelzang, Alexis/C-5440-2017; Gengenbacher, Martin/C-6876-2015; Rao, Martin/B-8996-2015; Kaufmann, Stefan HE/I-5454-2014	Gengenbacher, Martin/0000-0002-0208-5920; Rao, Martin/0000-0002-0579-1097; Vogelzang, Alexis/0000-0002-2921-1755; Kaufmann, Stefan HE/0000-0001-9866-8268	European 7th Framework Program NEWTBVAC [HEALTH-F3-2009-241745]	European 7th Framework Program NEWTBVAC	This work received financial support from the European 7th Framework Program NEWTBVAC (HEALTH-F3-2009-241745). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2005, BLOOD, V106, P1843, DOI 10.1182/blood-2005-03-1281; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; APPASAMY PM, 1993, CANCER INVEST, V11, P487, DOI 10.3109/07357909309018880; Arama C, 2012, VACCINE, V30, P5578, DOI 10.1016/j.vaccine.2011.09.054; Behr MA, 1999, VACCINE, V17, P915, DOI 10.1016/S0264-410X(98)00277-1; Biet F, 2002, INFECT IMMUN, V70, P6549, DOI 10.1128/IAI.70.12.6549-6557.2002; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; DINARELLO CA, 1991, BRAIN RES, V562, P199, DOI 10.1016/0006-8993(91)90622-3; FENNELLY GJ, 1995, J INFECT DIS, V172, P698, DOI 10.1093/infdis/172.3.698; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; GOODWIN RG, 1989, P NATL ACAD SCI USA, V86, P302, DOI 10.1073/pnas.86.1.302; Gracie JA, 2003, J LEUKOCYTE BIOL, V73, P213, DOI 10.1189/jlb.0602313; Grode L, 2005, J CLIN INVEST, V115, P2472, DOI 10.1172/JCI24617; Grode L, 2013, VACCINE; Hess J, 1998, P NATL ACAD SCI USA, V95, P5299, DOI 10.1073/pnas.95.9.5299; Hesseling AC, 2007, VACCINE, V25, P14, DOI 10.1016/j.vaccine.2006.07.020; Jaiswal AI, 1996, INT IMMUNOL, V8, P275, DOI 10.1093/intimm/8.2.275; Joseph J, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/357370; Kaufmann SHE, 2005, NAT MED, V11, pS33, DOI 10.1038/nm1221; Kaufmann SHE, 2007, NAT REV MICROBIOL, V5, P491, DOI 10.1038/nrmicro1688; Kaufmann SHE, 2012, CURR OPIN BIOTECH, V23, P900, DOI 10.1016/j.copbio.2012.03.007; Kaufmann SHE, 2012, TRENDS IMMUNOL, V33, P373, DOI 10.1016/j.it.2012.03.004; Kaufmann SHE, 2011, LANCET INFECT DIS, V11, P633, DOI 10.1016/S1473-3099(11)70146-3; Kaufmann SHE, 2010, IMMUNITY, V33, P567, DOI 10.1016/j.immuni.2010.09.015; Kipnis A, 2003, IMMUNOLOGY, V109, P547, DOI 10.1046/j.1365-2567.2003.01680.x; Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10; Lalvani A, 2010, THORAX, V65, P1036, DOI 10.1136/thx.2010.140996; LANGERMANN S, 1994, J EXP MED, V180, P2277, DOI 10.1084/jem.180.6.2277; Lin WW, 2012, INFECT IMMUN, V80, P2771, DOI 10.1128/IAI.06195-11; LOTZ M, 1988, J EXP MED, V167, P1253, DOI 10.1084/jem.167.3.1253; Mackall CL, 2011, NAT REV IMMUNOL, V11, P330, DOI 10.1038/nri2970; Maeurer MJ, 2000, INFECT IMMUN, V68, P2962, DOI 10.1128/IAI.68.5.2962-2970.2000; Malaga W, 2003, FEMS MICROBIOL LETT, V219, P261, DOI 10.1016/S0378-1097(03)00003-X; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Murray PJ, 1996, P NATL ACAD SCI USA, V93, P934, DOI 10.1073/pnas.93.2.934; Netea MG, 2006, PLOS MED, V3, P1310, DOI 10.1371/journal.pmed.0030277; Norton Brianna L, 2012, Infect Drug Resist, V5, P163, DOI 10.2147/IDR.S29180; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; ODONNELL MA, 1994, INFECT IMMUN, V62, P2508, DOI 10.1128/IAI.62.6.2508-2514.1994; Redford PS, 2010, EUR J IMMUNOL, V40, P2200, DOI 10.1002/eji.201040433; Reece ST, 2008, INT J MED MICROBIOL, V298, P143, DOI 10.1016/j.ijmm.2007.07.004; Roberts AW, 2005, GROWTH FACTORS, V23, P33, DOI 10.1080/08977190500055836; Rovai LE, 1998, J LEUKOCYTE BIOL, V64, P494, DOI 10.1002/jlb.64.4.494; SCHALL TJ, 1990, NATURE, V347, P669, DOI 10.1038/347669a0; Schneider BE, 2010, EUR J IMMUNOL, V40, P396, DOI 10.1002/eji.200939583; SEHGAL PB, 1987, SCIENCE, V235, P731, DOI 10.1126/science.3492764; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Singh V, 2010, J INFECT DIS, V202, P480, DOI 10.1086/653827; STOVER CK, 1993, J EXP MED, V178, P197, DOI 10.1084/jem.178.1.197; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Sugawara I, 1999, INFECT IMMUN, V67, P2585, DOI 10.1128/IAI.67.5.2585-2589.1999; Vesosky B, 2010, J LEUKOCYTE BIOL, V87, P1153, DOI 10.1189/jlb.1109742; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Yamada G, 2000, AM J RESP CRIT CARE, V161, P1786, DOI 10.1164/ajrccm.161.6.9911054	55	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78966	10.1371/journal.pone.0078966	http://dx.doi.org/10.1371/journal.pone.0078966			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236077	Green Submitted, Green Published, gold			2022-12-27	WOS:000327254700074
J	Thent, ZC; Das, S; Henry, LJ				Thent, Zar Chi; Das, Srijit; Henry, Leonard Joseph			Role of Exercise in the Management of Diabetes Mellitus: the Global Scenario	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; INSULIN SENSITIVITY; RESISTANCE EXERCISE; AEROBIC EXERCISE; SKELETAL-MUSCLE; RISK-FACTORS; GLUCOSE-TRANSPORT; PHYSICAL-ACTIVITY; GLYCEMIC CONTROL; OLDER-ADULTS	Background: Exercise training programs have emerged as a useful therapeutic regimen for the management of type 2 diabetes mellitus (T2DM). Majority of the Western studies highlighted the effective role of exercise in T2DM. Therefore, the main aim was to focus on the extent, type of exercise and its clinical significance in T2DM in order to educate the clinicians from developing countries, especially in Asians. Methods: Pubmed, Science Direct, Scopus, ISI Web of Knowledge and Google scholar were searched using the terms "type 2 diabetes mellitus," "type 2 DM," "exercise," and/or "physical activity," and " type 2 diabetes mellitus with exercise." Only clinical or human studies published in English language between 2000 and 2012 were included. Certain criteria were assigned to achieve appropriate results. Results: Twenty five studies met the selected criteria. The majority of the studies were randomized controlled trial study design (65%). Most of the aerobic exercise based studies showed a beneficial effect in T2DM. Resistance exercise also proved to have positive effect on T2DM patients. Minimal studies related to other types of exercises such as yoga classes, joba riding and endurance-type exercise were found. On the other hand, United States of America (USA) showed strong interest of exercise management towards T2DM. Conclusion: Aerobic exercise is more common in clinical practice compared to resistance exercise in managing T2DM. Treatment of T2DM with exercise training showed promising role in USA. A large number of researches are mandatory in the developing countries for incorporating exercise in the effective management of T2DM.	[Thent, Zar Chi; Das, Srijit] Univ Kebangsaan Malaysia, Fac Med, Dept Anat, Kuala Lumpur, Malaysia; [Henry, Leonard Joseph] Univ Kebangsaan Malaysia, Fac Hlth Sci, Physiotherapy Programme, Kuala Lumpur, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Das, S (corresponding author), Univ Kebangsaan Malaysia, Fac Med, Dept Anat, Kuala Lumpur, Malaysia.	drsrijit@gmail.com	Das, Srijit/E-8457-2017; theint, zar chi/AAA-5780-2019	Das, Srijit/0000-0001-8302-7257; theint, zar chi/0000-0002-7915-0364				AgursCollins TD, 1997, DIABETES CARE, V20, P1503, DOI 10.2337/diacare.20.10.1503; Angadi SS, 2009, CLIN SPORT MED, V28, P379, DOI 10.1016/j.csm.2009.02.002; Bacchi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049937; Balducci S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049297; Bauer TA, 2007, DIABETES CARE, V30, P2880, DOI 10.2337/dc07-0843; Bello AI, 2011, INT J GEN MED, V4, P723, DOI 10.2147/IJGM.S16717; Boudou P, 2000, DIABETES METAB, V26, P450; Boule NG, 2001, JAMA-J AM MED ASSOC, V286, P1218, DOI 10.1001/jama.286.10.1218; Boule NG, 2003, DIABETOLOGIA, V46, P1071, DOI 10.1007/s00125-003-1160-2; Brazeau AS, 2008, DIABETES CARE, V31, P2108, DOI 10.2337/dc08-0720; Brooks Naomi, 2006, Int J Med Sci, V4, P19; Bruce CR, 2004, DIABETOLOGIA, V47, P23, DOI 10.1007/s00125-003-1265-7; Castaneda C, 2002, DIABETES CARE, V25, P2335, DOI 10.2337/diacare.25.12.2335; Church TS, 2010, JAMA-J AM MED ASSOC, V304, P2253, DOI 10.1001/jama.2010.1710; Eves ND, 2006, DIABETES CARE, V29, P1933, DOI 10.2337/dc05-1981; Garvey WT, 1998, J CLIN INVEST, V101, P2377, DOI 10.1172/JCI1557; Goldhaber-Fiebert JD, 2003, DIABETES CARE, V26, P24, DOI 10.2337/diacare.26.1.24; Gordon PL, 2006, INT J IMMUNOPATH PH, V19, P739, DOI 10.1177/039463200601900404; Hayashi T, 1997, AM J PHYSIOL-ENDOC M, V273, pE1039, DOI 10.1152/ajpendo.1997.273.6.E1039; Holloszy JO, 1996, REV PHYSIOL BIOCH P, V128, P99; Hordern MD, 2011, J SCI MED SPORT, V14, P238, DOI 10.1016/j.jsams.2010.11.003; Hosaka Y, 2010, NAGOYA J MED SCI, V72, P129; Hunter GR, 2004, SPORTS MED, V34, P329, DOI 10.2165/00007256-200434050-00005; Hurley BF, 2000, SPORTS MED, V30, P249, DOI 10.2165/00007256-200030040-00002; Innes KE, 2007, EVID-BASED COMPL ALT, V4, P469, DOI 10.1093/ecam/nel103; Ishii T, 2001, METABOLISM, V50, P1136, DOI 10.1053/meta.2001.26745; Janevic MR, 2013, CHRONIC ILLN, V9, P251, DOI 10.1177/1742395313475461; Kubota M, 2006, DIABETES RES CLIN PR, V71, P124, DOI 10.1016/j.diabres.2005.06.012; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Ligtenberg PC, 1997, CLIN SCI, V93, P127, DOI 10.1042/cs0930127; Loimaala A, 2003, DIABETES, V52, P1837, DOI 10.2337/diabetes.52.7.1837; Maiorana A, 2001, J AM COLL CARDIOL, V38, P860, DOI 10.1016/S0735-1097(01)01439-5; Manders RJF, 2010, MED SCI SPORT EXER, V42, P219, DOI 10.1249/MSS.0b013e3181b3b16d; Vancea DMM, 2009, ARQ BRAS CARDIOL, V92, P22, DOI 10.1590/S0066-782X2009000100005; Mogensen CE, 2002, HDB EXERCISE DIABETE, P433; Morais PK, 2011, DIABETES METAB, V37, P112, DOI 10.1016/j.diabet.2010.08.008; Musi N, 2001, DIABETES, V50, P921, DOI 10.2337/diabetes.50.5.921; Ng CLW, 2010, J PHYSIOTHER, V56, P163, DOI 10.1016/S1836-9553(10)70021-7; Otterman NM, 2011, DIABETIC MED, V28, P212, DOI 10.1111/j.1464-5491.2010.03128.x; Peirce NS, 1999, BRIT J SPORT MED, V33, P161, DOI 10.1136/bjsm.33.3.161; Plotnikoff RC, 2000, DIABETES EDUCATOR, V26, P450, DOI 10.1177/014572170002600312; Poehlman ET, 2000, J CLIN ENDOCR METAB, V85, P2463, DOI 10.1210/jc.85.7.2463; Pourmoghaddas A, 2013, ARYA ATHEROSCLER, V9, P167; Riddell MC, 2006, PEDIATR DIABETES, V7, P60, DOI 10.1111/j.1399-543X.2006.00146.x; Riddell Michael, 2009, J Diabetes Sci Technol, V3, P914; Ross R, 2000, ANN INTERN MED, V133, P92, DOI 10.7326/0003-4819-133-2-200007180-00008; SEGAL KR, 1991, J APPL PHYSIOL, V71, P2402, DOI 10.1152/jappl.1991.71.6.2402; Sigal RJ, 2004, DIABETES CARE, V27, P2518, DOI 10.2337/diacare.27.10.2518; Skoro-Kondza L, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-33; Snowling NJ, 2006, DIABETES CARE, V29, P2518, DOI 10.2337/dc06-1317; Stewart KJ, 2002, JAMA-J AM MED ASSOC, V288, P1622, DOI 10.1001/jama.288.13.1622; Sukala WR, 2012, AUSTRALAS MED J, V5, P429, DOI 10.4066/AMJ.2012.1311; Tecilazich F, 2013, J VASC SURG, V57, P997, DOI 10.1016/j.jvs.2012.10.011; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; van Dijk JW, 2012, DIABETOLOGIA, V55, P1273, DOI 10.1007/s00125-011-2380-5; Wallberg-Henriksson H, 1998, SPORTS MED, V25, P25, DOI 10.2165/00007256-199825010-00003; YAMANOUCHI K, 1995, DIABETES CARE, V18, P775, DOI 10.2337/diacare.18.6.775; Yavari A, 2010, J SPORT MED PHYS FIT, V50, P501; Yokoyama H, 2004, DIABETES RES CLIN PR, V65, P85, DOI 10.1016/j.diabres.2003.12.005; Yokoyama H, 2004, DIABETES CARE, V27, P1756, DOI 10.2337/diacare.27.7.1756; Zachwieja JJ, 1996, METABOLISM, V45, P254, DOI 10.1016/S0026-0495(96)90063-3	61	56	63	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80436	10.1371/journal.pone.0080436	http://dx.doi.org/10.1371/journal.pone.0080436			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236181	gold, Green Published, Green Submitted			2022-12-27	WOS:000327254700182
J	Yang, CH; Lin, YD; Chuang, LY; Chen, JB; Chang, HW				Yang, Cheng-Hong; Lin, Yu-Da; Chuang, Li-Yeh; Chen, Jin-Bor; Chang, Hsueh-Wei			MDR-ER: Balancing Functions for Adjusting the Ratio in Risk Classes and Classification Errors for Imbalanced Cases and Controls Using Multifactor-Dimensionality Reduction	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PARTICLE SWARM OPTIMIZATION; GENE-GENE INTERACTIONS; SNP-SNP INTERACTION; BREAST-CANCER; ENVIRONMENT INTERACTIONS; SUSCEPTIBILITY; HYPERTENSION; EPISTASIS; DISEASE	Background: Determining the complex relationship between diseases, polymorphisms in human genes and environmental factors is challenging. Multifactor dimensionality reduction (MDR) has proven capable of effectively detecting statistical patterns of epistasis. However, MDR has its weakness in accurately assigning multilocus genotypes to either high-risk and low-risk groups, and does generally not provide accurate error rates when the case and control data sets are imbalanced. Consequently, results for classification error rates and odds ratios (OR) may provide surprising values in that the true positive (TP) value is often small. Methodology/Principal Findings: To address this problem, we introduce a classifier function based on the ratio between the percentage of cases in case data and the percentage of controls in control data to improve MDR (MDR-ER) for multilocus genotypes to be classified correctly into high-risk and low-risk groups. In this study, a real data set with different ratios of cases to controls (1:4) was obtained from the mitochondrial D-loop of chronic dialysis patients in order to test MDR-ER. The TP and TN values were collected from all tests to analyze to what degree MDR-ER performed better than MDR. Conclusions/Significance: Results showed that MDR-ER can be successfully used to detect the complex associations in imbalanced data sets.	[Yang, Cheng-Hong; Lin, Yu-Da] Natl Kaohsiung Univ Appl Sci, Dept Elect Engn, Kaohsiung 807, Taiwan; [Chuang, Li-Yeh] I Shou Univ, Dept Chem Engn, Kaohsiung, Taiwan; [Chuang, Li-Yeh] I Shou Univ, Inst Biotechnol & Chem Engn, Kaohsiung, Taiwan; [Chen, Jin-Bor] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Coll Med, Dept Internal Med,Div Nephrol,Mitochondrial Res U, Kaohsiung, Taiwan; [Chang, Hsueh-Wei] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan; [Chang, Hsueh-Wei] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan	National Kaohsiung University of Science & Technology; I Shou University; I Shou University; Chang Gung Memorial Hospital; Chang Gung University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Chuang, LY (corresponding author), I Shou Univ, Dept Chem Engn, Kaohsiung, Taiwan.	chuang@isu.edu.tw; changhw@kmu.edu.tw	Yang, Cheng-Hong/K-2438-2019; Chang, Hsueh-Wei/C-9654-2009; Lin, Yu-da/M-7946-2013	Chang, Hsueh-Wei/0000-0003-0068-2366; Lin, Yu-da/0000-0001-5100-6072	National Science Council [NSC102-2221-E-151-024-MY3, NSC100-2221-E-151-049-MY3, NSC102-2622-E-151-003-CC3, NSC 102-2622-B-037-003-CC2]; Kaohsiung Chang Gung Memorial Hospital [CMRPG850271, CMRPG850272, CMRPG850242, CMRPG850252]; Department of Health, Executive Yuan, Taiwan, Republic of China [DOH102-TD-C-111-002]; National Sun Yat-Sen University-KMU Joint Research Project [NSYSU-KMU 102-034]	National Science Council(Ministry of Science and Technology, Taiwan); Kaohsiung Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Department of Health, Executive Yuan, Taiwan, Republic of China; National Sun Yat-Sen University-KMU Joint Research Project	This study was supported by grants from the National Science Council (NSC102-2221-E-151-024-MY3, NSC100-2221-E-151-049-MY3, NSC102-2622-E-151-003-CC3, NSC 102-2622-B-037-003-CC2), from Kaohsiung Chang Gung Memorial Hospital (CMRPG850271, CMRPG850272, CMRPG850242, and CMRPG850252), from the Department of Health, Executive Yuan, Taiwan, Republic of China (DOH102-TD-C-111-002), and from the National Sun Yat-Sen University-KMU Joint Research Project (#NSYSU-KMU 102-034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bush WS, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-238; Calle ML, 2008, STAT MED, V27, P6532, DOI 10.1002/sim.3431; Chang HW, 2009, COMPUT BIOL CHEM, V33, P114, DOI 10.1016/j.compbiolchem.2008.07.029; Chen JB, 2013, MITOCHONDRI IN PRESS; Chen JB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041125, 10.1371/journal.pone.0046878]; Chuang LY, 2012, EUR J CANCER PREV, V21, P336, DOI 10.1097/CEJ.0b013e32834e31f6; Chuang LY, 2012, PLOS ONE, V7; Chung YJ, 2007, BIOINFORMATICS, V23, P71, DOI 10.1093/bioinformatics/btl557; Coutinho AM, 2007, HUM GENET, V121, P243, DOI 10.1007/s00439-006-0301-3; Fanale D, 2012, ONCOGENE, V31, P2121, DOI 10.1038/onc.2011.408; Gui J, 2011, ANN HUM GENET, V75, P20, DOI 10.1111/j.1469-1809.2010.00624.x; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Kraft P, 2010, NAT GENET, V42, P819, DOI 10.1038/ng1010-819; Li JM, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2772; Lou XY, 2007, AM J HUM GENET, V80, P1125, DOI 10.1086/518312; Meindl A, 2009, BREAST CARE, V4, P93, DOI 10.1159/000211991; Moore JH, 2010, BIOINFORMATICS, V26, P445, DOI 10.1093/bioinformatics/btp713; Moore JH, 2005, BIOESSAYS, V27, P637, DOI 10.1002/bies.20236; Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735; Moore JH, 2002, ANN MED, V34, P88, DOI 10.1080/07853890252953473; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Sanada H, 2006, CLIN CHEM, V52, P352, DOI 10.1373/clinchem.2005.059139; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Thornton-Wells TA, 2004, TRENDS GENET, V20, P640, DOI 10.1016/j.tig.2004.09.007; Tsai CT, 2007, ATHEROSCLEROSIS, V195, P172, DOI 10.1016/j.atherosclerosis.2006.09.014; Van Steen K, 2012, BRIEF BIOINFORM, V13, P1, DOI 10.1093/bib/bbr012; Velez DR, 2007, GENET EPIDEMIOL, V31, P306, DOI 10.1002/gepi.20211; Williams SM, 2004, HUM HERED, V57, P28, DOI 10.1159/000077387; Wu SJ, 2013, MOL BIOL REP, V40, P4227, DOI 10.1007/s11033-013-2504-8; Yang CH, 2013, IEEE ACM T COMPUT BI, V10, P361, DOI 10.1109/TCBB.2013.27; Yang CH, 2012, KAOHSIUNG J MED SCI, V28, P362, DOI 10.1016/j.kjms.2012.02.002; Yang CH, 2011, OMICS, V15, P399, DOI 10.1089/omi.2010.0028; Yang CH, 2009, CANCER EPIDEMIOL, V33, P147, DOI 10.1016/j.canep.2009.07.001; Yang PY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S10; Yu JC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2821	35	26	26	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79387	10.1371/journal.pone.0079387	http://dx.doi.org/10.1371/journal.pone.0079387			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236125	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700124
J	Jang, TH; Park, JH; Park, HH				Jang, Tae-ho; Park, Jin Hee; Park, Hyun Ho			Novel Disulfide Bond-Mediated Dimerization of the CARD Domain Was Revealed by the Crystal Structure of CARMA1 CARD	PLOS ONE			English	Article							NF-KAPPA-B; CASPASE-RECRUITMENT DOMAIN; CHROMOSOMAL TRANSLOCATION; ANTIGEN RECEPTOR; ACTIVATION; BCL10; DEATH; MALT1; PHOSPHORYLATION; SUPERFAMILY	CARMA1, BCL10 and MALT1 form a large molecular complex known as the CARMA1 signalosome during lymphocyte activation. Lymphocyte activation via the CARMA1 signalosome is critical to immune response and linked to many immune diseases. Despite the important role of the CARMA1 signalosome during lymphocyte activation and proliferation, limited structural information is available. Here, we report the dimeric structure of CARMA1 CARD at a resolution of 3.2 angstrom. Interestingly, although CARMA1 CARD has a canonical six helical-bundles structural fold similar to other CARDs, CARMA1 CARD shows the first homo-dimeric structure of CARD formed by a disulfide bond and reveals a possible biologically important homo-dimerization mechanism.	[Park, Hyun Ho] Yeungnam Univ, Sch Biotechnol, Gyongsan, South Korea; Yeungnam Univ, Grad Sch Biochem, Gyongsan, South Korea	Yeungnam University; Yeungnam University	Park, HH (corresponding author), Yeungnam Univ, Sch Biotechnol, Gyongsan, South Korea.	hyunho@ynu.ac.kr		park, hyun ho/0000-0001-9928-0847	Basic Science Research Program through the National Research Foundation of Korea (NRF) of the Ministry of Education, Science and Technology [2013-009083]	Basic Science Research Program through the National Research Foundation of Korea (NRF) of the Ministry of Education, Science and Technology	This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) of the Ministry of Education, Science and Technology (2013-009083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae JY, 2011, J BIOL CHEM, V286, P39528, DOI 10.1074/jbc.M111.278812; Bertin J, 2001, J BIOL CHEM, V276, P11877, DOI 10.1074/jbc.M010512200; Blonska M, 2009, IMMUNOL REV, V228, P199, DOI 10.1111/j.1600-065X.2008.00749.x; BU JY, 1995, P NATL ACAD SCI USA, V92, P5106, DOI 10.1073/pnas.92.11.5106; Coussens NP, 2007, BIOCHEM BIOPH RES CO, V353, P1, DOI 10.1016/j.bbrc.2006.11.122; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Dueber EC, 2011, SCIENCE, V334, P376, DOI 10.1126/science.1207862; Dzivenu OK, 2004, PROTEIN EXPRES PURIF, V38, P1, DOI 10.1016/j.pep.2004.07.016; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gaide O, 2001, FEBS LETT, V496, P121, DOI 10.1016/S0014-5793(01)02414-0; Handa N, 2006, ACTA CRYSTALLOGR D, V62, P1502, DOI 10.1107/S0907444906039369; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Hiller S, 2003, STRUCTURE, V11, P1199, DOI 10.1016/j.str.2003.08.009; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Humke EW, 2000, CELL, V103, P99, DOI 10.1016/S0092-8674(00)00108-2; Jang TH, 2011, J BIOTECHNOL, V151, P335, DOI 10.1016/j.jbiotec.2011.01.003; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kwon D, 2012, NUCLEIC ACIDS RES, V40, pD331, DOI 10.1093/nar/gkr1149; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042775; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; Lucas PC, 2004, J CELL SCI, V117, P31, DOI 10.1242/jcs.00904; Manon F, 2007, J MOL BIOL, V365, P160, DOI 10.1016/j.jmb.2006.09.067; Otwinowski Z., 1990, DENZO DATA PROCESSIN; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Park HH, 2011, APOPTOSIS, V16, P209, DOI 10.1007/s10495-010-0571-z; Park JH, 2013, ACTA CRYSTALLOGR F, V69, P435, DOI 10.1107/S1744309113005642; Potter JA, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-11; Qi SQ, 2010, CELL, V141, P446, DOI 10.1016/j.cell.2010.03.017; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Reed J. C., 2004, SCI STKE, V2004, pre9, DOI DOI 10.1126/STKE.2392004RE9; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Sanchez-Izquierdo D, 2003, BLOOD, V101, P4539, DOI 10.1182/blood-2002-10-3236; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shen LJ, 2003, BLOOD, V102, P1553, DOI 10.1182/blood-2003-04-1286; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Srimathi T, 2008, BIOCHEMISTRY-US, V47, P1319, DOI 10.1021/bi7016602; Tanner MJ, 2007, J BIOL CHEM, V282, P17141, DOI 10.1074/jbc.M700169200; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Thome M, 2003, TRENDS IMMUNOL, V24, P419, DOI 10.1016/S1471-4906(03)00177-7; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Weber CH, 2001, TRENDS BIOCHEM SCI, V26, P475, DOI 10.1016/S0968-0004(01)01905-3; WEGENER E, 2007, SCI STKE, pE21; Yan N, 2005, NATURE, V437, P831, DOI 10.1038/nature04002; Zhou P, 1999, P NATL ACAD SCI USA, V96, P11265, DOI 10.1073/pnas.96.20.11265	50	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79778	10.1371/journal.pone.0079778	http://dx.doi.org/10.1371/journal.pone.0079778			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224005	Green Published, Green Submitted, gold			2022-12-27	WOS:000326597400086
J	Li, P; Shen, Y; Sui, X; Chen, CM; Feng, TY; Li, H; Holroyd, C				Li, Peng; Shen, Yue; Sui, Xue; Chen, Changming; Feng, Tingyong; Li, Hong; Holroyd, Clay			The Neural Basis of Responsibility Attribution in Decision-Making	PLOS ONE			English	Article							RIGHT TEMPOROPARIETAL JUNCTION; DIFFUSION; REWARD; REGRET; BRAIN; MINDS; PSYCHOLOGY; MOTIVATION; FEEDBACK; SYSTEM	Social responsibility links personal behavior with societal expectations and plays a key role in affecting an agent's emotional state following a decision. However, the neural basis of responsibility attribution remains unclear. In two previous event-related brain potential (ERP) studies we found that personal responsibility modulated outcome evaluation in gambling tasks. Here we conducted a functional magnetic resonance imaging (fMRI) study to identify particular brain regions that mediate responsibility attribution. In a context involving team cooperation, participants completed a task with their teammates and on each trial received feedback about team success and individual success sequentially. We found that brain activity differed between conditions involving team success vs. team failure. Further, different brain regions were associated with reinforcement of behavior by social praise vs. monetary reward. Specifically, right temporoparietal junction (RTPJ) was associated with social pride whereas dorsal striatum and dorsal anterior cingulate cortex (ACC) were related to reinforcement of behaviors leading to personal gain. The present study provides evidence that the RTPJ is an important region for determining whether self-generated behaviors are deserving of praise in a social context.	[Li, Peng; Sui, Xue; Li, Hong] Liaoning Normal Univ, Res Ctr Psychol Dev & Educ, Dalian, Peoples R China; [Li, Peng; Sui, Xue; Li, Hong] Liaoning Normal Univ, Sch Psychol, Dalian, Peoples R China; [Shen, Yue] Dalian Univ Technol, Inst Neuroinformat, Dalian, Peoples R China; [Chen, Changming; Feng, Tingyong] Southwest Univ, Sch Psychol, Chongqing, Peoples R China; [Holroyd, Clay] Univ Victoria, Dept Psychol, Victoria, BC, Canada	Liaoning Normal University; Liaoning Normal University; Dalian University of Technology; Southwest University - China; University of Victoria	Li, H (corresponding author), Liaoning Normal Univ, Res Ctr Psychol Dev & Educ, Dalian, Peoples R China.	lihong@lnnu.edu.cn; holroyd@uvic.ca		Holroyd, Clay/0000-0003-3084-8574; Feng, Tingyong/0000-0001-9278-6474	National Natural Science Foundation of China [NSFC31300872, 81171289]; Special Public-welfare Project of the Ministry of Health [201002003]; Natural Sciences and Engineering Research Council Discovery Grant [RGPIN 312409-05]; MOE (Ministry of Education in China) Project of Humanities and Social Sciences [13YJC190013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Public-welfare Project of the Ministry of Health; Natural Sciences and Engineering Research Council Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); MOE (Ministry of Education in China) Project of Humanities and Social Sciences	This research was supported by the National Natural Science Foundation of China (NSFC31300872, 81171289), and the Special Public-welfare Project of the Ministry of Health (201002003) and a Natural Sciences and Engineering Research Council Discovery Grant (RGPIN 312409-05), and MOE (Ministry of Education in China) Project of Humanities and Social Sciences (13YJC190013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; [Anonymous], 1971, ATTRIBUTION PERCEIV; Blackwood NJ, 2003, NEUROIMAGE, V20, P1076, DOI 10.1016/S1053-8119(03)00331-8; Camille N, 2010, COGN AFFECT BEHAV NE, V10, P460, DOI 10.3758/CABN.10.4.460; Cohen MX, 2009, BEHAV BRAIN RES, V199, P141, DOI 10.1016/j.bbr.2008.09.029; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Coricelli G, 2005, NAT NEUROSCI, V8, P1255, DOI 10.1038/nn1514; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Forsyth DR, 2002, PERS SOC PSYCHOL B, V28, P54, DOI 10.1177/0146167202281005; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Hajcak G, 2006, BIOL PSYCHOL, V71, P148, DOI 10.1016/j.biopsycho.2005.04.001; Heider F., 1958, PSYCHOL INTERPERSONA, DOI DOI 10.1037/14200-000; Holroyd CB, 2004, NAT NEUROSCI, V7, P497, DOI 10.1038/nn1238; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Holroyd CB, 2012, TRENDS COGN SCI, V16, P122, DOI 10.1016/j.tics.2011.12.008; JONES EE, 1976, AM SCI, V64, P300; KASARI C, 1993, J CHILD PSYCHOL PSYC, V34, P353, DOI 10.1111/j.1469-7610.1993.tb00997.x; Lawrence EJ, 2006, NEUROIMAGE, V29, P1173, DOI 10.1016/j.neuroimage.2005.09.001; Legrand D, 2009, PSYCHOL REV, V116, P252, DOI 10.1037/a0014172; Li P, 2011, PSYCHOPHYSIOLOGY, V48, P1129, DOI 10.1111/j.1469-8986.2011.01182.x; Li P, 2010, NEUROIMAGE, V52, P1727, DOI 10.1016/j.neuroimage.2010.04.275; Mars RB, 2012, CEREB CORTEX, V22, P1894, DOI 10.1093/cercor/bhr268; MILLER DT, 1975, PSYCHOL BULL, V82, P213, DOI 10.1037/h0076486; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Mitchell JP, 2006, BRAIN RES, V1079, P66, DOI 10.1016/j.brainres.2005.12.113; Moll J, 2005, NAT REV NEUROSCI, V6, P799, DOI 10.1038/nrn1768; MORRIS MW, 1994, J PERS SOC PSYCHOL, V67, P949, DOI 10.1037/0022-3514.67.6.949; MYNATT C, 1975, J PERS SOC PSYCHOL, V32, P1111; Nicolle A, 2011, SOC NEUROSCI-UK, V6, P178, DOI 10.1080/17470919.2010.506128; Nicolle A, 2011, J COGNITIVE NEUROSCI, V23, P845, DOI 10.1162/jocn.2010.21510; Nieuwenhuis S, 2005, NEUROIMAGE, V25, P1302, DOI 10.1016/j.neuroimage.2004.12.043; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Saxe R, 2004, ANNU REV PSYCHOL, V55, P87, DOI 10.1146/annurev.psych.55.090902.142044; Saxe R, 2005, NEUROPSYCHOLOGIA, V43, P1391, DOI 10.1016/j.neuropsychologia.2005.02.013; Schlenker BR, 2009, PERSONALITY, IDENTITY, AND CHARACTER: EXPLORATIONS IN MORAL PSYCHOLOGY, P316, DOI 10.1017/CBO9780511627125.015; SCHLENKER BR, 1994, PSYCHOL REV, V101, P632, DOI 10.1037/0033-295X.101.4.632; SILLARS AL, 1980, COMMUN MONOGR, V47, P180, DOI 10.1080/03637758009376031; Talairach J., 1988, COPLANAR STEREOTAXIC; WEINER B, 1985, PSYCHOL REV, V92, P548, DOI 10.1037/0033-295X.92.4.548; Yates D, 1999, PRACTICE STAT, V1st; Yeung N, 2004, J NEUROSCI, V24, P6258, DOI 10.1523/JNEUROSCI.4537-03.2004; Young L, 2007, P NATL ACAD SCI USA, V104, P8235, DOI 10.1073/pnas.0701408104; Young L, 2011, SOC NEUROSCI-UK, V6, P302, DOI 10.1080/17470919.2010.529712; Young L, 2010, P NATL ACAD SCI USA, V107, P6753, DOI 10.1073/pnas.0914826107; Zeelenberg M, 2000, ACTA PSYCHOL, V104, P303, DOI 10.1016/S0001-6918(00)00034-2	47	6	7	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80389	10.1371/journal.pone.0080389	http://dx.doi.org/10.1371/journal.pone.0080389			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	247EE	24224053	Green Published, Green Submitted, gold			2022-12-27	WOS:000326597400119
J	Pipoly, I; Bokony, V; Seress, G; Szabo, K; Liker, A				Pipoly, Ivett; Bokony, Veronika; Seress, Gabor; Szabo, Krisztian; Liker, Andras			Effects of Extreme Weather on Reproductive Success in a Temperate-Breeding Songbird	PLOS ONE			English	Article							CLIMATE-CHANGE; POPULATION DECLINES; INCUBATION PERIOD; HOUSE SPARROWS; SEX; SIZE; EVOLUTIONARY; RESPONSES; FOOD; PATTERNS	The frequency of extreme meteorological events such as heat waves and rainstorms is predicted to increase with climate change. However, there is still little information about how extreme weather influences reproduction in animals. It may not only affect breeding success but might also alter offspring sex ratio if males and females are differentially sensitive to meteorological conditions during development. We investigated the relationship between meteorological conditions and reproductive success over 6 years in a house sparrow population in central Europe. We found that hatching success increased with the number of extremely hot days (daily maximum >31 degrees C) and decreased with the number of extremely cold days (<16 degrees C) during incubation, although the latter effect held only for clutches with relatively short incubation periods. Fledging success was unrelated to weather variables. However, the frequency of extremely hot days had a negative effect on fledglings' body mass and tarsus length, although both of these traits were positively related to average temperature. Additionally, fledglings' body mass increased with the length of period without rainfall before fledging. Male to female ratio among fledglings did not differ from 1: 1 and did not vary with weather variables. The magnitude of the effects of extreme meteorological events was usually small, although in some cases comparable to those of ecologically relevant predictors of reproductive success. Our results indicate that meteorological conditions have complex effects on breeding success, as the effects of extreme weather can differ between different aspects of reproduction and also from the effects of overall meteorological conditions.	[Pipoly, Ivett; Bokony, Veronika; Seress, Gabor; Liker, Andras] Univ Pannonia, Dept Limnol, Veszprem, Hungary; [Szabo, Krisztian] Szent Istvan Univ, Dept Ecol, Budapest, Hungary	University of Pannonia; Hungarian University of Agriculture & Life Sciences	Pipoly, I (corresponding author), Univ Pannonia, Dept Limnol, Veszprem, Hungary.	pipoly.ivett@gmail.com	Bókony, Veronika/AAH-7679-2020	Bókony, Veronika/0000-0002-2136-5346; Pipoly, Ivett/0000-0002-4541-6056; Seress, Gabor/0000-0001-9828-4934	Hungarian Scientific Research Fund [OTKA K72827, K84132]; European Union; European Social Fund [TAMOP-4.2.2.A-11/1/KONV-2012-0064]; Marie Curie Intra-European Fellowship	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Union(European Commission); European Social Fund(European Social Fund (ESF)); Marie Curie Intra-European Fellowship(European Commission)	The study was supported by Hungarian Scientific Research Fund (OTKA K72827, K84132) and was realized with the support of the European Union, with the co-funding of the European Social Fund (TAMOP-4.2.2.A-11/1/KONV-2012-0064). A. L. was supported by a Marie Curie Intra-European Fellowship during a part of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbuckle J, 2011, IBM SPSS AMOS 20 USE; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Brzek P, 2009, J EXP BIOL, V212, P1284, DOI 10.1242/jeb.023911; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Chalfoun AD, 2007, ANIM BEHAV, V73, P579, DOI 10.1016/j.anbehav.2006.09.010; Cohen J.E., 1988, STAT POWER ANAL BEHA; Crick HQP, 2004, IBIS, V146, P48, DOI 10.1111/j.1474-919X.2004.00327.x; Crick QP, 2006, ACTA ZOOL SINICA, V52, P154; Csorgo Tibor, 2009, Termeszetvedelmi Kozlemenyek, V15, P1; Dawson RD, 2008, CAN J ZOOL, V86, P843, DOI 10.1139/Z08-065; Deeming DC, 2008, J THERM BIOL, V33, P345, DOI 10.1016/j.jtherbio.2008.05.002; Deschenes O, 2007, XTREME WEA EVENTS MO, P1; Dijkstra C, 2010, BEHAV ECOL SOCIOBIOL, V64, P1393, DOI 10.1007/s00265-010-0954-8; Dingemanse NJ, 2010, ANIM BEHAV, V79, P439, DOI 10.1016/j.anbehav.2009.11.024; Elkins N., 2004, WEATHER BIRD BEHAV; Field C. B., 2012, SPECIAL REPORT WORKI, P1, DOI DOI 10.1017/CBO9781139177245; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Gasparrini A, 2011, EPIDEMIOLOGY, V22, P68, DOI 10.1097/EDE.0b013e3181fdcd99; Gemmell NJ, 1996, TRENDS GENET, V12, P338, DOI 10.1016/S0168-9525(96)80005-9; Grace JB, 2010, ECOL MONOGR, V80, P67, DOI 10.1890/09-0464.1; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Hansen J, 2012, P NATL ACAD SCI USA, V109, pE2415, DOI 10.1073/pnas.1205276109; Hegyi G, 2013, OECOLOGIA, V172, P279, DOI 10.1007/s00442-012-2487-5; Hepp GR, 2006, FUNCT ECOL, V20, P307, DOI 10.1111/j.1365-2435.2006.01108.x; Hoi H, 2003, FOLIA ZOOL, V52, P299; Holm E., 1973, Ecology, V54, P45; Hungarian, 2013, MET SERV; Jentsch A, 2008, CR GEOSCI, V340, P621, DOI 10.1016/j.crte.2008.07.002; KATZ RW, 1992, CLIMATIC CHANGE, V21, P289, DOI 10.1007/BF00139728; Kilner R, 1998, ANIM BEHAV, V56, P155, DOI 10.1006/anbe.1998.0775; Knape J, 2011, P ROY SOC B-BIOL SCI, V278, P985, DOI 10.1098/rspb.2010.1333; Kovacs S, 2011, J ORNITHOL, V152, P365, DOI 10.1007/s10336-010-0596-7; Lavergne S, 2010, ANNU REV ECOL EVOL S, V41, P321, DOI 10.1146/annurev-ecolsys-102209-144628; Ligon RA, 2010, ANIM BEHAV, V79, P727, DOI 10.1016/j.anbehav.2009.12.028; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; MARTIN TE, 1987, ANNU REV ECOL SYST, V18, P453, DOI 10.1146/annurev.ecolsys.18.1.453; McDonald PG, 2004, J ANIM ECOL, V73, P683; McIntyre NE, 2000, ANN ENTOMOL SOC AM, V93, P825, DOI 10.1603/0013-8746(2000)093[0825:EOUAAR]2.0.CO;2; Miller-Rushing AJ, 2010, PHILOS T R SOC B, V365, P3177, DOI 10.1098/rstb.2010.0148; Mock DW, 2010, WILSON J ORNITHOL, V122, P207, DOI 10.1676/09-206.1; Moller AP, 2011, CURR ZOOL, V57, P351, DOI 10.1093/czoolo/57.3.351; Moller AP, 2008, P NATL ACAD SCI USA, V105, P16195, DOI 10.1073/pnas.0803825105; Moller AP, 2002, OECOLOGIA, V132, P492, DOI 10.1007/s00442-002-0952-2; MURPHY MT, 1985, ECOLOGY, V66, P162, DOI 10.2307/1941316; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Peach WJ, 2008, ANIM CONSERV, V11, P493, DOI 10.1111/j.1469-1795.2008.00209.x; Pipoly I, 2011, ALLATTANI KOZLEMENYE, V96, P97; R Core Team, 2021, R LANGUAGE ENV STAT; Radford AN, 2001, BIRD STUDY, V48, P214, DOI 10.1080/00063650109461220; Reid JM, 2000, P ROY SOC B-BIOL SCI, V267, P37, DOI 10.1098/rspb.2000.0963; Reid JM, 2002, BEHAV ECOL SOCIOBIOL, V51, P255, DOI 10.1007/S00265-001-0435-1; Ringsby TH, 1998, J AVIAN BIOL, V29, P241, DOI 10.2307/3677106; Rosivall B, 2010, BEHAV ECOL SOCIOBIOL, V64, P1555, DOI 10.1007/s00265-010-0969-1; Salido L, 2012, ECOGRAPHY, V35, P604, DOI 10.1111/j.1600-0587.2011.06797.x; Schwagmeyer PL, 2008, ANIM BEHAV, V75, P291, DOI 10.1016/j.anbehav.2007.05.023; Shultz S, 2005, P ROY SOC B-BIOL SCI, V272, P2305, DOI 10.1098/rspb.2005.3250; Smith PA, 2010, J AVIAN BIOL, V41, P292, DOI 10.1111/j.1600-048X.2009.04815.x; Strausberger BM, 1998, AUK, V115, P843, DOI 10.2307/4089503; TAYLOR LR, 1963, J ANIM ECOL, V32, P99, DOI 10.2307/2520; Torres R, 2009, OECOLOGIA, V161, P447, DOI 10.1007/s00442-009-1378-x; Vegvari Z, 2010, GLOBAL CHANGE BIOL, V16, P1, DOI 10.1111/j.1365-2486.2009.01876.x; Vincze O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060998; Weatherhead PJ, 2005, OECOLOGIA, V144, P168, DOI 10.1007/s00442-005-0009-4; Westneat DF, 2002, CONDOR, V104, P598, DOI 10.1650/0010-5422(2002)104[0598:POSRVI]2.0.CO;2; Winkler DW, 2013, OECOLOGIA, V173, P129, DOI 10.1007/s00442-013-2605-z; Yom-Tov Y, 2006, OIKOS, V112, P91, DOI 10.1111/j.0030-1299.2006.14183.x; ZANN RA, 1995, EMU, V95, P208, DOI 10.1071/MU9950208	68	38	38	4	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80033	10.1371/journal.pone.0080033	http://dx.doi.org/10.1371/journal.pone.0080033			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224033	Green Published, Green Submitted, gold			2022-12-27	WOS:000326597400105
J	Toki, W; Takahashi, Y; Togashi, K				Toki, Wataru; Takahashi, Yukiko; Togashi, Katsumi			Fungal Garden Making inside Bamboos by a Non-Social Fungus-Growing Beetle	PLOS ONE			English	Article							COLEOPTERA EROTYLIDAE LANGURIINAE; PHYLOGENETIC-RELATIONSHIPS; ASCOMYCETOUS YEASTS; AGRICULTURE; MUTUALISM; PICHIA; PLANTS; ANT	In fungus-growing mutualism, it is indispensable for host animals to establish gardens of the symbiotic fungus as rapidly as possible. How to establish fungal gardens has been well-documented in social fungus-farming insects, whereas poorly documented in non-social fungus-farming insects. Here we report that the non-social, fungus-growing lizard beetle Doubledaya bucculenta (Coleoptera: Erotylidae: Languriinae) transmits the symbiotic yeast Wickerhamomyces anomalus from the ovipositor-associated mycangium into bamboo internode cavities and disperses the yeast in the cavities to make gardens. Microbial isolation and cryo-scanning electron microscopy observation revealed that W. anomalus was constantly located on the posterior ends of eggs, where larvae came out, and on the inner openings of oviposition holes. Direct observation of oviposition behavior inside internodes revealed that the distal parts of ovipositors showed a peristaltic movement when they were in contact with the posterior ends of eggs. Rearing experiments showed that W. anomalus was spread much more rapidly and widely on culture media and internodes in the presence of the larvae than in the absence. These results suggest that the ovipositors play a critical role in vertical transmission of W. anomalus and that the larvae contribute actively to the garden establishment, providing a novel case of fungal garden founding in non-social insect-fungus mutualism.	[Toki, Wataru; Togashi, Katsumi] Univ Tokyo, Dept Forest Sci, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 113, Japan; [Takahashi, Yukiko] Univ Tokyo, Grad Sch Frontier Sci, Dept Nat Environm Studies, Kashiwa, Chiba, Japan	University of Tokyo; University of Tokyo	Toki, W (corresponding author), Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan.	watarutoki@08.alumni.u-tokyo.ac.jp	Takahashi, Yukiko/N-6194-2019; Takahashi, Yukiko/F-4561-2014	Takahashi, Yukiko/0000-0003-2810-316X; Takahashi, Yukiko/0000-0003-2810-316X	Sasakawa Scientific Research Grant from The Japan Science Society; Japan Society for the Promotion of Science KAKENHI Grant [25840153]	Sasakawa Scientific Research Grant from The Japan Science Society; Japan Society for the Promotion of Science KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	WT was supported by the Sasakawa Scientific Research Grant from The Japan Science Society and the Japan Society for the Promotion of Science KAKENHI Grant (no. 25840153). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATRA LEKH R., 1963, TRANS KANAS ACAD SCI, V66, P213, DOI 10.2307/3626562; Biedermann PHW, 2011, P NATL ACAD SCI USA, V108, P17064, DOI 10.1073/pnas.1107758108; BORKENT A, 1985, Symbiosis, V1, P185; Brock DA, 2011, NATURE, V469, P393, DOI 10.1038/nature09668; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL, P909; COUTTS MP, 1969, FOREST SCI, V15, P412; Francke-Grosmann H., 1967, P141; Grebennikov VV, 2010, ENTOMOL SCI, V13, P81, DOI 10.1111/j.1479-8298.2009.00351.x; Groenewald M, 2010, INT J SYST EVOL MICR, V60, P2675, DOI 10.1099/ijs.0.018580-0; Hata H, 2006, BIOL LETT-UK, V2, P593, DOI 10.1098/rsbl.2006.0528; Hayashi N., 1974, NAT INSECT, V9, P17; Holldobler B., 1990, pi; Kobayashi C, 2008, EVOL ECOL, V22, P711, DOI 10.1007/s10682-007-9196-2; Kurtzman CP, 2008, FEMS YEAST RES, V8, P939, DOI 10.1111/j.1567-1364.2008.00419.x; Kurtzman CP, 2011, ANTON LEEUW INT J G, V99, P13, DOI 10.1007/s10482-010-9505-6; Kurtzman CP, 2003, FEMS YEAST RES, V3, P417, DOI 10.1016/S1567-1356(03)00012-6; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; LEUTHOLD RH, 1989, INSECT SOC, V36, P328, DOI 10.1007/BF02224884; Li XQ, 2012, J INSECT PHYSIOL, V58, P867, DOI 10.1016/j.jinsphys.2012.03.011; MORGAN FD, 1968, ANNU REV ENTOMOL, V13, P239, DOI 10.1146/annurev.en.13.010168.001323; Mueller UG, 2002, AM NAT, V160, pS67, DOI 10.1086/342084; Mueller UG, 2005, ANNU REV ECOL EVOL S, V36, P563, DOI 10.1146/annurev.ecolsys.36.102003.152626; Norris D.M., 1979, P53; QUINLAN RJ, 1978, INSECT SOC, V25, P237, DOI 10.1007/BF02224744; R Development Core Team, 2012, R LANG ENV STAT COMP; Rohfritsch O, 2008, ENTOMOL EXP APPL, V128, P208, DOI 10.1111/j.1570-7458.2008.00726.x; Schultz TR, 2005, ECOLOGICAL EVOLUTION, P149; Silliman BR, 2003, P NATL ACAD SCI USA, V100, P15643, DOI 10.1073/pnas.2535227100; Swada Y., 1986, Science Bulletin of the Faculty of Agriculture Kyushu University, V40, P197; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tanahashi M, 2010, NATURWISSENSCHAFTEN, V97, P311, DOI 10.1007/s00114-009-0643-5; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toki W., 2012, ELYTRA, V1, P253; Toki W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041893; Toki W, 2011, ZOOL SCI, V28, P348, DOI 10.2108/zsj.28.348; Toki Wataru, 2009, Biogeography, V11, P109; White TJ., 1990, PCR PROTOCOLS GUIDE, P315	37	14	15	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79515	10.1371/journal.pone.0079515	http://dx.doi.org/10.1371/journal.pone.0079515			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223958	Green Published, Green Submitted, gold			2022-12-27	WOS:000326597400069
J	Saint-Criq, V; Kim, SH; Katzenellenbogen, JA; Harvey, BJ				Saint-Criq, Vinciane; Kim, Sung Hoon; Katzenellenbogen, John A.; Harvey, Brian J.			Non-Genomic Estrogen Regulation of Ion Transport and Airway Surface Liquid Dynamics in Cystic Fibrosis Bronchial Epithelium	PLOS ONE			English	Article							PROTEIN-KINASE-C; RAT DISTAL COLON; CHLORIDE SECRETION; PSEUDOMONAS-AERUGINOSA; STEROID-HORMONES; RECEPTOR-ALPHA; LUNG-DISEASE; GENDER-GAP; 17-BETA-ESTRADIOL; CELLS	Male cystic fibrosis (CF) patients survive longer than females and lung exacerbations in CF females vary during the estrous cycle. Estrogen has been reported to reduce the height of the airway surface liquid (ASL) in female CF bronchial epithelium. Here we investigated the effect of 17 beta-estradiol on the airway surface liquid height and ion transport in normal (NuLi-1) and CF (CuFi-1) bronchial epithelial monolayers. Live cell imaging using confocal microscopy revealed that airway surface liquid height was significantly higher in the non-CF cells compared to the CF cells. 17 beta-estradiol (0.1-10 nM) reduced the airway surface liquid height in non-CF and CF cells after 30 min treatment. Treatment with the nuclear-impeded Estrogen Dendrimer Conjugate mimicked the effect of free estrogen by reducing significantly the airway surface liquid height in CF and non-CF cells. Inhibition of chloride transport or basolateral potassium recycling decreased the airway surface liquid height and 17 beta-estradiol had no additive effect in the presence of these ion transporter inhibitors. 17 beta-estradiol decreased bumetanide-sensitive transepithelial short-circuit current in non-CF cells and prevented the forskolin-induced increase in ASL height. 17 beta-estradiol stimulated an amiloride-sensitive transepithelial current and increased ouabain-sensitive basolateral short-circuit current in CF cells. 17 beta-estradiol increased PKC delta activity in CF and non-CF cells. These results demonstrate that estrogen dehydrates CF and non-CF ASL, and these responses to 17 beta-estradiol are non-genomic rather than involving the classical nuclear estrogen receptor pathway. 17 beta-estradiol acts on the airway surface liquid by inhibiting cAMP-mediated chloride secretion in non-CF cells and increasing sodium absorption via the stimulation of PKC delta, ENaC and the Na+/K+ ATPase in CF cells.	[Saint-Criq, Vinciane; Harvey, Brian J.] Beaumont Hosp, Royal Coll Surg Ireland, Dept Mol Med, Dublin 9, Ireland; [Kim, Sung Hoon; Katzenellenbogen, John A.] Univ Illinois, Dept Chem, Urbana, IL USA	Royal College of Surgeons - Ireland; University of Illinois System; University of Illinois Urbana-Champaign	Harvey, BJ (corresponding author), Beaumont Hosp, Royal Coll Surg Ireland, Dept Mol Med, Dublin 9, Ireland.	bjpharvey@rcsi.ie	Saint-Criq, Vinciane/A-6602-2010; Harvey, Brian/AAJ-4085-2020; Harvey, Brian J/A-5120-2010	Saint-Criq, Vinciane/0000-0003-0042-3735; Harvey, Brian/0000-0002-7388-8034; Harvey, Brian J/0000-0002-7388-8034	Marie Curie fellowship CEMP; National Biophotonics Imaging Platform Ireland HEA PRTLI 4; National Institutes of Health [DK015556]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK015556, R01DK015556] Funding Source: NIH RePORTER	Marie Curie fellowship CEMP; National Biophotonics Imaging Platform Ireland HEA PRTLI 4; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a Marie Curie fellowship CEMP (VSC), the National Biophotonics Imaging Platform Ireland HEA PRTLI 4 (BJH), and the National Institutes of Health DK015556 (JAK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alyea RA, 2008, J NEUROCHEM, V106, P1525, DOI 10.1111/j.1471-4159.2008.05491.x; Alzamora R, 2011, STEROIDS, V76, P867, DOI 10.1016/j.steroids.2011.04.016; Arrington-Sanders R, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-5; Beers KW, 1996, BIOCHEM BIOPH RES CO, V221, P442, DOI 10.1006/bbrc.1996.0614; Block JK, 2006, THORAX, V61, P969, DOI 10.1136/thx.2006.061366; Boucher RC, 2002, ADV DRUG DELIVER REV, V54, P1359, DOI 10.1016/S0169-409X(02)00144-8; Burchfield JG, 2004, J BIOL CHEM, V279, P18623, DOI 10.1074/jbc.M401504200; Cao G, 2009, J BIOL CHEM, V284, P14788, DOI 10.1074/jbc.M808752200; Chambliss KL, 2010, J CLIN INVEST, V120, P2319, DOI 10.1172/JCI38291; Chotirmall SH, 2012, NEW ENGL J MED, V366, P1978, DOI 10.1056/NEJMoa1106126; Chotirmall SH, 2010, AM J RESP CRIT CARE, V182, P62, DOI 10.1164/rccm.201001-0053OC; Coakley RD, 2008, J CLIN INVEST, V118, P4025, DOI 10.1172/JCI33893; Condliffe SB, 2001, J PHYSIOL-LONDON, V530, P47, DOI 10.1111/j.1469-7793.2001.0047m.x; Corey M, 1997, J PEDIATR-US, V131, P809, DOI 10.1016/S0022-3476(97)70025-8; Corey M, 1996, PEDIATR PULM, V21, P149, DOI 10.1002/1099-0496(199603)21:3<149::AID-PPUL1950210302>3.0.CO;2-C; Doolan CM, 1996, AM J PHYSIOL-CELL PH, V271, pC1935, DOI 10.1152/ajpcell.1996.271.6.C1935; Doolan CM, 2000, BRIT J PHARMACOL, V129, P1375, DOI 10.1038/sj.bjp.0703193; Doolan CM, 1996, J BIOL CHEM, V271, P8763, DOI 10.1074/jbc.271.15.8763; Gerlach U, 2001, J MED CHEM, V44, P3831, DOI 10.1021/jm0109255; Groenestege WMT, 2006, J AM SOC NEPHROL, V17, P1035, DOI 10.1681/ASN.2005070700; Guilbault C, 2005, LAB ANIM-UK, V39, P336, DOI 10.1258/0023677054306944; Hammes SR, 2007, ENDOCR REV, V28, P726, DOI 10.1210/er.2007-0022; Harrington WR, 2006, MOL ENDOCRINOL, V20, P491, DOI 10.1210/me.2005-0186; Hofmeister MV, 2012, AM J PHYSIOL-RENAL, V302, pF358, DOI 10.1152/ajprenal.00343.2011; Irnaten M, 2009, STEROIDS, V74, P642, DOI 10.1016/j.steroids.2009.02.002; Kim SH, 2006, ANGEW CHEM INT EDIT, V45, P7243, DOI 10.1002/anie.200601923; Lam RS, 2003, J PHYSIOL-LONDON, V548, P475, DOI 10.1113/jphysiol.2002.036806; Laube M, 2011, PEDIATR RES, V69, P200, DOI 10.1203/PDR.0b013e3182070ec8; Levin ER, 2009, J PHYSIOL-LONDON, V587, P5019, DOI 10.1113/jphysiol.2009.177097; Li Y, 2011, J BIOL CHEM, V286, P32289, DOI 10.1074/jbc.M111.247825; Madak-Erdogan Z, 2008, MOL ENDOCRINOL, V22, P2116, DOI 10.1210/me.2008-0059; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; MOHRMANN M, 1987, AM J PHYSIOL, V253, pF372, DOI 10.1152/ajprenal.1987.253.2.F372; Moro L, 2005, BLOOD, V105, P115, DOI 10.1182/blood-2003-11-3840; Musselman TM, 2010, STEROIDS, V75, P760, DOI 10.1016/j.steroids.2010.05.014; O'Mahony F, 2007, J BIOL CHEM, V282, P24563, DOI 10.1074/jbc.M611682200; O'Mahony F, 2009, MOL ENDOCRINOL, V23, P1885, DOI 10.1210/me.2008-0248; Razandi M, 2004, MOL ENDOCRINOL, V18, P2854, DOI 10.1210/me.2004-0115; ROCHWERGER L, 1993, ENDOCRINOLOGY, V133, P921, DOI 10.1210/en.133.2.921; Rosenfeld M, 1997, AM J EPIDEMIOL, V145, P794; Saint-Criq V, 2012, STEROIDS, V77, P918, DOI 10.1016/j.steroids.2012.02.017; Santanam N, 1998, J LIPID RES, V39, P2111; Singh AK, 2000, J PHARMACOL EXP THER, V295, P195; Soukup B, 2012, AM J PHYSIOL-LUNG C, V302, pL133, DOI 10.1152/ajplung.00031.2011; Stevis PE, 1999, ENDOCRINOLOGY, V140, P5455, DOI 10.1210/en.140.11.5455; Sweezey NB, 1997, AM J PHYSIOL-LUNG C, V272, pL844, DOI 10.1152/ajplung.1997.272.5.L844; Taguchi Yasuto, 2004, Nucl Recept, V2, P5, DOI 10.1186/1478-1336-2-5; Tam A, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-24; Tong JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015408; Verma N, 2005, CHEST, V128, P2824, DOI 10.1016/S0012-3692(15)52709-8; Verriere V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037746; Wang ZY, 2006, P NATL ACAD SCI USA, V103, P9063, DOI 10.1073/pnas.0603339103; Wang ZY, 2005, BIOCHEM BIOPH RES CO, V336, P1023, DOI 10.1016/j.bbrc.2005.08.226; Xu YD, 2010, RESP RES, V11, DOI [10.1186/1465-9921-11-166, 10.1186/1465-9921-11-107]; Yang GZ, 2011, CELL MOL BIOL, V57, P1480, DOI 10.1170/170; Yang LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009851; Zabner J, 2003, AM J PHYSIOL-LUNG C, V284, pL844, DOI 10.1152/ajplung.00355.2002	57	24	24	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78593	10.1371/journal.pone.0078593	http://dx.doi.org/10.1371/journal.pone.0078593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223826	Green Published, Green Submitted, gold			2022-12-27	WOS:000326503400075
J	Zimolzak, AJ; Spettell, CM; Fernandes, J; Fusaro, VA; Palmer, NP; Saria, S; Kohane, IS; Jonikas, MA; Mandl, KD				Zimolzak, Andrew J.; Spettell, Claire M.; Fernandes, Joaquim; Fusaro, Vincent A.; Palmer, Nathan P.; Saria, Suchi; Kohane, Isaac S.; Jonikas, Magdalena A.; Mandl, Kenneth D.			Early Detection of Poor Adherers to Statins: Applying Individualized Surveillance to Pay for Performance	PLOS ONE			English	Article							THERAPY; INTERVENTIONS; PATIENT	Background: Medication nonadherence costs $300 billion annually in the US. Medicare Advantage plans have a financial incentive to increase medication adherence among members because the Centers for Medicare and Medicaid Services (CMS) now awards substantive bonus payments to such plans, based in part on population adherence to chronic medications. We sought to build an individualized surveillance model that detects early which beneficiaries will fall below the CMS adherence threshold. Methods: This was a retrospective study of over 210,000 beneficiaries initiating statins, in a database of private insurance claims, from 2008-2011. A logistic regression model was constructed to use statin adherence from initiation to day 90 to predict beneficiaries who would not meet the CMS measure of proportion of days covered 0.8 or above, from day 91 to 365. The model controlled for 15 additional characteristics. In a sensitivity analysis, we varied the number of days of adherence data used for prediction. Results: Lower adherence in the first 90 days was the strongest predictor of one-year nonadherence, with an odds ratio of 25.0 (95% confidence interval 23.7-26.5) for poor adherence at one year. The model had an area under the receiver operating characteristic curve of 0.80. Sensitivity analysis revealed that predictions of comparable accuracy could be made only 40 days after statin initiation. When members with 30-day supplies for their first statin fill had predictions made at 40 days, and members with 90-day supplies for their first fill had predictions made at 100 days, poor adherence could be predicted with 86% positive predictive value. Conclusions: To preserve their Medicare Star ratings, plan managers should identify or develop effective programs to improve adherence. An individualized surveillance approach can be used to target members who would most benefit, recognizing the tradeoff between improved model performance over time and the advantage of earlier detection.	[Zimolzak, Andrew J.; Kohane, Isaac S.; Jonikas, Magdalena A.; Mandl, Kenneth D.] Boston Childrens Hosp, Childrens Hosp Informat Program, Harvard Massachusetts Inst Technol Hlth Sci & Tec, Boston, MA USA; [Spettell, Claire M.; Fernandes, Joaquim] Aetna, Blue Bell, PA USA; [Fusaro, Vincent A.; Palmer, Nathan P.; Kohane, Isaac S.; Mandl, Kenneth D.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA USA; [Saria, Suchi] Johns Hopkins Univ, Div Hlth Sci & Informat, Baltimore, MD USA; [Zimolzak, Andrew J.; Kohane, Isaac S.; Mandl, Kenneth D.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA USA	Harvard University; Boston Children's Hospital; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Johns Hopkins University; Harvard University; Harvard Medical School	Mandl, KD (corresponding author), Boston Childrens Hosp, Childrens Hosp Informat Program, Harvard Massachusetts Inst Technol Hlth Sci & Tec, Boston, MA USA.	kenneth_mandl@harvard.edu	Zimolzak, Andrew/K-8237-2019	Zimolzak, Andrew/0000-0003-0973-5639	National Library of Medicine [5-T15-LM007092-20, 5R01LM007677]; Office of the National Coordinator of Health Information Technology [90TR0001/01]; NICHD [5T32HD040128]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD040128] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007092, R01LM007677] Funding Source: NIH RePORTER	National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Office of the National Coordinator of Health Information Technology; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by grant 5-T15-LM007092-20 and 5R01LM007677 from the National Library of Medicine, by 90TR0001/01 from the Office of the National Coordinator of Health Information Technology and 5T32HD040128 from the NICHD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benner JS, 2002, JAMA-J AM MED ASSOC, V288, P455, DOI 10.1001/jama.288.4.455; Centers for Medicare and Medicaid Services, 2012, MED HLTH DRUG PLAN Q; Chan DC, 2010, MED CARE, V48, P196, DOI 10.1097/MLR.0b013e3181c132ad; Cook NR, 2008, CLIN CHEM, V54, P17, DOI 10.1373/clinchem.2007.096529; Cutler DM, 2010, NEW ENGL J MED, V362, P1553, DOI 10.1056/NEJMp1002305; HORWITZ RI, 1990, LANCET, V336, P542, DOI 10.1016/0140-6736(90)92095-Y; Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462; Jacobson G, 2011, MEDICARE ADVANTAGE P; Jonikas MA, 2012, J AM MED INFORM ASSN, V19, P649, DOI 10.1136/amiajnl-2011-000416; McDonald HP, 2002, JAMA-J AM MED ASSOC, V288, P2868, DOI 10.1001/jama.288.22.2868; *NEW ENGL HEALLTHC, 2009, THINK OUTS PILLB SYS; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Pittman DG, 2011, AM J CARDIOL, V107, P1662, DOI 10.1016/j.amjcard.2011.01.052; Reid RO, 2013, JAMA-J AM MED ASSOC, V309, P267, DOI 10.1001/jama.2012.173925; Simpson RJ, 2010, J CLIN LIPIDOL, V4, P462, DOI 10.1016/j.jacl.2010.08.026; Steiner JF, 2012, ANN INTERN MED, V157, P580, DOI 10.7326/0003-4819-157-8-201210160-00013; Viswanathan M, 2012, ANN INTERN MED, V157, P785, DOI 10.7326/0003-4819-157-11-201212040-00538	17	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79611	10.1371/journal.pone.0079611	http://dx.doi.org/10.1371/journal.pone.0079611			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223977	Green Published, Green Submitted, gold			2022-12-27	WOS:000326503400128
J	Chalan, P; Kroesen, BJ; van der Geest, KSM; Huitema, MG; Abdulahad, WH; Bijzet, J; Brouwer, E; Boots, AMH				Chalan, Paulina; Kroesen, Bart-Jan; van der Geest, Kornelis S. M.; Huitema, Minke G.; Abdulahad, Wayel H.; Bijzet, Johan; Brouwer, Elisabeth; Boots, Annemieke M. H.			Circulating CD4+CD161+T Lymphocytes Are Increased in Seropositive Arthralgia Patients but Decreased in Patients with Newly Diagnosed Rheumatoid Arthritis	PLOS ONE			English	Article							T-CELL SUBSETS; TH17 CELLS; HUMAN NKR-P1A; CUTTING EDGE; EXPRESSION; LIGAND; CLASSIFICATION; STRATEGIES; SYNOVITIS; CYTOKINES	Improved understanding of the immune events discriminating between seropositive arthralgia and clinical synovitis is of key importance in rheumatology research. Ample evidence suggests a role for Th17 cells in rheumatoid arthritis. We hypothesized that CD4+CD161+ cells representing Th17 lineage cells may be modulated prior to or after development of clinical synovitis. Therefore, in a cross-sectional study, we investigated the occurrence of CD4+CD161+ T-cells in seropositive arthralgia patients who are at risk for developing rheumatoid arthritis and in newly diagnosed rheumatoid arthritis patients. In a prospective study, we evaluated the effect of methotrexate treatment on circulating CD4+CD161+ T-cells. Next, we assessed if these cells can be detected at the level of the RA joints. Precursor Th17 lineage cells bearing CD161 were found to be increased in seropositive arthralgia patients. In contrast, circulating CD4+CD161+ T-cells were decreased in newly diagnosed rheumatoid arthritis patients. The decrease in CD4+CD161+ T-cells correlated inversely with C-reactive protein and with the 66 swollen joint count. Methotrexate treatment led to normalization of CD4+CD161+ T-cells and reduced disease activity. CD4+CD161+ T cells were readily detected in synovial tissues from both early and late-stage rheumatoid arthritis. In addition, synovial fluid from late-stage disease was found to be enriched for CD4+CD161+ T-cells. Notably, synovial fluid accumulated CD4+CD161+ T-cells showed skewing towards the Th1 phenotype as evidenced by increased interferon-gamma expression. The changes in peripheral numbers of CD4+CD161+ T-cells in seropositive arthralgia and early rheumatoid arthritis and the enrichment of these cells at the level of the joint predict a role for CD4+CD161+ T-cells in the early immune events leading to clinical synovitis. Our findings may add to the development of RA prediction models and provide opportunities for early intervention.	[Chalan, Paulina; van der Geest, Kornelis S. M.; Huitema, Minke G.; Abdulahad, Wayel H.; Bijzet, Johan; Brouwer, Elisabeth; Boots, Annemieke M. H.] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, NL-9713 AV Groningen, Netherlands; [Kroesen, Bart-Jan] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, NL-9713 AV Groningen, Netherlands; [Chalan, Paulina; Kroesen, Bart-Jan; van der Geest, Kornelis S. M.; Huitema, Minke G.; Abdulahad, Wayel H.; Bijzet, Johan; Brouwer, Elisabeth; Boots, Annemieke M. H.] Univ Groningen, Univ Med Ctr Groningen, Groningen Res Initiat Hlth Ageing & Immune Longev, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Boots, AMH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, NL-9713 AV Groningen, Netherlands.	m.boots@umcg.nl	Brouwer, Elisabeth/AAL-9029-2020	Brouwer, Elisabeth/0000-0002-5652-4423; /0000-0003-3109-4487; van der Geest, Kornelis/0000-0003-2798-6765	University Medical Center Groningen (UMCG)	University Medical Center Groningen (UMCG)	The project was funded by University Medical Center Groningen (UMCG). The funders had no role in study design, data collection and analysis. decision to publish, or preparation of the manuscript.	Aldemir H, 2005, J IMMUNOL, V175, P7791, DOI 10.4049/jimmunol.175.12.7791; Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Annunziato F, 2013, ANN NY ACAD SCI, V1284, P66, DOI 10.1111/nyas.12075; Annunziato F, 2012, TRENDS IMMUNOL, V33, P505, DOI 10.1016/j.it.2012.05.004; Arend WP, 2012, NAT REV RHEUMATOL, V8, P573, DOI 10.1038/nrrheum.2012.134; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bos WH, 2010, ANN RHEUM DIS, V69, P490, DOI 10.1136/ard.2008.105759; Burgoyne CH, 2008, ANN RHEUM DIS, V67, P750, DOI 10.1136/ard.2007.073833; Cascao R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3168; Church LD, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3152; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Cosmi L, 2011, ARTHRITIS RHEUM-US, V63, P2504, DOI 10.1002/art.30332; Dolhain RJEM, 1998, BRIT J RHEUMATOL, V37, P502; Germain C, 2011, J BIOL CHEM, V286, P37964, DOI 10.1074/jbc.M111.285312; Germain C, 2010, J BIOL CHEM, V285, P36207, DOI 10.1074/jbc.M110.179622; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Klarenbeek NB, 2011, ANN RHEUM DIS, V70, P1039, DOI 10.1136/ard.2010.141234; Kleinschek MA, 2009, J EXP MED, V206, P525, DOI 10.1084/jem.20081712; Kokkonen H, 2010, ARTHRITIS RHEUM-US, V62, P383, DOI 10.1002/art.27186; Krenn V, 2006, HISTOPATHOLOGY, V49, P358, DOI 10.1111/j.1365-2559.2006.02508.x; LANIER LL, 1994, J IMMUNOL, V153, P2417; Maddur MS, 2012, AM J PATHOL, V181, P8, DOI 10.1016/j.ajpath.2012.03.044; Maggi L, 2012, EUR J IMMUNOL, V42, P3180, DOI 10.1002/eji.201242648; Maggi L, 2010, EUR J IMMUNOL, V40, P2174, DOI 10.1002/eji.200940257; Miao J, 2013, MOD RHEUMATOL; Nistala K, 2010, P NATL ACAD SCI USA, V107, P14751, DOI 10.1073/pnas.1003852107; Page G, 2004, J PATHOL, V204, P28, DOI 10.1002/path.1607; Poggi A, 1997, EUR J IMMUNOL, V27, P2345, DOI 10.1002/eji.1830270932; Rosen DB, 2008, J IMMUNOL, V180, P6508, DOI 10.4049/jimmunol.180.10.6508; Rosen DB, 2005, J IMMUNOL, V175, P7796, DOI 10.4049/jimmunol.175.12.7796; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Smith MD, 2001, RHEUMATOLOGY, V40, P965, DOI 10.1093/rheumatology/40.9.965; Tanida S, 2009, CYTOKINE, V47, P112, DOI 10.1016/j.cyto.2009.05.009; van Baarsen LGM, 2010, ARTHRITIS RHEUM-US, V62, P694, DOI 10.1002/art.27294; van de Stadt LA, 2012, ANN RHEUM DIS; VANDERHEIJDE DMFM, 1992, ARTHRITIS RHEUM-US, V35, P26; Yamada H, 2008, ANN RHEUM DIS, V67, P1299, DOI 10.1136/ard.2007.080341	37	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79370	10.1371/journal.pone.0079370	http://dx.doi.org/10.1371/journal.pone.0079370			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223933	Green Published, gold, Green Submitted			2022-12-27	WOS:000326499300078
J	Elder, AM; Henderson, DM; Nalls, AV; Wilham, JM; Caughey, BW; Hoover, EA; Kincaid, AE; Bartz, JC; Mathiason, CK				Elder, Alan M.; Henderson, Davin M.; Nalls, Amy V.; Wilham, Jason M.; Caughey, Byron W.; Hoover, Edward A.; Kincaid, Anthony E.; Bartz, Jason C.; Mathiason, Candace K.			In Vitro Detection of prionemia in TSE-Infected Cervids and Hamsters	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; SCRAPIE VIRUS-INFECTION; CHRONIC WASTING DISEASE; BLOOD-TRANSFUSION; CYCLIC AMPLIFICATION; SEEDED CONVERSION; PROTEIN; TRANSMISSION; TISSUES; DEER	Blood-borne transmission of infectious prions during the symptomatic and asymptomatic stages of disease occurs for both human and animal transmissible spongiform encephalopathies (TSEs). The geographical distribution of the cervid TSE, chronic wasting disease (CWD), continues to spread across North America and the prospective number of individuals harboring an asymptomatic infection of human variant Creutzfeldt-Jakob Disease (vCJD) in the United Kingdom has been projected to be similar to 1 in 3000 residents. Thus, it is important to monitor cervid and human blood products to ensure herd health and human safety. Current methods for detecting blood-associated prions rely primarily upon bioassay in laboratory animals. While bioassay provides high sensitivity and specificity, it requires many months, animals, and it is costly. Here we report modification of the real time quaking-induced conversion (RT-QuIC) assay to detect blood-borne prions in whole blood from prion-infected preclinical white-tailed deer, muntjac deer, and Syrian hamsters, attaining sensitivity of > 90% while maintaining 100% specificity. Our results indicate that RT-QuIC methodology as modified can provide consistent and reliable detection of blood-borne prions in preclinical and symptomatic stages of two animal TSEs, offering promise for prionemia detection in other species, including humans.	[Elder, Alan M.; Henderson, Davin M.; Nalls, Amy V.; Hoover, Edward A.; Mathiason, Candace K.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Wilham, Jason M.; Caughey, Byron W.] NIAID, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA; [Kincaid, Anthony E.; Bartz, Jason C.] Creighton Univ, Omaha, NE 68178 USA	Colorado State University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Creighton University	Mathiason, CK (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	candace.mathiason@colostate.edu	Mathiason, Candace/H-9769-2017; Mathiason, Candace K/E-7843-2017	Mathiason, Candace/0000-0002-5920-4556; Mathiason, Candace K/0000-0002-5920-4556; Bartz, Jason/0000-0003-4081-7886; Elder, Alan/0000-0002-0386-1792; Kincaid, Anthony/0000-0002-5700-5887	Morris Animal Foundation [D12ZO-045];  [NIH-RO1 093634-01];  [NIH-R01 N5061902];  [NIAID-NO1-AI-25491];  [RO1 NS061994];  [RO1 NS061994-03S1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI112956, N01AI025491, R01AI093634, ZIAAI001086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061902, R01NS061994] Funding Source: NIH RePORTER	Morris Animal Foundation; ; ; ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work at Colorado State University was supported by NIH-RO1 093634-01, NIH-R01 N5061902, NIAID-NO1-AI-25491 and Morris Animal Foundation D12ZO-045. Work done at Creighton University was supported by RO1 NS061994 and RO1 NS061994-03S1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Andreoletti O, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002782; Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Bannach O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036620; Barria MA, 2012, METHODS MOL BIOL, V849, P199, DOI 10.1007/978-1-61779-551-0_14; Castilla J, 2005, NAT MED, V11, P982, DOI 10.1038/nm1286; Chen BA, 2010, NAT METHODS, V7, P519, DOI [10.1038/NMETH.1465, 10.1038/nmeth.1465]; Colby DW, 2007, P NATL ACAD SCI USA, V104, P20914, DOI 10.1073/pnas.0710152105; D'Castro L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015679; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2005, J BIOL CHEM, V280, P26873, DOI 10.1074/jbc.M503973200; Denkers ND, 2013, J VIROL, V87, P1890, DOI 10.1128/JVI.02852-12; Denkers ND, 2011, J VIROL, V85, P1396, DOI 10.1128/JVI.01655-10; Dominguez K, 2009, SYST BIOL REPROD MED, V55, P193, DOI 10.3109/19396360903234052; Edgeworth JA, 2011, LANCET, V377, P487, DOI 10.1016/S0140-6736(10)62308-2; EKLUND CM, 1967, J INFECT DIS, V117, P15, DOI 10.1093/infdis/117.1.15; FRASER H, 1978, J COMP PATHOL, V88, P563, DOI 10.1016/0021-9975(78)90010-5; Glier H, 2012, J IMMUNOL METHODS, V380, P65, DOI 10.1016/j.jim.2012.04.002; Gonzalez-Romero D, 2008, FEBS LETT, V582, P3161, DOI 10.1016/j.febslet.2008.08.003; Gregori L, 2004, LANCET, V364, P529, DOI 10.1016/S0140-6736(04)16812-8; HADLOW WJ, 1974, J INFECT DIS, V129, P559, DOI 10.1093/infdis/129.5.559; Henderson DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074377; Hofmann JP, 2013, P NATL ACAD SCI USA, V110, P5951, DOI 10.1073/pnas.1217321110; Holada K, 2002, J VIROL, V76, P4649, DOI 10.1128/JVI.76.9.4649-4650.2002; HORIUCHI M, 1995, J GEN VIROL, V76, P2583, DOI 10.1099/0022-1317-76-10-2583; Houston F, 2008, BLOOD, V112, P4739, DOI 10.1182/blood-2008-04-152520; Hunter N, 2002, J GEN VIROL, V83, P2897, DOI 10.1099/0022-1317-83-11-2897; Kincaid AE, 2007, J VIROL, V81, P4482, DOI 10.1128/JVI.02649-06; Kincaid AE, 2012, J VIROL, V86, P12731, DOI 10.1128/JVI.01930-12; KITAMOTO T, 1989, J GEN VIROL, V70, P3371, DOI 10.1099/0022-1317-70-12-3371; Krebs MRH, 2005, J STRUCT BIOL, V149, P30, DOI 10.1016/j.jsb.2004.08.002; Lacroux C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042019; Lacroux C, 2012, J VIROL, V86, P2056, DOI 10.1128/JVI.06532-11; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; LOVELOCK JE, 1954, NATURE, V173, P659, DOI 10.1038/173659a0; LOVELOCK JE, 1955, BRIT J HAEMATOL, V1, P117, DOI 10.1111/j.1365-2141.1955.tb05493.x; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Mathiason CK, 2010, J VIROL, V84, P5097, DOI 10.1128/JVI.02169-09; Mathiason CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005916; McCutcheon S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023169; Morales R, 2008, BIOCHEM BIOPH RES CO, V377, P373, DOI 10.1016/j.bbrc.2008.09.141; Murayama Y, 2007, J GEN VIROL, V88, P2890, DOI 10.1099/vir.0.82786-0; Nalls AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071844; Orru CD, 2012, PRION, V6, P147, DOI 10.4161/pri.19430; Orru CD, 2009, PROTEIN ENG DES SEL, V22, P515, DOI 10.1093/protein/gzp031; PATTISON IH, 1962, J COMP PATHOL THERAP, V72, P233, DOI 10.1016/S0368-1742(62)80026-5; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Peden Alexander H, 2008, Expert Opin Med Diagn, V2, P207, DOI 10.1517/17530059.2.2.207; Prowse CV, 2000, VOX SANG, V79, P248, DOI 10.1046/j.1423-0410.2000.7940248.x; RACE RE, 1992, J GEN VIROL, V73, P3319, DOI 10.1099/0022-1317-73-12-3319; REED L. J., 1938, AMER JOUR HYG, V27, P493; Saa P, 2006, SCIENCE, V313, P92, DOI 10.1126/science.1129051; Saa Paula, 2004, V299, P53; Team E, 2007, EUROSURVEILLANCE, V12; Terry LA, 2009, J VIROL, V83, P12552, DOI 10.1128/JVI.00311-09; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217; Wong C, 2001, EMBO J, V20, P377, DOI 10.1093/emboj/20.3.377; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8; Yokoyama T, 2011, NEUROSCI LETT, V498, P119, DOI 10.1016/j.neulet.2011.04.072	60	66	67	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e80203	10.1371/journal.pone.0080203	http://dx.doi.org/10.1371/journal.pone.0080203			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24224043	Green Published, Green Submitted, gold			2022-12-27	WOS:000326499300097
J	Yang, JJ; Yuan, PF; Wen, DQ; Sheng, Y; Zhu, SY; Yu, YZ; Gao, X; Wei, WS				Yang, Junjiao; Yuan, Pengfei; Wen, Dingqiao; Sheng, Ying; Zhu, Shiyou; Yu, Yuezhou; Gao, Xiang; Wei, Wensheng			ULtiMATE System for Rapid Assembly of Customized TAL Effectors	PLOS ONE			English	Article							DNA-BINDING SPECIFICITY	Engineered TAL-effector nucleases (TALENs) and TALE-based constructs have become powerful tools for eukaryotic genome editing. Although many methods have been reported, it remains a challenge for the assembly of designer-based TALE repeats in a fast, precise and cost-effective manner. We present an ULtiMATE (USER-based Ligation Mediated Assembly of TAL Effector) system for speedy and accurate assembly of customized TALE constructs. This method takes advantage of uracil-specific excision reagent (USER) to create multiple distinct sticky ends between any neighboring DNA fragments for specific ligation. With pre-assembled templates, multiple TALE DNA-binding domains could be efficiently assembled in order within hours with minimal manual operation. This system has been demonstrated to produce both functional TALENs for effective gene knockout and TALE-mediated gene-specific transcription activation (TALE-TA). The feature of both ease-of-operation and high efficiency of ULtiMATE system makes it not only an ideal method for biologic labs, but also an approach well suited for large-scale assembly of TALENs and any other TALE-based constructions.	[Yang, Junjiao; Yuan, Pengfei; Wen, Dingqiao; Sheng, Ying; Zhu, Shiyou; Yu, Yuezhou; Wei, Wensheng] Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Gao, Xiang] Peking Univ, Dept Elect, Sch Elect Engn & Comp Sci, Beijing 100871, Peoples R China	Peking University; Peking University	Wei, WS (corresponding author), Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.	wswei@pku.edu.cn	Wei, Wensheng/AAF-1325-2020	Yang, Junjiao/0000-0003-4844-2492; Wen, Dingqiao/0000-0001-8229-2294; Wei, Wensheng/0000-0002-8053-2423	Major State Basic Research Development Program of China [2010CB911800]; National Science Foundation of China [NSFC31070115, NSFC31170126]; 985 Project of Peking University; Peking-Tsinghua Center for Life Sciences	Major State Basic Research Development Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); 985 Project of Peking University(Peking University); Peking-Tsinghua Center for Life Sciences	This work was supported in part by the Major State Basic Research Development Program of China (grant number 2010CB911800), the National Science Foundation of China (grant numbers NSFC31070115, NSFC31170126), and a grant of the 985 Project of Peking University and Peking-Tsinghua Center for Life Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Briggs AW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks624; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1962; Garg A, 2012, NUCLEIC ACIDS RES, V40, P7584, DOI 10.1093/nar/gks404; Geissler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019509; Geu-Flores F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm106; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Mahfouz MM, 2012, PLANT MOL BIOL, V78, P311, DOI 10.1007/s11103-011-9866-x; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Morbitzer R, 2011, NUCLEIC ACIDS RES, V39, P5790, DOI 10.1093/nar/gkr151; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; SCHMIDBURGK JL, 2012, NAT BIOTECHNOL; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019722; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	20	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75649	10.1371/journal.pone.0075649	http://dx.doi.org/10.1371/journal.pone.0075649			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24228087	Green Submitted, Green Published, gold			2022-12-27	WOS:000325223900054
J	Hamashima, C; Ogoshi, K; Okamoto, M; Shabana, M; Kishimoto, T; Fukao, A				Hamashima, Chisato; Ogoshi, Kazuei; Okamoto, Mikizo; Shabana, Michiko; Kishimoto, Takuji; Fukao, Akira			A Community-Based, Case-Control Study Evaluating Mortality Reduction from Gastric Cancer by Endoscopic Screening in Japan	PLOS ONE			English	Article							STOMACH-CANCER; POPULATION; PROGRAM; ASSOCIATION; PREFECTURE	Aims: Although the incidence of gastric cancer has decreased in the last 3 decades, it remains the second leading cause of cancer death worldwide. In Asian countries, the burden of gastric cancer has remained, and cancer screening is normally expected to reduce gastric cancer death. We conducted a community-based, case-control study to evaluate the reduction of mortality from gastric cancer by endoscopic screening. Methods: Case subjects were defined as individuals who had died of gastric cancer between 2003 and 2006 in 4 cities in Tottori Prefecture, and between 2006 and 2010 in Niigata City, Japan. Up to 6 control subjects were matched by sex, birth year (+/- 3 years), and the residence of each corresponding case subject from the population lists in the study areas. Control subjects were required to be disease-free at the time when the corresponding case subjects were diagnosed as having gastric cancer. The odds ratios (ORs) were calculated for those who had participated in endoscopic or radiographic screening before the reference date when the case subjects were diagnosed as having gastric cancer, compared with subjects who had never participated in any screening. Conditional logistic-regression models for matched sets were used to estimate the ORs and 95% confidence intervals (CIs). Results: The case subjects consisted of 288 men and 122 women for case subjects, with 2,292 matched control subjects. Compared with those who had never been screened before the date of diagnosis of gastric cancer in the case subjects, the ORs within 36 months from the date of diagnosis were 0.695 (95% CI: 0.489-0.986) for endoscopic screening and 0.865 (95% CI : 0.631-1.185) for radiographic screening. Conclusions: The results suggest a 30% reduction in gastric cancer mortality by endoscopic screening compared with no screening within 36 months before the date of diagnosis of gastric cancer.	[Hamashima, Chisato] Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Canc Screening Assessment & Management Div, Tokyo 104, Japan; [Ogoshi, Kazuei] Niigata Canc Ctr Hosp, Niigata, Japan; [Okamoto, Mikizo] Tottori Univ, Fac Med, Dept Social Med, Div Hlth Adm & Promot, Yonago, Tottori 683, Japan; [Shabana, Michiko] San in Rosai Hosp, Dept Internal Med, Yonago, Tottori, Japan; [Kishimoto, Takuji] Tottori Univ, Fac Med, Dept Social Med, Div Environm & Prevent Med, Yonago, Tottori 683, Japan; [Fukao, Akira] Yamagata Univ, Sch Med, Dept Publ Hlth, Yamagata, Yamagata, Japan	National Cancer Center - Japan; Tottori University; Tottori University; Yamagata University	Hamashima, C (corresponding author), Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Canc Screening Assessment & Management Div, Tokyo 104, Japan.	chamashi@ncc.go.jp	Hamashima, Chisato/AAI-3061-2021		Ministry of Health, Labor and Welfare of Japan [15-3, 20-9]	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by Grant-in-Aid for Cancer Control from Ministry of Health, Labor and Welfare of Japan (Grant number 15-3 and 20-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Yohsuke, 1995, Japanese Journal of Gastroenterology, V92, P836; Cronin KA, 1998, J NATL CANCER I, V90, P498, DOI 10.1093/jnci/90.7.498; FUKAO A, 1995, INT J CANCER, V60, P45, DOI 10.1002/ijc.2910600106; FUKAO A, 1992, TOHOKU J EXP MED, V166, P459, DOI 10.1620/tjem.166.459; Hamashima C, 2008, JPN J CLIN ONCOL, V38, P259, DOI 10.1093/jjco/hyn017; Hamashima Chisato, 2003, Asian Pac J Cancer Prev, V4, P39; Hosokawa O, 2008, SCAND J GASTROENTERO, V43, P1112, DOI 10.1080/00365520802085395; International Agency for Research on Cancer, 2008, GLOBOCAN 2008; Kim Y, 2011, ASIAN PAC J CANCER P, V12, P725; Lee SJ, 2012, BMJ-BRIT MED J, V345, pe8441; Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X; Matsumoto S, 2007, WORLD J GASTROENTERO, V13, P4316, DOI 10.3748/wjg.v13.i32.4316; Ministry of Health Labour and Welfare of Japan, 2010, NAT SURV CANC SCREEN; Ministry of Health Welfare and Labour., 2007, JAP ETH GUID EP STUD; Ministry of Health Welfare and Labour, 2006, PAT BEH SURV 2005; MORRISON AS, 1982, AM J EPIDEMIOL, V115, P6; MOSS SM, 1991, INT J EPIDEMIOL, V20, P1, DOI 10.1093/ije/20.1.1; Nam JH, 2012, CANCER-AM CANCER SOC, V118, P4953, DOI 10.1002/cncr.27495; Ogoshi K, 2010, JPN J ENDOSC FORUM D, V26, P5; OSHIMA A, 1986, INT J CANCER, V38, P829, DOI 10.1002/ijc.2910380608; PISANI P, 1994, BRIT J CANCER, V69, P1102, DOI 10.1038/bjc.1994.216; Riecken B, 2002, PREV MED, V34, P22, DOI 10.1006/pmed.2001.0925; Shabana M., 2010, JPN J CANC DIAGN, V17, P229; Tsubono Y, 1999, J GASTROENTEROL MASS, V37, P182; Wahrendorf J, 1993, Eur J Cancer Prev, V2, P221, DOI 10.1097/00008469-199305000-00005	25	94	101	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79088	10.1371/journal.pone.0079088	http://dx.doi.org/10.1371/journal.pone.0079088			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236091	Green Published, gold			2022-12-27	WOS:000327254700089
J	Hyodo, H; Terao, A; Furukawa, J; Sakamoto, N; Yurimoto, H; Satoh, S; Iwai, H				Hyodo, Hiromi; Terao, Azusa; Furukawa, Jun; Sakamoto, Naoya; Yurimoto, Hisayoshi; Satoh, Shinobu; Iwai, Hiroaki			Tissue Specific Localization of Pectin-Ca2+ Cross-Linkages and Pectin Methyl-Esterification during Fruit Ripening in Tomato (Solanum lycopersicum)	PLOS ONE			English	Article							CELL-WALL; METHYLESTERASE GENE; GOLGI-APPARATUS; SIDE-CHAINS; CDNA-CLONE; IDENTIFICATION; CALCIUM; METHYLTRANSFERASE; EXPRESSION; POLYGALACTURONASE	Fruit ripening is one of the developmental processes accompanying seed development. The tomato is a well-known model for studying fruit ripening and development, and the disassembly of primary cell walls and the middle lamella, such as through pectin de-methylesterified by pectin methylesterase (PE) and depolymerization by polygalacturonase (PG), is generally accepted to be one of the major changes that occur during ripening. Although many reports of the changes in pectin during tomato fruit ripening are focused on the relation to softening of the pericarp or the Blossom-end rot by calcium (Ca2+) deficiency disorder, the changes in pectin structure and localization in each tissues during tomato fruit ripening is not well known. In this study, to elucidate the tissue-specific role of pectin during fruit development and ripening, we examined gene expression, the enzymatic activities involved in pectin synthesis and depolymerisation in fruit using biochemical and immunohistochemical analyses, and uronic acids and calcium (Ca)-bound pectin were determined by secondary ion-microprobe mass spectrometry. These results show that changes in pectin properties during fruit development and ripening have tissue-specific patterns. In particular, differential control of pectin methyl-esterification occurs in each tissue. Variations in the cell walls of the pericarp are quite different from that of locular tissues. The Ca-binding pectin and hairy pectin in skin cell layers are important for intercellular and tissue-tissue adhesion. Maintenance of the globular form and softening of tomato fruit may be regulated by the arrangement of pectin structures in each tissue.	[Hyodo, Hiromi; Terao, Azusa; Furukawa, Jun; Satoh, Shinobu; Iwai, Hiroaki] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Sakamoto, Naoya; Yurimoto, Hisayoshi] Hokkaido Univ, Creat Res Inst CRIS, Sapporo, Hokkaido, Japan; [Yurimoto, Hisayoshi] Hokkaido Univ, Sapporo, Hokkaido, Japan	University of Tsukuba; Hokkaido University; Hokkaido University	Iwai, H (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan.	iwai.hiroaki.gb@u.tsukuba.ac.jp	Iwai, Hiroaki/B-3171-2014; Yurimoto, Hisayoshi/S-9938-2018; Furukawa, Jun/D-4293-2016	Yurimoto, Hisayoshi/0000-0003-0702-0533; 	 [18075004];  [24114006]; Grants-in-Aid for Scientific Research [25800299, 25440125] Funding Source: KAKEN	; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research on Priority Areas (18075004) and a Grant-in-Aid for Scientific Research on Innovative Areas (24114006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Massih RM, 2003, PLANTA, V216, P502, DOI 10.1007/s00425-002-0861-y; Bapat VA, 2010, BIOTECHNOL ADV, V28, P94, DOI 10.1016/j.biotechadv.2009.10.002; BIRD CR, 1988, PLANT MOL BIOL, V11, P651, DOI 10.1007/BF00017465; Bosch M, 2005, PLANT CELL, V17, P3219, DOI 10.1105/tpc.105.037473; Braccini I, 2005, BIOMACROMOLECULES, V6, P1322, DOI 10.1021/bm049457h; Braccini I, 2001, BIOMACROMOLECULES, V2, P1089, DOI 10.1021/bm010008g; Brummell DA, 2006, FUNCT PLANT BIOL, V33, P103, DOI 10.1071/FP05234; Brummell DA, 2001, PLANT MOL BIOL, V47, P311, DOI 10.1023/A:1010656104304; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Davuluri GR, 2005, NAT BIOTECHNOL, V23, P890, DOI 10.1038/nbt1108; de Freitas ST, 2012, PLANT J, V71, P824, DOI 10.1111/j.1365-313X.2012.05034.x; DEMARTY M, 1984, PLANT CELL ENVIRON, V7, P441, DOI 10.1111/j.1365-3040.1984.tb01434.x; Dharmapuri S, 2002, FEBS LETT, V519, P30, DOI 10.1016/S0014-5793(02)02699-6; Eriksson EM, 2004, PLANT PHYSIOL, V136, P4184, DOI 10.1104/pp.104.045765; Fang YP, 2008, CARBOHYD POLYM, V72, P334, DOI 10.1016/j.carbpol.2007.08.021; Fraeye I, 2009, FOOD HYDROCOLLOID, V23, P2069, DOI 10.1016/j.foodhyd.2009.03.022; Fraser PD, 2004, PROG LIPID RES, V43, P228, DOI 10.1016/j.plipres.2003.10.002; Giovannoni J, 2001, ANNU REV PLANT PHYS, V52, P725, DOI 10.1146/annurev.arplant.52.1.725; Giovannoni JJ, 2004, PLANT CELL, V16, pS170, DOI 10.1105/tpc.019158; Goubet F, 1998, PLANT PHYSIOL, V116, P337, DOI 10.1104/pp.116.1.337; GRIERSON D, 1986, NUCLEIC ACIDS RES, V14, P8595, DOI 10.1093/nar/14.21.8595; HAGERMAN AE, 1986, J AGR FOOD CHEM, V34, P440, DOI 10.1021/jf00069a015; HALL LN, 1994, PLANT MOL BIOL, V25, P313, DOI 10.1007/BF00023246; HARRIMAN RW, 1991, PLANT PHYSIOL, V97, P80, DOI 10.1104/pp.97.1.80; Hepler PK, 2010, J INTEGR PLANT BIOL, V52, P147, DOI 10.1111/j.1744-7909.2010.00923.x; Ishikawa M, 2000, PLANTA, V210, P782, DOI 10.1007/s004250050680; Iwai H, 2001, PLANTA, V213, P907, DOI 10.1007/s004250100559; JARVIS MC, 1984, PLANT CELL ENVIRON, V7, P153, DOI 10.1111/1365-3040.ep11614586; KOCH JL, 1989, PLANT PHYSIOL, V91, P816, DOI 10.1104/pp.91.3.816; Lewinsohn E, 2001, PLANT PHYSIOL, V127, P1256, DOI 10.1104/pp.127.3.1256; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Milner Y., 1967, CARBOHYD RES, V4, P359, DOI DOI 10.1016/S0008-6215(00)80191-3; Mouille G, 2007, PLANT J, V50, P605, DOI 10.1111/j.1365-313X.2007.03086.x; Muir SR, 2001, NAT BIOTECHNOL, V19, P470, DOI 10.1038/88150; NATH P, 2007, STEWART POSTHARVEST, V3, P1, DOI DOI 10.2212/SPR.2007.2.6; Phan TD, 2007, PLANT PHYSIOL, V144, P1960, DOI 10.1104/pp.107.096347; Popper ZA, 2005, ANN BOT-LONDON, V96, P91, DOI 10.1093/aob/mci153; Powell ALT, 2003, J AGR FOOD CHEM, V51, P7450, DOI 10.1021/jf034165d; PRESSEY R, 1982, J FOOD BIOCHEM, V6, P57, DOI 10.1111/j.1745-4514.1982.tb00296.x; QI XY, 1995, PLANT PHYSIOL, V108, P1691, DOI 10.1104/pp.108.4.1691; RAY J, 1988, EUR J BIOCHEM, V174, P119, DOI 10.1111/j.1432-1033.1988.tb14070.x; Rose JK, 2003, PLANT CELL WALL, V8, P264, DOI DOI 10.1002/9781119312994.APR0075; Rose JKC, 2004, CURR OPIN PLANT BIOL, V7, P296, DOI 10.1016/j.pbi.2004.03.013; Saladie M, 2007, PLANT PHYSIOL, V144, P1012, DOI 10.1104/pp.107.097477; SEYMOUR GB, 1987, PHYTOCHEMISTRY, V26, P3137, DOI 10.1016/S0031-9422(00)82457-7; Seymour GB, 2013, PLANT BIOTECHNOL J, V11, P269, DOI 10.1111/j.1467-7652.2012.00738.x; Smith DL, 2002, PLANT PHYSIOL, V129, P1755, DOI 10.1104/pp.011025; STAEHELIN LA, 1995, ANNU REV PLANT PHYS, V46, P261, DOI 10.1146/annurev.pp.46.060195.001401; Sterling JD, 2006, P NATL ACAD SCI USA, V103, P5236, DOI 10.1073/pnas.0600120103; Sterling JD, 2001, PLANT PHYSIOL, V127, P360, DOI 10.1104/pp.127.1.360; Teyssier E, 2008, PLANTA, V228, P391, DOI 10.1007/s00425-008-0743-z; THEOLOGIS A, 1992, CELL, V70, P181, DOI 10.1016/0092-8674(92)90093-R; TIEMAN DM, 1992, PLANT CELL, V4, P667, DOI 10.1105/tpc.4.6.667; Vignon MR, 2004, CARBOHYD RES, V339, P123, DOI 10.1016/j.carres.2003.09.023; Vrebalov J, 2002, SCIENCE, V296, P343, DOI 10.1126/science.1068181; Wolf S, 2009, PLANT J, V58, P361, DOI 10.1111/j.1365-313X.2009.03784.x; YURIMOTO H, 2003, APPL SURF SCI, V793, P203; ZHANG GF, 1992, PLANT PHYSIOL, V99, P1070, DOI 10.1104/pp.99.3.1070; Zykwinska AW, 2005, PLANT PHYSIOL, V139, P397, DOI 10.1104/pp.105.065912	59	34	37	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78949	10.1371/journal.pone.0078949	http://dx.doi.org/10.1371/journal.pone.0078949			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236073	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700070
J	Muzny, CA; Sunesara, IR; Kumar, R; Mena, LA; Griswold, ME; Martin, DH; Lefkowitz, EJ; Schwebke, JR				Muzny, Christina A.; Sunesara, Imran R.; Kumar, Ranjit; Mena, Leandro A.; Griswold, Michael E.; Martin, David H.; Lefkowitz, Elliot J.; Schwebke, Jane R.			Characterization of the Vaginal Microbiota among Sexual Risk Behavior Groups of Women with Bacterial Vaginosis	PLOS ONE			English	Article							PEROXIDE-PRODUCING LACTOBACILLI; SIMPLEX-VIRUS TYPE-2; TRANSMITTED INFECTIONS; GARDNERELLA-VAGINALIS; GRAM STAIN; FLORA; METRONIDAZOLE; PREVALENCE; DIAGNOSIS; CONTRACEPTION	Background: The pathogenesis of bacterial vaginosis (BV) remains elusive. BV may be more common among women who have sex with women (WSW). The objective of this study was to use 454 pyrosequencing to investigate the vaginal microbiome of WSW, women who have sex with women and men (WSWM), and women who have sex with men (WSM) with BV to determine if there are differences in organism composition between groups that may inform new hypotheses regarding the pathogenesis of BV. Methods: Vaginal swab specimens from eligible women with BV at the Mississippi State Department of Health STD Clinic were used. After DNA extraction, 454 pyrosequencing of PCR-amplified 16S rRNA gene sequences was performed. Sequence data was classified using the Ribosomal Database Program classifer. Complete linkage clustering analysis was performed to compare bacterial community composition among samples. Differences in operational taxonomic units with an abundance of >= 2% between risk behavior groups were determined. Alpha and beta diversity were measured using Shannon's Index implemented in QIIME and Unifrac analysis, respectively. Results: 33 WSW, 35 WSWM, and 44 WSM were included. The vaginal bacterial communities of all women clustered into four taxonomic groups with the dominant taxonomic group in each being Lactobacillus, Lachnospiraceae, Prevotella, and Sneathia. Regarding differences in organism composition between risk behavior groups, the abundance of Atopobium (relative ratio (RR)=0.24; 95%CI 0.11-0.54) and Parvimonas (RR=0.33; 95%CI 0.11-0.93) were significantly lower in WSW than WSM, the abundance of Prevotella was significantly higher in WSW than WSWM (RR=1.77; 95%CI 1.10-2.86), and the abundance of Atopobium (RR=0.41; 95%CI 0.18-0.88) was significantly lower in WSWM than WSM. Overall, WSM had the highest diversity of bacterial taxa. Conclusion: The microbiology of BV among women in different risk behavior groups is heterogeneous. WSM in this study had the highest diversity of bacterial taxa. Additional studies are needed to better understand these differences.	[Muzny, Christina A.; Sunesara, Imran R.; Schwebke, Jane R.] Univ Alabama Birmingham, Div Infect Dis, Birmingham, AL 35294 USA; [Sunesara, Imran R.; Griswold, Michael E.] Univ Mississippi, Med Ctr, Ctr Biostat & Bioinformat, Jackson, MS 39216 USA; [Kumar, Ranjit; Lefkowitz, Elliot J.] Univ Alabama Birmingham, Ctr Clin & Translat Sci, Birmingham, AL USA; [Mena, Leandro A.; Schwebke, Jane R.] Univ Mississippi, Med Ctr, Div Infect Dis, Jackson, MS 39216 USA; [Martin, David H.] Louisiana State Univ, Hlth Sci Ctr, Div Infect Dis, New Orleans, LA 70112 USA; [Lefkowitz, Elliot J.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Mississippi; University of Mississippi Medical Center; University of Alabama System; University of Alabama Birmingham; University of Mississippi; University of Mississippi Medical Center; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Alabama System; University of Alabama Birmingham	Schwebke, JR (corresponding author), Univ Alabama Birmingham, Div Infect Dis, Birmingham, AL 35294 USA.	edswiatlo@gmail.com		Lefkowitz, Elliot/0000-0002-4748-4925; Muzny, Christina/0000-0002-4005-3858	UAB Center for Clinical and Translational Science from the National Center for Advancing Translational Sciences (NCATS) [UL1TR000165]; National Center for Research Resources (NCRR) component of the National Institutes of Health (NIH); American Sexually Transmitted Diseases Association; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000165] Funding Source: NIH RePORTER	UAB Center for Clinical and Translational Science from the National Center for Advancing Translational Sciences (NCATS); National Center for Research Resources (NCRR) component of the National Institutes of Health (NIH); American Sexually Transmitted Diseases Association; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Bioinformatics support for this study was made possible by the UAB Center for Clinical and Translational Science grant number UL1TR000165 from the National Center for Advancing Translational Sciences (NCATS) and the National Center for Research Resources (NCRR) component of the National Institutes of Health (NIH). Christina Muzny is partially supported by a Developmental Award from the American Sexually Transmitted Diseases Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsel R., 1983, AM J MED, V14, P74, DOI DOI 10.1016/0002-9343(83)91112-9.PUBMED:6600371; Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Aroutcheva A, 2008, ANAEROBE, V14, P256, DOI 10.1016/j.anaerobe.2008.08.002; Bailey JV, 2004, SEX TRANSM INFECT, V80, P244, DOI 10.1136/sti.2003.007641; BARBONE F, 1990, AM J OBSTET GYNECOL, V163, P510, DOI 10.1016/0002-9378(90)91186-G; Boyles AL, 2011, EPIDEMIOLOGY, V22, P746, DOI 10.1097/EDE.0b013e318225ba48; Bradshaw CS, 2006, J INFECT DIS, V193, P1478, DOI 10.1086/503780; Bradshaw CS, 2005, OBSTET GYNECOL, V106, P105, DOI 10.1097/01.AOG.0000163247.78533.7b; Brotman RM, 2010, J INFECT DIS, V202, P1907, DOI 10.1086/657320; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CATLIN BW, 1992, CLIN MICROBIOL REV, V5, P213, DOI 10.1128/CMR.5.3.213-237.1992; Cherpes TL, 2008, SEX TRANSM DIS, V35, P78, DOI 10.1097/OLQ.0b013e318156a5d0; Cherpes TL, 2003, CLIN INFECT DIS, V37, P319, DOI 10.1086/375819; Citron DM, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P911; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edwards A, 1990, Int J STD AIDS, V1, P178; Eren AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026732; ESCHENBACH DA, 1988, AM J OBSTET GYNECOL, V158, P819, DOI 10.1016/0002-9378(88)90078-6; Evans AL, 2007, SEX TRANSM INFECT, V83, P470, DOI 10.1136/sti.2006.022277; Evans BA, 1998, SEX TRANSM INFECT, V74, P45, DOI 10.1136/sti.74.1.45; Falsen E, 1999, INT J SYST BACTERIOL, V49, P217, DOI 10.1099/00207713-49-1-217; Ferris MJ, 2007, J CLIN MICROBIOL, V45, P1016, DOI 10.1128/JCM.02085-06; Ferris MJ, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-5; Fethers K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030633; FLEURY F J, 1981, Clinical Obstetrics and Gynecology, V24, P407, DOI 10.1097/00003081-198106000-00008; Flynn TR, 2012, J ORAL MAXIL SURG, V70, P1854, DOI 10.1016/j.joms.2011.09.009; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; GARDNER HL, 1955, AM J OBSTET GYNECOL, V69, P962, DOI 10.1016/0002-9378(55)90095-8; HILL GB, 1993, AM J OBSTET GYNECOL, V169, P450, DOI 10.1016/0002-9378(93)90339-K; HILLIER SL, 1993, CLIN INFECT DIS, V16, pS273, DOI 10.1093/clinids/16.Supplement_4.S273; Hillier SL MJ., 2008, SEX TRANSM DIS, P737; Jakobsson T, 2007, J CLIN MICROBIOL, V45, P3145, DOI 10.1128/JCM.00558-07; JousimiesSomer H, 1997, CLIN INFECT DIS, V25, pS78, DOI 10.1086/516227; Koumans EH, 2007, SEX TRANSM DIS, V34, P864, DOI 10.1097/OLQ.0b013e318074e565; Leitich H, 2003, AM J OBSTET GYNECOL, V189, P139, DOI 10.1067/mob.2003.339; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Marrazzo JM, 2012, J INFECT DIS, V205, P1580, DOI 10.1093/infdis/jis242; Marrazzo JM, 2010, SEX TRANSM DIS, V37, P732, DOI 10.1097/OLQ.0b013e3181fbbc95; Marrazzo JM, 2010, SEX TRANSM DIS, V37, P335, DOI 10.1097/OLQ.0b013e3181ca3cac; Marrazzo JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011139; Marrazzo JM, 2002, J INFECT DIS, V185, P1307, DOI 10.1086/339884; Marrazzo JM, 2001, INT J STD AIDS, V12, P41, DOI 10.1258/0956462011916721; Martin David H, 2012, Trans Am Clin Climatol Assoc, V123, P242; Martin HL, 1999, J INFECT DIS, V180, P1863, DOI 10.1086/315127; McCaffrey M, 1999, INT J STD AIDS, V10, P305, DOI 10.1258/0956462991914168; Mitchell C, 2011, SEX TRANSM DIS, V38, P1137, DOI 10.1097/OLQ.0b013e31822e6121; Moi H, 1990, Int J STD AIDS, V1, P86; Muzny CA, 2013, CURR INFECT DIS REP, V15, P130, DOI 10.1007/s11908-013-0318-4; Muzny CA, 2011, SEX TRANSM DIS, V38, P1118, DOI 10.1097/OLQ.0b013e31822e6179; Myer L, 2005, J INFECT DIS, V192, P1372, DOI 10.1086/462427; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Peipert JF, 2008, SEX TRANSM DIS, V35, P363, DOI 10.1097/OLQ.0b013e31815e4179; Pinto VM, 2005, AIDS, V19, pS64, DOI 10.1097/01.aids.0000191493.43865.2a; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Rein M., 1983, CURRENT CLIN TOPICS, V4, P281; Rifkin SB, 2009, CONTRACEPTION, V80, P63, DOI 10.1016/j.contraception.2009.01.008; Sanchez S, 2004, AM J OBSTET GYNECOL, V191, P1898, DOI 10.1016/j.ajog.2004.06.089; Schwebke JR, 2009, J INFECT DIS, V200, P1633, DOI 10.1086/648093; Schwebke JR, 2005, SEX TRANSM DIS, V32, P654, DOI 10.1097/01.olq.0000175396.10304.62; SHAH HN, 1990, INT J SYST BACTERIOL, V40, P205, DOI 10.1099/00207713-40-2-205; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Srinivasan Sujatha, 2008, Interdiscip Perspect Infect Dis, V2008, P750479, DOI 10.1155/2008/750479; Sweet R L, 2000, Infect Dis Obstet Gynecol, V8, P184, DOI 10.1155/S1064744900000260; Swidsinski A, 2010, GYNECOL OBSTET INVES, V70, P256, DOI 10.1159/000314015; Verhelst R, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-16; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zhou Xiaoping, 2007, U S Forest Service Pacific Northwest Research Station General Technical Report PNW-GTR, P1; Zozaya-Hinchliffe M, 2010, J CLIN MICROBIOL, V48, P1812, DOI 10.1128/JCM.00851-09	70	19	19	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80254	10.1371/journal.pone.0080254	http://dx.doi.org/10.1371/journal.pone.0080254			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236175	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700176
J	Netto, LR; Cavalcanti-Ribeiro, P; Pereira, JL; Nogueira, JF; Santos, LL; Lira, SB; Guedes, GM; Teles, CA; Koenen, KC; Quarantini, LC				Netto, Liana R.; Cavalcanti-Ribeiro, Patricia; Pereira, Juliana L.; Nogueira, Jose F.; Santos, Lene L.; Lira, Sidnei B.; Guedes, Gisela M.; Teles, Carlos A.; Koenen, Karestan C.; Quarantini, Lucas C.		TADSG UFBA	Clinical and Socio-Demographic Characteristics of College Students Exposed to Traumatic Experiences: A Census of Seven College Institutions in Northeastern Brazil	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; NATIONAL COMORBIDITY SURVEY; IMPULSIVENESS SCALE; SUICIDE ATTEMPTS; MENTAL-HEALTH; FULL PTSD; VIOLENCE; IMPACT; ADOLESCENTS; PERSONALITY	Background: Epidemiological studies show that most of the adult population will be exposed to at least one potentially traumatic event in the course of his/her life; adolescence and early adulthood are the most vulnerable periods of life for exposure to traumatic experiences (70% of their deaths are due to external causes). Posttraumatic Stress Disorder is characterized by the development of dysfunctional symptoms that cause distress or social, academic, or occupational impairment, as result of exposure to a traumatic event. The aim of this multicentric study is to establish the proportion of college students, within seven institutions in Northeastern Brazil, who were exposed to traumatic experience and met PTSD criteria. Methods/Design: A one-phase census protocol of seven college institutions in three metropolitan regions in Northeastern Brazil was performed (April to July 2011). All students aged 18 years or older, matriculated and attending their first or final semester were eligible. The self-applied protocol consisted of a socio-demographic questionnaire and the following scales adjusted to Brazilian Portuguese standards Trauma History Questionnaire (THQ), PTSD Checklist-Civilian (PCL-C), Impulsivity Scale (BIS-11). Data were entered into SPSS 17.0. Results: 2213 (85.5%) students consented to participate, and completely filled in the protocols. Of these, 66.1% were woman, mean age 23.9 (SD 6.3), 82.7% were single, and 57.3% attended university outside their native cities. The total PTSD prevalence was 14%, and the median for frequency of trauma exposure was 5 events. Conclusion: A high frequency of exposure to violence, as well as a high rate of PTSD, suicide attempts, and high-risk sexual behavior was found in Brazilian college students. This highlights the importance of effective public health actions in relation to the prevention and treatment of PTSD and other dysfunctional behaviors resulting from traumatic exposure in young individuals, usually an at risk population for violence and traumatic situations.	[Netto, Liana R.; Cavalcanti-Ribeiro, Patricia; Pereira, Juliana L.; Nogueira, Jose F.; Santos, Lene L.; Lira, Sidnei B.; Guedes, Gisela M.; Quarantini, Lucas C.] Univ Fed Bahia, Fac Med Bahia, Programa Posgrad Med & Saude, Salvador, BA, Brazil; [Quarantini, Lucas C.] Univ Fed Bahia, Fac Med Bahia, Dept Neurociencias & Saude Mental, Salvador, BA, Brazil; [Pereira, Juliana L.; Teles, Carlos A.] Univ Estadual Feira de Santana, Feira De Santana, BA, Brazil; [Koenen, Karestan C.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	Universidade Federal da Bahia; Universidade Federal da Bahia; Universidade Estadual de Feira de Santana; Columbia University	Netto, LR (corresponding author), Univ Fed Bahia, Fac Med Bahia, Programa Posgrad Med & Saude, Salvador, BA, Brazil.	lianetto@uol.com.br	quarantini, l/K-8483-2014		Edital Universal Ministerio da Ciencia e Tecnologia/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [474869/2010-5]	Edital Universal Ministerio da Ciencia e Tecnologia/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	The funding for the study came partially from the Edital Universal Ministerio da Ciencia e Tecnologia/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico 14/2010, 474869/2010-5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Adkins JW, 2008, J ANXIETY DISORD, V22, P1393, DOI 10.1016/j.janxdis.2008.02.002; Andrade LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031879; [Anonymous], PTSD NCF US PTSD CHE; Association A.P., 2000, DIAGN STAT MAN MENT, VFourth; Banyard VL, 2006, J INTERPERS VIOLENCE, V21, P1314, DOI 10.1177/0886260506291657; Berger William, 2004, Rev. psiquiatr. Rio Gd. Sul, V26, P167, DOI 10.1590/S0101-81082004000200006; Berger W, 2007, J TRAUMA STRESS, V20, P637, DOI 10.1002/jts.20242; Breslau N, 1998, ARCH GEN PSYCHIAT, V55, P626, DOI 10.1001/archpsyc.55.7.626; Breslau N, 2004, PSYCHOL MED, V34, P1205, DOI 10.1017/S0033291704002594; Caribe AC, 2012, J NERV MENT DIS, V200, P863, DOI 10.1097/NMD.0b013e31826b6d05; Casey BJ, 2008, DEV REV, V28, P62, DOI [10.1016/j.dr.2007.08.003, 10.1196/annals.1440.010]; DATASUS, 2006, IND DAD BAS IDB 2006; de Jong JTVM, 2001, JAMA-J AM MED ASSOC, V286, P555, DOI 10.1001/jama.286.5.555; Dubow EF, 2012, J CLIN CHILD ADOLESC, V41, P402, DOI 10.1080/15374416.2012.684274; Educacao M.D., 2011, CENS ED SUP BRAS 201, P24; Fiszman Adriana, 2005, Rev. Bras. Psiquiatr., V27, P63, DOI 10.1590/S1516-44462005000100014; FONAPRACE, 2011, PERF SOC CULT EST GR; Forke CM, 2008, ARCH PEDIAT ADOL MED, V162, P634, DOI 10.1001/archpedi.162.7.634; Passos RBF, 2012, REV BRAS PSIQUIATR, V34, P155, DOI 10.1590/S1516-44462012000200007; Gawryszewski VP, 2007, SAO PAULO MED J, V125, P139, DOI 10.1590/S1516-31802007000300003; Gawryszewski Vilma Pinheiro, 2006, Sao Paulo Med. J., V124, P208, DOI 10.1590/S1516-31802006000400007; Green B.L., 1996, MEASUREMENT STRESS T, P366; IBGE ( Instituto Brasileiro de Geografia e Estatistica), 2011, SIN CENS DEM 2010; Kalichman Seth C, 2004, J Child Sex Abus, V13, P1, DOI 10.1300/J070v13n01_01; Kessler RC, 1999, ARCH GEN PSYCHIAT, V56, P617, DOI 10.1001/archpsyc.56.7.617; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Netto LR, 2010, PSYCHOL RES PROG, P79; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Ribeiro Wagner S., 2009, Rev. Bras. Psiquiatr., V31, pS49, DOI 10.1590/S1516-44462009000600003; Ribeiro WS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063545; RICH CL, 1986, ARCH GEN PSYCHIAT, V43, P577; Rosenberg SD, 2001, COMPR PSYCHIAT, V42, P263, DOI 10.1053/comp.2001.24576; Caiuby AVS, 2012, CAD SAUDE PUBLICA, V28, P597, DOI 10.1590/S0102-311X2012000300019; Bordin IAS, 2006, REV BRAS PSIQUIATR, V28, P290, DOI 10.1590/S1516-44462006000700008; Shin SH, 2012, ADDICT BEHAV, V37, P102, DOI 10.1016/j.addbeh.2011.09.006; Soares AMS, 2007, EPIDEMIOL SERV SAUDE, V16, P7; Swann AC, 2002, BIOL PSYCHIAT, V51, P988, DOI 10.1016/S0006-3223(01)01357-9; von Diemen L, 2007, REV BRAS PSIQUIATR, V29, P153, DOI 10.1590/S1516-44462006005000020; WAISELFISZ Julio Jacobo, 2012, MAPA VIOLENCIA 2012; Wilcox HC, 2009, ARCH GEN PSYCHIAT, V66, P305, DOI 10.1001/archgenpsychiatry.2008.557; Zhang Z, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029651, 10.1371/journal.pone.0046449, 10.1371/journal.pone.0030551]	41	12	12	6	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78677	10.1371/journal.pone.0078677	http://dx.doi.org/10.1371/journal.pone.0078677			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236033	gold, Green Published, Green Submitted			2022-12-27	WOS:000327254700030
J	McIlroy, SK; Lind, AJ; Allen-Diaz, BH; Roche, LM; Frost, WE; Grasso, RL; Tate, KW				McIlroy, Susan K.; Lind, Amy J.; Allen-Diaz, Barbara H.; Roche, Leslie M.; Frost, William E.; Grasso, Rob L.; Tate, Kenneth W.			Determining the Effects of Cattle Grazing Treatments on Yosemite Toads (Anaxyrus [=Bufo] canorus) in Montane Meadows	PLOS ONE			English	Article							AMPHIBIAN POPULATION DECLINES; COLUMBIA SPOTTED FROG; SIERRA-NEVADA; HABITAT; CALIFORNIA; EXTINCTIONS; COMMUNITIES; FLOODPLAIN; MECHANISMS; LIVESTOCK	Amphibians are experiencing a precipitous global decline, and population stability on public lands with multiple uses is a key concern for managers. In the Sierra Nevada Mountains (California, USA), managers have specifically identified livestock grazing as an activity that may negatively affect Yosemite toads due to the potential overlap of grazing with toad habitat. Grazing exclusion from Yosemite toad breeding and rearing areas and/or entire meadows have been proposed as possible management actions to alleviate the possible impact of cattle on this species. The primary objective of this study was to determine if different fencing treatments affect Yosemite toad populations. We specifically examined the effect of three fencing treatments on Yosemite toad breeding pool occupancy, tadpoles, and young of the year (YOY). Our hypothesis was that over the course of treatment implementation (2006 through 2010), Yosemite toad breeding pool occupancy and early life stage densities would increase within two fencing treatments relative to actively grazed meadows due to beneficial changes to habitat quality in the absence of grazing. Our results did not support our hypothesis, and showed no benefit to Yosemite toad presence or early life stages in fenced or partially fenced meadows compared to standard USDA Forest Service grazing levels. We found substantial Yosemite toad variation by both meadow and year. This variation was influenced by meadow wetness, with water table depth significant in both the tadpole and YOY models.	[McIlroy, Susan K.; Allen-Diaz, Barbara H.] Univ Calif Berkeley, Environm Sci Policy & Management Dept, Berkeley, CA 94720 USA; [Lind, Amy J.; Grasso, Rob L.] USDA Forest Serv, Pacific Southwest Res Stn, Davis, CA USA; [Roche, Leslie M.; Tate, Kenneth W.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Frost, William E.] Agr & Nat Resources Res & Extens Ctr, Davis, CA USA	University of California System; University of California Berkeley; United States Department of Agriculture (USDA); United States Forest Service; University of California System; University of California Davis	McIlroy, SK (corresponding author), USGS Forest & Rangeland Ecosyst Sci Ctr, Snake River Field Stn, Boise, ID 83706 USA.	smcilroy@usgs.gov		Roche, Leslie/0000-0003-2954-8056	USDA Forest Service, Pacific Southwest Region	USDA Forest Service, Pacific Southwest Region(United States Department of Agriculture (USDA)United States Forest Service)	This research was funded by USDA Forest Service, Pacific Southwest Region. Other than providing preliminary data, funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2009, J HERPETOL, V43, P132, DOI 10.1670/08-016R2.1; Bailey DW, 1996, J RANGE MANAGE, V49, P386, DOI 10.2307/4002919; Bull EL, 2000, J RANGE MANAGE, V53, P291, DOI 10.2307/4003434; Burton EC, 2009, J WILDLIFE MANAGE, V73, P269, DOI 10.2193/2007-562; California Department of Fish and Game, 2011, CAL NAT DAT SPEC AN; Chambers JC, 1999, J RANGE MANAGE, V52, P92, DOI 10.2307/4003497; Cushman SA, 2006, BIOL CONSERV, V128, P231, DOI 10.1016/j.biocon.2005.09.031; Daly C, 2002, CLIM RES, V22, P99, DOI 10.3354/cr022099; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; Derlet RW, 2012, J ENV PUBLIC HLTH, V2012; Drost CA, 1996, CONSERV BIOL, V10, P414, DOI 10.1046/j.1523-1739.1996.10020414.x; George M, 2007, RANGELAND MANAGEMENT, V8217, P20; Healey M, 1997, AUST J ECOL, V22, P270, DOI 10.1111/j.1442-9993.1997.tb00672.x; Houlahan JE, 2000, NATURE, V404, P752, DOI 10.1038/35008052; Interagency Technical Team, 1996, BLMRSST96004; Jansen A, 2003, BIOL CONSERV, V109, P207, DOI 10.1016/S0006-3207(02)00148-9; Jennings M. R., 1994, AMPHIBIAN REPTILE SP; Jennings Mark R., 1996, P921; Jofre MB, 1999, ENVIRON TOXICOL CHEM, V18, P1806, DOI 10.1002/etc.5620180829; KARLSTROM ERNEST L., 1962, UNIV CALIFORNIA PUBL ZOO1, V62, P1; Knapp RA, 2001, ECOL MONOGR, V71, P401, DOI 10.1890/0012-9615(2001)071[0401:RAROAL]2.0.CO;2; Liang C.T., 2010, THESIS U CALIFORNIA; Lind AJ, 2011, DETERMINING EFFECTS, V5, P25; McIlroy SK, 2012, WETL ECOL MANAG, V20, P287, DOI 10.1007/s11273-012-9253-7; Mcllroy S.K., 2011, RANGELAND ECOL MANAG, V64, P187, DOI [10.2111/REM-D-09-00130.1, DOI 10.2111/REM-D-09-00130.1]; Mcllroy SK, 2008, THESIS U CALIFORNIA; Morton ML, 2010, HERPETOL CONSERV BIO, V5, P388; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Roche LM, 2012, RANGELAND ECOL MANAG, V65, P56, DOI 10.2111/REM-D-11-00092.1; Sadinsky W, 2004, FINAL REPORT YOSEMIT; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID; Schmutzer AC, 2008, FRESHWATER BIOL, V53, P2613, DOI 10.1111/j.1365-2427.2008.02072.x; Semlitsch RD, 2009, BIOSCIENCE, V59, P853, DOI 10.1525/bio.2009.59.10.7; Sherman C.K., 1980, THESIS U MICHIGAN; SHERMAN CK, 1993, J HERPETOL, V27, P186, DOI 10.2307/1564935; SHERMAN CK, 1984, NAT HIST, V93, P72; Sparling DW, 2003, AMPHIBIAN DECLINE: AN INTEGRATED ANALYSIS OF MULTIPLE STRESSOR EFFECTS, P257; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; [USDA] US DEPARTMENT OF AGRICULTURE, 2001, SIERR NEV FOR PLAN A; USDI, 2002, FED REGISTER, V67, P75834; USDI, 2004, FED REGISTER, V69, P25876; Weixelman DA, 1996, R4ECOL9601; IUCN RED LIST THREAT	44	8	8	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79263	10.1371/journal.pone.0079263	http://dx.doi.org/10.1371/journal.pone.0079263			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223919	Green Published, Green Submitted, gold			2022-12-27	WOS:000326597400057
J	Stein, C; Makarewicz, O; Pfeifer, Y; Brandt, C; Ramos, JC; Klinger, M; Pletz, MW				Stein, Claudia; Makarewicz, Oliwia; Pfeifer, Yvonne; Brandt, Christian; Ramos, Joao Costa; Klinger, Mareike; Pletz, Mathias W.			Direct RNA-Based Detection and Differentiation of CTX-M-Type Extended-Spectrum beta-Lactamases (ESBL)	PLOS ONE			English	Article							KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; ANTIMICROBIAL THERAPY; INFECTIONS; IMPACT; ENTEROBACTERIACEAE; EMERGENCE; MORTALITY	The current global spread of multi-resistant Gram-negatives, particularly extended spectrum beta-lactamases expressing bacteria, increases the likelihood of inappropriate empiric treatment of critically ill patients with subsequently increased mortality. From a clinical perspective, fast detection of resistant pathogens would allow a pre-emptive correction of an initially inappropriate treatment. Here we present diagnostic amplification-sequencing approach as proof of principal based on the fast molecular detection and correct discrimination of CTX-M-beta-lactamases, the most frequent ESBL family. The workflow consists of the isolation of total mRNA and CTX-M-specific reverse transcription (RT), amplification and pyrosequencing. Due to the high variability of the CTX-M-beta-lactamasegenes, degenerated primers for RT, qRT as well as for pyrosequencing, were used and the suitability and discriminatory performance of two conserved positions within the CTX-M genes were analyzed, using one protocol for all isolates and positions, respectively. Using this approach, no information regarding the expected CTX-M variant is needed since all sequences are covered by these degenerated primers. The presented workflow can be conducted within eight hours and has the potential to be expanded to other beta-lactamase families.	[Stein, Claudia; Makarewicz, Oliwia; Brandt, Christian; Ramos, Joao Costa; Klinger, Mareike; Pletz, Mathias W.] Jena Univ Hosp, Ctr Infect Dis & Infect Control, Jena, Germany; [Makarewicz, Oliwia; Klinger, Mareike; Pletz, Mathias W.] Jena Univ Hosp, Ctr Sepsis Control & Care, Jena, Germany; [Pfeifer, Yvonne] Robert Koch Inst, Wernigerode, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Robert Koch Institute	Pletz, MW (corresponding author), Jena Univ Hosp, Ctr Infect Dis & Infect Control, Jena, Germany.	Mathias.pletz@med.uni-jena.de	Pletz, Mathias Wilhelm/H-9782-2019	Pletz, Mathias Wilhelm/0000-0001-8157-2753; Brandt, Christian/0000-0002-7199-3957	German Ministry of Education and Research (BMBF) [01KI1204, 01EO1002]	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The work was supported by a grant from the German Ministry of Education and Research (BMBF); grant numbers 01KI1204 and 01EO1002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Bloos F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046003; Bonnet R, 2003, J ANTIMICROB CHEMOTH, V52, P29, DOI 10.1093/jac/dkg256; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Canton R, 2006, CURR OPIN MICROBIOL, V9, P466, DOI 10.1016/j.mib.2006.08.011; Canton R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00110; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Chong Y, 2011, INFECT GENET EVOL, V11, P1499, DOI 10.1016/j.meegid.2011.06.001; CLSI, 2012, M100MS22 CLSI; Daikos GL, 2009, ANTIMICROB AGENTS CH, V53, P1868, DOI 10.1128/AAC.00782-08; Dalhoff K, 2012, Pneumologie, V66, P707, DOI 10.1055/s-0032-1325924; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Eller C, J ANTIMICROB CHEMOTH; European Study Group on Antibiotic Resistance, 1987, EUR J CLIN MICROBIOL, V6, P460, DOI [10.1007/BF02013111, DOI 10.1007/BF02013111]; Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x; Grobner S, 2009, J MED MICROBIOL, V58, P912, DOI 10.1099/jmm.0.005850-0; Hanson ND, 1999, CURR PHARM DESIGN, V5, P881; Hyle EP, 2005, ARCH INTERN MED, V165, P1375, DOI 10.1001/archinte.165.12.1375; Kumar A, 2009, CRIT CARE CLIN, V25, P733, DOI 10.1016/j.ccc.2009.08.004; Leclercq R, 2013, CLIN MICROBIOL INFEC, V19, P141, DOI 10.1111/j.1469-0691.2011.03703.x; Lu SY, 2010, APPL ENVIRON MICROB, V76, P5972, DOI 10.1128/AEM.00711-10; Ma JY, 2012, APPL ENVIRON MICROB, V78, P3668, DOI 10.1128/AEM.07507-11; Marra AR, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-24; Naas T, 2007, ANTIMICROB AGENTS CH, V51, P223, DOI 10.1128/AAC.00611-06; Novais A, 2008, ANTIMICROB AGENTS CH, V52, P2377, DOI 10.1128/AAC.01658-07; Novais A, 2006, ANTIMICROB AGENTS CH, V50, P2741, DOI 10.1128/AAC.00274-06; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Pfeifer Y, 2012, ANTIMICROB AGENTS CH, V56, P2125, DOI 10.1128/AAC.05315-11; Pfeifer Y, 2011, J ANTIMICROB CHEMOTH, V66, P1998, DOI 10.1093/jac/dkr256; Pfeifer Y, 2010, INT J MED MICROBIOL, V300, P371, DOI 10.1016/j.ijmm.2010.04.005; Pfeifer Y, 2009, EMERG INFECT DIS, V15, P1533, DOI 10.3201/eid1509.090567; Pletz MW, 2011, INTENS CARE MED, V37, P1069, DOI 10.1007/s00134-011-2245-x; Reinhart K, 2010, Ger Med Sci, V8, pDoc14, DOI 10.3205/000103; Ruppe E, 2009, EMERG INFECT DIS, V15, P741, DOI 10.3201/eid1505.071299; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Tumbarello M, 2006, ANTIMICROB AGENTS CH, V50, P498, DOI 10.1128/AAC.50.2.498-504.2006; Tumbarello M, 2007, ANTIMICROB AGENTS CH, V51, P1987, DOI 10.1128/AAC.01509-06; Tzouvelekis LS, 2000, INT J ANTIMICROB AG, V14, P137, DOI 10.1016/S0924-8579(99)00165-X	38	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80079	10.1371/journal.pone.0080079	http://dx.doi.org/10.1371/journal.pone.0080079			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224038	Green Published, gold, Green Submitted			2022-12-27	WOS:000326597400110
J	Vega, Y; Marques, I; Castro, S; Loureiro, J				Vega, Yesenia; Marques, Isabel; Castro, Silvia; Loureiro, Joao			Outcomes of Extensive Hybridization and Introgression in Epidendrum (Orchidaceae): Can We Rely on Species Boundaries?	PLOS ONE			English	Article							GENOME SIZE; REPRODUCTIVE ISOLATION; MOLECULAR EVOLUTION; FLOW-CYTOMETRY; HYBRIDS; POLLINATION; DIVERGENCE; PATTERNS; BARRIERS; PROGRAM	Hybridization has the potential to contribute to phenotypic and genetic variation and can be a major evolutionary mechanism. However, when hybridization is extensive it can also lead to the blurring of species boundaries and the emergence of cryptic species (i.e., two or more species not distinguishable morphologically). In this study, we address this hypothesis in Epidendrum, the largest Neotropical genus of orchids where hybridization is apparently so common that it may explain the high levels of morphological diversity found. Nonetheless, this hypothesis is mostly based on the intermediacy of morphological characters and intermediacy by itself is not a proof of hybridization. Therefore, in this study, we first assessed the existence of hybrids using cpDNA and AFLP data gathered from a large-scale sampling comprising 1038 plants of three species of Epidendrum (E. calanthum, E. cochlidium and E. schistochilum). Subsequently, a Bayesian assignment of individuals into different genetic classes (pure species, F1, F2 or backcross generations) revealed that hybrid genotypes were prevalent in all sympatric populations. In most cases, parental species were not assigned as pure individuals, rather consisting in backcrossed genotypes or F1 hybrids. We also found that reproductive barriers are apparently very weak in Epidendrum because the three species largely overlapped in their flowering periods and interspecific crosses always produced viable seeds. Further, hybridization contributed to enhance floral variability, genome size and reproductive success since we found that these traits were always higher in hybrid classes (F1, F2 and backcrosses) than in pure parental species, and offer an explanation for the blurring of species boundaries in this genus of orchids. We hypothesize that these natural hybrids possess an evolutionary advantage, which may explain the high rates of cryptic species observed in this genus.	[Vega, Yesenia; Marques, Isabel] Univ Tecn Particular Loja, Dept Ciencias Nat, Loja, Ecuador; [Marques, Isabel] Univ Zaragoza, High Polytech Sch Huesca, Dept Agr Bot, Huesca, Spain; [Castro, Silvia; Loureiro, Joao] Univ Coimbra, Dept Life Sci, CFE Ctr Funct Ecol, Coimbra, Portugal	Universidad Tecnica Particular de Loja; University of Zaragoza; Universidade de Coimbra	Marques, I (corresponding author), Univ British Columbia, UBC Bot Garden, Vancouver, BC V5Z 1M9, Canada.	isabel.ic@gmail.com	Loureiro, João/B-4830-2008; Castro, Sílvia/C-2469-2008; Marques, Isabel/G-6773-2015; loureiro, joão/GZL-6236-2022	Loureiro, João/0000-0002-9068-3954; Castro, Sílvia/0000-0002-7358-6685; Marques, Isabel/0000-0001-9788-4831; 	IM though a postdoctoral grant [PROY-CBCM-0021]; Portuguese Foundation for Science and Technology and European Social Funds [FCT/SFRH/BPD/41200/2007]	IM though a postdoctoral grant; Portuguese Foundation for Science and Technology and European Social Funds	UTPL financed the work of IM though a postdoctoral grant (PROY-CBCM-0021) and the Portuguese Foundation for Science and Technology and European Social Funds financed the work of SC (FCT/SFRH/BPD/41200/2007). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Anderson EC, 2002, GENETICS, V160, P1217; Arnold ML, 2012, HEREDITY, V108, P159, DOI 10.1038/hdy.2011.65; ARNOLD ML, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P115; Baack EJ, 2005, NEW PHYTOL, V167, P623, DOI 10.1111/j.1469-8137.2005.01433.x; Baack EJ, 2007, CURR OPIN GENET DEV, V17, P513, DOI 10.1016/j.gde.2007.09.001; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Bures P, 2004, ANN BOT-LONDON, V94, P353, DOI 10.1093/aob/mch151; Campbell DR, 2005, OECOLOGIA, V144, P214, DOI 10.1007/s00442-005-0064-x; Chung MY, 2005, MOL ECOL, V14, P4389, DOI 10.1111/j.1365-294X.2005.02738.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Dolezel J, 1998, ANN BOT-LONDON, V82, P17, DOI 10.1006/anbo.1998.0730; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Elmer KR, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-247; Feulner PGD, 2007, J EVOLUTION BIOL, V20, P403, DOI 10.1111/j.1420-9101.2006.01181.x; Gay L, 2007, MOL ECOL, V16, P3215, DOI 10.1111/j.1365-294X.2007.03363.x; Hagsater E., 2005, GENERA ORCHIDACEARUM, P236; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Jersakova J, 2006, BIOL REV, V81, P219, DOI 10.1017/S1464793105006986; Kelchner SA, 1997, MOL PHYLOGENET EVOL, V8, P385, DOI 10.1006/mpev.1997.0432; Kim SC, 1999, GENETICS, V153, P965; Loureiro J, 2007, ANN BOT-LONDON, V100, P875, DOI 10.1093/aob/mcm152; Lowry DB, 2008, PHILOS T R SOC B, V363, P3009, DOI 10.1098/rstb.2008.0064; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Mallet J, 1998, EVOLUTION, V52, P503, DOI 10.1111/j.1558-5646.1998.tb01649.x; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Mant J, 2005, MOL ECOL, V14, P3067, DOI 10.1111/j.1365-294X.2005.02659.x; Marques I, 2012, ANN BOT-LONDON, V109, P257, DOI 10.1093/aob/mcr282; Marques I, 2011, J ECOL, V99, P1508, DOI 10.1111/j.1365-2745.2011.01876.x; Martin NH, 2007, EVOLUTION, V61, P68, DOI 10.1111/j.1558-5646.2007.00006.x; Mayr E, 1942, SYSTEMATICS ORIGIN S; McMillan WO, 1999, EVOLUTION, V53, P247, DOI 10.1111/j.1558-5646.1999.tb05350.x; Muntzing A, 1932, HEREDITAS, V16, P105; O'Neill RJW, 1998, NATURE, V393, P68, DOI 10.1038/29985; Pansarin ER, 2008, FLORA, V203, P474, DOI 10.1016/j.flora.2007.07.004; Peakall R, 1997, AUST J BOT, V45, P839, DOI 10.1071/BT96081; Pinheiro F, 2010, MOL ECOL, V19, P3981, DOI 10.1111/j.1365-294X.2010.04780.x; Pinheiro F, 2009, PLANT SYST EVOL, V283, P165, DOI 10.1007/s00606-009-0224-2; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rayburn AL, 1993, CLASSICAL MOL CYTOGE, p[110, 95]; Rencher AC, 2002, METHODS MULTIVARIATE; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; RIESEBERG LH, 1993, CRIT REV PLANT SCI, V12, P213, DOI 10.1080/713608045; Ross CL, 2002, EVOLUTION, V56, P2296, DOI 10.1111/j.0014-3820.2002.tb00153.x; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Scopece G, 2008, AM NAT, V171, P315, DOI 10.1086/527501; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tiffin P, 2001, P ROY SOC B-BIOL SCI, V268, P861, DOI 10.1098/rspb.2000.1578; UNEP-WCMC, 2003, UNEP WCMC SPEC DAT C; Vega Y., 2011, EVOLUCION BARRERAS R; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wendt T, 2002, PLANT SYST EVOL, V232, P201, DOI 10.1007/s006060200043; Xu SQ, 2011, EVOLUTION, V65, P2606, DOI 10.1111/j.1558-5646.2011.01323.x	57	24	25	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80662	10.1371/journal.pone.0080662	http://dx.doi.org/10.1371/journal.pone.0080662			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224057	Green Submitted, Green Published, gold			2022-12-27	WOS:000326597400121
J	Zehendner, CM; Tsohataridis, S; Luhmann, HJ; Yang, JW				Zehendner, Christoph M.; Tsohataridis, Simeon; Luhmann, Heiko J.; Yang, Jenq-Wei			Developmental Switch in Neurovascular Coupling in the Immature Rodent Barrel Cortex	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; VIBRISSAL STIMULATION; NEURONAL-ACTIVITY; RESPONSES; CHILDREN; DENSITY; MICE	Neurovascular coupling (NVC) in the adult central nervous system (CNS) is a mechanism that provides regions of the brain with more oxygen and glucose upon increased levels of neural activation. Hemodynamic changes that go along with neural activation evoke a blood oxygen level-dependent (BOLD) signal in functional magnetic resonance imaging (fMRI) that can be used to study brain activity non-invasively. A correct correlation of the BOLD signal to neural activity is pivotal to understand this signal in neuronal development, health and disease. However, the function of NVC during development is largely unknown. The rodent whisker-to-barrel cortex is an experimentally well established model to study neurovascular interdependences. Using extracellular multi-electrode recordings and laser-Doppler-flowmetry (LDF) we show in the murine barrel cortex of postnatal day 7 (P7) and P30 mice in vivo that NVC undergoes a physiological shift during the first month of life. In the mature CNS it is well accepted that cortical sensory processing results in a rise in regional cerebral blood flow (rCBF). We show in P7 animals that rCBF decreases during prolonged multi-whisker stimulation and goes along with multi unit activity (MUA) fatigue. In contrast at P30, MUA remains stable during repetitive stimulation and is associated with an increase in rCBF. Further we characterize in both age groups the responses in NVC to single sensory stimuli. We suggest that the observed shift in NVC is an important process in cortical development that may be of high relevance for the correct interpretation of brain activity e.g. in fMRI studies of the immature central nervous system (CNS).	[Zehendner, Christoph M.; Tsohataridis, Simeon; Luhmann, Heiko J.; Yang, Jenq-Wei] Johannes Gutenberg Univ Mainz, Inst Physiol, Univ Med Ctr, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz	Zehendner, CM (corresponding author), Johannes Gutenberg Univ Mainz, Inst Physiol, Univ Med Ctr, D-55122 Mainz, Germany.	Zehendner@uni-mainz.de; YangJ@uni-mainz.de	Luhmann, Heiko J./N-8797-2019	Luhmann, Heiko J./0000-0002-7934-8661	University Medical Center of the Johannes Gutenberg-University Mainz; Deutsche Studienstiftung	University Medical Center of the Johannes Gutenberg-University Mainz; Deutsche Studienstiftung	HJL was supported by DFG grants, CMZ is supported by a Stufe 1 grant of the University Medical Center of the Johannes Gutenberg-University Mainz, ST is supported by the Deutsche Studienstiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SM, 2012, J NEUROSCI, V32, P9511, DOI 10.1523/JNEUROSCI.1212-12.2012; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Ayata C, 1996, J CEREBR BLOOD F MET, V16, P539, DOI 10.1097/00004647-199607000-00002; Barber PA, 2013, SENSORS-BASEL, V13, P6981, DOI 10.3390/s130606981; CHIRON C, 1992, J NUCL MED, V33, P696; Colonnese MT, 2008, NAT NEUROSCI, V11, P72, DOI 10.1038/nn2017; D'Agostino RB, 1990, EST DEPARTURES NORMA, V44, P316; Dangata YY, 1997, EUR J MORPHOL, V35, P3, DOI 10.1076/ejom.35.1.3.13057; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; Dorrn AL, 2010, NATURE, V465, P932, DOI 10.1038/nature09119; Enager P, 2009, J CEREBR BLOOD F MET, V29, P976, DOI 10.1038/jcbfm.2009.23; Favrais G, 2011, ANN NEUROL, V70, P550, DOI 10.1002/ana.22489; Feldmeyer D, 2013, PROG NEUROBIOL, V103, P3, DOI 10.1016/j.pneurobio.2012.11.002; FORAN DR, 1992, J NEUROSCI, V12, P4890; Harris JJ, 2012, NEURON, V75, P762, DOI 10.1016/j.neuron.2012.08.019; Harris JJ, 2011, DEV COGN NEUROS-NETH, V1, P199, DOI 10.1016/j.dcn.2011.04.001; Huth AG, 2012, NEURON, V76, P1210, DOI 10.1016/j.neuron.2012.10.014; Kocharyan A, 2008, J CEREBR BLOOD F MET, V28, P221, DOI 10.1038/sj.jcbfm.9600558; Kozberg MG, 2013, P NATL ACAD SCI USA, V110, P4380, DOI 10.1073/pnas.1212785110; Krupa DJ, 2001, J NEUROSCI METH, V104, P199, DOI 10.1016/S0165-0270(00)00345-9; Lecrux C, 2011, J NEUROSCI, V31, P9836, DOI 10.1523/JNEUROSCI.4943-10.2011; Li J, 2011, EUR J NEUROSCI, V34, P1983, DOI 10.1111/j.1460-9568.2011.07927.x; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Ma JY, 1996, AM J PHYSIOL-HEART C, V270, pH1085, DOI 10.1152/ajpheart.1996.270.3.H1085; Martin E, 1999, PEDIATR RES, V46, P135, DOI 10.1203/00006450-199908000-00001; Masamoto K, 2012, J CEREBR BLOOD F MET, V32, P1233, DOI 10.1038/jcbfm.2012.50; MITZDORF U, 1987, INT J NEUROSCI, V33, P33, DOI 10.3109/00207458708985928; Naselaris T, 2011, NEUROIMAGE, V56, P400, DOI 10.1016/j.neuroimage.2010.07.073; Nicolakakis N, 2011, J CEREBR BLOOD F MET, V31, P1354, DOI 10.1038/jcbfm.2011.43; Nielsen AN, 2001, J PHYSIOL-LONDON, V533, P773, DOI 10.1111/j.1469-7793.2001.00773.x; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Petersen CCH, 2013, NEURON, V78, P28, DOI 10.1016/j.neuron.2013.03.020; Roche-Labarbe N, 2013, NEUROIMAGE, DOI [10.1016/j.neuroimage.2013.01.035, DOI 10.1016/J.NEUR0IMAGE.2013.01.035.PUBMED:23370052]; Seidl AH, 2013, NEUROSCIENCE; Sengupta B, 2013, J CEREBR BLOOD F MET, V33, P1465, DOI 10.1038/jcbfm.2013.103; Takuwa H, 2013, J CEREBR BLOOD F MET, V33, P774, DOI 10.1038/jcbfm.2013.16; Tsuji M, 2000, PEDIATRICS, V106, P625, DOI 10.1542/peds.106.4.625; Wojtkiewicz S, 2009, PHYS MED BIOL, V54, P679, DOI 10.1088/0031-9155/54/3/014; Wolfe J, 2011, BEHAV NEUROSCI, V125, P900, DOI 10.1037/a0026165; Yang JW, 2013, CEREB CORTEX, V23, P1299, DOI 10.1093/cercor/bhs103; Zehendner CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062628	42	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80749	10.1371/journal.pone.0080749	http://dx.doi.org/10.1371/journal.pone.0080749			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224059	Green Published, gold, Green Submitted			2022-12-27	WOS:000326597400122
J	Zhu, YN; Shi, DQ; Ruan, MB; Zhang, LL; Meng, ZH; Liu, J; Yang, WC				Zhu, Ya-Na; Shi, Dong-Qiao; Ruan, Meng-Bin; Zhang, Li-Li; Meng, Zhao-Hong; Liu, Jie; Yang, Wei-Cai			Transcriptome Analysis Reveals Crosstalk of Responsive Genes to Multiple Abiotic Stresses in Cotton (Gossypium hirsutum L.)	PLOS ONE			English	Article							DIFFERENTIALLY EXPRESSED GENES; CONFERS ENHANCED TOLERANCE; DEPENDENT PROTEIN-KINASE; HIGH-SALINITY STRESSES; ABSCISIC-ACID; OXIDATIVE STRESS; ARABIDOPSIS-THALIANA; SIGNAL-TRANSDUCTION; STARCH DEGRADATION; FREEZING TOLERANCE	Abiotic stress is a major environmental factor that limits cotton growth and yield, moreover, this problem has become more and more serious recently, as multiple stresses often occur simultaneously due to the global climate change and environmental pollution. In this study, we sought to identify genes involved in diverse stresses including abscisic acid (ABA), cold, drought, salinity and alkalinity by comparative microarray analysis. Our result showed that 5790, 3067, 5608, 778 and 6148 transcripts, were differentially expressed in cotton seedlings under treatment of ABA (1 mu M ABA), cold (4 degrees C), drought (200mM mannitol), salinity (200mM NaCl) and alkalinity (pH= 11) respectively. Among the induced or suppressed genes, 126 transcripts were shared by all of the five kinds of abiotic stresses, with 64 up-regulated and 62 down-regulated. These common members are grouped as stress signal transduction, transcription factors (TFs), stress response/defense proteins, metabolism, transport facilitation, as well as cell wall/structure, according to the function annotation. We also noticed that large proportion of significant differentially expressed genes specifically regulated in response to different stress. Nine of the common transcripts of multiple stresses were selected for further validation with quantitative real time RT-PCR (qRT-PCR). Furthermore, several well characterized TF families, for example, WRKY, MYB, NAC, AP2/ERF and zinc finger were shown to be involved in different stresses. As an original report using comparative microarray to analyze transcriptome of cotton under five abiotic stresses, valuable information about functional genes and related pathways of anti-stress, and/or stress tolerance in cotton seedlings was unveiled in our result. Besides this, some important common factors were focused for detailed identification and characterization. According to our analysis, it suggested that there was crosstalk of responsive genes or pathways to multiple abiotic or even biotic stresses, in cotton. These candidate genes will be worthy of functional study under diverse stresses.	[Zhu, Ya-Na; Shi, Dong-Qiao; Ruan, Meng-Bin; Zhang, Li-Li; Meng, Zhao-Hong; Liu, Jie; Yang, Wei-Cai] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Shi, DQ (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing, Peoples R China.	dqshi@genetics.ac.cn; wcyang@genetics.ac.cn	Yang, Wei-Cai/AAX-7879-2021	Yang, Wei-Cai/0000-0003-0252-7079	Chinese National Major Program on Transgenic Organisms, Ministry of Agriculture of China [2013ZX08009-003]; DQS [2013ZX08009-004]	Chinese National Major Program on Transgenic Organisms, Ministry of Agriculture of China; DQS	This work was supported by Chinese National Major Program on Transgenic Organisms from Ministry of Agriculture of China to WCY (2013ZX08009-003) and DQS (2013ZX08009-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja I, 2010, TRENDS PLANT SCI, V15, P664, DOI 10.1016/j.tplants.2010.08.002; Antolin-Llovera M, 2011, PLANT SIGNAL BEHAV, V6, P1127, DOI 10.4161/psb.6.8.16363; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Chaudhary B, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-378; Cheng H, 2013, MOL BIOL REP, V40, P707, DOI 10.1007/s11033-012-2111-0; Chinnusamy V, 2004, J EXP BOT, V55, P225, DOI 10.1093/jxb/erh005; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; Christianson JA, 2010, PLANT CELL PHYSIOL, V51, P21, DOI 10.1093/pcp/pcp163; Christmann A, 2006, PLANT BIOLOGY, V8, P314, DOI 10.1055/s-2006-924120; Costaglioli P, 2005, BBA-MOL CELL BIOL L, V1734, P247, DOI 10.1016/j.bbalip.2005.04.002; Curtiss J, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-49; Dieterle M, 2001, GENE DEV, V15, P939, DOI 10.1101/gad.197201; Dill A, 2001, P NATL ACAD SCI USA, V98, P14162, DOI 10.1073/pnas.251534098; Franz S, 2011, MOL PLANT, V4, P83, DOI 10.1093/mp/ssq064; Gagne JM, 2004, P NATL ACAD SCI USA, V101, P6803, DOI 10.1073/pnas.0401698101; Gao SQ, 2009, PLANT CELL REP, V28, P301, DOI 10.1007/s00299-008-0623-9; Goujon T, 2003, PLANT J, V33, P677, DOI 10.1046/j.1365-313X.2003.01654.x; Guo HW, 2003, CELL, V115, P667, DOI 10.1016/S0092-8674(03)00969-3; Guo Y, 2002, DEV CELL, V3, P233, DOI 10.1016/S1534-5807(02)00229-0; Harish SR, 2011, ENVIRON RES, V111, P1070, DOI 10.1016/j.envres.2011.07.002; Huang GT, 2012, MOL BIOL REP, V39, P969, DOI 10.1007/s11033-011-0823-1; Jensen MK, 2010, BIOCHEM J, V426, P183, DOI 10.1042/BJ20091234; Ji HT, 2013, MOL PLANT, V6, P275, DOI 10.1093/mp/sst017; Jia JP, 2006, PLANT J, V48, P710, DOI 10.1111/j.1365-313X.2006.02905.x; Jin LG, 2010, J INTEGR PLANT BIOL, V52, P485, DOI 10.1111/j.1744-7909.2010.00914.x; Kanneganti V, 2008, PLANT MOL BIOL, V66, P445, DOI 10.1007/s11103-007-9284-2; Kawasaki T, 2006, P NATL ACAD SCI USA, V103, P230, DOI 10.1073/pnas.0509875103; Kode A, 2004, FUND CLIN PHARMACOL, V18, P565, DOI 10.1111/j.1472-8206.2004.00274.x; Kotting O, 2009, PLANT CELL, V21, P334, DOI 10.1105/tpc.108.064360; Kotaka A, 2008, J BIOSCI BIOENG, V105, P622, DOI 10.1263/jbb.105.622; Lakhssassi N, 2012, PLANT PHYSIOL, V158, P1252, DOI 10.1104/pp.111.188920; Lemaire K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018517; Leung J, 1997, PLANT CELL, V9, P759, DOI 10.1105/tpc.9.5.759; Li DD, 2013, NEW PHYTOL, V199, P695, DOI 10.1111/nph.12309; Liu HZ, 2008, GENE, V420, P57, DOI 10.1016/j.gene.2008.05.006; Liu JZ, 2013, PLANT J, V74, P110, DOI 10.1111/tpj.12108; Pais SM, 2009, PLANT SIGNAL BEHAV, V4, P1013, DOI 10.4161/psb.4.11.9783; Marrocco K, 2006, PLANT J, V45, P423, DOI 10.1111/j.1365-313X.2005.02635.x; Mathioudakis MM, 2012, VIRUS RES, V163, P28, DOI 10.1016/j.virusres.2011.08.007; Medina-Silva R, 2006, RES MICROBIOL, V157, P275, DOI 10.1016/j.resmic.2005.07.004; Meng XP, 2010, PLANT MOL BIOL REP, V28, P176, DOI 10.1007/s11105-009-0136-x; Mitchell C, 2010, TOXICOL LETT, V195, P23, DOI 10.1016/j.toxlet.2010.02.020; Miura K, 2013, INT J MOL SCI, V14, P5312, DOI 10.3390/ijms14035312; Munnik T, 2001, FEBS LETT, V498, P172, DOI 10.1016/S0014-5793(01)02492-9; Munshi MK, 2006, PLANT PHYSIOL, V141, P737, DOI 10.1104/pp.106.080267; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakagami H, 2005, TRENDS PLANT SCI, V10, P339, DOI 10.1016/j.tplants.2005.05.009; Ozler A, 2008, PREP BIOCHEM BIOTECH, V38, P358, DOI 10.1080/10826060802325469; Padmalatha KV, 2012, PLANT MOL BIOL, V78, P223, DOI 10.1007/s11103-011-9857-y; Pang Y, 2010, PLANT BIOLOGY, V12, P903, DOI 10.1111/j.1438-8677.2009.00313.x; Park W, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-90; Patharkar OR, 2000, PLANT J, V24, P679, DOI 10.1046/j.1365-313x.2000.00912.x; Rabbani MA, 2003, PLANT PHYSIOL, V133, P1755, DOI 10.1104/pp.103.025742; Rapala-Kozik M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-2; Rodriguez-Uribe L, 2011, PLANT SCI, V180, P461, DOI 10.1016/j.plantsci.2010.10.009; Romieu I, 2008, EUR RESPIR J, V31, P179, DOI 10.1183/09031936.00128106; Rosado A, 2006, PLANT PHYSIOL, V142, P1113, DOI 10.1104/pp.106.085191; Rosado A, 2010, PLANT SIGNAL BEHAV, V5, P450, DOI 10.4161/psb.5.4.11341; Rosado A, 2010, PLANT CELL, V22, P143, DOI 10.1105/tpc.109.068320; Ruan YL, 2013, J INTEGR PLANT BIOL, V55, P572, DOI 10.1111/jipb.12074; Sabatini S, 2003, GENE DEV, V17, P354, DOI 10.1101/gad.252503; Samajova O, 2013, BIOTECHNOL ADV, V31, P118, DOI 10.1016/j.biotechadv.2011.12.002; Samaniego R, 2006, PLANTA, V223, P1201, DOI 10.1007/s00425-005-0168-x; Sancenon V, 2003, PLANT MOL BIOL, V51, P577, DOI 10.1023/A:1022345507112; Schneider K, 2005, J BIOL CHEM, V280, P13962, DOI 10.1074/jbc.M413578200; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Seki M, 2003, CURR OPIN BIOTECH, V14, P194, DOI 10.1016/S0958-1669(03)00030-2; Seto Y, 2011, BIOSCI BIOTECH BIOCH, V75, P2316, DOI 10.1271/bbb.110454; Shi HT, 2013, PLANT PHYSIOL BIOCH, V67, P209, DOI 10.1016/j.plaphy.2013.03.016; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; Shi YT, 2013, NEW PHYTOL, V199, P135, DOI 10.1111/nph.12275; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Sondheimer N, 2010, BIOCHEMISTRY-US, V49, P7467, DOI 10.1021/bi1008479; Sreenivasulu N, 2007, GENE, V388, P1, DOI 10.1016/j.gene.2006.10.009; Sun HL, 2011, J EXP BOT, V62, P5713, DOI 10.1093/jxb/err274; Suzuki K, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-38; Tan JF, 2013, PLANT PHYSIOL, V162, P86, DOI 10.1104/pp.112.212142; Tani T, 2008, PLANTA, V227, P517, DOI 10.1007/s00425-007-0635-7; Tonelli F, 2013, BRIT J PHARMACOL, V168, P1497, DOI 10.1111/bph.12035; Tunc-Ozdemir M, 2009, PLANT PHYSIOL, V151, P421, DOI 10.1104/pp.109.140046; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valliyodan B, 2006, CURR OPIN PLANT BIOL, V9, P189, DOI 10.1016/j.pbi.2006.01.019; van Ooijen G, 2010, PLANT J, V63, P563, DOI 10.1111/j.1365-313X.2010.04260.x; WAN CY, 1994, ANAL BIOCHEM, V223, P7, DOI 10.1006/abio.1994.1538; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang YY, 2012, TRENDS PLANT SCI, V17, P458, DOI 10.1016/j.tplants.2012.04.006; Xin MM, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-61; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Yano R, 2005, PLANT PHYSIOL, V138, P837, DOI 10.1104/pp.104.056374; Yao DX, 2011, GENOMICS, V98, P47, DOI 10.1016/j.ygeno.2011.04.007; You MK, 2010, PLANT PHYSIOL, V152, P1015, DOI 10.1104/pp.109.147645; Zeeman SC, 2004, PLANT PHYSIOL, V135, P849, DOI 10.1104/pp.103.032631; Zhang YY, 2007, PLANT CELL, V19, P1912, DOI 10.1105/tpc.106.048488; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	95	77	87	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80218	10.1371/journal.pone.0080218	http://dx.doi.org/10.1371/journal.pone.0080218			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224045	Green Published, Green Submitted, gold			2022-12-27	WOS:000326597400115
J	Lavallee, LT; Fergusson, D; Mallick, R; Grenon, R; Morgan, SC; Momoli, F; Witiuk, K; Morash, C; Cagiannos, I; Breau, RH				Lavallee, Luke T.; Fergusson, Dean; Mallick, Ranjeeta; Grenon, Renee; Morgan, Scott C.; Momoli, Franco; Witiuk, Kelsey; Morash, Chris; Cagiannos, Ilias; Breau, Rodney H.			Radiotherapy after Radical Prostatectomy: Treatment Recommendations Differ between Urologists and Radiation Oncologists	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIAL; ADJUVANT RADIOTHERAPY; BIOCHEMICAL RECURRENCE; SALVAGE RADIOTHERAPY; POSTOPERATIVE RADIOTHERAPY; SURGICAL MARGINS; FOLLOW-UP; CANCER; PROGRESSION; THERAPY	Purpose: There is no consensus on optimal use of radiotherapy following radical prostatectomy. The purpose of this study was to describe opinions of urologists and radiation oncologists regarding adjuvant and salvage radiotherapy following radical prostatectomy. Methods: Urologists and genitourinary radiation oncologists were solicited to participate in an online survey. Respondent characteristics included demographics, training, practice setting, patient volume/experience, and access to radiotherapy. Participant practice patterns and attitudes towards use of adjuvant and salvage radiotherapy in standardized clinical scenarios were assessed. Results: One hundred and forty-six staff physicians participated in the survey (104 urologists and 42 genitourinary radiation oncologists). Overall, high Gleason score (Gleason 7 vs. 6, RR 1.37 95% CI 1.19-1.56, p<0.0001 and Gleason 8-10 vs. 6, RR 1.56 95% CI 1.37-1.78, p<0.0001), positive surgical margin (RR 1.43 95% CI 1.26-1.62, p<0.0001), and extraprostatic tumour extension (RR 1.16 95% CI 1.05-1.28, p<0.002) conferred an increased probability of recommending adjuvant radiotherapy. Radiation oncologists were more likely to recommend adjuvant radiotherapy across all clinical scenarios (RR 1.48, 95% CI 1.39, 1.60, p<0.001). Major differences were found for patients with Gleason 6 and isolated positive surgical margin (radiotherapy selected by 21% of urologists vs. 70% of radiation oncologists), and patients with extraprostatic extension and negative surgical margins (radiotherapy selected by 18% of urologist vs. 57% of radiation oncologists). Conclusions: Urologists and radiation oncologists frequently disagree about recommendation for post-prostatectomy adjuvant radiotherapy. Since clinical equipoise exists between adjuvant versus early salvage postoperative radiotherapy, support of clinical trials comparing these approaches is strongly encouraged.	[Lavallee, Luke T.; Morash, Chris; Cagiannos, Ilias; Breau, Rodney H.] Univ Ottawa, Ottawa Hosp, Dept Surg, Div Urol, Ottawa, ON, Canada; [Fergusson, Dean; Mallick, Ranjeeta; Momoli, Franco; Witiuk, Kelsey; Breau, Rodney H.] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Grenon, Renee; Momoli, Franco] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada; [Morgan, Scott C.] Univ Ottawa, Ottawa Hosp, Div Radiat Oncol, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Ottawa Hospital Research Institute	Breau, RH (corresponding author), Univ Ottawa, Ottawa Hosp, Dept Surg, Div Urol, Ottawa, ON, Canada.	rbreau@toh.on.ca		Fergusson, Dean/0000-0002-3389-2485; Morgan, Scott/0000-0002-6568-3346; Breau, Rodney/0000-0003-2344-9022				Amling CL, 2000, J UROLOGY, V164, P101, DOI 10.1016/S0022-5347(05)67457-5; Anscher MS, 2001, INT J CANCER, V96, P91, DOI 10.1002/ijc.1011; Bolla M, 2005, LANCET, V366, P572, DOI 10.1016/S0140-6736(05)67101-2; Cooperberg MR, 2004, J UROLOGY, V171, P1393, DOI 10.1097/01.ju.0000107247.81471.06; Fowler FJ, 2000, JAMA-J AM MED ASSOC, V283, P3217, DOI 10.1001/jama.283.24.3217; Han M, 2001, UROL CLIN N AM, V28, P555, DOI 10.1016/S0094-0143(05)70163-4; Hull GW, 2002, J UROLOGY, V167, P528, DOI 10.1016/S0022-5347(01)69079-7; Klein EA, 2008, J UROLOGY, V179, P2212, DOI 10.1016/j.juro.2008.01.107; Moinpour CM, 2008, J CLIN ONCOL, V26, P112, DOI 10.1200/JCO.2006.10.4505; Moul JW, 2000, J UROLOGY, V163, P1632, DOI 10.1016/S0022-5347(05)67511-8; Parker C, 2007, CLIN ONCOL-UK, V19, P167, DOI 10.1016/j.clon.2007.01.001; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; Savdie R, 2012, BJU INT, V109, P1794, DOI 10.1111/j.1464-410X.2011.10572.x; Stephenson AJ, 2004, JAMA-J AM MED ASSOC, V291, P1325, DOI 10.1001/jama.291.11.1325; Stephenson AJ, 2007, J CLIN ONCOL, V25, P2035, DOI 10.1200/JCO.2006.08.9607; Stephenson AJ, 2006, JNCI-J NATL CANCER I, V98, P715, DOI 10.1093/jnci/djj190; Stephenson AJ, 2012, EUR UROL, V61, P443, DOI 10.1016/j.eururo.2011.10.010; Swanson GP, 2007, J CLIN ONCOL, V25, P2225, DOI 10.1200/JCO.2006.09.6495; Swindle P, 2008, J UROLOGY, V179, pS47, DOI 10.1016/j.juro.2008.03.137; Thompson IM, 2009, J UROLOGY, V181, P956, DOI 10.1016/j.juro.2008.11.032; Thompson IM, 2006, JAMA-J AM MED ASSOC, V296, P2329, DOI 10.1001/jama.296.19.2329; Trock BJ, 2008, JAMA-J AM MED ASSOC, V299, P2760, DOI 10.1001/jama.299.23.2760; Underwood W, 2005, CANCER-AM CANCER SOC, V103, P538, DOI 10.1002/cncr.20796; Van der Kwast TH, 2007, J CLIN ONCOL, V25, P4178, DOI 10.1200/JCO.2006.10.4067; Van Poppel H, 2011, EUR UROL SUPPL, V10, P93, DOI 10.1016/S1569-9056(11)60227-3; Ward JF, 2004, J UROLOGY, V172, P1328, DOI 10.1097/01.ju.0000138681.64035.dc; Wein AJ, 2007, CAMPBELL WALSH UROLO; Wiegel T, 2009, J CLIN ONCOL, V27, P2924, DOI 10.1200/JCO.2008.18.9563; Yossepowitch O, 2013, EUR UROL	29	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79773	10.1371/journal.pone.0079773	http://dx.doi.org/10.1371/journal.pone.0079773			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24224003	Green Published, gold			2022-12-27	WOS:000326503400142
J	Su, J; Lu, DB; Zhou, X; Wang, SR; Zhuge, HX				Su, Jing; Lu, Da-Bing; Zhou, Xia; Wang, Su-Rong; Zhuge, Hong-Xiang			Control Efficacy of Annual Community-Wide Treatment against Schistosoma japonicum in China: A Meta-Analysis	PLOS ONE			English	Article							NEGLECTED TROPICAL DISEASES; SOIL-TRANSMITTED HELMINTHS; POYANG LAKE; BASE-LINE; PRAZIQUANTEL; CHEMOTHERAPY; TRANSMISSION; INFECTIONS; DYNAMICS; LESSONS	Backgrounds: Human schistosomiasis is caused by schistosome, with annual loss of over 70 million disability adjusted life years in the world. China is endemic with Schistosoma japonicum and large-scale chemotherapy with praziquantel has become the mainstay of control in China since 1990s. However, the control effects of mass treatment in the field have been uneven. Moreover, mass treatment has come into a wide use in other countries with limited health resources. Therefore, a better understanding of the control effect of mass treatment is in an urgent need. Methods: We performed a systematic search of the literature to investigate the control efficiency of annual community-wide treatment (ACWT, treatment to an entire community without any preliminary screening) with a single dose of PZQ (40 mg kg(-1) bodyweight) against schistosome in humans in China. Three Chinese literature databases, including China National Knowledge Infrastructure, WanFang and Chinese Scientific Journal Databases, and the PubMed were searched. Pooled prevalence ratios (prevalence after to before treatment) were used to assess effect. Our protocol is available on PROSPERO (No. CRD42013003628). Results: 22 articles were included. Meta-analyses on data from 18 studies on one round of ACWT, 17 studies on two consecutive rounds and 6 studies on three consecutive rounds were performed. The results showed control effects of ACWT plus other measures were statistically significant, with prevalence ratios being 0.38 (0.31, 0.46) for one round, 0.28 (0.22, 0.35) for two rounds and 0.22 (0.10, 0.46) for three rounds. When ACWT was performed alone or with health education only, the values for one and two rounds were 0.389 (0.307, 0.492) and 0.348 (0.300, 0.403), respectively. Conclusions: The control effect of ACWT alone or with other measures is significant and increases with the number of rounds. Such program is recommended in high endemic areas and the criteria yet merit further assessment.	[Su, Jing; Lu, Da-Bing] Soochow Univ, Sch Publ Hlth, Dept Epidemiol & Stat, Suzhou, Peoples R China; [Zhou, Xia; Wang, Su-Rong; Zhuge, Hong-Xiang] Soochow Univ, Sch Biol & Basic Med Sci, Dept Parasitol, Suzhou, Peoples R China	Soochow University - China; Soochow University - China	Lu, DB (corresponding author), Soochow Univ, Sch Publ Hlth, Dept Epidemiol & Stat, Suzhou, Peoples R China.	ludabing@suda.edu.cn			National Sciences Foundation of China [81273141]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was funded by the National Sciences Foundation of China (No. 81273141) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade ZA, 1998, MEM I OSWALDO CRUZ, V93, P313, DOI 10.1590/S0074-02761998000700062; [Anonymous], 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001009; Borges DS, 2013, PARASITOL I IN PRESS; Cai ZongDa, 2003, Chinese Journal of Schistosomiasis Control, V15, P38; Cai ZongDa, 2005, Chinese Journal of Schistosomiasis Control, V17, P138; Chen DJ, 1992, CHIN J SCHISTO CONT, V4, P88; Chen MG, 2005, ACTA TROP, V96, P168, DOI 10.1016/j.actatropica.2005.07.011; Chitsulo L, 2000, ACTA TROP, V77, P41, DOI 10.1016/S0001-706X(00)00122-4; Danso-Appiah A, 2002, TRENDS PARASITOL, V18, P125, DOI 10.1016/S1471-4922(01)02209-7; Davis GM, 2002, AM J TROP MED HYG, V66, P359, DOI 10.4269/ajtmh.2002.66.359; Engels D, 2005, ACTA TROP, V96, P67, DOI 10.1016/j.actatropica.2005.07.004; Fenwick A, 2009, PARASITOLOGY, V136, P1719, DOI 10.1017/S0031182009990400; Fenwick A, 2011, LANCET INFECT DIS, V11, P346, DOI 10.1016/S1473-3099(11)70110-4; Gan HJ, 2000, PRACTICAL PREVENTIVE, V8, P188; Gong ZhenBiao, 2002, Chinese Journal of Schistosomiasis Control, V14, P371; Gray DJ, 2010, LANCET INFECT DIS, V10, P733, DOI 10.1016/S1473-3099(10)70099-2; Gray DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005900; Guo JG, 2005, ACTA TROP, V96, P177, DOI 10.1016/j.actatropica.2005.07.012; Guo JG, 2001, AM J TROP MED HYG, V65, P272, DOI 10.4269/ajtmh.2001.65.272; Guo JianDuo, 2002, Chinese Journal of Parasitic Disease Control, V15, P234; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000485; Huang XB, 1995, HUBEI PREVENTIVE MED, V6, p[23, 16]; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Ioannidis JPA, 2007, CAN MED ASSOC J, V176, P1091, DOI 10.1503/cmaj.060410; Jia TW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001621; Jiang Q, 1996, Southeast Asian J Trop Med Public Health, V27, P535; Jiang ShunDe, 1999, Chinese Journal of Schistosomiasis Control, V11, P85; Jin JM, 1990, CHIN J SCHISTO CONTR, V2, P67; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; KUMAR V, 1994, INT J ANTIMICROB AG, V4, P313, DOI 10.1016/0924-8579(94)90032-9; Lau J, 2006, BMJ-BRIT MED J, V333, P597, DOI 10.1136/bmj.333.7568.597; Lin DanDan, 1998, Chinese Journal of Parasitic Disease Control, V11, P43; Lin Dandnan, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P274; Lin DD, 2005, ACTA TROP, V96, P242, DOI 10.1016/j.actatropica.2005.07.018; Lin DD, 2001, CHIN J SCHISTO CONTR, V13, P112; Lu DB, 1998, CHIN J SCHISTO CONTR, V10, P95; Luo YJ, 1991, CHINESE J PARASITOLO, V9, P154; McManus DP, 2012, EXPERT REV ANTI-INFE, V10, P1233, DOI [10.1586/ERI.12.121, 10.1586/eri.12.121]; Minggang Chen, 1999, Parasitology International, V48, P11, DOI 10.1016/S1383-5769(99)00004-5; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Molyneux DH, 2005, PLOS MED, V2, P1064, DOI 10.1371/journal.pmed.0020336; Morris K, 2010, LANCET INFECT DIS, V10, P821, DOI 10.1016/S1473-3099(10)70267-X; Parker M, 2008, J BIOSOC SCI, V40, P161, DOI 10.1017/S0021932007002301; Parker M, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-3; Patsopoulos NA, 2009, INT J EPIDEMIOL, V38, P1740, DOI 10.1093/ije/dyn235; Pu CH, 1997, J TROPICAL DIS PARAS, V26, P5; Qiu Lishu, 1994, Chinese Journal of Parasitology & Parasitic Diseases, V12, P221; Seto EYW, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001372; Seto EYW, 2011, AM J TROP MED HYG, V85, P74, DOI 10.4269/ajtmh.2011.10-0542; Shao BY, 1996, ANHUI J PREVENTIVE M, V2, P11; Sorensen E, 1999, INT J PARASITOL, V29, P1907, DOI 10.1016/S0020-7519(99)00159-9; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Tan DL, 2001, PRACTICAL PREVENTIVE, V8, P165; Wang LD, 2009, NEW ENGL J MED, V360, P121, DOI 10.1056/NEJMoa0800135; Wang ShangWei (et al), 2000, Chinese Journal of Zoonoses, V16, P95; WHO, 1985, WHO TECH REP SER, V728, P1; WHO, 1993, WHO TECH REP SER, V830; WHO, 2006, COORD US ANTH DRUGS; Woolhouse MEJ, 1998, PARASITOLOGY, V117, P475, DOI 10.1017/S003118209800331X; Yi ZH, 1993, CHIN J SCHISTO CONTR, V6, P57; Yu DB, 2001, T ROY SOC TROP MED H, V95, P537, DOI 10.1016/S0035-9203(01)90032-X; Yu Dongbao, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P441; Yu SS, 2002, PARASITOSES INFECT D, V10, P16; Zhang GH WT, 1998, CHINESE PRIMARY HLTH, P46; Zhang Li-Juan, 2012, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V24, P627; Zhang W, 2003, ACTA TROP, V85, P303, DOI 10.1016/S0001-706X(02)00263-2; Zhang Y, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-27; Zheng J., 1996, Chinese Journal of Schistosomiasis Control, V8, P65; Zhou Xiao-nong, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P555; Zhou XN, 2010, ADV PARASIT, V72, P145, DOI 10.1016/S0065-308X(10)72006-6; Zhou XN, 2005, ACTA TROP, V96, P255, DOI 10.1016/j.actatropica.2005.07.026; Zhou XN, 2005, ACTA TROP, V96, P97, DOI 10.1016/j.actatropica.2005.07.005	72	3	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78509	10.1371/journal.pone.0078509	http://dx.doi.org/10.1371/journal.pone.0078509			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223819	Green Submitted, gold, Green Published			2022-12-27	WOS:000326503400071
J	Wang, QS; Mohamed, AAM; Takeda, M				Wang, Qiushi; Mohamed, Ahmed A. M.; Takeda, Makio			Serotonin Receptor B May Lock the Gate of PTTH Release/Synthesis in the Chinese Silk Moth, Antheraea pernyi; A Diapause Initiation/Maintenance Mechanism?	PLOS ONE			English	Article							PROTHORACICOTROPIC HORMONE PTTH; CEPHALIC NERVOUS-SYSTEM; CORPUS ALLATUM COMPLEX; BOMBYX-MORI; MANDUCA-SEXTA; INSECT PHOTOPERIODISM; ECLOSION HORMONE; PUPAL DIAPAUSE; BRAIN; DROSOPHILA	The release of prothoracicotropic hormone, PTTH, or its blockade is the major endocrine switch regulating the developmental channel either to metamorphosis or to pupal diapause in the Chinese silk moth, Antheraea pernyi. We have cloned cDNAs encoding two types of serotonin receptors (5HTR(A and B)). 5HTR(A-), and 5HTR(B)-like immunohistochemical reactivities (-ir) were colocalized with PTTH-ir in two pairs of neurosecretory cells at the dorsolateral region of the protocerebrum (DL). Therefore, the causal involvement of these receptors was suspected in PTTH release/synthesis. The level of mRNA(5HTRB) responded to 10 cycles of long-day activation, falling to 40% of the original level before activation, while that of 5HTR(A) was not affected by long-day activation. Under LD 16:8 and 12:12, the injection of dsRNA(5HTRB) resulted in early diapause termination, whereas that of dsRNA(5HTRA) did not affect the rate of diapause termination. The injection of dsRNA(5HTRB) induced PTTH accumulation, indicating that 5HTR(B) binding suppresses PTTH synthesis also. This conclusion was supported pharmacologically; the injection of luzindole, a melatonin receptor antagonist, plus 5th inhibited photoperiodic activation under LD 16:8, while that of 5,7-DHT, induced emergence in a dose dependent fashion under LD 12:12. The results suggest that 5HTR(B) may lock the PTTH release/synthesis, maintaining diapause. This could also work as diapause induction mechanism.	[Wang, Qiushi; Mohamed, Ahmed A. M.; Takeda, Makio] Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo 657, Japan	Kobe University	Takeda, M (corresponding author), Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo 657, Japan.	mtakeda@kobe-u.ac.jp			JSPS [15003114]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Funding was provided by JSPS grant (15003114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHIYAMADA T, 1994, EUR J BIOCHEM, V220, P633, DOI 10.1111/j.1432-1033.1994.tb18665.x; Bembenek J, 2004, THESIS KOBE U; Blenau W, 2011, ARTHROPOD STRUCT DEV, V40, P381, DOI 10.1016/j.asd.2011.01.004; Dacks AM, 2006, INSECT BIOCHEM MOLEC, V36, P741, DOI 10.1016/j.ibmb.2006.07.002; Danilevskii A.S., 1965, PHOTOPERIODISM SEASO; Danks HV, 2003, EUR J ENTOMOL, V100, P209, DOI 10.14411/eje.2003.036; HEWES RS, 1991, J COMP PHYSIOL A, V168, P697; Hiragaki S, 2009, CELL TISSUE RES, V335, P607, DOI 10.1007/s00441-008-0747-9; Hiragaki Susumu, 2009, International Journal of Wild Silkmoth & Silk, V13, P1; Ichihara N, 2000, THESIS KOBE U; Lucki I, 1998, BIOL PSYCHIAT, V44, P151, DOI 10.1016/S0006-3223(98)00139-5; MIZOGUCHI A, 1990, DEV GROWTH DIFFER, V32, P591; Moncalvo VGR, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-66; Nichols R, 2006, PEPTIDES, V27, P1130, DOI 10.1016/j.peptides.2005.07.032; Raymond JR, 2001, PHARMACOL THERAPEUT, V92, P179, DOI 10.1016/S0163-7258(01)00169-3; Richter K, 2000, J PINEAL RES, V28, P129; Roy A, 2012, ZOOL SCI, V29, P333, DOI 10.2108/zsj.29.333; Sauman I, 1996, DEV BIOL, V178, P418, DOI 10.1006/dbio.1996.0228; Saunders DS, 2011, ENTOMOL SCI, V14, P235, DOI 10.1111/j.1479-8298.2011.00463.x; Saunders DS, 2005, J INSECT PHYSIOL, V51, P599, DOI 10.1016/j.jinsphys.2004.12.002; Sedlak BJ, 1981, ENDOCRINOLOGIST, V44, P207; Sehadova H, 2004, J BIOL RHYTHM, V19, P466, DOI 10.1177/0748730404269153; Shao QM, 2010, J INSECT PHYSIOL, V56, P1576, DOI 10.1016/j.jinsphys.2010.05.015; Shionoya M, 2003, INSECT BIOCHEM MOLEC, V33, P795, DOI 10.1016/S0965-1748(03)00078-X; SHIRAI Y, 1994, J INSECT PHYSIOL, V40, P469, DOI 10.1016/0022-1910(94)90119-8; SHIRAI Y, 1995, COMP BIOCHEM PHYS C, V110, P143, DOI 10.1016/0742-8413(94)00101-F; Takeda M, 1997, EUR J ENTOMOL, V94, P67; Takeda Makio, 2011, International Journal of Wild Silkmoth & Silk, V16, P97; Thamm M, 2010, CELL MOL LIFE SCI, V67, P2467, DOI 10.1007/s00018-010-0350-6; TOMIOKA K, 1993, NATURWISSENSCHAFTEN, V80, P137, DOI 10.1007/BF01131019; Tschuch C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-60; Tsugehara T, 2013, COMP BIOCHEM PHYS C, V157, P93, DOI 10.1016/j.cbpc.2012.10.003; Uno T, 2013, HISTOCHEM CELL BIOL, V139, P299, DOI 10.1007/s00418-012-1021-5; VonNickischRosenegk E, 1996, INSECT BIOCHEM MOLEC, V26, P817, DOI 10.1016/S0965-1748(96)00031-8; WILLIAMS CM, 1964, SCIENCE, V144, P569, DOI 10.1126/science.144.3618.569-c; WILLIAMS CM, 1964, BIOL BULL, V127, P511, DOI 10.2307/1539252; Yuan Q, 2005, NEURON, V47, P115, DOI 10.1016/j.neuron.2005.05.027; Yuan Q, 2006, CURR BIOL, V16, P1051, DOI 10.1016/j.cub.2006.04.032; Zavodska R, 2003, J BIOL RHYTHM, V18, P106, DOI 10.1177/0748730403251711	39	20	20	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79381	10.1371/journal.pone.0079381	http://dx.doi.org/10.1371/journal.pone.0079381			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223937	Green Published, gold, Green Submitted			2022-12-27	WOS:000326503400110
J	Zhou, MY; Wang, GL; Li, D; Zhao, DL; Qin, QL; Chen, XL; Chen, B; Zhou, BC; Zhang, XY; Zhang, YZ				Zhou, Ming-Yang; Wang, Guang-Long; Li, Dan; Zhao, Dian-Li; Qin, Qi-Long; Chen, Xiu-Lan; Chen, Bo; Zhou, Bai-Cheng; Zhang, Xi-Ying; Zhang, Yu-Zhong			Diversity of Both the Cultivable Protease-Producing Bacteria and Bacterial Extracellular Proteases in the Coastal Sediments of King George Island, Antarctica	PLOS ONE			English	Article							DEEP-SEA; COMMUNITIES; ENZYMES	Protease-producing bacteria play a vital role in degrading sedimentary organic nitrogen. However, the diversity of these bacteria and their extracellular proteases in most regions remain unknown. In this paper, the diversity of the cultivable protease-producing bacteria and of bacterial extracellular proteases in the sediments of Maxwell Bay, King George Island, Antarctica was investigated. The cultivable protease-producing bacteria reached 10(5) cells/g in all 8 sediment samples. The cultivated protease-producing bacteria were mainly affiliated with the phyla Actinobacteria, Firmicutes, Bacteroidetes, and Proteobacteria, and the predominant genera were Bacillus (22.9%), Flavobacterium (21.0%) and Lacinutrix (16.2%). Among these strains, Pseudoalteromonas and Flavobacteria showed relatively high protease production. Inhibitor analysis showed that nearly all the extracellular proteases from the bacteria were serine proteases or metalloproteases. These results begin to address the diversity of protease-producing bacteria and bacterial extracellular proteases in the sediments of the Antarctic Sea.	[Zhou, Ming-Yang; Wang, Guang-Long; Li, Dan; Zhao, Dian-Li; Qin, Qi-Long; Chen, Xiu-Lan; Zhou, Bai-Cheng; Zhang, Xi-Ying; Zhang, Yu-Zhong] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Zhou, Ming-Yang; Wang, Guang-Long; Li, Dan; Zhao, Dian-Li; Qin, Qi-Long; Chen, Xiu-Lan; Zhou, Bai-Cheng; Zhang, Xi-Ying; Zhang, Yu-Zhong] Shandong Univ, Marine Biotechnol Res Ctr, Jinan 250100, Peoples R China; [Chen, Bo] Polar Res Inst China, SOA Key Lab Polar Sci, Shanghai, Peoples R China	Shandong University; Shandong University; Polar Research Institute of China	Zhang, XY (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	zhangxiying@sdu.edu.cn			Hi-Tech Research and Development program of China [2012AA092105, 2012AA092103, 2011AA09070303]; National Natural Science Foundation of China [31025001, 31290231, 41106161, 31070061]; COMRA Program [DY125-15-T-05]; Special Fund of China for Marine-scientific Research in the Public Interest [201005032-6]; Independent Innovation Foundation of Shandong University [2009TS079]; Program of Shandong for Taishan Scholars [2008BS02019]; Foundation for Young Excellent Scientists in Shandong Province [BS2010SW015]	Hi-Tech Research and Development program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); COMRA Program; Special Fund of China for Marine-scientific Research in the Public Interest; Independent Innovation Foundation of Shandong University; Program of Shandong for Taishan Scholars; Foundation for Young Excellent Scientists in Shandong Province	The work was supported by Hi-Tech Research and Development program of China (2012AA092105, 2012AA092103, 2011AA09070303), National Natural Science Foundation of China (31025001, 31290231, 41106161, 31070061), COMRA Program (DY125-15-T-05), Special Fund of China for Marine-scientific Research in the Public Interest (201005032-6), Independent Innovation Foundation of Shandong University (2009TS079), Program of Shandong for Taishan Scholars, (2008BS02019), and Foundation for Young Excellent Scientists in Shandong Province (BS2010SW015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowman JP, 2003, APPL ENVIRON MICROB, V69, P2463, DOI 10.1128/AEM.69.5.2463-2483.2003; Chen XL, 2003, MAR BIOL, V143, P989, DOI 10.1007/s00227-003-1128-2; Gerday C, 2000, TRENDS BIOTECHNOL, V18, P103, DOI 10.1016/S0167-7799(99)01413-4; Gray JP, 1996, APPL ENVIRON MICROB, V62, P4049, DOI 10.1128/AEM.62.11.4049-4059.1996; Hunter EM, 2006, APPL ENVIRON MICROB, V72, P5689, DOI 10.1128/AEM.03007-05; Li HR, 2009, EXTREMOPHILES, V13, P233, DOI 10.1007/s00792-009-0225-7; Liao L, 2009, J ZHEJIANG UNIV-SC B, V10, P890, DOI 10.1631/jzus.B0920181; Loperena L, 2012, WORLD J MICROB BIOT, V28, P2249, DOI 10.1007/s11274-012-1032-3; Nercessian O, 2005, ENVIRON MICROBIOL, V7, P698, DOI 10.1111/j.1462-2920.2005.00744.x; Olivera NL, 2007, EXTREMOPHILES, V11, P517, DOI 10.1007/s00792-007-0064-3; Polymenakou PN, 2005, MICROB ECOL, V50, P447, DOI 10.1007/s00248-005-0005-6; Sohrin Y, 2000, DEEP-SEA RES PT I, V47, P55, DOI 10.1016/S0967-0637(99)00049-7; Talbot V, 1997, DEEP-SEA RES PT II, V44, P1069, DOI 10.1016/S0967-0645(96)00107-5; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van Trappen S, 2004, INT J SYST EVOL MICR, V54, P85, DOI 10.1099/ijs.0.02857-0; Vazquez SC, 2008, REV ARGENT MICROBIOL, V40, P63; Vazquez SC, 2002, POLAR RES, V21, P63, DOI 10.1111/j.1751-8369.2002.tb00067.x; VAZQUEZ SC, 1995, POLAR BIOL, V15, P131; WHITAKER TM, 1982, PROC R SOC SER B-BIO, V214, P169, DOI 10.1098/rspb.1982.0003; Xiong HR, 2007, J IND MICROBIOL BIOT, V34, P63, DOI 10.1007/s10295-006-0165-5; [徐宏翔 Xu Hongxiang], 2008, [生态学报, Acta Ecologica Sinica], V28, P479; Zhou MY, 2009, MICROB ECOL, V58, P582, DOI 10.1007/s00248-009-9506-z	23	28	33	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79668	10.1371/journal.pone.0079668	http://dx.doi.org/10.1371/journal.pone.0079668			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223990	Green Published, gold, Green Submitted			2022-12-27	WOS:000326503400135
J	Shen, YX; Gao, L; Xia, X; Li, YH; Guan, HL				Shen, You-xin; Gao, Lei; Xia, Xue; Li, Yuhui; Guan, Huilin			Successional Distance between the Source and Recipient Influence Seed Germination and Seedling Survival during Surface Soil Replacement in SW China	PLOS ONE			English	Article							RESTORATION TOOL; FOREST; ECOSYSTEM; ESTABLISHMENT; DEGRADATION; RECRUITMENT; COMPETITION; MICROSITE; MODELS; LITTER	Adding propagules (source) to a degraded site (recipient) is a common way of manipulating secondary succession to restore diversity and services formerly provided by forests. However, heretofore no study has considered the effect of "successional distance" between source and recipient site. Four sites in the Shilin karst area of SW China were treated as different states along a secondary successional sere: grass, shrub, young secondary forest, and primary forest. Ten 1 m x 1m soil quadrats in the grass, shrub and young forest sites were replaced with 10 cm deep soil sources from corresponding later successional stage(s) in January 2009. Woody plant seed germination was monitored in the first year and seedling survival was monitored until the end of the second year. At the end of 2010, 2097 seeds of woody plants belonging to 45 taxa had germinated, and 3.9% of the seedlings and 7.8% of the species survived. Germination of most species was sensitive to ambient light (red, far-red, R:FR ratios, photosynthetically active radiation). Soil source and recipient site had a significant effect on the total number of seeds and number of species that germinated, and on the percentage of seedlings that survived through the end of the second year. Closer successional stages between recipient site and soil source had higher seed germination and seedling-survival percentages. However, a transition threshold exists in the young forest state, where seeds can germinate but not survive the second year. Our results, although based on an unreplicated chronosequence, suggest that successional distance between soil sources and recipient sites affect forest recruitment and restoration in degraded karst of SW China.	[Shen, You-xin; Gao, Lei] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Menglun, Yunnan, Peoples R China; [Shen, You-xin; Gao, Lei; Xia, Xue] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Restorat Ecol Grp, Kunming, Peoples R China; [Li, Yuhui; Guan, Huilin] Yunnan Normal Univ, Kunming, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Yunnan Normal University	Shen, YX (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Menglun, Yunnan, Peoples R China.	yxshen@xtbg.ac.cn	li, yuhui/Q-1730-2019		Chinese Academy of Sciences; National Nature Scientific Foundation of China [41262013, 41371514, 41361075]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Nature Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	Funding was provided by grants from "Light in Western China" Program of Chinese Academy of Sciences and the National Nature Scientific Foundation of China (41262013, 41371514, 41361075). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Loayza P, 2011, J ECOL, V99, P1045, DOI 10.1111/j.1365-2745.2011.01835.x; Aronson J., 1993, Restoration Ecology, V1, P8, DOI 10.1111/j.1526-100X.1993.tb00004.x; Baskin CC, 1998, SEEDS ECOLOGY BIOGEO; Brang P, 1998, CAN J FOREST RES, V28, P626, DOI 10.1139/cjfr-28-4-626; Castro-Marin G, 2011, TROP ECOL, V52, P1; Clark CJ, 2007, AM NAT, V170, P128, DOI 10.1086/518565; Farrell C, 2011, PLANT SOIL, V348, P397, DOI 10.1007/s11104-011-0850-7; Foster BL, 2007, RESTOR ECOL, V15, P652, DOI 10.1111/j.1526-100X.2007.00277.x; Giordano CV, 2009, NEW PHYTOL, V181, P880, DOI 10.1111/j.1469-8137.2008.02708.x; Graae BJ, 2004, FLORA, V199, P263, DOI 10.1078/0367-2530-00154; Hall SL, 2010, RESTOR ECOL, V18, P834, DOI 10.1111/j.1526-100X.2008.00509.x; Hobbs R.J., 2007, LINKING RESTORATION, P168, DOI DOI 10.1111/J.1466-822X.2006.00212.X; Hobbs RJ, 1996, RESTOR ECOL, V4, P93, DOI 10.1111/j.1526-100X.1996.tb00112.x; Holl KD, 2011, FOREST ECOL MANAG, V261, P1558, DOI 10.1016/j.foreco.2010.07.004; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hunziker U, 2005, FOREST ECOL MANAG, V210, P67, DOI 10.1016/j.foreco.2005.02.019; Jiang YJ, 2006, ENVIRON GEOL, V50, P911, DOI 10.1007/s00254-006-0262-9; King EG, 2006, RESTOR ECOL, V14, P369, DOI 10.1111/j.1526-100X.2006.00145.x; Koch JM, 2007, RESTOR ECOL, V15, pS137, DOI 10.1111/j.1526-100X.2007.00301.x; [劳文科 LAO Wenke], 2008, [地球与环境, Earth and Environment], V36, P119; Lopez DR, 2011, APPL VEG SCI, V14, P6, DOI 10.1111/j.1654-109X.2010.01095.x; Menz MHM, 2013, SCIENCE, V339, P526, DOI 10.1126/science.1228334; Parise M, 2003, ENVIRON GEOL, V44, P247, DOI 10.1007/s00254-003-0773-6; Pearson TRH, 2003, FUNCT ECOL, V17, P394, DOI 10.1046/j.1365-2435.2003.00747.x; Perez-Garcia EA, 2004, PLANT ECOL, V175, P147, DOI 10.1007/s11258-005-4841-8; PICKETT STA, 1987, BOT REV, V53, P335, DOI 10.1007/BF02858321; Prach K, 2007, LINKING RESTORATION; Sheley RL, 2006, ECOL MONOGR, V76, P365, DOI 10.1890/0012-9615(2006)076[0365:PFSTTG]2.0.CO;2; [沈有信 Shen Youxin], 2005, [广西植物, Guihaia], V25, P321; Thompson K., 2000, Seeds: the ecology of regeneration in plant communities, P215, DOI 10.1079/9780851994321.0215; Travlos IS, 2007, J FOOD AGRIC ENVIRON, V5, P153; Tropek R, 2010, J APPL ECOL, V47, P139, DOI 10.1111/j.1365-2664.2009.01746.x; Turnbull LA, 2000, OIKOS, V88, P225, DOI 10.1034/j.1600-0706.2000.880201.x; VAZQUEZYANES C, 1990, ECOLOGY, V71, P1952, DOI 10.2307/1937603; Zhang F.M., 1997, STUDY LUNAN STONE FO	36	5	6	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79125	10.1371/journal.pone.0079125	http://dx.doi.org/10.1371/journal.pone.0079125			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223891	Green Published, Green Submitted, gold			2022-12-27	WOS:000326499300060
J	Becker, S; Ceko, M; Louis-Foster, M; Elfassy, NM; Leyton, M; Shir, Y; Schweinhardt, P				Becker, Susanne; Ceko, Marta; Louis-Foster, Mytsumi; Elfassy, Nathaniel M.; Leyton, Marco; Shir, Yoram; Schweinhardt, Petra			Dopamine and Pain Sensitivity: Neither Sulpiride nor Acute Phenylalanine and Tyrosine Depletion Have Effects on Thermal Pain Sensations in Healthy Volunteers	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS; CATECHOLAMINE SYNTHESIS; PARKINSONS-DISEASE; TEMPORAL SUMMATION; DOUBLE-BLIND; AMINO-ACIDS; EFFECT SIZE; ANTINOCICEPTIVE ACTIONS; FIBROMYALGIA PATIENTS; WORKING-MEMORY	Based on animal studies and some indirect clinical evidence, dopamine has been suggested to have anti-nociceptive effects. Here, we investigated directly the effects of increased and decreased availability of extracellular dopamine on pain perception in healthy volunteers. In Study 1, participants ingested, in separate sessions, a placebo and a low dose of the centrally acting D2-receptor antagonist sulpiride, intended to increase synaptic dopamine via predominant pre-synaptic blockade. No effects were seen on thermal pain thresholds, tolerance, or temporal summation. Study 2 used the acute phenylalanine and tyrosine depletion (APTD) method to transiently decrease dopamine availability. In one session participants ingested a mixture that depletes the dopamine amino acid precursors, phenylalanine and tyrosine. In the other session they ingested a nutritionally balanced control mixture. APTD led to a small mood-lowering response following aversive thermal stimulation, but had no effects on the perception of cold, warm, or pain stimuli. In both studies the experimental manipulation of dopaminergic neurotransmission was successful as indicated by manipulation checks. The results contradict proposals that dopamine has direct anti-nociceptive effects in acute experimental pain. Based on dopamine's well-known role in reward processing, we hypothesize that also in the context of pain, dopamine acts on stimulus salience and might play a role in the initiation of avoidance behavior rather than having direct antinociceptive effects in acute experimental pain.	[Becker, Susanne; Louis-Foster, Mytsumi; Elfassy, Nathaniel M.; Schweinhardt, Petra] McGill Univ, Alan Edwards Ctr Res Pain, Montreal, PQ, Canada; [Becker, Susanne; Louis-Foster, Mytsumi; Elfassy, Nathaniel M.; Schweinhardt, Petra] McGill Univ, Fac Dent, Montreal, PQ, Canada; [Becker, Susanne] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Cognit & Clin Neurosci, Mannheim, Germany; [Ceko, Marta] NIH, Natl Ctr Complementary & Alternat Med, Bethesda, MD 20892 USA; [Leyton, Marco; Schweinhardt, Petra] McGill Univ, Fac Med, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Leyton, Marco] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Leyton, Marco] Concordia Univ, Ctr Studies Behav Neurobiol, Montreal, PQ H3G 1M8, Canada; [Shir, Yoram] McGill Univ, Ctr Hlth, Montreal Gen Hosp, Alan Edwards Pain Management Unit, Montreal, PQ, Canada	McGill University; McGill University; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; National Institutes of Health (NIH) - USA; NIH National Center for Complementary & Alternative Medicine; McGill University; McGill University; Concordia University - Canada; McGill University	Becker, S (corresponding author), McGill Univ, Alan Edwards Ctr Res Pain, Montreal, PQ, Canada.	susanne.becker@zi-mannheim.de	Schweinhardt, Petra/AAC-6797-2021; Becker, Susanne/F-7209-2019; Ceko, Marta/AAD-2011-2022; Leyton, Marco/AAY-7557-2020	Becker, Susanne/0000-0002-5681-4084; Leyton, Marco/0000-0002-1243-2252; CEKO, MARTA/0000-0001-8679-8145; Schweinhardt, Petra/0000-0003-4837-6595	International Association for the Study of Pain (IASP); German Research Foundation [BE4309/2-1]; Canadian Institutes for Health Research [MOP-102636]	International Association for the Study of Pain (IASP); German Research Foundation(German Research Foundation (DFG)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the International Association for the Study of Pain (IASP) (no grant number) http://www.iasp-pain.org; The German Research Foundation, BE4309/2-1, http://www.dfg.de/en/; Canadian Institutes for Health Research, MOP-102636, http://www.cihr-irsc.gc.ca/; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE ED, 1989, J NEUROCHEM, V52, P1655, DOI 10.1111/j.1471-4159.1989.tb09224.x; ALFREDSSON G, 1984, PSYCHOPHARMACOLOGY, V84, P237, DOI 10.1007/BF00427452; Altier N, 1999, LIFE SCI, V65, P2269, DOI 10.1016/S0024-3205(99)00298-2; Ansah OB, 2007, EXP NEUROL, V205, P536, DOI 10.1016/j.expneurol.2007.03.010; BARASI S, 1987, BRIT J PHARMACOL, V90, P15, DOI 10.1111/j.1476-5381.1987.tb16820.x; Becker S, EUR J NEUROSCI; Becker S, 2012, PAIN RES TREAT, V2012, DOI 10.1155/2012/741746; BENFENATI F, 1981, NEUROSCI LETT, V26, P289, DOI 10.1016/0304-3940(81)90147-6; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Berridge KC, 2009, CURR OPIN PHARMACOL, V9, P65, DOI 10.1016/j.coph.2008.12.014; Brefel-Courbon C, 2005, MOVEMENT DISORD, V20, P1557, DOI 10.1002/mds.20629; Brooks AM, 2013, TRENDS COGN SCI, V17, P281, DOI 10.1016/j.tics.2013.04.001; Cabib S, 2012, NEUROSCI BIOBEHAV R, V36, P79, DOI 10.1016/j.neubiorev.2011.04.012; CARLSSON A, 1978, N-S ARCH PHARMACOL, V303, P157, DOI 10.1007/BF00508062; Cevoli S, 2006, EUR J NEUROL, V13, P1009, DOI 10.1111/j.1468-1331.2006.01415.x; Choi SJ, 2009, PHYSIOL BEHAV, V98, P156, DOI 10.1016/j.physbeh.2009.05.004; CLARKE PBS, 1992, BRAIN RES, V580, P106, DOI 10.1016/0006-8993(92)90932-Y; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; COSTALL B, 1980, EUR J PHARMACOL, V63, P347, DOI 10.1016/0014-2999(80)90265-4; Coull JT, 2012, J NEUROSCI, V32, P16704, DOI 10.1523/JNEUROSCI.1258-12.2012; Daskalakis ZJ, 2008, J PSYCHOPHARMACOL, V22, P203, DOI 10.1177/0269881107084002; Dellapina E, 2011, MOVEMENT DISORD, V26, P153, DOI 10.1002/mds.23406; DICKEY RP, 1972, NEW ENGL J MED, V286, P843; Ertas M, 1998, PAIN, V75, P257, DOI 10.1016/S0304-3959(98)00003-7; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; FERNSTROM JD, 1979, AM J CLIN NUTR, V32, P1912, DOI 10.1093/ajcn/32.9.1912; FLEETWOODWALKER SM, 1988, J PHYSIOL-LONDON, V399, P335; Gear RW, 1999, J NEUROSCI, V19, P7175, DOI 10.1523/JNEUROSCI.19-16-07175.1999; Gerdelat-Mas A, 2007, J NEUROL NEUROSUR PS, V78, P1140, DOI 10.1136/jnnp.2007.120212; Gierthmuhlen J, 2010, MOVEMENT DISORD, V25, P1195, DOI 10.1002/mds.23128; GIRODO M, 1979, COGNITIVE THER RES, V3, P23, DOI 10.1007/BF01172716; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; Granot M, 2006, PAIN, V122, P295, DOI 10.1016/j.pain.2006.02.003; Graven-Nielsen T, 2000, PAIN, V85, P483, DOI 10.1016/S0304-3959(99)00308-5; Hagelberg N, 2004, EUR J PHARMACOL, V500, P187, DOI 10.1016/j.ejphar.2004.07.024; Hagelberg N, 2003, PAIN, V106, P43, DOI 10.1016/S0304-3959(03)00275-6; Hagelberg N, 2003, PAIN, V101, P149, DOI 10.1016/S0304-3959(02)00323-8; Holman AJ, 2005, ARTHRITIS RHEUM-US, V52, P2495, DOI 10.1002/art.21191; HORN PT, 1982, J CARDIOVASC PHARM, V4, P668, DOI 10.1097/00005344-198207000-00020; Jarcho JM, 2012, PAIN, V153, P744, DOI 10.1016/j.pain.2012.01.002; KALIVAS PW, 1995, BRAIN RES, V675, P325, DOI 10.1016/0006-8993(95)00013-G; KENDLER KS, 1982, EUR J PHARMACOL, V79, P217, DOI 10.1016/0014-2999(82)90627-6; Kuroki T, 1999, J PHARMACOL EXP THER, V288, P774; Lapirot O, 2011, PAIN, V152, P1821, DOI 10.1016/j.pain.2011.03.030; Leknes S, 2008, NAT REV NEUROSCI, V9, P314, DOI 10.1038/nrn2333; Leyton M, 2004, NEUROPSYCHOPHARMACOL, V29, P427, DOI 10.1038/sj.npp.1300328; Leyton M, 2000, NEUROPSYCHOPHARMACOL, V22, P52, DOI 10.1016/S0893-133X(99)00086-X; Loggia ML, 2008, J PAIN, V9, P784, DOI 10.1016/j.jpain.2008.03.014; LORR M, 1982, J PERS ASSESS, V46, P432, DOI 10.1207/s15327752jpa4604_16; Magnusson JE, 2000, BRAIN RES, V855, P260, DOI 10.1016/S0006-8993(99)02396-3; Malt EA, 2003, J AFFECT DISORDERS, V75, P77, DOI 10.1016/S0165-0327(02)00025-3; Marsala SZ, 2011, J NEUROL, V258, P627, DOI 10.1007/s00415-010-5812-0; MCCLELLAND GR, 1990, BRIT J CLIN PHARMACO, V30, P795, DOI 10.1111/j.1365-2125.1990.tb05444.x; McTavish SFB, 2001, BRIT J PSYCHIAT, V179, P356, DOI 10.1192/bjp.179.4.356; McTavish SFB, 1999, PSYCHOPHARMACOLOGY, V141, P182, DOI 10.1007/s002130050823; Mehta MA, 2004, PSYCHOPHARMACOLOGY, V176, P331, DOI 10.1007/s00213-004-1899-2; Mehta MA, 2008, PSYCHOPHARMACOLOGY, V196, P157, DOI 10.1007/s00213-007-0947-0; Millan MJ, 2002, J PHARMACOL EXP THER, V303, P791, DOI 10.1124/jpet.102.039867; Montgomery AJ, 2003, AM J PSYCHIAT, V160, P1887, DOI 10.1176/appi.ajp.160.10.1887; Nandhagopal R, 2010, PAIN MED, V11, P834, DOI 10.1111/j.1526-4637.2010.00866.x; Nielsen J, 1998, EUR J PAIN, V2, P329, DOI 10.1016/S1090-3801(98)90031-3; OCONNOR SE, 1982, GEN PHARMACOL-VASC S, V13, P185, DOI 10.1016/0306-3623(82)90088-X; Olejnik S, 2000, CONTEMP EDUC PSYCHOL, V25, P241, DOI 10.1006/ceps.2000.1040; Olejnik S, 2003, PSYCHOL METHODS, V8, P434, DOI 10.1037/1082-989X.8.4.434; Pecina S, 2003, J NEUROSCI, V23, P9395; Potvin S, 2009, SYNAPSE, V63, P390, DOI 10.1002/syn.20616; PRICE DD, 1977, PAIN, V3, P57, DOI 10.1016/0304-3959(77)90035-5; PUECH AJ, 1978, EUR J PHARMACOL, V50, P291, DOI 10.1016/0014-2999(78)90134-6; Saade NE, 1997, BRAIN RES, V751, P1, DOI 10.1016/S0006-8993(96)01164-X; Salamone JD, 2012, NEURON, V76, P470, DOI 10.1016/j.neuron.2012.10.021; Schestatsky P, 2007, NEUROLOGY, V69, P2162, DOI 10.1212/01.wnl.0000295669.12443.d3; Scott DJ, 2006, J NEUROSCI, V26, P10789, DOI 10.1523/JNEUROSCI.2577-06.2006; Shimizu T, 2004, PAIN, V110, P246, DOI 10.1016/j.pain.2004.03.038; SMIT AJ, 1990, EUR J CLIN PHARMACOL, V39, P221, DOI 10.1007/BF00315100; Soares BG, 2000, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD001162, 10.1002/14651858.CD001162, DOI 10.1002/14651858.CD001162.PUBMED:10796605]; Sommer C, 2012, SCHMERZ, V26, P297, DOI 10.1007/s00482-012-1172-2; Sorensen J, 1995, SCAND J RHEUMATOL, V24, P360; Sorensen J, 1997, J RHEUMATOL, V24, P1615; STANDISHBARRY HMAS, 1983, PSYCHOPHARMACOLOGY, V81, P258, DOI 10.1007/BF00427274; Taniguchi W, 2011, PAIN, V152, P95, DOI 10.1016/j.pain.2010.09.034; Tomori L, 1992, Acta Pharm Hung, V62, P39; Treister R, 2013, NEUROSCI LETT, V548, P115, DOI 10.1016/j.neulet.2013.05.041; Treister R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063808; Treister R, 2009, PAIN, V147, P187, DOI 10.1016/j.pain.2009.09.001; Villemure C, 2003, PAIN, V106, P101, DOI 10.1016/S0304-3959(03)00297-5; Vrshek-Schallhorn S, 2013, PHARMACOL BIOCHEM BE, V105, P51, DOI 10.1016/j.pbb.2013.01.013; WESTERINK BHC, 1989, NEUROSCI LETT, V99, P197, DOI 10.1016/0304-3940(89)90289-9; Wood PB, 2007, EUR J NEUROSCI, V25, P3576, DOI 10.1111/j.1460-9568.2007.05623.x; Wood PB, 2007, J PAIN, V8, P51, DOI 10.1016/j.jpain.2006.05.014; Wood Patrick B, 2008, Expert Rev Neurother, V8, P781, DOI 10.1586/14737175.8.5.781; Wyvell CL, 2000, J NEUROSCI, V20, P8122; Yarnitsky D, 2012, PAIN, V153, P1193, DOI 10.1016/j.pain.2012.02.021; YOUNG SN, 1985, PSYCHOPHARMACOLOGY, V87, P173, DOI 10.1007/BF00431803	93	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80766	10.1371/journal.pone.0080766	http://dx.doi.org/10.1371/journal.pone.0080766			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236199	gold, Green Published, Green Submitted			2022-12-27	WOS:000327254700202
J	Blomquist, TM; Crawford, EL; Lovett, JL; Yeo, J; Stanoszek, LM; Levin, A; Li, J; Lu, M; Shi, LM; Muldrew, K; Willey, JC				Blomquist, Thomas M.; Crawford, Erin L.; Lovett, Jennie L.; Yeo, Jiyoun; Stanoszek, Lauren M.; Levin, Albert; Li, Jia; Lu, Mei; Shi, Leming; Muldrew, Kenneth; Willey, James C.			Targeted RNA-Sequencing with Competitive Multiplex-PCR Amplicon Libraries	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; MESSENGER-RNA; EXPRESSION; SEQ; QUANTITATION; DNA; TRANSCRIPTS; TOOL	Whole transcriptome RNA-sequencing is a powerful tool, but is costly and yields complex data sets that limit its utility in molecular diagnostic testing. A targeted quantitative RNA-sequencing method that is reproducible and reduces the number of sequencing reads required to measure transcripts over the full range of expression would be better suited to diagnostic testing. Toward this goal, we developed a competitive multiplex PCR-based amplicon sequencing library preparation method that a) targets only the sequences of interest and b) controls for inter-target variation in PCR amplification during library preparation by measuring each transcript native template relative to a known number of synthetic competitive template internal standard copies. To determine the utility of this method, we intentionally selected PCR conditions that would cause transcript amplification products (amplicons) to converge toward equimolar concentrations (normalization) during library preparation. We then tested whether this approach would enable accurate and reproducible quantification of each transcript across multiple library preparations, and at the same time reduce (through normalization) total sequencing reads required for quantification of transcript targets across a large range of expression. We demonstrate excellent reproducibility (R-2 = 0.997) with 97% accuracy to detect 2-fold change using External RNA Controls Consortium (ERCC) reference materials; high inter-day, inter-site and inter-library concordance (R-2 = 0.97-0.99) using FDA Sequencing Quality Control (SEQC) reference materials; and cross-platform concordance with both TaqMan qPCR (R-2 = 0.96) and whole transcriptome RNA-sequencing following "traditional'' library preparation using Illumina NGS kits (R-2 = 0.94). Using this method, sequencing reads required to accurately quantify more than 100 targeted transcripts expressed over a 10(7)-fold range was reduced more than 10,000-fold, from 2.3x10(9) to 1.4x10(5) sequencing reads. These studies demonstrate that the competitive multiplex-PCR amplicon library preparation method presented here provides the quality control, reproducibility, and reduced sequencing reads necessary for development and implementation of targeted quantitative RNA-sequencing biomarkers in molecular diagnostic testing.	[Blomquist, Thomas M.; Crawford, Erin L.; Yeo, Jiyoun; Stanoszek, Lauren M.; Willey, James C.] Univ Toledo, Dept Med, Toledo, OH 43606 USA; [Lovett, Jennie L.; Muldrew, Kenneth] Univ Toledo, Dept Pathol, Toledo, OH USA; [Levin, Albert; Li, Jia; Lu, Mei] Henry Ford Hlth Syst, Dept Publ Hlth Sci, Detroit, MI USA; [Shi, Leming] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; Henry Ford Health System; Henry Ford Hospital; US Food & Drug Administration (FDA)	Blomquist, TM (corresponding author), Univ Toledo, Dept Med, Hlth Sci Campus, Toledo, OH 43606 USA.	thomas.blomquist@utoledo.edu	Shi, Leming/B-3150-2010; Lovett, Jennie/S-2996-2016	Shi, Leming/0000-0002-7143-2033; Lovett, Jennie/0000-0002-3710-9400	National Institutes of Health, National Cancer Institute [RC2-CA147652, IMAT R21-CA138397]; National Heart Lung and Blood Institute [RO1-HL108016]; University of Toledo Medical Center George Isaac Research Fund; NATIONAL CANCER INSTITUTE [R21CA138397] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108016] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Toledo Medical Center George Isaac Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Significant portions of this study were paid for with funding provided by National Institutes of Health, National Cancer Institute (RC2-CA147652 and IMAT R21-CA138397) and National Heart Lung and Blood Institute (RO1-HL108016); and the University of Toledo Medical Center George Isaac Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreson R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-172; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Bustin SA, 2004, A Z QUANTITATIVE PCR; Canales RD, 2006, NAT BIOTECHNOL, V24, P1115, DOI 10.1038/nbt1236; Crawford EL, 2001, MOL DIAGN, V6, P217, DOI 10.1054/modi.2001.29789; Crawford EL, 2002, BIOCHEM BIOPH RES CO, V293, P509, DOI 10.1016/S0006-291X(02)00243-7; GILLILAND G, 1990, P NATL ACAD SCI USA, V87, P2725, DOI 10.1073/pnas.87.7.2725; Halvardson J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks816; Hecker KH, 1996, BIOTECHNIQUES, V20, P478; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Hoorfar J, 2004, J CLIN MICROBIOL, V42, P1863, DOI 10.1128/JCM.42.5.1863-1868.2004; Huggett Jim F, 2008, BMC Res Notes, V1, P70, DOI 10.1186/1756-0500-1-70; Jiang LC, 2011, GENOME RES, V21, P1543, DOI 10.1101/gr.121095.111; Kane M, 2006, PROG FORENSIC MED, V1288, P694; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Krjutskov K, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn357; LeProust EM, 2010, NUCLEIC ACIDS RES, V38, P2522, DOI 10.1093/nar/gkq163; Levin JZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r115; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mercer TR, 2012, NAT BIOTECHNOL, V30, P99, DOI 10.1038/nbt.2024; MULDER J, 1994, J CLIN MICROBIOL, V32, P292, DOI 10.1128/JCM.32.2.292-300.1994; Raz T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019287; Roche, 2007, 510 K SUMM AMPLICOR; Schageman J, 2013, J BIOMOLECULAR TEC S, V24, pS42; Svensen N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024906; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Turner EH, 2009, ANNU REV GENOM HUM G, V10, P263, DOI 10.1146/annurev-genom-082908-150112; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; WANG AM, 1989, P NATL ACAD SCI USA, V86, P9717, DOI 10.1073/pnas.86.24.9717; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Zhou JZ, 2011, ISME J, V5, P1303, DOI 10.1038/ismej.2011.11	34	24	42	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79120	10.1371/journal.pone.0079120	http://dx.doi.org/10.1371/journal.pone.0079120			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236095	Green Submitted, Green Published, gold			2022-12-27	WOS:000327254700093
J	Brown, LL; Acevedo, B; Fisher, HE				Brown, Lucy L.; Acevedo, Bianca; Fisher, Helen E.			Neural Correlates of Four Broad Temperament Dimensions: Testing Predictions for a Novel Construct of Personality	PLOS ONE			English	Article							PREFRONTAL CORTEX; SEX-DIFFERENCES; ROMANTIC LOVE; HUMAN BRAIN; ORBITOFRONTAL CORTEX; GENERAL INTELLIGENCE; DECISION-MAKING; SUICIDE VICTIMS; TRAITS; NEUROANATOMY	Four suites of behavioral traits have been associated with four broad neural systems: the 1) dopamine and related norepinephrine system; 2) serotonin; 3) testosterone; 4) and estrogen and oxytocin system. A 56-item questionnaire, the Fisher Temperament Inventory (FTI), was developed to define four temperament dimensions associated with these behavioral traits and neural systems. The questionnaire has been used to suggest romantic partner compatibility. The dimensions were named: Curious/Energetic; Cautious/Social Norm Compliant; Analytical/Tough-minded; and Prosocial/Empathetic. For the present study, the FTI was administered to participants in two functional magnetic resonance imaging studies that elicited feelings of love and attachment, near-universal human experiences. Scores for the Curious/Energetic dimension co-varied with activation in a region of the substantia nigra, consistent with the prediction that this dimension reflects activity in the dopamine system. Scores for the Cautious/Social Norm Compliant dimension correlated with activation in the ventrolateral prefrontal cortex in regions associated with social norm compliance, a trait linked with the serotonin system. Scores on the Analytical/Tough-minded scale co-varied with activity in regions of the occipital and parietal cortices associated with visual acuity and mathematical thinking, traits linked with testosterone. Also, testosterone contributes to brain architecture in these areas. Scores on the Prosocial/Empathetic scale correlated with activity in regions of the inferior frontal gyrus, anterior insula and fusiform gyrus. These are regions associated with mirror neurons or empathy, a trait linked with the estrogen/oxytocin system, and where estrogen contributes to brain architecture. These findings, replicated across two studies, suggest that the FTI measures influences of four broad neural systems, and that these temperament dimensions and neural systems could constitute foundational mechanisms in personality structure and play a role in romantic partnerships.	[Brown, Lucy L.] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; [Acevedo, Bianca] Univ Calif Santa Barbara, Dept Psychol & Brain Sci, Santa Barbara, CA 93106 USA; [Fisher, Helen E.] Rutgers State Univ, Dept Anthropol, New Brunswick, NJ 08903 USA	Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California Santa Barbara; Rutgers State University New Brunswick	Fisher, HE (corresponding author), Rutgers State Univ, Dept Anthropol, New Brunswick, NJ 08903 USA.	helenfisher@helenfisher.com	Acevedo, Bianca/AAV-1627-2021	Acevedo, Bianca/0000-0001-6603-7218	W. Burghardt Turner Fellowship; Psychology Department at Stony Brook University; National Science Foundation [0958171]	W. Burghardt Turner Fellowship; Psychology Department at Stony Brook University; National Science Foundation(National Science Foundation (NSF))	This research was partially supported by funding from the W. Burghardt Turner Fellowship to BA, the Psychology Department at Stony Brook University, and a post-doctoral fellowship to BA grant No. 0958171 from the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov I, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-20; Acevedo BP, 2012, SOC COGN AFFECT NEUR, V7, P145, DOI 10.1093/scan/nsq092; Acevedo BP, 2013, BASES ADULT IN PRESS; Allport GW, 1936, J PERS SOC PSY, V41, P916; ARANGO V, 1995, BRAIN RES, V688, P121, DOI 10.1016/0006-8993(95)00523-S; Arango V, 1997, ANN NY ACAD SCI, V836, P269, DOI 10.1111/j.1749-6632.1997.tb52365.x; Aron A, 2005, J NEUROPHYSIOL, V94, P327, DOI 10.1152/jn.00838.2004; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; Bartels A, 2000, NEUROREPORT, V11, P3829, DOI 10.1097/00001756-200011270-00046; Canli T, 2004, J PERS, V72, P1105, DOI 10.1111/j.1467-6494.2004.00292.x; Canli T, 2009, CAMBRIDGE HANDBOOK OF PERSONALITY PSYCHOLOGY, P305; Cattell R. B., 1993, 16 FACTOR QUESTIONNA; Cattell RB, 1943, J ABNORM SOC PSYCH, V38, P476, DOI 10.1037/h0054116; Chang SWC, 2013, NAT NEUROSCI, V16, P243, DOI 10.1038/nn.3287; Cheng Y, 2009, NEUROSCIENCE, V158, P713, DOI 10.1016/j.neuroscience.2008.10.026; CLARK AS, 1988, ENDOCRINOLOGY, V123, P932, DOI 10.1210/endo-123-2-932; CLONINGER CR, 1987, ARCH GEN PSYCHIAT, V44, P573; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Costa P. T., 1992, REVISED NEO PERSONAL, DOI [10.1007/978-0-387-79948-3_2000, DOI 10.1007/978-0-387-79948-3_2000]; Davis KL., 2003, NEUROPSYCHOANALYSIS, V5, P57, DOI [DOI 10.1080/15294145.2003.10773410, 10.1080/15294145.2003.10773410]; Depue R.A., 2005, MAJOR THEORIES PERSO, V2nd, P391; Depue RA, 1999, BEHAV BRAIN SCI, V22, P491; DeYoung CG, 2010, PSYCHOL SCI, V21, P820, DOI 10.1177/0956797610370159; DeYoung CG, 2009, CAMBRIDGE HANDBOOK OF PERSONALITY PSYCHOLOGY, P323; DONOHEW L, 1991, COMMUNIC, P209; Ehringer H, 1998, Parkinsonism Relat Disord, V4, P53, DOI 10.1016/S1353-8020(98)00012-1; Eysenck H. J., 1985, EYSENCK PERSONALITY; Fan J, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-14; Feis DL, 2013, NEUROIMAGE, V70, P250, DOI 10.1016/j.neuroimage.2012.12.068; Fisher H., 2009, WHY HIM WHY HER; Fisher HE, 2010, PERS INDIV DIFFER, V49, P773, DOI 10.1016/j.paid.2010.06.027; Fisher HE, 2010, J NEUROPHYSIOL, V104, P51, DOI 10.1152/jn.00784.2009; Fleming SM, 2012, PHILOS T R SOC B, V367, P1338, DOI 10.1098/rstb.2011.0417; Furnham A., 2006, EUR J PERSONALITY, V2, P67, DOI [10.1002/per.2410020106, DOI 10.1002/PER.2410020106]; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; GESCHWIND N, 1985, ARCH NEUROL-CHICAGO, V42, P428, DOI 10.1001/archneur.1985.04060050026008; Golimbet VE, 2004, MOL BIOL+, V38, P337, DOI 10.1023/B:MBIL.0000032202.83988.09; Gosling SD, 1999, CURR DIR PSYCHOL SCI, V8, P69, DOI 10.1111/1467-8721.00017; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Gray JA, 2000, NEUROPSYCHOLOGY ANXI; Hanggi J, 2010, J COGNITIVE NEUROSCI, V22, P139, DOI 10.1162/jocn.2008.21175; Haier RJ, 2005, NEUROIMAGE, V25, P320, DOI 10.1016/j.neuroimage.2004.11.019; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Knickmeyer R, 2005, J CHILD PSYCHOL PSYC, V46, P198, DOI 10.1111/j.1469-7610.2004.00349.x; Koscik T, 2009, BRAIN COGNITION, V69, P451, DOI 10.1016/j.bandc.2008.09.004; Krawczyk DC, 2002, NEUROSCI BIOBEHAV R, V26, P631, DOI 10.1016/S0149-7634(02)00021-0; Kwee IL, 2003, J NEUROL, V250, P525, DOI 10.1007/s00415-003-1028-x; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Levin JM, 1998, AM J PSYCHIAT, V155, P434, DOI 10.1176/ajp.155.3.434; LINDVALL O, 1974, BRAIN RES, V81, P325, DOI 10.1016/0006-8993(74)90947-0; LINDVALL O, 1974, ACTA PHYSIOL SCAND, P1; LOGUE AW, 1986, APPETITE, V7, P109, DOI 10.1016/S0195-6663(86)80012-5; Luders E, 2009, J NEUROSCI, V29, P14265, DOI 10.1523/JNEUROSCI.2261-09.2009; Mai JK., 2008, ATLAS HUMAN BRAIN, V3rd ed; Manning JT, 2001, DEV MED CHILD NEUROL, V43, P160, DOI 10.1017/S0012162201000317; Manning JT, 2002, DIGIT RATIO POINTER, P24; McCrae RR, 2000, J PERS SOC PSYCHOL, V78, P173, DOI 10.1037/0022-3514.78.1.173; McGuinness D, 1976, EXPLORATIONS SEX DIF, P21; Nunez JL, 2003, J NEUROBIOL, V56, P293, DOI 10.1002/neu.10236; Ortigue S, 2007, J COGNITIVE NEUROSCI, V19, P1218, DOI 10.1162/jocn.2007.19.7.1218; Petrides M, 1996, PHILOS T ROY SOC B, V351, P1455, DOI 10.1098/rstb.1996.0130; Riceberg JS, 2012, J NEUROSCI, V32, P16402, DOI 10.1523/JNEUROSCI.0776-12.2012; Riemann R, 1997, J PERS, V65, P449, DOI 10.1111/j.1467-6494.1997.tb00324.x; Roberts BW, 2008, CURR DIR PSYCHOL SCI, V17, P31, DOI 10.1111/j.1467-8721.2008.00543.x; Roberts BW, 2000, PSYCHOL BULL, V126, P3, DOI 10.1037/0033-2909.126.1.3; Roberts BW, 2006, PSYCHOL BULL, V132, P29, DOI 10.1037/0033-2909.132.1.29; Rosenbloom MH, 2012, J NEUROPSYCH CLIN N, V24, P266, DOI 10.1176/appi.neuropsych.11060139; Salinas J, 2012, GENDER MED, V9, P44, DOI 10.1016/j.genm.2012.01.003; SCHIERMAN MJ, 1985, PERS INDIV DIFFER, V6, P599, DOI 10.1016/0191-8869(85)90009-1; Spitzer M, 2007, NEURON, V56, P185, DOI 10.1016/j.neuron.2007.09.011; Steiner AP, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00131; Takahashi R, 2011, HUM BRAIN MAPP, V32, P1050, DOI 10.1002/hbm.21088; Taki Y, 2011, NEUROIMAGE, V58, P709, DOI 10.1016/j.neuroimage.2011.07.020; Taki Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022734; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P1; Volkow ND, 1996, J NUCL MED, V37, P1242; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Watson KK, 2012, CURR BIOL, V22, P2268, DOI 10.1016/j.cub.2012.10.016; Witte AV, 2010, NEUROIMAGE, V49, P1205, DOI 10.1016/j.neuroimage.2009.09.046; Xu XM, 2011, HUM BRAIN MAPP, V32, P249, DOI 10.1002/hbm.21017; Yamagata S, 2006, J PERS SOC PSYCHOL, V90, P987, DOI 10.1037/0022-3514.90.6.987; Yamasue H, 2008, CEREB CORTEX, V18, P2331, DOI 10.1093/cercor/bhm254; Zeki S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015802; Zuckerman M., 2005, PSYCHOBIOLOGY PERSON; Zuckerman M., 1994, BEHAV EXPRESSIONS BI	85	12	12	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78734	10.1371/journal.pone.0078734	http://dx.doi.org/10.1371/journal.pone.0078734			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236043	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700040
J	Eriksen, HLF; Kesmodel, US; Underbjerg, M; Kilburn, TR; Bertrand, J; Mortensen, EL				Eriksen, Hanne-Lise Falgreen; Kesmodel, Ulrik Schioler; Underbjerg, Mette; Kilburn, Tina Rondrup; Bertrand, Jacquelyn; Mortensen, Erik Lykke			Predictors of Intelligence at the Age of 5: Family, Pregnancy and Birth Characteristics, Postnatal Influences, and Postnatal Growth	PLOS ONE			English	Article							BODY-MASS INDEX; COGNITIVE-ABILITY; HOME-ENVIRONMENT; MATERNAL IQ; EARLY-CHILDHOOD; EARLY-LIFE; WEIGHT; ASSOCIATION; COHORT; PERFORMANCE	Parental education and maternal intelligence are well-known predictors of child IQ. However, the literature regarding other factors that may contribute to individual differences in IQ is inconclusive. The aim of this study was to examine the contribution of a number of variables whose predictive status remain unclarified, in a sample of basically healthy children with a low rate of pre- and postnatal complications. 1,782 5-year-old children sampled from the Danish National Birth Cohort (2003-2007) were assessed with a short form of the Wechsler Preschool and Primary Scale of Intelligence - Revised. Information on parental characteristics, pregnancy and birth factors, postnatal influences, and postnatal growth was collected during pregnancy and at follow-up. A model including study design variables and child's sex explained 7% of the variance in IQ, while parental education and maternal IQ increased the explained variance to 24%. Other predictors were parity, maternal BMI, birth weight, breastfeeding, and the child's head circumference and height at follow-up. These variables, however, only increased the explained variance to 29%. The results suggest that parental education and maternal IQ are major predictors of IQ and should be included routinely in studies of cognitive development. Obstetrical and postnatal factors also predict IQ, but their contribution may be of comparatively limited magnitude.	[Eriksen, Hanne-Lise Falgreen; Kesmodel, Ulrik Schioler; Underbjerg, Mette; Kilburn, Tina Rondrup] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark; [Kesmodel, Ulrik Schioler] Aarhus Univ Hosp, Dept Obstet & Gynaecol, DK-8000 Aarhus, Denmark; [Underbjerg, Mette] Vejlefjord Rehabil Ctr, Childrens Neuroctr, Stouby, Denmark; [Bertrand, Jacquelyn] Ctr Dis Control & Prevent CDC, Atlanta, GA USA; [Mortensen, Erik Lykke] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Mortensen, Erik Lykke] Univ Copenhagen, Ctr Healthy Ageing, Copenhagen, Denmark	Aarhus University; Aarhus University; Centers for Disease Control & Prevention - USA; University of Copenhagen; University of Copenhagen	Eriksen, HLF (corresponding author), Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark.	hfe@soci.au.dk		Mortensen, Erik Lykke/0000-0002-6985-451X	Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA; Pharmacy Foundation; Egmont Foundation; March of Dimes Birth Defects Foundation; Augustinus Foundation; Health Foundation	Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Pharmacy Foundation; Egmont Foundation; March of Dimes Birth Defects Foundation(March of Dimes); Augustinus Foundation; Health Foundation	This study was supported by the Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA. The Danish National Research Foundation has established the Danish Epidemiology Science Centre that initiated and created the Danish National Birth Cohort. The cohort is furthermore a result of a major grant from this Foundation. Additional support for the Danish National Birth Cohort was obtained from the Pharmacy Foundation, the Egmont Foundation, the March of Dimes Birth Defects Foundation, the Augustinus Foundation and the Health Foundation. The funders provided financial support for the data collection, but had no role in the decision to conduct and publish the analyses presented in this paper.	Alati R, 2008, PEDIATR RES, V64, P659, DOI 10.1203/PDR.0b013e318187cc31; [Anonymous], 1958, STANDARD PROGR MATRI; Bacharach VR, 1998, J APPL DEV PSYCHOL, V19, P361, DOI 10.1016/S0193-3973(99)80045-8; Bacharach VR, 1998, J PEDIATR PSYCHOL, V23, P197, DOI 10.1093/jpepsy/23.3.197; Bennett DS, 2008, DEV PSYCHOL, V44, P919, DOI 10.1037/0012-1649.44.4.919; BRADLEY RH, 1993, INT J BEHAV DEV, V16, P61, DOI 10.1177/016502549301600104; Chapman DA, 2002, AM J MENT RETARD, V107, P46, DOI 10.1352/0895-8017(2002)107<0046:ERFFMR>2.0.CO;2; Deary IJ, 2005, INTELLIGENCE, V33, P445, DOI 10.1016/j.intell.2005.05.004; Der G, 2006, BMJ-BRIT MED J, V333, P945, DOI 10.1136/bmj.38978.699583.55; Elgen I, 2003, PEDIATR NEUROL, V29, P111, DOI 10.1016/S0887-8994(03)00211-X; Fergusson D M, 1993, Paediatr Perinat Epidemiol, V7, P77, DOI 10.1111/j.1365-3016.1993.tb00604.x; Heinonen K, 2008, PEDIATRICS, V121, pE1325, DOI 10.1542/peds.2007-1172; Jensen A.R., 1998, G FACTOR SCI MENTAL; Kesmodel US, 2012, BJOG-INT J OBSTET GY, V119, P1180, DOI 10.1111/j.1471-0528.2012.03393.x; Kesmodel US, 2010, SCAND J PUBLIC HEALT, V38, P208, DOI 10.1177/1403494809357093; LABUDA MC, 1986, CHILD DEV, V57, P1142, DOI 10.2307/1130438; Lawlor DA, 2005, J EPIDEMIOL COMMUN H, V59, P656, DOI 10.1136/jech.2004.030205; Matte TD, 2001, BRIT MED J, V323, P310, DOI 10.1136/bmj.323.7308.310; Mink PJ, 2004, EPIDEMIOLOGY, V15, P385, DOI 10.1097/01.ede.0000128402.86336.7e; Molfese VJ, 2002, DEVELOPMENTAL VARIATIONS IN LEARNING, P1; Mortensen EL, 2002, JAMA-J AM MED ASSOC, V287, P2365, DOI 10.1001/jama.287.18.2365; National Collaborative Group for the Revision of the Wechsler Adult Intelligence Scale, 1983, MANUAL WECHSLER ADUL, V03, P362; Neggers YH, 2003, ACTA OBSTET GYN SCAN, V82, P235, DOI 10.1034/j.1600-0412.2003.00090.x; Neisser U, 1996, AM PSYCHOL, V51, P77, DOI 10.1037/0003-066X.51.2.77; Nohr EA, 2006, EPIDEMIOLOGY, V17, P413, DOI 10.1097/01.ede.0000220549.14177.60; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Pearce MS, 2005, INT J EPIDEMIOL, V34, P673, DOI 10.1093/ije/dyi038; Rampersaud GC, 2005, J AM DIET ASSOC, V105, P743, DOI 10.1016/j.jada.2005.02.007; Richards M, 2002, INT J EPIDEMIOL, V31, P342, DOI 10.1093/ije/31.2.342; Royston P, 2009, STATA J, V9, P466, DOI 10.1177/1536867X0900900308; Saha S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000040; SCHUERGER JM, 1989, J CLIN PSYCHOL, V45, P294, DOI 10.1002/1097-4679(198903)45:2<294::AID-JCLP2270450218>3.0.CO;2-N; Shenkin SD, 2004, PSYCHOL BULL, V130, P989, DOI 10.1037/0033-2909.130.6.989; Smith E, 2011, OBES REV, V12, P740, DOI 10.1111/j.1467-789X.2011.00920.x; Thorsdottir I, 2005, EUR J CLIN NUTR, V59, P426, DOI 10.1038/sj.ejcn.1602092; Tong S, 2007, J PEDIATR-US, V151, P284, DOI 10.1016/j.jpeds.2007.03.020; Wechsler D, 1999, MANUAL WECHSLER PRES; Wechsler D., 1990, MANUAL WECHSLER PRES; YEATES KO, 1983, DEV PSYCHOL, V19, P731	39	91	91	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79200	10.1371/journal.pone.0079200	http://dx.doi.org/10.1371/journal.pone.0079200			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236109	Green Published, gold			2022-12-27	WOS:000327254700108
J	Kruger, K; Gessner, DK; Seimetz, M; Banisch, J; Ringseis, R; Eder, K; Weissmann, N; Mooren, FC				Krueger, Karsten; Gessner, Denise K.; Seimetz, Michael; Banisch, Jasmin; Ringseis, Robert; Eder, Klaus; Weissmann, Norbert; Mooren, Frank C.			Functional and Muscular Adaptations in an Experimental Model for Isometric Strength Training in Mice	PLOS ONE			English	Article							SKELETAL-MUSCLE ADAPTATIONS; VOLUNTARY EXERCISE; LOADING CONTROL; RESISTANCE; ENDURANCE; FIBER; YOUNG; HYPERTROPHY; INTENSITY; ACTIN	Exercise training induces muscular adaptations that are highly specific to the type of exercise. For a systematic study of the differentiated exercise adaptations on a molecular level mouse models have been used successfully. The aim of the current study was to develop a suitable mouse model of isometric strength exercise training characterized by specific adaptations known from strength training. C57BL/6 mice performed an isometric strength training (ST) for 10 weeks 5 days/week. Additionally, either a sedentary control group (CT) or a regular endurance training group (ET) groups were used as controls. Performance capacity was determined by maximum holding time (MHT) and treadmill spirometry, respectively. Furthermore, muscle fiber types and diameter, muscular concentration of phosphofructokinase 1 (PFK), succinate dehydrogenase (SDHa), and glucose transporter type 4 (GLUT4) were determined. In a further approach, the effect of ST on glucose intolerance was tested in diabetic mice. In mice of the ST group we observed an increase of MHT in isometric strength tests, a type II fiber hypertrophy, and an increased GLUT4 protein content in the membrane fraction. In contrast, in mice of the ET group an increase of VO2max, a shift to oxidative muscle fiber type and an increase of oxidative enzyme content was measured. Furthermore strength training was effective in reducing glucose intolerance in mice fed a high fat diet. An effective murine strength training model was developed and evaluated, which revealed marked differences in adaptations known from endurance training. This approach seems also suitable to test for therapeutical effects of strength training.	[Krueger, Karsten; Banisch, Jasmin; Mooren, Frank C.] Univ Giessen, Inst Sports Sci, Dept Sports Med, D-35390 Giessen, Germany; [Gessner, Denise K.; Ringseis, Robert; Eder, Klaus] Univ Giessen, Inst Anim Nutr & Nutr Physiol, D-35390 Giessen, Germany; [Seimetz, Michael; Weissmann, Norbert] Univ Giessen & Marburg Lung Ctr, Excellence Cluster Cardiopulm Syst ECCPS, Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen	Kruger, K (corresponding author), Univ Giessen, Inst Sports Sci, Dept Sports Med, D-35390 Giessen, Germany.	karsten.krueger@sport.uni-giessen.de	Ringseis, Robert/AAH-1509-2021; krueger, karsten/A-3062-2015	Weissmann, Norbert/0000-0003-2675-3871; Kruger, Karsten/0000-0003-1506-8254				Allen DL, 2001, J APPL PHYSIOL, V90, P1900, DOI 10.1152/jappl.2001.90.5.1900; Booth FW, 1998, ACTA PHYSIOL SCAND, V162, P343, DOI 10.1046/j.1365-201X.1998.0326e.x; Bradley RL, 2008, AM J PHYSIOL-ENDOC M, V295, pE586, DOI 10.1152/ajpendo.00309.2007; CARTEE GD, 1994, MED SCI SPORT EXER, V26, P577; Claflin DR, 2011, J APPL PHYSIOL, V111, P1021, DOI 10.1152/japplphysiol.01119.2010; D'Antona G, 2006, J PHYSIOL-LONDON, V570, P611, DOI 10.1113/jphysiol.2005.101642; Davidson SR, 2006, MED SCI SPORT EXER, V38, P250, DOI 10.1249/01.mss.0000183179.86594.4f; Diaz-Herrera P, 2001, J ORTHOPAED RES, V19, P229, DOI 10.1016/S0736-0266(00)00031-0; Diaz-Herrera P, 2001, HISTOL HISTOPATHOL, V16, P29, DOI 10.14670/HH-16.29; Farup J, 2012, J STRENGTH COND RES, V26, P398, DOI 10.1519/JSC.0b013e318225a26f; Fluck M, 2006, J EXP BIOL, V209, P2239, DOI 10.1242/jeb.02149; Fry AC, 2004, SPORTS MED, V34, P663, DOI 10.2165/00007256-200434100-00004; Gilda JE, 2013, ANAL BIOCHEM, V440, P186, DOI 10.1016/j.ab.2013.05.027; HAMALAINEN N, 1993, J HISTOCHEM CYTOCHEM, V41, P733, DOI 10.1177/41.5.8468455; Holten MK, 2004, DIABETES, V53, P294, DOI 10.2337/diabetes.53.2.294; Karavirta L, 2011, MED SCI SPORT EXER, V43, P484, DOI 10.1249/MSS.0b013e3181f1bf0d; Kivela R, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-13; KLITGAARD H, 1988, J APPL PHYSIOL, V64, P1740, DOI 10.1152/jappl.1988.64.4.1740; Konhilas JP, 2005, AM J PHYSIOL-HEART C, V289, pH455, DOI 10.1152/ajpheart.00085.2005; Kruger K, 2008, BRAIN BEHAV IMMUN, V22, P324, DOI 10.1016/j.bbi.2007.08.008; Kruger K, 2009, AM J PHYSIOL-REG I, V296, pR1518, DOI 10.1152/ajpregu.90994.2008; LaPier TLK, 2001, AM J HYPERTENS, V14, P708; Lee S, 2012, DIABETES, V29; Leick L, 2008, AM J PHYSIOL-ENDOC M, V294, pE463, DOI 10.1152/ajpendo.00666.2007; Loimaala A, 2009, AM J CARDIOL, V103, P972, DOI 10.1016/j.amjcard.2008.12.026; Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252; Ngo KTA, 2012, ACTA PHYSIOL, V205, P133, DOI 10.1111/j.1748-1716.2011.02379.x; Nicastro H, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/457065; Pasini E, 2012, EXP GERONTOL, V47, P23, DOI 10.1016/j.exger.2011.10.003; Ringseis R, 2011, MOL NUTR FOOD RES; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Ross A, 2001, SPORTS MED, V31, P1063, DOI 10.2165/00007256-200131150-00003; Seimetz M, 2011, CELL, V147, P293, DOI 10.1016/j.cell.2011.08.035; Shoelson SE, 2009, NAT MED, V15, P373, DOI 10.1038/nm0409-373; Tang JE, 2006, APPL PHYSIOL NUTR ME, V31, P495, DOI 10.1139/H06-026; Verdijk LB, 2009, J SPORT SCI, V27, P59, DOI 10.1080/02640410802428089; Wilson JM, 2012, J STRENGTH COND RES, V26, P1724, DOI 10.1519/JSC.0b013e318234eb6f; Yano H, 1997, JPN J PHYSIOL, V47, P139, DOI 10.2170/jjphysiol.47.139	38	20	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79069	10.1371/journal.pone.0079069	http://dx.doi.org/10.1371/journal.pone.0079069			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236089	gold, Green Published, Green Submitted			2022-12-27	WOS:000327254700087
J	Li, YP; Zhang, HZ; Wang, XD; She, L; Yan, ZC; Zhang, N; Du, RF; Yan, KX; Xu, EX; Pang, LJ				Li, Yuping; Zhang, Hengzhu; Wang, Xiaodong; She, Lei; Yan, Zhengcun; Zhang, Nan; Du, Renfei; Yan, Kaixuan; Xu, Enxi; Pang, Lujun			Neuroendoscopic Surgery versus External Ventricular Drainage Alone or with Intraventricular Fibrinolysis for Intraventricular Hemorrhage Secondary to Spontaneous Supratentorial Hemorrhage: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							SPONTANEOUS INTRACEREBRAL HEMORRHAGE; ENDOSCOPIC EVACUATION; HEMATOMA EVACUATION; HYDROCEPHALUS; REMOVAL; MANAGEMENT; OUTCOMES; SHUNT	Background and Purpose: Although neuroendoscopy (NE) has been applied to many cerebral diseases, the effect of NE for intraventricular hemorrhage (IVH) secondary to spontaneous supratentorial hemorrhage remains controversial. The purpose of this study was to analyze the effect of NE compared with external ventricular drainage (EVD) alone or with intraventricular fibrinolysis (IVF) on the management of IVH secondary to spontaneous supratentorial hemorrhage. Methodology/Principal Findings: A systematic search of electronic databases (PubMed, EMBASE, OVID, Web of Science, The Cochrane Library, CBM, VIP, CNKI, and Wan Fang database) was performed to identify related studies published from 1970 to 2013. Randomized controlled trials (RCTs) or observational studies (OS) comparing NE with EVD alone or with IVF for the treatment of IVH were included. The quality of the included trials was assessed by Jaded scale and the Newcastle-Ottawa Scale (NOS). RevMan 5.1 software was used to conduct the meta-analysis. Results: Eleven trials (5 RCTs and 6 ORs) involving 680 patients were included. The odds ratio (OR) showed a statistically significant difference between the NE + EVD and EVD + IVF groups in terms of mortality (OR, 0.31; 95% CI, 0.16-0.59; P=0.0004), effective hematoma evacuation rate (OR, 25.50, 95% CI; 14.30, 45.45; P<0.00001), good functional outcome (GFO) (OR, 4.51; (95% CI, 2.81-7.72; P<0.00001), and the ventriculo-peritoneal (VP) shunt dependence rate (OR, 0.16; 95% CI; 0.06, 0.40; P<0.0001). Conclusion: Applying neuroendoscopic approach with EVD may be a better management for IVH secondary to spontaneous supratentorial hemorrhage than NE + IVF. However, there is still no concluive evidence regarding the preference of NE vs. EVD alone in the case of IVH, because insufficient data has been published thus far. This study suggests that the NE approach with EVD could become an alternative to EVD + IVF for IVH in the future.	[Li, Yuping; Zhang, Hengzhu; Wang, Xiaodong; She, Lei; Yan, Zhengcun; Zhang, Nan; Du, Renfei; Yan, Kaixuan; Pang, Lujun] Yang Zhou Univ, Clin Med Coll, Dept Neurosurg, Yangzhou, Jiangsu, Peoples R China; [Xu, Enxi] First Peoples Hosp Zhenjiang, Dept Neurosurg, Zhenjiang, Jiangsu, Peoples R China	Yangzhou University	Zhang, HZ (corresponding author), Yang Zhou Univ, Clin Med Coll, Dept Neurosurg, Yangzhou, Jiangsu, Peoples R China.	zhanghengzhu@sina.com	de Lima, Juliana/R-7501-2018; Li, Yuping/C-4122-2014	Li, Yuping/0000-0002-4527-2582				Basaldella L, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.1.FOCUS11349; Bhattathiri PS, 2006, ACTA NEUROCHIR SUPPL, V96, P65; Brand RA, 2009, CLIN ORTHOP RELAT R, V467, P1393, DOI 10.1007/s11999-009-0786-x; Chen CC, 2011, WORLD NEUROSURG, V75, P264, DOI 10.1016/j.wneu.2010.07.041; DUAN HB, 2007, CHINA J EMERGENCY RE, V2, P75; Gaab MR, 2011, WORLD NEUROSURG, V75, P206, DOI 10.1016/j.wneu.2010.10.003; Gaberel T, 2012, NEUROSURG REV, V35, P485, DOI 10.1007/s10143-012-0399-9; Gaberel T, 2011, STROKE, V42, P2776, DOI 10.1161/STROKEAHA.111.615724; Garton HJL, 2002, NEUROSURGERY, V51, P69, DOI 10.1097/00006123-200207000-00012; GRAEB DA, 1982, RADIOLOGY, V143, P91, DOI 10.1148/radiology.143.1.6977795; Hamada H, 2008, MINIM INVAS NEUROSUR, V51, P345, DOI 10.1055/s-0028-1085449; Horvath Z, 2000, MINIM INVAS NEUROSUR, V43, P4, DOI 10.1055/s-2000-8410; Hsieh PC, 2005, SURG NEUROL, V64, P147, DOI 10.1016/j.surneu.2004.11.028; Huttner HB, 2006, J NEUROSURG, V105, P412, DOI 10.3171/jns.2006.105.3.412; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Komatsu F, 2010, NEUROL MED-CHIR, V50, P972, DOI 10.2176/nmc.50.972; Kuo LT, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.2.FOCUS10313; LANG M, 2009, MINIMALLY INVASIVE M, V4, P362; LI WJ, 2013, CHINESE J POSTGRADUA, V35, P47; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; LU ZW, 2011, CLIN MED CHINA, V27, P1192; Morgan T, 2008, ACTA NEUROCHIR SUPPL, V105, P217; Naff NJ, 2000, STROKE, V31, P841, DOI 10.1161/01.STR.31.4.841; Nieuwkamp DJ, 2000, J NEUROL, V247, P117, DOI 10.1007/PL00007792; Nishikawa T, 2009, CLIN NEUROL NEUROSUR, V111, P450, DOI 10.1016/j.clineuro.2009.01.005; Oertel JMK, 2009, J NEUROSURG, V110, P14, DOI 10.3171/2008.7.JNS0887; PATIL V, 2013, ACTA NEUROCHIR WIEN; RITSCHL E, 1987, ARCH DIS CHILD, V62, P1163, DOI 10.1136/adc.62.11.1163; Rosen DS, 2007, J NEUROSURG, V107, P261, DOI 10.3171/JNS-07/08/0261; Rosenberg MS, 2005, EVOLUTION, V59, P464, DOI 10.1111/j.0014-3820.2005.tb01004.x; Singh D, 2012, BRIT J NEUROSURG, V26, P747, DOI 10.3109/02688697.2012.690908; SONG TM, 2010, JILIN MED J, V31, P2205; Staykov D, 2012, MED KLIN-INTENSIVMED, V107, P192, DOI 10.1007/s00063-012-0100-7; Staykov D, 2011, NEUROCRIT CARE, V15, P194, DOI 10.1007/s12028-010-9390-x; Steiner T, 2006, NEUROSURGERY, V59, P767, DOI 10.1227/01.NEU.0000232837.34992.32; WANG LF, 2011, CHINA PRAC MED, V6, P64; Webb AJS, 2012, STROKE, V43, P1666, DOI 10.1161/STROKEAHA.112.650523; WELLS GA, 2006, NEWCASTLE OTTAWA SCA; Yadav YR, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-1; YU LL, 2012, CHINESE J POSTGRADUA, V35, P59; ZHANG HL, 2008, CHINESE J PRACTICAL, V11, P18; Zhang ZQ, 2007, CEREBROVASC DIS, V24, P91, DOI 10.1159/000103122; Zhou HG, 2011, J NEUROL, V258, P661, DOI 10.1007/s00415-011-5902-7; Zhu HW, 2012, TURK NEUROSURG, V22, P294, DOI 10.5137/1019-5149.JTN.5136-11.1	45	35	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80599	10.1371/journal.pone.0080599	http://dx.doi.org/10.1371/journal.pone.0080599			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24232672	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700188
J	Schmidt, VJ; Hilgert, JG; Covi, JM; Weis, C; Wietbrock, JO; de Wit, C; Horch, RE; Kneser, U				Schmidt, Volker J.; Hilgert, Johannes G.; Covi, Jennifer M.; Weis, Christian; Wietbrock, Johanna O.; de Wit, Cor; Horch, Raymund E.; Kneser, Ulrich			High Flow Conditions Increase Connexin43 Expression in a Rat Arteriovenous and Angioinductive Loop Model	PLOS ONE			English	Article							GAP-JUNCTION COMMUNICATION; ANGIOGENESIS; MIGRATION; DILATIONS; CELLS; ENDOTHELIUM; ARTERIOLES; MATRIX	Gap junctions are involved in vascular growth and their expression pattern is modulated in response to hemodynamic conditions. They are clusters of intercellular channels formed by connexins (Cx) of which four subtypes are expressed in the cardiovascular system, namely Cx37, Cx40, Cx43 and Cx45. We hypothesize that high flow conditions affect vascular expression of Cx in vivo. To test this hypothesis, flow hemodynamics and subsequent changes in vascular expression of Cx were studied in an angioinductive rat arteriovenous (AV) loop model. Fifteen days after interposition of a femoral vein graft between femoral artery and vein encased in a fibrin-filled chamber strong neovascularization was evident that emerged predominantly from the graft. Blood flow through the grafted vessel was enhanced similar to 4.5-fold accompanied by increased pulsatility exceeding arterial levels. Whereas Cx43 protein expression in the femoral vein is negligible at physiologic flow conditions as judged by immunostaining its expression was enhanced in the endothelium of the venous graft exposed to these hemodynamic changes for 5 days. This was most likely due to enhanced transcription since Cx43 mRNA increased likewise, whereas Cx37 mRNA expression remained unaffected and Cx40 mRNA was reduced. Although enhanced Cx43 expression in regions of high flow in vivo has already been demonstrated, the arteriovenous graft used in the present study provides a reliable model to verify an association between Cx43 expression and high flow conditions in vivo that was selective for this Cx. We conclude that enhancement of blood flow and its oscillation possibly associated with the transition from laminar to more turbulent flow induces Cx43 expression in a vein serving as an AV loop. It is tempting to speculate that this upregulation is involved in the vessel formation occuring in this model as Cx43 was suggested to be involved in angiogenesis.	[Schmidt, Volker J.; Hilgert, Johannes G.; Covi, Jennifer M.; Horch, Raymund E.; Kneser, Ulrich] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Plast & Hand Surg, D-91054 Erlangen, Germany; [Schmidt, Volker J.; Wietbrock, Johanna O.; Kneser, Ulrich] Heidelberg Univ, Dept Hand Plast & Reconstruct Surg, BG Unfallklin Ludwigshafen, Heidelberg, Germany; [Weis, Christian] Univ Erlangen Nurnberg, Dept Phys, D-91054 Erlangen, Germany; [de Wit, Cor] Univ Lubeck, Dept Physiol, Lubeck, Germany	University of Erlangen Nuremberg; Ruprecht Karls University Heidelberg; University of Erlangen Nuremberg; University of Lubeck	Schmidt, VJ (corresponding author), Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Plast & Hand Surg, D-91054 Erlangen, Germany.	schmidtvolker@gmx.net	de Wit, Cor/A-5560-2009; Horch, Raymund E./H-8128-2019	de Wit, Cor/0000-0003-4621-0399; Horch, Raymund E./0000-0002-6561-2353	Interdisciplinary Center for Clinical Research (IZKF) at the University Hospital of the University Erlangen-Nuremberg [TP J-15]	Interdisciplinary Center for Clinical Research (IZKF) at the University Hospital of the University Erlangen-Nuremberg	This work was supported by the Interdisciplinary Center for Clinical Research (IZKF) at the University Hospital of the University Erlangen-Nuremberg (to VJS, TP J-15, www.izkf.med.uni-erlangen.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkudas A, 2007, MOL MED, V13, P480, DOI 10.2119/2007-00057.Arkudas; Arkudas A, 2010, TISSUE ENG PART C-ME, V16, P1503, DOI 10.1089/ten.tec.2010.0016; Batra N, 2012, P NATL ACAD SCI USA, V109, P3359, DOI 10.1073/pnas.1115967109; Boettcher M, 2011, HYPERTENSION, V57, P802, DOI 10.1161/HYPERTENSIONAHA.110.165894; Buschmann I, 2010, DEVELOPMENT, V137, P2187, DOI 10.1242/dev.045351; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Cowan DB, 1998, CIRC RES, V82, P786, DOI 10.1161/01.RES.82.7.786; de Wit C, 2006, BIOL CHEM, V387, P3, DOI 10.1515/BC.2006.002; de Wit C, 2004, NEWS PHYSIOL SCI, V19, P148, DOI 10.1152/nips.01520.2004; de Wit C, 2010, CARDIOVASC RES, V85, P604, DOI 10.1093/cvr/cvp340; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; EROL OO, 1979, SURG FORUM, V30, P530; Fang JS, 2011, AM J PHYSIOL-HEART C, V301, pH1872, DOI 10.1152/ajpheart.00683.2011; Gabriels JE, 1998, CIRC RES, V83, P636, DOI 10.1161/01.RES.83.6.636; Gartner C, 2012, PHARMACOL RES, V65, P347, DOI 10.1016/j.phrs.2011.11.012; Gustafsson F, 2003, HISTOCHEM CELL BIOL, V119, P139, DOI 10.1007/s00418-002-0493-0; Hill CE, 2012, J CARDIOVASC PHARM; Hong T, 1998, J ANAT, V192, P583, DOI 10.1046/j.1469-7580.1998.19240583.x; Inai T, 2009, ANAT SCI INT, V84, P237, DOI 10.1007/s12565-009-0029-y; Jansen JA, 2010, J MOL CELL CARDIOL, V48, P76, DOI 10.1016/j.yjmcc.2009.08.018; Jia GH, 2008, J MOL CELL CARDIOL, V44, P882, DOI 10.1016/j.yjmcc.2008.03.002; Jobs A, 2012, HYPERTENSION, V60, P1422, DOI 10.1161/HYPERTENSIONAHA.112.201194; Kneser U, 2006, TISSUE ENG, V12, P1721, DOI 10.1089/ten.2006.12.1721; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Laws MJ, 2008, DEVELOPMENT, V135, P2659, DOI 10.1242/dev.019810; Olk S, 2009, CELL MOTIL CYTOSKEL, V66, P1000, DOI 10.1002/cm.20404; Polykandriotis E, 2008, MICROVASC RES, V75, P25, DOI 10.1016/j.mvr.2007.04.003; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Rhee DY, 2009, DEVELOPMENT, V136, P3185, DOI 10.1242/dev.032334; Rummery NM, 2002, ARTERIOSCL THROM VAS, V22, P1427, DOI 10.1161/01.ATV.0000028814.45706.E5; Sarieddine MZR, 2009, J CELL MOL MED, V13, P4560, DOI 10.1111/j.1582-4934.2008.00654.x; Schmidt VJ, 2008, PHARMACOL REP, V60, P68; Schmidt VJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042287; Vorderwulbecke BJ, 2011, AM J PHYSL HEART CIR; Wang HH, 2008, CARDIOVASC RES, V79, P509, DOI 10.1093/cvr/cvn112; Wolfle SE, 2007, CIRC RES, V101, P1292, DOI 10.1161/CIRCRESAHA.107.163279	36	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78782	10.1371/journal.pone.0078782	http://dx.doi.org/10.1371/journal.pone.0078782			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236049	Green Published, gold			2022-12-27	WOS:000327254700046
J	Sutter, AG; Palanisamy, AP; Kurtz, N; Spyropoulos, DD; Chavin, KD				Sutter, Alton G.; Palanisamy, Arun P.; Kurtz, Nichole; Spyropoulos, Demetri D.; Chavin, Kenneth D.			Efficient Method of Genotyping Ob/Ob Mice Using High Resolution Melting Analysis	PLOS ONE			English	Article							LEP(OB) MUTATION; LEPTIN; GENE; PCR; ASSAY; SNP	Objective: Direct health care costs of obesity continue to grow throughout the world and research on obesity disease models are on the rise. The ob/ob mouse is a well-characterized model of obesity and associated risk factors. Successful breeding and backcrossing onto different backgrounds are essential to create knockout models. Ob/ob mice are sterile and heterozygotes must be identified by genotyping to maintain breeding colonies. Several methods are employed to detect the ob mutant allele, a single nucleotide polymorphism (SNP). Gel based methods are time consuming and inconsistent, and non-gel based assays rely upon expensive and complex reagents or instruments. A fast, high-throughput, cost effective, and consistent method to identify Lep(ob) mutation is much needed. Design and Methods: Primers to produce an amplicon for High Resolution Melting Analysis (HRM) of the Lep(ob) SNP were designed and validated. Results: Fluorescence normalized high resolution melting curve plots delineated ob/+, ob/ob, and WT genotypes. Genotypes were also confirmed phenotypically. Conclusions: HRM of the Lep(ob) SNP allows closed-tube identification of the Lep(ob) mutation using a real-time PCR machine now common to most labs/departments. Advantages of this method include assay sensitivity/accuracy, low cost dyes, less optimization, and cost effectiveness as compared to other genotyping techniques.	[Sutter, Alton G.; Palanisamy, Arun P.; Kurtz, Nichole; Chavin, Kenneth D.] Med Univ S Carolina, Dept Surg, Div Transplant Surg, Charleston, SC 29425 USA; [Spyropoulos, Demetri D.] Med Univ S Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Palanisamy, AP (corresponding author), Med Univ S Carolina, Dept Surg, Div Transplant Surg, Charleston, SC 29425 USA.	arunp@musc.edu	Palanisamy, Arun/I-7712-2019; Sutter, Alton/GWV-3369-2022; Palanisamy, Arun/L-2019-2014	Palanisamy, Arun/0000-0002-7793-0682; Palanisamy, Arun/0000-0002-7793-0682				Chehab FE, 1996, NAT GENET, V12, P318, DOI 10.1038/ng0396-318; Chen WJ, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-45; Chung WK, 1997, OBES RES, V5, P183, DOI 10.1002/j.1550-8528.1997.tb00291.x; COLEMAN DL, 1979, SCIENCE, V203, P663, DOI 10.1126/science.760211; Ellett JD, 2009, OBESITY, V17, P402, DOI 10.1038/oby.2008.443; Haller EW, 1999, AM J PHYSIOL-ENDOC M, V276, pE762, DOI 10.1152/ajpendo.1999.276.4.E762; Hill HR, 2010, J MOL DIAGN, V12, P368, DOI 10.2353/jmoldx.2010.090147; Hirasawa T, 1997, EXP ANIM TOKYO, V46, P75, DOI 10.1538/expanim.46.75; Jackson, 2012, GENOTYPING PROTOCOLS; Malik VS, 2013, NAT REV ENDOCRINOL, V9, P13, DOI 10.1038/nrendo.2012.199; Namae M, 1998, LAB ANIM SCI, V48, P103; Oler AT, 2008, J LIPID RES, V49, P1126, DOI 10.1194/jlr.D800002-JLR200; Ong DCT, 2010, J CLIN MICROBIOL, V48, P1047, DOI 10.1128/JCM.02036-09; Siegmund B, 2004, J LEUKOCYTE BIOL, V76, P782, DOI 10.1189/jlb.0404239; Sinthuwiwat T, 2008, MOL CELL PROBE, V22, P329, DOI 10.1016/j.mcp.2008.07.004; Trevaskis JL, 2005, ENDOCRINOLOGY, V146, P4257, DOI 10.1210/en.2005-0492	16	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78840	10.1371/journal.pone.0078840	http://dx.doi.org/10.1371/journal.pone.0078840			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236058	gold, Green Published, Green Submitted			2022-12-27	WOS:000327254700055
J	Hijaz, FM; Manthey, JA; Folimonova, SY; Davis, CL; Jones, SE; Reyes-De-Corcuera, JI				Hijaz, Faraj M.; Manthey, John A.; Folimonova, Svetlana Y.; Davis, Craig L.; Jones, Shelley E.; Reyes-De-Corcuera, Jose I.			An HPLC-MS Characterization of the Changes in Sweet Orange Leaf Metabolite Profile following Infection by the Bacterial Pathogen Candidatus Liberibacter asiaticus	PLOS ONE			English	Article							HUANGLONGBING DISEASE; PHENOLIC-COMPOUNDS; TOMATO LEAVES; CITRUS; ACID; DIFFERENTIATION; IDENTIFICATION; ACCUMULATION; DIAGNOSIS; DEFENSE	Huanglongbing (HLB) presumably caused by Candidatus Liberibacter asiaticus (CLas) threatens the commercial U.S. citrus crop of an annual value of $3 billion. The earliest shift in metabolite profiles of leaves from greenhouse-grown sweet orange trees infected with Clas, and of healthy leaves, was characterized by HPLC-MS concurrently with PCR testing for the presence of Clas bacteria and observation of disease symptoms. Twenty, 8-month-old 'Valencia' and 'Hamlin' trees were grafted with budwood from PCR-positive HLB source trees. Five graft-inoculated trees of each variety and three control trees were sampled biweekly and analyzed by HPLC-MS and PCR. Thirteen weeks after inoculation, Clas was detected in newly growing flushes in 33% and 55% of the inoculated 'Hamlin' and 'Valencia' trees, respectively. Inoculated trees remained asymptomatic in the first 20 weeks, but developed symptoms 30 weeks after grafting. No significant differences in the leaf metabolite profiles were detected in Clas-infected trees 23 weeks after inoculation. However, 27 weeks after inoculation, differences in metabolite profiles between control leaves and those of Clas-infected trees were evident. Affected compounds were identified with authentic standards or structurally classified by their UV and mass spectra. Included among these compounds are flavonoid glycosides, polymethoxylated flavones, and hydroxycinnamates. Four structurally related hydroxycinnamate compounds increased more than 10-fold in leaves from 'Hamlin' and 'Valencia' sweet orange trees in response to Clas infection. Possible roles of these hydroxycinnamates as plant defense compounds against the Clas infection are discussed.	[Hijaz, Faraj M.; Davis, Craig L.; Reyes-De-Corcuera, Jose I.] Univ Florida, Citrus Res & Educ Ctr, IFAS, Lake Alfred, FL USA; [Manthey, John A.] ARS, US Hort Res Lab, USDA, Ft Pierce, FL USA; [Folimonova, Svetlana Y.; Davis, Craig L.] Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; United States Department of Agriculture (USDA); State University System of Florida; University of Florida	Reyes-De-Corcuera, JI (corresponding author), Univ Georgia, Dept Food Sci & Technol, CAES, Athens, GA 30602 USA.	jireyes@ufl.edu	Folimonova, Svetlana/T-2592-2019	Hijaz, Faraj/0000-0002-8079-161X	USDA CSREES NIFA [2009-34446-20228]	USDA CSREES NIFA(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This research was funded by the USDA CSREES NIFA project number 2009-34446-20228. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin E, 2010, J AGR FOOD CHEM, V58, P1247, DOI 10.1021/jf9031958; Batool A, 2007, HORTIC SCI, V34, P159, DOI 10.17221/1897-HORTSCI; Bove JM, 2006, J PLANT PATHOL, V88, P7; Cevallos-Cevallos JM, 2012, PLANT PHYSIOL BIOCH, V53, P69, DOI 10.1016/j.plaphy.2012.01.010; Cevallos-Cevallos JM, 2011, PHYTOCHEM ANALYSIS, V22, P236, DOI 10.1002/pca.1271; Cevallos-Cevallos JM, 2009, ELECTROPHORESIS, V30, P1240, DOI 10.1002/elps.200800594; Coletta HD, 2010, EUR J PLANT PATHOL, V126, P53, DOI 10.1007/s10658-009-9523-2; Daayf F, 2000, J CHEM ECOL, V26, P1579, DOI 10.1023/A:1005578510954; De Vos RCH, 2007, NAT PROTOC, V2, P778, DOI 10.1038/nprot.2007.95; Dettmer K, 2007, MASS SPECTROM REV, V26, P51, DOI 10.1002/mas.20108; Duenas M, 2005, J SCI FOOD AGR, V85, P297, DOI 10.1002/jsfa.1924; Folimonova SY, 2010, PHYTOPATHOLOGY, V100, P949, DOI 10.1094/PHYTO-100-9-0949; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; HOOKER ME, 1993, PLANT DIS, V77, P174, DOI 10.1094/PD-77-0174; KANES K, 1993, PHYTOCHEMISTRY, V32, P967, DOI 10.1016/0031-9422(93)85237-L; Lin H, 2013, PHYTOPATHOLOGY, V103, P524, DOI 10.1094/PHYTO-09-12-0238-RVW; Manthey J, 2008, P FLA STATE HORT SOC, V12, P285; Manthey JA, 2001, J AGR FOOD CHEM, V49, P3268, DOI 10.1021/jf010011r; Manthey JA, 2000, PLANT PHYSIOL BIOCH, V38, P333, DOI 10.1016/S0981-9428(00)00748-8; Cevallos-Cevallos JM, 2008, PROC FL STATE HORTIC, V121, P85; Belles JM, 2008, PLANT SCI, V174, P524, DOI 10.1016/j.plantsci.2008.02.008; Markham KR, FLAVONOIDS, DOI 10.1016/0022-2860(71)87109-0; Pearce G, 1998, PHYTOCHEMISTRY, V47, P659, DOI 10.1016/S0031-9422(97)00620-1; Lopez-Gresa MP, 2010, PHYTOCHEM ANALYSIS, V21, P89, DOI 10.1002/pca.1179; Lopez-Gresa MP, 2011, ENVIRON EXP BOT, V74, P216, DOI 10.1016/j.envexpbot.2011.06.003; Rashed A, 2013, PHYTOPATHOLOGY, V103, P419, DOI 10.1094/PHYTO-09-12-0244-R; RISCH B, 1987, PHYTOCHEMISTRY, V26, P509, DOI 10.1016/S0031-9422(00)81444-2; RISCH B, 1988, PHYTOCHEMISTRY, V27, P3327, DOI 10.1016/0031-9422(88)80059-1; Slisz AM, 2012, J PROTEOME RES, V11, P4223, DOI 10.1021/pr300350x; STRACK D, 1986, PHYTOCHEMISTRY, V25, P2605, DOI 10.1016/S0031-9422(00)84518-5; Takushi T., 2007, Japanese Journal of Phytopathology, V73, P3, DOI 10.3186/jjphytopath.73.3; Tatineni S, 2008, PHYTOPATHOLOGY, V98, P592, DOI 10.1094/PHYTO-98-5-0592; von Roepenack-Lahaye E, 2003, J BIOL CHEM, V278, P43373, DOI 10.1074/jbc.M305084200; Wallis CM, 2012, PHYTOPATHOLOGY, V102, P816, DOI 10.1094/PHYTO-04-12-0074-R; WHEATON TA, 1965, NATURE, V206, P620, DOI 10.1038/206620a0; WHEATON TA, 1965, ANAL BIOCHEM, V12, P585, DOI 10.1016/0003-2697(65)90226-5	36	39	42	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79485	10.1371/journal.pone.0079485	http://dx.doi.org/10.1371/journal.pone.0079485			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223954	gold, Green Submitted, Green Published			2022-12-27	WOS:000326597400068
J	Oohashi, H; Watanabe, H; Taga, G				Oohashi, Hiroki; Watanabe, Hama; Taga, Gentaro			Development of a Serial Order in Speech Constrained by Articulatory Coordination	PLOS ONE			English	Article							MOTOR CONTROL; CONSONANT SEQUENCES; GESTURAL OVERLAP; INFANTS; MODEL; ORGANIZATION; MOVEMENTS; PATTERNS; ORIGIN; VOWELS	Universal linguistic constraints seem to govern the organization of sound sequences in words. However, our understanding of the origin and development of these constraints is incomplete. One possibility is that the development of neuromuscular control of articulators acts as a constraint for the emergence of sequences in words. Repetitions of the same consonant observed in early infancy and an increase in variation of consonantal sequences over months of age have been interpreted as a consequence of the development of neuromuscular control. Yet, it is not clear how sequential coordination of articulators such as lips, tongue apex and tongue dorsum constrains sequences of labial, coronal and dorsal consonants in words over the course of development. We examined longitudinal development of consonant-vowel-consonant(-vowel) sequences produced by Japanese children between 7 and 60 months of age. The sequences were classified according to places of articulation for corresponding consonants. The analyses of individual and group data show that infants prefer repetitive and fronting articulations, as shown in previous studies. Furthermore, we reveal that serial order of different places of articulations within the same organ appears earlier and then gradually develops, whereas serial order of different articulatory organs appears later and then rapidly develops. In the same way, we also analyzed the sequences produced by English children and obtained similar developmental trends. These results suggest that the development of intra-and inter-articulator coordination constrains the acquisition of serial orders in speech with the complexity that characterizes adult language.	[Oohashi, Hiroki; Watanabe, Hama; Taga, Gentaro] Univ Tokyo, Grad Sch Educ, Tokyo, Japan; [Oohashi, Hiroki] Koujimachi Business Ctr, Japan Soc Promot Sci, Tokyo, Japan	University of Tokyo; Japan Society for the Promotion of Science	Oohashi, H (corresponding author), Univ Tokyo, Grad Sch Educ, Tokyo, Japan.	hiro084@gmail.com			Japan Society for the Promotion of Science [12J08436];  [20670001];  [24119002]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; 	The study was supported by a grant for the Fellows of the Japan Society for the Promotion of Science (No. 12J08436) awarded to H.O. and a Grant-in-Aid for Scientific Research (No. 20670001 and No. 24119002) awarded to G. T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano S, 2006, J ACOUST SOC AM, V119, P1636, DOI 10.1121/1.2161443; Amano S, 2009, SPEECH COMMUN, V51, P510, DOI 10.1016/j.specom.2009.01.009; Bishop C. M, 2006, PATTERN RECOGNITION; BROWMAN CP, 1990, J PHONETICS, V18, P299, DOI 10.1016/S0095-4470(19)30376-6; Byrd D, 1996, J PHONETICS, V24, P209, DOI 10.1006/jpho.1996.0012; Chitoran I, 2002, PHONOL PHONET, V4-1, P419; Chomsky Noam, 1968, SOUND PATTERN ENGLIS; Davis B, 2007, PHONBANK ENGLISH DAV; DAVIS BL, 1995, J SPEECH HEAR RES, V38, P1199, DOI 10.1044/jshr.3806.1199; de Boysson-Bardies B., 1999, LANGUAGE COMES CHILD; Fikkert P, 2008, PHONOL PHONET, V13, P231; FUJIMURA O, 1981, PHONETICA, V38, P66, DOI 10.1159/000260015; Giulivi S, 2011, LANG LEARN DEV, V7, P202, DOI 10.1080/15475441.2011.564569; Goffman L, 1999, J EXP PSYCHOL HUMAN, V25, P649, DOI 10.1037/0096-1523.25.3.649; Golfinopoulos E, 2010, NEUROIMAGE, V52, P862, DOI 10.1016/j.neuroimage.2009.10.023; Green JR, 2000, J SPEECH LANG HEAR R, V43, P239, DOI 10.1044/jslhr.4301.239; Grimme B, 2011, MOTOR CONTROL, V15, P5, DOI 10.1123/mcj.15.1.5; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Ingram D, 1974, J CHILD LANG, Vi, P233, DOI DOI 10.1017/S0305000900000672; Ishizuka K, 2007, J ACOUST SOC AM, V121, P2272, DOI 10.1121/1.2535806; Kajikawa S, 2004, J CHILD LANG, V31, P215, DOI 10.1017/S0305000903005968; KELSO JAS, 1984, J EXP PSYCHOL HUMAN, V10, P812, DOI 10.1037/0096-1523.10.6.812; Kent RD, 2004, CLIN LINGUIST PHONET, V18, P495, DOI 10.1080/02699200410001703600; Lashley K., 1951, CEREBRAL MECH BEHAV, P112, DOI DOI 10.1093/RFS/HHQ153; Locke J., 1983, PHONOLOGICAL ACQUISI, DOI DOI 10.2307/414500; MacNeilage P.F., 2008, ORIGIN SPEECH; MacNeilage PF, 2000, SCIENCE, V288, P527, DOI 10.1126/science.288.5465.527; MacNeilage PF, 1999, PSYCHOL SCI, V10, P459, DOI 10.1111/1467-9280.00187; MacWhinney B., 2000, CHILDES PROJECT, V2; Matyear CL, 1998, PHONETICA, V55, P1, DOI 10.1159/000028422; Nam H, 2009, PHONOL PHONET, V16, P299; Nazzi T, 2009, J ACOUST SOC AM, V126, P1440, DOI 10.1121/1.3158931; Nip ISB, 2009, J COMMUN DISORD, V42, P286, DOI 10.1016/j.jcomdis.2009.03.008; NITTROUER S, 1993, J SPEECH HEAR RES, V36, P959, DOI 10.1044/jshr.3605.959; Rochet-Capellan A, 2007, J ACOUST SOC AM, V121, P3740, DOI 10.1121/1.2734497; Serkhane JE, 2007, J PHONETICS, V35, P321, DOI 10.1016/j.wocn.2006.10.002; Smith A, 2004, DEV PSYCHOL, V45, P1077; Tremblay S, 2003, NATURE, V423, P866, DOI 10.1038/nature01710; Tsuji S, 2012, COGNITION, V125, P413, DOI 10.1016/j.cognition.2012.07.017; Vihman M. M., 1978, UNIVERSALS HUMAN LAN, V2, P281; Vilain A., 1999, P 14 INT C PHON SCI, V3, P2497; Vorperian HK, 2005, J ACOUST SOC AM, V117, P338, DOI 10.1121/1.1835958; Walker JF, 2006, INT J LANG COMM DIS, V41, P541, DOI 10.1080/10428190500343043; Wilson Erin M., 2008, Seminars in Speech and Language, V29, P257, DOI 10.1055/s-0028-1103389; ZSIGA EC, 1994, J PHONETICS, V22, P121, DOI 10.1016/S0095-4470(19)30189-5	45	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78600	10.1371/journal.pone.0078600	http://dx.doi.org/10.1371/journal.pone.0078600			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	247EE	24223827	Green Published, Green Submitted, gold			2022-12-27	WOS:000326597400034
J	Zhang, TT; Bai, XH; Mao, XH				Zhang, Tiantian; Bai, Xuehua; Mao, Xiaohua			Systemic Delivery of Small Interfering RNA Targeting the Interleukin-2/15 Receptor beta Chain Prevents Disease Progression in Experimental Arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; TUMOR-NECROSIS-FACTOR; RHEUMATOID-ARTHRITIS; MURINE ARTHRITIS; QUANTUM DOTS; FACTOR-ALPHA; TNF-ALPHA; IN-VIVO; CYTOKINE; IL-15	The role of interleukin (IL)-15 in the pathogenesis of rheumatoid arthritis (RA) is well established; however, systemic knockdown of IL-15 receptor (IL-15R) for reduction in inflammation at local sites has not been demonstrated. In this study, the therapeutic effect of intravenously administered siRNA targeting the beta chain of IL-15R which is shared by the receptor for IL-2 was examined in rats with adjuvant-induced arthritis (AA). Polyethylenimine (PEI)-complexed siRNA nanoparticles could easily accumulate in arthritic paws of AA rats. In the paws, the nanoparticles were avidly taken up by macrophages and to a lesser extent by T cells. Weekly administered IL-2/15R beta siRNA polyplexes were capable of decreasing disease progression in AA rats, with striking inhibition of clinical, radiologic, and histologic features of RA. The observed therapeutic effect was associated with reduced expression of proinflammatory mediators in the inflamed joints. Thus, this study provides evidence that IL-2/15R beta could be targeted for the treatment of RA.	[Zhang, Tiantian; Bai, Xuehua; Mao, Xiaohua] Southeast Univ, Sch Life Sci, Minist Educ Dev Genes & Human Dis, Key Lab, Nanjing, Jiangsu, Peoples R China; [Mao, Xiaohua] Southeast Univ, Sch Med, Dept Biochem, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China	Mao, XH (corresponding author), Southeast Univ, Sch Life Sci, Minist Educ Dev Genes & Human Dis, Key Lab, Nanjing, Jiangsu, Peoples R China.	xmao@seu.edu.cn			National Natural Science Foundation of China [81071445]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (81071445). The URL of the funder's website is www.nsfc.gov.cn. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2007, J CLIN INVEST, V117, P3623, DOI 10.1172/JCI33494; Andersson AK, 2008, SCAND J IMMUNOL, V68, P103, DOI 10.1111/j.1365-3083.2008.02118.x; Arend WP, 2001, ARTHRIT RHEUM-ARTHR, V45, P101; Asquith DL, 2007, CURR OPIN RHEUMATOL, V19, P246, DOI 10.1097/BOR.0b013e3280eec78c; Bachmann MF, 2007, EMBO REP, V8, P1142, DOI 10.1038/sj.embor.7401099; Bartlett DW, 2006, NUCLEIC ACIDS RES, V34, P322, DOI 10.1093/nar/gkj439; Bonnet ME, 2008, PHARM RES-DORDR, V25, P2972, DOI 10.1007/s11095-008-9693-1; Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389; Choi HS, 2007, NAT BIOTECHNOL, V25, P1165, DOI 10.1038/nbt1340; Choi HS, 2009, NANO LETT, V9, P2354, DOI 10.1021/nl900872r; Depis F, 2012, ARTHRITIS RHEUM-US, V64, P3189, DOI 10.1002/art.34497; Ernestam S, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1871; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Ferrari-Lacraz S, 2004, J IMMUNOL, V173, P5818, DOI 10.4049/jimmunol.173.9.5818; Frohlich E, 2012, INT J NANOMED, V7, P5577, DOI 10.2147/IJN.S36111; Gao J, 2011, BIOMATERIALS, V32, P3459, DOI 10.1016/j.biomaterials.2011.01.034; Gonzalez-Alvaro I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029492; Guo ST, 2010, ACS NANO, V4, P5505, DOI 10.1021/nn101638u; Howard KA, 2009, MOL THER, V17, P162, DOI 10.1038/mt.2008.220; Khoury M, 2006, ARTHRITIS RHEUM, V54, P1867, DOI 10.1002/art.21876; Khoury M, 2008, ARTHRITIS RHEUM-US, V58, P2356, DOI 10.1002/art.23660; Knevel R, 2012, ANN RHEUM DIS, V71, P1651, DOI 10.1136/annrheumdis-2011-200724; Kurreeman FAS, 2009, ANN RHEUM DIS, V68, P1789, DOI 10.1136/ard.2008.106393; Kuuliala A, 2006, ANN RHEUM DIS, V65, P26, DOI 10.1136/ard.2004.034728; McInnes IB, 2010, ANN RHEUM DIS, V69, P1898, DOI 10.1136/ard.2010.134684; McInnes IB, 2004, CURR OPIN PHARMACOL, V4, P392, DOI 10.1016/j.coph.2004.04.003; McInnes IB, 1997, NAT MED, V3, P189, DOI 10.1038/nm0297-189; McInnes IB, 1996, NAT MED, V2, P175, DOI 10.1038/nm0296-175; Mitragotri S, 2011, ARCH PHARM RES, V34, P1887, DOI 10.1007/s12272-011-1109-9; Naeye B, 2013, BIOMATERIALS, V34, P2350, DOI 10.1016/j.biomaterials.2012.11.058; Ogata Y, 1999, J IMMUNOL, V162, P2754; Ruchatz H, 1998, J IMMUNOL, V160, P5654; Schett G, 2012, NAT REV RHEUMATOL, V8, P656, DOI 10.1038/nrrheum.2012.153; Schindler CW, 2002, J CLIN INVEST, V109, P1133, DOI 10.1172/JCI200215644; Waldmann TA, 1999, ANNU REV IMMUNOL, V17, P19, DOI 10.1146/annurev.immunol.17.1.19; Wang DL, 2010, MOL IMMUNOL, V47, P1535, DOI 10.1016/j.molimm.2010.01.023; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Ye C, 2013, SCAND J RHEUMATOL, V42, P266, DOI 10.3109/03009742.2013.777779; Zuckerman JE, 2012, P NATL ACAD SCI USA, V109, P3137, DOI 10.1073/pnas.1200718109	39	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78619	10.1371/journal.pone.0078619	http://dx.doi.org/10.1371/journal.pone.0078619			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223832	Green Published, Green Submitted, gold			2022-12-27	WOS:000326597400036
J	Saman, DM; Kavanagh, KT				Saman, Daniel M.; Kavanagh, Kevin T.			Assessing the Necessity of the Standardized Infection Ratio for Reporting Central Line-Associated Bloodstream Infections	PLOS ONE			English	Article								This brief article presents results that support the contention that risk adjustment via the standardized infection ratio (SIR) for the reporting of central line-associated bloodstream infections (CLABSIs) may be no more predictive than standard rate adjustments utilizing CLABSIs per central line days (i.e., CLABSI rates). Recent data posted on the U. S. Department of Health and Human Services' Hospital Compare website showed that nearly 70% of 1721 reporting hospitals with at least 1000 central line days had five or fewer infections during 2011. These hospitals had 39.3% of the total central line days and a significantly lower SIR than poorer performing hospitals with six or more CLABSIs (p<0.0001). In addition, 19 hospitals are presented which had central line days between 9000 to over 22,000 that also had zero to three CLABSIs. Some of these hospitals were university referral centers and inner city facilities. There was great variation of CLABSI cases among US hospitals. Evidence is mounting that all hospitals should be able to achieve a near zero incidence of CLABSIs and that these infections may in fact be near 'never events', which begs whether risk adjustment with the SIR is needed and whether it adds more information than does rate adjustment using CLABSI rates.	[Saman, Daniel M.] Essentia Inst Rural Hlth, Div Res, Duluth, MN USA; [Saman, Daniel M.; Kavanagh, Kevin T.] Hlth Watch USA, Somerset, KY USA		Saman, DM (corresponding author), Essentia Inst Rural Hlth, Div Res, Duluth, MN USA.	dmsaman@eirh.org		Saman, Daniel/0000-0002-8372-4615; Kavanagh, Kevin/0000-0002-4588-6509				Berenholtz SM, 2004, CRIT CARE MED, V32, P2014, DOI 10.1097/01.CCM.0000142399.70913.2F; Center for Disease Control and Prevention, 2011, NAT STAT HEALTHC ASS; Centers for Disease Control and Prevention, 2012, NAT STAT HEALTHC ASS; Centers for Medicare & Medicaid Services, 2012, HOSOP COMP RETR OUTP; Centre for Disease Control and Prevention National Center for Emerging and Zoonotic Infectious Diseases, 2009, NAT HEALTHC ASS INF; Consumer Reports Health, 2013, CONSUMER REPORTS HLT; Edwards JR, 2009, AM J INFECT CONTROL, V37, P783, DOI 10.1016/j.ajic.2009.10.001; Harnage SA, 2012, INNOVATION TECHNOLOG; Lin MY, 2010, JAMA-J AM MED ASSOC, V304, P2035, DOI 10.1001/jama.2010.1637; Lipitz-Snyderman A, 2011, ARCH INTERN MED, V171, P856, DOI 10.1001/archinternmed.2011.161; Margolin F. S., 2011, GETTING ZERO REDUCIN; Mayer J, 2012, CLIN INFECT DIS, V55, P364, DOI 10.1093/cid/cis410; Pronovost Peter, 2008, Am J Infect Control, V36, DOI 10.1016/j.ajic.2008.10.008; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Saman DM, 2013, J PATIENT SAF, V9, P55, DOI 10.1097/PTS.0b013e3182809f31; Silow-Carroll S, 2011, BRONSON METHODIST	16	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79554	10.1371/journal.pone.0079554	http://dx.doi.org/10.1371/journal.pone.0079554			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223966	Green Published, gold, Green Submitted			2022-12-27	WOS:000326503400124
J	Sarikonda, G; Pettus, J; Sachithanantham, S; Phatak, S; Miller, JF; Ganesan, L; Chae, J; Mallios, R; Edelman, S; Peters, B; von Herrath, M				Sarikonda, Ghanashyam; Pettus, Jeremy; Sachithanantham, Sowbarnika; Phatak, Sonal; Miller, Jacqueline F.; Ganesan, Lakshmi; Chae, Ji; Mallios, Ronna; Edelman, Steve; Peters, Bjoern; von Herrath, Matthias			Temporal Intra-Individual Variation of Immunological Biomarkers in Type 1 Diabetes Patients: Implications for Future Use in Cross-Sectional Assessment	PLOS ONE			English	Article							T-CELL RESPONSES; THERAPY; COMPLICATIONS; EUROPE; TRENDS	Multiple immune parameters such as frequencies of autoreactive CD4(+), CD8(+) T-cells and CD4(+)CD25(+)Foxp3(+) T-cells have been explored as biomarkers in human T1D. However, intra-individual temporal variation of these parameters has not been assessed systematically over time. We determined the variation in each of these parameters in a cohort of T1D and healthy donors (HDs), at monthly intervals for one year. Despite low intra- and inter-assay co-efficient of variation (CV), mean CVs for each of the immune parameters were 119.1% for CD4(+) T-cell-derived IFN-gamma, 50.44% for autoreactive CD8(+) T-cells, and 31.24% for CD4(+)CD25(+)Foxp3(+) T-cells. Further, both HDs and T1D donors had similar CVs. The variation neither correlated with BMI, age, disease duration or insulin usage, nor were there detectable cyclical patterns of variation. However, averaging results from multiple visits for an individual provided a better estimate of the CV between visits. Based on our data we predict that by averaging values from three visits a treatment effect on these parameters with a 50% effect size could be detected with the same power using 1.8-4-fold fewer patients within a trial compared to using values from a single visit. Thus, our present data contribute to a more robust, accurate endpoint design for future clinical trials in T1D and aid in the identification of truly efficacious therapies.	[Sarikonda, Ghanashyam; Pettus, Jeremy; Sachithanantham, Sowbarnika; Miller, Jacqueline F.; Ganesan, Lakshmi; Chae, Ji; Mallios, Ronna; Peters, Bjoern; von Herrath, Matthias] La Jolla Inst Allergy & Immunol, Type Diabet Ctr 1, La Jolla, CA USA; [Pettus, Jeremy; Phatak, Sonal; Ganesan, Lakshmi; Chae, Ji; Edelman, Steve] Univ Calif San Diego, San Diego, CA 92103 USA; [von Herrath, Matthias] Novo Nordisk Inc, Type Diabet R&D Ctr 1, Seattle, WA USA	La Jolla Institute for Immunology; University of California System; University of California San Diego; Novo Nordisk	von Herrath, M (corresponding author), La Jolla Inst Allergy & Immunol, Type Diabet Ctr 1, La Jolla, CA USA.	matthias@liai.org			T1D center of San Diego; University of Michigan, Ann Arbor (UMich) [3002074563]; NIH [3UL1RR024986-05S1]	T1D center of San Diego; University of Michigan, Ann Arbor (UMich); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	GS was supported by a postdoctoral fellowship from the T1D center of San Diego. This work was supported by a subaward number 3002074563 from University of Michigan, Ann Arbor (UMich), to MvH, issued under NIH award number 3UL1RR024986-05S1 to UMich under the direction of Dr. Thomas P. Shanley, P. I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arif S, 2004, J CLIN INVEST, V113, P451, DOI 10.1172/JCI200419585; Bergenstal RM, 2010, NEW ENGL J MED, V363, P311, DOI 10.1056/NEJMoa1002853; Brusko T, 2007, DIABETES, V56, P604, DOI 10.2337/db06-1248; Buchhave P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006294; Gale EAM, 2002, DIABETES, V51, P3353, DOI 10.2337/diabetes.51.12.3353; Herold KC, 2009, DIABETES, V58, P2588, DOI 10.2337/db09-0249; Huurman VAL, 2008, CLIN EXP IMMUNOL, V152, P488, DOI 10.1111/j.1365-2249.2008.03656.x; Kilpatrick ES, 2007, DIABETES CARE, V30, P707, DOI 10.2337/dc06-1982; Lachin JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026471; Lebastchi J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007708; Long SA, 2010, DIABETES, V59, P407, DOI 10.2337/db09-0694; Martinuzzi E, 2008, J IMMUNOL METHODS, V333, P61, DOI 10.1016/j.jim.2008.01.003; Oseroff C, 2012, J IMMUNOL, V189, P1800, DOI 10.4049/jimmunol.1200850; Palmer Jerry P., 2004, Diabetes, V53, P250; Patterson CC, 2012, DIABETOLOGIA, V55, P2142, DOI 10.1007/s00125-012-2571-8; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Penaranda C, 2011, J IMMUNOL, V187, P2015, DOI 10.4049/jimmunol.1100713; REICHARD P, 1993, NEW ENGL J MED, V329, P304, DOI 10.1056/NEJM199307293290502; Roep BO, 2011, CURR OPIN IMMUNOL, V23, P746, DOI 10.1016/j.coi.2011.10.001; Roep BO, 2010, NAT REV IMMUNOL, V10, P145, DOI 10.1038/nri2705; Roep BO, 2003, DIABETOLOGIA, V46, P305, DOI 10.1007/s00125-003-1089-5; Sanda S, 2008, CLIN IMMUNOL, V127, P138, DOI 10.1016/j.clim.2007.12.003; Sarikonda G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054712; Schneider A, 2008, J IMMUNOL, V181, P7350, DOI 10.4049/jimmunol.181.10.7350; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Tamborlane WV, 2008, NEW ENGL J MED, V359, P1464, DOI 10.1056/NEJMoa0805017; Velthuis JH, 2010, DIABETES, V59, P1721, DOI 10.2337/db09-1486; von Herrath M, 2007, NAT REV IMMUNOL, V7, P988, DOI 10.1038/nri2192; Wood JR, 2013, DIABETES CARE	29	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79383	10.1371/journal.pone.0079383	http://dx.doi.org/10.1371/journal.pone.0079383			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223938	Green Published, gold, Green Submitted			2022-12-27	WOS:000326503400111
J	Bakouche, N; Vandenbroucke, AT; Goubau, P; Ruelle, J				Bakouche, Nordine; Vandenbroucke, Anne-Therese; Goubau, Patrick; Ruelle, Jean			Study of the HIV-2 Env Cytoplasmic Tail Variability and Its Impact on Tat, Rev and Nef	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; C-TERMINAL TAIL; CELL-CELL FUSION; ENVELOPE GLYCOPROTEIN; TRANSMEMBRANE PROTEIN; HTLV-III; INTRACYTOPLASMIC TAIL; CLATHRIN ADAPTER; ATOMIC-STRUCTURE; POINT MUTATIONS	Background: The HIV-2 env's 3' end encodes the cytoplasmic tail (CT) of the Env protein. This genomic region also encodes the rev, Tat and Nef protein in overlapping reading frames. We studied the variability in the CT coding region in 46 clinical specimens and in 2 reference strains by sequencing and by culturing. The aims were to analyse the variability of Env CT and the evolution of proteins expressed from overlapping coding sequences. Results: A 70% reduction of the length of the CT region affected the HIV-2 ROD and EHO strains in vitro due to a premature stop codon in the env gene. In clinical samples this wasn't observed, but the CT length varied due to insertions and deletions. We noted 3 conserved and 3 variable regions in the CT. The conserved regions were those containing residues involved in Env endocytosis, the potential HIV-2 CT region implicated in the NF-kB activation and the potential end of the lentiviral lytic peptide one. The variable regions were the potential HIV-2 Kennedy region, the potential lentiviral lytic peptide two and the beginning of the potential lentiviral lytic peptide one. A very hydrophobic region was coded downstream of the premature stop codon observed in vitro, suggesting a membrane spanning region. Interestingly, the nucleotides that are responsible for the variability of the CT don't impact rev and Nef. However, in the Kennedy-like coding region variability resulted only from nucleotide changes that impacted Env and Tat together. Conclusion: The HIV-2 Env, Tat and Rev C-terminal part are subject to major length variations in both clinical samples and cultured strains. The HIV-2 Env CT contains variable and conserved regions. These regions don't affect the rev and Nef amino acids composition which evolves independently. In contrast, Tat co-evolves with the Env CT.	[Bakouche, Nordine; Vandenbroucke, Anne-Therese; Goubau, Patrick; Ruelle, Jean] Catholic Univ Louvain, Inst Rech Expt & Clin, B-1200 Brussels, Belgium	Universite Catholique Louvain	Ruelle, J (corresponding author), Catholic Univ Louvain, Inst Rech Expt & Clin, B-1200 Brussels, Belgium.	jean.ruelle@uclouvain.be			Fonds de la Recherche Scientifique (a public funding)	Fonds de la Recherche Scientifique (a public funding)	NB is financed by the Fonds de la Recherche Scientifique (a public funding) url: http://www.frs-fnrs.be/. The funders (FNRS) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affranchino JL, 2006, VIROLOGY, V347, P217, DOI 10.1016/j.virol.2005.11.032; Boge M, 1998, J BIOL CHEM, V273, P15773, DOI 10.1074/jbc.273.25.15773; BOSCH ML, 1989, SCIENCE, V244, P694, DOI 10.1126/science.2541505; Byland R, 2007, MOL BIOL CELL, V18, P414, DOI 10.1091/mbc.E06-06-0535; CHANH TC, 1986, EMBO J, V5, P3065, DOI 10.1002/j.1460-2075.1986.tb04607.x; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; CLAVEL F, 1986, SCIENCE, V233, P343, DOI 10.1126/science.2425430; Cleveland SM, 2003, J GEN VIROL, V84, P591, DOI 10.1099/vir.0.18630-0; DILLON PJ, 1990, J VIROL, V64, P4428, DOI 10.1128/JVI.64.9.4428-4437.1990; Edwards TG, 2002, J VIROL, V76, P2683, DOI 10.1128/JVI.76.6.2683-2691.2002; EISENBERG D, 1990, BIOPOLYMERS, V29, P171, DOI 10.1002/bip.360290122; FREED EO, 1995, J VIROL, V69, P1984, DOI 10.1128/JVI.69.3.1984-1989.1995; Freed EO, 1996, J VIROL, V70, P341, DOI 10.1128/JVI.70.1.341-351.1996; GABUZDA DH, 1992, J VIROL, V66, P3306, DOI 10.1128/JVI.66.6.3306-3315.1992; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; HAERTLE T, 1988, J BIOL CHEM, V263, P5870; HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0; HARADA S, 1985, SCIENCE, V229, P563, DOI 10.1126/science.2992081; Jeang KT, 1999, J BIOL CHEM, V274, P28837, DOI 10.1074/jbc.274.41.28837; Kalia V, 2005, J VIROL, V79, P2097, DOI 10.1128/JVI.79.4.2097-2107.2005; Kalia V, 2003, J VIROL, V77, P3634, DOI 10.1128/JVI.77.6.3634-3646.2003; KENNEDY RC, 1986, SCIENCE, V231, P1556, DOI 10.1126/science.3006246; LARDER BA, 1989, SCIENCE, V243, P1731, DOI 10.1126/science.2467383; LEE SJ, 1989, AIDS RES HUM RETROV, V5, P441, DOI 10.1089/aid.1989.5.441; Lu L, 2008, J BIOL CHEM, V283, P16723, DOI 10.1074/jbc.M801083200; MANN DL, 1989, AIDS RES HUM RETROV, V5, P253, DOI 10.1089/aid.1989.5.253; MILLER MA, 1991, AIDS RES HUM RETROV, V7, P511, DOI 10.1089/aid.1991.7.511; MILLER MA, 1993, VIROLOGY, V196, P89, DOI 10.1006/viro.1993.1457; Murakami T, 2000, J VIROL, V74, P3548, DOI 10.1128/JVI.74.8.3548-3554.2000; NAIDU YM, 1988, J VIROL, V62, P4691, DOI 10.1128/JVI.62.12.4691-4696.1988; Newman JT, 2007, VIROLOGY, V367, P102, DOI 10.1016/j.virol.2007.05.027; Noble B, 2006, J VIROL, V80, P2924, DOI 10.1128/JVI.80.6.2924-2932.2006; Ohno H, 1997, VIROLOGY, V238, P305, DOI 10.1006/viro.1997.8839; PAUWELS R, 1987, J VIROL METHODS, V16, P171, DOI 10.1016/0166-0934(87)90002-4; POPOVIC M, 1984, LANCET, V2, P1472; POPOVIC M, 1984, SCIENCE, V224, P497, DOI 10.1126/science.6200935; Postler TS, 2012, CELL HOST MICROBE, V11, P181, DOI 10.1016/j.chom.2011.12.005; REY MA, 1989, VIROLOGY, V173, P258, DOI 10.1016/0042-6822(89)90242-0; Ribeiro AC, 2005, J VIROL, V79, P823, DOI 10.1128/JVI.79.2.823-833.2005; ROWELL JF, 1995, J IMMUNOL, V155, P473; Schmitt AO, 1997, J THEOR BIOL, V188, P369, DOI 10.1006/jtbi.1997.0493; Shang L, 2008, J VIROL, V82, P5417, DOI 10.1128/JVI.02666-07; SPIES CP, 1994, J VIROL, V68, P585, DOI 10.1128/JVI.68.2.585-591.1994; Steckbeck JD, 2011, J BIOL CHEM, V286, P27156, DOI 10.1074/jbc.M111.258855; Sung JH, 2001, J NEUROVIROL, V7, P454; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; VENABLE RM, 1989, AIDS RES HUM RETROV, V5, P7, DOI 10.1089/aid.1989.5.7; Waheed AA, 2007, P NATL ACAD SCI USA, V104, P8467, DOI 10.1073/pnas.0701443104; Waheed AA, 2006, J BIOL CHEM, V281, P28699, DOI 10.1074/jbc.M603609200; Waheed AA, 2010, J VIROL, V84, P3121, DOI 10.1128/JVI.02002-09; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; WILK T, 1992, VIROLOGY, V189, P167, DOI 10.1016/0042-6822(92)90692-I; Wyss S, 2001, J VIROL, V75, P2982, DOI 10.1128/JVI.75.6.2982-2992.2001; Yang PL, 2010, J VIROL, V84, P59, DOI 10.1128/JVI.00899-09; YU XF, 1993, J VIROL, V67, P213, DOI 10.1128/JVI.67.1.213-221.1993	55	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79129	10.1371/journal.pone.0079129	http://dx.doi.org/10.1371/journal.pone.0079129			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223892	Green Published, gold, Green Submitted			2022-12-27	WOS:000326499300062
J	Estes, AM; Hearn, DJ; Snell-Rood, EC; Feindler, M; Feeser, K; Abebe, T; Hotopp, JCD; Moczek, AP				Estes, Anne M.; Hearn, David J.; Snell-Rood, Emilie C.; Feindler, Michele; Feeser, Karla; Abebe, Tselotie; Hotopp, Julie C. Dunning; Moczek, Armin P.			Brood Ball-Mediated Transmission of Microbiome Members in the Dung Beetle, Onthophagus taurus (Coleoptera: Scarabaeidae)	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; LARVAE COLEOPTERA; BACTERIA; GUT; IDENTIFICATION; ENDOSYMBIONTS; COMMUNITY; HINDGUT; INSECT; GENES	Insects feeding on plant sap, blood, and other nutritionally incomplete diets are typically associated with mutualistic bacteria that supplement missing nutrients. Herbivorous mammal dung contains more than 86% cellulose and lacks amino acids essential for insect development and reproduction. Yet one of the most ecologically necessary and evolutionarily successful groups of beetles, the dung beetles (Scarabaeinae) feeds primarily, or exclusively, on dung. These associations suggest that dung beetles may benefit from mutualistic bacteria that provide nutrients missing from dung. The nesting behaviors of the female parent and the feeding behaviors of the larvae suggest that a microbiome could be vertically transmitted from the parental female to her offspring through the brood ball. Using sterile rearing and a combination of molecular and culture-based techniques, we examine transmission of the microbiome in the bull-headed dung beetle, Onthophagus taurus. Beetles were reared on autoclaved dung and the microbiome was characterized across development. A similar to 1425 bp region of the 16S rRNA identified Pseudomonadaceae, Enterobacteriaceae, and Comamonadaceae as the most common bacterial families across all life stages and populations, including cultured isolates from the 3rd instar digestive system. Finer level phylotyping analyses based on lepA and gyrB amplicons of cultured isolates placed the isolates closest to Enterobacter cloacae, Providencia stuartii, Pusillimonas sp., Pedobacter heparinus, and Lysinibacillus sphaericus. Scanning electron micrographs of brood balls constructed from sterile dung reveals secretions and microbes only in the chamber the female prepares for the egg. The use of autoclaved dung for rearing, the presence of microbes in the brood ball and offspring, and identical 16S rRNA sequences in both parent and offspring suggests that the O. taurus female parent transmits specific microbiome members to her offspring through the brood chamber. The transmission of the dung beetle microbiome highlights the maintenance and likely importance of this newly-characterized bacterial community.	[Estes, Anne M.; Hearn, David J.; Feindler, Michele; Feeser, Karla; Abebe, Tselotie] Towson Univ, Dept Biol Sci, Baltimore, MD USA; [Estes, Anne M.; Hotopp, Julie C. Dunning] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Snell-Rood, Emilie C.; Moczek, Armin P.] Indiana Univ, Dept Biol, Bloomington, IN USA; [Hotopp, Julie C. Dunning] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Hearn, David J.] J Craig Venter Inst Inc, Plant Genom, Rockville, MD USA	University System of Maryland; Towson University; University System of Maryland; University of Maryland Baltimore; Indiana University System; Indiana University Bloomington; University System of Maryland; University of Maryland Baltimore	Estes, AM (corresponding author), Towson Univ, Dept Biol Sci, Baltimore, MD USA.	anneestes@gmail.com		Feeser, Karla/0000-0003-0030-9449; Estes, Anne/0000-0002-8775-2656	Towson University Fisher College; Towson University; Orchid Society of Arizona; NSF REU [DBI0552654]; NSF IOS [0445661, 0718522]; State of Maryland	Towson University Fisher College; Towson University; Orchid Society of Arizona; NSF REU(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF IOS(National Science Foundation (NSF)); State of Maryland	This research was supported in part through funds from: the Towson University Fisher College Undergraduate Research Awards (KF, TA), a Towson University Undergraduate Research Award (KF), Orchid Society of Arizona funding (AME), NSF REU DBI0552654 (MF), NSF IOS 0445661 (AM), NSF IOS 0718522 (AM), and State of Maryland internal funds (JDH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand AAP, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.10701; Andert J, 2010, FEMS MICROBIOL ECOL, V74, P439, DOI 10.1111/j.1574-6941.2010.00950.x; Angiuoli SV, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-356; Attardo GM, 2008, J INSECT PHYSIOL, V54, P1236, DOI 10.1016/j.jinsphys.2008.06.008; Balmand S, 2013, J INVERTEBR PATHOL, V112, pS116, DOI 10.1016/j.jip.2012.04.002; Baumann L, 1999, J MOL EVOL, V48, P77, DOI 10.1007/PL00006447; BELDA E, 2010, BMC GENOMICS, V11, P1, DOI DOI 10.1186/1471-2164-11-S5-S1.PUBMED:20044946; Ben Beard C, 2002, ANNU REV ENTOMOL, V47, P123, DOI 10.1146/annurev.ento.47.091201.145144; Ben-Yosef M, 2008, PHYSIOL ENTOMOL, V33, P145, DOI 10.1111/j.1365-3032.2008.00617.x; Beninati T, 2009, FEMS MICROBIOL LETT, V299, P241, DOI 10.1111/j.1574-6968.2009.01757.x; Bressan A, 2009, ENVIRON MICROBIOL, V11, P3265, DOI 10.1111/j.1462-2920.2009.02055.x; Bright M, 2010, NAT REV MICROBIOL, V8, P218, DOI 10.1038/nrmicro2262; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL; Castrillo LA, 2000, J ECON ENTOMOL, V93, P226, DOI 10.1603/0022-0493-93.2.226; Chin K, 1996, PALAIOS, V11, P280, DOI 10.2307/3515235; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Davis ALV, 2002, J BIOGEOGR, V29, P1217, DOI 10.1046/j.1365-2699.2002.00776.x; Delalibera I, 2007, SYMBIOSIS, V43, P97; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Egert M, 2005, APPL ENVIRON MICROB, V71, P4556, DOI 10.1128/AEM.71.8.4556-4566.2005; Egert M, 2003, APPL ENVIRON MICROB, V69, P6659, DOI 10.1128/AEM.69.11.6659-6668.2003; Estes AM, 2012, ENVIRON ENTOMOL, V41, P265, DOI 10.1603/EN11245; Estes AM, 2009, APPL ENVIRON MICROB, V75, P7097, DOI 10.1128/AEM.00778-09; FINCHER TG, 1975, COLEOPT B, V29, P349; FOX GE, 1992, INT J SYST BACTERIOL, V42, P166, DOI 10.1099/00207713-42-1-166; Fukatsu T, 2002, APPL ENVIRON MICROB, V68, P389, DOI 10.1128/AEM.68.1.389-396.2002; GOIDANICH A, 1964, ANN FACOLTA SCI AGRA, V2, P213; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; GREENBERG B, 1959, AM J TROP MED HYG, V8, P613, DOI 10.4269/ajtmh.1959.8.613; Halffter G, 1982, NESTING BEHAV DUNG B, P1; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hoebeke ER, 1997, ENTOMOL NEWS, V108, P345; Holter P, 2009, J ARID ENVIRON, V73, P1090, DOI 10.1016/j.jaridenv.2009.04.009; Holter P, 2013, J MORPHOL, V274, P657, DOI 10.1002/jmor.20123; HOWDEN H F, 1986, Coleopterists Bulletin, V40, P313; Howden H. F., 1963, Proceedings of the United States National Museum, V114, P1; Huang SW, 2010, INSECT SCI, V17, P175, DOI 10.1111/j.1744-7917.2010.01320.x; Huang SW, 2012, INT J MOL SCI, V13, P2563, DOI 10.3390/ijms13032563; HUNTER JS, 1985, J ENTOMOL SCI, V20, P24, DOI 10.18474/0749-8004-20.1.24; Husseneder Claudia, 2010, Open Microbiol J, V4, P53, DOI 10.2174/1874285801004010053; Kaltenpoth M, 2005, CURR BIOL, V15, P475, DOI 10.1016/j.cub.2004.12.084; Kellner RLL, 2002, CHEMOECOLOGY, V12, P133, DOI 10.1007/s00012-002-8338-1; Kohler T, 2012, APPL ENVIRON MICROB, V78, P4691, DOI 10.1128/AEM.00683-12; KRELL FT, 2006, COLEOPT SOC MONO DEC, P120, DOI DOI 10.1649/0010-065X(2006)60[; Kroiss J, 2010, NAT CHEM BIOL, V6, P261, DOI [10.1038/NCHEMBIO.331, 10.1038/nchembio.331]; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; Kuczynski J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-210; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; MacDonald SJ, 2011, MOL ECOL, V20, P2073, DOI 10.1111/j.1365-294X.2011.05031.x; Martinez-Sanudo I, 2011, CAN J MICROBIOL, V57, P969, DOI [10.1139/W11-057, 10.1139/w11-057]; Mateos M, 2006, GENETICS, V174, P363, DOI 10.1534/genetics.106.058818; Moczek AP, 2005, EVOL DEV, V7, P175, DOI 10.1111/j.1525-142X.2005.05020.x; Moran NA, 2003, ENVIRON MICROBIOL, V5, P116, DOI 10.1046/j.1462-2920.2003.00391.x; Muller Z., 1980, FAO ANIMAL PRODUCTIO; NALEPA CA, 1984, BEHAV ECOL SOCIOBIOL, V14, P273, DOI 10.1007/BF00299498; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; Noda S, 2007, MOL ECOL, V16, P1257, DOI 10.1111/j.1365-294X.2006.03219.x; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P16315, DOI 10.1073/pnas.0905129106; Philips T. Keith, 2011, P21; Pittman GW, 2008, APPL ENVIRON MICROB, V74, P762, DOI 10.1128/AEM.01831-07; Price DL, 2012, P ENTOMOL SOC WASH, V114, P142, DOI 10.4289/0013-8797.114.1.142; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Roux S, 2011, FEMS MICROBIOL ECOL, V78, P617, DOI 10.1111/j.1574-6941.2011.01190.x; RUPERT LLK, 2003, ENTOMOL EXP APPL, V107, P115, DOI DOI 10.1046/J.1570-7458.2003.00042.X; Santos SR, 2004, ENVIRON MICROBIOL, V6, P754, DOI 10.1111/j.1462-2920.2004.00617.x; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shi WB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003131; Simonnet F, 2011, EVOL DEV, V13, P280, DOI 10.1111/j.1525-142X.2011.00479.x; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stoll S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-308; Vilo C., 2012, METAGENOMICS, V1, P1, DOI DOI 10.4303/MG/235551; White J, 2011, ROUTL FILM GUIDEBOOK, P1; White JR, 2011, NATURE PRECEDINGS; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151; Zhang H, 2008, J APPL MICROBIOL, V105, P1277, DOI 10.1111/j.1365-2672.2008.03867.x; Zientz E, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-12-reviews1032	77	54	55	4	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79061	10.1371/journal.pone.0079061	http://dx.doi.org/10.1371/journal.pone.0079061			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223880	gold, Green Published, Green Submitted			2022-12-27	WOS:000326499300050
J	Yamazaki, T; Yamori, M; Tanaka, S; Yamamoto, K; Sumi, E; Nishimoto-Sano, M; Asai, K; Takahashi, K; Nakayama, T; Bessho, K				Yamazaki, Toru; Yamori, Masashi; Tanaka, Shiro; Yamamoto, Keiichi; Sumi, Eriko; Nishimoto-Sano, Megumi; Asai, Keita; Takahashi, Katsu; Nakayama, Takeo; Bessho, Kazuhisa			Risk Factors and Indices of Osteomyelitis of the Jaw in Osteoporosis Patients: Results from a Hospital-Based Cohort Study in Japan	PLOS ONE			English	Article							BISPHOSPHONATE-RELATED OSTEONECROSIS; ORAL BISPHOSPHONATES; CANCER-PATIENTS; ASSOCIATION; ZOLEDRONATE; SURGERY; DISEASE	Background: Several studies have reported osteomyelitis of the jaw (OMJ) as a side effect of bisphosphonates (BPs), and the risk of oral BPs has been recently clarified. However, other systemic risk factors of OMJ remain unclear. Importantly, the possibility of risk classification based on the clinical characteristics of patients has not been explored. Here, we clarified risk factors of OMJ and evaluate the predictive accuracy of risk indices in osteoporosis patients. Methods: We performed sub-analysis using a database developed for a retrospective cohort study in patients taking medications for osteoporosis at Kyoto University Hospital. Risk indices for OMJ were constructed using logistic regression analysis, and odds ratios (OR) for OMJ cases and 95% confidence intervals (CI) were estimated. Potential risk factors included in the statistical analysis were age; sex; diabetes; use of oral BPs, corticosteroids, cancer chemotherapy, antirheumatic drugs, and biologic agents; and their interactions. Risk indices were calculated by the sum of potential risk factors of an individual patient multiplied by the regression coefficients. The discriminatory power of the risk indices was assessed by receiver operating characteristic (ROC) analysis. Results: In analysis of all patients, oral BPs (OR: 4.98, 95% CIs: 1.94-12.75), age (OR: 1.28, 95% CI: 1.06-1.60) and sex-chemotherapy interaction (OR: 11.70, 95% CI: 1.46-93.64) were significant risk factors of OMJ. Areas under the ROC curves of these risk indices provided moderate sensitivity or specificity regardless of group (0.683 to 0.718). Conclusions: Our data suggest that oral BP use, age, and sex-chemotherapy are predictors of OMJ in osteoporosis patients. The risk indices are moderately high, and allow the prediction of OMJ incidence.	[Yamazaki, Toru; Yamori, Masashi; Nishimoto-Sano, Megumi; Asai, Keita; Takahashi, Katsu; Bessho, Kazuhisa] Kyoto Univ, Dept Oral & Maxillofacial Surg, Grad Sch Med, Kyoto, Japan; [Tanaka, Shiro] Kyoto Univ, Sch Publ Hlth, Grad Sch Med, Dept Pharmacoepidemiol, Kyoto, Japan; [Yamamoto, Keiichi] Natl Cerebral & Cardiovasc Ctr, Res & Dev Initiat Ctr, Dept Prevent Med & Epidemiol Informat, Osaka, Japan; [Sumi, Eriko] Kyoto Univ, Translat Res Ctr, Dept Clin Innovat Med, Kyoto, Japan; [Nakayama, Takeo] Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Hlth Informat, Kyoto, Japan	Kyoto University; Kyoto University; National Cerebral & Cardiovascular Center - Japan; Kyoto University; Kyoto University	Yamazaki, T (corresponding author), Kyoto Univ, Dept Oral & Maxillofacial Surg, Grad Sch Med, Kyoto, Japan.	toruy@kuhp.kyoto-u.ac.jp	NAKAYAMA, Takeo/HCH-0537-2022; Yamamoto, Keiichi/AFQ-9006-2022; 田中, 司朗/GON-6916-2022	Yamamoto, Keiichi/0000-0003-3278-5001; 田中, 司朗/0000-0001-6817-5235; Nakayama, Takeo/0000-0002-7918-6252	Grants-in-Aid for Scientific Research [23790566] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Badros A, 2008, J CLIN ONCOL, V26, P5904, DOI 10.1200/JCO.2008.16.9300; Balla B, 2012, ORAL DIS, V18, P580, DOI 10.1111/j.1601-0825.2012.01912.x; Barasch A, 2011, J DENT RES, V90, P439, DOI 10.1177/0022034510397196; Berenson JR, 2011, AM J HEMATOL, V86, P25, DOI 10.1002/ajh.21912; Bertoldo F, 2007, NAT CLIN PRACT ONCOL, V4, P711, DOI 10.1038/ncponc1000; Boonyapakorn T, 2008, ORAL ONCOL, V44, P857, DOI 10.1016/j.oraloncology.2007.11.012; Campisi G, 2009, J RHEUMATOL, V36, P451, DOI 10.3899/jrheum.080843; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Dimopoulos MA, 2006, HAEMATOL-HEMATOL J, V91, P968; Etminan M, 2008, J RHEUMATOL, V35, P691; Fellows JL, 2011, J DENT RES, V90, P433, DOI 10.1177/0022034510387795; Hutchinson M, 2010, J ORAL MAXIL SURG, V68, P2232, DOI 10.1016/j.joms.2010.05.003; Junquera L, 2008, J ORAL MAXIL SURG, V66, P1516, DOI 10.1016/j.joms.2008.02.012; Khamaisi M, 2007, J CLIN ENDOCR METAB, V92, P1172, DOI 10.1210/jc.2006-2036; Khosla S, 2007, J BONE MINER RES, V22, P1479, DOI 10.1359/JBMR.0707ONJ; Kos M, 2010, INT J ORAL MAX SURG, V39, P1097, DOI 10.1016/j.ijom.2010.04.054; La Ferla F, 2012, BIOMARK MED, V6, P201, DOI [10.2217/BMM.12.14, 10.2217/bmm.12.14]; Lapi F, 2013, OSTEOPOROSIS INT, V24, P697, DOI 10.1007/s00198-012-2013-y; Mawardi H, 2009, J ORAL MAXIL SURG, V67, P593, DOI 10.1016/j.joms.2008.09.031; Miyazaki H, 2012, BJU INT, V110, pE520, DOI 10.1111/j.1464-410X.2012.11205.x; Nicoletti P, 2012, ONCOLOGIST, V17, P279, DOI 10.1634/theoncologist.2011-0202; Ortega C, 2007, ACTA ONCOL, V46, P664, DOI 10.1080/02841860601185917; Patel V, 2011, BRIT J ORAL MAX SURG, V49, P251, DOI 10.1016/j.bjoms.2010.05.007; Pazianas M, 2008, OSTEOPOROSIS INT, V19, P773, DOI 10.1007/s00198-007-0502-1; Rizzoli R, 2008, BONE, V42, P841, DOI 10.1016/j.bone.2008.01.003; Rudic JS, 2011, COCHRANE DB SYST REV; Ruggiero S, 2006, J ONCOL PRACT, V2, P7, DOI 10.1200/JOP.2.1.7; Ruggiero SL, 2009, J ORAL MAXIL SURG, V67, P2, DOI 10.1016/j.joms.2009.01.009; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; Skrepnek Grant H, 2010, Gen Dent, V58, P484; Tennis P, 2012, PHARMACOEPIDEM DR S, V21, P810, DOI 10.1002/pds.3292; Van den Wyngaert T, 2009, ANN ONCOL, V20, P331, DOI 10.1093/annonc/mdn630; Vestergaard P, 2012, J ORAL MAXIL SURG, V70, P821, DOI 10.1016/j.joms.2011.02.093; Watters AL, 2013, OR SURG OR MED OR PA, V115, P192, DOI 10.1016/j.oooo.2012.05.017; Wessel JH, 2008, J ORAL MAXIL SURG, V66, P625, DOI 10.1016/j.joms.2007.11.032; Wilkinson GS, 2007, JNCI-J NATL CANCER I, V99, P1016, DOI 10.1093/jnci/djm025; Yamamoto K, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001622; Yamazaki T, 2012, BONE, V51, P882, DOI 10.1016/j.bone.2012.08.115; Yoneda T, 2010, J BONE MINER METAB, V28, P365, DOI 10.1007/s00774-010-0162-7	39	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79376	10.1371/journal.pone.0079376	http://dx.doi.org/10.1371/journal.pone.0079376			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223935	Green Published, gold, Green Submitted			2022-12-27	WOS:000326499300079
J	Bradley, J; Rehman, AM; Schwabe, C; Vargas, D; Monti, F; Ela, C; Riloha, M; Kleinschmidt, I				Bradley, John; Rehman, Andrea M.; Schwabe, Christopher; Vargas, Daniel; Monti, Feliciano; Ela, Camilo; Riloha, Matilde; Kleinschmidt, Immo			Reduced Prevalence of Malaria Infection in Children Living in Houses with Window Screening or Closed Eaves on Bioko Island, Equatorial Guinea	PLOS ONE			English	Article							DAR-ES-SALAAM; RISK-FACTORS; SATELLITE VILLAGES; RESIDUAL LIFE; RURAL TOWN; ENTRY; VECTORS; TRANSMISSION; INTERVENTIONS; INSECTICIDE	Background: Previous studies demonstrated that fewer mosquitoes enter houses which are screened or have closed eaves. There is little evidence about the effect on malaria infection in humans that changes in house construction may have. This study examines the impact of protective housing improvements on malaria infection on Bioko Island. Methodology/Principal Findings: Data from the annual malaria indicator surveys between 2009 and 2012 were used to assess trends in housing characteristics and their effect on RDT confirmed malaria infection in household members. Odds ratios were adjusted for socio-economic status of the household. 22726 children between the ages of 2 and 14 years were tested for P. falciparum. Prevalence of infection in those living in houses with open eaves was 23.0% compared to 18.8% for those living in houses with closed eaves (OR = 0.81, 95% CI 0.67 - 0.98). The prevalence of infection for children in screened houses was 9.1% versus 20.1% for those living in unscreened houses (OR = 0.44, 95% CI 0.27 - 0.71). The proportion of houses with closed eaves increased from 66.0% in 2009 to 74.3% in 2012 (test for trend p = 0.01). The proportion of screened houses remained unchanged over time at 1.3%. Conclusion/Significance: As a malaria control intervention, house modification has the advantages that it is not affected by the growing threat of insecticide resistance; it protects all household members equally and at all times while indoors; and it offers protection against a number of vector borne diseases. The study provides evidence in support of efforts to regulate or encourage housing improvements which impede vector access into residences as part of an integrated vector control approach to complement existing measures which have been only partially successful in reducing malaria transmission in some parts of Bioko.	[Bradley, John; Rehman, Andrea M.; Kleinschmidt, Immo] London Sch Hyg & Trop Med, Trop Epidemiol Grp, London WC1, England; [Schwabe, Christopher] Med Care Dev Int, Silver Spring, MD USA; [Vargas, Daniel; Monti, Feliciano] Med Care Dev Int, Malabo, Guinea; [Ela, Camilo; Riloha, Matilde] Minist Hlth & Social Welf, Malabo, Guinea	University of London; London School of Hygiene & Tropical Medicine	Bradley, J (corresponding author), London Sch Hyg & Trop Med, Trop Epidemiol Grp, London WC1, England.	john.bradley@lshtm.ac.uk	Rehman, Andrea M/H-1351-2015; Rehman, Andrea/AAP-3172-2020; Vargas-Pacherrez, Daniel/N-9349-2016	Rehman, Andrea M/0000-0001-9967-5822; Rehman, Andrea/0000-0001-9967-5822; Vargas-Pacherrez, Daniel/0000-0003-0989-1199; Bradley, John/0000-0002-9449-4608	Marathon Oil Corporation; government of EG; Medical Research Council [MR/K012126/1] Funding Source: researchfish	Marathon Oil Corporation; government of EG; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funded by a private sector consortium led by Marathon Oil Corporation and the government of EG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOYD MARK F., 1926, AMER JOUR TROP MED, V6, P157; Bradley J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-242; Cano J, 2004, J MED ENTOMOL, V41, P158, DOI 10.1603/0022-2585-41.2.158; Cook J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025137; DOBSON MJ, 1997, CONTOURS DEATH DIS E, P1; Drakeley C, 2009, ADV PARASIT, V69, P299, DOI 10.1016/S0065-308X(09)69005-9; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Geissbuhler Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005107; Ghebreyesus TA, 2000, T ROY SOC TROP MED H, V94, P17, DOI 10.1016/S0035-9203(00)90424-3; Kirby MJ, 2010, AM J TROP MED HYG, V83, P965, DOI 10.4269/ajtmh.2010.10-0311; Kirby MJ, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-41; Kirby MJ, 2009, LANCET, V374, P998, DOI 10.1016/S0140-6736(09)60871-0; Kirby MJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-2; Kleinschmidt I, 2006, AM J TROP MED HYG, V74, P972, DOI 10.4269/ajtmh.2006.74.972; Kleinschmidt I, 2007, AM J TROP MED HYG, V76, P1027, DOI 10.4269/ajtmh.2007.76.1027; Kleinschmidt I, 2009, AM J TROP MED HYG, V81, P519, DOI 10.4269/ajtmh.2009.81.519; Kleinschmidt I, 2009, AM J TROP MED HYG, V80, P882, DOI 10.4269/ajtmh.2009.80.882; Lindsay SW, 2003, TROP MED INT HEALTH, V8, P512, DOI 10.1046/j.1365-3156.2003.01059.x; Lindsay SW, 2002, TRENDS PARASITOL, V18, P510, DOI 10.1016/S1471-4922(02)02382-6; LINDSAY SW, 1988, T ROY SOC TROP MED H, V82, P645, DOI 10.1016/0035-9203(88)90546-9; Lwetoijera DW, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-57; Maharaj R, 2004, J MED ENTOMOL, V41, P130, DOI 10.1603/0022-2585-41.1.130; Njie M, 2009, J MED ENTOMOL, V46, P505, DOI 10.1603/033.046.0314; Ogoma SB, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000773; Ogoma SB, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-221; Pates H, 2005, ANNU REV ENTOMOL, V50, P53, DOI 10.1146/annurev.ento.50.071803.130439; RAO JNK, 1992, BIOMETRICS, V48, P577, DOI 10.2307/2532311; Rehman AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019205; StataCorp, 2011, STAT STAT SOFTW REL; *STATACORP LP, 2011, STAT SURV DAT REF MA; Tsuang A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-211; Tusting LS, 2013, LANCET, V382, P963, DOI 10.1016/S0140-6736(13)60851-X; WHO, 2012, WORLD MALARIA REPORT 2012, P1; *WHO, 2012, LOB PLAN INS RES MAN	34	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80626	10.1371/journal.pone.0080626	http://dx.doi.org/10.1371/journal.pone.0080626			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236191	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000327254700194
J	Dellicour, S; Desai, M; Mason, L; Odidi, B; Aol, G; Phillips-Howard, PA; Laserson, KF; ter Kuile, FO				Dellicour, Stephanie; Desai, Meghna; Mason, Linda; Odidi, Beatrice; Aol, George; Phillips-Howard, Penelope A.; Laserson, Kayla F.; ter Kuile, Feiko O.			Exploring Risk Perception and Attitudes to Miscarriage and Congenital Anomaly in Rural Western Kenya	PLOS ONE			English	Article							DEMOGRAPHIC SURVEILLANCE; HEALTH; PREVALENCE; MORTALITY; RATES	Background: Understanding the socio-cultural context and perceptions of adverse pregnancy outcomes is important for informing the best approaches for public health programs. This article describes the perceptions, beliefs and health-seeking behaviours of women from rural western Kenya regarding congenital anomalies and miscarriages. Methods: Ten focus group discussions (FGDs) were undertaken in a rural district in western Kenya in September 2010. The FGDs included separate groups consisting of adult women of childbearing age, adolescent girls, recently pregnant women, traditional birth attendants and mothers of children with a birth defect. Participants were selected purposively. A deductive thematic framework approach using the questions from the FGD guides was used to analyse the transcripts. Results: There was substantial overlap between perceived causes of miscarriages and congenital anomalies and these were broadly categorized into two groups: biomedical and cultural. The biomedical causes included medications, illnesses, physical and emotional stresses, as well as hereditary causes. Cultural beliefs mostly related to the breaking of a taboo or not following cultural norms. Mothers were often stigmatised and blamed following miscarriage, or the birth of a child with a congenital anomaly. Often, women did not seek care following miscarriage unless there was a complication. Most reported that children with a congenital anomaly were neglected either because of lack of knowledge of where care could be sought or because these children brought shame to the family and were hidden from society. Conclusion: The local explanatory model of miscarriage and congenital anomalies covered many perceived causes within biomedical and cultural beliefs. Some of these fuelled stigmatisation and blame of the mother. Understanding of these beliefs, improving access to information about the possible causes of adverse outcomes, and greater collaboration between traditional healers and healthcare providers may help to reduce stigma and increase access to formal healthcare providers.	[Dellicour, Stephanie; Desai, Meghna; Odidi, Beatrice] Ctr Dis Control & Prevent CDC Res & Publ Hlth Col, Malaria Branch, Kenya Med Res Inst, Kisumu, Nyanza Province, Kenya; [Dellicour, Stephanie; Mason, Linda; Phillips-Howard, Penelope A.; ter Kuile, Feiko O.] Univ Liverpool, Liverpool Sch Trop Med, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England; [Desai, Meghna; Laserson, Kayla F.] Ctr Dis Control & Prevent, Ctr Global Hlth, Atlanta, GA USA; [Aol, George] Ctr Dis Control & Prevent Res & Publ Hlth Collabo, Int Emerging Infect Branch, Kenya Med Res Inst, Kisumu, Nyanza Province, Kenya; [Aol, George] Kenya Res & Publ Hlth Collaborat, Kisumu, Nyanza Province, Kenya; [Laserson, Kayla F.] Ctr Dis Control & Prevent Res & Publ Hlth Col, Kenya Med Res Inst, Hlth & Demog Surveillance Syst Branch, Kisumu, Nyanza Province, Kenya	Kenya Medical Research Institute; Liverpool School of Tropical Medicine; University of Liverpool; Centers for Disease Control & Prevention - USA; Kenya Medical Research Institute; Kenya Medical Research Institute	Dellicour, S (corresponding author), Ctr Dis Control & Prevent CDC Res & Publ Hlth Col, Malaria Branch, Kenya Med Res Inst, Kisumu, Nyanza Province, Kenya.	s.dellicour@liverpool.ac.uk		Phillips-Howard, Penelope A/0000-0003-1018-116X	US Centers for Disease Control and Prevention (CDC), Division of Parasitic Diseases and Malaria through Kenya Medical Research Institute (KEMRI), Center for Global Health Research (CGHR), Kisumu, Kenya; Malaria in Pregnancy Consortium; Bill & Melinda Gates Foundation; US CDC; MRC [G1100677] Funding Source: UKRI; Medical Research Council [G1100677] Funding Source: researchfish	US Centers for Disease Control and Prevention (CDC), Division of Parasitic Diseases and Malaria through Kenya Medical Research Institute (KEMRI), Center for Global Health Research (CGHR), Kisumu, Kenya; Malaria in Pregnancy Consortium; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); US CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The funding source was the US Centers for Disease Control and Prevention (CDC), Division of Parasitic Diseases and Malaria through a cooperative agreement with Kenya Medical Research Institute (KEMRI), Center for Global Health Research (CGHR), Kisumu, Kenya. SD is partly funded by the Malaria in Pregnancy Consortium which is funded through a grant from the Bill & Melinda Gates Foundation to the Liverpool School of Tropical Medicine. SD is also grateful to the US CDC for salary support through a cooperative agreement between the Division of Parasitic Diseases and Malaria (Centers for Disease Control and Prevention, USA) and the Malaria Epidemiology Unit of the Child and Reproductive Health group, Liverpool School of Tropical Medicine held by FOtK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adazu K, 2005, AM J TROP MED HYG, V73, P1151, DOI 10.4269/ajtmh.2005.73.1151; Amornkul PN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006470; Baird P A, 1999, Community Genet, V2, P9, DOI 10.1159/000016177; Bale JR, 2003, REDUCING BIRTH DEFEC; Brabin L, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-25; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Dyer SJ, 2007, J PSYCHOSOM OBST GYN, V28, P69, DOI 10.1080/01674820701409959; EDMONDS LD, 1993, TERATOLOGY, V48, P647, DOI 10.1002/tera.1420480606; Filippi V, 1997, TROP MED INT HEALTH, V2, P47, DOI 10.1046/j.1365-3156.1997.d01-126.x; Hausmann-Muela S, 1998, ANTHR MED, P5; Howson CP, 2008, CONTROLLING BIRTH DE; KEMRI/CDC, 2009, KEMRI CDC HLTH DEM S; Kenya National Bureau of Statistics (KNBS), 2010, MACR I KENY DEM HLTH; Kgwatalala G, 2009, HLTH SEEKING BEHAV P; LANDRINE H, 1994, J BEHAV MED, V17, P181, DOI 10.1007/BF01858104; Leininger M M, 1991, NLN Publ, P373; Minhas RS, 2007, UNIV TOR MED J, V84; Odhiambo FO, 2012, INT J EPIDEMIOL, V41, P977, DOI 10.1093/ije/dys108; OKUNADE AO, 1981, CHILD CARE HLTH DEV, V7, P187, DOI 10.1111/j.1365-2214.1981.tb00836.x; Olasoji HO, 2007, BRIT J ORAL MAX SURG, V45, P302, DOI 10.1016/j.bjoms.2006.09.005; Penchaszadeh Victor B, 2002, Community Genet, V5, P61, DOI 10.1159/000064632; Rahman M, 2010, INT PERSPECT SEX R H, V36, P170, DOI 10.1363/3617010; Reardon DC, 2002, SOUTH MED J, V95, P834, DOI 10.1097/00007611-200295080-00011; Stanton C, 2006, LANCET, V367, P1487, DOI 10.1016/S0140-6736(06)68586-3; Stokes E, 2008, BJOG-INT J OBSTET GY, V115, P1641, DOI 10.1111/j.1471-0528.2008.01950.x; UN, 2010, WORLD POP PROSP 2010; van't Hoog AH, 2011, AM J RESP CRIT CARE, V183, P1245, DOI 10.1164/rccm.201008-1269OC	27	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80551	10.1371/journal.pone.0080551	http://dx.doi.org/10.1371/journal.pone.0080551			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236185	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000327254700186
J	Galtier, MN; Touboul, J				Galtier, Mathieu N.; Touboul, Jonathan			Macroscopic Equations Governing Noisy Spiking Neuronal Populations with Linear Synapses	PLOS ONE			English	Article							GAP-JUNCTIONS; NETWORKS; MODELS	Deriving tractable reduced equations of biological neural networks capturing the macroscopic dynamics of sub-populations of neurons has been a longstanding problem in computational neuroscience. In this paper, we propose a reduction of large-scale multi-population stochastic networks based on the mean-field theory. We derive, for a wide class of spiking neuron models, a system of differential equations of the type of the usual Wilson-Cowan systems describing the macroscopic activity of populations, under the assumption that synaptic integration is linear with random coefficients. Our reduction involves one unknown function, the effective non-linearity of the network of populations, which can be analytically determined in simple cases, and numerically computed in general. This function depends on the underlying properties of the cells, and in particular the noise level. Appropriate parameters and functions involved in the reduction are given for different models of neurons: McKean, Fitzhugh-Nagumo and Hodgkin-Huxley models. Simulations of the reduced model show a precise agreement with the macroscopic dynamics of the networks for the first two models.	[Galtier, Mathieu N.] Jacobs Univ, Bremen, Germany; [Touboul, Jonathan] UPMC, CIRB Coll France, CNRS, INSERM,MEMOLIFE PSL,UMR 7421,U1050,ED 158,Math Ne, Paris, France; [Touboul, Jonathan] INRIA Rocquencourt, BANG Lab, Paris, France	Jacobs University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Sorbonne Universite	Galtier, MN (corresponding author), Jacobs Univ, Bremen, Germany.	m.galtier@jacobs-university.de; jonathan.touboul@college-de-france.fr			Amarsi project (FP7-ICT) [24833]; INRIA	Amarsi project (FP7-ICT); INRIA	MNG is funded by the Amarsi project (FP7-ICT #24833). JT is funded by INRIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amari S., 1972, SYST MAN CYBERNET; AMIT DJ, 1991, NETWORK-COMP NEURAL, V2, P259, DOI 10.1088/0954-898X/2/3/003; Ananthanarayanan R, 2009, HIGH PERF COMP NETW, px1; [Anonymous], 2012, HUMAN BRAIN PROJECT; Bressloff PC, 2012, J PHYS A-MATH THEOR, V45, DOI 10.1088/1751-8113/45/3/033001; Bressloff PC, 2009, SIAM J APPL MATH, V70, P1488, DOI 10.1137/090756971; Brunel N, 2003, NEURAL COMPUT, V15, P2281, DOI 10.1162/089976603322362365; Brunel N, 1999, NEURAL COMPUT, V11, P1621, DOI 10.1162/089976699300016179; Buzsaki G., 2004, RHYTHMS BRAIN; Coombes S, 2008, SIAM J APPL DYN SYST, V7, P1101, DOI 10.1137/070707579; Coombes S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.148102; Coombes S, 2001, PHYSICA D, V160, P173, DOI 10.1016/S0167-2789(01)00352-9; Djurfeldt M, 2008, IBM J RES DEV, V52, P31, DOI 10.1147/rd.521.0031; ERMENTROUT B, 1994, NEURAL COMPUT, V6, P679, DOI 10.1162/neco.1994.6.4.679; Ermentrout B, 1987, SIMULATING ANAL ANIM, V14; Ermentrout G., 2010, MATH FDN NEUROSCIENC, V35; ERMENTROUT GB, 1980, SIAM J APPL MATH, V38, P1, DOI 10.1137/0138001; Evans WH, 2002, MOL MEMBR BIOL, V19, P121, DOI 10.1080/09687680210139839; FitzHugh R, MATH MODELS EXCITATI; Gerstner W, 2002, SPIKING NEURON MODEL; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; Izhikevich E., 2005, SIMULATION LARGE SCA; Izhikevich EM, 2006, NEURAL COMPUT, V18, P245, DOI 10.1162/089976606775093882; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; MCKEAN HP, 1970, ADV MATH, V4, P209, DOI 10.1016/0001-8708(70)90023-X; Nykamp DQ, 2000, J COMPUT NEUROSCI, V8, P19, DOI 10.1023/A:1008912914816; Quininao C, 2013, PREPRINT; RINZEL J, 1992, NEURAL COMPUT, V4, P534, DOI 10.1162/neco.1992.4.4.534; Shriki O, 2003, NEURAL COMPUT, V15, P1809, DOI 10.1162/08997660360675053; Thorpe S, 2001, NEURAL NETWORKS, V14, P715, DOI 10.1016/S0893-6080(01)00083-1; Touboul J, 2011, ARXIV11082414V1; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; WILSON HR, 1973, KYBERNETIK, V13, P55, DOI 10.1007/BF00288786	34	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78917	10.1371/journal.pone.0078917	http://dx.doi.org/10.1371/journal.pone.0078917			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236067	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700064
J	Liu, GC; Sui, GY; Liu, GY; Zheng, Y; Deng, Y; Gao, YY; Wang, L				Liu, Guang-cong; Sui, Guo-yuan; Liu, Guang-ying; Zheng, Yang; Deng, Yan; Gao, Yan-yan; Wang, Lie			A Bayesian Meta-Analysis on Prevalence of Hepatitis B Virus Infection among Chinese Volunteer Blood Donors	PLOS ONE			English	Article							C-VIRUS; TRANSFUSION; TRENDS; STILL	Background: Although transfusion-transmitted infection of hepatitis B virus (HBV) threatens the blood safety of China, the nationwide circumstance of HBV infection among blood donors is still unclear. Objectives: To comprehensively estimate the prevalence of HBsAg positive and HBV occult infection (OBI) among Chinese volunteer blood donors through bayesian meta-analysis. Methods: We performed an electronic search in Pub-Med, Web of Knowledge, Medline, Wanfang Data and CNKI, complemented by a hand search of relevant reference lists. Two authors independently extracted data from the eligible studies. Then two bayesian random-effect meta-analyses were performed, followed by bayesian meta-regressions. Results: 5957412 and 571227 donors were identified in HBsAg group and OBI group, respectively. The pooled prevalence of HBsAg group and OBI group among donors is 1.085% (95% credible interval [CI] 0.859%similar to 1.398%) and 0.094% (95% CI 0.0578%similar to 0.1655%). For HBsAg group, subgroup analysis shows the more developed area has a lower prevalence than the less developed area; meta-regression indicates there is a significant decreasing trend in HBsAg positive prevalence with sampling year (beta = -0.1202, 95% -0.2081 similar to 0.0312). Conclusion: Blood safety against HBV infection in China is suffering serious threats and the government should take effective measures to improve this situation.	[Liu, Guang-cong; Sui, Guo-yuan; Zheng, Yang; Deng, Yan; Gao, Yan-yan; Wang, Lie] China Med Univ, Sch Publ Hlth, Shenyang, Liaoning, Peoples R China; [Liu, Guang-ying] Liaoning Univ Tradit Chinese Med, Affiliated Hosp 1, Shenyang, Liaoning, Peoples R China	China Medical University; Liaoning University of Traditional Chinese Medicine	Wang, L (corresponding author), China Med Univ, Sch Publ Hlth, Shenyang, Liaoning, Peoples R China.	liewang@mail.cmu.edu.cn						Adams V, 2009, SOC SCI MED, V68, P410, DOI 10.1016/j.socscimed.2008.11.006; Al Shaer L, 2012, TRANSFUSION, V52, P2300, DOI 10.1111/j.1537-2995.2012.03740.x; Allain JP, 2012, BIOLOGICALS, V40, P180, DOI 10.1016/j.biologicals.2011.09.014; Asim M, 2010, INDIAN J MED RES, V132, P312; Candotti D, 2012, GUT, V61, P1744, DOI 10.1136/gutjnl-2011-301281; Cao J, 2009, J STAT PLAN INFER, V139, P4111, DOI 10.1016/j.jspi.2009.05.041; Chai JY, 2008, JPMT, V1, P11; CHEN DS, 1993, SCIENCE, V262, P369, DOI 10.1126/science.8211155; Chow S-C, 2008, SAMPLE SIZE CALCULAT; Dai ZC, 1999, VIRAL HEPATITIS CH 1, P39; Dhawan HK, 2008, WORLD J GASTROENTERO, V14, P5327, DOI 10.3748/wjg.14.5327; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Hollinger F.B., 2001, FIELDS VIROLOGY, P2971; Ji Yong-Ping, 2011, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V25, P457; Ji ZH, 2013, INT J INFECT DIS, V17, pE259, DOI 10.1016/j.ijid.2012.10.006; Joseph L, 1997, J ROY STAT SOC D-STA, V46, P209; JQ-L, 2012, CHIN J CLIN RATIONAL, V5, P130; Kao JH, 2002, LANCET INFECT DIS, V2, P395, DOI 10.1016/S1473-3099(02)00315-8; Li CQ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-176; Li FQ, 2008, PRACTICAL PREVENTIVE, V15, P63; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Makroo RN, 2008, INDIAN J MED RES, V127, P140; Margolis H S, 1998, Bull World Health Organ, V76 Suppl 2, P152; Panigrahi R, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-204; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Pillonel J, 2002, TRANSFUS CLIN BIOL, V9, P289, DOI 10.1016/S1246-7820(02)00263-X; Q ZY, 1986, CHIN J MICROBIOL IMM, V6, P20; Schmunis GA, 2001, AM J TROP MED HYG, V65, P924, DOI 10.4269/ajtmh.2001.65.924; Shan H, 2002, LANCET, V360, P1770, DOI 10.1016/S0140-6736(02)11669-2; Spiegelhalter D J, 2000, Health Technol Assess, V4, P1; Stramer SL, 2012, TRANSFUSION, V52, P440, DOI 10.1111/j.1537-2995.2011.03283.x; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sutton AJ, 2001, STAT METHODS MED RES, V10, P277, DOI 10.1191/096228001678227794; Tison GH, 2007, TRANSFUSION, V47, P1871, DOI 10.1111/j.1537-2995.2007.01410.x; Wang JS, 1994, XIAN DAI YU FANG YI, V21, P18; Wang MH, 2010, CHINESE MED MODERN D, V8, P196; Xia GL, 1996, INT HEPATOL COMMUN, V5, P62, DOI 10.1016/S0928-4346(96)82012-3; Yan J, 2000, Zhonghua Liu Xing Bing Xue Za Zhi, V21, P10; Yuan Q, 2010, J CLIN MICROBIOL, V48, P357, DOI 10.1128/JCM.01781-09; Zhang R, 2010, TRANSFUSION MED, V20, P322, DOI 10.1111/j.1365-3148.2010.01007.x; [张燕 Zhang Yan], 2011, [中国输血杂志, Chinese Journal of Blood Transfusion], V24, P944; Zhao Shu Ming, 2001, Asian Pac J Cancer Prev, V2, P299; ZHENG X, 2000, CHIN J EPIDEMIOL, V21, P253; Zhu CT, 2009, HEPATOB PANCREAT DIS, V8, P397; Zhuang H, 2004, CHIN J VACCINES IMMU, V10, P180	45	12	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79203	10.1371/journal.pone.0079203	http://dx.doi.org/10.1371/journal.pone.0079203			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236110	Green Submitted, Green Published, gold			2022-12-27	WOS:000327254700109
J	Napolitano, F; Izzo, MT; Di Giuseppe, G; Angelillo, IF				Napolitano, Francesco; Izzo, Maria Teresa; Di Giuseppe, Gabriella; Angelillo, Italo F.		Collaborative Working Grp	Evaluation of the Appropriate Perioperative Antibiotic Prophylaxis in Italy	PLOS ONE			English	Article							SURGICAL SITE INFECTION; ANTIMICROBIAL-PROPHYLAXIS; GUIDELINES; ADHERENCE; SURGERY; RECOMMENDATIONS; PREVENTION; SURVEILLANCE; RISK	Background: The appropriate use of antibiotics prophylaxis in the prevention and reduction in the incidence of surgical site infection is widespread. This study evaluates the appropriateness of the prescription of antibiotics prophylaxis prior to surgery amongst hospitalized patients in the geographic area of Avellino, Caserta, and Naples (Italy) and the factors associated with a poor adherence. Methods: A sample of 382 patients admitted to 23 surgical wards and undergoing surgery in five hospitals were randomly selected. Results: Perioperative antibiotic prophylaxis was appropriate in 18.1% of cases. The multivariate logistic regression analysis showed that patients with hypoalbuminemia, with a clinical infection, with a wound clean were more likely to receive an appropriate antibiotic prophylaxis. Compared with patients with an American Society of Anesthesiologists (ASA) score >= 4, those with a score of 2 were correlated with a 64% reduction in the odds of having an appropriate prophylaxis. The appropriateness of the timing of prophylactic antibiotic administration was observed in 53.4% of the procedures. Multivariate logistic regression model showed that such appropriateness was more frequent in older patients, in those admitted in general surgery wards, in those not having been underwent an endoscopic surgery, in those with a higher length of surgery, and in patients with ASA score 1 when a score >= 4 was chosen as the reference category. The most common antibiotics used inappropriately were ceftazidime, sultamicillin, levofloxacin, and teicoplanin. Conclusions: Educational interventions are needed to improve perioperative appropriate antibiotic prophylaxis.	[Napolitano, Francesco; Izzo, Maria Teresa; Di Giuseppe, Gabriella; Angelillo, Italo F.; Collaborative Working Grp] Univ Naples 2, Dept Expt Med, Naples, Italy	Universita della Campania Vanvitelli	Angelillo, IF (corresponding author), Univ Naples 2, Dept Expt Med, Naples, Italy.	italof.angelillo@unina2.it	Angelillo, Italo Francesco/AAK-1301-2021	Angelillo, Italo Francesco/0000-0003-1213-6602; DI GIUSEPPE, Gabriella/0000-0003-4466-6683; Napolitano, Francesco/0000-0003-4694-2418	Second University of Naples (Naples, Italy)	Second University of Naples (Naples, Italy)	This study was supported by a research grant from the Second University of Naples (Naples, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bratzler DW, 2013, SURG INFECT, V14, P73, DOI 10.1089/sur.2013.9999; Capuano A, 2006, J CHEMOTHERAPY, V18, P293, DOI 10.1179/joc.2006.18.3.293; Castella A, 2006, INFECT CONT HOSP EP, V27, P835, DOI 10.1086/506396; Durando P, 2012, AM J INFECT CONTROL, V40, P969, DOI 10.1016/j.ajic.2011.11.016; Hawn MT, 2008, J AM COLL SURGEONS, V206, P814, DOI 10.1016/j.jamcollsurg.2007.12.013; Hohmann C, 2012, INFECTION, V40, P131, DOI 10.1007/s15010-011-0204-7; Imai-Kamata S, 2011, INT J QUAL HEALTH C, V23, P167, DOI 10.1093/intqhc/mzq080; Junker T, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13616; Lundine KM, 2010, CAN J SURG, V53, P367; Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X; Miliani K, 2009, J ANTIMICROB CHEMOTH, V64, P1307, DOI 10.1093/jac/dkp367; Parulekar L, 2009, INDIAN J SURG, V71, P15, DOI 10.1007/s12262-009-0004-9; Peel TN, 2012, ANTIMICROB AGENTS CH, V56, P2386, DOI 10.1128/AAC.06246-11; Prospero E, 2011, EPIDEMIOL INFECT, V139, P1326, DOI 10.1017/S0950268810002505; Schmitt C, 2012, AM J INFECT CONTROL, V40, P960, DOI 10.1016/j.ajic.2012.01.016; Sistema nazionale per le linee guida (SNLG) website, ANT PER AD LIN GUID; Stata Corporation, 2007, STAT REF MAN REL 10; Steinberg JP, 2009, ANN SURG, V250, P10, DOI 10.1097/SLA.0b013e3181ad5fca; Tourmousoglou CE, 2008, J ANTIMICROB CHEMOTH, V61, P214, DOI 10.1093/jac/dkm406; Young B, 2011, ANTIMICROB AGENTS CH, V55, P4659, DOI 10.1128/AAC.00562-11	20	24	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79532	10.1371/journal.pone.0079532	http://dx.doi.org/10.1371/journal.pone.0079532			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236142	gold, Green Published, Green Submitted			2022-12-27	WOS:000327254700141
J	Pascual, G; Sotomayor, S; Rodriguez, M; Bayon, Y; Bellon, JM				Pascual, Gemma; Sotomayor, Sandra; Rodriguez, Marta; Bayon, Yves; Bellon, Juan M.			Behaviour of a New Composite Mesh for the Repair of Full-Thickness Abdominal Wall Defects in a Rabbit Model	PLOS ONE			English	Article							ADHESION FORMATION; POLYPROPYLENE MESH; PROSTHETIC MESH; TISSUE-RESPONSE; HERNIA REPAIR; PREVENTION; SEPRAMESH; MIGRATION	Introduction: Composite biomaterials designed for the repair of abdominal wall defects are composed of a mesh component and a laminar barrier in contact with the visceral peritoneum. This study assesses the behaviour of a new composite mesh by comparing it with two latest-generation composites currently used in clinical practice. Methods: Defects (7x5cm) created in the anterior abdominal wall of New Zealand White rabbits were repaired using a polypropylene mesh and the composites: Physiomesh (TM); Ventralight (TM) and a new composite mesh with a three-dimensional macroporous polyester structure and an oxidized collagen/chitosan barrier. Animals were sacrificed on days 14 and 90 postimplant. Specimens were processed to determine host tissue incorporation, gene/protein expression of neo-collagens (RT-PCR/immunofluorescence), macrophage response (RAM-11-immunolabelling) and biomechanical resistance. On postoperative days 7/14, each animal was examined laparoscopically to quantify adhesions between the visceral peritoneum and implant. Results: The new composite mesh showed the lowest incidence of seroma in the short term. At each time point, the mesh surface covered with adhesions was greater in controls than composites. By day 14, the implants were fully infiltrated by a loose connective tissue that became denser over time. At 90 days, the peritoneal mesh surface was lined with a stable mesothelium. The new composite mesh induced more rapid tissue maturation than Physiomesh (TM), giving rise to a neoformed tissue containing more type I collagen. In Ventralight (TM) the macrophage reaction was intense and significantly greater than the other composites at both follow-up times. Tensile strengths were similar for each biomaterial. Conclusions: All composites showed optimal peritoneal behaviour, inducing good peritoneal regeneration and scarce postoperative adhesion formation. A greater foreign body reaction was observed for Ventralight (TM). All composites induced good collagen deposition accompanied by optimal tensile strength. The three-dimensional macroporous structure of the new composite mesh may promote rapid tissue regeneration within the mesh.	[Pascual, Gemma; Sotomayor, Sandra; Rodriguez, Marta; Bellon, Juan M.] Alcala Univ, Fac Med, Dept Surg & Med Specialties, Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Madrid, Spain; [Bayon, Yves] Covidien Sofradim Prod, Trevoux, France	CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Universidad de Alcala; Covidien	Bellon, JM (corresponding author), Alcala Univ, Fac Med, Dept Surg & Med Specialties, Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Madrid, Spain.	juanm.bellon@uah.es	; PASCUAL, GEMMA/M-6564-2016	Sotomayor Nunez, Sandra/0000-0003-4998-762X; BELLON, JUAN M./0000-0002-6071-5011; PASCUAL, GEMMA/0000-0002-1623-4384	company COVIDIEN	company COVIDIEN	The authors have a financial research grant with the company COVIDIEN. The funders had no role in study design, data collection and analysis and decision to publish.	AMID PK, 1994, J BIOMED MATER RES, V28, P373, DOI 10.1002/jbm.820280312; Anurov MV, 2012, HERNIA, V16, P199, DOI 10.1007/s10029-011-0877-y; BALIQUE JG, 2005, HERNIA, V9, P68, DOI DOI 10.1007/S10029-004-0300-Z.PUBMED:15578245; Baptista ML, 2000, J AM COLL SURGEONS, V190, P271, DOI 10.1016/S1072-7515(99)00277-X; Bellon JM, 1996, J AM COLL SURGEONS, V183, P11; Bellon JM, 2003, J MATER SCI-MATER M, V14, P359, DOI 10.1023/A:1022936016618; Bellon JM, 2001, WORLD J SURG, V25, P147, DOI 10.1007/s002680020069; Bellon JM, 1996, BIOMATERIALS, V17, P1369, DOI 10.1016/0142-9612(96)87276-0; Bendavid R, 1997, HERNIA, V1, P5, DOI [10.1007/BF02426380, DOI 10.1007/BF02426380]; Binnebosel M, 2007, SURGERY, V142, P365, DOI 10.1016/j.surg.2007.04.024; Breuing K, 2010, SURGERY, V148, P544, DOI 10.1016/j.surg.2010.01.008; Chelala E, 2010, HERNIA, V14, P123, DOI 10.1007/s10029-010-0637-4; Chuback JA, 2000, SURGERY, V127, P475, DOI 10.1067/msy.2000.104122; Deeken CR, 2012, HERNIA, V16, P69, DOI 10.1007/s10029-011-0854-5; Deeken CR, 2012, SURG ENDOSC, V26, P566, DOI 10.1007/s00464-011-1899-3; Diener MK, 2010, ANN SURG, V251, P843, DOI 10.1097/SLA.0b013e3181d973e4; Dinsmore RC, 1999, AM SURGEON, V65, P383; Felemovicius I, 2004, J AM COLL SURGEONS, V198, P543, DOI 10.1016/j.jamcollsurg.2003.12.004; Gray SH, 2008, SURG CLIN N AM, V88, P17, DOI 10.1016/j.suc.2007.11.007; Greenawalt KE, 2000, J SURG RES, V94, P92, DOI 10.1006/jsre.2000.6020; Hernandez B, 2011, J MECH BEHAV BIOMED, V4, P392, DOI 10.1016/j.jmbbm.2010.11.012; Hernandez-Gascon B, 2012, J MECH BEHAV BIOMED, V5, P257, DOI 10.1016/j.jmbbm.2011.09.005; Hoer J, 2002, CHIRURG, V73, P881, DOI 10.1007/s00104-002-0539-9; Judge TW, 2007, J AM COLL SURGEONS, V204, P276, DOI 10.1016/j.jamcollsurg.2006.11.003; Junge K, 2005, Hernia, V9, P212, DOI 10.1007/s10029-004-0315-5; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Konerding MA, 2012, MED ENG PHYS, V34, P806, DOI 10.1016/j.medengphy.2011.09.022; Konerding MA, 2011, MED ENG PHYS, V33, P789, DOI 10.1016/j.medengphy.2011.01.010; Lambrecht J, 2011, HERNIA, V15, P473, DOI 10.1007/s10029-011-0817-x; Matthews BD, 2005, J SURG RES, V123, P227, DOI 10.1016/j.jss.2004.08.012; Matthews BD, 2002, AM SURGEON, V68, P936; Moreno-Egea A, 2010, SURG ENDOSC, V24, P359, DOI 10.1007/s00464-009-0573-5; Moussi A, 2012, HERNIA, V16, P215, DOI 10.1007/s10029-010-0734-4; Ott V, 2005, Hernia, V9, P103, DOI 10.1007/s10029-004-0271-0; Pierce RA, 2009, SURG INNOV, V16, P46, DOI 10.1177/1553350608330479; Reinke JM, 2012, EUR SURG RES, V49, P35, DOI 10.1159/000339613; Savioz D, 1997, EUR J SURG, V163, P631; SCHEIN M, 1995, J AM COLL SURGEONS, V180, P745; Schreinemacher MHF, 2009, BRIT J SURG, V96, P305, DOI 10.1002/bjs.6446; Schug-Pass C, 2009, SURG ENDOSC, V23, P487, DOI 10.1007/s00464-008-0085-8; Sugerman HJ, 1996, AM J SURG, V171, P80, DOI 10.1016/S0002-9610(99)80078-6; van't Riet M, 2003, ANN SURG, V237, P123, DOI 10.1097/00000658-200301000-00017; WALKER AP, 1993, J SURG RES, V55, P32, DOI 10.1006/jsre.1993.1104; Yang F, 2013, AM J SURG, V205, P15, DOI 10.1016/j.amjsurg.2012.04.007	44	28	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80647	10.1371/journal.pone.0080647	http://dx.doi.org/10.1371/journal.pone.0080647			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236192	Green Submitted, gold, Green Published			2022-12-27	WOS:000327254700195
J	Powis, TG; Murrieta, EG; Lesure, R; Bravo, RL; Grivetti, L; Kucera, H; Gaikwad, NW				Powis, Terry G.; Gallaga Murrieta, Emiliano; Lesure, Richard; Lopez Bravo, Roberto; Grivetti, Louis; Kucera, Heidi; Gaikwad, Nilesh W.			Prehispanic Use of Chili Peppers in Chiapas, Mexico	PLOS ONE			English	Article							CAPSICUM	The genus Capsicum is New World in origin and represents a complex of a wide variety of both wild and domesticated taxa. Peppers or fruits of Capsicum species rarely have been identified in the paleoethnobotanical record in either Meso- or South America. We report here confirmation of Capsicum sp. residues from pottery samples excavated at Chiapa de Corzo in southern Mexico dated from Middle to Late Preclassic periods (400 BCE to 300 CE). Residues from 13 different pottery types were collected and extracted using standard techniques. Presence of Capsicum was confirmed by ultra-performance liquid chromatography (UPLC)/MS-MS Analysis. Five pottery types exhibited chemical peaks for Capsicum when compared to the standard (dihydrocapsaicin). No peaks were observed in the remaining eight samples. Results of the chemical extractions provide conclusive evidence for Capsicum use at Chiapas de Corzo during a 700 year period (400 BCE-300 CE). Presence of Capsicum in different types of culinary-associated pottery raises questions how chili pepper could have been used during this early time period. As Pre-Columbian cacao products sometimes were flavored using Capsicum, the same pottery sample set was tested for evidence of cacao using a theobromine marker: these results were negative. As each vessel that tested positive for Capsicum had a culinary use we suggest here the possibility that chili residues from the Chiapas de Corzo pottery samples reflect either paste or beverage preparations for religious, festival, or every day culinary use. Alternatively, some vessels that tested positive merely could have been used to store peppers. Most interesting from an archaeological context was the presence of Capsicum residue obtained from a spouted jar, a pottery type previously thought only to be used for pouring liquids.	[Powis, Terry G.] Kennesaw State Univ, Dept Geog & Anthropol, Kennesaw, GA 30144 USA; [Gallaga Murrieta, Emiliano] Univ Autonoma Chiapas UNACH, Dept Tourism Adm, Tuxtla Gutierrez, Mexico; [Lesure, Richard] Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90024 USA; [Lopez Bravo, Roberto] Inst Nacl Antropol & Hist Chiapas, Tuxtla Gutierrez, Mexico; [Grivetti, Louis] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Kucera, Heidi; Gaikwad, Nilesh W.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Kucera, Heidi; Gaikwad, Nilesh W.] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; [Gallaga Murrieta, Emiliano] Univ Arizona, Dept Anthropol, Tucson, AZ 85721 USA	University System of Georgia; Kennesaw State University; Universidad Autonoma de Chiapas; University of California System; University of California Los Angeles; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of Arizona	Powis, TG (corresponding author), Kennesaw State Univ, Dept Geog & Anthropol, Kennesaw, GA 30144 USA.	tpowis@kennesaw.edu			Wenner Gren Foundation for Anthropological Research [8312]	Wenner Gren Foundation for Anthropological Research	The research was funded by a grant to Lesure from the Wenner Gren Foundation for Anthropological Research (Grant 8312). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrinier Pierre, 1975, PAPERS NEW WORLD ARC, V37; Agrinier Pierre, 1964, PAPERS NEW WORLD ARC, V16; Beliaev D, 2010, PRE-COLUMBIAN FOODWAYS: INTERDISCIPLINARY APPROACHES TO FOOD, CULTURE, AND MARKETS IN ANCIENT MESOAMERICA, P257, DOI 10.1007/978-1-4419-0471-3_10; Cichewicz RH, 1996, J ETHNOPHARMACOL, V52, P61, DOI 10.1016/0378-8741(96)01384-0; Clark John E., 2000, CULTURAS CHIAPAS PER, P37; Cliff M. B, 1989, RES ECONOMIC ANTH S4, P259; Coe SD, 1995, AM 1 CUISINE; Colas Pierre Robert, 2002, MEXICON, V24, P33; Colunga-GarciaMarin P, 2004, ECON BOT, V58, pS101, DOI 10.1663/0013-0001(2004)58[S101:DOPIML]2.0.CO;2; Dietler Michael, 2001, FEASTS ARCHAEOLOGICA; Dixon Keith A., 1959, PAPERS NEW WORLD ARC, V5; Gonzalez Cruz A., 1998, CANTO VERSUS CANTO M; Green JS, 2009, PRECOLUMBIAN FOODWAY, P341; Hammond Norman, 1981, J FIELD ARCHAEOL, V8, P260; Henderson JS, 2007, P NATL ACAD SCI USA, V104, P18937, DOI 10.1073/pnas.0708815104; Henderson John S., 2006, CHOCOLATE MESOAMERIC, P140; Hull K, 2010, PRE-COLUMBIAN FOODWAYS: INTERDISCIPLINARY APPROACHES TO FOOD, CULTURE, AND MARKETS IN ANCIENT MESOAMERICA, P235, DOI 10.1007/978-1-4419-0471-3_9; Hurst WJ, 2002, NATURE, V418, P289, DOI 10.1038/418289a; Lentz D.L., 1991, LAT AM ANTIQ, V2, P269, DOI [10.2307/972172, DOI 10.2307/972172]; Lentz David L., 1999, REPORT DEP CONSERVAT, P3; LENTZ DL, 1996, LAT AM ANTIQ, V7, P247; Loughmiller-Newman Jennifer, 2012, THESIS STATE U NEW Y; Lowe G.W., 1960, PAPERS NEW WORLD ARC; Lowe GarethW., 1962, PAPERS NEW WORLD ARC, V12; McAnany P., 1999, ANCIENT MESOAM, V10, P129, DOI DOI 10.1017/S0956536199101081; MCLEOD MJ, 1982, ECON BOT, V36, P361, DOI 10.1007/BF02862689; McNeil Cameron L, 2006, CHOCOLATE MESOAMERIC; McNeil Cameron L., 2006, CHOCOLATE MESOAMERIC, P1; Miksicek Charles H., 1991, CUELLO EARLY MAYA CO, P70; Minnis PE, 2010, AM ANTIQUITY, V75, P245, DOI 10.7183/0002-7316.75.2.245; Perry L, 2007, P NATL ACAD SCI USA, V104, P11905, DOI 10.1073/pnas.0704936104; Perry L, 2007, SCIENCE, V315, P986, DOI 10.1126/science.1136914; PICKERSGILL B, 1969, AM ANTIQUITY, V34, P54, DOI 10.2307/278313; Powis TG, 2011, P NATL ACAD SCI USA, V108, P8595, DOI 10.1073/pnas.1100620108; Powis Terry G., 2008, MEXICON, V30, P35; Powis TG, 2002, LAT AM ANTIQ, V13, P85, DOI 10.2307/971742; Smith BD, 2005, P NATL ACAD SCI USA, V102, P9438, DOI 10.1073/pnas.0502847102; Sotelo A, 2012, PLANT FOOD HUM NUTR, V67, P148, DOI 10.1007/s11130-012-0281-5; STUART D, 1988, ANTIQUITY, V62, P153, DOI 10.1017/S0003598X00073634; Stuart D., 2006, CHOCOLATE MESOAMERIC, P184; TURNER BL, 1984, ECON BOT, V38, P179, DOI 10.1007/BF02858831; Valverde M, 2000, CULTURAS CHIAPAS FOR, P89; WARREN BW, 1959, ARCHAEOLOGY, V12, P98	43	12	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79013	10.1371/journal.pone.0079013	http://dx.doi.org/10.1371/journal.pone.0079013			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	255QK	24236083	gold, Green Published, Green Submitted			2022-12-27	WOS:000327254700081
J	Strand, M; Micchelli, CA				Strand, Marie; Micchelli, Craig A.			Regional Control of Drosophila Gut Stem Cell Proliferation: EGF Establishes GSSC Proliferative Set Point & Controls Emergence from Quiescence	PLOS ONE			English	Article							MIDGUT; MAINTAIN; ACID	Adult stem cells vary widely in their rates of proliferation. Some stem cells are constitutively active, while others divide only in response to injury. The mechanism controlling this differential proliferative set point is not well understood. The anterior-posterior (A/P) axis of the adult Drosophila midgut has a segmental organization, displaying physiological compartmentalization and region-specific epithelia. These distinct midgut regions are maintained by defined stem cell populations with unique division schedules, providing an excellent experimental model with which to investigate this question. Here, we focus on the quiescent gastric stem cells (GSSCs) of the acidic copper cell region (CCR), which exhibit the greatest period of latency between divisions of all characterized gut stem cells, to define the molecular basis of differential stem cell activity. Our molecular genetic analysis demonstrates that the mitogenic EGF signaling pathway is a limiting factor controlling GSSC proliferation. We find that under baseline conditions, when GSSCs are largely quiescent, the lowest levels of EGF ligands in the midgut are found in the CCR. However, acute epithelial injury by enteric pathogens leads to an increase in EGF ligand expression in the CCR and rapid expansion of the GSSC lineage. Thus, the unique proliferative set points for gut stem cells residing in physiologically distinct compartments are governed by regional control of niche signals along the A/P axis.	[Strand, Marie; Micchelli, Craig A.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Micchelli, CA (corresponding author), Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63130 USA.	micchelli@wustl.edu			NIH [R01 DK095871]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095871] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	NIH R01 DK095871; http://www2.niddk.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Beebe K, 2010, DEV BIOL, V338, P28, DOI 10.1016/j.ydbio.2009.10.045; Biteau B, 2011, DEVELOPMENT, V138, P1045, DOI 10.1242/dev.056671; Bogdan S, 2001, CURR BIOL, V11, pR292, DOI 10.1016/S0960-9822(01)00167-1; Buchon N, 2013, CELL REP, V3, P1725, DOI 10.1016/j.celrep.2013.04.001; Buchon N, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-152; Coffey RJ, 2007, J CLIN INVEST, V117, P70, DOI 10.1172/JCI30491; Dubreuil RR, 2004, INT J BIOCHEM CELL B, V36, P745, DOI 10.1016/j.biocel.2003.07.004; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Guo Z, 2013, J CELL BIOL, V201, P945, DOI 10.1083/jcb.201302049; Jiang HQ, 2011, EXP CELL RES, V317, P2780, DOI 10.1016/j.yexcr.2011.07.020; Jiang HQ, 2011, CELL STEM CELL, V8, P84, DOI 10.1016/j.stem.2010.11.026; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee WC, 2009, DEVELOPMENT, V136, P2255, DOI 10.1242/dev.035196; Li HJ, 2013, CELL REP, V4, P10, DOI 10.1016/j.celrep.2013.05.040; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Marianes A, 2013, ELIFE, V2, DOI 10.7554/eLife.00886; McNulty M, 2001, CELL TISSUE RES, V304, P383, DOI 10.1007/s004410100371; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Mills JC, 2011, GASTROENTEROLOGY, V140, P412, DOI 10.1053/j.gastro.2010.12.001; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Poulsen D. F., 1952, Experimental Cell Research New York Supplement, VNo. 2, P161; POULSON D. F., 1960, AUSTRALIAN JOUR BIOL SCI, V13, P541; Shanbhag S, 2009, J EXP BIOL, V212, P1731, DOI 10.1242/jeb.029306; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Strand M, 2011, P NATL ACAD SCI USA, V108, P17696, DOI 10.1073/pnas.1109794108; Strasburger M, 1932, Z WISS ZOOL ABT A, V140, P539; Veenstra JA, 2008, CELL TISSUE RES, V334, P499, DOI 10.1007/s00441-008-0708-3; Xu N, 2011, DEV BIOL, V354, P31, DOI 10.1016/j.ydbio.2011.03.018; Zheng Leizhen, 2004, Gastric Cancer, V7, P61	29	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80608	10.1371/journal.pone.0080608	http://dx.doi.org/10.1371/journal.pone.0080608			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236188	Green Published, gold			2022-12-27	WOS:000327254700191
J	Tehrani, JJ				Tehrani, Jamshid J.			The Phylogeny of Little Red Riding Hood	PLOS ONE			English	Article							EVOLUTION; TRANSMISSION; EXPANSION; INDEX; BIAS; TALE	Researchers have long been fascinated by the strong continuities evident in the oral traditions associated with different cultures. According to the 'historic-geographic' school, it is possible to classify similar tales into "international types" and trace them back to their original archetypes. However, critics argue that folktale traditions are fundamentally fluid, and that most international types are artificial constructs. Here, these issues are addressed using phylogenetic methods that were originally developed to reconstruct evolutionary relationships among biological species, and which have been recently applied to a range of cultural phenomena. The study focuses on one of the most debated international types in the literature: ATU 333, 'Little Red Riding Hood'. A number of variants of ATU 333 have been recorded in European oral traditions, and it has been suggested that the group may include tales from other regions, including Africa and East Asia. However, in many of these cases, it is difficult to differentiate ATU 333 from another widespread international folktale, ATU 123, 'The Wolf and the Kids'. To shed more light on these relationships, data on 58 folktales were analysed using cladistic, Bayesian and phylogenetic network-based methods. The results demonstrate that, contrary to the claims made by critics of the historic-geographic approach, it is possible to identify ATU 333 and ATU 123 as distinct international types. They further suggest that most of the African tales can be classified as variants of ATU 123, while the East Asian tales probably evolved by blending together elements of both ATU 333 and ATU 123. These findings demonstrate that phylogenetic methods provide a powerful set of tools for testing hypotheses about cross-cultural relationships among folktales, and point towards exciting new directions for research into the transmission and evolution of oral narratives.	[Tehrani, Jamshid J.] Univ Durham, Dept Anthropol, Durham, England; [Tehrani, Jamshid J.] Univ Durham, Ctr Coevolut Biol & Culture, Durham, England	Durham University; Durham University	Tehrani, JJ (corresponding author), Univ Durham, Dept Anthropol, Sci Site South Rd, Durham, England.	jamie.tehrani@durham.ac.uk		Tehrani, Jamshid/0000-0001-8565-6057	RCUK Fellowship	RCUK Fellowship(UK Research & Innovation (UKRI))	The author was supported by an RCUK Fellowship during a part of the time in which the research was carried out. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aarne Antti, 1961, TYPES FOLKTALE CLASS; Barbrook AC, 1998, NATURE, V394, P839, DOI 10.1038/29667; Bouckaert R, 2012, SCIENCE, V337, P957, DOI 10.1126/science.1219669; Buchanan B, 2008, J ARCHAEOL SCI, V35, P1683, DOI 10.1016/j.jas.2007.11.009; Buckley CD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052064; Chih-chun H, 1993, MERVEILLES CONTES, V7, P513; Collard M, 2006, EVOL HUM BEHAV, V27, P169, DOI 10.1016/j.evolhumbehav.2005.07.003; Currie TE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0695; d'Huy J, 2013, ROCK ART RES, V30, P115; Dundes A, 1997, J FOLKLORE RES, V34, P195; Dundes Alan, 1989, LITTLE RED RIDING HO; Eberhard W, 1971, STUDIES TAIWANESE FO; FARRIS JS, 1989, CLADISTICS, V5, P417, DOI 10.1111/j.1096-0031.1989.tb00573.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Frazer JG, 1889, FOLK LORE J, V7, P167; GOLDBERG C, 1984, J FOLKLORE RES, V21, P1; Goldberg C, 2009, NARRATIVE CULTURE: STUDIES IN NARRATIVE CULTURE PRESENTED TO HANS-JORG UTHER ON THE OCCASION OF HIS 65TH BIRTHDAY, P277, DOI 10.1515/9783110214727.4.277; Gottschall J, 2003, HUM NATURE-INT BIOS, V14, P365, DOI 10.1007/s12110-003-1011-3; Gray RD, 2009, SCIENCE, V323, P479, DOI 10.1126/science.1166858; Gray RD, 2010, PHILOS T R SOC B, V365, P3923, DOI 10.1098/rstb.2010.0162; Greenhill SJ, 2009, P ROY SOC B-BIOL SCI, V276, P2299, DOI 10.1098/rspb.2008.1944; Grimm J, 1812, CHILDRENS HOUSEHOLD; Grimm W, 1884, CHILDRENS HOUSEHOLD; Holland BR, 2002, MOL BIOL EVOL, V19, P2051, DOI 10.1093/oxfordjournals.molbev.a004030; Howe CJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001069; Howe CJ, 2001, TRENDS GENET, V17, P147, DOI 10.1016/S0168-9525(00)02210-1; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ikeda H., 1971, TYPE MOTIF INDEX JAP; JACOBS M, 1966, J AM FOLKLORE, V79, P413, DOI 10.2307/537506; Jordan P, 2009, J ANTHROPOL ARCHAEOL, V28, P342, DOI 10.1016/j.jaa.2009.05.004; Kitchen A, 2009, P ROY SOC B-BIOL SCI, V276, P2703, DOI 10.1098/rspb.2009.0408; Klipple MA, 1992, AFRICAN FOLKTALES FO; Lee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062243; Lycett SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007404; Maddison WP, 2019, MESQUITE MODULAR SYS; Matthews LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014810; Mesoudi A, 2006, BRIT J PSYCHOL, V97, P405, DOI 10.1348/000712605X85871; Norenzayan A, 2006, COGNITIVE SCI, V30, P531, DOI 10.1207/s15516709cog0000_68; Nunn CL, 2010, PHILOS T R SOC B, V365, P3807, DOI 10.1098/rstb.2010.0009; OBrien M.J., 2003, CLADISTICS ARCHAEOLO; Perrault Charles, 1697, HISTOIRES CONTES TEM; Propp V., 1968, MORPHOLOGY FOLKTALE, DOI University of Texas Press; Ronquist F, 2012, SYSTEMATIC BIOL; Roos T, 2009, LIT LINGUIST COMPUT, V24, P417, DOI 10.1093/llc/fqp002; Ross RM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.3065; Sperber Dan, 1996, EXPLAINING CULTURE N; Stubbersfield J, 2013, SOC SCI COMPUT REV, V31, P90, DOI 10.1177/0894439312453567; Sugiyama MS, 2003, HUM NATURE-INT BIOS, V14, P383, DOI 10.1007/s12110-003-1012-2; Sugiyama MS, 2004, INTERDISCIPLINARY LI, V5, P110; Swofford DL, 1998, PAUP 4 PHYLOGENETIC; Sydow C., 1948, SELECTED PAPERS FOLK; Tehrani J, 2002, J ANTHROPOL ARCHAEOL, V21, P443, DOI 10.1016/S0278-4165(02)00002-8; Temkin I, 2007, CURR ANTHROPOL, V48, P146, DOI 10.1086/510463; Ter Haar BarendJ., 2006, TELLING STORIES WITC; Thomas NT, 1913, ANTHR REPORT IBO SPE; Thompson S., 1951, FOLKTALE; Ting N, 1978, TYPE INDEX CHINESE F; Uther Hans-Jorg, 2004, TYPES INT FOLKTALE 1; ZIOLKOWSKI JM, 1992, SPECULUM, V67, P549, DOI 10.2307/2863656; Zipes J., 2006, WHY FAIRY TALES STIC; Zipes Jack, 1993, TRIALS TRIBULATIONS	62	74	78	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78871	10.1371/journal.pone.0078871	http://dx.doi.org/10.1371/journal.pone.0078871			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	255QK	24236061	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700058
J	Tilley, A; Lopez-Angarita, J; Turner, JR				Tilley, Alexander; Lopez-Angarita, Juliana; Turner, John R.			Diet Reconstruction and Resource Partitioning of a Caribbean Marine Mesopredator Using Stable Isotope Bayesian Modelling	PLOS ONE			English	Article							STINGRAY DASYATIS-AMERICANA; SOUTHERN STINGRAY; FEEDING-HABITS; ONTOGENIC CHANGES; FOOD-WEB; DELTA-N-15; NICHE; COMMUNITIES; POPULATIONS; ASSUMPTIONS	The trophic ecology of epibenthic mesopredators is not well understood in terms of prey partitioning with sympatric elasmobranchs or their effects on prey communities, yet the importance of omnivores in community trophic dynamics is being increasingly realised. This study used stable isotope analysis of N-15 and C-13 to model diet composition of wild southern stingrays Dasyatis americana and compare trophic niche space to nurse sharks Ginglymostoma cirratum and Caribbean reef sharks Carcharhinus perezi on Glovers Reef Atoll, Belize. Bayesian stable isotope mixing models were used to investigate prey choice as well as viable Diet-Tissue Discrimination Factors for use with stingrays. Stingray delta N-15 values showed the greatest variation and a positive relationship with size, with an isotopic niche width approximately twice that of sympatric species. Shark species exhibited comparatively restricted delta N-15 values and greater delta C-13 variation, with very little overlap of stingray niche space. Mixing models suggest bivalves and annelids are proportionally more important prey in the stingray diet than crustaceans and teleosts at Glovers Reef, in contrast to all but one published diet study using stomach contents from other locations. Incorporating gut contents information from the literature, we suggest diet-tissue discrimination factors values of Delta N-15 approximate to 2.7 parts per thousand and Delta C-13 approximate to 0.9 parts per thousand for stingrays in the absence of validation experiments. The wide trophic niche and lower trophic level exhibited by stingrays compared to sympatric sharks supports their putative role as important base stabilisers in benthic systems, with the potential to absorb trophic perturbations through numerous opportunistic prey interactions.	[Tilley, Alexander; Turner, John R.] Bangor Univ, Sch Ocean Sci, Menai Bridge, Anglesey, Wales; [Tilley, Alexander; Lopez-Angarita, Juliana] Talking Oceans Fdn, Bogota, Colombia; [Lopez-Angarita, Juliana] Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England	Bangor University; University of York - UK	Tilley, A (corresponding author), Bangor Univ, Sch Ocean Sci, Menai Bridge, Anglesey, Wales.	alex@talkingoceans.co.uk	Tilley, Alexander/P-2431-2019	Tilley, Alexander/0000-0002-6363-0945; Lopez-Angarita, Juliana/0000-0002-8725-0795	Ulysses S. Seal Conservation Award from the Minnesota Zoo	Ulysses S. Seal Conservation Award from the Minnesota Zoo	This research was funded in part by the Ulysses S. Seal Conservation Award from the Minnesota Zoo and received logistical support from the Glovers Reef Research Station (Wildlife Conservation Society). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar AA, 2009, J MAR BIOL ASSOC UK, V89, P1147, DOI 10.1017/S0025315409000058; Arthur KE, 2008, MAR ECOL PROG SER, V362, P303, DOI 10.3354/meps07440; Bascompte J, 2005, P NATL ACAD SCI USA, V102, P5443, DOI 10.1073/pnas.0501562102; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; Bigelow H.B., 1953, FISHES W N ATLANTIC; Bowman R.E., 2000, NMFSNE155 NOAA, DOI DOI 10.1093/icesjms/fsp225; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; CORTES E, 1990, COPEIA, P204; Cortes E, 1999, ICES J MAR SCI, V56, P707, DOI 10.1006/jmsc.1999.0489; Cummings DO, 2010, MAR ECOL PROG SER, V419, P211, DOI 10.3354/meps08827; Dale JJ, 2011, MAR ECOL PROG SER, V433, P221, DOI 10.3354/meps09171; Fagan WF, 1997, AM NAT, V150, P554, DOI 10.1086/286081; FROESE R, 2000, FISHBASE 2000 CONCEP; GILLIAM D, 1993, B MAR SCI, V52, P1007; Grijalba Bendeck Marcela, 2007, Bol. Invest. Mar. Cost., V36, P251; Henningsen AD, 2000, COPEIA, P826; Howarth LM, 2014, FISH FISH, V15, P690, DOI 10.1111/faf.12041; Hussey NE, 2012, J FISH BIOL, V80, P1449, DOI 10.1111/j.1095-8649.2012.03251.x; Hussey NE, 2012, J EXP MAR BIOL ECOL, V434, P7, DOI 10.1016/j.jembe.2012.07.012; Hussey NE, 2011, LIMNOL OCEANOGR-METH, V9, P524, DOI 10.4319/lom.2011.9.524; Hussey NE, 2010, COMP BIOCHEM PHYS A, V155, P445, DOI 10.1016/j.cbpa.2009.09.023; Hussey NE, 2010, J ANIM ECOL, V79, P184, DOI 10.1111/j.1365-2656.2009.01623.x; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Kim SL, 2012, ENVIRON BIOL FISH, V95, P53, DOI 10.1007/s10641-011-9860-9; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; LIN GH, 1991, AQUAT BOT, V40, P333, DOI 10.1016/0304-3770(91)90079-K; Lopez-Garro A., 2009, REV CIENC MAR COSTER, V1, P145, DOI DOI 10.15359/revmar.1.8; MacNeil MA, 2006, CAN J FISH AQUAT SCI, V63, P345, DOI 10.1139/F05-219; Matich P, 2011, J ANIM ECOL, V80, P294, DOI 10.1111/j.1365-2656.2010.01753.x; Michener RH, 2007, ECOL METHOD CONCEPT, P238, DOI 10.1002/9780470691854.ch9; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; O'Gorman EJ, 2008, OECOLOGIA, V158, P557, DOI 10.1007/s00442-008-1165-0; O'Gorman EJ, 2009, P NATL ACAD SCI USA, V106, P13393, DOI 10.1073/pnas.0903682106; O'Shea OR, 2012, MAR FRESHWATER RES, V63, P189, DOI 10.1071/MF11180; PAN-Tiburones, 2015, PLAN ACC NAC CONS MA; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Peterson CH, 2001, OECOLOGIA, V129, P349, DOI 10.1007/s004420100742; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; PRESTON T, 1983, ANALYST, V108, P971, DOI 10.1039/an9830800971; RANDALL JOHN E., 1967, STUD TROP OCEANOGR INST MAR SCI UNIV MIAMI, V5, P665; Robbins CT, 2010, OECOLOGIA, V162, P571, DOI 10.1007/s00442-009-1485-8; Robbins CT, 2005, OECOLOGIA, V144, P534, DOI 10.1007/s00442-005-0021-8; Saglam H, 2010, CAH BIOL MAR, V51, P37; SMITH JW, 1985, ESTUARIES, V8, P305, DOI 10.2307/1351491; SMITH KN, 1992, J EXP MAR BIOL ECOL, V157, P3, DOI 10.1016/0022-0981(92)90070-Q; Smith WD, 2008, MAR FRESHWATER RES, V59, P575, DOI 10.1071/MF07020; SNELSON FF, 1981, ESTUARIES, V4, P110, DOI 10.2307/1351673; STOKES MD, 1992, J FISH BIOL, V41, P1043, DOI 10.1111/j.1095-8649.1992.tb02732.x; Thrush SE, 1999, AUST J ECOL, V24, P344, DOI 10.1046/j.1442-9993.1999.00981.x; Tilley A, 2013, MAR ECOL PROG SER, V482, P169, DOI 10.3354/meps10285; Tilley A, 2013, AQUAT CONSERV, V23, P202, DOI 10.1002/aqc.2317; VALENTINE JF, 1994, J EXP MAR BIOL ECOL, V178, P181, DOI 10.1016/0022-0981(94)90035-3; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; Vaudo JJ, 2011, MAR ECOL PROG SER, V425, P247, DOI 10.3354/meps08988; Ward-Campbell BMS, 2005, ENVIRON BIOL FISH, V72, P251, DOI 10.1007/s10641-004-1744-9; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Wetherbee BM, 2004, CRC MAR BIOL SER, P225	62	41	42	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79560	10.1371/journal.pone.0079560	http://dx.doi.org/10.1371/journal.pone.0079560			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236144	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700143
J	Vitevitch, MS; Sereno, J; Jongman, A; Goldstein, R				Vitevitch, Michael S.; Sereno, Joan; Jongman, Allard; Goldstein, Rutherford			Speaker Sex Influences Processing of Grammatical Gender	PLOS ONE			English	Article							INFORMATION; MODEL	Spoken words carry linguistic and indexical information to listeners. Abstractionist models of spoken word recognition suggest that indexical information is stripped away in a process called normalization to allow processing of the linguistic message to proceed. In contrast, exemplar models of the lexicon suggest that indexical information is retained in memory, and influences the process of spoken word recognition. In the present study native Spanish listeners heard Spanish words that varied in grammatical gender (masculine, ending in -o, or feminine, ending in -a) produced by either a male or a female speaker. When asked to indicate the grammatical gender of the words, listeners were faster and more accurate when the sex of the speaker "matched'' the grammatical gender than when the sex of the speaker and the grammatical gender "mismatched.'' No such interference was observed when listeners heard the same stimuli, but identified whether the speaker was male or female. This finding suggests that indexical information, in this case the sex of the speaker, influences not just processes associated with word recognition, but also higher-level processes associated with grammatical processing. This result also raises questions regarding the widespread assumption about the cognitive independence and automatic nature of grammatical processes.	[Vitevitch, Michael S.; Goldstein, Rutherford] Univ Kansas, Dept Psychol, Lawrence, KS 66045 USA; [Sereno, Joan; Jongman, Allard] Univ Kansas, Dept Linguist, Lawrence, KS 66045 USA	University of Kansas; University of Kansas	Vitevitch, MS (corresponding author), Univ Kansas, Dept Psychol, Lawrence, KS 66045 USA.	mvitevit@ku.edu	jongman, allard/A-8377-2009	jongman, allard/0000-0002-7384-2036; Sereno, Joan/0000-0002-1227-7715; Vitevitch, Michael/0000-0002-1209-0838	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005803, T32DC000052] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Abercrombie D., 1967, ELEMENTS GEN PHONETI; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; Cohen J.E., 1988, STAT POWER ANAL BEHA; Corbett GG, 2005, WORLD ATLAS LANGUAGE, P134; Goldinger SD, 1998, PSYCHOL REV, V105, P251, DOI 10.1037/0033-295X.105.2.251; Johnson Keith, 1997, TALKER VARIABILITY S, P145, DOI DOI 10.1017/S1366728914000790; LADEFOGED P, 1957, J ACOUST SOC AM, V29, P98, DOI 10.1121/1.1908694; MCCLELLAND JL, 1986, COGNITIVE PSYCHOL, V18, P1, DOI 10.1016/0010-0285(86)90015-0; Moore CB, 1997, J ACOUST SOC AM, V102, P1864, DOI 10.1121/1.420092; MULLENNIX JW, 1989, J ACOUST SOC AM, V85, P365, DOI 10.1121/1.397688; NORRIS D, 1994, COGNITION, V52, P189, DOI 10.1016/0010-0277(94)90043-4; Nygaard LC, 2002, MEM COGNITION, V30, P583, DOI 10.3758/BF03194959; PALMERI TJ, 1993, J EXP PSYCHOL LEARN, V19, P309, DOI 10.1037/0278-7393.19.2.309; Pierrehumbert JB, 2002, PHONOL PHONET, V4-1, P101; PINKER S, 1991, SCIENCE, V253, P530, DOI 10.1126/science.1857983; Pisoni David, 1997, TALKER VARIABILITY S, P9; Sahin NT, 2009, SCIENCE, V326, P445, DOI 10.1126/science.1174481; Schiller NO, 2003, PSYCHOPHYSIOLOGY, V40, P869, DOI 10.1111/1469-8986.00105; Sebastian Galles N, 2000, LEXESP LEXICO INFORM; Ullman MT, 1997, J COGNITIVE NEUROSCI, V9, P266, DOI 10.1162/jocn.1997.9.2.266; Vitevitch MS, 2011, Q J EXP PSYCHOL, V64, P1484, DOI 10.1080/17470218.2011.578749	22	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79701	10.1371/journal.pone.0079701	http://dx.doi.org/10.1371/journal.pone.0079701			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236155	Green Published, gold			2022-12-27	WOS:000327254700154
J	Yamamoto, H; Maruo, T; Majima, T; Ishizaki, H; Tanaka-Okamoto, M; Miyoshi, J; Mandai, K; Takai, Y				Yamamoto, Hideaki; Maruo, Tomohiko; Majima, Takashi; Ishizaki, Hiroyoshi; Tanaka-Okamoto, Miki; Miyoshi, Jun; Mandai, Kenji; Takai, Yoshimi			Genetic Deletion of Afadin Causes Hydrocephalus by Destruction of Adherens Junctions in Radial Glial and Ependymal Cells in the Midbrain	PLOS ONE			English	Article							CANINE KIDNEY-CELLS; TIGHT JUNCTIONS; ADHESION MOLECULE; NERVOUS-SYSTEM; MOTILE CILIA; MUTANT MICE; E-CADHERIN; NECTIN; MOUSE; POLARITY	Adherens junctions (AJs) play a role in mechanically connecting adjacent cells to maintain tissue structure, particularly in epithelial cells. The major cell-cell adhesion molecules at AJs are cadherins and nectins. Afadin binds to both nectins and alpha-catenin and recruits the cadherin-beta-catenin complex to the nectin-based cell-cell adhesion site to form AJs. To explore the role of afadin in radial glial and ependymal cells in the brain, we generated mice carrying a nestin-Cre-mediated conditional knockout (cKO) of the afadin gene. Newborn afadin-cKO mice developed hydrocephalus and died neonatally. The afadin-cKO brain displayed enlarged lateral ventricles and cerebral aqueduct, resulting from stenosis of the caudal end of the cerebral aqueduct and obliteration of the ventral part of the third ventricle. Afadin deficiency further caused the loss of ependymal cells from the ventricular and aqueductal surfaces. During development, radial glial cells, which terminally differentiate into ependymal cells, scattered from the ventricular zone and were replaced by neurons that eventually covered the ventricular and aqueductal surfaces of the afadin-cKO midbrain. Moreover, the denuded ependymal cells were only occasionally observed in the third ventricle and the cerebral aqueduct of the afadin-cKO midbrain. Afadin was co-localized with nectin-1 and N-cadherin at AJs of radial glial and ependymal cells in the control midbrain, but these proteins were not concentrated at AJs in the afadin-cKO midbrain. Thus, the defects in the afadin-cKO midbrain most likely resulted from the destruction of AJs, because AJs in the midbrain were already established before afadin was genetically deleted. These results indicate that afadin is essential for the maintenance of AJs in radial glial and ependymal cells in the midbrain and is required for normal morphogenesis of the cerebral aqueduct and ventral third ventricle in the midbrain.	[Yamamoto, Hideaki; Maruo, Tomohiko; Mandai, Kenji; Takai, Yoshimi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Pathogenet Signaling, Kobe, Hyogo 657, Japan; [Yamamoto, Hideaki; Maruo, Tomohiko; Mandai, Kenji; Takai, Yoshimi] Kobe Univ, Grad Sch Med, Div Mol & Cellular Biol, Dept Biochem & Mol Biol, Kobe, Hyogo 657, Japan; [Yamamoto, Hideaki; Maruo, Tomohiko; Majima, Takashi; Ishizaki, Hiroyoshi; Tanaka-Okamoto, Miki; Miyoshi, Jun; Mandai, Kenji; Takai, Yoshimi] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan; [Majima, Takashi; Takai, Yoshimi] Osaka Univ, Grad Sch Med, Dept Mol Biol & Biochem, Suita, Osaka, Japan; [Majima, Takashi; Ishizaki, Hiroyoshi; Tanaka-Okamoto, Miki; Miyoshi, Jun] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Mol Biol, Osaka, Japan	Kobe University; Kobe University; Japan Science & Technology Agency (JST); Osaka University; Osaka Medical Center for Cancer & Cardiovascular Diseases	Mandai, K (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Pathogenet Signaling, Kobe, Hyogo 657, Japan.	ytakai@med.kobe-u.ac.jp; mandai@med.kobe-u.ac.jp		Tanaka-Okamoto, Miki/0000-0002-6429-7662; Mandai, Kenji/0000-0002-0115-6635	Global COE Program "Global Center for Education and Research in Integrative Membrane Biology"; Targeted Proteins Research Program; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Japan Society for the Promotion of Science; Yasuda Medical Foundation	Global COE Program "Global Center for Education and Research in Integrative Membrane Biology"(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Yasuda Medical Foundation	This work was supported by the Global COE Program "Global Center for Education and Research in Integrative Membrane Biology", the Targeted Proteins Research Program, Grants-in-Aid for Scientific Research on Innovative Areas ("Brain Environment" and "Neural Diversity and Neocortical Organization") (for K. M.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, Grants-in-Aid for Scientific Research (S) (for Y.T.) and (C) (for K. M.) from the Japan Society for the Promotion of Science, and the grants (for Y.T.) from the Yasuda Medical Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Borradori L, 1996, CURR OPIN CELL BIOL, V8, P647, DOI 10.1016/S0955-0674(96)80106-2; BRONSON RT, 1990, DEV BRAIN RES, V54, P131, DOI 10.1016/0165-3806(90)90073-8; Cinalli G, 2011, CHILD NERV SYST, V27, P1621, DOI 10.1007/s00381-011-1546-2; Dahme M, 1997, NAT GENET, V17, P346, DOI 10.1038/ng1197-346; Dejana E, 1996, J CLIN INVEST, V98, P1949, DOI 10.1172/JCI118997; Del Bigio MR, 2010, ACTA NEUROPATHOL, V119, P55, DOI 10.1007/s00401-009-0624-y; Del Bigio MR, 1998, EXP NEUROL, V154, P157, DOI 10.1006/exnr.1998.6922; Del Bigio MR, 2000, J NEUROPATH EXP NEUR, V59, P946, DOI 10.1093/jnen/59.11.946; Delva E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002543; ENG LF, 1971, BRAIN RES, V28, P351, DOI 10.1016/0006-8993(71)90668-8; Fukuhara A, 2002, ONCOGENE, V21, P7642, DOI 10.1038/sj.onc.1205875; Fukuhara A, 2002, GENES CELLS, V7, P1059, DOI 10.1046/j.1365-2443.2002.00578.x; Getsios S, 2004, NAT REV MOL CELL BIO, V5, P271, DOI 10.1038/nrm1356; Gonzalez-Mariscal L, 2003, PROG BIOPHYS MOL BIO, V81, P1, DOI 10.1016/S0079-6107(02)00037-8; Goodenough DA, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002576; Goto J, 2008, MOL CELL NEUROSCI, V38, P203, DOI 10.1016/j.mcn.2008.02.009; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Guirao B, 2010, NAT CELL BIOL, V12, P341, DOI 10.1038/ncb2040; GUMBINER B, 1986, J CELL BIOL, V102, P457, DOI 10.1083/jcb.102.2.457; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; HATTA K, 1986, NATURE, V320, P447, DOI 10.1038/320447a0; Hoshino T, 2005, J BIOL CHEM, V280, P24095, DOI 10.1074/jbc.M414447200; Ikeda W, 1999, J CELL BIOL, V146, P1117, DOI 10.1083/jcb.146.5.1117; Imai F, 2006, DEVELOPMENT, V133, P1735, DOI 10.1242/dev.02330; Kadowaki M, 2007, DEV BIOL, V304, P22, DOI 10.1016/j.ydbio.2006.12.014; Kuramitsu K, 2008, GENES CELLS, V13, P797, DOI 10.1111/j.1365-2443.2008.01206.x; Kurita S., 2013, J BIOL CHEM; Lien WH, 2006, SCIENCE, V311, P1609, DOI 10.1126/science.1121449; Majima T, 2009, BIOCHEM BIOPH RES CO, V385, P539, DOI 10.1016/j.bbrc.2009.05.097; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; Mandai K, 2013, PROG MOL BIOL TRANSL, V116, P433, DOI 10.1016/B978-0-12-394311-8.00019-4; Matter K, 2003, NAT REV MOL CELL BIO, V4, P225, DOI 10.1038/nrm1055; Meng W, 2008, CELL, V135, P948, DOI 10.1016/j.cell.2008.09.040; Mirzadeh Z, 2010, J NEUROSCI, V30, P2600, DOI 10.1523/JNEUROSCI.3744-09.2010; Mitchell B, 2007, NATURE, V447, P97, DOI 10.1038/nature05771; Nagafuchi A, 2001, CURR OPIN CELL BIOL, V13, P600, DOI 10.1016/S0955-0674(00)00257-X; Ohtoshi Akihira, 2008, Cerebrospinal Fluid Res, V5, P16, DOI 10.1186/1743-8454-5-16; Ooshio T, 2010, J BIOL CHEM, V285, P5003, DOI 10.1074/jbc.M109.043760; Paez P, 2007, J NEUROPATH EXP NEUR, V66, P1082, DOI 10.1097/nen.0b013e31815c1952; Perez-Figares JM, 2001, MICROSC RES TECHNIQ, V52, P591, DOI 10.1002/1097-0029(20010301)52:5<591::AID-JEMT1043>3.0.CO;2-7; PRASAD R, 1993, CANCER RES, V53, P5624; Rasin MR, 2007, NAT NEUROSCI, V10, P819, DOI 10.1038/nn1924; Ray HJ, 2012, DEVELOPMENT, V139, P1701, DOI 10.1242/dev.068338; Sato T, 2006, J BIOL CHEM, V281, P5288, DOI 10.1074/jbc.M510070200; SCHNEEBERGER EE, 1992, AM J PHYSIOL, V262, pL647, DOI 10.1152/ajplung.1992.262.6.L647; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Silva-Alvarez C, 2005, NEUROCHEM RES, V30, P1227, DOI 10.1007/s11064-005-8794-z; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Socci DJ, 1999, EXP NEUROL, V155, P109, DOI 10.1006/exnr.1998.6969; Spassky N, 2005, J NEUROSCI, V25, P10, DOI 10.1523/JNEUROSCI.1108-04.2005; SULLIVAN KF, 1988, ANNU REV CELL BIOL, V4, P687, DOI 10.1146/annurev.cb.04.110188.003351; Tachibana K, 2000, J CELL BIOL, V150, P1161, DOI 10.1083/jcb.150.5.1161; Takahashi K, 1999, J CELL BIOL, V145, P539, DOI 10.1083/jcb.145.3.539; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; Tapanes-Castillo A, 2010, NEUROGENETICS, V11, P53, DOI 10.1007/s10048-009-0203-3; Tissir F, 2010, NAT NEUROSCI, V13, P700, DOI 10.1038/nn.2555; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Utriainen A, 2004, HUM MOL GENET, V13, P2089, DOI 10.1093/hmg/ddh213; vanderNeut R, 1996, NAT GENET, V13, P366, DOI 10.1038/ng0796-366; Vives V, 2003, J COMP NEUROL, V457, P404, DOI 10.1002/cne.10552; Wagner C, 2003, J NEUROPATH EXP NEUR, V62, P1019, DOI 10.1093/jnen/62.10.1019; Wyss L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045619; Yamada T, GENES TOCCE IN PRESS; Yokoyama S, 2001, MOL BIOL CELL, V12, P1595, DOI 10.1091/mbc.12.6.1595; Zhang W, 2006, MOL CELL BIOL, V26, P3764, DOI 10.1128/MCB.26.10.3764-3772.2006	67	33	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80356	10.1371/journal.pone.0080356	http://dx.doi.org/10.1371/journal.pone.0080356			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236178	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700179
J	Usami, M; Okada, T; Sasayama, D; Iwadare, Y; Watanabe, K; Ushijima, H; Kodaira, M; Sugiyama, N; Sawa, T; Saito, K				Usami, Masahide; Okada, Takashi; Sasayama, Daimei; Iwadare, Yoshitaka; Watanabe, Kyota; Ushijima, Hirokage; Kodaira, Masaki; Sugiyama, Nobuhiro; Sawa, Tetsuji; Saito, Kazuhiko			What Time Periods of the Day Are Concerning for Parents of Children with Attention Deficit Hyperactivity Disorder?	PLOS ONE			English	Article							DEFICIT/HYPERACTIVITY DISORDER; ADHD; COMORBIDITY; COSTS	Background/Aim: The questionnaire-children with difficulties (QCD) is a parent-assessed questionnaire designed to evaluate a child's difficulties in functioning during specific time periods of the day. In this study, the QCD was applied to determine the time periods of the day that are concerning for the parents of children with attention deficit hyperactivity disorder (ADHD). The results were compared with those for a community sample. Methods: Elementary and junior high school students with ADHD (243 boys, 55 girls) and a community sample of children (518 boys, 618 girls) were enrolled in this study. Their behaviors were assessed by the QCD, the ADHD-rating scale (ADHD-RS), and the Oppositional Defiant Behavior Inventory (ODBI). The effects of gender (boy/girl) and diagnosis (ADHD/community sample) on the total QCD score were analyzed across each school grade (elementary/junior high school). Correlation coefficients between QCD and ADHD-RS/ODBI scores were analyzed. Results: The QCD score for the ADHD group was significantly lower than that for the community sample (P < 0.001). There were significantly strong correlations between "evening" and ADHD-RS and ODBI scores for all children with ADHD (r > 0.41, P < 0.001) and between "night" and inattention and oppositional symptoms for the girls with ADHD (r > 0.40, P < 0.001). Conclusions: Parents reported that children with ADHD faced greater difficulties in completing basic daily activities compared with the community controls, particularly in the evening. Furthermore, these difficulties were related to the severity of ADHD symptoms. The parents' perceptions depended on the gender, ADHD and oppositional symptoms, and the time period of the day. This study determined that children with ADHD face greater difficulties in daily functioning compared with community sample children, that these difficulties are time-dependent, and that these difficulties were particularly experienced in the evening.	[Usami, Masahide; Iwadare, Yoshitaka; Watanabe, Kyota; Ushijima, Hirokage] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Child & Adolescent Psychiat, Ichikawa, Japan; [Okada, Takashi] Nagoya Univ, Grad Sch Med, Dept Child & Adolescent Psychiat, Nagoya, Aichi 4648601, Japan; [Sasayama, Daimei; Sugiyama, Nobuhiro; Saito, Kazuhiko] Aiiku Hosp, Aiiku Maternal & Child Hlth Ctr, Imperial Gift Fdn, Dept Child & Adolescent Mental Hlth,Minato Ku, Tokyo, Japan; [Kodaira, Masaki] Shinshu Univ, Sch Med, Dept Neuropsychiat, Matsumoto, Nagano 390, Japan; [Sawa, Tetsuji] Kitasato Univ, Grad Sch Med Sci, Dept Dev Psychiat, Sagamihara, Kanagawa 228, Japan	National Center for Global Health & Medicine - Japan; Nagoya University; Shinshu University; Kitasato University	Usami, M (corresponding author), Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Child & Adolescent Psychiat, Ichikawa, Japan.	usami.masahide@hospk.ncgm.go.jp	Sugiyama, Nobuhiro/C-6388-2008; Usami, Masahide/G-1404-2015; Sugiyama, Nobuhiro/AFH-2358-2022; OKADA, Takashi/M-8902-2014	Usami, Masahide/0000-0002-1145-9971; Sugiyama, Nobuhiro/0000-0002-7134-7680; OKADA, Takashi/0000-0001-5580-9913				BAKER DB, 1994, J EMOT BEHAV DISORD, V2, P46, DOI 10.1177/106342669400200106; BARKLEY RA, 1990, J AM ACAD CHILD PSY, V29, P546, DOI 10.1097/00004583-199007000-00007; Biederman J, 1998, J AM ACAD CHILD PSY, V37, P305, DOI 10.1097/00004583-199803000-00016; Coghill David, 2008, Child Adolesc Psychiatry Ment Health, V2, P31, DOI 10.1186/1753-2000-2-31; De Ridder A, 2006, CLIN DRUG INVEST, V26, P75, DOI 10.2165/00044011-200626020-00003; DuPaul G.J., 1998, ADHD RATING SCALE 4, P1; DuPaul GJ, 2008, ADHD RATING SCALE 4; Goto T., 2011, JPN J PEDIAT, V64, P99; Jonson-Reid M, 2010, J AM ACAD CHILD PSY, V49, P321, DOI 10.1016/j.jaac.2009.11.015; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Loeber R, 2000, J AM ACAD CHILD PSY, V39, P1468, DOI 10.1097/00004583-200012000-00007; Margari F, 2013, RES DEV DISABIL, V34, P1036, DOI 10.1016/j.ridd.2012.12.001; Maziade M, 2009, J CHILD ADOL PSYCHOP, V19, P709, DOI 10.1089/cap.2008.0166; Pliszka S. R., 2009, TREATING ADHD COMORB; Pliszka SR, 1998, J CLIN PSYCHIAT, V59, P50; PLISZKA SR, 1991, AM FAM PHYSICIAN, V43, P1267; SAITO K, 2009, ATTENTION DEFICIET H; SAITO K, 2009, ATTENTION DEFICIIT H; Steele M, 2006, CLIN THER, V28, P1892, DOI 10.1016/j.clinthera.2006.11.006; Stein MA, 2012, NEUROTHERAPEUTICS, V9, P509, DOI 10.1007/s13311-012-0130-0; Strine Tara W, 2006, Prev Chronic Dis, V3, pA52; Swensen AR, 2003, J AM ACAD CHILD PSY, V42, P1415, DOI 10.1097/00004583-200312000-00008; Usami M, 2013, CHILD ADOL PSYCH MEN, V7, DOI 10.1186/1753-2000-7-11; Wilens TE, 2002, ANNU REV MED, V53, P113, DOI 10.1146/annurev.med.53.082901.103945	24	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79806	10.1371/journal.pone.0079806	http://dx.doi.org/10.1371/journal.pone.0079806			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	247EE	24224007	Green Published, Green Submitted, gold			2022-12-27	WOS:000326597400088
J	Vigil, JM; Rowell, LN; Chouteau, S; Chavez, A; Jaramillo, E; Neal, M; Waid, D				Vigil, Jacob M.; Rowell, Lauren N.; Chouteau, Simone; Chavez, Alexandre; Jaramillo, Elisa; Neal, Michael; Waid, David			Sex Differences in How Social Networks and Relationship Quality Influence Experimental Pain Sensitivity	PLOS ONE			English	Article							FACIAL EXPRESSION; SUPPORT; RESPONSES; WOMEN; GENDER; SPOUSE; PERCEPTION; INTENSITY; BEHAVIORS; ANALGESIA	This is the first study to examine how both structural and functional components of individuals' social networks may moderate the association between biological sex and experimental pain sensitivity. One hundred and fifty-two healthy adults (mean age = 22yrs., 53% males) were measured for cold pressor task (CPT) pain sensitivity (i.e., intensity ratings) and core aspects of social networks (e. g., proportion of friends vs. family, affection, affirmation, and aid). Results showed consistent sex differences in how social network structures and intimate relationship functioning modulated pain sensitivity. Females showed higher pain sensitivity when their social networks consisted of a higher proportion of intimate types of relationship partners (e. g., kin vs. non kin), when they had known their network partners for a longer period of time, and when they reported higher levels of logistical support from their significant other (e. g., romantic partner). Conversely, males showed distinct patterns in the opposite direction, including an association between higher levels of logistical support from one's significant other and lower CPT pain intensity. These findings show for the first time that the direction of sex differences in exogenous pain sensitivity is likely dependent on fundamental components of the individual's social environment. The utility of a social-signaling perspective of pain behaviors for examining, comparing, and interpreting individual and group differences in experimental and clinical pain reports is discussed.	[Vigil, Jacob M.; Rowell, Lauren N.; Chouteau, Simone; Chavez, Alexandre; Jaramillo, Elisa; Neal, Michael; Waid, David] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA	University of New Mexico	Vigil, JM (corresponding author), Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA.	vigilj@unm.edu			Research Allocations Committee Grant from the University of New Mexico	Research Allocations Committee Grant from the University of New Mexico	The research was supported by a Research Allocations Committee Grant from the University of New Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLOCK AR, 1980, PAIN, V9, P243, DOI 10.1016/0304-3959(80)90011-1; Brown JL, 2003, PSYCHOSOM MED, V65, P276, DOI 10.1097/01.PSY.0000030388.62434.46; Campbell P, 2013, INT ARCH OCC ENV HEA, V86, P119, DOI 10.1007/s00420-012-0804-2; Campbell P, 2012, PAIN MED, V13, P204, DOI 10.1111/j.1526-4637.2011.01298.x; Cano A, 2008, CLIN J PAIN, V24, P678, DOI 10.1097/AJP.0b013e31816753d8; Cano A, 2010, PAIN, V149, P9, DOI 10.1016/j.pain.2009.10.010; Carothers BJ, 2013, J PERS SOC PSYCHOL; Cohen J.E., 1988, STAT POWER ANAL BEHA; Craig KD, 2009, CAN PSYCHOL, V50, P22, DOI 10.1037/a0014772; DEWAAL FBM, 1993, SOC ECON, P285; Fillingim RB, 2003, CLIN J PAIN, V19, P217, DOI 10.1097/00002508-200307000-00004; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; FLOR H, 1987, J PSYCHOSOM RES, V31, P251, DOI 10.1016/0022-3999(87)90082-1; Geary D.C., 2010, MALE FEMALE EVOLUTIO; Geary DC, 2003, DEV REV, V23, P444, DOI 10.1016/j.dr.2003.08.001; Geary DC, 2002, ADV CHILD DEV BEHAV, V30, P41, DOI 10.1016/S0065-2407(02)80039-8; Gigliotti E, 2002, NURS RES, V55, P217; Gigliotti E, 2011, ISRN NURSING, V2011, P2011; Gijsbers K, 2005, PERCEPT MOTOR SKILL, V101, P803, DOI 10.2466/PMS.101.7.803-807; GIL KM, 1987, PAIN, V29, P209, DOI 10.1016/0304-3959(87)91037-2; Greenspan JD, 2007, PAIN, V132, pS26, DOI 10.1016/j.pain.2007.10.014; IBM Corp, 2012, IBM SPSS STAT WINDOW; Kallai I, 2004, PAIN, V112, P142, DOI 10.1016/j.pain.2004.08.008; Kerns RD, 2002, ANN BEHAV MED, V24, P100, DOI 10.1207/S15324796ABM2402_06; KULIK JA, 1989, HEALTH PSYCHOL, V8, P221, DOI 10.1037/0278-6133.8.2.221; LEVINE FM, 1991, PAIN, V44, P69, DOI 10.1016/0304-3959(91)90149-R; Lopez-Martinez AE, 2008, J PAIN, V9, P373, DOI 10.1016/j.jpain.2007.12.002; McClelland LE, 2008, J BEHAV MED, V31, P413, DOI 10.1007/s10865-008-9163-6; Mitchell LA, 2004, J PAIN, V5, P233, DOI 10.1016/j.jpain.2004.03.004; Montoya P, 2004, ARTHRITIS RHEUM, V50, P4035, DOI 10.1002/art.20660; Newton-John TRO, 2002, PAIN REV, V9, P7, DOI 10.1191/0968130202pr186ra; NORBECK JS, 1981, NURS RES, V30, P264; NORBECK JS, 1983, NURS RES, V32, P4; Orbach-Zinger S, 2012, ANESTH ANALG, V114, P654, DOI 10.1213/ANE.0b013e318241f4f3; Osborne TL, 2007, PAIN, V127, P52, DOI 10.1016/j.pain.2006.07.017; Palchykov Vasyl, 2012, Sci Rep, V2, P370, DOI 10.1038/srep00370; Pinquart M, 2010, CRIT REV ONCOL HEMAT, V75, P122, DOI 10.1016/j.critrevonc.2009.06.003; Pud D, 2009, NEUROSCI LETT, V467, P237, DOI 10.1016/j.neulet.2009.10.048; Racine M, 2012, PAIN, V153, P602, DOI 10.1016/j.pain.2011.11.025; Riley JL, 1998, PAIN, V74, P181, DOI 10.1016/S0304-3959(97)00199-1; Romano JM, 1995, PAIN, V63, P353, DOI 10.1016/0304-3959(95)00062-3; Romano JM, 2000, BEHAV THER, V31, P415, DOI 10.1016/S0005-7894(00)80023-4; Romano JM, 2009, J BEHAV MED, V32, P558, DOI 10.1007/s10865-009-9234-3; Rose AJ, 2006, PSYCHOL BULL, V132, P98, DOI 10.1037/0033-2909.132.1.98; Ruau D, 2012, J PAIN, V13, P228, DOI 10.1016/j.jpain.2011.11.002; Schiavenato M, 2010, CLIN J PAIN, V26, P667, DOI 10.1097/AJP.0b013e3181e72507; TURK DC, 1992, REHABIL PSYCHOL, V37, P259, DOI 10.1037/h0079108; Vervoort T, 2008, PAIN, V138, P277, DOI 10.1016/j.pain.2007.12.013; Vigil JM, 2007, HUM NATURE-INT BIOS, V18, P143, DOI 10.1007/s12110-007-9003-3; Vigil JM, 2011, PAIN RES MANAG, V16, P317, DOI 10.1155/2011/280531; Vigil JM, 2011, PAIN, V152, P2125, DOI 10.1016/j.pain.2011.05.019; Vigil JM, 2008, EVOL PSYCHOL, V6, P506; Vigil JM, 2009, BEHAV BRAIN SCI, V32, P375, DOI 10.1017/S0140525X09991075; Vigil JM, 2009, BEHAV BRAIN SCI, V32, P408, DOI 10.1017/S0140525X09990999; Vigil JM, WORLD J ANE IN PRESS; Vigil JM, PAIN RES MA IN PRESS; von Baeyer CL, 2005, J PAIN, V6, P218, DOI 10.1016/j.jpain.2005.01.349; Vowles KE, 2010, PAIN, V151, P680, DOI 10.1016/j.pain.2010.08.031; Williams ACD, 2002, BEHAV BRAIN SCI, V25, P439, DOI 10.1017/S0140525X02000080	59	16	16	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78663	10.1371/journal.pone.0078663	http://dx.doi.org/10.1371/journal.pone.0078663			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	247EE	24223836	Green Submitted, Green Published, gold			2022-12-27	WOS:000326597400039
J	Dol-Gleizes, F; Delesque-Touchard, N; Mares, AM; Nestor, AL; Schaeffer, P; Bono, F				Dol-Gleizes, Frederique; Delesque-Touchard, Nathalie; Mares, Anne-Marie; Nestor, Anne-Laure; Schaeffer, Paul; Bono, Francoise			A New Synthetic FGF Receptor Antagonist Inhibits Arteriosclerosis in a Mouse Vein Graft Model and Atherosclerosis in Apolipoprotein E-Deficient Mice	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; SMOOTH-MUSCLE-CELLS; ANGIOGENESIS; EXPRESSION; PLAQUE; INFLAMMATION; PROGRESSION; CHEMOKINES; VEGF; ATHEROGENESIS	Objective: The role of fibroblast growth factors (FGFs) in the development of vascular diseases remains incompletely understood. The objective of this study was to examine the effects of a new small-molecule multi-FGF receptor blocker with allosteric properties, SSR128129E, on neointimal proliferation after a vein graft procedure in mice and on the development of atherosclerosis in atherosclerosis-prone apolipoprotein E (apoE)-deficient mice. Methods and Results: Vein grafts were performed in 3 month-old male C57BL6 mice. Segments of the vena cava were interposed at the level of the carotid artery. In SSR128129E (50 mg/kg/d)-treated animals, a dramatic decrease in neointimal proliferation was observed 2 and 8 weeks after the graft (72.5 %, p<0.01, and 47.8 %, p<0.05, respectively). Four-week old male apoE-deficient mice were treated with SSR128129E (50 mg/kg/d) for 3 and 5 months in comparison with a control group. SSR128129E treatment resulted in a reduction of lesion size in the aortic sinus (16.4 % (ns) at 3 months and 42.9 % (p<0.01) at 5 months, without any change in serum lipids. SSR128129 significantly reduced FGFR2 mRNA levels in the aortic sinus (p<0.05, n=5-6), but did not affect the mRNA expression levels of other FGF receptors or ligands. Conclusion: These studies indicate that FGFs have an important role in the development of vascular diseases like atherosclerosis and graft arteriosclerosis. These data suggest that inhibition of FGF receptors by compounds like SSR128129E might be useful as a new therapeutic approach for these vascular pathologies.	[Dol-Gleizes, Frederique; Delesque-Touchard, Nathalie; Mares, Anne-Marie; Nestor, Anne-Laure; Schaeffer, Paul; Bono, Francoise] Sanofi Rech, F-31036 Toulouse, France	Sanofi-Aventis; Sanofi France	Bono, F (corresponding author), Sanofi Rech, F-31036 Toulouse, France.	francoise.bono@sanofi.com	Schaeffer, Paul/AAZ-9961-2020; Schaeffer, Paul/D-7069-2014; Stefanadis, Christodoulos/ABH-2232-2020	Schaeffer, Paul/0000-0002-2835-1801; Schaeffer, Paul/0000-0002-2835-1801; Stefanadis, Christodoulos/0000-0001-5974-6454				Bono F, 2013, CANCER CELL, V23, P477, DOI 10.1016/j.ccr.2013.02.019; Che JS, 2011, AM J PHYSIOL-HEART C, V300, pH154, DOI 10.1152/ajpheart.00075.2010; Cheng C, 2013, TRENDS CARDIOVAS MED, V23, P153, DOI 10.1016/j.tcm.2012.10.004; Dell'Era P, 2003, CIRC RES, V93, P414, DOI 10.1161/01.RES.0000089460.12061.E1; Dol F, 2001, J CARDIOVASC PHARM, V38, P395, DOI 10.1097/00005344-200109000-00008; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; FLUGELMAN MY, 1993, CIRCULATION, V88, P2493, DOI 10.1161/01.CIR.88.6.2493; Fons P, 2004, J CELL PHYSIOL, V200, P351, DOI 10.1002/jcp.20076; Fox JC, 1996, J BIOL CHEM, V271, P12578, DOI 10.1074/jbc.271.21.12578; Fuster V, 2005, J AM COLL CARDIOL, V46, P937, DOI 10.1016/j.jacc.2005.03.074; Geng YH, 2002, ARTERIOSCL THROM VAS, V22, P1370, DOI 10.1161/01.ATV.0000031341.84618.A4; Gerszten RE, 2000, J LAB CLIN MED, V136, P87, DOI 10.1067/mlc.2000.108154; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hao HY, 2003, ARTERIOSCL THROM VAS, V23, P1510, DOI 10.1161/01.ATV.0000090130.85752.ED; Hauer AD, 2007, ARTERIOSCL THROM VAS, V27, P2050, DOI 10.1161/ATVBAHA.107.143743; Herrmann J, 2006, ARTERIOSCL THROM VAS, V26, P1948, DOI 10.1161/01.ATV.0000233387.90257.9b; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Jimenez SK, 2004, CARDIOVASC RES, V62, P548, DOI 10.1016/j.cardiores.2004.01.032; Kavurma MM, 2005, J THROMB HAEMOST, V3, P465, DOI 10.1111/j.1538-7836.2005.01120.x; Khurana R, 2005, CIRCULATION, V112, P1813, DOI 10.1161/CIRCULATIONAHA.105.535294; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; LINDNER V, 1991, P NATL ACAD SCI USA, V88, P3739, DOI 10.1073/pnas.88.9.3739; Luo WS, 2004, ARTERIOSCL THROM VAS, V24, P1081, DOI 10.1161/01.ATV.0000128201.65443.ea; Martin G, 2004, J CARDIOVASC PHARM, V43, P191, DOI 10.1097/00005344-200402000-00005; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Petrovan RJ, 2007, ARTERIOSCL THROM VAS, V27, P1095, DOI 10.1161/ATVBAHA.106.139246; Raj T, 2006, ARTERIOSCL THROM VAS, V26, P1845, DOI 10.1161/01.ATV.0000227689.41288.5e; Sluimer JC, 2009, J PATHOL, V218, P7, DOI 10.1002/path.2518; SPEIR E, 1992, CIRC RES, V71, P251, DOI 10.1161/01.RES.71.2.251; Sun L, 1999, J MED CHEM, V42, P5120, DOI 10.1021/jm9904295; Toutouzas K, 2004, EUR HEART J, V25, P1679, DOI 10.1016/j.ehj.2004.06.011; Weber C, 2005, CIRC RES, V96, P612, DOI 10.1161/01.RES.0000160077.17427.57; Xu QB, 2004, AM J PATHOL, V165, P1, DOI 10.1016/S0002-9440(10)63270-1; Zittermann SI, 2006, AM J PATHOL, V168, P835, DOI 10.2353/ajpath.2006.050479; Zou YP, 1998, AM J PATHOL, V153, P1301, DOI 10.1016/S0002-9440(10)65675-1	36	10	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e80027	10.1371/journal.pone.0080027	http://dx.doi.org/10.1371/journal.pone.0080027			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24224032	Green Submitted, gold, Green Published			2022-12-27	WOS:000326503400150
J	Kedir, H; Berhane, Y; Worku, A				Kedir, Haji; Berhane, Yemane; Worku, Alemayehu			Khat Chewing and Restrictive Dietary Behaviors Are Associated with Anemia among Pregnant Women in High Prevalence Rural Communities in Eastern Ethiopia	PLOS ONE			English	Article							CURRENT SITUATION; MATERNAL ANEMIA; RISK-FACTORS; HEMOGLOBIN; IRON; DETERMINANTS; NUTRITION; INFECTION; MALARIA; AFRICA	Background: Anemia affects a high proportion of pregnant women in the developing countries. Factors associated with it vary in context. This study aimed to determine the prevalence and predictors of anemia among pregnant women in the rural eastern Ethiopia. Methods: A community-based cross-sectional study was done on 1678 pregnant women who were selected by a cluster random sampling technique. A pregnant woman was identified as anemic if her hemoglobin concentration was <11 g/dl. Data were collected in a community-based setting. Multilevel mixed effect logistic regression was used to determine the adjusted odds ratios (AOR) with 95% confidence intervals (CI) for the predictors of anemia. Results: Anemia was observed among 737(43.9%) of the 1678 pregnant women studied (95% CI 41.5%-46.3%). After controlling for the confounders, the risk of anemia was 29% higher in the women who chewed khat daily than those who sometimes or never did so (AOR, 1.29; 95% CI, 1.02-1.62). The study subjects with restrictive dietary behavior (reduced either meal size or frequency) had a 39% higher risk of anemia compared to those without restrictive dietary behavior (AOR, 1.39; 95% CI, 1.02-1.88). The risk of anemia was increased by 68% (AOR, 1.68; 95% CI, 1.15-2.47), and 60% (AOR, 1.60; 95% CI, 1.08-2.37) in parity levels of 2 births and 3 births, respectively. Compared to the first trimester, the risk of anemia was higher by two-fold (AOR, 2.09; 95% CI, 1.46-3.00) in the second trimester and by four-fold (AOR, 4.23; 95% CI, 2.97-6.02) in the third trimester. Conclusion: In this study, two out of five women were anemic. Chewing khat and restrictive dietary habits that are associated with anemia in the setting should be addressed through public education programs. Interventions should also focus on the women at higher parity levels and those who are in advanced stages of pregnancy.	[Kedir, Haji] Haramaya Univ, Coll Hlth & Med Sci, Harar, Ethiopia; [Berhane, Yemane; Worku, Alemayehu] Addis Continental Inst Publ Hlth, Addis Ababa, Ethiopia; [Worku, Alemayehu] Univ Addis Ababa, Sch Publ Hlth, Addis Ababa, Ethiopia	Haramaya University; Addis Continental Institute of Public Health; Addis Ababa University	Kedir, H (corresponding author), Haramaya Univ, Coll Hlth & Med Sci, Harar, Ethiopia.	hajikedir2007@yahoo.com	Berhane, Yemane/ABB-8154-2020	Berhane, Yemane/0000-0002-2527-1339	Haramaya University	Haramaya University	This study was financially supported by Haramaya University as part of PhD program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agan TU, 2010, INT J WOMENS HEALTH, V2, P229; Al-Farsi YM, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-7; Al-Motarreb A, 2010, J ETHNOPHARMACOL, V132, P540, DOI 10.1016/j.jep.2010.07.001; Alem M., 2013, J INTERDISCIP HISTOP, V1, P137, DOI [10.5455/jihp.20130122042052, DOI 10.5455/JIHP.20130122042052]; [Anonymous], 2008, WORLDW PREV AN 1993; Ayoya MA, 2006, FOOD NUTR BULL, V27, P3, DOI 10.1177/156482650602700101; BAIDOO SE, 2010, J BACTERIOL RES, V2, P9; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Barroso F, 2011, EUR J OBSTET GYN R B, V159, P99, DOI 10.1016/j.ejogrb.2011.07.041; Beaton GH, 2000, AM J CLIN NUTR, V72, p265S, DOI 10.1093/ajcn/72.1.265S; Belachew Tefera, 2006, Ethiop Med J, V44, P211; Bodeau-Livinec F, 2011, AM J TROP MED HYG, V85, P414, DOI 10.4269/ajtmh.2011.10-0599; Brooker S, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000291; Central Statistical Agency [Ethiopia] and ICF International, 2012, ETH DEM HLTH SURV 20; *CTR STAT AG, 2006, ETH DEM HLTH SURV 20; DESALEGN S, 1993, ETHIOPIAN MED J, V31, P251; Diamantopoulos A, 2012, J ACAD MARKET SCI, V40, P434, DOI 10.1007/s11747-011-0300-3; Dim Cyril C, 2007, MedGenMed, V9, P11; Garg Aashima, 2006, Indian Journal of Pediatrics, V73, P687, DOI 10.1007/BF02898446; Gebissa E, 2010, J ETHNOPHARMACOL, V132, P607, DOI 10.1016/j.jep.2010.01.063; Gebremedhin S, 2011, ETHIOP J HEALTH DEV, V25, P22; Ghosh S, 2009, J BIOSOC SCI, V41, P763, DOI 10.1017/S0021932009990149; Gibson RS, 2008, J NUTR, V138, P581, DOI 10.1093/jn/138.3.581; Gies S, 2003, TROP MED INT HEALTH, V8, P301, DOI 10.1046/j.1365-3156.2003.01037.x; Griffiths P, 2010, J ETHNOPHARMACOL, V132, P578, DOI 10.1016/j.jep.2010.04.046; Haidar J, 2010, J HEALTH POPUL NUTR, V28, P359; Haidar Jemal A, 2009, BMC Blood Disord, V9, P7, DOI 10.1186/1471-2326-9-7; Hinderaker SG, 2002, EUR J CLIN NUTR, V56, P192, DOI 10.1038/sj.ejcn.1601300; Lamina S, 2010, S AFR J SCI, V106, P28, DOI 10.4102/sajs.v106i3/4.155; Lartey A, 2008, P NUTR SOC, V67, P105, DOI 10.1017/S0029665108006083; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Melaku Umeta, 2008, Ethiopian Journal of Health Development, V22, P252; Morris LD, 2007, VOX SANG, V93, P64, DOI 10.1111/j.1423-0410.2007.00919.x; Msuya S. E., 2011, Tanzania Journal of Health Research, V13, P40; Ndyomugyenyi R, 2008, T ROY SOC TROP MED H, V102, P130, DOI 10.1016/j.trstmh.2007.09.015; Nestel P., 2002, ADJUSTING HEMOGLOBIN; Nkrumah B, 2011, BMC CLIN PATHOL, V11, DOI 10.1186/1472-6890-11-5; Odenwald M, 2010, J ETHNOPHARMACOL, V132, P615, DOI 10.1016/j.jep.2009.11.005; Robert T, 2011, AFR J HLTH SCI, V18, P96; Rothman K.J., 2008, MODERN EPIDEMIOLOGY, P128; Stanback J, 2008, REV PANAM SALUD PUBL, V23, P116, DOI 10.1590/S1020-49892008000200007; StataCorp, 2009, STAT QUICK REF IND R; Swindale A., 2006, FHI 360FANTA; Torpey K, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-249; Uneke CJ, 2007, J HEALTH POPUL NUTR, V25, P328; Wabe N.T, 2012, J EXP INTEGR MED, V2, P29, DOI [DOI 10.5455/JEIM.221211.RW.005, 10.5455/jeim.221211.rw.005]; WHO, 2011, WHONMHNHDMNM111; World Health Organization, 1995, PHYS STAT US INT ANT; Zhang QY, 2009, PAEDIATR PERINAT EP, V23, P282, DOI 10.1111/j.1365-3016.2009.01031.x; Zimmermann M.B., 2007, NUTR ANEMIA, P199	50	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78601	10.1371/journal.pone.0078601	http://dx.doi.org/10.1371/journal.pone.0078601			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223828	gold, Green Submitted, Green Published			2022-12-27	WOS:000326503400076
J	Venturini, C; Hassan, KA; Chowdhury, PR; Paulsen, IT; Walker, MJ; Djordjevic, SP				Venturini, Carola; Hassan, Karl A.; Chowdhury, Piklu Roy; Paulsen, Ian T.; Walker, Mark J.; Djordjevic, Steven P.			Sequences of Two Related Multiple Antibiotic Resistance Virulence Plasmids Sharing a Unique IS26-Related Molecular Signature Isolated from Different Escherichia coli Pathotypes from Different Hosts	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; SPECTRUM BETA-LACTAMASE; GRAM-NEGATIVE BACTERIA; SHIGA TOXIN; SOS RESPONSE; ANTIMICROBIAL RESISTANCE; COMPARATIVE GENOMICS; INCP-1 PLASMIDS; RANGE PLASMIDS; GENE	Enterohemorrhagic Escherichia coli (EHEC) and atypical enteropathogenic E. coli (aEPEC) are important zoonotic pathogens that increasingly are becoming resistant to multiple antibiotics. Here we describe two plasmids, pO26-CRL125 (125 kb) from a human O26:H- EHEC, and pO111-CRL115 (115kb) from a bovine O111 aEPEC, that impart resistance to ampicillin, kanamycin, neomycin, streptomycin, sulfathiazole, trimethoprim and tetracycline and both contain atypical class 1 integrons with an identical IS26-mediated deletion in their 3'-conserved segment. Complete sequence analysis showed that pO26-CRL125 and pO111-CRL115 are essentially identical except for a 9.7 kb fragment, present in the backbone of pO26-CRL125 but absent in pO111-CRL115, and several indels. The 9.7 kb fragment encodes IncI-associated genes involved in plasmid stability during conjugation, a putative transposase gene and three imperfect repeats. Contiguous sequence identical to regions within these pO26-CRL125 imperfect repeats was identified in pO111-CRL115 precisely where the 9.7 kb fragment is missing, suggesting it may be mobile. Sequences shared between the plasmids include a complete IncZ replicon, a unique toxin/antitoxin system, IncI stability and maintenance genes, a novel putative serine protease autotransporter, and an IncI1 transfer system including a unique shufflon. Both plasmids carry a derivate Tn21 transposon with an atypical class 1 integron comprising a dfrA5 gene cassette encoding resistance to trimethoprim, and 24 bp of the 3'-conserved segment followed by Tn6026, which encodes resistance to ampicillin, kanymycin, neomycin, streptomycin and sulfathiazole. The Tn21-derivative transposon is linked to a truncated Tn1721, encoding resistance to tetracycline, via a region containing the IncP-1 alpha oriV. Absence of the 5 bp direct repeats flanking Tn3-family transposons, indicates that homologous recombination events played a key role in the formation of this complex antibiotic resistance gene locus. Comparative sequence analysis of these closely related plasmids reveals aspects of plasmid evolution in pathogenic E. coli from different hosts.	[Venturini, Carola; Walker, Mark J.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Venturini, Carola; Walker, Mark J.] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia; [Hassan, Karl A.; Chowdhury, Piklu Roy; Paulsen, Ian T.] Macquarie Univ, Dept Chem & Biomol Sci, Macquarie Pk, NSW, Australia; [Chowdhury, Piklu Roy] NSW Dept Primary Ind, Camden, NSW, Australia; [Chowdhury, Piklu Roy; Djordjevic, Steven P.] Univ Technol Sydney, Ithree Inst Infect Immun Innovat, Sydney, NSW 2007, Australia	University of Queensland; University of Queensland; Macquarie University; NSW Department of Primary Industries; University of Technology Sydney	Djordjevic, SP (corresponding author), Univ Technol Sydney, Ithree Inst Infect Immun Innovat, Sydney, NSW 2007, Australia.	steven.djordjevic@uts.edu.au	djordjevic, steven/GNP-4000-2022; Venturini, Carola/G-6642-2018; Djordjevic, Steven/A-2024-2013; Walker, Mark J./F-6940-2011; Hassan, Karl/B-2802-2013; Paulsen, Ian/K-3832-2012	djordjevic, steven/0000-0001-9301-5372; Venturini, Carola/0000-0003-2370-8661; Djordjevic, Steven/0000-0001-9301-5372; Walker, Mark/0000-0001-7423-2769; Roy Chowdhury, Piklu/0000-0003-4352-603X; Hassan, Karl/0000-0003-2031-9679; Paulsen, Ian/0000-0001-9015-9418	Australian Research Council (ARC) [LP034885]; Australian National Health and Medical Research Council (NHMRC); UTS	Australian Research Council (ARC)(Australian Research Council); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); UTS	This work was supported by of the Australian Research Council (ARC) and the Australian National Health and Medical Research Council (NHMRC). This work was partly funded by UTS start-up monies to SPD. The authors acknowledge the financial support of the Australian Research Council (ARC) for provision of a PhD scholarship to CV and research support provided through the ARC Linkage grant LP034885 and the Australian National Health and Medical Research Council (NHMRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk M, 2003, ACTA BIOCHIM POL, V50, P425; ALLMEIER H, 1992, GENE, V111, P11, DOI 10.1016/0378-1119(92)90597-I; Althorpe NJ, 1999, MOL MICROBIOL, V31, P133, DOI 10.1046/j.1365-2958.1999.01153.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; BAGDASARIAN M, 1992, MOL MICROBIOL, V6, P885, DOI 10.1111/j.1365-2958.1992.tb01539.x; Baharoglu Z, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001165; Bates S, 1999, MICROBIOL-SGM, V145, P2655, DOI 10.1099/00221287-145-10-2655; Bettelheim KA, 2003, J MED MICROBIOL, V52, P155, DOI 10.1099/jmm.0.04903-0; Bettelheim KA, 2007, CRIT REV MICROBIOL, V33, P67, DOI 10.1080/10408410601172172; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; Buvens G, 2010, ANTIMICROB AGENTS CH, V54, P4907, DOI 10.1128/AAC.00551-10; Cain AK, 2010, MICROB DRUG RESIST, V16, P197, DOI 10.1089/mdr.2010.0042; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Dautin N, 2010, TOXINS, V2, P1179, DOI 10.3390/toxins2061179; Dawes FE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012754; De Gelder L, 2007, MICROBIOL-SGM, V153, P452, DOI 10.1099/mic.0.2006/001784-0; Djordjevic SP, 2004, APPL ENVIRON MICROB, V70, P3910, DOI 10.1128/AEM.70.7.3910-3917.2004; Djordjevic SP, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00086; Doublet B, 2009, J ANTIMICROB CHEMOTH, V63, P282, DOI 10.1093/jac/dkn500; Eikmeyer F, 2012, PLASMID, V68, P13, DOI 10.1016/j.plasmid.2012.01.011; FURUYA N, 1991, J BACTERIOL, V173, P6612, DOI 10.1128/jb.173.20.6612-6617.1991; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Gotfredsen M, 1998, MOL MICROBIOL, V29, P1065, DOI 10.1046/j.1365-2958.1998.00993.x; GRINSTED J, 1982, PLASMID, V8, P276, DOI 10.1016/0147-619X(82)90065-8; Guerin E, 2009, SCIENCE, V324, P1034, DOI 10.1126/science.1172914; Haines AS, 2007, PLASMID, V58, P76, DOI 10.1016/j.plasmid.2007.01.001; HALFORD SE, 1985, MOL GEN GENET, V200, P169, DOI 10.1007/BF00383331; Hastings PJ, 2004, TRENDS MICROBIOL, V12, P401, DOI 10.1016/j.tim.2004.07.003; Heuer H, 2011, CURR OPIN MICROBIOL, V14, P236, DOI 10.1016/j.mib.2011.04.009; Hornitzky MA, 2005, APPL ENVIRON MICROB, V71, P3405, DOI 10.1128/AEM.71.7.3405-3412.2005; Hornitzky MA, 2002, APPL ENVIRON MICROB, V68, P6439, DOI 10.1128/AEM.68.12.6439-6445.2002; Johnson KE, 2006, CLIN INFECT DIS, V43, P1587, DOI 10.1086/509573; Johnson TJ, 2011, PLASMID, V66, P144, DOI 10.1016/j.plasmid.2011.07.003; Karch H, 2005, INT J MED MICROBIOL, V295, P405, DOI 10.1016/j.ijmm.2005.06.009; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Kimmitt PT, 2000, EMERG INFECT DIS, V6, P458, DOI 10.3201/eid0605.000503; Komano T, 1999, ANNU REV GENET, V33, P171, DOI 10.1146/annurev.genet.33.1.171; KONISKY J, 1982, ANNU REV MICROBIOL, V36, P125, DOI 10.1146/annurev.mi.36.100182.001013; Labar AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038142; Lee JH, 2009, VET MICROBIOL, V135, P401, DOI 10.1016/j.vetmic.2008.09.076; Leyton DL, 2003, INFECT IMMUN, V71, P6307, DOI 10.1128/IAI.71.11.6307-6319.2003; Masai H, 1997, CELL, V89, P897, DOI 10.1016/S0092-8674(00)80275-5; MCDANIEL TK, 1995, P NATL ACAD SCI USA, V92, P1664, DOI 10.1073/pnas.92.5.1664; McKenzie GJ, 2000, P NATL ACAD SCI USA, V97, P6646, DOI 10.1073/pnas.120161797; Mellmann A, 2008, EMERG INFECT DIS, V14, P1287, DOI 10.3201/eid1408.071082; Moura RA, 2009, APPL ENVIRON MICROB, V75, P7399, DOI 10.1128/AEM.00636-09; Muniesa M, 2012, APPL ENVIRON MICROB, V78, P4065, DOI 10.1128/AEM.00217-12; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Nordstrom L, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00029; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106; Partridge SR, 2011, FEMS MICROBIOL REV, V35, P820, DOI 10.1111/j.1574-6976.2011.00277.x; Perron GG, 2012, P ROY SOC B-BIOL SCI, V279, P1477, DOI 10.1098/rspb.2011.1933; Pinyon JL, 2011, MICROB DRUG RESIST, V17, P339, DOI 10.1089/mdr.2010.0196; Pollock KGJ, 2011, EMERG INFECT DIS, V17, P1777, DOI 10.3201/eid1709.110199; PRASZKIER J, 1991, J BACTERIOL, V173, P2393, DOI 10.1128/JB.173.7.2393-2397.1991; Ramachandran V, 2003, J CLIN MICROBIOL, V41, P5022, DOI 10.1128/JCM.41.11.5022-5032.2003; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Safdar N, 2002, JAMA-J AM MED ASSOC, V288, P996, DOI 10.1001/jama.288.8.996; Schluter A, 2003, MICROBIOL-SGM, V149, P3139, DOI 10.1099/mic.0.26570-0; Sen D, 2011, APPL ENVIRON MICROB, V77, P7975, DOI 10.1128/AEM.05439-11; Shiomi M, 1999, PEDIATR INT, V41, P228, DOI 10.1046/j.1442-200X.1999.4121038.x; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Smalla K, 2006, APPL ENVIRON MICROB, V72, P7253, DOI 10.1128/AEM.00922-06; Sota M, 2007, J BACTERIOL, V189, P3091, DOI 10.1128/JB.01906-06; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Szczepanowski R, 2005, MICROBIOL-SGM, V151, P1095, DOI 10.1099/mic.0.27773-0; Takahashi H, 2011, PLASMID, V66, P112, DOI 10.1016/j.plasmid.2011.06.004; Valat C, 2012, APPL ENVIRON MICROB, V78, P1308, DOI 10.1128/AEM.06997-11; Vally H, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-63; Venturini C, 2010, FASEB J, V24, P1160, DOI 10.1096/fj.09-144972; WALKER MJ, 1987, ARCH MICROBIOL, V146, P390, DOI 10.1007/BF00410941; Zimmerhackl LB, 2010, SEMIN THROMB HEMOST, V36, P586, DOI 10.1055/s-0030-1262880	75	39	40	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78862	10.1371/journal.pone.0078862	http://dx.doi.org/10.1371/journal.pone.0078862			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223859	Green Submitted, Green Published, gold			2022-12-27	WOS:000326503400092
J	Yu, HJ; Serebryannyy, LA; Fry, M; Greene, M; Chernaya, O; Hu, WY; Chew, TL; Mahmud, N; Kadkol, SS; Glover, S; Prins, G; Strakova, Z; de Lanerolle, P				Yu, Hui-Jun; Serebryannyy, Leonid A.; Fry, Madeline; Greene, Madelyne; Chernaya, Olga; Hu, Wen-Yang; Chew, Teng-Leong; Mahmud, Nadim; Kadkol, Shrihari S.; Glover, Sarah; Prins, Gail; Strakova, Zuzana; de Lanerolle, Primal			Tumor Stiffness Is Unrelated to Myosin Light Chain Phosphorylation in Cancer Cells	PLOS ONE			English	Article							PROTEIN-KINASE; CYTOKINESIS; DIFFERENTIATION; CONTRACTION; METASTASIS; EXPRESSION; MOTILITY; GENE; ROCK; MLCK	Many tumors are stiffer than their surrounding tissue. This increase in stiffness has been attributed, in part, to a Rho-dependent elevation of myosin II light chain phosphorylation. To characterize this mechanism further, we studied myosin light chain kinase (MLCK), the main enzyme that phosphorylates myosin II light chains. We anticipated that increases in MLCK expression and activity would contribute to the increased stiffness of cancer cells. However, we find that MLCK mRNA and protein levels are substantially less in cancer cells and tissues than in normal cells. Consistent with this observation, cancer cells contract 3D collagen matrices much more slowly than normal cells. Interestingly, inhibiting MLCK or Rho kinase did not affect the 3D gel contractions while blebbistatin partially and cytochalasin D maximally inhibited contractions. Live cell imaging of cells in collagen gels showed that cytochalasin D inhibited filopodia-like projections that formed between cells while a MLCK inhibitor had no effect on these projections. These data suggest that myosin II phosphorylation is dispensable in regulating the mechanical properties of tumors.	[Yu, Hui-Jun; Serebryannyy, Leonid A.; Fry, Madeline; Greene, Madelyne; Chernaya, Olga; de Lanerolle, Primal] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60680 USA; [Chew, Teng-Leong] Univ Illinois, Dept Urol, Chicago, IL USA; [Chew, Teng-Leong] Northwestern Univ, Dept Cell Biol, Chicago, IL 60611 USA; [Mahmud, Nadim] Univ Illinois, Dept Hematol & Oncol, Chicago, IL USA; [Kadkol, Shrihari S.] Univ Illinois, Dept Pathol, Chicago, IL USA; [Glover, Sarah] Univ Illinois, Dept Med, Chicago, IL USA; [Strakova, Zuzana] Univ Illinois, Dept Obstet & Gynecol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	de Lanerolle, P (corresponding author), Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60680 USA.	primal@uic.edu	HU, WENYANG/L-2026-2019	Glover, Sarah/0000-0002-9899-0473	Northwestern University Physical Sciences Oncology Center [CA143869]; National Institutes of Health [CA113975, ES018758, ES02207, CA172220, ARRA HD044713]; Leukemia and Lymphoma Society (White Plains, New York, United States of America); American Gastroenterological Association; UIC Gastrointestinal and Liver Disease fund; Office of the Vice Chancellor for Research, UIC; American Heart Association [13PRE17050060]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD044713] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U54CA143869, R01CA113975, R01CA172220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [RC2ES018758] Funding Source: NIH RePORTER	Northwestern University Physical Sciences Oncology Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society (White Plains, New York, United States of America)(Leukemia and Lymphoma Society); American Gastroenterological Association; UIC Gastrointestinal and Liver Disease fund; Office of the Vice Chancellor for Research, UIC; American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported in part by grants from Northwestern University Physical Sciences Oncology Center (CA143869) sub-award to PdeL, from National Institutes of Health to SG (CA113975), GP (ES018758, ES02207 and CA172220) and ZS (ARRA HD044713), the Leukemia and Lymphoma Society (White Plains, New York, United States of America), The American Gastroenterological Association and UIC Gastrointestinal and Liver Disease fund to SG, an Areas of Excellence Award from the Office of the Vice Chancellor for Research, UIC to NM and an American Heart Association fellowship (13PRE17050060) to LAS. The authors certify that they have no competing financial interests. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki H, 2009, EXP HEMATOL, V37, P1084, DOI 10.1016/j.exphem.2009.05.012; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Barnes JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050973; Beadle C, 2008, MOL BIOL CELL, V19, P3357, DOI 10.1091/mbc.E08-03-0319; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; Brand-Arpon V, 1999, GENOMICS, V56, P98, DOI 10.1006/geno.1998.5690; Cai XF, 2010, MICRON, V41, P257, DOI 10.1016/j.micron.2009.08.011; Cai YF, 2009, CURR OPIN CELL BIOL, V21, P47, DOI 10.1016/j.ceb.2009.01.020; Chew TL, 1998, J MUSCLE RES CELL M, V19, P839, DOI 10.1023/A:1005417926585; Clayburgh DR, 2004, J BIOL CHEM, V279, P55506, DOI 10.1074/jbc.M408822200; Connell LE, 2006, J CELL SCI, V119, P2269, DOI 10.1242/jcs.02926; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; Cross SE, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/38/384003; DELANEROLLE P, 1981, P NATL ACAD SCI-BIOL, V78, P4738; Fazal F, 2005, MOL CELL BIOL, V25, P6259, DOI 10.1128/MCB.25.14.6259-6266.2005; Fukata Y, 2001, TRENDS PHARMACOL SCI, V22, P32, DOI 10.1016/S0165-6147(00)01596-0; Grinnell F, 2010, ANNU REV CELL DEV BI, V26, P335, DOI 10.1146/annurev.cellbio.042308.113318; Gu LZ, 2006, EUR J CANCER, V42, P948, DOI 10.1016/j.ejca.2005.12.017; Han YJ, 2011, FASEB J, V25, P2305, DOI 10.1096/fj.10-177808; Indra I, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015015; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Khuon S, 2010, J CELL SCI, V123, P431, DOI 10.1242/jcs.053793; Kress H, 2007, P NATL ACAD SCI USA, V104, P11633, DOI 10.1073/pnas.0702449104; Lazar V, 1999, GENOMICS, V57, P256, DOI 10.1006/geno.1999.5774; Li QS, 2008, BIOCHEM BIOPH RES CO, V374, P609, DOI 10.1016/j.bbrc.2008.07.078; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; Minamiya Y, 2005, TUMOR BIOL, V26, P153, DOI 10.1159/000086487; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; OBARA K, 1995, J BIOL CHEM, V270, P18734, DOI 10.1074/jbc.270.32.18734; OBARA K, 1989, PFLUG ARCH EUR J PHY, V414, P134, DOI 10.1007/BF00580954; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; POTIER MC, 1995, GENOMICS, V29, P562, DOI 10.1006/geno.1995.9965; REDDEL RR, 1988, CANCER RES, V48, P1904; Remmerbach TW, 2009, CANCER RES, V69, P1728, DOI 10.1158/0008-5472.CAN-08-4073; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Samuel MS, 2011, CANCER CELL, V19, P776, DOI 10.1016/j.ccr.2011.05.008; SOULE HD, 1990, CANCER RES, V50, P6075; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Strakova Z, 2008, CELL TISSUE RES, V332, P479, DOI 10.1007/s00441-008-0604-x; Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002; Swaminathan V, 2011, CANCER RES, V71, P5075, DOI 10.1158/0008-5472.CAN-11-0247; Tee SY, 2009, CURR BIOL, V19, pR745, DOI 10.1016/j.cub.2009.06.034; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; Vonna L, 2007, EUR BIOPHYS J BIOPHY, V36, P145, DOI 10.1007/s00249-006-0118-y; WILSON AK, 1991, J CELL BIOL, V114, P277, DOI 10.1083/jcb.114.2.277; Wozniak MA, 2003, J CELL BIOL, V163, P583, DOI 10.1083/jcb.200305010; Wu Q, 2010, ONCOGENE, V29, P4183, DOI 10.1038/onc.2010.165; Xiong D, 2012, ONCOL REP, V28, P1625, DOI 10.3892/or.2012.1965	50	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79776	10.1371/journal.pone.0079776	http://dx.doi.org/10.1371/journal.pone.0079776			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24224004	Green Submitted, gold, Green Published			2022-12-27	WOS:000326503400143
J	Zanaruddin, SNS; Yee, PS; Hor, SY; Kong, YH; Abd Ghani, WMNW; Mustafa, WMW; Zain, RB; Prime, SS; Abd Rahman, ZA; Cheong, SC				Zanaruddin, Sharifah Nurain Syed; Yee, Pei San; Hor, Seen Yii; Kong, Yink Heay; Abd Ghani, Wan Maria Nabillah Wan; Mustafa, Wan Mahadzir Wan; Zain, Rosnah Binti; Prime, Stephen S.; Abd Rahman, Zainal Ariff; Cheong, Sok-Ching			Common Oncogenic Mutations Are Infrequent in Oral Squamous Cell Carcinoma of Asian Origin	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; P53 GENE-MUTATIONS; TP53 MUTATIONS; RAS ONCOGENE; HUMAN CANCER; PIK3CA MUTATIONS; HIGH-FREQUENCY; TOBACCO-SMOKE; HEAD; TUMOR	Objectives: The frequency of common oncogenic mutations and TP53 was determined in Asian oral squamous cell carcinoma (OSCC). Materials and Methods: The OncoCarta (TM) panel v1.0 assay was used to characterize oncogenic mutations. In addition, exons 4-11 of the TP53 gene were sequenced. Statistical analyses were conducted to identify associations between mutations and selected clinico-pathological characteristics and risk habits. Results: Oncogenic mutations were detected in PIK3CA (5.7%) and HRAS (2.4%). Mutations in TP53 were observed in 27.7% (31/112) of the OSCC specimens. Oncogenic mutations were found more frequently in nonsmokers (p = 0.049) and TP53 truncating mutations were more common in patients with no risk habits (p = 0.019). Patients with mutations had worse overall survival compared to those with absence of mutations; and patients who harbored DNA binding domain (DBD) and L2/L3/LSH mutations showed a worse survival probability compared to those patients with wild type TP53. The majority of the oncogenic and TP53 mutations were G: C > A: T and A: T > G: C base transitions, regardless of the different risk habits. Conclusion: Hotspot oncogenic mutations which are frequently present in common solid tumors are exceedingly rare in OSCC. Despite differences in risk habit exposure, the mutation frequency of PIK3CA and HRAS in Asian OSCC were similar to that reported in OSCC among Caucasians, whereas TP53 mutations rates were significantly lower. The lack of actionable hotspot mutations argue strongly for the need to comprehensively characterize gene mutations associated with OSCC for the development of new diagnostic and therapeutic tools.	[Zanaruddin, Sharifah Nurain Syed; Abd Rahman, Zainal Ariff; Cheong, Sok-Ching] Univ Malaya, Fac Dent, Dept Oral & Maxillofacial Surg, Kuala Lumpur, Malaysia; [Zanaruddin, Sharifah Nurain Syed; Yee, Pei San; Hor, Seen Yii; Kong, Yink Heay; Cheong, Sok-Ching] Canc Res Initiat Fdn, Sime Darby Med Ctr, Oral Canc Res Team, Selangor, Malaysia; [Kong, Yink Heay; Abd Ghani, Wan Maria Nabillah Wan; Zain, Rosnah Binti] Univ Malaya, Oral Canc Res & Coordinating Ctr, Kuala Lumpur, Malaysia; [Mustafa, Wan Mahadzir Wan] Hosp Kuala Lumpur, Dept Oral & Maxillofacial Surg, Kuala Lumpur, Malaysia; [Zain, Rosnah Binti] Univ Malaya, Fac Dent, Dept Oral Pathol Oral Med & Periodontol, Kuala Lumpur, Malaysia; [Prime, Stephen S.] Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Dent, Ctr Clin & Diagnost Oral Sci, London, England	Universiti Malaya; Universiti Malaya; Universiti Malaya; University of London; Queen Mary University London	Cheong, SC (corresponding author), Univ Malaya, Fac Dent, Dept Oral & Maxillofacial Surg, Kuala Lumpur, Malaysia.	sokching.cheong@carif.com.my	Zain, Rosnah/B-8054-2010	Ghani, Wan Maria Nabillah/0000-0002-6782-558X	University of Malaya [UMRG: RG159/09HTM, HIRG: UM.C/HIR/MOHE/DENT/03]; Cancer Research Initiatives Foundation(CARIF)	University of Malaya(Universiti Malaya); Cancer Research Initiatives Foundation(CARIF)	This study was funded by University of Malaya (UMRG: RG159/09HTM; HIRG: UM.C/HIR/MOHE/DENT/03), and other sponsors of the Cancer Research Initiatives Foundation(CARIF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bader AG, 2006, P NATL ACAD SCI USA, V103, P1475, DOI 10.1073/pnas.0510857103; Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; Da Silva L, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2603; Das N, 2000, ORAL ONCOL, V36, P76, DOI 10.1016/S1368-8375(99)00058-5; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Di Nicolantonio F, 2010, J CLIN INVEST, V120, P2858, DOI 10.1172/JCI37539; Ferlay J, 2010, IARC CANCERBASE; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Forozan F, 1999, BRIT J CANCER, V81, P1328, DOI 10.1038/sj.bjc.6695007; Fumagalli D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-101; Gazdar AF, 1998, INT J CANCER, V78, P766, DOI 10.1002/(SICI)1097-0215(19981209)78:6<766::AID-IJC15>3.0.CO;2-L; Ghani WMN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-82; Grandis JR, 1996, CANCER-AM CANCER SOC, V78, P1284, DOI 10.1002/(SICI)1097-0142(19960915)78:6<1284::AID-CNCR17>3.0.CO;2-X; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Gualberto A, 1998, P NATL ACAD SCI USA, V95, P5166, DOI 10.1073/pnas.95.9.5166; Hamid S, 2007, INT J MOL MED, V19, P453; Hsieh LL, 2001, CARCINOGENESIS, V22, P1497, DOI 10.1093/carcin/22.9.1497; Husgafvel-Pursiainen K, 2000, CANCER RES, V60, P2906; Ihle NT, 2009, CANCER RES, V69, P143, DOI 10.1158/0008-5472.CAN-07-6656; Isakoff SJ, 2005, CANCER RES, V65, P10992, DOI 10.1158/0008-5472.CAN-05-2612; Janku F, 2013, CANCER RES, V73, P276, DOI 10.1158/0008-5472.CAN-12-1726; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Kennedy AL, 2011, MOL CELL, V42, P36, DOI 10.1016/j.molcel.2011.02.020; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Kozaki KI, 2006, CANCER SCI, V97, P1351, DOI 10.1111/j.1349-7006.2006.00343.x; Le Calvez F, 2005, CANCER RES, V65, P5076, DOI 10.1158/0008-5472.CAN-05-0551; Lechner M, 2013, GENOME MED, V5, DOI 10.1186/gm453; Lee CH, 2011, INT J CANCER, V129, P1741, DOI 10.1002/ijc.25809; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Lim KP, 2005, ONCOL REP, V14, P963; Lindenbergh-van der Plas M, 2011, CLIN CANCER RES, V17, P3733, DOI 10.1158/1078-0432.CCR-11-0183; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Molinolo AA, 2009, ORAL ONCOL, V45, P324, DOI 10.1016/j.oraloncology.2008.07.011; Munirajan AK, 1996, INT J CANCER, V66, P297; Murugan AK, 2008, INT J ONCOL, V32, P101; Peltonen JK, 2011, HEAD NECK ONCOL, V3, DOI 10.1186/1758-3284-3-20; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Petti S, 2009, ORAL ONCOL, V45, P340, DOI 10.1016/j.oraloncology.2008.05.018; Pickering CR, 2013, CANCER DISCOV, V3, P770, DOI 10.1158/2159-8290.CD-12-0537; Poeta ML, 2007, NEW ENGL J MED, V357, P2552, DOI 10.1056/NEJMoa073770; Provencher DM, 2000, IN VITRO CELL DEV-AN, V36, P357; Qiu WL, 2006, CLIN CANCER RES, V12, P1441, DOI 10.1158/1078-0432.CCR-05-2173; Ralhan R, 2001, ORAL ONCOL, V37, P243, DOI 10.1016/S1368-8375(00)00092-0; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sano D, 2011, CLIN CANCER RES, V17, P6658, DOI 10.1158/1078-0432.CCR-11-0046; SARANATH D, 1991, BRIT J CANCER, V63, P573, DOI 10.1038/bjc.1991.133; Sartore-Bianchi A, 2009, CANCER RES, V69, P1851, DOI 10.1158/0008-5472.CAN-08-2466; Sathyan KM, 2007, MODERN PATHOL, V20, P1141, DOI 10.1038/modpathol.3800948; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Song H, 2007, NAT CELL BIOL, V9, P573, DOI 10.1038/ncb1571; Squarize CH, 2002, J ORAL PATHOL MED, V31, P379, DOI 10.1034/j.1600-0714.2002.00142.x; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; SUGIMOTO K, 1992, BLOOD, V79, P2378, DOI 10.1182/blood.V79.9.2378.2378; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Tuch BB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009317; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; WARNAKULASURIYA KAAS, 1992, J ORAL PATHOL MED, V21, P225, DOI 10.1111/j.1600-0714.1992.tb00106.x; YEUDALL WA, 1995, ORAL ONCOL, V31B, P136, DOI 10.1016/0964-1955(94)00030-8; YEUDALL WA, 1993, ORAL ONCOL, V29B, P63, DOI 10.1016/0964-1955(93)90012-4; Zain RB, 2013, CELL TISSUE BANK, V14, P45, DOI 10.1007/s10561-012-9298-0; Zhao JJ, 2005, P NATL ACAD SCI USA, V102, P18443, DOI 10.1073/pnas.0508988102	66	27	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e80229	10.1371/journal.pone.0080229	http://dx.doi.org/10.1371/journal.pone.0080229			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24224046	Green Submitted, Green Published, gold			2022-12-27	WOS:000326503400152
J	Kalari, KR; Necela, BM; Tang, XJ; Thompson, KJ; Lau, M; Eckel-Passow, JE; Kachergus, JM; Anderson, SK; Sun, ZF; Baheti, S; Carr, JM; Baker, TR; Barman, P; Radisky, DC; Joseph, RW; McLaughlin, SA; Chai, HS; Camille, S; Rossell, D; Asmann, YW; Thompson, EA; Perez, EA				Kalari, Krishna R.; Necela, Brian M.; Tang, Xiaojia; Thompson, Kevin J.; Lau, Melissa; Eckel-Passow, Jeanette E.; Kachergus, Jennifer M.; Anderson, S. Keith; Sun, Zhifu; Baheti, Saurabh; Carr, Jennifer M.; Baker, Tiffany R.; Barman, Poulami; Radisky, Derek C.; Joseph, Richard W.; McLaughlin, Sarah A.; Chai, High-seng; Camille, Stephan; Rossell, David; Asmann, Yan W.; Thompson, E. Aubrey; Perez, Edith A.			An Integrated Model of the Transcriptome of HER2-Positive Breast Cancer	PLOS ONE			English	Article							PLUS ADJUVANT CHEMOTHERAPY; MONOCLONAL-ANTIBODY; 1ST-LINE TREATMENT; TRASTUZUMAB; EFFICACY; REVEALS; SAFETY; TUMORS; ALIGNMENT; VARIANTS	Our goal in these analyses was to use genomic features from a test set of primary breast tumors to build an integrated transcriptome landscape model that makes relevant hypothetical predictions about the biological and/or clinical behavior of HER2-positive breast cancer. We interrogated RNA-Seq data from benign breast lesions, ER+, triple negative, and HER2-positive tumors to identify 685 differentially expressed genes, 102 alternatively spliced genes, and 303 genes that expressed single nucleotide sequence variants (eSNVs) that were associated with the HER2-positive tumors in our survey panel. These features were integrated into a transcriptome landscape model that identified 12 highly interconnected genomic modules, each of which represents a cellular processes pathway that appears to define the genomic architecture of the HER2-positive tumors in our test set. The generality of the model was confirmed by the observation that several key pathways were enriched in HER2-positive TCGA breast tumors. The ability of this model to make relevant predictions about the biology of breast cancer cells was established by the observation that integrin signaling was linked to lapatinib sensitivity in vitro and strongly associated with risk of relapse in the NCCTG N9831 adjuvant trastuzumab clinical trial dataset. Additional modules from the HER2 transcriptome model, including ubiquitin-mediated proteolysis, TGF-beta signaling, RHO-family GTPase signaling, and M-phase progression, were linked to response to lapatinib and paclitaxel in vitro and/or risk of relapse in the N9831 dataset. These data indicate that an integrated transcriptome landscape model derived from a test set of HER2-positive breast tumors has potential for predicting outcome and for identifying novel potential therapeutic strategies for this breast cancer subtype.	[Kalari, Krishna R.; Necela, Brian M.; Tang, Xiaojia; Thompson, Kevin J.; Lau, Melissa; Kachergus, Jennifer M.; Carr, Jennifer M.; Baker, Tiffany R.; Radisky, Derek C.; Thompson, E. Aubrey] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA; [Kalari, Krishna R.; Eckel-Passow, Jeanette E.; Anderson, S. Keith; Sun, Zhifu; Baheti, Saurabh; Barman, Poulami; Chai, High-seng; Asmann, Yan W.] Mayo Clin, Dept Biomed Stat & Informat, Rochester, MN USA; [Joseph, Richard W.; Perez, Edith A.] Mayo Clin, Div Hematol & Oncol, Dept Internal Med, Jacksonville, FL 32224 USA; [McLaughlin, Sarah A.] Mayo Clin, Dept Surg, Jacksonville, FL 32224 USA; [Camille, Stephan; Rossell, David] Inst Res Biomed, Barcelona, Espirito Santo, Spain	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona	Thompson, EA (corresponding author), Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA.	thompson.aubrey@mayo.edu	Radisky, Derek/B-6569-2018; Barman, Poulami/ABG-1426-2020; Rossell, David/AAM-4292-2021	Radisky, Derek/0000-0002-1962-8784; Barman, Poulami/0000-0002-4604-9868; Rossell, David/0000-0002-7104-5789; Thompson, Kevin/0000-0002-9348-4686; Joseph, Richard/0000-0001-6102-4661; Sun, Zhifu/0000-0001-8461-7523; Kalari, Krishna/0000-0001-8944-8378; Tang, Xiaojia/0000-0003-2457-9953	Donna Foundation [26.2]; Eveleigh Family Foundation; Carmichael Family; Mayo Foundation; National Cancer Institute [CA129949, CA155129]; NATIONAL CANCER INSTITUTE [R01CA129949, R21CA155129] Funding Source: NIH RePORTER	Donna Foundation; Eveleigh Family Foundation; Carmichael Family; Mayo Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	These studies were supported in part by funds from the 26.2 With Donna Foundation, the Eveleigh Family Foundation, the Carmichael Family, and the Mayo Foundation. Additional support was obtained from National Cancer Institute grants CA129949 (to EAP) and CA155129 (to EAT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asmann YW, 2012, CANCER RES, V72, P1921, DOI 10.1158/0008-5472.CAN-11-3142; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; DUNNETT CW, 1980, J AM STAT ASSOC, V75, P796, DOI 10.2307/2287161; Efron B, 2010, TESTING SIGNIFICANCE; Eswaran J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01689; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Goya R, 2010, BIOINFORMATICS, V26, P730, DOI 10.1093/bioinformatics/btq040; Kalari KR, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00012; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lapuk A, 2010, MOL CANCER RES, V8, P961, DOI 10.1158/1541-7786.MCR-09-0528; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marty M, 2005, J CLIN ONCOL, V23, P4265, DOI 10.1200/JCO.2005.04.173; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Menon R, 2010, CANCER RES, V70, P3440, DOI 10.1158/0008-5472.CAN-09-2631; Owens Marilyn A, 2004, Clin Breast Cancer, V5, P63, DOI 10.3816/CBC.2004.n.011; Perez EA, 2012, CANC RES S, V72, p145s; Perez EAE-P, 2012, CANC RES, V72; Perez EA, 2012, JNCI-J NATL CANCER I, V104, P159, DOI 10.1093/jnci/djr490; Perez EA, 2011, J CLIN ONCOL, V29, P4491, DOI 10.1200/JCO.2011.36.7045; Perez EA, 2011, J CLIN ONCOL, V29, P3366, DOI 10.1200/JCO.2011.35.0868; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Sjogren S, 1998, J CLIN ONCOL, V16, P462; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; von Minckwitz G, 2009, J CLIN ONCOL, V27, P1999, DOI 10.1200/JCO.2008.19.6618; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	34	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79298	10.1371/journal.pone.0079298	http://dx.doi.org/10.1371/journal.pone.0079298			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223926	Green Submitted, Green Published, gold			2022-12-27	WOS:000326499300073
J	Wolfensberger, A; Sax, H; Weber, R; Zbinden, R; Kuster, SP; Hombach, M				Wolfensberger, Aline; Sax, Hugo; Weber, Rainer; Zbinden, Reinhard; Kuster, Stefan P.; Hombach, Michael			Change of Antibiotic Susceptibility Testing Guidelines from CLSI to EUCAST: Influence on Cumulative Hospital Antibiograms	PLOS ONE			English	Article							CLINICAL BREAKPOINT CHANGES; INFECTIOUS-DISEASES; SOCIETY; UNIT; SURVEILLANCE; RESISTANCE; SELECTION	Objective: We studied whether the change in antibiotic susceptibility testing (AST) guidelines from CLSI to EUCAST influenced cumulative antibiograms in a tertiary care hospital in Switzerland. Methods: Antibiotic susceptibilities of non-duplicate isolates collected within a one-year period before (period A) and after (period B) changing AST interpretation from CLSI 2009 to EUCAST 1.3 (2011) guidelines were analysed. In addition, period B isolates were reinterpreted according to the CLSI 2009, CLSI 2013 and EUCAST 3.1 (2013) guidelines. Results: The majority of species/drug combinations showed no differences in susceptibility rates comparing periods A and B. However, in some gram-negative bacilli, decreased susceptibility rates were observed when comparing CLSI 2009 with EUCAST 1.3 within period B: Escherichia coli / cefepime, 95.8% (CLSI 2009) vs. 93.1% (EUCAST 1.3), P = 0.005; Enterobacter cloacae /cefepime, 97.0 (CLSI 2009) vs. 90.5% (EUCAST 1.3), P = 0.012; Pseudomonas aeruginosa / meropenem, 88.1% (CLSI 2009) vs. 78.3% (EUCAST 1.3), P = 0.002. These differences were still evident when comparing susceptibility rates according to the CLSI 2013 guideline with EUCAST 3.1 guideline. For P. aeruginosa and imipenem, a trend towards a lower antibiotic susceptibility rate in ICUs compared to general wards turned into a significant difference after the change to EUCAST: 87.9% vs. 79.8%, P = 0.08 (CLSI 2009) and 86.3% vs. 76.8%, P = 0.048 (EUCAST 1.3). Conclusions: The change of AST guidelines from CLSI to EUCAST led to a clinically relevant decrease of susceptibility rates in cumulative antibiograms for defined species/drug combinations, particularly in those with considerable differences in clinical susceptibility breakpoints between the two guidelines.	[Wolfensberger, Aline; Sax, Hugo; Weber, Rainer; Kuster, Stefan P.] Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, CH-8091 Zurich, Switzerland; [Wolfensberger, Aline; Sax, Hugo; Weber, Rainer; Kuster, Stefan P.] Univ Zurich, Zurich, Switzerland; [Zbinden, Reinhard; Hombach, Michael] Univ Zurich, Inst Med Microbiol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich	Wolfensberger, A (corresponding author), Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, CH-8091 Zurich, Switzerland.	aline.wolfensberger@usz.ch	Wolfensberger, Aline/T-1740-2017; Kuster, Stefan/T-7388-2019; Weber, Rainer/D-5175-2012; Sax, Hugo S/A-9377-2016	Wolfensberger, Aline/0000-0001-9028-0007; Kuster, Stefan/0000-0002-0525-6529; Sax, Hugo S/0000-0002-1532-2198				Bax R, 2001, CLIN MICROBIOL INFEC, V7, P316, DOI 10.1046/j.1198-743x.2001.00239.x; Binkley S, 2006, INFECT CONT HOSP EP, V27, P682, DOI 10.1086/505921; Clinical and Laboratory Standards Insitute, 2009, M100S19 CLIN LAB STA; Clinical and Laboratory Standards Institute (CLSI), 2008, M23A3 CLSI, Vthird; Clinical and Laboratory Standards Institute (CLSI), 2010, PERF STAND ANT SUSC; CLSI, 2011, M100S20 CLSI, P172; CLSI, 2013, PERFORMANCE STANDARD; CLSI, 2012, M02A11 CLSI; *EUR COMM ANT SUSC, BREAKP TABL INT MICS; European Committee on Antimicrobial Susceptibility Testing, 2010, SETT BREAKP NEW AG; Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI [10.1093/cid/ciq257, 10.1093/cid/cir102]; Hawser SP, 2010, INT J ANTIMICROB AG, V36, P293, DOI 10.1016/j.ijantimicag.2010.05.012; Hindler JF, 2007, CLIN INFECT DIS, V44, P867, DOI 10.1086/511864; Hombach M, 2013, CLIN MICROBIOL INFEC, V19, pE59, DOI 10.1111/1469-0691.12090; Hombach M, 2012, J ANTIMICROB CHEMOTH, V67, P622, DOI 10.1093/jac/dkr524; Kahlmeter G, 2003, J ANTIMICROB CHEMOTH, V52, P145, DOI 10.1093/jac/dkg312; Kronvall G, 2011, INT J ANTIMICROB AG, V38, P281, DOI 10.1016/j.ijantimicag.2011.04.006; Kuster SP, 2008, J ANTIMICROB CHEMOTH, V62, P1451, DOI 10.1093/jac/dkn384; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Marchese A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-181; Pakyz AL, 2007, PHARMACOTHERAPY, V27, P1306, DOI 10.1592/phco.27.9.1306; Rhomberg PR, 2006, DIAGN MICR INFEC DIS, V56, P57, DOI 10.1016/j.diagmicrobio.2005.12.009; Rodriguez-Bano J, 2012, CLIN MICROBIOL INFEC, V18, P894, DOI 10.1111/j.1469-0691.2011.03673.x; van der Bij AK, 2012, CLIN MICROBIOL INFEC, V18, pE466, DOI 10.1111/j.1469-0691.2012.03996.x	24	33	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79130	10.1371/journal.pone.0079130	http://dx.doi.org/10.1371/journal.pone.0079130			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223893	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000326499300063
J	Cheng, YJ; Yao, FJ; Liu, LJ; Tang, K; Lin, XX; Li, WJ; Zhang, J; Wu, SH				Cheng, Yun-Jiu; Yao, Feng-Juan; Liu, Li-Juan; Tang, Kai; Lin, Xiao-Xiong; Li, Wei-Jie; Zhang, Jing; Wu, Su-Hua			B-Type Natriuretic Peptide and Prognosis of End-Stage Renal Disease: A Meta-Analysis	PLOS ONE			English	Article							CARDIAC TROPONIN-T; LEFT-VENTRICULAR MASS; LONG-TERM DIALYSIS; HEMODIALYSIS-PATIENTS; NT-PROBNP; PREDICT MORTALITY; HEART-FAILURE; PERITONEAL-DIALYSIS; RISK STRATIFICATION; BASE-LINE	Background: The prognostic importance of B-type natriuretic peptide (BNP) or N-terminal pro BNP (NT-proBNP) in patients with end-stage renal disease (ESRD) remains controversial. Methodology/Principal Findings: We conducted an unrestricted search from the MEDLINE and EMBASE in all languages that were published between 1966 and Augest2013. Twenty-seven long-term prospective studies met our inclusion criterias. From the pooled analysis, elevated BNP/NT-proBNP was significantly associated with increased all cause mortality [ odds ratio (OR), 3.85; 95% CI, 3.11 to 4.75], cardiovascular mortality (OR, 4.05; 95% CI, 2.53 to 6.84), and cardiovascular events (OR, 7.02; 95% CI, 2.21 to 22.33). The funnel plot showed no evidence of publication bias. The corresponding pooled positive and negative likelihood ratio for prediction of all cause mortality were 1.86 (95% CI, 1.66 to 2.08) and 0.48 (95% CI, 0.42 to 0.55), respectively. Conclusions/Significance: BNP/NT-proBNP is a promising prognostic tool to risk-stratify the patients with ESRD. Further investigations are warranted to elucidate the specific pathogenic mechanisms and the impact of other potential prognostic factors.	[Cheng, Yun-Jiu; Liu, Li-Juan; Tang, Kai; Lin, Xiao-Xiong; Li, Wei-Jie; Zhang, Jing; Wu, Su-Hua] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiovasc Med, Guangzhou 510275, Guangdong, Peoples R China; [Yao, Feng-Juan] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Ultrasonog, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Wu, SH (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiovasc Med, Guangzhou 510275, Guangdong, Peoples R China.	wusuhua@hotmail.com	li, wj/HGD-7322-2022	Liu, Li-juan/0000-0001-8068-8498	National Natural Science Foundation of China [81370285]; Guangdong Province Natural Science Foundation [06021338]; Guangdong Province Science and Technology Program [2012B031800091, 2007B031508003]; National Ministry of Education Scholarly Exchanges Foundation [200724]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Guangdong Province Science and Technology Program; National Ministry of Education Scholarly Exchanges Foundation	This work was supported by National Natural Science Foundation of China (No. 81370285), Guangdong Province Natural Science Foundation (No. 06021338); Guangdong Province Science and Technology Program (No. 2012B031800091, 2007B031508003) and National Ministry of Education Scholarly Exchanges Foundation (No. 200724). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apple FS, 2004, CLIN CHEM, V50, P2279, DOI 10.1373/clinchem.2004.035741; Biasioli S, 2007, ASAIO J, V53, P587, DOI 10.1097/MAT.0b013e31814a57c3; Booth J, 2010, CLIN J AM SOC NEPHRO, V5, P1036, DOI 10.2215/CJN.09001209; Codognotto M, 2010, J NEPHROL, V23, P465; Daniels LB, 2007, J AM COLL CARDIOL, V50, P2357, DOI 10.1016/j.jacc.2007.09.021; Dastoor H, 2005, J HYPERTENS, V23, P23, DOI 10.1097/00004872-200501000-00006; de Lemos JA, 2003, LANCET, V362, P316, DOI 10.1016/S0140-6736(03)13976-1; Deville Walter L, 2002, BMC Med Res Methodol, V2, P9, DOI 10.1186/1471-2288-2-9; Dickstein K, 2008, EUR J HEART FAIL, V10, P933, DOI 10.1016/j.ejheart.2008.08.005; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Flemmer M, 2008, SOUTH MED J, V101, P1094, DOI 10.1097/SMJ.0b013e318189aa56; Foley RN, 2010, CLIN J AM SOC NEPHRO, V5, P805, DOI 10.2215/CJN.07761109; Goto T, 2002, NEPHRON, V92, P610, DOI 10.1159/000064100; Guo Q, 2009, AM J NEPHROL, V29, P516, DOI 10.1159/000185628; Gutierrez OM, 2008, CLIN CHEM, V54, P1339, DOI 10.1373/clinchem.2007.101691; Hallen J, 2011, SCAND J UROL NEPHROL, V45, P151, DOI 10.3109/00365599.2010.529819; Heinz J, 2009, AM J KIDNEY DIS, V54, P478, DOI 10.1053/j.ajkd.2009.01.266; Herselman M, 2010, NUTRITION, V26, P10, DOI 10.1016/j.nut.2009.07.009; Herzog CA, 1998, NEW ENGL J MED, V339, P799, DOI 10.1056/NEJM199809173391203; Hickman PE, 2009, INTERN MED J, V39, P812, DOI 10.1111/j.1445-5994.2009.01846.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ishii J, 2001, CLIN CHIM ACTA, V312, P69, DOI 10.1016/S0009-8981(01)00592-7; Khan NA, 2005, CIRCULATION, V112, P3088, DOI 10.1161/CIRCULATIONAHA.105.560128; Kim YK, 2010, INT UROL NEPHROL, V42, P537, DOI 10.1007/s11255-009-9689-8; Koch M, 2010, CLIN NEPHROL, V73, P21; Lee SW, 2003, AM J KIDNEY DIS, V41, P1257, DOI 10.1016/S0272-6386(03)00358-5; Luchner A, 2005, HYPERTENSION, V46, P118, DOI 10.1161/01.HYP.0000170140.36633.8f; Madsen LH, 2007, KIDNEY INT, V71, P548, DOI 10.1038/sj.ki.5002087; Mark PB, 2007, SEMIN DIALYSIS, V20, P40, DOI 10.1111/j.1525-139X.2007.00240.x; Naganuma T, 2002, AM J NEPHROL, V22, P437, DOI 10.1159/000065272; Nishikimi T, 2001, AM J KIDNEY DIS, V37, P1201; Palmer SC, 2009, J AM COLL CARDIOL, V53, P891, DOI 10.1016/j.jacc.2008.11.031; Paniagua R, 2008, CLIN J AM SOC NEPHRO, V3, P407, DOI 10.2215/CJN.03820907; Paniagua R, 2010, NEPHROL DIAL TRANSPL, V25, P551, DOI 10.1093/ndt/gfp395; Ritz E, 2011, BLOOD PURIFICAT, V31, P70, DOI 10.1159/000321848; Roberts MA, 2008, CLIN J AM SOC NEPHRO, V3, P1057, DOI 10.2215/CJN.05151107; Safley DM, 2005, ADV CHRONIC KIDNEY D, V12, P117, DOI 10.1053/j.ackd.2004.11.002; Satyan S, 2007, AM J KIDNEY DIS, V50, P1009, DOI 10.1053/j.ajkd.2007.08.017; Schou M, 2009, HEART, V95, P1514, DOI 10.1136/hrt.2009.173666; Selim G, 2011, NEPHRON CLIN PRACT, V119, pC162, DOI 10.1159/000327615; Sharma R, 2006, HEART, V92, P1518, DOI 10.1136/hrt.2005.082313; Sivalingam M, 2011, HEMODIAL INT, V15, P359, DOI 10.1111/j.1542-4758.2011.00557.x; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sun LL, 2008, NEPHRON CLIN PRACT, V110, pC178, DOI 10.1159/000167270; Svensson M, 2009, CLIN NEPHROL, V71, P380; Trape J, 2008, SCAND J CLIN LAB INV, V68, P415, DOI 10.1080/00365510701813088; van Kimmenade RRJ, 2009, J AM COLL CARDIOL, V53, P884, DOI 10.1016/j.jacc.2008.11.032; Wang AYM, 2007, J AM SOC NEPHROL, V18, P321, DOI 10.1681/ASN.2005121299; Westenbrink BD, 2011, CLIN NEPHROL, V76, P373, DOI 10.5414/CN106858; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Zoccali C, 2001, J AM SOC NEPHROL, V12, P1508, DOI 10.1681/ASN.V1271508	51	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79302	10.1371/journal.pone.0079302	http://dx.doi.org/10.1371/journal.pone.0079302			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236118	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700117
J	Novelli, D; Drury, J; Reicher, S; Stott, C				Novelli, David; Drury, John; Reicher, Stephen; Stott, Clifford			Crowdedness Mediates the Effect of Social Identification on Positive Emotion in a Crowd: A Survey of Two Crowd Events	PLOS ONE			English	Article							PERSONAL-SPACE; EXPERIENCE	Exposure to crowding is said to be aversive, yet people also seek out and enjoy crowded situations. We surveyed participants at two crowd events to test the prediction of self-categorization theory that variable emotional responses to crowding are a function of social identification with the crowd. In data collected from participants who attended a crowded outdoor music event (n = 48), identification with the crowd predicted feeling less crowded; and there was an indirect effect of identification with the crowd on positive emotion through feeling less crowded. Identification with the crowd also moderated the relation between feeling less crowded and positive emotion. In data collected at a demonstration march (n = 112), identification with the crowd predicted central (most dense) location in the crowd; and there was an indirect effect of identification with the crowd on positive emotion through central location in the crowd. Positive emotion in the crowd also increased over the duration of the crowd event. These findings are in line with the predictions of self-categorization theory. They are inconsistent with approaches that suggest that crowding is inherently aversive; and they cannot easily be explained through the concept of 'personal space'.	[Novelli, David] Univ Hertfordshire, Dept Psychol, Hatfield AL10 9AB, Herts, England; [Drury, John] Univ Sussex, Sch Psychol, Brighton, E Sussex, England; [Reicher, Stephen] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland; [Stott, Clifford] Univ Leeds, Sch Law, Leeds, W Yorkshire, England	University of Hertfordshire; University of Sussex; University of St Andrews; University of Leeds	Drury, J (corresponding author), Univ Sussex, Sch Psychol, Brighton, E Sussex, England.	j.drury@sussex.ac.uk	Drury, John/A-6479-2012; Drury, John/AAO-4119-2020	Drury, John/0000-0002-7748-5128; Drury, John/0000-0002-7748-5128; Stott, Clifford/0000-0001-5399-3294	Economic and Social Research Council [PTA-031-2005-00096]; Leverhulme Trust [F/00 230/AO]	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Leverhulme Trust(Leverhulme Trust)	This research was made possible by a grant from the Economic and Social Research Council awarded to the first author, grant number PTA-031-2005-00096, and a grant from the Leverhulme Trust awarded to the second and fourth authors, grant number F/00 230/AO. ESRC: http://www.esrc.ac.uk/Leverhulme: http://www.leverhulme.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO JR, 1974, HUM ECOL, V2, P177, DOI 10.1007/BF01531420; [Anonymous], 2002, BIG BEACH BOUT UNPUB; Aylott R., 1998, INT J RETAIL DISTRIB, V26, P362, DOI DOI 10.1108/09590559810237908; Bogovic A, 2014, ENVIRON BEHAV, V46, P929, DOI 10.1177/0013916513477653; Brighton and Hove City Council, 2002, UNPUB; Cassidy C., 2007, PSYCHOL STUD, V52, P286; COCHRAN CD, 1984, J PSYCHOL, V117, P121, DOI 10.1080/00223980.1984.9923667; Doosje B, 1998, J PERS SOC PSYCHOL, V75, P872, DOI 10.1037/0022-3514.75.4.872; DOOSJE B, 1995, J EXP SOC PSYCHOL, V31, P410, DOI 10.1006/jesp.1995.1018; Evans GW, 2007, J ENVIRON PSYCHOL, V27, P90, DOI 10.1016/j.jenvp.2006.10.002; Evans GW, 2010, ENVIRON BEHAV, V42, P135, DOI 10.1177/0013916509333509; Field A., 2013, DISCOVERING STAT USI; Freedman JL, 1975, CROWDING BEHAV; GRIFFITT W, 1971, J PERS SOC PSYCHOL, V17, P92, DOI 10.1037/h0030458; Hall E.T., 1966, HIDDEN DIMENSION, V609; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Kennedy DP, 2009, NAT NEUROSCI, V12, P1226, DOI 10.1038/nn.2381; LAWRENCE JE, 1974, PSYCHOL BULL, V81, P712, DOI 10.1037/h0037066; McNeill W. H., 1995, KEEPING TOGETHER TIM; McVeigh T, 2002, GUARDIAN NEWS W 0721; Muller D, 2005, J PERS SOC PSYCHOL, V89, P852, DOI 10.1037/0022-3514.89.6.852; Neisser U, 1996, MEMORY, V4, P337, DOI 10.1080/096582196388898; Neville F, 2011, CONTEMP SOC SCI, V6, P377, DOI 10.1080/21582041.2012.627277; Novelli D, 2010, BRIT J SOC PSYCHOL, V49, P223, DOI 10.1348/014466609X449377; Preacher KJ, 2011, PSYCHOL METHODS, V16, P93, DOI 10.1037/a0022658; Proshansky HM, 1976, ENV PSYCHOL PEOPLE T, P170; Rosenthal BG, 1983, CROWDING BEHAV FUTUR; Tewari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047291; Turner J.C., 1987, REDISCOVERING SOCIAL; TURNER JC, 1994, PERS SOC PSYCHOL B, V20, P454, DOI 10.1177/0146167294205002; Uzzell D, 2006, BRIT J SOC PSYCHOL, V45, P579, DOI 10.1348/014466605X58384; Valdesolo P, 2010, J EXP SOC PSYCHOL, V46, P693, DOI 10.1016/j.jesp.2010.03.004; Willis F. N., 1966, PSYCHON SCI, V5, P221, DOI DOI 10.3758/BF03328362; Wiltermuth SS, 2009, PSYCHOL SCI, V20, P1, DOI 10.1111/j.1467-9280.2008.02253.x; WORCHEL S, 1976, J PERS SOC PSYCHOL, V34, P30	35	53	54	4	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78983	10.1371/journal.pone.0078983	http://dx.doi.org/10.1371/journal.pone.0078983			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236079	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000327254700077
J	Skarn, M; Baroy, T; Stratford, EW; Myklebost, O				Skarn, Magne; Baroy, Tale; Stratford, Eva Wessel; Myklebost, Ola			Epigenetic Regulation and Functional Characterization of MicroRNA-142 in Mesenchymal Cells	PLOS ONE			English	Article							MESSENGER-RNAS; EXPRESSION; METHYLATION; GENES; DNA; TRANSCRIPTION; IDENTIFICATION; BINDING; TISSUE; ACTIVATION	The transcripts encoded by the microRNA mir-142 gene are highly active in hematopoietic cells, but expressed at low levels in many other cell types. Treatment with the demethylating agent 5-Aza-'9-deoxycytidine increased both the 1,636 nucleotide primary transcript and mature miR-142-5p/3p in mesenchymal cells, indicating that mir-142 is epigenetically repressed by DNA methylation. The transcription start site was determined to be located 1,205 base pairs upstream of the precursor sequence within a highly conserved CpG island. In addition, a second CpG island overlapped with the precursor. A TATA-box, several promoter-proximal elements and enrichment of conserved transcription factor binding sites within the first 100 base pairs upstream of the transcription start site, suggests that this region represents the core/proximal mir-142 promoter. Moreover, both CpG islands were heavily methylated in mesenchymal cells, having low levels of miR-142-5p/3p, and unmethylated in hematopoietic cells where both miRNAs were abundantly expressed. We show that treatment with 5-Aza-'9-deoxycytidine significantly reduced the DNA methylation of the upstream CpG island, which led to increased expression, and that in vitro DNA methylation of the upstream region of the mir-142 precursor repressed its transcriptional activity. When overexpressed, miR-142-5p/3p reduced proliferation of cells with epigenetic silencing of endogenous mir-142. This finding is interesting as miR-142-5p/3p have been reported to be deregulated in tumors of mesenchymal origin. We provide the first experimental evidence that transcription of mir-142 is directly repressed by DNA methylation. In addition, we discovered that the antisense strand of mir-142 might act as a precursor for functional mature antisense miRNAs. Thus, our study expands the current knowledge about the regulation of mir-142 and function of miR-142-5p/3p, and adds novel insight into the rapidly increasing field of microRNA regulation.	[Skarn, Magne; Baroy, Tale; Stratford, Eva Wessel; Myklebost, Ola] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Tumor Biol, Oslo, Norway; [Stratford, Eva Wessel] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Canc Stem Cell Innovat Ctr, Oslo, Norway; [Myklebost, Ola] Oslo Univ Hosp, Norwegian Stem Cell Ctr, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Skarn, M (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Tumor Biol, Oslo, Norway.	magne.skarn@rr-research.no	Stratford, Eva/M-7002-2017	Stratford, Eva/0000-0001-6312-5781; Baroy, Tale/0000-0002-6796-7959	Norwegian Cancer Society; Norwegian Stem Cell Centre; Research Council of Norway	Norwegian Cancer Society(Norwegian Cancer Society); Norwegian Stem Cell Centre; Research Council of Norway(Research Council of Norway)	The study was supported by the Norwegian Cancer Society and the Norwegian Stem Cell Centre (funded by the Research Council of Norway). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Basyuk E, 2003, NUCLEIC ACIDS RES, V31, P6593, DOI 10.1093/nar/gkg855; Bender W, 2008, GENE DEV, V22, P14, DOI 10.1101/gad.1614208; Bissels U, 2011, STEM CELLS, V29, P847, DOI 10.1002/stem.627; Bookout AL, 2001, HIGH THROUGHPUT REAL; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Carr IM, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm330; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Ding S, 2012, ARTHRITIS RHEUM-US, V64, P2953, DOI 10.1002/art.34505; Dohi O, 2013, INT J ONCOL, V42, P411, DOI 10.3892/ijo.2012.1724; Euskirchen GM, 2007, GENOME RES, V17, P898, DOI 10.1101/gr.5583007; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; Gao Y, 2011, NUCLEIC ACIDS RES, V39, P454, DOI 10.1093/nar/gkq782; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Griswold MD, 2001, BIOL REPROD, V64, P602, DOI 10.1095/biolreprod64.2.602; Hackenberg M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-446; Hackett JA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0328; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Huang B, 2009, EMBO REP, V10, P180, DOI 10.1038/embor.2008.224; Iorio MV, 2010, BBA-GENE REGUL MECH, V1799, P694, DOI 10.1016/j.bbagrm.2010.05.005; Jones KB, 2012, CANCER RES, V72, P1865, DOI 10.1158/0008-5472.CAN-11-2663; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Joyce CE, 2011, HUM MOL GENET, V20, P4025, DOI 10.1093/hmg/ddr331; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Kresse SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048262; Kwanhian W, 2012, CANCER MED-US, V1, P141, DOI 10.1002/cam4.29; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Liu HQ, 2005, BIOINFORMATICS, V21, P671, DOI 10.1093/bioinformatics/bth437; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lv M, 2012, LEUKEMIA, V26, P769, DOI 10.1038/leu.2011.273; Namlos HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048086; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Pizzinat N, 1999, BIOCHEM PHARMACOL, V58, P1735, DOI 10.1016/S0006-2952(99)00270-1; PRENDERGAST GC, 1991, SCIENCE, V251, P186, DOI 10.1126/science.1987636; Ram O, 2011, CELL, V147, P1628, DOI 10.1016/j.cell.2011.09.057; Ramkissoon SH, 2006, LEUKEMIA RES, V30, P643, DOI 10.1016/j.leukres.2005.09.001; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Rosenbloom KR, 2010, NUCLEIC ACIDS RES, V38, pD620, DOI 10.1093/nar/gkp961; Saini HK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-564; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Sato F, 2011, FEBS J, V278, P1598, DOI 10.1111/j.1742-4658.2011.08089.x; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Schanen BC, 2011, GENOMICS, V97, P1, DOI 10.1016/j.ygeno.2010.10.005; Skarn M, 2012, STEM CELLS DEV, V21, P873, DOI 10.1089/scd.2010.0503; Stark A, 2008, GENE DEV, V22, P8, DOI 10.1101/gad.1613108; Stratford Eva W., 2012, Sarcoma, V2012, P148614, DOI 10.1155/2012/148614; Sun W, 2010, CELL RES, V20, P1158, DOI 10.1038/cr.2010.134; Suzuki H, 2011, CANC RES; Takai Daiya, 2003, In Silico Biology, V3, P235; Tenstad E, 2010, LAB CHIP, V10, P1401, DOI 10.1039/b926738g; Toyota M, 2008, CANCER RES, V68, P4123, DOI 10.1158/0008-5472.CAN-08-0325; Tyler DM, 2008, GENE DEV, V22, P26, DOI 10.1101/gad.1615208; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vaissiere T, 2008, MUTAT RES-REV MUTAT, V659, P40, DOI 10.1016/j.mrrev.2008.02.004; Venkatesh B, 2005, BIOESSAYS, V27, P100, DOI 10.1002/bies.20134; Vrba L, 2011, GENOME RES, V21, P2026, DOI 10.1101/gr.123935.111; Wang F, MOL BIOL REP, P1; Wang F, 2012, MOL BIOL REP, V39, P2713, DOI 10.1007/s11033-011-1026-5; Wang XW, 2009, GENOME RES, V19, P266, DOI 10.1101/gr.081638.108; WATT F, 1988, GENE DEV, V2, P1136, DOI 10.1101/gad.2.9.1136; Weber B, 2007, CELL CYCLE, V6, P1001, DOI 10.4161/cc.6.9.4209; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Witten D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-58; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Wu LF, 2011, FEBS LETT, V585, P1322, DOI 10.1016/j.febslet.2011.03.067; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100; Zhang PY, 2012, CANCER RES, V72, P1751, DOI 10.1158/0008-5472.CAN-11-3027	84	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79231	10.1371/journal.pone.0079231	http://dx.doi.org/10.1371/journal.pone.0079231			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236112	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700111
J	Alpern, R; Canavan, ME; Thompson, JT; McNatt, Z; Tatek, D; Lindfield, T; Bradley, EH				Alpern, Rachelle; Canavan, Maureen E.; Thompson, Jennifer T.; McNatt, Zahirah; Tatek, Dawit; Lindfield, Tessa; Bradley, Elizabeth H.			Development of a Brief Instrument for Assessing Healthcare Employee Satisfaction in a Low-Income Setting	PLOS ONE			English	Article							JOB-SATISFACTION; SCALING-UP; NURSES; MORALE	Background: Ethiopia is one of 57 countries identified by the World Health Report 2006 as having a severely limited number of health care professionals. In recognition of this shortage, the Ethiopian Federal Ministry of Health, through the Ethiopian Hospital Management Initiative, prioritized the need to improve retention of health care workers. Accordingly, we sought to develop the Satisfaction of Employees in Health Care (SEHC) survey for use in hospitals and health centers throughout Ethiopia. Methods: Literature reviews and cognitive interviews were used to generate a staff satisfaction survey for use in the Ethiopian healthcare setting. We pretested the survey in each of the six hospitals and four health centers across Ethiopia (98% response rate). We assessed content validity and convergent validity using factor analysis and examined reliability using the Cronbach alpha coefficients to assess internal consistency. The final survey was comprised of 18 questions about specific aspects of an individual's work and two overall staff satisfaction questions. Results: We found support for content validity, as data from the 18 responses factored into three factors, which we characterized as 1) relationship with management and supervisors, 2) job content, and 3) relationships with coworkers. Summary scores for two factors (relationship with management and supervisors and job content) were significantly associated (P-value, <0.001) with the two overall satisfaction items. Cronbach's alpha coefficients showed good to excellent internal consistency (Cronbach alpha coefficients >0.70) for the items in the three summary scores. Conclusions: The introduction of consistent and reliable measures of staff satisfaction is crucial to understand and improve employee retention rates, which threaten the successful achievement of the Millennium Development Goals in low-income countries. The use of the SEHC survey in Ethiopian healthcare facilities has ample leadership support, which is essential for addressing problems that reduce staff satisfaction and exacerbate excessive workforce shortages.	[Alpern, Rachelle] Univ N Carolina, Chapel Hill, NC USA; [Canavan, Maureen E.; McNatt, Zahirah; Tatek, Dawit; Bradley, Elizabeth H.] Yale Univ, Sch Publ Hlth, New Haven, CT 06520 USA; [Thompson, Jennifer T.] Harvard Pilgrim Hlth Care Inst, Dept Populat Med, Boston, MA USA; [Thompson, Jennifer T.] Suffolk Primary Care Trust, Ipswich, Suffolk, England	University of North Carolina; University of North Carolina Chapel Hill; Yale University; Harvard Pilgrim Health Care	Bradley, EH (corresponding author), Yale Univ, Sch Publ Hlth, New Haven, CT 06520 USA.	Elizabeth.Bradley@yale.edu		Bisrat, Dawit/0000-0001-8659-5102	Centers for Disease Control; Clinton Health Access Initiative [1U2GPS0028242]	Centers for Disease Control(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Clinton Health Access Initiative	This study was supported, by a grant from the Centers for Disease Control; Clinton Health Access Initiative (1U2GPS0028242). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyepong IA, 2004, INT J HEALTH PLAN M, V19, P319, DOI 10.1002/hpm.770; Ajiboye PO, 2009, AFR J PSYCHIATRY, V12, P303; Atun R, 2010, HEALTH POLICY PLANN, V25, P104, DOI 10.1093/heapol/czp055; Berwick DM, 1996, BMJ; Bhandari N, 2008, MATERN CHILD NUTR, V4, P5, DOI 10.1111/j.1740-8709.2007.00126.x; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Chirdan OO, 2009, ANN AFR MED, V8, P243, DOI 10.4103/1596-3519.59579; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Delobelle P, 2011, J ADV NURS, V67, P371, DOI 10.1111/j.1365-2648.2010.05496.x; Dickson KE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001133; Dreesch N, 2005, HEALTH POLICY PLANN, V20, P267, DOI 10.1093/heapol/czi036; Elzinga G, 2010, HUMAN RESOURCES HLTH; Hagopian A, 2009, HEALTH AFFAIR, V28, pW863, DOI 10.1377/hlthaff.28.5.w863; Initiative USGH, 2011, GLOB HLTH IN ETH STR; Kebede S, 2012, GLOB PUBLIC HEALTH, V7, P164, DOI 10.1080/17441692.2010.542171; Kestler E, 2006, REPROD HEALTH MATTER, V14, P138, DOI 10.1016/S0968-8080(06)27235-5; Khatri GR, 2002, B WORLD HEALTH ORGAN, V80, P457; LLOYD S, 1994, AM J EMERG MED, V12, P1, DOI 10.1016/0735-6757(94)90187-2; Mathauer I, 2006, HUMAN RESOURCES HLTH, V4; Mbindyo PM, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-40; McAuliffe E, 2009, REPROD HEALTH MATTER, V17, P80, DOI 10.1016/S0968-8080(09)33443-6; MUELLER CW, 1990, NURS RES, V39, P113; Ntabaye MK, 1999, COMMUNITY DENT HLTH, V16, P40; Nyathi M, 2008, Curationis, V31, P28; Pillay R, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-15; Rogers E.M., 1995, DIFFUSION INNOVATION; Rubin DB, 2004, MULTIPLE IMPUTATION; Songstad NG, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-34; SPECTOR PE, 1985, AM J COMMUN PSYCHOL, V13, P693, DOI 10.1007/BF00929796; TRAYNOR M, 1993, J ADV NURS, V18, P127, DOI 10.1046/j.1365-2648.1993.18010127.x; Willis G.B., 1997, B METHODOL SOC, V5, P40, DOI [10.1177/075910639705500105, DOI 10.1177/075910639705500105]; WILLIS GB, 1991, APPL COGNITIVE PSYCH, V5, P251, DOI 10.1002/acp.2350050307; Wilson D, 2007, PLOS MED, V4, P988, DOI 10.1371/journal.pmed.0040204; World Health Organization (WHO), 2006, WORLD HLTH REP 2006; Yamey G, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001049	35	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79053	10.1371/journal.pone.0079053	http://dx.doi.org/10.1371/journal.pone.0079053			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	247EE	24223878	Green Submitted, Green Published, gold			2022-12-27	WOS:000326597400046
J	Chen, J; Zhang, XY; Zhang, H; Lin, J; Zhang, C; Wu, Q; Ding, XQ				Chen, Jing; Zhang, Xiaoyan; Zhang, Han; Lin, Jing; Zhang, Chen; Wu, Qing; Ding, Xiaoqiang			Elevated Klotho Promoter Methylation Is Associated with Severity of Chronic Kidney Disease	PLOS ONE			English	Article							REDUCES APOPTOSIS; RENAL-DISEASE; GENE; EXPRESSION; PROTEIN; URINARY; STRESS; INJURY; FGF23	Klotho (KL) expression is down-regulated in the renal tissues of chronic kidney disease (CKD) animal models and patients with end-stage renal disease. The putative role of KL promoter hypermethylation in the progression of CKD remains unclear. The present study aimed to determine renal and peripheral blood mononuclear cells (PBMC) levels of KL promoter methylation and analyze their relationship with clinical and histological severity in patients with CKD. Using bisulfite pyrosequencing, renal and PBMC levels of KL promoter methylation were quantified in 47 patients with CKD. 47 nephrectomy specimens of patients with renal cell carcinoma and 48 PBMC specimens of healthy volunteers were used as renal tissue and PBMC controls, respectively. Renal expression of KL protein was assayed by immunohistochemistry staining. Receiver operating characteristic (ROC) curve was used to identify the optimal cut-off value of PBMC KL promoter methylation level for renal KL promoter hypermethylation. Higher levels of KL promoter methylation were observed in renal tissue and PBMC in patients with CKD compared with controls (8.79 +/- 3.24 vs. 5.17 +/- 1.11%, P<0.001; 7.20 +/- 2.79 vs. 3.27 +/- 0.79%, P<0.001). In these patients, renal KL methylation level correlated inversely with renal KL immunostaining intensity (rho=-0.794, P<0.001). Estimated glomerular filtration rate correlated inversely with renal and PBMC levels of KL promoter methylation (r=-0.829, P<0.001; r=-0.645, P<0.001), while tubulointerstistial fibrosis score correlated positively (rho=0.826, P<0.001; rho=0.755, P<0.001). PBMC KL promoter methylation level correlated positively with renal KL promoter methylation level in patients with CKD (r=0.787, P<0.001). In ROC curve, the area under curve was 0.964 (P<0.001) and the optimal cut-off value was 5.83% with a sensitivity of 93.8% and specificity of 86.7% to predict renal KL promoter hypermethylation. The degree of KL promoter methylation is associated with clinical and histological severity of CKD. PBMC KL promoter methylation level may act as a potential biomarker of renal KL promoter hypermethylation.	[Chen, Jing; Ding, Xiaoqiang] Fudan Univ, Zhongshan Hosp, Shanghai Med Coll, Lab Kidney Dis, Shanghai 200433, Peoples R China; [Zhang, Xiaoyan; Zhang, Han; Lin, Jing; Ding, Xiaoqiang] Fudan Univ, Zhongshan Hosp, Shanghai Med Coll, Dept Nephrol, Shanghai 200433, Peoples R China; [Zhang, Chen; Wu, Qing] Fudan Univ, Sch Publ Hlth, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Zhang, XY (corresponding author), Fudan Univ, Zhongshan Hosp, Shanghai Med Coll, Dept Nephrol, Shanghai 200433, Peoples R China.	zhang.xiaoyan@zs-hospital.sh.cn; ding.xiaoqiang@zs-hospital.sh.cn			Ministry of Science and Technology of People's Republic of China [2011BAI10B03]; young physician training program by Shanghai Health and Family Planning Commission	Ministry of Science and Technology of People's Republic of China(Ministry of Science and Technology, China); young physician training program by Shanghai Health and Family Planning Commission	This study was supported by research grant by the Ministry of Science and Technology of People's Republic of China (2011BAI10B03) and young physician training program by Shanghai Health and Family Planning Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa H, 1998, BIOCHEM BIOPH RES CO, V249, P865, DOI 10.1006/bbrc.1998.9246; Akimoto T, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-155; Dwivedi RS, 2011, KIDNEY INT, V79, P23, DOI 10.1038/ki.2010.335; Goetz R, 2010, P NATL ACAD SCI USA, V107, P407, DOI 10.1073/pnas.0902006107; Haruna Y, 2007, P NATL ACAD SCI USA, V104, P2331, DOI 10.1073/pnas.0611079104; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Hu MC, 2010, FASEB J, V24, P3438, DOI 10.1096/fj.10-154765; Jiang SH, 2007, CELL BIOCHEM FUNCT, V25, P335, DOI 10.1002/cbf.1395; Kato Y, 2000, BIOCHEM BIOPH RES CO, V267, P597, DOI 10.1006/bbrc.1999.2009; Koh N, 2001, BIOCHEM BIOPH RES CO, V280, P1015, DOI 10.1006/bbrc.2000.4226; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Lim K, 2012, CIRCULATION, V125, P2243, DOI 10.1161/CIRCULATIONAHA.111.053405; Mitani H, 2002, HYPERTENSION, V39, P838, DOI 10.1161/01.HYP.0000013734.33441.EA; Mitobe M, 2005, NEPHRON EXP NEPHROL, V101, pE67, DOI 10.1159/000086500; Ohyama Y, 1998, BIOCHEM BIOPH RES CO, V251, P920, DOI 10.1006/bbrc.1998.9576; Pavik I, 2013, NEPHROL DIAL TRANSPL, V28, P352, DOI 10.1093/ndt/gfs460; Rao M, 2007, KIDNEY INT, V72, P549, DOI 10.1038/sj.ki.5002391; Shimada T, 2010, J CLIN ENDOCR METAB, V95, P578, DOI 10.1210/jc.2009-1603; Stenvinkel P, 2007, J INTERN MED, V261, P488, DOI 10.1111/j.1365-2796.2007.01777.x; Sugiura H, 2005, NEPHROL DIAL TRANSPL, V20, P2636, DOI 10.1093/ndt/gfi165; Sugiura H, 2010, NEPHROL DIAL TRANSPL, V25, P60, DOI 10.1093/ndt/gfp451; Sun CY, 2012, KIDNEY INT, V81, P640, DOI 10.1038/ki.2011.445; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Tan Y, 2009, CLIN EXP IMMUNOL, V156, P111, DOI 10.1111/j.1365-2249.2008.03868.x; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Wang YH, 2009, HYPERTENSION, V54, P810, DOI 10.1161/HYPERTENSIONAHA.109.134320; Woo HD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034615; Yu J, 2010, BIOCHEM BIOPH RES CO, V391, P261, DOI 10.1016/j.bbrc.2009.11.046; Zhang C, 2013, TOXICOL APPL PHARM, V271, P78, DOI 10.1016/j.taap.2013.04.025	31	29	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79856	10.1371/journal.pone.0079856	http://dx.doi.org/10.1371/journal.pone.0079856			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224012	Green Submitted, Green Published, gold			2022-12-27	WOS:000326597400091
J	Feigenbutz, M; Garland, W; Turner, M; Mitchell, P				Feigenbutz, Monika; Garland, William; Turner, Martin; Mitchell, Phil			The Exosome Cofactor Rrp47 Is Critical for the Stability and Normal Expression of Its Associated Exoribonuclease Rrp6 in Saccharomyces cerevisiae	PLOS ONE			English	Article							HUMAN PM-SCL; YEAST EXOSOME; RIBOSOMAL-RNA; NUCLEAR-RNA; BIDIRECTIONAL PROMOTERS; QUALITY-CONTROL; DEGRADATION; POLYADENYLATION; TRANSCRIPTION; SURVEILLANCE	Rrp6 is a conserved catalytic subunit of the eukaryotic nuclear exosome ribonuclease complex that functions in the productive 3' end maturation of stable RNAs, the degradation of transiently expressed noncoding transcripts and in discard pathways that eradicate the cell of incorrectly processed or assembled RNAs. The function of Rrp6 in these pathways is at least partially dependent upon its interaction with a small nuclear protein called Rrp47/Lrp1, but the underlying mechanism(s) by which Rrp47 functions in concert with Rrp6 are not established. Previous work on yeast grown in rich medium has suggested that Rrp6 expression is not markedly reduced in strains lacking Rrp47. Here we show that Rrp6 expression in rrp47 Delta. mutants is substantially reduced during growth in minimal medium through effects on both transcript levels and protein stability. Exogenous expression of Rrp6 enables normal levels to be attained in rrp47 Delta. mutants. Strikingly, exogenous expression of Rrp6 suppresses many, but not all, of the RNA processing and maturation defects observed in an rrp47. mutant and complements the synthetic lethality of rrp47. mpp6 Delta and rrp47 rex1 Delta. double mutants. Increased Rrp6 expression in the resultant rrp47. rex1 Delta. double mutant suppresses the defect in the 3' maturation of box C/D snoRNAs. In contrast, increased Rrp6 expression in the rrp47. mpp6. double mutant diminishes the block in the turnover of CUTs and in the degradation of the substrates of RNA discard pathways. These results demonstrate that a principal function of Rrp47 is to facilitate appropriate expression levels of Rrp6 and support the conclusion that the Rrp6/Rrp47 complex and Rex1 provide redundant exonuclease activities for the 3' end maturation of box C/D snoRNAs.	[Feigenbutz, Monika; Garland, William; Turner, Martin; Mitchell, Phil] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Mitchell, P (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.	p.j.mitchell@shef.ac.uk		Mitchell, Phil/0000-0002-3178-0439; Garland, William/0000-0001-5167-8004	Wellcome Trust [08836/Z/09/Z]; BBSRC-funded PhD studentships	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC-funded PhD studentships(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by research grant 08836/Z/09/Z from the Wellcome Trust (www.wellcome.ac.uk) and BBSRC-funded PhD studentships to WG and MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Bonneau F, 2009, CELL, V139, P547, DOI 10.1016/j.cell.2009.08.042; Briggs MW, 1998, J BIOL CHEM, V273, P13255, DOI 10.1074/jbc.273.21.13255; Burkard KTD, 2000, MOL CELL BIOL, V20, P604, DOI 10.1128/MCB.20.2.604-616.2000; Butler JS, 2010, ADV EXP MED BIOL, V702, P91, DOI 10.1007/978-1-4419-7841-7_8; Cairrao F, 2001, MOL MICROBIOL, V39, P1550, DOI 10.1046/j.1365-2958.2001.02342.x; Callahan KP, 2008, NUCLEIC ACIDS RES, V36, P6645, DOI 10.1093/nar/gkn743; Chen CL, 2010, RNA, V16, P667, DOI 10.1261/rna.1981010; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Chlebowski A, 2013, BBA-GENE REGUL MECH, V1829, P552, DOI 10.1016/j.bbagrm.2013.01.006; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Costello JL, 2011, J BIOL CHEM, V286, P4535, DOI 10.1074/jbc.M110.162826; Feigenbutz M, 2013, J BIOL CHEM, V288, P15959, DOI 10.1074/jbc.M112.445759; GARLAND W, 2013, RNA, P6327; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Grzechnik P, 2008, MOL CELL, V32, P247, DOI 10.1016/j.molcel.2008.10.003; Gudipati RK, 2012, MOL CELL, V48, P409, DOI 10.1016/j.molcel.2012.08.018; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Kadaba S, 2006, RNA, V12, P508, DOI 10.1261/rna.2305406; Lardenois A, 2011, P NATL ACAD SCI USA, V108, P1058, DOI 10.1073/pnas.1016459108; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Liang WX, 2012, J BIOL CHEM, V287, P33472, DOI 10.1074/jbc.M112.375287; Liang WX, 2011, MOL CELL, V44, P160, DOI 10.1016/j.molcel.2011.06.037; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Makino DL, 2013, NATURE, V495, P70, DOI 10.1038/nature11870; Mian IS, 1997, NUCLEIC ACIDS RES, V25, P3187, DOI 10.1093/nar/25.16.3187; Midtgaard SF, 2006, P NATL ACAD SCI USA, V103, P11898, DOI 10.1073/pnas.0604731103; Milligan L, 2005, MOL CELL BIOL, V25, P9996, DOI 10.1128/MCB.25.22.9996-10004.2005; Milligan L, 2008, MOL CELL BIOL, V28, P5446, DOI 10.1128/MCB.00463-08; Mitchell P, 2003, MOL CELL BIOL, V23, P6982, DOI 10.1128/MCB.23.19.6982-6992.2003; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Moreira RN, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-268; Moser MJ, 1997, NUCLEIC ACIDS RES, V25, P5110, DOI 10.1093/nar/25.24.5110; Motley AM, 2012, EMBO J, V31, P2852, DOI 10.1038/emboj.2012.151; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Nishizawa M, 2008, PLOS BIOL, V6, P2817, DOI 10.1371/journal.pbio.0060326; Ozanick SG, 2009, NUCLEIC ACIDS RES, V37, P298, DOI 10.1093/nar/gkn925; Parker R, 2012, GENETICS, V191, P671, DOI 10.1534/genetics.111.137265; Peng WT, 2003, CELL, V113, P919, DOI 10.1016/S0092-8674(03)00466-5; Porrua O, 2013, BBA-GENE REGUL MECH, V1829, P604, DOI 10.1016/j.bbagrm.2013.02.012; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Schilders G, 2007, NUCLEIC ACIDS RES, V35, P2564, DOI 10.1093/nar/gkm082; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schneider C, 2012, MOL CELL, V48, P422, DOI 10.1016/j.molcel.2012.08.013; Schneider C, 2009, NUCLEIC ACIDS RES, V37, P1127, DOI 10.1093/nar/gkn1020; SIKORSKI RS, 1989, GENETICS, V122, P19; Stead JA, 2007, NUCLEIC ACIDS RES, V35, P5556, DOI 10.1093/nar/gkm614; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; STUPAREVIC I, 2013, J BIOL CHEM, P47896; TOLLERVEY D, 1987, EMBO J, V6, P469, DOI 10.1002/j.1460-2075.1987.tb04777.x; Tomecki R, 2010, EMBO J, V29, P2342, DOI 10.1038/emboj.2010.121; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; van Hoof A, 2000, EMBO J, V19, P1357, DOI 10.1093/emboj/19.6.1357; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Wasmuth EV, 2012, MOL CELL, V48, P133, DOI 10.1016/j.molcel.2012.07.012; Wilmes GM, 2008, MOL CELL, V32, P735, DOI 10.1016/j.molcel.2008.11.012; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; YEH LCC, 1990, J MOL BIOL, V211, P699, DOI 10.1016/0022-2836(90)90071-S	64	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80752	10.1371/journal.pone.0080752	http://dx.doi.org/10.1371/journal.pone.0080752			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224060	Green Published, Green Accepted, gold			2022-12-27	WOS:000326597400123
J	Jin, MJ; Chen, BB; Mao, YY; Zhu, YM; Yu, YX; Wu, YY; Zhang, MW; Zhu, SK; Chen, K				Jin, Ming-Juan; Chen, Bing-Bing; Mao, Ying-Ying; Zhu, Yi-Min; Yu, Yun-Xian; Wu, Yin-Yin; Zhang, Ming-Wu; Zhu, Shan-Kuan; Chen, Kun			Prevalence of Overweight and Obesity and Their Associations with Socioeconomic Status in a Rural Han Chinese Adult Population	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; ABDOMINAL OBESITY; PREVENTION; GENDER	Background: The purpose of this study is to describe the prevalence of overweight, general obesity, and abdominal obesity and examine their associations with socioeconomic status in a rural Chinese adult population. Methods: This cross-sectional study was performed on 15,236 participants >= 35 years of age (6,313 men [41.4%] and 8,923 women [58.6%]). Each participant's weight, height, waist circumference (WC), and hipline circumference (HC) were measured, and demographic and socioeconomic data were collected using questionnaires. Results: The mean body mass index (BMI) values were 23.31 +/- 2.96 and 23.89 +/- 3.23 kg m(-2) and the mean WC values were 79.13 +/- 8.43 and 79.54 +/- 8.27 cm for men and women, respectively. The age-standardized prevalence rates of overweight (BMI >= 24.0 kg m(-2)), general obesity (BMI >= 28.0 kg m(-2)), and abdominal obesity (WC >= 85 cm for men and >= 80 cm for women) were 32.0%, 6.7%, and 27.0% for men and 35.1%, 9.7%, and 48.3% for women, respectively. All gender differences were statistically significant (p < 0.001). In addition, the age-specific prevalence rates of general and abdominal obesity slowly decreased among men but sharply increased among women as age increased (p < 0.001). In subsequent logistic regression analysis, educational level was negatively associated with both general obesity and abdominal obesity among women but positively associated with abdominal obesity among men. No significant correlation was found between obesity and income. Conclusions: These results suggest a high prevalence of obesity which might differ by gender and age, and an inverse association among women and a mixed association among men noted between education and obesity in our locality. Preventive and therapeutic programs are warranted to control this serious public health problem. The gender-specific characteristics of populations at high-risk of developing obesity should be taken into consideration when designing interventional programs.	[Jin, Ming-Juan; Chen, Bing-Bing; Mao, Ying-Ying; Zhu, Yi-Min; Yu, Yun-Xian; Wu, Yin-Yin; Zhang, Ming-Wu; Chen, Kun] Zhejiang Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hangzhou 310003, Zhejiang, Peoples R China; [Wu, Yin-Yin] Hangzhou Normal Univ, Sch Publ Hlth, Hangzhou, Zhejiang, Peoples R China; [Zhang, Ming-Wu] Zhejiang Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Zhu, Shan-Kuan] Zhejiang Univ, Sch Publ Hlth, Injury Control Res Ctr, Obes & Body Composit Res Ctr, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Hangzhou Normal University; Zhejiang University	Chen, K (corresponding author), Zhejiang Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hangzhou 310003, Zhejiang, Peoples R China.	ck@zju.edu.cn	Zhu, Yimin/D-6387-2017; Mao, Yingying/Q-9996-2018	Zhu, Yimin/0000-0001-8409-7636; Mao, Yingying/0000-0003-3644-9160	Ministry of Science and Technology, China [2012BAI02B03]; Natural Science Foundation of Zhejiang Province, China [LY12H26004]	Ministry of Science and Technology, China(Ministry of Science and Technology, China); Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province)	This work was supported by the Twelfth Five-Year Plan Key Projects of the Ministry of Science and Technology, China (No. 2012BAI02B03) and Natural Science Foundation of Zhejiang Province, China (No. LY12H26004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayatollahi SMT, 2010, OBES REV, V11, P335, DOI 10.1111/j.1467-789X.2010.00725.x; Booth ML, 2000, INT J OBESITY, V24, P1058, DOI 10.1038/sj.ijo.0801359; *BUR DIS MOH, 2006, GUID OV OB CONTR CHI; Chen CM, 2008, OBES REV, V9, P14, DOI 10.1111/j.1467-789X.2007.00433.x; Chen Z, 2009, LANCET, V373, P1322, DOI 10.1016/S0140-6736(09)60753-4; Dahly DL, 2010, J NUTR, V140, P366, DOI 10.3945/jn.109.114207; Dinsa GD, 2012, OBES REV, V13, P1067, DOI 10.1111/j.1467-789X.2012.01017.x; Du SF, 2002, PUBLIC HEALTH NUTR, V5, P169, DOI 10.1079/PHN2001290; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; Haap M, 2011, J CLIN ENDOCR METAB, V96, pE958, DOI 10.1210/jc.2010-2682; Ismail M N, 2002, Obes Rev, V3, P203, DOI 10.1046/j.1467-789X.2002.00074.x; Jafar TH, 2006, CAN MED ASSOC J, V175, P1071, DOI 10.1503/cmaj.060464; Jakobsen MU, 2007, EPIDEMIOL REV, V29, P77, DOI 10.1093/epirev/mxm002; James P T, 2001, Obes Res, V9 Suppl 4, p228S, DOI 10.1038/oby.2001.123; Kaidar-Person O, 2011, OBES SURG, V21, P1792, DOI 10.1007/s11695-011-0490-2; Kantartzis K, 2010, DIABETOLOGIA, V53, P882, DOI 10.1007/s00125-010-1663-6; Letamo G, 2011, J BIOSOC SCI, V43, P75, DOI 10.1017/S0021932010000519; Lindstrom J, 2010, HORM METAB RES, V42, pS37, DOI 10.1055/s-0029-1240975; Ma Guan-sheng, 2005, Zhonghua Yufang Yixue Zazhi, V39, P311; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940; National Bureau of Statistics of China, 2012, CHINA STAT PRESS; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Olatunbosun ST, 2011, OBES REV, V12, P233, DOI 10.1111/j.1467-789X.2010.00801.x; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Reynolds K, 2007, OBESITY, V15, P10, DOI 10.1038/oby.2007.527; SCHWARZ PE, 2012, NAT REV ENDOCRINOL, V8, P363, DOI [DOI 10.1038/NRENDO.2011.232, DOI 10.1038/nrendo.2011.232]; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Spence-Jones Gregory, 2003, Crit Care Nurs Q, V26, P83; *UN DEV PROGR CHIN, 2010, HUM DEV REP 2010; *UN DEV PROGR CHIN, 2010, CHIN HUM DEV REP 200; WHO, 2004, LANCET, V363, P902; Yoo S, 2010, PREV MED, V51, P460, DOI 10.1016/j.ypmed.2010.10.004	33	21	22	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79946	10.1371/journal.pone.0079946	http://dx.doi.org/10.1371/journal.pone.0079946			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224024	Green Published, Green Submitted, gold			2022-12-27	WOS:000326597400098
J	Mehling, M; Fritz, S; Hafner, P; Eichin, D; Yonekawa, T; Klimkait, T; Lindberg, RLP; Kappos, L; Hess, C				Mehling, Matthias; Fritz, Stefanie; Hafner, Patricia; Eichin, Dominik; Yonekawa, Tomomi; Klimkait, Thomas; Lindberg, Raija L. P.; Kappos, Ludwig; Hess, Christoph			Preserved Antigen-Specific Immune Response in Patients with Multiple Sclerosis Responding to IFN beta-Therapy	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; SEARCHING BEHAVIOR; NEURONS; PROTEIN; THERMOTAXIS; CHEMOTAXIS; SIMILARITY; OLFACTION	Background: Interferon-beta (IFN beta) regulates the expression of a complex set of pro-as well as anti-inflammatory genes. In cohorts of MS patients unstratified for therapeutic response to IFN beta, normal vaccine-specific immune responses have been observed. Data capturing antigen-specific immune responses in cohorts of subjects defined by response to IFN beta-therapy are not available. Objective: To assess antigen-specific immune responses in a cohort of MS patients responding clinically and radiologically to IFN beta. Methods: In 26 MS patients, clinical and MRI disease activity were assessed before and under treatment with IFN beta. Humoral and cellular immune response to influenza vaccine was prospectively characterized in these individuals, and 33 healthy controls by influenza-specific Enzyme-Linked Immunosorbent Assay (ELISA) and Enzyme Linked Immuno Spot Technique (ELISPOT). Results: Related to pre-treatment disease activity, IFN beta reduced clinical and radiological MS disease-activity. Following influenza vaccination, frequencies of influenza-specific T cells and concentrations of anti-influenza A and B IgM and IgG increased comparably in MS-patients and in healthy controls. Conclusions: By showing in a cohort of MS-patients responding to IFN beta vaccine-specific immune responses comparable to controls, this study indicates that antigen-specific immune responses can be preserved under successful IFN beta-therapy.	[Mehling, Matthias; Fritz, Stefanie; Eichin, Dominik; Hess, Christoph] Univ Basel Hosp, Immunobiol Lab, Dept Biomed, CH-4031 Basel, Switzerland; [Mehling, Matthias; Fritz, Stefanie; Eichin, Dominik; Hess, Christoph] Univ Basel Hosp, Immunobiol Lab, Med Outpatient Dept, CH-4031 Basel, Switzerland; [Mehling, Matthias; Hafner, Patricia; Lindberg, Raija L. P.; Kappos, Ludwig] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland; [Mehling, Matthias; Hafner, Patricia; Lindberg, Raija L. P.; Kappos, Ludwig] Univ Basel Hosp, Clin Neuroimmunol Lab, Dept Biomed, CH-4031 Basel, Switzerland; [Yonekawa, Tomomi] Univ Basel Hosp, Med Image Anal Ctr, CH-4031 Basel, Switzerland; [Klimkait, Thomas] Univ Basel, Inst Med Microbiol, Dept Biomed, Basel, Switzerland	University of Basel; University of Basel; University of Basel; University of Basel; University of Basel; University of Basel	Kappos, L (corresponding author), Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland.	lkappos@uhbs.ch; chess@uhbs.ch		Eichin, Dominik/0000-0002-6772-1086; Klimkait, Thomas/0000-0003-4945-6511; Mehling, Matthias/0000-0001-8599-1226	Novartis AG, Basel, Switzerland; Swiss National Science Foundation [PP00B-114850, 31003A_135677]; Swiss MS Society	Novartis AG, Basel, Switzerland; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss MS Society	This investigator initiated and sponsored study was supported by Novartis AG, Basel, Switzerland. C. Hess is supported by the Swiss National Science Foundation (PP00B-114850 and 31003A_135677), and L. Kappos and M. Mehling by the Swiss MS Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz M., 1972, HDB MATH FUNCTIONS F; Albrecht DR, 2011, NAT METHODS, V8, P599, DOI [10.1038/NMETH.1630, 10.1038/nmeth.1630]; [Anonymous], 2006, C ELEGANS RES COMMUN, DOI [10.1895/wormbook.1.123.1, DOI 10.1895/W0RMB00K.1.123.1.AVAILABLE:HTTP://WWW.W0RMB00K.0RG]; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bell WJ, 1991, SEARCHING BEHAV BEHA, DOI DOI 10.1371/journal.pone.0086271; BENHAMOU S, 1992, J THEOR BIOL, V159, P67, DOI 10.1016/S0022-5193(05)80768-4; Benichou O, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.198101; BEUKEMA JJ, 1968, BEHAVIOUR, V31, P1, DOI 10.1163/156853968X00018; Butcher RA, 2009, P NATL ACAD SCI USA, V106, P1875, DOI 10.1073/pnas.0810338106; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; Colbert HA, 1997, J NEUROSCI, V17, P8259; CROLL NA, 1975, J ZOOL, V176, P159, DOI 10.1111/j.1469-7998.1975.tb03191.x; DETHIER VG, 1957, SCIENCE, V125, P331, DOI 10.1126/science.125.3243.331; Fujiwara M, 2002, NEURON, V36, P1091, DOI 10.1016/S0896-6273(02)01093-0; Gabel CV, 2007, J NEUROSCI, V27, P7586, DOI 10.1523/JNEUROSCI.0775-07.2007; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; Hills T, 2004, J NEUROSCI, V24, P1217, DOI 10.1523/JNEUROSCI.1569-03.2004; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; Iino Y, 2009, J NEUROSCI, V29, P5370, DOI 10.1523/JNEUROSCI.3633-08.2009; Inada H, 2006, GENETICS, V172, P2239, DOI 10.1534/genetics.105.050013; JANDER R, 1975, ANNU REV ECOL SYST, V6, P171, DOI 10.1146/annurev.es.06.110175.001131; JONES RE, 1977, BEHAVIOUR, V60, P236; Kocabas A, 2012, NATURE, V490, P273, DOI 10.1038/nature11431; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; LEWIS JA, 1977, J COMP NEUROL, V172, P489, DOI 10.1002/cne.901720306; Li W, 2009, NATURE, V440, P684; Liu J, 2010, NAT NEUROSCI, V13, P715, DOI 10.1038/nn.2540; Luo LJ, 2006, J EXP BIOL, V209, P4652, DOI 10.1242/jeb.02590; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; MANDELBROT B, 1967, SCIENCE, V156, P636, DOI 10.1126/science.156.3775.636; MCBRIDE JM, 1966, NATURE, V211, P545, DOI 10.1038/211545b0; PEREIRA HS, 1993, P NATL ACAD SCI USA, V90, P5044, DOI 10.1073/pnas.90.11.5044; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Priess JR, 1997, C ELEGANS; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; Ryu WS, 2002, J NEUROSCI, V22, P5727; Schtickzelle N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-4; Sliusarenko O, 2006, P NATL ACAD SCI USA, V103, P1534, DOI 10.1073/pnas.0507720103; SMITH JNM, 1974, BEHAVIOUR, V49, P1, DOI 10.1163/156853974X00390; Stephens GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013914; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Swoboda P, 2000, MOL CELL, V5, P411, DOI 10.1016/S1097-2765(00)80436-0; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; Uchida O, 2003, DEVELOPMENT, V130, P1215, DOI 10.1242/dev.00341; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Wakabayashi T, 2004, NEUROSCI RES, V50, P103, DOI 10.1016/j.neures.2004.06.005; Wittlinger M, 2007, J EXP BIOL, V210, P198, DOI 10.1242/jeb.02657; Zollner PA, 1999, ECOLOGY, V80, P1019, DOI 10.2307/177035	51	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78532	10.1371/journal.pone.0078532	http://dx.doi.org/10.1371/journal.pone.0078532			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223820	Green Published, Green Submitted, gold			2022-12-27	WOS:000326597400032
J	Bogino, P; Abod, A; Nievas, F; Giordano, W				Bogino, Pablo; Abod, Ayelen; Nievas, Fiorela; Giordano, Walter			Water-Limiting Conditions Alter the Structure and Biofilm-Forming Ability of Bacterial Multispecies Communities in the Alfalfa Rhizosphere	PLOS ONE			English	Article							PEANUT ARACHIS-HYPOGAEA; SINORHIZOBIUM-MELILOTI; RHIZOBIUM-MELILOTI; PSEUDOMONAS-AERUGINOSA; DESICCATION TOLERANCE; MICROBIAL COMMUNITY; SOIL TYPE; PLANT; DIVERSITY; GROWTH	Biofilms are microbial communities that adhere to biotic or abiotic surfaces and are enclosed in a protective matrix of extracellular compounds. An important advantage of the biofilm lifestyle for soil bacteria (rhizobacteria) is protection against water deprivation (desiccation or osmotic effect). The rhizosphere is a crucial microhabitat for ecological, interactive, and agricultural production processes. The composition and functions of bacterial biofilms in soil microniches are poorly understood. We studied multibacterial communities established as biofilm-like structures in the rhizosphere of Medicago sativa (alfalfa) exposed to 3 experimental conditions of water limitation. The whole biofilm-forming ability (WBFA) for rhizospheric communities exposed to desiccation was higher than that of communities exposed to saline or nonstressful conditions. A culture-dependent ribotyping analysis indicated that communities exposed to desiccation or saline conditions were more diverse than those under the nonstressful condition. 16S rRNA gene sequencing of selected strains showed that the rhizospheric communities consisted primarily of members of the Actinobacteria and alpha- and gamma-Proteobacteria, regardless of the water-limiting condition. Our findings contribute to improved understanding of the effects of environmental stress factors on plant-bacteria interaction processes and have potential application to agricultural management practices.	[Bogino, Pablo; Abod, Ayelen; Nievas, Fiorela; Giordano, Walter] Univ Nacl Rio Cuarto, Dept Biol Mol, Fac Ciencias Exactas Fis Quim & Nat, Rio Cuarto, Cordoba, Argentina	Universidad Nacional Rio Cuarto	Giordano, W (corresponding author), Univ Nacl Rio Cuarto, Dept Biol Mol, Fac Ciencias Exactas Fis Quim & Nat, Rio Cuarto, Cordoba, Argentina.	wgiordano@exa.unrc.edu.ar		Bogino, Pablo/0000-0001-7841-6119	Secretaria de Ciencia y Tecnica de la UNRC; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas of the Republica Argentina (CONICET); CONICET	Secretaria de Ciencia y Tecnica de la UNRC; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas of the Republica Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by grants from the Secretaria de Ciencia y Tecnica de la UNRC, Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) and Consejo Nacional de Investigaciones Cientificas y Tecnicas of the Republica Argentina (CONICET). AA and FN were supported by a fellowship from the CONICET. PB and WG are Career Members of CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaras B, 2012, APPL SOIL ECOL, V61, P305, DOI 10.1016/j.apsoil.2011.11.016; Alami Y, 2000, APPL ENVIRON MICROB, V66, P3393, DOI 10.1128/AEM.66.8.3393-3398.2000; Albareda M, 2006, FEMS MICROBIOL LETT, V259, P67, DOI 10.1111/j.1574-6968.2006.00244.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; An DS, 2006, INT J SYST EVOL MICR, V56, P443, DOI 10.1099/ijs.0.63942-0; Andreote FD, 2008, ANTON LEEUW INT J G, V93, P415, DOI 10.1007/s10482-007-9219-6; ANGLE JS, 1996, SOIL BIOCH, V9, P233; Appuhn A, 2006, SOIL BIOL BIOCHEM, V38, P1040, DOI 10.1016/j.soilbio.2005.09.002; Bailly X, 2006, MOL ECOL, V15, P2719, DOI 10.1111/j.1365-294X.2006.02969.x; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Balzarini M., 2003, INFOGEN SOFTWARE ANA; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Bhattacharya I, 2003, MICROBIOL RES, V158, P187, DOI 10.1078/0944-5013-00195; Billi D, 2000, CE MO RE ST, P181; Bogino P, 2006, ANN APPL BIOL, V148, P207, DOI 10.1111/j.1744-7348.2006.00055.x; Bogino P, 2011, EUR J SOIL BIOL, V47, P188, DOI 10.1016/j.ejsobi.2011.01.005; Bradshaw A.D., 1980, RESTORATION LAND ECO; Buee M, 2009, PLANT SOIL, V321, P189, DOI 10.1007/s11104-009-9991-3; Burmolle M, 2006, SOIL BIOL, V8, P397; Burmolle M, 2007, MICROB ECOL, V54, P352, DOI 10.1007/s00248-007-9222-5; Burmolle M, 2006, APPL ENVIRON MICROB, V72, P3916, DOI 10.1128/AEM.03022-05; Campbell GRO, 2003, J BACTERIOL, V185, P3853, DOI 10.1128/JB.185.13.3853-3862.2003; Carelli M, 2000, APPL ENVIRON MICROB, V66, P4785, DOI 10.1128/AEM.66.11.4785-4789.2000; Castellanos T, 2009, EUR J SOIL BIOL, V45, P383, DOI 10.1016/j.ejsobi.2009.07.006; Catroux G, 2001, PLANT SOIL, V230, P21, DOI 10.1023/A:1004777115628; Chang WS, 2007, J BACTERIOL, V189, P8290, DOI 10.1128/JB.00727-07; Cheng HP, 1998, J BACTERIOL, V180, P20, DOI 10.1128/JB.180.1.20-26.1998; Christensen BB, 2002, APPL ENVIRON MICROB, V68, P2495, DOI 10.1128/AEM.68.5.2495-2502.2002; Compant S, 2010, SOIL BIOL BIOCHEM, V42, P669, DOI 10.1016/j.soilbio.2009.11.024; Conrad JC, 2012, RES MICROBIOL, V163, P619, DOI 10.1016/j.resmic.2012.10.016; Costa R, 2006, FEMS MICROBIOL ECOL, V56, P236, DOI 10.1111/j.1574-6941.2005.00026.x; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Dardanelli MS, 2008, SOIL BIOL BIOCHEM, V40, P2713, DOI 10.1016/j.soilbio.2008.06.016; Deaker R, 2004, SOIL BIOL BIOCHEM, V36, P1275, DOI 10.1016/j.soilbio.2004.04.009; Dell'Amico E, 2005, FEMS MICROBIOL ECOL, V52, P153, DOI 10.1016/j.femsec.2004.11.005; Dimkpa C, 2009, PLANT CELL ENVIRON, V32, P1682, DOI 10.1111/j.1365-3040.2009.02028.x; Downie JA, 2010, FEMS MICROBIOL REV, V34, P150, DOI 10.1111/j.1574-6976.2009.00205.x; Dunbar J, 2001, APPL ENVIRON MICROB, V67, P190, DOI 10.1128/AEM.67.1.190-197.2001; Farina R, 2012, APPL SOIL ECOL, V55, P44, DOI 10.1016/j.apsoil.2011.12.011; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI 10.1051/agro:2008021; Farrand SK, 2002, METHOD ENZYMOL, V358, P452; Fierer N, 2003, MICROB ECOL, V45, P63, DOI 10.1007/s00248-002-1007-2; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Fujishige NA, 2006, BOT J LINN SOC, V150, P79, DOI 10.1111/j.1095-8339.2006.00492.x; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; Garbeva P, 2008, PLANT SOIL, V302, P19, DOI 10.1007/s11104-007-9432-0; Garbeva P, 2004, ANNU REV PHYTOPATHOL, V42, P243, DOI 10.1146/annurev.phyto.42.012604.135455; Garbeva P, 2004, FEMS MICROBIOL ECOL, V47, P51, DOI 10.1016/S0168-6496(03)00234-4; Ghigo JM, 2001, NATURE, V412, P442, DOI 10.1038/35086581; Griffiths RI, 2003, APPL ENVIRON MICROB, V69, P6961, DOI 10.1128/AEM.69.12.6961-6968.2003; Gurtler V, 1996, MICROBIOL-SGM, V142, P3, DOI 10.1099/13500872-142-1-3; Han LL, 2009, J MICROBIOL, V47, P287, DOI 10.1007/s12275-009-0001-5; Hartmann A, 2008, PLANT SOIL, V312, P7, DOI 10.1007/s11104-007-9514-z; Henry A, 2007, J ENVIRON QUAL, V36, P904, DOI 10.2134/jeq2006.0425sc; Hinsinger P, 2009, PLANT SOIL, V321, P117, DOI 10.1007/s11104-008-9885-9; Hooshangi S, 2008, CURR OPIN BIOTECH, V19, P550, DOI 10.1016/j.copbio.2008.10.007; Houlden A, 2008, FEMS MICROBIOL ECOL, V65, P193, DOI 10.1111/j.1574-6941.2008.00535.x; Jackson CR, 2003, OIKOS, V101, P444, DOI 10.1034/j.1600-0706.2003.12254.x; Jones KM, 2007, NAT REV MICROBIOL, V5, P619, DOI 10.1038/nrmicro1705; Karagoz K, 2012, EUR J SOIL BIOL, V50, P144, DOI 10.1016/j.ejsobi.2012.01.007; Khamna S, 2009, WORLD J MICROB BIOT, V25, P649, DOI 10.1007/s11274-008-9933-x; Kirk JL, 2004, J MICROBIOL METH, V58, P169, DOI 10.1016/j.mimet.2004.04.006; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Kuklinsky-Sobral J, 2004, ENVIRON MICROBIOL, V6, P1244, DOI 10.1111/j.1462-2920.2004.00658.x; LEIGH JA, 1985, P NATL ACAD SCI USA, V82, P6231, DOI 10.1073/pnas.82.18.6231; Li YH, 2012, SENSORS-BASEL, V12, P2519, DOI 10.3390/s120302519; LLORET J, 1995, APPL ENVIRON MICROB, V61, P3701, DOI 10.1128/AEM.61.10.3701-3704.1995; Lloret J, 1998, APPL ENVIRON MICROB, V64, P1024; Velazquez-Hernandez ML, 2011, ARCH MICROBIOL, V193, P137, DOI 10.1007/s00203-010-0651-z; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Lunsdorf H, 2000, ENVIRON MICROBIOL, V2, P161; Mark GL, 2005, P NATL ACAD SCI USA, V102, P17454, DOI 10.1073/pnas.0506407102; Marschner P, 2001, SOIL BIOL BIOCHEM, V33, P1437, DOI 10.1016/S0038-0717(01)00052-9; Martinez-Bueno MA, 2002, ENVIRON MICROBIOL, V4, P842, DOI 10.1046/j.1462-2920.2002.00371.x; McClean KH, 1997, MICROBIOL-UK, V143, P3703, DOI 10.1099/00221287-143-12-3703; MERCKX R, 1987, BIOL FERT SOILS, V5, P126, DOI 10.1007/BF00257647; Nievas F, 2012, SENSORS-BASEL, V12, P2851, DOI 10.3390/s120302851; Nievas F, 2012, APPL SOIL ECOL, V53, P74, DOI 10.1016/j.apsoil.2011.11.010; Nimnoi P, 2011, ANN MICROBIOL, V61, P237, DOI 10.1007/s13213-010-0128-y; Nogueira MA, 2006, AGR ECOSYST ENVIRON, V115, P237, DOI 10.1016/j.agee.2006.01.008; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; PAPENDICK RI, 1980, WATER POTENTIAL RELA, P1; Parsek MR, 2005, TRENDS MICROBIOL, V13, P27, DOI 10.1016/j.tim.2004.11.007; Pearce D., 1995, MICROBIAL BIOFILMS, P207; Pini F, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-78; Pongsilp N, 2012, WORLD J MICROB BIOT, V28, P615, DOI 10.1007/s11274-011-0855-7; Potera C, 1996, SCIENCE, V273, P1795, DOI 10.1126/science.273.5283.1795; POTTS M, 1994, MICROBIOL REV, V58, P755, DOI 10.1128/MMBR.58.4.755-805.1994; Raaijmakers JM, 2009, PLANT SOIL, V321, P341, DOI 10.1007/s11104-008-9568-6; Rickard AH, 2003, TRENDS MICROBIOL, V11, P94, DOI 10.1016/S0966-842X(02)00034-3; Rickard AH, 2006, MOL MICROBIOL, V60, P1446, DOI 10.1111/j.1365-2958.2006.05202.x; Rinaudi LV, 2009, J BACTERIOL, V191, P7216, DOI 10.1128/JB.01063-09; ROBERSON EB, 1992, APPL ENVIRON MICROB, V58, P1284, DOI 10.1128/AEM.58.4.1284-1291.1992; Roumiantseva ML, 2002, APPL ENVIRON MICROB, V68, P4694, DOI 10.1128/AEM.68.9.4694-4697.2002; Sambrook, 1989, MOL CLONING LAB MANU, P68; Sessitsch A, 2002, CRIT REV PLANT SCI, V21, P323, DOI 10.1080/0735-260291044278; Sharma A, 2005, ORAL MICROBIOL IMMUN, V20, P39, DOI 10.1111/j.1399-302X.2004.00175.x; Shi JY, 2011, INT J MOL SCI, V12, P3770, DOI 10.3390/ijms12063770; Smalla K, 2006, FEMS MICROBIOL ECOL, V56, P165, DOI 10.1111/j.1574-6941.2006.00148.x; Smalla K, 2007, J MICROBIOL METH, V69, P470, DOI 10.1016/j.mimet.2007.02.014; Sorensen SJ, 2005, NAT REV MICROBIOL, V3, P700, DOI 10.1038/nrmicro1232; Sorroche FG, 2012, APPL ENVIRON MICROB, V78, P4092, DOI 10.1128/AEM.07826-11; Sorroche FG, 2010, CURR MICROBIOL, V61, P465, DOI 10.1007/s00284-010-9639-9; Stach JEM, 2002, ENVIRON MICROBIOL, V4, P169, DOI 10.1046/j.1462-2920.2002.00283.x; Stewart PS, 1997, MICROBIAL ECOL, V33, P2, DOI 10.1007/s002489900002; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; Torsvik V, 1996, J IND MICROBIOL, V17, P170, DOI 10.1007/BF01574690; Udvardi MK, 2007, PLANT PHYSIOL, V144, P538, DOI 10.1104/pp.107.098061; Ulrich A, 2006, FEMS MICROBIOL ECOL, V56, P430, DOI 10.1111/j.1574-6941.2006.00085.x; Vanderlinde EM, 2010, FEMS MICROBIOL ECOL, V71, P327, DOI 10.1111/j.1574-6941.2009.00824.x; Verstraeten N, 2008, TRENDS MICROBIOL, V16, P496, DOI 10.1016/j.tim.2008.07.004; von Mering C, 2007, SCIENCE, V315, P1126, DOI 10.1126/science.1133420; Vriezen JAC, 2007, APPL ENVIRON MICROB, V73, P3451, DOI 10.1128/AEM.02991-06; Wardle DA, 1998, SOIL BIOL BIOCHEM, V30, P1627, DOI 10.1016/S0038-0717(97)00201-0; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Welbaum GE, 2004, CRIT REV PLANT SCI, V23, P175, DOI 10.1080/07352680490433295; Willems A, 2001, INT J SYST EVOL MICR, V51, P111, DOI 10.1099/00207713-51-1-111; Williams P, 2007, MICROBIOL-SGM, V153, P3923, DOI 10.1099/mic.0.2007/012856-0; Xu YX, 2009, SOIL BIOL BIOCHEM, V41, P919, DOI 10.1016/j.soilbio.2008.10.027; Yang JK, 2005, SOIL BIOL BIOCHEM, V37, P141, DOI 10.1016/j.soilbio.2004.06.016; Ying YX, 2012, BIOCHEM GENET, V50, P848, DOI 10.1007/s10528-012-9525-1; Zahran HH, 1999, MICROBIOL MOL BIOL R, V63, P968, DOI 10.1128/MMBR.63.4.968-989.1999; Zhang F, 2010, APPL MICROBIOL BIOT, V88, P1413, DOI 10.1007/s00253-010-2841-7	124	51	53	4	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79614	10.1371/journal.pone.0079614	http://dx.doi.org/10.1371/journal.pone.0079614			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223979	Green Submitted, gold, Green Published			2022-12-27	WOS:000326503400130
J	Gandini, S; De Vries, E; Tosti, G; Botteri, E; Spadola, G; Maisonneuve, P; Martinoli, C; Joosse, A; Ferrucci, PF; Baldini, F; Cocorocchio, E; Pennacchioli, E; Cataldo, F; Bazolli, B; Clerici, A; Barberis, M; Bataille, V; Testori, A				Gandini, Sara; De Vries, Esther; Tosti, Giulio; Botteri, Edoardo; Spadola, Giuseppe; Maisonneuve, Patrick; Martinoli, Chiara; Joosse, Arjen; Ferrucci, Pier Francesco; Baldini, Federica; Cocorocchio, Emilia; Pennacchioli, Elisabetta; Cataldo, Francesco; Bazolli, Barbara; Clerici, Alessandra; Barberis, Massimo; Bataille, Veronique; Testori, Alessandro			Sunny Holidays before and after Melanoma Diagnosis Are Respectively Associated with Lower Breslow Thickness and Lower Relapse Rates in Italy	PLOS ONE			English	Article							CUTANEOUS MALIGNANT-MELANOMA; VITAMIN-D SUPPLEMENTATION; RISK-FACTORS; RECALL BIAS; EXPOSURE; MORTALITY; CANCER; METAANALYSIS; SURVIVAL; SKIN	Background: Previous studies have reported an association between sun exposure and improved cutaneous melanoma (CM) survival. We analysed the association of UV exposure with prognostic factors and outcome in a large melanoma cohort. Methods: A questionnaire was given to 289 (42%) CM patients at diagnosis (Group 1) and to 402 CM patients (58%) during follow-up (Group 2). Analyses were carried out to investigate the associations between sun exposure and melanoma prognostic factors and survival. Results: Holidays in the sun two years before CM diagnosis were significantly associated with lower Breslow thickness (p=0.003), after multiple adjustment. Number of weeks of sunny holidays was also significantly and inversely associated with thickness in a dose-dependent manner (p=0.007). However when stratifying by gender this association was found only among women (p=0.0004) the risk of CM recurrence in both sexes was significantly lower in patients (n=271) who had holidays in the sun after diagnosis, after multiple adjustment including education: HR=0.30 (95% CI: 0.10-0.87; p=0.03) conclusions: Holidays in the sun were associated with thinner melanomas in women and reduced rates of relapse in both sexes. However, these results do not prove a direct causal effect of sun exposure on survival since other confounding factors, such as vitamin D serum levels and socio-economic status, may play a role. Other factors in sun seeking individuals may also possibly affect these results.	[Gandini, Sara; Botteri, Edoardo; Maisonneuve, Patrick; Bazolli, Barbara; Clerici, Alessandra] European Inst Oncol, Div Epidemiol & Biostat, Milan, Italy; [De Vries, Esther; Joosse, Arjen] Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Tosti, Giulio; Spadola, Giuseppe; Baldini, Federica; Pennacchioli, Elisabetta; Cataldo, Francesco; Testori, Alessandro] European Inst Oncol, Div Melanoma & Muscle Cutaneous Sarcomas, Milan, Italy; [Martinoli, Chiara; Ferrucci, Pier Francesco; Cocorocchio, Emilia] European Inst Oncol, Dept Med Oncol, Milan, Italy; [Barberis, Massimo] European Inst Oncol, Dept Pathol & Lab Med, Milan, Italy; [Bataille, Veronique] Kings Coll London, Twin Res & Genet Epidemiol Unit, London WC2R 2LS, England	IRCCS European Institute of Oncology (IEO); Erasmus University Rotterdam; Erasmus MC; IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO); University of London; King's College London	Gandini, S (corresponding author), European Inst Oncol, Div Epidemiol & Biostat, Milan, Italy.	sara.gandini@ieo.it	de Vries, Esther/A-6603-2009; Maisonneuve, Patrick/U-9789-2018; gandini, sara/J-4916-2018; Spadola, Giuseppe/ABI-7556-2020; cocorocchio, emilia/AAN-8263-2020; Barberis, Massimo/AAL-5446-2020; Tosti, Giulio/AAR-2056-2020; Ferrucci, Pier Francesco/AAQ-9002-2020	de Vries, Esther/0000-0002-5560-2258; Maisonneuve, Patrick/0000-0002-5309-4704; gandini, sara/0000-0002-1348-4548; Spadola, Giuseppe/0000-0001-5203-9503; cocorocchio, emilia/0000-0003-1184-6426; Ferrucci, Pier Francesco/0000-0001-6255-5851; Botteri, Edoardo/0000-0002-9023-8068; tosti, giulio/0000-0001-8231-2814; martinoli, chiara/0000-0002-8173-5046; TESTORI, ALESSANDRO/0000-0003-3685-0210	Fondazione Grazia Focacci	Fondazione Grazia Focacci	The authors thank the "Fondazione Grazia Focacci" for the financial support. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730; Berwick M, 2005, J NATL CANCER I, V97, P195, DOI 10.1093/jnci/dji019; Carnevale V, 2001, OSTEOPOROSIS INT, V12, P1026, DOI 10.1007/s001980170012; Cockburn M, 2001, AM J EPIDEMIOL, V153, P1021, DOI 10.1093/aje/153.10.1021; Davies JR, 2011, CANCER CAUSE CONTROL, V22, P1471, DOI 10.1007/s10552-011-9827-3; de Vries E, 2003, INT J CANCER, V107, P119, DOI 10.1002/ijc.11360; Egan KM, 2005, JNCI-J NATL CANCER I, V97, P161, DOI 10.1093/jnci/dji047; Gambichler T, 2013, BRIT J DERMATOL, V168, P625, DOI 10.1111/j.1365-2133.2012.11212.x; Gandini S, 2005, EUR J CANCER, V41, P45, DOI 10.1016/j.ejca.2004.10.016; Gandini S, 2011, INT J CANCER, V128, P1414, DOI 10.1002/ijc.25439; Gandini S, 2009, EUR J CANCER, V45, P634, DOI 10.1016/j.ejca.2008.10.003; Grange F, 2012, ARCH DERMATOL, V148, P1370, DOI 10.1001/archdermatol.2012.2937; Guerrieri-Gonzaga A, 2013, PIGM CELL MELANOMA R, V26, P16, DOI 10.1111/pcmr.12036; HOLMAN CDJ, 1986, J NATL CANCER I, V76, P403; Idorn LW, 2013, BRIT J DERMATOL, V168, P367, DOI 10.1111/bjd.12066; Idorn LW, 2011, BRIT J DERMATOL, V165, P164, DOI 10.1111/j.1365-2133.2011.10348.x; Lazzeroni M, 2013, ANTI-CANCER AGENT ME, V13, P118, DOI 10.2174/187152013804487281; Mandala M, 2011, MAYO CLIN PROC, V86, P113, DOI 10.4065/mcp.2010.0671; Newton Bishop J, 2006, MELANOMA RES, V16; Newton-Bishop JA, 2009, J CLIN ONCOL, V27, P5439, DOI 10.1200/JCO.2009.22.1135; Parr CL, 2009, AM J EPIDEMIOL, V169, P257, DOI 10.1093/aje/kwn363; Raimondi S, 2009, CARCINOGENESIS, V30, P1170, DOI 10.1093/carcin/bgp103; Randerson-Moor JA, 2009, EUR J CANCER, V45, P3271, DOI 10.1016/j.ejca.2009.06.011; Rosso S, 2008, EUR J CANCER, V44, P1275, DOI 10.1016/j.ejca.2008.03.009; Soto E, 2010, MELANOMA RES, V20, P147, DOI 10.1097/CMR.0b013e328328f802; Tryggvadottir L, 2010, ACTA ONCOL, V49, P665, DOI 10.3109/02841861003702528; Yang L, 2011, CANCER EPIDEM BIOMAR, V20, P683, DOI 10.1158/1055-9965.EPI-10-0982	27	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78820	10.1371/journal.pone.0078820	http://dx.doi.org/10.1371/journal.pone.0078820			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223851	Green Published, gold			2022-12-27	WOS:000326503400089
J	Fauchais, AL; Lise, MC; Marget, P; Lapeybie, FX; Bezanahary, H; Martel, C; Dumonteil, S; Sparsa, A; Lalloue, F; Ly, K; Essig, M; Vidal, E; Jauberteau, MO				Fauchais, Anne-Laure; Lise, Marie-Claude; Marget, Pierre; Lapeybie, Francois-Xavier; Bezanahary, Holy; Martel, Clothilde; Dumonteil, Stephanie; Sparsa, Agnes; Lalloue, Fabrice; Ly, Kim; Essig, Marie; Vidal, Elisabeth; Jauberteau, Marie-Odile			Serum and Lymphocytic Neurotrophins Profiles in Systemic Lupus Erythematosus: a Case-Control Study	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; FACTOR INHIBITS APOPTOSIS; REGULATORY T-CELLS; DISEASE-ACTIVITY; DIFFERENTIAL REGULATION; RHEUMATOID-ARTHRITIS; CIRCULATING LEVELS; GENE-EXPRESSION; B-LYMPHOCYTES; PLASMA-LEVELS	Background: Neurotrophins play a central role in the development and maintenance of the nervous system. However, neurotrophins can also modulate B and T cell proliferation and activation, especially via autocrine loops. We hypothesized that both serum and lymphocytic neurotrophin levels may be deregulated in systemic Lupus erythematosus (SLE) and may reflect clinical symptoms of the disease. Methods: Neurotrophins in the serum (ELISA tests) and lymphocytes (flow cytometry) were measured in 26 SLE patients and 26 control subjects. Th1 (interferon-gamma) and Th2 (IL-10) profiles and serum concentration of BAFF were assessed by ELISA in the SLE and control subjects. Findings: We have demonstrated that both NGF and BDNF serum levels are higher in SLE patients than healthy controls (p=0.003 and p<0.001), independently of Th1 or Th2 profiles. Enhanced serum NT-3 levels (p=0.003) were only found in severe lupus flares (i.e. SLEDAI >= 10) and significantly correlated with complement activation (decreased CH 50, Gamma=-0.28, p=0.03). Furthermore, there was a negative correlation between serum NGF levels and the number of circulating T regulatory cells (Gamma=0.48, p=0.01). In circulating B cells, production of both NGF and BDNF was greater in SLE patients than in healthy controls. In particular, the number of NGF-secreting B cells correlated with decreased complement levels (p=0.05). One month after SLE flare treatment, BDNF levels decreased; in contrast, NGF and NT-3 levels remained unchanged. Conclusion: This study demonstrates that serum and B cell levels of both NGF and BDNF are increased in SLE, suggesting that the neurotrophin production pathway is deregulated in this disease. These results must be confirmed in a larger study with naive SLE patients, in order to avoid the potential confounding influence of prior immune-modulating treatments on neurotrophin levels.	[Fauchais, Anne-Laure; Lise, Marie-Claude; Marget, Pierre; Lapeybie, Francois-Xavier; Bezanahary, Holy; Martel, Clothilde; Sparsa, Agnes; Lalloue, Fabrice; Ly, Kim; Vidal, Elisabeth; Jauberteau, Marie-Odile] Limoges Univ Hosp, Equipe Accueil 3842, Clin Immunol Lab, Fr GEIST, Limoges, France; [Fauchais, Anne-Laure; Lapeybie, Francois-Xavier; Bezanahary, Holy; Martel, Clothilde; Dumonteil, Stephanie; Ly, Kim; Vidal, Elisabeth; Jauberteau, Marie-Odile] Limoges Univ Hosp, Dept Internal Med, Limoges, France; [Sparsa, Agnes] Limoges Univ Hosp, Dept Dermatol, Limoges, France; [Essig, Marie] Limoges Univ Hosp, Dept Nephrol, Limoges, France	CHU Limoges; CHU Limoges; CHU Limoges; CHU Limoges	Fauchais, AL (corresponding author), Limoges Univ Hosp, Equipe Accueil 3842, Clin Immunol Lab, Fr GEIST, Limoges, France.	anne-laure.fauchais@chu-limoges.fr	Essig, Marie/ABH-1342-2021; Essig, Marie/Q-5770-2016; Ly, Kim/AAN-4092-2021	Essig, Marie/0000-0002-2030-5616; Essig, Marie/0000-0002-2030-5616; Lalloue, Fabrice/0000-0003-0382-4948; Fauchais, Anne Laure/0000-0002-0489-8570; Jauberteau, Marie-Odile/0000-0002-8811-8948; Ly, Kim Heang/0000-0002-8511-903X				Aalto K, 2002, CYTOKINE, V20, P136, DOI 10.1006/cyto.2002.1991; Abram M, 2009, J IMMUNOL, V182, P4705, DOI 10.4049/jimmunol.0802814; Aloe L, 1997, ALLERGY, V52, P883, DOI 10.1111/j.1398-9995.1997.tb01247.x; Antonucci MT, 2009, NEPHRON CLIN PRACT, V111, pC21, DOI 10.1159/000178819; Barouch R, 2000, J NEUROIMMUNOL, V103, P112, DOI 10.1016/S0165-5728(99)00233-7; Barthel C, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2716; Bayas A, 2003, NEUROSCI LETT, V335, P155, DOI 10.1016/S0304-3940(02)01152-7; Beebe AM, 2002, CYTOKINE GROWTH F R, V13, P403, DOI 10.1016/S1359-6101(02)00025-4; Benoit ME, 2011, J NEUROSCI, V31, P3459, DOI 10.1523/JNEUROSCI.3932-10.2011; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Bonelli M, 2008, ANN RHEUM DIS, V67, P664, DOI 10.1136/ard.2007.074690; Bonelli M, 2010, ANN RHEUM DIS, V69, P65, DOI 10.1136/ard.2009.117135; BracciLaudiero L, 1996, NEUROSCI LETT, V204, P13, DOI 10.1016/0304-3940(96)12304-1; BRACCILAUDIERO L, 1993, NEUROREPORT, V4, P563, DOI 10.1097/00001756-199305000-00025; Brodie C, 1996, FEBS LETT, V394, P117, DOI 10.1016/0014-5793(96)00911-8; BRODIE C, 1994, J NEUROIMMUNOL, V52, P87, DOI 10.1016/0165-5728(94)90166-X; BRODIE C, 1992, J IMMUNOL, V148, P3492; Caggiula M, 2005, SCAND J IMMUNOL, V62, P176, DOI 10.1111/j.1365-3083.2005.01649.x; Cepika AM, 2012, CELL IMMUNOL, V276, P196, DOI 10.1016/j.cellimm.2012.05.009; Chang DM, 2002, IMMUNOL INVEST, V31, P1, DOI 10.1081/IMM-120003217; Cristofaro B, 2010, ARTERIOSCL THROM VAS, V30, P1143, DOI 10.1161/ATVBAHA.109.205468; Dagnell C, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-156; Del Porto F, 2006, ANN NY ACAD SCI, V1069, P438, DOI 10.1196/annals.1351.042; di Mola FF, 2000, GUT, V46, P670, DOI 10.1136/gut.46.5.670; Dolff S, 2007, SCAND J IMMUNOL, V66, P584, DOI 10.1111/j.1365-3083.2007.02008.x; Falcini F, 1996, ANN RHEUM DIS, V55, P745, DOI 10.1136/ard.55.10.745; Falcini F, 1996, J RHEUMATOL, V23, P1798; Fauchais A, 2008, J IMMUNOL; Fauchais AL, 2009, SCAND J RHEUMATOL, V38, P50, DOI 10.1080/03009740802378832; Gomez D, 2004, SEMIN ARTHRITIS RHEU, V33, P404, DOI 10.1016/j.semarthrit.2003.11.002; Grimsholm O, 2008, CLIN RHEUMATOL, V27, P1289, DOI 10.1007/s10067-008-0910-4; Hikawa S, 2002, HISTOCHEM CELL BIOL, V118, P51, DOI 10.1007/s00418-002-0426-y; Ikenouchi A, 2006, PROG NEURO-PSYCHOPH, V30, P1359, DOI 10.1016/j.pnpbp.2006.03.006; Ikenouchi-Sugita Atsuko, 2008, Neuropsychiatr Dis Treat, V4, P1277; Ikenouchi-Sugita A, 2010, WORLD J BIOL PSYCHIA, V11, P121, DOI 10.3109/15622970903521131; Ishii H, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.106; JockersScherubl MC, 1996, LANCET, V347, P982, DOI 10.1016/S0140-6736(96)91476-2; Kalinowska-Lyszczarz A, 2011, J NEUROIMMUNOL, V240, P109, DOI 10.1016/j.jneuroim.2011.10.002; Kemi C, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-18; Kerschensteiner M, 1999, J EXP MED, V189, P865, DOI 10.1084/jem.189.5.865; KIMATA H, 1991, EUR J IMMUNOL, V21, P137, DOI 10.1002/eji.1830210121; Kuhn A, 2009, ARCH DERMATOL RES, V301, P71, DOI 10.1007/s00403-008-0891-9; Lindquist S, 2011, MULT SCLER J, V17, P851, DOI 10.1177/1352458511399797; Lisak RP, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-30; Lise MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013918; Liu JU, 2009, J IMMUNOL, V182, P3855, DOI 10.4049/jimmunol.0803330; Manni L, 2005, INT J CARDIOL, V102, P169, DOI 10.1016/j.ijcard.2004.10.041; MANNING PT, 1985, BRAIN RES, V340, P61, DOI 10.1016/0006-8993(85)90773-5; Matucci-Cerinic M, 2001, ANN RHEUM DIS, V60, P487, DOI 10.1136/ard.60.5.487; Miret C, 2001, ANTICANCER RES, V21, P3053; Mizoguchi Y, 2009, J IMMUNOL, V183, P7778, DOI 10.4049/jimmunol.0901326; Moalem G, 2000, J AUTOIMMUN, V15, P331, DOI 10.1006/jaut.2000.0441; Noga O, 2007, CLIN EXP ALLERGY, V37, P1701, DOI 10.1111/j.1365-2222.2007.02832.x; Ola MS, 2013, CELL MOL NEUROBIOL, V33, P359, DOI 10.1007/s10571-012-9901-8; OTTEN U, 1989, P NATL ACAD SCI USA, V86, P10059, DOI 10.1073/pnas.86.24.10059; Raychaudhuri SP, 2011, ARTHRITIS RHEUM-US, V63, P3243, DOI 10.1002/art.30564; Ricci A, 2005, SARCOIDOSIS VASC DIF, V22, P186; Rihl M, 2005, ANN RHEUM DIS, V64, P1542, DOI 10.1136/ard.2004.032599; SANTAMBROGIO L, 1994, J IMMUNOL, V153, P4488; Schuhmann B, 2005, J NEUROIMMUNOL, V163, P15, DOI 10.1016/j.jneuroim.2005.01.023; Seidel MF, 2010, SEMIN ARTHRITIS RHEU, V40, P109, DOI 10.1016/j.semarthrit.2009.03.002; Shi Y, 2012, INFLAMM RES, V61, P1369, DOI 10.1007/s00011-012-0538-3; Steinkamp M, 2012, MED SCI MONITOR, V18, pBR117, DOI 10.12659/MSM.882612; Takei Y, 2008, TRENDS MOL MED, V14, P381, DOI 10.1016/j.molmed.2008.07.002; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; THORPE LW, 1987, J NEUROSCI RES, V18, P134, DOI 10.1002/jnr.490180120; Torcia M, 2001, J BIOL CHEM, V276, P39027, DOI 10.1074/jbc.M102970200; Urshansky N, 2010, J NEUROL SCI, V295, P31, DOI 10.1016/j.jns.2010.05.019; Villoslada P, 2000, J EXP MED, V191, P1799, DOI 10.1084/jem.191.10.1799; Walz JC, 2009, J PSYCHIATR RES, V43, P721, DOI 10.1016/j.jpsychires.2008.10.005; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Weinstock-Guttman B, 2007, J NEUROIMMUNOL, V188, P167, DOI 10.1016/j.jneuroim.2007.06.003; Yanagida M, 1996, LIFE SCI, V59, P2075, DOI 10.1016/S0024-3205(96)00561-9; Yang ZF, 2006, ONCOL REP, V16, P1237; Yoshimura S, 2010, MULT SCLER J, V16, P1178, DOI 10.1177/1352458510375706	75	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79414	10.1371/journal.pone.0079414	http://dx.doi.org/10.1371/journal.pone.0079414			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223945	gold, Green Published, Green Submitted			2022-12-27	WOS:000326499300083
J	Feinberg-Gorenshtein, G; Guedj, A; Shichrur, K; Jeison, M; Luria, D; Kodman, Y; Ash, S; Feinmesser, M; Edry, L; Shomron, N; Weizman, A; Yaniv, I; Avigad, S				Feinberg-Gorenshtein, Galina; Guedj, Avital; Shichrur, Keren; Jeison, Marta; Luria, Drorit; Kodman, Yona; Ash, Shifra; Feinmesser, Meora; Edry, Liat; Shomron, Noam; Weizman, Abraham; Yaniv, Isaac; Avigad, Smadar			miR-192 Directly Binds and Regulates Dicer1 Expression in Neuroblastoma	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; MICRORNA EXPRESSION; CANCER-PATIENTS; DIFFERENTIATION; ADENOCARCINOMA; METASTASIS; PROGNOSIS; APOPTOSIS; SURVIVAL; MIRNAS	Neuroblastoma (NB) arises from the embryonic neural crest and is the most common extracranial solid tumor in children under 5 years of age. Reduced expression of Dicer1 has recently been shown to be in correlation with poor prognosis in NB patients. This study aimed to investigate the mechanisms that could lead to the down-regulation of Dicer1 in neuroblastoma. We used computational prediction to identify potential miRs down-regulating Dicer1 in neuroblastoma. One of the miRs that were predicted to target Dicer1 was miR-192. We measured the levels of miR-192 in 43 primary tumors using real time PCR. Following the silencing of miR-192, the levels of dicer1 cell viability, cell proliferation and migration capability were analyzed. Multivariate analysis identified miR-192 as an independent prognostic marker for relapse in neuroblastoma patients (p=0.04). We were able to show through a dual luciferase assay and side-directed mutational analysis that miR-192 directly binds the 3' UTR of Dicer1 on positions 1232-1238 and 2282-2288. An increase in cell viability, proliferation and migration rates were evident in NB cells transfected with miR-192-mimic. Yet, there was a significant decrease in proliferation when NB cells were transfected with an miR-192-inhibitor We suggest that miR-192 might be a key player in NB by regulating Dicer1 expression.	[Feinberg-Gorenshtein, Galina; Guedj, Avital; Shichrur, Keren; Weizman, Abraham; Yaniv, Isaac; Avigad, Smadar] Felsenstein Med Res Ctr, Petah Tiqwa, Israel; [Feinberg-Gorenshtein, Galina; Guedj, Avital; Shichrur, Keren; Ash, Shifra; Feinmesser, Meora; Weizman, Abraham; Yaniv, Isaac; Avigad, Smadar] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Jeison, Marta; Luria, Drorit; Kodman, Yona; Ash, Shifra; Yaniv, Isaac; Avigad, Smadar] Schneider Childrens Med Ctr Israel, Petah Tiqwa, Israel; [Feinmesser, Meora] Rabin Med Ctr, Inst Pathol, Petah Tiqwa, Israel; [Edry, Liat; Shomron, Noam] Tel Aviv Univ, Sackler Fac Med, Dept Cell & Dev Biol, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Avigad, S (corresponding author), Felsenstein Med Res Ctr, Petah Tiqwa, Israel.	savigad@post.tau.ac.il	Weizman, Abraham/AAK-6450-2020	Weizman, Abraham/0000-0002-9765-8938	Rina Zaizov Memorial Fund	Rina Zaizov Memorial Fund	This work was supported by the Rina Zaizov Memorial Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamin H, 2010, J MOL DIAGN, V12, P771, DOI 10.2353/jmoldx.2010.090169; Bilen J, 2006, CELL CYCLE, V5, P2835, DOI 10.4161/cc.5.24.3579; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Chiosea S, 2007, CANCER RES, V67, P2345, DOI 10.1158/0008-5472.CAN-06-3533; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Huang TC, 2011, FEBS LETT, V585, P3582, DOI 10.1016/j.febslet.2011.10.025; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Le MTN, 2009, MOL CELL BIOL, V29, P5290, DOI 10.1128/MCB.01694-08; Lin RJ, 2010, CANCER RES, V70, P7841, DOI 10.1158/0008-5472.CAN-10-0970; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Mathe EA, 2009, CLIN CANCER RES, V15, P6192, DOI 10.1158/1078-0432.CCR-09-1467; Mayr D, 2009, HISTOPATHOLOGY, V55, P716, DOI 10.1111/j.1365-2559.2009.03427.x; Muralidhar B, 2007, J PATHOL, V212, P368, DOI 10.1002/path.2179; Muth D, 2010, CANCER RES, V70, P3791, DOI 10.1158/0008-5472.CAN-09-1245; Pasquinelli AE, 2005, CURR OPIN GENET DEV, V15, P200, DOI 10.1016/j.gde.2005.01.002; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Sugito N, 2006, CLIN CANCER RES, V12, P7322, DOI 10.1158/1078-0432.CCR-06-0515; Tokumaru S, 2008, CARCINOGENESIS, V29, P2073, DOI 10.1093/carcin/bgn187	25	33	34	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78713	10.1371/journal.pone.0078713	http://dx.doi.org/10.1371/journal.pone.0078713			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223844	Green Published, gold, Green Submitted			2022-12-27	WOS:000326499300031
J	Bao, LM; Gao, C; Li, MM; Chen, Y; Lin, WQ; Yang, YJ; Han, N; Bian, HW; Zhu, MY; Wang, JH				Bao, Lieming; Gao, Chen; Li, Miaomiao; Chen, Yong; Lin, Weiqiang; Yang, Yanjun; Han, Ning; Bian, Hongwu; Zhu, Muyuan; Wang, Junhui			Biomonitoring of Non-Dioxin-Like Polychlorinated Biphenyls in Transgenic Arabidopsis Using the Mammalian Pregnane X Receptor System: A Role of Pectin in Pollutant Uptake	PLOS ONE			English	Article							PLANT-MICROBE INTERACTIONS; ORGANIC CONTAMINANTS; GENE-EXPRESSION; RISK-ASSESSMENT; TOBACCO PLANTS; PCBS; PXR; PHYTOREMEDIATION; BIOAVAILABILITY; TRANSFORMATION	Polychlorinated biphenyls (PCBs) are persistent organic pollutants damaging to human health and the environment. Techniques to indicate PCB contamination in planta are of great interest to phytoremediation. Monitoring of dioxin-like PCBs in transgenic plants carrying the mammalian aryl hydrocarbon receptor (AHR) has been reported previously. Herein, we report the biomonitoring of non-dioxin-like PCBs (NDL-PCBs) using the mammalian pregnane X receptor (PXR). In the transgenic Arabidopsis designated NDL-PCB Reporter, the EGFP-GUS reporter gene was driven by a promoter containing 18 repeats of the xenobiotic response elements, while PXR and its binding partner retinoid X receptor (RXR) were coexpressed. Results showed that, in live cells, the expression of reporter gene was insensitive to endogenous lignans, carotenoids and flavonoids, but responded to all tested NDL-PCBs in a dose-and time-dependent manner. Two types of putative PCB metabolites, hydroxy-PCBs and methoxy-PCBs, displayed different activation properties. The vascular tissues seemed unable to transport NDL-PCBs, whereas mutation in QUASIMODO1 encoding a 1,4-galacturonosyltransferase led to reduced PCB accumulation in Arabidopsis, revealing a role for pectin in the control of PCB translocation. Taken together, the reporter system may serve as a useful tool to biomonitor the uptake and metabolism of NDL-PCBs in plants.	[Bao, Lieming; Gao, Chen; Li, Miaomiao; Chen, Yong; Lin, Weiqiang; Yang, Yanjun; Han, Ning; Bian, Hongwu; Zhu, Muyuan; Wang, Junhui] Zhejiang Univ, Coll Life Sci, Inst Genet, Dept Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Wang, JH (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Genet, Dept Biotechnol, Zijingang Campus, Hangzhou 310003, Zhejiang, Peoples R China.	junhuiwang@zju.edu.cn			National Natural Science Foundation of China [31170211]; China Agricultural Research system [CARS-05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agricultural Research system	The work was supported by funding from the National Natural Science Foundation of China (grant no. 31170211 to JW) and the China Agricultural Research system (CARS-05 to MZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhilash PC, 2012, TRENDS BIOTECHNOL, V30, P416, DOI 10.1016/j.tibtech.2012.04.004; Abhilash PC, 2009, BIOTECHNOL ADV, V27, P474, DOI 10.1016/j.biotechadv.2009.04.002; Al-Salman F, 2012, TOXICOL APPL PHARM, V263, P7, DOI 10.1016/j.taap.2012.05.016; Anderson M, 2000, PRACT APPROACH SER, V223, P1; Barber JL, 2002, ENVIRON SCI TECHNOL, V36, P4282, DOI 10.1021/es025623m; Boldt TS, 2004, FEMS MICROBIOL ECOL, V48, P139, DOI 10.1016/j.femsec.2004.01.002; Bouton S, 2002, PLANT CELL, V14, P2577, DOI 10.1105/tpc.004259; Brown JF, 2007, TOXICOL SCI, V98, P375, DOI 10.1093/toxsci/kfm122; Burken JG, 1998, ENVIRON SCI TECHNOL, V32, P3379, DOI 10.1021/es9706817; COBBETT CS, 2002, ARABIDOPSIS BOOK, V1, P32; Cui JY, 2010, NUCLEIC ACIDS RES, V38, P7943, DOI 10.1093/nar/gkq654; Cui XY, 2013, ENVIRON POLLUT, V172, P223, DOI 10.1016/j.envpol.2012.09.013; Doty SL, 2008, NEW PHYTOL, V179, P318, DOI 10.1111/j.1469-8137.2008.02446.x; Dronnet VM, 1996, CARBOHYD POLYM, V30, P253, DOI 10.1016/S0144-8617(96)00107-5; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Eljarrat E, 2003, TRAC-TREND ANAL CHEM, V22, P655, DOI 10.1016/S0165-9936(03)01001-X; Ficko SA, 2010, SCI TOTAL ENVIRON, V408, P3469, DOI 10.1016/j.scitotenv.2010.04.036; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Giesy JP, 1998, CRIT REV TOXICOL, V28, P511, DOI 10.1080/10408449891344263; Gou JY, 2012, PLANT CELL, V24, P50, DOI 10.1105/tpc.111.092411; Hamorsky KT, 2012, ANAL CHEM, V84, P7648, DOI 10.1021/ac301872u; Honkakoski P, 2003, ANN MED, V35, P172, DOI 10.1080/07853890310008224; Jacobs MN, 2005, TOXICOL APPL PHARM, V209, P123, DOI 10.1016/j.taap.2005.03.015; Jacobson JL, 1996, NEW ENGL J MED, V335, P783, DOI 10.1056/NEJM199609123351104; Jander G, 2002, PLANT PHYSIOL, V129, P440, DOI 10.1104/pp.003533; Jin XF, 2011, PLANT GROWTH REGUL, V65, P127, DOI 10.1007/s10725-011-9582-1; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kato Y, 2004, TOXICOL SCI, V81, P309, DOI 10.1093/toxsci/kfh225; Kliewer SA, 2002, ENDOCR REV, V23, P687, DOI 10.1210/er.2001-0038; Kodama S, 2007, PLANTA, V227, P37, DOI 10.1007/s00425-007-0592-1; Kodama S, 2009, PLANT BIOTECHNOL J, V7, P119, DOI 10.1111/j.1467-7652.2008.00378.x; Kojima H, 2011, TOXICOLOGY, V280, P77, DOI 10.1016/j.tox.2010.11.008; Komp P, 1997, ENVIRON SCI TECHNOL, V31, P2944, DOI 10.1021/es970141+; Li HS, 2011, CHEMOSPHERE, V84, P943, DOI 10.1016/j.chemosphere.2011.06.007; Liu JY, 2008, CHEMOSPHERE, V73, P1608, DOI 10.1016/j.chemosphere.2008.08.009; Lukowitz W, 2000, PLANT PHYSIOL, V123, P795, DOI 10.1104/pp.123.3.795; Mouille G, 2007, PLANT J, V50, P605, DOI 10.1111/j.1365-313X.2007.03086.x; Narasimhan K, 2003, PLANT PHYSIOL, V132, P146, DOI 10.1104/pp.102.016295; Peer WA, 2001, PLANT PHYSIOL, V126, P536, DOI 10.1104/pp.126.2.536; Pu XZ, 2006, TOXICOLOGY, V217, P14, DOI 10.1016/j.tox.2005.08.012; Rezek J, 2008, ENVIRON SCI TECHNOL, V42, P5746, DOI 10.1021/es800445h; Rezek J, 2012, CHEMOSPHERE, V89, P383, DOI 10.1016/j.chemosphere.2012.05.041; SAFE SH, 1994, CRIT REV TOXICOL, V24, P87, DOI 10.3109/10408449409049308; Schantz SL, 2003, ENVIRON HEALTH PERSP, V111, P357, DOI 10.1289/ehp.5461; Schiewer S, 2008, BIORESOURCE TECHNOL, V99, P1896, DOI 10.1016/j.biortech.2007.03.060; Schuetz EG, 1998, MOL PHARMACOL, V54, P1113, DOI 10.1124/mol.54.6.1113; Schwarzenbach RP, 2006, SCIENCE, V313, P1072, DOI 10.1126/science.1127291; Segura A, 2013, CURR OPIN BIOTECH, V24, P467, DOI 10.1016/j.copbio.2012.09.011; She WJ, 2010, GENETICS, V185, P1141, DOI 10.1534/genetics.110.117960; SILBERHORN EM, 1990, CRIT REV TOXICOL, V20, P439, DOI 10.3109/10408449009029331; Sterling JD, 2006, P NATL ACAD SCI USA, V103, P5236, DOI 10.1073/pnas.0600120103; Sylvestre M, 2013, ENVIRON MICROBIOL, V15, P907, DOI 10.1111/1462-2920.12007; Sylvestre M, 2009, CURR OPIN BIOTECH, V20, P242, DOI 10.1016/j.copbio.2009.01.006; Synold TW, 2001, NAT MED, V7, P584, DOI 10.1038/87912; Tabb MM, 2004, ENVIRON HEALTH PERSP, V112, P163, DOI 10.1289/ehp.6560; Turner K, 2007, ANAL CHEM, V79, P5740, DOI 10.1021/ac0705162; Van Aken B, 2010, ENVIRON SCI TECHNOL, V44, P2767, DOI 10.1021/es902514d; Wen FS, 1999, PLANT CELL, V11, P1129, DOI 10.1105/tpc.11.6.1129; Yang YJ, 2012, NEW PHYTOL, V193, P81, DOI 10.1111/j.1469-8137.2011.03867.x; YE QP, 1992, CHEMOSPHERE, V25, P1475, DOI 10.1016/0045-6535(92)90172-N	60	2	2	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79428	10.1371/journal.pone.0079428	http://dx.doi.org/10.1371/journal.pone.0079428			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236133	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700132
J	do Amaral, MCF; Lee, RE; Costanzo, JP				do Amaral, M. Clara F.; Lee, Richard E., Jr.; Costanzo, Jon P.			Enzymatic Regulation of Glycogenolysis in a Subarctic Population of the Wood Frog: Implications for Extreme Freeze Tolerance	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; RANA-SYLVATICA; PSEUDACRIS-TRISERIATA; CRYOPROTECTANT SYNTHESIS; ECTOTHERMIC VERTEBRATES; PHOSPHORYLASE ACTIVITY; GLUCOSE MOBILIZATION; LIVER-GLYCOGEN; CHORUS FROGS; COOLING RATE	The wood frog, Rana sylvatica, from Interior Alaska survives freezing at -16 degrees C, a temperature 10-13 degrees C below that tolerated by its southern conspecifics. We investigated the hepatic freezing response in this northern phenotype to determine if its profound freeze tolerance is associated with an enhanced glucosic cryoprotectant system. Alaskan frogs had a larger liver glycogen reserve that was mobilized faster during early freezing as compared to conspecifics from a cool-temperate region (southern Ohio, USA). In Alaskan frogs the rapid glucose production in the first hours of freezing was associated with a 7-fold increase in glycogen phosphorylase activity above unfrozen frog levels, and the activity of this enzyme was higher than that of frozen Ohioan frogs. Freezing of Ohioan frogs induced a more modest (4-fold) increase in glycogen phosphorylase activity above unfrozen frog values. Relative to the Ohioan frogs, Alaskan frogs maintained a higher total protein kinase A activity throughout an experimental freezing/thawing time course, and this may have potentiated glycogenolysis during early freezing. We found populational variation in the activity and protein level of protein kinase A which suggested that the Alaskan population had a more efficient form of this enzyme. Alaskan frogs modulated their glycogenolytic response by decreasing the activity of glycogen phosphorylase after cryoprotectant mobilization was well under way, thereby conserving their hepatic glycogen reserve. Ohioan frogs, however, sustained high glycogen phosphorylase activity until early thawing and consumed nearly all their liver glycogen. These unique hepatic responses of Alaskan R. sylvatica likely contribute to this phenotype's exceptional freeze tolerance, which is necessary for their survival in a subarctic climate.	[do Amaral, M. Clara F.; Lee, Richard E., Jr.; Costanzo, Jon P.] Miami Univ, Dept Zool, Oxford, OH 45056 USA	University System of Ohio; Miami University	do Amaral, MCF (corresponding author), Miami Univ, Dept Zool, Oxford, OH 45056 USA.	figueim@miamioh.edu			Portuguese Science and Technology Foundation (Fundacao para a Ciencia e Tecnologia, Ministerio da Educacao e Ciencia, Portugal) [SFRH/BD/63151/2009]; Sigma Xi [G20111015158541]; National Science Foundation [IOS1022788]	Portuguese Science and Technology Foundation (Fundacao para a Ciencia e Tecnologia, Ministerio da Educacao e Ciencia, Portugal); Sigma Xi; National Science Foundation(National Science Foundation (NSF))	This work was supported by the Portuguese Science and Technology Foundation (Fundacao para a Ciencia e Tecnologia, Ministerio da Educacao e Ciencia, Portugal) (SFRH/BD/63151/2009 to M. C. F. A.), Sigma Xi (G20111015158541 to M. C. F. A.) and the National Science Foundation (IOS1022788 to J. P. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdrakhamanova A, 2003, PLANT CELL PHYSIOL, V44, P676, DOI 10.1093/pcp/pcg097; Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; CLAUSSEN DL, 1991, AM J PHYSIOL, V261, pR626, DOI 10.1152/ajpregu.1991.261.3.R626; Costanzo JP, 2013, J EXP BIOL, V216, P3461, DOI 10.1242/jeb.089342; Costanzo JP, 2013, J EXP BIOL, V216, P1961, DOI 10.1242/jeb.070268; COSTANZO JP, 1993, CAN J ZOOL, V71, P71, DOI 10.1139/z93-011; COSTANZO JP, 1993, J EXP BIOL, V181, P245; COSTANZO JP, 1992, J EXP ZOOL, V261, P373, DOI 10.1002/jez.1402610403; COSTANZO JP, 1991, J COMP PHYSIOL B, V161, P225, DOI 10.1007/BF00262302; Cowan KJ, 2001, COMP BIOCHEM PHYS B, V130, P565, DOI 10.1016/S1096-4959(01)00467-5; CRERAR MM, 1988, BIOCHIM BIOPHYS ACTA, V971, P72, DOI 10.1016/0167-4889(88)90163-2; Dalton GD, 2006, NEUROPEPTIDES, V40, P23, DOI 10.1016/j.npep.2005.10.002; Dinsmore SC, 2008, CAN J ZOOL, V86, P1095, DOI 10.1139/Z08-088; Edwards JR, 2000, COMP BIOCHEM PHYS A, V125, P367, DOI 10.1016/S1095-6433(00)00168-9; Hemmings SJ, 1996, CELL BIOCHEM FUNCT, V14, P139, DOI 10.1002/cbf.661; HERREID CF, 1967, ECOLOGY, V48, P579; Hochachka P. W., 2002, BIOCH ADAPTATION MEC, DOI 10.1002/bmb.2002.494030030071; HOFFMANN RJ, 1981, BIOCHEM GENET, V19, P129, DOI 10.1007/BF00486143; Holden CP, 1996, AM J PHYSIOL-REG I, V271, pR1205, DOI 10.1152/ajpregu.1996.271.5.R1205; Holden CP, 1997, J COMP PHYSIOL B, V167, P305, DOI 10.1007/s003600050078; HOLDEN CP, 1993, J COMP PHYSIOL B, V163, P499; Holden CP, 2000, CRYOBIOLOGY, V40, P323, DOI 10.1006/cryo.2000.2252; Holmstrup M, 2007, SOIL BIOL BIOCHEM, V39, P2640, DOI 10.1016/j.soilbio.2007.05.018; Humphries KM, 2007, J BIOL CHEM, V282, P22072, DOI 10.1074/jbc.M702582200; Irwin JT, 2003, J EXP BIOL, V206, P2859, DOI 10.1242/jeb.00500; Jenkins JL, 2005, J THERM BIOL, V30, P485, DOI 10.1016/j.jtherbio.2005.05.008; JOHANSEN K, 1962, ECOLOGY, V43, P146, DOI 10.2307/1932056; Karege F, 2001, BRAIN RES, V903, P86, DOI 10.1016/S0006-8993(01)02409-X; KESSEL B, 1965, ECOLOGY, V46, P206, DOI 10.2307/1935277; Lang F, 2007, J AM COLL NUTR, V26, p613S, DOI 10.1080/07315724.2007.10719667; MacDonald JA, 1999, MAR BIOL, V133, P193, DOI 10.1007/s002270050458; Martof B. S., 1959, AM MIDL NAT, V61, P350, DOI [10.2307/2422506, DOI 10.2307/2422506]; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; MEHRANI H, 1995, MOL CELL BIOCHEM, V145, P81, DOI 10.1007/BF00925717; MERRITT RB, 1972, AM NAT, V106, P173, DOI 10.1086/282760; METZGER BE, 1968, BIOCHEMISTRY-US, V7, P2021, DOI 10.1021/bi00846a003; Middle LB, 2000, AM ZOOL, V40, P1132; MOMMSEN TP, 1986, CAN J ZOOL, V64, P1110, DOI 10.1139/z86-166; MOMMSEN TP, 1992, GEN COMP ENDOCR, V87, P44, DOI 10.1016/0016-6480(92)90148-D; Nick P, 2013, PLANT J, V75, P309, DOI 10.1111/tpj.12102; Pfister TD, 2006, INSECT BIOCHEM MOLEC, V36, P18, DOI 10.1016/j.ibmb.2005.10.002; POWERS DA, 1991, ANNU REV GENET, V25, P629; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schliess F, 2003, INT REV CYTOL, V225, P187, DOI 10.1016/S0074-7696(05)25005-2; Slotsbo S, 2008, CRYOBIOLOGY, V57, P286, DOI 10.1016/j.cryobiol.2008.09.010; STOREY KB, 1992, ANNU REV PHYSIOL, V54, P619, DOI 10.1146/annurev.physiol.54.1.619; STOREY KB, 1984, J COMP PHYSIOL B, V155, P29, DOI 10.1007/BF00688788; Storey KB, 2004, LIFE IN THE FROZEN STATE, P243, DOI 10.1201/9780203647073.ch7; Storey KB, 2004, CRYOBIOLOGY, V48, P134, DOI 10.1016/j.cryobiol.2003.10.008; STOREY KB, 1988, P NATL ACAD SCI USA, V85, P8350, DOI 10.1073/pnas.85.21.8350; STOREY KB, 1994, AM J PHYSIOL, V266, pR1477, DOI 10.1152/ajpregu.1994.266.5.R1477; STOREY KB, 1988, PHYSIOL REV, V68, P27, DOI 10.1152/physrev.1988.68.1.27; Swanson DL, 1996, J COMP PHYSIOL B, V166, P110, DOI 10.1007/BF00301174; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; VIJAYAN MM, 1994, GEN COMP ENDOCR, V96, P75, DOI 10.1006/gcen.1994.1160; Vornanen M, 2011, J COMP PHYSIOL B, V181, P917, DOI 10.1007/s00360-011-0580-4; Williams JB, 2008, J COMP PHYSIOL B, V178, P365, DOI 10.1007/s00360-007-0229-5; Zhang TF, 2012, CELL METAB, V15, P75, DOI 10.1016/j.cmet.2011.12.005	58	12	12	2	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79169	10.1371/journal.pone.0079169	http://dx.doi.org/10.1371/journal.pone.0079169			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236105	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700103
J	Flindall, JW; Gonzalez, CLR				Flindall, Jason W.; Gonzalez, Claudia L. R.			On the Evolution of Handedness: Evidence for Feeding Biases	PLOS ONE			English	Article							CHIMPANZEES PAN-TROGLODYTES; HUMAN PRECISION GRIP; HEMISPHERIC-SPECIALIZATION; PREHENSION MOVEMENTS; ACTION ORGANIZATION; MOUTH COORDINATION; KINEMATIC ANALYSIS; INFERIOR PARIETAL; VENTRAL PREMOTOR; MOTOR CORTEX	Many theories have been put forward to explain the origins of right-handedness in humans. Here we present evidence that this preference may stem in part from a right hand advantage in grasping for feeding. Thirteen participants were asked to reach-to-grasp food items of 3 different sizes: SMALL (CheeriosH), MEDIUM (Froot Loops (R)), and LARGE (Oatmeal Squares (R)). Participants used both their right-and left-hands in separate blocks (50 trials each, starting order counterbalanced) to grasp the items. After each grasp, participants either a) ate the food item, or b) placed it inside a bib worn beneath his/her chin (25 trials each, blocked design, counterbalanced). The conditions were designed such that the outward and inward movement trajectories were similar, differing only in the final step of placing it in the mouth or bib. Participants wore Plato liquid crystal goggles that blocked vision between trials. All trials were conducted in closed-loop with 5000 ms of vision. Hand kinematics were recorded by an Optotrak Certus, which tracked the position of three infrared diodes attached separately to the index finger, thumb, and wrist. We found a task (EAT/PLACE) by hand (LEFT/RIGHT) interaction on maximum grip aperture (MGA; the maximum distance between the index finger and thumb achieved during grasp pre-shaping). MGAs were smaller during right-handed movements, but only when grasping with intent to eat. Follow-up tests show that the RIGHT-HAND/EAT MGA was significantly smaller than all other hand/task conditions. Because smaller grip apertures are typically associated with greater precision, our results demonstrate a right-hand advantage for the grasp-to-eat movement. From an evolutionary perspective, early humans may have preferred the hand that could grasp food with more precision, thereby maximizing the likelihood of retrieval, consumption, and consequently, survival.	[Flindall, Jason W.; Gonzalez, Claudia L. R.] Univ Lethbridge, Dept Kinesiol & Phys Educ, Brain Act Lab, Lethbridge, AB T1K 3M4, Canada	University of Lethbridge	Flindall, JW (corresponding author), Univ Lethbridge, Dept Kinesiol & Phys Educ, Brain Act Lab, Lethbridge, AB T1K 3M4, Canada.	jason.flindall@uleth.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) [14367]; Canadian Foundation for Innovation (CFI) [45561]; Canada Research Chairs program; University of Lethbridge	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Canada Research Chairs program(Canada Research Chairs); University of Lethbridge	The current study was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC Fund # 14367), the Canadian Foundation for Innovation (CFI Fund # 45561), the Canada Research Chairs program, and the University of Lethbridge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansuini C, 2006, J NEUROPHYSIOL, V95, P2456, DOI 10.1152/jn.01107.2005; Ansuini C, 2008, EXP BRAIN RES, V185, P111, DOI 10.1007/s00221-007-1136-4; Armbruster C, 2006, MOTOR CONTROL, V10, P311, DOI 10.1123/mcj.10.4.311; Begliomini C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003388; Berthier NE, 1996, J MOTOR BEHAV, V28, P187, DOI 10.1080/00222895.1996.9941744; Binkofski F, 1998, NEUROLOGY, V50, P1253, DOI 10.1212/WNL.50.5.1253; Bonini L, 2012, J NEUROPHYSIOL, V108, P1607, DOI 10.1152/jn.01158.2011; Bonini L, 2010, CEREB CORTEX, V20, P1372, DOI 10.1093/cercor/bhp200; BOOTSMA RJ, 1994, EXP BRAIN RES, V98, P535; Borchers S, 2012, RECOGNITION EVERYDAY; Boulenger V, 2009, CEREB CORTEX, V19, P1905, DOI 10.1093/cercor/bhn217; Castiello U, 1998, PERCEPT PSYCHOPHYS, V60, P662, DOI 10.3758/BF03206053; Castiello U, 1998, EXP BRAIN RES, V123, P289, DOI 10.1007/s002210050571; Castiello U, 1997, EXP BRAIN RES, V115, P552, DOI 10.1007/PL00005726; Castiello U., 2000, COGN SYST RES, V1, P89, DOI [10.1016/S1389-0417(99)00011-X, DOI 10.1016/S1389-0417(99)00011-X]; Cochet H, 2012, DEV PSYCHOBIOL, V54, P105, DOI 10.1002/dev.20576; Corballis MC, 2003, BEHAV BRAIN SCI, V26, P199, DOI 10.1017/S0140525X03000062; CORNWELL KS, 1991, DEV NEUROPSYCHOL, V7, P19, DOI 10.1080/87565649109540475; Cox RFA, 2006, DEVELOPMENTAL SCI, V9, P628, DOI 10.1111/j.1467-7687.2006.00541.x; Culham JC, 2006, NEUROPSYCHOLOGIA, V44, P2668, DOI 10.1016/j.neuropsychologia.2005.11.003; Fagard J, 2000, DEVELOPMENTAL SCI, V3, P137, DOI 10.1111/1467-7687.00107; Ferri F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015855; Ferri F, 2010, EXP BRAIN RES, V203, P637, DOI 10.1007/s00221-010-2271-x; Flindall JW, 2012, MANUAL ASYMMETRIES K; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; FORSSBERG H, 1991, EXP BRAIN RES, V85, P451; FORSSBERG H, 1992, EXP BRAIN RES, V90, P393; Frey SH, 2005, COGNITIVE BRAIN RES, V23, P397, DOI 10.1016/j.cogbrainres.2004.11.010; Gallivan JP, 2011, J NEUROSCI, V31, P9599, DOI 10.1523/JNEUROSCI.0080-11.2011; Gallivan JP, 2009, J NEUROSCI, V29, P4381, DOI 10.1523/JNEUROSCI.0377-09.2009; GENTILUCCI M, 1994, EXP BRAIN RES, V99, P483; Gonzalez CLR, 2008, NEUROPSYCHOLOGIA, V46, P624, DOI 10.1016/j.neuropsychologia.2007.09.006; Gonzalez CLR, 2006, J NEUROPHYSIOL, V95, P3496, DOI 10.1152/jn.01187.2005; Gonzalez CLR, 2009, NEUROPSYCHOLOGIA, V47, P3182, DOI 10.1016/j.neuropsychologia.2009.07.019; Goodale M. A, 1990, VISION ACTION CONTRO; Graziano M, 2006, ANNU REV NEUROSCI, V29, P105, DOI 10.1146/annurev.neuro.29.051605.112924; Graziano MSA, 2005, J NEUROPHYSIOL, V94, P4209, DOI 10.1152/jn.01303.2004; Graziano MSA, 2004, EXP BRAIN RES, V155, P30, DOI 10.1007/s00221-003-1701-4; Grefkes C, 2005, J ANAT, V207, P3, DOI 10.1111/j.1469-7580.2005.00426.x; Grosskopf A, 2006, EXP BRAIN RES, V168, P230, DOI 10.1007/s00221-005-0083-1; Harvey M, 2001, BEHAV NEUROL, V13, P17; Hecaen H, 1971, Cortex, V7, P19; Hepper PG, 1998, NEUROPSYCHOLOGIA, V36, P531, DOI 10.1016/S0028-3932(97)00156-5; Hopkins B, 1998, DEV SENSORY MOTOR CO, P189; Hopkins WD, 2005, INT J PRIMATOL, V26, P259, DOI 10.1007/s10764-005-2924-y; Hopkins WD, 2002, J EXP PSYCHOL GEN, V131, P412, DOI 10.1037//0096-3445.131.3.412; Hopkins WD, 2011, J HUM EVOL, V60, P605, DOI 10.1016/j.jhevol.2010.12.008; Hu Y, 1999, EXP BRAIN RES, V126, P109, DOI 10.1007/s002210050720; Hu Y, 2000, J COGNITIVE NEUROSCI, V12, P856, DOI 10.1162/089892900562462; JAKOBSON LS, 1991, EXP BRAIN RES, V86, P199; Kaas JH, 2012, EUR J PHYS REHAB MED, V48, P299; Kaas JH, 2011, BRAIN BEHAV EVOLUT, V78, P5, DOI 10.1159/000327973; Knecht S, 2000, BRAIN, V123, P2512, DOI 10.1093/brain/123.12.2512; Leconte P, 2006, BRAIN COGNITION, V60, P88, DOI 10.1016/j.bandc.2005.09.009; Lew AR, 1997, INFANT BEHAV DEV, V20, P59, DOI 10.1016/S0163-6383(97)90061-8; LEWKOWICZ DJ, 1982, DEV PSYCHOL, V18, P301, DOI 10.1037/0012-1649.18.2.301; MacNeilage Peter F., 2007, Special Topics in Primatology, V5, P58; MACNEILAGE PF, 1987, BEHAV BRAIN SCI, V10, P247, DOI 10.1017/S0140525X00047695; MARTENIUK RG, 1987, CAN J PSYCHOL, V41, P365, DOI 10.1037/h0084157; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olivier E, 2007, CURR OPIN NEUROBIOL, V17, P644, DOI 10.1016/j.conb.2008.01.008; Parma V, 2011, EXP BRAIN RES, V212, P339, DOI 10.1007/s00221-011-2733-9; Parma V, 2011, APPETITE, V56, P249, DOI 10.1016/j.appet.2010.12.013; PETERS M, 1983, MANUAL SPECIALIZATIO, P367; Piaget J., 1953, ORIGIN INTELLIGENCE; Pouydebat E, 2011, BEHAV BRAIN RES, V218, P21, DOI 10.1016/j.bbr.2010.11.021; Pulvermuller F, 2005, NAT REV NEUROSCI, V6, P576, DOI 10.1038/nrn1706; Rogers LJ, 2002, ADV STUD BEHAV, V31, P107, DOI 10.1016/S0065-3454(02)80007-9; Sacrey LAR, 2012, DEV PSYCHOBIOLOGY; Sacrey LAR, 2012, INFANT BEHAV DEV, V35, P543, DOI 10.1016/j.infbeh.2012.05.006; Sartori L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025203; Schettino LF, 2003, EXP BRAIN RES, V151, P158, DOI 10.1007/s00221-003-1435-3; Schneiberg S, 2002, EXP BRAIN RES, V146, P142, DOI 10.1007/s00221-002-1156-z; Stone KD, 2012, EXPT BRAIN RES, P1; Stout D, 2009, CAMB ARCHAEOL J, V19, P85, DOI 10.1017/S0959774309000055; Szaflarski JP, 2002, NEUROLOGY, V59, P238, DOI 10.1212/WNL.59.2.238; Tretriluxana J, 2008, EXP BRAIN RES, V188, P305, DOI 10.1007/s00221-008-1364-2; Vauclair J, 2009, DEVELOPMENTAL SCI, V12, P1060, DOI 10.1111/j.1467-7687.2009.00850.x; Whishaw IQ, 2003, BEHAV BRAIN RES, V146, P31, DOI 10.1016/j.bbr.2003.09.027; Whishaw IQ, 2002, BEHAV BRAIN RES, V133, P165, DOI 10.1016/S0166-4328(01)00479-X; Whitwell RL, 2011, VISION RES, V51, P908, DOI 10.1016/j.visres.2011.02.005; WING AM, 1986, J MOTOR BEHAV, V18, P245; Wong JD, 2012, J NEUROPHYSIOL, V108, P3313, DOI 10.1152/jn.00122.2012	83	22	22	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78967	10.1371/journal.pone.0078967	http://dx.doi.org/10.1371/journal.pone.0078967			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236078	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700075
J	Gao, S; Hsieh, CL; Zhou, J; Shemshedini, L				Gao, Shuai; Hsieh, Chen-Lin; Zhou, Jun; Shemshedini, Lirim			Zinc Finger 280B Regulates sGC alpha 1 and p53 in Prostate Cancer Cells	PLOS ONE			English	Article							ANDROGEN RECEPTOR; COLORECTAL-CANCER; SIGNALING PATHWAY; MDM2; PROTEIN; ACTIVATION; PROGRESSION; EXPRESSION; APOPTOSIS; GENE	The Zinc Finger (ZNF) 280B protein was identified as an unexpected target of an shRNA designed for sGC alpha 1. Further analysis showed that these two proteins are connected in another way, with 280B up-regulation of sGC alpha 1 expression. Knock-down and over-expression experiments showed that 280B serves pro-growth and pro-survival functions in prostate cancer. Surprisingly however, these pro-cancer functions of 280B are not mediated by sGC alpha 1, which itself has similar functions in prostate cancer, but by down-regulated p53. The p53 protein is a second target of 280B in prostate cancer, but unlike sGC alpha 1, p53 is down-regulated by 280B. 280B induces p53 nuclear export, leading to subsequent proteasomal degradation. The protein responsible for p53 regulation by 280B is Mdm2, the E3 ubiquitin ligase that promotes p53 degradation by inducing its nuclear export. We show here that 280B up-regulates expression of Mdm2 in prostate cancer cells, and this regulation is via the Mdm2 promoter. To demonstrate an in vivo relevance to this interaction, expression studies show that 280B protein levels are up-regulated in prostate cancer and these levels correspond to reduced levels of p53. Thus, by enhancing the expression of Mdm2, the uncharacterized 280B protein provides a novel mechanism of p53 suppression in prostate cancer.	[Gao, Shuai; Hsieh, Chen-Lin; Zhou, Jun; Shemshedini, Lirim] Univ Toledo, Dept Biol Sci, Toledo, OH 43606 USA	University System of Ohio; University of Toledo	Shemshedini, L (corresponding author), Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA.	lshemsh@utnet.utoledo.edu		Gao, Shuai/0000-0002-7304-8801	National Institutes of Health (NIH) [R01CA127873-01A1]; NATIONAL CANCER INSTITUTE [R01CA127873] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by National Institutes of Health (NIH) R01CA127873-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achour M, 2009, BIOCHEM BIOPH RES CO, V390, P523, DOI 10.1016/j.bbrc.2009.09.131; Cai C, 2007, ONCOGENE, V26, P1606, DOI 10.1038/sj.onc.1209956; Cai C, 2007, PROSTATE CANCER P D, V10, P39, DOI 10.1038/sj.pcan.4500912; Cai CM, 2007, MOL ENDOCRINOL, V21, P1835, DOI 10.1210/me.2006-0480; Cai CM, 2007, MOL CANCER RES, V5, P725, DOI 10.1158/1541-7786.MCR-06-0430; Cai CM, 2012, MOL ENDOCRINOL, V26, P292, DOI 10.1210/me.2010-0394; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Cronauer MV, 2004, ONCOGENE, V23, P3541, DOI 10.1038/sj.onc.1207346; Dang DT, 2000, INT J BIOCHEM CELL B, V32, P1103, DOI 10.1016/S1357-2725(00)00059-5; Denninger JW, 1999, BBA-BIOENERGETICS, V1411, P334, DOI 10.1016/S0005-2728(99)00024-9; Eastham JA, 1995, CLIN CANCER RES, V1, P1111; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Gao S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064189; Gurova KV, 2002, ONCOGENE, V21, P153, DOI 10.1038/sj.onc.1205001; Hu RZ, 2011, CANCER RES, V71, P6524, DOI 10.1158/0008-5472.CAN-11-0853; Huang CX, 2007, EXP CELL RES, V313, P254, DOI 10.1016/j.yexcr.2006.10.009; Iijima K, 2012, EUR J IMMUNOL, V42, P3405, DOI 10.1002/eji.201242530; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Iuchi S, 2001, CELL MOL LIFE SCI, V58, P625, DOI 10.1007/PL00000885; Jackson JG, 2006, CANCER RES, V66, P8356, DOI 10.1158/0008-5472.CAN-06-1752; Kalkhoven E, 2002, MOL CELL BIOL, V22, P1961, DOI 10.1128/MCB.22.7.1961-1970.2002; KLUG A, 1995, FASEB J, V9, P597, DOI 10.1096/fasebj.9.8.7768350; Kobet E, 2000, P NATL ACAD SCI USA, V97, P12547, DOI 10.1073/pnas.97.23.12547; Kofunato Y, 2012, ONCOL REP, V28, P1997, DOI 10.3892/or.2012.2064; Kubbutat MHG, 1997, MOL CELL BIOL, V17, P460, DOI 10.1128/MCB.17.1.460; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Lei QY, 2006, CANCER CELL, V9, P367, DOI 10.1016/j.ccr.2006.03.031; Li J, 2007, BIOCHEM BIOPH RES CO, V363, P895, DOI 10.1016/j.bbrc.2007.08.180; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; Maki CG, 1999, J BIOL CHEM, V274, P16531, DOI 10.1074/jbc.274.23.16531; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Nie LH, 2007, J BIOL CHEM, V282, P14616, DOI 10.1074/jbc.M610515200; Osman I, 1999, CLIN CANCER RES, V5, P2082; Qian JQ, 2002, MODERN PATHOL, V15, P35, DOI 10.1038/modpathol.3880487; Razin SV, 2012, BIOCHEMISTRY-MOSCOW+, V77, P217, DOI 10.1134/S0006297912030017; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Shenk JL, 2001, J BIOL CHEM, V276, P38472, DOI 10.1074/jbc.M103652200; Slack A, 2005, P NATL ACAD SCI USA, V102, P731, DOI 10.1073/pnas.0405495102; Tian C, 2009, NAT CELL BIOL, V11, P580, DOI 10.1038/ncb1864; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; YANG CL, 1995, CANCER RES, V55, P4210; Yang L, 2008, CANCER RES, V68, P4321, DOI 10.1158/0008-5472.CAN-08-0407; Zhou MX, 2002, J PHARMACOL EXP THER, V303, P124, DOI 10.1124/jpet.102.037192	50	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78766	10.1371/journal.pone.0078766	http://dx.doi.org/10.1371/journal.pone.0078766			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236047	Green Submitted, Green Published, gold			2022-12-27	WOS:000327254700044
J	Nino, EL; Malka, O; Hefetz, A; Tarpy, DR; Grozinger, CM				Nino, Elina L.; Malka, Osnat; Hefetz, Abraham; Tarpy, David R.; Grozinger, Christina M.			Chemical Profiles of Two Pheromone Glands Are Differentially Regulated by Distinct Mating Factors in Honey Bee Queens (Apis mellifera L.)	PLOS ONE			English	Article							DUFOURS GLAND; GENETIC DIVERSITY; INSEMINATION QUANTITY; MANDIBULAR PHEROMONE; EGG-MARKING; COLONIES; EXPRESSION; FERTILITY; SECRETION; BEHAVIOR	Pheromones mediate social interactions among individuals in a wide variety of species, from yeast to mammals. In social insects such as honey bees, pheromone communication systems can be extraordinarily complex and serve to coordinate behaviors among many individuals. One of the primary mediators of social behavior and organization in honey bee colonies is queen pheromone, which is produced by multiple glands. The types and quantities of chemicals produced differ significantly between virgin and mated queens, and recent studies have suggested that, in newly mated queens, insemination volume or quantity can affect pheromone production. Here, we examine the long-term impact of different factors involved during queen insemination on the chemical composition of the mandibular and Dufour's glands, two of the major sources of queen pheromone. Our results demonstrate that carbon dioxide (an anesthetic used in instrumental insemination), physical manipulation of genital tract (presumably mimicking the act of copulation), insemination substance (saline vs. semen), and insemination volume (1 vs. 8 mu l) all have long-term effects on mandibular gland chemical profiles. In contrast, Dufour's gland chemical profiles were changed only upon insemination and were not influenced by exposure to carbon dioxide, manipulation, insemination substance or volume. These results suggest that the chemical contents of these two glands are regulated by different neuro-physiological mechanisms. Furthermore, workers responded differently to the different mandibular gland extracts in a choice assay. Although these studies must be validated in naturally mated queens of varying mating quality, our results suggest that while the chemical composition of Dufour's gland is associated with mating status, that of the mandibular glands is associated with both mating status and insemination success. Thus, the queen appears to be signaling both status and reproductive quality to the workers, which may impact worker behavior and physiology as well as social organization and productivity of the colony.	[Nino, Elina L.; Tarpy, David R.; Grozinger, Christina M.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Nino, Elina L.; Tarpy, David R.; Grozinger, Christina M.] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA; [Malka, Osnat; Hefetz, Abraham] Tel Aviv Univ, Dept Zool, Jerusalem, Israel; [Grozinger, Christina M.] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Tel Aviv University; University of North Carolina; North Carolina State University	Nino, EL (corresponding author), N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.	elnino@psu.edu	Hefetz, Abraham/I-3853-2015	Tarpy, David/0000-0001-8601-6094	United States Department of Agriculture-National Research Initiative [2006-35607-16625]; United States-Israel Binational Science Foundation [2007233]	United States Department of Agriculture-National Research Initiative(United States Department of Agriculture (USDA)); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation)	This research was supported by the United States Department of Agriculture-National Research Initiative grant 2006-35607-16625 to CMG and DRT, and Grant No. 2007233 from the United States-Israel Binational Science Foundation (BSF) to AH and CMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla F. C., 2001, Brazilian Journal of Biology, V61, P95, DOI 10.1590/S0034-71082001000100013; Al-Qarni Abdulaziz S., 2005, Saudi Journal of Biological Sciences, V12, P39; Al-Qarni AS, 2005, J KING SAUD U, V17, P125; Alaux C, 2011, J INVERTEBR PATHOL, V106, P380, DOI 10.1016/j.jip.2010.12.005; [Anonymous], 2014, PHEROMONES ANIMAL BE; Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823; Blomquist GJ, 2012, PHEROMONE PRODUCTION; Collins AM, 2004, J APICULT RES, V43, P128, DOI 10.1080/00218839.2004.11101123; Delaney DA, 2011, APIDOLOGIE, V42, P1, DOI 10.1051/apido/2010027; Dussaubat C, 2010, J CHEM ECOL, V36, P522, DOI 10.1007/s10886-010-9786-2; Endler A, 2006, BEHAV ECOL SOCIOBIOL, V59, P490, DOI 10.1007/s00265-005-0073-0; Fischer P, 2008, NATURWISSENSCHAFTEN, V95, P723, DOI 10.1007/s00114-008-0378-8; Furgala B, 1962, GLEANINGS BEE CULT, V90, P294; Gozansky Tamar Katzav, 1997, Invertebrate Neuroscience, V3, P239; Green K, 2009, ANIM BEHAV, V77, P887, DOI 10.1016/j.anbehav.2008.12.017; Grozinger CM, 2007, NATURWISSENSCHAFTEN, V94, P375, DOI 10.1007/s00114-006-0197-8; Grozinger CM, 2003, P NATL ACAD SCI USA, V100, P14519, DOI 10.1073/pnas.2335884100; HIGO HA, 1992, CAN ENTOMOL, V124, P409, DOI 10.4039/Ent124409-2; Hoover SER, 2005, BEHAV ECOL SOCIOBIOL, V59, P278, DOI 10.1007/s00265-005-0039-2; Hoover SER, 2003, NATURWISSENSCHAFTEN, V90, P477, DOI 10.1007/s00114-003-0462-z; Jaffe R, 2010, NATURWISSENSCHAFTEN, V97, P337, DOI 10.1007/s00114-009-0638-2; Johnson JN, 2010, J INSECT PHYSIOL, V56, P761, DOI 10.1016/j.jinsphys.2010.01.004; KAMINSKI LA, 1990, J CHEM ECOL, V16, P841, DOI 10.1007/BF01016494; KARLSON P, 1959, NATURE, V183, P55, DOI 10.1038/183055a0; Katzav-Gozansky T, 2003, INSECT SOC, V50, P20, DOI 10.1007/s000400300003; Katzav-Gozansky T, 2001, BEHAV ECOL SOCIOBIOL, V51, P76, DOI 10.1007/s002650100406; Katzav-Gozansky T, 2006, J COMP PHYSIOL A, V192, P737, DOI 10.1007/s00359-006-0110-0; KatzavGozansky T, 1997, NATURWISSENSCHAFTEN, V84, P238, DOI 10.1007/s001140050386; Keeling CI, 2003, P NATL ACAD SCI USA, V100, P4486, DOI 10.1073/pnas.0836984100; KELLER L, 1993, ANIM BEHAV, V45, P787, DOI 10.1006/anbe.1993.1092; KINGAN TG, 1993, J EXP BIOL, V183, P61; Kocher SD, 2011, J CHEM ECOL, V37, P1263, DOI 10.1007/s10886-011-0036-z; Kocher SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009116; Kocher SD, 2009, BEHAV ECOL, V20, P1007, DOI 10.1093/beheco/arp090; Kocher SD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-232; Kotwica J, 2006, J PHYSIOL PHARMACOL, V57, P107; Laidlaw HH., 1997, QUEEN REARING BEE BR; Landis GN, 2004, P NATL ACAD SCI USA, V101, P7663, DOI 10.1073/pnas.0307605101; Le Conte Y, 2008, ANNU REV ENTOMOL, V53, P523, DOI 10.1146/annurev.ento.52.110405.091434; Martin SJ, 2002, NATURWISSENSCHAFTEN, V89, P528, DOI 10.1007/s00114-002-0367-2; Mattila HR, 2007, SCIENCE, V317, P362, DOI 10.1126/science.1143046; Mitra A, 2011, NATURWISSENSCHAFTEN, V98, P157, DOI 10.1007/s00114-010-0749-9; Morgan SM, 1998, BEHAV BRAIN RES, V91, P115, DOI 10.1016/S0166-4328(97)00118-6; NAUMANN K, 1991, BEHAV ECOL SOCIOBIOL, V29, P321, DOI 10.1007/BF00165956; Nino EL, 2011, INSECT MOL BIOL, V20, P387, DOI 10.1111/j.1365-2583.2011.2011.01072.x; Nino EL, 2012, J INSECT PHYSIOL, V58, P1082, DOI 10.1016/j.jinsphys.2012.04.015; Oldroyd BP, 2007, TRENDS ECOL EVOL, V22, P408, DOI 10.1016/j.tree.2007.06.001; Ortius D, 1999, BEHAV ECOL SOCIOBIOL, V45, P151, DOI 10.1007/s002650050548; Pankiw T, 1998, J INSECT PHYSIOL, V44, P685, DOI 10.1016/S0022-1910(98)00040-7; PANKIW T, 1994, J INSECT BEHAV, V7, P1, DOI 10.1007/BF01989823; Pankiw T, 1996, J CHEM ECOL, V22, P605, DOI 10.1007/BF02033573; Park D, 2001, ENVIRON HEALTH PERSP, V109, P669, DOI 10.2307/3454782; Peso M, 2012, INSECT SOC, DOI [10.1007/s00040-012-0275-1: 1-11, DOI 10.1007/S00040-012-0275-1:1-11]; PETTIS JS, 1995, INSECT SOC, V42, P113, DOI 10.1007/BF01242447; Plettner E, 1997, J CHEM ECOL, V23, P363, DOI 10.1023/B:JOEC.0000006365.20996.a2; RATNIEKS FLW, 1995, J APICULT RES, V34, P31, DOI 10.1080/00218839.1995.11100883; RATNIEKS FLW, 1989, NATURE, V342, P796, DOI 10.1038/342796a0; Richard FJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000980; Richard FJ, 2011, J CHEM ECOL, V37, P1027, DOI 10.1007/s10886-011-9999-z; Schal C, 1998, AM ZOOL, V38, P382; Seeley TD, 2007, P ROY SOC B-BIOL SCI, V274, P67, DOI 10.1098/rspb.2006.3702; Slessor KN, 2005, J CHEM ECOL, V31, P2731, DOI 10.1007/s10886-005-7623-9; SLESSOR KN, 1988, NATURE, V332, P354, DOI 10.1038/332354a0; SLESSOR KN, 1990, J CHEM ECOL, V16, P851, DOI 10.1007/BF01016495; Strauss K, 2008, BEHAV ECOL SOCIOBIOL, V62, P1523, DOI 10.1007/s00265-008-0581-9; Tanaka ED, 2004, ARTHROPOD STRUCT DEV, V33, P431, DOI 10.1016/j.asd.2004.06.006; Tarpy DR, 2002, ANN ENTOMOL SOC AM, V95, P513, DOI 10.1603/0013-8746(2002)095[0513:SEEPAE]2.0.CO;2; Tarpy DR, 2006, NATURWISSENSCHAFTEN, V93, P195, DOI 10.1007/s00114-006-0091-4; Tarpy DR, 2003, P ROY SOC B-BIOL SCI, V270, P99, DOI 10.1098/rspb.2002.2199; Thomas ML, 2011, BIOL REV, V86, P1, DOI 10.1111/j.1469-185X.2010.00130.x; Wedell N, 2005, J EXP BIOL, V208, P3433, DOI 10.1242/jeb.01774; WILLIAMS JL, 1982, ANN ENTOMOL SOC AM, V75, P457, DOI 10.1093/aesa/75.4.457; WINSTON ML, 1989, INSECT SOC, V36, P15, DOI 10.1007/BF02225877; Wolfner MF, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001191; Wossler TC, 1999, J INSECT BEHAV, V12, P343, DOI 10.1023/A:1020839505622; Yang MX, 2010, APIDOLOGIE, V41, P54, DOI 10.1051/apido/2009047	76	24	26	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78637	10.1371/journal.pone.0078637	http://dx.doi.org/10.1371/journal.pone.0078637			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236028	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700025
J	Rivera, A; Weidberg, N; Pardinas, AF; Gonzalez-Gil, R; Garcia-Florez, L; Acuna, JL				Rivera, Antonella; Weidberg, Nicolas; Pardinas, Antonio F.; Gonzalez-Gil, Ricardo; Garcia-Florez, Lucia; Acuna, J. L.			Role of Upwelling on Larval Dispersal and Productivity of Gooseneck Barnacle Populations in the Cantabrian Sea: Management Implications	PLOS ONE			English	Article							POLLICIPES-POLLICIPES GMELIN; GENETIC-STRUCTURE; LIKELIHOOD-ESTIMATION; MAXIMUM-LIKELIHOOD; SEASCAPE GENETICS; MARINE RESERVE; SOUTHERN BAY; NW SPAIN; RECRUITMENT; PATTERNS	The effect of coastal upwelling on the recruitment and connectivity of coastal marine populations has rarely been characterized to a level of detail to be included into sound fishery management strategies. The gooseneck barnacle (Pollicipes pollicipes) fishery at the Cantabrian Coast (Northern Spain) is located at the fringes of the NW Spanish Upwelling system. This fishery is being co-managed through a fine-scale, interspersed set of protected rocks where each rock receives a distinct level of protection. Such interspersion is potentially beneficial, but the extent to which such spacing is consistent with mean larval dispersal distances is as yet unknown. We have simulated the spread of gooseneck barnacle larvae in the Central Cantabrian Coast using a high-resolution time-series of current profiles measured at a nearshore location. During a year of high upwelling activity (2009), theoretical recruitment success was 94% with peak recruitment predicted 56 km west of the emission point. However, for a year of low upwelling activity (2011) theoretical recruitment success dropped to 15.4% and peak recruitment was expected 13 km east of the emission point. This is consistent with a positive correlation between catch rates and the Integrated Upwelling Index, using a 4-year lag to allow recruits to reach commercial size. Furthermore, a net long-term westward larval transport was estimated by means of mitochondrial cytochrome c oxidase subunit I (COI) sequences for five populations in the Cantabrian Sea. Our results call into question the role of long distance dispersal, driven by the mesoscale processes in the area, in gooseneck barnacle populations and point to the prevalent role of small-scale, asymmetric connectivity more consistent with the typical scale of the co-management process in this fishery.	[Rivera, Antonella; Weidberg, Nicolas; Pardinas, Antonio F.; Gonzalez-Gil, Ricardo; Acuna, J. L.] Univ Oviedo, Dept Biol Organismos & Sistemas, Oviedo, Spain; [Garcia-Florez, Lucia] Consejeria Agroganaderia & Recursos Autoctonos, Ctr Expt Pesquera, Gijon, Spain	University of Oviedo	Rivera, A (corresponding author), Univ Oviedo, Dept Biol Organismos & Sistemas, Oviedo, Spain.	riveralidia@uniovi.es	Rivera, Antonella/AAM-7428-2021; Rivera, Antonella/I-5883-2016; Fernández, José Luis Acuña/I-7482-2016	Rivera, Antonella/0000-0001-8680-9115; Fernández, José Luis Acuña/0000-0003-3306-7212; Gonzalez-Gil, Ricardo/0000-0003-4377-317X; Pardinas, Antonio/0000-0001-6845-7590; Weidberg, Nicolas/0000-0001-5726-518X	Spanish Government through project COSTAS [CTM2006-05588/MAR]; Spanish Government through project DOSMARES [CTM2010-21810-C03-02]; Principality of Asturias Government through project FRENTES [IB08-122]; FPU [AP2010-5376, AP2008-03992]; AFP [BP09038]	Spanish Government through project COSTAS; Spanish Government through project DOSMARES; Principality of Asturias Government through project FRENTES; FPU(Spanish Government); AFP	This work was financed by the Spanish Government through projects COSTAS (CTM2006-05588/MAR, Ministry of Education and Science) and DOSMARES (CTM2010-21810-C03-02, Ministry of Science and Innovation), and by the Principality of Asturias Government through project FRENTES (IB08-122, FICYT). AR and RGG were supported by a FPU fellowship (ref. AP2010-5376 and AP2008-03992, respectively, Ministerio de Educacion de Espana) and AFP by a "Severo Ochoa" FICYT-PCTI fellowship (ref. BP09038, Asturias Regional Government). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto F, 2011, MOL ECOL, V20, P2543, DOI 10.1111/j.1365-294X.2011.05117.x; Bakun A., 1973, COASTAL UPWELLING IN; Bald J, 2006, ECOL MODEL, V194, P306, DOI 10.1016/j.ecolmodel.2005.10.024; Balloux F, 2010, HEREDITY, V104, P419, DOI 10.1038/hdy.2009.122; Banks SC, 2007, ECOLOGY, V88, P3055, DOI 10.1890/07-0091.1; Beerli P, 1999, GENETICS, V152, P763; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Beerli Peter, 2009, V17, P42; BERNARD FR, 1988, FISH RES, V6, P287, DOI 10.1016/0165-7836(88)90020-3; Bertsekas D. P., 2002, INTRO PROBABILITY, V1; Bode A, 1996, HYDROBIOLOGIA, V341, P225, DOI 10.1007/BF00014687; Borja A, 2006, ICES J MAR SCI, V63, P626, DOI 10.1016/j.icesjms.2005.12.008; BOTAS JA, 1990, ESTUAR COAST SHELF S, V30, P185, DOI 10.1016/0272-7714(90)90063-W; Campo D, 2010, MAR BIOL, V157, P147, DOI 10.1007/s00227-009-1305-z; CARLON DB, 1993, J EXP MAR BIOL ECOL, V173, P247, DOI 10.1016/0022-0981(93)90056-T; Castilla JC, 1998, ECOL APPL, V8, pS124, DOI 10.1890/1051-0761(1998)8[S124:SBFICO]2.0.CO;2; Costantini F, 2007, MAR ECOL PROG SER, V340, P109, DOI 10.3354/meps340109; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Cruz T, 1999, J CRUSTACEAN BIOL, V19, P260, DOI 10.2307/1549232; Cruz T., 2000, BIOL ECOLOGIA PERCEB; Cruz T, 2010, J EXP MAR BIOL ECOL, V392, P200, DOI 10.1016/j.jembe.2010.04.020; De La Hoz J.J., 1993, Publicaciones Especiales Instituto Espanol de Oceanografia, V11, P65; Domingues CP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035794; FARRELL TM, 1991, LIMNOL OCEANOGR, V36, P279, DOI 10.4319/lo.1991.36.2.0279; FERNANDEZ E, 1993, J PLANKTON RES, V15, P619, DOI 10.1093/plankt/15.6.619; Gaines SD, 2003, ECOL APPL, V13, pS32; Gelman A, 1998, STAT SCI, V13, P163; Hastings A, 2003, ECOL APPL, V13, pS65; Haynes R, 1990, POLEWARD FLOW ATLANT; Hey J, 2003, NAT REV GENET, V4, P535, DOI 10.1038/nrg1112; Isla JA, 2004, ICES J MAR SCI, V61, P526, DOI 10.1016/j.icesjms.2004.03.014; Jacinto D, 2010, ICES J MAR SCI, V67, P19, DOI 10.1093/icesjms/fsp226; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kirincich AR, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002611; Largier JL, 2003, ECOL APPL, V13, pS71; Legendre P., 2012, NUMERICAL ECOLOGY; Lentz SJ, 2004, J PHYS OCEANOGR, V34, P2444, DOI 10.1175/JPO2644.1; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Levins R, 1970, LECT NOTES MATH, P275; LINDLEY JA, 1994, MAR BIOL, V120, P385, DOI 10.1007/BF00680212; Llope M, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC002963; Macho G, 2006, THESIS U VIGO; Metaxas A, 2009, BIOL BULL-US, V216, P257, DOI 10.1086/BBLv216n3p257; Mills LS, 1996, CONSERV BIOL, V10, P1509, DOI 10.1046/j.1523-1739.1996.10061509.x; Molares J, 2003, FISH RES, V65, P485, DOI 10.1016/j.fishres.2003.09.034; MOLARES J, 1994, MAR BIOL, V120, P261, DOI 10.1007/BF00349686; Morgan SG, 2009, ECOLOGY, V90, P3489, DOI 10.1890/08-1550.1; NATH HB, 1993, J MATH BIOL, V31, P841, DOI 10.1007/BF00168049; Nielsen R, 2001, GENETICS, V158, P885; Nolasco R, 2013, MAR ECOL PROG SER, V485, P123, DOI 10.3354/meps10324; Orensanz J. M., 1998, Canadian Special Publication of Fisheries and Aquatic Sciences, V125, P441; Orensanz J.M. Lobo, 2006, Developments in Aquaculture and Fisheries Science, V35, P765; Pavon MC, 2003, THESIS U OVIEDO OVIE; Pineda J, 2002, CONT SHELF RES, V22, P1183, DOI 10.1016/S0278-4343(01)00098-X; PINGREE RD, 1992, DEEP-SEA RES, V39, P1147, DOI 10.1016/0198-0149(92)90062-X; Quinteiro J, 2007, MAR BIOL, V153, P47, DOI 10.1007/s00227-007-0783-0; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; ROUGHGARDEN J, 1988, SCIENCE, V241, P1460, DOI 10.1126/science.11538249; Selkoe KA, 2008, FISH FISH, V9, P363, DOI 10.1111/j.1467-2979.2008.00300.x; Selkoe KA, 2010, MOL ECOL, V19, P3708, DOI 10.1111/j.1365-294X.2010.04658.x; Sestelo M, 2011, J SHELLFISH RES, V30, P939, DOI 10.2983/035.030.0336; Siegel DA, 2003, MAR ECOL PROG SER, V260, P83, DOI 10.3354/meps260083; Sotka EE, 2006, ECOLOGY, V87, P1094, DOI 10.1890/0012-9658(2006)87[1094:TUOGCT]2.0.CO;2; Tapia FJ, 2010, ESTUAR COAST SHELF S, V86, P265, DOI 10.1016/j.ecss.2009.11.003; Thompson J, 1978, UPWELLING ECOSYSTEMS, P203; Valde L, 2007, PROG OCEANOGR, V74, P98, DOI 10.1016/j.pocean.2007.04.016; Varela RA, 2005, J MARINE SYST, V54, P97, DOI 10.1016/j.jmarsys.2004.07.006; Watson JR, 2011, ECOLOGY, V92, P1193, DOI 10.1890/10-1436.1; Weidberg N, 2013, J EXP MAR BIOL ECOL, V442, P47, DOI 10.1016/j.jembe.2013.01.028; White JW, 2010, MAR ECOL PROG SER, V398, P49, DOI 10.3354/meps08327; Wolanski E., 1994, PHYS OCEANOGRAPHIC P; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Wood SN, 2003, J ROY STAT SOC B, V65, P95, DOI 10.1111/1467-9868.00374; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	75	15	15	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78482	10.1371/journal.pone.0078482	http://dx.doi.org/10.1371/journal.pone.0078482			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236020	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700017
J	Sahle, Y; Hutchings, WK; Braun, DR; Sealy, JC; Morgan, LE; Negash, A; Atnafu, B				Sahle, Yonatan; Hutchings, W. Karl; Braun, David R.; Sealy, Judith C.; Morgan, Leah E.; Negash, Agazi; Atnafu, Balemwal			Earliest Stone-Tipped Projectiles from the Ethiopian Rift Date to > 279,000 Years Ago	PLOS ONE			English	Article							PLEISTOCENE HOMO-SAPIENS; RED-SEA COAST; MIDDLE AWASH; COMPLEX COGNITION; KIBISH FORMATION; DECAY CONSTANTS; KLASIES-RIVER; MODERN HUMANS; SOUTH-AFRICA; VARIABILITY	Projectile weapons (i.e. those delivered from a distance) enhanced prehistoric hunting efficiency by enabling higher impact delivery and hunting of a broader range of animals while reducing confrontations with dangerous prey species. Projectiles therefore provided a significant advantage over thrusting spears. Composite projectile technologies are considered indicative of complex behavior and pivotal to the successful spread of Homo sapiens. Direct evidence for such projectiles is thus far unknown from >80,000 years ago. Data from velocity-dependent microfracture features, diagnostic damage patterns, and artifact shape reported here indicate that pointed stone artifacts from Ethiopia were used as projectile weapons (in the form of hafted javelin tips) as early as >279,000 years ago. In combination with the existing archaeological, fossil and genetic evidence, these data isolate eastern Africa as a source of modern cultures and biology.	[Sahle, Yonatan; Braun, David R.; Sealy, Judith C.] Univ Cape Town, Dept Archaeol, ZA-7925 Cape Town, South Africa; [Hutchings, W. Karl] Thompson Rivers Univ, Dept Sociol & Anthropol, Kamloops, BC, Canada; [Braun, David R.] George Washington Univ, Dept Anthropol, Washington, DC USA; [Morgan, Leah E.] Scottish Univ Environm Res Ctr, E Kilbride, Lanark, Scotland; [Negash, Agazi] Univ Addis Ababa, Paleoanthropol & Paleoenvironm Program, Addis Ababa, Ethiopia; [Atnafu, Balemwal] Univ Addis Ababa, Dept Earth Sci, Addis Ababa, Ethiopia	University of Cape Town; George Washington University; Scottish Universities Research & Reactor Center; Addis Ababa University; Addis Ababa University	Sahle, Y (corresponding author), Univ Calif Berkeley, Human Evolut Res Ctr, Berkeley, CA 94720 USA.	yonatan.chemere@uct.ac.za		Sealy, Judith/0000-0001-5071-8211; Sahle, Yonatan/0000-0003-1098-1685; Morgan, Leah/0000-0001-9930-524X	University of Cape Town's Center for African Origins initiative; Paleontological Scientific Trust (Scatterlings of Africa Program); Wenner-Gren Foundation; Marie Curie Fellowship program; NERC [aif10001] Funding Source: UKRI; Natural Environment Research Council [aif10001] Funding Source: researchfish	University of Cape Town's Center for African Origins initiative; Paleontological Scientific Trust (Scatterlings of Africa Program); Wenner-Gren Foundation; Marie Curie Fellowship program(European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	University of Cape Town's Center for African Origins initiative and the Paleontological Scientific Trust (Scatterlings of Africa Program) financially supported research. Wenner-Gren Foundation supported YS's doctoral study. The Marie Curie Fellowship program supported LEM's post-doctoral study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basell LS, 2008, QUATERNARY SCI REV, V27, P2484, DOI 10.1016/j.quascirev.2008.09.010; Beyin A, 2013, QUATERN INT, V300, P195, DOI 10.1016/j.quaint.2013.02.015; Boeda E, 1999, ANTIQUITY, V73, P394, DOI 10.1017/S0003598X00088335; Brooks A, MULTIDISCIP IN PRESS; Brooks AS, 2006, INTERD CONTRIB ARCH, P233, DOI 10.1007/0-387-24661-4_13; Brown FH, 2012, J HUM EVOL, V63, P577, DOI 10.1016/j.jhevol.2012.05.014; Brown KS, 2012, NATURE, V491, P590, DOI 10.1038/nature11660; Brown KS, 2009, SCIENCE, V325, P859, DOI 10.1126/science.1175028; Churchill SE, 2009, VERTEBR PALEOBIOL PA, P201, DOI 10.1007/978-1-4020-9699-0_15; Clark JD, 2003, NATURE, V423, P747, DOI 10.1038/nature01670; COTTERELL B, 1987, AM ANTIQUITY, V52, P675, DOI 10.2307/281378; Fischer A., 1984, J DAN ARCHAEOL, V3, P19, DOI DOI 10.1080/0108464X.1984.10589910; Fisher SE, 2013, SCIENCE, V340, P929, DOI 10.1126/science.1236171; Haynes C.V., 1980, CAN J ANTHROPOL, V1, P115; Henshilwood CS, 2011, SCIENCE, V334, P219, DOI 10.1126/science.1211535; Hutchings WK, 2011, J ARCHAEOL SCI, V38, P1737, DOI 10.1016/j.jas.2011.03.005; Iovita R, 2014, J ARCHAEOL SCI, V48, P73, DOI 10.1016/j.jas.2013.01.031; Klein R., 2002, DAWN HUMAN CULTURE; Kurashina H., 1978, EXAMINATION PREHISTO; Lahr MM, 1998, YEARB PHYS ANTHROPOL, V41, P137; Lombard M, 2012, CAMB ARCHAEOL J, V22, P237, DOI 10.1017/S095977431200025X; Lombard M, 2010, ANTIQUITY, V84, P635, DOI 10.1017/S0003598X00100134; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; McDougall I, 2005, NATURE, V433, P733, DOI 10.1038/nature03258; Milo RG, 1998, J ARCHAEOL SCI, V25, P99, DOI 10.1006/jasc.1997.0233; Morgan LE, 2008, GEOLOGY, V36, P967, DOI 10.1130/G25213A.1; Negash A., 2010, SINET ETHIOP J SCI, V33, P21; Negash A, 2011, ARCHAEOMETRY, V53, P661, DOI 10.1111/j.1475-4754.2010.00579.x; Newman K, 2013, J ARCHAEOL SCI, V40, P2614, DOI 10.1016/j.jas.2013.01.023; Pargeter J, 2013, J ARCHAEOL SCI, V40, P4056, DOI 10.1016/j.jas.2013.05.021; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; Ravi-Chandar K, 2004, DYNAMIC FRACTURE; Renne PR, 2011, GEOCHIM COSMOCHIM AC, V75, P5097, DOI 10.1016/j.gca.2011.06.021; Roach NT, 2013, NATURE, V498, P483, DOI 10.1038/nature12267; Rose JI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028239; Rots V, 2011, J HUM EVOL, V60, P637, DOI 10.1016/j.jhevol.2011.01.001; Sahle Y, 2014, QUATERN INT, V331, P6, DOI 10.1016/j.quaint.2013.03.010; Sano K., 2009, QUARTAR, V56, P67; Shea J, 2001, J ARCHAEOL SCI, V28, P807, DOI 10.1006/jasc.2000.0590; Shea J.J., 2010, PALAEOANTHROPOLOGY, V2010, P100; Shea JJ, 2006, J ARCHAEOL SCI, V33, P823, DOI 10.1016/j.jas.2005.10.015; Shea JJ, 2008, J HUM EVOL, V55, P448, DOI 10.1016/j.jhevol.2008.05.014; Shea JJ, 2012, CURR ANTHROPOL, V53, P130, DOI 10.1086/663334; Shea JJ, 2011, CURR ANTHROPOL, V52, P1, DOI 10.1086/658067; Sisk Matthew L, 2011, Int J Evol Biol, V2011, P968012, DOI 10.4061/2011/968012; Soares P, 2012, MOL BIOL EVOL, V29, P915, DOI 10.1093/molbev/msr245; STEIGER RH, 1977, EARTH PLANET SC LETT, V36, P359, DOI 10.1016/0012-821X(77)90060-7; Thieme H, 1997, NATURE, V385, P807, DOI 10.1038/385807a0; Tomenchuk, 1985, THESIS U TORONTO TOR; Villa P, 2009, J ARCHAEOL SCI, V36, P850, DOI 10.1016/j.jas.2008.11.012; Vogel N, 2006, J ARCHAEOL SCI, V33, P1749, DOI 10.1016/j.jas.2006.03.008; Wadley L, 2013, CAMB ARCHAEOL J, V23, P163, DOI 10.1017/S0959774313000309; Wadley L, 2009, P NATL ACAD SCI USA, V106, P9590, DOI 10.1073/pnas.0900957106; Walter RC, 2000, NATURE, V405, P65, DOI 10.1038/35011048; WENDORF F, 1993, QUATERNARIA NOVA, V3, P39; Wendorf F., 1974, MIDDLE STONE AGE SEQ; White TD, 2003, NATURE, V423, P742, DOI 10.1038/nature01669; Wilkins J, 2012, SCIENCE, V338, P942, DOI 10.1126/science.1227608; Wurz S, 2002, J ARCHAEOL SCI, V29, P1001, DOI 10.1006/jasc.2001.0799; Wynn T, 2009, P NATL ACAD SCI USA, V106, P9544, DOI 10.1073/pnas.0904369106; Yellen John, 2005, Paleoanthropology, V3, P25; Yotova V, 2007, HUM GENET, V122, P431, DOI 10.1007/s00439-007-0413-4; Zilhao J, 2010, P NATL ACAD SCI USA, V107, P1023, DOI 10.1073/pnas.0914088107	63	68	70	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78092	10.1371/journal.pone.0078092	http://dx.doi.org/10.1371/journal.pone.0078092			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	255QK	24236011	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000327254700008
J	Shu, CC; Chatterjee, A; Hu, WS; Ramkrishna, D				Shu, Che-Chi; Chatterjee, Anushree; Hu, Wei-Shou; Ramkrishna, Doraiswami			Role of Intracellular Stochasticity in Biofilm Growth. Insights from Population Balance Modeling	PLOS ONE			English	Article							FAECALIS PLASMID PCF10; PHEROMONE-INDUCIBLE CONJUGATION; CELLULAR-AUTOMATON APPROACH; ENTEROCOCCUS-FAECALIS; GENE-EXPRESSION; STEADY-STATE; ANTIBIOTIC-RESISTANCE; AGGREGATION SUBSTANCE; BACTERIAL PHEROMONE; PERSISTER CELLS	There is increasing recognition that stochasticity involved in gene regulatory processes may help cells enhance the signal or synchronize expression for a group of genes. Thus the validity of the traditional deterministic approach to modeling the foregoing processes cannot be without exception. In this study, we identify a frequently encountered situation, i.e., the biofilm, which has in the past been persistently investigated with intracellular deterministic models in the literature. We show in this paper circumstances in which use of the intracellular deterministic model appears distinctly inappropriate. In Enterococcus faecalis, the horizontal gene transfer of plasmid spreads drug resistance. The induction of conjugation in planktonic and biofilm circumstances is examined here with stochastic as well as deterministic models. The stochastic model is formulated with the Chemical Master Equation (CME) for planktonic cells and Reaction-Diffusion Master Equation (RDME) for biofilm. The results show that although the deterministic model works well for the perfectly-mixed planktonic circumstance, it fails to predict the averaged behavior in the biofilm, a behavior that has come to be known as stochastic focusing. A notable finding from this work is that the interception of antagonistic feedback loops to signaling, accentuates stochastic focusing. Moreover, interestingly, increasing particle number of a control variable could lead to an even larger deviation. Intracellular stochasticity plays an important role in biofilm and we surmise by implications from the model, that cell populations may use it to minimize the influence from environmental fluctuation.	[Shu, Che-Chi; Ramkrishna, Doraiswami] Purdue Univ, Sch Chem Engn, W Lafayette, IN 47907 USA; [Chatterjee, Anushree; Hu, Wei-Shou] Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Minnesota System; University of Minnesota Twin Cities	Ramkrishna, D (corresponding author), Purdue Univ, Sch Chem Engn, W Lafayette, IN 47907 USA.	ramkrish@purdue.edu		Shu, Che-Chi/0000-0002-6930-1050	National Institutes of Health [GM081888]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (GM081888) to WSH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARVIN E, 1990, WATER SCI TECHNOL, V22, P171, DOI 10.2166/wst.1990.0145; Bae T, 2004, MOL MICROBIOL, V51, P271, DOI 10.1046/j.1365-2958.2003.03832.x; Baras F, 1996, PHYS REV E, V54, P6139, DOI 10.1103/PhysRevE.54.6139; Bensing BA, 1997, MOL MICROBIOL, V24, P295, DOI 10.1046/j.1365-2958.1997.3311709.x; Bradie B, 2006, FRIENDLY INTRO NUMER; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Cao Y, 2006, J CHEM PHYS, P124; Chambless JD, 2006, APPL ENVIRON MICROB, V72, P2005, DOI 10.1128/AEM.72.3.2005-2013.2006; Chatterjee A, 2013, P NATL ACAD SCI USA, V110, P7086, DOI 10.1073/pnas.1212256110; Chatterjee A, 2011, P NATL ACAD SCI USA, V108, P9721, DOI 10.1073/pnas.1101569108; Chuang ON, 2009, INFECT IMMUN, V77, P539, DOI 10.1128/IAI.01034-08; CHUNG JW, 1995, J BACTERIOL, V177, P2118, DOI 10.1128/jb.177.8.2118-2124.1995; Cook L, 2011, MOL MICROBIOL, V81, P1499, DOI 10.1111/j.1365-2958.2011.07786.x; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Dillon R, 1996, J COMPUT PHYS, V129, P57, DOI 10.1006/jcph.1996.0233; Dunny GM, 2007, PHILOS T R SOC B, V362, P1185, DOI 10.1098/rstb.2007.2043; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Fixen KR, 2007, J BACTERIOL, V189, P1399, DOI 10.1128/JB.01226-06; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Hirt H, 2005, J BACTERIOL, V187, P1044, DOI 10.1128/JB.187.3.1044-1054.2005; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Johnson CM, 2010, J BACTERIOL, V192, P1634, DOI 10.1128/JB.01525-09; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Karmakar R, 2007, PHYS BIOL, V4, P29, DOI 10.1088/1478-3975/4/1/004; Kaufmann BB, 2007, CURR OPIN GENET DEV, V17, P107, DOI 10.1016/j.gde.2007.02.007; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Kozlowicz BK, 2006, INT J MED MICROBIOL, V296, P141, DOI 10.1016/j.ijmm.2006.01.040; Kozlowicz BK, 2004, MOL MICROBIOL, V54, P520, DOI 10.1111/j.1365-2958.2004.04286.x; Kozlowicz BK, 2006, MOL MICROBIOL, V62, P958, DOI 10.1111/j.1365-2958.2006.05434.x; Kreft JU, 2001, MICROBIOL-SGM, V147, P2897, DOI 10.1099/00221287-147-11-2897; Kristich CJ, 2004, J BACTERIOL, V186, P154, DOI 10.1128/JB.186.1.154-163.2004; Leonard BAB, 1996, P NATL ACAD SCI USA, V93, P260, DOI 10.1073/pnas.93.1.260; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Licht TR, 1999, MICROBIOL-SGM, V145, P2615, DOI 10.1099/00221287-145-9-2615; Paulsson J, 2000, P NATL ACAD SCI USA, V97, P7148, DOI 10.1073/pnas.110057697; Picioreanu C, 2000, BIOTECHNOL BIOENG, V69, P504, DOI 10.1002/1097-0290(20000905)69:5<504::AID-BIT5>3.0.CO;2-S; Picioreanu C, 1998, BIOTECHNOL BIOENG, V57, P718, DOI 10.1002/(SICI)1097-0290(19980320)57:6<718::AID-BIT9>3.0.CO;2-O; Picioreanu C, 2004, APPL ENVIRON MICROB, V70, P3024, DOI 10.1128/AEM.70.5.3024-3040.2004; Picioreanu C, 1998, BIOTECHNOL BIOENG, V58, P101, DOI 10.1002/(SICI)1097-0290(19980405)58:1<101::AID-BIT11>3.0.CO;2-M; Ramkrishna D., 2000, POPULATION BALANCES; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Rao CV, 2003, J CHEM PHYS, V118, P4999, DOI 10.1063/1.1545446; RITTMANN BE, 1980, BIOTECHNOL BIOENG, V22, P2343, DOI 10.1002/bit.260221110; RITTMANN BE, 1992, BIOTECHNOL BIOENG, V39, P914, DOI 10.1002/bit.260390906; Russell DF, 1999, NATURE, V402, P291, DOI 10.1038/46279; Samoilov MS, 2006, NAT BIOTECHNOL, V24, P1235, DOI 10.1038/nbt1253; SHAH BH, 1977, AICHE J, V23, P897, DOI 10.1002/aic.690230617; Shi K., 2005, Abstracts of the General Meeting of the American Society for Microbiology, V105, P307; Shu CC, 2012, CHEM ENG SCI, V70, P188, DOI 10.1016/j.ces.2011.07.062; Shu CC, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002140; Stewart PS, 1998, BIOTECHNOL BIOENG, V59, P261, DOI 10.1002/(SICI)1097-0290(19980805)59:3<261::AID-BIT1>3.0.CO;2-9; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; van Loosdrecht MCM, 2002, ANTON LEEUW INT J G, V81, P245, DOI 10.1023/A:1020527020464; VanKampen NG, 2007, NORTH-HOLL PERS LIBR, P1; WANNER O, 1986, BIOTECHNOL BIOENG, V28, P314, DOI 10.1002/bit.260280304; Waters CM, 2004, MOL MICROBIOL, V52, P1159, DOI 10.1111/j.1365-2958.2004.04045.x; WIESENFELD K, 1995, NATURE, V373, P33, DOI 10.1038/373033a0; Wilkinson DJ, 2009, NAT REV GENET, V10, P122, DOI 10.1038/nrg2509; Wimpenny JWT, 1997, FEMS MICROBIOL ECOL, V22, P1, DOI 10.1111/j.1574-6941.1997.tb00351.x	66	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79196	10.1371/journal.pone.0079196	http://dx.doi.org/10.1371/journal.pone.0079196			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24232571	gold, Green Published, Green Submitted			2022-12-27	WOS:000327254700105
J	Shutto, Y; Shimada, M; Kitajima, M; Yamabe, H; Saitoh, Y; Saitoh, H; Razzaque, MS				Shutto, Yoshiko; Shimada, Michiko; Kitajima, Maiko; Yamabe, Hideaki; Saitoh, Yoko; Saitoh, Hisao; Razzaque, Mohammed S.			Inadequate Awareness among Chronic Kidney Disease Patients Regarding Food and Drinks Containing Artificially Added Phosphate	PLOS ONE			English	Article							SOFT-TISSUE CALCIFICATION; SERUM PHOSPHATE; CARDIOVASCULAR-DISEASE; GENETIC-EVIDENCE; METABOLISM; RISK; MORTALITY; CALCIUM; HOMEOSTASIS; TOXICITY	Hyperphosphatemia is an important determinant of morbidity and mortality in patients with chronic kidney disease (CKD). Patients with CKD are advised to consume a low phosphate diet and are often prescribed phosphate-lowering drug therapy. However, commercially processed food and drinks often contain phosphate compounds, but the phosphate level is not usually provided in the ingredient list, which makes it difficult for CKD patients to choose a correct diet. We conducted a survey of the awareness of food/beverages containing artificially added phosphate among CKD patients undergoing hemodialysis. The subjects were 153 patients (77 males and 76 females; average age 56611 years) who were randomly selected from the Dialysis Center of Hirosaki City, Japan. The subjects were provided with a list of questions. The survey results showed that 93% of the subjects were aware of the presence of high sugar content in soda, whereas only 25% were aware of the presence of phosphate (phosphoric acid) in such drinks. Despite 78% of the subjects being aware of the detrimental effects of consumption of a high phosphate diet, 43% drank at least 1 to 5 cans of soda per week and about 17% consumed "fast food" once each week. We also assessed the immediate effects of high-phosphate containing carbonated soda consumption by determining urinary calcium, phosphate, protein and sugar contents in overnight fasted healthy volunteers (n = 55; average age 20.7+/-60.3 years old, 20 males and 35 females). Significantly higher urinary calcium (adjusted using urinary creatinine) excretion was found 2 h after consuming 350 ml of carbonated soda compared to the fasting baseline level (0.156+/-0.01 vs. 0.096+/-0.01, p = 0.001). Our survey results suggest that CKD patients undergoing hemodialysis are not adequately aware of the hidden source of phosphate in their diet, and emphasize the need for educational initiatives to raise awareness of this issue among CKD patients.	[Shutto, Yoshiko] Hirosaki Univ, Grad Sch Hlth Sci, Dept Hlth Promot, Hirosaki, Aomori, Japan; [Shimada, Michiko; Kitajima, Maiko; Yamabe, Hideaki] Hirosaki Univ, Grad Sch Med, Dept Cardiol Resp Med & Nephrol, Hirosaki, Aomori, Japan; [Saitoh, Yoko; Saitoh, Hisao] Hirosaki Hosp, Oyokyo Kidney Res Inst, Hirosaki, Aomori, Japan; [Razzaque, Mohammed S.] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA	Hirosaki University; Hirosaki University; Harvard University; Harvard School of Dental Medicine	Razzaque, MS (corresponding author), Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, 188 Longwood Ave, Boston, MA 02115 USA.	mrazzaque@hms.harvard.edu	Razzaque, Mohammed S./K-4282-2019		National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlenstiel T, 2010, NEPHROL DIAL TRANSPL, V25, P3241, DOI 10.1093/ndt/gfq161; Barsoum RS, 2006, NEW ENGL J MED, V354, P997, DOI 10.1056/NEJMp058318; Block G, 2003, SEMIN DIALYSIS, V16, P140, DOI 10.1046/j.1525-139X.2003.160301.x; Econs MJ, 1999, BONE, V25, P131, DOI 10.1016/S8756-3282(99)00108-8; Eddington H, 2010, CLIN J AM SOC NEPHRO, V5, P2251, DOI 10.2215/CJN.00810110; Fukagawa M, 2006, J BONE MINER METAB, V24, P434, DOI 10.1007/s00774-006-0719-7; Hruska K, 2011, KIDNEY INT, V79, pS9, DOI 10.1038/ki.2011.24; Kanbay M, 2009, BLOOD PURIFICAT, V27, P220, DOI 10.1159/000197562; Kestenbaum B, 2005, J AM SOC NEPHROL, V16, P520, DOI 10.1681/ASN.2004070602; Ketteler M, 2009, BLOOD PURIFICAT, V27, P345, DOI 10.1159/000209247; Molony DA, 2011, ADV CHRONIC KIDNEY D, V18, P120, DOI 10.1053/j.ackd.2011.02.004; Nakatani T, 2009, FASEB J, V23, P3702, DOI 10.1096/fj.08-123992; Nakatani T, 2009, FASEB J, V23, P433, DOI 10.1096/fj.08-114397; Ohnishi M, 2010, FASEB J, V24, P3562, DOI 10.1096/fj.09-152488; Ohnishi M, 2009, CIRC-CARDIOVASC GENE, V2, P583, DOI 10.1161/CIRCGENETICS.108.847814; Ohnishi M, 2009, KIDNEY INT, V75, P1166, DOI 10.1038/ki.2009.24; Osuka S, 2012, J BONE MINER METAB, V30, P10, DOI 10.1007/s00774-011-0343-z; Razzaque MS, 2011, KIDNEY INT, V79, P708, DOI 10.1038/ki.2010.432; Razzaque MS, 2011, CLIN SCI, V120, P91, DOI 10.1042/CS20100377; Razzaque MS, 2009, NAT REV ENDOCRINOL, V5, P611, DOI 10.1038/nrendo.2009.196; Razzaque MS, 2009, AM J PHYSIOL-RENAL, V296, pF470, DOI 10.1152/ajprenal.90538.2008; Razzaque MS, 2013, CONTRIB NEPHROL, V180, P74, DOI 10.1159/000346784; Razzaque MS, 2011, IUBMB LIFE, V63, P240, DOI 10.1002/iub.437; Shoji T, 2004, NEPHROL DIAL TRANSPL, V19, P179, DOI 10.1093/ndt/gfg513; Shutto Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029105; Sigrist MK, 2009, J RENAL CARE, V35, P71, DOI 10.1111/j.1755-6686.2009.00064.x; Snively CS, 2004, AM FAM PHYSICIAN, V70, P1921; Terai K, 2009, BRIT J PHARMACOL, V156, P1267, DOI 10.1111/j.1476-5381.2008.00108.x; Tokunaga S, 2002, ANN EPIDEMIOL, V12, P157, DOI 10.1016/S1047-2797(01)00307-6; Voormolen N, 2007, NEPHROL DIAL TRANSPL, V22, P2909, DOI 10.1093/ndt/gfm286; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127	31	20	22	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78660	10.1371/journal.pone.0078660	http://dx.doi.org/10.1371/journal.pone.0078660			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236030	Green Submitted, gold, Green Published			2022-12-27	WOS:000327254700027
J	Stammler, A; Muller, D; Tabuchi, Y; Konrad, L; Middendorff, R				Stammler, Angelika; Mueller, Dieter; Tabuchi, Yoshiaki; Konrad, Lutz; Middendorff, Ralf			TGF beta s Modulate Permeability of the Blood-Epididymis Barrier in an In Vitro Model	PLOS ONE			English	Article							TRANSFORMING GROWTH FACTOR-BETA-3; TIGHT JUNCTIONS; RAT EPIDIDYMIS; TESTIS BARRIER; CYCLIC-GMP; MICE; EXPRESSION; OCCLUDIN; GROWTH-FACTOR-BETA-1; PROTEINS	The blood-epididymis barrier (BEB) is formed by epithelial tight junctions mediating selective permeability of the epididymal epithelium. Defective barrier function can disturb the balance of the epididymal milieu, which may result in infertility. The stroma of the epididymis contains high amounts of cytokines of the TGF beta family of unknown function. We screened possible effects of all three TGF beta isoforms on paracellular tightness in a BEB in vitro model based on the strongly polarized mouse epididymal epithelial MEPC5 cells in the transwell system. In this model we found a robust transepithelial electrical resistance (TER) of about 840 Omega x cm(2). Effects on the paracellular permeability were evaluated by two methods, TER and FITC-Dextran-based tracer diffusion assays. Both assays add up to corresponding results indicating a time-dependent disturbance of the BEB differentially for the three TGF beta isoforms (TGF beta 3>TGF beta 1>TGF beta 2) in a TGF beta-recetor-1 kinase- and Smad-dependent manner. The tight junction protein claudin-1 was found to be reduced by the treatment with TGF beta s, whereas occludin was not influenced. Epididymal epithelial cells are predominantly responsive to TGF beta s from the basolateral side, suggesting that TGF beta may have an impact on the epididymal epithelium from the stroma in vivo. Our data show for the first time that TGF beta s decrease paracellular tightness in epididymal epithelial cells, thus establishing a novel mechanism of regulation of BEB permeability, which is elementary for sperm maturation and male fertility.	[Stammler, Angelika; Mueller, Dieter; Middendorff, Ralf] Univ Giessen, Inst Anat & Cell Biol, D-35390 Giessen, Germany; [Stammler, Angelika; Konrad, Lutz] Univ Giessen, Dept Gynecol & Obstet, D-35390 Giessen, Germany; [Tabuchi, Yoshiaki] Toyama Univ, Grad Sch Med Pharmaceut Sci, Life Sci Res Ctr, Div Mol Genet Res, Toyama 930, Japan	Justus Liebig University Giessen; Justus Liebig University Giessen; University of Toyama	Konrad, L (corresponding author), Univ Giessen, Dept Gynecol & Obstet, D-35390 Giessen, Germany.	Lutz.Konrad@gyn.med.uni-giessen.de; Ralf.Middendorff@anatomie.med.uni-giessen.de		Tabuchi, Yoshiaki/0000-0002-6007-6176	state of Hesse, Germany	state of Hesse, Germany	This project is part of LOEWE Focus Group Male Infertility and Urogenital Infections (MIBIE) funded by state of Hesse, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn JF, 2008, J CELL SCI, V121, P1036, DOI 10.1242/jcs.019455; Bomgardner D, 1999, J ANDROL, V20, P375; Capaldo CT, 2009, BBA-BIOMEMBRANES, V1788, P864, DOI 10.1016/j.bbamem.2008.08.027; Chalmers AD, 2012, ESSAYS BIOCHEM, V53, P41, DOI [10.1042/bse0530041, 10.1042/BSE0530041]; CHEIFETZ S, 1990, J BIOL CHEM, V265, P20533; Cornwall GA, 2009, HUM REPROD UPDATE, V15, P213, DOI 10.1093/humupd/dmn055; Cyr DG, 2007, ASIAN J ANDROL, V9, P463, DOI 10.1111/j.1745-7262.2007.00308.x; Da Silva N, 2011, REPRODUCTION, V141, P653, DOI 10.1530/REP-10-0493; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Desai KV, 1998, CELL TISSUE RES, V294, P271, DOI 10.1007/s004410051177; DICKSON MC, 1995, DEVELOPMENT, V121, P1845; Dube E, 2010, BIOL REPROD, V82, P1119, DOI 10.1095/biolreprod.109.083196; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Gregory M, 2006, MOL REPROD DEV, V73, P580, DOI 10.1002/mrd.20467; Henderson NA, 2006, J ENDOCRINOL, V190, P779, DOI 10.1677/joe.1.06862; Hinton BT, 2011, J ANDROL, V32, P558, DOI 10.2164/jandrol.111.013029; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; Kaitu'u-Lino TJ, 2007, REPRODUCTION, V133, P1169, DOI 10.1530/REP-06-0385; Konrad L, 2009, REGUL PEPTIDES, V155, P28, DOI 10.1016/j.regpep.2009.04.012; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Lui WY, 2001, ENDOCRINOLOGY, V142, P1865, DOI 10.1210/en.142.5.1865; Middendorff R, 2002, J CLIN ENDOCR METAB, V87, P3486, DOI 10.1210/jc.87.7.3486; Mochizuki T, 2009, BIOSCI BIOTECH BIOCH, V73, P2422, DOI 10.1271/bbb.90383; Muller D, 2010, MOL CELL ENDOCRINOL, V320, P118, DOI 10.1016/j.mce.2010.01.022; PROETZEL G, 1995, NAT GENET, V11, P409, DOI 10.1038/ng1295-409; Prozialeck WC, 2006, TOXICOL IN VITRO, V20, P942, DOI 10.1016/j.tiv.2005.11.006; Ronaldson PT, 2009, J CEREBR BLOOD F MET, V29, P1084, DOI 10.1038/jcbfm.2009.32; Runkle EA, 2012, J BIOL CHEM, V287, P28790, DOI 10.1074/jbc.M112.367987; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Schulzke JD, 2005, BBA-BIOMEMBRANES, V1669, P34, DOI 10.1016/j.bbamem.2005.01.008; Schulzke JD, 2012, ANN NY ACAD SCI, V1257, P1, DOI 10.1111/j.1749-6632.2012.06485.x; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; SHULL MM, 1994, MOL REPROD DEV, V39, P239, DOI 10.1002/mrd.1080390218; Siu ER, 2009, ENDOCRINOLOGY, V150, P3336, DOI 10.1210/en.2008-1741; Tabuchi Y, 2005, BIOCHEM BIOPH RES CO, V329, P812, DOI 10.1016/j.bbrc.2005.02.066; Wang FJ, 2005, AM J PATHOL, V166, P409, DOI 10.1016/S0002-9440(10)62264-X; Xia WL, 2009, DEV BIOL, V327, P48, DOI 10.1016/j.ydbio.2008.11.028; Zhu YH, 2010, ENDOCRINOLOGY, V151, P5497, DOI 10.1210/en.2010-0486	39	14	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80611	10.1371/journal.pone.0080611	http://dx.doi.org/10.1371/journal.pone.0080611			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236189	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700192
J	Zhou, ZZ; Li, WN; Song, Y; Wang, LL; Zhang, K; Yang, J; Zhang, W; Su, HC; Zhang, YQ				Zhou, Zhizhong; Li, Weina; Song, Yang; Wang, Lili; Zhang, Kuo; Yang, Jing; Zhang, Wei; Su, Haichuan; Zhang, Yingqi			Growth Differentiation Factor-15 Suppresses Maturation and Function of Dendritic Cells and Inhibits Tumor-Specific Immune Response	PLOS ONE			English	Article							TGF-BETA; CANCER; EXPRESSION; MIC-1; PROGNOSIS; MECHANISM; CARCINOMA	Dendritic cells (DCs) play a key role in the initiation stage of an antigen-specific immune response. A variety of tumor-derived factors (TDFs) can suppress DC maturation and function, resulting in defects in the tumor-specific immune response. To identify unknown TDFs that may suppress DCs maturation and function, we established a high-throughput screening technology based on a human liver tumor T7 phage cDNA library and screened all of the proteins derived from hepatoma cells that potentially interact with immature DCs. Growth/differentiation factor-15 (GDF-15) was detected and chosen for further study. By incubation of DCs cultures with GDF-15, we demonstrate that GDF-15 can inhibit surface protrusion formation during DC maturation; suppress the membrane expression of CD83, CD86 and HLA-DR on DCs; enhance phagocytosis by DCs; reduce IL-12 and elevate TGF-beta 1 secretion by DCs; inhibit T cell stimulation and cytotoxic T lymphocyte (CTL) activation by DCs. By building tumor-bearing mouse models, we demonstrate that GDF-15 can inhibit the ability of DCs to stimulate a tumor-specific immune response in vivo. These results indicate that GDF-15 may be one of the critical molecules that inhibit DC maturation and function and are involved in tumor immune escape. Thus, GDF-15 may be a novel target in tumor immunotherapy.	[Zhou, Zhizhong; Li, Weina; Wang, Lili; Zhang, Wei; Zhang, Yingqi] Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China; [Zhou, Zhizhong; Li, Weina; Wang, Lili; Zhang, Wei; Zhang, Yingqi] Fourth Mil Med Univ, Dept Biopharmaceut, Xian 710032, Shaanxi, Peoples R China; [Song, Yang; Yang, Jing; Su, Haichuan] Tangdu Hosp, Dept Oncol, Xian, Shaanxi, Peoples R China; [Zhang, Kuo] Northwest Univ, Sch Life Sci, Xian, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Northwest University Xi'an	Zhang, W (corresponding author), Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China.	zhangw90@fmmu.edu.cn; suhc@fmmu.edu.cn; zhangyqh@fmmu.edu.cn	wang, lili/HDL-7210-2022		Natural Science Foundation of China (NSFC) [81171978]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the Natural Science Foundation of China (NSFC No 81171978, http://isisn.nsfc.gov.cn/egrantweb). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apetoh L, 2011, SEMIN IMMUNOL, V23, P42, DOI 10.1016/j.smim.2011.01.003; Bhattacharyya S, 2004, BLOOD, V104, P1100, DOI 10.1182/blood-2003-12-4302; Brown DA, 2003, CLIN CANCER RES, V9, P2642; Dhodapkar MV, 2008, CELL DEATH DIFFER, V15, P39, DOI 10.1038/sj.cdd.4402247; Dong Zhi-wei, 2013, Zhonghua Shao Shang Za Zhi, V29, P41; Fainaru O, 2007, GENES IMMUN, V8, P239, DOI 10.1038/sj.gene.6364380; Fricke I, 2006, IMMUNOL INVEST, V35, P459, DOI 10.1080/08820130600803429; Griner SE, 2013, BIOCHEM PHARMACOL, V85, P46, DOI 10.1016/j.bcp.2012.10.007; Huang JX, 2012, ANTIMICROB AGENTS CH, V56, P4569, DOI 10.1128/AAC.00567-12; Hubert P, 2007, J LEUKOCYTE BIOL, V82, P781, DOI 10.1189/jlb.1106694; Li R, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-19; Manna PP, 2013, CYTOKINE, V61, P118, DOI 10.1016/j.cyto.2012.09.004; Michielsen AJ, 2012, ONCOIMMUNOLOGY, V1, P751, DOI 10.4161/onci.19570; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Pinzon-Charry A, 2005, IMMUNOL CELL BIOL, V83, P451, DOI 10.1111/j.1440-1711.2005.01371.x; Podgrabinska S, 2009, J IMMUNOL, V183, P1767, DOI 10.4049/jimmunol.0802167; Rasiah KK, 2006, CANCER EPIDEM BIOMAR, V15, P711, DOI 10.1158/1055-9965.EPI-05-0752; Segerer SE, 2012, HUM REPROD, V27, P200, DOI 10.1093/humrep/der358; Soucek K, 2010, HUM REPROD, V25, P2962, DOI 10.1093/humrep/deq264; Suesskind D, 2012, GRAEF ARCH CLIN EXP, V250, P887, DOI 10.1007/s00417-011-1786-6; Tong S, 2004, LANCET, V363, P129, DOI 10.1016/S0140-6736(03)15265-8; Zhang L, 2009, ORAL ONCOL, V45, P627, DOI 10.1016/j.oraloncology.2008.07.017; Zou WP, 2001, NAT MED, V7, P1339, DOI 10.1038/nm1201-1339	23	41	49	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78618	10.1371/journal.pone.0078618	http://dx.doi.org/10.1371/journal.pone.0078618			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236027	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700024
J	Leung, K; Elmes, MW; Glaser, ST; Deutsch, DG; Kaczocha, M				Leung, KwanNok; Elmes, Matthew W.; Glaser, Sherrye T.; Deutsch, Dale G.; Kaczocha, Martin			Role of FAAH-Like Anandamide Transporter in Anandamide Inactivation	PLOS ONE			English	Article							ACID AMIDE HYDROLASE; PERIAQUEDUCTAL GRAY; BINDING PROTEINS; CLEARANCE SYSTEM; CB1 RECEPTOR; LOCALIZATION; IDENTIFICATION; ANALGESIA; SITES; CELLS	The endocannabinoid system modulates numerous physiological processes including nociception and reproduction. Anandamide (AEA) is an endocannabinoid that is inactivated by cellular uptake followed by intracellular hydrolysis by fatty acid amide hydrolase (FAAH). Recently, FAAH-like anandamide transporter (FLAT), a truncated and catalytically-inactive variant of FAAH, was proposed to function as an intracellular AEA carrier and mediate its delivery to FAAH for hydrolysis. Pharmacological inhibition of FLAT potentiated AEA signaling and produced antinociceptive effects. Given that endocannabinoids produce analgesia through central and peripheral mechanisms, the goal of the current work was to examine the expression of FLAT in the central and peripheral nervous systems. In contrast to the original report characterizing FLAT, expression of FLAT was not observed in any of the tissues examined. To investigate the role of FLAT as a putative AEA binding protein, FLAT was generated from FAAH using polymerase chain reaction and further analyzed. Despite its low cellular expression, FLAT displayed residual catalytic activity that was sensitive to FAAH inhibitors and abolished following mutation of its catalytic serine. Overexpression of FLAT potentiated AEA cellular uptake and this appeared to be dependent upon its catalytic activity. Immunofluorescence revealed that FLAT localizes primarily to intracellular membranes and does not contact the plasma membrane, suggesting that its capability to potentiate AEA uptake may stem from its enzymatic rather than transport activity. Collectively, our data demonstrate that FLAT does not serve as a global intracellular AEA carrier, although a role in mediating localized AEA inactivation in mammalian tissues cannot be ruled out.	[Leung, KwanNok; Elmes, Matthew W.; Deutsch, Dale G.; Kaczocha, Martin] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Glaser, Sherrye T.] Kingsborough Community Coll, Dept Biol Sci, Brooklyn, NY USA; [Kaczocha, Martin] SUNY Stony Brook, Dept Anesthesiol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; City University of New York (CUNY) System; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Kaczocha, M (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	Martin.Kaczocha@Stonybrook.edu		Kaczocha, Martin/0000-0002-2527-1398	NIH [DA032232, DA021806, DA026953, DA016419]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016419, K01DA021806, R21DA032232, R21DA026953, R01DA035923] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants DA032232, DA021806, DA026953, and DA016419. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2007, NAT NEUROSCI, V10, P870, DOI 10.1038/nn1916; Beltramo M, 1997, SCIENCE, V277, P1094, DOI 10.1126/science.277.5329.1094; Bojesen IN, 2005, J LIPID RES, V46, P1652, DOI 10.1194/jlr.M400498-JLR200; Booker L, 2012, BRIT J PHARMACOL, V165, P2485, DOI 10.1111/j.1476-5381.2011.01445.x; Bouskila J, 2012, NEUROSCIENCE, V202, P117, DOI 10.1016/j.neuroscience.2011.11.041; Chen H, 2005, P NATL ACAD SCI USA, V102, P2766, DOI 10.1073/pnas.0409719102; Clapper JR, 2010, NAT NEUROSCI, V13, P1265, DOI 10.1038/nn.2632; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Cravatt BF, 2004, P NATL ACAD SCI USA, V101, P10821, DOI 10.1073/pnas.0401292101; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; Day TA, 2001, MOL PHARMACOL, V59, P1369, DOI 10.1124/mol.59.6.1369; DESARNAUD F, 1995, J BIOL CHEM, V270, P6030, DOI 10.1074/jbc.270.11.6030; DEUTSCH DG, 1993, BIOCHEM PHARMACOL, V46, P791, DOI 10.1016/0006-2952(93)90486-G; Deutsch DG, 2001, J BIOL CHEM, V276, P6967, DOI 10.1074/jbc.M003161200; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2008, BRIT J PHARMACOL, V153, P1272, DOI 10.1038/sj.bjp.0707682; Di Pasquale E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004989; Egertova M, 1998, P ROY SOC B-BIOL SCI, V265, P2081, DOI 10.1098/rspb.1998.0543; Fu J, 2012, NAT NEUROSCI, V15, P64, DOI 10.1038/nn.2986; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Glaser ST, 2003, P NATL ACAD SCI USA, V100, P4269, DOI 10.1073/pnas.0730816100; Glaser ST, 2005, LIFE SCI, V77, P1584, DOI 10.1016/j.lfs.2005.05.007; Hillard CJ, 2003, BRIT J PHARMACOL, V140, P802, DOI 10.1038/sj.bjp.0705468; Kaczocha M, 2006, J BIOL CHEM, V281, P9066, DOI 10.1074/jbc.M509721200; Kaczocha M, 2012, ACS CHEM NEUROSCI, V3, P364, DOI 10.1021/cn300001w; Kaczocha M, 2012, J BIOL CHEM, V287, P3415, DOI 10.1074/jbc.M111.304907; Kaczocha M, 2009, P NATL ACAD SCI USA, V106, P6375, DOI 10.1073/pnas.0901515106; KAWAHARA H, 2010, BRIT J PHARMACOL, V163, P1214, DOI DOI 10.1111/11476-5381.2010.01157.X; Lever IJ, 2009, J NEUROSCI, V29, P3766, DOI 10.1523/JNEUROSCI.4071-08.2009; Lichtman AH, 1996, J PHARMACOL EXP THER, V276, P585; Oddi S, 2009, CHEM BIOL, V16, P624, DOI 10.1016/j.chembiol.2009.05.004; Ortar G, 2003, BIOCHEM PHARMACOL, V65, P1473, DOI 10.1016/S0006-2952(03)00109-6; Sandberg A, 2005, CHEM PHYS LIPIDS, V134, P131, DOI 10.1016/j.chemphyslip.2004.12.010; SCHMID PC, 1985, J BIOL CHEM, V260, P4145; Sun XF, 2010, P NATL ACAD SCI USA, V107, P16887, DOI 10.1073/pnas.1010892107; Suplita RL, 2005, NEUROPHARMACOLOGY, V49, P1201, DOI 10.1016/j.neuropharm.2005.07.007; Tachikawa M, 2012, J PHARMACOL EXP THER, V343, P608, DOI 10.1124/jpet.112.197012; Tachikawa M, 2012, J NEUROCHEM, V123, P750, DOI 10.1111/jnc.12018; Tsou K, 1998, NEUROSCI LETT, V254, P137, DOI 10.1016/S0304-3940(98)00700-9; Walker JM, 1999, P NATL ACAD SCI USA, V96, P12198, DOI 10.1073/pnas.96.21.12198; Wei BQQ, 2006, J BIOL CHEM, V281, P36569, DOI 10.1074/jbc.M606646200; Yazulla S, 1999, J COMP NEUROL, V415, P80, DOI 10.1002/(SICI)1096-9861(19991206)415:1<80::AID-CNE6>3.0.CO;2-H	42	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79355	10.1371/journal.pone.0079355	http://dx.doi.org/10.1371/journal.pone.0079355			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223930	gold, Green Published			2022-12-27	WOS:000326503400107
J	Otieno, C; Spada, H; Renkl, A				Otieno, Christine; Spada, Hans; Renkl, Alexander			Effects of News Frames on Perceived Risk, Emotions, and Learning	PLOS ONE			English	Article							MODEL; ACHIEVEMENT; PERCEPTIONS; INTUITION; THOUGHTS; MOOD	The media play a key role in forming opinions by influencing people's understanding and perception of a topic. People gather information about topics of interest from the internet and print media, which employ various news frames to attract attention. One example of a common news frame is the human-interest frame, which emotionalizes and dramatizes information and often accentuates individual affectedness. Our study investigated effects of human-interest frames compared to a neutral-text condition with respect to perceived risk, emotions, and knowledge acquisition, and tested whether these effects can be " generalized" to common variants of the human-interest frame. Ninety-one participants read either one variant of the human-interest frame or a neutrally formulated version of a newspaper article describing the effects of invasive species in general and the Asian ladybug (an invasive species) in particular. The framing was achieved by varying the opening and concluding paragraphs (about invasive species), as well as the headline. The core text (about the Asian ladybug) was the same across all conditions. All outcome variables on framing effects referred to this common core text. We found that all versions of the human-interest frame increased perceived risk and the strength of negative emotions compared to the neutral text. Furthermore, participants in the human-interest frame condition displayed better (quantitative) learning outcomes but also biased knowledge, highlighting a potential dilemma: Human-interest frames may increase learning, but they also lead to a rather unbalanced view of the given topic on a "deeper level".	[Otieno, Christine; Renkl, Alexander] Univ Freiburg, Dept Psychol Educ & Dev Psychol, D-79106 Freiburg, Germany; [Spada, Hans] Univ Freiburg, Dept Psychol Cognit Emot Commun, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg	Otieno, C (corresponding author), Univ Freiburg, Dept Psychol Educ & Dev Psychol, Hugstetter Str 55, D-79106 Freiburg, Germany.	otieno@psychologie.uni-freiburg.de	Renkl, Alexander/K-6130-2012		Ministry of Science, Research, and the Arts of Baden - Wurttemberg, Germany [33-720.281/34]; German Research Foundation (DFG); Albert Ludwigs University Freiburg	Ministry of Science, Research, and the Arts of Baden - Wurttemberg, Germany; German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg	This work was supported by the Ministry of Science, Research, and the Arts of Baden - Wurttemberg, Germany [grant number 33-720.281/34]. Homepage: http://mwk.baden-wuerttemberg.de/. The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berinsky AJ, 2006, J POLIT, V68, P640, DOI 10.1111/j.1468-2508.2006.00451.x; Bohm G, 2003, J ENVIRON PSYCHOL, V23, P199, DOI 10.1016/S0272-4944(02)00114-7; Bohm G, 2008, JUDGM DECIS MAK, V3, P1; Bolte A, 2003, PSYCHOL SCI, V14, P416, DOI 10.1111/1467-9280.01456; Chi MTH, 1997, J LEARN SCI, V6, P271, DOI 10.1207/s15327809jls0603_1; Chong D, 2007, ANNU REV POLIT SCI, V10, P103, DOI 10.1146/annurev.polisci.10.072805.103054; Cohen J.E., 1988, STAT POWER ANAL BEHA; Davis M, 2011, NATURE, V474, P153, DOI 10.1038/474153a; De Vreese C., 2003, COMMUNICATIONS-GER, V28, P361, DOI DOI 10.1515/comm.2003.024; de Vreese C.H., 2005, INFORM DESIGN J DOCU, V13, P51, DOI [DOI 10.1075/IDJDD.13.1.06VRE, 10.1075/idjdd.13.1.06vre]; De Vreese C. H., 2004, MASS COMMUNICATION S, V7, P191, DOI [DOI 10.1207/S15327825MCS0702_4, 10.1207/s15327825mcs0702_4]; de Vreese CH, 2012, AM BEHAV SCI, V56, P365, DOI 10.1177/0002764211426331; de Vreese CH, 2011, COMMUN RES, V38, P179, DOI 10.1177/0093650210384934; DiCiccio TJ, 1996, STAT SCI, V11, P189; Ellsworth PC, 2003, SER AFFECTIVE SCI, P572; ENTMAN RM, 1993, J COMMUN, V43, P51, DOI 10.1111/j.1460-2466.1993.tb01304.x; Fleiss JL., 2003, STAT METHODS RATES P; FORGAS JP, 1995, PSYCHOL BULL, V117, P39, DOI 10.1037/0033-2909.117.1.39; Frijda NH, 2009, EMOT REV, V1, P264, DOI 10.1177/1754073909103595; GARNER R, 1989, COGNITION INSTRUCT, V6, P41, DOI 10.1207/s1532690xci0601_2; Gross K, 2004, POLIT PSYCHOL, V25, P1, DOI 10.1111/j.1467-9221.2004.00354.x; Gross K, 2008, POLIT PSYCHOL, V29, P169, DOI 10.1111/j.1467-9221.2008.00622.x; Hayes A. F., 2013, INTRO MEDIATION MODE, DOI DOI 10.1111/JEDM.12050; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Hulme PE, 2009, SCIENCE, V324, P40, DOI 10.1126/science.1171111; Igartua JJ, 2011, J MEDIA PSYCHOL-GER, V23, P174, DOI 10.1027/1864-1105/a000050; Iyengar S., 1991, IS ANYONE RESPONSIBL; Johnson-Laird P.N., 1983, MENTAL MODELS COGNIT; KAHNEMAN D, 1984, AM PSYCHOL, V39, P341, DOI 10.1037/0003-066X.39.4.341; Kinder DR, 2007, J COMMUN, V57, P155, DOI 10.1111/j.1460-2466.2006.00335.x; KINTSCH W, 1978, PSYCHOL REV, V85, P363, DOI 10.1037/0033-295X.85.5.363; KINTSCH W, 1991, RELATING THEORY AND DATA : ESSAYS ON HUMAN MEMORY IN HONOR OF BENNET B MURDOCK, P367; Kintsch W, 1998, COMPREHENSION PARADI; Lang A, 2003, J BROADCAST ELECTRON, V47, P650, DOI 10.1207/s15506878jobem4704_11; Lazarus R.S., 1991, EMOTION ADAPTATION; Lazo JK, 2000, RISK ANAL, V20, P179, DOI 10.1111/0272-4332.202019; Lecheler SK, 2012, FRAMING EFFECTS TIME; Lecheler S, 2011, J COMMUN, V61, P959, DOI 10.1111/j.1460-2466.2011.01580.x; Lecheler S, 2009, COMMUN RES, V36, P400, DOI 10.1177/0093650209333028; Livingstone DW, 2006, COUNTERPOINTS STUDIE, V249, p[1058, 203]; Lopez WL, 2007, EUR PSYCHOL, V12, P147, DOI 10.1027/1016-9040.12.2.147; MacKinnon DP., 2008, INTRO STAT MEDIATION; Matthes J, 2007, COMMUNICATIONS-GER, V32, P51, DOI 10.1515/COMMUN.2007.003; MCDANIELS T, 1995, RISK ANAL, V15, P575, DOI 10.1111/j.1539-6924.1995.tb00754.x; Nelson TE, 1997, POLIT BEHAV, V19, P221, DOI 10.1023/A:1024834831093; Nerb J, 2001, COGNITION EMOTION, V15, P521, DOI 10.1080/02699930143000013; Neuman WR., 1992, COMMON KNOWLEDGE NEW; Ortony A., 1988, COGNITIVE STRUCTURE; Otieno C, 2014, ENVIRON EDUC RES, V20, P612, DOI 10.1080/13504622.2013.833589; Pan Z., 1993, POLIT COMMUN, V10, P55, DOI [DOI 10.1080/10584609.1993.9962963, 10.1080/10584609.1993.9962963]; Pekrun R, 2002, EDUC PSYCHOL-US, V37, P91, DOI 10.1207/S15326985EP3702_4; Pekrun R, 2006, EDUC PSYCHOL REV, V18, P315, DOI 10.1007/s10648-006-9029-9; PERKINS DN, 1988, REV EDUC RES, V58, P303, DOI 10.3102/00346543058003303; PETTY RE, 1983, J CONSUM RES, V10, P135, DOI 10.1086/208954; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Price V, 1997, COMMUN RES, V24, P481, DOI 10.1177/009365097024005002; RENN O, 1992, J SOC ISSUES, V48, P137, DOI 10.1111/j.1540-4560.1992.tb01949.x; Scheufele B, 2004, COMMUNICATIONS-GER, V29, P401, DOI 10.1515/comm.2004.29.4.401; Scheufele D. A., 2012, OXFORD HDB POLITICAL; Scheufele D.A., 2000, MASS COMMUNICATION S, V3, P297, DOI DOI 10.1207/S15327825MCS0323_07; Scheufele DA, 1999, J COMMUN, V49, P103, DOI 10.1111/j.1460-2466.1999.tb02784.x; Semetko HA, 2000, J COMMUN, V50, P93, DOI 10.1111/j.1460-2466.2000.tb02843.x; Shah DV, 2004, HUM COMMUN RES, V30, P102; Shen FY, 2004, J MASS COMMUN Q, V81, P400, DOI 10.1177/107769900408100211; Slovic P, 2004, RISK ANAL, V24, P311, DOI 10.1111/j.0272-4332.2004.00433.x; Tankard JW, 2001, LEA COMMUN SER, P95; Tewksbury D, 2000, JOURNALISM MASS COMM, V77, P804, DOI 10.1177/107769900007700406; Um E, 2012, J EDUC PSYCHOL, V104, P485, DOI 10.1037/a0026609; Valkenburg PM, 1999, COMMUN RES, V26, P550, DOI 10.1177/009365099026005002; van Gorp B., 2009, J MEDIA PSYCHOL-GER, V21, P161, DOI DOI 10.1027/1864-1105.21.4.161; von Sikorski C, 2012, J MEDIA PSYCHOL-GER, V24, P113, DOI 10.1027/1864-1105/a000069; Wegner-Kiss G, 2008, BADISCHE WINZER, V26; Yegiyan NS, 2010, MEDIA PSYCHOL, V13, P77, DOI 10.1080/15213260903563014	74	21	21	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79696	10.1371/journal.pone.0079696	http://dx.doi.org/10.1371/journal.pone.0079696			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	245ZC	24223999	Green Published, gold, Green Submitted			2022-12-27	WOS:000326503400141
J	Wangkumhang, P; Shaw, PJ; Chaichoompu, K; Ngamphiw, C; Assawamakin, A; Nuinoon, M; Sripichai, O; Svasti, S; Fucharoen, S; Praphanphoj, V; Tongsima, S				Wangkumhang, Pongsakorn; Shaw, Philip James; Chaichoompu, Kridsadakorn; Ngamphiw, Chumpol; Assawamakin, Anunchai; Nuinoon, Manit; Sripichai, Orapan; Svasti, Saovaros; Fucharoen, Suthat; Praphanphoj, Verayuth; Tongsima, Sissades			Insight into the Peopling of Mainland Southeast Asia from Thai Population Genetic Structure	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; GENOME-WIDE ASSOCIATION; HUMAN DISPERSALS; HAN CHINESE; MITOCHONDRIAL; HISTORY; DIVERSITY; ANCESTRY; ORIGINS; RISK	There is considerable ethno-linguistic and genetic variation among human populations in Asia, although tracing the origins of this diversity is complicated by migration events. Thailand is at the center of Mainland Southeast Asia (MSEA), a region within Asia that has not been extensively studied. Genetic substructure may exist in the Thai population, since waves of migration from southern China throughout its recent history may have contributed to substantial gene flow. Autosomal SNP data were collated for 438,503 markers from 992 Thai individuals. Using the available self-reported regional origin, four Thai subpopulations genetically distinct from each other and from other Asian populations were resolved by Neighbor-Joining analysis using a 41,569 marker subset. Using an independent Principal Components-based unsupervised clustering approach, four major MSEA subpopulations were resolved in which regional bias was apparent. A major ancestry component was common to these MSEA subpopulations and distinguishes them from other Asian subpopulations. On the other hand, these MSEA subpopulations were admixed with other ancestries, in particular one shared with Chinese. Subpopulation clustering using only Thai individuals and the complete marker set resolved four subpopulations, which are distributed differently across Thailand. A Sino-Thai subpopulation was concentrated in the Central region of Thailand, although this constituted a minority in an otherwise diverse region. Among the most highly differentiated markers which distinguish the Thai subpopulations, several map to regions known to affect phenotypic traits such as skin pigmentation and susceptibility to common diseases. The subpopulation patterns elucidated have important implications for evolutionary and medical genetics. The subpopulation structure within Thailand may reflect the contributions of different migrants throughout the history of MSEA. The information will also be important for genetic association studies to account for population-structure confounding effects.	[Wangkumhang, Pongsakorn; Shaw, Philip James; Chaichoompu, Kridsadakorn; Ngamphiw, Chumpol; Tongsima, Sissades] Natl Ctr Genet Engn & Biotechnol BioTeC, Khlong Luang, Pathum Thani, Thailand; [Wangkumhang, Pongsakorn; Ngamphiw, Chumpol] Chulalongkorn Univ, Interdept Program Biomed Sci, Bangkok, Thailand; [Assawamakin, Anunchai] Mahidol Univ, Fac Pharm, Bangkok 10700, Thailand; [Nuinoon, Manit] Walailak Univ, Sch Allied Hlth Sci & Publ Hlth, Thai Buri, Nakhon Sri Tham, Thailand; [Sripichai, Orapan; Svasti, Saovaros; Fucharoen, Suthat] Mahidol Univ, Thalassemia Res Ctr, Salaya, Nakhon Pathom, Thailand; [Praphanphoj, Verayuth] Rajanukul Inst, Med Genet Res Ctr, Bangkok, Thailand	National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Chulalongkorn University; Mahidol University; Mahidol University	Tongsima, S (corresponding author), Natl Ctr Genet Engn & Biotechnol BioTeC, Khlong Luang, Pathum Thani, Thailand.	sissades@biotec.or.th	Chaichoompu, Kridsadakorn/AAC-1493-2020; Nuinoon, Manit/AAV-8949-2020; Ngamphiw, Chumpol/ABB-6488-2021; Nuinoon, Manit/ABG-5451-2021; Sripichai, Orapan/AGV-4273-2022; Wangkumhang, Pongsakorn/I-9005-2014; Svasti, Saovaros/AAH-6111-2020; Tongsima, Sissades/F-4891-2011	Chaichoompu, Kridsadakorn/0000-0002-8123-3409; Nuinoon, Manit/0000-0002-1325-5489; Ngamphiw, Chumpol/0000-0002-8581-397X; Nuinoon, Manit/0000-0002-1325-5489; Tongsima, Sissades/0000-0002-1491-1839	Thailand Research Fund [RSA5480026]; Research Chair Grant National Science and Technology Development Agency; department of mental health, Ministry of Public Health, Thailand	Thailand Research Fund(Thailand Research Fund (TRF)); Research Chair Grant National Science and Technology Development Agency; department of mental health, Ministry of Public Health, Thailand	ST is funded by the Thailand Research Fund (grant no. RSA5480026) and the Research Chair Grant National Science and Technology Development Agency. VP was funded by the department of mental health, Ministry of Public Health, Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Ang KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042752; Baker CJ, 2009, HIST THAILAND, P315; Bellwood PS, 1996, AUSTRONESIANS HIST C; Benjamin G, 2002, TRIBAL COMMUNITIES M, P489; Besaggio D, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S2-S12; Breurec S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022058; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN, V518, P541; Chen JM, 2009, AM J HUM GENET, V85, P775, DOI 10.1016/j.ajhg.2009.10.016; Dancause KN, 2009, J HUM GENET, V54, P86, DOI 10.1038/jhg.2008.12; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Fucharoen G, 2001, J HUM GENET, V46, P115, DOI 10.1007/s100380170098; Giardina E, 2008, CURR GENOMICS, V9, P110, DOI 10.2174/138920208784139528; Higham C., 1996, BRONZE AGE SE ASIA; Hill C, 2006, MOL BIOL EVOL, V23, P2480, DOI 10.1093/molbev/msl124; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Intarapanich A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-382; Jinam TA, 2012, MOL BIOL EVOL, V29, P3513, DOI 10.1093/molbev/mss169; Kutanan W, 2011, J HUM GENET, V56, P130, DOI 10.1038/jhg.2010.135; Lee JH, 2008, ARCH NEUROL-CHICAGO, V65, P1518, DOI 10.1001/archneur.65.11.1518; Lertrit P, 2008, AM J PHYS ANTHROPOL, V137, P425, DOI 10.1002/ajpa.20884; Li Yi, 2005, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V27, P274; Limpiti T, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-255; Listman JB, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-21; Luca D, 2008, AM J HUM GENET, V82, P453, DOI 10.1016/j.ajhg.2007.11.003; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Mahasirimongkol S, 2006, J HUM GENET, V51, P896, DOI 10.1007/s10038-006-0041-1; Matsumura H, 2005, HOMO, V56, P93, DOI 10.1016/j.jchb.2005.05.004; Matsumura H, 2005, AM J PHYS ANTHROPOL, V127, P182, DOI 10.1002/ajpa.20067; Noguchi E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002170; Nuinoon M, 2010, HUM GENET, V127, P303, DOI 10.1007/s00439-009-0770-2; Ooi Keat Gin, 2004, SE ASIA HIST ENCY AN; Oota H, 2001, HUM BIOL, V73, P225, DOI 10.1353/hub.2001.0023; Oze I, 2009, CANCER EPIDEM BIOMAR, V18, P3097, DOI 10.1158/1055-9965.EPI-09-0499; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Peng MS, 2010, MOL BIOL EVOL, V27, P2417, DOI 10.1093/molbev/msq131; Pritchard JK, 2000, GENETICS, V155, P945; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Reich D, 2011, AM J HUM GENET, V89, P516, DOI 10.1016/j.ajhg.2011.09.005; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Schliesinger J., 2000, ETHNIC GROUPS THAILA; Simonson TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016338; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stoneking M, 2010, CURR BIOL, V20, pR188, DOI 10.1016/j.cub.2009.11.052; Tan AH, 2012, HUM MOL GENET, V21, P1658, DOI 10.1093/hmg/ddr587; Thangaraj K, 2006, J HUM GENET, V51, P800, DOI 10.1007/s10038-006-0026-0; Wu LJ, 2013, DIABETES VASC DIS RE, V10, P202, DOI 10.1177/1479164112455535; Xing JC, 2010, GENOMICS, V96, P199, DOI 10.1016/j.ygeno.2010.07.004; Xu SH, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-18; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Zimmermann B, 2009, INT J LEGAL MED, V123, P495, DOI 10.1007/s00414-009-0373-4	54	21	21	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79522	10.1371/journal.pone.0079522	http://dx.doi.org/10.1371/journal.pone.0079522			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223962	Green Published, gold, Green Submitted			2022-12-27	WOS:000326503400122
J	Zirk-Sadowski, J; Szucs, D; Holmes, J				Zirk-Sadowski, Jan; Szucs, Denes; Holmes, Joni			Content-Specificity in Verbal Recall: A Randomized Controlled Study	PLOS ONE			English	Article							SHORT-TERM-MEMORY; WORKING-MEMORY; INDIVIDUAL-DIFFERENCES; EXECUTIVE FUNCTIONS; SPAN; COMPONENTS; ABILITIES; CHILDREN	In this controlled experiment we examined whether there are content effects in verbal short-term memory and working memory for verbal stimuli. Thirty-seven participants completed forward and backward digit and letter recall tasks, which were constructed to control for distance effects between stimuli. A maximum-likelihood mixed-effects logistic regression revealed main effects of direction of recall (forward vs backward) and content (digits vs letters). There was an interaction between type of recall and content, in which the recall of digits was superior to the recall of letters in verbal short-term memory but not in verbal working memory. These results demonstrate that the recall of information from verbal short-term memory is content-specific, whilst the recall of information from verbal working memory is content-general.	[Zirk-Sadowski, Jan; Szucs, Denes] Univ Cambridge, Ctr Neurosci Educ, Cambridge, England; [Holmes, Joni] MRC, Cognit & Brain Sci Unit, Cambridge, England	University of Cambridge	Zirk-Sadowski, J (corresponding author), Univ Cambridge, Ctr Neurosci Educ, Cambridge, England.	jmzirk@gmail.com; ds377@cam.ac.uk		Szucs, Denes/0000-0002-9477-0801; Holmes, Joni/0000-0002-6821-2793	Jolanta and Leszek Czarnecki Foundation; Medical Research Council [G90951]; MRC [G0900643, MC_UP_A060_1104] Funding Source: UKRI; Medical Research Council [G0900643, MC_UP_A060_1104, G0001354B, G1000183B, G0001354] Funding Source: researchfish	Jolanta and Leszek Czarnecki Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was funded by a Jolanta and Leszek Czarnecki Foundation studentship to JZ and Medical Research Council grant G90951 awarded to DS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JW, 1997, J EXP CHILD PSYCHOL, V67, P21, DOI 10.1006/jecp.1997.2397; Alloway TP, 2006, CHILD DEV, V77, P1698, DOI 10.1111/j.1467-8624.2006.00968.x; Archibald LMD, 2006, INT J LANG COMM DIS, V41, P675, DOI 10.1080/13682820500442602; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A, 1986, WORKING MEMORY, V11; Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Bayliss DM, 2003, J EXP PSYCHOL GEN, V132, P71, DOI 10.1037/0096-3445.132.1.71; Bedard AC, 2007, J CHILD PSYCHOL PSYC, V48, P872, DOI 10.1111/j.1469-7610.2007.01760.x; Bopp KL, 2005, J GERONTOL B-PSYCHOL, V60, pP223, DOI 10.1093/geronb/60.5.P223; Cain K, 2004, J EDUC PSYCHOL, V96, P31, DOI 10.1037/0022-0663.96.1.31; Cowan N, 1999, MODELS WORKING MEMOR, P62, DOI [10.1017/CBO9781139174909.006, DOI 10.1017/CBO9781139174909.006]; Cowan N, 1995, ATTENTION MEMORY; DANEMAN M, 1987, ATTENTION PERFORM, P491; DEHAENE S, 1990, J EXP PSYCHOL HUMAN, V16, P626, DOI 10.1037/0096-1523.16.3.626; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Engle Randall W., 1999, MODELS WORKING MEMOR, P102; Engle RW, 1999, J EXP PSYCHOL GEN, V128, P309, DOI 10.1037/0096-3445.128.3.309; Friedman NP, 2000, J EXP PSYCHOL GEN, V129, P61, DOI 10.1037/0096-3445.129.1.61; Fulbright RK, 2003, AM J NEURORADIOL, V24, P193; Gathercole SE, 2004, DEV PSYCHOL, V40, P177, DOI 10.1037/0012-1649.40.2.177; Gathercole SE, 2005, J CHILD PSYCHOL PSYC, V46, P598, DOI 10.1111/j.1469-7610.2004.00379.x; Gathercole SE, 2008, APPL COGNITIVE PSYCH, V22, P1019, DOI 10.1002/acp.1407; Gevers W, 2003, COGNITION, V87, pB87, DOI 10.1016/S0010-0277(02)00234-2; Hale JB, 2002, J PSYCHOEDUC ASSESS, V20, P128, DOI 10.1177/073428290202000202; Hale S, 2011, PSYCHOL AGING, V26, P92, DOI 10.1037/a0021483; Holloway ID, 2009, J EXP CHILD PSYCHOL, V103, P17, DOI 10.1016/j.jecp.2008.04.001; Jacquemot C, 2006, TRENDS COGN SCI, V10, P480, DOI 10.1016/j.tics.2006.09.002; Jarvis H.L., 2003, ED CHILD PSYCHOL, V20, P123; Kane MJ, 2004, J EXP PSYCHOL GEN, V133, P189, DOI 10.1037/0096-3445.133.2.189; Kane MJ, 2001, J EXP PSYCHOL GEN, V130, P169, DOI 10.1037/0096-3445.130.2.169; LINDSTROM MJ, 1990, BIOMETRICS, V46, P673, DOI 10.2307/2532087; Miyake A, 2001, J EXP PSYCHOL GEN, V130, P621, DOI 10.1037/0096-3445.130.4.621; MOYER RS, 1967, NATURE, V215, P1519, DOI 10.1038/2151519a0; Oberauer K, 2003, INTELLIGENCE, V31, P167, DOI 10.1016/S0160-2896(02)00115-0; Pennington BF, 1996, J CHILD PSYCHOL PSYC, V37, P51, DOI 10.1111/j.1469-7610.1996.tb01380.x; Pinheiro JC, 2000, LINEAR MIXED EFFECTS; Quene H, 2004, SPEECH COMMUN, V43, P103, DOI 10.1016/j.specom 2004.02.004; Shah P, 1996, J EXP PSYCHOL GEN, V125, P4, DOI 10.1037/0096-3445.125.1.4; St Clair-Thompson HL, 2006, Q J EXP PSYCHOL, V59, P745, DOI 10.1080/17470210500162854; Ten Have TR, 1998, BIOMETRICS, V54, P367; Towse J, 2007, VARIATION WORKING ME; TROUP GA, 1983, INT J NEUROSCI, V19, P231, DOI 10.3109/00207458309148659; Van Opstal F, 2008, PSYCHON B REV, V15, P419, DOI 10.3758/PBR.15.2.419; Wechsler D, 2001, WECHSLER ADULT INTEL	44	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79528	10.1371/journal.pone.0079528	http://dx.doi.org/10.1371/journal.pone.0079528			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	245ZC	24223963	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000326503400123
J	Butcher, J; Stintzi, A				Butcher, James; Stintzi, Alain			The Transcriptional Landscape of Campylobacter jejuni under Iron Replete and Iron Limited Growth Conditions	PLOS ONE			English	Article							GENE-EXPRESSION; HELICOBACTER-PYLORI; OXIDATIVE STRESS; GENOME SEQUENCE; REGULATOR FUR; RNA-SEQ; COLONIZATION; IDENTIFICATION; REGULON; NCTC11168	The genome-wide Campylobacter jejuni transcriptional response under iron replete and iron limited conditions was characterized using RNA-seq. We have identified 111 novel C. jejuni 5'UTRs and mapped 377 co-transcribed genes into 230 transcriptional operons. In contrast to previous microarray results, the C. jejuni iron stimulon is less extensive than previously believed and consists of 77 iron activated genes and 50 iron repressed genes. As anticipated, the iron repressed genes are primarily those involved in iron acquisition or oxidative stress defense. Interestingly, these experiments have revealed that iron is an important modulator of flagellar biogenesis with almost all the components of the flagella found to be iron activated. Given that motility is a well-known C. jejuni colonization factor, this suggests that there is an important regulatory coupling of flagellar biogenesis and iron level in C. jejuni. In addition we have identified several consensus mutations in the C. jejuni NCTC11168 strain that are widespread in the Campylobacter research community and which may explain conflicting phenotypic reports for this strain. Comparative analysis of iron responsive genes with the known Fur regulon indicates that many iron responsive genes are not Fur responsive; suggesting that additional iron regulatory factors remain to be characterized in C. jejuni. Further analysis of the RNA-seq data identified multiple novel transcripts including 19 potential ncRNAs. The expression of selected ncRNAs was confirmed and quantified with qRT-PCR. The qRT-PCR results indicate that several of these novel transcripts are either Fur and/or iron responsive. The fact that several of these ncRNAs are iron responsive or Fur regulated suggests that they may perform regulatory roles in iron homeostasis.	[Butcher, James; Stintzi, Alain] Univ Ottawa, Ottawa Inst Syst Biol, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	University of Ottawa	Stintzi, A (corresponding author), Univ Ottawa, Ottawa Inst Syst Biol, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	astintzi@uottawa.ca	Butcher, James/AAC-8339-2020	Butcher, James/0000-0002-7050-1834	CIHR (MOP) [84224]; CIHR-Banting graduate scholarship	CIHR (MOP)(Canadian Institutes of Health Research (CIHR)); CIHR-Banting graduate scholarship(Canadian Institutes of Health Research (CIHR))	This work was supported by CIHR (MOP#84224) to A. S. and a CIHR-Banting graduate scholarship to J.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed IH, 2002, MICROBIOL-SGM, V148, P1203, DOI 10.1099/00221287-148-4-1203; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Butcher J, 2012, P NATL ACAD SCI USA; Butcher J, 2012, P NATL ACAD SCI USA, V109, P10047, DOI 10.1073/pnas.1118321109; Butcher J, 2010, IRON UPTAKE AND HOMEOSTASIS IN MICROORGANISMS, P167; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; CHAN VL, 1991, GENE, V101, P51, DOI 10.1016/0378-1119(91)90223-X; Chang C, 2006, INFECT IMMUN, V74, P5261, DOI 10.1128/IAI.01094-05; Chaudhuri RR, 2011, MICROBIOL-SGM, V157, P2922, DOI 10.1099/mic.0.050278-0; Cooper KK, 2013, RES MICROBIOL, V164, P6, DOI 10.1016/j.resmic.2012.10.002; Dugar G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003495; Fantappie L, 2009, INFECT IMMUN, V77, P1842, DOI 10.1128/IAI.01216-08; Gaasbeek EJ, 2009, J BACTERIOL, V191, P3785, DOI 10.1128/JB.01817-08; Gaynor EC, 2004, J BACTERIOL, V186, P503, DOI 10.1128/JB.186.2.503-517.2004; Grabowska AD, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-166; Guccione E, 2010, ENVIRON MICROBIOL, V12, P576, DOI 10.1111/j.1462-2920.2009.02096.x; Gundogdu O, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-162; Han J, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000083; Hartley-Tassell LE, 2010, MOL MICROBIOL, V75, P710, DOI 10.1111/j.1365-2958.2009.07010.x; Holmes K, 2005, MICROBIOL-SGM, V151, P243, DOI 10.1099/mic.0.27412-0; Jerome JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016399; John A, 2011, RES MICROBIOL, V162, P410, DOI 10.1016/j.resmic.2011.02.004; Jones MA, 2004, INFECT IMMUN, V72, P3769, DOI 10.1128/IAI.72.7.3769-3776.2004; Kamal N, 2007, MICROBIOL-SGM, V153, P3099, DOI 10.1099/mic.0.2007/007401-0; KONKEL ME, 1994, GENE, V146, P83, DOI 10.1016/0378-1119(94)90837-0; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Masse E, 2007, CURR OPIN MICROBIOL, V10, P140, DOI 10.1016/j.mib.2007.03.013; Mey AR, 2005, INFECT IMMUN, V73, P5706, DOI 10.1128/IAI.73.9.5706-5719.2005; Miles S, 2010, INFECT IMMUN, V78, P3073, DOI 10.1128/IAI.00190-10; Miller CE, 2008, J BACTERIOL, V190, P1900, DOI 10.1128/JB.01761-07; Mooney M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061088; Mutz KO, 2013, CURR OPIN BIOTECH, V24, P22, DOI 10.1016/j.copbio.2012.09.004; Oglesby AG, 2005, MOL MICROBIOL, V58, P1354, DOI 10.1111/j.1365-2958.2005.04920.x; Palyada K, 2004, J BACTERIOL, V186, P4714, DOI 10.1128/JB.186.14.4714-4729.2004; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Price MN, 2005, NUCLEIC ACIDS RES, V33, P880, DOI 10.1093/nar/gki232; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ridley KA, 2006, J BACTERIOL, V188, P7862, DOI 10.1128/JB.00994-06; Ritz M, 2009, J MICROBIOL METH, V76, P196, DOI 10.1016/j.mimet.2008.10.014; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Simonsen KT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016387; Sirbu A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050986; van Vliet AHM, 2000, FEMS MICROBIOL LETT, V188, P115, DOI 10.1016/S0378-1097(00)00222-6; van Vliet AHM, 2010, FEMS MICROBIOL LETT, V302, P1, DOI 10.1111/j.1574-6968.2009.01767.x; Velayudhan J, 2002, MICROBIOL-SGM, V148, P685, DOI 10.1099/00221287-148-3-685; Verhoeff-Bakkenes L, 2008, LETT APPL MICROBIOL, V46, P377, DOI 10.1111/j.1472-765X.2008.02326.x; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xu GR, 2011, SOURCE CODE BIOL MED, V6, DOI 10.1186/1751-0473-6-2; Yamasaki M, 2004, FEMS MICROBIOL LETT, V235, P57, DOI 10.1016/j.femsle.2004.04.012	53	34	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79475	10.1371/journal.pone.0079475	http://dx.doi.org/10.1371/journal.pone.0079475			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223952	Green Published, gold, Green Submitted			2022-12-27	WOS:000326499300086
J	Lorente, E; Barriga, A; Johnstone, C; Mir, C; Jimenez, M; Lopez, D				Lorente, Elena; Barriga, Alejandro; Johnstone, Carolina; Mir, Carmen; Jimenez, Mercedes; Lopez, Daniel			Concerted In Vitro Trimming of Viral HLA-B27-Restricted Ligands by Human ERAP1 and ERAP2 Aminopeptidases	PLOS ONE			English	Article							VIRUS-INFECTED CELLS; CD8(+) T-LYMPHOCYTES; ENDOPLASMIC-RETICULUM; ANTIGEN PRESENTATION; MOLECULES; PEPTIDES; OXYTOCINASE; MULTIPLE; EPITOPES; ER	In the classical human leukocyte antigen (HLA) class I antigen processing and presentation pathway, the antigenic peptides are generated from viral proteins by multiple proteolytic cleavages of the proteasome (and in some cases other cytosolic proteases) and transported to the endoplasmic reticulum (ER) lumen where they are exposed to aminopeptidase activity. In human cells, two different ER-resident enzymes, ERAP1 and ERAP2, can trim the N-terminally extended residues of peptide precursors. In this study, the possible cooperative effect of generating five naturally processed HLA-B27 ligands by both proteases was analyzed. We identified differences in the products obtained with increased detection of natural HLA-B27 ligands by comparing double versus single enzyme digestions by mass spectrometry analysis. These in vitro data suggest that each enzyme can use the degradation products of the other as a substrate for new N-terminal trimming, indicating concerted aminoproteolytic activity of ERAP 1 and ERAP2.	[Lorente, Elena; Barriga, Alejandro; Johnstone, Carolina; Mir, Carmen; Jimenez, Mercedes; Lopez, Daniel] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Lopez, D (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain.	dlopez@isciii.es	Johnstone, Carolina/K-9907-2014; López, Daniel/I-2632-2014; Lorente, Elena/B-1219-2019	Johnstone, Carolina/0000-0002-4966-6212; López, Daniel/0000-0003-0268-5878; Lorente, Elena/0000-0002-2246-6851; Barriga, Alejandro/0000-0001-6357-1917	Ministerio de Ciencia e Innovacion	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by grants to D. L. from the Ministerio de Ciencia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Dror L, 2010, ARTHRITIS RHEUM-US, V62, P420, DOI 10.1002/art.27257; Birtley JR, 2012, BIOCHEMISTRY-US, V51, P286, DOI 10.1021/bi201230p; Del-Val M, 2002, MOL IMMUNOL, V39, P235, DOI 10.1016/S0161-5890(02)00104-9; Gil-Torregrosa BC, 1998, J EXP MED, V188, P1105, DOI 10.1084/jem.188.6.1105; Hattori A, 1999, J BIOCHEM-TOKYO, V125, P931, DOI 10.1093/oxfordjournals.jbchem.a022371; Infantes S, 2010, MOL CELL PROTEOMICS, V9, P1533, DOI 10.1074/mcp.M900508-MCP200; Infantes S, 2010, J IMMUNOL, V184, P3351, DOI 10.4049/jimmunol.0901560; Kessler JH, 2011, NAT IMMUNOL, V12, P45, DOI 10.1038/ni.1974; Lopez D, 2011, J BIOL CHEM, V286, P16910, DOI 10.1074/jbc.M111.234658; Lopez D, 2010, J IMMUNOL, V184, P5193, DOI 10.4049/jimmunol.1000050; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Samino Y, 2006, J BIOL CHEM, V281, P6358, DOI 10.1074/jbc.M512263200; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Tanioka T, 2003, J BIOL CHEM, V278, P32275, DOI 10.1074/jbc.M305076200; York IA, 1999, IMMUNOL REV, V172, P49, DOI 10.1111/j.1600-065X.1999.tb01355.x; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860	19	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79596	10.1371/journal.pone.0079596	http://dx.doi.org/10.1371/journal.pone.0079596			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223975	Green Published, gold, Green Submitted			2022-12-27	WOS:000326499300092
J	Szmydynger-Chodobska, J; Gandy, JR; Varone, A; Shan, RZ; Chodobski, A				Szmydynger-Chodobska, Joanna; Gandy, Jessica R.; Varone, Andrew; Shan, Rongzi; Chodobski, Adam			Synergistic Interactions between Cytokines and AVP at the Blood-CSF Barrier Result in Increased Chemokine Production and Augmented Influx of Leukocytes after Brain Injury	PLOS ONE			English	Article							CHOROID-PLEXUS; VASOPRESSIN V-1A; V-2 RECEPTORS; EXPRESSION; DAMAGE; MICE; INFILTRATION; TISSUE; CELLS; RATS	Several lines of evidence indicate that the blood-cerebrospinal fluid barrier (BCSFB), which primarily resides in the choroid plexus (CP), plays a significant pathophysiological role not only in neuroinflammatory diseases, such as multiple sclerosis, but also in traumatic brain injury (TBI). Here we investigated how arginine vasopressin (AVP) regulates function of the BCSFB in the context of post-traumatic neuroinflammation. It has previously been shown that AVP exacerbates various forms of brain injury, but the mechanisms underlying this AVP action are poorly understood. Type 1A AVP receptor is highly expressed on the CP epithelium and the CP synthesizes AVP. Using the controlled cortical impact model of TBI, we demonstrated decreased post-traumatic production of proinflammatory mediators by the CP and reduced influx of inflammatory cells across the BCSFB in AVP-deficient Brattleboro rats when compared with Long-Evans rats, a parental strain for Brattleboro rats. Arginine vasopressin was also found to play an important role in post-traumatic activation of c-Jun Nterminal kinase (JNK) in the CP. In the CP epithelial cell cultures, AVP augmented the tumor necrosis factor-alpha- and interleukin-1 beta-dependent increase in synthesis of proinflammatory mediators, including neutrophil chemoattractants, an action largely dependent on the JNK signaling pathway. Under in vivo conditions, a selective JNK inhibitor decreased the post-traumatic production of neutrophil chemoattractants by the CP and reduced the influx of neutrophils across the BCSFB. These results provide evidence for the synergistic interactions between proinflammatory cytokines and AVP, a ligand for G protein-coupled receptors, and support a pathophysiological role of AVP in post-traumatic neuroinflammation.	[Szmydynger-Chodobska, Joanna; Gandy, Jessica R.; Varone, Andrew; Shan, Rongzi; Chodobski, Adam] Brown Univ, Dept Emergency Med, Alpert Med Sch, Neurotrauma & Brain Barriers Res Lab, Providence, RI 02912 USA	Brown University	Szmydynger-Chodobska, J (corresponding author), Brown Univ, Dept Emergency Med, Alpert Med Sch, Neurotrauma & Brain Barriers Res Lab, Providence, RI 02912 USA.	Joanna_Szmydynger-Chodobska@brown.edu			NIH [NS49479]; Department of Emergency Medicine at the Alpert Medical School of Brown University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049479] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Emergency Medicine at the Alpert Medical School of Brown University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grant NS49479 from the NIH (to AC) and by funds from the Department of Emergency Medicine at the Alpert Medical School of Brown University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstead WM, 1996, J NEUROTRAUM, V13, P115, DOI 10.1089/neu.1996.13.115; Armstead WM, 2001, STROKE, V32, P1408, DOI 10.1161/01.STR.32.6.1408; Bao F, 2012, J NEUROTRAUM, V29, P2375, DOI 10.1089/neu.2012.2408; Chodobski A, 2013, VASCULAR ME IN PRESS; HANAZAWA S, 1993, J BIOL CHEM, V268, P9526; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Kim DS, 2003, MOL IMMUNOL, V40, P633, DOI 10.1016/j.molimm.2003.07.001; Kleindienst A, 2013, ACTA NEUROCHIR, V155, P151, DOI 10.1007/s00701-012-1558-z; Manaenko A, 2011, NEUROCHEM INT, V58, P542, DOI 10.1016/j.neuint.2011.01.018; Marques F, 2008, J CEREBR BLOOD F MET, V28, P450, DOI 10.1038/sj.jcbfm.9600557; NAKAGAWA H, 1994, BIOCHEM J, V301, P545, DOI 10.1042/bj3010545; Rauen K, 2013, J NEUROTRAUM, V30, P1442, DOI 10.1089/neu.2012.2807; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; SCHMALE H, 1984, NATURE, V308, P705, DOI 10.1038/308705a0; Schmitt C, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-187; Semple BD, 2010, NEUROBIOL DIS, V40, P394, DOI 10.1016/j.nbd.2010.06.015; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Strazielle N, 2000, J NEUROPATH EXP NEUR, V59, P561, DOI 10.1093/jnen/59.7.561; Szmydynger-Chodobska J, 2004, J NEUROTRAUM, V21, P1090, DOI 10.1089/0897715041651033; Szmydynger-Chodobska J, 2006, NEUROENDOCRINOLOGY, V84, P339, DOI 10.1159/000097989; Szmydynger-Chodobska J, 2012, J CEREBR BLOOD F MET, V32, P93, DOI 10.1038/jcbfm.2011.111; Szmydynger-Chodobska Joanna, 2007, Cerebrospinal Fluid Res, V4, P11, DOI 10.1186/1743-8454-4-11; Szmydynger-Chodobska J, 2009, J CEREBR BLOOD F MET, V29, P1503, DOI 10.1038/jcbfm.2009.71; Trabold R, 2008, J NEUROTRAUM, V25, P1459, DOI 10.1089/neu.2008.0597; Utagawa A, 2008, BRAIN RES, V1207, P155, DOI 10.1016/j.brainres.2008.02.057; Vakili A, 2005, J CEREBR BLOOD F MET, V25, P1012, DOI 10.1038/sj.jcbfm.9600097; Wang YF, 2006, J NEUROCHEM, V98, P1046, DOI 10.1111/j.1471-4159.2006.03950.x; Xu Miao, 2007, Chin J Traumatol, V10, P90; Zheng W, 2002, BRAIN RES, V958, P371, DOI 10.1016/S0006-8993(02)03683-1	30	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79328	10.1371/journal.pone.0079328	http://dx.doi.org/10.1371/journal.pone.0079328			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223928	Green Published, gold, Green Submitted			2022-12-27	WOS:000326499300075
J	Zhang, YW; Chen, YM; Liu, Y; Zhao, YJ; Liao, FF; Xu, HX				Zhang, Yun-Wu; Chen, Yaomin; Liu, Yun; Zhao, Yingjun; Liao, Francesca-Fang; Xu, Huaxi			APP Regulates NGF Receptor Trafficking and NGF-Mediated Neuronal Differentiation and Survival	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; NERVE GROWTH-FACTOR; TRANS-GOLGI NETWORK; ALZHEIMERS-DISEASE; AXONAL-TRANSPORT; INTRACELLULAR TRAFFICKING; TAU PHOSPHORYLATION; PC12 CELLS; EXPRESSION; KINASE	beta-amyloid precursor protein (APP) is a key factor in Alzheimer's disease (AD) but its physiological function is largely undetermined. APP has been found to regulate retrograde transport of nerve growth factor (NGF), which plays a crucial role in mediating neuronal survival and differentiation. Herein, we reveal the mechanism underlying APP-mediated NGF trafficking, by demonstrating a direct interaction between APP and the two NGF receptors, TrkA and p75NTR. Downregulation of APP leads to reduced cell surface levels of TrkA/p75NTR and increased endocytosis of TrkA/p75NTR and NGF. In addition, APP-deficient cells manifest defects in neurite outgrowth and are more susceptible to A beta-induced neuronal death at physiological levels of NGF. However, APP-deficient cells show better responses to NGF-stimulated differentiation and survival than control cells. This may be attributed to increased receptor endocytosis and enhanced activation of Akt and MAPK upon NGF stimulation in APP-deficient cells. Together, our results suggest that APP mediates endocytosis of NGF receptors through direct interaction, thereby regulating endocytosis of NGF and NGF-induced downstream signaling pathways for neuronal survival and differentiation.	[Zhang, Yun-Wu; Zhao, Yingjun] Xiamen Univ, Coll Med, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen, Peoples R China; [Zhang, Yun-Wu; Zhao, Yingjun] Xiamen Univ, Coll Med, Inst Neurosci, Xiamen, Peoples R China; [Zhang, Yun-Wu; Chen, Yaomin; Liu, Yun; Zhao, Yingjun; Xu, Huaxi] Sanford Burnham Med Res Inst, Neurodegenerat Dis Res Program, La Jolla, CA USA; [Liao, Francesca-Fang] Univ Tennessee, Hlth Sci Ctr, Coll Med, Dept Pharmacol, Memphis, TN USA	Xiamen University; Xiamen University; Sanford Burnham Prebys Medical Discovery Institute; University of Tennessee System; University of Tennessee Health Science Center	Zhang, YW (corresponding author), Xiamen Univ, Coll Med, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen, Peoples R China.	yunzhang@xmu.edu.cn; xuh@sanfordburnham.org	Xu, Huaxi/AAV-7177-2021; Chen, Yaomin/H-5205-2013; Zhao, Yingjun/G-9173-2016	Zhang, Yun-wu/0000-0002-7152-7630; Zhao, Yingjun/0000-0003-2832-6590	National Institutes of Health [R01AG038710, R01AG021173, R01AG044420, R01NS046673, R01AG031893, R21AG041934, R21NS083908]; Alzheimer's Association; National Natural Science Foundation of China [81225008, 81161120496]; Fundamental Research Funds for the Central Universities of China; Fok Ying Tung Education Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046673, R21NS083908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG044420, R01AG021173, R21AG041934, R01AG038710, R01AG031893] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Fok Ying Tung Education Foundation(Fok Ying Tung Education Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants from National Institutes of Health (R01AG038710, R01AG021173, R01AG044420, R01NS046673, R01AG031893, R21AG041934 and R21NS083908), the Alzheimer's Association, National Natural Science Foundation of China (81225008 and 81161120496), the Fundamental Research Funds for the Central Universities of China, and Fok Ying Tung Education Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergeron JJM, 1995, BIOSCIENCE REP, V15, P411, DOI 10.1007/BF01204345; Binnington JC, 2007, J NEUROCHEM, V101, P422, DOI 10.1111/j.1471-4159.2006.04378.x; Cabeza C, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-11; CAPORASO GL, 1994, J NEUROSCI, V14, P3122; Capsoni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037555; Cattaneo A, 2008, J ALZHEIMERS DIS, V15, P255; Cuello AC, 2007, CURR ALZHEIMER RES, V4, P351, DOI 10.2174/156720507781788774; Cuello AC, 2007, NEUROCHEM RES, V32, P1041, DOI 10.1007/s11064-006-9270-0; Cui BX, 2007, P NATL ACAD SCI USA, V104, P13666, DOI 10.1073/pnas.0706192104; Fombonne J, 2009, ANN NEUROL, V65, P294, DOI 10.1002/ana.21578; FUKUYAMA R, 1993, MOL BRAIN RES, V17, P17, DOI 10.1016/0169-328X(93)90067-Y; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; Han P, 2005, J NEUROSCI, V25, P11542, DOI 10.1523/JNEUROSCI.3831-05.2005; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Houeland G, 2010, J NEUROSCI, V30, P13089, DOI 10.1523/JNEUROSCI.0457-10.2010; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; Lazarov O, 2005, J NEUROSCI, V25, P2386, DOI 10.1523/JNEUROSCI.3089-04.2005; Liu Y, 2009, J BIOL CHEM, V284, P12145, DOI 10.1074/jbc.M808497200; Matrone C, 2013, BIOESSAYS, V35, P847, DOI 10.1002/bies.201300041; Matrone C, 2011, J NEUROSCI, V31, P11756, DOI 10.1523/JNEUROSCI.1960-11.2011; MILWARD EA, 1992, NEURON, V9, P129, DOI 10.1016/0896-6273(92)90228-6; NORDSTEDT C, 1993, J BIOL CHEM, V268, P608; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; Salehi A, 2006, NEURON, V51, P29, DOI 10.1016/j.neuron.2006.05.022; Tarr PE, 2002, BIOCHEM BIOPH RES CO, V295, P324, DOI 10.1016/S0006-291X(02)00678-2; Tian LL, 2012, BRAIN RES, V1440, P47, DOI 10.1016/j.brainres.2011.12.059; Wang B, 2007, P NATL ACAD SCI USA, V104, P14140, DOI 10.1073/pnas.0704070104; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; York RD, 2000, MOL CELL BIOL, V20, P8069, DOI 10.1128/MCB.20.21.8069-8083.2000; Zhang X, 2006, FASEB J, V20, P1272, DOI 10.1096/fj.06-5721fje; Zhang YW, 2007, P NATL ACAD SCI USA, V104, P10613, DOI 10.1073/pnas.0703903104; Zhang YW, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-3; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000; Zheng H, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-5; Zheng H, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-27	39	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e80571	10.1371/journal.pone.0080571	http://dx.doi.org/10.1371/journal.pone.0080571			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24224055	gold, Green Published, Green Submitted			2022-12-27	WOS:000326499300098
J	Alzaid, F; Cheung, HM; Preedy, VR; Sharp, PA				Alzaid, Fawaz; Cheung, Hoi-Man; Preedy, Victor R.; Sharp, Paul A.			Regulation of Glucose Transporter Expression in Human Intestinal Caco-2 Cells following Exposure to an Anthocyanin-Rich Berry Extract	PLOS ONE			English	Article							RAT SMALL-INTESTINE; SUGAR ABSORPTION; DIFFERENTIAL EXPRESSION; DIFFUSIVE COMPONENT; DIETARY POLYPHENOLS; EPITHELIAL-CELLS; APICAL GLUT2; SGLT1; MICE; ENTEROCYTES	Polyphenols contained within plant tissues are consumed in significant amounts in the human diet and are known to influence a number of biological processes. This study investigated the effects of an anthocyanin-rich berry-extract on glucose uptake by human intestinal Caco-2 cells. Acute exposure (15 min) to berry extract (0.125%, w/v) significantly decreased both sodium-dependent (Total uptake) and sodium-independent (facilitated uptake) H-3-D-glucose uptake. In longer-term studies, SGLT1 mRNA and GLUT2 mRNA expression were reduced significantly. Polyphenols are known to interact directly with glucose transporters to regulate the rate of glucose absorption. Our in vitro data support this mechanism and also suggest that berry flavonoids may modulate post-prandial glycaemia by decreasing glucose transporter expression. Further studies are warranted to investigate the longer term effects of berry flavonoids on the management of glycaemia in human volunteers.	[Alzaid, Fawaz; Cheung, Hoi-Man; Preedy, Victor R.; Sharp, Paul A.] Kings Coll London, Diabet & Nutr Sci Div, London WC2R 2LS, England	University of London; King's College London	Preedy, VR (corresponding author), Kings Coll London, Diabet & Nutr Sci Div, London WC2R 2LS, England.	victor.preedy@kcl.ac.uk; paul.a.sharp@kcl.ac.uk		Sharp, Paul Anthony/0000-0003-3400-6702; Alzaid, Fawaz/0000-0003-3056-3640	Ministry of Higher Education of the state of Kuwait; Arab-British Chamber of Commerce	Ministry of Higher Education of the state of Kuwait; Arab-British Chamber of Commerce	The authors thank the Ministry of Higher Education of the state of Kuwait and the Arab-British Chamber of Commerce for providing a studentship and extra consumables funding, respectively to F. Alzaid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Omar A, 2011, DIABETES, V60, P2598, DOI 10.2337/db10-1740; BURANT CF, 1994, AM J PHYSIOL, V267, pG71, DOI 10.1152/ajpgi.1994.267.1.G71; CHANTRET I, 1994, J CELL SCI, V107, P213; Chaston T, 2008, GUT, V57, DOI 10.1136/gut.2007.131722; Corpe CP, 1996, PFLUG ARCH EUR J PHY, V432, P192, DOI 10.1007/s004240050124; DEBNAM ES, 1975, J PHYSIOL-LONDON, V246, P181, DOI 10.1113/jphysiol.1975.sp010885; Faria A, 2009, MOL NUTR FOOD RES, V53, P1430, DOI 10.1002/mnfr.200900007; FERRARIS RP, 1993, P NATL ACAD SCI USA, V90, P5868, DOI 10.1073/pnas.90.12.5868; Gorboulev V, 2012, DIABETES, V61, P187, DOI 10.2337/db11-1029; Gouyon F, 2003, J PHYSIOL-LONDON, V552, P823, DOI 10.1113/jphysiol.2003.049247; Helliwell PA, 2000, BIOCHEM J, V350, P163, DOI 10.1042/0264-6021:3500163; Johnston K, 2005, FEBS LETT, V579, P1653, DOI 10.1016/j.febslet.2004.12.099; Kellett GL, 2008, ANNU REV NUTR, V28, P35, DOI 10.1146/annurev.nutr.28.061807.155518; Kellett GL, 2000, BIOCHEM J, V350, P155, DOI 10.1042/0264-6021:3500155; Kellett GL, 2001, J PHYSIOL-LONDON, V531, P585, DOI 10.1111/j.1469-7793.2001.0585h.x; Khoursandi S, 2004, AM J PHYSIOL-CELL PH, V287, pC1041, DOI 10.1152/ajpcell.00197.2004; Kwon O, 2007, FASEB J, V21, P366, DOI 10.1096/fj.06-6620com; Le Gall M, 2007, J CELL PHYSIOL, V213, P834, DOI 10.1002/jcp.21245; Mace OJ, 2007, J PHYSIOL-LONDON, V582, P379, DOI 10.1113/jphysiol.2007.130906; MAHRAOUI L, 1994, BIOCHEM J, V298, P629, DOI 10.1042/bj2980629; Manzano S, 2010, MOL NUTR FOOD RES, V54, P1773, DOI 10.1002/mnfr.201000019; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; McDougall GJ, 2005, J AGR FOOD CHEM, V53, P2760, DOI 10.1021/jf0489926; Morgan EL, 2007, J PHYSIOL-LONDON, V580, P593, DOI 10.1113/jphysiol.2006.124768; Oliveira DM, 2008, J AGR FOOD CHEM, V56, P10527, DOI 10.1021/jf8021404; Puupponen-Pimia R, 2005, BIOFACTORS, V23, P243, DOI 10.1002/biof.5520230410; Raybould HE, 2008, J PHYSIOL BIOCHEM, V64, P349, DOI 10.1007/BF03174091; Sharp PA, 1996, GUT, V39, P545, DOI 10.1136/gut.39.4.545; Tobin V, 2008, DIABETES, V57, P555, DOI 10.2337/db07-0928; Torronen R, 2010, BRIT J NUTR, V103, P1094, DOI 10.1017/S0007114509992868; Williams M, 2002, BBA-BIOMEMBRANES, V1559, P179, DOI 10.1016/S0005-2736(01)00449-7; Williamson G, 2013, MOL NUTR FOOD RES, V57, P48, DOI 10.1002/mnfr.201200511	32	87	90	3	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78932	10.1371/journal.pone.0078932	http://dx.doi.org/10.1371/journal.pone.0078932			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236070	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700067
J	Bhattacharyya, S; Saha, S; Giri, K; Lanza, IR; Nair, KS; Jennings, NB; Rodriguez-Aguayo, C; Lopez-Berestein, G; Basal, E; Weaver, AL; Visscher, DW; Cliby, W; Sood, AK; Bhattacharya, R; Mukherjee, P				Bhattacharyya, Sanjib; Saha, Sounik; Giri, Karuna; Lanza, Ian R.; Nair, K. Sreekumar; Jennings, Nicholas B.; Rodriguez-Aguayo, Cristian; Lopez-Berestein, Gabriel; Basal, Eati; Weaver, Amy L.; Visscher, Daniel W.; Cliby, William; Sood, Anil K.; Bhattacharya, Resham; Mukherjee, Priyabrata			Cystathionine Beta-Synthase (CBS) Contributes to Advanced Ovarian Cancer Progression and Drug Resistance	PLOS ONE			English	Article							NF-KAPPA-B; HYDROGEN-SULFIDE; CARDIOVASCULAR EVENTS; GOLD NANOPARTICLES; CELL-PROLIFERATION; MOUSE MODEL; IN-VITRO; H2S; GLUTATHIONE; APOPTOSIS	Background: Epithelial ovarian cancer is the leading cause of gynecologic cancer deaths. Most patients respond initially to platinum-based chemotherapy after surgical debulking, however relapse is very common and ultimately platinum resistance emerges. Understanding the mechanism of tumor growth, metastasis and drug resistant relapse will profoundly impact the therapeutic management of ovarian cancer. Methods/Principal Findings: Using patient tissue microarray (TMA), in vitro and in vivo studies we report a role of of cystathionine-beta-synthase (CBS), a sulfur metabolism enzyme in ovarian carcinoma. We report here that the expression of cystathionine-beta-synthase (CBS), a sulfur metabolism enzyme, is common in primary serous ovarian carcinoma. The in vitro effects of CBS silencing can be reversed by exogenous supplementation with the GSH and H2S producing chemical Na2S. Silencing CBS in a cisplatin resistant orthotopic model in vivo by nanoliposomal delivery of CBS siRNA inhibits tumor growth, reduces nodule formation and sensitizes ovarian cancer cells to cisplatin. The effects were further corroborated by immunohistochemistry that demonstrates a reduction of H&E, Ki-67 and CD31 positive cells in si-RNA treated as compared to scrambled-RNA treated animals. Furthermore, CBS also regulates bioenergetics of ovarian cancer cells by regulating mitochondrial ROS production, oxygen consumption and ATP generation. This study reports an important role of CBS in promoting ovarian tumor growth and maintaining drug resistant phenotype by controlling cellular redox behavior and regulating mitochondrial bioenergetics. Conclusion: The present investigation highlights CBS as a potential therapeutic target in relapsed and platinum resistant ovarian cancer.	[Bhattacharyya, Sanjib; Giri, Karuna] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN USA; [Saha, Sounik; Mukherjee, Priyabrata] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Stephenson Canc Ctr, Oklahoma City, OK USA; [Lanza, Ian R.; Nair, K. Sreekumar] Mayo Clin, Coll Med, Div Endocrinol, Rochester, MN USA; [Jennings, Nicholas B.; Sood, Anil K.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; [Rodriguez-Aguayo, Cristian; Lopez-Berestein, Gabriel; Sood, Anil K.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Lopez-Berestein, Gabriel; Sood, Anil K.] Univ Texas Houston, MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNA, Houston, TX 77030 USA; [Basal, Eati; Cliby, William] Mayo Clin, Coll Med, Dept Obstet & Gynecol, Rochester, MN USA; [Weaver, Amy L.] Mayo Clin, Coll Med, Dept Biostat & Bioinformat, Rochester, MN USA; [Visscher, Daniel W.] Mayo Clin, Coll Med, Dept Pathol, Rochester, MN USA; [Bhattacharya, Resham] Univ Oklahoma, Hlth Sci Ctr, Dept Obstet & Gynecol, Stephenson Canc Ctr, Oklahoma City, OK 73190 USA	Mayo Clinic; University of Oklahoma System; University of Oklahoma Health Sciences Center; Mayo Clinic; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Oklahoma System; University of Oklahoma Health Sciences Center	Bhattacharya, R (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Obstet & Gynecol, Stephenson Canc Ctr, Oklahoma City, OK 73190 USA.	Bhattacharya.Resham@mayo.edu; Mukherjee.Priyabrata@mayo.edu	jain, amita/ABA-9223-2020; Bhattacharyya, Sanjib/F-1577-2013; Sood, Anoop Kumar/A-7344-2013	Sood, Anoop Kumar/0000-0001-5702-4108; Lanza, Ian/0000-0002-9858-3384; RODRIGUEZ-AGUAYO, CRISTIAN/0000-0002-7880-7723; Bhattacharyya, Sanjib/0000-0001-8738-7188	National Institutes of Health (NIH) [CA135011, CA136494, CA 157481, CA148747]; Mayo Clinic Women's Cancer Program; NATIONAL CANCER INSTITUTE [P50CA136393, R01CA148747, R01CA136494, R01CA135011, R01CA157481] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041973] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Women's Cancer Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Institutes of Health (NIH) CA135011 and CA136494 (PM), CA 157481 (RB), CA148747 (WC) and Mayo Clinic Women's Cancer Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; Backos DS, 2012, BIOCHEM PHARMACOL, V83, P1005, DOI 10.1016/j.bcp.2011.11.016; Bao LM, 1998, ARCH BIOCHEM BIOPHYS, V350, P95, DOI 10.1006/abbi.1997.0486; Beard RS, 2011, AM J PHYSIOL-HEART C, V300, pH13, DOI 10.1152/ajpheart.00598.2010; Bhattacharya R, 2008, CLIN CANCER RES, V14, P7659, DOI 10.1158/1078-0432.CCR-08-1414; Blackstone E, 2005, SCIENCE, V308, P518, DOI 10.1126/science.1108581; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Caliendo G, 2010, J MED CHEM, V53, P6275, DOI 10.1021/jm901638j; Choi BK, 2004, NEUROTOXICOLOGY, V25, P915, DOI 10.1016/j.neuro.2004.06.002; Chompoosor A, 2010, SMALL, V6, P2246, DOI 10.1002/smll.201000463; Dayal S, 2012, BLOOD, V119, P3176, DOI 10.1182/blood-2011-09-380568; Desaint S, 2004, J BIOL CHEM, V279, P31157, DOI 10.1074/jbc.M401888200; Ebbing M, 2008, JAMA-J AM MED ASSOC, V300, P795, DOI 10.1001/jama.300.7.795; Fiorucci S, 2006, GASTROENTEROLOGY, V131, P259, DOI 10.1053/j.gastro.2006.02.033; Fu M, 2012, P NATL ACAD SCI USA, V109, P2943, DOI 10.1073/pnas.1115634109; Guzman MA, 2006, HUM MOL GENET, V15, P3168, DOI 10.1093/hmg/ddl393; Hutter E, 2004, BIOCHEM J, V380, P919, DOI 10.1042/BJ20040095; Laborde E, 2010, CELL DEATH DIFFER, V17, P1373, DOI 10.1038/cdd.2010.80; Lanza IR, 2009, METHOD ENZYMOL, V457, P349, DOI 10.1016/S0076-6879(09)05020-4; Lotem J, 1996, P NATL ACAD SCI USA, V93, P9166, DOI 10.1073/pnas.93.17.9166; Lou H, 2007, J BIOL CHEM, V282, P29470, DOI 10.1074/jbc.M706145200; Ludwig ML, 1997, ANNU REV BIOCHEM, V66, P269, DOI 10.1146/annurev.biochem.66.1.269; Mabuchi S, 2004, J BIOL CHEM, V279, P23477, DOI 10.1074/jbc.M313709200; Mangala LS, 2009, CLIN CANCER RES, V15, P3770, DOI 10.1158/1078-0432.CCR-08-2306; Martelli A, 2012, CURR MED CHEM, V19, P3325, DOI 10.2174/092986712801215928; Merritt WM, 2008, J NATL CANCER I, V100, P359, DOI 10.1093/jnci/djn024; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Mukherjee P, 2005, CLIN CANCER RES, V11, P3530, DOI 10.1158/1078-0432.CCR-04-2482; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Papa S, 2005, CELL DEATH DIFFER, V12, P1259, DOI 10.1038/sj.cdd.4401694; Paul BD, 2012, NAT REV MOL CELL BIO, V13, P499, DOI 10.1038/nrm3391; Predmore BL, 2010, J CARDIOVASC TRANSL, V3, P487, DOI 10.1007/s12265-010-9201-y; Rooyackers OE, 1996, P NATL ACAD SCI USA, V93, P15364, DOI 10.1073/pnas.93.26.15364; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shatalin K, 2011, SCIENCE, V334, P986, DOI 10.1126/science.1209855; Singh Simendra, 2012, J Exp Ther Oncol, V9, P303; Stein SJ, 2011, ONCOGENE, V30, P4557, DOI 10.1038/onc.2011.156; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Szabo C, 2013, P NATL ACAD SCI USA, V110, P12474, DOI 10.1073/pnas.1306241110; Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940; Troen AM, 2008, P NATL ACAD SCI USA, V105, P12474, DOI 10.1073/pnas.0805350105; Vandiver MS, 2012, J MOL MED, V90, P255, DOI 10.1007/s00109-012-0873-4; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Wang EF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017918; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; Xiao LC, 2012, INT J MOL MED, V30, P1126, DOI 10.3892/ijmm.2012.1090; Yin FQ, 2013, ONCOL REP, V30, P3, DOI 10.3892/or.2013.2446; Hung YP, 2011, CELL METAB, V14, P545, DOI 10.1016/j.cmet.2011.08.012	50	176	183	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79167	10.1371/journal.pone.0079167	http://dx.doi.org/10.1371/journal.pone.0079167			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236104	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700102
J	Cai, R; Richardus, JH; Looman, CWN; de Vlas, SJ				Cai, Rui; Richardus, Jan Hendrik; Looman, Caspar W. N.; de Vlas, Sake J.			Trends in High-Risk Sexual Behaviors among General Population Groups in China: A Systematic Review	PLOS ONE			English	Review							REPUBLIC-OF-CHINA; TRANSMITTED INFECTIONS; HIV; WORKERS	Background: The objective of this review was to investigate whether Chinese population groups that do not belong to classical high risk groups show an increasing trend of engaging in high-risk sexual behaviors. Methods: We systematically searched the English and Chinese literature on sexual risk behaviors published between January 1980 and March 2012 in PubMed and the China National Knowledge Infrastructure (CNKI). We included observational studies that focused on population groups other than commercial sex workers (CSWs) and their clients, and men who have sex with men (MSM) and quantitatively reported one of the following indicators of recent high-risk sexual behavior: premarital sex, commercial sex, multiple sex partners, condom use or sexually transmitted infections (STIs). We used generalized linear mixed model to examine the time trend in engaging in high-risk sexual behaviors. Results: We included 174 observational studies involving 932,931 participants: 55 studies reported on floating populations, 73 on college students and 46 on other groups (i.e. out-of-school youth, rural residents, and subjects from gynecological or obstetric clinics and premarital check-up centers). From the generalized linear mixed model, no significant trends in engaging in high-risk sexual behaviors were identified in the three population groups. Discussion: Sexual risk behaviors among certain general population groups have not increased substantially. These groups are therefore unlikely to incite a STI/HIV epidemic among the general Chinese population. Because the studied population groups are not necessarily representative of the general population, the outcomes found may not reflect those of the general population.	[Cai, Rui; Richardus, Jan Hendrik; Looman, Caspar W. N.; de Vlas, Sake J.] Univ Med Ctr, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Cai, Rui] China Scholarship Council, Beijing, Peoples R China	Erasmus University Rotterdam; Erasmus MC; China Scholarship Council	Cai, R (corresponding author), Univ Med Ctr, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands.	c.rui@erasmusmc.nl	González-Rodríguez, Diego/F-3425-2016; Richardus, Jan Hendrik/AAE-1278-2021	González-Rodríguez, Diego/0000-0001-7584-9103; Richardus, Jan Hendrik/0000-0003-0564-6313; de Vlas, Sake J./0000-0002-1830-5668	China Scholarship Council	China Scholarship Council(China Scholarship Council)	The work was funded by China Scholarship Council, [http://www.csc.edu.cn/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, DICT CHIN COR J PEK; Boyle M.H., 1998, EVID BASED MENT HLTH, V1, P193; Chen YuanShou, 2011, Modern Preventive Medicine, V38, P661; Cheng JQ, 2007, SEX TRANSM INFECT, V83, P347, DOI 10.1136/sti.2006.023655; China Development Gateway, 2011, CHIN MOD REP 2010; Chow EPF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022768; Cohen MS, 2000, SEX TRANSM DIS, V27, P143, DOI 10.1097/00007435-200003000-00004; Deng QP, 2000, J PRACTICAL NURSING, V16, P23; He AJ ZL, 2007, CHINA J MATERNAL CHI, V22, P2827; He N, 2007, BIOSCI TRENDS, V1, P72; Higgins LT, 2007, CULT HEALTH SEX, V9, P31, DOI 10.1080/13691050600963914; Hong Y, 2008, AIDS BEHAV, V12, P623, DOI 10.1007/s10461-007-9287-7; Huang YY, 2004, SEX TRANSM DIS, V31, P695, DOI 10.1097/01.olq.0000143107.06988.ea; Li ChengWen, 2010, Modern Preventive Medicine, V37, P1073; Ma J, 2001, Zhonghua Liu Xing Bing Xue Za Zhi, V22, P323; NDRC, 2013, CHIN MIGR DEV REP 20; NHFPC, 2013, CHIN HLTH STAT YB 20; Poon AN, 2011, AIDS CARE, V23, P5, DOI 10.1080/09540121.2011.554519; Shahmanesh M, 2008, TROP MED INT HEALTH, V13, P659, DOI 10.1111/j.1365-3156.2008.02040.x; Sun XY, 2011, CHIN J FAM PLANN, V19, P22; Tan Xiaodong, 2007, Int J Environ Res Public Health, V4, P248, DOI 10.3390/ijerph2007030009; Wang L, 2009, JAIDS-J ACQ IMM DEF, V50, P414, DOI 10.1097/QAI.0b013e3181958530; Wang Q, 2009, CHIN J AIDS STDS, V15, P398; Wu HM, 2000, CHINESE J PUBLIC HLT, V16, P1022; Wu JM, 2007, CHIN PRE MED, V10, P604; Wu ZY, 2011, B WORLD HEALTH ORGAN, V89, P227, DOI 10.2471/BLT.10.082552; Xue B, 2005, INT J STD AIDS, V16, P459, DOI 10.1258/0956462054308477; Yang HM, 2005, SEX TRANSM DIS, V32, P270, DOI 10.1097/01.olq.0000162360.11910.5a; Zhang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031076; Zhang Y, 2007, CHIN J SCH HLTH, V28, P109; 李爱兰, 1999, [中国公共卫生, China Public Health], V15, P545	31	15	20	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79320	10.1371/journal.pone.0079320	http://dx.doi.org/10.1371/journal.pone.0079320			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236121	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700120
J	Chen, S; Zhao, Y; Gou, WF; Zhao, S; Takano, Y; Zheng, HC				Chen, Shuo; Zhao, Yang; Gou, Wen-feng; Zhao, Shuang; Takano, Yasuo; Zheng, Hua-chuan			The Anti-Tumor Effects and Molecular Mechanisms of Suberoylanilide Hydroxamic Acid (SAHA) on the Aggressive Phenotypes of Ovarian Carcinoma Cells	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; CANCER; GROWTH; VORINOSTAT; APOPTOSIS; EXPRESSION; LYMPHOMA; SURVIVAL; INVASION; LINES	Histone deacetylase inhibitors (HDACi), such as suberoylanilide hydroxamic acid (SAHA), have been shown to act selectively on gene expression, and are potent inducers of growth arrest, differentiation and apoptosis in various types of cancers in vitro and in vivo. This study aimed to elucidate the anti-tumor effects and molecular mechanisms of SAHA on the aggressive phenotypes of ovarian carcinoma. Two pairs of cell lines (SKOV3 and SKOV3/DDP; HO8910 and HO8910-PM) were exposed to SAHA treatment, and the effects on acetyl-Histone H3 and H4 expression levels were analyzed and compared against the aggressive behaviors of ovarian carcinoma. Our results showed that SAHA suppressed proliferation in both a concentration-and time-dependent manner in all four cell lines; induced S/G2 arrest in SKOV3 and SKOV3/DDP cells; and conversely, induced G(1) arrest in HO8910 and HO8910-PM cells. SAHA treatment induced apoptosis and reduced migration, invasion and lamellipodia formation in the ovarian carcinoma cells; furthermore, SAHA decreased expression of Cyclin B-1 and CDC2P34 mRNA, and downregulated CDC2P34, Erk1/2, CyclinB1 and MMP-9 proteins. In contrast, SAHA increased expression of Caspase-3, p21 and p53 mRNA, and upregulated acetyl-Histones H3 and H4, Caspase-8, and p53 proteins. Basal acetylation of histone H3 and H4 was higher in ovarian carcinoma compared to normal ovarian tissues and benign ovarian tumors, and in borderline tumor than in normal ovarian tissues, and was positively correlated with differentiation and expression of the proliferative marker, Ki-67 (P<0.05).We suggest that SAHA may suppress growth, migration and invasion in ovarian carcinoma cells, including cisplatin-resistant or highly-invasive ovarian cells, by promoting histone acetylation and modulating their phenotype-related molecules. As such, aberrant acetylation of histone H3 and H4 may play an important role in the carcinogenesis and differentiation of ovarian carcinoma.	[Chen, Shuo; Zhao, Yang] China Med Univ, Affiliated Hosp 1, Dept Gynecol, Shenyang, Peoples R China; [Gou, Wen-feng; Zhao, Shuang; Zheng, Hua-chuan] China Med Univ, Coll Basic Med, Dept Biochem & Mol Biol, Shenyang, Peoples R China; [Takano, Yasuo] Kanagawa Canc Ctr, Clin Canc Inst, Yokohama, Kanagawa 2410815, Japan	China Medical University; China Medical University; Kanagawa Prefectural Cancer Center	Zheng, HC (corresponding author), China Med Univ, Coll Basic Med, Dept Biochem & Mol Biol, Shenyang, Peoples R China.	zheng_huachuan@hotmail.com		Shuo, Chen/0000-0002-5122-3656; Gou, Wenfeng/0000-0002-4828-4298	Shenyang Science and Technology Grant [F11-264-1-10, F12-277-1-01]; Liaoning Provincial Education Department [L2010633]; Liaoning Science and Technology Grant [2009225008-11]; Natural Scientific Foundation of China [81172371, 81202049]; Ministry of Education, Culture, Sports and Technology of Japan [23659958]; Shenyang Outstanding Talent Foundation of China	Shenyang Science and Technology Grant; Liaoning Provincial Education Department; Liaoning Science and Technology Grant; Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education, Culture, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Shenyang Outstanding Talent Foundation of China	This study was supported by Shenyang Outstanding Talent Foundation of China; Shenyang Science and Technology Grant (F11-264-1-10; F12-277-1-01); the Project Supported by the Scientific Research Fund of Liaoning Provincial Education Department (L2010633); Liaoning Science and Technology Grant (2009225008-11); the Natural Scientific Foundation of China (81172371; 81202049); and the Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports and Technology of Japan (23659958). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Yacoub N, 2012, J INVEST DERMATOL, V48, P217; Angelucci A, 2010, GYNECOL ONCOL, V119, P557, DOI 10.1016/j.ygyno.2010.07.036; Bandera CA, 2005, J REPROD MED, V50, P399; Chao KC, 2010, EUR J GYNAECOL ONCOL, V31, P402; Dietrich CS, 2010, GYNECOL ONCOL, V116, P126, DOI 10.1016/j.ygyno.2009.09.039; Duvic M, 2007, BLOOD, V109, P31, DOI 10.1182/blood-2006-06-025999; Emanuele S, 2007, APOPTOSIS, V12, P1327, DOI 10.1007/s10495-007-0063-y; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Hu X, 2011, CELL PROLIFERAT, V44, P205, DOI 10.1111/j.1365-2184.2011.00753.x; Jin JS, 2012, PATHOL ONCOL RES, V18, P713, DOI 10.1007/s12253-012-9499-7; Kawamata N, 2007, BLOOD, V110, P2667, DOI 10.1182/blood-2005-11-026344; Kelly WK, 2005, J CLIN ONCOL, V23, P3923, DOI 10.1200/JCO.2005.14.167; Kumada T, 2004, MODERN PATHOL, V17, P1141, DOI 10.1038/modpathol.3800165; Kumagai T, 2007, INT J CANCER, V121, P656, DOI 10.1002/ijc.22558; Lobjois V, 2009, EUR J CANCER, V45, P2402, DOI 10.1016/j.ejca.2009.05.026; Lu ZM, 2006, IUBMB LIFE, V58, P621, DOI 10.1080/15216540600957438; Marks PA, 2007, ONCOGENE, V26, P1351, DOI 10.1038/sj.onc.1210204; Minardi D, 2009, J CELL MOL MED, V13, P2115, DOI 10.1111/j.1582-4934.2008.00482.x; Miyazaki T, 2007, CELL CYCLE, V6, P1419; Modesitt SC, 2008, GYNECOL ONCOL, V109, P182, DOI 10.1016/j.ygyno.2008.01.009; Pajalunga D, 2008, CELL MOL LIFE SCI, V65, P8, DOI 10.1007/s00018-007-7425-z; Piek JMJ, 2008, ADV EXP MED BIOL, V622, P79, DOI 10.1007/978-0-387-68969-2_7; Rajendran P, 2011, CLIN EPIGENETICS, V3, DOI 10.1186/1868-7083-3-4; Vrana JA, 1999, ONCOGENE, V18, P7016, DOI 10.1038/sj.onc.1203176; Wang DG, 2008, INT J UROL, V15, P435, DOI 10.1111/j.1442-2042.2008.02025.x; Wang LG, 2009, AM J TRANSL RES, V1, P62; Xiao LJ, 2013, ONCOL LETT IN PRESS; Yamamoto S, 2008, ANTICANCER RES, V28, P1585; Yi X, 2008, BIOCHEM PHARMACOL, V75, P1697, DOI 10.1016/j.bcp.2007.10.035; Zheng HC, 2006, ANTICANCER RES, V26, P3579	30	28	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79781	10.1371/journal.pone.0079781	http://dx.doi.org/10.1371/journal.pone.0079781			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236158	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700158
J	Ehlen, F; Krugel, LK; Vonberg, I; Schoenecker, T; Kuhn, AA; Klostermann, F				Ehlen, Felicitas; Krugel, Lea K.; Vonberg, Isabelle; Schoenecker, Thomas; Kuehn, Andrea A.; Klostermann, Fabian			Intact Lexicon Running Slowly - Prolonged Response Latencies in Patients with Subthalamic DBS and Verbal Fluency Deficits	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; PARKINSONS-DISEASE; NUCLEUS STIMULATION; BASAL GANGLIA; DECLARATIVE/PROCEDURAL MODEL; NEUROPSYCHOLOGICAL CHANGES; BILATERAL STIMULATION; COGNITIVE FUNCTION; GLOBUS-PALLIDUS; FOLLOW-UP	Background: Verbal Fluency is reduced in patients with Parkinson's disease, particularly if treated with deep brain stimulation. This deficit could arise from general factors, such as reduced working speed or from dysfunctions in specific lexical domains. Objective: To test whether DBS-associated Verbal Fluency deficits are accompanied by changed dynamics of word processing. Methods: 21 Parkinson's disease patients with and 26 without deep brain stimulation of the subthalamic nucleus as well as 19 healthy controls participated in the study. They engaged in Verbal Fluency and (primed) Lexical Decision Tasks, testing phonemic and semantic word production and processing time. Most patients performed the experiments twice, ON and OFF stimulation or, respectively, dopaminergic drugs. Results: Patients generally produced abnormally few words in the Verbal Fluency Task. This deficit was more severe in patients with deep brain stimulation who additionally showed prolonged response latencies in the Lexical Decision Task. Slowing was independent of semantic and phonemic word priming. No significant changes of performance accuracy were obtained. The results were independent from the treatment ON or OFF conditions. Conclusion: Low word production in patients with deep brain stimulation was accompanied by prolonged latencies for lexical decisions. No indication was found that the latter slowing was due to specific lexical dysfunctions, so that it probably reflects a general reduction of cognitive working speed, also evident on the level of Verbal Fluency. The described abnormalities seem to reflect subtle sequelae of the surgical procedure for deep brain stimulation rather than of the proper neurostimulation.	[Ehlen, Felicitas; Krugel, Lea K.; Vonberg, Isabelle; Klostermann, Fabian] Charite, Dept Neurol, Motor & Cognit Grp, D-13353 Berlin, Germany; [Schoenecker, Thomas; Kuehn, Andrea A.] Charite, Dept Neurol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Klostermann, F (corresponding author), Charite, Dept Neurol, Motor & Cognit Grp, D-13353 Berlin, Germany.	fabian.klostermann@charite.de		Kuhn, Andrea A./0000-0002-4134-9060; Ehlen, Felicitas/0000-0003-4595-1822	German Research Foundation [Kl 1276/5 in KFO 247]	German Research Foundation(German Research Foundation (DFG))	The project was supported by the German Research Foundation, Kl 1276/5 in KFO 247. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMDP, 2007, AMDP SYST MAN DOK PS; Apfelbaum KS, 2011, PSYCHON B REV, V18, P141, DOI 10.3758/s13423-010-0039-8; Ardouin C, 1999, ANN NEUROL, V46, P217, DOI 10.1002/1531-8249(199908)46:2<217::AID-ANA11>3.0.CO;2-Z; Arnott WL, 2001, J CLIN EXP NEUROPSYC, V23, P502, DOI 10.1076/jcen.23.4.502.1224; Aschenbrenner A, 2000, RWT REGENSBURGER WOR; BENTIN S, 1985, ELECTROEN CLIN NEURO, V60, P343, DOI 10.1016/0013-4694(85)90008-2; Birn RM, 2010, NEUROIMAGE, V49, P1099, DOI 10.1016/j.neuroimage.2009.07.036; Bronstein JM, 2011, ARCH NEUROL-CHICAGO, V68, P165, DOI 10.1001/archneurol.2010.260; Castner JE, 2007, BRAIN, V130, P1395, DOI 10.1093/brain/awm059; Cilia R, 2007, PARKINSONISM RELAT D, V13, P290, DOI 10.1016/j.parkreldis.2006.11.011; Contarino MF, 2007, J NEUROL NEUROSUR PS, V78, P248, DOI 10.1136/jnnp.2005.086660; CROSSON B, 1985, BRAIN LANG, V25, P257, DOI 10.1016/0093-934X(85)90085-9; Crosson B., 2021, NEUROPSYCHOL REV, V31; De Gaspari D, 2006, PARKINSONISM RELAT D, V12, P289, DOI 10.1016/j.parkreldis.2006.01.001; Dromey C, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/796205; Frank MJ, 2007, SCIENCE, V318, P1309, DOI 10.1126/science.1146157; Funkiewiez A, 2004, J NEUROL NEUROSUR PS, V75, P834, DOI 10.1136/jnnp.2002.009803; Gironell A, 2003, J NEUROL, V250, P917, DOI 10.1007/s00415-003-1109-x; Henry JD, 2004, J INT NEUROPSYCH SOC, V10, P608, DOI 10.1017/S1355617704104141; Herzog J, 2010, NERVENARZT, V81, P669, DOI 10.1007/s00115-010-2938-3; HOLCOMB PJ, 1990, LANG COGNITIVE PROC, V5, P281, DOI 10.1080/01690969008407065; Koss AM, 2005, ANN NEUROL, V58, P168, DOI 10.1002/ana.20525; Krack P, 2003, NEW ENGL J MED, V349, P1925, DOI 10.1056/NEJMoa035275; Lefaucheur R, 2012, J NEUROL SCI, V321, P96, DOI 10.1016/j.jns.2012.07.033; Marshall DF, 2012, EUR J NEUROL; McDonald C, 1996, J CLIN EXP NEUROPSYC, V18, P793, DOI 10.1080/01688639608408303; MEYER DE, 1971, J EXP PSYCHOL, V90, P227, DOI 10.1037/h0031564; Mikos A, 2011, NEUROIMAGE, V54, pS238, DOI 10.1016/j.neuroimage.2010.03.068; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Moretti R, 2003, PARKINSONISM RELAT D, V10, P73, DOI 10.1016/S1353-8020(03)00073-7; Morrison CE, 2004, ARCH CLIN NEUROPSYCH, V19, P165, DOI 10.1016/S0887-6177(03)00004-0; Nadeau SE, 1997, BRAIN LANG, V58, P355, DOI 10.1006/brln.1997.1707; NEELY JH, 1976, MEM COGNITION, V4, P648, DOI 10.3758/BF03213230; Obeso I, 2012, BEHAV NEUROL, V25, P111, DOI 10.1155/2012/673610; Obeso JA, 2008, MOVEMENT DISORD, V23, pS548, DOI 10.1002/mds.22062; Okun MS, 2009, ANN NEUROL, V65, P586, DOI 10.1002/ana.21596; Pillon B, 2000, NEUROLOGY, V55, P411, DOI 10.1212/WNL.55.3.411; Radeau M, 1998, BIOL PSYCHOL, V48, P183, DOI 10.1016/S0301-0511(98)00012-X; Riedel O, 2008, J NEUROL, V255, P255, DOI 10.1007/s00415-008-0720-2; RUBENSTEIN H, 1970, J VERB LEARN VERB BE, V9, P487, DOI 10.1016/S0022-5371(70)80091-3; Saez-Zea C, 2012, EUR NEUROL, V68, P361, DOI 10.1159/000341380; Saint-Cyr JA, 2000, BRAIN, V123, P2091, DOI 10.1093/brain/123.10.2091; Schonecker T, 2009, AM J NEURORADIOL, V30, P1914, DOI 10.3174/ajnr.A1741; Smeding HMM, 2006, NEUROLOGY, V66, P1830, DOI 10.1212/01.wnl.0000234881.77830.66; Teichmann M, 2008, NEUROPSYCHOLOGIA, V46, P174, DOI 10.1016/j.neuropsychologia.2007.07.022; Temel Y, 2005, PROG NEUROBIOL, V76, P393, DOI 10.1016/j.pneurobio.2005.09.005; Tinaz S, 2006, BRAIN RES, V1067, P239, DOI 10.1016/j.brainres.2005.10.057; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Troster AI, 1998, BRAIN COGNITION, V38, P125, DOI 10.1006/brcg.1998.1025; Ullman MT, 2001, J PSYCHOLINGUIST RES, V30, P37, DOI 10.1023/A:1005204207369; Ullman MT, 2004, COGNITION, V92, P231, DOI 10.1016/j.cognition.2003.10.008; Ullman MT, 1997, J COGNITIVE NEUROSCI, V9, P266, DOI 10.1162/jocn.1997.9.2.266; Volkmann J, 2004, J CLIN NEUROPHYSIOL, V21, P6, DOI 10.1097/00004691-200401000-00003; Wallesch C-W., 1988, APHASIA, P256; Whelan BM, 2003, J NEUROL NEUROSUR PS, V74, P1543, DOI 10.1136/jnnp.74.11.1543; Witt K, 2008, LANCET NEUROL, V7, P605, DOI 10.1016/S1474-4422(08)70114-5; Witt K, 2013, BRAIN, V136, P2109, DOI 10.1093/brain/awt151; Wojtecki L, 2006, ARCH NEUROL-CHICAGO, V63, P1273, DOI 10.1001/archneur.63.9.1273; Yamanaka T, 2012, CLIN NEUROL NEUROSUR, V114, P347, DOI 10.1016/j.clineuro.2011.11.009; York MK, 2009, J NEUROL SCI, V287, P159, DOI 10.1016/j.jns.2009.08.003; Zahodne LB, 2009, J NEUROL, V256, P1321, DOI 10.1007/s00415-009-5121-7; Zangaglia R, 2009, MOVEMENT DISORD, V24, P1621, DOI 10.1002/mds.22603; Zec RF, 1999, ARCH CLIN NEUROPSYCH, V14, P255, DOI 10.1016/S0887-6177(98)00008-0	63	21	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79247	10.1371/journal.pone.0079247	http://dx.doi.org/10.1371/journal.pone.0079247			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236114	gold, Green Published, Green Submitted			2022-12-27	WOS:000327254700113
J	OuYang, PY; Su, Z; Mao, YP; Deng, WG; Xie, FY				OuYang, Pu-Yun; Su, Zhen; Mao, Yan-Ping; Deng, Wuguo; Xie, Fang-Yun			Combination of EGFR-TKIs and Chemotherapy as First-Line Therapy for Advanced NSCLC: A Meta-Analysis	PLOS ONE			English	Article							CELL LUNG-CANCER; GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITORS; PHASE-III TRIAL; GEFITINIB; MUTATIONS; ERLOTINIB; PACLITAXEL; CARBOPLATIN; SENSITIVITY	The impact of combining epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) and chemotherapy as first-line therapy for patients with advanced non-small-cell lung cancer (NSCLC) remains controversial. Therefore, randomized trials that compared this combined regimen with chemotherapy or EGFR-TKIs monotherapy were included for this meta-analysis. We used published hazard ratios (HRs), if available, or derived treatment estimates from other survival data. Pooled estimates of treatment efficacy of the combined regimen in the entire unselected population and selected patients by EGFR-mutation status and smoking history were calculated. Eight trials eventually entered into this meta-analysis, including 4585 patients. Overall, the combined regimen significantly delayed disease progression (HR = 0.81, 95% CI 0.69-0.95, P = 0.01); subgroup analysis showed significantly higher progression free survival advantages in Asian patients (P<0.001), with sequential combination of TKIs and chemotherapy (P = 0.02). In selected patients by EGFR-mutation, both mutation positive (HR = 0.48, 95% CI 0.28-0.83, P = 0.009) and negative (HR = 0.84, 95% CI 0.72-0.98, P = 0.02) patients gained progression free survival benefit from the combined regimen, albeit the magnitude of benefit was marginally larger in mutation positive patients (P = 0.05). In selected patients by smoking history, never/light smokers achieved a great progression free survival benefit from the combined regimen (HR = 0.51, 95% CI 0.35-0.74, P = 0.0004). Unfortunately, the combined regimen had no significant impact on overall survival, irrespective of ethnicity, dose schedules or EGFR-mutation status. Severe anorexia (RR = 2.01, 95% CI 1.11-3.63; P = 0.02) and diarrhea (RR = 2.70, 95% CI 1.94-3.76; P<0.001) were more frequent in the combined regimen arm. This strategy of combining EGFR-TKIs and chemotherapy deserved to be considered in the future, although it is not approved for advanced NSCLC at the moment.	[OuYang, Pu-Yun; Su, Zhen; Mao, Yan-Ping; Deng, Wuguo; Xie, Fang-Yun] Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [OuYang, Pu-Yun; Su, Zhen; Mao, Yan-Ping; Xie, Fang-Yun] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University	Deng, WG (corresponding author), Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.	dengwg@sysucc.org.cn; xiefy@sysucc.org.cn						Bai H, 2012, J CLIN ONCOL, V30, P3077, DOI 10.1200/JCO.2011.39.3744; Bell DW, 2005, J CLIN ONCOL, V23, P8081, DOI 10.1200/JCO.2005.02.7078; Bria E, 2011, ANN ONCOL, V22, P2277, DOI 10.1093/annonc/mdq742; Carey KD, 2006, CANCER RES, V66, P8163, DOI 10.1158/0008-5472.CAN-06-0453; Chan SK, 2006, EUR J CANCER, V42, P17, DOI 10.1016/j.ejca.2005.07.031; Chen P, 2011, EUR J CLIN PHARMACOL, V67, P235, DOI 10.1007/s00228-010-0965-4; Ciardiello F, 2000, CLIN CANCER RES, V6, P2053; Davies AM, 2006, CLIN LUNG CANCER, V7, P385, DOI 10.3816/CLC.2006.n.021; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; Gao GH, 2012, INT J CANCER, V131, pE822, DOI 10.1002/ijc.27396; Gatzemeier U, 2007, J CLIN ONCOL, V25, P1545, DOI 10.1200/JCO.2005.05.1474; Giaccone G, 2004, J CLIN ONCOL, V22, P777, DOI 10.1200/JCO.2004.08.001; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Herbst RS, 2004, J CLIN ONCOL, V22, P785, DOI 10.1200/JCO.2004.07.215; Herbst RS, 2005, J CLIN ONCOL, V23, P5892, DOI 10.1200/JCO.2005.02.840; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hirsch FR, 2011, J CLIN ONCOL, V29, P3567, DOI 10.1200/JCO.2010.34.4929; Hotta K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026646; Janne PA, 2012, J CLIN ONCOL, V30, P2063, DOI 10.1200/JCO.2011.40.1315; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Mok TSK, 2009, J CLIN ONCOL, V27, P5080, DOI 10.1200/JCO.2008.21.5541; Moyer JD, 1997, CANCER RES, V57, P4838; Mukohara T, 2005, JNCI-J NATL CANCER I, V97, P1185, DOI 10.1093/jnci/dji238; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Petrelli F, 2012, CLIN LUNG CANCER, V13, P107, DOI 10.1016/j.cllc.2011.08.005; Shigematsu H, 2006, INT J CANCER, V118, P257, DOI 10.1002/ijc.21496; Sirotnak FM, 2000, CLIN CANCER RES, V6, P4885; Solit DB, 2005, CLIN CANCER RES, V11, P1983, DOI 10.1158/1078-0432.CCR-04-1347; Wu YL, 2013, LANCET ONCOL, V14, P777, DOI 10.1016/S1470-2045(13)70254-7; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	36	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79000	10.1371/journal.pone.0079000	http://dx.doi.org/10.1371/journal.pone.0079000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236082	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700080
J	Simone, D; Bay, DC; Leach, T; Turner, RJ				Simone, Domenico; Bay, Denice C.; Leach, Thorin; Turner, Raymond J.			Diversity and Evolution of Bacterial Twin Arginine Translocase Protein, TatC, Reveals a Protein Secretion System That Is Evolving to Fit Its Environmental Niche	PLOS ONE			English	Article							PERIPLASMIC NITRATE REDUCTASE; ESCHERICHIA-COLI; TRANSPORT-SYSTEM; SIGNAL PEPTIDE; MEMBRANE-PROTEINS; BINDING-SITE; EXPORT; COMPONENT; SEQUENCE; PATHWAY	Background: The twin-arginine translocation (Tat) protein export system enables the transport of fully folded proteins across a membrane. This system is composed of two integral membrane proteins belonging to TatA and TatC protein families and in some systems a third component, TatB, a homolog of TatA. TatC participates in substrate protein recognition through its interaction with a twin arginine leader peptide sequence. Methodology/Principal Findings: The aim of this study was to explore TatC diversity, evolution and sequence conservation in bacteria to identify how TatC is evolving and diversifying in various bacterial phyla. Surveying bacterial genomes revealed that 77% of all species possess one or more tatC loci and half of these classes possessed only tatC and tatA genes. Phylogenetic analysis of diverse TatC homologues showed that they were primarily inherited but identified a small subset of taxonomically unrelated bacteria that exhibited evidence supporting lateral gene transfer within an ecological niche. Examination of bacilli tatCd/tatCy isoform operons identified a number of known and potentially new Tat substrate genes based on their frequent association to tatC loci. Evolutionary analysis of these Bacilli isoforms determined that TatCy was the progenitor of TatCd. A bacterial TatC consensus sequence was determined and highlighted conserved and variable regions within a three dimensional model of the Escherichia coli TatC protein. Comparative analysis between the TatC consensus sequence and Bacilli TatCd/y isoform consensus sequences revealed unique sites that may contribute to isoform substrate specificity or make TatA specific contacts. Synonymous to non-synonymous nucleotide substitution analyses of bacterial tatC homologues determined that tatC sequence variation differs dramatically between various classes and suggests TatC specialization in these species. Conclusions/Significance: TatC proteins appear to be diversifying within particular bacterial classes and its specialization may be driven by the substrates it transports and the environment of its host.	[Simone, Domenico] CNR, Inst Biomembranes & Bioenerget, Bari, Italy; [Bay, Denice C.; Leach, Thorin; Turner, Raymond J.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	Consiglio Nazionale delle Ricerche (CNR); University of Calgary	Turner, RJ (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	turnerr@ucalgary.ca	Turner, Raymond J./M-3961-2015; Bay, Denice/D-1682-2016; Simone, Domenico/B-5427-2014	Turner, Raymond J./0000-0002-9263-0776; Bay, Denice/0000-0002-3620-828X; Simone, Domenico/0000-0003-2858-9809	Canadian Institute of Health Research (CIHR)	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Funding for this work was provided by a grant from the Canadian Institute of Health Research (CIHR) to RJT. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Alfaro ME, 2003, MOL BIOL EVOL, V20, P255, DOI 10.1093/molbev/msg028; Allen SCH, 2002, J BIOL CHEM, V277, P10362, DOI 10.1074/jbc.M109135200; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AWADE AC, 1994, PROTEINS, V20, P34, DOI 10.1002/prot.340200106; Behrendt J, 2004, FEMS MICROBIOL LETT, V234, P303, DOI 10.1016/j.femsle.2004.03.048; Blaudeck N, 2005, J BIOL CHEM, V280, P3426, DOI 10.1074/jbc.M411210200; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; Buchanan G, 2002, MOL MICROBIOL, V43, P1457, DOI 10.1046/j.1365-2958.2002.02853.x; Butler CS, 2001, FEBS LETT, V500, P71, DOI 10.1016/S0014-5793(01)02577-7; Butler CS, 2000, BIOCHEM J, V352, P859, DOI 10.1042/0264-6021:3520859; Caldelari I, 2008, ARCH MICROBIOL, V189, P597, DOI 10.1007/s00203-008-0356-8; Clark AC, 1999, J MOL BIOL, V285, P1765, DOI 10.1006/jmbi.1998.2402; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Eijlander RT, 2009, MICROBIOL-SGM, V155, P1776, DOI 10.1099/mic.0.027987-0; Eijlander RT, 2009, J BACTERIOL, V191, P196, DOI 10.1128/JB.01264-08; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Goosens VJ, 2013, ANTIOXID REDOX SIGN, V18, P1159, DOI 10.1089/ars.2012.4664; Goosens VJ, 2013, J PROTEOME RES, V12, P796, DOI 10.1021/pr300866f; Hatzixanthis K, 2005, BIOCHEM SOC T, V33, P124, DOI 10.1042/BST0330124; Hatzixanthis K, 2003, MOL MICROBIOL, V49, P1377, DOI 10.1046/j.1365-2958.2003.03642.x; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hinsley AP, 2002, MICROBIOL-SGM, V148, P3631, DOI 10.1099/00221287-148-11-3631; Hinsley AP, 2001, FEBS LETT, V497, P45, DOI 10.1016/S0014-5793(01)02428-0; Holzapfel E, 2007, BIOCHEMISTRY-US, V46, P2892, DOI 10.1021/bi062205b; Ize B, 2004, J BIOL CHEM, V279, P47543, DOI 10.1074/jbc.M406910200; Jack RL, 2001, J BACTERIOL, V183, P1801, DOI 10.1128/JB.183.5.1801-1804.2001; Jack RL, 2004, EMBO J, V23, P3962, DOI 10.1038/sj.emboj.7600409; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; Jongbloed JDH, 2002, J BIOL CHEM, V277, P44068, DOI 10.1074/jbc.M203191200; Jongbloed JDH, 2000, J BIOL CHEM, V275, P41350, DOI 10.1074/jbc.M004887200; Jongbloed JDH, 2004, MOL MICROBIOL, V54, P1319, DOI 10.1111/j.1365-2958.2004.04341.x; Kneuper H, 2012, MOL MICROBIOL, V85, P945, DOI 10.1111/j.1365-2958.2012.08151.x; Kreutzenbeck P, 2007, J BIOL CHEM, V282, P7903, DOI 10.1074/jbc.M610126200; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Lausberg F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039867; Lavander M, 2006, INFECT IMMUN, V74, P1768, DOI 10.1128/IAI.74.3.1768-1776.2006; Leake MC, 2008, P NATL ACAD SCI USA, V105, P15376, DOI 10.1073/pnas.0806338105; Luke I, 2008, ARCH MICROBIOL, V190, P685, DOI 10.1007/s00203-008-0420-4; Madhusudhan M.S., 2007, CURR PROTOC PROTEIN, V2; Maldonado B, 2011, J MOL MICROB BIOTECH, V20, P168, DOI 10.1159/000329076; Maldonado B, 2011, FEBS LETT, V585, P478, DOI 10.1016/j.febslet.2011.01.016; Mangels D, 2005, J MOL BIOL, V345, P415, DOI 10.1016/j.jmb.2004.10.043; Matos CFRO, 2009, EMBO REP, V10, P474, DOI 10.1038/embor.2009.34; Maurer C, 2010, MOL BIOL CELL, V21, P4151, DOI 10.1091/mbc.E10-07-0585; McCutcheon JP, 2012, NAT REV MICROBIOL, V10, P13, DOI 10.1038/nrmicro2670; McDevitt CA, 2006, FEBS J, V273, P5656, DOI 10.1111/j.1742-4658.2006.05554.x; Miethke M, 2013, BBA-MOL CELL RES, V1833, P2267, DOI 10.1016/j.bbamcr.2013.05.027; Monteferrante CG, 2012, J BIOL CHEM, V287, P29789, DOI 10.1074/jbc.M112.378190; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Orriss GL, 2007, FEBS LETT, V581, P4091, DOI 10.1016/j.febslet.2007.07.044; OTA T, 1994, MOL BIOL EVOL, V11, P613; Palmer T, 2005, TRENDS MICROBIOL, V13, P175, DOI 10.1016/j.tim.2005.02.002; Palmer T, 2012, NAT REV MICROBIOL, V10, P483, DOI 10.1038/nrmicro2814; Penfold DW, 2006, FEMS MICROBIOL LETT, V262, P135, DOI 10.1111/j.1574-6968.2006.00333.x; Pop O, 2002, J BIOL CHEM, V277, P3268, DOI 10.1074/jbc.M110829200; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rasmussen T, 2005, DALTON T, P3501, DOI 10.1039/b501846c; Ridder ANJA, 2009, J BACTERIOL, V191, P4410, DOI 10.1128/JB.00215-09; Rollauer SE, 2012, NATURE, V492, P210, DOI 10.1038/nature11683; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sargent F, 2007, BIOCHEM SOC T, V35, P835, DOI 10.1042/BST0350835; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Tarry M, 2009, J MOL BIOL, V386, P504, DOI 10.1016/j.jmb.2008.12.043; van der Ploeg R, 2011, J BIOL CHEM, V286, P43759, DOI 10.1074/jbc.M111.243824; van der Ploeg R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018140; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200; Wu LF, 2000, J MOL MICROB BIOTECH, V2, P179; Yen MR, 2002, ARCH MICROBIOL, V177, P441, DOI 10.1007/s00203-002-0408-4; Zoufaly S, 2012, J BIOL CHEM, V287, P13430, DOI 10.1074/jbc.M112.343798	76	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78742	10.1371/journal.pone.0078742	http://dx.doi.org/10.1371/journal.pone.0078742			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236045	Green Submitted, gold, Green Published			2022-12-27	WOS:000327254700042
J	Tonelli, P; Mouret, JB				Tonelli, Paul; Mouret, Jean-Baptiste			On the Relationships between Generative Encodings, Regularity, and Learning Abilities when Evolving Plastic Artificial Neural Networks	PLOS ONE			English	Article							EVOLUTIONARY ROBOTICS; WIRING OPTIMIZATION; BASAL GANGLIA; BRAIN; MODEL	A major goal of bio-inspired artificial intelligence is to design artificial neural networks with abilities that resemble those of animal nervous systems. It is commonly believed that two keys for evolving nature-like artificial neural networks are (1) the developmental process that links genes to nervous systems, which enables the evolution of large, regular neural networks, and (2) synaptic plasticity, which allows neural networks to change during their lifetime. So far, these two topics have been mainly studied separately. The present paper shows that they are actually deeply connected. Using a simple operant conditioning task and a classic evolutionary algorithm, we compare three ways to encode plastic neural networks: a direct encoding, a developmental encoding inspired by computational neuroscience models, and a developmental encoding inspired by morphogen gradients (similar to HyperNEAT). Our results suggest that using a developmental encoding could improve the learning abilities of evolved, plastic neural networks. Complementary experiments reveal that this result is likely the consequence of the bias of developmental encodings towards regular structures: (1) in our experimental setup, encodings that tend to produce more regular networks yield networks with better general learning abilities; (2) whatever the encoding is, networks that are the more regular are statistically those that have the best learning abilities.	[Tonelli, Paul; Mouret, Jean-Baptiste] Univ Paris 06, CNRS, ISIR, UMR 7222, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Mouret, JB (corresponding author), Univ Paris 06, CNRS, ISIR, UMR 7222, Paris, France.	mouret@isir.upmc.fr	Mouret, Jean Baptiste/B-5166-2019; Mouret, Jean-Baptiste/A-9949-2012	Mouret, Jean Baptiste/0000-0002-2513-027X; Mouret, Jean-Baptiste/0000-0002-2513-027X	Agence Nationale de la Recherche; Creadapt [ANR-12-JS03-0009]; EvoNeuro [ANR-09-EMER-005]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Creadapt; EvoNeuro	This work was funded by the Agence Nationale de la Recherche (http://www.agence-nationale-recherche.fr/) by the grants Creadapt (ANR-12-JS03-0009) and EvoNeuro (ANR-09-EMER-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; [Anonymous], 2018, REINFORCEMENT LEARNI, DOI 10.1016/S1364-6613(99)01331-5; [Anonymous], 1998, NEURAL NETWORKS COMP; Bongard J, 2002, IEEE C EVOL COMPUTAT, P1872, DOI 10.1109/CEC.2002.1004528; Braitenberg V, 2001, J COMPUT NEUROSCI, V10, P71, DOI 10.1023/A:1008920127052; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chalmers DJ, 1990, P 1990 CONN MOD SUMM, P81; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; Cherniak C, 2004, P NATL ACAD SCI USA, V101, P1081, DOI 10.1073/pnas.0305212101; Chklovskii DB, 2002, NEURON, V34, P341, DOI 10.1016/S0896-6273(02)00679-7; Clune J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2863; Clune J, 2011, IEEE T EVOLUT COMPUT, V15, P346, DOI 10.1109/TEVC.2010.2104157; Cybenko G., 1989, Mathematics of Control, Signals, and Systems, V2, P303, DOI 10.1007/BF02551274; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Deb K., 2001, WIL INT S SYS OPT; Floreano D., 2008, BIOINSPIRED ARTIFICI; Floreano D, 2008, EVOL INTELL, V1, P47, DOI 10.1007/s12065-007-0002-4; Frank MJ, 2006, PSYCHOL REV, V113, P300, DOI 10.1037/0033-295X.113.2.300; Girard B, 2008, NEURAL NETWORKS, V21, P628, DOI 10.1016/j.neunet.2008.03.009; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Grossberg S, 2000, TRENDS COGN SCI, V4, P233, DOI 10.1016/S1364-6613(00)01464-9; Gruau F, 1993, EVOL COMPUT, V1, P213, DOI 10.1162/evco.1993.1.3.213; Gurney K, 2001, BIOL CYBERN, V84, P411, DOI 10.1007/PL00007985; Hayashida M, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S2-S13; Hebb Donald O., 1949, ORG BEHAV; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Hornby GS, 2005, GECCO 2005: Genetic and Evolutionary Computation Conference, Vols 1 and 2, P1729; Hornby GS, 2002, ARTIF LIFE, V8, P223, DOI 10.1162/106454602320991837; Houk JC, 1995, MODELS INFORMATION P, P249; Ijspeert AJ, 2007, SCIENCE, V315, P1416, DOI 10.1126/science.1138353; Junttila T, 2007, SIAM PROC S, P135; Kandel E.R., 2012, PRINCIPLES NEURAL SC; Katebi H, 2012, TURING 100 EPIC, P181; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Lehman J, 2011, EVOL COMPUT, V19, P189, DOI 10.1162/EVCO_a_00025; Li M., 2008, INTRO KOLMOGOROV COM; Lipson Hod, 2007, Journal of Biological Physics and Chemistry, V7, P125, DOI 10.4024/40701.jbpc.07.04; Mattiussi C, 2007, IEEE T EVOLUT COMPUT, V11, P596, DOI 10.1109/TEVC.2006.886801; Mckay B. D., 1981, C NUMERANTIUM, V30, P45, DOI DOI 10.1016/J.JSC.2013.09.003; Meunier D, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00200; Minsky ML, 1987, PERCEPTRONS EXPANDED; Mouret JB, 2012, EVOL COMPUT, V20, P91, DOI 10.1162/EVCO_a_00048; Mouret JB, 2010, P GECCO, P587; Mouret JB, 2011, STUD COMPUT INTELL, V341, P139; Mouret JB, 2009, IEEE C EVOL COMPUTAT, P1161, DOI 10.1109/CEC.2009.4983077; MOWSHOWITZ A, 1968, B MATH BIOPHYS, V30, P175, DOI 10.1007/BF02476948; MOWSHOWITZ A, 1968, B MATH BIOPHYS, V30, P225, DOI 10.1007/BF02476692; Niv Y, 2002, ADAPT BEHAV, V10, P5, DOI 10.1177/10597123020101001; Ollion C, 2012, ARTIF LIFE, V13, P407; Peshkin L, 2007, IEEE DATA COMPR CONF, P53; Pfeifer R., 2006, BODY SHAPES WAY WE T; Pinville T, 2011, GECCO-2011: PROCEEDINGS OF THE 13TH ANNUAL GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P259; Potts R, 1999, EVOL ANTHROPOL, V7, P81, DOI 10.1002/(SICI)1520-6505(1998)7:3<81::AID-EVAN3>3.3.CO;2-1; Richerson PJ, 2005, HANDBOOK OF EVOLUTION, VOL 2: THE EVOLUTION OF LIVING SYSTEMS (INCLUDING HOMINIDS), P223, DOI 10.1002/9783527619719.ch7; Risi S, 2011, GECCO-2011: PROCEEDINGS OF THE 13TH ANNUAL GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P1539; Risi S, 2010, ADAPT BEHAV, V18, P470, DOI 10.1177/1059712310379923; Risi S, 2010, LECT NOTES ARTIF INT, V6226, P533, DOI 10.1007/978-3-642-15193-4_50; Rougier NP, 2006, NEURAL NETWORKS, V19, P573, DOI 10.1016/j.neunet.2005.04.004; Soltoggio A, 2009, P 11 ANN C GEN EV CO, P169; Soltoggio A., 2008, ARTIFICIAL LIFE, VXI, P569; Soltoggio A, 2007, IEEE C EVOL COMPUTAT, P2471, DOI 10.1109/CEC.2007.4424781; Stanley KO, 2009, ARTIF LIFE, V15, P185, DOI 10.1162/artl.2009.15.2.15202; Stanley KO, 2003, ARTIF LIFE, V9, P93, DOI 10.1162/106454603322221487; Stanley KO, 2002, EVOL COMPUT, V10, P99, DOI 10.1162/106365602320169811; Striedter G.F., 2005, PRINCIPLES BRAIN EVO; Urzelai J, 2001, EVOL COMPUT, V9, P495, DOI 10.1162/10636560152642887; Verbancsics P, 2011, GECCO-2011: PROCEEDINGS OF THE 13TH ANNUAL GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P1483; Zenil H, 2013, ARXIV13060322	68	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79138	10.1371/journal.pone.0079138	http://dx.doi.org/10.1371/journal.pone.0079138			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236099	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700097
J	Du, XP; Ewert, DL; Cheng, WH; West, MB; Lu, JZ; Li, W; Floyd, RA; Kopke, RD				Du, Xiaoping; Ewert, Donald L.; Cheng, Weihua; West, Matthew B.; Lu, Jianzhong; Li, Wei; Floyd, Robert A.; Kopke, Richard D.			Effects of Antioxidant Treatment on Blast-Induced Brain Injury	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; IMPULSE NOISE BLAST; REDUCES OXIDATIVE STRESS; N-ACETYLCYSTEINE; C-FOS; RAT-BRAIN; INDUCED NEUROTRAUMA; COCHLEAR NUCLEUS; SPIRAL GANGLION; ANIMAL-MODEL	Blast-induced traumatic brain injury has dramatically increased in combat troops in today's military operations. We previously reported that antioxidant treatment can provide protection to the peripheral auditory end organ, the cochlea. In the present study, we examined biomarker expression in the brains of rats at different time points (3 hours to 21 days) after three successive 14 psi blast overpressure exposures to evaluate antioxidant treatment effects on blast-induced brain injury. Rats in the treatment groups received a combination of antioxidants (2,4-disulfonyl alpha-phenyl tertiary butyl nitrone and N-acetylcysteine) one hour after blast exposure and then twice a day for the following two days. The biomarkers examined included an oxidative stress marker (4-hydroxy-2-nonenal, 4-HNE), an immediate early gene (c-fos), a neural injury marker (glial fibrillary acidic protein, GFAP) and two axonal injury markers [amyloid beta (A4) precursor protein, APP, and 68 kDa neurofilament, NF-68]. The results demonstrate that blast exposure induced or up-regulated the following: 4-HNE production in the dorsal hippocampus commissure and the forceps major corpus callosum near the lateral ventricle; c-fos and GFAP expression in most regions of the brain, including the retrosplenial cortex, the hippocampus, the cochlear nucleus, and the inferior colliculus; and NF-68 and APP expression in the hippocampus, the auditory cortex, and the medial geniculate nucleus (MGN). Antioxidant treatment reduced the following: 4-HNE in the hippocampus and the forceps major corpus callosum, c-fos expression in the retrosplenial cortex, GFAP expression in the dorsal cochlear nucleus (DCN), and APP and NF-68 expression in the hippocampus, auditory cortex, and MGN. This preliminary study indicates that antioxidant treatment may provide therapeutic protection to the central auditory pathway (the DCN and MGN) and the non-auditory central nervous system (hippocampus and retrosplenial cortex), suggesting that these compounds have the potential to simultaneously treat blast-induced injuries in the brain and auditory system.	[Du, Xiaoping; Ewert, Donald L.; Cheng, Weihua; West, Matthew B.; Lu, Jianzhong; Li, Wei; Kopke, Richard D.] Hough Ear Inst, Oklahoma City, OK 73112 USA; [Floyd, Robert A.; Kopke, Richard D.] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; [Kopke, Richard D.] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK USA; [Kopke, Richard D.] Univ Oklahoma, Hlth Sci Ctr, Dept Otolaryngol, Oklahoma City, OK USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Kopke, RD (corresponding author), Hough Ear Inst, Oklahoma City, OK 73112 USA.	rkopke@houghear.org			United States Department of Navy, Office of Naval Research [N00014-09-1-0999]	United States Department of Navy, Office of Naval Research	This research was supported by grant N00014-09-1-0999 from the United States Department of Navy, Office of Naval Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Abi-Hachem Ralph N, 2010, Recent Pat CNS Drug Discov, V5, P147; Ahmed F, 2012, ELECTROPHORESIS, V33, P3705, DOI 10.1002/elps.201200299; Armstrong KL, 1998, BIOCHEM BIOPH RES CO, V253, P114, DOI 10.1006/bbrc.1998.9762; Baalman KL, 2013, J NEUROTRAUM, V30, P741, DOI 10.1089/neu.2012.2478; Baki SGA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012490; Bemeur C, 2010, METAB BRAIN DIS, V25, P241, DOI 10.1007/s11011-010-9201-2; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; BROWN MC, 1995, J COMP NEUROL, V357, P85, DOI 10.1002/cne.903570109; BROWN RFR, 1993, INT J EXP PATHOL, V74, P151; Cernak I, 2000, J NEUROTRAUM, V17, P53, DOI 10.1089/neu.2000.17.53; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Cernak I, 1999, BRAIN INJURY, V13, P1005; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chang EY, 2011, J MATERN-FETAL NEO M, V24, P732, DOI 10.3109/14767058.2010.528089; Chavko M, 2009, SHOCK, V32, P325, DOI 10.1097/SHK.0b013e31819c38f1; Chen G, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/716458; Choi CH, 2011, FREE RADICAL RES, V45, P1162, DOI 10.3109/10715762.2011.605360; Clausen F, 2008, J NEUROTRAUM, V25, P1449, DOI 10.1089/neu.2008.0585; CORNELIUS C, 2013, ANTIOXID REDOX SIGNA; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; De Gasperi Rita, 2012, Front Neurol, V3, P177, DOI 10.3389/fneur.2012.00177; DELLANNA ME, 1995, EXP NEUROL, V131, P144, DOI 10.1016/0014-4886(95)90016-0; Dennis AM, 2009, J NEUROTRAUM, V26, P889, DOI 10.1089/neu.2008.0512; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; Du Xiaoping, 2011, Int J Otolaryngol, V2011, P612690, DOI 10.1155/2011/612690; Du XP, 2012, HEARING RES, V283, P1, DOI 10.1016/j.heares.2011.11.013; DunnMeynell AA, 1997, BRAIN RES, V761, P25, DOI 10.1016/S0006-8993(97)00210-2; EHRET G, 1991, BRAIN RES, V567, P350, DOI 10.1016/0006-8993(91)90819-H; Elsayed NM, 2003, TOXICOLOGY, V189, P63, DOI 10.1016/S0300-483X(03)00153-7; Elsayed NM, 2000, TOXICOLOGY, V155, P91, DOI 10.1016/S0300-483X(00)00281-X; Elsayed NM, 1997, TOXICOLOGY, V121, P1, DOI 10.1016/S0300-483X(97)03651-2; Ewert DL, 2012, HEARING RES, V285, P29, DOI 10.1016/j.heares.2012.01.013; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Floyd RA, 2008, FREE RADICAL BIO MED, V45, P1361, DOI 10.1016/j.freeradbiomed.2008.08.017; Franke LM, 2012, J REHABIL RES DEV, V49, P985, DOI 10.1682/JRRD.2011.12.0250; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Gleich O, 1995, NEUROREPORT, V7, P29, DOI 10.1097/00001756-199512000-00006; Gorbunov NV, 1997, AM J PHYSIOL-LUNG C, V272, pL320, DOI 10.1152/ajplung.1997.272.2.L320; Haase GM, 2011, AM J OTOLARYNG, V32, P55, DOI 10.1016/j.amjoto.2009.09.002; Han M, 2003, CELL MOL BIOL, V49, P1249; Harch PG, 2012, J NEUROTRAUM, V29, P168, DOI 10.1089/neu.2011.1895; Hausmann R, 2000, INT J LEGAL MED, V113, P70, DOI 10.1007/PL00007711; Herrera DG, 1996, PROG NEUROBIOL, V50, P83, DOI 10.1016/S0301-0082(96)00021-4; Hicdonmez T, 2006, NEUROCHEM RES, V31, P473, DOI 10.1007/s11064-006-9040-z; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Holland MA, 2008, J NEUROTRAUM, V25, P140, DOI 10.1089/neu.2007.0312; Hoshino S, 2003, NEUROL MED-CHIR, V43, P165, DOI 10.2176/nmc.43.165; Idrizbegovic E, 1998, BRAIN RES, V800, P86, DOI 10.1016/S0006-8993(98)00504-6; Jatana M, 2006, PEDIATR RES, V59, P684, DOI 10.1203/01.pdr.0000215045.91122.44; Kamnaksh A, 2012, ELECTROPHORESIS, V33, P3680, DOI 10.1002/elps.201200319; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; Kato K, 2007, J NEUROSURG, V106, P667, DOI 10.3171/jns.2007.106.4.667; Kaur C, 1997, NEUROSCI RES, V27, P317, DOI 10.1016/S0168-0102(97)01164-4; Kaur C., 1997, Annals Academy of Medicine Singapore, V26, P27; KAUR C, 1995, NEUROPATH APPL NEURO, V21, P369, DOI 10.1111/j.1365-2990.1995.tb01073.x; Khan M, 2004, J NEUROSCI RES, V76, P519, DOI 10.1002/jnr.20087; KOCHANEK PM, 2013, J NEUROTRAUMA; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kopke RD, 2007, HEARING RES, V226, P114, DOI 10.1016/j.heares.2006.10.008; KOVESDI E, 2012, NEUROLOGIST, V3, P111, DOI DOI 10.3389/FNEUR.2012.00111; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; Kraus KS, 2010, NEUROSCIENCE, V167, P1216, DOI 10.1016/j.neuroscience.2010.02.071; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; Kuroda S, 1999, J CEREBR BLOOD F MET, V19, P778, DOI 10.1097/00004647-199907000-00008; Lee TF, 2008, PEDIATR RES, V64, P256, DOI 10.1203/PDR.0b013e31817cfcc0; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Leung Lai Yee, 2008, Molecular & Cellular Biomechanics, V5, P155; Li DR, 2012, LEGAL MED-TOKYO, V14, P84, DOI 10.1016/j.legalmed.2011.12.007; Liu JQ, 2010, J NEUROTRAUM, V27, P1865, DOI 10.1089/neu.2010.1325; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lu J, 2012, J NEUROTRAUM, V29, P1434, DOI 10.1089/neu.2010.1591; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Marshall JWB, 2001, STROKE, V32, P190, DOI 10.1161/01.STR.32.1.190; Miller JM, 2007, J NEUROSCI RES, V85, P1959, DOI 10.1002/jnr.21320; Moochhala SM, 2004, J TRAUMA, V56, P393, DOI 10.1097/01.TA.0000066181.50879.7A; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Nakagawa A, 2008, ACTA NEUROCHIR SUPPL, V102, P421, DOI 10.1007/978-3-211-85578-2_82; Niu YL, 2011, ARCH BIOCHEM BIOPHYS, V515, P89, DOI 10.1016/j.abb.2011.07.016; Olucha F E, 1997, Acta Otorrinolaringol Esp, V48, P85; Patterson JH, 1997, TOXICOLOGY, V121, P29, DOI 10.1016/S0300-483X(97)03653-6; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Phillips Y Y, 1989, Ann Otol Rhinol Laryngol Suppl, V140, P17; PODE D, 1989, MIL MED, V154, P288; Pun Pamela B L, 2011, Front Neurol, V2, P19, DOI 10.3389/fneur.2011.00019; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; ROBERTO M, 1989, ANN OTO RHINOL LARYN, V98, P23; Saint Marie RL, 1999, J COMP NEUROL, V404, P258, DOI 10.1002/(SICI)1096-9861(19990208)404:2<258::AID-CNE9>3.0.CO;2-U; Saljo A, 2002, J NEUROTRAUM, V19, P379, DOI 10.1089/089771502753594945; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Saljo A, 2010, J NEUROTRAUM, V27, P383, DOI 10.1089/neu.2009.1053; SATO K, 1993, ACTA OTO-LARYNGOL, P18; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Sekhon B, 2003, BRAIN RES, V971, P1, DOI 10.1016/S0006-8993(03)02244-3; Sekiya T, 2009, EXP NEUROL, V218, P117, DOI 10.1016/j.expneurol.2009.04.014; Singh V, 2007, INDIAN J EXP BIOL, V45, P1037; SKOTAK M, 2013, J NEUROTRAUMA; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Svetlov SI, 2009, J NEUROTRAUM, V26, P913, DOI 10.1089/neu.2008.0609; Tumer N, 2013, NEUROSCI LETT, V544, P62, DOI 10.1016/j.neulet.2013.03.042; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Valiyaveettil M, 2013, NEUROSCI LETT, V539, P1, DOI 10.1016/j.neulet.2013.01.028; Valiyaveettil M, 2012, J REHABIL RES DEV, V49, P1153, DOI 10.1682/JRRD.2011.09.0182; Valiyaveettil M, 2012, NEUROSCI LETT, V506, P141, DOI 10.1016/j.neulet.2011.10.067; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Wallhausser-Franke E, 2003, EXP BRAIN RES, V153, P649, DOI 10.1007/s00221-003-1614-2; Wang XY, 2007, ANN NEUROL, V61, P263, DOI 10.1002/ana.21066; Wu AG, 2006, EXP NEUROL, V197, P309, DOI 10.1016/j.expneurol.2005.09.004; Wu JA, 2011, AM J OTOLARYNG, V32, P8, DOI 10.1016/j.amjoto.2009.08.012; Xiong Y, 1999, J NEUROTRAUM, V16, P1067, DOI 10.1089/neu.1999.16.1067; Yi JH, 2006, J NEUROTRAUM, V23, P86, DOI 10.1089/neu.2006.23.86; Zhao ZG, 2001, BRAIN RES, V909, P46, DOI 10.1016/S0006-8993(01)02618-X	120	28	31	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80138	10.1371/journal.pone.0080138	http://dx.doi.org/10.1371/journal.pone.0080138			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224042	Green Submitted, Green Published, gold			2022-12-27	WOS:000326597400113
J	Hong, JJ; Wu, TY; Chang, TY; Chen, CY				Hong, Jun-Jie; Wu, Tzong-Yuan; Chang, Tsair-Yuan; Chen, Chung-Yung			Viral IRES Prediction System - a Web Server for Prediction of the IRES Secondary Structure In Silico	PLOS ONE			English	Article							INDEPENDENT TRANSLATION; RNA PSEUDOKNOTS; ENTRY SITE; INITIATION; VIRUS; SEQUENCE; SUBUNIT; REGION; CODON; TOOL	The internal ribosomal entry site (IRES) functions as cap-independent translation initiation sites in eukaryotic cells. IRES elements have been applied as useful tools for bi-cistronic expression vectors. Current RNA structure prediction programs are unable to predict precisely the potential IRES element. We have designed a viral IRES prediction system (VIPS) to perform the IRES secondary structure prediction. In order to obtain better results for the IRES prediction, the VIPS can evaluate and predict for all four different groups of IRESs with a higher accuracy. RNA secondary structure prediction, comparison, and pseudoknot prediction programs were implemented to form the three-stage procedure for the VIPS. The backbone of VIPS includes: the RNAL fold program, aimed to predict local RNA secondary structures by minimum free energy method; the RNA Align program, intended to compare predicted structures; and pknotsRG program, used to calculate the pseudoknot structure. VIPS was evaluated by using UTR database, IRES database and Virus database, and the accuracy rate of VIPS was assessed as 98.53%, 90.80%, 82.36% and 80.41% for IRES groups 1, 2, 3, and 4, respectively. This advance useful search approach for IRES structures will facilitate IRES related studies. The VIPS on-line website service is available at http://140.135.61.250/vips/.	[Hong, Jun-Jie; Wu, Tzong-Yuan; Chen, Chung-Yung] Chung Yuan Christian Univ, Dept Biosci Technol, Chungli, Taiwan; [Wu, Tzong-Yuan; Chen, Chung-Yung] Chung Yuan Christian Univ, Ctr Nanotechnol, Chungli, Taiwan; [Wu, Tzong-Yuan; Chen, Chung-Yung] Chung Yuan Christian Univ, Inst Biomed Technol, Chungli, Taiwan; [Wu, Tzong-Yuan] Chung Yuan Christian Univ, R&D Ctr Membrane Technol, Chungli, Taiwan; [Chang, Tsair-Yuan] Ming Chuan Univ, Informat Management Dept, Tao Yuan, Taiwan	Chung Yuan Christian University; Chung Yuan Christian University; Chung Yuan Christian University; Chung Yuan Christian University; Ming Chuan University	Chen, CY (corresponding author), Chung Yuan Christian Univ, Dept Biosci Technol, Chungli, Taiwan.	cychen@cycu.edu.tw	Chen, Chung-Yung/AAJ-2111-2020		National Science Counsel of Taiwan [NSC-99-2632-M-033-001-MY3]; R&D Center of Membrane Technology, Chung Yuan Christian University, Chung-Li, Taiwan	National Science Counsel of Taiwan(Ministry of Science and Technology, Taiwan); R&D Center of Membrane Technology, Chung Yuan Christian University, Chung-Li, Taiwan	This project was supported by the National Science Counsel of Taiwan (NSC-99-2632-M-033-001-MY3), and the R&D Center of Membrane Technology, Chung Yuan Christian University, Chung-Li, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed F., 2011, J NAT SCI BIOL MED, V2, P2; Baird SD, 2006, RNA, V12, P1755, DOI 10.1261/rna.157806; Berry KE, 2011, STRUCTURE, V19, P1456, DOI 10.1016/j.str.2011.08.002; Berry KE, 2010, RNA, V16, P1559, DOI 10.1261/rna.2197210; Brierley I, 2008, BIOCHEM SOC T, V36, P684, DOI 10.1042/BST0360684; De Rijk P, 2003, BIOINFORMATICS, V19, P299, DOI 10.1093/bioinformatics/19.2.299; EVSTAFIEVA AG, 1991, NUCLEIC ACIDS RES, V19, P665, DOI 10.1093/nar/19.3.665; Filbin ME, 2009, CURR OPIN STRUC BIOL, V19, P267, DOI 10.1016/j.sbi.2009.03.005; Firth AE, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-193; Gao JZM, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-27; Giedroc DP, 2000, J MOL BIOL, V298, P167, DOI 10.1006/jmbi.2000.3668; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; HALLER AA, 1993, J VIROL, V67, P7461, DOI 10.1128/JVI.67.12.7461-7471.1993; Hofacker IL, 2004, BIOINFORMATICS, V20, P186, DOI 10.1093/bioinformatics/btg388; JANG SK, 1990, ENZYME, V44, P292, DOI 10.1159/000468766; Jiang T, 2002, J COMPUT BIOL, V9, P371, DOI 10.1089/10665270252935511; Kieft JS, 2008, TRENDS BIOCHEM SCI, V33, P274, DOI 10.1016/j.tibs.2008.04.007; Manzano M, 2011, J BIOL CHEM, V286, P22521, DOI 10.1074/jbc.M111.234302; Mathews DH, 2004, RNA, V10, P1178, DOI 10.1261/rna.7650904; Otto GA, 2004, CELL, V119, P369, DOI 10.1016/j.cell.2004.09.038; Pestova TV, 2004, EMBO REP, V5, P906, DOI 10.1038/sj.embor.7400240; Reeder J, 2007, NUCLEIC ACIDS RES, V35, pW320, DOI 10.1093/nar/gkm258; Rijnbrand RCA, 1996, VIROLOGY, V226, P47, DOI 10.1006/viro.1996.0626; Shibuya N, 2003, J VIROL, V77, P12002, DOI 10.1128/JVI.77.22.12002-12010.2003; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Wower IK, 2009, RNA, V15, P128, DOI 10.1261/rna.1192409; Wu TY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-160; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	28	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79288	10.1371/journal.pone.0079288	http://dx.doi.org/10.1371/journal.pone.0079288			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223923	Green Published, Green Submitted, gold			2022-12-27	WOS:000326597400059
J	Purdy, SJ; Bussell, JD; Nunn, CP; Smith, SM				Purdy, Sarah J.; Bussell, John D.; Nunn, Christopher P.; Smith, Steven M.			Leaves of the Arabidopsis maltose exporter1 Mutant Exhibit a Metabolic Profile with Features of Cold Acclimation in the Warm	PLOS ONE			English	Article							SUCROSE-SPECIFIC INDUCTION; FREEZING TOLERANCE; LOW-TEMPERATURES; GENE-EXPRESSION; PLANT; STARCH; PHOTOSYNTHESIS; THALIANA; CARBON; BIOSYNTHESIS	Background: Arabidopsis plants accumulate maltose from starch breakdown during cold acclimation. The Arabidopsis mutant, maltose excess1-1, accumulates large amounts of maltose in the plastid even in the warm, due to a deficient plastid envelope maltose transporter. We therefore investigated whether the elevated maltose level in mex1-1 in the warm could result in changes in metabolism and physiology typical of WT plants grown in the cold. Principal Findings: Grown at 21 degrees C, mex1-1 plants were much smaller, with fewer leaves, and elevated carbohydrates and amino acids compared to WT. However, after transfer to 4 degrees C the total soluble sugar pool and amino acid concentration was in equal abundance in both genotypes, although the most abundant sugar in mex1-1 was still maltose whereas sucrose was in greatest abundance in WT. The chlorophyll a/b ratio in WT was much lower in the cold than in the warm, but in mex1-1 it was low in both warm and cold. After prolonged growth at 4 degrees C, the shoot biomass, rosette diameter and number of leaves at bolting were similar in mex1-1 and WT. Conclusions: The mex1-1 mutation in warm-grown plants confers aspects of cold acclimation, including elevated levels of sugars and amino acids and low chlorophyll a/b ratio. This may in turn compromise growth of mex1-1 in the warm relative to WT. We suggest that elevated maltose in the plastid could be responsible for key aspects of cold acclimation.	[Purdy, Sarah J.; Bussell, John D.; Nunn, Christopher P.; Smith, Steven M.] Univ Western Australia, Ctr Excellence Plant Energy Biol, Australian Res Council, Perth, WA 6009, Australia; [Purdy, Sarah J.; Nunn, Christopher P.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales	University of Western Australia; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	Purdy, SJ (corresponding author), Univ Western Australia, Ctr Excellence Plant Energy Biol, Australian Res Council, Perth, WA 6009, Australia.	sap@aber.ac.uk	Bussell, John/E-7952-2010; Smith, Steven/HDM-9496-2022; Smith, Steven M/G-7183-2015; Nunn, Chris/P-1909-2019	Smith, Steven M/0000-0001-5661-9994; Purdy, Sarah/0000-0002-6334-069X	Australian Research Council [DP0666434, FF0457721]; Centres of Excellence scheme of the Government of Western Australia	Australian Research Council(Australian Research Council); Centres of Excellence scheme of the Government of Western Australia	The authors gratefully acknowledge funding support from the Australian Research Council (grants DP0666434 and FF0457721) and the Centres of Excellence scheme of the Government of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boughton BA, 2011, ANAL CHEM, V83, P7523, DOI 10.1021/ac201610x; Chalker-Scott L, 1999, PHOTOCHEM PHOTOBIOL, V70, P1, DOI 10.1111/j.1751-1097.1999.tb01944.x; Chang CSJ, 2008, PLANT J, V54, P205, DOI 10.1111/j.1365-313X.2008.03401.x; Coruzzi GM, 2001, CURR OPIN PLANT BIOL, V4, P247, DOI 10.1016/S1369-5266(00)00168-0; Diaz C, 2005, PLANT PHYSIOL, V138, P898, DOI 10.1104/pp.105.060764; Douce R, 2001, TRENDS PLANT SCI, V6, P167, DOI 10.1016/S1360-1385(01)01892-1; Edner C, 2007, PLANT PHYSIOL, V145, P17, DOI 10.1104/pp.107.104224; Espinoza C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014101; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Guy Charles, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P231; Hurry V, 2000, PLANT J, V24, P383, DOI 10.1046/j.1365-313x.2000.00888.x; Kaplan F, 2005, PLANT J, V44, P730, DOI 10.1111/j.1365-313X.2005.02565.x; Kaplan F, 2004, PLANT PHYSIOL, V136, P4159, DOI 10.1104/pp.104.052142; Kaplan F, 2004, PLANT PHYSIOL, V135, P1674, DOI 10.1104/pp.104.040808; Kaplan F, 2007, PLANT J, V50, P967, DOI 10.1111/j.1365-313X.2007.03100.x; Less H, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-14; Lundmark M, 2006, PLANT CELL ENVIRON, V29, P1703, DOI 10.1111/j.1365-3040.2006.01543.x; Meyer RC, 2007, P NATL ACAD SCI USA, V104, P4759, DOI 10.1073/pnas.0609709104; Ni ZF, 2009, NATURE, V457, P327, DOI 10.1038/nature07523; Niittyla T, 2004, SCIENCE, V303, P87, DOI 10.1126/science.1091811; Purdy SJ, 2011, J PLANT PHYSIOL, V168, P263, DOI 10.1016/j.jplph.2010.07.001; Reyes-Diaz M, 2006, J EXP BOT, V57, P3687, DOI 10.1093/jxb/erl125; Roessner U, 2001, PLANT CELL, V13, P11, DOI 10.1105/tpc.13.1.11; Solfanelli C, 2006, PLANT PHYSIOL, V140, P637, DOI 10.1104/pp.105.072579; Stettler M, 2009, MOL PLANT, V2, P1233, DOI 10.1093/mp/ssp093; Stitt M, 2002, CURR OPIN PLANT BIOL, V5, P199, DOI 10.1016/S1369-5266(02)00258-3; Strand A, 1999, PLANT PHYSIOL, V119, P1387, DOI 10.1104/pp.119.4.1387; Strand A, 1997, PLANT J, V12, P605, DOI 10.1046/j.1365-313X.1997.00605.x; Sulpice R, 2009, P NATL ACAD SCI USA, V106, P10348, DOI 10.1073/pnas.0903478106; Teng S, 2005, PLANT PHYSIOL, V139, P1840, DOI 10.1104/pp.105.066688; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; VANOOSTEN JJ, 1994, PLANT CELL ENVIRON, V17, P913, DOI 10.1111/j.1365-3040.1994.tb00320.x; Wanner LA, 1999, PLANT PHYSIOL, V120, P391, DOI 10.1104/pp.120.2.391; Xin ZG, 1998, P NATL ACAD SCI USA, V95, P7799, DOI 10.1073/pnas.95.13.7799; Yano R, 2005, PLANT PHYSIOL, V138, P837, DOI 10.1104/pp.104.056374; Zeeman SC, 2007, BIOCHEM J, V401, P13, DOI 10.1042/BJ20061393; Zhan XQ, 2012, P NATL ACAD SCI USA, V109, P18198, DOI 10.1073/pnas.1216199109; Zhou Xiaoping, 2007, U S Forest Service Pacific Northwest Research Station General Technical Report PNW-GTR, P1	38	18	18	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79412	10.1371/journal.pone.0079412	http://dx.doi.org/10.1371/journal.pone.0079412			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223944	gold, Green Published, Green Submitted			2022-12-27	WOS:000326597400064
J	Kim, CK; Lee, CH; Lee, SB; Oh, JW				Kim, Chang Kyu; Lee, Chi Ho; Lee, Seung-Bae; Oh, Jae-Wook			Simplified Large-Scale Refolding, Purification, and Characterization of Recombinant Human Granulocyte-Colony Stimulating Factor in Escherichia coli	PLOS ONE			English	Article							CELL-DENSITY CULTIVATION; G-CSF; PROTEIN; EXPRESSION; CHEMOTHERAPY; CLONING	Granulocyte-colony stimulating factor (G-CSF) is a pleiotropic cytokine that stimulates the development of committed hematopoietic progenitor cells and enhances the functional activity of mature cells. Here, we report a simplified method for fed-batch culture as well as the purification of recombinant human (rh) G-CSF. The new system for rhG-CSF purification was performed using not only temperature shift strategy without isopropyl-l-thio-beta-d-galactoside (IPTG) induction but also the purification method by a single step of prep-HPLC after the pH precipitation of the refolded samples. Through these processes, the final cell density and overall yield of homogenous rhG-CSF were obtained 42.8 g as dry cell weights, 1.75 g as purified active proteins, from 1 L culture broth, respectively. The purity of rhG-CSF was finally 99% since the isoforms of rhG-CSF could be separated through the prep-HPLC step. The result of biological activity indicated that purified rhG-CSF has a similar profile to the World Health Organization (WHO) 2nd International Standard for G-CSF. Taken together, our results demonstrate that the simple purification through a single step of prep-HPLC may be valuable for the industrial-scale production of biologically active proteins.	[Kim, Chang Kyu; Oh, Jae-Wook] Konkuk Univ, Coll Anim Biosci & Biotechnol, Dept Anim Biotechnol, Anim Resources Res Ctr, Seoul, South Korea; [Lee, Chi Ho] Konkuk Univ, Coll Anim Biosci & Biotechnol, Dept Food Sci & Biotechnol Anim Resources, Seoul, South Korea; [Lee, Seung-Bae] Sangji Univ, Div Anim Resources & Life Sci, Wonju, South Korea	Konkuk University; Konkuk University; Sangji University	Oh, JW (corresponding author), Konkuk Univ, Coll Anim Biosci & Biotechnol, Dept Anim Biotechnol, Anim Resources Res Ctr, Seoul, South Korea.	ohjw@konkuk.ac.kr	Oh, Jae-Wook/D-3597-2011		Konkuk University	Konkuk University	This study was supported by Konkuk University in 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreda DR, 2004, DEV COMP IMMUNOL, V28, P509, DOI 10.1016/j.dci.2003.09.010; Basu S, 2002, INT J MOL MED, V10, P3; Boubeva R, 2012, CHIMIA, V66, P281, DOI 10.2533/chimia.2012.281; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; European Directorate for the Quality of Medicines, 2009, EUR PHARM 6 3 FILGR; Gascon P, 2012, TARGET ONCOL, V7, pS29, DOI 10.1007/s11523-011-0190-9; Gomes FR, 2012, WORLD J MICROB BIOT, V28, P2593, DOI 10.1007/s11274-012-1068-4; Gravel P, 2012, TARGET ONCOL, V7, pS3, DOI 10.1007/s11523-011-0187-4; HAMMERLING U, 1995, J PHARMACEUT BIOMED, V13, P9, DOI 10.1016/0731-7085(94)00128-O; Hinderer W, 2012, Patent, Patent No. [US2012/0328560, 20120328560]; Hubel K, 2003, ONKOLOGIE, V26, P73, DOI 10.1159/000069868; Jungbauer A, 2007, J BIOTECHNOL, V128, P587, DOI 10.1016/j.jbiotec.2006.12.004; Kelker MS, 2004, J MOL BIOL, V342, P1237, DOI 10.1016/j.jmb.2004.07.089; Khalilzadeh R, 2008, J IND MICROBIOL BIOT, V35, P1643, DOI 10.1007/s10295-008-0408-8; Kim CK, 2010, FOOD SCI BIOTECHNOL, V19, P1627, DOI 10.1007/s10068-010-0230-8; LU HS, 1993, PROTEIN EXPRES PURIF, V4, P465, DOI 10.1006/prep.1993.1061; LU HS, 1989, ARCH BIOCHEM BIOPHYS, V268, P81, DOI 10.1016/0003-9861(89)90567-5; Metcalf D, 2010, NAT REV CANCER, V10, P425, DOI 10.1038/nrc2843; Min CK, 2011, J BIOTECHNOL, V151, P350, DOI 10.1016/j.jbiotec.2010.12.023; Murray HD, 2003, J BACTERIOL, V185, P28, DOI 10.1128/JB.185.1.28-34.2003; NAGATA S, 1989, BIOESSAYS, V10, P113, DOI 10.1002/bies.950100405; NAGATA S, 1986, NATURE, V319, P415, DOI 10.1038/319415a0; Rao DVK, 2008, MOL BIOTECHNOL, V38, P221, DOI 10.1007/s12033-007-9018-3; Rao DVK, 2008, BIOTECHNOL APPL BIOC, V50, P77, DOI 10.1042/BA20070130; Rathore AS, 2003, BIOTECHNOL APPL BIOC, V37, P51, DOI 10.1042/BA20020068; Rubenstein EB, 2000, INT J ANTIMICROB AG, V16, P117, DOI 10.1016/S0924-8579(00)00214-4; Schwanke RC, 2009, INT J BIOL MACROMOL, V45, P97, DOI 10.1016/j.ijbiomac.2009.04.005; Son YJ, 2007, BIOTECHNOL BIOPROC E, V12, P556, DOI 10.1007/BF02931354; Sonoda H, 2008, BIOSCI BIOTECH BIOCH, V72, P2675, DOI 10.1271/bbb.80332; Thomas J, 2002, CURR OPIN HEMATOL, V9, P183, DOI 10.1097/00062752-200205000-00002; Thomson CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049891; van Reis R, 2001, CURR OPIN BIOTECH, V12, P208, DOI 10.1016/S0958-1669(00)00201-9; Vanz ALS, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-13; Wagley Yadav, 2013, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V32, P277, DOI 10.1089/mab.2013.0015; Wang CZ, 2012, PROCESS BIOCHEM, V47, P2262, DOI 10.1016/j.procbio.2012.09.002; WINGFIELD P, 1988, EUR J BIOCHEM, V173, P65, DOI 10.1111/j.1432-1033.1988.tb13967.x; Wittman B, 2006, CANCER TREAT REV, V32, P289, DOI 10.1016/j.ctrv.2006.03.002	37	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e80109	10.1371/journal.pone.0080109	http://dx.doi.org/10.1371/journal.pone.0080109			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24224041	Green Published, gold, Green Submitted			2022-12-27	WOS:000326503400151
J	Yuan, K; Jin, CW; Cheng, P; Yang, XJ; Dong, T; Bi, YZ; Xing, LH; von Deneen, KM; Yu, DH; Liu, JY; Liang, J; Cheng, TT; Qin, W; Tian, J				Yuan, Kai; Jin, Chenwang; Cheng, Ping; Yang, Xuejuan; Dong, Tao; Bi, Yanzhi; Xing, Lihong; von Deneen, Karen M.; Yu, Dahua; Liu, Junyu; Liang, Jun; Cheng, Tingting; Qin, Wei; Tian, Jie			Amplitude of Low Frequency Fluctuation Abnormalities in Adolescents with Online Gaming Addiction	PLOS ONE			English	Article							INTERNET ADDICTION; REGIONAL HOMOGENEITY	The majority of previous neuroimaging studies have demonstrated both structural and task-related functional abnormalities in adolescents with online gaming addiction (OGA). However, few functional magnetic resonance imaging (fMRI) studies focused on the regional intensity of spontaneous fluctuations in blood oxygen level-dependent (BOLD) during the resting state and fewer studies investigated the relationship between the abnormal resting-state properties and the impaired cognitive control ability. In the present study, we employed the amplitude of low frequency fluctuation (ALFF) method to explore the local features of spontaneous brain activity in adolescents with OGA and healthy controls during resting-state. Eighteen adolescents with OGA and 18 age-, education-and gender-matched healthy volunteers participated in this study. Compared with healthy controls, adolescents with OGA showed a significant increase in ALFF values in the left medial orbitofrontal cortex (OFC), the left precuneus, the left supplementary motor area (SMA), the right parahippocampal gyrus (PHG) and the bilateral middle cingulate cortex (MCC). The abnormalities of these regions were also detected in previous addiction studies. More importantly, we found that ALFF values of the left medial OFC and left precuneus were positively correlated with the duration of OGA in adolescents with OGA. The ALFF values of the left medial OFC were also correlated with the color-word Stroop test performance. Our results suggested that the abnormal spontaneous neuronal activity of these regions may be implicated in the underlying pathophysiology of OGA.	[Yuan, Kai; Cheng, Ping; Yang, Xuejuan; Dong, Tao; Bi, Yanzhi; Xing, Lihong; von Deneen, Karen M.; Yu, Dahua; Qin, Wei; Tian, Jie] Xidian Univ, Sch Life Sci & Technol, Xian, Peoples R China; [Jin, Chenwang] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Med Imaging, Xian 710049, Shaanxi, Peoples R China; [Yu, Dahua] Inner Mongolia Univ Sci & Technol, Sch Informat Engn, Informat Proc Lab, Baotou, Inner Mongolia, Peoples R China; [Liu, Junyu; Liang, Jun; Cheng, Tingting] Baotou Heping Middle Sch, Baotou, Inner Mongolia, Peoples R China; [Tian, Jie] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China	Xidian University; Xi'an Jiaotong University; Inner Mongolia University of Science & Technology; Chinese Academy of Sciences; Institute of Automation, CAS	Yuan, K (corresponding author), Xidian Univ, Sch Life Sci & Technol, Xian, Peoples R China.	kyuan@xidian.edu.cn	tian, jie/M-6336-2013; Yu, Dahua/N-7242-2013; 秦, 伟/J-9770-2016; Yuan, Kai/I-4150-2016; Yuan, Kai/M-9403-2013; Tian, Jie/H-1190-2011	Yu, Dahua/0000-0001-7850-7512; 秦, 伟/0000-0003-4583-0406; Yuan, Kai/0000-0002-3098-1124; Tian, Jie/0000-0003-0498-0432	Project for the National Key Basic Research and Development Program (973) [2011CB707700]; National Natural Science Foundation of China [81227901, 81271644, 81271546, 30930112, 81000640, 81000641, 81101036, 81101108, 31200837, 81030027, 81301281]; Fundamental Research Funds for the Central Universities, the Natural Science Foundation of Inner Mongolia [2012MS0908]	Project for the National Key Basic Research and Development Program (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities, the Natural Science Foundation of Inner Mongolia	This paper is supported by the Project for the National Key Basic Research and Development Program (973) under Grant No. 2011CB707700; the National Natural Science Foundation of China under Grant Nos. 81227901, 81271644, 81271546, 30930112, 81000640, 81000641, 81101036, 81101108, 31200837, 81030027, 81301281; and the Fundamental Research Funds for the Central Universities, the Natural Science Foundation of Inner Mongolia under Grant No. 2012MS0908. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beard KW, 2001, CYBERPSYCHOL BEHAV, V4, P377, DOI 10.1089/109493101300210286; Byun S, 2009, CYBERPSYCHOL BEHAV, V12, P203, DOI 10.1089/cpb.2008.0102; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Christakis DA, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-61; Dong GH, 2011, NEUROSCI LETT, V499, P114, DOI 10.1016/j.neulet.2011.05.047; Duff EP, 2008, HUM BRAIN MAPP, V29, P778, DOI 10.1002/hbm.20601; Engle RW, 2004, PSYCHOL LEARN MOTIV, V44, P145; Flisher C, 2010, J PAEDIATR CHILD H, V46, P557, DOI 10.1111/j.1440-1754.2010.01879.x; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Goni J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017408; Ko CH, 2011, ADDICTION BIOL; Ko CH, 2009, J PSYCHIATR RES, V43, P739, DOI 10.1016/j.jpsychires.2008.09.012; Liu J, 2010, CHINESE MED J-PEKING, V123, P1904, DOI 10.3760/cma.j.issn.0366-6999.2010.14.014; Luck D, 2010, BRAIN COGNITION, V72, P255, DOI 10.1016/j.bandc.2009.09.009; Ma N, 2010, NEUROIMAGE, V49, P738, DOI 10.1016/j.neuroimage.2009.08.037; Murali V, 2007, ADV PSYCHIAT TREATME, V13, P24; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Ochsner KN, 2009, J COGNITIVE NEUROSCI, V21, P1841, DOI 10.1162/jocn.2009.21129; Park HS, 2010, CNS SPECTRUMS, V15, P159, DOI 10.1017/S1092852900027437; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Volkow ND, 2012, ANNU REV PHARMACOL, V52, P321, DOI 10.1146/annurev-pharmtox-010611-134625; Xu J, 2007, NEUROPSYCHOPHARMACOL, V32, P1421, DOI 10.1038/sj.npp.1301272; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yang H, 2007, NEUROIMAGE, V36, P144, DOI 10.1016/j.neuroimage.2007.01.054; Young K.S., 1998, CYBER PSYCHOL BEHAV, V1, P237, DOI [10.1089/cpb.1998.1.237, DOI 10.1089/CPB.1998.1.237]; Yuan K, 2011, COMMUNICATIVE INTEGR, V4; Yuan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053055; Yuan K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020708; Yuan K, 2010, NEUROSCI LETT, V482, P101, DOI 10.1016/j.neulet.2010.07.005; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002	33	50	51	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78708	10.1371/journal.pone.0078708	http://dx.doi.org/10.1371/journal.pone.0078708			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223843	Green Submitted, gold, Green Published			2022-12-27	WOS:000326503400085
J	Genova, HM; Rajagopalan, V; DeLuca, J; Das, A; Binder, A; Arjunan, A; Chiaravalloti, N; Wylie, G				Genova, Helen M.; Rajagopalan, Venkateswaran; DeLuca, John; Das, Abhijit; Binder, Allison; Arjunan, Aparna; Chiaravalloti, Nancy; Wylie, Glenn			Examination of Cognitive Fatigue in Multiple Sclerosis using Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging	PLOS ONE			English	Article							BASAL GANGLIA; SEVERITY SCALE; POSTSTROKE FATIGUE; CORTICAL ATROPHY; IMPACT; WHITE; PERFORMANCE; IMAGES; TOOL	The present study investigated the neural correlates of cognitive fatigue in Multiple Sclerosis (MS), looking specifically at the relationship between self-reported fatigue and objective measures of cognitive fatigue. In Experiment 1, functional magnetic resonance imaging (fMRI) was used to examine where in the brain BOLD activity covaried with "state" fatigue, assessed during performance of a task designed to induce cognitive fatigue while in the scanner. In Experiment 2, diffusion tensor imaging (DTI) was used to examine where in the brain white matter damage correlated with increased "trait" fatigue in individuals with MS, assessed by the Fatigue Severity Scale (FSS) completed outside the scanning session. During the cognitively fatiguing task, the MS group had increased brain activity associated with fatigue in the caudate as compared with HCs. DTI findings revealed that reduced fractional anisotropy in the anterior internal capsule was associated with increased self-reported fatigue on the FSS. Results are discussed in terms of identifying a "fatigue-network" in MS.	[Genova, Helen M.; Rajagopalan, Venkateswaran; DeLuca, John; Das, Abhijit; Chiaravalloti, Nancy; Wylie, Glenn] Kessler Fdn Res Ctr, Neuropsychol & Neurosci Lab, W Orange, NJ 07052 USA; [Genova, Helen M.; Rajagopalan, Venkateswaran; DeLuca, John; Das, Abhijit; Chiaravalloti, Nancy; Wylie, Glenn] Rutgers, Dept Phys Med & Rehabil, New Jersey Med Sch, Newark, NJ USA; [Binder, Allison] Univ Massachusetts, Dept Psychol, Amherst, MA 01003 USA; [Arjunan, Aparna] Suffolk Univ, Dept Clin Psychol, Boston, MA 02114 USA	Kessler Institute for Rehabilitation; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Massachusetts System; University of Massachusetts Amherst; Suffolk University	Genova, HM (corresponding author), Kessler Fdn Res Ctr, Neuropsychol & Neurosci Lab, W Orange, NJ 07052 USA.	hgenova@kesslerfoundation.org; gwylie@kesslerfoundation.org	Das, Abhijit/AAQ-1729-2020; R, Venkateswaran/GOV-7176-2022	R, Venkateswaran/0000-0001-9040-0785; Chiaravalloti, Nancy/0000-0003-2943-7567	National Multiple Sclerosis Society (NMSS) [PP1364]; NMSS RG [4232A1/1, 3330A1/3]	National Multiple Sclerosis Society (NMSS)(National Multiple Sclerosis Society); NMSS RG	This work was supported in part by the National Multiple Sclerosis Society (NMSS) PP1364 to Glenn Wylie, NMSS RG 4232A1/1 to Helen Genova, and NMSS RG 3330A1/3 to Nancy Chiaravalloti. NMSS website: www.nationalmssociety.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman P.L., 2011, COGNITIVE FATIGUE MU; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Baudewig J, 2003, MAGN RESON IMAGING, V21, P1121, DOI 10.1016/j.mri.2003.08.013; Beatty WW, 2003, CLIN NEUROPSYCHOL, V17, P551, DOI 10.1076/clin.17.4.551.27942; Benito-Leon J, 2007, MULT SCLER J, V13, P645, DOI 10.1177/1352458506073528; Calabrese M, 2010, MULT SCLER J, V16, P1220, DOI 10.1177/1352458510376405; Chaudhuri A, 2000, J NEUROL SCI, V179, P34, DOI 10.1016/S0022-510X(00)00411-1; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Cook DB, 2007, NEUROIMAGE, V36, P108, DOI 10.1016/j.neuroimage.2007.02.033; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Delis DC, 2001, DELIS KAPLAN EXECUTI; DeLuca J, 2008, J NEUROL SCI, V270, P28, DOI 10.1016/j.jns.2008.01.018; DeLuca J, 2005, ISS CLIN COGN NEUROP, P37; DeLuca J, 2005, ISS CLIN COGN NEUROP, P319; DeLuca J, 2009, PHYS MED REH CLIN N, V20, P325, DOI 10.1016/j.pmr.2008.12.007; Filippi M, 2002, NEUROIMAGE, V15, P559, DOI 10.1006/nimg.2001.1011; FISK JD, 1994, CAN J NEUROL SCI, V21, P9, DOI 10.1017/S0317167100048691; FREAL JE, 1984, ARCH PHYS MED REHAB, V65, P135; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; JENNEKENSSCHINKEL A, 1988, J NEUROL SCI, V85, P173, DOI 10.1016/0022-510X(88)90154-2; Johnson S K, 1997, Appl Neuropsychol, V4, P145, DOI 10.1207/s15324826an0403_1; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; KRUPP LB, 1988, ARCH NEUROL-CHICAGO, V45, P435, DOI 10.1001/archneur.1988.00520280085020; Learmonth YC, 2013, J NEUROL SCI, V331, P102, DOI 10.1016/j.jns.2013.05.023; LEE KA, 1991, PSYCHIAT RES, V36, P291, DOI 10.1016/0165-1781(91)90027-M; Logan GD, 2003, J EXP PSYCHOL HUMAN, V29, P575, DOI 10.1037/0096-1523.29.3.575; Mills RJ, 2009, MULT SCLER J, V15, P81, DOI 10.1177/1352458508096215; Multiple Sclerosis Council for Clinical Practice Guidelines, 1998, FAT MULT SCLER EV BA; Nebes RD, 2006, AGING NEUROPSYCHOL C, V13, P326, DOI 10.1080/138255890969294; Pardini M, 2010, BEHAV NEUROSCI, V124, P329, DOI 10.1037/a0019585; Pavese N, 2010, BRAIN, V133, P3434, DOI 10.1093/brain/awq268; Pellicano C, 2010, ARCH NEUROL-CHICAGO, V67, P447, DOI 10.1001/archneurol.2010.48; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Popescu V, 2012, NEUROIMAGE, V61, P1484, DOI 10.1016/j.neuroimage.2012.03.074; Raz E, 2010, RADIOLOGY, V254, P227, DOI 10.1148/radiol.2541090817; Ritvo P. G., 1977, MULTIPLE SCLEROSIS Q; Roelcke U, 1997, NEUROLOGY, V48, P1566, DOI 10.1212/WNL.48.6.1566; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Schmidt P, 2012, NEUROIMAGE, V59, P3774, DOI 10.1016/j.neuroimage.2011.11.032; Sepulcre J, 2009, MULT SCLER J, V15, P337, DOI 10.1177/1352458508098373; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Suda M, 2009, BRAIN RES, V1252, P152, DOI 10.1016/j.brainres.2008.11.077; Tang WK, 2013, J NEUROL SCI, V324, P131, DOI 10.1016/j.jns.2012.10.022; Tang WK, 2010, J NEUROL, V257, P178, DOI 10.1007/s00415-009-5284-2; Tedeschi G, 2007, J NEUROL SCI, V263, P15, DOI 10.1016/j.jns.2007.07.004; Tellez N, 2008, NEURORADIOLOGY, V50, P17, DOI 10.1007/s00234-007-0304-3; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Weissman DH, 2002, COGNITIVE BRAIN RES, V15, P47, DOI 10.1016/S0926-6410(02)00215-X; Wilkinson G, 1993, WRAT 3 WIDE RANGE AC; Wylie GR, 2006, CEREB CORTEX, V16, P394, DOI 10.1093/cercor/bhi118; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	55	88	90	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78811	10.1371/journal.pone.0078811	http://dx.doi.org/10.1371/journal.pone.0078811			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223850	Green Published, Green Submitted, gold			2022-12-27	WOS:000326499300034
J	Koshkin, V; Yang, BB; Krylov, SN				Koshkin, Vasilij; Yang, Burton B.; Krylov, Sergey N.			Kinetics of MDR Transport in Tumor-Initiating Cells	PLOS ONE			English	Article							BREAST-CANCER CELLS; LASER-SCANNING CYTOMETRY; ACUTE MYELOID-LEUKEMIA; FLOW-CYTOMETRY; P-GLYCOPROTEIN; STEM-CELLS; RESISTANCE; EXPRESSION; EFFLUX; TUMORIGENICITY	Multidrug resistance (MDR) driven by ABC (ATP binding cassette) membrane transporters is one of the major causes of treatment failure in human malignancy. MDR capacity is thought to be unevenly distributed among tumor cells, with higher capacity residing in tumor-initiating cells (TIC) (though opposite finding are occasionally reported). Functional evidence for enhanced MDR of TICs was previously provided using a "side population" assay. This assay estimates MDR capacity by a single parameter - cell's ability to retain fluorescent MDR substrate, so that cells with high MDR capacity ("side population") demonstrate low substrate retention. In the present work MDR in TICs was investigated in greater detail using a kinetic approach, which monitors MDR efflux from single cells. Analysis of kinetic traces obtained allowed for the estimation of both the velocity (V-max) and affinity (K-M) of MDR transport in single cells. In this way it was shown that activation of MDR in TICs occurs in two ways: through the increase of V-max in one fraction of cells, and through decrease of K-M in another fraction. In addition, kinetic data showed that heterogeneity of MDR parameters in TICs significantly exceeds that of bulk cells. Potential consequences of these findings for chemotherapy are discussed.	[Koshkin, Vasilij; Krylov, Sergey N.] York Univ, Dept Chem, Toronto, ON M3J 2R7, Canada; [Koshkin, Vasilij; Krylov, Sergey N.] York Univ, Ctr Res Biomol Interact, Toronto, ON M3J 2R7, Canada; [Yang, Burton B.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada	York University - Canada; York University - Canada; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Krylov, SN (corresponding author), York Univ, Dept Chem, Toronto, ON M3J 2R7, Canada.	skrylov@yorku.ca			Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study has been funded only by the Natural Sciences and Engineering Research Council of Canada (NSERC). This is the government funding agency that had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Afrimzon E, 2013, J IMMUNOL METHODS, V387, P96, DOI 10.1016/j.jim.2012.10.001; [Anonymous], ABC TRANSPORTERS MUL; Aulmann S, 2010, HUM PATHOL, V41, P574, DOI 10.1016/j.humpath.2009.08.023; Bansal N, 2009, CURR PHARM BIOTECHNO, V10, P192, DOI 10.2174/138920109787315015; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chan LL, 2011, CYTOM PART A, V79A, P507, DOI 10.1002/cyto.a.21071; Chepko G, 1997, TISSUE CELL, V29, P239, DOI 10.1016/S0040-8166(97)80024-9; Cioce M, 2010, CELL CYCLE, V9, P2878, DOI 10.4161/cc.9.14.12371; DIVE C, 1990, CYTOMETRY, V11, P244, DOI 10.1002/cyto.990110205; Eckford PDW, 2008, BIOCHEMISTRY-US, V47, P13686, DOI 10.1021/bi801409r; FINLAY TH, 1993, ENDOCRINOLOGY, V133, P996, DOI 10.1210/en.133.3.996; Golebiewska A, 2011, CELL STEM CELL, V8, P136, DOI 10.1016/j.stem.2011.01.007; Goodale D, 2009, CYTOM PART A, V75A, P344, DOI 10.1002/cyto.a.20657; Gorbulev S, 2001, P NATL ACAD SCI USA, V98, P3732, DOI 10.1073/pnas.061467898; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Gupta V, 2011, METHODS MOL BIOL, V716, P179, DOI 10.1007/978-1-61779-012-6_11; Guttilla IK, 2012, BREAST CANCER RES TR, V132, P75, DOI 10.1007/s10549-011-1534-y; Karaszi E, 2001, BRIT J HAEMATOL, V112, P308, DOI 10.1046/j.1365-2141.2001.02554.x; Karimi-Busheri F, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2583; Kars MD, 2006, ANTICANCER RES, V26, P4559; Koshkin V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041368; Koslikin V, 2011, ANAL CHEM, V83, P6132, DOI 10.1021/ac201690t; Lacerda L, 2010, DRUG RESIST UPDATE, V13, P99, DOI 10.1016/j.drup.2010.08.001; LEARY JF, 1994, METHOD CELL BIOL, V42, P331; Lebedeva IV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022429; Lee JT, 2007, J CELL PHYSIOL, V213, P603, DOI 10.1002/jcp.21252; LEITH CP, 1995, BLOOD, V86, P2329, DOI 10.1182/blood.V86.6.2329.bloodjournal8662329; Leung E, 2010, CANCER BIOL THER, V9, P717, DOI 10.4161/cbt.9.9.11432; Liao D, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/6/065005; Morrow CS, 2006, MOL PHARMACOL, V69, P1499, DOI 10.1124/mol.105.017988; Oswald J, 2004, CYTOM PART A, V57A, P100, DOI 10.1002/cyto.a.10118; Pallis M, 2005, METH MOLEC MED, V111, P167; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Purich DL, 2010, ENZYME KINETICS: CATALYSIS & CONTROL, P1; Shapiro HM, 2005, PRACTICAL FLOW CYTOM; Stein WD, 1997, PHYSIOL REV, V77, P545, DOI 10.1152/physrev.1997.77.2.545; Sumantran VN, 2011, METHODS MOL BIOL, V731, P219, DOI 10.1007/978-1-61779-080-5_19; Taylor BJ, 2001, LEUKEMIA RES, V25, P1127, DOI 10.1016/S0145-2126(01)00085-6; Theodoropoulos PA, 2010, CANCER LETT, V288, P99, DOI 10.1016/j.canlet.2009.06.027; Vesuna F, 2009, NEOPLASIA, V11, P1318, DOI 10.1593/neo.91084; Wang HX, 2011, ONCOLOGIST, V16, P966, DOI 10.1634/theoncologist.2010-0230; Wong WW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100172; Wu C, 2008, CANCER LETT, V268, P1, DOI 10.1016/j.canlet.2008.03.048; Xie GZ, 2012, CANCER LETT, V316, P53, DOI 10.1016/j.canlet.2011.10.018; Yan H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024397; Yang XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059147; Yang ZL, 2012, J BREAST CANCER, V15, P388, DOI 10.4048/jbc.2012.15.4.388; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhan JF, 2011, CELL ONCOL, V34, P451, DOI 10.1007/s13402-011-0020-1; Zhang FY, 2009, PHARM RES-DORDR, V26, P914, DOI 10.1007/s11095-008-9793-y; Zhao LH, 2011, MED ONCOL, V28, P1188, DOI 10.1007/s12032-010-9624-y; Zhao LH, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-98	53	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79222	10.1371/journal.pone.0079222	http://dx.doi.org/10.1371/journal.pone.0079222			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223908	Green Published, gold, Green Submitted			2022-12-27	WOS:000326499300067
J	Zhi, L; Chi, X; Vostal, JG				Zhi, Li; Chi, Xuan; Vostal, Jaroslav G.			In Vitro and In Vivo Characterization of Ultraviolet Light C-Irradiated Human Platelets in a 2 Event Mouse Model of Transfusion	PLOS ONE			English	Article							PATHOGEN REDUCTION TECHNOLOGY; ACUTE LUNG INJURY; BLOOD COMPONENTS; AMOTOSALEN HCL; A LIGHT; SAFETY; INACTIVATION; ACTIVATION; PLASMA; RIBOFLAVIN	UV-based pathogen reduction technologies have been developed in recent years to inactivate pathogens and contaminating leukocytes in platelet transfusion products in order to prevent transfusion-transmitted infections and alloimmunization. UVC-based technology differs from UVA or UVB-based technologies in that it uses a specific wavelength at 254 nm without the addition of any photosensitizers. Previously, it was reported that UVC irradiation induces platelet aggregation and activation. To understand if UVC-induced changes of platelet quality correlate with potential adverse events when these platelets are transfused into animals, we used a 2-event SCID mouse model in which the predisposing event was LPS treatment and the second event was infusion of UVC-irradiated platelets. We analyzed lung platelet accumulation, protein content in bronchoalveolar lavage fluid as an indication of lung injury, and macrophage inflammatory protein-2 (MIP-2) release in mice received UVC-irradiated or untreated control platelets. Our results showed UVC-irradiated platelets accumulated in lungs of the mice in a dose-dependent manner. High-doses of UVC-irradiated platelets were sequestered in the lungs to a similar level as we previously reported for UVB-irradiated platelets. Unlike UVB-platelets, UVC-platelets did not lead to lung injury or induce MIP-2 release. This could potentially be explained by our observation that although UVC treatment activated platelet surface aIIb beta 3, it failed to activate platelet cells. It also suggests lung platelet accumulation and subsequent lung damage are due to different and separate mechanisms which require further investigation.	[Zhi, Li; Chi, Xuan; Vostal, Jaroslav G.] US FDA, Lab Cellular Hematol, Div Hematol, OBRR,Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA)	Vostal, JG (corresponding author), US FDA, Lab Cellular Hematol, Div Hematol, OBRR,Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA.	jaroslav.vostal@fda.hhs.gov			US FDA	US FDA(United States Department of Health & Human Services)	This work was supported by Critical Path Funding from the US FDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AuBuchon JP, 2005, TRANSFUSION, V45, P1335, DOI 10.1111/j.1537-2995.2005.00202.x; Bashir S, 2013, TRANSFUSION, V53, P990, DOI 10.1111/j.1537-2995.2012.03854.x; Bassler N, 2007, ARTERIOSCL THROM VAS, V27, pE9, DOI 10.1161/01.ATV.0000255307.65939.59; Bertrand ME, 2000, CIRCULATION, V102, P624, DOI 10.1161/01.CIR.102.6.624; Cazenave JP, 2010, TRANSFUSION, V50, P2362, DOI 10.1111/j.1537-2995.2010.02694.x; Chi X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044829; Ciaravino V, 2003, VOX SANG, V85, P171, DOI 10.1046/j.1423-0410.2003.00351.x; Council of Europe, 2002, GUIDE PREPARATION US; Gelderman MP, 2011, TRANSFUSION, V51, P2343, DOI 10.1111/j.1537-2995.2011.03135.x; Harm W, 1980, BIOL EFFECTS ULTRAVI; Hillyer Christopher D, 2003, Hematology Am Soc Hematol Educ Program, P575; Irsch J, 2011, TRANSFUS MED HEMOTH, V38, P19, DOI 10.1159/000323937; Kirkeby S, 2005, J IMMUNOL METHODS, V301, P102, DOI 10.1016/j.jim.2005.04.006; LASKY LA, 1992, SCIENCE, V258, P964, DOI 10.1126/science.1439808; Lockwood WB, TECHNICAL MANUAL; Marschner S, 2011, TRANSFUS MED HEMOTH, V38, P8, DOI 10.1159/000324160; Merten M, 2000, CIRCULATION, V102, P1931, DOI 10.1161/01.CIR.102.16.1931; Mohr H, 2009, TRANSFUSION, V49, P2612, DOI 10.1111/j.1537-2995.2009.02334.x; Montag T, 2008, CLIN CHEM LAB MED, V46, P926, DOI 10.1515/CCLM.2008.176; Picker SM, 2009, TRANSFUSION, V49, P2311, DOI 10.1111/j.1537-2995.2009.02316.x; Reddy HL, 2008, TRANSFUS MED REV, V22, P133, DOI 10.1016/j.tmrv.2007.12.003; Sandgren P, 2011, VOX SANG, V101, P35, DOI 10.1111/j.1423-0410.2010.01454.x; Seltsam A, 2011, TRANSFUS MED HEMOTH, V38, P43, DOI 10.1159/000323845; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; SHATTIL SJ, 1987, BLOOD, V70, P307; Snyder E, 2005, TRANSFUSION, V45, P1864, DOI 10.1111/j.1537-2995.2005.00639.x; Snyder E, 2004, TRANSFUSION, V44, P1732, DOI 10.1111/j.0041-1132.2004.04145.x; Stramer SL, 2009, TRANSFUSION, V49, p1S, DOI 10.1111/j.1537-2995.2009.02279.x; TAUB R, 1989, J BIOL CHEM, V264, P259; Teitel JM, 2000, ANN MED, V32, P485, DOI 10.3109/07853890009002024; Toy P, 2005, CRIT CARE MED, V33, P721, DOI 10.1097/01.CCM.0000159849.94750.51; Verhaar R, 2008, BLOOD, V112, P4935, DOI 10.1182/blood-2008-04-151043; Zhi L, 2012, TRANSFUSION	34	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79869	10.1371/journal.pone.0079869	http://dx.doi.org/10.1371/journal.pone.0079869			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24224014	Green Published, Green Submitted, gold			2022-12-27	WOS:000326499300094
J	Dehmer, M; Mueller, LAJ; Emmert-Streib, F				Dehmer, Matthias; Mueller, Laurin A. J.; Emmert-Streib, Frank			Quantitative Network Measures as Biomarkers for Classifying Prostate Cancer Disease States: A Systems Approach to Diagnostic Biomarkers	PLOS ONE			English	Article							GENE-EXPRESSION; TOPOLOGICAL INDEXES; INFORMATION-CONTENT; ENTROPY MEASURES; IN-VITRO; GRAPHS; COMPLEXITY; DISCRIMINATION; CELLS; VIVO	Identifying diagnostic biomarkers based on genomic features for an accurate disease classification is a problem of great importance for both, basic medical research and clinical practice. In this paper, we introduce quantitative network measures as structural biomarkers and investigate their ability for classifying disease states inferred from gene expression data from prostate cancer. We demonstrate the utility of our approach by using eigenvalue and entropy-based graph invariants and compare the results with a conventional biomarker analysis of the underlying gene expression data.	[Dehmer, Matthias; Mueller, Laurin A. J.] UMIT, Inst Bioinformat & Translat Res, Hall In Tyrol, Germany; [Emmert-Streib, Frank] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Canc Res & Cell Biol, Computat Biol & Machine Learning Lab, Belfast, Antrim, North Ireland	Queens University Belfast	Dehmer, M (corresponding author), UMIT, Inst Bioinformat & Translat Res, Hall In Tyrol, Germany.	matthias.dehmer@umit.at; v@bio-complexity.com	Emmert-Streib, Frank/G-8099-2011; Emmert-Streib, Frank/AAF-2878-2020	Emmert-Streib, Frank/0000-0003-0745-5641; Emmert-Streib, Frank/0000-0003-0745-5641	Austrian Science Funds [P22029-N13]; Austrian Science Fund (FWF) [P 22029] Funding Source: researchfish	Austrian Science Funds(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Matthias Dehmer thanks the Austrian Science Funds for supporting this work (project P22029-N13). The authors also thank the 'Zentraler Informatikdienst' of the Technical University of Vienna for providing computing resources to perform large scale computations on the Phoenix Cluster. Also, Matthias Dehmer and Laurin Mueller thank the Standortagentur Tirol for supporting this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altay G, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-132; [Anonymous], [No title captured]; Arias CR, 2012, SCI WORLD J, P24873; BALABAN AT, 1991, J MATH CHEM, V8, P383, DOI 10.1007/BF01166951; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; BONCHEV D, 1981, J COMPUT CHEM, V2, P127, DOI 10.1002/jcc.540020202; Bonchev D, 2009, ENCY COMPLEXITY SYST, V5, P4820, DOI [10.1007/978-0-387-30440-3_285, DOI 10.1007/978-0-387-30440-3_285]; Bonchev D, 1983, INFORM THEORETIC IND; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; CHEN JY, 2009, BMC GENOMICS, P10; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Cristianini N, 2000, INTRO SUPPORT VECTOR; Dehmer M, 2012, ADV COMPUTATIONAL MA; Dehmer M., 2011, APPL STAT NETWORK BI; Dehmer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031214; Dehmer M, 2012, MATCH-COMMUN MATH CO, V67, P147; Dehmer M, 2011, COMPLEXITY, V17, P45, DOI 10.1002/cplx.20379; Dehmer M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015733; Dehmer M, 2011, INFORM SCIENCES, V181, P57, DOI 10.1016/j.ins.2010.08.041; Dorogovtsev SN, 2003, EVOLUTION NETWORKS B; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Emmert-Streib F, 2007, J COMPUT BIOL, P14; Estrada E, 2002, BIOINFORMATICS, V18, P697, DOI 10.1093/bioinformatics/18.5.697; Gutman I, 2006, LINEAR ALGEBRA APPL, V414, P29, DOI 10.1016/j.laa.2005.09.008; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Harary F., 1969, GRAPH THEORY; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Jain K.K, 2010, HDB BIOMARKERS; Janezic D, 2007, MATH CHEM MONOGRAPHS; Jin GX, 2008, J PROTEOME RES, V7, P4013, DOI 10.1021/pr8002886; Konstantinova EV, 1996, J CHEM INF COMP SCI, V36, P54, DOI 10.1021/ci9502461; Korner J., 1973, T 6 PRAG C INF THEOR, P411; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; Massoner P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055207; Mayeux Richard, 2004, NeuroRx, V1, P182, DOI 10.1007/BF03206601; Meyer D., 2012, E1071 MISC FUNCTIONS; MOWSHOWI.A, 1968, B MATH BIOPHYS, V30, P533, DOI 10.1007/BF02476673; MOWSHOWI A, 1968, B MATH BIOPHYS, V30, P387, DOI 10.1007/BF02476603; MOWSHOWITZ A, 1968, B MATH BIOPHYS, V30, P175, DOI 10.1007/BF02476948; MOWSHOWITZ A, 1968, B MATH BIOPHYS, V30, P225, DOI 10.1007/BF02476692; Mowshowitz A, 2010, SYMMETRY, V21, P321; Mowshowitz A, 2012, ENTROPY-SWITZ, V14, P559, DOI 10.3390/e14030559; Mueller LAJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-492; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Quinlan JR., 1993, C45 PROGRAMS MACHINE; Rahman M. R., 2011, TECHNICAL REPORT; RASHEVSKY N., 1955, BULL MATH BIOPHYS, V17, P229, DOI 10.1007/BF02477860; RAYCHAUDHURY C, 1984, J COMPUT CHEM, V5, P581, DOI 10.1002/jcc.540050612; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Tsavachidou D, 2009, JNCI-J NATL CANCER I, V101, P306, DOI 10.1093/jnci/djn512; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Wallace TA, 2008, CANCER RES, V68, P927, DOI 10.1158/0008-5472.CAN-07-2608; Wang XM, 2011, J BIOMED BIOTECHNOL, P1, DOI 10.1155/2011/419343; Wang YS, 2011, ADV MAT SCI ENG-BOCA, P1; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	56	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e77602	10.1371/journal.pone.0077602	http://dx.doi.org/10.1371/journal.pone.0077602			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236006	Green Submitted, gold, Green Published			2022-12-27	WOS:000327254700002
J	Meyer, K; Korz, V				Meyer, Katrin; Korz, Volker			Estrogen Receptor alpha Functions in the Regulation of Motivation and Spatial Cognition in Young Male Rats	PLOS ONE			English	Article							LONG-TERM POTENTIATION; FACTOR MESSENGER-RNA; SYNAPTIC PLASTICITY; STEROID-HORMONES; MEDIAL AMYGDALA; BRAIN; BETA; MEMORY; HIPPOCAMPUS; EXPRESSION	Estrogenic functions in regulating behavioral states such as motivation, mood, anxiety, and cognition are relatively well documented in female humans and animals. In males, however, although the entire enzymatic machinery for producing estradiol and the corresponding receptors are present, estrogenic functions have been largely neglected. Therefore, and as a follow-up study to previous research, we sub-chronically applied a specific estrogen receptor alpha (ER alpha) antagonist in young male rats before and during a spatial learning task (holeboard). The male rats showed a dose-dependent increase in motivational, but not cognitive, behavior. The expression of hippocampal steroid receptor genes, such as glucocorticoid (GR), mineralocorticoid (MR), androgen (AR), and the estrogen receptor ER alpha but not ER beta was dose-dependently reduced. The expression of the aromatase but not the brain-derived neurotrophic factor (BDNF) encoding gene was also suppressed. Reduced gene expression and increased behavioral performance converged at an antagonist concentration of 7.4 mu mol. The hippocampal and blood serum hormone levels (corticosterone, testosterone, and 17 beta-estradiol) did not differ between the experimental groups and controls. We conclude that steroid receptors (and BDNF) act in a concerted, network-like manner to affect behavior and mutual gene expression. Therefore, the isolated view on single receptor types is probably insufficient to explain steroid effects on behavior. The steroid network may keep motivation in homeostasis by supporting and constraining the behavioral expression of motivation.	[Meyer, Katrin] Leibniz Inst Neurobiol, Magdeburg, Germany; [Meyer, Katrin; Korz, Volker] Otto Von Guericke Univ, Inst Biol, Magdeburg, Germany; [Korz, Volker] Ctr Behav Neurosci, Magdeburg, Germany	Leibniz Institut fur Neurobiologie (LIN); Otto von Guericke University	Korz, V (corresponding author), Otto Von Guericke Univ, Inst Biol, Magdeburg, Germany.	volker.korz@ovgu.de			federal state of Saxony-Anhalt; Center for Behavioral Brain Studies [FKZ: 1211080005]	federal state of Saxony-Anhalt; Center for Behavioral Brain Studies	This work was funded by the federal state of Saxony-Anhalt and the "European Regional Development Fund" (ERDF 2007-2013; Center for Behavioral Brain Studies; FKZ: 1211080005)(http:// www.med.uni-magdeburg.de/neuromd). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barha CK, 2010, BBA-GEN SUBJECTS, V1800, P1056, DOI 10.1016/j.bbagen.2010.01.006; Bowers J Michael, 2010, Biol Sex Differ, V1, P8, DOI 10.1186/2042-6410-1-8; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Chen SY, 1997, J BIOL CHEM, V272, P14087, DOI 10.1074/jbc.272.22.14087; Cornil CA, 2012, FRONT NEUROENDOCRIN, V33, P425, DOI 10.1016/j.yfrne.2012.08.003; Cvoro A, 2011, J IMMUNOL, V186, P4354, DOI 10.4049/jimmunol.1002205; FALKENBERG T, 1992, NEUROSCI LETT, V138, P153, DOI 10.1016/0304-3940(92)90494-R; Fester L, 2006, J NEUROCHEM, V97, P1136, DOI 10.1111/j.1471-4159.2006.03809.x; Fester L, 2011, CELL TISSUE RES, V345, P285, DOI 10.1007/s00441-011-1221-7; Frye CA, 2007, NEUROBIOL LEARN MEM, V88, P208, DOI 10.1016/j.nlm.2007.04.003; Galea LAM, 2008, CAN J EXP PSYCHOL, V62, P247, DOI 10.1037/a0014501; Gillies GE, 2010, PHARMACOL REV, V62, P155, DOI 10.1124/pr.109.002071; Gonzalez-Burgos I, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/309494; Hajszan T, 2007, PROG BRAIN RES, V163, P399, DOI 10.1016/S0079-6123(07)63023-4; Han XX, 2013, J NEUROSCI, V33, P2671, DOI 10.1523/JNEUROSCI.4937-12.2013; Harrington WR, 2003, MOL CELL ENDOCRINOL, V206, P13, DOI 10.1016/S0303-7207(03)00255-7; Korz V, 2007, LEARN MEMORY, V14, P160, DOI 10.1101/lm.459807; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Lagunas N, 2011, HORM BEHAV, V59, P581, DOI 10.1016/j.yhbeh.2011.02.014; Liu F, 2008, NAT NEUROSCI, V11, P334, DOI 10.1038/nn2057; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma YL, 1998, NEUROSCIENCE, V82, P957; MACLUSKY NJ, 1979, BRAIN RES, V178, P129, DOI 10.1016/0006-8993(79)90093-3; McEwen B, 2002, RECENT PROG HORM RES, V57, P357, DOI 10.1210/rp.57.1.357; MCEWEN BS, 1975, J STEROID BIOCHEM, V6, P971, DOI 10.1016/0022-4731(75)90337-4; MCEWEN BS, 1992, HORM RES, V37, P1, DOI 10.1159/000182393; MCEWEN BS, 1988, J STEROID BIOCHEM, V30, P179, DOI 10.1016/0022-4731(88)90091-X; Meyer K, 2013, HORM BEHAV, V63, P376, DOI 10.1016/j.yhbeh.2012.12.002; Mukai H, 2010, BBA-GEN SUBJECTS, V1800, P1030, DOI 10.1016/j.bbagen.2009.11.002; Neese SL, 2010, HORM BEHAV, V58, P878, DOI 10.1016/j.yhbeh.2010.08.017; Nomura M, 2006, EUR J NEUROSCI, V23, P1860, DOI 10.1111/j.1460-9568.2006.04703.x; Paisley JC, 2012, HORM BEHAV, V62, P50, DOI 10.1016/j.yhbeh.2012.04.018; Perlman WR, 2005, BIOL PSYCHIAT, V58, P812, DOI 10.1016/j.biopsych.2005.04.047; Ranhotra HS, 2012, J RECEPT SIG TRANSD, V32, P47, DOI 10.3109/10799893.2011.647350; Richter JD, 2002, CURR OPIN NEUROBIOL, V12, P300, DOI 10.1016/S0959-4388(02)00318-5; Rissman EF, 2008, J NEUROENDOCRINOL, V20, P873, DOI 10.1111/j.1365-2826.2008.01738.x; Sano K, 2013, EUR J NEUROSCI, V37, P1308, DOI 10.1111/ejn.12131; Savatier J, 2010, BIOCHEMISTRY-US, V49, P772, DOI 10.1021/bi9013006; Schaaf MJM, 1997, J NEUROSCI RES, V48, P334, DOI 10.1002/(SICI)1097-4547(19970515)48:4<334::AID-JNR5>3.0.CO;2-C; Scharfman HE, 2006, FRONT NEUROENDOCRIN, V27, P415, DOI 10.1016/j.yfrne.2006.09.004; Schulz K, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00187; Scordalakes EM, 2003, BEHAV NEUROSCI, V117, P38, DOI 10.1037/0735-7044.117.1.38; Solum DT, 2002, J NEUROSCI, V22, P2650, DOI 10.1523/JNEUROSCI.22-07-02650.2002; Spencer-Segal JL, 2012, NEUROSCIENCE, V202, P131, DOI 10.1016/j.neuroscience.2011.11.035; Sun J, 2002, ENDOCRINOLOGY, V143, P941, DOI 10.1210/en.143.3.941; Takeshita H, 1976, Yonago Acta Med, V20, P125; Tetel MJ, 2010, BBA-GEN SUBJECTS, V1800, P1084, DOI 10.1016/j.bbagen.2010.01.008; Uzakov S, 2005, LEARN MEMORY, V12, P165, DOI 10.1101/lm.89305; Wu TW, 2011, BRAIN RES, V1379, P34, DOI 10.1016/j.brainres.2011.01.034; Yang LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009851	51	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79303	10.1371/journal.pone.0079303	http://dx.doi.org/10.1371/journal.pone.0079303			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236119	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700118
J	Moore, AM; Patel, S; Forsberg, KJ; Wang, B; Bentley, G; Razia, Y; Qin, X; Tarr, PI; Dantas, G				Moore, Aimee M.; Patel, Sanket; Forsberg, Kevin J.; Wang, Bin; Bentley, Gayle; Razia, Yasmin; Qin, Xuan; Tarr, Phillip I.; Dantas, Gautam			Pediatric Fecal Microbiota Harbor Diverse and Novel Antibiotic Resistance Genes	PLOS ONE			English	Article							BACTEROIDES CONJUGATIVE TRANSPOSON; COMPLETE GENOME SEQUENCE; ESCHERICHIA-COLI; MULTIDRUG-RESISTANCE; HEALTHY-CHILDREN; CLINICAL ISOLATE; GUT MICROBIOTA; TIGECYCLINE; BACTERIA; PLASMID	Emerging antibiotic resistance threatens human health. Gut microbes are an epidemiologically important reservoir of resistance genes (resistome), yet prior studies indicate that the true diversity of gut-associated resistomes has been underestimated. To deeply characterize the pediatric gut-associated resistome, we created metagenomic recombinant libraries in an Escherichia coli host using fecal DNA from 22 healthy infants and children (most without recent antibiotic exposure), and performed functional selections for resistance to 18 antibiotics from eight drug classes. Resistance-conferring DNA fragments were sequenced (Illumina HiSeq 2000), and reads assembled and annotated with the PARFuMS computational pipeline. Resistance to 14 of the 18 antibiotics was found in stools of infants and children. Recovered genes included chloramphenicol acetyltransferases, drug-resistant dihydrofolate reductases, rRNA methyltransferases, transcriptional regulators, multidrug efflux pumps, and every major class of beta-lactamase, aminoglycoside-modifying enzyme, and tetracycline resistance protein. Many resistance-conferring sequences were mobilizable; some had low identity to any known organism, emphasizing cryptic organisms as potentially important resistance reservoirs. We functionally confirmed three novel resistance genes, including a 16S rRNA methylase conferring aminoglycoside resistance, and two tetracycline-resistance proteins nearly identical to a bifidobacterial MFS transporter (B. longum s. longum JDM301). We provide the first report to our knowledge of resistance to folate-synthesis inhibitors conferred by a predicted Nudix hydrolase (part of the folate synthesis pathway). This functional metagenomic survey of gut-associated resistomes, the largest of its kind to date, demonstrates that fecal resistomes of healthy children are far more diverse than previously suspected, that clinically relevant resistance genes are present even without recent selective antibiotic pressure in the human host, and that cryptic gut microbes are an important resistance reservoir. The observed transferability of gut-associated resistance genes to a gram-negative (E. coli) host also suggests that the potential for gut-associated resistomes to threaten human health by mediating antibiotic resistance in pathogens warrants further investigation.	[Moore, Aimee M.; Patel, Sanket; Forsberg, Kevin J.; Wang, Bin; Dantas, Gautam] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63130 USA; [Moore, Aimee M.; Razia, Yasmin; Tarr, Phillip I.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Patel, Sanket; Wang, Bin; Bentley, Gayle; Dantas, Gautam] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Razia, Yasmin] Childrens Hosp & Reg Med Ctr, Dept Pediat, Div Gastroenterol, Seattle, WA USA; [Qin, Xuan] Seattle Childrens Hosp, Dept Microbiol, Seattle, WA USA; [Qin, Xuan] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Seattle Children's Hospital; Seattle Children's Hospital; University of Washington; University of Washington Seattle	Dantas, G (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63130 USA.	Dantas@wustl.edu		Dantas, Gautam/0000-0003-0455-8370; Forsberg, Kevin/0000-0002-1545-8925	Children's Discovery Institute [MD-II-2011-117]; International Center for Advanced Renewable Energy and Sustainability at Washington University; National Academies Keck Futures Initiatives; National Institutes of Health (NIH) [A14799-S01]; National Institutes of Health [5P30 DK052574]; NIH [T32 HD043010-08]; National Science Foundation [DGE-1143954]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD043010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007067] Funding Source: NIH RePORTER	Children's Discovery Institute; International Center for Advanced Renewable Energy and Sustainability at Washington University; National Academies Keck Futures Initiatives; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by awards to G. D. through the Children's Discovery Institute (MD-II-2011-117), the International Center for Advanced Renewable Energy and Sustainability at Washington University, and the National Academies Keck Futures Initiatives (Synthetic Biology - SB2). Sample collection and curation was supported by National Institutes of Health (NIH) grants (A14799-S01) to P. I. T. and National Institutes of Health Grant 5P30 DK052574 (to Washington University Digestive Diseases Research Core Center Biobank). A. M. M. was supported by an NIH T32 fellowship (T32 HD043010-08; PI. Dr. Alan Schwartz), K.J.F. is a National Science Foundation graduate research fellow (DGE-1143954). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; ARIZA RR, 1995, J BACTERIOL, V177, P1655, DOI 10.1128/jb.177.7.1655-1661.1995; Bacic M, 2005, J BACTERIOL, V187, P2858, DOI 10.1128/JB.187.8.2858-2869.2005; Bartha NA, 2011, INT J ANTIMICROB AG, V38, P522, DOI 10.1016/j.ijantimicag.2011.07.010; Bartoloni A, 2006, EMERG INFECT DIS, V12, P907, DOI 10.3201/eid1206.051258; Caceres NE, 1997, J BACTERIOL, V179, P5046, DOI 10.1128/jb.179.16.5046-5055.1997; Cheng QI, 2000, J BACTERIOL, V182, P4035, DOI 10.1128/JB.182.14.4035-4043.2000; Clinical and Laboratory Standards Institute (CLSI), 2009, METH DIL ANT SUSC TE; Coco A, 2010, PEDIATRICS, V125, P214, DOI 10.1542/peds.2009-1115; Copp HL, 2011, PEDIATRICS, V127, P1027, DOI 10.1542/peds.2010-3465; Dominguez E, 2002, MICROB DRUG RESIST, V8, P321, DOI 10.1089/10766290260469589; Eggesbo M, 2011, APMIS, V119, P17, DOI 10.1111/j.1600-0463.2010.02688.x; Erwin AL, 2006, INFECT IMMUN, V74, P6226, DOI 10.1128/IAI.00722-06; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Forsberg KJ, 2012, SCIENCE, V337, P1107, DOI 10.1126/science.1220761; Forslund K, 2013, GENOME RES, V23, P1163, DOI 10.1101/gr.155465.113; GAMBINO L, 1993, J BACTERIOL, V175, P2888, DOI 10.1128/JB.175.10.2888-2894.1993; Geng JN, 2011, J BACTERIOL, V193, P5596, DOI 10.1128/JB.05670-11; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Gueimonde M, 2006, FEMS IMMUNOL MED MIC, V48, P21, DOI 10.1111/j.1574-695X.2006.00112.x; Guimaraes B, 2009, MICROB DRUG RESIST, V15, P211, DOI 10.1089/mdr.2009.0910; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Hersh AL, 2011, PEDIATRICS, V128, P1053, DOI 10.1542/peds.2011-1337; Inc SI, 2000, SAS 9 1 3 HELP DOC; Johnson TJ, 2005, ANTIMICROB AGENTS CH, V49, P4681, DOI 10.1128/AAC.49.11.4681-4688.2005; Karami N, 2007, J ANTIMICROB CHEMOTH, V60, P1142, DOI 10.1093/jac/dkm327; Klaus SMJ, 2005, J BIOL CHEM, V280, P5274, DOI 10.1074/jbc.M413759200; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Koutsolioutsou A, 2001, ANTIMICROB AGENTS CH, V45, P38, DOI 10.1128/AAC.45.1.38-43.2001; Kronvall G, 2006, J ANTIMICROB CHEMOTH, V57, P498, DOI 10.1093/jac/dki489; Liu G, 2007, JPN J INFECT DIS, V60, P295; Livermore DM, 2011, INT J ANTIMICROB AG, V37, P415, DOI 10.1016/j.ijantimicag.2011.01.012; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Mathur S, 2005, INT J FOOD MICROBIOL, V105, P281, DOI 10.1016/j.ijfoodmicro.2005.03.008; Mitsou EK, 2010, BENEF MICROBES, V1, P297, DOI 10.3920/BM2010.0007; Pagotto F, 2000, PLASMID, V43, P24, DOI 10.1006/plas.1999.1431; Partridge SR, 2012, ANTIMICROB AGENTS CH, V56, P2166, DOI 10.1128/AAC.05796-11; Peterson G, 2011, MICROB PATHOGENESIS, V51, P1, DOI 10.1016/j.micpath.2011.03.002; Qin X, 2006, ANTIMICROB AGENTS CH, V50, P3325, DOI 10.1128/AAC.00548-06; Robicsek A, 2006, LANCET INFECT DIS, V6, P629, DOI 10.1016/S1473-3099(06)70599-0; Rose WE, 2006, PHARMACOTHERAPY, V26, P1099, DOI 10.1592/phco.26.8.1099; Salyers AA, 2004, TRENDS MICROBIOL, V12, P412, DOI 10.1016/j.tim.2004.07.004; Schmitz FJ, 2001, J ANTIMICROB CHEMOTH, V48, P935, DOI 10.1093/jac/48.6.935; Schroder J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-141; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; Song SJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00458; Stecher B, 2012, P NATL ACAD SCI USA, V109, P1269, DOI 10.1073/pnas.1113246109; Stein GE, 2006, CLIN INFECT DIS, V43, P518, DOI 10.1086/505494; Wang YP, 2004, J BACTERIOL, V186, P2548, DOI 10.1128/JB.186.9.2548-2557.2004; Wei YX, 2012, WORLD J GASTROENTERO, V18, P479, DOI 10.3748/wjg.v18.i5.479; Williams DJ, 2011, PEDIATRICS, V128, pE479, DOI 10.1542/peds.2010-3681; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Young PG, 2009, J BACTERIOL, V191, P4133, DOI 10.1128/JB.00149-09; Zhang L, 2011, APPL ENVIRON MICROB, V77, P7134, DOI 10.1128/AEM.05087-11	54	115	118	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78822	10.1371/journal.pone.0078822	http://dx.doi.org/10.1371/journal.pone.0078822			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236055	gold, Green Published, Green Submitted			2022-12-27	WOS:000327254700052
J	Renne, U; Langhammer, M; Brenmoehl, J; Walz, C; Zeissler, A; Tuchscherer, A; Piechotta, M; Wiesner, RJ; Bielohuby, M; Hoeflich, A				Renne, Ulla; Langhammer, Martina; Brenmoehl, Julia; Walz, Christina; Zeissler, Anja; Tuchscherer, Armin; Piechotta, Marion; Wiesner, Rudolf J.; Bielohuby, Maximilian; Hoeflich, Andreas			Lifelong Obesity in a Polygenic Mouse Model Prevents Age- and Diet-Induced Glucose Intolerance- Obesity Is No Road to Late-Onset Diabetes in Mice	PLOS ONE			English	Article							LONG-TERM SELECTION; STRAIN FZT-DU; METABOLICALLY BENIGN; GENETIC-DETERMINANTS; ANIMAL-MODEL; GROWTH; LINES; FAT; MELLITUS; WEIGHT	Aims/Hypothesis: Visceral obesity holds a central position in the concept of the metabolic syndrome characterized by glucose intolerance in humans. However, until now it is unclear if obesity by itself is responsible for the development of glucose intolerance. Methods: We have used a novel polygenic mouse model characterized by genetically fixed obesity (DU6) and addressed age-and high fat diet-dependent glucose tolerance. Results: Phenotype selection over 146 generations increased body weight by about 2.7-fold in male 12-week DU6 mice (P<0.0001) if compared to unselected controls (Fzt:DU). Absolute epididymal fat mass was particularly responsive to weight selection and increased by more than 5-fold (P<0.0001) in male DU6 mice. At an age of 6 weeks DU6 mice consumed about twice as much food if compared to unselected controls (P<0.001). Absolute food consumption was higher at all time points measured in DU6 mice than in Fzt: DU mice. Between 6 and 12 weeks of age, absolute food intake was reduced by 15% in DU6 mice (P<0.001) but not in Fzt: DU mice. In both mouse lines feeding of the high fat diet elevated body mass if compared to the control diet (P<0.05). In contrast to controls, DU6 mice did not display high fat diet-induced increases of epididymal and renal fat. Control mice progressively developed glucose intolerance with advancing age and even more in response to the high fat diet. In contrast, obese DU6 mice did neither develop a glucose intolerant phenotype with progressive age nor when challenged with a high fat diet. Conclusions/Interpretation: Our results from a polygenic mouse model demonstrate that genetically pre-determined and life-long obesity is no precondition of glucose intolerance later in life.	[Renne, Ulla; Langhammer, Martina; Brenmoehl, Julia; Walz, Christina; Zeissler, Anja; Hoeflich, Andreas] Leibniz Inst Farm Anim Biol, Lab Mouse Genet, Dummerstorf, Germany; [Tuchscherer, Armin] Leibniz Inst Farm Anim Biol, Inst Genet & Biometry, Livestock Genet & Breeding Unit, Dummerstorf, Germany; [Piechotta, Marion] Univ Vet Med, Clin Cattle, Hannover, Germany; [Wiesner, Rudolf J.] Univ Cologne, Inst Vegetat Physiol, Ctr Physiol & Pathophysiol, D-50931 Cologne, Germany; [Wiesner, Rudolf J.] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Wiesner, Rudolf J.] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Bielohuby, Maximilian] Klinikum Univ, Med Klin & Poliklin 4, Endocrine Res Unit, Munich, Germany; [Brenmoehl, Julia; Walz, Christina; Zeissler, Anja; Hoeflich, Andreas] Leibniz Inst Farm Anim Biol, Cell Signaling Unit, Inst Genome Biol, Dummerstorf, Germany	Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN); University of Veterinary Medicine Hannover, Foundation; University of Cologne; University of Cologne; University of Cologne; University of Munich; Forschungsinstitut fur Nutztierbiologie (FBN)	Hoeflich, A (corresponding author), Leibniz Inst Farm Anim Biol, Lab Mouse Genet, Dummerstorf, Germany.	hoeflich@fbn-dummerstorf.de	Bielohuby, Maximilian/A-2304-2015	Bielohuby, Maximilian/0000-0002-9859-8156; Hoeflich, Andreas/0000-0003-2018-2836	Deutsche Forschungsgemeinschaft [DFG H0 2003/6-1]; Europaischer Sozialfond	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Europaischer Sozialfond	AH was supported by grants from the Deutsche Forschungsgemeinschaft (DFG H0 2003/6-1) and from the Europaischer Sozialfond. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan MF, 2004, OBES RES, V12, P1397, DOI 10.1038/oby.2004.176; Almind K, 2004, DIABETES, V53, P3274, DOI 10.2337/diabetes.53.12.3274; Brenmoehl J, 2013, MED SCI SPORT EXER, V45, P841, DOI 10.1249/MSS.0b013e31827e0fca; Brockmann GA, 2001, FASEB J, V15, P978, DOI 10.1096/fj.00-0391com; Bunger L, 1998, GENET RES, V72, P93, DOI 10.1017/S0016672398003401; Choquet H, 2011, CURR GENOMICS, V12, P169, DOI 10.2174/138920211795677895; Clee SM, 2007, ENDOCR REV, V28, P48, DOI 10.1210/er.2006-0035; DeBerardinis RJ, 2012, CELL, V148, P1132, DOI 10.1016/j.cell.2012.02.032; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Dietl G, 2004, ARCH TIERZUCHT, V47, P595, DOI 10.5194/aab-47-595-2004; Ehrich TH, 2003, OBES RES, V11, P1400, DOI 10.1038/oby.2003.189; Falkenberg H, 2000, ARCH TIERZUCHT, V43, P513, DOI 10.5194/aab-43-513-2000; Fernandez-Twinn DS, 2010, ANN NY ACAD SCI, V1212, P78, DOI 10.1111/j.1749-6632.2010.05798.x; HERBERG L, 1977, METABOLISM, V26, P59, DOI 10.1016/0026-0495(77)90128-7; HUMMEL KP, 1966, SCIENCE, V153, P1127, DOI 10.1126/science.153.3740.1127; INGALLS AM, 1950, J HERED, V41, P317, DOI 10.1093/oxfordjournals.jhered.a106073; Kanasaki K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/197636; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Klein M, 1999, J ANIM PHYSIOL AN N, V81, P75, DOI 10.1046/j.1439-0396.1999.812197.x; Kusminski CM, 2012, NAT MED, V18, P1539, DOI 10.1038/nm.2899; Loos RJF, 2012, BEST PRACT RES CL EN, V26, P211, DOI 10.1016/j.beem.2011.11.003; MacLean PS, 2004, AM J PHYSIOL-REG I, V287, pR1306, DOI 10.1152/ajpregu.00463.2004; Nakamura M, 1967, Diabetologia, V3, P212, DOI 10.1007/BF01222198; PAIGEN B, 1987, P NATL ACAD SCI USA, V84, P3763, DOI 10.1073/pnas.84.11.3763; REBUFFESCRIVE M, 1993, METABOLISM, V42, P1405, DOI 10.1016/0026-0495(93)90190-Y; Renne U, 2003, J EXP ANIM SCI, V42, P218, DOI 10.1016/S0939-8600(03)80004-4; Ritter S, 2012, POSTGRAD MED, V124, P168, DOI 10.3810/pgm.2012.07.2578; Rodgers RJ, 2012, DIS MODEL MECH, V5, P621, DOI 10.1242/dmm.009621; SAS Institute Inc, 2009, BAS SAS 9 2 PROC GUI; SAS S., 2009, STAT US GUID VERS 9; SCHULER L, 1985, ARCH TIERZUCHT, V28, P357; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; Stefan N, 2011, DIABETES, V60, P2011, DOI 10.2337/db11-0231; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Suzuki W, 1999, EXP ANIM TOKYO, V48, P181, DOI 10.1538/expanim.48.181; Timtchenko D, 1999, INT J OBESITY, V23, P586, DOI 10.1038/sj.ijo.0800872; UEDA H, 1995, DIABETOLOGIA, V38, P503, DOI 10.1007/BF00400717; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; WOLF E, 1991, GROWTH DEVELOP AGING, V55, P225; Yi CX, 2012, DIS MODEL MECH, V5, P583, DOI 10.1242/dmm.009902	40	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79788	10.1371/journal.pone.0079788	http://dx.doi.org/10.1371/journal.pone.0079788			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236159	Green Submitted, Green Published, gold			2022-12-27	WOS:000327254700159
J	Vartanian, LR; Sokol, N; Herman, CP; Polivy, J				Vartanian, Lenny R.; Sokol, Nicole; Herman, C. Peter; Polivy, Janet			Social Models Provide a Norm of Appropriate Food Intake for Young Women	PLOS ONE			English	Article							CONSUMPTION; OTHERS; EAT	It is often assumed that social models influence people's eating behavior by providing a norm of appropriate food intake, but this hypothesis has not been directly tested. In three experiments, female participants were exposed to a low-intake model, a high-intake model, or no model (control condition). Experiments 1 and 2 used a remote-confederate manipulation and were conducted in the context of a cookie taste test. Experiment 3 used a live confederate and was conducted in the context of a task during which participants were given incidental access to food. Participants also rated the extent to which their food intake was influenced by a variety of factors (e. g., hunger, taste, how much others ate). In all three experiments, participants in the low-intake conditions ate less than did participants in the high-intake conditions, and also reported a lower perceived norm of appropriate intake. Furthermore, perceived norms of appropriate intake mediated the effects of the social model on participants' food intake. Despite the observed effects of the social models, participants were much more likely to indicate that their food intake was influenced by taste and hunger than by the behavior of the social models. Thus, social models appear to influence food intake by providing a norm of appropriate eating behavior, but people may be unaware of the influence of a social model on their behavior.	[Vartanian, Lenny R.; Sokol, Nicole] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia; [Herman, C. Peter; Polivy, Janet] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada	University of New South Wales Sydney; University of Toronto	Vartanian, LR (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW, Australia.	lvartanian@psy.unsw.edu.au		Herman, C. Peter/0000-0001-5738-6803; Polivy, Janet/0000-0003-3997-8586; Vartanian, Lenny/0000-0001-8238-6151	Australian Research Council [DP110101124]	Australian Research Council(Australian Research Council)	This research was supported under Australian Research Council's Discovery Projects funding scheme (project number DP110101124) (arc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; CIALDINI RB, 1990, J PERS SOC PSYCHOL, V58, P1015, DOI 10.1037/0022-3514.58.6.1015; Cruwys T, 2012, APPETITE, V58, P754, DOI 10.1016/j.appet.2011.12.002; Exline JJ, 2012, J SOC CLIN PSYCHOL, V31, P169, DOI 10.1521/jscp.2012.31.2.169; Feeney JR, 2011, EAT BEHAV, V12, P75, DOI 10.1016/j.eatbeh.2010.09.007; GOLDMAN SJ, 1991, APPETITE, V17, P129, DOI 10.1016/0195-6663(91)90068-4; Herman CP, 2005, PHYSIOL BEHAV, V86, P762, DOI 10.1016/j.physbeh.2005.08.064; Herman CP, 2005, APPETITE, V45, P108, DOI 10.1016/j.appet.2005.03.013; Herman CP, 2003, PSYCHOL BULL, V129, P873, DOI 10.1037/0033-2909.129.6.873; Hermans RCJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031027; Hermans RCJ, 2012, BRIT J NUTR, V107, P588, DOI 10.1017/S0007114511003278; Hermans RCJ, 2009, APPETITE, V53, P135, DOI 10.1016/j.appet.2009.05.004; Louis W, 2007, J SOC PSYCHOL, V147, P57, DOI 10.3200/SOCP.147.1.57-74; McFerran B, 2010, J CONSUM RES, V36, P915, DOI 10.1086/644611; POLIVY J, 1979, J PERS, V47, P100, DOI 10.1111/j.1467-6494.1979.tb00617.x; Povey R, 1999, PSYCHOL HEALTH, V14, P991, DOI 10.1080/08870440008407363; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; RENO RR, 1993, J PERS SOC PSYCHOL, V64, P104, DOI 10.1037/0022-3514.64.1.104; Robinson E, 2013, APPETITE, V65, P20, DOI 10.1016/j.appet.2013.01.010; Robinson E, 2011, APPETITE, V56, P747, DOI 10.1016/j.appet.2011.03.001; Roth DA, 2001, APPETITE, V36, P165, DOI 10.1006/appe.2000.0388; Salvy SJ, 2008, APPETITE, V50, P514, DOI 10.1016/j.appet.2007.10.009; Salvy SJ, 2007, APPETITE, V49, P92, DOI 10.1016/j.appet.2006.12.004; Spanos S, 2013, HLTH PSYCHO IN PRESS; Vartanian LR, 2008, HEALTH PSYCHOL, V27, P533, DOI 10.1037/0278-6133.27.5.533; Vartanian LR, 2007, APPETITE, V48, P265, DOI 10.1016/j.appet.2006.10.008; [No title captured]	28	48	49	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79268	10.1371/journal.pone.0079268	http://dx.doi.org/10.1371/journal.pone.0079268			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236117	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700116
J	Sadler, KE; Stratton, JM; DeBerry, JJ; Kolber, BJ				Sadler, Katelyn E.; Stratton, Jarred M.; DeBerry, Jennifer J.; Kolber, Benedict J.			Optimization of a Pain Model: Effects of Body Temperature and Anesthesia on Bladder Nociception in Mice	PLOS ONE			English	Article							GLUTAMATE-RECEPTOR 5; DORSAL-HORN NEURONS; URINARY-BLADDER; VISCEROMOTOR RESPONSES; INTERSTITIAL CYSTITIS; VISCERAL PAIN; RATS; DISTENSION; ISOFLURANE; ERK	Interstitial cystitis/bladder pain syndrome (IC/BPS) is a debilitating urological condition that is resistant to treatment and poorly understood. To determine novel molecular treatment targets and to elucidate the contribution of the nervous system to IC/BPS, many rodent bladder pain models have been developed. In this study we evaluated the effects of anesthesia induction and temperature variation in a mouse model of bladder pain known as urinary bladder distension (UBD). In this model compressed air is used to distend the bladder to distinct pressures while electrodes record the reflexive visceromotor response (VMR) from the overlying abdominal muscle. Two isoflurane induction models are commonly used before UBD: a short method lasting approximately 30 minutes and a long method lasting approximately 90 minutes. Animals were anesthetized with one of the methods then put through three sets of graded bladder distensions. Distensions performed following the short anesthesia protocol were significantly different from one another despite identical testing parameters; this same effect was not observed when the long anesthesia protocol was used. In order to determine the effect of temperature on VMRs, animals were put through three graded distension sets at 37.5 (normal mouse body temperature), 35.5, and 33.5 degrees C. Distensions performed at 33.5 and 35.5 degrees C were significantly lower than those performed at 37.5 degrees C. Additionally, Western blot analysis revealed significantly smaller increases in spinal levels of phosphorylated extracellular-signal regulated kinase 2 (pERK2) following bladder distension in animals whose body temperature was maintained at 33.5 degrees C as opposed to 37.5 degrees C. These results highlight the significance of the dynamic effects of anesthesia on pain-like changes and the importance of close monitoring of temperature while performing UBD. For successful interpretation of VMRs and translation to human disease, body temperature should be maintained at 37.5 degrees C and isoflurane induction should gradually decrease over the course of 90 minutes.	[Sadler, Katelyn E.; Stratton, Jarred M.; Kolber, Benedict J.] Duquesne Univ, Dept Biol Sci & Chron Pain Res Consortium, Pittsburgh, PA 15219 USA; [DeBerry, Jennifer J.] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA USA; [DeBerry, Jennifer J.] Univ Pittsburgh, Ctr Pain Res, Pittsburgh, PA USA	Duquesne University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kolber, BJ (corresponding author), Duquesne Univ, Dept Biol Sci & Chron Pain Res Consortium, Pittsburgh, PA 15219 USA.	Kolberb@duq.edu		DeBerry, Jennifer/0000-0002-6613-2909; Kolber, Benedict/0000-0001-8665-1805	International Association for the Study of Pain Early Career Award; Hunkele Dreaded Disease Award	International Association for the Study of Pain Early Career Award; Hunkele Dreaded Disease Award	This work was funded by grants to BJK: International Association for the Study of Pain Early Career Award (http://www.iasp-pain.org/Content/NavigationMenu/Grants2/IASPEarlyCareerResearchGrantsProgram/default.htm); Hunkele Dreaded Disease Award (http://www.duq.edu/research/office-of-research/hunkele-dreaded-disease-competition). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RH, 1987, PHYSIOL BEHAV, V41, P635, DOI 10.1016/0031-9384(87)90322-2; BERGE OG, 1988, NEUROSCI LETT, V86, P284, DOI 10.1016/0304-3940(88)90497-1; Berry SH, 2011, J UROLOGY, V186, P540, DOI 10.1016/j.juro.2011.03.132; BIGELOW WG, 1950, ANN SURG, V132, P531, DOI 10.1097/00000658-195009000-00018; Bogart LM, 2007, J UROLOGY, V177, P450, DOI 10.1016/j.juro.2006.09.032; Bon K, 2003, J UROLOGY, V170, P1008, DOI 10.1097/01.ju.0000079766.49550.94; Castroman P, 2001, NEUROSCI LETT, V306, P97, DOI 10.1016/S0304-3940(01)01886-9; Cilia J, 1998, J PHARMACOL TOXICOL, V40, P21, DOI 10.1016/S1056-8719(98)00030-6; COHN BT, 1989, AM J SPORT MED, V17, P344, DOI 10.1177/036354658901700306; Crock LW, 2012, J NEUROSCI, V32, P14217, DOI 10.1523/JNEUROSCI.1473-12.2012; Crock LW, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-20; DildyMayfield JE, 1996, J PHARMACOL EXP THER, V276, P1058; EGER EI, 1981, ANESTHESIOLOGY, V55, P559, DOI 10.1097/00000542-198111000-00014; EGER EI, 1987, ANESTH ANALG, V66, P977; Ewald A. J., 2011, COLD SPRING HARB PRO, V2011; Flecknell PA., 2009, LAB ANIMAL ANESTHESI, V3rd edition; Grasshoff C, 2006, BRIT J ANAESTH, V97, P687, DOI 10.1093/bja/ael239; Hu HJ, 2003, J NEUROPHYSIOL, V90, P1680, DOI 10.1152/jn.00341.2003; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; Kort WJ, 1998, LAB ANIM-UK, V32, P260, DOI 10.1258/002367798780559329; Laboratory TSotJ, 1966, BIOL LAB MOUSE; Lai HH, 2011, PAIN, V152, P2117, DOI 10.1016/j.pain.2011.05.017; LEVY AS, 1993, CLIN ORTHOP RELAT R, P174; Luber-Narod J, 1997, UROL RES, V25, P395, DOI 10.1007/BF01268854; MCMAHON SB, 1987, PAIN, V28, P109, DOI 10.1016/0304-3959(87)91065-7; Ness TJ, 2004, J UROLOGY, V171, P1704, DOI 10.1097/01.ju.0000116430.67100.8f; Ness TJ, 2001, J UROLOGY, V165, P968, DOI 10.1016/S0022-5347(05)66586-X; Ness TJ, 1998, PAIN, V76, P61, DOI 10.1016/S0304-3959(98)00023-2; Nordmann GR, 2006, BRIT J ANAESTH, V96, P779, DOI 10.1093/bja/ael092; Qin Y, 2005, GENE DEV, V19, P2000, DOI 10.1101/gad.342205; Rivas DA, 1997, J UROLOGY, V157, P1937, DOI 10.1016/S0022-5347(01)64905-X; Roman K, 2013, ISRN PAIN, V2013, P10; ROSLAND JH, 1991, PAIN, V45, P211, DOI 10.1016/0304-3959(91)90190-9; SCHEFFLER N M, 1992, Journal of Foot Surgery, V31, P141; Seo K, 2010, NEUROSCI LETT, V472, P1, DOI 10.1016/j.neulet.2010.01.031; Shimizu I, 1999, NEUROUROL URODYNAM, V18, P115, DOI 10.1002/(SICI)1520-6777(1999)18:2<115::AID-NAU7>3.0.CO;2-D; Simpson S, 1905, J PHYSIOL-LONDON, V32, P305; Slack SE, 2004, EUR J NEUROSCI, V20, P1769, DOI 10.1111/j.1460-9568.2004.03656.x; Stemler KM, 2013, J UROLOGY, V189, P343, DOI 10.1016/j.juro.2012.08.189; Wei F, 2006, J NEUROSCI, V26, P851, DOI 10.1523/JNEUROSCI.3292-05.2006; Yang M, 2011, AM J PHYSIOL-RENAL, V300, pF1353, DOI 10.1152/ajprenal.00009.2011	41	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79617	10.1371/journal.pone.0079617	http://dx.doi.org/10.1371/journal.pone.0079617			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223980	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000326597400075
J	Aguado-Urda, M; Gibello, A; Blanco, MD; Fernandez-Garayzabal, JF; Lopez-Alonso, V; Lopez-Campos, GH				Aguado-Urda, Monica; Gibello, Alicia; Blanco, M. del Mar; Fernandez-Garayzabal, Jose F.; Lopez-Alonso, Victoria; Lopez-Campos, Guillermo H.			Global Transcriptome Analysis of Lactococcus garvieae Strains in Response to Temperature	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; GENOME SEQUENCE; RNA-POLYMERASE; DELTA-SUBUNIT; STREPTOCOCCUS-PNEUMONIAE; RESPIRATION METABOLISM; MOLECULAR-COMPONENTS; STRESS RESPONSES; GENE-EXPRESSION; VIRULENCE	Lactococcus garvieae is an important fish and an opportunistic human pathogen. The genomic sequences of several L. garvieae strains have been recently published, opening the possibility of global studies on the biology of this pathogen. In this study, a whole genome DNA microarray of two strains of L. garvieae was designed and validated. This DNA microarray was used to investigate the effects of growth temperature (18 degrees C and 37 degrees C) on the transcriptome of two clinical strains of L. garvieae that were isolated from fish (Lg8831) and from a human case of septicemia (Lg21881). The transcriptome profiles evidenced a strain-specific response to temperature, which was more evident at 18 degrees C. Among the most significant findings, Lg8831 was found to up-regulate at 18 degrees C several genes encoding different cold-shock and cold-induced proteins involved in an efficient adaptive response of this strain to low-temperature conditions. Another relevant result was the description, for the first time, of respiratory metabolism in L. garvieae, whose gene expression regulation was temperature-dependent in Lg21881. This study provides new insights about how environmental factors such as temperature can affect L. garvieae gene expression. These data could improve our understanding of the regulatory networks and adaptive biology of this important pathogen.	[Aguado-Urda, Monica; Gibello, Alicia; Blanco, M. del Mar; Fernandez-Garayzabal, Jose F.] Univ Complutense, Fac Vet Sci, Dept Anim Hlth, E-28040 Madrid, Spain; [Fernandez-Garayzabal, Jose F.] Univ Complutense, Anim Hlth Surveillance Ctr VISAVET, E-28040 Madrid, Spain; [Lopez-Alonso, Victoria] Hlth Inst Carlos III, Bioinformat & Publ Hlth Dept, Madrid, Spain; [Lopez-Campos, Guillermo H.] Univ Melbourne, Sch Med, Hlth & Biomed Informat Res Unit, Melbourne, Vic 3010, Australia	Complutense University of Madrid; Complutense University of Madrid; University of Melbourne	Lopez-Campos, GH (corresponding author), Univ Melbourne, Sch Med, Hlth & Biomed Informat Res Unit, Melbourne, Vic 3010, Australia.	guillermo.lopez@unimelb.edu.au	FERNANDEZ-GARAYZABAL, JOSE FRANCISCO/K-9611-2014; Gibello, Alicia/F-4140-2016; studies, IT VISAVET Account for bibliometric/C-3115-2014; Gibello, Alicia/K-6516-2019; Campos, Guillermo H Lopez/G-2883-2015; Lopez-Campos, Guillermo/O-4349-2017	FERNANDEZ-GARAYZABAL, JOSE FRANCISCO/0000-0003-1597-0643; Gibello, Alicia/0000-0002-3006-8685; studies, IT VISAVET Account for bibliometric/0000-0003-3319-0050; Lopez Alonso, Victoria/0000-0001-8129-8352; BLANCO, MARIA DEL MAR/0000-0003-4335-4346; Lopez-Campos, Guillermo/0000-0003-3011-0940	Spanish Ministry of Economy and Competiveness [AGL2009-12447, AGL2012-35419]; Complutense University of Madrid	Spanish Ministry of Economy and Competiveness(Spanish Government); Complutense University of Madrid	This research was supported by grants AGL2009-12447 and AGL2012-35419 from the Spanish Ministry of Economy and Competiveness. MAU was recipient of a Ph.D. fellowship from the Complutense University of Madrid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado-Urda M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040119; Aguado-Urda M, 2011, J BACTERIOL, V193, P4263, DOI 10.1128/JB.05326-11; Aguado-Urda M, 2011, J BACTERIOL, V193, P4033, DOI 10.1128/JB.05090-11; Aguado-Urda M, 2010, INT MICROBIOL, V13, P189, DOI 10.2436/20.1501.01.125; Anderson ES, 2009, INFECT IMMUN, V77, P3466, DOI 10.1128/IAI.00444-09; Angelidis AS, 2003, APPL ENVIRON MICROB, V69, P7492, DOI 10.1128/AEM.69.12.7492-7498.2003; Ayala-Castro C, 2008, MICROBIOL MOL BIOL R, V72, P110, DOI 10.1128/MMBR.00034-07; Barriere C, 2005, J BACTERIOL, V187, P3752, DOI 10.1128/JB.187.11.3752-3761.2005; Florez AB, 2012, J BACTERIOL, V194, P5118, DOI 10.1128/JB.00975-12; Boyer E, 2002, INFECT IMMUN, V70, P6032, DOI 10.1128/IAI.70.11.6032-6042.2002; Chattopadhyay MK, 2006, J BIOSCIENCES, V31, P157, DOI 10.1007/BF02705244; Claverys JP, 2006, ANNU REV MICROBIOL, V60, P451, DOI 10.1146/annurev.micro.60.080805.142139; Cotter PD, 2003, MICROBIOL MOL BIOL R, V67, P429, DOI 10.1128/MMBR.67.3.429-453.2003; Crack JC, 2012, CURR OPIN CHEM BIOL, V16, P35, DOI 10.1016/j.cbpa.2012.02.009; Datta PP, 2007, MOL CELL, V28, P434, DOI 10.1016/j.molcel.2007.08.026; den Besten HMW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013746; Dressaire C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-343; Dubbs James M., 2007, V44, P143; Fedtke I, 2007, MOL MICROBIOL, V65, P1078, DOI 10.1111/j.1365-2958.2007.05854.x; Fernandez A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000860; Ferrario C, 2012, FEMS MICROBIOL LETT, V332, P153, DOI 10.1111/j.1574-6968.2012.02591.x; Gabrielsen C, 2012, J BACTERIOL, V194, P6976, DOI 10.1128/JB.01864-12; GARCIABUSTOS JF, 1987, J BACTERIOL, V169, P447, DOI 10.1128/jb.169.2.447-453.1987; Gaudu P, 2003, MOL MICROBIOL, V50, P183, DOI 10.1046/j.1365-2958.2003.03700.x; Gaudu P, 2002, ANTON LEEUW INT J G, V82, P263, DOI 10.1023/A:1020635600343; Giangrossi M, 2007, MOL MICROBIOL, V64, P807, DOI 10.1111/j.1365-2958.2007.05699.x; Gibello A, 1999, APPL ENVIRON MICROB, V65, P4346; Ginsburg I, 2002, APMIS, V110, P753, DOI 10.1034/j.1600-0463.2002.1101101.x; Giuliodori AM, 2007, RNA, V13, P1355, DOI 10.1261/rna.455607; Harishchandra RK, 2010, BIOPHYS CHEM, V150, P37, DOI 10.1016/j.bpc.2010.02.007; Hoffmann T, 2011, J BACTERIOL, V193, P1552, DOI 10.1128/JB.01319-10; Jones AL, 2003, INFECT IMMUN, V71, P4011, DOI 10.1128/IAI.71.7.4011-4017.2003; Jones PG, 1996, MOL MICROBIOL, V21, P1207, DOI 10.1111/j.1365-2958.1996.tb02582.x; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Knapen D, 2009, TRENDS BIOTECHNOL, V27, P406, DOI 10.1016/j.tibtech.2009.03.007; Kocabas Pinar, 2009, Biotechnology Journal, V4, P1012, DOI 10.1002/biot.200800330; Kubota H, 2010, APPL ENVIRON MICROB, V76, P5440, DOI 10.1128/AEM.03132-09; KUSUDA R, 1991, INT J SYST BACTERIOL, V41, P406, DOI 10.1099/00207713-41-3-406; Li J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0025777, 10.1371/journal.pone.0028840, 10.1371/journal.pone.0027198]; Liu YL, 2011, J BACTERIOL, V193, P2826, DOI 10.1128/JB.00056-11; Marceau A, 2004, APPL ENVIRON MICROB, V70, P7260, DOI 10.1128/AEM.70.12.7260-7268.2004; Mereghetti L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002785; Morita H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023184; PAPPWALLACE KM, 2000, ANNU REV MICROBIOL, V60, P187; Pedersen MB, 2012, ANNU REV FOOD SCI T, V3, P37, DOI 10.1146/annurev-food-022811-101255; Perry RD, 2012, MICROBIOL-SGM, V158, P804, DOI 10.1099/mic.0.053710-0; Phadtare S, 2004, CURR ISSUES MOL BIOL, V6, P125; Phadtare S, 2010, RNA BIOL, V7, P788, DOI 10.4161/rna.7.6.13482; Pot B, 1996, SYST APPL MICROBIOL, V19, P213, DOI 10.1016/S0723-2020(96)80047-6; Price CE, 2012, FEMS MICROBIOL REV, V36, P949, DOI 10.1111/j.1574-6976.2011.00323.x; Que Q, 2000, MOL MICROBIOL, V35, P1454, DOI 10.1046/j.1365-2958.2000.01811.x; Rattanama P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032523; Ray MK, 2006, STRESS RESPONSE MOL, P1; Raynaud S, 2005, APPL ENVIRON MICROB, V71, P8016, DOI 10.1128/AEM.71.12.8016-8023.2005; Redon E, 2005, J BACTERIOL, V187, P3589, DOI 10.1128/JB.187.10.3589-3592.2005; Reimundo P, 2011, J BACTERIOL, V193, P3684, DOI 10.1128/JB.05210-11; Rezaiki L, 2004, MOL MICROBIOL, V53, P1331, DOI 10.1111/j.1365-2958.2004.04217.x; Ricci G, 2013, GENOME ANNOUNC, V1; Ricci G, 2012, J BACTERIOL, V194, P1249, DOI 10.1128/JB.06655-11; Rice KC, 2003, MOL MICROBIOL, V50, P729, DOI 10.1046/j.1365-2958.2003.t01-1-03720.x; Russo G, 2012, NEW MICROBIOL, V35, P495; Sabri M, 2008, INFECT IMMUN, V76, P601, DOI 10.1128/IAI.00789-07; Seepersaud R, 2006, J BACTERIOL, V188, P2096, DOI 10.1128/JB.188.6.2096-2105.2006; Shah P, 2011, MICROBIOL-SGM, V157, P504, DOI 10.1099/mic.0.042564-0; Shivaji S, 2010, ARCH MICROBIOL, V192, P85, DOI 10.1007/s00203-009-0539-y; Simon R, 2007, CANCER INFORM, V3, P11; Smoot LM, 2001, P NATL ACAD SCI USA, V98, P10416, DOI 10.1073/pnas.191267598; Stintzi A, 2003, J BACTERIOL, V185, P2009, DOI 10.1128/JB.185.6.2009-2016.2003; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; van de Guchte M, 2002, ANTON LEEUW INT J G, V82, P187, DOI 10.1023/A:1020631532202; Vendrell D, 2006, COMP IMMUNOL MICROB, V29, P177, DOI 10.1016/j.cimid.2006.06.003; Ware D, 2006, INFECT IMMUN, V74, P352, DOI 10.1128/IAI.74.1.352-361.2006; Wick LM, 2004, ADV BIOCHEM ENG BIOT, V89, P1; Wu DQ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-438; Wurtzel O, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002945; Xue XL, 2010, J BACTERIOL, V192, P5081, DOI 10.1128/JB.00653-10	76	13	13	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79692	10.1371/journal.pone.0079692	http://dx.doi.org/10.1371/journal.pone.0079692			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223997	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000326503400140
J	Goldenberg, G; Harris, TJC				Goldenberg, Gabrielle; Harris, Tony J. C.			Adherens Junction Distribution Mechanisms during Cell-Cell Contact Elongation in Drosophila	PLOS ONE			English	Article							E-CADHERIN; DE-CADHERIN; ENDOCYTOSIS; REARRANGEMENT; ARMADILLO; DYNAMICS; PATHWAY; BINDING; FORMS; SEC5	During Drosophila gastrulation, amnioserosa (AS) cells flatten and spread as an epithelial sheet. We used AS morphogenesis as a model to investigate how adherens junctions (AJs) distribute along elongating cell-cell contacts in vivo. As the contacts elongated, total AJ protein levels increased along their length. However, genetically blocking this AJ addition indicated that it was not essential for maintaining AJ continuity. Implicating other remodeling mechanisms, AJ photobleaching revealed non-directional lateral mobility of AJs along the elongating contacts, as well as local AJ removal from the membranes. Actin stabilization with jasplakinolide reduced AJ redistribution, and live imaging of myosin II along elongating contacts revealed fragmented, expanding and contracting actomyosin networks, suggesting a mechanism for lateral AJ mobility. Actin stabilization also increased total AJ levels, suggesting an inhibition of AJ removal. Implicating AJ removal by endocytosis, clathrin endocytic machinery accumulated at AJs. However, dynamin disruption had no apparent effect on AJs, suggesting the involvement of redundant or dynamin-independent mechanisms. Overall, we propose that new synthesis, lateral diffusion, and endocytosis play overlapping roles to populate elongating cell-cell contacts with evenly distributed AJs in this in vivo system.	[Goldenberg, Gabrielle; Harris, Tony J. C.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada	University of Toronto	Harris, TJC (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.	tony.harris@utoronto.ca			Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	T. Harris holds a Tier 2 Canada Research Chair and the work is supported by a Natural Sciences and Engineering Research Council of Canada Discovery Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armenti Stephen T, 2012, Subcell Biochem, V60, P279, DOI 10.1007/978-94-007-4186-7_12; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Boggetti Barbara, 2012, Subcell Biochem, V60, P321, DOI 10.1007/978-94-007-4186-7_14; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Bulgakova NA, 2013, J CELL BIOL, V201, P887, DOI 10.1083/jcb.201211159; Cavey M, 2008, NATURE, V453, P751, DOI 10.1038/nature06953; Classen AK, 2005, DEV CELL, V9, P805, DOI 10.1016/j.devcel.2005.10.016; David Daryl J V, 2012, Methods Mol Biol, V839, P1, DOI 10.1007/978-1-61779-510-7_1; de Beco S, 2009, P NATL ACAD SCI USA, V106, P7010, DOI 10.1073/pnas.0811253106; Ebrahim S, 2013, CURR BIOL, V23, P731, DOI 10.1016/j.cub.2013.03.039; Georgiou M, 2008, CURR BIOL, V18, P1631, DOI 10.1016/j.cub.2008.09.029; Godt D, 1998, NATURE, V395, P387, DOI 10.1038/26493; GonzalezGaitan M, 1997, CELL, V88, P767, DOI 10.1016/S0092-8674(00)81923-6; Grammont M, 2007, J CELL BIOL, V177, P139, DOI 10.1083/jcb.200609079; Han Siew Ping, 2012, Subcell Biochem, V60, P111, DOI 10.1007/978-94-007-4186-7_6; Harris TJC, 2012, INT REV CEL MOL BIO, V293, P45, DOI 10.1016/B978-0-12-394304-0.00007-5; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Hong S, 2013, J CELL BIOL, V201, P131, DOI 10.1083/jcb.201211054; Hong S, 2010, P NATL ACAD SCI USA, V107, P3528, DOI 10.1073/pnas.0911027107; Huang J, 2011, J CELL SCI, V124, P4001, DOI 10.1242/jcs.086694; Iino R, 2001, BIOPHYS J, V80, P2667, DOI 10.1016/S0006-3495(01)76236-4; Ishiyama Noboru, 2012, Subcell Biochem, V60, P39, DOI 10.1007/978-94-007-4186-7_3; Kametani Y, 2007, NAT CELL BIOL, V9, P92, DOI 10.1038/ncb1520; KIM YT, 1990, J NEUROGENET, V7, P1, DOI 10.3109/01677069009084149; Kowalczyk Andrew P, 2012, Subcell Biochem, V60, P197, DOI 10.1007/978-94-007-4186-7_9; Langevin J, 2005, DEV CELL, V9, P365, DOI 10.1016/j.devcel.2005.07.013; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; Leibfried A, 2008, CURR BIOL, V18, P1639, DOI 10.1016/j.cub.2008.09.063; Letizia Annalisa, 2012, Subcell Biochem, V60, P251, DOI 10.1007/978-94-007-4186-7_11; Levayer R, 2011, NAT CELL BIOL, V13, P734, DOI 10.1038/ncb0611-734a; MASUR SK, 1990, J NEUROGENET, V6, P191, DOI 10.3109/01677069009107110; McCartney BM, 2001, NAT CELL BIOL, V3, P933, DOI 10.1038/ncb1001-933; McGill MA, 2009, J CELL BIOL, V185, P787, DOI 10.1083/jcb.200812146; Murthy M, 2003, NEURON, V37, P433, DOI 10.1016/S0896-6273(03)00031-X; Niewiadomska P, 1999, J CELL BIOL, V144, P533, DOI 10.1083/jcb.144.3.533; Nishimura T, 2009, CURR TOP DEV BIOL, V89, P33, DOI 10.1016/S0070-2153(09)89002-9; Oda H, 2001, J CELL SCI, V114, P493; PEIFER M, 1994, DEV BIOL, V166, P543, DOI 10.1006/dbio.1994.1336; Pokutta S, 2007, ANNU REV CELL DEV BI, V23, P237, DOI 10.1146/annurev.cellbio.22.010305.104241; Pope KL, 2008, DEVELOPMENT, V135, P2227, DOI 10.1242/dev.019802; Royou A, 2002, J CELL BIOL, V158, P127, DOI 10.1083/jcb.200203148; Sako Y, 1998, J CELL BIOL, V140, P1227, DOI 10.1083/jcb.140.5.1227; Tepass U, 1996, GENE DEV, V10, P672, DOI 10.1101/gad.10.6.672; Troyanovsky Sergey, 2012, Subcell Biochem, V60, P89, DOI 10.1007/978-94-007-4186-7_5; Uemura T, 1996, GENE DEV, V10, P659, DOI 10.1101/gad.10.6.659; Vasioukhin Valeri, 2012, Subcell Biochem, V60, P379, DOI 10.1007/978-94-007-4186-7_16	48	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79613	10.1371/journal.pone.0079613	http://dx.doi.org/10.1371/journal.pone.0079613			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223978	gold, Green Published, Green Submitted			2022-12-27	WOS:000326503400129
J	Zoghi, M; Galea, M; Morgan, D				Zoghi, Maryam; Galea, Mary; Morgan, David			A Brain Motor Control Assessment (BMCA) Protocol for Upper Limb Function	PLOS ONE			English	Article							SPINAL-CORD-INJURY; VOLUNTARY RESPONSE INDEX; SURFACE EMG; ARM; RELIABILITY; STROKE; SPASTICITY; SHOULDER; PATTERNS; HUMANS	The Brain Motor Control Assessment (BMCA) protocol is a surface electromyography (sEMG)-based measure of motor output from central nervous system during a variety of reflex and voluntary motor tasks performed under strictly controlled conditions. The aim of this study was to evaluate the BMCA protocol for upper limb with the addition of shoulder voluntary tasks. The voluntary response index (VRI) was calculated from quantitative analysis of sEMG data during defined voluntary movement in neurologically intact people for comparison with that of patients after neurological injuries. The BMCA protocol included one bilateral and 4 unilateral voluntary tasks at different joints of both arms. The VRI, measured from 19 neurologically intact participants, comprises the total muscle activity recorded for the voluntary motor task (magnitude). The calculated similarity index (SI) for each phase of each task show the similarity of "the distribution of activity across the recorded muscles" for that task in this group off participants. Results: The VRI magnitude values from right and left sides for different tasks showed no significant difference (ANOVA: F-Side: 0.09, P = 0.77). Therefore these values were pooled before calculating SI. SI values were higher for tasks against gravity: elbow flexion (0.99 +/- 0.03), wrist flexion with palm up (0.98 +/- 0.03) and wrist extension with palm down (0.97 +/- 0.07). On the other hand, the SI values were the lowest for bilateral shoulder abduction (0.84 +/- 0.08) and shoulder adduction (0.84 +/- 0.08). Conclusion: To validate this index for clinical use, serial studies on patients with neurological impairments should be performed. Tasks involving movement against gravity may be more suitable in future BMCAs.	[Zoghi, Maryam; Galea, Mary; Morgan, David] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3050, Australia	Royal Melbourne Hospital; University of Melbourne	Zoghi, M (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3050, Australia.	mzoghi@unimelb.edu.au	Morgan, David L/B-9545-2008; , Zoghi/AAF-9536-2019; Galea, Mary/F-4242-2010	, Zoghi/0000-0002-1819-6895; Galea, Mary/0000-0003-0045-7978	Victorian Neurotrauma Initiative [D113]	Victorian Neurotrauma Initiative	This work was supported by the Victorian Neurotrauma Initiative project grant no. D113: Functional electrical stimulation for hand function in quadriplegia (website: http://www.tac.vic.gov.au/about-us/research/tac-neurotrauma-research/program-grants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashford S, 2013, CLIN REHABIL; Ashford S, 2008, J REHABIL MED, V40, P787, DOI 10.2340/16501977-0276; Barreca SR, 2005, ARCH PHYS MED REHAB, V86, P1616, DOI 10.1016/j.apmr.2005.03.017; CIONI B, 1986, APPL NEUROPHYSIOL, V49, P315; DIMITRIJEVIC MR, 1984, ANN NEUROL, V16, P216, DOI 10.1002/ana.410160208; DIMITRIJEVIC MR, 1992, J NEUROTRAUM, V9, pS293; Grice KO, 2003, AM J OCCUP THER, V57, P570; HANSON RW, 1976, ARCH PHYS MED REHAB, V57, P291; KRONBERG M, 1990, CLIN ORTHOP RELAT R, P76; Lee DC, 2004, J ELECTROMYOGR KINES, V14, P379, DOI 10.1016/j.jelekin.2003.10.006; Lim HK, 2005, J REHABIL RES DEV, V42, P413, DOI 10.1682/JRRD.2004.07.0079; Lin JJ, 2006, J ELECTROMYOGR KINES, V16, P458, DOI 10.1016/j.jelekin.2005.09.008; McDonnell M, 2008, AUST J PHYSIOTHER, V54, P220, DOI 10.1016/S0004-9514(08)70034-5; Mckay WB, 2011, SPINAL CORD, V49, P421, DOI 10.1038/sc.2010.145; McKay WB, 2004, NEUROREHAB NEURAL RE, V18, P144, DOI 10.1177/0888439004267674; Morris DM, 2001, ARCH PHYS MED REHAB, V82, P750, DOI 10.1053/apmr.2001.23183; Mulcahey Mary Jane, 2012, J Pediatr Orthop, V32 Suppl 2, pS114, DOI 10.1097/BPO.0b013e3182595423; Priebe MM, 1997, SPINAL CORD, V35, P171, DOI 10.1038/sj.sc.3100366; SHERWOOD AM, 1993, RESTOR NEUROL NEUROS, V5, P119, DOI 10.3233/RNN-1993-5202; Sherwood AM, 1996, MUSCLE NERVE, V19, P966, DOI 10.1002/(SICI)1097-4598(199608)19:8<966::AID-MUS5>3.3.CO;2-N; Sherwood AM, 2000, J REHABIL RES DEV, V37, P41; Snoek GJ, 2004, SPINAL CORD, V42, P526, DOI 10.1038/sj.sc.3101638; Uswatte G, 2006, NEUROLOGY, V67, P1189, DOI 10.1212/01.wnl.0000238164.90657.c2; VIRJIBABUL N, 1994, EXP BRAIN RES, V99, P338; Wickham J, 2010, J ELECTROMYOGR KINES, V20, P212, DOI 10.1016/j.jelekin.2009.06.004; Wolfe SA, 2000, PLAST RECONSTR SURG, V106, P1642, DOI 10.1097/00006534-200012000-00036	26	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79483	10.1371/journal.pone.0079483	http://dx.doi.org/10.1371/journal.pone.0079483			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223953	Green Published, gold			2022-12-27	WOS:000326503400117
J	Obregon-Henao, A; Henao-Tamayo, M; Orme, IM; Ordway, DJ				Obregon-Henao, Andres; Henao-Tamayo, Marcela; Orme, Ian M.; Ordway, Diane J.			Gr1(int)CD11b(+) Myeloid-Derived Suppressor Cells in Mycobacterium tuberculosis Infection	PLOS ONE			English	Article							W-BEIJING STRAINS; L-ARGININE; MOUSE MODEL; GUINEA-PIG; EXPRESSION; MECHANISMS; GRANULOMAS; GENE; RESPONSES; ARGINASE	Background: Tuberculosis is one of the world's leading killers, stealing 1.4 million lives and causing 8.7 million new and relapsed infections in 2011. The only vaccine against tuberculosis is BCG which demonstrates variable efficacy in adults worldwide. Human infection with Mycobacterium tuberculosis results in the influx of inflammatory cells to the lung in an attempt to wall off bacilli by forming a granuloma. Gr1(int)CD11b(+) cells are called myeloid-derived suppressor cells (MDSC) and play a major role in regulation of inflammation in many pathological conditions. Although MDSC have been described primarily in cancer their function in tuberculosis remains unknown. During M. tuberculosis infection it is crucial to understand the function of cells involved in the regulation of inflammation during granuloma formation. Understanding their relative impact on the bacilli and other cellular phenotypes is necessary for future vaccine and drug design. Methodology/Principal Findings: We compared the bacterial burden, lung pathology and Gr1(int)CD11b(+) myeloid-derived suppressor cell immune responses in M. tuberculosis infected NOS2-/-, RAG-/-, C3HeB/FeJ and C57/BL6 mice. Gr-1(+) cells could be found on the edges of necrotic lung lesions in NOS2-/-, RAG-/-, and C3HeB/FeJ, but were absent in wild-type mice. Both populations of Gr1(+)CD11b(+) cells expressed high levels of arginase-1, and IL-17, additional markers of myeloid derived suppressor cells. We then sorted the Gr1(hi) and Gr1(int) populations from M. tuberculosis infected NOS-/- mice and placed the sorted both Gr1(int) populations at different ratios with naive or M. tuberculosis infected splenocytes and evaluated their ability to induce activation and proliferation of CD4+ T cells. Our results showed that both Gr1(hi) and Gr1(int) cells were able to induce activation and proliferation of CD4+ T cells. However this response was reduced as the ratio of CD4(+) T to Gr1(+) cells increased. Our results illustrate a yet unrecognized interplay between Gr1(+) cells and CD4(+) T cells in tuberculosis.	[Obregon-Henao, Andres; Henao-Tamayo, Marcela; Orme, Ian M.; Ordway, Diane J.] Colorado State Univ, Mycobacteria Res Labs, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	Colorado State University	Obregon-Henao, A (corresponding author), Colorado State Univ, Mycobacteria Res Labs, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Andres.Obregon@ColoState.EDU; D.Ordway@colostate.edu	Henao-Tamayo, Marcela/D-8189-2017; Ordway, Diane/H-9732-2017	Henao-Tamayo, Marcela/0000-0002-4249-9650; Ordway, Diane/0000-0003-0003-326X	NIH [1DP2OD006450 - 01, AI081959]; American Recovery and Reinvestment Act; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI081959] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006450] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH innovator award grant number 1DP2OD006450 - 01 and AI081959. This study was also funded under the American Recovery and Reinvestment Act of 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basaraba RJ, 2008, TUBERCULOSIS, V88, pS35, DOI 10.1016/S1472-9792(08)70035-0; Basaraba RJ, 2010, COLOR ATLAS COMP PAT; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Cooper AM, 2000, INFECT IMMUN, V68, P6879, DOI 10.1128/IAI.68.12.6879-6882.2000; Corzo CA, 2010, J EXP MED, V207, P2439, DOI 10.1084/jem.20100587; Derive M, 2012, INTENS CARE MED, V38, P1040, DOI 10.1007/s00134-012-2574-4; Dharmadhikari AS, 2011, TUBERCULOSIS, V91, P329, DOI 10.1016/j.tube.2011.03.002; Dilek N, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00208; Driver ER, 2012, ANTIMICROB AGENTS CH, V56, P3181, DOI 10.1128/AAC.00217-12; Durante W, 2007, CLIN EXP PHARMACOL P, V34, P906, DOI 10.1111/j.1440-1681.2007.04638.x; Ehlers S, 2000, FRONTIERS IMMUNOLOGY, V3, P411; Eruslanov EB, 2005, INFECT IMMUN, V73, P1744, DOI 10.1128/IAI.73.3.1744-1753.2005; Eum SY, 2010, CHEST, V137, P122, DOI 10.1378/chest.09-0903; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gama L, 2009, J LEUKOCYTE BIOL, V91, P803; Gonzalez-Juarrero M, 2005, J LEUKOCYTE BIOL, V77, P914, DOI 10.1189/jlb.1204723; Gonzalez-Juarrero M, 2003, J IMMUNOL, V171, P3128, DOI 10.4049/jimmunol.171.6.3128; Harper J, 2012, J INFECT DIS, V205, P595, DOI 10.1093/infdis/jir786; Hoff DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017550; Ino Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055146; Jassal MS, 2010, CLIN INFECT DIS, V50, pS156, DOI 10.1086/651486; Kramnik I, 2008, CURR TOP MICROBIOL, V321, P123; Martino A, 2010, J IMMUNOL, V184, P2038, DOI 10.4049/jimmunol.0903348; Mazzoni A, 2002, J IMMUNOL, V168, P689, DOI 10.4049/jimmunol.168.2.689; Nagaraj S, 2008, CANCER RES, V68, P2561, DOI 10.1158/0008-5472.CAN-07-6229; Nagaraj S, 2013, J IMMUNOL, V191, P17, DOI 10.4049/jimmunol.1300654; Nagaraj S, 2012, SEMIN CANCER BIOL, V22, P282, DOI 10.1016/j.semcancer.2012.01.010; Nandi B, 2011, J EXP MED, V208, P2251, DOI 10.1084/jem.20110919; Ordway D, 2007, J IMMUNOL, V179, P2532, DOI 10.4049/jimmunol.179.4.2532; Ordway DJ, 2011, CLIN VACCINE IMMUNOL, V18, P1527, DOI 10.1128/CVI.05127-11; Ordway DJ, 2010, ANTIMICROB AGENTS CH, V54, P1820, DOI 10.1128/AAC.01521-09; Ordway DJ, 2009, CURR PROTOC IMMUNOL; Orme IM, 2011, FUTURE MICROBIOL, V6, P161, DOI 10.2217/FMB.10.168; Orme IM, 2003, TUBERCULOSIS, V83, P112, DOI 10.1016/S1472-9792(02)00069-0; Palanisamy GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026254; Pan H, 2005, NATURE, V434, P767, DOI 10.1038/nature03419; Pessanha AP, 2012, FEMS IMMUNOL MED MIC, V66, P265, DOI 10.1111/j.1574-695X.2012.01012.x; Raber P, 2012, IMMUNOL INVEST, V41, P614, DOI 10.3109/08820139.2012.680634; Raviglione M, 2010, LANCET, V379, P1902; Rieber N, 2013, J IMMUNOL, V190, P1276, DOI 10.4049/jimmunol.1202144; Rodriguez PC, 2007, BLOOD, V109, P1568, DOI 10.1182/blood-2006-06-031856; Rodriguez PC, 2004, CANCER RES, V64, P5839, DOI 10.1158/0008-5472.CAN-04-0465; Rodriguez PC, 2003, J IMMUNOL, V171, P1232, DOI 10.4049/jimmunol.171.3.1232; Rodriguez PC, 2002, J BIOL CHEM, V277, P21123, DOI 10.1074/jbc.M110675200; Shang SB, 2011, TUBERCULOSIS, V91, P378, DOI 10.1016/j.tube.2011.06.001; Skold M, 2008, J IMMUNOL, V181, P6349, DOI 10.4049/jimmunol.181.9.6349; Turner OC, 2003, GRANULOMATOUS INFECTIONS AND INFLAMMATIONS: CELLULAR AND MOLECULAR MECHANISMS, P65; Turner OC, 2003, INFECT IMMUN, V71, P864, DOI 10.1128/IAI.71.2.864-871.2003; Vollbrecht T, 2012, AIDS, V26, pF31, DOI 10.1097/QAD.0b013e328354b43f; Youn JI, 2010, EUR J IMMUNOL, V40, P2969, DOI 10.1002/eji.201040895; Zea AH, 2006, J INFECT DIS, V194, P1385, DOI 10.1086/508200; Zhang C, 2012, INFECT IMMUN, V80, P3634, DOI 10.1128/IAI.00668-12	53	59	61	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e80669	10.1371/journal.pone.0080669	http://dx.doi.org/10.1371/journal.pone.0080669			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24224058	Green Published, gold, Green Submitted			2022-12-27	WOS:000326499300099
J	Viklund, J; Martijn, J; Ettema, TJG; Andersson, SGE				Viklund, Johan; Martijn, Joran; Ettema, Thijs J. G.; Andersson, Siv G. E.			Comparative and Phylogenomic Evidence That the Alphaproteobacterium HIMB59 Is Not a Member of the Oceanic SAR11 Clade	PLOS ONE			English	Article							GENOME REDUCTION; DIVERSITY; SELECTION	SAR11 is a globally abundant group of Alphaproteobacteria in the oceans that is taxonomically not well defined. It has been suggested SAR11 should be classified into the novel order Pelagibacterales. Features such as conservation of gene content and synteny have been taken as evidence that also the divergent member HIMB59 should be included in the order. However, this proposition is controversial since phylogenetic analyses have questioned the monophyly of this grouping. Here, we performed phylogenetic analyses and reinvestigated the genomic similarity of SAR11 and HIMB59. Our phylogenetic analysis confirmed that HIMB59 is not a sister group to the other SAR11 strains. By placing the comparison in the context of the evolution of the Alphaproteobacteria, we found that none of the measures of genomic similarity supports a clustering of HIMB59 and SAR11 to the exclusion of other Alphaproteobacteria. First, pairwise sequence similarity measures for the SAR11 and HIMB59 genomes were within the range observed for unrelated pairs of Alphaproteobacteria. Second, pairwise comparisons of gene contents revealed a higher similarity of SAR11 to several other alphaproteobacterial genomes than to HIMB59. Third, the SAR11 genomes are not more similar in gene order to the HIMB59 genome than what they are to several other alphaproteobacterial genomes. Finally, in contrast to earlier reports, we observed no sequence similarity between the hypervariable region HVR2 in the SAR11 genomes and the region located at the corresponding position in the HIMB59 genome. Based on these observations, we conclude that the alphaproteobacterium HIMB59 is not monophyletic with the SAR11 strains and that genome streamlining has evolved multiple times independently in Alphaproteobacteria adapted to the upper surface waters of the oceans.	[Viklund, Johan; Martijn, Joran; Ettema, Thijs J. G.; Andersson, Siv G. E.] Biomed Ctr, Dept Mol Evolut, Sci Life Lab, Uppsala, Sweden		Andersson, SGE (corresponding author), Biomed Ctr, Dept Mol Evolut, Sci Life Lab, Uppsala, Sweden.	Siv.Andersson@icm.uu.se		Martijn, Joran/0000-0001-7651-5252	Swedish Research Council; Knut and Alice Wallenberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by grants from the Swedish Research Council and the Knut and Alice Wallenberg Foundation to SGEA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Biers EJ, 2009, APPL ENVIRON MICROB, V75, P2221, DOI 10.1128/AEM.02118-08; Brindefalk B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024457; BUTTON DK, 1991, APPL ENVIRON MICROB, V57, P2033, DOI 10.1128/AEM.57.7.2033-2038.1991; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Dufresne A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r14; Georgiades K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024857; GIOVANNONI SJ, 1990, NATURE, V345, P60, DOI 10.1038/345060a0; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Grote J, 2012, MBIO, V3, DOI 10.1128/mBio.00252-12; Hrdy I, 2004, NATURE, V432, P618, DOI 10.1038/nature03149; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Lartillot N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S4; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; ROBBERTSE B, 2011, PLOS CURR, V3, DOI DOI 10.1371/CURRENTS.RRN1213.PUBMED:21327165; Rodriguez-Ezpeleta N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030520; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Stamatakis A., 2006, P 20 IEEE INT PAR DI, P8, DOI DOI 10.1109/IPDPS.2006.1639535; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Thrash JC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00013; Viklund J, 2012, MOL BIOL EVOL, V29, P599, DOI 10.1093/molbev/msr203; Williams KP, 2007, J BACTERIOL, V189, P4578, DOI 10.1128/JB.00269-07; Yelton AP, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002230	27	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78858	10.1371/journal.pone.0078858	http://dx.doi.org/10.1371/journal.pone.0078858			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223857	Green Published, Green Submitted, gold			2022-12-27	WOS:000326499300036
J	Li, SJ; Wu, CH; Chen, JX; Lu, P; Chen, C; Fu, MH; Fang, J; Gao, J; Zhu, L; Liang, RX; Shen, X; Yang, HJ				Li, Shaojing; Wu, Chuanhong; Chen, Jianxin; Lu, Peng; Chen, Chang; Fu, Meihong; Fang, Jing; Gao, Jian; Zhu, Li; Liang, Rixin; Shen, Xin; Yang, Hongjun			An Effective Solution to Discover Synergistic Drugs for Anti-Cerebral Ischemia from Traditional Chinese Medicinal Formulae	PLOS ONE			English	Article							BILOBA EXTRACT EGB; ARTERY OCCLUSION; GINSENOSIDE-RE; MITOCHONDRIAL DYSFUNCTION; IN-VITRO; STROKE; GENIPOSIDE; BERBERINE; BRAIN; INJURY	Recently, the pharmaceutical industry has shifted to pursuing combination therapies that comprise more than one active ingredient. Interestingly, combination therapies have been used for more than 2500 years in traditional Chinese medicine (TCM). Understanding optimal proportions and synergistic mechanisms of multi-component drugs are critical for developing novel strategies to combat complex diseases. A new multi-objective optimization algorithm based on least angle regression-partial least squares was proposed to construct the predictive model to evaluate the synergistic effect of the three components of a novel combination drug Yi-qi-jie-du formula (YJ), which came from clinical TCM prescription for the treatment of encephalopathy. Optimal proportion of the three components, ginsenosides (G), berberine (B) and jasminoidin (J) was determined via particle swarm optimum. Furthermore, the combination mechanisms were interpreted using PLS VIP and principal components analysis. The results showed that YJ had optimal proportion 3(G): 2(B): 0.5(J), and it yielded synergy in the treatment of rats impaired by middle cerebral artery occlusion induced focal cerebral ischemia. YJ with optimal proportion had good pharmacological effects on acute ischemic stroke. The mechanisms study demonstrated that the combination of G, B and J could exhibit the strongest synergistic effect. J might play an indispensable role in the formula, especially when combined with B for the acute stage of stroke. All these data in this study suggested that in the treatment of acute ischemic stroke, besides restoring blood supply and protecting easily damaged cells in the area of the ischemic penumbra as early as possible, we should pay more attention to the removal of the toxic metabolites at the same time. Mathematical system modeling may be an essential tool for the analysis of the complex pharmacological effects of multi-component drug. The powerful mathematical analysis method could greatly improve the efficiency in finding new combination drug from TCM.	[Li, Shaojing; Wu, Chuanhong; Chen, Chang; Fu, Meihong; Fang, Jing; Zhu, Li; Liang, Rixin; Shen, Xin; Yang, Hongjun] China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing, Peoples R China; [Chen, Jianxin] Beijing Univ Chinese Med, Informat Ctr, Beijing, Peoples R China; [Lu, Peng] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China; [Gao, Jian] Hebei Univ, Coll Pharmaceut Sci, Baoding, Hebei, Peoples R China; [Zhu, Li] Jiangxi Univ Tradit Chinese Med Pharm, Jiangxi Univ Tradit Chinese Med, NanChang, Jiangxi, Peoples R China	China Academy of Chinese Medical Sciences; Institute of Chinese Materia Medica, CACMS; Beijing University of Chinese Medicine; Chinese Academy of Sciences; Institute of Automation, CAS; Hebei University; Jiangxi University of Traditional Chinese Medicine	Yang, HJ (corresponding author), China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing, Peoples R China.	hongjun0420@vip.sina.com	Chen, Jianxin/G-5881-2015; Chen, Chang/Z-3748-2019	Chen, Jianxin/0000-0003-4067-5638; Chen, Chang/0000-0003-1674-973X	National Natural Science Foundation of China [30901976, 81274133]; Major Scientific and Technological Special Project for "Significant New Drugs Creation" [2012ZX09103-201-055]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Scientific and Technological Special Project for "Significant New Drugs Creation"	This work was supported by grants from the National Natural Science Foundation of China (No. 30901976 and No. 81274133) and the Major Scientific and Technological Special Project for "Significant New Drugs Creation" (No. 2012ZX09103-201-055). The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebiyi OA, 2003, COMPUT CHEM ENG, V27, P143, DOI 10.1016/S0098-1354(02)00034-0; [Anonymous], SWARM INTELLIGENCE; Appice A, 2007, LECT NOTES ARTIF INT, V4701, P502; Benaissa F, 2009, ACTA PHYSIOL HUNG, V96, P213, DOI 10.1556/APhysiol.96.2009.2.6; Blomgren K, 2003, BIOCHEM BIOPH RES CO, V304, P551, DOI 10.1016/S0006-291X(03)00628-4; Boas DA, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3285504; Briers JD, 2001, PHYSIOL MEAS, V22, pR35, DOI 10.1088/0967-3334/22/4/201; Chen C, 2011, PHARM BIOL, V49, P445, DOI 10.3109/13880209.2010.523426; Chen JX, 2012, MOLECULES, V17, P9855, DOI 10.3390/molecules17089855; Chen JX, 2011, J ETHNOPHARMACOL, V134, P919, DOI 10.1016/j.jep.2011.01.048; Chen LM, 2008, J ASIAN NAT PROD RES, V10, P439, DOI 10.1080/10286020801892292; Dancey JE, 2006, NAT REV DRUG DISCOV, V5, P649, DOI 10.1038/nrd2089; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Dave KR, 2008, J NEUROSCI, V28, P4172, DOI 10.1523/JNEUROSCI.5471-07.2008; Della-Morte D, 2011, NEUROSCI LETT, V487, P158, DOI 10.1016/j.neulet.2010.10.013; Draijer M, 2009, LASER MED SCI, V24, P639, DOI 10.1007/s10103-008-0626-3; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Everett H, 2002, J EXP MED, V196, P1127, DOI 10.1084/jem.20011247; Fang KT, 2003, HANDB STAT, V22, P131, DOI 10.1016/S0169-7161(03)22006-X; Gao M, 2008, J ASIAN NAT PROD RES, V10, P551, DOI 10.1080/10286020801966955; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; Gertsch J, 2011, PLANTA MED, V77, P1086, DOI 10.1055/s-0030-1270904; Gilan SS, 2012, CONSTR BUILD MATER, V34, P321, DOI 10.1016/j.conbuildmat.2012.02.038; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; Hata R, 1998, J CEREBR BLOOD F MET, V18, P367, DOI 10.1097/00004647-199804000-00004; He XL, 2009, BRAIN RES, V1249, P212, DOI 10.1016/j.brainres.2008.10.005; HIRANO K, 1991, DEV GROWTH DIFFER, V33, P451; Hu Jingqing, 2011, Front Med, V5, P203, DOI 10.1007/s11684-011-0138-6; Hu J, 2012, EUR J PHARMACOL, V674, P132, DOI 10.1016/j.ejphar.2011.11.014; Iwanami J, 2007, EUR J PHARMACOL, V566, P153, DOI 10.1016/j.ejphar.2007.03.043; Jiang WL, 2010, PHYTOTHER RES, V24, P547, DOI 10.1002/ptr.2978; Jonker DM, 2005, PHARMACOL THERAPEUT, V106, P1, DOI 10.1016/j.pharmthera.2004.10.014; Kannan K, 2000, MOL CELL BIOCHEM, V205, P53, DOI 10.1023/A:1007080910396; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Kettmann V, 2004, PHARMAZIE, V59, P548; Khanal T, 2012, TOXICOL LETT, V209, P246, DOI 10.1016/j.toxlet.2011.12.017; Koh PO, 2011, AM J CHINESE MED, V39, P971, DOI 10.1142/S0192415X11009342; Koo H, 2004, PLANTA MED, V70, P467, DOI 10.1055/s-2004-818978; Kuo WH, 2004, PHARMACOLOGY, V70, P15, DOI 10.1159/000074238; Le Tran Q, 2003, J ETHNOPHARMACOL, V86, P249, DOI 10.1016/S0378-8741(03)00045-X; Leung KW, 2007, FEBS LETT, V581, P2423, DOI 10.1016/j.febslet.2007.04.055; Li PF, 2009, TRANSPORT REV, V29, P619, DOI 10.1080/01441640902829454; Li S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S1-S10; Lindvall O, 2004, STROKE, V35, P2691, DOI 10.1161/01.STR.0000143323.84008.f4; Liu JH, 2012, TOXICOL IN VITRO, V26, P1093, DOI 10.1016/j.tiv.2012.07.004; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Lu TT, 2011, BIOL PHARM BULL, V34, P1319, DOI 10.1248/bpb.34.1319; Ma HM, 2010, ANIM REPROD SCI, V121, P106, DOI 10.1016/j.anireprosci.2010.05.005; Malthouse EC, 1997, COMPUT CHEM ENG, V21, P875, DOI 10.1016/S0098-1354(96)00311-0; Nakaya Yutaka, 2007, J Med Invest, V54, P381, DOI 10.2152/jmi.54.381; Peng J, 2008, J SHANGHAI JIAOTONG, V42, P189; QIN SJ, 1992, COMPUT CHEM ENG, V16, P379, DOI 10.1016/0098-1354(92)80055-E; Radad K, 2011, CNS NEUROSCI THER, V17, P761, DOI 10.1111/j.1755-5949.2010.00208.x; Rudzinski W, 2007, NUCL MED REV, V10, P29; Saraf MK, 2010, PHARMACOL BIOCHEM BE, V97, P192, DOI 10.1016/j.pbb.2010.07.017; Shen H, 2009, FASEB J, V23, P1958, DOI 10.1096/fj.08-123281; Shen JG, 2011, CHIN MED-UK, V6, DOI 10.1186/1749-8546-6-8; Shi C, 2010, PLATELETS, V21, P373, DOI 10.3109/09537100903511448; Shi LL, 2011, LIFE SCI, V88, P521, DOI 10.1016/j.lfs.2011.01.011; Sims NR, 2002, NEUROCHEM INT, V40, P511, DOI 10.1016/S0197-0186(01)00122-X; Sucher NJ, 2006, EPILEPSY BEHAV, V8, P350, DOI 10.1016/j.yebeh.2005.11.015; Suzuki Y, 2001, PLANTA MED, V67, P807, DOI 10.1055/s-2001-18842; Tan CB, 2009, BIOL PHARM BULL, V32, P1359, DOI 10.1248/bpb.32.1359; Tian JW, 2005, NEUROSCI LETT, V374, P92, DOI 10.1016/j.neulet.2004.10.030; Umetrics AB, 2006, MULTI MEGAVARIATE 1, V2; Vosler PS, 2009, STROKE, V40, P3149, DOI 10.1161/STROKEAHA.108.543769; Wang L, 2008, P NATL ACAD SCI USA, V105, P4826, DOI 10.1073/pnas.0712365105; Xia T, 2002, FEBS LETT, V510, P62, DOI 10.1016/S0014-5793(01)03228-8; Xutian S, 2009, AM J CHINESE MED, V37, P411, DOI 10.1142/S0192415X09006941; Yang HJ, 2009, J BIOL SYST, V17, P329, DOI 10.1142/S0218339009002971; Yang L, 2009, ANAL BIOANAL CHEM, V395, P1441, DOI 10.1007/s00216-009-3121-1; Ye MZ, 2009, J PHARM PHARMACOL, V61, P831, DOI [10.1211/jpp.61.07.0001, 10.1211/jpp/61.07.0001]; Ye R, 2011, NEUROSCIENCE, V178, P169, DOI 10.1016/j.neuroscience.2011.01.007; Zhang G, 2012, INT J MOL MED, V30, P561, DOI 10.3892/ijmm.2012.1030; Zhang HX, 2004, ACTA PHARMACOL SIN, V25, P385; Zhang HX, 2003, NEUROL RES, V25, P471; Zhang XL, 2012, BRAIN RES, V1459, P61, DOI 10.1016/j.brainres.2012.03.065; Zhang ZJ, 2006, BRAIN RES, V1123, P188, DOI 10.1016/j.brainres.2006.09.063; Zhang ZJ, 2012, BRAIN RES BULL, V87, P193, DOI 10.1016/j.brainresbull.2011.11.002; Zheng CY, 2008, J NEUROSCI RES, V86, P2432, DOI 10.1002/jnr.21681; Zheng GQ, 2011, J ETHNOPHARMACOL, V133, P724, DOI 10.1016/j.jep.2010.01.064; Zhou XQ, 2008, NEUROSCI LETT, V447, P31, DOI 10.1016/j.neulet.2008.09.064; Zhou XM, 2006, BIOL PHARM BULL, V29, P2502, DOI 10.1248/bpb.29.2502; Zhu Xiao-lei, 2004, Zhongguo Zhongyao Zazhi, V29, P1065; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735	85	14	19	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78902	10.1371/journal.pone.0078902	http://dx.doi.org/10.1371/journal.pone.0078902			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236065	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700062
J	Olson, KR; Heberlein, AS; Kensinger, E; Burrows, C; Dweck, CS; Spelke, ES; Banaji, MR				Olson, Kristina R.; Heberlein, Andrea S.; Kensinger, Elizabeth; Burrows, Christopher; Dweck, Carol S.; Spelke, Elizabeth S.; Banaji, Mahzarin R.			The Role of Forgetting in Undermining Good Intentions	PLOS ONE			English	Article							DECISION-MAKING; MEMORY; INFORMATION; ATTITUDES; CONSUMERS; COGNITION; CHILDREN; BEHAVIOR; AMYGDALA; CULTURE	Evaluating others is a fundamental feature of human social interaction-we like those who help more than those who hinder. In the present research, we examined social evaluation of those who not only intentionally performed good and bad actions but also those to whom good things have happened (the lucky) and those to whom bad things have happened (the unlucky). In Experiment 1a, subjects demonstrated a sympathetic preference for the unlucky. However, under cognitive load (Experiment 1b), no such preference was expressed. Further, in Experiments 2a and 2b, when a time delay between impression formation (learning) and evaluation (memory test) was introduced, results showed that younger (Experiment 2a) and older adults (Experiment 2b) showed a significant preference for the lucky. Together these experiments show that a consciously motivated sympathetic preference for those who are unlucky dissolves when memory is disrupted. The observed dissociation provides evidence for the presence of conscious good intentions (favoring the unlucky) and the cognitive compromising of such intentions when memory fails.	[Olson, Kristina R.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [Heberlein, Andrea S.; Kensinger, Elizabeth] Boston Coll, Dept Psychol, Boston, MA USA; [Burrows, Christopher] Univ Connecticut, Dept Psychol, Storrs, CT USA; [Dweck, Carol S.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Spelke, Elizabeth S.; Banaji, Mahzarin R.] Harvard Univ, Cambridge, MA 02138 USA	Yale University; Boston College; University of Connecticut; Stanford University; Harvard University	Olson, KR (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06520 USA.	krolson@uw.edu		Kensinger, Elizabeth/0000-0003-1940-231X				Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Banerjee R, 1999, EUR J SOC PSYCHOL, V29, P105, DOI 10.1002/(SICI)1099-0992(199902)29:1<105::AID-EJSP910>3.0.CO;2-K; Bizer GY, 2006, J EXP SOC PSYCHOL, V42, P646, DOI 10.1016/j.jesp.2005.09.002; Blanchard-fields, 1982, AGEING SOC, V2, P183, DOI [10.1017/S0144686X00009429, DOI 10.1017/S0144686X00009429]; Cansino S, 2000, INT J PSYCHOPHYSIOL, V71, P64; Cole C, 2008, MARKET LETT, V19, P355, DOI 10.1007/s11002-008-9058-x; De Houwer J, 2001, PSYCHOL BULL, V127, P853, DOI 10.1037//0033-2909.127.6.853; Diamond A, 2005, PSYCHOL SCI, V16, P291, DOI 10.1111/j.0956-7976.2005.01530.x; Epley N, 2004, J EXP SOC PSYCHOL, V40, P760, DOI 10.1016/j.jesp.2004.02.002; GILBERT DT, 1991, J PERS SOC PSYCHOL, V60, P509, DOI 10.1037/0022-3514.60.4.509; GILBERT DT, 1988, J PERS SOC PSYCHOL, V54, P733, DOI 10.1037/0022-3514.54.5.733; Hamlin JK, 2007, NATURE, V450, P557, DOI 10.1038/nature06288; Hamlin JK, 2010, DEVELOPMENTAL SCI, V13, P923, DOI 10.1111/j.1467-7687.2010.00951.x; HASTIE R, 1986, PSYCHOL REV, V93, P258, DOI 10.1037/0033-295X.93.3.258; Hebl MR, 2003, PERS SOC PSYCHOL B, V29, P28, DOI 10.1177/0146167202238369; Hermer-Vazquez L, 1999, COGNITIVE PSYCHOL, V39, P3, DOI 10.1006/cogp.1998.0713; JOHNSON MK, 1985, J EXP PSYCHOL LEARN, V11, P22, DOI 10.1037/0278-7393.11.1.22; Knowles ED, 2001, PERS SOC PSYCHOL B, V27, P1344, DOI 10.1177/01461672012710010; Koutstaal W, 2006, PSYCHON B REV, V13, P84, DOI 10.3758/BF03193817; Lerner M., 1980, BELIEF JUST WORLD FU, DOI DOI 10.1007/978-1-4899-0448-5; Lerner MJ, 2003, PERS SOC PSYCHOL REV, V7, P388, DOI 10.1207/S15327957PSPR0704_10; Li V., CHILD DEV IN PRESS; Lieberman MD, 2001, PSYCHOL SCI, V12, P135, DOI 10.1111/1467-9280.00323; LODGE M, 1989, AM POLIT SCI REV, V83, P399, DOI 10.2307/1962397; MANIS M, 1974, J PERS SOC PSYCHOL, V30, P81, DOI 10.1037/h0036639; MEHTA SI, 1988, J SOC CLIN PSYCHOL, V7, P192, DOI 10.1521/jscp.1988.7.2-3.192; Old SR, 2008, PSYCHOL AGING, V23, P104, DOI 10.1037/0882-7974.23.1.104; Olson KR, 2008, J PERS SOC PSYCHOL, V94, P757, DOI 10.1037/0022-3514.94.5.757; Olson KR, 2006, PSYCHOL SCI, V17, P845, DOI 10.1111/j.1467-9280.2006.01792.x; Pavlov I.P., 1927, CONDITIONED REFLEXES; Pham MT, 1998, J CONSUM RES, V25, P144, DOI 10.1086/209532; PHILLIPS WA, 1971, PSYCHON SCI, V22, P73; Resorla RA, 1982, ANN REV PSYCH, V33, P265; ROZIN P, 1989, B PSYCHONOMIC SOC, V27, P367; ROZIN P, 1994, J ABNORM PSYCHOL, V103, P495, DOI 10.1037/0021-843X.103.3.495; Rutland A, 2005, CHILD DEV, V76, P451, DOI 10.1111/j.1467-8624.2005.00856.x; Shank DR, 1994, ANIMAL LEARNING COGN, P335; Shaw A, 2013, NAVIGATING SOCIAL WO; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Skowronski JJ, 1998, J PERS SOC PSYCHOL, V74, P837, DOI 10.1037/0022-3514.74.4.837; Somerville LH, 2006, J COGNITIVE NEUROSCI, V18, P1253, DOI 10.1162/jocn.2006.18.8.1253; Thorndike EL., 1911, ANIMAL INTELLIGENCE, DOI DOI 10.4324/9781351321044; Todorov A, 2008, SOC COGN AFFECT NEUR, V3, P195, DOI 10.1093/scan/nsn013; TRANEL D, 1993, J COGNITIVE NEUROSCI, V5, P79, DOI 10.1162/jocn.1993.5.1.79; Uleman JS, 2005, NEW UNCONSCIOUS; Walther E, 2002, J PERS SOC PSYCHOL, V82, P919, DOI 10.1037//0022-3514.82.6.919; Wasserman EA, 1997, ANNU REV PSYCHOL, V48, P573, DOI 10.1146/annurev.psych.48.1.573; Yoon C, 1997, J CONSUM RES, V24, P329, DOI 10.1086/209514	48	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79091	10.1371/journal.pone.0079091	http://dx.doi.org/10.1371/journal.pone.0079091			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236093	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700091
J	Capeness, MJ; Lambert, C; Lovering, AL; Till, R; Uchida, K; Chaudhuri, R; Alderwick, LJ; Lee, DJ; Swarbreck, D; Liddell, S; Aizawa, SI; Sockett, RE				Capeness, Michael J.; Lambert, Carey; Lovering, Andrew L.; Till, Rob; Uchida, Kaoru; Chaudhuri, Roy; Alderwick, Luke J.; Lee, David J.; Swarbreck, David; Liddell, Susan; Aizawa, Shin-Ichi; Sockett, Renee Elizabeth			Activity of Bdellovibrio Hit Locus Proteins, Bd0108 and Bd0109, Links Type IVa Pilus Extrusion/Retraction Status to Prey-Independent Growth Signalling	PLOS ONE			English	Article							ESCHERICHIA-COLI; GENE FAMILY; LIFE-CYCLE; BACTERIOVORUS; MUTANTS; SYSTEM; REVEALS; RHS; BIOGENESIS; EXPRESSION	Bdellovibrio bacteriovorus are facultatively predatory bacteria that grow within gram-negative prey, using pili to invade their periplasmic niche. They also grow prey-independently on organic nutrients after undergoing a reversible switch. The nature of the growth switching mechanism has been elusive, but several independent reports suggested mutations in the hit (host-interaction) locus on the Bdellovibrio genome were associated with the transition to prey-independent growth. Pili are essential for prey entry by Bdellovibrio and sequence analysis of the hit locus predicted that it was part of a cluster of Type IVb pilus-associated genes, containing bd0108 and bd0109. In this study we have deleted the whole bd0108 gene, which is unique to Bdellovibrio, and compared its phenotype to strains containing spontaneous mutations in bd0108 and the common natural 42 bp deletion variant of bd0108. We find that deletion of the whole bd0108 gene greatly reduced the extrusion of pili, whereas the 42 bp deletion caused greater pilus extrusion than wild-type. The pili isolated from these strains were comprised of the Type IVa pilin protein; PilA. Attempts to similarly delete gene bd0109, which like bd0108 encodes a periplasmic/secreted protein, were not successful, suggesting that it is likely to be essential for Bdellovibrio viability in any growth mode. Bd0109 has a sugar binding YD-repeat motif and an N-terminus with a putative pilin-like fold and was found to interact directly with Bd0108. These results lead us to propose that the Bd0109/Bd0108 interaction regulates pilus production in Bdellovibrio (possibly by interaction with the pilus fibre at the cell wall), and that the presence (and possibly retraction state) of the pilus feeds back to alter the growth state of the Bdellovibrio cell. We further identify a novel small RNA encoded by the hit locus, the transcription of which is altered in different bd0108 mutation backgrounds.	[Capeness, Michael J.; Lambert, Carey; Till, Rob; Sockett, Renee Elizabeth] Univ Nottingham, Sch Life Sci, Nottingham NG7 2RD, England; [Lovering, Andrew L.; Alderwick, Luke J.; Lee, David J.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Uchida, Kaoru; Aizawa, Shin-Ichi] Prefectural Univ Hiroshima, Dept Life Sci, Shobara, Japan; [Chaudhuri, Roy] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Swarbreck, David] Genome Anal Ctr, Norwich, Norfolk, England; [Liddell, Susan] Univ Nottingham, Div Anim Sci, Prote Lab, Nottingham NG7 2RD, England	University of Nottingham; University of Birmingham; University of Liverpool; The Genome Analysis Centre (TGAC); University of Nottingham	Sockett, RE (corresponding author), Univ Nottingham, Sch Life Sci, Nottingham NG7 2RD, England.	liz.sockett@nottingham.ac.uk	Chaudhuri, Roy/E-3774-2014; Lambert, Carey/AAY-9270-2020	Chaudhuri, Roy/0000-0001-5037-2695; Lee, David/0000-0003-2395-351X; Lambert, Carey/0000-0002-1844-457X; Alderwick, Luke/0000-0002-1257-6053; Lovering, Andrew/0000-0002-1856-7975; Swarbreck, David/0000-0002-5453-1013; Aizawa, Shin-Ichi/0000-0002-9068-0825	BBSRC [G013632/1]; Butterfield award from the Sasakawa foundation; BBSRC [BBS/E/T/000PR6193, BBS/E/T/000PR5885, BB/G013632/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G013632/1, BBS/E/T/000PR5885, BBS/E/T/000PR6193] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Butterfield award from the Sasakawa foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This project was funded by BBSRC Grant G013632/1 to RES for CL and MJC and by a Butterfield award from the Sasakawa foundation to RES and S-IA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atterbury RJ, 2011, APPL ENVIRON MICROB, V77, P5794, DOI 10.1128/AEM.00426-11; Barel G, 2001, ARCH MICROBIOL, V176, P211, DOI 10.1007/s002030100312; Burrows LL, 2012, MOL MICROBIOL, V86, P765, DOI 10.1111/mmi.12034; Cahoon LA, 2013, BIOTECHNOLOGY, V9; Cahoon LA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003074; Chaudhuri RR, 2011, MICROBIOL-SGM, V157, P2922, DOI 10.1099/mic.0.050278-0; Chugani S, 2012, P NATL ACAD SCI USA, V109, pE2823, DOI 10.1073/pnas.1214128109; COTTER TW, 1992, J BACTERIOL, V174, P6018, DOI 10.1128/JB.174.19.6018-6024.1992; COTTER TW, 1992, J BACTERIOL, V174, P6011, DOI 10.1128/JB.174.19.6011-6017.1992; Dori-Bachash M, 2008, APPL ENVIRON MICROB, V74, P7152, DOI 10.1128/AEM.01736-08; DUPUY B, 1991, J BACTERIOL, V173, P7589, DOI 10.1128/jb.173.23.7589-7598.1991; Eggenhofer F, 2011, NUCLEIC ACIDS RES, V39, pW149, DOI 10.1093/nar/gkr467; Evans KJ, 2007, J BACTERIOL, V189, P4850, DOI 10.1128/JB.01942-06; Fenton AK, 2010, J BACTERIOL, V192, P6329, DOI 10.1128/JB.00914-10; Fenton AK, 2010, J BACTERIOL, V192, P1299, DOI 10.1128/JB.01157-09; Fernandez-Tornero C, 2001, NAT STRUCT BIOL, V8, P1020, DOI 10.1038/nsb724; FOSTER SJ, 1993, MOL MICROBIOL, V8, P299, DOI 10.1111/j.1365-2958.1993.tb01574.x; Giltner CL, 2010, J MOL BIOL, V398, P444, DOI 10.1016/j.jmb.2010.03.028; HESPELL RB, 1975, J BACTERIOL, V123, P481, DOI 10.1128/JB.123.2.481-491.1975; Ho JGS, 2005, P NATL ACAD SCI USA, V102, P18373, DOI 10.1073/pnas.0506391102; Hobley L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002493; Jackson AP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-584; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Korotkov KV, 2012, NAT REV MICROBIOL, V10, P336, DOI 10.1038/nrmicro2762; Lambert C, 2006, MOL MICROBIOL, V60, P274, DOI 10.1111/j.1365-2958.2006.05081.x; Lambert C, 2003, ENVIRON MICROBIOL, V5, P127, DOI 10.1046/j.1462-2920.2003.00385.x; Lambert C, 2013, FEMS MICROBIOL LETT; Lambert C, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-99; Lambert C, 2010, CURR MICROBIOL, V60, P419, DOI 10.1007/s00284-009-9559-8; Lambert C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008599; Lerner TR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002524; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Liu ZY, 2012, MOL MICROBIOL, V86, P140, DOI 10.1111/j.1365-2958.2012.08178.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mahmoud KK, 2010, MICROBIOL-SGM, V156, P1040, DOI 10.1099/mic.0.036137-0; MATIN A, 1972, Journal of Bacteriology, V111, P664; McNulty C, 2006, MOL MICROBIOL, V59, P907, DOI 10.1111/j.1365-2958.2005.05010.x; Medina AA, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-33; Minet AD, 1999, J CELL SCI, V112, P2019; Morehouse KA, 2011, J BACTERIOL, V193, P932, DOI 10.1128/JB.00941-10; Pelicic V, 2008, MOL MICROBIOL, V68, P827, DOI 10.1111/j.1365-2958.2008.06197.x; Poole SJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002217; Rendulic S, 2004, SCIENCE, V303, P689, DOI 10.1126/science.1093027; ROBERTS RC, 1987, J GEN MICROBIOL, V133, P3065; ROGERS M, 1986, MOL GEN GENET, V205, P550, DOI 10.1007/BF00338097; Roschanski N, 2011, J BACTERIOL; Roschanski N, 2011, CURR MICROBIOL, V62, P589, DOI 10.1007/s00284-010-9748-5; SADOSKY AB, 1989, J BACTERIOL, V171, P636, DOI 10.1128/jb.171.2.636-642.1989; Santini CL, 2001, J BIOL CHEM, V276, P8159, DOI 10.1074/jbc.C000833200; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schwudke D, 2005, CURR MICROBIOL, V51, P310, DOI 10.1007/s00284-005-0030-1; SEIDLER RJ, 1969, J BACTERIOL, V100, P769, DOI 10.1128/JB.100.2.769-785.1969; SHILO M, 1965, J GEN MICROBIOL, V40, P317, DOI 10.1099/00221287-40-3-317; Sisto A, 2010, ANTON LEEUW INT J G, V98, P505, DOI 10.1007/s10482-010-9468-7; Steyert SR, 2007, APPL ENVIRON MICROB, V73, P4717, DOI 10.1128/AEM.00640-07; STOLP H, 1963, ANTON VAN LEE J M S, V29, P217, DOI 10.1007/BF02046064; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; THOMASHOW MF, 1979, DEV BIOL PROKARYOTES; VARON M, 1975, J BACTERIOL, V124, P1191, DOI 10.1128/JB.124.3.1191-1197.1975; Vik A, 2012, MOL MICROBIOL, V85, P1166, DOI 10.1111/j.1365-2958.2012.08166.x; VLAZNY DA, 1995, J BACTERIOL, V177, P2209, DOI 10.1128/jb.177.8.2209-2213.1995; Wang YD, 1998, J BACTERIOL, V180, P4102, DOI 10.1128/JB.180.16.4102-4110.1998; Woods RD, 2007, NANO LETT, V7, P1809, DOI 10.1021/nl0702968; Wurtzel O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015628; Youderian P, 2007, GENETICS, V177, P557, DOI 10.1534/genetics.107.076182	67	32	32	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79759	10.1371/journal.pone.0079759	http://dx.doi.org/10.1371/journal.pone.0079759			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224002	Green Accepted, Green Published, gold			2022-12-27	WOS:000326597400085
J	Jhun, JY; Moon, SJ; Yoon, BY; Byun, JK; Kim, EK; Yang, EJ; Ju, JH; Hong, YS; Min, JK; Park, SH; Kim, HY; Cho, ML				Jhun, Joo Yeon; Moon, Su-Jin; Yoon, Bo Young; Byun, Jae Kyung; Kim, Eun Kyung; Yang, Eun Ji; Ju, Ji Hyeon; Hong, Yeon Sik; Min, Jun Ki; Park, Sung Hwan; Kim, Ho Youn; Cho, Mi-La			Grape Seed Proanthocyanidin Extract-Mediated Regulation of STAT3 Proteins Contributes to Treg Differentiation and Attenuates Inflammation in a Murine Model of Obesity-Associated Arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; BROWN ADIPOSE-TISSUE; T-CELLS; JOINT INFLAMMATION; SELF-TOLERANCE; LEPTIN; RATS; DIET; HOMEOSTASIS; ACTIVATION	Grape seed proanthocyanidin extract (GSPE) is a natural flavonoid that exerts anti-inflammatory properties. Obesity is an inflammatory condition and inflammatory cells and their secretion of pro-inflammatory molecules contribute to the pathogenesis of obesity. Rheumatoid arthritis (RA) is a chronic autoimmune disease that is characterized by inflammation of joints lined by synovium. Previously, we demonstrated that obesity augmented arthritis severity in collagen induced arthritis (CIA), a murine model of human RA. Here, we investigated whether oral administration of GSPE showed antiobesity and anti-arthritic effects in high-fat diet-induced obese (DIO) mice and in obese CIA mice, respectively. The pathophysiologic mechanisms by which GSPE attenuates weight gain and arthritis severity in vivo were also investigated. In DIO mice, GSPE administration significantly inhibited weight gain, reduced fat infiltration in liver and improved serum lipid profiles. The antiobesity effect of GSPE was associated with increased populations of regulatory T (Treg) cells and those of decreased Th17 cells. Decrease of Th17 cells was associated with significant inhibition of their key transcriptional factors, pSTAT3(Tyr705) and pSTAT3(Ser727). On the contrary, GSPE-induced Treg induction was associated with enhanced pSTAT5 expression. To identify the anti-arthritis effects of GSPE, GSPE was given orally for 7 weeks after type II collagen immunization. GSPE treatment significantly attenuated the development of autoimmune arthritis in obese CIA model. In line with DIO mice, GSPE administration decreased Th17 cells and reciprocally increased Treg cells by regulating STAT proteins in autoimmune arthritis model. The expressions of pro-inflammatory cytokines and nitrotyrosine in synovium were significantly inhibited by GSPE treatment. Taken together, GSPE functions as a reciprocal regulator of T cell differentiation - suppression of Th17 cells and induction of Tregs in both DIO and obese CIA mice. GSPE may act as a therapeutic agent to treat immunologic diseases related with enhanced STAT3 activity such as metabolic disorders and autoimmune diseases.	[Jhun, Joo Yeon; Byun, Jae Kyung; Kim, Eun Kyung; Yang, Eun Ji; Cho, Mi-La] Catholic Univ Korea, Coll Med, Conversant Res Consortium Immunol Dis, Seoul, South Korea; [Jhun, Joo Yeon; Byun, Jae Kyung; Kim, Eun Kyung; Yang, Eun Ji; Cho, Mi-La] Catholic Univ Korea, Coll Med, Rheumatism Res Ctr, Seoul, South Korea; [Moon, Su-Jin; Ju, Ji Hyeon; Hong, Yeon Sik; Min, Jun Ki; Park, Sung Hwan; Kim, Ho Youn] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea; [Yoon, Bo Young] Inje Univ, Dept Internal Med, Ilsan Paik Hosp, Goyang, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Inje University	Cho, ML (corresponding author), Catholic Univ Korea, Coll Med, Conversant Res Consortium Immunol Dis, Seoul, South Korea.	iammila@catholic.ac.kr			Korea Health Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A092258]; Bio & Medical Technology Development Program of the National Research Foundation (NRF); Korean government Ministry of Education, Science and Technology (MEST) [2012049783]	Korea Health Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea; Bio & Medical Technology Development Program of the National Research Foundation (NRF)(National Research Foundation of Korea); Korean government Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This research was supported by a grant from the Korea Health Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (grant number A092258), Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government Ministry of Education, Science and Technology (MEST) (grant number 2012049783). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antov A, 2003, J IMMUNOL, V171, P3435, DOI 10.4049/jimmunol.171.7.3435; Bagchi D, 2000, TOXICOLOGY, V148, P187, DOI 10.1016/S0300-483X(00)00210-9; Barclay JL, 2011, ENDOCRINOLOGY, V152, P181, DOI 10.1210/en.2010-0537; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Blade C, 2010, MOL NUTR FOOD RES, V54, P37, DOI 10.1002/mnfr.200900476; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Cho ML, 2009, IMMUNOL LETT, V124, P102, DOI 10.1016/j.imlet.2009.05.001; Cui Y, 2007, HEPATOLOGY, V46, P504, DOI 10.1002/hep.21713; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Gainsford T, 1996, P NATL ACAD SCI USA, V93, P14564, DOI 10.1073/pnas.93.25.14564; Inglis JJ, 2008, NAT PROTOC, V3, P612, DOI 10.1038/nprot.2008.19; Jhun JY, 2012, EXP MOL MED, V44, P424, DOI 10.3858/emm.2012.44.7.047; La Cava A, 2004, NAT REV IMMUNOL, V4, P371, DOI 10.1038/nri1350; Lazarevic V, 2011, NAT IMMUNOL, V12, P96, DOI 10.1038/ni.1969; Li WG, 2001, ACTA PHARMACOL SIN, V22, P1117; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; Maddur MS, 2012, AM J PATHOL, V181, P8, DOI 10.1016/j.ajpath.2012.03.044; Matarese G, 2005, J IMMUNOL, V174, P3137, DOI 10.4049/jimmunol.174.6.3137; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Pajuelo D, 2012, BRIT J NUTR, V107, P170, DOI 10.1017/S0007114511002728; Park MK, 2011, IMMUNOL LETT, V135, P50, DOI 10.1016/j.imlet.2010.09.011; Rasmussen SE, 2005, MOL NUTR FOOD RES, V49, P159, DOI 10.1002/mnfr.200400082; Rosloniec EF, 2001, CURR PROTOC IMMUNOL; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Shevach EM, 2001, ADV EXP MED BIOL, V490, P21; Sos BC, 2011, J CLIN INVEST, V121, P1412, DOI 10.1172/JCI42894; Terra X, 2009, J NUTR BIOCHEM, V20, P210, DOI 10.1016/j.jnutbio.2008.02.005; Thiruchenduran M, 2011, CARDIOVASC PATHOL, V20, P361, DOI 10.1016/j.carpath.2010.09.002; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Wang DM, 2010, BIOL CELL, V102, P1, DOI 10.1042/BC20090070; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Winer S, 2009, EUR J IMMUNOL, V39, P2629, DOI 10.1002/eji.200838893; Woo YJ, 2011, EXP MOL MED, V43, P561, DOI 10.3858/emm.2011.43.10.062	37	25	30	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78843	10.1371/journal.pone.0078843	http://dx.doi.org/10.1371/journal.pone.0078843			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223854	Green Published, gold, Green Submitted			2022-12-27	WOS:000326597400041
J	Wylie, SJ; Li, H; Jones, MGK				Wylie, Stephen J.; Li, Hua; Jones, Michael G. K.			Donkey Orchid Symptomless Virus: A Viral 'Platypus' from Australian Terrestrial Orchids	PLOS ONE			English	Article							FAMILY FLEXIVIRIDAE; PLANT-VIRUSES; RNA VIRUSES; CONSERVATION; POTYVIRUSES; POPULATIONS; PHYLOGENY; DIVERSITY; EVOLUTION; MOVEMENT	Complete and partial genome sequences of two isolates of an unusual new plant virus, designated Donkey orchid symptomless virus (DOSV) were identified using a high-throughput sequencing approach. The virus was identified from asymptomatic plants of Australian terrestrial orchid Diuris longifolia (Common donkey orchid) growing in a remnant forest patch near Perth, western Australia. DOSV was identified from two D. longifolia plants of 264 tested, and from at least one plant of 129 Caladenia latifolia (pink fairy orchid) plants tested. Phylogenetic analysis of the genome revealed open reading frames (ORF) encoding seven putative proteins of apparently disparate origins. A 69-kDa protein (ORF1) that overlapped the replicase shared low identity with MPs of plant tymoviruses (Tymoviridae). A 157-kDa replicase (ORF2) and 22-kDa coat protein (ORF4) shared 32% and 40% amino acid identity, respectively, with homologous proteins encoded by members of the plant virus family Alphaflexiviridae. A 44-kDa protein (ORF3) shared low identity with myosin and an autophagy protein from Squirrelpox virus. A 27-kDa protein (ORF5) shared no identity with described proteins. A 14-kDa protein (ORF6) shared limited sequence identity (26%) over a limited region of the envelope glycoprotein precursor of mammal-infecting Crimea-Congo hemorrhagic fever virus (Bunyaviridae). The putative 25-kDa movement protein (MP) (ORF7) shared limited (27%) identity with 3A-like MPs of members of the plant-infecting Tombusviridae and Virgaviridae. Transmissibility was shown when DOSV systemically infected Nicotiana benthamiana plants. Structure and organization of the domains within the putative replicase of DOSV suggests a common evolutionary origin with 'potexvirus-like' replicases of viruses within the Alphaflexiviridae and Tymoviridae, and the CP appears to be ancestral to CPs of allexiviruses (Alphaflexiviridae). The MP shares an evolutionary history with MPs of dianthoviruses, but the other putative proteins are distant from plant viruses. DOSV is not readily classified in current lower order virus taxa.	[Wylie, Stephen J.; Li, Hua; Jones, Michael G. K.] Murdoch Univ, Australian Plant Virol Lab, Western Australian State Agr Biotechnol Ctr, Sch Vet & Life Sci, Perth, WA, Australia	Murdoch University	Wylie, SJ (corresponding author), Murdoch Univ, Australian Plant Virol Lab, Western Australian State Agr Biotechnol Ctr, Sch Vet & Life Sci, Perth, WA, Australia.	s.wylie@murdoch.edu.au	Jones, Michael G.K./M-5932-2013; Wylie, Stephen/M-5910-2013	Jones, Michael G.K./0000-0001-5002-0227; Wylie, Stephen/0000-0002-5639-7460; Li, Hua/0000-0002-0973-5762	Australian Research Council Linkage grant [LP110200180]; Western Australian Botanic Gardens and Parks Authority; Australian Orchid Foundation	Australian Research Council Linkage grant(Australian Research Council); Western Australian Botanic Gardens and Parks Authority; Australian Orchid Foundation	This study was funded by Australian Research Council Linkage grant LP110200180 'The roles viruses play in the decline of terrestrial orchids in Australia's hotspot of global biodiversity', with financial support from the Western Australian Botanic Gardens and Parks Authority and the Australian Orchid Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2004, ARCH VIROL, V149, P1045, DOI [10.1007/s00705-003-0304-0, 10.1007/s00705-004-0304-0]; Bonnardeaux Y, 2007, MYCOL RES, V111, P51, DOI 10.1016/j.mycres.2006.11.006; Coutts BA, 2011, ARCH VIROL, V156, P1757, DOI 10.1007/s00705-011-1046-4; Cribb P.J., 2003, ORCHID CONSERVATION, P1; DOLJA VV, 1991, VIROLOGY, V184, P79, DOI 10.1016/0042-6822(91)90823-T; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GUY PL, 1985, PLANT PATHOL, V34, P532, DOI 10.1111/j.1365-3059.1985.tb01404.x; Hall GS, 2010, PLANT PATHOL, V59, P1152, DOI 10.1111/j.1365-3059.2010.02351.x; Hoffman N, 2011, ORCHIDS S W AUSTR, P513; Hopper SD, 2004, ANNU REV ECOL EVOL S, V35, P623, DOI 10.1146/annurev.ecolsys.35.112202.130201; Ingwell LL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00578; KOONIN EV, 1993, CRIT REV BIOCHEM MOL, V28, P375, DOI 10.3109/10409239309078440; KOONIN EV, 1991, J GEN VIROL, V72, P2197, DOI 10.1099/0022-1317-72-9-2197; Lebouvier M, 2011, BIOL INVASIONS, V13, P1195, DOI 10.1007/s10530-011-9946-5; Malmstrom CM, 2011, VIRUS RES, V159, P84, DOI 10.1016/j.virusres.2011.05.010; Malmstrom CM, 2005, OECOLOGIA, V145, P153, DOI 10.1007/s00442-005-0099-z; Marquez LM, 2007, SCIENCE, V315, P513, DOI 10.1126/science.1136237; Martelli GP, 2007, ANNU REV PHYTOPATHOL, V45, P73, DOI 10.1146/annurev.phyto.45.062806.094401; Martelli GP, 2002, ARCH VIROL, V147, P1837, DOI 10.1007/s007050200045; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Melcher U, 2000, J GEN VIROL, V81, P257, DOI 10.1099/0022-1317-81-1-257; Morozov SY, 2003, J GEN VIROL, V84, P1351, DOI 10.1099/vir.0.18922-0; Moyal A., 2004, PLATYPUS EXTRAORDINA; Muthukumar V, 2009, VIRUS RES, V141, P169, DOI 10.1016/j.virusres.2008.06.016; Phillips RD, 2011, J BIOGEOGR, V38, P487, DOI 10.1111/j.1365-2699.2010.02413.x; Power AG, 2011, VIRUS RES, V159, P95, DOI 10.1016/j.virusres.2011.05.016; Roossinck MJ, 2010, PHILOS T R SOC B, V365, P1899, DOI 10.1098/rstb.2010.0057; Roossinck MJ, 2010, MOL ECOL, V19, P81, DOI 10.1111/j.1365-294X.2009.04470.x; ROZANOV MN, 1992, J GEN VIROL, V73, P2129, DOI 10.1099/0022-1317-73-8-2129; SABANADZOVIC S, 2010, PHYTOPATHOLOGY S, V100, pS112; Sabanadzovic S, 2011, ARCH VIROL, V156, P1665, DOI 10.1007/s00705-011-1015-y; SCHOLTHOF HB, 1995, VIROLOGY, V213, P425, DOI 10.1006/viro.1995.0015; Skotnicki ML, 1996, ARCH VIROL, V141, P99, DOI 10.1007/BF01718591; Swarts ND, 2009, ANN BOT-LONDON, V104, P543, DOI 10.1093/aob/mcp025; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Webster CG, 2007, PLANT PATHOL, V56, P729, DOI 10.1111/j.1365-3059.2007.01653.x; Wylie S, 2011, ARCH VIROL, V156, P1245, DOI 10.1007/s00705-011-0963-6; Wylie SJ, 2013, VIRUS RES, V171, P22, DOI 10.1016/j.virusres.2012.10.003; Wylie SJ, 2012, ARCH VIROL, V157, P2447, DOI 10.1007/s00705-012-1452-2; Wylie SJ, 2012, ARCH VIROL, V157, P271, DOI 10.1007/s00705-011-1166-x; Xu P, 2008, NEW PHYTOL, V180, P911, DOI 10.1111/j.1469-8137.2008.02627.x; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	42	16	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79587	10.1371/journal.pone.0079587	http://dx.doi.org/10.1371/journal.pone.0079587			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223974	Green Published, gold, Green Submitted			2022-12-27	WOS:000326597400074
J	Zhang, T; Rong, NN; Chen, J; Zou, CW; Jing, HY; Zhu, XL; Zhang, WL				Zhang, Tao; Rong, Ningning; Chen, Juan; Zou, Chengwei; Jing, Haiyan; Zhu, Xiaolong; Zhang, Wenlong			SIRT1 Expression Is Associated with the Chemotherapy Response and Prognosis of Patients with Advanced NSCLC	PLOS ONE			English	Article							BREAST-CANCER; PROSTATE-CANCER; CELLS; APOPTOSIS; SENESCENCE; RADIATION; MICE; TUMORIGENESIS; DEACETYLASE; METASTASIS	Aim: The role of Sirtuin 1 (SIRT 1) in carcinogenesis is controversial. This study was to explore the association between the SIRT1 expression and the clinical characteristics, the responsiveness to chemotherapy and prognosis in Non-small cell lung cancer (NSCLC). Methods: We enrolled 295 patients with inoperable advanced stage of NSCLC, namely, stage III (A+B) and IV NSCLC. All patients had received platinum-based chemotherapy after diagnosis and the chemotherapy response were evaluated. All patients were followed up for overall survival (OS) and progression free survival (PFS). In vitro, H292 cells were tranfected with SIRT1 small interfering RNA (siRNA). The cell biological behaviors and chemosensitivity to cisplatin treatment were studied. The in vivo tumorgenesis and metastasis assays were performed in nude mice. Results: We found that the SIRT1 expressions were significantly associated with the tumor stage, tumor size and differentiation status. Patients with high SIRT 1 expressions had a significantly higher chance to be resistant to chemotherapy than those with low SIRT 1 expression. Patients with high expression of SIRT1 had significantly shorter OS and DFS than those with low expression. Cox analyses confirmed that the SIRT 1 expression was a strong predictor for a poor OS and PFS in NSCLC patients underwent Platinum-based chemotherapy. In vitro studies revealed that the reduced expression SIRT 1 by siRNA technique significantly inhibited cell proliferation, migration and invasion. More importantly, SIRT1 si-RNA significantly enhanced the chemosensitivity of H292 cells to cisplatin treatment. The in vivo tumorgenesis and metastasis assays showed that SIRT1 knockdown dramatically reduced the tumor volume and the metastatic ability in nude mice. Conclusion: Collectively, our data suggest that the SIRT1 expression may be a molecular marker associated with the NSLCLC clinical features, treatment responsiveness and prognosis of advanced NSCLC.	[Zhang, Tao; Zou, Chengwei; Zhu, Xiaolong; Zhang, Wenlong] Shandong Univ, Prov Hosp Affiliated, Dept Cardiovasc Surg, Jinan 250100, Shandong, Peoples R China; [Rong, Ningning] Shandong Prov Chest Hosp, Intens Care Unit, Jinan, Shandong, Peoples R China; [Chen, Juan] Jinan seventh peoples Hosp, Dept Cardiovasc Surg, Jinan, Shandong, Peoples R China; [Jing, Haiyan] Shandong Univ, Prov Hosp Affiliated, Dept Pathol, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University	Zhang, WL (corresponding author), Shandong Univ, Prov Hosp Affiliated, Dept Cardiovasc Surg, Jinan 250100, Shandong, Peoples R China.	drwenlongzhang@sina.cn			Shandong University (QL) [1B-34]	Shandong University (QL)	This study was financially supported by a grant from Shandong University (QL-No. 1B-34). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida GM, 2008, INT J CANCER, V122, P1810, DOI 10.1002/ijc.23188; Bae HJ, 2012, ONCOL LETT, V4, P873, DOI 10.3892/ol.2012.875; Brooks CL, 2009, AGING-US, V1, P278, DOI 10.18632/aging.100031; Brooks CL, 2009, NAT REV CANCER, V9, P123, DOI 10.1038/nrc2562; Chang CJ, 2009, BIOCHEM BIOPH RES CO, V380, P236, DOI 10.1016/j.bbrc.2009.01.040; Chen HC, 2012, ANN SURG ONCOL, V19, P2011, DOI 10.1245/s10434-011-2159-4; Chen WY, 2013, CURR OPIN HEMATOL, V20, P308, DOI 10.1097/MOH.0b013e328360ab64; Dai CX, 2013, ENDOCRINOLOGY, V154, P1247, DOI 10.1210/en.2012-1908; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Fu MF, 2006, MOL CELL BIOL, V26, P8122, DOI 10.1128/MCB.00289-06; Fusco S, 2012, CELL CYCLE, V11, P4135, DOI 10.4161/cc.22074; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Gridelli C, 2002, TUMORI J, V88, pS143, DOI 10.1177/030089160208800142; Hildebrandt MAT, 2009, EXPERT OPIN DRUG MET, V5, P745, DOI 10.1517/17425250902973711; Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085; Jang KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045119; Kong SY, 2012, IMMUNOL CELL BIOL, V90, P6, DOI 10.1038/icb.2011.102; Kosmidis P, 2002, LUNG CANCER, V38, pS19; Kozako T, 2012, INT J CANCER, V131, P2044, DOI 10.1002/ijc.27481; Lee H, 2011, HUM PATHOL, V42, P204, DOI 10.1016/j.humpath.2010.05.023; Li XL, 2013, ACTA BIOCH BIOPH SIN, V45, P51, DOI 10.1093/abbs/gms108; Lovaas JD, 2013, PROSTATE, V73, P522, DOI 10.1002/pros.22592; Mantel C, 2008, CURR OPIN HEMATOL, V15, P326, DOI 10.1097/MOH.0b013e3283043819; Matsushita N, 2005, GENES CELLS, V10, P321, DOI 10.1111/j.1365-2443.2005.00836.x; Metoyer Cheynita F, 2008, Pathophysiology, V15, P103, DOI 10.1016/j.pathophys.2008.04.002; Oppenheimer H, 2012, ARTHRITIS RHEUM-US, V64, P718, DOI 10.1002/art.33407; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; REMMELE W, 1987, PATHOLOGE, V8, P138; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Stuschke M, 2010, NAT REV CLIN ONCOL, V7, P613, DOI 10.1038/nrclinonc.2010.165; Subramaniam Sangeetha, 2013, J Carcinog, V12, P3, DOI 10.4103/1477-3163.107958; Sun YN, 2007, LUNG CANCER, V58, P21, DOI 10.1016/j.lungcan.2007.05.013; Sundaresan NR, 2011, J MOL CELL CARDIOL, V51, P614, DOI 10.1016/j.yjmcc.2011.01.008; Suzuki K, 2012, ONCOL REP, V27, P1726, DOI 10.3892/or.2012.1750; Tsim S, 2010, RESP MED, V104, P1767, DOI 10.1016/j.rmed.2010.08.005; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wu FL, 2012, CELL ONCOL, V35, P175, DOI 10.1007/s13402-012-0075-7; Wu MQ, 2012, MED ONCOL, V29, P3240, DOI 10.1007/s12032-012-0260-6; Xie YX, 2012, J RADIAT RES, V53, P44, DOI 10.1269/jrr.11062; Zhou C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063142; Zschoernig B, 2008, BIOCHEM BIOPH RES CO, V376, P251, DOI 10.1016/j.bbrc.2008.08.137	41	43	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79162	10.1371/journal.pone.0079162	http://dx.doi.org/10.1371/journal.pone.0079162			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223900	gold, Green Published, Green Submitted			2022-12-27	WOS:000326597400050
J	Makino, A; Klein, CJ; Beger, M; Jupiter, SD; Possingham, HP				Makino, Azusa; Klein, Carissa J.; Beger, Maria; Jupiter, Stacy D.; Possingham, Hugh P.			Incorporating Conservation Zone Effectiveness for Protecting Biodiversity in Marine Planning	PLOS ONE			English	Article							GREAT-BARRIER-REEF; RESERVES; AREAS; MANAGEMENT; FISHERIES; COSTS; PHILIPPINES; NETWORKS; DESIGN; MODEL	Establishing different types of conservation zones is becoming commonplace. However, spatial prioritization methods that can accommodate multiple zones are poorly understood in theory and application. It is typically assumed that management regulations across zones have differential levels of effectiveness ("zone effectiveness") for biodiversity protection, but the influence of zone effectiveness on achieving conservation targets has not yet been explored. Here, we consider the zone effectiveness of three zones: permanent closure, partial protection, and open, for planning for the protection of five different marine habitats in the Vatu-i-Ra Seascape, Fiji. We explore the impact of differential zone effectiveness on the location and costs of conservation priorities. We assume that permanent closure zones are fully effective at protecting all habitats, open zones do not contribute towards the conservation targets and partial protection zones lie between these two extremes. We use four different estimates for zone effectiveness and three different estimates for zone cost of the partial protection zone. To enhance the practical utility of the approach, we also explore how much of each traditional fishing ground can remain open for fishing while still achieving conservation targets. Our results show that all of the high priority areas for permanent closure zones would not be a high priority when the zone effectiveness of the partial protection zone is equal to that of permanent closure zones. When differential zone effectiveness and costs are considered, the resulting marine protected area network consequently increases in size, with more area allocated to permanent closure zones to meet conservation targets. By distributing the loss of fishing opportunity equitably among local communities, we find that 84-88% of each traditional fishing ground can be left open while still meeting conservation targets. Finally, we summarize the steps for developing marine zoning that accounts for zone effectiveness.	[Makino, Azusa; Klein, Carissa J.; Beger, Maria; Possingham, Hugh P.] Univ Queensland, Sch Biol Sci, Australian Res Council, Ctr Excellence Environm Decis, Brisbane, Qld, Australia; [Jupiter, Stacy D.] Wildlife Conservat Soc, Fiji Country Program, Suva, Fiji; [Possingham, Hugh P.] Imperial Coll London, Dept Life Sci, Ascot, Berks, England	University of Queensland; Imperial College London	Makino, A (corresponding author), Univ Queensland, Sch Biol Sci, Australian Res Council, Ctr Excellence Environm Decis, Brisbane, Qld, Australia.	azusamakino@gmail.com	Klein, Carissa J/F-1632-2011; Beger, Maria/ABC-5975-2022; Possingham, Hugh/B-1337-2008; Beger, Maria/F-9049-2013; POSSINGHAM, HUGH/R-8310-2019	Klein, Carissa J/0000-0002-6299-6451; Beger, Maria/0000-0003-1363-3571; Possingham, Hugh/0000-0001-7755-996X; Beger, Maria/0000-0003-1363-3571; POSSINGHAM, HUGH/0000-0001-7755-996X; Jupiter, Stacy/0000-0001-9742-1677	National Center for Ecological Analysis and Synthesis, as a part of the working group "Conservation Decision Making in The Coral Triangle"; David and Lucile Packard Foundation; John D. and Catherine T. MacArthur Foundation [0-94985-000-GSS]; Australian Research Council Centre of Excellence for Environmental Decisions; Australian Research Council Centre of Excellence for Coral Reef Studies; ITO Foundation, Japan; University of Queensland; Australian Research Council Postdoctoral Fellowship [DP110102153]; Discovery Early Career Research Award [CE110001014]	National Center for Ecological Analysis and Synthesis, as a part of the working group "Conservation Decision Making in The Coral Triangle"; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); John D. and Catherine T. MacArthur Foundation; Australian Research Council Centre of Excellence for Environmental Decisions(Australian Research Council); Australian Research Council Centre of Excellence for Coral Reef Studies(Australian Research Council); ITO Foundation, Japan; University of Queensland(University of Queensland); Australian Research Council Postdoctoral Fellowship(Australian Research Council); Discovery Early Career Research Award(Australian Research Council)	The authors are thankful for support from the National Center for Ecological Analysis and Synthesis, as a part of the working group "Conservation Decision Making in The Coral Triangle", funded by the David and Lucile Packard Foundation, and a grant from the John D. and Catherine T. MacArthur Foundation (0-94985-000-GSS) to the Wildlife Conservation Society. Additional support was provided by the Australian Research Council Centre of Excellence for Environmental Decisions and the Australian Research Council Centre of Excellence for Coral Reef Studies. AM is funded by the by ITO Foundation, Japan, by the Australian Research Council Centre of Excellence for Environmental Decisions, and the University of Queensland. CJK is supported by an Australian Research Council Postdoctoral Fellowship (Project number DP110102153). MB is supported by a Discovery Early Career Research Award to the ARC Centre of Excellence for Environmental Decisions (CE110001014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams VM, 2011, BIOL CONSERV, V144, P350, DOI 10.1016/j.biocon.2010.09.012; Agardy T, 2003, AQUAT CONSERV, V13, P353, DOI 10.1002/aqc.583; Agostini V.N., 2010, MARINE ZONING SAINT; Alcala AC, 2006, AMBIO, V35, P245, DOI 10.1579/05-A-054R1.1; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Balmford A, 2004, P NATL ACAD SCI USA, V101, P9694, DOI 10.1073/pnas.0403239101; Ban NC, 2009, CONSERV LETT, V2, P206, DOI 10.1111/j.1755-263X.2009.00071.x; Bartlett CY, 2009, CONSERV BIOL, V23, P1475, DOI 10.1111/j.1523-1739.2009.01293.x; Berkes F, 2000, ECOL APPL, V10, P1251, DOI 10.1890/1051-0761(2000)010[1251:ROTEKA]2.0.CO;2; Brown K, 2001, ECOL ECON, V37, P417, DOI 10.1016/S0921-8009(00)00293-7; Bruce EM, 2006, COAST MANAGE, V34, P17, DOI 10.1080/08920750500364898; Burke L., 2011, REEFS RISK REVISITED; Chape S, 2005, PHILOS T R SOC B, V360, P443, DOI 10.1098/rstb.2004.1592; Cinner J, 2006, ECOL SOC, V11; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Cohen PJ, 2013, MAR POLICY, V37, P278, DOI 10.1016/j.marpol.2012.05.010; Crowder LB, 2006, SCIENCE, V313, P617, DOI 10.1126/science.1129706; Day JC, 2002, OCEAN COAST MANAGE, V45, P139, DOI 10.1016/S0964-5691(02)00052-2; Douvere F, 2008, MAR POLICY, V32, P762, DOI 10.1016/j.marpol.2008.03.021; Edwards HJ, 2010, BIOL CONSERV, V143, P457, DOI 10.1016/j.biocon.2009.11.013; Fernandes L, 2005, CONSERV BIOL, V19, P1733, DOI 10.1111/j.1523-1739.2005.00302.x; Fernandes L, 2012, BIOPHYSICAL PRINCIPL; Foale S, 2011, FISH FISH, V12, P357, DOI 10.1111/j.1467-2979.2010.00395.x; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Fraley C, 2012, 597 U WASH; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18251, DOI 10.1073/pnas.1002098107; Govan H., 2009, STATUS POTENTIAL LOC; Grantham HS, 2013, MAR POLICY, V38, P184, DOI 10.1016/j.marpol.2012.05.035; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2013, P NATL ACAD SCI USA, V110, P6229, DOI 10.1073/pnas.1217689110; Halpern BS, 2003, ECOL APPL, V13, pS117; Halpern BS, 2002, ECOL LETT, V5, P361, DOI 10.1046/j.1461-0248.2002.00326.x; Klein CJ, 2012, ECOL APPL, V22, P1246, DOI 10.1890/11-1718.1; Klein CJ, 2010, FRONT ECOL ENVIRON, V8, P349, DOI 10.1890/090047; Lahdelma R, 2000, ENVIRON MANAGE, V26, P595, DOI 10.1007/s002670010118; Leslie H, 2003, ECOL APPL, V13, pS185; Lester SE, 2008, MAR ECOL PROG SER, V367, P49, DOI 10.3354/meps07599; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; McClanahan TR, 2008, AQUAT CONSERV, V18, P493, DOI 10.1002/aqc.874; McLeod E, 2009, FRONT ECOL ENVIRON, V7, P362, DOI 10.1890/070211; Merrifield MS, 2013, OCEAN COAST MANAGE, V74, P67, DOI 10.1016/j.ocecoaman.2012.06.011; Mills M, 2011, CONSERV BIOL, V25, P1155, DOI 10.1111/j.1523-1739.2011.01749.x; Mora C, 2006, SCIENCE, V312, P1750, DOI 10.1126/science.1125295; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; Pomeroy R, 2008, MAR POLICY, V32, P816, DOI 10.1016/j.marpol.2008.03.017; Portman ME, 2007, OCEAN COAST MANAGE, V50, P499, DOI 10.1016/j.ocecoaman.2007.02.008; Pressey RL, 2009, ORYX, V43, P464, DOI 10.1017/S0030605309990500; Scholz AJ, 2011, CONSERV BIOL, V25, P485, DOI 10.1111/j.1523-1739.2010.01626.x; Sciberras M, 2013, ENVIRON EVID, V2, DOI 10.1186/2047-2382-2-4; Shahabuddin G, 2010, BIOL CONSERV, V143, P2926, DOI 10.1016/j.biocon.2010.04.040; Tallis H, 2008, CONSERV BIOL, V22, P120, DOI 10.1111/j.1523-1739.2007.00861.x; Teh LCL, 2009, MAR POLICY, V33, P807, DOI 10.1016/j.marpol.2009.03.001; Villa F, 2002, CONSERV BIOL, V16, P515, DOI 10.1046/j.1523-1739.2002.00425.x; Watts ME, 2009, ENVIRON MODELL SOFTW, V24, P1513, DOI 10.1016/j.envsoft.2009.06.005; Weeks R, 2010, CONSERV BIOL, V24, P531, DOI 10.1111/j.1523-1739.2009.01340.x; Yates KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068424	57	16	17	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78986	10.1371/journal.pone.0078986	http://dx.doi.org/10.1371/journal.pone.0078986			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	245ZC	24223870	Green Submitted, gold, Green Published			2022-12-27	WOS:000326503400094
J	Wu, T; Deng, SN; Li, WG; Yu, YG; Li, F; Mao, M				Wu, Ting; Deng, Shining; Li, Wei-Guang; Yu, Yongguo; Li, Fei; Mao, Meng			Maternal Obesity Caused by Overnutrition Exposure Leads to Reversal Learning Deficits and Striatal Disturbance in Rats	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; DIET-INDUCED OBESITY; FREELY MOVING RATS; FRONTAL-CORTEX; ATTENTIONAL SET; DORSOMEDIAL STRIATUM; ORBITOFRONTAL CORTEX; METABOLIC SYNDROME; LEPTIN ACTION; LESIONS	Maternal obesity caused by overnutrition during pregnancy increases susceptibility to metabolic risks in adulthood, such as obesity, insulin resistance, and type 2 diabetes; however, whether and how it affects the cognitive system associated with the brain remains elusive. Here, we report that pregnant obesity induced by exposure to excessive high fatty or highly palatable food specifically impaired reversal learning, a kind of adaptive behavior, while leaving serum metabolic metrics intact in the offspring of rats, suggesting a much earlier functional and structural defects possibly occurred in the central nervous system than in the metabolic system in the offspring born in unfavorable intrauterine nutritional environment. Mechanically, we found that above mentioned cognitive inflexibility might be associated with significant striatal disturbance including impaired dopamine homeostasis and disrupted leptin signaling in the adult offspring. These collective data add a novel perspective of understanding the adverse postnatal sequelae in central nervous system induced by developmental programming and the related molecular mechanism through which priming of risk for developmental disorders may occur during early life.	[Wu, Ting; Mao, Meng] Sichuan Univ, West China Hosp 2, Chengdu 610064, Sichuan, Peoples R China; [Wu, Ting; Deng, Shining; Yu, Yongguo; Li, Fei] Shanghai Jiao Tong Univ, Dept Dev & Behav Pediat, Shanghai Childrens Med Ctr, Shanghai Inst Pediat Translat Med,Sch Med, Shanghai 200030, Peoples R China; [Wu, Ting; Mao, Meng] Chengdu Womens & Childrens Cent Hosp, Chengdu, Sichuan, Peoples R China; [Deng, Shining; Yu, Yongguo; Li, Fei] Shanghai Jiao Tong Univ, Sch Med, MOE Shanghai Key Lab Childrens Environm Hlth, Shanghai 200030, Peoples R China; [Li, Wei-Guang] Shanghai Jiao Tong Univ, Shanghai Key Lab Tumor Microenvironm & Inflamm, Inst Med Sci, Dept Anat & Embryol,Sch Med, Shanghai 200030, Peoples R China; [Li, Wei-Guang] Shanghai Jiao Tong Univ, Shanghai Key Lab Tumor Microenvironm & Inflamm, Inst Med Sci, Dept Biochem & Mol Cell Biol,Sch Med, Shanghai 200030, Peoples R China	Sichuan University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Li, F (corresponding author), Shanghai Jiao Tong Univ, Dept Dev & Behav Pediat, Shanghai Childrens Med Ctr, Shanghai Inst Pediat Translat Med,Sch Med, Shanghai 200030, Peoples R China.	feili@shsmu.edu.cn; dffmmao@126.com		yu, yongguo/0000-0002-4472-0910	Ministry of Education of China (NCET program); National Science Foundation of China [81000592, 81222012, 91232706]; National Basic Research Program of China (973 Project) [2013CB835100]; Science and Technology Commission of Shanghai Municipality [10DZ2272200, 09DZ2200900, 10PJ1407500, 10PJ1403500, 10231203903, 10JC1411200]; Shanghai Municipal Education Commission [11ZZ103]; Shanghai Municipal Health Bureau [2010004]; Morning Star Rewarding Fund of Shanghai Jiao Tong University; Xingbairen plan of Shanghai Jiao Tong University School of Medicine	Ministry of Education of China (NCET program)(Program for New Century Excellent Talents in University (NCET)Ministry of Education, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Project)(National Basic Research Program of China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Shanghai Municipal Health Bureau; Morning Star Rewarding Fund of Shanghai Jiao Tong University; Xingbairen plan of Shanghai Jiao Tong University School of Medicine	Ministry of Education of China (NCET program), National Science Foundation of China (81000592, 81222012, and 91232706), the National Basic Research Program of China (973 Project, 2013CB835100), Science and Technology Commission of Shanghai Municipality (10DZ2272200, 09DZ2200900, 10PJ1407500, 10PJ1403500, 10231203903 and 10JC1411200), Shanghai Municipal Education Commission (11ZZ103). Shanghai Municipal Health Bureau (2010004), Morning Star Rewarding Fund (Category B, 2011) of Shanghai Jiao Tong University and Xingbairen plan of Shanghai Jiao Tong University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basatemur E, 2013, PEDIATRICS, V131, P56, DOI 10.1542/peds.2012-0788; Bilbo SD, 2010, FASEB J, V24, P2104, DOI 10.1096/fj.09-144014; Birrell JM, 2000, J NEUROSCI, V20, P4320; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Burghardt PR, 2012, J NEUROSCI, V32, P15369, DOI 10.1523/JNEUROSCI.2521-12.2012; Bussey TJ, 1997, BEHAV NEUROSCI, V111, P908, DOI 10.1037/0735-7044.111.5.908; Bussey TJ, 1997, BEHAV NEUROSCI, V111, P920, DOI 10.1037/0735-7044.111.5.920; Castane A, 2010, BEHAV BRAIN RES, V210, P74, DOI 10.1016/j.bbr.2010.02.017; Chudasama Y, 2003, J NEUROSCI, V23, P8771; Clarke HF, 2008, J NEUROSCI, V28, P10972, DOI 10.1523/JNEUROSCI.1521-08.2008; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Couvreur O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018043; DEVAUGES V, 1990, BEHAV BRAIN RES, V39, P19, DOI 10.1016/0166-4328(90)90118-X; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; ELLIOTT R, 1995, PSYCHOL MED, V25, P619, DOI 10.1017/S0033291700033523; Ferezou-Viala J, 2007, AM J PHYSIOL-REG I, V293, pR1056, DOI 10.1152/ajpregu.00117.2007; Gallou-Kabani C, 2005, DIABETES, V54, P1899, DOI 10.2337/diabetes.54.7.1899; Gobert A, 1997, J NEUROCHEM, V69, P2616; Gorski JN, 2006, AM J PHYSIOL-REG I, V291, pR768, DOI 10.1152/ajpregu.00138.2006; GUO F, 1995, PHYSIOL BEHAV, V57, P681, DOI 10.1016/0031-9384(94)00342-4; Harding JE, 2001, INT J EPIDEMIOL, V30, P15, DOI 10.1093/ije/30.1.15; Hill EL, 2004, TRENDS COGN SCI, V8, P26, DOI 10.1016/j.tics.2003.11.003; Izquierdo A, 2010, NEUROPSYCHOPHARMACOL, V35, P505, DOI 10.1038/npp.2009.155; JONES B, 1972, EXP NEUROL, V36, P362, DOI 10.1016/0014-4886(72)90030-1; Kehagia AA, 2010, CURR OPIN NEUROBIOL, V20, P199, DOI 10.1016/j.conb.2010.01.007; Lapiz MDS, 2006, NEUROSCIENCE, V137, P1039, DOI 10.1016/j.neuroscience.2005.09.031; Matsumoto M, 1998, EUR J PHARMACOL, V343, P165, DOI 10.1016/S0014-2999(97)01544-6; Myers MG, 2009, CELL METAB, V9, P117, DOI 10.1016/j.cmet.2008.12.001; Pantelis C, 1999, SCHIZOPHR RES, V37, P251, DOI 10.1016/S0920-9964(98)00156-X; PAXINOS G, 2003, RAT BRAIN ATLAS STER; Peterson DA, 2009, NEUROSCIENCE, V163, P1092, DOI 10.1016/j.neuroscience.2009.07.033; Ragozzino ME, 2007, ANN NY ACAD SCI, V1121, P355, DOI 10.1196/annals.1401.013; Ring LE, 2010, J CLIN INVEST, V120, P2931, DOI 10.1172/JCI41985; Rodriguez A, 2008, INT J OBESITY, V32, P550, DOI 10.1038/sj.ijo.0803741; Rodriguez A, 2010, J CHILD PSYCHOL PSYC, V51, P134, DOI 10.1111/j.1469-7610.2009.02133.x; Ruager-Martin R, 2010, EARLY HUM DEV, V86, P715, DOI 10.1016/j.earlhumdev.2010.08.007; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; Tait DS, 2007, ANN NY ACAD SCI, V1121, P407, DOI 10.1196/annals.1401.010; Tait DS, 2008, BEHAV BRAIN RES, V187, P100, DOI 10.1016/j.bbr.2007.08.035; Tozuka Y, 2010, NEUROCHEM INT, V57, P235, DOI 10.1016/j.neuint.2010.05.015; Tozuka Y, 2009, FASEB J, V23, P1920, DOI 10.1096/fj.08-124784; Traykov L, 2007, COGN BEHAV NEUROL, V20, P219, DOI 10.1097/WNN.0b013e31815e6254; van der Meulen JAJ, 2007, CEREB CORTEX, V17, P1444, DOI 10.1093/cercor/bhl057; Williams KW, 2009, AM J CLIN NUTR, V89, p985S, DOI 10.3945/ajcn.2008.26788D	44	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78876	10.1371/journal.pone.0078876	http://dx.doi.org/10.1371/journal.pone.0078876			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223863	Green Published, Green Submitted, gold			2022-12-27	WOS:000326503400093
J	Xu, JL; Donepudi, AC; Moscovitz, JE; Slitt, AL				Xu, Jialin; Donepudi, Ajay C.; Moscovitz, Jamie E.; Slitt, Angela L.			Keap1-Knockdown Decreases Fasting-Induced Fatty Liver via Altered Lipid Metabolism and Decreased Fatty Acid Mobilization from Adipose Tissue	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; DIET-INDUCED OBESITY; HEPATOCYTE-SPECIFIC DELETION; HEPATIC STEATOSIS; PROTEIN-KINASE; TRANSCRIPTION FACTOR; INSULIN-RESISTANCE; TRANSPORT PROTEIN; BINDING-PROTEIN; GENE-EXPRESSION	Aims: The purpose of this study was to determine whether Nrf2 activation, via Keap1-knockdown (Keap1-KD), regulates lipid metabolism and mobilization induced by food deprivation (e. g. fasting). Methods and Results: Male C57BL/6 (WT) and Keap1-KD mice were either fed ad libitum or food deprived for 24 hours. After fasting, WT mice exhibited a marked increase in hepatic lipid accumulation, but Keap1-KD mice had an attenuated increase of lipid accumulation, along with reduced expression of lipogenic genes (acetyl-coA carboxylase, stearoyl-CoA desaturase-1, and fatty acid synthase) and reduced expression of genes related to fatty acid transport, such as fatty acid translocase/CD36 (CD36) and Fatty acid transport protein (FATP) 2, which may attribute to the reduced induction of Peroxisome proliferator-activated receptor (Ppar) a signaling in the liver. Additionally, enhanced Nrf2 activity by Keap1-KD increased AMP-activated protein kinase (AMPK) phosphorylation in liver. In white adipose tissue, enhanced Nrf2 activity did not change the lipolysis rate by fasting, but reduced expression of fatty acid transporters - CD36 and FATP1, via a PPAR alpha-dependent mechanism, which impaired fatty acid transport from white adipose tissue to periphery circulation system, and resulted in increased white adipose tissue fatty acid content. Moreover, enhanced Nrf2 activity increased glucose tolerance and Akt phosphorylation levels upon insulin administration, suggesting Nrf2 signaling pathway plays a key role in regulating insulin signaling and enhanced insulin sensitivity in skeletal muscle. Conclusion: Enhanced Nrf2 activity via Keap1-KD decreased fasting-induced steatosis, pointing to an important function of Nrf2 on lipid metabolism under the condition of nutrient deprivation.	[Xu, Jialin; Donepudi, Ajay C.; Moscovitz, Jamie E.; Slitt, Angela L.] Univ Rhode Isl, Dept Biomed & Pharmaceut Sci, Kingston, RI 02881 USA; [Xu, Jialin] Northeastern Univ, Coll Life & Hlth Sci, Inst Biochem & Mol Biol, Shenyang, Peoples R China	University of Rhode Island; Northeastern University - China	Slitt, AL (corresponding author), Univ Rhode Isl, Dept Biomed & Pharmaceut Sci, Kingston, RI 02881 USA.	aslitt@uri.edu			National Institute of Health [5R01ES016042-04, 3R01ES016042-2S2, 5K22ES013782-03]; Rhode Island IDeA Network of Biomedical Research Excellence grant from National Center for Research Resources [5P20RR016457-11]; Rhode Island IDeA Network of Biomedical Research Excellence grant from National Institute for General Medical Science, National Institutes of Health (NIH) [8P20GM103430-11]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016042, K22ES013782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103430] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rhode Island IDeA Network of Biomedical Research Excellence grant from National Center for Research Resources; Rhode Island IDeA Network of Biomedical Research Excellence grant from National Institute for General Medical Science, National Institutes of Health (NIH); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of Health [5R01ES016042-04; 3R01ES016042-2S2; 5K22ES013782-03], and also supported, in part, by Rhode Island IDeA Network of Biomedical Research Excellence grants from the National Center for Research Resources (5P20RR016457-11) and the National Institute for General Medical Science (8P20GM103430-11), components of the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Berentzen T, 2006, NUTR REV, V64, P502, DOI [10.1301/nr.2006.nov.502507, 10.1111/j.1753-4887.2006.tb00183.x]; Bradbury MW, 2006, AM J PHYSIOL-GASTR L, V290, pG194, DOI 10.1152/ajpgi.00413.2005; Chartoumpekis DV, 2011, DIABETES, V60, P2465, DOI 10.2337/db11-0112; Choi SH, 2011, TRENDS ENDOCRIN MET, V22, P353, DOI 10.1016/j.tem.2011.04.007; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; Dharancy S, 2005, GASTROENTEROLOGY, V128, P334, DOI 10.1053/j.gastro.2004.11.016; Miquilena-Colina ME, 2011, GUT, V60, P1394, DOI 10.1136/gut.2010.222844; Falcon A, 2010, AM J PHYSIOL-ENDOC M, V299, pE384, DOI 10.1152/ajpendo.00226.2010; Fruchart JC, 1999, CURR OPIN LIPIDOL, V10, P245, DOI 10.1097/00041433-199906000-00007; Gertow K, 2004, DIABETOLOGIA, V47, P1118, DOI 10.1007/s00125-004-1417-4; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; Goto T, 2011, J LIPID RES, V52, P873, DOI 10.1194/jlr.M011320; Guan HP, 2009, J BIOL CHEM, V284, P24644, DOI 10.1074/jbc.M109.034397; Guillet-Deniau I, 2002, DIABETES, V51, P1722, DOI 10.2337/diabetes.51.6.1722; Hardwick JP, 2009, PPAR RES, V2009, DOI 10.1155/2009/952734; Hirsch D, 1998, P NATL ACAD SCI USA, V95, P8625, DOI 10.1073/pnas.95.15.8625; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Hubbard B, 2006, GASTROENTEROLOGY, V130, P1259, DOI 10.1053/j.gastro.2006.02.012; Ibdah JA, 2005, GASTROENTEROLOGY, V128, P1381, DOI 10.1053/j.gastro.2005.02.001; Im SS, 2006, BIOCHEM J, V399, P131, DOI 10.1042/BJ20060696; Itoh K, 1999, FREE RADICAL RES, V31, P319, DOI 10.1080/10715769900300881; JENSEN MD, 1987, J CLIN INVEST, V79, P207, DOI 10.1172/JCI112785; Kazantzis M, 2012, BBA-MOL CELL BIOL L, V1821, P852, DOI 10.1016/j.bbalip.2011.09.010; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kintscher U, 2005, AM J PHYSIOL-ENDOC M, V288, pE287, DOI 10.1152/ajpendo.00440.2004; Klaassen CD, 2010, TOXICOL APPL PHARM, V244, P57, DOI 10.1016/j.taap.2010.01.013; Koonen DPY, 2007, DIABETES, V56, P2863, DOI 10.2337/db07-0907; Krammer J, 2011, INT J MED SCI, V8, P599, DOI 10.7150/ijms.8.599; Le May C, 2000, FEBS LETT, V475, P163, DOI 10.1016/S0014-5793(00)01648-3; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Martin G, 1997, J BIOL CHEM, V272, P28210, DOI 10.1074/jbc.272.45.28210; Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064; More VR, 2013, FREE RADICAL BIO MED, V61, P85, DOI 10.1016/j.freeradbiomed.2013.03.007; Morgan K, 2008, EUR J GASTROEN HEPAT, V20, P843, DOI 10.1097/MEG.0b013e3282f9b203; Motojima K, 1998, J BIOL CHEM, V273, P16710, DOI 10.1074/jbc.273.27.16710; Muoio DM, 2002, DIABETES, V51, P901, DOI 10.2337/diabetes.51.4.901; Nilsson PM, 2008, DIABETES CARE, V31, pS278, DOI 10.2337/dc08-s268; Okawa H, 2006, BIOCHEM BIOPH RES CO, V339, P79, DOI 10.1016/j.bbrc.2005.10.185; Patsouris D, 2006, ENDOCRINOLOGY, V147, P1508, DOI 10.1210/en.2005-1132; Pi JB, 2010, J BIOL CHEM, V285, P9292, DOI 10.1074/jbc.M109.093955; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Rinella ME, 2008, J LIPID RES, V49, P1068, DOI 10.1194/jlr.M800042-JLR200; Rouvinen-Watt K, 2010, LIPIDS, V45, P111, DOI 10.1007/s11745-009-3377-4; Saraf N, 2012, J PHARM PHARMACOL, V64, P161, DOI 10.1111/j.2042-7158.2011.01366.x; SCHWIETERMAN W, 1988, P NATL ACAD SCI USA, V85, P359, DOI 10.1073/pnas.85.2.359; Shao J, 2000, J ENDOCRINOL, V167, P107, DOI 10.1677/joe.0.1670107; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Sherry B., 2010, Morbidity and Mortality Weekly Report, V59, P951; Shin S, 2009, EUR J PHARMACOL, V620, P138, DOI 10.1016/j.ejphar.2009.08.022; Stapleton D, 1997, FEBS LETT, V409, P452, DOI 10.1016/S0014-5793(97)00569-3; STREMMEL W, 1985, P NATL ACAD SCI USA, V82, P4, DOI 10.1073/pnas.82.1.4; Tanaka Y, 2008, J PHARMACOL EXP THER, V325, P655, DOI 10.1124/jpet.107.135822; Viollet B, 2009, ACTA PHYSIOL, V196, P81, DOI 10.1111/j.1748-1716.2009.01970.x; Viollet B, 2006, J PHYSIOL-LONDON, V574, P41, DOI 10.1113/jphysiol.2006.108506; Xu JL, 2012, DIABETES, V61, P3208, DOI 10.2337/db11-1716; Xu JL, 2012, DRUG METAB DISPOS, V40, P259, DOI 10.1124/dmd.111.039925; Yates MS, 2009, CARCINOGENESIS, V30, P1024, DOI 10.1093/carcin/bgp100; Yu Z, 2011, DIABETOLOGIA, V54, P922, DOI 10.1007/s00125-010-2001-8; Zhang LY, 2010, BBA-MOL CELL BIOL L, V1801, P1, DOI 10.1016/j.bbalip.2009.09.014; Zhang YKJ, 2010, TOXICOL APPL PHARM, V245, P326, DOI 10.1016/j.taap.2010.03.016	62	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79841	10.1371/journal.pone.0079841	http://dx.doi.org/10.1371/journal.pone.0079841			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24224011	Green Published, Green Submitted, gold			2022-12-27	WOS:000326503400145
J	Mahmoud, RS; Narisawa, K				Mahmoud, Rola S.; Narisawa, Kazuhiko			A New Fungal Endophyte, Scolecobasidium humicola, Promotes Tomato Growth under Organic Nitrogen Conditions	PLOS ONE			English	Article							DARK SEPTATE ENDOPHYTES; ARBUSCULAR MYCORRHIZAL FUNGI; CHINESE-CABBAGE; PINUS-CONTORTA; SOIL; SUPPRESSION; SYMBIOSIS; PLANT	A new fungal endophyte, Scolecobasidium humicola, was identified as a common dark septate endophytic fungal (DSE) species under both natural and agricultural conditions. This fungus was found to grow endophylically in the roots of tomato seedlings. Light microscopy of cross-sections of colonized tomato roots showed that the intercellular, pigmented hyphae of the fungus were mostly limited to the epidermal layer and formed outer mantle-like structures. Two isolates of S. humicola, H2-2 and F1-3, have shown the ability to increase plant biomass with an organic nitrogen source. This finding is the first report of S. humicola as an endophyte and could help to improve plant growth with organic nitrogen sources.	[Mahmoud, Rola S.] Tokyo Univ Agr & Technol, United Grad Sch Agr Sci, Fuchu, Tokyo, Japan; [Narisawa, Kazuhiko] Ibaraki Univ, Coll Agr, Ami, Ibaraki 30003, Japan	Tokyo University of Agriculture & Technology; Ibaraki University	Mahmoud, RS (corresponding author), Tokyo Univ Agr & Technol, United Grad Sch Agr Sci, Fuchu, Tokyo, Japan.	rola_s_m@yahoo.com			Japan Society for the Promotion of Science [23380190]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research (B) (No. 23380190) from the Japan Society for the Promotion of Science; http://www.jsps.go.jp/english/e-grants/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT E. V., 1927, MYCOLOGIA, V19, P29; Addy HD, 2000, MYCOL RES, V104, P1213, DOI 10.1017/S0953756200002896; [Anonymous], 2009, WORLD ORGANIC AGR ST; BARRON G. L., 1962, CANADIAN JOUR BOT, V40, P77, DOI 10.1139/b62-009; Caldwell BA, 2003, 4 INT C MYC MONTR CA, P312; Finlay R., 1992, Mycorrhizal functioning: an integrative plant-fungal process., P134; FINLAY RD, 1992, NEW PHYTOL, V120, P105, DOI 10.1111/j.1469-8137.1992.tb01063.x; Gosling P, 2006, AGR ECOSYST ENVIRON, V113, P17, DOI 10.1016/j.agee.2005.09.009; GRANDI RAP, 2002, COGN REVISTA BRASILE, V25, P79, DOI DOI 10.1590/S0100-84042002000100010; HASELWANDTER K, 1982, OECOLOGIA, V53, P352, DOI 10.1007/BF00389012; Hoberg P., 1989, Mineral nutrients in tropical forest and savanna ecosystems., P121; Inselsbacher E, 2012, NEW PHYTOL, V195, P329, DOI 10.1111/j.1469-8137.2012.04169.x; Jumpponen A, 1998, NEW PHYTOL, V140, P295, DOI 10.1046/j.1469-8137.1998.00265.x; Jumpponen A, 1998, MYCORRHIZA, V7, P261, DOI 10.1007/s005720050190; Jumpponen A, 2001, MYCORRHIZA, V11, P207, DOI 10.1007/s005720100112; Narisawa K, 2004, PHYTOPATHOLOGY, V94, P412, DOI 10.1094/PHYTO.2004.94.5.412; Narisawa K, 2002, EUR J PLANT PATHOL, V108, P103, DOI 10.1023/A:1015080311041; Narisawa K, 1998, PLANT PATHOL, V47, P206, DOI 10.1046/j.1365-3059.1998.00225.x; Newsham KK, 2011, NEW PHYTOL, V190, P783, DOI 10.1111/j.1469-8137.2010.03611.x; Priyadharsini P, 2012, ACTA BOT CROAT, V71, P159, DOI 10.2478/v10184-011-0058-1; Reeve JR, 2008, SOIL BIOL BIOCHEM, V40, P2547, DOI 10.1016/j.soilbio.2008.06.015; Rodrigues MA, 2006, EUR J AGRON, V25, P328, DOI 10.1016/j.eja.2006.07.002; ROY RY, 1962, LLOYD, V25, P164; Silvani VA, 2008, SOIL BIOL BIOCHEM, V40, P1259, DOI 10.1016/j.soilbio.2007.11.022; Usuki F, 2007, MYCOLOGIA, V99, P175, DOI 10.3852/mycologia.99.2.175; Wilson BJ, 2004, CAN J BOT, V82, P607, DOI 10.1139/B04-030; Zubek S, 2012, APPL SOIL ECOL, V59, P106, DOI 10.1016/j.apsoil.2012.04.008	27	41	46	4	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78746	10.1371/journal.pone.0078746	http://dx.doi.org/10.1371/journal.pone.0078746			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223848	Green Submitted, Green Published, gold			2022-12-27	WOS:000326499300033
J	Ruttermann, S; Trellenkamp, T; Bergmann, N; Beikler, T; Ritter, H; Janda, R				Ruettermann, Stefan; Trellenkamp, Taina; Bergmann, Nora; Beikler, Thomas; Ritter, Helmut; Janda, Ralf			Bacterial Viability and Physical Properties of Antibacterially Modified Experimental Dental Resin Composites	PLOS ONE			English	Article							SURFACE-FREE-ENERGY; ENAMEL IN-SITU; STREPTOCOCCUS-MUTANS ADHESION; RESTORATIVE MATERIALS; FILLING MATERIALS; PLAQUE-FORMATION; POLYETHYLENIMINE NANOPARTICLES; BIOFILM DEVELOPMENT; BIOCIDAL ACTIVITIES; AGED RESTORATIONS	Purpose: To investigate the antibacterial effect and the effect on the material properties of a novel delivery system with Irgasan as active agent and methacrylated polymerizable Irgasan when added to experimental dental resin composites. Materials and Methods: A delivery system based on novel polymeric hollow beads, loaded with Irgasan and methacrylated polymerizable Irgasan as active agents were used to manufacture three commonly formulated experimental resin composites. The non-modified resin was used as standard (ST). Material A contained the delivery system providing 4 % (m/m) Irgasan, material B contained 4 % (m/m) methacrylated Irgasan and material C 8 % (m/m) methacrylated Irgasan. Flexural strength (FS), flexural modulus (FM), water sorption (WS), solubility (SL), surface roughness R-a, polymerization shrinkage, contact angle Theta, total surface free energy Upsilon(S) and its apolar Upsilon(LW)(S), polar Upsilon(AB)(S), Lewis acid Upsilon(+)(S) and base Upsilon(-)(S) term as well as bacterial viability were determined. Significance was p < 0.05. Results: The materials A to C were not unacceptably influenced by the modifications and achieved the minimum values for FS, WS and SL as requested by EN ISO 4049 and did not differ from ST what was also found for R-a. Only A had lower FM than ST. Theta of A and C was higher and Upsilon(AB)(S) of A and B was lower than of ST. Materials A to C had higher Upsilon(+)(S) than ST. The antibacterial effect of materials A to C was significantly increased when compared with ST meaning that significantly less vital cells were found. Conclusion: Dental resin composites with small quantities of a novel antibacterially doped delivery system or with an antibacterial monomer provided acceptable physical properties and good antibacterial effectiveness. The sorption material being part of the delivery system can be used as a vehicle for any other active agent.	[Ruettermann, Stefan; Bergmann, Nora; Beikler, Thomas; Janda, Ralf] Univ Dusseldorf, Fac Med, Ctr Dent, Dept Operat Dent Periodontol & Endodont, Dusseldorf, Germany; [Trellenkamp, Taina; Ritter, Helmut] Univ Dusseldorf, Inst Organ Chem & Macromol Chem, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Ruttermann, S (corresponding author), Univ Dusseldorf, Fac Med, Ctr Dent, Dept Operat Dent Periodontol & Endodont, Dusseldorf, Germany.	stefan.ruettermann@uni-duesseldorf.de			DFG Deutsche Forschungsgemeinschaft, Bonn, Germany [RU 825/3-1]	DFG Deutsche Forschungsgemeinschaft, Bonn, Germany(German Research Foundation (DFG))	This study was supported by the DFG Deutsche Forschungsgemeinschaft, Bonn, Germany (Project No. RU 825/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 2009, DENT MATER, V25, P206, DOI 10.1016/j.dental.2008.06.002; Al-Ahmad A, 2007, J MED MICROBIOL, V56, P681, DOI 10.1099/jmm.0.47094-0; Al-Ahmad A, 2009, J MED MICROBIOL, V58, P1359, DOI 10.1099/jmm.0.011213-0; [Anonymous], 4288 DIN EN ISO; [Anonymous], 4049 EN ISO; Aykent F, 2010, J PROSTHET DENT, V103, P221, DOI 10.1016/S0022-3913(10)60034-0; Beyth N, 2006, BIOMATERIALS, V27, P3995, DOI 10.1016/j.biomaterials.2006.03.003; Beyth N, 2008, BIOMATERIALS, V29, P4157, DOI 10.1016/j.biomaterials.2008.07.003; Beyth N, 2008, DENT MATER, V24, P732, DOI 10.1016/j.dental.2007.08.003; Bollen CML, 1996, CLIN ORAL IMPLAN RES, V7, P201, DOI 10.1034/j.1600-0501.1996.070302.x; Bollen CML, 1997, DENT MATER, V13, P258, DOI 10.1016/S0109-5641(97)80038-3; Buergers R, 2007, J PROSTHET DENT, V98, P461, DOI 10.1016/S0022-3913(07)60146-2; Buergers R, 2009, DENT MATER, V25, P269, DOI 10.1016/j.dental.2008.07.011; Cho E, 2011, DENT MATER, V27, P1070, DOI 10.1016/j.dental.2011.07.008; Choi SB, 2007, MACROMOL SYMP, V249, P660, DOI 10.1002/masy.200750452; da Silva EM, 2008, J APPL ORAL SCI, V16, P161, DOI 10.1590/S1678-77572008000200015; Feng L, 2006, J BIOMED MATER RES B, V76B, P196, DOI 10.1002/jbm.b.30355; Goncalves L, 2008, J BIOMED MATER RES B, V85B, P320, DOI 10.1002/jbm.b.30949; Gosau M, 2010, CLIN ORAL IMPLAN RES, V21, P866, DOI 10.1111/j.1600-0501.2009.01908.x; Gyo M, 2008, APPL ENVIRON MICROB, V74, P1428, DOI 10.1128/AEM.02039-07; Hahnel S, 2008, J MATER SCI-MATER M, V19, P2619, DOI 10.1007/s10856-007-3352-7; Hahnel S, 2009, DENT MATER, V25, P969, DOI 10.1016/j.dental.2009.02.003; Hahnel S, 2008, J DENT, V36, P977, DOI 10.1016/j.jdent.2008.08.004; Hannig C, 2007, ARCH ORAL BIOL, V52, P1048, DOI 10.1016/j.archoralbio.2007.05.006; Hannig C, 2010, J MED MICROBIOL, V59, P1, DOI 10.1099/jmm.0.015420-0; Hannig M, 2007, J NANOSCI NANOTECHNO, V7, P4642, DOI 10.1166/jnn.2007.005; Imazato S, 2003, BIOMATERIALS, V24, P3605, DOI 10.1016/S0142-9612(03)00217-5; Imazato S, 2008, DENT MATER J, V27, P145, DOI 10.4012/dmj.27.145; Janda R, 2006, DENT MATER, V22, P1103, DOI 10.1016/j.dental.2005.09.005; Janda R, 2007, J BIOMED MATER RES B, V82B, P545, DOI 10.1002/jbm.b.30760; Jung DJ, 2010, J MICROBIOL METH, V81, P166, DOI 10.1016/j.mimet.2010.03.002; Kapoor M, 2004, BIOCHEM J, V381, P719, DOI 10.1042/BJ20031821; Knorr SD, 2005, DENT MATER, V21, P272, DOI 10.1016/j.dental.2004.06.002; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; Konishi N, 2003, J ORAL REHABIL, V30, P790, DOI 10.1046/j.1365-2842.2003.01129.x; Lee SP, 2009, ANGLE ORTHOD, V79, P353, DOI 10.2319/021308-88.1; Li F, 2009, J DENT, V37, P289, DOI 10.1016/j.jdent.2008.12.004; Lupu R, 2006, CURR PHARM BIOTECHNO, V7, P483, DOI 10.2174/138920106779116928; Namba N, 2009, DENT MATER, V25, P424, DOI 10.1016/j.dental.2008.08.012; Oh ST, 1996, J APPL POLYM SCI, V59, P1871, DOI 10.1002/(SICI)1097-4628(19960321)59:12<1871::AID-APP8>3.0.CO;2-N; OH ST, 1994, J APPL POLYM SCI, V54, P859, DOI 10.1002/app.1994.070540704; Persson A, 2005, CARIES RES, V39, P201, DOI 10.1159/000084799; Persson A, 2005, ACTA ODONTOL SCAND, V63, P21, DOI 10.1080/00016350510019649; QUIRYNEN M, 1995, J CLIN PERIODONTOL, V22, P1, DOI 10.1111/j.1600-051X.1995.tb01765.x; QUIRYNEN M, 1989, J DENT RES, V68, P796, DOI 10.1177/00220345890680050801; Quirynen M, 1996, Int J Oral Maxillofac Implants, V11, P169; QUIRYNEN M, 1990, J CLIN PERIODONTOL, V17, P138, DOI 10.1111/j.1600-051X.1990.tb01077.x; Rosan B, 2000, MICROBES INFECT, V2, P1599, DOI 10.1016/S1286-4579(00)01316-2; Ruttermann S, 2007, J DENT, V35, P806, DOI 10.1016/j.jdent.2007.07.014; Ruttermann S, 2012, ARCH ORAL BIOL, V57, P1512, DOI 10.1016/j.archoralbio.2012.05.005; Ruttermann S, 2011, ACTA BIOMATER, V7, P1160, DOI 10.1016/j.actbio.2010.10.002; Rupp F, 2002, J BIOMED MATER RES, V62, P567, DOI 10.1002/jbm.10198; Sharifi S, 2008, J BIOMED MATER RES A, V84A, P545, DOI 10.1002/jbm.a.31384; Sharma S, 2003, ANTIMICROB AGENTS CH, V47, P3859, DOI 10.1128/AAC.47.12.3859-3866.2003; Sideridou ID, 2009, J BIOMAT SCI-POLYM E, V20, P1831, DOI 10.1163/156856208X386435; Silikas N, 2000, DENT MATER, V16, P292, DOI 10.1016/S0109-5641(00)00020-8; Sojka MS, 1998, US Patent No, Patent No. [US5830960, 5830960]; ten Cate JM, 2006, ODONTOLOGY, V94, P1, DOI 10.1007/s10266-006-0063-3; Teughels W, 2006, CLIN ORAL IMPLAN RES, V17, P68, DOI 10.1111/j.1600-0501.2006.01353.x; Thomas RZ, 2008, ORAL MICROBIOL IMMUN, V23, P7, DOI 10.1111/j.1399-302X.2007.00381.x; vanDijken JWV, 1997, CARIES RES, V31, P379, DOI 10.1159/000262422; VANOSS CJ, 1988, CHEM REV, V88, P927, DOI 10.1021/cr00088a006; Vogel BS, 1996, J BIOL CHEM, V271, P23262, DOI 10.1074/jbc.271.38.23262; WEERKAMP AH, 1985, J DENT RES, V64, P1204, DOI 10.1177/00220345850640100501; Wiegand A, 2007, DENT MATER, V23, P343, DOI 10.1016/j.dental.2006.01.022	65	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79119	10.1371/journal.pone.0079119	http://dx.doi.org/10.1371/journal.pone.0079119			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223890	Green Published, gold			2022-12-27	WOS:000326499300059
J	Chen, XF; Qiu, JR; Yang, DP; Lu, JL; Yan, CY; Zha, XM; Yin, YM				Chen, Xiaofeng; Qiu, Jinrong; Yang, Dapeng; Lu, Jianlei; Yan, Caiyun; Zha, Xiaoming; Yin, Yongmei			MDM2 Promotes Invasion and Metastasis in Invasive Ductal Breast Carcinoma by Inducing Matrix Metalloproteinase-9	PLOS ONE			English	Article							CANCER METASTASIS; EXPRESSION; TUMOR; ACTIVATION; P53; GENE; ONCOGENE; PATHWAY; DOMAIN; CELLS	The molecular mechanisms that underpin invasive ductal breast cancer (IDC) invasion and metastasis are incompletely understood. The oncogene, mouse double minute 2 (MDM2), has been implicated in the pathogenesis of numerous cancers, where it stimulates the expression of matrix metalloproteinase 9 (MMP9), an important enzyme in the breakdown of the extracellular matrix. However, its role in breast cancer remains poorly understood. This study assessed the clinical significance of MDM2 expression in IDC and used in vitro expression assays to determine the molecular roles of MDM2. Immunohistochemical staining for MMP9 and MDM2 was performed using archived tumor blocks from 321 women who underwent surgical resection for IDC at the First Affiliated Hospital of Nanjing Medical University, China between January 2002 and December 2003. MCF-7 and MDA-MD-231 cell lines were transfected with siRNA targeted against MDM2, or MDM2 was overexpressed using transiently expressed vectors. The invasion, cell migration and proteolytic capabilities of cells that over-or underexpressed MDM2 was then assessed and compared against control cells, in addition to the consequent effects on MMP9 expression using RT-PCR. In vivo, 54.9% and 49.6% of samples were positive for MMP9 and MDM2 expression, respectively, and their expression was significantly correlated (r(2) = 0.171, P = 0.012). Moreover, MDM2 expression was markedly correlated with disease-free survival (HR 2.56, 95% CI 1.02-6.40, P = 0.038). In vitro, MDM2 overexpression significantly enhanced cell invasion, migration and proteolysis compared with control cells, and the converse effects were observed after MDM2-siRNA treatment. MDM2 overexpression induced MMP9 expression in a dose-dependent manner. Taken together, these results suggest that high levels of MDM2 are associated with a poorer prognosis in IDC. This might result from increased tumor invasiveness due to enhanced MMP9 expression causing increased extracellular matrix breakdown.	[Chen, Xiaofeng; Qiu, Jinrong; Yan, Caiyun; Yin, Yongmei] Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China; [Yang, Dapeng; Lu, Jianlei] Nanjing Med Univ, Dept Dev Genet, Nanjing, Jiangsu, Peoples R China; [Zha, Xiaoming] Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Zha, XM (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China.	zhaxm@medmail.com.cn; ym.yin@hotmail.com			Jiangsu province clinical science and technology projects (clinical research center) [BL 2012008]; Provincial Initiative Program for Excellency Disciplines, Jiangsu Province, China; National Natural Science Foundation of China [81172503]; Jiangsu healthy major project [RC01153]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Jiangsu province clinical science and technology projects (clinical research center); Provincial Initiative Program for Excellency Disciplines, Jiangsu Province, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu healthy major project; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the following Programs: Jiangsu province clinical science and technology projects (clinical research center, BL 2012008); Provincial Initiative Program for Excellency Disciplines, Jiangsu Province, China; National Natural Science Foundation of China (81172503); Jiangsu healthy major project (RC01153); The Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allred DC, 1998, MODERN PATHOL, V11, P155; Carvalho ST, 2011, CLINICS, V66, P607, DOI 10.1590/S1807-59322011000400014; Chang C, 2001, TRENDS CELL BIOL, V11, pS37, DOI 10.1016/S0962-8924(01)82222-4; Chau NM, 2004, BREAST CANCER RES, V6, P55, DOI 10.1186/bcr739; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; FAKHARZADEH SS, 1991, EMBO J, V10, P1565, DOI 10.1002/j.1460-2075.1991.tb07676.x; Farina AR, 1999, CELL GROWTH DIFFER, V10, P353; Farina AR, 2002, CELL GROWTH DIFFER, V13, P343; Farina AR, 1998, INT J CANCER, V75, P721; Fernando RI, 2010, J CLIN INVEST, V120, P533, DOI 10.1172/JCI38379; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Guarneri V, 2009, ONCOLOGIST, V14, P645, DOI 10.1634/theoncologist.2009-0078; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hara MR, 2011, NATURE, V477, P349, DOI 10.1038/nature10368; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Himelstein BP, 1997, ONCOGENE, V14, P1995, DOI 10.1038/sj.onc.1201012; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Iwakuma T, 2003, MOL CANCER RES, V1, P993; Jiang Y, 2002, CANCER RES, V62, P1910; Kim HG, 2011, FEBS LETT, V585, P421, DOI 10.1016/j.febslet.2010.12.030; MACKAY AR, 1992, INVAS METAST, V12, P168; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Punglia RS, 2007, NEW ENGL J MED, V356, P2399, DOI 10.1056/NEJMra065241; Qin L, 2008, MOL CELL BIOL, V28, P5937, DOI 10.1128/MCB.00579-08; Rayburn E, 2005, CURR CANCER DRUG TAR, V5, P27, DOI 10.2174/1568009053332636; Rayburn ER, 2009, ANTI-CANCER AGENT ME, V9, P882, DOI 10.2174/187152009789124628; Shi W, 2011, MOL CELL BIOCHEM; Shi WD, 2009, CANCER LETT, V283, P84, DOI 10.1016/j.canlet.2009.03.030; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Thut CJ, 1997, GENE DEV, V11, P1974, DOI 10.1101/gad.11.15.1974; Uhrinova S, 2005, J MOL BIOL, V350, P587, DOI 10.1016/j.jmb.2005.05.010; van Beijnum Judy R, 2009, Front Biosci (Schol Ed), V1, P216; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vernon AE, 2007, REV ENDOCR METAB DIS, V8, P199, DOI 10.1007/s11154-007-9041-5; Wade M, 2006, J BIOL CHEM, V281, P33036, DOI 10.1074/jbc.M605405200; Walerych D, 2012, CARCINOGENESIS, V33, P2007, DOI 10.1093/carcin/bgs232; Wang X, 2011, ONCOGENE, V30, P1901, DOI 10.1038/onc.2010.563; Weigelt B, 2003, P NATL ACAD SCI USA, V100, P15901, DOI 10.1073/pnas.2634067100; Weil RJ, 2005, AM J PATHOL, V167, P913, DOI 10.1016/S0002-9440(10)61180-7; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zou L, 2008, FASEB J, V22, P355, DOI 10.1096/fj.07-9046com	42	19	22	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78794	10.1371/journal.pone.0078794	http://dx.doi.org/10.1371/journal.pone.0078794			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236052	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700049
J	Dupuy, A; Valton, J; Leduc, S; Armier, J; Galetto, R; Gouble, A; Lebuhotel, C; Stary, A; Paques, F; Duchateau, P; Sarasin, A; Daboussi, F				Dupuy, Aurelie; Valton, Julien; Leduc, Sophie; Armier, Jacques; Galetto, Roman; Gouble, Agnes; Lebuhotel, Celine; Stary, Anne; Paques, Frederic; Duchateau, Philippe; Sarasin, Alain; Daboussi, Fayza			Targeted Gene Therapy of Xeroderma Pigmentosum Cells Using Meganuclease and TALEN (TM)	PLOS ONE			English	Article							INTRACHROMOSOMAL HOMOLOGOUS RECOMBINATION; DOUBLE-STRAND BREAKS; GROUP-C; DNA-REPAIR; DAMAGE; EXPRESSION; CONVERSION; PROTEIN	Xeroderma pigmentosum group C (XP-C) is a rare human syndrome characterized by hypersensitivity to UV light and a dramatic predisposition to skin neoplasms. XP-C cells are deficient in the nucleotide excision repair (NER) pathway, a complex process involved in the recognition and removal of DNA lesions. Several XPC mutations have been described, including a founder mutation in North African patients involving the deletion of a TG dinucleotide (Delta TG) located in the middle of exon 9. This deletion leads to the expression of an inactive truncated XPC protein, normally involved in the first step of NER. New approaches used for gene correction are based on the ability of engineered nucleases such as Meganucleases, Zinc-Finger nucleases or TALE nucleases to accurately generate a double strand break at a specific locus and promote correction by homologous recombination through the insertion of an exogenous DNA repair matrix. Here, we describe the targeted correction of the DTG mutation in XP-C cells using engineered meganuclease and TALEN (TM). The methylated status of the XPC locus, known to inhibit both of these nuclease activities, led us to adapt our experimental design to optimize their in vivo efficacies. We show that demethylating treatment as well as the use of TALEN (TM) insensitive to CpG methylation enable successful correction of the Delta TG mutation. Such genetic correction leads to re-expression of the full-length XPC protein and to the recovery of NER capacity, attested by UV-C resistance of the corrected cells. Overall, we demonstrate that nuclease-based targeted approaches offer reliable and efficient strategies for gene correction.	[Dupuy, Aurelie; Valton, Julien; Leduc, Sophie; Paques, Frederic; Duchateau, Philippe; Daboussi, Fayza] Cellectis SA, Paris, France; [Dupuy, Aurelie; Armier, Jacques; Stary, Anne; Sarasin, Alain] Inst Gustave Roussy, Unite Mixte Rech 8200, Villejuif, France; [Galetto, Roman; Gouble, Agnes; Lebuhotel, Celine] Cellectis Therapeut, Paris, France	UNICANCER; Gustave Roussy	Duchateau, P (corresponding author), Cellectis SA, Paris, France.	philippe.duchateau@cellectis.com	stary, anne/GRY-3781-2022	Daboussi, Fayza/0000-0001-7689-7975; Valton, Julien/0000-0003-0826-5401	Agence Nationale de la Recherche, Association Nationale de la recherche et de la Technologie [Cifre 535/2008]; Association de Recherche sur le Cancer (Villejuif, France)	Agence Nationale de la Recherche, Association Nationale de la recherche et de la Technologie(French National Research Agency (ANR)); Association de Recherche sur le Cancer (Villejuif, France)	<SUP>T</SUP>his work was supported by Agence Nationale de la Recherche, Association Nationale de la recherche et de la Technologie, contrat Cifre 535/2008 and Association de Recherche sur le Cancer (Villejuif, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimoolam S, 2002, P NATL ACAD SCI USA, V99, P12985, DOI 10.1073/pnas.202485699; Bergoglio V, 2007, MOL THER, V15, P2186, DOI 10.1038/sj.mt.6300292; Bradford PT, 2011, J MED GENET, V48, P168, DOI 10.1136/jmg.2010.083022; Brenneman M, 1996, P NATL ACAD SCI USA, V93, P3608, DOI 10.1073/pnas.93.8.3608; Connelly JP, 2010, MOL THER, V18, P1103, DOI 10.1038/mt.2010.57; Daboussi F, 2012, NUCLEIC ACIDS RES, V40, P6367, DOI 10.1093/nar/gks268; DAYAGROSJEAN L, 1987, MUTAT RES, V183, P185, DOI 10.1016/0167-8817(87)90061-7; Donoho G, 1998, MOL CELL BIOL, V18, P4070, DOI 10.1128/MCB.18.7.4070; Elliott B, 1998, MOL CELL BIOL, V18, P93, DOI 10.1128/MCB.18.1.93; Elliott B, 2001, MOL CELL BIOL, V21, P2671, DOI 10.1128/MCB.21.8.2671-2682.2001; Ergun SS, 2002, PLAST RECONSTR SURG, V110, P1290, DOI 10.1097/01.PRS.0000025230.84677.C7; Fischer A, 2005, PLOS MED, V2, P22, DOI 10.1371/journal.pmed.0020010; Gram GJ, 1998, J HEMATOTHER, V7, P333, DOI 10.1089/scd.1.1998.7.333; Grizot S, 2009, NUCLEIC ACIDS RES, V37, P5405, DOI 10.1093/nar/gkp548; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hoeijmakers JHJ, 2001, MUTAT RES-DNA REPAIR, V485, P43, DOI 10.1016/S0921-8777(00)00079-3; Khan SG, 2006, CARCINOGENESIS, V27, P84, DOI 10.1093/carcin/bgi204; Lommel L, 2002, CURR GENET, V42, P9, DOI 10.1007/s00294-002-0332-9; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Ng JMY, 2003, GENE DEV, V17, P1630, DOI 10.1101/gad.260003; Palii SS, 2008, MOL CELL BIOL, V28, P752, DOI 10.1128/MCB.01799-07; Rezvani HR, 2007, J BIOL CHEM, V282, P16413, DOI 10.1074/jbc.M611397200; Sebastiano V, 2011, STEM CELLS, V29, P1717, DOI 10.1002/stem.718; Soufir N, 2010, J INVEST DERMATOL, V130, P1537, DOI 10.1038/jid.2009.409; Stary A, 2002, BIOCHIMIE, V84, P49, DOI 10.1016/S0300-9084(01)01358-X; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Valton J, 2012, J BIOL CHEM, V287, P38427, DOI 10.1074/jbc.C112.408864; Valton J, 2012, J BIOL CHEM, V287, P30139, DOI 10.1074/jbc.M112.379966; Warrick E, 2012, MOL THER, V20, P798, DOI 10.1038/mt.2011.233; Xu KQ, 2012, J BIOL CHEM, V287, P29543, DOI 10.1074/jbc.M112.352302; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424; Zeng L, 1997, GENE THER, V4, P1077, DOI 10.1038/sj.gt.3300495	33	48	50	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78678	10.1371/journal.pone.0078678	http://dx.doi.org/10.1371/journal.pone.0078678			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236034	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700031
J	Gadalla, SM; Pfeiffer, RM; Kristinsson, SY; Bjorkholm, M; Hilbert, JE; Moxley, RT; Landgren, O; Greene, MH				Gadalla, Shahinaz M.; Pfeiffer, Ruth M.; Kristinsson, Sigurdur Y.; Bjorkholm, Magnus; Hilbert, James E.; Moxley, Richard T., III; Landgren, Ola; Greene, Mark H.			Quantifying Cancer Absolute Risk and Cancer Mortality in the Presence of Competing Events after a Myotonic Dystrophy Diagnosis	PLOS ONE			English	Article							MUSCULAR-DYSTROPHY; CTG REPEAT; SURVIVAL; GENE; EXPANSION; TYPE-1; DEATH	Recent studies show that patients with myotonic dystrophy (DM) have an increased risk of specific malignancies, but estimates of absolute cancer risk accounting for competing events are lacking. Using the Swedish Patient Registry, we identified 1,081 patients with an inpatient and/or outpatient diagnosis of DM between 1987 and 2007. Date and cause of death and date of cancer diagnosis were extracted from the Swedish Cause of Death and Cancer Registries. We calculated non-parametric estimates of absolute cancer risk and cancer mortality accounting for the high non-cancer competing mortality associated with DM. Absolute cancer risk after DM diagnosis was 1.6% (95% CI=0.4-4%), 5% (95% CI=3-9%) and 9% (95% CI=6-13%) at ages 40, 50 and 60 years, respectively. Females had a higher absolute risk of all cancers combined than males: 9% (95% CI=4-14), and 13% (95% CI=9-20) vs. 2% (95% CI=0.7-6) and 4% (95% CI=2-8) by ages 50 and 60 years, respectively) and developed cancer at younger ages (median age =51 years, range=22-74 vs. 57, range=43-84, respectively, p=0.02). Cancer deaths accounted for 10% of all deaths, with an absolute cancer mortality risk of 2% (95% CI=1-4.5%), 4% (95% CI=2-6%), and 6% (95% CI=4-9%) by ages 50, 60, and 70 years, respectively. No gender difference in cancer-specific mortality was observed (p=0.6). In conclusion, cancer significantly contributes to morbidity and mortality in DM patients, even after accounting for high competing DM mortality from non-neoplastic causes. It is important to apply population-appropriate, validated cancer screening strategies in DM patients.	[Gadalla, Shahinaz M.; Greene, Mark H.] NCI, Clin Genet Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Pfeiffer, Ruth M.] NCI, Biostat Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Kristinsson, Sigurdur Y.; Bjorkholm, Magnus] Karolinska Univ Hosp Solna, Div Hematol, Dept Med, Stockholm, Sweden; [Kristinsson, Sigurdur Y.; Bjorkholm, Magnus] Karolinska Inst, Stockholm, Sweden; [Kristinsson, Sigurdur Y.] Univ Iceland, Fac Med, Reykjavik, Iceland; [Kristinsson, Sigurdur Y.] Landspitali Natl Univ Hosp, Dept Hematol, Reykjavik, Iceland; [Hilbert, James E.; Moxley, Richard T., III] Univ Rochester, Med Ctr, Dept Neurol, Neuromuscular Dis Ctr, Rochester, NY 14642 USA; [Landgren, Ola] NCI, Metab Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; University of Iceland; Landspitali National University Hospital; University of Rochester; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Greene, MH (corresponding author), NCI, Clin Genet Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.	greenem@mail.nih.gov	Kristinsson, Sigurdur Y/M-2910-2015; Gadalla, Shahinaz M/C-4005-2015; Gadalla, Shahinaz/U-2848-2019	Kristinsson, Sigurdur Y/0000-0002-4964-7476; Gadalla, Shahinaz M/0000-0002-3255-8143; 	Swedish Cancer Society; Stockholm County Council; Karolinska Institutet Foundations; Intramural Research Program of the National Cancer Institute, USA [N02CP31003-3]; University of Rochester's Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center [NIH/U54/NS048843]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS048843] Funding Source: NIH RePORTER	Swedish Cancer Society(Swedish Cancer Society); Stockholm County Council(Stockholm County Council); Karolinska Institutet Foundations(Karolinska Institutet); Intramural Research Program of the National Cancer Institute, USA; University of Rochester's Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Swedish Cancer Society, Stockholm County Council, the Karolinska Institutet Foundations, the Intramural Research Program of the National Cancer Institute, USA (contract N02CP31003-3), and the University of Rochester's Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center (NIH/U54/NS048843). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, PATIENTREGISTRET 198; BROOK, 1992, CELL, V69, P385; Das M, 2012, J NEUROL, V259, P2161, DOI 10.1007/s00415-012-6476-8; de Die-Smulders CEM, 1998, BRAIN, V121, P1557, DOI 10.1093/brain/121.8.1557; Du HQ, 2010, NAT STRUCT MOL BIOL, V17, P187, DOI 10.1038/nsmb.1720; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; Gadalla SM, 2011, JAMA-J AM MED ASSOC, V306, P2480, DOI 10.1001/jama.2011.1796; Groh WJ, 2011, MUSCLE NERVE, V43, P648, DOI 10.1002/mus.21934; Harper PS, 2001, MYOTONIC DYSTROPHY; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Marubini E, 1995, ANAL SURVIVAL DATA C; Mathieu J, 1999, NEUROLOGY, V52, P1658, DOI 10.1212/WNL.52.8.1658; MATTSSON B, 1984, ACTA RADIOL ONCOL, V23, P305, DOI 10.3109/02841868409136026; Mladenovic J, 2006, EUR J NEUROL, V13, P451, DOI 10.1111/j.1468-1331.2006.01261.x; Mohamed Shirine, 2013, Presse Med, V42, pe281, DOI 10.1016/j.lpm.2013.01.052; Mueller CM, 2009, CANCER CAUSE CONTROL, V20, P2009, DOI 10.1007/s10552-009-9395-y; *NAT BOARD HLTH WE, 2008, CANC INC SWED 2007; Nilsson A C, 1994, Lakartidningen, V91, P603; Organisation for Economic Co-operation and Development (OECD), 2012, LIF EXP BIRTH TOT PO; Osborne RJ, 2009, HUM MOL GENET, V18, P1471, DOI 10.1093/hmg/ddp058; Ranum Laura P W, 2002, Curr Neurol Neurosci Rep, V2, P465, DOI 10.1007/s11910-002-0074-6; Satagopan JM, 2004, BRIT J CANCER, V91, P1229, DOI 10.1038/sj.bjc.6602102; Turesson I, 2007, INT J CANCER, V121, P2260, DOI 10.1002/ijc.22912; Vihola A, 2010, ACTA NEUROPATHOL, V119, P465, DOI 10.1007/s00401-010-0637-6; Win AK, 2012, MAYO CLIN PROC, V87, P130, DOI 10.1016/j.mayocp.2011.09.005	26	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79851	10.1371/journal.pone.0079851	http://dx.doi.org/10.1371/journal.pone.0079851			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236163	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700164
J	Kiyaga, C; Sendagire, H; Joseph, E; McConnell, I; Grosz, J; Narayan, V; Esiru, G; Elyanu, P; Akol, Z; Kirungi, W; Musinguzi, J; Opio, A				Kiyaga, Charles; Sendagire, Hakim; Joseph, Eleanor; McConnell, Ian; Grosz, Jeff; Narayan, Vijay; Esiru, Godfrey; Elyanu, Peter; Akol, Zainab; Kirungi, Wilford; Musinguzi, Joshua; Opio, Alex			Uganda's New National Laboratory Sample Transport System: A Successful Model for Improving Access to Diagnostic Services for Early Infant HIV Diagnosis and Other Programs	PLOS ONE			English	Article							DRIED BLOOD SPOTS	Introduction: Uganda scaled-up Early HIV Infant Diagnosis (EID) when simplified methods for testing of infants using dried blood spots (DBS) were adopted in 2006 and sample transport and management was therefore made feasible in rural settings. Before this time only 35% of the facilities that were providing EID services were reached through the national postal courier system, Posta Uganda. The transportation of samples during this scale-up, therefore, quickly became a challenge and varied from facility to facility as different methods were used to transport the samples. This study evaluates a novel specimen transport network system for EID testing. Methods: A retrospective study was done in mid-2012 on 19 pilot hubs serving 616 health facilities in Uganda. The effect on sample-result turnaround time (TAT) and the cost of DBS sample transport on 876 sample-results was analyzed. Results: The HUB network system provided increased access to EID services ranging from 36% to 51%, drastically reduced transportation costs by 62%, reduced turn-around times by 46.9% and by a further 46.2% through introduction of SMS printers. Conclusions: The HUB model provides a functional, reliable and efficient national referral network against which other health system strengthening initiatives can be built to increase access to critical diagnostic and treatment monitoring services, improve the quality of laboratory and diagnostic services, with reduced turn-around times and improved quality of prevention and treatment programs thereby reducing long-term costs.	[Kiyaga, Charles; Sendagire, Hakim; Esiru, Godfrey; Elyanu, Peter; Akol, Zainab; Kirungi, Wilford; Musinguzi, Joshua; Opio, Alex] Minist Hlth, Kampala, Uganda; [Sendagire, Hakim] Makerere Univ, Coll Hlth Sci, Kampala, Uganda; [Joseph, Eleanor; McConnell, Ian; Grosz, Jeff; Narayan, Vijay] Clinton Fdn Hlth Access Initiat, Kampala, Uganda	Makerere University	Sendagire, H (corresponding author), Minist Hlth, Kampala, Uganda.	hsendagire@yahoo.com	; Elyanu, Peter James/B-9760-2019	Narayan, Vijay/0000-0003-3890-7321; Elyanu, Peter James/0000-0002-4075-622X	Uganda Ministry of Health; Clinton Foundation Health Access Initiative Uganda	Uganda Ministry of Health; Clinton Foundation Health Access Initiative Uganda	This work was supported by the Uganda Ministry of Health and Clinton Foundation Health Access Initiative Uganda. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aledort Julia E, 2006, Nature, V444 Suppl 1, P19, DOI 10.1038/nature05443; Creek T, 2008, PEDIATR INFECT DIS J, V27, P22, DOI 10.1097/INF.0b013e3181469050; Ministry of Health-Uganda, 2010, NAT HLTH FAC INV; Ministry of Health-Uganda, 2012, HIV AIDS IND SURV; Sherman GG, 2005, JAIDS-J ACQ IMM DEF, V38, P615, DOI 10.1097/01.qai.0000143604.71857.5d; United Nations General Assembly, 2011, POL DECL HIV AIDS IN	6	69	69	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78609	10.1371/journal.pone.0078609	http://dx.doi.org/10.1371/journal.pone.0078609			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236026	Green Published, gold			2022-12-27	WOS:000327254700023
J	Martin-Garrido, A; Williams, HC; Lee, M; Seidel-Rogol, B; Ci, X; Dong, JT; Lassegue, B; Martin, AS; Griendling, KK				Martin-Garrido, Abel; Williams, Holly C.; Lee, Minyoung; Seidel-Rogol, Bonnie; Ci, Xinpei; Dong, Jin-Tang; Lassegue, Bernard; Martin, Alejandra San; Griendling, Kathy K.			Transforming Growth Factor beta Inhibits Platelet Derived Growth Factor-Induced Vascular Smooth Muscle Cell Proliferation via Akt-Independent, Smad-Mediated Cyclin D1 Downregulation	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; NEOINTIMAL FORMATION; SIGNAL-TRANSDUCTION; CORONARY-ARTERY; GENE-EXPRESSION; RAT MODEL; INJURY; PDGF; GROWTH-FACTOR-BETA-1; MIGRATION	In adult tissue, vascular smooth muscle cells (VSMCs) exist in a differentiated phenotype, which is defined by the expression of contractile proteins and lack of proliferation. After vascular injury, VSMC adopt a synthetic phenotype associated with proliferation, migration and matrix secretion. The transition between phenotypes is a consequence of the extracellular environment, and in particular, is regulated by agonists such as the pro-differentiating cytokine transforming growth factor beta (TGF beta) and the pro-proliferative cytokine platelet derived growth factor (PDGF). In this study, we investigated the interplay between TGF beta and PDGF with respect to their ability to regulate VSMC proliferation. Stimulation of human aortic VSMC with TGF beta completely blocked proliferation induced by all isoforms of PDGF, as measured by DNA synthesis and total cell number. Mechanistically, PDGF-induced Cyclin D1 mRNA and protein expression was inhibited by TGF beta. TGF beta had no effect on PDGF activation of its receptor and ERK1/2, but inhibited Akt activation. However, constitutively active Akt did not reverse the inhibitory effect of TGF beta on Cyclin D1 expression even though inhibition of the proteasome blocked the effect of TGF beta. siRNA against Smad4 completely reversed the inhibitory effect of TGF beta on PDGF-induced Cyclin D1 expression and restored proliferation in response to PDGF. Moreover, siRNA against KLF5 prevented Cyclin D1 upregulation by PDGF and overexpression of KLF5 partially reversed TGF beta-induced inhibition of Cyclin D1 expression. Taken together, our results demonstrate that KLF5 is required for PDGF-induced Cyclin D1 expression, which is inhibited by TGF beta via a Smad dependent mechanism, resulting in arrest of VSMCs in the G1 phase of the cell cycle.	[Martin-Garrido, Abel; Williams, Holly C.; Lee, Minyoung; Seidel-Rogol, Bonnie; Lassegue, Bernard; Martin, Alejandra San; Griendling, Kathy K.] Emory Univ, Dept Med, Div Cardiol, Atlanta, GA 30322 USA; [Ci, Xinpei; Dong, Jin-Tang] Emory Univ, Winship Canc Ctr, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA	Emory University; Emory University	Griendling, KK (corresponding author), Emory Univ, Dept Med, Div Cardiol, Atlanta, GA 30322 USA.	kgriend@emory.edu	San Martin, Alejandra/HDN-0012-2022	Griendling, Kathy/0000-0002-9456-8582; San Martin, Alejandra/0000-0002-4620-1591; Williams, Holly/0000-0002-1890-1830; Dong, Jin-Tang/0000-0003-2349-5782; Lassegue, Bernard/0000-0003-4924-6506	National Institutes of Health (NIH) [HL38206, HL095070]; NATIONAL CANCER INSTITUTE [R01CA171189] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038206, R29HL038206, P01HL095070, R37HL038206] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) grants HL38206 and HL095070. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres V, 2004, CARDIOVASC RES, V63, P11, DOI 10.1016/j.cardiores.2004.02.009; ASSOIAN RK, 1986, J CELL BIOL, V102, P1217, DOI 10.1083/jcb.102.4.1217; BATTEGAY EJ, 1990, CELL, V63, P515, DOI 10.1016/0092-8674(90)90448-N; Bilder G, 1999, CIRCULATION, V99, P3292, DOI 10.1161/01.CIR.99.25.3292; Boggy GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012355; Boucher JM, 2011, J BIOL CHEM, V286, P28312, DOI 10.1074/jbc.M111.221945; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Cohen MD, 1997, AM J RESP CELL MOL, V16, P85, DOI 10.1165/ajrcmb.16.1.8998083; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Du JX, 2007, J BIOL CHEM, V282, P4782, DOI 10.1074/jbc.M603413200; Du JX, 2011, J BIOL CHEM, V286, P40354, DOI 10.1074/jbc.M111.258707; FERNS GAA, 1991, SCIENCE, V253, P1129, DOI 10.1126/science.1653454; Fukumoto S, 1999, CIRC RES, V85, P985; Fukumoto S, 1997, J BIOL CHEM, V272, P13816, DOI 10.1074/jbc.272.21.13816; Guo P, 2009, J BIOL CHEM, V284, P6071, DOI 10.1074/jbc.M806270200; Hautmann MB, 1997, J BIOL CHEM, V272, P10948; Ishigami M, 1998, J BIOL CHEM, V273, P20156, DOI 10.1074/jbc.273.32.20156; Jay DB, 2008, FREE RADICAL BIO MED, V45, P329, DOI 10.1016/j.freeradbiomed.2008.04.024; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Klein EA, 2008, J CELL SCI, V121, P3853, DOI 10.1242/jcs.039131; Kluk MJ, 2001, CIRC RES, V89, P496, DOI 10.1161/hh1801.096338; Kobayashi K, 2005, CIRC RES, V96, P904, DOI 10.1161/01.RES.0000163980.55495.44; LINDNER V, 1991, P NATL ACAD SCI USA, V88, P3739, DOI 10.1073/pnas.88.9.3739; Liu Y, 2010, ACTA PHARMACOL SIN, V31, P10, DOI 10.1038/aps.2009.185; Lockman K, 2007, CIRC RES, V101, pE115, DOI 10.1161/CIRCRESAHA.107.164178; Long XC, 2011, J BIOL CHEM, V286, P30119, DOI 10.1074/jbc.M111.258814; Lyle AN, 2009, CIRC RES, V105, P249, DOI 10.1161/CIRCRESAHA.109.193722; MAJACK RA, 1990, J CELL BIOL, V111, P239, DOI 10.1083/jcb.111.1.239; MAJESKY MW, 1991, J CLIN INVEST, V88, P904, DOI 10.1172/JCI115393; Mallat Z, 2001, CIRC RES, V89, P930, DOI 10.1161/hh2201.099415; Mao X, 2012, ARTERIOSCL THROM VAS, V32, P2171, DOI 10.1161/ATVBAHA.112.253872; Martin-Garrido A, 2011, FREE RADICAL BIO MED, V50, P354, DOI 10.1016/j.freeradbiomed.2010.11.007; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; MII S, 1993, SURGERY, V114, P464; Morishita R, 1998, CLIN CHEM LAB MED, V36, P529, DOI 10.1515/CCLM.1998.090; Mu YB, 2012, CELL TISSUE RES, V347, P11, DOI 10.1007/s00441-011-1201-y; Oshima M, 1996, DEV BIOL, V179, P297, DOI 10.1006/dbio.1996.0259; OWENS GK, 1995, PHYSIOL REV, V75, P487; Ritz C, 2008, BIOINFORMATICS, V24, P1549, DOI 10.1093/bioinformatics/btn227; Ruef J, 1999, CIRCULATION, V100, P659, DOI 10.1161/01.CIR.100.6.659; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Sirois MG, 1997, CIRCULATION, V95, P669, DOI 10.1161/01.CIR.95.3.669; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Suzuki T, 2009, J BIOL CHEM, V284, P9549, DOI 10.1074/jbc.M806230200; Team RDC, 2012, LANG ENV STAT COMP; WAKEFIELD LM, 1995, CLIN CANCER RES, V1, P129; WOLF YG, 1994, J CLIN INVEST, V93, P1172, DOI 10.1172/JCI117070; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Yamamoto K, 2000, CIRCULATION, V102, P1308, DOI 10.1161/01.CIR.102.11.1308	52	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79657	10.1371/journal.pone.0079657	http://dx.doi.org/10.1371/journal.pone.0079657			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236150	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700149
J	Niu, XD; Wang, Z; Li, Y; Zhao, ZJ; Liu, JY; Jiang, L; Xu, HR; Li, ZQ				Niu, Xuedun; Wang, Zhi; Li, Yang; Zhao, Zijian; Liu, Jiayin; Jiang, Li; Xu, Haoran; Li, Zhengqiang			"Fish-in-Net", a Novel Method for Cell Immobilization of Zymomonas mobilis	PLOS ONE			English	Article							MESOPOROUS MOLECULAR-SIEVES; ETHANOL-PRODUCTION; ENZYME IMMOBILIZATION; GLUCOSE-CONCENTRATION; HYDROGEN-PRODUCTION; SILICA; SYSTEMS; FERMENTATION; ENCAPSULATION; STABILITY	Background: Inorganic mesoporous materials exhibit good biocompatibility and hydrothermal stability for cell immobilization. However, it is difficult to encapsulate living cells under mild conditions, and new strategies for cell immobilization are needed. We designed a "fish-in-net" approach for encapsulation of enzymes in ordered mesoporous silica under mild conditions. The main objective of this study is to demonstrate the potential of this approach in immobilization of living cells. Methodology/Principal Findings: Zymomonas mobilis cells were encapsulated in mesoporous silica-based materials under mild conditions by using a "fish-in-net" approach. During the encapsulation process, polyethyleneglycol was used as an additive to improve the immobilization efficiency. After encapsulation, the pore size, morphology and other features were characterized by various methods, including scanning electron microscopy, nitrogen adsorption-desorption analysis, transmission electron microscopy, fourier transform infrared spectroscopy, and elemental analysis. Furthermore, the capacity of ethanol production by immobilized Zymomonas mobilis and free Zymomonas mobilis was compared. Conclusions/Significance: In this study, Zymomonas mobilis cells were successfully encapsulated in mesoporous silica-based materials under mild conditions by the "fish-in-net" approach. Encapsulated cells could perform normal metabolism and exhibited excellent reusability. The results presented here illustrate the enormous potential of the "fish-in-net" approach for immobilization of living cells.	[Niu, Xuedun; Wang, Zhi; Li, Yang; Zhao, Zijian; Liu, Jiayin; Xu, Haoran; Li, Zhengqiang] Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130023, Jilin Province, Peoples R China; [Niu, Xuedun; Wang, Zhi; Li, Zhengqiang] Jilin Univ, Coll Life Sci, Changchun 130023, Jilin Province, Peoples R China; [Jiang, Li] NE Normal Univ, Inst Grassland Sci, Minist Educ, Key Lab Vegetat Ecol, Changchun, Jilin Province, Peoples R China	Jilin University; Jilin University; Northeast Normal University - China	Li, ZQ (corresponding author), Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130023, Jilin Province, Peoples R China.	lzq@jlu.edu.cn			National High Technology Research and Development Program of China ("863' Program) [2006AA02Z232]; Social Development Research Project of Science and Technology Department of Jilin Province [20090404]	National High Technology Research and Development Program of China ("863' Program); Social Development Research Project of Science and Technology Department of Jilin Province	This work was financially supported by the National High Technology Research and Development Program of China ("863' Program, 2006AA02Z232, http://www.863.gov.cn), and Social Development Research Project of Science and Technology Department of Jilin Province (20090404, http://kjt.jl.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdogan HA, 2011, J MATER CHEM, V15, P3690; Banerjee A, 2011, INT BIODETER BIODEGR, V65, P1052, DOI 10.1016/j.ibiod.2011.04.011; BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Cabrera S, 1999, ADV MATER, V11, P379, DOI 10.1002/(SICI)1521-4095(199903)11:5<379::AID-ADMA379>3.0.CO;2-6; Chu CY, 2011, INT J HYDROGEN ENERG, V36, P14078, DOI 10.1016/j.ijhydene.2011.04.101; Corma A, 2002, STUD SURF SCI CATAL, V142, P487; Deng W, 2002, MICROPOR MESOPOR MAT, V52, P169, DOI 10.1016/S1387-1811(02)00315-3; Du D, 2005, BIOMATERIALS, V26, P6487, DOI 10.1016/j.biomaterials.2005.03.048; Fan J, 2005, CHEM-EUR J, V11, P5391, DOI 10.1002/chem.200500060; Freeman A, 1998, ENZYME MICROB TECH, V23, P335, DOI 10.1016/S0141-0229(98)00046-5; Fuertes AB, 2004, MICROPOR MESOPOR MAT, V67, P273, DOI 10.1016/j.micromeso.2003.11.012; Genisheva Z, 2011, IND CROP PROD, V34, P979, DOI 10.1016/j.indcrop.2011.03.006; He SY, 2011, BIORESOURCE TECHNOL, V102, P5609, DOI 10.1016/j.biortech.2011.02.030; Jin YL, 1998, FOOD RES INT, V31, P421, DOI 10.1016/S0963-9969(99)00021-6; KING FG, 1982, BIOTECHNOL LETT, V4, P531, DOI 10.1007/BF00131577; Li LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064794; Liu JY, 2012, J HAZARD MATER, V217, P156, DOI 10.1016/j.jhazmat.2012.03.008; Liu NG, 2003, CHEM COMMUN, P1146, DOI 10.1039/b301910a; Manju NJ, 2009, AQUACULTURE, V294, P65, DOI 10.1016/j.aquaculture.2009.05.008; MARGARITIS A, 1983, INT J HYDROGEN ENERG, V8, P281, DOI 10.1016/0360-3199(83)90138-6; MARGARITIS A, 1984, CRC CR REV BIOTECHN, V1, P339; Panesar R, 2011, J CHEM TECHNOL BIOT, V86, P42, DOI 10.1002/jctb.2481; Rogers PL, 2007, ADV BIOCHEM ENG BIOT, V108, P263, DOI 10.1007/10_2007_060; Seol E, 2011, INT J HYDROGEN ENERG, V36, P8681, DOI 10.1016/j.ijhydene.2010.05.118; Sun QY, 2002, J PHYS CHEM B, V106, P11539, DOI 10.1021/jp026011r; Takahashi H, 2000, CHEM MATER, V12, P3301, DOI 10.1021/cm000487a; Takahashi R, 2000, J SOL-GEL SCI TECHN, V17, P7, DOI 10.1023/A:1008753718586; Tao F, 2005, PROCESS BIOCHEM, V40, P183, DOI 10.1016/j.procbio.2003.11.054; Tope AM, 2001, J MOL CATAL B-ENZYM, V16, P17, DOI 10.1016/S1381-1177(01)00040-6; Wan Y, 2007, CHEM REV, V107, P2821, DOI 10.1021/cr068020s; Wu ZF, 2010, J MOL CATAL B-ENZYM, V63, P75, DOI 10.1016/j.molcatb.2009.12.012; Yamashita Y, 2008, BIOCHEM ENG J, V42, P314, DOI 10.1016/j.bej.2008.07.013; Yan SB, 2011, J CHEM TECHNOL BIOT, V86, P731, DOI 10.1002/jctb.2581; Yang XY, 2006, ADV MATER, V18, P410, DOI 10.1002/adma.200502003; Yaykasli KO, 2005, J FOOD ENG, V70, P518, DOI 10.1016/j.jfoodeng.2004.10.006; Yiu HHP, 2001, J MOL CATAL B-ENZYM, V15, P81, DOI 10.1016/S1381-1177(01)00011-X; Zhang X, 2005, J MOL CATAL B-ENZYM, V33, P43, DOI 10.1016/j.molcatb.2005.02.001; Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548	39	15	15	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79569	10.1371/journal.pone.0079569	http://dx.doi.org/10.1371/journal.pone.0079569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236145	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700144
J	Wang, Y; Chen, JM; Liu, X; Wang, J; Li, LH; Deng, JP; Duan, YY				Wang, Yu; Chen, Jian Mei; Liu, Xi; Wang, Jia; Li, Li Hong; Deng, Jian Ping; Duan, Yun You			Evaluation of the Combined Application of Ultrasound Imaging Techniques for Middle Cerebral Artery Stent Surveillance and Follow-Up Study	PLOS ONE			English	Article							ATHEROSCLEROTIC STENOSIS; PROGRESSION	Objective: In recent years, cerebral artery stenting has become an effective method for the treatment of cerebral artery stenosis. However, methods for assessing efficacy and techniques for follow-up imaging still need to be developed. This study was designed to evaluate the application of transcranial color-coded sonography (TCCS) in assessing stenting of middle cerebral artery (MCA) stenosis. And, two new imaging techniques (vascular enhancement technology (VET) and 3-dimensional (3D) imaging) were tried out and evaluated. Method: We enrolled 43 patients with cerebral artery stenosis for vascular stent implantation. All patients were examined by ultrasonography and confirmed through digital subtraction angiography. The stenosis was imaged and blood flow parameters were analyzed before and after the procedure using TCCS. VET and 3D imaging model were used in part of the patients. Important postoperative hemodynamic changes were noted. Results: 1) Adequate stent image was present in 41 out of 43 patients as detected by postoperative 2-dimensional imaging. Images lacking clarity were obtained in 2 patients. 2) The perioperative and postoperative (one week follow-up) instantaneous blood flow velocity at the site of stenosis was significantly decreased (P<0.05) when compared with preoperative levels. Differences between postoperative (one week follow-up) and preoperative blood flow velocity were significant (P<0.05). Differences in blood flow velocity at long-term follow-up (six months and two years) compared to one-week values were not statistically significant (P>0.05). 3) VET imaging visualizes the MCA lumen and stent morphology clearly. 3D ultrasound can be used for imaging of the stent shape as well as its inner surface. Conclusion: TCCD can be considered a quick and effective clinical detection method to evaluate the intracranial arterial hemodynamics changes before and after stenting treatment for MCA stenosis. New imaging technologies 3D and VET can achieve additional image information.	[Wang, Yu; Chen, Jian Mei; Liu, Xi; Wang, Jia; Duan, Yun You] Fourth Mil Med Univ, Tangdu Hosp, Dept Ultrasound Diagnost, Xian 710032, Peoples R China; [Li, Li Hong; Deng, Jian Ping] Fourth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Liu, X (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Ultrasound Diagnost, Xian 710032, Peoples R China.	liuxi2007@fmmu.edu.cn; duanyy@fmmu.edu.cn	Demchuk, Andrew M/E-1103-2012	Demchuk, Andrew M/0000-0002-4930-7789				Kablak-Ziembicka A, 2010, J ENDOVASC THER, V17, P556, DOI 10.1583/09-2980.1; Kim DE, 2012, STROKE, V43, P1824, DOI 10.1161/STROKEAHA.112.653659; Liu X, 2009, ULTRASOUND MED BIOL, V35, P1502, DOI 10.1016/j.ultrasmedbio.2009.04.005; Moreira T, 2012, CLIN NEUROL NEUROSUR, V114, P922, DOI 10.1016/j.clineuro.2012.02.005; Park Soonchan, 2013, Neurointervention, V8, P9, DOI 10.5469/neuroint.2013.8.1.9; Qu H, 2013, EXP THER MED, V5, P471, DOI 10.3892/etm.2012.805; Schreiber S, 2009, STROKE, V40, pE478, DOI 10.1161/STROKEAHA.109.549378; Shi MC, 2012, NEUROL RES, V34, P153, DOI 10.1179/1743132811Y.0000000065; Turek G, 2012, NEUROL NEUROCHIR POL, V46, P233, DOI 10.5114/ninp.2012.29131; Wong KS, 2002, STROKE, V33, P532, DOI 10.1161/hs0202.102602; Zhang L, 2013, J CLIN NEUROSCI, V20, P362, DOI 10.1016/j.jocn.2012.03.033	11	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79410	10.1371/journal.pone.0079410	http://dx.doi.org/10.1371/journal.pone.0079410			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236130	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700129
J	Wu, SL; Shi, YZ; Wang, CX; Jia, Q; Zhang, N; Zhao, XQ; Liu, GF; Wang, YL; Liu, LP; Wang, YJ				Wu, Shuolin; Shi, Yuzhi; Wang, Chunxue; Jia, Qian; Zhang, Ning; Zhao, Xingquan; Liu, Gaifen; Wang, Yilong; Liu, Liping; Wang, Yongjun		Investigators Survey Abnormal Gluc	Glycated Hemoglobin Independently Predicts Stroke Recurrence within One Year after Acute First-Ever Non-Cardioembolic Strokes Onset in A Chinese Cohort Study	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; TYPE-2 DIABETES-MELLITUS; CARDIOVASCULAR-DISEASE; VASCULAR COMPLICATIONS; MYOCARDIAL-INFARCTION; GLYCEMIC CONTROL; RISK-FACTORS; ASSOCIATION; GLUCOSE; PREVENTION	Objective: Hyperglycemia is related to stroke. Glycated hemoglobin (HbA1c) can reflect pre-stroke glycaemia status. However, the information on the direct association between HbA1c and recurrence after non-cardioembolic acute ischemic strokes is rare and there is no consistent conclusion. Methods: The ACROSS-China database comprised of 2186 consecutive first-ever acute ischemic stroke patients with baseline HbA1c values. After excluding patients who died from non-stroke recurrence and patients lost to follow up, 1817 and 1540 were eligible for 3-month and 1-year analyses, respectively. Multivariate Cox regression was performed to evaluate the associations between HbA1c and 3-month and 1-year stroke recurrence. Results: The HbA1c values at admission were divided into 4 levels by quartiles: Q1 (<5.5%); Q2 (5.5 to <6.1%); Q3 (6.1% to <7.2%); and Q4 (>= 7.2%). The cumulative recurrence rates were 8.3% and 11.0% for 3 months and 1 year, respectively. In multivariate analyses, when compared with Q1, the adjusted hazard ratios (AHRs) were 2.83 (95% confidence interval (CI) 1.28-6.26) in Q3 and 3.71(95% CI 1.68-8.21) in Q4 for 3-month stroke recurrence; 3.30 (95% CI 1.31-8.34) in Q3 and 3.35 (95% CI 1.36-8.21) in Q4 for 1-year stroke recurrence. Adding fasting plasma glucose in the multivariate analyses did not modify the association: AHRs were 2.75 (95% CI 1.24-6.11) in Q3 and 3.67 (95% CI 1.59-8.53) in Q4 for 3-month analysis; AHRs were 3.08 (95% CI 1.10-8.64) in Q3 and 3.31(95% CI 1.35-8.14) in Q4 for 1-year analysis. Conclusions: A higher "normal" HbA1c level reflecting pre-stroke glycaemia status independently predicts stroke recurrence within one year after non-cardioembolic acute ischemic stroke onset. HbA1c is recommended as a routine test in acute ischemic stroke patients.	[Wu, Shuolin; Shi, Yuzhi; Wang, Chunxue; Jia, Qian; Zhang, Ning; Zhao, Xingquan; Liu, Gaifen; Wang, Yilong; Liu, Liping; Wang, Yongjun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China	Capital Medical University	Wang, CX (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China.	snowsen@126.com	liu, li/HGC-0900-2022	Shi, YuZhi/0000-0002-4018-6984	Beijing Science and Technology Committee [7102050]; National Science Foundation [81071115]; Young Scientists Fund of the Beijing Health Bureau [2009-009]; State Key Development, Program of Basic Research of China [2009CB521905]	Beijing Science and Technology Committee; National Science Foundation(National Science Foundation (NSF)); Young Scientists Fund of the Beijing Health Bureau; State Key Development, Program of Basic Research of China(State Key Development Program for Basic Research of China)	This study was funded jointly by the Beijing Science and Technology Committee (grant no. 7102050, www.bjkw.gov.cn), the National Science Foundation (grant no. 81071115, www.nsfc.gov.cn), the Young Scientists Fund of the Beijing Health Bureau (grant No. 2009-009, www.bjhb.gov.cn), and the State Key Development, Program of (for) Basic Research of China (2009CB521905 http://www.973.gov.cn/Default_3.aspx). This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Adams RJ, 2009, OBESITY, V17, P559, DOI 10.1038/oby.2008.592; Allen NB, 2010, NEUROEPIDEMIOLOGY, V34, P123, DOI 10.1159/000274804; Alter M, 1997, STROKE, V28, P1153, DOI 10.1161/01.STR.28.6.1153; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; An Ya-chen, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P816; [Anonymous], 2012, DIABETES CARE S1, V35, pS4, DOI DOI 10.2337/DC12-S004; Arima H, 2011, J CLIN HYPERTENS, V13, P693, DOI 10.1111/j.1751-7176.2011.00530.x; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; Buse JB, 2007, AM J CARDIOL, V99, p21I, DOI 10.1016/j.amjcard.2007.03.003; Chiquete E, 2013, CEREBROVASC DIS, V35, P168, DOI 10.1159/000346603; Chmielewska B, 1999, Ann Univ Mariae Curie Sklodowska Med, V54, P261; Coutts SB, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-18; Donahue RP, 2011, NUTR METAB CARDIOVAS, V21, P504, DOI 10.1016/j.numecd.2009.11.012; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Ford ES, 2010, J AM COLL CARDIOL, V55, P1310, DOI 10.1016/j.jacc.2009.10.060; Fuentes B, 2010, STROKE, V41, P2362, DOI 10.1161/STROKEAHA.110.591529; Gast KB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052036; Ichikawa H, 2012, EUR NEUROL, V67, P26, DOI 10.1159/000333284; Ismail-Beigi Faramarz, 2008, Endocr Pract, V14, P639; Japan Diabetes Society, 2007, TREATM GUID DIAB 200, P1; Jia Q, 2012, STROKE, V43, P650, DOI 10.1161/STROKEAHA.111.633784; Kamouchi M, 2011, STROKE, V42, P2788, DOI 10.1161/STROKEAHA.111.617415; Kirshner HS, 2009, J NEUROL SCI, V279, P1, DOI 10.1016/j.jns.2008.12.012; Kono Y, 2011, CEREBROVASC DIS, V31, P365, DOI 10.1159/000323233; Kuwashiro T, 2012, CEREBROVASC DIS, V33, P141, DOI 10.1159/000334190; Lee M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3564; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Liu LP, 2011, STROKE, V42, P3651, DOI 10.1161/STROKEAHA.111.635755; National Glycohemoglobin Standardization Program (NGSP), 2013, LIST NGSP CERT METH; Oh HG, 2011, DIABETES METAB J, V35, P551, DOI 10.4093/dmj.2011.35.5.551; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; Petty GW, 2000, STROKE, V31, P1062, DOI 10.1161/01.STR.31.5.1062; Poppe AY, 2009, DIABETES CARE, V32, P617, DOI 10.2337/dc08-1754; Sacks DB, 2011, DIABETES CARE, V34, P518, DOI 10.2337/dc10-1546; Schwartz Kendra L, 2005, BMC Fam Pract, V6, P28, DOI 10.1186/1471-2296-6-28; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Skyler JS, 2009, DIABETES CARE, V32, P187, DOI 10.2337/dc08-9026; Stettler C, 2006, AM HEART J, V152, P27, DOI 10.1016/j.ahj.2005.09.015; Terry T, 2012, CURR CARDIOL REP, V14, DOI 10.1007/s11886-011-0238-6; the WHO. task force on stroke and other cerebrovascular disorders, 1989, STROKE, V20; Toole JF, 2004, JAMA-J AM MED ASSOC, V291, P565, DOI 10.1001/jama.291.5.565; Wang YL, 2013, STROKE, V44, P1232, DOI 10.1161/STROKEAHA.111.000302; Weimar C, 2009, STROKE, V40, P350, DOI 10.1161/STROKEAHA.108.521419; Zoungas S, 2012, DIABETOLOGIA, V55, P636, DOI 10.1007/s00125-011-2404-1	46	23	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80690	10.1371/journal.pone.0080690	http://dx.doi.org/10.1371/journal.pone.0080690			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236195	Green Submitted, Green Published, gold			2022-12-27	WOS:000327254700198
J	Barone, R; Macaluso, F; Catanese, P; Gammazza, AM; Rizzuto, L; Marozzi, P; Lo Giudice, G; Stampone, T; Cappello, F; Morici, G; Zummo, G; Farina, F; Di Felice, V				Barone, Rosario; Macaluso, Filippo; Catanese, Patrizia; Gammazza, Antonella Marino; Rizzuto, Luigi; Marozzi, Paola; Lo Giudice, Giuseppe; Stampone, Tomaso; Cappello, Francesco; Morici, Giuseppe; Zummo, Giovanni; Farina, Felicia; Di Felice, Valentina			Endurance Exercise and Conjugated Linoleic Acid (CLA) Supplementation Up-Regulate CYP17A1 and Stimulate Testosterone Biosynthesis	PLOS ONE			English	Article							RAT ADRENAL-CELLS; BODY-COMPOSITION; ANABOLIC-STEROIDS; SKELETAL-MUSCLE; GENE-EXPRESSION; RESISTANCE; INCREASE; BONE; PERFORMANCE; CAPACITY	A new role for fat supplements, in particular conjugated linoleic acid (CLA), has been delineated in steroidogenesis, although the underlying molecular mechanisms have not yet been elucidated. The aims of the present study were to identify the pathway stimulated by CLA supplementation using a cell culture model and to determine whether this same pathway is also stimulated in vivo by CLA supplementation associated with exercise. In vitro, Leydig tumour rat cells (R2C) supplemented with different concentrations of CLA exhibited increasing testosterone biosynthesis accompanied by increasing levels of CYP17A1 mRNA and protein. In vivo, trained mice showed an increase in free plasma testosterone and an up-regulation of CYP17A1 mRNA and protein. The effect of training on CYP17A1 expression and testosterone biosynthesis was significantly higher in the trained mice supplemented with CLA compared to the placebo. The results of the present study demonstrated that CLA stimulates testosterone biosynthesis via CYP17A1, and endurance training led to the synthesis of testosterone in vivo by inducing the overexpression of CYP17A1 mRNA and protein in the Leydig cells of the testis. This effect was enhanced by CLA supplementation. Therefore, CLA-associated physical activity may be used for its steroidogenic property in different fields, such as alimentary industry, human reproductive medicine, sport science, and anti-muscle wasting.	[Barone, Rosario; Macaluso, Filippo; Catanese, Patrizia; Gammazza, Antonella Marino; Rizzuto, Luigi; Cappello, Francesco; Morici, Giuseppe; Zummo, Giovanni; Farina, Felicia; Di Felice, Valentina] Univ Palermo, Dept Expt Biomed & Clin Neurosci BioNeC, Palermo, Italy; [Marozzi, Paola] Hosp OR Villa Sofia Cervello, Nucl Med Lab, Palermo, Italy; [Lo Giudice, Giuseppe; Stampone, Tomaso] Hosp OR Villa Sofia Cervello, Clin Pathol Lab, Palermo, Italy	University of Palermo	Macaluso, F (corresponding author), Univ Palermo, Dept Expt Biomed & Clin Neurosci BioNeC, Palermo, Italy.	filippo.macaluso@unipa.it	Di Felice, Valentina/A-4457-2009; Barone, Rosario/ABD-8488-2020; Gammazza, Antonella Marino/AAV-3123-2020; barone, rosario/ABA-6758-2021; Di Felice, Valentina/AAG-3740-2021; Cappello, Francesco/F-9153-2012	Di Felice, Valentina/0000-0002-4132-1260; Di Felice, Valentina/0000-0002-4132-1260; Macaluso, Filippo/0000-0001-5109-2070; Marino Gammazza, Antonella/0000-0002-1683-3803; barone, rosario/0000-0002-8240-1240; Cappello, Francesco/0000-0001-9288-1148	Ministero dell'Istruzione dell'Universita e della Ricerca (PRIN) [prot. 2009WBFZYM_003]	Ministero dell'Istruzione dell'Universita e della Ricerca (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This Study was partly funded by the Ministero dell'Istruzione dell'Universita e della Ricerca; PRIN2009 - Prof. Zummo; prot. 2009WBFZYM_003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banu J, 2008, J BONE MINER METAB, V26, P436, DOI 10.1007/s00774-008-0863-3; Barone R, 2009, SCAND J MED SCI SPOR, V19, P782, DOI 10.1111/j.1600-0838.2008.00863.x; Bellafiore M, 2007, INT J SPORTS MED, V28, P749, DOI 10.1055/s-2007-964899; Bhattacharya A, 2005, J NUTR, V135, P1124, DOI 10.1093/jn/135.5.1124; Brasaemle DL, 2009, MOL CELL BIOCHEM, V326, P15, DOI 10.1007/s11010-008-9998-8; Chimenti L, 2007, AM J RESP CRIT CARE, V175, P442, DOI 10.1164/rccm.200608-1086OC; Chung SY, 2005, J LIPID RES, V46, P885, DOI 10.1194/jlr.M400476-JLR200; Clark AM, 1996, BIOL REPROD, V55, P347, DOI 10.1095/biolreprod55.2.347; Colakoglu S, 2006, J SPORT MED PHYS FIT, V46, P570; CRIVELLO JF, 1980, J BIOL CHEM, V255, P8144; Di Felice V, 2007, J STRENGTH COND RES, V21, P193, DOI 10.1519/00124278-200702000-00035; Di Felice V, 2009, J CELL PHYSIOL, V221, P729, DOI 10.1002/jcp.21912; DIFELICE V, 2013, J TISSUE ENG REGEN M, DOI DOI 10.1002/TERM.1739.PUBMED:23592297; Dilzer Allison, 2012, Crit Rev Food Sci Nutr, V52, P488, DOI 10.1080/10408398.2010.501409; Enoki T, 2006, J PHYSIOL-LONDON, V577, P433, DOI 10.1113/jphysiol.2006.115436; FRINCHI M, 2013, INT J SPORTS MED MED, DOI DOI 10.1055/S-0033-1343405.PUBMED:23868681; Greenlund LJS, 2003, MECH AGEING DEV, V124, P287, DOI 10.1016/S0047-6374(02)00196-3; Hartgens F, 2004, SPORTS MED, V34, P513, DOI 10.2165/00007256-200434080-00003; Jeukendrup AE, 2004, NUTRITION, V20, P678, DOI 10.1016/j.nut.2004.04.018; Keogh JWL, 2012, J PAIN SYMPTOM MANAG, V43, P96, DOI 10.1016/j.jpainsymman.2011.03.006; Kim JH, 2012, LIPIDS, V47, P855, DOI 10.1007/s11745-012-3698-6; Kim JH, 2010, J MED FOOD, V13, P1057, DOI 10.1089/jmf.2009.1358; Kim YC, 1997, STEROIDS, V62, P10, DOI 10.1016/S0039-128X(96)00153-5; KRAEMER WJ, 1991, INT J SPORTS MED, V12, P228, DOI 10.1055/s-2007-1024673; Kreider RB, 2002, J STRENGTH COND RES, V16, P325; Lin H, 2001, J CELL BIOCHEM, V83, P147, DOI 10.1002/jcb.1213; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macaluso F, 2012, J MUSCLE RES CELL M, V33, P187, DOI 10.1007/s10974-012-9302-0; Macaluso F, 2012, SCAND J MED SCI SPOR, V22, pE38, DOI 10.1111/j.1600-0838.2011.01389.x; Macaluso F, 2013, MUSCLE NERVE, V48, P109, DOI 10.1002/mus.23721; Macaluso F, 2013, NUTRIENTS, V5, P509, DOI 10.3390/nu5020509; Macaluso F, 2012, J STRENGTH COND RES, V26, P1667, DOI 10.1519/JSC.0b013e318231ab78; Maggio M, 2013, CURR OPIN CLIN NUTR, V16, P3, DOI 10.1097/MCO.0b013e32835b6044; Mirand PP, 2004, J NUTR, V134, P2263, DOI 10.1093/jn/134.9.2263; Serradifalco C, 2011, EUR J HISTOCHEM, V55, P229, DOI 10.4081/ejh.2011.e41; SERVETNICK DA, 1995, J BIOL CHEM, V270, P16970, DOI 10.1074/jbc.270.28.16970; Sinha-Hikim I, 2004, J CLIN ENDOCR METAB, V89, P5245, DOI 10.1210/jc.2004-0084; Stojkov NJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE1239, DOI 10.1152/ajpendo.00554.2011; Storey A, 2012, SPORTS MED, V42, P769, DOI 10.2165/11633000-000000000-00000; Svechnikov K, 2009, J APPL TOXICOL, V29, P673, DOI 10.1002/jat.1456; Tamaki T, 2001, AM J PHYSIOL-ENDOC M, V280, pE973; Weisser J, 2011, MOL CELL ENDOCRINOL, V341, P18, DOI 10.1016/j.mce.2011.03.008; Ye LP, 2011, MOLECULES, V16, P9983, DOI 10.3390/molecules16129983	43	38	40	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79686	10.1371/journal.pone.0079686	http://dx.doi.org/10.1371/journal.pone.0079686			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223995	Green Published, gold			2022-12-27	WOS:000326597400081
J	Islam, S; Griffiths, CA; Blomstedt, CK; Le, TN; Gaff, DF; Hamill, JD; Neale, AD				Islam, Sharmin; Griffiths, Cara A.; Blomstedt, Cecilia K.; Tuan-Ngoc Le; Gaff, Donald F.; Hamill, John D.; Neale, Alan D.			Increased Biomass, Seed Yield and Stress Tolerance Is Conferred in Arabidopsis by a Novel Enzyme from the Resurrection Grass Sporobolus stapfianus That Glycosylates the Strigolactone Analogue GR24	PLOS ONE			English	Article							LEAF SENESCENCE; BIOCHEMICAL-CHARACTERIZATION; DESICCATION-TOLERANCE; PHOSPHATE DEFICIENCY; DROUGHT TOLERANCE; GENES; EXPRESSION; ACID; GLYCOSYLTRANSFERASES; INHIBITION	Isolation of gene transcripts from desiccated leaf tissues of the resurrection grass, Sporobolus stapfianus, resulted in the identification of a gene, SDG8i, encoding a Group 1 glycosyltransferase (UGT). Here, we examine the effects of introducing this gene, under control of the CaMV35S promoter, into the model plant Arabidopsis thaliana. Results show that Arabidopsis plants constitutively over-expressing SDG8i exhibit enhanced growth, reduced senescence, cold tolerance and a substantial improvement in protoplasmic drought tolerance. We hypothesise that expression of SDG8i in Arabidopsis negatively affects the bioactivity of metabolite/s that mediate/s environmentally-induced repression of cell division and expansion, both during normal development and in response to stress. The phenotype of transgenic plants over-expressing SDG8i suggests modulation in activities of both growth-and stress-related hormones. Plants overexpressing the UGT show evidence of elevated auxin levels, with the enzyme acting downstream of ABA to reduce drought-induced senescence. Analysis of the in vitro activity of the UGT recombinant protein product demonstrates that SDG8i can glycosylate the synthetic strigolactone analogue GR24, evoking a link with strigolactone-related processes in vivo. The large improvements observed in survival of transgenic Arabidopsis plants under cold-, salt-and drought-stress, as well as the substantial increases in growth rate and seed yield under non-stress conditions, indicates that overexpression of SDG8i in crop plants may provide a novel means of increasing plant productivity.	[Islam, Sharmin; Griffiths, Cara A.; Blomstedt, Cecilia K.; Tuan-Ngoc Le; Gaff, Donald F.; Neale, Alan D.] Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia; [Tuan-Ngoc Le] Victorian AgriBiosci Ctr, Biosci Res Div, Melbourne, Vic, Australia; [Hamill, John D.] Univ Melbourne, Dept Forest & Ecosyst Sci, Creswick, Vic, Australia	Monash University; University of Melbourne	Neale, AD (corresponding author), Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia.	alan.neale@monash.edu		Blomstedt, Cecilia/0000-0003-1919-6982	Monash University Graduate Research Scholarship; Monash University Faculty of Science Dean's Postgraduate Research Scholarship	Monash University Graduate Research Scholarship; Monash University Faculty of Science Dean's Postgraduate Research Scholarship	Sharmin Islam was supported by a Monash University Graduate Research Scholarship and Cara Griffiths by a Monash University Faculty of Science Dean's Postgraduate Research Scholarship; URL;www.monash.edu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama K, 2006, ANN BOT-LONDON, V97, P925, DOI 10.1093/aob/mcl063; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Bai F, 2008, AM J BOT, V95, P133, DOI 10.3732/ajb.95.2.133; Blomstedt CK, 2010, PLANT GROWTH REGUL, V62, P217, DOI 10.1007/s10725-010-9485-6; Bowles D, 2010, ENCY LIFE SCI CHICHE; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Dubrovsky JG, 2009, ANN BOT-LONDON, V103, P807, DOI 10.1093/aob/mcn267; Dun EA, 2009, TRENDS PLANT SCI, V14, P364, DOI 10.1016/j.tplants.2009.04.003; Gaff DF, 2009, FUNCT PLANT BIOL, V36, P589, DOI 10.1071/FP08166; GAN SS, 1995, SCIENCE, V270, P1986, DOI 10.1126/science.270.5244.1986; Ghasempour HR, 2001, AUST J PLANT PHYSIOL, V28, P1115; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Hajouj T, 2000, PLANT PHYSIOL, V124, P1305, DOI 10.1104/pp.124.3.1305; Hou BK, 2004, J BIOL CHEM, V279, P47822, DOI 10.1074/jbc.M409569200; Jackson RG, 2001, J BIOL CHEM, V276, P4350, DOI 10.1074/jbc.M006185200; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Jordi W, 2000, PLANT CELL ENVIRON, V23, P279, DOI 10.1046/j.1365-3040.2000.00544.x; Kapulnik Y, 2011, PLANTA, V233, P209, DOI 10.1007/s00425-010-1310-y; Kohlen W, 2011, PLANT PHYSIOL, V155, P974, DOI 10.1104/pp.110.164640; Koltai H, 2011, NEW PHYTOL, V190, P545, DOI 10.1111/j.1469-8137.2011.03678.x; Kuppu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064190; Le TN, 2007, FUNCT PLANT BIOL, V34, P589, DOI 10.1071/FP06231; Levitt J, 1960, B RES COUNC ISRAEL D, V8D, P177; Leyser O, 2009, PLANT CELL ENVIRON, V32, P694, DOI 10.1111/j.1365-3040.2009.01930.x; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Lim EK, 2005, TETRAHEDRON-ASYMMETR, V16, P143, DOI 10.1016/j.tetasy.2004.11.062; Lim EK, 2004, EMBO J, V23, P2915, DOI 10.1038/sj.emboj.7600295; Lim EK, 2002, J BIOL CHEM, V277, P586, DOI 10.1074/jbc.M109287200; Lopez-Raez JA, 2010, NEW PHYTOL, V187, P343, DOI 10.1111/j.1469-8137.2010.03291.x; Lopez-Raez JA, 2008, NEW PHYTOL, V178, P863, DOI 10.1111/j.1469-8137.2008.02406.x; Marillonnet S, 2005, NAT BIOTECHNOL, V23, P718, DOI 10.1038/nbt1094; Martinez-Trujillo M, 2004, PLANT MOL BIOL REP, V22, P63, DOI 10.1007/BF02773350; Neale AD, 2000, PLANT CELL ENVIRON, V23, P265, DOI 10.1046/j.1365-3040.2000.00548.x; Oliver MJ, 2011, PLANT CELL, V23, P1231, DOI 10.1105/tpc.110.082800; OWEN PC, 1952, J EXP BOT, V3, P188, DOI 10.1093/jxb/3.2.188; Poppenberger B, 2005, P NATL ACAD SCI USA, V102, P15253, DOI 10.1073/pnas.0504279102; Potters G, 2007, TRENDS PLANT SCI, V12, P98, DOI 10.1016/j.tplants.2007.01.004; Rivero RM, 2007, P NATL ACAD SCI USA, V104, P19631, DOI 10.1073/pnas.0709453104; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Ruyter-Spira C, 2011, PLANT PHYSIOL, V155, P721, DOI 10.1104/pp.110.166645; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Snowden KC, 2005, PLANT CELL, V17, P746, DOI 10.1105/tpc.104.027714; Song JT, 2005, J PLANT BIOL, V48, P422, DOI 10.1007/BF03030584; Stirnberg P, 2002, DEVELOPMENT, V129, P1131; Stirnberg P, 2007, PLANT J, V50, P80, DOI 10.1111/j.1365-313X.2007.03032.x; Sykorova B, 2008, J EXP BOT, V59, P377, DOI 10.1093/jxb/erm319; Tang DZ, 2005, PLANT PHYSIOL, V138, P1018, DOI 10.1104/pp.105.060400; Tognetti VB, 2010, PLANT CELL, V22, P2660, DOI 10.1105/tpc.109.071316; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Umehara M, 2010, PLANT CELL PHYSIOL, V51, P1118, DOI 10.1093/pcp/pcq084; Weigel D., 2002, ARABIDOPSIS LAB MANU; Woo HR, 2004, PLANT CELL PHYSIOL, V45, P923, DOI 10.1093/pcp/pch110; Woo HR, 2001, PLANT CELL, V13, P1779, DOI 10.1105/tpc.13.8.1779; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083	55	17	17	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80035	10.1371/journal.pone.0080035	http://dx.doi.org/10.1371/journal.pone.0080035			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224034	gold, Green Published, Green Submitted			2022-12-27	WOS:000326597400106
J	Zhu, FF; Zhang, QL; Qiu, J				Zhu, Feifei; Zhang, Qinglin; Qiu, Jiang			Relating Inter-Individual Differences in Verbal Creative Thinking to Cerebral Structures: An Optimal Voxel-Based Morphometry Study	PLOS ONE			English	Article							INFERIOR FRONTAL GYRUS; TORRANCE TESTS; BROCAS AREA; INHIBITION; CORTEX; CONNECTIVITY; MECHANISMS; EEG; SEX	Creativity can be defined the capacity of an individual to produce something original and useful. An important measurable component of creativity is divergent thinking. Despite existing studies on creativity-related cerebral structural basis, no study has used a large sample to investigate the relationship between individual verbal creativity and regional gray matter volumes (GMVs) and white matter volumes (WMVs). In the present work, optimal voxel-based morphometry (VBM) was employed to identify the structure that correlates verbal creativity (measured by the verbal form of Torrance Tests of Creative Thinking) across the brain in young healthy subjects. Verbal creativity was found to be significantly positively correlated with regional GMV in the left inferior frontal gyrus (IFG), which is believed to be responsible for language production and comprehension, new semantic representation, and memory retrieval, and in the right IFG, which may involve inhibitory control and attention switching. A relationship between verbal creativity and regional WMV in the left and right IFG was also observed. Overall, a highly verbal creative individual with superior verbal skills may demonstrate a greater computational efficiency in the brain areas involved in high-level cognitive processes including language production, semantic representation and cognitive control.	[Zhu, Feifei; Zhang, Qinglin; Qiu, Jiang] Minist Educ, Key Lab Cognit & Personal SWU, Chongqing, Peoples R China; [Zhu, Feifei; Zhang, Qinglin; Qiu, Jiang] Southwest Univ, Sch Psychol, Chongqing, Peoples R China	Southwest University - China	Qiu, J (corresponding author), Minist Educ, Key Lab Cognit & Personal SWU, Chongqing, Peoples R China.	qiuj318@swu.edu.cn			National Natural Science Foundation of China [31070900, 31271087]; Program for New Century Excellent Talents in University by the Ministry of Education; Fundamental Research Funds for the Central Universities [SWU1209101]; Key Discipline Fund of National 211 Project [TR201208-1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University by the Ministry of Education(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Key Discipline Fund of National 211 Project	This research was supported by the National Natural Science Foundation of China (31070900; 31271087), the Program for New Century Excellent Talents in University (2011) by the Ministry of Education, the Fundamental Research Funds for the Central Universities (SWU1209101) and the Key Discipline Fund of National 211 Project (TR201208-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Badre D, 2005, NEURON, V47, P907, DOI 10.1016/j.neuron.2005.07.023; Badre D, 2007, NEUROPSYCHOLOGIA, V45, P2883, DOI 10.1016/j.neuropsychologia.2007.06.015; Bechtereva NP, 2004, INT J PSYCHOPHYSIOL, V53, P11, DOI 10.1016/j.ijpsycho.2004.01.001; Caplan D, 2006, CORTEX, V42, P469, DOI 10.1016/S0010-9452(08)70379-4; CARSON DK, 1994, CREATIVITY RES J, V7, P145, DOI 10.1080/10400419409534520; Chikazoe J, 2007, J COGNITIVE NEUROSCI, V19, P69, DOI 10.1162/jocn.2007.19.1.69; Chrysikou EG, 2011, HUM BRAIN MAPP, V32, P665, DOI 10.1002/hbm.21056; Cools R, 2002, J NEUROSCI, V22, P4563, DOI 10.1523/JNEUROSCI.22-11-04563.2002; Costafreda SG, 2006, HUM BRAIN MAPP, V27, P799, DOI 10.1002/hbm.20221; DAN L, 1989, COMBINED REVENS TREA; de Souza LC, 2010, NEUROPSYCHOLOGIA, V48, P3733, DOI 10.1016/j.neuropsychologia.2010.09.010; DeHaan RL, 2009, CBE-LIFE SCI EDUC, V8, P172, DOI 10.1187/cbe.08-12-0081; Dietrich A, 2010, PSYCHOL BULL, V136, P822, DOI 10.1037/a0019749; Fink A, 2006, EUR J NEUROSCI, V23, P2241, DOI 10.1111/j.1460-9568.2006.04751.x; FINK A, 2011, HUM BRAIN MAPP; FINK A, 2013, BRAIN STRUCT FUNCT, V218, P1; FINK A, 2012, NEUROSCI BIOBEHAV R, P46442; Fink A, 2006, INT J PSYCHOPHYSIOL, V62, P46, DOI 10.1016/j.ijpsycho.2006.01.001; Fink A, 2011, INT J PSYCHOPHYSIOL, V82, P233, DOI 10.1016/j.ijpsycho.2011.09.003; Fink A, 2010, NEUROIMAGE, V52, P1687, DOI 10.1016/j.neuroimage.2010.05.072; Fink A, 2009, HUM BRAIN MAPP, V30, P734, DOI 10.1002/hbm.20538; Gansier DA, 2011, NEUROPSYCHOLOGIA, V49, P2527, DOI 10.1016/j.neuropsychologia.2011.05.001; Vidorreta JG, 2011, HUM BRAIN MAPP, V32, P331, DOI 10.1002/hbm.21026; Gazzaniga MS, 2000, BRAIN, V123, P1293, DOI 10.1093/brain/123.7.1293; Good CD, 2002, VOXEL BASED MORPHOME, P16; Grabner RH, 2007, BEHAV NEUROSCI, V121, P224, DOI 10.1037/0735-7044.121.1.224; Green AE, 2010, CEREB CORTEX, V20, P70, DOI 10.1093/cercor/bhp081; Grewe T, 2005, HUM BRAIN MAPP, V26, P178, DOI 10.1002/hbm.20154; Guilford JP, 1950, AM PSYCHOL, V5, P444, DOI 10.1037/h0063487; Guilford J.P., 1967, NATURE HUMAN INTELLI; Hampshire A, 2007, J NEUROSCI, V27, P6219, DOI 10.1523/JNEUROSCI.0851-07.2007; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; HEAUSLER NL, 1988, EDUC PSYCHOL MEAS, V48, P463, DOI 10.1177/0013164488482021; Heilman KM, 2003, NEUROCASE, V9, P369, DOI 10.1076/neur.9.5.369.16553; HUANG P, 2012, HUM BRAIN MAPP; Jung RE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009818; Jung RE, 2010, HUM BRAIN MAPP, V31, P398, DOI 10.1002/hbm.20874; Jung RE, 2009, J NEUROSCI, V29, P5319, DOI 10.1523/JNEUROSCI.0588-09.2009; Kanai R, 2011, J NEUROSCI, V31, P6620, DOI 10.1523/JNEUROSCI.5864-10.2011; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Kim KH, 2006, EDUC PSYCHOL MEAS, V66, P459, DOI 10.1177/0013164405282456; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Ming W. D. Q., 1989, PSYCHOL SCI, V5; Moore DW, 2009, BRAIN COGNITION, V70, P267, DOI 10.1016/j.bandc.2009.02.011; Paus T, 2005, TRENDS COGN SCI, V9, P60, DOI 10.1016/j.tics.2004.12.008; Razumnikova O. M., 2009, Human Physiology, V35, P285, DOI 10.1134/S0362119709030049; Ridgway GR, 2009, NEUROIMAGE, V44, P99, DOI 10.1016/j.neuroimage.2008.08.045; Runco MA, 2010, CREATIVITY RES J, V22, P361, DOI 10.1080/10400419.2010.523393; Shamay-Tsoory SG, 2011, NEUROPSYCHOLOGIA, V49, P178, DOI 10.1016/j.neuropsychologia.2010.11.020; Silvia PJ, 2011, THINK SKILLS CREAT, V6, P24, DOI 10.1016/j.tsc.2010.06.001; Skipper JI, 2007, BRAIN LANG, V101, P260, DOI 10.1016/j.bandl.2007.02.008; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Sowell ER, 2001, J NEUROSCI, V21, P8819, DOI 10.1523/JNEUROSCI.21-22-08819.2001; Sternberg RJ, 1996, AM PSYCHOL, V51, P677, DOI 10.1037/0003-066X.51.7.677; Stuss DT, 1998, J INT NEUROPSYCH SOC, V4, P265, DOI 10.1017/S1355617798002653; Takeuchi H, 2012, CEREB CORTEX, V22, P2921, DOI 10.1093/cercor/bhr371; Takeuchi H, 2011, HUM BRAIN MAPP, V32, P1497, DOI 10.1002/hbm.21122; Takeuchi H, 2010, NEUROIMAGE, V51, P578, DOI 10.1016/j.neuroimage.2010.02.078; Takeuchi H, 2010, NEUROIMAGE, V51, P11, DOI 10.1016/j.neuroimage.2010.02.035; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021050; Taki Y, 2012, HUM BRAIN MAPP; Torrance E.P., 1987, FRONTIERS CREATIVITY, P189; Torrance EP., 1974, TEST CREATIVE THINKI; Zabelina DL, 2010, PSYCHOL AESTHET CREA, V4, P136, DOI 10.1037/a0017379; ZHANG H, 2013, CORTEX, P82377	69	41	42	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79272	10.1371/journal.pone.0079272	http://dx.doi.org/10.1371/journal.pone.0079272			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223921	Green Submitted, Green Published, gold			2022-12-27	WOS:000326597400058
J	Vossen, CJ; Vossen, HGM; Marcus, MAE; van Os, J; Lousberg, R				Vossen, Catherine J.; Vossen, Helen G. M.; Marcus, Marco A. E.; van Os, Jim; Lousberg, Richel			Introducing the Event Related Fixed Interval Area (ERFIA) Multilevel Technique: a Method to Analyze the Complete Epoch of Event-Related Potentials at Single Trial Level	PLOS ONE			English	Article							LASER-EVOKED POTENTIALS; MULTIPLE LINEAR-REGRESSION; CEREBRAL POTENTIALS; PAIN; HABITUATION; ATTENTION; AMPLITUDE; STIMULI; HEAT; FIBROMYALGIA	In analyzing time-locked event-related potentials (ERPs), many studies have focused on specific peaks and their differences between experimental conditions. In theory, each latency point after a stimulus contains potentially meaningful information, regardless of whether it is peak-related. Based on this assumption, we introduce a new concept which allows for flexible investigation of the whole epoch and does not primarily focus on peaks and their corresponding latencies. For each trial, the entire epoch is partitioned into event-related fixed-interval areas under the curve (ERFIAs). These ERFIAs, obtained at single trial level, act as dependent variables in a multilevel random regression analysis. The ERFIA multilevel method was tested in an existing ERP dataset of 85 healthy subjects, who underwent a rating paradigm of 150 painful and non-painful somatosensory electrical stimuli. We modeled the variability of each consecutive ERFIA with a set of predictor variables among which were stimulus intensity and stimulus number. Furthermore, we corrected for latency variations of the P2 (260 ms). With respect to known relationships between stimulus intensity, habituation, and pain-related somatosensory ERP, the ERFIA method generated highly comparable results to those of commonly used methods. Notably, effects on stimulus intensity and habituation were also observed in non-peak-related latency ranges. Further, cortical processing of actual stimulus intensity depended on the intensity of the previous stimulus, which may reflect pain-memory processing. In conclusion, the ERFIA multilevel method is a promising tool that can be used to study event-related cortical processing.	[Vossen, Catherine J.; Marcus, Marco A. E.] Maastricht Univ, Med Ctr, Dept Anesthesiol & Pain Med, Maastricht, Netherlands; [Vossen, Helen G. M.] Univ Amsterdam, Amsterdam Sch Commun Res, Amsterdam, Netherlands; [Vossen, Catherine J.; van Os, Jim; Lousberg, Richel] Maastricht Univ, Dept Psychiat & Psychol, Maastricht, Netherlands; [van Os, Jim] Kings Coll London, Kings Hlth Partners, Dept Psychosis Studies, Inst Psychiat, London WC2R 2LS, England	Maastricht University; University of Amsterdam; Maastricht University; University of London; King's College London	Vossen, CJ (corresponding author), Maastricht Univ, Med Ctr, Dept Anesthesiol & Pain Med, Maastricht, Netherlands.	c.vossen@mumc.nl	van Os, Jim/V-8884-2019; van Os, Jim/C-2113-2014; Vossen, Catherine/S-7436-2019; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022	van Os, Jim/0000-0002-7245-1586; Vossen, Catherine/0000-0003-3523-1696				Becker DE, 2000, PAIN, V84, P37, DOI 10.1016/S0304-3959(99)00182-7; BEYDOUN A, 1993, ELECTROEN CLIN NEURO, V88, P173, DOI 10.1016/0168-5597(93)90002-7; Bingel U, 2008, PHYSIOLOGY, V23, P371, DOI 10.1152/physiol.00024.2008; BROMM B, 1987, INT J NEUROSCI, V33, P15, DOI 10.3109/00207458708985926; BROMM B, 1991, REV NEUROL-FRANCE, V147, P625; BROMM B, 1984, METHOD FIND EXP CLIN, V6, P405; DAWSON GD, 1951, J PHYSIOL-LONDON, V115, pP2; DAWSON GD, 1954, ELECTROEN CLIN NEURO, V6, P65, DOI 10.1016/0013-4694(54)90007-3; de Tommaso M, 2011, J PAIN, V12, P116, DOI 10.1016/j.jpain.2010.06.004; Goldstein H., 2011, MULTILEVEL STAT MODE, V4th; Granovsky Y, 2008, J PAIN, V9, P53, DOI 10.1016/j.jpain.2007.08.010; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Hatem SM, 2012, CLIN NEUROPHYSIOL, V123, P2437, DOI 10.1016/j.clinph.2012.05.007; Hoormann J, 1998, BEHAV RES METH INS C, V30, P103, DOI 10.3758/BF03209420; Hu L, 2011, J NEUROPHYSIOL, V106, P3216, DOI 10.1152/jn.00220.2011; Hu L, 2010, NEUROIMAGE, V50, P99, DOI 10.1016/j.neuroimage.2009.12.010; Iannetti GD, 2005, NEUROSCIENCE, V131, P199, DOI 10.1016/j.neuroscience.2004.10.035; Jung TP, 2001, HUM BRAIN MAPP, V14, P166, DOI 10.1002/hbm.1050; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Le Pera D, 2002, BRAIN TOPOGR, V15, P115, DOI 10.1023/A:1021472524739; Luck S, 2005, EVENTRELATED POTENTI, P17; Luck S.J., 2005, INTRO EVENT RELATED; Mayhew SD, 2006, CLIN NEUROPHYSIOL, V117, P1331, DOI 10.1016/j.clinph.2006.02.017; MILNE RJ, 1991, EXP BRAIN RES, V87, P438; MILTNER W, 1989, PAIN, V38, P303, DOI 10.1016/0304-3959(89)90217-0; Mouraux A, 2008, MAGN RESON IMAGING, V26, P1041, DOI 10.1016/j.mri.2008.01.011; Mouraux A, 2004, NEUROSCI LETT, V361, P241, DOI 10.1016/j.neulet.2003.12.110; Quiroga RQ, 2003, CLIN NEUROPHYSIOL, V114, P376, DOI 10.1016/S1388-2457(02)00365-6; Rankin CH, 2009, NEUROBIOL LEARN MEM, V92, P135, DOI 10.1016/j.nlm.2008.09.012; Smith BW, 2008, PAIN, V140, P420, DOI 10.1016/j.pain.2008.09.018; STOWELL H, 1977, BRAIN RES BULL, V2, P23, DOI 10.1016/0361-9230(77)90021-1; THOMPSON RF, 1966, PSYCHOL REV, V73, P16, DOI 10.1037/h0022681; Valentini E, 2011, J COGNITIVE NEUROSCI, V23, P2822, DOI 10.1162/jocn.2011.21609; Valeriani M, 2003, PAIN, V105, P57, DOI 10.1016/S0304-3959(03)00137-4; Vossen CJ, 2012, LOW BACK PAINT TECH, P1; Vossen H, 2011, INT J METH PSYCH RES, V20, pE56, DOI 10.1002/mpr.348; Vossen HGM, 2006, CLIN J PAIN, V22, P725, DOI 10.1097/01.ajp.0000210913.95664.1a; WOESTENBURG JC, 1983, BIOL PSYCHOL, V17, P173, DOI 10.1016/0301-0511(83)90018-2; Zaslansky R, 1996, PAIN, V66, P39, DOI 10.1016/0304-3959(96)03020-5	39	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79905	10.1371/journal.pone.0079905	http://dx.doi.org/10.1371/journal.pone.0079905			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24224018	gold, Green Published, Green Submitted			2022-12-27	WOS:000326503400147
J	Benros, ME; Laursen, TM; Dalton, SO; Nordentoft, M; Mortensen, PB				Benros, Michael Eriksen; Laursen, Thomas Munk; Dalton, Susanne Oksbjerg; Nordentoft, Merete; Mortensen, Preben Bo			The Risk of Schizophrenia and Child Psychiatric Disorders in Offspring of Mothers with Lung Cancer and Other Types of Cancer: A Danish Nationwide Register Study	PLOS ONE			English	Article							HU ANTIBODIES; AUTOANTIBODIES; PARENTS; HYPERACTIVITY; INFECTIONS; IMPAIRMENT; PREGNANCY; PSYCHOSIS; EXPOSURE; HISTORY	Background: Maternal immune responses and brain-reactive antibodies have been proposed as possible causal mechanisms for schizophrenia and some child psychiatric disorders. According to this hypothesis maternal antibodies may cross the placenta and interact with the developing CNS of the fetus causing future neurodevelopmental disorders. Therefore, we investigated if children of mothers with cancer might be at higher risk of developing psychiatric disorders, with particular focus on small-cell lung cancer, which is known to induce production of antibodies binding to CNS elements. Methods: Nationwide population-based registers were linked, including the Danish Psychiatric Central Register and The Danish Cancer Registry. Data were analyzed as a cohort study using survival analysis techniques. Incidence rate ratios (IRRs) and accompanying 95% confidence intervals (CIs) were used as measures of relative risk. Results: In general, parental cancer was not associated with schizophrenia in the offspring (IRR, 0.98; 95% CI, 0.95-1.01). Furthermore, we found no temporal associations with maternal cancer in general; neither around the pregnancy period. However, maternal small-cell lung cancer increased the risk of early-onset schizophrenia and maternal small-cell lung cancer diagnosed within 20 years after childbirth increased the risk of schizophrenia. Parental cancer was not associated with child psychiatric disorders (IRR, 1.01; 95% CI, 0.98-1.05) except for the smoking related cancers. There was a significantly increased risk of child psychiatric disorders in offspring of both mothers (IRR, 1.35; 95% CI, 1.16-1.58) and fathers (IRR, 1.47; 95% CI, 1.30-1.66) with lung cancer of all types. Conclusions: In general, parental cancer did not increase the risk of schizophrenia nor of child psychiatric disorders. However, maternal small-cell lung cancer increased the risk of schizophrenia in subgroups; and lung cancer in general increased the risk of child psychiatric disorders, which could be due to risk factors associated with parental smoking.	[Benros, Michael Eriksen; Laursen, Thomas Munk; Mortensen, Preben Bo] Aarhus Univ, Natl Ctr Register Based Res, Aarhus, Denmark; [Benros, Michael Eriksen; Nordentoft, Merete] Univ Copenhagen, Fac Hlth Sci, Mental Hlth Ctr Copenhagen, Copenhagen, Denmark; [Benros, Michael Eriksen; Laursen, Thomas Munk; Nordentoft, Merete; Mortensen, Preben Bo] Lundbeck Fdn Initiat Integrat Psychiat Res, iPSYCH, Aarhus, Denmark; [Dalton, Susanne Oksbjerg] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark	Aarhus University; University of Copenhagen; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Danish Cancer Society	Benros, ME (corresponding author), Aarhus Univ, Natl Ctr Register Based Res, Aarhus, Denmark.	Benros@ncrr.dk	Mortensen, Preben B/D-2358-2015; Laursen, Thomas Munk/AFQ-8066-2022; Nordentoft, Merete/AAH-3253-2019; Benros, Michael Eriksen/N-5868-2016	Mortensen, Preben B/0000-0002-5230-9865; Benros, Michael Eriksen/0000-0003-4939-9465; Laursen, Thomas Munk/0000-0001-6934-1784; Dalton, Susanne Oksbjerg/0000-0002-5485-2730	Stanley Medical Research Institute; ERC [294838]; Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH	Stanley Medical Research Institute; ERC(European Research Council (ERC)European Commission); Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH	The study was supported financially by a grant from the Stanley Medical Research Institute, ERC Advanced Grant Project no. 294838 and the Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benros ME, 2009, INT J CANCER, V124, P2917, DOI 10.1002/ijc.24274; Blatt J, 2010, PEDIATR BLOOD CANCER, V54, P144, DOI 10.1002/pbc.22303; Bo Mortensen P, 2007, BIOL PSYCHIAT, V61, P688, DOI 10.1016/j.biopsych.2006.05.024; Braunschweig D, 2008, NEUROTOXICOLOGY, V29, P226, DOI 10.1016/j.neuro.2007.10.010; Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361; Brown AS, 2005, AM J PSYCHIAT, V162, P767, DOI 10.1176/appi.ajp.162.4.767; Buka SL, 2001, ARCH GEN PSYCHIAT, V58, P1032, DOI 10.1001/archpsyc.58.11.1032; Carpentier AF, 1998, NEUROLOGY, V50, P1919, DOI 10.1212/WNL.50.6.1919; Connors SL, 2008, PEDIATR NEUROL, V38, P163, DOI 10.1016/j.pediatrneurol.2007.10.009; DALMAU J, 1995, CANCER, V75, P99, DOI 10.1002/1097-0142(19950101)75:1<99::AID-CNCR2820750117>3.0.CO;2-I; Dalton SO, 2005, AM J PSYCHIAT, V162, P1024, DOI 10.1176/appi.ajp.162.5.1024-a; Dalton SO, 2004, AM J PSYCHIAT, V161, P903, DOI 10.1176/appi.ajp.161.5.903; Darnell RB, 2003, NEW ENGL J MED, V349, P1543, DOI 10.1056/NEJMra023009; DENHOLLANDER AM, 1989, GEN HOSP PSYCHIAT, V11, P388, DOI 10.1016/0163-8343(89)90132-1; Diamond B, 2009, NAT REV IMMUNOL, V9, P449, DOI 10.1038/nri2529; Eaton WW, 2010, BIPOLAR DISORD, V12, P638, DOI 10.1111/j.1399-5618.2010.00853.x; Graus F, 2010, J NEUROL, V257, P509, DOI 10.1007/s00415-009-5431-9; Hills, 1993, STAT MODELS EPIDEMIO; Hsieh FY, 2000, CONTROL CLIN TRIALS, V21, P552, DOI 10.1016/S0197-2456(00)00104-5; Insel BJ, 2005, SCHIZOPHR RES, V80, P331, DOI 10.1016/j.schres.2005.06.005; Ji JG, 2013, SCHIZOPHRENIA BULL, V39, P527, DOI 10.1093/schbul/sbs065; Johansen C, 1997, BRIT J CANCER, V75, P144, DOI 10.1038/bjc.1997.24; Karlsgodt KH, 2008, DEV PSYCHOPATHOL, V20, P1297, DOI 10.1017/S095457940800062X; Kayser MS, 2010, AM J PSYCHIAT, V167, P1039, DOI 10.1176/appi.ajp.2010.09101547; Lee JY, 2009, NAT MED, V15, P91, DOI 10.1038/nm.1892; Levav I, 2007, BRIT J PSYCHIAT, V190, P156, DOI 10.1192/bjp.bp.106.024943; Lichtermann D, 2001, ARCH GEN PSYCHIAT, V58, P573, DOI 10.1001/archpsyc.58.6.573; Linnet KM, 2003, AM J PSYCHIAT, V160, P1028, DOI 10.1176/appi.ajp.160.6.1028; MANLEY GT, 1995, ANN NEUROL, V38, P102, DOI 10.1002/ana.410380117; Margutti P, 2006, CURR NEUROVASC RES, V3, P149, DOI 10.2174/156720206776875894; Martin LA, 2008, BRAIN BEHAV IMMUN, V22, P806, DOI 10.1016/j.bbi.2007.12.007; MEDNICK SA, 1988, ARCH GEN PSYCHIAT, V45, P189, DOI 10.1001/archpsyc.1988.01800260109013; Monstad SE, 2004, J CLIN ONCOL, V22, P795, DOI 10.1200/JCO.2004.01.028; Mors O, 2011, SCAND J PUBLIC HEALT, V39, P54, DOI 10.1177/1403494810395825; MunkJorgensen P, 1997, DAN MED BULL, V44, P82; Nahmias AJ, 2006, CLIN DEV IMMUNOL, V13, P167, DOI 10.1080/17402520600801745; Nielsen PR, 2013, SCHIZOPHRENIA BULL, V39, P230, DOI 10.1093/schbul/sbr149; Niemela M, 2012, INT J CANCER, V131, P2117, DOI 10.1002/ijc.27466; OLSEN JH, 1995, NEW ENGL J MED, V333, P1594, DOI 10.1056/NEJM199512143332403; Ozawa K, 2006, BIOL PSYCHIAT, V59, P546, DOI 10.1016/j.biopsych.2005.07.031; Pedersen CB, 2006, DAN MED BULL, V53, P441; Pedersen CB, 2001, BRIT J PSYCHIAT, V179, P46, DOI 10.1192/bjp.179.1.46; Pedersen CB, 2001, ARCH GEN PSYCHIAT, V58, P1039, DOI 10.1001/archpsyc.58.11.1039; Shea AK, 2008, NICOTINE TOB RES, V10, P267, DOI 10.1080/14622200701825908; Singer HS, 2009, J NEUROIMMUNOL, V211, P39, DOI 10.1016/j.jneuroim.2009.03.011; Storm HH, 1997, DAN MED BULL, V44, P535; Swedo SE, 1998, AM J PSYCHIAT, V155, P264; SYSE A, 2012, J CLIN EPIDEMIOL, V4, P41; Verschuuren JJ, 1999, J NEUROL NEUROSUR PS, V67, P353, DOI 10.1136/jnnp.67.3.353; Vincent A, 2003, ANN NY ACAD SCI, V992, P48, DOI 10.1111/j.1749-6632.2003.tb03137.x; Wasserman EE, 2008, AM J EPIDEMIOL, V167, P701, DOI 10.1093/aje/kwm342; World Health Organization, 1994, WHO ICD 10 PSYK LID; World Health Organization, 1971, KLASS SYGD UDV DANSK, V8; Yolken RH, 2008, MOL PSYCHIATR, V13, P470, DOI 10.1038/mp.2008.5; Zandi MS, 2011, J NEUROL, V258, P686, DOI 10.1007/s00415-010-5788-9; Zimmerman AW, 2007, BRAIN BEHAV IMMUN, V21, P351, DOI 10.1016/j.bbi.2006.08.005	56	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79031	10.1371/journal.pone.0079031	http://dx.doi.org/10.1371/journal.pone.0079031			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	245XZ	24223877	Green Published, Green Submitted, gold			2022-12-27	WOS:000326499300048
J	Ludwig, Y; Zhang, YX; Hochholdinger, F				Ludwig, Yvonne; Zhang, Yanxiang; Hochholdinger, Frank			The Maize (Zea mays L.) AUXIN/INDOLE-3-ACETIC ACID Gene Family: Phylogeny, Synteny, and Unique Root-Type and Tissue-Specific Expression Patterns during Development	PLOS ONE			English	Article							AUX/IAA PROTEINS; AUXIN; ARABIDOPSIS; INITIATION; ROLES	The plant hormone auxin plays a key role in the coordination of many aspects of growth and development. AUXIN/INDOLE-3-ACETIC ACID (Aux/IAA) genes encode instable primary auxin responsive regulators of plant development that display a protein structure with four characteristic domains. In the present study, a comprehensive analysis of the 34 members of the maize Aux/IAA gene family was performed. Phylogenetic reconstructions revealed two classes of Aux/IAA proteins that can be distinguished by alterations in their domain III. Seven pairs of paralogous maize Aux/IAA proteins were discovered. Comprehensive root-type and tissue-specific expression profiling revealed unique expression patterns of the diverse members of the gene family. Remarkably, five of seven pairs of paralogous genes displayed highly correlated expression patterns in roots. All but one (ZmIAA23) tested maize Aux/IAA genes were auxin inducible, displaying two types of auxin induction within three hours of treatment. Moreover, 51 of 55 (93%) differential Aux/IAA expression patterns between different root-types followed the expression tendency: crown roots > seminal roots > primary roots > lateral roots. This pattern might imply root-type-specific regulation of Aux/IAA transcript abundance. In summary, the detailed analysis of the maize Aux/IAA gene family provides novel insights in the evolution and developmental regulation and thus the function of these genes in different root-types and tissues.	[Ludwig, Yvonne; Zhang, Yanxiang; Hochholdinger, Frank] Univ Bonn, Inst Crop Sci & Resource Conservat, Bonn, Germany	University of Bonn	Hochholdinger, F (corresponding author), Univ Bonn, Inst Crop Sci & Resource Conservat, Bonn, Germany.	hochholdinger@uni-bonn.de		Hochholdinger, Frank/0000-0002-5155-0884	DFG (Deutsche Forschungsgemeinschaft); University of Bonn	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); University of Bonn	This work was supported by a DFG (Deutsche Forschungsgemeinschaft) grant to F.H. and funding by the University of Bonn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL S, 1995, J MOL BIOL, V251, P533, DOI 10.1006/jmbi.1995.0454; Abel S, 1996, PLANT PHYSIOL, V111, P9, DOI 10.1104/pp.111.1.9; ABEL S, 1994, P NATL ACAD SCI USA, V91, P326, DOI 10.1073/pnas.91.1.326; AINLEY WM, 1988, J BIOL CHEM, V263, P10658; Audran-Delalande C, 2012, PLANT CELL PHYSIOL, V53, P659, DOI 10.1093/pcp/pcs022; Berendzen KW, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-125; BLATT MR, 1993, ANNU REV PLANT PHYS, V44, P543, DOI 10.1146/annurev.pp.44.060193.002551; Cakir B, 2013, ACTA PHYSIOL PLANT, V35, P365, DOI 10.1007/s11738-012-1079-7; Chen WQ, 1999, PLANT J, V19, P667, DOI 10.1046/j.1365-313x.1999.00560.x; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dreher KA, 2006, PLANT CELL, V18, P699, DOI 10.1105/tpc.105.039172; Duarte JM, 2006, MOL BIOL EVOL, V23, P469, DOI 10.1093/molbev/msj051; ESTELLE M, 1992, BIOESSAYS, V14, P439, DOI 10.1002/bies.950140703; Fahn A, 1990, PLANT ANATOMY; GUILFOYLE TJ, 1986, CRIT REV PLANT SCI, V4, P247, DOI 10.1080/07352688609382226; GUILFOYLE TJ, 1999, BIOCH MOL BIOL PLANT; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Han XY, 2012, GENE, V503, P83, DOI 10.1016/j.gene.2012.03.069; Hetz W, 1996, PLANT J, V10, P845, DOI 10.1046/j.1365-313X.1996.10050845.x; Jain Mukesh, 2006, Functional & Integrative Genomics, V6, P47, DOI 10.1007/s10142-005-0005-0; Jansen L, 2012, PHILOS T R SOC B, V367, P1525, DOI 10.1098/rstb.2011.0239; Kim J, 1997, P NATL ACAD SCI USA, V94, P11786, DOI 10.1073/pnas.94.22.11786; Liscum E, 2002, PLANT MOL BIOL, V49, P387, DOI 10.1023/A:1015255030047; Lynch M, 2000, GENETICS, V154, P459; Lyons E, 2008, PLANT J, V53, P661, DOI 10.1111/j.1365-313X.2007.03326.x; Overvoorde PJ, 2005, PLANT CELL, V17, P3282, DOI 10.1105/tpc.105.036723; Paponov IA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-126; Reed JW, 2001, TRENDS PLANT SCI, V6, P420, DOI 10.1016/S1360-1385(01)02042-8; Remington DL, 2004, PLANT PHYSIOL, V135, P1738, DOI 10.1104/pp.104.039669; Rogg LE, 2001, PLANT CELL, V13, P465, DOI 10.1105/tpc.13.3.465; Schnable JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017855; Schnable JC, 2011, P NATL ACAD SCI USA, V108, P4069, DOI 10.1073/pnas.1101368108; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shin R, 2007, PLANT CELL, V19, P2440, DOI 10.1105/tpc.107.050963; Song YL, 2009, PLANTA, V229, P577, DOI 10.1007/s00425-008-0853-7; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THEOLOGIS A, 1986, ANNU REV PLANT PHYS, V37, P407, DOI 10.1146/annurev.arplant.37.1.407; Tian Q, 2002, PLANT CELL, V14, P301, DOI 10.1105/tpc.010283; Tiwari SB, 2004, PLANT CELL, V16, P533, DOI 10.1105/tpc.017384; Tiwari SB, 2001, PLANT CELL, V13, P2809, DOI 10.1105/tpc.13.12.2809; Tiwari SB, 2003, PLANT CELL, V15, P533, DOI 10.1105/tpc.008417; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; von Behrens I, 2011, PLANT J, V66, P341, DOI 10.1111/j.1365-313X.2011.04495.x; WALKER JC, 1982, P NATL ACAD SCI-BIOL, V79, P7185, DOI 10.1073/pnas.79.23.7185; Wang SK, 2010, FUNCT INTEGR GENOMIC, V10, P533, DOI 10.1007/s10142-010-0174-3; Wang YiJun, 2010, Acta Agronomica Sinica, V36, P688, DOI 10.3724/SP.J.1006.2010.00688; Wang YJ, 2010, MOL BIOL REP, V37, P3991, DOI 10.1007/s11033-010-0058-6; Went FW., 1937, PHYTOHORMONES; Woll K, 2005, PLANT PHYSIOL, V139, P1255, DOI 10.1104/pp.105.067330; Woodhouse MR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000409; Wu J, 2012, MOL GENET GENOMICS, V287, P295, DOI 10.1007/s00438-012-0675-y	51	34	37	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78859	10.1371/journal.pone.0078859	http://dx.doi.org/10.1371/journal.pone.0078859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223858	Green Published, gold, Green Submitted			2022-12-27	WOS:000326499300037
J	Rao, MN; Blackwell, T; Redline, S; Punjabi, NM; Barrett-Connor, E; Neylan, TC; Stone, KL				Rao, Madhu N.; Blackwell, Terri; Redline, Susan; Punjabi, Naresh M.; Barrett-Connor, Elizabeth; Neylan, Thomas C.; Stone, Katie L.		Osteoporotic Fractures Men MrOS St	Association between Sleep Duration and 24-Hour Urine Free Cortisol in the MrOS Sleep Study	PLOS ONE			English	Article							SELF-REPORTED SLEEP; OSTEOPOROTIC FRACTURES; DEPRIVATION; ACTIGRAPHY; FREQUENCY; MEN	Context: Short sleep duration is associated with adverse health outcomes, but the mechanisms involved are unknown. It has been postulated that short sleep duration may elevate cortisol levels, but studies have had conflicting results. It is unclear whether these differing findings may be due to methodological issues, such as assessment of sleep duration. Specifically, objective versus subjective methods of measuring habitual sleep duration may account for the conflicting results found in epidemiological studies. Objective: Our goal was to determine whether habitual sleep duration, measured objectively (by actigraphy) and subjectively (by self-report), was associated with 24-hour urine free cortisol (UFC), a measure of integrated cortisol secretion. Our secondary goal was to determine whether slow wave sleep (SWS, determined by polysomnography) was associated with 24-hour UFC. Design/Setting: Cross sectional study of community dwelling older men. Patients/Participants: 325 men (mean age = 76.6 years, SD = 5.5) from the Portland site of the MrOS Sleep Study, who underwent 24-hour urine collection, polysomnography, actigraphy and sleep questionnaire. Primary Outcome: 24-hour UFC. Results: In this study of community dwelling older men, self-reported sleep duration was inversely related to 24-hour UFC levels. Participants reporting <5 hours of habitual sleep had an adjusted mean 24-hour UFC of 29.8 ug, compared to 28.0 ug in participants reporting >5 to <8 hours of sleep 25.5 ug in those reporting >8 hours of habitual sleep. However, sleep duration determined by actigraphy was not associated with 24-hour UFC in either univariable or multivariable regression models. SWS was not associated with 24-hour UFC. Conclusion: Objectively measured (i.e., actigraphic) sleep duration is not associated with 24-hour UFC in these community dwelling older men. This finding, together with prior studies, suggests that elevated levels of integrated cortisol secretion is not the mechanisms by which short sleep duration leads to adverse health outcomes.	[Rao, Madhu N.] Univ Calif San Francisco, Div Endocrinol, San Francisco, CA 94143 USA; [Blackwell, Terri; Stone, Katie L.] Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA; [Redline, Susan] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Redline, Susan] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; [Punjabi, Naresh M.] Johns Hopkins Univ, Div Pulm & Crit Care Med, Baltimore, MD USA; [Barrett-Connor, Elizabeth] Univ Calif San Diego, Dept Epidemiol, La Jolla, CA 92093 USA; [Neylan, Thomas C.] San Francisco VA Med Ctr, San Francisco, CA USA; [Neylan, Thomas C.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA	University of California System; University of California San Francisco; California Pacific Medical Center; California Pacific Medical Center Research Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Johns Hopkins University; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco	Rao, MN (corresponding author), Univ Calif San Francisco, Div Endocrinol, San Francisco, CA 94143 USA.	Madhu.Rao@ucsf.edu	Punjabi, Naresh/EMH-1007-2022		National Institutes of Health; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); National Institute on Aging (NIA); National Cancer Institute (NCI); National Center for Research Resources (NCRR); NIH Roadmap for Medical Research [U01 AR45580, U01 AR45614, U01 AR45632, U01 AR45647, U01 AR45654, U01 AR45583, U01 AG18197, U01-AG027810, UL1 RR024140]; National Heart, Lung, and Blood Institute (NHLBI) [R01 HL071194, R01 HL070848, R01 HL070847, R01 HL070842, R01 HL070841, R01 HL070837, R01 HL070838, R01 HL070839]; NIH Heart, Lung and Blood Institute [K23HL096832]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024140] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070837, R01HL070848, R01HL070838, R01HL070839, R01HL070842, R01HL071194, K23HL096832, R01HL070847, R01HL070841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U01AR045654, U01AR045580, U01AR045583, U01AR045632, U01AR045614, U01AR045647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG018197, U01AG027810] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Osteoporotic Fractures in Men (MrOS) Study is supported by National Institutes of Health funding. The following institutes provide support: the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the National Institute on Aging (NIA), the National Cancer Institute (NCI), the National Center for Research Resources (NCRR) and NIH Roadmap for Medical Research under the following grant numbers: U01 AR45580, U01 AR45614, U01 AR45632, U01 AR45647, U01 AR45654, U01 AR45583, U01 AG18197, U01-AG027810, and UL1 RR024140. The National Heart, Lung, and Blood Institute (NHLBI) provides funding for the MrOS Sleep ancillary study "Outcomes of Sleep Disorders in Older Men" under the following grant numbers: R01 HL071194, R01 HL070848, R01 HL070847, R01 HL070842, R01 HL070841, R01 HL070837, R01 HL070838, and R01 HL070839. Dr. Rao received funding from the NIH Heart, Lung and Blood Institute (K23HL096832), which also paid for measurement of 24-hour urine free cortisol. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; [Anonymous], ACT W US GUID VERS 2; Aron D.C., 2004, BASIC CLIN ENDOCRINO, P362; Blackwell T, 2007, SLEEP, V30, pA346; Blackwell T, 2005, SLEEP, V28, P1599, DOI 10.1093/sleep/28.12.1599; Blank JB, 2005, CONTEMP CLIN TRIALS, V26, P557, DOI 10.1016/j.cct.2005.05.005; BROWN PH, 1991, RESP MED, V85, P511, DOI 10.1016/S0954-6111(06)80269-6; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Chapotot F, 2001, NEUROENDOCRINOLOGY, V73, P312, DOI 10.1159/000054648; CONTRERAS LN, 1986, J CLIN ENDOCR METAB, V62, P965, DOI 10.1210/jcem-62-5-965; DINGES DF, 1994, J CLIN INVEST, V93, P1930, DOI 10.1172/JCI117184; FOLLENIUS M, 1992, SLEEP, V15, P21, DOI 10.1093/sleep/15.1.21; Gatti R, 2009, CLIN BIOCHEM, V42, P1205, DOI 10.1016/j.clinbiochem.2009.04.011; Jean-Louis G, 2001, J NEUROSCI METH, V105, P185, DOI 10.1016/S0165-0270(00)00364-2; KANT GJ, 1984, SLEEP, V7, P142, DOI 10.1093/sleep/7.2.142; KRIPKE DF, 1979, ARCH GEN PSYCHIAT, V36, P103; Kumari M, 2009, J CLIN ENDOCR METAB, V94, P4801, DOI 10.1210/jc.2009-0555; Lauderdale DS, 2008, EPIDEMIOLOGY, V19, P838, DOI 10.1097/EDE.0b013e318187a7b0; Leproult R, 1997, SLEEP, V20, P865; MULLER JE, 1985, NEW ENGL J MED, V313, P1315, DOI 10.1056/NEJM198511213132103; National Sleep Foundation, 2011, SLEEP AM POLL; Nicolson N.A., 2008, HDB PHYSL RES METHOD; Nieman LK, 2008, J CLIN ENDOCR METAB, V93, P1526, DOI 10.1210/jc.2008-0125; Orwoll E, 2005, CONTEMP CLIN TRIALS, V26, P569, DOI 10.1016/j.cct.2005.05.006; Patel SR, 2008, INT J OBESITY, V32, P1825, DOI 10.1038/ijo.2008.198; Quan SF, 2006, SLEEP MED, V7, P498, DOI 10.1016/j.sleep.2006.02.005; Rao MN, 2009, SLEEP, V32, P483, DOI 10.1093/sleep/32.4.483; Rechtschaffen A, 1968, NIH PUBLICATION, V204; Redline S, 1998, SLEEP, V21, P759; Regestein QR, 2004, MENOPAUSE, V11, P198, DOI 10.1097/01.GME.0000097741.18446.3E; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Spiegel K, 2002, JAMA-J AM MED ASSOC, V288, P1471, DOI 10.1001/jama.288.12.1471-a; Stewart J, 1999, SALIVARY CORTISOL ME; Washburn RA, 1999, J SPORT MED PHYS FIT, V39, P336; Zhang JH, 2011, SLEEP, V34, P225, DOI 10.1093/sleep/34.2.225	36	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75205	10.1371/journal.pone.0075205	http://dx.doi.org/10.1371/journal.pone.0075205			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24228086	Green Submitted, Green Published, gold			2022-12-27	WOS:000325223900037
J	Barboro, P; Borzi, L; Repaci, E; Ferrari, N; Balbi, C				Barboro, Paola; Borzi, Luana; Repaci, Erica; Ferrari, Nicoletta; Balbi, Cecilia			Androgen Receptor Activity Is Affected by Both Nuclear Matrix Localization and the Phosphorylation Status of the Heterogeneous Nuclear Ribonucleoprotein K in Anti-Androgen-Treated LNCaP Cells	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; PROSTATE-CANCER; HNRNP-K; EXPRESSION; BINDING; PROTEINS; IDENTIFICATION; PROGRESSION; DIAGNOSIS; CONTAINS	The androgen receptor (AR) plays a central role in the development and progression of prostate cancer (PCa) and antiandrogen therapy is a standard treatment. Unfortunately, after a few years, the majority of patients progress, developing androgen-independent PCa. AR-driven gene transcription recruits a large number of co-activator/co-repressor complexes; among these, the heterogeneous nuclear ribonucleoprotein K (hnRNP K) directly interacts with and regulates the AR translational apparatus. Here we examined AR and hnRNP K expression in response to the treatment of LNCaP cells with anti-androgen cyproterone acetate (CPA) or bicalutamide (BIC). AR and hnRNP K modulation and compartmentalization were studied by Western blot and confocal microscopy. Phosphate-affinity gel electrophoresis was employed to examine how anti-androgens modified hnRNP K phosphorylation. 10(-6) M CPA significantly stimulated LNCaP proliferation, whereas for 10(-4) M CPA or 10(-5) M BIC an antagonistic effect was observed. After anti-androgen treatment, AR expression was remarkably down-regulated within both the cytoplasm and the nucleus; however, when CPA had an agonist activity, the AR associated with the nuclear matrix (NM) increased approximately 2.5 times. This increase was synchronous with a higher PSA expression, indicating that the NM-associated AR represents the active complex. After BIC treatment, hnRNP K expression was significantly lower in the NM, the protein was hypophosphorylated and the co-localization of AR and hnRNP K decreased. In contrast, CPA as an agonist caused hnRNP K hyperphosphorylation and an increase in the co-localization of two proteins. These findings demonstrate that, in vitro, there is a strong relationship between NM-associated AR and both cell viability and PSA levels, indicating that AR transcriptional activity is critically dependent on its subnuclear localization. Moreover, the agonistic/antagonistic activity of anti-androgens is associated with modifications in hnRNP K phosphorylation, indicating an involvement of this protein in the AR transcriptional activity and likely in the onset of the androgen-independent phenotype.	[Barboro, Paola; Borzi, Luana; Repaci, Erica; Balbi, Cecilia] Univ San Martino, Azienda Osped, IRCCS, IST Inst Nazl Ric Cancro,Translat Urol Res Unit, Genoa, Italy; [Ferrari, Nicoletta] Univ San Martino, Azienda Osped, IRCCS, IST Inst Nazl Ric Cancro,Mol Oncol & Angiogenesis, Genoa, Italy	University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS AOU San Martino IST	Balbi, C (corresponding author), Univ San Martino, Azienda Osped, IRCCS, IST Inst Nazl Ric Cancro,Translat Urol Res Unit, Genoa, Italy.	cecilia.balbi@istge.it	Barboro, Paola/AAE-7144-2019; Ferrari, Nicoletta/AAG-6049-2019; Repaci, Erica/H-6576-2017	Barboro, Paola/0000-0001-9074-9290; Ferrari, Nicoletta/0000-0002-6027-1035; Repaci, Erica/0000-0002-6441-9308	Regione Liguria [563/2009]; Compagnia San Paolo [2009.127]	Regione Liguria(Regione Liguria); Compagnia San Paolo(Compagnia di San Paolo)	This work was partially supported by Regione Liguria (www.regione.liguria.it), grant number 563/2009; Compagnia San Paolo (www.fondazioneintesasanpaoloonlus.org) grant number 2009.127. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti I, 2000, J CELL BIOCHEM, V79, P471, DOI 10.1002/1097-4644(20001201)79:3<471::AID-JCB120>3.3.CO;2-F; Barboro P, 2005, ANTICANCER RES, V25, P3999; Barboro P, 2003, J CELL BIOCHEM, V88, P113, DOI 10.1002/jcb.10378; Barboro P, 2002, EXP CELL RES, V279, P202, DOI 10.1006/excr.2002.5605; Barboro P, 2009, BRIT J CANCER, V100, P1608, DOI 10.1038/sj.bjc.6605057; Barboro P, 2008, CELL ONCOL, V30, P13; Barboro P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040617; Barboro P, 2011, PROSTATE, V71, P1466, DOI 10.1002/pros.21366; Barboro P, 2009, EXP CELL RES, V315, P226, DOI 10.1016/j.yexcr.2008.10.017; BARRACK ER, 1983, ENDOCRINOLOGY, V113, P430, DOI 10.1210/endo-113-1-430; Bertram J, 2006, PROSTATE, V66, P895, DOI 10.1002/pros.20411; Boccardo F, 2003, PROSTATE, V55, P259, DOI 10.1002/pros.10248; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; BROWN TR, 1986, J CLIN ENDOCR METAB, V62, P542, DOI 10.1210/jcem-62-3-542; BUTTYAN R, 1983, J BIOL CHEM, V258, P4366; Ciarlo M, 2012, INT J CANCER, V131, P582, DOI 10.1002/ijc.26402; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Gluch A., 2008, V186, P67, DOI 10.1007/978-3-540-72843-6_4; GONOR SE, 1984, J UROLOGY, V131, P1196, DOI 10.1016/S0022-5347(17)50871-X; Habelhah H, 2001, J BIOL CHEM, V276, P18090, DOI 10.1074/jbc.M011396200; Habelhah H, 2001, NAT CELL BIOL, V3, P325, DOI 10.1038/35060131; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; HOZAK P, 1995, J CELL SCI, V108, P635; Jackson DA, 2006, VIRUSES NUCL, P1; KAUFMANN SH, 1991, EXP CELL RES, V192, P524, DOI 10.1016/0014-4827(91)90072-3; Kim D, 2006, MOL CELL BIOL, V26, P2187, DOI 10.1128/MCB.26.6.2187-2201.2006; Kimura Y, 2010, PROTEOMICS, V10, P3884, DOI 10.1002/pmic.201000349; Lin JQ, 1999, CANCER RES, V59, P2891; Marcelli M, 2006, J CELL BIOCHEM, V98, P770, DOI 10.1002/jcb.20593; Masiello D, 2004, MOL ENDOCRINOL, V18, P2388, DOI 10.1210/me.2003-0436; Moumen A, 2013, CELL CYCLE, V12, P698, DOI 10.4161/cc.23592; Mukhopadhyay NK, 2009, CANCER RES, V69, P2210, DOI 10.1158/0008-5472.CAN-08-2308; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Ostrowski J, 2001, P NATL ACAD SCI USA, V98, P9044, DOI 10.1073/pnas.161284098; Ricci F, 2012, J CANCER RES CLIN, V138, P1379, DOI 10.1007/s00432-012-1216-0; Saitoh N, 2004, MOL BIOL CELL, V15, P3876, DOI 10.1091/mbc.E04-03-0253; Saraon P, 2011, CLIN CHEM, V57, P1366, DOI 10.1373/clinchem.2011.165977; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Steinberg TH, 2003, PROTEOMICS, V3, P1128, DOI 10.1002/pmic.200300434; Tyagi RK, 2000, MOL ENDOCRINOL, V14, P1162, DOI 10.1210/me.14.8.1162; VELDSCHOLTE J, 1992, J STEROID BIOCHEM, V41, P665, DOI 10.1016/0960-0760(92)90401-4; Wirth MP, 2007, EUR UROL, V51, P306, DOI 10.1016/j.eururo.2006.08.043; Zeng CM, 1998, P NATL ACAD SCI USA, V95, P1585, DOI 10.1073/pnas.95.4.1585; Zink D, 2004, NAT REV CANCER, V4, P677, DOI 10.1038/nrc1430	44	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79212	10.1371/journal.pone.0079212	http://dx.doi.org/10.1371/journal.pone.0079212			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236111	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700110
J	Ferreira, JC; Ferrari, GO; Neves, KR; Cavallari, RT; Dominguez, WV; dos Reis, LM; Graciolli, FG; Oliveira, EC; Liu, SG; Sabbagh, Y; Jorgetti, V; Schiavi, S; Moyses, RMA				Ferreira, Juliana C.; Ferrari, Guaraciaba O.; Neves, Katia R.; Cavallari, Raquel T.; Dominguez, Wagner V.; dos Reis, Luciene M.; Graciolli, Fabiana G.; Oliveira, Elizabeth C.; Liu, Shiguang; Sabbagh, Yves; Jorgetti, Vanda; Schiavi, Susan; Moyses, Rosa M. A.			Effects of Dietary Phosphate on Adynamic Bone Disease in Rats with Chronic Kidney Disease - Role of Sclerostin?	PLOS ONE			English	Article							PARATHYROID-HORMONE; GENE-EXPRESSION; RENAL OSTEODYSTROPHY; MINERAL DENSITY; FAILURE; TARGET; WNT; PTH; OSTEOCYTES; FRACTURES	High phosphate intake is known to aggravate renal osteodystrophy along various pathogenetic pathways. Recent studies have raised the possibility that dysregulation of the osteocyte Wnt/beta-catenin signaling pathway is also involved in chronic kidney disease (CKD)-related bone disease. We investigated the role of dietary phosphate and its possible interaction with this pathway in an experimental model of adynamic bone disease (ABD) in association with CKD and hypoparathyroidism. Partial nephrectomy (Nx) and total parathyroidectomy (PTx) were performed in male Wistar rats. Control rats with normal kidney and parathyroid function underwent sham operations. Rats were divided into three groups and underwent pair-feeding for 8 weeks with diets containing either 0.6% or 1.2% phosphate: sham 0.6%, Nx+PTx 0.6%, and Nx+ PTx 1.2%. In the two Nx+ PTx groups, serum creatinine increased and blood ionized calcium decreased compared with sham control group. They also presented hyperphosphatemia and reduced serum parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23) levels. Fractional urinary excretion of phosphate increased in Nx+ PTx 1.2% rats despite lower PTH and FGF23 levels than in sham group. These biochemical changes were accompanied by a decrease in bone formation rates. The Nx+ PTx 1.2% group had lower bone volume (BV/TV), higher osteoblast and osteocyte apoptosis, and higher SOST and Dickkopf-1 gene expression than the Nx +PTx 0.6% group. Nx+ PTx 0.6% rat had very low serum sclerostin levels, and Nx+ PTx 1.2% had intermediate sclerostin levels compared with sham group. Finally, there was a negative correlation between BV/TV and serum sclerostin. These results suggest that high dietary phosphate intake decreases bone volume in an experimental model of CKD-ABD, possibly via changes in SOST expression through a PTH-independent mechanism. These findings could have relevance for the clinical setting of CKD-ABD in patients who low turnover bone disease might be attenuated by optimal control of phosphate intake and/or absorption.	[Ferreira, Juliana C.; Ferrari, Guaraciaba O.; Neves, Katia R.; Cavallari, Raquel T.; Dominguez, Wagner V.; dos Reis, Luciene M.; Graciolli, Fabiana G.; Oliveira, Elizabeth C.; Jorgetti, Vanda; Moyses, Rosa M. A.] Univ Sao Paulo, Div Nephrol, Dept Internal Med, Sao Paulo, Brazil; [Liu, Shiguang; Sabbagh, Yves; Schiavi, Susan] Genzyme Corp, Sanofi Genzyme R&D Ctr, Framingham, MA USA	Universidade de Sao Paulo; Sanofi-Aventis; Genzyme Corporation	Moyses, RMA (corresponding author), Univ Sao Paulo, Div Nephrol, Dept Internal Med, Sao Paulo, Brazil.	rosa.moyses@uol.com.br	dos Reis, Luciene M/C-7143-2013; Sabbagh, Yves/I-9792-2019; Dominguez, Wagner/AAR-6693-2020; JORGETTI, VANDA/C-9470-2012; Neves, Katia/CAF-1819-2022; Moyses, Rosa M A/F-8268-2012	dos Reis, Luciene M/0000-0001-8476-6780; Sabbagh, Yves/0000-0001-5339-6705; JORGETTI, VANDA/0000-0002-4824-8879; Moyses, Rosa M A/0000-0002-7902-2127	Fundacao de Auxilio a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/58849-3]; CNPQ, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [303325/2010-0]	Fundacao de Auxilio a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPQ, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was performed with grants from Fundacao de Auxilio a Pesquisa do Estado de Sao Paulo (FAPESP, Grant 2008/58849-3) and Genzyme Co. Research in the laboratory of RMM is supported by CNPQ, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (grant 303325/2010-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andress DL, 2008, KIDNEY INT, V73, P1345, DOI 10.1038/ki.2008.60; Atsumi K, 1999, AM J KIDNEY DIS, V33, P287, DOI 10.1016/S0272-6386(99)70302-1; Baron R, 2007, ENDOCRINOLOGY, V148, P2635, DOI 10.1210/en.2007-0270; Barreto FC, 2008, KIDNEY INT, V73, P771, DOI 10.1038/sj.ki.5002769; Batista DG, 2010, CALCIFIED TISSUE INT, V87, P60, DOI 10.1007/s00223-010-9367-y; Bellido T, 2005, ENDOCRINOLOGY, V146, P4577, DOI 10.1210/en.2005-0239; Bilezikian JP, 2011, J BONE MINER RES, V26, P2317, DOI 10.1002/jbmr.483; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Brandenburg VM, 2008, CLIN KIDNEY J, V1, P135, DOI 10.1093/ndtplus/sfn040; Cejka D, 2011, CLIN J AM SOC NEPHRO, V6, P877, DOI 10.2215/CJN.06550810; Coco M, 2000, AM J KIDNEY DIS, V36, P1115, DOI 10.1053/ajkd.2000.19812; Coen G, 2005, J NEPHROL, V18, P117; Couttenye MM, 1999, KIDNEY INT, V56, pS70, DOI 10.1046/j.1523-1755.1999.07308.x; de Oliveira RB, 2013, NEPHROL DIAL TRANSPL, V28, P1; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Galli C, 2010, J DENT RES, V89, P331, DOI 10.1177/0022034510363963; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Gouveia CHA, 1997, J BONE MINER RES, V12, P2098, DOI 10.1359/jbmr.1997.12.12.2098; Hoeppner LH, 2009, EXPERT OPIN THER TAR, V13, P485, DOI [10.1517/14728220902841961, 10.1517/14728220902841961 ]; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Huttunen MM, 2006, J NUTR BIOCHEM, V17, P479, DOI 10.1016/j.jnutbio.2005.09.001; Iwasaki-Ishizuka Y, 2005, NEPHROL DIAL TRANSPL, V20, P1904, DOI 10.1093/ndt/gfh876; Keller H, 2005, BONE, V37, P148, DOI 10.1016/j.bone.2005.03.018; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Kramer I, 2010, MOL CELL BIOL, V30, P3071, DOI 10.1128/MCB.01428-09; Lavi-Moshayoff V, 2010, AM J PHYSIOL-RENAL, V299, pF882, DOI 10.1152/ajprenal.00360.2010; Lopez I, 2011, KIDNEY INT, V80, P475, DOI 10.1038/ki.2011.107; Malluche HH, 2004, NEPHROL DIAL TRANSPL, V19, pI9, DOI 10.1093/ndt/gfh1002; Mancini G, 1965, Immunochemistry, V2, P235, DOI 10.1016/0019-2791(65)90004-2; McGartland C, 2003, J BONE MINER RES, V18, P1563, DOI 10.1359/jbmr.2003.18.9.1563; Meleti Z, 2000, BONE, V27, P359, DOI 10.1016/S8756-3282(00)00346-X; Moe SM, 2006, EUR J CLIN INVEST, V36, P51, DOI 10.1111/j.1365-2362.2006.01665.x; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Neves KR, 2004, KIDNEY INT, V66, P2237, DOI 10.1111/j.1523-1755.2004.66013.x; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Sabbagh Y, 2012, J BONE MINER RES, V27, P1757, DOI 10.1002/jbmr.1630; Salusky IB, 2001, J AM SOC NEPHROL, V12, P1978, DOI 10.1681/ASN.V1291978; Sanchez CP, 2006, PERITON DIALYSIS INT, V26, P43; Sato T, 2004, AM J KIDNEY DIS, V44, P481, DOI 10.1053/j.ajkd.2004.05.026; Sherrard DJ, 1996, NEPHROL DIAL TRANSPL, V11, P29; Tani Y, 2007, J CLIN BIOCHEM NUTR, V40, P221, DOI 10.3164/jcbn.40.221; Tucker KL, 2006, AM J CLIN NUTR, V84, P936, DOI 10.1093/ajcn/84.4.936	42	35	37	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79721	10.1371/journal.pone.0079721	http://dx.doi.org/10.1371/journal.pone.0079721			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236156	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700155
J	Govindasamy, D; Kranzer, K; van Schaik, N; Noubary, F; Wood, R; Walensky, RP; Freedberg, KA; Bassett, IV; Bekker, LG				Govindasamy, Darshini; Kranzer, Katharina; van Schaik, Nienke; Noubary, Farzad; Wood, Robin; Walensky, Rochelle P.; Freedberg, Kenneth A.; Bassett, Ingrid V.; Bekker, Linda-Gail			Linkage to HIV, TB and Non-Communicable Disease Care from a Mobile Testing Unit in Cape Town, South Africa	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; RISK-FACTORS; HYPERTENSION; COMMUNITY; ACCESS; DETERMINANTS; POPULATION; STRATEGIES; DIAGNOSIS; SERVICES	Background: HIV counseling and testing may serve as an entry point for non-communicable disease screening. Objectives: To determine the yield of newly-diagnosed HIV, tuberculosis (TB) symptoms, diabetes and hypertension, and to assess CD4 count testing, linkage to care as well as correlates of linkage and barriers to care from a mobile testing unit. Methods: A mobile unit provided screening for HIV, TB symptoms, diabetes and hypertension in Cape Town, South Africa between March 2010 and September 2011. The yield of newly-diagnosed cases of these conditions was measured and clients were followed-up between January and November 2011 to assess linkage. Linkage to care was defined as accessing care within one, three or six months post-HIV diagnosis (dependent on CD4 count) and one month post-diagnosis for other conditions. Clinical and socio-demographic correlates of linkage to care were evaluated using Poisson regression and barriers to care were determined. Results: Of 9,806 clients screened, the yield of new diagnoses was: HIV (5.5%), TB suspects (10.1%), diabetes (0.8%) and hypertension (58.1%). Linkage to care for HIV-infected clients, TB suspects, diabetics and hypertensives was: 51.3%, 56.7%, 74.1% and 50.0%. Only disclosure of HIV-positive status to family members or partners (RR=2.6, 95% CI:1.04-6.3, p=0.04) was independently associated with linkage to HIV care. The main barrier to care reported by all groups was lack of time to access a clinic. Conclusion: Screening for HIV, TB symptoms and hypertension at mobile units in South Africa has a high yield but inadequate linkage. After-hours and weekend clinics may overcome a major barrier to accessing care.	[Govindasamy, Darshini; Kranzer, Katharina; van Schaik, Nienke; Wood, Robin; Bekker, Linda-Gail] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; [Kranzer, Katharina] London Sch Hyg & Trop Med, Dept Clin Res, Fac Infect & Trop Dis, London WC1, England; [Noubary, Farzad; Walensky, Rochelle P.; Freedberg, Kenneth A.; Bassett, Ingrid V.] Massachusetts Gen Hosp, Dept Med, Med Practice Evaluat Ctr, Boston, MA 02114 USA; [Noubary, Farzad] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA USA; [Noubary, Farzad] Tufts Univ, Tufts Clin & Translat Sci Inst, Boston, MA 02111 USA; [Wood, Robin; Bekker, Linda-Gail] Univ Cape Town, Fac Hlth Sci, Dept Med, ZA-7925 Cape Town, South Africa; [Walensky, Rochelle P.; Freedberg, Kenneth A.; Bassett, Ingrid V.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [Walensky, Rochelle P.; Freedberg, Kenneth A.; Bassett, Ingrid V.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Walensky, Rochelle P.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Walensky, Rochelle P.; Freedberg, Kenneth A.; Bassett, Ingrid V.] Harvard Univ, Ctr AIDS Res CFAR, Boston, MA 02115 USA; [Freedberg, Kenneth A.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	University of Cape Town; University of London; London School of Hygiene & Tropical Medicine; Harvard University; Massachusetts General Hospital; Tufts Medical Center; Tufts University; University of Cape Town; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health	Govindasamy, D (corresponding author), Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa.	gdarsh@gmail.com	Bekker, Linda-Gail/AAZ-8929-2020; Bassett, Ingrid V./ABI-7674-2020; Kranzer, Katharina/O-8845-2014	Bassett, Ingrid V./0000-0001-6920-6080; Kranzer, Katharina/0000-0001-5691-7270; BEKKER, LINDA-GAIL/0000-0002-0755-4386; Walensky, Rochelle P./0000-0002-8795-379X	National Institute of Allergy and Infectious Disease [3R01AI058736, K24 AI062476]; Harvard University Center for AIDS Research [P30 AI060354]; National Institute of Mental Health [R01 MH090326, R01 MH073445]; Presidents Emergency Plan for AIDS Relief (PEPFAR); Claflin Distinguished Scholar Award; PEPFAR through the Anova Health Institute; United States Agency for International Development program; Agence Francaise de Developpement; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, K24AI062476, R01AI058736] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073445, R01MH090326] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Harvard University Center for AIDS Research; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Presidents Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Claflin Distinguished Scholar Award; PEPFAR through the Anova Health Institute; United States Agency for International Development program(United States Agency for International Development (USAID)); Agence Francaise de Developpement; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by: the National Institute of Allergy and Infectious Disease: 3R01AI058736, K24 AI062476; the Harvard University Center for AIDS Research P30 AI060354; the National Institute of Mental Health: R01 MH090326, R01 MH073445, the Presidents Emergency Plan for AIDS Relief (PEPFAR); and the Claflin Distinguished Scholar Award. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The mobile testing unit is partially funded by PEPFAR through the Anova Health Institute and the United States Agency for International Development program and received further funding through the Agence Francaise de Developpement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amolloh M, 2011, 18 C RETR OPP INF BO, P1077; Assefa Y, 2010, AIDS PATIENT CARE ST, V24, P521, DOI 10.1089/apc.2009.0286; Bertram MY, 2012, SAMJ S AFR MED J, V102, P743, DOI [10.7196/samj.5832, 10.7196/SAMJ.5832]; Cape Western Department of Health, 2009, HIV COUNS TEST PROT; Cape Western Government, 2010, COMPR SERV PLAN IMPL; Chamie G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043400; Connor M, 2005, SAMJ S AFR MED J, V95, P334; Corbett EL, 2010, LANCET, V376, P1244, DOI 10.1016/S0140-6736(10)61425-0; Dalal S, 2011, INT J EPIDEMIOL, V40, P885, DOI 10.1093/ije/dyr050; Govindasamy D, 2012, AIDS, V26, P2059, DOI 10.1097/QAD.0b013e3283578b9b; Govindasamy D, 2011, JAIDS-J ACQ IMM DEF, V58, P344, DOI 10.1097/QAI.0b013e31822e0c4c; Grabbe KL, 2010, JAIDS-J ACQ IMM DEF, V54, P317, DOI 10.1097/QAI.0b013e3181ced126; Guariguata L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-44; Hall V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-564; Health Department: Republic of South Africa, 2013, S AFR ANT THER GUID; Hendriks ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032638; Human Sciences Research Council, 2013, S AFR NAT HLTH NUTR; International Union Against Tuberculosis and Lung Disease, 2000, TECHN GUID SPUT EX T; Janssens B, 2007, B WORLD HEALTH ORGAN, V85, P880, DOI 10.2471/BLT.06.036574; Joint National Hypertension Guideline Working Group, 2006, AFR HYP GUID 2; Kandala NB, 2013, AM J HYPERTENS, V26, P382, DOI 10.1093/ajh/hps063; Kayigamba FR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036792; Khumalo-Sakutukwa G, 2008, JAIDS-J ACQ IMM DEF, V49, P422, DOI 10.1097/QAI.0b013e31818a6cb5; Kohler PK, 2011, AIDS, V25, P1657, DOI 10.1097/QAD.0b013e32834957fd; Kranzer K, 2012, HIV MED, V13, P132, DOI 10.1111/j.1468-1293.2011.00947.x; Kranzer K, 2011, INT J TUBERC LUNG D, V15, P1077, DOI 10.5588/ijtld.10.0684; Kranzer K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001281; Kundu CK, 2012, J TROP PEDIATRICS, V58, P31, DOI 10.1093/tropej/fmr026; Larson BA, 2012, JAIDS-J ACQ IMM DEF, V61, pE13, DOI 10.1097/QAI.0b013e31825eec60; Levitt NS, 2011, AM J CLIN NUTR, V94, p1690S, DOI 10.3945/ajcn.111.019075; MacPherson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044794; Maheswaran H, 2012, JAIDS-J ACQ IMM DEF, V59, pE43, DOI 10.1097/QAI.0b013e3182414ed7; Malaza A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047761; Matovu JKB, 2007, TROP MED INT HEALTH, V12, P1315, DOI 10.1111/j.1365-3156.2007.01923.x; Mbopi-Keou FX, 2007, AIDS, V21, P1994, DOI 10.1097/QAD.0b013e3282f006c3; Micek MA, 2009, JAIDS-J ACQ IMM DEF, V52, P397, DOI 10.1097/QAI.0b013e3181ab73e2; Morin SF, 2006, JAIDS-J ACQ IMM DEF, V41, P218, DOI 10.1097/01.qai.0000179455.01068.ab; Muhamadi L, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-184; Mulissa Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013268; Mwangemi F, 2010, HIV HLTH SYST PREC V; Nakigozi G, 2011, AIDS CARE, V23, P764, DOI 10.1080/09540121.2010.525614; National Department of Health South Africa, 2010, CLIN GUID MAN HIV AI; Nglazi M, 2012, J ACQ IMMUN DEF SYND, V59, P281, DOI [10.1097/QAI.0b013e31823e5bee, DOI 10.1097/QAI.0B013E31823E5BEE.PUBMED:22067662]; Nolan M, 2011, 19 INT AIDS C ROM IT; Nsigaye R, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-31; Ostermann J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016488; Peltzer K, 2013, CARDIOVASC J AFR, V24, P66, DOI 10.5830/CVJA-2013-002; Rabkin M, 2011, JAIDS-J ACQ IMM DEF, V57, pS87, DOI 10.1097/QAI.0b013e31821db92a; Rabkin M, 2011, GLOB PUBLIC HEALTH, V6, P247, DOI 10.1080/17441692.2011.552068; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; South African Government News Agency, 2012, 20 MILLION S AFR HAV; Steyn K, 1996, E AFR MED J, V73, P758; Steyn K, 2008, SAMJ S AFR MED J, V98, P376; The National HIV Counselling and Testing Campaign Strategy, 2010, POLICY GUIDELINES; Thorogood M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-326; UNICEF, 2011, CHRON CAR HIV NONC D; van Schaik N, 2010, SAMJ S AFR MED J, V100, P671, DOI 10.7196/SAMJ.4162; Wall K, 2012, AIDS, V26, P217, DOI 10.1097/QAD.0b013e32834dc593; Wanyenze R, 2011, 16 INT AIDS C TOR CA; Wanyenze RK, 2011, AIDS BEHAV, V15, P751, DOI 10.1007/s10461-010-9704-1; World Health Organization, 2019, GLOB TUB REP; World Health Organization, 2011, WHO GLOB HIV AIDS RE	62	61	61	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80017	10.1371/journal.pone.0080017	http://dx.doi.org/10.1371/journal.pone.0080017			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236170	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000327254700171
J	Graca, AP; Bondoso, J; Gaspar, H; Xavier, JR; Monteiro, MC; de la Cruz, M; Oves-Costales, D; Vicente, F; Lage, OM				Graca, Ana Patricia; Bondoso, Joana; Gaspar, Helena; Xavier, Joana R.; Monteiro, Maria Candida; de la Cruz, Mercedes; Oves-Costales, Daniel; Vicente, Francisca; Lage, Olga Maria			Antimicrobial Activity of Heterotrophic Bacterial Communities from the Marine Sponge Erylus discophorus (Astrophorida, Geodiidae)	PLOS ONE			English	Article							NONRIBOSOMAL PEPTIDE SYNTHETASES; TRITERPENE GLYCOSIDES; DRUG DISCOVERY; SP-NOV.; PHYLOGENETIC ANALYSIS; POLYKETIDE SYNTHASES; MICROBIAL COMMUNITY; ELECTRON-MICROSCOPE; APLYSINA-AEROPHOBA; MEDITERRANEAN-SEA	Heterotrophic bacteria associated with two specimens of the marine sponge Erylus discophorus were screened for their capacity to produce bioactive compounds against a panel of human pathogens (Staphylococcus aureus wild type and methicillin-resistant S. aureus (MRSA), Bacillus subtilis, Pseudomonas aeruginosa, Acinetobacter baumanii, Candida albicans and Aspergillus fumigatus), fish pathogen (Aliivibrio fischeri) and environmentally relevant bacteria (Vibrio harveyi). The sponges were collected in Berlengas Islands, Portugal. Of the 212 isolated heterotrophic bacteria belonging to Alpha-and Gammaproteobacteria, Actinobacteria and Firmicutes, 31% produced antimicrobial metabolites. Bioactivity was found against both Gram positive and Gram negative and clinically and environmentally relevant target microorganisms. Bioactivity was found mainly against B. subtilis and some bioactivity against S. aureus MRSA, V. harveyi and A. fisheri. No antifungal activity was detected. The three most bioactive genera were Pseudovibrio (47.0%), Vibrio (22.7%) and Bacillus (7.6%). Other less bioactive genera were Labrenzia, Acinetobacter, Microbulbifer, Pseudomonas, Gordonia, Microbacterium, Micrococcus and Mycobacterium, Paenibacillus and Staphylococcus. The search of polyketide I synthases (PKS-I) and nonribosomal peptide synthetases (NRPSs) genes in 59 of the bioactive bacteria suggested the presence of PKS-I in 12 strains, NRPS in 3 strains and both genes in 3 strains. Our results show the potential of the bacterial community associated with Erylus discophorus sponges as producers of bioactive compounds.	[Graca, Ana Patricia; Bondoso, Joana; Lage, Olga Maria] Univ Porto, Dept Biol, Fac Sci, P-4100 Oporto, Portugal; [Graca, Ana Patricia; Bondoso, Joana; Lage, Olga Maria] Interdisciplinary Ctr Marine & Environm Res CIMAR, Oporto, Portugal; [Gaspar, Helena] Univ Lisboa Campo Grande, Fac Ciencias, Ctr Quim & Bioquim, Lisbon, Portugal; [Gaspar, Helena] Univ Lisboa Campo Grande, Fac Ciencias, Dept Quim & Bioquim, Lisbon, Portugal; [Xavier, Joana R.] Univ Acores, Polo Acores Dept Biol, InBIO Lab Associado, Ctr Invest Biodiversidade & Recursos Genet,CIBIO, Ponta Delgada, Portugal; [Xavier, Joana R.] CSIC, Ctr Estudis Avancats Blanes, CEAB, Blanes, Girona, Spain; [Monteiro, Maria Candida; de la Cruz, Mercedes; Oves-Costales, Daniel; Vicente, Francisca] Fdn MEDINA, Ctr Excelencia Invest Medicamentos Innovadores An, Granada, Spain	Universidade do Porto; Universidade de Lisboa; Universidade Nova de Lisboa; Universidade de Lisboa; Universidade Nova de Lisboa; Universidade dos Acores; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB)	Lage, OM (corresponding author), Univ Porto, Dept Biol, Fac Sci, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	olga.lage@fc.up.pt	Bondoso, Joana/C-9365-2015; DE LA CRUZ MORENO, MERCEDES/M-1533-2014; Oves-Costales, Daniel/I-1543-2015; Gaspar, Helena/E-6798-2012; Xavier, Joana/J-8387-2012; Bondoso, Joana/AAX-5602-2020; vicente, francisca/N-5126-2014; Lage, Olga/A-9218-2010	Bondoso, Joana/0000-0002-7501-2335; DE LA CRUZ MORENO, MERCEDES/0000-0002-2389-8576; Oves-Costales, Daniel/0000-0001-9986-4623; Gaspar, Helena/0000-0002-1613-7023; Xavier, Joana/0000-0003-1386-4492; Bondoso, Joana/0000-0002-7501-2335; vicente, francisca/0000-0003-3198-9205; Lage, Olga/0000-0002-3950-3970; Graca, Ana Patricia/0000-0001-5738-0161	European Regional Development Fund (ERDF) through the COMPETE - Operational Competitiveness Programme; FCT - Foundation for Science and Technology [PEst-C/MAR/LA0015/2013, PEst-OE/QUI/UI0612/2011, PTDC/QUI-QUI/098053/2008, SFRH/BD/35933/2007, SFRH/BPD/62946/2009]; ERAMUS fellowship; Fundacion MEDINA	European Regional Development Fund (ERDF) through the COMPETE - Operational Competitiveness Programme; FCT - Foundation for Science and Technology(Portuguese Foundation for Science and Technology); ERAMUS fellowship; Fundacion MEDINA	This research was supported by the European Regional Development Fund (ERDF) through the COMPETE - Operational Competitiveness Programme and national funds through FCT - Foundation for Science and Technology, under the projects PEst-C/MAR/LA0015/2013, PEst-OE/QUI/UI0612/2011 and PTDC/QUI-QUI/098053/2008. Ana Patricia Gracia acknowledges an ERAMUS fellowship. Joana Bondoso was financed by FCT - Foundation for Science and Technology (PhD grant SFRH/BD/35933/2007). Joana R. Xavier's research is funded by an FCT - Foundation for Science and Technology postdoctoral fellowship (grant no. SFRH/BPD/62946/2009). In addition, this work was funded by the Fundacion MEDINA, a public-private partnership of Merck Sharp and Dohme of Espana/Universidad de Granada/Junta de Andalucia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen UR, 2010, MAR DRUGS, V8, P399, DOI 10.3390/md8030399; Afiyatullov SS, 2007, J NAT PROD, V70, P1871, DOI 10.1021/np070319y; AMADE P, 1987, MAR BIOL, V94, P271, DOI 10.1007/BF00392940; Anand TP, 2006, MICROBIOL RES, V161, P252, DOI 10.1016/j.micres.2005.09.002; Antonov AS, 2007, J NAT PROD, V70, P169, DOI 10.1021/np060364q; Antonov AS, 2011, CARBOHYD RES, V346, P2182, DOI 10.1016/j.carres.2011.07.008; Arenskotter M, 2004, APPL ENVIRON MICROB, V70, P3195, DOI 10.1128/AEM.70.6.3195-3204.2004; Ayuso-Sacido A, 2005, MICROB ECOL, V49, P10, DOI 10.1007/s00248-004-0249-6; Bode HB, 2002, CHEMBIOCHEM, V3, P619, DOI 10.1002/1439-7633(20020703)3:7<619::AID-CBIC619>3.0.CO;2-9; Bultel-Ponce V, 1999, MAR BIOTECHNOL, V1, P384, DOI 10.1007/PL00011792; Monteiro MC, 2012, J BIOMOL SCREEN, V17, P542, DOI 10.1177/1087057111433459; CARMELY S, 1989, J NAT PROD, V52, P167, DOI 10.1021/np50061a022; Chen GH, 2000, J ANTIBIOT, V53, P1145, DOI 10.7164/antibiotics.53.1145; Chen YH, 2012, WORLD J MICROB BIOT, V28, P3269, DOI 10.1007/s11274-012-1138-7; Chung YR, 2000, INT J SYST EVOL MICR, V50, P1495, DOI 10.1099/00207713-50-4-1495; COHENBAZIRE G, 1957, J CELL COMPAR PHYSL, V49, P25, DOI 10.1002/jcp.1030490104; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; DAURIA MV, 1992, TETRAHEDRON, V48, P491, DOI 10.1016/S0040-4020(01)89011-6; Devi P, 2010, MAR DRUGS, V8, P1203, DOI 10.3390/md8041203; Donadio S, 2007, NAT PROD REP, V24, P1073, DOI 10.1039/b514050c; Donnelly A.C., 2006, MARINE NATURAL PRODU; Duetz WA, 2000, APPL ENVIRON MICROB, V66, P2641, DOI 10.1128/AEM.66.6.2641-2646.2000; Esteves AIS, 2013, FEMS MICROBIOL ECOL, V85, P519, DOI 10.1111/1574-6941.12140; Farmer JJ, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P508, DOI 10.1007/0-387-30746-x_18; Fenical W, 2006, NAT CHEM BIOL, V2, P666, DOI 10.1038/nchembio841; Fickers P., 2012, AM J BIOCH BIOTECHNO, V8, P38; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Flemer B, 2012, J APPL MICROBIOL, V112, P289, DOI 10.1111/j.1365-2672.2011.05211.x; Fouad M, 2004, ARKIVOC, P17, DOI 10.3998/ark.5550190.0005.d03; Friedrich AB, 2001, FEMS MICROBIOL ECOL, V38, P105, DOI 10.1111/j.1574-6941.2001.tb00888.x; Gebhardt K, 2002, FEMS MICROBIOL LETT, V217, P199, DOI 10.1111/j.1574-6968.2002.tb11475.x; Gokhale RS, 2007, CURR OPIN STRUC BIOL, V17, P736, DOI 10.1016/j.sbi.2007.08.021; Gontang EA, 2010, APPL ENVIRON MICROB, V76, P2487, DOI 10.1128/AEM.02852-09; Gurgui C, 2010, METHODS MOL BIOL, V668, P247, DOI 10.1007/978-1-60761-823-2_17; Hentschel U, 2001, FEMS MICROBIOL ECOL, V35, P305, DOI 10.1111/j.1574-6941.2001.tb00816.x; Hochmuth T, 2009, PHYTOCHEMISTRY, V70, P1841, DOI 10.1016/j.phytochem.2009.04.010; Hodges TW, 2012, MAR BIOTECHNOL, V14, P270, DOI 10.1007/s10126-011-9410-7; Hooper J. N. A., 2002, SYSTEMA PORIFERA, DOI [10.1007/978-1-4615-0747-5_3, DOI 10.1007/978-1-4615-0747-5_3]; Hutchinson CR, 2003, P NATL ACAD SCI USA, V100, P3010, DOI 10.1073/pnas.0730689100; Isnansetyo A, 2009, J IND MICROBIOL BIOT, V36, P1239, DOI 10.1007/s10295-009-0611-2; Izumida H, 1996, J ANTIBIOT, V49, P76, DOI 10.7164/antibiotics.49.76; JASPARS M, 1994, TETRAHEDRON LETT, V35, P7501, DOI 10.1016/S0040-4039(00)78328-6; Kamat T., 2011, RECENT RES SCI TECHN, V3, P46; Kanagasabhapathy M, 2008, WORLD J MICROB BIOT, V24, P2315, DOI 10.1007/s11274-008-9746-y; Kim DS, 2004, INT J SYST EVOL MICR, V54, P2031, DOI 10.1099/ijs.0.02414-0; Kim TK, 2006, ENVIRON MICROBIOL, V8, P1460, DOI 10.1111/j.1462-2920.2006.01040.x; KOBAYASHI M, 1994, PURE APPL CHEM, V66, P819, DOI 10.1351/pac199466040819; Koopmans M, 2009, MAR DRUGS, V7, P787, DOI 10.3390/md7040787; Kubanek J, 2002, OECOLOGIA, V131, P125, DOI 10.1007/s00442-001-0853-9; Kubanek J, 2001, NAT PROD LETT, V15, P275, DOI 10.1080/10575630108041292; Kubanek J, 2000, MAR ECOL PROG SER, V207, P69, DOI 10.3354/meps207069; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lang S, 2004, MAR BIOTECHNOL, V6, P152, DOI 10.1007/s10126-003-0009-5; Laport MS, 2009, CURR PHARM BIOTECHNO, V10, P86, DOI 10.2174/138920109787048625; Lo Giudice A, 2007, FEMS MICROBIOL ECOL, V60, P383, DOI 10.1111/j.1574-6941.2007.00300.x; Luis NA, 2006, IDENTIFICATION PHYLO; Mansson M, 2011, MAR DRUGS, V9, P1440, DOI 10.3390/md9091440; Moore BS, 2005, ANTON LEEUW INT J G, V87, P49, DOI 10.1007/s10482-004-6541-0; Muscholl-Silberhorn A, 2008, MICROB ECOL, V55, P94, DOI 10.1007/s00248-007-9255-9; Neilan BA, 1999, J BACTERIOL, V181, P4089, DOI 10.1128/JB.181.13.4089-4097.1999; Nicolai Marisa H., 2007, V28, P491; Nishijima M, 2009, INT J SYST EVOL MICR, V59, P1696, DOI 10.1099/ijs.0.006452-0; OCLARIT JM, 1994, MICROBIOS, V78, P7; Okada Y, 2006, J ORG CHEM, V71, P4884, DOI 10.1021/jo060653j; OlguinUribe G, 1997, J CHEM ECOL, V23, P2507, DOI 10.1023/B:JOEC.0000006663.28348.03; Penesyan A, 2011, MAR DRUGS, V9, P1391, DOI 10.3390/md9081391; Penesyan A, 2009, FEMS MICROBIOL ECOL, V69, P113, DOI 10.1111/j.1574-6941.2009.00688.x; Phelan RW, 2012, J APPL MICROBIOL, V112, P65, DOI 10.1111/j.1365-2672.2011.05173.x; Quevrain E, 2009, ENVIRON MICROBIOL, V11, P1527, DOI 10.1111/j.1462-2920.2009.01880.x; Romanenko LA, 2008, MICROBIOL RES, V163, P633, DOI 10.1016/j.micres.2006.10.001; Sanchez-Hidalgo M, 2012, ANTON LEEUW INT J G, V102, P361, DOI 10.1007/s10482-012-9746-7; Sandler JS, 2005, TETRAHEDRON, V61, P1199, DOI 10.1016/j.tet.2004.11.039; Santos OCS, 2010, RES MICROBIOL, V161, P604, DOI 10.1016/j.resmic.2010.05.013; Schirmer A, 2005, APPL ENVIRON MICROB, V71, P4840, DOI 10.1128/AEM.71.8.4840-4849.2005; Schwarzer D, 2002, P NATL ACAD SCI USA, V99, P14083, DOI 10.1073/pnas.212382199; Schwedt A, 2011, THESIS U BREMEN MAX; Sertan-de Guzman AA, 2007, FEMS MICROBIOL LETT, V277, P188, DOI 10.1111/j.1574-6968.2007.00950.x; Simmons TL, 2005, MOL CANCER THER, V4, P333; Stead P, 2000, BIOORG MED CHEM LETT, V10, P661, DOI 10.1016/S0960-894X(00)00063-9; Sun W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042847; Takada K, 2002, J NAT PROD, V65, P411, DOI 10.1021/np010480n; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Thomas TRA, 2010, MAR DRUGS, V8, P1417, DOI 10.3390/md8041417; Tupinamba G, 2008, J APPL MICROBIOL, V105, P1044, DOI 10.1111/j.1365-2672.2008.03844.x; VACELET J, 1975, J MICROSC BIOL CELL, V23, P271; VACELET J, 1977, J EXP MAR BIOL ECOL, V30, P301, DOI 10.1016/0022-0981(77)90038-7; Wagner-Dobler Irene, 2002, Adv Biochem Eng Biotechnol, V74, P207; Wahl M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00292; Wang GY, 2006, J IND MICROBIOL BIOT, V33, P545, DOI 10.1007/s10295-006-0123-2; Webster NS, 2001, MAR BIOL, V138, P843, DOI 10.1007/s002270000503; Williams PG, 2009, TRENDS BIOTECHNOL, V27, P45, DOI 10.1016/j.tibtech.2008.10.005; Xi LJ, 2012, INT J MOL SCI, V13, P5917, DOI 10.3390/ijms13055917	93	60	63	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78992	10.1371/journal.pone.0078992	http://dx.doi.org/10.1371/journal.pone.0078992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236081	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700079
J	La Mantia, J; Klapste, J; El-Kassaby, YA; Azam, S; Guy, RD; Douglas, CJ; Mansfield, SD; Hamelin, R				La Mantia, Jonathan; Klapste, Jaroslav; El-Kassaby, Yousry A.; Azam, Shofiul; Guy, Robert D.; Douglas, Carl J.; Mansfield, Shawn D.; Hamelin, Richard			Association Analysis Identifies Melampsora xcolumbiana Poplar Leaf Rust Resistance SNPs	PLOS ONE			English	Article							COTTONWOOD POPULUS-TRICHOCARPA; GENOME-WIDE ASSOCIATION; RESTRICTED GENE MIGRATION; POPULATION-STRUCTURE; LARICI-POPULINA; REGIONAL DIFFERENTIATION; LINKAGE DISEQUILIBRIUM; CRYPTIC RELATEDNESS; DISEASE RESISTANCE; HYBRID POPLARS	Populus species are currently being domesticated through intensive time- and resource-dependent programs for utilization in phytoremediation, wood and paper products, and conversion to biofuels. Poplar leaf rust disease can greatly reduce wood volume. Genetic resistance is effective in reducing economic losses but major resistance loci have been race-specific and can be readily defeated by the pathogen. Developing durable disease resistance requires the identification of non-racespecific loci. In the presented study, area under the disease progress curve was calculated from natural infection of Melampsora xcolumbiana in three consecutive years. Association analysis was performed using 412 P. trichocarpa clones genotyped with 29,355 SNPs covering 3,543 genes. We found 40 SNPs within 26 unique genes significantly associated (permutated P<0.05) with poplar rust severity. Moreover, two SNPs were repeated in all three years suggesting non-race-specificity and three additional SNPs were differentially expressed in other poplar rust interactions. These five SNPs were found in genes that have orthologs in Arabidopsis with functionality in pathogen induced transcriptome reprogramming, Ca2+/calmodulin and salicylic acid signaling, and tolerance to reactive oxygen species. The additive effect of non-R gene functional variants may constitute high levels of durable poplar leaf rust resistance. Therefore, these findings are of significance for speeding the genetic improvement of this long-lived, economically important organism.	[La Mantia, Jonathan; Klapste, Jaroslav; El-Kassaby, Yousry A.; Azam, Shofiul; Guy, Robert D.; Hamelin, Richard] Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC V5Z 1M9, Canada; [Douglas, Carl J.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Mansfield, Shawn D.] Univ British Columbia, Dept Wood Sci, Vancouver, BC, Canada; [Hamelin, Richard] Nat Resources Canada, Laurentian Forestry Ctr, Quebec City, PQ, Canada; [Klapste, Jaroslav] Czech Univ Life Sci Prague, Fac Forestry & Wood Sci, Dept Dendrol & Forest Tree Breeding, Kamycka, Czech Republic	University of British Columbia; University of British Columbia; University of British Columbia; Natural Resources Canada; Czech University of Life Sciences Prague	Hamelin, R (corresponding author), Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC V5Z 1M9, Canada.	richard.hamelin@ubc.ca	Guy, Robert/GPX-8421-2022; El-Kassaby, Yousry A/K-9856-2016; Klapste, Jaroslav/B-6668-2016; Hamelin, Richard/F-7006-2010	El-Kassaby, Yousry A/0000-0002-4887-8977; Klapste, Jaroslav/0000-0001-5504-3735; Mansfield, Shawn/0000-0002-0175-554X; Hamelin, Richard/0000-0003-4006-532X	Genome British Columbia [103BIO]; Applied Genomics Innovation Program and Genome Canada [168BIO]	Genome British Columbia; Applied Genomics Innovation Program and Genome Canada	This work was supported by Genome British Columbia (103BIO) Applied Genomics Innovation Program and Genome Canada (168BIO) Large Scale Applied Research Project funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astle W, 2009, STAT SCI, V24, P451, DOI 10.1214/09-STS307; Bourassa M, 2007, PHYTOPATHOLOGY, V97, P603, DOI 10.1094/PHYTO-97-5-0603; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Bresson A, 2011, NEW PHYTOL, V192, P151, DOI 10.1111/j.1469-8137.2011.03786.x; Camanes G, 2012, PLANT PHYSIOL, V158, P1054, DOI 10.1104/pp.111.184424; Chandrashekar M, 1980, PHYTOPATHOLOGY, V71, P421; Crossa J, 2007, GENETICS, V177, P1889, DOI 10.1534/genetics.107.078659; Dowkiw A, 2003, PHYTOPATHOLOGY, V93, P421, DOI 10.1094/PHYTO.2003.93.4.421; Dowkiw A, 2010, PLANT PATHOL, V59, P523, DOI 10.1111/j.1365-3059.2010.02277.x; FLOR HH, 1955, PHYTOPATHOLOGY, V45, P680; Geraldes A, 2013, MOL ECOL RE IN PRESS; Gerard PR, 2006, PHYTOPATHOLOGY, V96, P1027, DOI 10.1094/PHYTO-96-1027; Gilmour A. R., 2002, ASREML USER GUIDE RE; Graffelman J, 2008, HUM HERED, V65, P77, DOI 10.1159/000108939; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Habier D, 2007, GENETICS, V177, P2389, DOI 10.1534/genetics.107.081190; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Ingvarsson PK, 2008, GENETICS, V178, P2217, DOI 10.1534/genetics.107.082354; Karkkainen HP, 2012, ANN HUM GENET, V76, P510, DOI 10.1111/j.1469-1809.2012.00729.x; Lescot M, 2004, THEOR APPL GENET, V109, P10, DOI 10.1007/s00122-004-1621-0; Levine MN, 1928, PHYTOPATHOLOGY, V18, P7; Levy M, 2005, PLANT J, V43, P79, DOI 10.1111/j.1365-313X.2005.02435.x; Li QZ, 2009, GENET EPIDEMIOL, V33, P432, DOI 10.1002/gepi.20396; Libault M, 2007, MOL PLANT MICROBE IN, V20, P900, DOI 10.1094/MPMI-20-8-0900; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Lynch M., 1998, GENETICS ANAL QUANTI; Nakamichi N, 2005, PLANT CELL PHYSIOL, V46, P686, DOI 10.1093/pcp/pci086; Newcombe G, 2000, MYCOL RES, V104, P261, DOI 10.1017/S0953756299001665; Newcombe G, 2001, PHYTOPATHOLOGY, V91, P981, DOI 10.1094/PHYTO.2001.91.10.981; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; Pant SD, 2010, GENOMICS, V95, P176, DOI 10.1016/j.ygeno.2010.01.001; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Quesada T, 2010, GENETICS, V186, P677, DOI 10.1534/genetics.110.117549; Rinaldi C, 2007, PLANT PHYSIOL, V144, P347, DOI 10.1104/pp.106.094987; RUPE JC, 1982, PHYTOPATHOLOGY, V72, P1587, DOI 10.1094/Phyto-72-1587; Setakis E, 2006, GENOME RES, V16, P290, DOI 10.1101/gr.4346306; SHANER G, 1977, PHYTOPATHOLOGY, V67, P1051, DOI 10.1094/Phyto-67-1051; Shin J-H., 2006, J STAT SOFTW, V16, P1, DOI [10.18637/jss.v016.c03, DOI 10.18637/JSS.V016.C03]; Slavov GT, 2012, NEW PHYTOL, V196, P713, DOI 10.1111/j.1469-8137.2012.04258.x; Steenackers J, 1996, BIOMASS BIOENERG, V10, P267, DOI 10.1016/0961-9534(95)00121-2; Stich B, 2008, GENETICS, V178, P1745, DOI 10.1534/genetics.107.079707; Stirnberg P, 2012, PLANT J, V71, P907, DOI 10.1111/j.1365-313X.2012.05038.x; Valluru R, 2011, PLANT SCI, V181, P387, DOI 10.1016/j.plantsci.2011.07.009; Wang MH, 2012, THEOR APPL GENET, V124, P233, DOI 10.1007/s00122-011-1697-2; Wegrzyn JL, 2010, NEW PHYTOL, V188, P515, DOI 10.1111/j.1469-8137.2010.03415.x; WIDIN KD, 1981, EUR J FOREST PATHOL, V11, P438; Xie CY, 2012, CAN J FOREST RES, V42, P400, DOI [10.1139/X11-187, 10.1139/x11-187]; Xie CY, 2009, CAN J FOREST RES, V39, P519, DOI 10.1139/X08-190; Yin TM, 2004, NEW PHYTOL, V164, P95, DOI 10.1111/j.1469-8137.2004.01161.x; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang J, 2001, PHYTOPATHOLOGY, V91, P1069, DOI 10.1094/PHYTO.2001.91.11.1069; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089	55	22	22	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78423	10.1371/journal.pone.0078423	http://dx.doi.org/10.1371/journal.pone.0078423			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236018	gold, Green Published, Green Submitted			2022-12-27	WOS:000327254700015
J	Martin, J; Chong, T; Ferree, PM				Martin, Jennifer; Chong, Trisha; Ferree, Patrick M.			Male Killing Spiroplasma Preferentially Disrupts Neural Development in the Drosophila melanogaster Embryo	PLOS ONE			English	Article							DOSAGE COMPENSATION; BACTERIAL TOXINS; LETHAL MUTATIONS; EXPRESSION; SR; PROTEIN; MSL-2; ELAV	Male killing bacteria such as Spiroplasma are widespread pathogens of numerous arthropods including Drosophila melanogaster. These maternally transmitted bacteria can bias host sex ratios toward the female sex in order to 'selfishly' enhance bacterial transmission. However, little is known about the specific means by which these pathogens disrupt host development in order to kill males. Here we show that a male-killing Spiroplasma strain severely disrupts nervous tissue development in male but not female D. melanogaster embryos. The neuroblasts, or neuron progenitors, form properly and their daughter cells differentiate into neurons of the ventral nerve chord. However, the neurons fail to pack together properly and they produce highly abnormal axons. In contrast, non-neural tissue, such as mesoderm, and body segmentation appear normal during this time, although the entire male embryo becomes highly abnormal during later stages. Finally, we found that Spiroplasma is altogether absent from the neural tissue but localizes within the gut and the epithelium immediately surrounding the neural tissue, suggesting that the bacterium secretes a toxin that affects neural tissue development across tissue boundaries. Together these findings demonstrate the unique ability of this insect pathogen to preferentially affect development of a specific embryonic tissue to induce male killing.	[Ferree, Patrick M.] Claremont Mckenna Coll, WM Keck Sci Dept, Claremont, CA 91711 USA; Scripps Coll, WM Keck Sci Dept, Claremont, CA 91711 USA; Pitzer Coll, WM Keck Sci Dept, Claremont, CA 91711 USA	Claremont Colleges; Claremont Graduate School; Claremont McKenna College; Claremont Colleges; Scripps College; Claremont Colleges; Pitzer College	Ferree, PM (corresponding author), Claremont Mckenna Coll, WM Keck Sci Dept, Claremont, CA 91711 USA.	pferree@kecksci.claremont.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007790] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barbieri JT, 2002, ANNU REV CELL DEV BI, V18, P315, DOI 10.1146/annurev.cellbio.18.012502.134748; BELOTE JM, 1983, GENETICS, V105, P881; BELOTE JM, 1980, GENETICS, V96, P165; Bentley JK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-9; BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9; COUNCE SJ, 1962, J EXP ZOOL, V151, P17, DOI 10.1002/jez.1401510103; COUNCE SJ, 1966, GENETICA, V37, P364, DOI 10.1007/BF01547143; COUNCE SJ, 1961, AM ZOOL, V1, P443; Doe CQ, 1996, CURR OPIN NEUROBIOL, V6, P18, DOI 10.1016/S0959-4388(96)80004-3; Ferree PM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000234; FRASCH M, 1987, EMBO J, V6, P749, DOI 10.1002/j.1460-2075.1987.tb04817.x; FUJITA SC, 1982, P NATL ACAD SCI-BIOL, V79, P7929, DOI 10.1073/pnas.79.24.7929; Haselkorn TS, 2010, FLY, V4, P80, DOI 10.4161/fly.4.1.10883; Herren JK, 2013, MBIO, V4, DOI 10.1128/mBio.00532-12; Hurst GDD, 2000, EMERG INFECT DIS, V6, P329, DOI 10.3201/eid0604.000402; Hurst GDD, 1999, P ROY SOC B-BIOL SCI, V266, P735, DOI 10.1098/rspb.1999.0698; Jiggins FM, 2000, PARASITOLOGY, V120, P439, DOI 10.1017/S0031182099005867; KELLEY RL, 1995, CELL, V81, P867, DOI 10.1016/0092-8674(95)90007-1; KOANA T, 1983, GENETICS, V104, P113; Landgraf M, 1999, NEURON, V22, P43, DOI 10.1016/S0896-6273(00)80677-7; McDowell KA, 1996, MECH DEVELOP, V57, P113, DOI 10.1016/0925-4773(96)00517-5; MIYAMOTO C, 1975, GENETICS, V79, P55; Montenegro H, 2005, INSECT MOL BIOL, V14, P281, DOI 10.1111/j.1365-2583.2005.00558.x; Oswald E, 2005, CURR OPIN MICROBIOL, V8, P83, DOI 10.1016/j.mib.2004.12.011; Pool JE, 2006, HEREDITY, V97, P27, DOI 10.1038/sj.hdy.6800830; Riparbelli MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030045; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; ROBINOW S, 1991, J NEUROBIOL, V22, P443, DOI 10.1002/neu.480220503; Tinsley MC, 2006, PARASITOLOGY, V132, P757, DOI 10.1017/S0031182005009789; TRUMAN JW, 1990, J NEUROBIOL, V21, P1072, DOI 10.1002/neu.480210711; TSUCHIYAMA S, 1978, GENETICS, V89, P711; Veneti Z, 2005, SCIENCE, V307, P1461, DOI 10.1126/science.1107182; WERREN JH, 1986, SCIENCE, V231, P990, DOI 10.1126/science.3945814; WERREN JH, 1994, J BACTERIOL, V176, P388, DOI 10.1128/JB.176.2.388-394.1994; WHITCOMB RF, 1980, ANNU REV MICROBIOL, V34, P677, DOI 10.1146/annurev.mi.34.100180.003333	35	28	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79368	10.1371/journal.pone.0079368	http://dx.doi.org/10.1371/journal.pone.0079368			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236124	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700123
J	Mercado, J; Valenzano, MC; Jeffers, C; Sedlak, J; Cugliari, MK; Papanikolaou, E; Clouse, J; Miao, J; Wertan, NE; Mullin, JM				Mercado, Joanna; Valenzano, Mary Carmen; Jeffers, Cameron; Sedlak, Jason; Cugliari, Marina K.; Papanikolaou, Eleni; Clouse, Jacob; Miao, Jingya; Wertan, Nina E.; Mullin, James M.			Enhancement of Tight Junctional Barrier Function by Micronutrients: Compound-Specific Effects on Permeability and Claudin Composition	PLOS ONE			English	Article							ZINC SUPPLEMENTATION; INTESTINAL BARRIER; EXPRESSION; QUERCETIN; BUTYRATE; OCCLUDIN; KINASE	Amid an increasing number of reports in the literature concerning epithelial barrier enhancement by various nutrient compounds, there has never been a study performing side-by-side comparisons of these agents in a single epithelial model. We compare five nutrient compounds (previously reported in various epithelial models to enhance barrier function) regarding their ability to increase transepithelial electrical resistance (R-t) and decrease transepithelial mannitol permeability (J(m)) across LLC-PK1 renal epithelial cell layers. The effects of these nutrients on the abundance of various tight junctional proteins are also compared. In the overall group of nutrients tested - zinc, indole, quercetin, butyrate and nicotine - only nicotine failed to improve barrier function by either parameter. Nicotine also was without effect on tight junctional proteins. Quercetin simultaneously increased R-t and decreased J(m). Zinc, butyrate and indole only exhibited statistically significant enhancement of R-t. Each of these four effective nutrient compounds had unique patterns of effects on the panel of tight junctional proteins studied. No two compounds produced the same pattern of effects. This unique pattern of effects on tight junctional complex composition by each compound establishes the chance for additive or even synergistic improvement of barrier function by combinations of compounds. A synergistic effect of the combination of quercetin and zinc on R-t is shown.	[Mercado, Joanna; Valenzano, Mary Carmen; Wertan, Nina E.; Mullin, James M.] Lankenau Inst Med Res, Wynnewood, PA USA; [Jeffers, Cameron; Sedlak, Jason; Cugliari, Marina K.; Papanikolaou, Eleni; Clouse, Jacob; Miao, Jingya] Drexel Univ, Philadelphia, PA 19104 USA	Lankenau Medical Center; Lankenau Institute for Medical Research; Drexel University	Mullin, JM (corresponding author), Lankenau Inst Med Res, Wynnewood, PA USA.	mullinj@mlhs.org	Mullin, James M./AAD-9348-2020	Mullin, James/0000-0001-5285-7530; Miao, Jingya/0000-0001-6482-5384	Sharpe Strumia Foundation	Sharpe Strumia Foundation	Funding came from Sharpe Strumia Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amasheh M, 2009, ANN N Y ACAD SCI; Amasheh M, 2008, J NUTR, V138, P1067, DOI 10.1093/jn/138.6.1067; Amasheh M, 2010, J CELL SCI, V123, P4145, DOI 10.1242/jcs.070896; Bansal T, 2010, P NATL ACAD SCI USA, V107, P228, DOI 10.1073/pnas.0906112107; Bednarczyk J, 2011, ACTA NEUROBIOL EXP, V71, P393; Camilleri M, 2012, NEUROGASTROENT MOTIL, V24, P503, DOI 10.1111/j.1365-2982.2012.01921.x; Catalioto RM, 2011, CURR MED CHEM, V18, P398, DOI 10.2174/092986711794839179; Chuenkitiyanon S, 2010, INT J TOXICOL, V29, P418, DOI 10.1177/1091581810366487; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Finamore A, 2008, J NUTR, V138, P1664, DOI 10.1093/jn/138.9.1664; Furuse M, 1999, J CELL BIOL, V147, P891, DOI 10.1083/jcb.147.4.891; HULL RN, 1976, IN VITRO CELL DEV B, V12, P670, DOI 10.1007/BF02797469; Li JH, 2011, PEDIATR NEPHROL, V26, P2133, DOI 10.1007/s00467-011-1824-y; McGilligan VE, 2007, FOOD CHEM TOXICOL, V45, P1593, DOI 10.1016/j.fct.2007.02.021; Mullin JM, 2005, DRUG DISCOV TODAY, V10, P395, DOI 10.1016/S1359-6446(05)03379-9; Mullin JM, 2012, J EPITHELIAL BIOL PH, V5, P10; Peng LY, 2009, J NUTR, V139, P1619, DOI 10.3945/jn.109.104638; Ploger S, 2012, ANN NY ACAD SCI, V1258, P52, DOI 10.1111/j.1749-6632.2012.06553.x; Rodriguez P, 1996, GUT, V39, P416, DOI 10.1136/gut.39.3.416; Sawada Norimasa, 2003, Medical Electron Microscopy, V36, P147, DOI 10.1007/s00795-003-0219-y; Sawada N, 2013, PATHOL INT, V63, P1, DOI 10.1111/pin.12021; Sazawal S, 1997, AM J CLIN NUTR, V66, P413, DOI 10.1093/ajcn/66.2.413; Shimizu M, 2010, BIOSCI BIOTECH BIOCH, V74, P232, DOI 10.1271/bbb.90730; Soini Y, 2012, INT J CLIN EXP PATHO, V5, P126; Sturniolo GC, 2002, J LAB CLIN MED, V139, P311, DOI 10.1067/mlc.2002.123624; Suzuki T, 2011, J NUTR BIOCHEM, V22, P401, DOI 10.1016/j.jnutbio.2010.08.001; Suzuki T, 2009, J NUTR, V139, P965, DOI 10.3945/jn.108.100867; Wang HB, 2012, DIGEST DIS SCI, V57, P3126, DOI 10.1007/s10620-012-2259-4; Wang XX, 2013, DIGEST DIS SCI, V58, P77, DOI 10.1007/s10620-012-2328-8; Zhang BK, 2009, BRIT J NUTR, V102, P687, DOI 10.1017/S0007114509289033; Zhong W, 2010, AM J PHYSIOL-GASTR L, V298, P18	31	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78775	10.1371/journal.pone.0078775	http://dx.doi.org/10.1371/journal.pone.0078775			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236048	Green Submitted, Green Published, gold			2022-12-27	WOS:000327254700045
J	Morgan, K; Rahman, M; Atkinson, M; Zhou, SM; Hill, R; Khanom, A; Paranjothy, S; Brophy, S				Morgan, Kelly; Rahman, Mohammed; Atkinson, Mark; Zhou, Shang-Ming; Hill, Rebecca; Khanom, Ashrafunnesa; Paranjothy, Shantini; Brophy, Sinead			Association of Diabetes in Pregnancy with Child Weight at Birth, Age 12 Months and 5 Years - A Population-Based Electronic Cohort Study	PLOS ONE			English	Article							TYPE-1; HYPERGLYCEMIA; MELLITUS; OBESITY; MOTHERS; PREVALENCE; PREDICTORS; OVERWEIGHT; ADIPOSITY; OUTCOMES	Background: This study examines the effect of diabetes in pregnancy on offspring weight at birth and ages 1 and 5 years. Methods: A population-based electronic cohort study using routinely collected linked healthcare data. Electronic medical records provided maternal diabetes status and offspring weight at birth and ages 1 and 5 years (n=147,773 mother child pairs). Logistic regression models were used to obtain odds ratios to describe the association between maternal diabetes status and offspring size, adjusted for maternal pre-pregnancy weight, age and smoking status. Findings: We identified 1,250 (0.9%) pregnancies with existing diabetes (27.8% with type 1 diabetes), 1,358 with gestational diabetes (0.9%) and 635 (0.4%) who developed diabetes post-pregnancy. Children whose mothers had existing diabetes were less likely to be large at 12 months (OR: 0.7 (95%CI: 0.6, 0.8)) than those without diabetes. Maternal diabetes was associated with high weight at age 5 years in children whose mothers had a high pre-pregnancy weight tertile (gestational diabetes, (OR: 2.1 (95%CI:1.25-3.6)), existing diabetes (OR:1.3(95%CI:1.0 to 1.6)). Conclusion: The prevention of childhood obesity should focus on mothers with diabetes with a high maternal pre-pregnancy weight. We found little evidence that diabetes in pregnancy leads to long term obesity 'programming'.	[Morgan, Kelly; Rahman, Mohammed; Atkinson, Mark; Zhou, Shang-Ming; Hill, Rebecca; Khanom, Ashrafunnesa; Brophy, Sinead] Swansea Univ, Coll Med, Swansea, W Glam, Wales; [Paranjothy, Shantini] Cardiff Univ, Sch Med, Cardiff CF10 3AX, S Glam, Wales	Swansea University; Cardiff University	Morgan, K (corresponding author), Swansea Univ, Coll Med, Swansea, W Glam, Wales.	kelly.morgan@swansea.ac.uk	Atkinson, Mark D/K-1813-2013; Zhou, Shang-Ming/A-8443-2008	Atkinson, Mark D/0000-0003-4237-3588; Khanom, Ashrafunnesa/0000-0002-5735-6601; Brophy, Sinead/0000-0001-7417-2858; Zhou, Shang-Ming/0000-0002-0719-9353; Morgan, Kelly/0000-0002-8685-1177	Swansea University; Public Health Wales; National Institute for Social Care and Health Research (NISCHR); NISCHR and was within the DECIPHer centre of excellence for Public Health Research; MRC [MR/K006525/1] Funding Source: UKRI; Medical Research Council [MR/K006525/1] Funding Source: researchfish	Swansea University; Public Health Wales; National Institute for Social Care and Health Research (NISCHR); NISCHR and was within the DECIPHer centre of excellence for Public Health Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project was funded by Swansea University, Public Health Wales and the National Institute for Social Care and Health Research (NISCHR). The study was also part of the EPI-screen network funded by NISCHR and was within the DECIPHer centre of excellence for Public Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balsells M, 2009, J CLIN ENDOCR METAB, V94, P4284, DOI 10.1210/jc.2009-1231; Baptiste-Roberts K, 2012, MATERN CHILD HLTH J, V16, P125, DOI 10.1007/s10995-011-0756-2; Boerschmann H, 2010, DIABETES CARE, V33, P1845, DOI 10.2337/dc10-0139; Clausen TD, 2008, DIABETES CARE, V31, P340, DOI 10.2337/dc07-1596; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Dabelea D, 2001, J PEDIATR ENDOCR MET, V14, P1085; Dabelea D, 2000, DIABETES, V49, P2208, DOI 10.2337/diabetes.49.12.2208; de Lusignan S, 2012, DIABETIC MED, V29, P181, DOI 10.1111/j.1464-5491.2011.03419.x; de Onis M, 2010, AM J CLIN NUTR; Diabetes UK, 2012, DIAB UK 2012 KEY STA, P1; Ford DV, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-157; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; FREINKEL N, 1980, DIABETES, V29, P1023, DOI 10.2337/diabetes.29.12.1023; Gluckman PD, 2004, TRENDS ENDOCRIN MET, V15, P183, DOI 10.1016/j.tem.2004.03.002; Han JC, 2010, LANCET, V375, P1737, DOI 10.1016/S0140-6736(10)60171-7; Hanna FWF, 2002, DIABETIC MED, V19, P351, DOI 10.1046/j.1464-5491.2002.00684.x; Haroush B, 2003, DIABETIC MED, V21, P103; Hummel S, 2009, DIABETES CARE, V32, P921, DOI [10.2337/dc08-1943, 10.2337/dc09-1379]; Husain MJ, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-24; Lindsay RS, 2010, DIABETES CARE, V33, P1080, DOI 10.2337/dc09-1766; Lindsay RS, 2009, DIABETES, V58, P302, DOI 10.2337/db08-1562; Lyons RA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-3; Manderson JG, 2002, DIABETOLOGIA, V45, P991, DOI 10.1007/s00125-002-0865-y; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; National Institute for Health and Care Excellence (NICE), 2008, DIAB PREGN MAN DIAB; Paliya O, 2013, POTENTIAL MECH NUTR, V30, P1; PEDERSEN J, 1954, ACTA ENDOCRINOL-COP, V16, P330, DOI 10.1530/acta.0.0160330; Pettitt DJ, 2010, DIABETES CARE, V33, P1219, DOI 10.2337/dc09-2384; Philipps LH, 2011, DIABETOLOGIA, V54, P1957, DOI 10.1007/s00125-011-2180-y; Shin Y., 2011, EMPIR SOFTW ENG, P1; SILVERMAN BL, 1995, DIABETES CARE, V18, P611, DOI 10.2337/diacare.18.5.611; Smith BJ, 2005, DIABETES CARE, V28, P2650, DOI 10.2337/diacare.28.11.2650; Sobngwi E, 2003, LANCET, V361, P1861, DOI 10.1016/S0140-6736(03)13505-2; Tobias D, 2012, ARCH INTERN MED, V172, P1; Weiss PAM, 2000, DIABETES CARE, V23, P905, DOI 10.2337/diacare.23.7.905	35	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79803	10.1371/journal.pone.0079803	http://dx.doi.org/10.1371/journal.pone.0079803			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236160	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700160
J	Franco-Trecu, V; Drago, M; Riet-Sapriza, FG; Parnell, A; Frau, R; Inchausti, P				Franco-Trecu, Valentina; Drago, Massimiliano; Riet-Sapriza, Federico G.; Parnell, Andrew; Frau, Rosina; Inchausti, Pablo			Bias in Diet Determination: Incorporating Traditional Methods in Bayesian Mixing Models	PLOS ONE			English	Article							STABLE-ISOTOPES; ARCTOCEPHALUS-AUSTRALIS; PRIOR INFORMATION; FISH; UNCERTAINTY; NITROGEN; CARBON; SEALS; SEGREGATION; PATTERNS	There are not "universal methods" to determine diet composition of predators. Most traditional methods are biased because of their reliance on differential digestibility and the recovery of hard items. By relying on assimilated food, stable isotope and Bayesian mixing models (SIMMs) resolve many biases of traditional methods. SIMMs can incorporate prior information (i.e. proportional diet composition) that may improve the precision in the estimated dietary composition. However few studies have assessed the performance of traditional methods and SIMMs with and without informative priors to study the predators' diets. Here we compare the diet compositions of the South American fur seal and sea lions obtained by scats analysis and by SIMMs-UP (uninformative priors) and assess whether informative priors (SIMMs-IP) from the scat analysis improved the estimated diet composition compared to SIMMs-UP. According to the SIMM-UP, while pelagic species dominated the fur seal's diet the sea lion's did not have a clear dominance of any prey. In contrast, SIMM-IP's diets compositions were dominated by the same preys as in scat analyses. When prior information influenced SIMMs' estimates, incorporating informative priors improved the precision in the estimated diet composition at the risk of inducing biases in the estimates. If preys isotopic data allow discriminating preys' contributions to diets, informative priors should lead to more precise but unbiased estimated diet composition. Just as estimates of diet composition obtained from traditional methods are critically interpreted because of their biases, care must be exercised when interpreting diet composition obtained by SIMMs-IP. The best approach to obtain a near-complete view of predators' diet composition should involve the simultaneous consideration of different sources of partial evidence (traditional methods, SIMM-UP and SIMM-IP) in the light of natural history of the predator species so as to reliably ascertain and weight the information yielded by each method.	[Franco-Trecu, Valentina; Riet-Sapriza, Federico G.; Frau, Rosina] Univ Republica, Fac Ciencias, Secc Etol, Proyecto Pinnipedos, Montevideo, Uruguay; [Drago, Massimiliano] Univ Barcelona, Fac Biol, Dept Anim Biol, Barcelona, Spain; [Parnell, Andrew] Univ Coll Dublin, Complex Adapt Syst Lab, Sch Math Sci Stat, Dublin 2, Ireland; [Inchausti, Pablo] Univ Repub, Ctr Univ Reg Este, Dept Ecol & Evoluc, Maldonado, Uruguay	Universidad de la Republica, Uruguay; University of Barcelona; University College Dublin; Universidad de la Republica, Uruguay	Inchausti, P (corresponding author), Univ Repub, Ctr Univ Reg Este, Dept Ecol & Evoluc, Maldonado, Uruguay.	pablo.inchausti.f@gmail.com	Franco-Trecu, Valentina/L-4649-2019; Parnell, Andrew/C-7284-2014; Franco-Trecu, Valentina/N-5266-2019; Drago, Massimiliano/K-1863-2017	Franco-Trecu, Valentina/0000-0003-1791-010X; Parnell, Andrew/0000-0001-7956-7939; Drago, Massimiliano/0000-0003-2764-9849; Riet, Federico/0000-0002-6568-2802	U.S. Marine Mammal Commission [E4047335]; Rufford Maurice Lain Foundation (UK) [RSG 02.10.09]; National Agency for Research and Innovation (ANII)	U.S. Marine Mammal Commission; Rufford Maurice Lain Foundation (UK); National Agency for Research and Innovation (ANII)	This work was partially funded by the U.S. Marine Mammal Commission under the order No. E4047335 and Rufford Maurice Lain Foundation (UK)(project RSG 02.10.09). VFT had a PhD scholarship from the National Agency for Research and Innovation (ANII). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allum LL, 2012, NEW ZEAL J MAR FRESH, V46, P91, DOI 10.1080/00288330.2011.604336; Alonso MK, 1998, FISH B-NOAA, V96, P366; Bakaloudis DE, 2012, J ARID ENVIRON, V77, P59, DOI 10.1016/j.jaridenv.2011.10.004; Bassi E, 2012, MAMM BIOL, V77, P369, DOI 10.1016/j.mambio.2011.12.002; Begon M., 2009, ECOLOGY INDIVIDUALS; BERTA A., 1999, MARINE MAMMALS EVOLU; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bond AL, 2011, ECOL APPL, V21, P1017, DOI 10.1890/09-2409.1; Budge SM, 2012, CAN J FISH AQUAT SCI, V69, P1033, DOI [10.1139/F2012-039, 10.1139/f2012-039]; Burns JM, 1998, POLAR BIOL, V19, P272, DOI 10.1007/s003000050245; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Clarke MR., 1986, HDB IDENTIFICATION C, P273; Cortes E, 1997, CAN J FISH AQUAT SCI, V54, P726, DOI 10.1139/cjfas-54-3-726; Croxall JP, 1997, J ZOOL, V242, P531, DOI 10.1111/j.1469-7998.1997.tb03854.x; Dalerum F, 2005, OECOLOGIA, V144, P647, DOI 10.1007/s00442-005-0118-0; Darimont CT, 2002, CAN J ZOOL, V80, P1638, DOI 10.1139/Z02-149; Davies-Mostert HT, 2010, S AFR J WILDL RES, V40, P105, DOI 10.3957/056.040.0201; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Forero MG, 2003, SCI MAR, V67, P23, DOI 10.3989/scimar.2003.67s223; Franco-Trecu V, 2010, EXITO CRIANZA HABITO; Franco-Trecu V, 2012, J MAMMAL, V93, P514, DOI 10.1644/11-MAMM-A-174.1; Galvan DE, 2012, OECOLOGIA, V169, P1083, DOI 10.1007/s00442-012-2273-4; Geweke J., 1992, BAYESIAN STAT, V4, P169, DOI DOI 10.21034/SR.148; Grilli MG, 2012, POLAR BIOL, V35, P299, DOI 10.1007/s00300-011-1054-6; Hall-Aspland S, 2011, POLAR BIOL, V34, P95, DOI 10.1007/s00300-010-0862-4; Hardy CM, 2010, MOL ECOL, V19, P197, DOI 10.1111/j.1365-294X.2009.04411.x; Hobson KA, 1996, CAN J FISH AQUAT SCI, V53, P528, DOI 10.1139/cjfas-53-3-528; Jaureguizar AJ, 2004, FISH RES, V66, P195, DOI 10.1016/S0165-7836(03)00200-5; Jaureguizar AJ, 2006, FISH OCEANOGR, V15, P326, DOI 10.1111/j.1365-2419.2006.00405.x; Klare U, 2011, MAMMAL REV, V41, P294, DOI 10.1111/j.1365-2907.2011.00183.x; LANGTON RW, 1982, FISH B-NOAA, V80, P745; Layman CA, 2012, BIOL REV, V87, P545, DOI 10.1111/j.1469-185X.2011.00208.x; Logan JM, 2011, MAR BIOL, V158, P73, DOI 10.1007/s00227-010-1543-0; Michener R.H., 1994, P138; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Moreno R, 2010, MAR BIOL, V157, P545, DOI 10.1007/s00227-009-1340-9; Naya DE, 2002, MAR MAMMAL SCI, V18, P734, DOI 10.1111/j.1748-7692.2002.tb01070.x; Newsome SD, 2012, J MAMMAL, V93, P329, DOI 10.1644/11-MAMM-S-187.1; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; Orr AJ, 2011, CAN J ZOOL, V89, P109, DOI 10.1139/Z10-101; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Perga ME, 2005, OECOLOGIA, V144, P598, DOI 10.1007/s00442-005-0069-5; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; R Development Core Team, 2008, R LANG ENV STAT COMP; Ramos R, 2009, MAR ECOL PROG SER, V377, P289, DOI 10.3354/meps07792; Rauber TW, 2008, PATTERN RECOGN, V41, P637, DOI 10.1016/j.patcog.2007.06.023; Riet Sapriza FG, 2013, DEEP SEA RES 2, V88-89, P106, DOI DOI 10.1016/J.DSR2.2012.09.005; Santos MM, 2012, J ORNITHOL, V153, P979, DOI 10.1007/s10336-012-0840-4; Tarroux A, 2010, METHODS ECOL EVOL, V1, P231, DOI 10.1111/j.2041-210X.2010.00033.x; Tornberg R, 2007, ORNIS FENNICA, V84, P21; Trites AW, 2005, J MAMMAL, V86, P704, DOI 10.1644/1545-1542(2005)086[0704:DAFFSH]2.0.CO;2; Volpedo A, 2003, FISH RES, V60, P551, DOI 10.1016/S0165-7836(02)00170-4; Wachter B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038066; Ward EJ, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00190.1; Ward EJ, 2010, ENVIRON SCI TECHNOL, V44, P4645, DOI 10.1021/es100053v; Weiser EL, 2011, J FIELD ORNITHOL, V82, P297, DOI 10.1111/j.1557-9263.2011.00333.x; Yeakel JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022015	59	48	48	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80019	10.1371/journal.pone.0080019	http://dx.doi.org/10.1371/journal.pone.0080019			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224031	Green Submitted, Green Published, gold			2022-12-27	WOS:000326597400104
J	Ilboudo, PGC; Russell, S; D'Exelle, B				Ilboudo, Patrick G. C.; Russell, Steve; D'Exelle, Ben			The Long Term Economic Impact of Severe Obstetric Complications for Women and Their Children in Burkina Faso	PLOS ONE			English	Article							MATERNAL HEALTH-CARE; LOW-INCOME; CONSEQUENCES; ILLNESS; HOUSEHOLD; MORBIDITY; MORTALITY; SERVICES; DELIVERY; PROGRESS	This study investigates the long term economic impact of severe obstetric complications for women and their children in Burkina Faso, focusing on measures of food security, expenditures and related quality of life measures. It uses a hospital based cohort, first visited in 2004/2005 and followed up four years later. This cohort of 1014 women consisted of two main groups of comparison: 677 women who had an uncomplicated delivery and 337 women who experienced a severe obstetric complication which would have almost certainly caused death had they not received hospital care (labelled a "near miss" event). To analyze the impact of such near miss events as well as the possible interaction with the pregnancy outcome, we compared household and individual level indicators between women without a near miss event and women with a near miss event who either had a live birth, a perinatal death or an early pregnancy loss. We used propensity score matching to remove initial selection bias. Although we found limited effects for the whole group of near miss women, the results indicated negative impacts: a) for near miss women with a live birth, on child development and education, on relatively expensive food consumption and on women's quality of life; b) for near miss women with perinatal death, on relatively expensive foods consumption and children's education and c) for near miss women who had an early pregnancy loss, on overall food security. Our results showed that severe obstetric complications have long lasting consequences for different groups of women and their children and highlighted the need for carefully targeted interventions.	[Ilboudo, Patrick G. C.] Agence Format Rech & Expertise Sante Afrique AFRI, Bobo Dioulasso, Burkina Faso; [Ilboudo, Patrick G. C.] Univ Oslo, Dept Community Med, Oslo, Norway; [Russell, Steve; D'Exelle, Ben] Univ E Anglia, Sch Int Dev, Norwich NR4 7TJ, Norfolk, England	University of Oslo; University of East Anglia	Ilboudo, PGC (corresponding author), Agence Format Rech & Expertise Sante Afrique AFRI, Bobo Dioulasso, Burkina Faso.	g.p.c.ilboudo@studmed.uio.no			Immpact; DFID-funded research programme consortium; UK Economic and Social Research Council [RES-183-25-0011]; Hewlett Foundation [RES-183-25-0011]; Research Council of Norway's ECONPOP programme [199730/H30]; Economic and Social Research Council [ES/F038402/1] Funding Source: researchfish; ESRC [ES/F038402/1] Funding Source: UKRI	Immpact; DFID-funded research programme consortium; UK Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Hewlett Foundation; Research Council of Norway's ECONPOP programme(Research Council of Norway); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The first wave was supported by Immpact (2005-2007) and a DFID-funded research programme consortium 'Towards 4 plus 5'. The second wave was supported by a joint UK Economic and Social Research Council and Hewlett Foundation grant (RES-183-25-0011; 2007-2010). Patrick G. C Ilboudo was funded by the Research Council of Norway's ECONPOP programme (Project number 199730/H30) during the analysis and writing of this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babalola S, 2011, J PAEDIATR CHILD H, V47, P276, DOI 10.1111/j.1440-1754.2010.01956.x; Baltes PB, 2001, INT ENCY SOCIAL BEHA, P14558; Bang RA, 2004, BJOG-INT J OBSTET GY, V111, P231, DOI 10.1111/j.1471-0528.2004.00063.x; Bhatia JC, 1996, SOC SCI MED, V43, P1507, DOI 10.1016/0277-9536(96)00105-0; BLOOM DE, 2009, INT PUBLIC HLTH DIS, P601; Borghi J, 2003, HEALTH POLICY PLANN, V18, P383, DOI 10.1093/heapol/czg046; DOR A, 1987, J HEALTH ECON, V6, P291, DOI 10.1016/0167-6296(87)90017-8; Elo I T, 1992, Health Transit Rev, V2, P49; Filippi V, 2007, LANCET, V370, P1329, DOI 10.1016/S0140-6736(07)61574-8; FORTNEY JA, 1996, BASE ICEBERG PREVALE; Fronczak N, 2005, INT J GYNECOL OBSTET, V91, P271, DOI 10.1016/j.ijgo.2005.09.006; Furuta M, 2006, INT FAM PLAN PERSPEC, V32, P17, DOI 10.1363/3201706; Gage AJ, 2007, SOC SCI MED, V65, P1666, DOI 10.1016/j.socscimed.2007.06.001; GERTLER P, 1993, SOC SCI MED, V37, P199, DOI 10.1016/0277-9536(93)90455-D; GLICK P, 2000, ED HLTH SERVICES MAD; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; KRISHNA A, 2010, ONE ILLNESS AWAY WHY, V17, P229; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Maxwell DG, 1996, FOOD POLICY, V21, P291, DOI 10.1016/0306-9192(96)00005-X; McIntyre D, 2006, SOC SCI MED, V62, P858, DOI 10.1016/j.socscimed.2005.07.001; Mrisho M, 2007, TROP MED INT HEALTH, V12, P862, DOI 10.1111/j.1365-3156.2007.01855.x; Powell-Jackson T, 2012, HEALTH ECON, V21, P796, DOI 10.1002/hec.1749; Ridde V, 2012, TROP MED INT HEALTH, V17, P782, DOI 10.1111/j.1365-3156.2012.02991.x; Ridde V, 2010, J EPIDEMIOL COMMUN H, V64, P10, DOI 10.1136/jech.2008.086793; Ridde V, 2008, SOC SCI MED, V66, P1368, DOI 10.1016/j.socscimed.2007.10.026; Ridde V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033082; Ridde V, 2011, SANTE PUBLIQUE, V23, P61, DOI 10.3917/spub.111.0061; RUBIN DB, 1980, BIOMETRICS, V36, P293, DOI 10.2307/2529981; RUGER JP, 1998, INT PUBLIC HLTH DIS; Russell S, 2005, HEALTH POLICY PLANN, V20, P277, DOI 10.1093/heapol/czi035; Russell S, 2004, AM J TROP MED HYG, V71, P147, DOI 10.4269/ajtmh.2004.71.147; Russell S, 2006, SOC SCI MED, V63, P1732, DOI 10.1016/j.socscimed.2006.04.017; *SANT MIN BURK FAS, 2006, STRAT NAT SUBV ACC S; *SANT MIN BURK FAS, 2010, ANN STAT 2009; Singh S, 2010, WOMENS HEALTH, V6, P849, DOI [10.2217/whe.10.70, 10.2217/WHE.10.70]; Starrs AM, 2006, LANCET, V368, P1130, DOI 10.1016/S0140-6736(06)69385-9; Stephenson R, 2006, AM J PUBLIC HEALTH, V96, P84, DOI 10.2105/AJPH.2004.057422; Storeng KT, 2008, SOC SCI MED, V66, P545, DOI 10.1016/j.socscimed.2007.10.001; Storeng KT, 2010, SOC SCI MED, V71, P1749, DOI 10.1016/j.socscimed.2010.03.056; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Uzma A, 1999, SOC SCI MED, V48, P313, DOI 10.1016/S0277-9536(98)00319-0; W.H. Organization, 2009, WORLD HLTH STAT 2009; Wagner KS, 2012, TROP MED INT HEALTH, V17, P9, DOI 10.1111/j.1365-3156.2011.02883.x; Wagstaff A, 2003, HEALTH ECON, V12, P921, DOI 10.1002/hec.776; Woldemicael G, 2010, MATERN CHILD HLTH J, V14, P988, DOI 10.1007/s10995-009-0535-5; World Health Organization, 2004, WHO QUAL LIF WHOQOL; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Zere E, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-16	48	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80010	10.1371/journal.pone.0080010	http://dx.doi.org/10.1371/journal.pone.0080010			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	247EE	24224028	Green Published, gold			2022-12-27	WOS:000326597400101
J	Sanchez-Gutierrez, D; Saez, A; Pascual, A; Escudero, LM				Sanchez-Gutierrez, Daniel; Saez, Aurora; Pascual, Alberto; Escudero, Luis M.			Topological Progression in Proliferating Epithelia Is Driven by a Unique Variation in Polygon Distribution	PLOS ONE			English	Article							CELL-SHAPE CHANGES; DROSOPHILA GASTRULATION; MORPHOGENESIS; POLARITY; CENTRALITY; NETWORKS; SHROOM; SIZE	Morphogenesis is consequence of lots of small coordinated variations that occur during development. In proliferating stages, tissue growth is coupled to changes in shape and organization. A number of studies have analyzed the topological properties of proliferating epithelia using the Drosophila wing disc as a model. These works are based in the existence of a fixed distribution of these epithelial cells according to their number of sides. Cell division, cell rearrangements or a combination of both mechanisms have been proposed to be responsible for this polygonal assembling. Here, we have used different system biology methods to compare images from two close proliferative stages that present high morphological similarity. This approach enables us to search for traces of epithelial organization. First, we show that geometrical and network characteristics of individual cells are mainly dependent on their number of sides. Second, we find a significant divergence between the distribution of polygons in epithelia from mid-third instar larva versus early prepupa. We show that this alteration propagates into changes in epithelial organization. Remarkably, only the variation in polygon distribution driven by morphogenesis leads to progression in epithelial organization. In addition, we identify the relevant features that characterize these rearrangements. Our results reveal signs of epithelial homogenization during the growing phase, before the planar cell polarity pathway leads to the hexagonal packing of the epithelium during pupal stages.	[Sanchez-Gutierrez, Daniel; Pascual, Alberto; Escudero, Luis M.] Univ Seville, Hosp Univ Virgen del Rocio, CSIC, Inst Biomed Sevilla, Seville, Spain; [Saez, Aurora] Univ Seville, Escuela Tecn Super Ingn, Seville, Spain; [Pascual, Alberto; Escudero, Luis M.] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; University of Sevilla; CIBERNED	Escudero, LM (corresponding author), Univ Seville, Hosp Univ Virgen del Rocio, CSIC, Inst Biomed Sevilla, Seville, Spain.	lmescudero-ibis@us.es	Pascual, Alberto P/E-9609-2015; Pascual, Alberto/L-2014-2019; IBIS, NEURONAL/O-9910-2015; Saez, Aurora/L-1060-2017	Pascual, Alberto P/0000-0001-5459-6207; Pascual, Alberto/0000-0001-5459-6207; Saez, Aurora/0000-0003-2555-7123; Escudero, Luis M./0000-0001-8030-1820	Miguel Servet (Instituto Carlos III) program; Spanish Ministry of Science [BFU2011-25734]; Consejeria de Innovacion, Ciencia y Empresa of the Junta de Andalucia	Miguel Servet (Instituto Carlos III) program; Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejeria de Innovacion, Ciencia y Empresa of the Junta de Andalucia(Junta de Andalucia)	LME is supported by the Miguel Servet (Instituto Carlos III) program that also funded the work. LME and DSG are funded by the Spanish Ministry of Science (BFU2011-25734). AS is funded by the Consejeria de Innovacion, Ciencia y Empresa of the Junta de Andalucia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aegerter-Wilmsen T, 2012, DEVELOPMENT, V139, P3221, DOI 10.1242/dev.082800; Aegerter-Wilmsen T, 2010, DEVELOPMENT, V137, P499, DOI 10.1242/dev.041731; Aldaz S, 2010, P NATL ACAD SCI USA, V107, P14217, DOI 10.1073/pnas.1008623107; Axelrod JD, 2006, CELL, V126, P643, DOI 10.1016/j.cell.2006.07.018; Barrett K, 1997, CELL, V91, P905, DOI 10.1016/S0092-8674(00)80482-1; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Classen AK, 2005, DEV CELL, V9, P805, DOI 10.1016/j.devcel.2005.10.016; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Costa LD, 2009, IMAGE PROCESS SER, P1; COSTA M, 1994, CELL, V76, P1075, DOI 10.1016/0092-8674(94)90384-0; Eaton S, 2011, CURR OPIN GENET DEV, V21, P747, DOI 10.1016/j.gde.2011.08.010; Escudero LM, 2007, DEV CELL, V13, P717, DOI 10.1016/j.devcel.2007.09.002; Escudero LM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1536; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Fukunaga K., 2013, INTRO STAT PATTERN R; Gho M, 1999, DEVELOPMENT, V126, P3573; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; Gibson WT, 2011, CELL, V144, P427, DOI 10.1016/j.cell.2010.12.035; Gibson WT, 2009, CURR TOP DEV BIOL, V89, P87, DOI 10.1016/S0070-2153(09)89004-2; Haigo SL, 2003, CURR BIOL, V13, P2125, DOI 10.1016/j.cub.2003.11.054; Hildebrand JD, 1999, CELL, V99, P485, DOI 10.1016/S0092-8674(00)81537-8; Kolsch V, 2007, SCIENCE, V315, P384, DOI 10.1126/science.1134833; Lecuit T, 2007, NATURE, V450, P189, DOI 10.1038/nature06304; LEPTIN M, 1990, DEVELOPMENT, V110, P73; Martin FA, 2009, DEVELOPMENT, V136, P3747, DOI 10.1242/dev.038406; Martinez-Arias M, 2002, MOL PRINCIPLES ANIMA; Milan M, 1996, P NATL ACAD SCI USA, V93, P11687, DOI 10.1073/pnas.93.21.11687; Newman MEJ, 2005, SOC NETWORKS, V27, P39, DOI 10.1016/j.socnet.2004.11.009; PARKS S, 1991, CELL, V64, P447, DOI 10.1016/0092-8674(91)90652-F; Patel AB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000412; Pilot F, 2005, DEV DYNAM, V232, P685, DOI 10.1002/dvdy.20334; Saez A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-77; Simoes SD, 2010, DEV CELL, V19, P377, DOI 10.1016/j.devcel.2010.08.011	34	12	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79227	10.1371/journal.pone.0079227	http://dx.doi.org/10.1371/journal.pone.0079227			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223910	Green Published, Green Submitted, gold			2022-12-27	WOS:000326597400053
J	Sun, CZ; Li, QL; Hu, ZD; He, JH; Li, C; Li, GJ; Tao, XF; Yang, AK				Sun, Chuanzheng; Li, Qiuli; Hu, Zedong; He, Jiehua; Li, Chao; Li, Guojun; Tao, Xiaofeng; Yang, Ankui			Treatment and Prognosis of Anaplastic Thyroid Carcinoma: Experience from a Single Institution in China	PLOS ONE			English	Article							TREATMENT OUTCOMES; SURVIVAL; CANCER; RADIOTHERAPY; SURGERY; NEUTROPHILIA; DOXORUBICIN; MANAGEMENT	Background: Anaplastic thyroid carcinoma (ATC), a highly aggressive malignancy, has a poor prognosis, and the consensus on the most effective treatment is needed. Methods: Clinical data from all ATC patients treated in our institution over a 30-year period (between May 1980 and May 2010) were analyzed retrospectively with regard to mortality and survival rates (Kaplan-Meier). Multivariate analysis was performed using a Cox proportional hazards model. Results: Sixty cases were analyzed. The overall 1- and 3-year survival rates were 35.0% and 22.9%, respectively. Univariate analysis showed that the best prognosis was seen in patients younger than 55 years, those without distant metastases, those with white blood cell (WBC) counts < 10.0 x 10(9)/L or blood platelet (PLT) counts < 300.0 x 10(9)/L at presentation, those who did not receive chemotherapy, and those who received radiotherapy doses >= 40 Gy or underwent surgery plus postoperative radiotherapy. According to multivariate analysis, the WBC count at first presentation and the type of therapeutic regimen independently influenced survival. Conclusions: We found that the elevated peripheral PLT count may be an adverse prognostic factor of ATC patients. The prognosis for ATC is especially poor for patients with distant metastasis, a WBC count >= 10.0x10(9)/L, a PLT count >= 300.0 x 10(9)/L, or age >= 55 years. WBC count at presentation and surgery with or without postoperative radiotherapy independently influenced the prognosis. Intensive treatment combining surgery with postoperative radiotherapy is recommended for ATC patients with stage IVA/B disease.	[Sun, Chuanzheng; Hu, Zedong] Kunming Med Univ, Affiliated Hosp 3, Dept Head & Neck Surg, Kunming, Yunnan, Peoples R China; [Li, Qiuli; Yang, Ankui] Sun Yat Sen Univ, Ctr Canc, Dept Head & Neck Surg, Guangzhou 510275, Guangdong, Peoples R China; [Li, Qiuli; He, Jiehua; Yang, Ankui] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [He, Jiehua] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Chao] Tumor Hosp Sichuan Prov, Dept Head & Neck Surg, Chengdu, Sichuan, Peoples R China; [Li, Guojun] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA; [Tao, Xiaofeng] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Dept Radiol, Shanghai 200030, Peoples R China	Kunming Medical University; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; University of Texas System; UTMD Anderson Cancer Center; Shanghai Jiao Tong University	Tao, XF (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Dept Radiol, Shanghai 200030, Peoples R China.	cjr.taoxiaofeng.@vip.163.com; Yangak@sysucc.org.cn			National Natural Science Foundation of China [30960444, 81260402, 81272955]; Special Foundation of High Levels of Health Technical Personnel Training in Yunnan Province [D-201243]; Natural Science Foundation of Guangdong Province, China [9451008901002400, S2011010003997]; Science and Technology Planning Project of Guangdong Province, China [2012B031800089]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Foundation of High Levels of Health Technical Personnel Training in Yunnan Province; Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangdong Province, China	This work was supported by grants from the National Natural Science Foundation of China (Numbers: 30960444, 81260402 and 81272955), Special Foundation of High Levels of Health Technical Personnel Training in Yunnan Province (No. D-201243), Natural Science Foundation of Guangdong Province, China (Numbers: 9451008901002400 and S2011010003997), and Science and Technology Planning Project of Guangdong Province, China (Number: 2012B031800089). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaishi J, 2011, THYROID, V21, P1183, DOI 10.1089/thy.2010.0332; Besic N, 2005, LANGENBECK ARCH SURG, V390, P203, DOI 10.1007/s00423-004-0524-5; Chen J, 2008, AM J CLIN ONCOL-CANC, V31, P460, DOI 10.1097/COC.0b013e31816a61f3; Derbel O, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-469; Edge SB, 2010, AJCC CANC STAGING MA; ENOMOTO T, 1990, CANCER, V65, P1971, DOI 10.1002/1097-0142(19900501)65:9<1971::AID-CNCR2820650916>3.0.CO;2-V; Foote RL, 2011, THYROID, V21, P25, DOI 10.1089/thy.2010.0220; Goutsouliak V, 2005, CLIN ONCOL-UK, V17, P75, DOI 10.1016/j.clon.2004.07.013; Haigh PI, 2001, CANCER-AM CANCER SOC, V91, P2335, DOI 10.1002/1097-0142(20010615)91:12<2335::AID-CNCR1266>3.3.CO;2-T; HOLTING T, 1989, LANGENBECK ARCH CHIR, V374, P72, DOI 10.1007/BF01261613; HOLTING T, 1990, WIEN KLIN WOCHENSCHR, V102, P264; Ito K, 2012, HEAD NECK-J SCI SPEC, V34, P230, DOI 10.1002/hed.21721; Ito Y, 2009, ASIAN J SURG, V32, P47, DOI 10.1016/S1015-9584(09)60008-7; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kebebew E, 2005, CANCER-AM CANCER SOC, V103, P1330, DOI 10.1002/cncr.20936; Kihara M, 2004, SURG TODAY, V34, P394, DOI 10.1007/s00595-003-2737-6; Lim SM, 2012, YONSEI MED J, V53, P352, DOI 10.3349/ymj.2012.53.2.352; McIver B, 2001, SURGERY, V130, P1028, DOI 10.1067/msy.2001.118266; Nakada T, 1996, INTERNAL MED, V35, P815, DOI 10.2169/internalmedicine.35.815; Noppen M, 2004, CHEST, V125, P723, DOI 10.1378/chest.125.2.723; Pasieka JL, 2003, CURR OPIN ONCOL, V15, P78, DOI 10.1097/00001622-200301000-00012; Perri F, 2011, WORLD J CLIN ONCOL, V2, P150, DOI 10.5306/wjco.v2.i3.150; Pierie JPEN, 2002, ANN SURG ONCOL, V9, P57, DOI 10.1245/aso.2002.9.1.57; Sato T, 2000, THYROID, V10, P1113, DOI 10.1089/thy.2000.10.1113; Segerhammar I, 2012, J SURG ONCOL, V106, P981, DOI 10.1002/jso.23177; Shaha AR, 2008, LARYNGOSCOPE, V118, P1195, DOI 10.1097/MLG.0b013e3181726d36; Sherman EJ, 2011, RADIOTHER ONCOL, V101, P425, DOI 10.1016/j.radonc.2011.09.004; SHIMAOKA K, 1985, CANCER, V56, P2155, DOI 10.1002/1097-0142(19851101)56:9<2155::AID-CNCR2820560903>3.0.CO;2-E; Siironen P, 2010, ONCOLOGY-BASEL, V79, P400, DOI 10.1159/000322640; Sugino K, 2002, SURGERY, V131, P245, DOI 10.1067/msy.2002.119936; Sugitani I, 2001, WORLD J SURG, V25, P617, DOI 10.1007/s002680020166; Sugitani I, 2012, WORLD J SURG, V36, P1247, DOI 10.1007/s00268-012-1437-z; Swaak-Kragten AT, 2009, RADIOTHER ONCOL, V92, P100, DOI 10.1016/j.radonc.2009.02.016; Tashima L, 2012, EUR ARCH OTO-RHINO-L, V269, P1251, DOI 10.1007/s00405-011-1762-0; Wein RO, 2011, CURR OPIN OTOLARYNGO, V19, P113, DOI 10.1097/MOO.0b013e328343af3d; Yau T, 2008, ANN SURG ONCOL, V15, P2500, DOI 10.1245/s10434-008-0005-0	36	30	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80011	10.1371/journal.pone.0080011	http://dx.doi.org/10.1371/journal.pone.0080011			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224029	Green Published, gold, Green Submitted			2022-12-27	WOS:000326597400102
J	Bruggmann, R; Jagannathan, V; Braunschweig, M				Bruggmann, Remy; Jagannathan, Vidhya; Braunschweig, Martin			In Search of Epigenetic Marks in Testes and Sperm Cells of Differentially Fed Boars	PLOS ONE			English	Article							GENE-EXPRESSION; INHERITANCE; MOUSE; METHYLATION; MAMMALS; ALLELE	In search of transmittable epigenetic marks we investigated gene expression in testes and sperm cells of differentially fed F0 boars from a three generation pig feeding experiment that showed phenotypic differences in the F2 generation. RNA samples from 8 testes of boars that received either a diet enriched in methylating micronutrients or a control diet were analyzed by microarray analysis. We found moderate differential expression between testes of differentially fed boars with a high FDR of 0.82 indicating that most of the differentially expressed genes were false positives. Nevertheless, we performed a pathway analysis and found disparate pathway maps of development_A2B receptor: action via G-protein alpha s, cell adhesion_Tight junctions and cell adhesion_Endothelial cell contacts by junctional mechanisms which show inconclusive relation to epigenetic inheritance. Four RNA samples from sperm cells of these differentially fed boars were analyzed by RNA-Seq methodology. We found no differential gene expression in sperm cells of the two groups (adjusted P-value > 0.05). Nevertheless, we also explored gene expression in sperm by a pathway analysis showing that genes were enriched for the pathway maps of bacterial infections in cystic fibrosis (CF) airways, glycolysis and gluconeogenesis p. 3 and cell cycle_Initiation of mitosis. Again, these pathway maps are miscellaneous without an obvious relationship to epigenetic inheritance. It is concluded that the methylating micronutrients moderately if at all affects RNA expression in testes of differentially fed boars. Furthermore, gene expression in sperm cells is not significantly affected by extensive supplementation of methylating micronutrients and thus RNA molecules could not be established as the epigenetic mark in this feeding experiment.	[Bruggmann, Remy] Univ Bern, Dept Biol, Bern, Switzerland; [Jagannathan, Vidhya; Braunschweig, Martin] Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland	University of Bern; University of Bern	Braunschweig, M (corresponding author), Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland.	martin.braunschweig@vetsuisse.unibe.ch	Jagannathan, Vidhya/P-1055-2019	Jagannathan, Vidhya/0000-0002-8155-0041; Bruggmann, Remy/0000-0001-5629-6363				Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Blewitt ME, 2006, PLOS GENET, V2, P399, DOI 10.1371/journal.pgen.0020049; Braunschweig M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030583; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Daxinger L, 2012, NAT REV GENET, V13, P153, DOI 10.1038/nrg3188; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Grossniklaus U, 2013, NAT REV GENET, V14, P228, DOI 10.1038/nrg3435; Gutzwiller A, 2009, VET REC, V165, P598, DOI 10.1136/vr.165.20.598; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wagner KD, 2008, DEV CELL, V14, P962, DOI 10.1016/j.devcel.2008.03.009	19	6	6	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78691	10.1371/journal.pone.0078691	http://dx.doi.org/10.1371/journal.pone.0078691			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223838	Green Published, Green Submitted, gold			2022-12-27	WOS:000326503400081
J	Heinis, FI; Andersson, KB; Christensen, G; Metzger, JM				Heinis, Frazer I.; Andersson, Kristin B.; Christensen, Geir; Metzger, Joseph M.			Prominent Heart Organ-Level Performance Deficits in a Genetic Model of Targeted Severe and Progressive SERCA2 Deficiency	PLOS ONE			English	Article							DIASTOLIC DYSFUNCTION; CARDIAC-PERFORMANCE; FAILURE; MICE; DISRUPTION; EXPRESSION; KNOCKOUT; ATPASE	The cardiac SERCA2 Ca2+ pump is critical for maintaining normal Ca2+ handling in the heart. Reduced SERCA2a content and blunted Ca2+ reuptake are frequently observed in failing hearts and evidence implicates poor cardiac Ca2+ handling in the progression of heart failure. To gain insight into mechanism we investigated a novel genetic mouse model of inducible severe and progressive SERCA2 deficiency (inducible Serca2 knockout, SERCA2 KO). These mice eventually die from overt heart failure 7-10 weeks after knockout but as yet there have been no reports on intrinsic mechanical performance at the isolated whole heart organ level. Thus we studied whole-organ ex vivo function of hearts isolated from SERCA2 KO mice at one and four weeks post-knockout in adult animals. We found that isolated KO heart function was only modestly impaired one week post-knockout, when SERCA2a protein was 32% of normal. At four weeks post-knockout, function was severely impaired with near non-detectable levels of SERCA2. During perfusion with 10 mM caffeine, LV developed pressures were similar between 4-week KO and control hearts, and end-diastolic pressures were lower in KO. When hearts were subjected to ischemia-reperfusion injury, recovery was not different between control and KO hearts at either one or four weeks post-knockout. Our findings indicate that ex vivo function of isolated SERCA2 KO hearts is severely impaired long before symptoms appear in vivo, suggesting that physiologically relevant heart function in vivo can be sustained for weeks in the absence of robust SR Ca2+ flux.	[Heinis, Frazer I.; Metzger, Joseph M.] Univ Minnesota, Sch Med, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA; [Heinis, Frazer I.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN USA; [Andersson, Kristin B.; Christensen, Geir] Univ Oslo, Ullevaal Hosp, Expt Med Res Inst, N-0407 Oslo, Norway; [Andersson, Kristin B.; Christensen, Geir] Univ Oslo, Oslo, Norway; [Andersson, Kristin B.; Christensen, Geir] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Oslo; University of Oslo; University of Oslo	Metzger, JM (corresponding author), Univ Minnesota, Sch Med, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA.	metzgerj@umn.edu			National Institutes of Health (NIH) [5R01HL059301-14]; NIA [5T32AG029796-05]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG029796] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (NIH) 5R01HL059301-14 to JMM. FIH was supported by NIA training grant 5T32AG029796-05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson KB, 2009, CELL CALCIUM, V46, P219, DOI 10.1016/j.ceca.2009.07.004; Andersson KB, 2009, J MOL CELL CARDIOL, V47, P180, DOI 10.1016/j.yjmcc.2009.03.013; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Cross HR, 2003, AM J PHYSIOL-HEART C, V284, pH683, DOI 10.1152/ajpheart.00567.2002; Elliott EB, 2012, CIRC RES, V110, P1618, DOI 10.1161/CIRCRESAHA.111.262337; Engelhardt S, 2004, CIRCULATION, V109, P1154, DOI 10.1161/01.CIR.0000117254.68497.39; GWATHMEY JK, 1987, CIRC RES, V61, P70, DOI 10.1161/01.RES.61.1.70; Hiranandani N, 2007, AM J PHYSIOL-REG I, V293, pR30, DOI 10.1152/ajpregu.00508.2006; Ji Y, 2000, J BIOL CHEM, V275, P38073, DOI 10.1074/jbc.M004804200; LOMPRE AM, 1991, CIRC RES, V69, P1380, DOI 10.1161/01.RES.69.5.1380; Louch WE, 2006, J PHYSIOL-LONDON, V574, P519, DOI 10.1113/jphysiol.2006.107227; Louch WE, 2010, J PHYSIOL-LONDON, V588, P465, DOI 10.1113/jphysiol.2009.183517; Mayosi BM, 2006, HEART, V92, P105, DOI 10.1136/hrt.2004.051037; Periasamy M, 1999, J BIOL CHEM, V274, P2556, DOI 10.1074/jbc.274.4.2556; Pogwizd SM, 1999, CIRC RES, V85, P1009; Schmidt U, 1998, J MOL CELL CARDIOL, V30, P1929, DOI 10.1006/jmcc.1998.0748; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Stokke MK, 2010, CARDIOVASC RES, V86, P63, DOI 10.1093/cvr/cvp401; Swift F, 2012, P NATL ACAD SCI USA, V109, P3997, DOI 10.1073/pnas.1120172109; Wei S, 2010, CIRC RES, V107, P520, DOI 10.1161/CIRCRESAHA.109.212324	20	9	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79609	10.1371/journal.pone.0079609	http://dx.doi.org/10.1371/journal.pone.0079609			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223976	gold, Green Published, Green Submitted			2022-12-27	WOS:000326503400127
J	Hoftberger, R; Sabater, L; Marignier, R; Aboul-Enein, F; Bernard-Valnet, R; Rauschka, H; Ruiz, A; Blanco, Y; Graus, F; Dalmau, J; Saiz, A				Hoeftberger, Romana; Sabater, Lidia; Marignier, Romain; Aboul-Enein, Fahmy; Bernard-Valnet, Raphael; Rauschka, Helmut; Ruiz, Anne; Blanco, Yolanda; Graus, Francesc; Dalmau, Josep; Saiz, Albert			An Optimized Immunohistochemistry Technique Improves NMO-IgG Detection: Study Comparison with Cell-Based Assays	PLOS ONE			English	Article							MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; REVISED DIAGNOSTIC-CRITERIA; NEUROMYELITIS-OPTICA; ANTIBODIES; SPECTRUM; PREDICTS; SERIES	Cell-based assays (CBA) have increased the sensitivity of the neuromyelitis optica (NMO)-IgG/aquaporin-4-antibody detection compared to classical tissue-based indirect assays. We describe the sensitivity of an optimized immunohistochemistry (IHC-o) to detect NMO-IgG/aquaporin-4-antibody in comparison with that of two CBA: an in-house (CBA-ih) and a commercial (CBA-c) assay (Euroimmun, Germany). Coded serum from 103 patients with definite NMO and 122 inflammatory controls were studied by IHC-o, CBA-ih, and CBA-c. IHC-o used the same protocol described to detect antibodies against cell surface antigens. CBA-ih used live cells transfected with the aquaporin-4-M23-isoform. The sensitivity of the IHC-o was 74.8% (95% confidence interval [CI] 65-83) and was similar to that of the CBA-ih 75.7% (95% CI 66-84) and the CBA-c 73.8% (95% CI 64-82). The specificity of the three assays was 100% (95% CI 97-100). Interassay concordance was high, 100 of 103 samples were coincident in all techniques. The optimized immunohistochemistry proves to be as sensitive and specific as the cell-based assays. This assay extends the available tools for NMO-IgG/aquaporin-4-antibody detection.	[Hoeftberger, Romana; Sabater, Lidia; Blanco, Yolanda; Graus, Francesc; Saiz, Albert] Univ Barcelona, Serv Neurol, Hosp Clin, Barcelona, Spain; [Hoeftberger, Romana; Sabater, Lidia; Blanco, Yolanda; Graus, Francesc; Saiz, Albert] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Hoeftberger, Romana] Med Univ Vienna, Inst Neurol, Vienna, Austria; [Marignier, Romain; Bernard-Valnet, Raphael; Ruiz, Anne] Lyon Neurosci Res Ctr, Team ONCOFLAM, INSERM U1028, CNRS 5292, Lyon, France; [Aboul-Enein, Fahmy; Rauschka, Helmut] SMZ Ost Donauspital, Dept Neurol, Vienna, Austria; [Dalmau, Josep] Hosp Clin Barcelona, IDIBAPS, Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain; [Dalmau, Josep] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Medical University of Vienna; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; Donauspital; ICREA; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Pennsylvania	Saiz, A (corresponding author), Univ Barcelona, Serv Neurol, Hosp Clin, Barcelona, Spain.	asaiz@clinic.ub.es	Graus, Francesc/K-9904-2018; Bernard-Valnet, Raphael/AAP-8978-2020; Bernard-Valnet, Raphaël/L-5971-2016; Sabater, Lidia/U-7570-2019; Saiz, Albert/K-8236-2014; Sabater, Lidia/C-7627-2018	Bernard-Valnet, Raphael/0000-0001-7447-344X; Bernard-Valnet, Raphaël/0000-0001-7447-344X; Saiz, Albert/0000-0002-5793-8791; Sabater, Lidia/0000-0001-8556-6166; Graus, Francesc/0000-0002-8924-8322; Dalmau, Josep/0000-0001-5856-2813; Hoftberger, Romana/0000-0002-5769-1100	Fondo de Investigaciones Sanitarias, Madrid, Spain [11/01780]; NIH [RO1NS077851]; Fundacio la Marato de TV3 [AS 101610]; Fonds zur Forderung der wissenschaftlichen Forschung, Austria [J3230]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077851] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	Fondo de Investigaciones Sanitarias, Madrid, Spain; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacio la Marato de TV3; Fonds zur Forderung der wissenschaftlichen Forschung, Austria(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); ICREA(ICREA)	This study has been supported in part by grant 11/01780 (JD) from the Fondo de Investigaciones Sanitarias, Madrid, Spain; NIH RO1NS077851 (JD), Fundacio la Marato de TV3 (JD; AS 101610), and the Fonds zur Forderung der wissenschaftlichen Forschung, Austria, Project J3230 (RH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboul-Enein F, 2010, AM J NEURORADIOL, V31, P76, DOI 10.3174/ajnr.A1791; Blanco Y, 2010, NEUROLOGIA, V25, P5; Dalmau J, 2008, LANCET NEUROL, V7, P1091, DOI 10.1016/S1474-4422(08)70224-2; Hsu MS, 2011, NEUROSCIENCE, V178, P21, DOI 10.1016/j.neuroscience.2011.01.020; Jarius S, 2010, J NEUROL SCI, V291, P52, DOI 10.1016/j.jns.2010.01.002; Jarius S, 2010, NAT REV NEUROL, V6, P383, DOI 10.1038/nrneurol.2010.72; Kitley J, 2012, NEUROLOGY, V79, P1273, DOI 10.1212/WNL.0b013e31826aac4e; Lancaster E, 2012, NAT REV NEUROL, V8, P380, DOI 10.1038/nrneurol.2012.99; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Mader S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-184; Mader S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010455; Marignier R, 2008, MULT SCLER, V14, P440, DOI 10.1177/1352458507084595; Matiello M, 2008, NEUROLOGY, V70, P2197, DOI 10.1212/01.wnl.0000303817.82134.da; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Rostasy K, 2012, MULT SCLER; Saiz A, 2007, J NEUROL, V254, P1233, DOI 10.1007/s00415-007-0509-8; Waters P, 2008, Int MS J, V15, P99; Waters PJ, 2012, NEUROLOGY, V78, P665, DOI 10.1212/WNL.0b013e318248dec1; Weinshenker BG, 2006, ANN NEUROL, V59, P566, DOI 10.1002/ana.20770; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8	21	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79083	10.1371/journal.pone.0079083	http://dx.doi.org/10.1371/journal.pone.0079083			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223884	Green Submitted, Green Published, gold			2022-12-27	WOS:000326503400097
J	Pandey, MK; Gowda, K; Doi, K; Sharma, AK; Wang, HG; Amin, S				Pandey, Manoj K.; Gowda, Krishne; Doi, Kenichiro; Sharma, Arun K.; Wang, Hong-Gang; Amin, Shantu			Proteasomal Degradation of Mcl-1 by Maritoclax Induces Apoptosis and Enhances the Efficacy of ABT-737 in Melanoma Cells	PLOS ONE			English	Article							BCL-2 FAMILY-MEMBERS; SMALL-MOLECULE; TARGETING MCL-1; BH3-MIMETIC ABT-737; ANTISENSE THERAPY; DOWN-REGULATION; UP-REGULATION; LUNG-CANCER; RESISTANCE; PROTEINS	Background and purpose: Metastatic melanoma remains one of the most invasive and highly drug resistant cancers. The over expression of anti-apoptotic protein Mcl-1 has been associated with inferior survival, poor prognosis and chemoresistance of malignant melanoma. A BH3 mimetic, ABT-737, has demonstrated efficacy in several forms of cancers. However, the efficacy of ABT-737 depends on Mcl-1. Because the over expression of Mcl-1 is frequently observed in melanoma, specifically targeting of Mcl-1 may overcome the resistance of ABT-737. In this study, we investigated the effects of Maritoclax, a novel Mcl-1-selective inhibitor, alone and in combination with ABT-737, on the survival of human melanoma cells. Experimental approach: For cell viability assessment we performed MTT assay. Apoptosis was determined using western blot and flow cytometric analysis. Key results: The treatment of Maritoclax reduced the cell viability of melanoma cells with an IC50 of between 2.2-5.0 mu M. Further, treatment of melanoma cells with Maritoclax showed significant decrease in Mcl-1 expression. We found that Maritoclax was able to induce apoptosis in melanoma cells in a caspase-dependent manner. Moreover, Maritoclax induced Mcl-1 degradation via the proteasome system, which was associated with its pro-apoptotic activity. We also found that Maritoclax treatment increased mitochondrial translocation of Bim and Bmf. Importantly, Maritoclax markedly enhanced the efficacy of ABT-737 against melanoma cells in both two-and three-dimensional spheroids. Conclusions and implications: Taken together, these results suggest that targeting of Mcl-1 by Maritoclax may represent a new therapeutic strategy for melanoma treatment that warrants further investigation as a single therapy or in combination with other agents such as Bcl-2 inhibitors.	[Pandey, Manoj K.; Gowda, Krishne; Doi, Kenichiro; Sharma, Arun K.; Wang, Hong-Gang; Amin, Shantu] Penn State Coll Med, Dept Pharmacol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Amin, S (corresponding author), Penn State Coll Med, Dept Pharmacol, Hershey, PA 17033 USA.	huw11@psu.edu; sga3@psu.edu	Pandey, Manoj K/K-9706-2015; Wang, Hong-Gang/A-3018-2015	Pandey, Manoj K/0000-0002-2767-2929; Wang, Hong-Gang/0000-0003-0551-0571; Sharma, Arun/0000-0002-7679-7779; GOWDA, KRISHNE/0000-0002-6042-0520	Penn State Hershey Cancer Institute of the Penn State College of Medicine	Penn State Hershey Cancer Institute of the Penn State College of Medicine	The Penn State Hershey Cancer Institute of the Penn State College of Medicine supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awan FT, 2009, BLOOD, V113, P535, DOI 10.1182/blood-2008-08-173450; Baggstrom MQ, 2011, J THORAC ONCOL, V6, P1757, DOI 10.1097/JTO.0b013e31822e2941; Bharadwaj U, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-106; Bush JA, 2003, CLIN EXP METASTAS, V20, P531, DOI 10.1023/A:1025874502181; Cao XF, 2003, BLOOD, V102, P2605, DOI 10.1182/blood-2003-01-0211; Carvajal RD, 2011, JAMA-J AM MED ASSOC, V305, P2327, DOI 10.1001/jama.2011.746; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Cohen NA, 2012, CHEM BIOL, V19, P1175, DOI 10.1016/j.chembiol.2012.07.018; Cory S, 2005, CANCER CELL, V8, P5, DOI 10.1016/j.ccr.2005.06.012; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Ding QQ, 2008, CANCER RES, V68, P6109, DOI 10.1158/0008-5472.CAN-08-0579; Doi K, 2012, J BIOL CHEM, V287, P10224, DOI 10.1074/jbc.M111.334532; Eberle J, 2008, CURR GENOMICS, V9, P409, DOI 10.2174/138920208785699571; Fecker LF, 2006, J INVEST DERMATOL, V126, P1366, DOI 10.1038/sj.jid.5700192; Friberg A, 2013, J MED CHEM, V56, P15, DOI 10.1021/jm301448p; Gao G, 2000, J CELL BIOCHEM, V80, P53; Gillings AS, 2009, FEBS J, V276, P6050, DOI 10.1111/j.1742-4658.2009.07329.x; Godugu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053708; Gomez-Bougie P, 2005, ONCOGENE, V24, P8076, DOI 10.1038/sj.onc.1208949; Gomez-Bougie P, 2011, BIOCHEM BIOPH RES CO, V413, P460, DOI 10.1016/j.bbrc.2011.08.118; Grossman D, 2001, CANCER METAST REV, V20, P3, DOI 10.1023/A:1013123532723; Hann CL, 2008, CANCER RES, V68, P2321, DOI 10.1158/0008-5472.CAN-07-5031; Hikita H, 2010, HEPATOLOGY, V52, P1310, DOI 10.1002/hep.23836; Hughes CC, 2009, J AM CHEM SOC, V131, P12094, DOI 10.1021/ja903149u; Jackson RS, 2012, NEOPLASIA, V14, P656, DOI 10.1593/neo.12640; Jansen B, 2000, LANCET, V356, P1728, DOI 10.1016/S0140-6736(00)03207-4; Jemal A, 2002, CA-CANCER J CLIN, V52, P23, DOI 10.3322/canjclin.52.1.23; Jiang CC, 2008, CANCER RES, V68, P6708, DOI 10.1158/0008-5472.CAN-08-0349; Keuling AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006651; Kinross KM, 2011, MOL CANCER THER, V10, P1440, DOI 10.1158/1535-7163.MCT-11-0240; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Lin X, 2007, ONCOGENE, V26, P3972, DOI 10.1038/sj.onc.1210166; Liu L, 2011, CANCER RES, V71, P3972, DOI 10.1158/0008-5472.CAN-10-3852; Liu Qiang, 2012, Commun Integr Biol, V5, P557, DOI 10.4161/cib.21554; Lucas KM, 2012, CLIN CANCER RES, V18, P783, DOI 10.1158/1078-0432.CCR-11-1166; Ma YH, 2003, MOL CANCER THER, V2, P73; Munshi A, 2005, METH MOLEC MED, V110, P21; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Nguyen N, 2011, CANCER PREV RES, V4, P248, DOI 10.1158/1940-6207.CAPR-10-0106; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Pandey MK, 2007, BLOOD, V110, P3517, DOI 10.1182/blood-2007-03-079616; Perets A, 2003, J BIOMED MATER RES A, V65A, P489, DOI 10.1002/jbm.a.10542; Pinon JD, 2008, ONCOGENE, V27, pS41, DOI 10.1038/onc.2009.42; Puthalakath H, 2001, SCIENCE, V293, P1829, DOI 10.1126/science.1062257; Qin JZ, 2006, CANCER RES, V66, P9636, DOI 10.1158/0008-5472.CAN-06-0747; Quinn BA, 2011, EXPERT OPIN INV DRUG, V20, P1397, DOI 10.1517/13543784.2011.609167; Selzer E, 1998, MELANOMA RES, V8, P197, DOI 10.1097/00008390-199806000-00001; Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454; Sondak Vernon K, 2009, Pigment Cell Melanoma Res, V22, P386, DOI 10.1111/j.1755-148X.2009.00593.x; Thallinger C, 2003, J INVEST DERMATOL, V120, P1081, DOI 10.1046/j.1523-1747.2003.12252.x; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Visone R, 2011, BLOOD, V118, P3072, DOI 10.1182/blood-2011-01-333484; Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137; Wang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052483; Weber A, 2009, TRANSL ONCOL, V2, P73, DOI 10.1593/tlo.08223; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wood DE, 1998, ONCOGENE, V17, P1069, DOI 10.1038/sj.onc.1202034; Woods NT, 2007, CANCER RES, V67, P10744, DOI 10.1158/0008-5472.CAN-07-3148; Yecies D, 2010, BLOOD, V115, P3304, DOI 10.1182/blood-2009-07-233304; Zambon AC, 2011, J BIOL CHEM, V286, P33260, DOI 10.1074/jbc.M111.268979	61	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78570	10.1371/journal.pone.0078570	http://dx.doi.org/10.1371/journal.pone.0078570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223823	Green Submitted, Green Published, gold			2022-12-27	WOS:000326503400073
J	Sarrade-Loucheur, A; Xu, SY; Chan, SH				Sarrade-Loucheur, Arthur; Xu, Shuang-yong; Chan, Siu-Hong			The Role of the Methyltransferase Domain of Bifunctional Restriction Enzyme RM.BpuSI in Cleavage Activity	PLOS ONE			English	Article							ADENOSYL-L-METHIONINE; MODIFICATION SYSTEM; RECOGNITION SITE; DNA CLEAVAGE; ENDONUCLEASE; SEQUENCE; FAMILY; MMEI; COMPLEX; BINDING	Restriction enzyme (REase) RM.BpuSI can be described as a Type IIS/C/G REase for its cleavage site outside of the recognition sequence (Type IIS), bifunctional polypeptide possessing both methyltransferase (MTase) and endonuclease activities (Type IIC) and endonuclease activity stimulated by S-adenosyl-L-methionine (SAM) (Type IIG). The stimulatory effect of SAM on cleavage activity presents a major paradox: a co-factor of the MTase activity that renders the substrate unsusceptible to cleavage enhances the cleavage activity. Here we show that the RM. BpuSI MTase activity modifies both cleavage substrate and product only when they are unmethylated. The MTase activity is, however, much lower than that of M1. BpuSI and is thought not to be the major MTase for host DNA protection. SAM and sinefungin (SIN) increase the V-max of the RM. BpuSI cleavage activity with a proportional change in Km, suggesting the presence of an energetically more favorable pathway is taken. We further showed that RM. BpuSI undergoes substantial conformational changes in the presence of Ca2+, SIN, cleavage substrate and/or product. Distinct conformers are inferred as the pre-cleavage/cleavage state (in the presence of Ca2+, substrate or both) and MTase state (in the presence of SIN and substrate, SIN and product or product alone). Interestingly, RM. BpuSI adopts a unique conformation when only SIN is present. This SIN-bound state is inferred as a branch point for cleavage and MTase activity and an intermediate to an energetically favorable pathway for cleavage, probably through increasing the binding affinity of the substrate to the enzyme under cleavage conditions. Mutation of a SAM-binding residue resulted in altered conformational changes in the presence of substrate or Ca2+ and eliminated cleavage activity. The present study underscores the role of the MTase domain as facilitator of efficient cleavage activity for RM. BpuSI.	[Sarrade-Loucheur, Arthur; Xu, Shuang-yong; Chan, Siu-Hong] New England Biolabs Inc, Ipswich, MA USA	New England Biolabs	Chan, SH (corresponding author), New England Biolabs Inc, Ipswich, MA USA.	chan@neb.com		Sarrade-Loucheur, Arthur/0000-0003-3505-2532; Chan, Siu-Hong/0000-0002-9554-7273	New England Biolabs, Inc.	New England Biolabs, Inc.	Authors Shuang-yong Xu and Siu-Hong Chan have an affiliation to a commercial funder of this research (New England Biolabs, Inc.). Author Shuang-yong Xu is an Academic Editor for PLOS ONE. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	BICKLE TA, 1978, P NATL ACAD SCI USA, V75, P3099, DOI 10.1073/pnas.75.7.3099; Bist P, 2001, J MOL BIOL, V310, P93, DOI 10.1006/jmbi.2001.4744; Borgaro JG, 2013, NUCLEIC ACIDS RES, V41, P4198, DOI 10.1093/nar/gkt102; Bourniquel AA, 2002, BIOCHIMIE, V84, P1047, DOI 10.1016/S0300-9084(02)00020-2; CHERNOV AV, 1995, NUCLEIC ACIDS RES, V23, P1213, DOI 10.1093/nar/23.7.1213; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Goedecke K, 2001, NAT STRUCT BIOL, V8, P121, DOI 10.1038/84104; JANULAITIS A, 1983, FEBS LETT, V151, P243, DOI 10.1016/0014-5793(83)80078-7; Jeltsch A, 2000, METH MOL B, V160, P287; Jurenaite-Urbanaviciene S, 2001, NUCLEIC ACIDS RES, V29, P895, DOI 10.1093/nar/29.4.895; Lepikhov K, 2001, NUCLEIC ACIDS RES, V29, P4691, DOI 10.1093/nar/29.22.4691; Matulis D, 1998, BIOPHYS J, V74, P422, DOI 10.1016/S0006-3495(98)77799-9; MEISEL A, 1995, EMBO J, V14, P2958, DOI 10.1002/j.1460-2075.1995.tb07296.x; Morgan RD, 2008, NUCLEIC ACIDS RES, V36, P6558, DOI 10.1093/nar/gkn711; Morgan RD, 2009, NUCLEIC ACIDS RES, V37, P5208, DOI 10.1093/nar/gkp534; Nakonieczna J, 2007, MOL BIOTECHNOL, V37, P127, DOI 10.1007/s12033-007-0034-0; Peakman LJ, 2003, J MOL BIOL, V333, P321, DOI 10.1016/j.jmb.2003.08.042; PETRUSYTE M, 1988, GENE, V74, P89, DOI 10.1016/0378-1119(88)90259-4; Pieper U, 2002, BIOCHEMISTRY-US, V41, P5245, DOI 10.1021/bi015687u; Pingoud A, 2001, NUCLEIC ACIDS RES, V29, P3705, DOI 10.1093/nar/29.18.3705; Roberts RJ, 2005, P NATL ACAD SCI USA, V102, P5905, DOI 10.1073/pnas.0500923102; Roberts RJ, 2003, NUCLEIC ACIDS RES, V31, P1805, DOI 10.1093/nar/gkg274; Shen BW, 2011, NUCLEIC ACIDS RES, V39, P8223, DOI 10.1093/nar/gkr543; Sistla S, 2004, CRIT REV BIOCHEM MOL, V39, P1, DOI 10.1080/10409230490440532; Wang H, 2011, NUCLEIC ACIDS RES, V39, P9294, DOI 10.1093/nar/gkr607; Xu SY, 2011, NUCLEIC ACIDS RES, V39, P5597, DOI 10.1093/nar/gkr098; Zheng Y, 2010, NUCLEIC ACIDS RES, V38, P5527, DOI 10.1093/nar/gkq327; Zylicz-Stachula A, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-13; Zylicz-Stachula A, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-62	29	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e80967	10.1371/journal.pone.0080967	http://dx.doi.org/10.1371/journal.pone.0080967			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24224063	Green Published, Green Submitted, gold			2022-12-27	WOS:000326503400157
J	Nefs, G; Pop, VJM; Denollet, J; Pouwer, F				Nefs, Giesje; Pop, Victor J. M.; Denollet, Johan; Pouwer, Francois			The Longitudinal Association between Depressive Symptoms and Initiation of Insulin Therapy in People with Type 2 Diabetes in Primary Care	PLOS ONE			English	Article							CO-MORBID DEPRESSION; EUROPEAN DEPRESSION; COMORBID DEPRESSION; CLINICAL INERTIA; GLYCEMIC CONTROL; RESISTANCE; MELLITUS; ADULTS; HYPERGLYCEMIA; PREVALENCE	Objective: To examine whether depressive symptoms are associated with time to insulin initiation in insulin-naive people with type 2 diabetes in primary care. Methods: 1,389 participants completed the Edinburgh Depression Scale (EDS) in 2005 and were followed until: 1) insulin therapy was started, 2) death, 3) an oral antihyperglycemic drug (OAD) prescription gap >1 year, 4) last OAD prescription in 2010 or 5) the end of the study (December 31, 2010). Cox regression analyses were used to determine whether there was a difference in time to insulin initiation between people with a low versus a high depression score at baseline, adjusting for potential demographic and clinical confounders, including HbA(1c) levels. Results: The prevalence of depression (EDS >= 12) was 12% (n=168). After a mean follow-up of 1,597 +/- 537 days, 253 (18%) participants had started insulin therapy. The rate of insulin initiation did not differ between depressed and non-depressed participants. People with depression were not more likely to start insulin therapy earlier or later than their non-depressed counterparts (HR=0.98, 95% CI 0.66-1.45), also after adjustment for sex and age (HR=0.95, 0.64-1.42). The association remained non-significant when individual candidate confounders were added to the age-and sex-adjusted base model. Conclusions: In the present study, depression was not associated with time to insulin initiation. The hypothesis that depression is associated with delayed initiation of insulin therapy merits more thorough testing, preferably in studies where more information is available about patient-, provider-and health care system factors that may influence the decision to initiate insulin.	[Nefs, Giesje; Pop, Victor J. M.; Denollet, Johan; Pouwer, Francois] Tilburg Univ, Dept Med & Clin Psychol, CORPS Ctr Res Psychol Somat Dis, NL-5000 LE Tilburg, Netherlands	Tilburg University	Pouwer, F (corresponding author), Tilburg Univ, Dept Med & Clin Psychol, CORPS Ctr Res Psychol Somat Dis, NL-5000 LE Tilburg, Netherlands.	f.pouwer@tilburguniversity.edu	Nefs, Giesje/C-9992-2018	Pouwer, Frans/0000-0002-8172-9818	ZonMW grant from the Netherlands Organisation for Health Research and Development; Vici grant from the Netherlands Organisation for Scientific Research (The Hague, The Netherlands)	ZonMW grant from the Netherlands Organisation for Health Research and Development; Vici grant from the Netherlands Organisation for Scientific Research (The Hague, The Netherlands)	This study was supported by a ZonMW grant from the Netherlands Organisation for Health Research and Development, and by a Vici grant from the Netherlands Organisation for Scientific Research (The Hague, The Netherlands). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; APA, 2000, DIAGN STAT MAN MENT; Black SA, 2003, DIABETES CARE, V26, P2822, DOI 10.2337/diacare.26.10.2822; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; de Cock ESA, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-141; De Grauw WJC, 2009, HUISARTS WET, V52, P586, DOI DOI 10.1007/BF03085802; Donnan PT, 2002, DIABETIC MED, V19, P606, DOI 10.1046/j.1464-5491.2002.00743.x; Egede LE, 2005, DIABETES CARE, V28, P1339, DOI 10.2337/diacare.28.6.1339; Egede LE, 2002, DIABETES CARE, V25, P464, DOI 10.2337/diacare.25.3.464; Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341; Grant RW, 2007, DIABETES CARE, V30, P1448, DOI 10.2337/dc06-2499; Grenard JL, 2011, J GEN INTERN MED, V26, P1175, DOI 10.1007/s11606-011-1704-y; HERINGS RMC, 1992, J EPIDEMIOL COMMUN H, V46, P136, DOI 10.1136/jech.46.2.136; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Larkin ME, 2008, DIABETES EDUCATOR, V34, P511, DOI 10.1177/0145721708317869; Lin EHB, 2010, DIABETES CARE, V33, P264, DOI 10.2337/dc09-1068; Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934; Makine C, 2009, DIABETIC MED, V26, P28, DOI 10.1111/j.1464-5491.2008.02606.x; Meece J, 2006, DIABETES EDUCATOR, V32, p9S, DOI 10.1177/0145721705285638; Nathan DM, 2006, DIABETES CARE, V29, P1963, DOI 10.2337/dc06-9912; Nefs G, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-388; Nichols GA, 2007, J GEN INTERN MED, V22, P453, DOI 10.1007/s11606-007-0139-y; Nyklicek I, 2004, PSYCHIAT RES, V128, P111, DOI 10.1016/j.psychres.2004.05.017; Parchman ML, 2007, ANN FAM MED, V5, P196, DOI 10.1370/afm.679; Parchman ML, 2012, PRIM CARE DIABETES, V6, P19, DOI 10.1016/j.pcd.2011.06.006; Peyrot M, 2005, DIABETES CARE, V28, P2673, DOI 10.2337/diacare.28.11.2673; Polonsky WH, 2005, DIABETES CARE, V28, P2543, DOI 10.2337/diacare.28.10.2543; POP VJ, 1992, J AFFECT DISORDERS, V26, P105, DOI 10.1016/0165-0327(92)90041-4; Pouwer F, 2003, DIABETOLOGIA, V46, P892, DOI 10.1007/s00125-003-1124-6; Ratanawongsa N, 2012, DIABETES EDUCATOR, V38, P94, DOI 10.1177/0145721711432649; Rubino A, 2007, DIABETIC MED, V24, P1412, DOI 10.1111/j.1464-5491.2007.02279.x; Rutten G.E.H.M., 2006, HUIS WETEN, V49, P137; Schram MT, 2009, CURR DIABETES REV, V5, P112, DOI 10.2174/157339909788166828; Spoelstra JA, 2002, NETH J MED, V60, P243; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1999, JAMA-J AM MED ASSOC, V281, P2005, DOI 10.1001/jama.281.21.2005; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; TURNER RC, 1995, DIABETES, V44, P1249; Twisk JWR., 2011, INLEIDING TOEGEPASTE; Woudenberg YJC, 2012, DIABETIC MED, V29, P796, DOI 10.1111/j.1464-5491.2011.03552.x	41	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78865	10.1371/journal.pone.0078865	http://dx.doi.org/10.1371/journal.pone.0078865			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223860	Green Published, gold, Green Submitted			2022-12-27	WOS:000326499300038
J	Nemethova, A; Michel, K; Gomez-Pinilla, PJ; Boeckxstaens, GE; Schemann, M				Nemethova, Andrea; Michel, Klaus; Gomez-Pinilla, Pedro J.; Boeckxstaens, Guy E.; Schemann, Michael			Nicotine Attenuates Activation of Tissue Resident Macrophages in the Mouse Stomach through the beta 2 Nicotinic Acetylcholine Receptor	PLOS ONE			English	Article							ALVEOLAR MACROPHAGES; INTRACELLULAR CA2+; STIMULATION; SURVIVAL; NEURONS	Background: The cholinergic anti-inflammatory pathway is an endogenous mechanism by which the autonomic nervous system attenuates macrophage activation via nicotinic acetylcholine receptors (nAChR). This concept has however not been demonstrated at a cellular level in intact tissue. To this end, we have studied the effect of nicotine on the activation of resident macrophages in a mouse stomach preparation by means of calcium imaging. Methods: Calcium transients ([Ca2+](i)) in resident macrophages were recorded in a mouse stomach preparation containing myenteric plexus and muscle layers by Fluo-4. Activation of macrophages was achieved by focal puff administration of ATP. The effects of nicotine on activation of macrophages were evaluated and the nAChR involved was pharmacologically characterized. The proximity of cholinergic nerves to macrophages was quantified by confocal microscopy. Expression of beta 2 and alpha 7 nAChR was evaluated by beta 2 immunohistochemistry and fluorophore-tagged alpha-bungarotoxin. Results: In 83% of macrophages cholinergic varicose nerve fibers were detected at distances <900nm. The ATP induced [Ca2+](i) increase was significantly inhibited in 65% or 55% of macrophages by 100 mu M or 10 mu M nicotine, respectively. This inhibitory effect was reversed by the beta 2 nAChR preferring antagonist dihydro-beta-eryhtroidine but not by hexamethonium (non-selective nAChR-antagonist), mecamylamine (alpha 3 beta 4 nAChR-preferring antagonist), alpha-bungarotoxin or methyllycaconitine (both alpha 7 nAChR-preferring antagonist). Macrophages in the stomach express beta 2 but not alpha 7 nAChR at protein level, while those in the intestine express both receptor subunits. Conclusion: This study is the first in situ demonstration of an inhibition of macrophage activation by nicotine suggesting functional signaling between cholinergic neurons and macrophages in the stomach. The data suggest that the beta 2 subunit of the nAChR is critically involved in the nicotine-induced inhibition of these resident macrophages.	[Nemethova, Andrea; Gomez-Pinilla, Pedro J.; Boeckxstaens, Guy E.] Katholieke Univ Leuven, Translat Res Ctr Gastrointestinal Disorders TARGI, Dept Clin & Expt Med, Louvain, Belgium; [Michel, Klaus; Schemann, Michael] Tech Univ Munich, Freising Weihenstephan, Germany	KU Leuven; Technical University of Munich	Schemann, M (corresponding author), Tech Univ Munich, Freising Weihenstephan, Germany.	schemann@wzw.tum.de	Boeckxstaens, Guy/AAP-2502-2020; Michel, Klaus/HDM-6232-2022	Michel, Klaus/0000-0003-2359-6428; Schemann, Michael/0000-0003-1007-9843	European Union; Deutsche Forschungsgemeinschaft [Sche267/9-1]; Research Foundation Flanders (FWO)	European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Research Foundation Flanders (FWO)(FWO)	This work was supported by a grant from the European Union 7th Framework Program (IPODD), by Deutsche Forschungsgemeinschaft Sche267/9-1 to MS; by a grant of the Research Foundation Flanders (FWO, Odysseus and Hercules program) to GEB, and by a FWO postdoctoral research fellowship to PJG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERTHOUD HR, 1991, AM J PHYSIOL, V260, pR200, DOI 10.1152/ajpregu.1991.260.1.R200; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Breunig E, 2007, J PHYSIOL-LONDON, V583, P731, DOI 10.1113/jphysiol.2007.139352; Conley E.C., 1996, ION CHANNEL FACTSBOO; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Di Virgilio Francesco, 2005, Purinergic Signal, V1, P205, DOI 10.1007/s11302-005-6312-z; Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6; Ghia JE, 2009, GASTROENTEROLOGY, V136, P2280, DOI 10.1053/j.gastro.2009.02.069; Giniatullin RA, 2000, MOL PHARMACOL, V58, P778, DOI 10.1124/mol.58.4.778; GURNEY AM, 1984, BRIT J PHARMACOL, V82, P623, DOI 10.1111/j.1476-5381.1984.tb10801.x; Hanley PJ, 2004, P NATL ACAD SCI USA, V101, P9479, DOI 10.1073/pnas.0400733101; Hosur V, 2011, MOL PHARMACOL, V79, P167, DOI 10.1124/mol.110.066381; Khan MAS, 2012, SHOCK, V38, P213, DOI 10.1097/SHK.0b013e31825d628c; Kiguchi N, 2012, NEUROCHEM INT, V61, P1212, DOI 10.1016/j.neuint.2012.09.001; Matsunaga K, 2001, J IMMUNOL, V167, P6518, DOI 10.4049/jimmunol.167.11.6518; Matteoli G, 2013, GUT             0808, V8, DOI [10.1136/gutjnl-2013-304676, DOI 10.1136/GUTJNL-2013-304676.PUBMED:23929694]; Mikulski Z, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-133; Murray TA, 2012, MOL PHARMACOL, V81, P175, DOI 10.1124/mol.111.074088; Myrtek D, 2008, J IMMUNOL, V181, P2181, DOI 10.4049/jimmunol.181.3.2181; Paterson D, 2000, PROG NEUROBIOL, V61, P75, DOI 10.1016/S0301-0082(99)00045-3; PICCIOTTO MR, 1995, NATURE, V374, P65, DOI 10.1038/374065a0; SCHEMANN M, 1992, AM J PHYSIOL, V263, pG709, DOI 10.1152/ajpgi.1992.263.5.G709; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; van der Zanden EP, 2009, GASTROENTEROLOGY, V137, P1029, DOI 10.1053/j.gastro.2009.04.057; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wehner S, 2007, GUT, V56, P176, DOI 10.1136/gut.2005.089615; Zoli M, 1999, TRENDS PHARMACOL SCI, V20, P142, DOI 10.1016/S0165-6147(99)01343-7	28	28	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79264	10.1371/journal.pone.0079264	http://dx.doi.org/10.1371/journal.pone.0079264			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223920	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000326499300072
J	Lu, XC; Tao, Y; Wu, C; Zhao, PL; Li, K; Zheng, JY; Li, LX				Lu, Xiao Cheng; Tao, Yi; Wu, Chen; Zhao, Peng Lai; Li, Kai; Zheng, Jin Yu; Li, Li Xin			Association between Variants of the Autophagy Related Gene - IRGM and Susceptibility to Crohn's Disease and Ulcerative Colitis: A Meta-Analysis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; POPULATION-BASED COHORT; JAPANESE PATIENTS; RISK-FACTORS; ATG16L1; POLYMORPHISMS; LOCI; CONFIRMATION; NOD2/CARD15; MULTIPLE	Background: Polymorphisms in immunity-related GTPase family M (IRGM) gene may be associated with inflammatory bowel disease (IBD) by affecting autophagy. However, the genetic association studies on three common variants in IRGM gene (rs13361189, rs4958847 and rs10065172) have shown inconsistent results. Methodology/Principal Findings: The PubMed and Embase were searched up to June 5, 2013 for studies on the association between three IRGM polymorphisms and IBD risk. Data were extracted and the odd ratios (ORs) and 95% confidence intervals (95% CIs) were calculated. Finally, we performed a meta-analysis of 25 eligible studies in 3 SNPs located at IRGM gene by using a total of 20590 IBD cases and 27670 controls. The analysis showed modest significant association for the rs13361189, rs4958847 and rs10065172 variants in Crohn's disease (CD): the risk estimates for the allele contrast were OR=1.306 (1.200-1.420), p=5.2x10(-10), OR= 1.182 (1.082-1.290), p=0.0002, and OR= 1.248 (1.057-1.473), p=0.009 respectively (still significant when the p value was Bonferroni adjusted to 0.017). When stratified by ethnicity, significantly increased CD risk was observed in Europeans, but not in Asians. Conversely, there was no association of rs13361189 or rs4958847 variant with risk of ulcerative colitis (UC). Conclusions/Significance: These results indicated that autophagy gene-IRGM polymorphisms appear to confer susceptibility to CD but not UC, especially in Europeans. Our data may provide further understanding of the role of autophagy in the pathogenesis of CD.	[Lu, Xiao Cheng; Tao, Yi; Wu, Chen; Zhao, Peng Lai; Li, Kai; Zheng, Jin Yu; Li, Li Xin] Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Li, LX (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China.	lilixin2@hotmail.com		Lu, Xiaocheng/0000-0003-4726-7194	National Natural Science Foundation of China [30973092, 81178147, 81171147]; "Xingwei Project" Key Personal Medical Research Foundation of Health Department of Jiangsu Province [RC201156]; "Six Categories of Key Person" Research Foundation of Jiangsu Province [069]; Program Sponsored for Scientific Innovation Research of College Graduate in Jiangsu Province [CXZZ12_0583]; Priority Academic Program Development of Jiangsu Higher Education Institutions [JX10231801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Xingwei Project" Key Personal Medical Research Foundation of Health Department of Jiangsu Province; "Six Categories of Key Person" Research Foundation of Jiangsu Province; Program Sponsored for Scientific Innovation Research of College Graduate in Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions	This study was supported by grants from the National Natural Science Foundation of China (No. 30973092 and No. 81178147), "Xingwei Project" Key Personal Medical Research Foundation of Health Department of Jiangsu Province (No. RC201156), "Six Categories of Key Person" Research Foundation of Jiangsu Province (No. 069), Program Sponsored for Scientific Innovation Research of College Graduate in Jiangsu Province (No. CXZZ12_0583), and Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (No. JX10231801). grants from the National Natural Science Foundation of China (No. 30973092 and No. 81178147)", replace 81178147 with 81171147. - In ACs, add author Kai Li to "analyzed the data" and "contributed reagents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Amre DK, 2009, INFLAMM BOWEL DIS, V15, P501, DOI 10.1002/ibd.20785; Cho JH, 2007, GASTROENTEROLOGY, V133, P1327, DOI 10.1053/j.gastro.2007.08.032; Collazo CM, 2001, J EXP MED, V194, P181, DOI 10.1084/jem.194.2.181; Dema B, 2009, HUM IMMUNOL, V70, P946, DOI 10.1016/j.humimm.2009.08.004; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duraes C, 2013, INFLAMM BOWEL DIS, V19, P230, DOI 10.1002/ibd.23007; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eglinton TW, 2012, AM J GASTROENTEROL, V107, P596, DOI 10.1038/ajg.2011.437; Fisher SA, 2008, NAT GENET, V40, P710, DOI 10.1038/ng.145; Fowler EV, 2008, AM J GASTROENTEROL, V103, P2519, DOI 10.1111/j.1572-0241.2008.02023.x; Franke A, 2008, NAT GENET, V40, P713, DOI 10.1038/ng.148; Fransen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045287; Fritz T, 2011, GUT, V60, P1580, DOI 10.1136/gut.2009.206466; Glas J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054338; Glas J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034349; Glas J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033682; Hancock L, 2008, INFLAMM BOWEL DIS, V14, P1667, DOI 10.1002/ibd.20517; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Latiano A, 2009, AM J GASTROENTEROL, V104, P110, DOI 10.1038/ajg.2008.3; Marquez A, 2009, INFLAMM BOWEL DIS, V15, P1697, DOI 10.1002/ibd.21001; Meggyesi N, 2010, WORLD J GASTROENTERO, V16, P5233, DOI 10.3748/wjg.v16.i41.5233; Moon CM, 2013, INFLAMM BOWEL DIS, V19, P106, DOI 10.1002/ibd.22972; Ng SC, 2012, INFLAMM BOWEL DIS, V18, P1164, DOI 10.1002/ibd.21845; Oostenbrug LE, 2006, DIGEST LIVER DIS, V38, P834, DOI 10.1016/j.dld.2006.06.042; Palomino-Morales RJ, 2009, GENES IMMUN, V10, P356, DOI 10.1038/gene.2009.25; Pang Z, 2011, CHIN J GASTROENTEROL, V16, P473; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Peter I, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-63; Prager M, 2012, INT J COLORECTAL DIS, V27, P565, DOI 10.1007/s00384-011-1345-y; Prescott NJ, 2010, HUM MOL GENET, V19, P1828, DOI 10.1093/hmg/ddq041; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Rigoli L, 2008, WORLD J GASTROENTERO, V14, P4454, DOI 10.3748/wjg.14.4454; Roberts RL, 2008, GENES IMMUN, V9, P561, DOI 10.1038/gene.2008.49; Scharl M, 2012, INFLAMM BOWEL DIS, V18, P900, DOI 10.1002/ibd.21913; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Trikalinos TA, 2008, ADV GENET, V60, P311, DOI 10.1016/S0065-2660(07)00413-0; Van Limbergen J, 2009, GUT, V58, P610, DOI 10.1136/gut.2008.160721; Wang MH, 2012, INFLAMM BOWEL DIS, V18, P2277, DOI 10.1002/ibd.22931; Wang ZW, 2011, WORLD J GASTROENTERO, V17, P118, DOI 10.3748/wjg.v17.i1.118; Weersma RK, 2009, AM J GASTROENTEROL, V104, P630, DOI 10.1038/ajg.2008.112; Wolfkamp SC, 2010, EUR J GASTROEN HEPAT, V22, P933, DOI 10.1097/MEG.0b013e32833775e6; Xavier RJ, 2008, GUT, V57, P717, DOI 10.1136/gut.2007.134254; Xue LN, 2013, INFLAMM BOWEL DIS, V19, P54, DOI 10.1002/ibd.22966; Yamazaki K, 2009, GUT, V58, P228, DOI 10.1136/gut.2007.140764; Yamazaki K, 2002, J HUM GENET, V47, P469, DOI 10.1007/s100380200067; Yazdanyar S, 2009, CLIN CHEM, V55, P1950, DOI 10.1373/clinchem.2009.127126; Zhang ZF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030551; Zheng LM, 2012, CHIN J GASTROENTEROL, V21, P437; Zintzaras E, 2008, J CLIN EPIDEMIOL, V61, P634, DOI 10.1016/j.jclinepi.2007.12.011	51	28	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80602	10.1371/journal.pone.0080602	http://dx.doi.org/10.1371/journal.pone.0080602			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24232856	Green Submitted, Green Published, gold			2022-12-27	WOS:000327254700190
J	Ma, XZ; Ambus, P; Wang, SP; Wang, YF; Wang, CJ				Ma, Xiuzhi; Ambus, Per; Wang, Shiping; Wang, Yanfen; Wang, Chengjie			Priming of Soil Carbon Decomposition in Two Inner Mongolia Grassland Soils following Sheep Dung Addition: A Study Using C-13 Natural Abundance Approach	PLOS ONE			English	Article							PIG SLURRY; MICROBIAL BIOMASS; SIZE FRACTIONS; NITROUS-OXIDE; N DYNAMICS; CO2; QUANTIFICATION; N2O; MECHANISMS; EMISSIONS	To investigate the effect of sheep dung on soil carbon (C) sequestration, a 152 days incubation experiment was conducted with soils from two different Inner Mongolian grasslands, i.e. a Leymus chinensis dominated grassland representing the climax community (2.1% organic matter content) and a heavily degraded Artemisia frigida dominated community (1.3% organic matter content). Dung was collected from sheep either fed on L. chinensis (C-3 plant with delta C-13= -26.8%; dung delta C-13= -26.2%) or Cleistogenes squarrosa (C-4 plant with delta C-13= -14.6%; dung delta C-13= -15.7%). Fresh C-3 and C-4 sheep dung was mixed with the two grassland soils and incubated under controlled conditions for analysis of C-13-CO2 emissions. Soil samples were taken at days 17, 43, 86, 127 and 152 after sheep dung addition to detect the delta C-13 signal in soil and dung components. Analysis revealed that 16.9% and 16.6% of the sheep dung C had decomposed, of which 3.5% and 2.8% was sequestrated in the soils of L. chinensis and A. frigida grasslands, respectively, while the remaining decomposed sheep dung was emitted as CO2. The cumulative amounts of C respired from dung treated soils during 152 days were 7-8 times higher than in the un-amended controls. In both grassland soils, ca. 60% of the evolved CO2 originated from the decomposing sheep dung and 40% from the native soil C. Priming effects of soil C decomposition were observed in both soils, i.e. 1.4 g and 1.6 g additional soil C kg(-1) dry soil had been emitted as CO2 for the L. chinensis and A. frigida soils, respectively. Hence, the net C losses from L. chinensis and A. frigida soils were 0.6 g and 0.9 g C kg(-1) soil, which was 2.6% and 7.0% of the total C in L. chinensis and A. frigida grasslands soils, respectively. Our results suggest that grazing of degraded Inner Mongolian pastures may cause a net soil C loss due to the positive priming effect, thereby accelerating soil deterioration.	[Ma, Xiuzhi] Inner Mongolia Agr Univ, Coll Forestry, Hohhot, Peoples R China; [Ambus, Per] Tech Univ Denmark, Dept Chem & Biochem Engn, DK-2800 Lyngby, Denmark; [Wang, Shiping] Chinese Acad Sci, Lab Alpine Ecol & Biodivers, Inst Tibetan Plateau Res, Beijing, Peoples R China; [Wang, Yanfen] Univ Chinese Acad Sci, Dept Life Coll, Beijing, Peoples R China; [Wang, Chengjie] Inner Mongolia Agr Univ, Coll Ecol & Environm Sci, Hohhot, Peoples R China	Inner Mongolia Agricultural University; Technical University of Denmark; Chinese Academy of Sciences; Institute of Tibetan Plateau Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Inner Mongolia Agricultural University	Wang, SP (corresponding author), Chinese Acad Sci, Lab Alpine Ecol & Biodivers, Inst Tibetan Plateau Res, Beijing, Peoples R China.	wangship2008@yahoo.cn	Ambus, Per L/B-2514-2015	Ambus, Per L/0000-0001-7580-524X	National Basic Research Program [2010CB833502]; Chinese National Natural Science Foundation [97711001, 31160117, 31260119]	National Basic Research Program(National Basic Research Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	The work was supported by the National Basic Research Program (2010CB833502) and Chinese National Natural Science Foundation (97711001, 31160117, 31260119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers DA, 2007, SOIL BIOL BIOCHEM, V39, P1234, DOI 10.1016/j.soilbio.2006.12.028; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Bao S., 2000, SOIL AGROCHEMICAL AN; Bertora C, 2008, SOIL BIOL BIOCHEM, V40, P1999, DOI 10.1016/j.soilbio.2008.03.021; Blagodatskaya E, 2008, BIOL FERT SOILS, V45, P115, DOI 10.1007/s00374-008-0334-y; Blagodatskaya E, 2011, SOIL BIOL BIOCHEM, V43, P159, DOI 10.1016/j.soilbio.2010.09.028; Bol R, 2003, RAPID COMMUN MASS SP, V17, P2585, DOI 10.1002/rcm.1184; Bol R, 2003, SOIL BIOL BIOCHEM, V35, P1411, DOI 10.1016/S0038-0717(03)00235-9; Chantigny MH, 2001, CAN J SOIL SCI, V81, P131, DOI 10.4141/S00-046; Chen WW, 2011, GLOBAL CHANGE BIOL, V17, P2803, DOI 10.1111/j.1365-2486.2011.02444.x; Chen ZZ, 2000, TYPICAL STEPPE ECOSY, P13; Dendooven L, 1998, BIOL FERT SOILS, V26, P224, DOI 10.1007/s003740050371; Dungait JAJ, 2005, ISOT ENVIRON HEALT S, V41, P3, DOI 10.1080/10256010500053516; Dungait JAJ, 2009, ORG GEOCHEM, V40, P1210, DOI 10.1016/j.orggeochem.2009.08.001; Fangueiro D, 2007, SOIL BIOL BIOCHEM, V39, P2608, DOI 10.1016/j.soilbio.2007.05.012; Fangueiro D, 2010, CHEMOSPHERE, V81, P100, DOI 10.1016/j.chemosphere.2010.06.049; Flessa H, 2000, J ENVIRON QUAL, V29, P262, DOI 10.2134/jeq2000.00472425002900010033x; Formanek P, 2004, RAPID COMMUN MASS SP, V18, P897, DOI 10.1002/rcm.1424; Glaser B, 2001, J PLANT NUTR SOIL SC, V164, P467, DOI 10.1002/1522-2624(200110)164:5<467::AID-JPLN467>3.0.CO;2-Q; Hamer U, 2005, SOIL BIOL BIOCHEM, V37, P445, DOI 10.1016/j.soilbio.2004.07.037; Harris D, 2001, SOIL SCI SOC AM J, V65, P1853, DOI 10.2136/sssaj2001.1853; HAYNES RJ, 1993, ADV AGRON, V49, P119, DOI 10.1016/S0065-2113(08)60794-4; Kristiansen SM, 2004, SOIL BIOL BIOCHEM, V36, P99, DOI 10.1016/j.soilbio.2003.07.002; Kuzyakov Y, 1999, AGRIBIOL RES, V52, P25; Kuzyakov Y, 2006, SOIL BIOL BIOCHEM, V38, P747, DOI 10.1016/j.soilbio.2005.06.025; Kuzyakov Y, 2002, J PLANT NUTR SOIL SC, V165, P382, DOI 10.1002/1522-2624(200208)165:4<382::AID-JPLN382>3.0.CO;2-#; Kuzyakov Y, 2005, RAPID COMMUN MASS SP, V19, P1417, DOI 10.1002/rcm.1938; Kuzyakov Y, 2000, SOIL BIOL BIOCHEM, V32, P1485, DOI 10.1016/S0038-0717(00)00084-5; Kuzyakov Y, 2004, J PLANT NUTR SOIL SC, V167, P669, DOI 10.1002/jpln.200421412; Kuzyakov Y, 2010, SOIL BIOL BIOCHEM, V42, P1363, DOI 10.1016/j.soilbio.2010.04.003; Liang C, 2002, J APPL ECOL, V39, P584, DOI 10.1046/j.1365-2664.2002.00735.x; Lin XW, 2009, SOIL BIOL BIOCHEM, V41, P718, DOI 10.1016/j.soilbio.2009.01.007; LIU ZK, 2004, CHINESE J APPL ECOLO, V15, P2255; Lovell RD, 1996, SOIL BIOL BIOCHEM, V28, P291, DOI 10.1016/0038-0717(95)00140-9; Luo Y, 2011, SOIL BIOL BIOCHEM, V43, P2304, DOI 10.1016/j.soilbio.2011.07.020; Lupwayi NZ, 1999, BIOL FERT SOILS, V28, P182, DOI 10.1007/s003740050482; Ma XZ, 2007, COMMUN SOIL SCI PLAN, V38, P1589, DOI 10.1080/00103620701378516; Ma XZ, 2006, NEW ZEAL J AGR RES, V49, P285, DOI 10.1080/00288233.2006.9513719; Ohm H, 2007, J PLANT NUTR SOIL SC, V170, P551, DOI 10.1002/jpln.200625087; Pausch J, 2012, SOIL BIOL BIOCHEM, V55, P40, DOI 10.1016/j.soilbio.2012.06.007; Pineiro G, 2006, GLOBAL CHANGE BIOL, V12, P1267, DOI 10.1111/j.1365-2486.2006.01173.x; Rochette P, 2004, SOIL SCI SOC AM J, V68, P1410, DOI 10.2136/sssaj2004.1410; Shen J, 1996, APPL ENVIRON MICROB, V62, P1428, DOI 10.1128/AEM.62.4.1428-1430.1996; Tong C, 2004, J ARID ENVIRON, V59, P133, DOI 10.1016/j.jaridenv.2004.01.004; Wang SP, 1997, CHINESE J ANIMAL NUT, V9, P49; WANG Y F, 1998, ACTA AGRESTIA SIN, V6, P299	46	4	6	4	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78578	10.1371/journal.pone.0078578	http://dx.doi.org/10.1371/journal.pone.0078578			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236024	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700021
J	Nakagome, S; Mano, S; Hasegawa, M				Nakagome, Shigeki; Mano, Shuhei; Hasegawa, Masami			Ancestral Polymorphisms and Sex-Biased Migration Shaped the Demographic History of Brown Bears and Polar Bears	PLOS ONE			English	Article							GENOMIC SEQUENCES REVEAL; GENETIC-VARIATION; DNA POLYMORPHISM; GRIZZLY BEARS; RECOMBINATION; DIVERGENCE; DISTANCE; LINEAGE; URSIDAE; ORIGIN	Recent studies have reported discordant gene trees in the evolution of brown bears and polar bears. Genealogical histories are different among independent nuclear loci and between biparentally inherited autosomal DNA (aDNA) and matrilineal mitochondrial DNA (mtDNA). Based on multi-locus genomic sequences from aDNA and mtDNA, we inferred the population demography of brown and polar bears and found that brown bears have 6 times (aDNA) or more than 14 times (mtDNA) larger population sizes than polar bears and that polar bear lineage is derived from within brown bear diversity. In brown bears, the effective population size ratio of mtDNA to aDNA was at least 0.62, which deviated from the expected value of 0.25, suggesting matriarchal population due to female philopatry and male-biased migration. These results emphasize that ancestral polymorphisms and sex-biased migration may have contributed to conflicting branching patterns in brown and polar bears across aDNA genes and mtDNA.	[Nakagome, Shigeki; Mano, Shuhei; Hasegawa, Masami] Inst Stat Math, Risk Anal Res Ctr, Tachikawa, Tokyo, Japan; [Mano, Shuhei] Inst Stat Math, Dept Math Anal & Stat Inference, Tachikawa, Tokyo, Japan; [Hasegawa, Masami] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China	Research Organization of Information & Systems (ROIS); Institute of Statistical Mathematics (ISM) - Japan; Research Organization of Information & Systems (ROIS); Institute of Statistical Mathematics (ISM) - Japan; Fudan University	Nakagome, S (corresponding author), Inst Stat Math, Risk Anal Res Ctr, Tachikawa, Tokyo, Japan.	nakagome@ism.ac.jp		Nakagome, Shigeki/0000-0001-9613-975X	Japan Society for the Promotion of Science (JSPS) [24-3234]; JSPS [C22570099]; Grants-in-Aid for Scientific Research [25440219] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	S.N. was supported as a Grant-in-Aid for the Japan Society for the Promotion of Science (JSPS, http://www.jsps.go.jp/english/index.html) Research Fellow (24-3234). M. H. was supported by Grants-in-Aid for Scientific Research C22570099 from JSPS. The funders had no role in study design, data collection and analysis.	Abella J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048985; BLANCHARD BM, 1991, BIOL CONSERV, V58, P41, DOI 10.1016/0006-3207(91)90044-A; Chesser RK, 1996, GENETICS, V144, P1225; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Edwards CJ, 2011, CURR BIOL, V21, P1251, DOI 10.1016/j.cub.2011.05.058; Fay JC, 2000, GENETICS, V155, P1405; FU YX, 1993, GENETICS, V133, P693; Fukumizu K., 2011, ADV NEURAL INFORM PR, V24, P1549; Griffiths R.C, 2007, GENETREE VERSION 9 0; Hailer F, 2012, SCIENCE, V336, P344, DOI 10.1126/science.1216424; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; HUDSON RR, 1985, GENETICS, V111, P147; Keinan A, 2010, MOL BIOL EVOL, V27, P2312, DOI 10.1093/molbev/msq117; Kingman J., 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; Krause J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-220; Laporte V, 2002, GENETICS, V162, P501; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lindqvist C, 2010, P NATL ACAD SCI USA, V107, P5053, DOI 10.1073/pnas.0914266107; McLellan BN, 2001, CAN J ZOOL, V79, P838, DOI 10.1139/cjz-79-5-838; Miller W, 2012, P NATL ACAD SCI USA, V109, pE2382, DOI 10.1073/pnas.1210506109; Nakagome S, STAT APPL G IN PRESS; Nakagome S, 2008, MOL BIOL EVOL, V25, P1344, DOI 10.1093/molbev/msn086; Nakagome S, 2013, SCIENCE, V339, DOI 10.1126/science.1227339; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Oota H, 2001, NAT GENET, V29, P20, DOI 10.1038/ng711; TAJIMA F, 1984, MOL BIOL EVOL, V1, P269; TAJIMA F, 1989, GENETICS, V123, P585; Talbot SL, 1996, MOL PHYLOGENET EVOL, V5, P477, DOI 10.1006/mpev.1996.0044; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WAYNE RK, 1991, MOL BIOL EVOL, V8, P297	31	3	3	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78813	10.1371/journal.pone.0078813	http://dx.doi.org/10.1371/journal.pone.0078813			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236053	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700050
J	Zhao, L; Tolbert, WD; Ericksen, B; Zhan, CY; Wu, XJ; Yuan, WR; Li, X; Pazgier, M; Lu, WY				Zhao, Le; Tolbert, W. David; Ericksen, Bryan; Zhan, Changyou; Wu, Xueji; Yuan, Weirong; Li, Xu; Pazgier, Marzena; Lu, Wuyuan			Single, Double and Quadruple Alanine Substitutions at Oligomeric Interfaces Identify Hydrophobicity as the Key Determinant of Human Neutrophil Alpha Defensin HNP1 Function	PLOS ONE			English	Article							HUMAN BETA-DEFENSINS; PRECURSOR LIPID II; SCANNING MUTAGENESIS; ANTIMICROBIAL PEPTIDES; INNATE IMMUNITY; BACTERICIDAL ACTIVITY; RESONANCE ASSIGNMENT; FUNGAL DEFENSIN; PANETH CELLS; BINDING	HNP1 is a human alpha defensin that forms dimers and multimers governed by hydrophobic residues, including Tyr(16), Ile(20), Leu(25), and Phe(28). Previously, alanine scanning mutagenesis identified each of these residues and other hydrophobic residues as important for function. Here we report further structural and functional studies of residues shown to interact with one another across oligomeric interfaces: I20A-HNP1 and L25A-HNP1, plus the double alanine mutants I20A/L25A-HNP1 and Y16A/F28A-HNP1, and the quadruple alanine mutant Y16A/I20A/L25A/F28A-HNP1. We tested binding to HIV-1 gp120 and HNP1 by surface plasmon resonance, binding to HIV-1 gp41 and HNP1 by fluorescence polarization, inhibition of anthrax lethal factor, and antibacterial activity using the virtual colony count assay. Similar to the previously described single mutant W26A-HNP1, the quadruple mutant displayed the least activity in all functional assays, followed by the double mutant Y16A/F28A-HNP1. The effects of the L25A and I20A single mutations were milder than the double mutant I20A/L25A-HNP1. Crystallographic studies confirmed the correct folding and disulfide pairing, and depicted an array of dimeric and tetrameric structures. These results indicate that side chain hydrophobicity is the critical factor that determines activity at these positions.	[Zhao, Le; Li, Xu] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Translat Med Ctr, Xian 710049, Peoples R China; [Zhao, Le; Tolbert, W. David; Ericksen, Bryan; Zhan, Changyou; Wu, Xueji; Yuan, Weirong; Pazgier, Marzena; Lu, Wuyuan] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Zhao, Le; Tolbert, W. David; Ericksen, Bryan; Zhan, Changyou; Wu, Xueji; Yuan, Weirong; Pazgier, Marzena; Lu, Wuyuan] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	Xi'an Jiaotong University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Li, X (corresponding author), Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Translat Med Ctr, Xian 710049, Peoples R China.	lixu56@mail.xjtu.edu.cn; mpazgier@ihv.umaryland.edu	Lu, Wuyuan/J-8452-2017; Zhan, Changyou/G-3667-2011; Lu, Wuyuan/B-2268-2010	Lu, Wuyuan/0000-0003-1318-9968; Tolbert, William/0000-0001-7549-9596; Ericksen, Bryan/0000-0002-8016-8289	National Institutes of Health [AI072732, AI061482]; Xi'an Jiaotong University School of Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072732, R01AI061482] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Xi'an Jiaotong University School of Medicine(Xi'an Jiaotong University); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health Grants AI072732 and AI061482 (to W. L.). L.Z. was a Guanghua Scholar supported by Xi'an Jiaotong University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ASHKENAZI A, 1990, P NATL ACAD SCI USA, V87, P7150, DOI 10.1073/pnas.87.18.7150; Bai Y, 2009, BIOCHEMISTRY-US, V48, P7229, DOI 10.1021/bi900670d; Bevins CL, 2006, BIOCHEM SOC T, V34, P263, DOI 10.1042/BST0340263; BLABER M, 1995, J MOL BIOL, V246, P317, DOI 10.1006/jmbi.1994.0087; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang TL, 2005, J CLIN INVEST, V115, P765, DOI 10.1172/JCI200521948; Chu HT, 2012, SCIENCE, V337, P477, DOI 10.1126/science.1218831; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Daly NL, 2007, BIOCHEMISTRY-US, V46, P9920, DOI 10.1021/bi700720e; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Leeuw E, 2010, FEBS LETT, V584, P1543, DOI 10.1016/j.febslet.2010.03.004; Demirkhanyan LH, 2012, J BIOL CHEM, V287, P28821, DOI 10.1074/jbc.M112.375949; Dill KA, 1997, J BIOL CHEM, V272, P701, DOI 10.1074/jbc.272.2.701; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericksen B, 2005, ANTIMICROB AGENTS CH, V49, P269, DOI 10.1128/AAC.49.1.269-275.2005; GABAY JE, 1989, P NATL ACAD SCI USA, V86, P5610, DOI 10.1073/pnas.86.14.5610; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; GIBBS CS, 1991, J BIOL CHEM, V266, P8923; Gounder AP, 2012, J BIOL CHEM, V287, P24554, DOI 10.1074/jbc.M112.354068; HILL CP, 1991, SCIENCE, V251, P1481, DOI 10.1126/science.2006422; Hong M, 2011, PROTEIN SCI, V20, P641, DOI 10.1002/pro.600; Hoover DM, 2000, J BIOL CHEM, V275, P32911, DOI 10.1074/jbc.M006098200; JONES DE, 1993, FEBS LETT, V315, P187, DOI 10.1016/0014-5793(93)81160-2; JONES DE, 1992, J BIOL CHEM, V267, P23216; Kim C, 2005, P NATL ACAD SCI USA, V102, P4830, DOI 10.1073/pnas.0500508102; Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kristensen C, 1997, J BIOL CHEM, V272, P12978, DOI 10.1074/jbc.272.20.12978; Lay FT, 2012, J BIOL CHEM, V287, P19961, DOI 10.1074/jbc.M111.331009; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198; Lehrer RI, 2012, J BIOL CHEM, V287, P27014, DOI 10.1074/jbc.R112.346098; Lehrer RI, 2012, IMMUNOL REV, V245, P84, DOI 10.1111/j.1600-065X.2011.01082.x; Lehrer RI, 2009, J IMMUNOL, V183, P480, DOI 10.4049/jimmunol.0900244; Mayer-Scholl A, 2005, PLOS PATHOG, V1, P179, DOI 10.1371/journal.ppat.0010023; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morrison KL, 2001, CURR OPIN CHEM BIOL, V5, P302, DOI 10.1016/S1367-5931(00)00206-4; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oeemig JS, 2012, J BIOL CHEM, V287, P42361, DOI 10.1074/jbc.M112.382028; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; Pazgier M, 2012, J BIOL CHEM, V287, P8944, DOI 10.1074/jbc.M111.332205; Rajabi M, 2012, J BIOL CHEM, V287, P21615, DOI 10.1074/jbc.M112.367995; Sass V, 2010, INFECT IMMUN, V78, P2793, DOI 10.1128/IAI.00688-09; Schibli DJ, 2002, J BIOL CHEM, V277, P8279, DOI 10.1074/jbc.M108830200; Schmitt P, 2010, J BIOL CHEM, V285, P29208, DOI 10.1074/jbc.M110.143388; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; SELSTED ME, 1985, J CLIN INVEST, V76, P1436, DOI 10.1172/JCI112121; SELSTED ME, 1985, J BIOL CHEM, V260, P4579; SINGH A, 1988, BIOCHEM BIOPH RES CO, V155, P524, DOI 10.1016/S0006-291X(88)81118-5; Szyk A, 2006, PROTEIN SCI, V15, P2749, DOI 10.1110/ps.062336606; Wei G, 2010, J BIOL CHEM, V285, P16275, DOI 10.1074/jbc.M110.102749; Wei G, 2009, J BIOL CHEM, V284, P29180, DOI 10.1074/jbc.M109.018085; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; WILDE CG, 1989, J BIOL CHEM, V264, P11200; Williams AD, 2006, J MOL BIOL, V357, P1283, DOI 10.1016/j.jmb.2006.01.041; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Wu ZB, 2003, J AM CHEM SOC, V125, P2402, DOI 10.1021/ja0294257; YU MH, 1995, J MOL BIOL, V249, P388, DOI 10.1006/jmbi.1995.0304; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; ZHANG XL, 1992, BIOCHEMISTRY-US, V31, P11348, DOI 10.1021/bi00161a012; Zhang Y, 2010, J MOL BIOL, V397, P408, DOI 10.1016/j.jmb.2010.01.030; Zhao L, 2012, J BIOL CHEM, V287, P18900, DOI 10.1074/jbc.M112.355255	68	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78937	10.1371/journal.pone.0078937	http://dx.doi.org/10.1371/journal.pone.0078937			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236072	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700069
J	Zhong, LR; Estes, S; Artinian, L; Rehder, V				Zhong, Lei Ray; Estes, Stephen; Artinian, Liana; Rehder, Vincent			Nitric Oxide Regulates Neuronal Activity via Calcium-Activated Potassium Channels	PLOS ONE			English	Article							GROWTH CONE FILOPODIA; LYMNAEA-STAGNALIS; VOLUME TRANSMITTER; MEMORY FORMATION; CA2+ SIGNALS; HELISOMA; APLYSIA; EXCITABILITY; MODULATION; SNAIL	Nitric oxide (NO) is an unconventional membrane-permeable messenger molecule that has been shown to play various roles in the nervous system. How NO modulates ion channels to affect neuronal functions is not well understood. In gastropods, NO has been implicated in regulating the feeding motor program. The buccal motoneuron, B19, of the freshwater pond snail Helisoma trivolvis is active during the hyper-retraction phase of the feeding motor program and is located in the vicinity of NO-producing neurons in the buccal ganglion. Here, we asked whether B19 neurons might serve as direct targets of NO signaling. Previous work established NO as a key regulator of growth cone motility and neuronal excitability in another buccal neuron involved in feeding, the B5 neuron. This raised the question whether NO might modulate the electrical activity and neuronal excitability of B19 neurons as well, and if so whether NO acted on the same or a different set of ion channels in both neurons. To study specific responses of NO on B19 neurons and to eliminate indirect effects contributed by other cells, the majority of experiments were performed on single cultured B19 neurons. Addition of NO donors caused a prolonged depolarization of the membrane potential and an increase in neuronal excitability. The effects of NO could mainly be attributed to the inhibition of two types of calcium-activated potassium channels, apamin-sensitive and iberiotoxin-sensitive potassium channels. NO was found to also cause a depolarization in B19 neurons in situ, but only after NO synthase activity in buccal ganglia had been blocked. The results suggest that NO acts as a critical modulator of neuronal excitability in B19 neurons, and that calcium-activated potassium channels may serve as a common target of NO in neurons.	[Zhong, Lei Ray; Estes, Stephen; Artinian, Liana; Rehder, Vincent] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University	Rehder, V (corresponding author), Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA.	vrehder@gsu.edu			NSF [0843173]; Brains and Behavior Fellowships; Sigma Xi; GSU; Direct For Biological Sciences [0843173] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Brains and Behavior Fellowships; Sigma Xi; GSU; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by NSF award #0843173 to VR, Brains and Behavior Fellowships to LRZ and SE, Sigma Xi grants-in-aid of research grant, GSU dissertation grant to LRZ. NSF award (http://www.nsf.gov/); Brains and Behavior fellowship (http://neuroscience.gsu.edu/brains_behavior.html); Sigma Xi grants-in-aid of research grant (http://www.sigmaxi.org/programs/giar/); GSU dissertation grant (http://www.gsu.edu/research/funding_opportunities.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Artinian L, 2012, EUR J NEUROSCI, V36, P3333, DOI 10.1111/j.1460-9568.2012.08260.x; Artinian L, 2010, J NEUROSCI, V30, P1699, DOI 10.1523/JNEUROSCI.4511-09.2010; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bicker G, 2007, ARCH INSECT BIOCHEM, V64, P43, DOI 10.1002/arch.20161; BOLOTINA VM, 1994, NATURE, V368, P850, DOI 10.1038/368850a0; CANDIA S, 1992, BIOPHYS J, V63, P583, DOI 10.1016/S0006-3495(92)81630-2; CETINER M, 1993, BRIT J PHARMACOL, V110, P995, DOI 10.1111/j.1476-5381.1993.tb13912.x; ELPHICK MR, 1995, J NEUROSCI, V15, P7653; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Herrera GM, 2002, J PHYSIOL-LONDON, V541, P483, DOI 10.1113/jphysiol.2002.017707; Hopper RA, 2006, J NEUROSCI, V26, P11513, DOI 10.1523/JNEUROSCI.2259-06.2006; Hui K, 2008, EUR J NEUROSCI, V27, P631, DOI 10.1111/j.1460-9568.2008.06023.x; Katzoff A, 2002, J NEUROSCI, V22, P9581; Katzoff A, 2006, J NEUROPHYSIOL, V96, P1247, DOI 10.1152/jn.00056.2006; Kemenes I, 2002, J NEUROSCI, V22, P1414, DOI 10.1523/JNEUROSCI.22-04-01414.2002; Kemenes I, 2006, CURR BIOL, V16, P1269, DOI 10.1016/j.cub.2006.05.049; Kobayashi S, 2000, NEUROSCI LETT, V285, P209, DOI 10.1016/S0304-3940(00)01079-X; Lukowiak K, 2006, RESP PHYSIOL NEUROBI, V154, P61, DOI 10.1016/j.resp.2006.02.009; MATTSON MP, 1987, J NEUROSCI, V7, P4034; Miller N, 2011, J NEUROPHYSIOL, V105, P1642, DOI 10.1152/jn.00827.2010; Miller N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017779; Moroz LL, 2011, FRONT BIOSCI-LANDMRK, V16, P2008, DOI 10.2741/3837; Moroz LL, 2000, MICROSC RES TECHNIQ, V49, P557, DOI 10.1002/1097-0029(20000615)49:6<557::AID-JEMT6>3.0.CO;2-S; MOROZ LL, 1993, NEUROREPORT, V4, P643, DOI 10.1097/00001756-199306000-00010; Murphy AD, 2001, PROG NEUROBIOL, V63, P383, DOI 10.1016/S0301-0082(00)00049-6; Nikonenko I, 2008, J CELL BIOL, V183, P1115, DOI 10.1083/jcb.200805132; Park JH, 1998, J NEUROSCI, V18, P5463, DOI 10.1523/JNEUROSCI.18-14-05463.1998; Prast H, 2001, PROG NEUROBIOL, V64, P51, DOI 10.1016/S0301-0082(00)00044-7; Quinlan EM, 1997, J NEUROPHYSIOL, V78, P812, DOI 10.1152/jn.1997.78.2.812; REHDER V, 1992, J NEUROSCI, V12, P3175, DOI 10.1523/JNEUROSCI.12-08-03175.1992; Sadamoto H, 1998, NEUROSCI RES, V32, P57, DOI 10.1016/S0168-0102(98)00066-2; Schrofner S, 2004, BRAIN RES, V999, P98, DOI 10.1016/j.brainres.2003.11.038; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Steinert JR, 2011, NEURON, V71, P291, DOI 10.1016/j.neuron.2011.05.037; Steinert JR, 2008, NEURON, V60, P642, DOI 10.1016/j.neuron.2008.08.025; Straub VA, 2007, J NEUROPHYSIOL, V97, P1088, DOI 10.1152/jn.01048.2006; Susswein AJ, 2012, PROG NEUROBIOL, V97, P304, DOI 10.1016/j.pneurobio.2012.03.004; Torreano PJ, 1997, J NEUROBIOL, V32, P150; Tozer AJB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032256; Tricoire L, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00082; Trimm KR, 2004, EUR J NEUROSCI, V19, P809, DOI 10.1111/j.0953-816X.2004.03182.x; Turner MB, 2011, BIOL BULL-US, V221, P110, DOI 10.1086/BBLv221n1p110; Van Wagenen S, 1999, J NEUROBIOL, V39, P168, DOI 10.1002/(SICI)1097-4695(199905)39:2<168::AID-NEU2>3.0.CO;2-F; Van Wagenen S, 2001, J NEUROBIOL, V46, P206, DOI 10.1002/1097-4695(20010215)46:3<206::AID-NEU1003>3.3.CO;2-J; Welshhans K, 2005, EUR J NEUROSCI, V22, P3006, DOI 10.1111/j.1460-9568.2005.04490.x; Wilson GW, 2010, EUR J NEUROSCI, V31, P1935, DOI 10.1111/j.1460-9568.2010.07226.x; Zhong LR, 2013, NEUROSCIENCE, V228, P109, DOI 10.1016/j.neuroscience.2012.10.005; Zhong LR, 2013, DEV NEUROBIOL, V73, P487, DOI 10.1002/dneu.22071	51	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78727	10.1371/journal.pone.0078727	http://dx.doi.org/10.1371/journal.pone.0078727			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236040	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700037
J	Conraux, L; Pech, C; Guerraoui, H; Loyaux, D; Ferrara, P; Guillemot, JC; Meininger, V; Pradat, PF; Salachas, F; Bruneteau, G; Le Forestier, N; Lacomblez, L				Conraux, Laurence; Pech, Catherine; Guerraoui, Halim; Loyaux, Denis; Ferrara, Pascual; Guillemot, Jean-Claude; Meininger, Vincent; Pradat, Pierre-Francois; Salachas, Francois; Bruneteau, Gaelle; Le Forestier, Nadine; Lacomblez, Lucette			Plasma Peptide Biomarker Discovery for Amyotrophic Lateral Sclerosis by MALDI -TOF Mass Spectrometry Profiling	PLOS ONE			English	Article							PLATELETS; INFLAMMATION; DIAGNOSIS; PLATELET-FACTOR-4	The diagnostic of Amyotrophic lateral sclerosis (ALS) remains based on clinical and neurophysiological observations. The actual delay between the onset of the symptoms and diagnosis is about 1 year, preventing early inclusion of patients into clinical trials and early care of the disease. Therefore, finding biomarkers with high sensitivity and specificity remains urgent. In our study, we looked for peptide biomarkers in plasma samples using reverse phase magnetic beads (C18 and C8) and MALDI-TOF mass spectrometry analysis. From a set of ALS patients (n=30) and healthy age-matched controls (n=30), C18- or C8-SVM-based models for ALS diagnostic were constructed on the base of the minimum of the most discriminant peaks. These two SVM-based models end up in excellent separations between the 2 groups of patients (recognition capability overall classes > 97%) and classify blinded samples (10 ALS and 10 healthy age-matched controls) with very high sensitivities and specificities (>90%). Some of these discriminant peaks have been identified by Mass Spectrometry (MS) analyses and correspond to (or are fragments of) major plasma proteins, partly linked to the blood coagulation.	[Conraux, Laurence; Pech, Catherine; Guerraoui, Halim; Loyaux, Denis; Ferrara, Pascual; Guillemot, Jean-Claude] Sanofi, Exploratory Unit, Toulouse, France; [Meininger, Vincent; Pradat, Pierre-Francois; Salachas, Francois; Bruneteau, Gaelle; Le Forestier, Nadine; Lacomblez, Lucette] UPMC, AP HP, La Salpetriere Hosp, Ctr Referent Malad Rares, Paris, France	Sanofi-Aventis; Sanofi France; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Conraux, L (corresponding author), Sanofi, Exploratory Unit, Toulouse, France.	Laurence.conraux@sanofi.com		BRUNETEAU, GAELLE/0000-0002-1905-7985				Aidoudi S, 2010, THROMB HAEMOSTASIS, V104, P941, DOI 10.1160/TH10-03-0193; An YM, 2010, DIS MARKERS, V29, P11, DOI [10.1155/2010/681876, 10.3233/DMA-2010-0721]; Arhart RW, 2010, MED HYPOTHESES, V75, P341, DOI 10.1016/j.mehy.2010.03.017; Bartanusz V, 2011, ANN NEUROL, V70, P194, DOI 10.1002/ana.22421; Behari M, 2013, INT J NEUROSCI, V123, P287, DOI 10.3109/00207454.2012.751534; Brettschneider J, 2010, NEUROSCI LETT, V468, P23, DOI 10.1016/j.neulet.2009.10.053; Dupuis L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013346; Evans MC, 2013, MOL CELL NEUROSCI, V53, P34, DOI 10.1016/j.mcn.2012.10.008; Fiedler GM, 2009, CLIN CANCER RES, V15, P3812, DOI 10.1158/1078-0432.CCR-08-2701; Ganesalingam J, 2011, J NEUROCHEM, V117, P528, DOI 10.1111/j.1471-4159.2011.07224.x; Hardiman O, 2011, NAT REV NEUROL, V7, P639, DOI 10.1038/nrneurol.2011.153; Kaneshiro N, 2009, RAPID COMMUN MASS SP, V23, P3720, DOI 10.1002/rcm.4315; Kawashima Y, 2010, J PROTEOME RES, V9, P1694, DOI 10.1021/pr9008018; Khansari Parto S., 2012, Inflammopharmacology, V20, P103, DOI 10.1007/s10787-012-0124-x; Kim JY, 2013, RAPID COMMUN MASS SP, V27, P521, DOI 10.1002/rcm.6480; Kowalska MA, 2010, THROMB RES, V125, P292, DOI 10.1016/j.thromres.2009.11.023; Kruger T, 2012, PROTEOMICS IN PRESS; Li YH, 2011, EUR NEUROL, V65, P105, DOI 10.1159/000323427; Liang TT, 2010, PROTEOMICS, V10, P90, DOI 10.1002/pmic.200900513; McNicol Archibald, 2008, Cardiovascular & Hematological Disorders - Drug Targets, V8, P99, DOI 10.2174/187152908784533739; Mitchell RM, 2010, MUSCLE NERVE, V42, P95, DOI 10.1002/mus.21625; Nanni P, 2008, THESIS; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Rai AJ, 2005, PROTEOMICS, V5, P3262, DOI 10.1002/pmic.200401245; Ryberg H, 2010, MUSCLE NERVE, V42, P104, DOI 10.1002/mus.21683; Shrivastava M, 2011, ULTRASTRUCT PATHOL, V35, P52, DOI 10.3109/01913123.2010.541985; Silani V, 2011, ARCH ITAL BIOL, V149, P5, DOI 10.4449/aib.v149i1.1260; Struyf S, 2004, CIRC RES, V95, P855, DOI 10.1161/01.RES.0000146674.38319.07; Turner MR, 2009, LANCET NEUROL, V8, P94, DOI 10.1016/S1474-4422(08)70293-X; Vandercappellen J, 2011, CYTOKINE GROWTH F R, V22, P1, DOI 10.1016/j.cytogfr.2010.10.011; Villanueva J, 2006, J CLIN INVEST, V116, P271, DOI 10.1172/JCI26022; Villanueva J, 2005, J PROTEOME RES, V4, P1060, DOI 10.1021/pr050034b; Villanueva J, 2004, ANAL CHEM, V76, P1560, DOI 10.1021/ac0352171; von Neuhoff N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044401; Zhang XX, 2012, CLIN EXP MED, V12, P145, DOI 10.1007/s10238-011-0154-5	36	15	15	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79733	10.1371/journal.pone.0079733	http://dx.doi.org/10.1371/journal.pone.0079733			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224000	Green Submitted, Green Published, gold			2022-12-27	WOS:000326597400083
J	Miquel, M; Spampinato, U; Latxague, C; Aviles-Olmos, I; Bader, B; Bertram, K; Bhatia, K; Burbaud, P; Burghaus, L; Cho, JW; Cuny, E; Danek, A; Foltynie, T; Ruiz, PJG; Gimenez-Roldan, S; Guehl, D; Guridi, J; Hariz, M; Jarman, P; Kefalopoulou, ZM; Limousin, P; Lipsman, N; Lozano, AM; Moro, E; Ngy, D; Rodriguez-Oroz, MC; Shang, HF; Shin, H; Walker, RH; Yokochi, F; Zrinzo, L; Tison, F				Miquel, Marie; Spampinato, Umberto; Latxague, Chrystelle; Aviles-Olmos, Iciar; Bader, Benedikt; Bertram, Kelly; Bhatia, Kailash; Burbaud, Pierre; Burghaus, Lothar; Cho, Jin Whan; Cuny, Emmanuel; Danek, Adrian; Foltynie, Thomas; Garcia Ruiz, Pedro J.; Gimenez-Roldan, Santiago; Guehl, Dominique; Guridi, Jorge; Hariz, Marwan; Jarman, Paul; Kefalopoulou, Zinovia Maria; Limousin, Patricia; Lipsman, Nir; Lozano, Andres M.; Moro, Elena; Ngy, Dhita; Cruz Rodriguez-Oroz, Maria; Shang, Huifang; Shin, Hyeeun; Walker, Ruth H.; Yokochi, Fusako; Zrinzo, Ludvic; Tison, Francois			Short and Long Term Outcome of Bilateral Pallidal Stimulation in Chorea-Acanthocytosis	PLOS ONE			English	Article							DEEP-BRAIN-STIMULATION; PRIMARY GENERALIZED DYSTONIA; PARKINSONS-DISEASE; GLOBUS-PALLIDUS; FOLLOW-UP; NEUROACANTHOCYTOSIS; NEURODEGENERATION; DISORDERS; PATIENT	Background: Chorea-acanthocytosis (ChAc) is a neuroacanthocytosis syndrome presenting with severe movement disorders poorly responsive to drug therapy. Case reports suggest that bilateral deep brain stimulation (DBS) of the ventro-postero-lateral internal globus pallidus (GPi) may benefit these patients. To explore this issue, the present multicentre (n=12) retrospective study collected the short and long term outcome of 15 patients who underwent DBS. Methods: Data were collected in a standardized way 2-6 months preoperatively, 1-5 months (early) and 6 months or more (late) after surgery at the last follow-up visit (mean follow-up: 29.5 months). Results: Motor severity, assessed by the Unified Huntington's Disease Rating Scale-Motor Score, UHDRS-MS), was significantly reduced at both early and late post-surgery time points (mean improvement 54.3% and 44.1%, respectively). Functional capacity (UHDRS-Functional Capacity Score) was also significantly improved at both post-surgery time points (mean 75.5% and 73.3%, respectively), whereas incapacity (UHDRS-Independence Score) improvement reached significance at early post-surgery only (mean 37.3%). Long term significant improvement of motor symptom severity (>= 20 % from baseline) was observed in 61.5 % of the patients. Chorea and dystonia improved, whereas effects on dysarthria and swallowing were variable. Parkinsonism did not improve. Linear regression analysis showed that preoperative motor severity predicted motor improvement at both post-surgery time points. The most serious adverse event was device infection and cerebral abscess, and one patient died suddenly of unclear cause, 4 years after surgery. Conclusion: This study shows that bilateral DBS of the GPi effectively reduces the severity of drug-resistant hyperkinetic movement disorders such as present in ChAc.	[Miquel, Marie; Spampinato, Umberto; Latxague, Chrystelle; Tison, Francois] CHU Bordeaux, Serv Neurol, Bordeaux, France; [Miquel, Marie] CH Francois Mitterrand, Serv Neurol, Pau, France; [Spampinato, Umberto] Univ Bordeaux, INSERM, U862, Neuroctr Magendie, Bordeaux, France; [Spampinato, Umberto; Aviles-Olmos, Iciar; Foltynie, Thomas; Hariz, Marwan; Kefalopoulou, Zinovia Maria; Limousin, Patricia; Zrinzo, Ludvic] UCL, Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, Unit Funct Neurosurg, London, England; [Bader, Benedikt; Danek, Adrian] Univ Munich, Neurol Klin & Poliklin, Munich, Germany; [Bertram, Kelly] Alfred Hosp, Melbourne, Vic, Australia; [Bertram, Kelly] Monash Univ, Van Cleef Roet Ctr Nervous Dis, Melbourne, Vic 3004, Australia; [Bhatia, Kailash] UCL, Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London, England; [Burbaud, Pierre; Guehl, Dominique] CHU Bordeaux, Serv Neurophysiol Clin, Bordeaux, France; [Burghaus, Lothar] Univ Hosp Cologne, Dept Neurol, Cologne, Germany; [Cho, Jin Whan; Shin, Hyeeun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea; [Cuny, Emmanuel] CHU Bordeaux, Serv Neurochirurg, Bordeaux, France; [Garcia Ruiz, Pedro J.] Fdn Jimenez Diaz, Dept Neurol, E-28040 Madrid, Spain; [Gimenez-Roldan, Santiago] Univ Gregorio Maranon, Gen Hosp, Serv Neurol, Madrid, Spain; [Guridi, Jorge] Univ Navarra Clin, Dept Neurol & Neurosurg, Pamplona, Spain; [Jarman, Paul] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England; [Lipsman, Nir; Lozano, Andres M.] Univ Toronto, Toronto Western Hosp, Univ Hlth Network, Div Neurosurg, Toronto, ON M5T 2S8, Canada; [Moro, Elena] Univ Toronto, Toronto Western Hosp, Univ Hlth Network, Morton & Gloria Shulman Movement Disorders Ctr, Toronto, ON M5T 2S8, Canada; [Moro, Elena] Univ Hosp Ctr Grenoble, Dept Psychiat & Neurol, Movement Disorders Ctr, Grenoble, France; [Ngy, Dhita; Walker, Ruth H.] Mt Sinai Sch Med, Dept Neurol, New York, NY USA; [Ngy, Dhita] Avicenna Med Ctr, New York, NY USA; [Cruz Rodriguez-Oroz, Maria] Univ Hosp Donostia, BioDonostia Res Inst, Dept Neurol, Neurosci Unit, San Sebastian, Spain; [Shang, Huifang] Sichuan Univ, West China Hosp, Dept Neurol, Chengdu 610064, Sichuan, Peoples R China; [Walker, Ruth H.] James J Peters Vet Affairs Med Ctr, Dept Neurol, Bronx, NY USA; [Yokochi, Fusako] Tokyo Metropolitan Neurol Hosp, Dept Neurol, Fuchu, Tokyo, Japan; [Tison, Francois] Univ Bordeaux, Inst Malad Neurodegenerat, UMR 5293, Bordeaux, France; [Tison, Francois] CNRS, Inst Malad Neurodegenerat, UMR 5293, Bordeaux, France	CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; University of London; University College London; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; Florey Institute of Neuroscience & Mental Health; Monash University; University of London; University College London; CHU Bordeaux; University of Cologne; Sungkyunkwan University (SKKU); Samsung Medical Center; CHU Bordeaux; General University Gregorio Maranon Hospital; University of Navarra; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; CHU Grenoble Alpes; Icahn School of Medicine at Mount Sinai; University Hospital Donostia; Sichuan University; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Tokyo Metropolitan Institute for Neuroscience; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Spampinato, U (corresponding author), CHU Bordeaux, Serv Neurol, Bordeaux, France.	umberto.spampinato@inserm.fr	AVILES-OLMOS, ICIAR/AAG-5965-2019; Rodriguez-Oroz, Maria Cruz/D-1490-2018; Lozano, Andres M/A-5058-2012; AVILES-OLMOS, ICIAR/E-3065-2018; Moro, Elena/AAC-3136-2019; Guridi, Jorge/G-2288-2018; Danek, Adrian/G-7339-2011; Garcia Ruiz, Pedro J/G-8660-2013	AVILES-OLMOS, ICIAR/0000-0002-1645-7406; Rodriguez-Oroz, Maria Cruz/0000-0001-5962-772X; AVILES-OLMOS, ICIAR/0000-0002-1645-7406; Guridi, Jorge/0000-0001-5714-5145; Danek, Adrian/0000-0001-8857-5383; Bhatia, Kailash/0000-0001-8185-286X; Lozano, Andres M./0000-0001-8257-3694; Walker, Ruth/0000-0002-8366-072X; Burghaus, Lothar/0000-0002-7883-190X; Bertram, Kelly/0000-0002-4283-1182; Garcia Ruiz, Pedro J/0000-0001-6194-672X	ERA-net E-Rare consortium European Multidisciplinary Initiative on Neuroacanthocytosis (EMINA); Neuroacanthocytosis Advocacy; EMINA consortium [BMBF 01GM1003]	ERA-net E-Rare consortium European Multidisciplinary Initiative on Neuroacanthocytosis (EMINA); Neuroacanthocytosis Advocacy; EMINA consortium	This study was supported by the ERA-net E-Rare consortium European Multidisciplinary Initiative on Neuroacanthocytosis (EMINA); www.e-rare.eu/node/474. Western blot analysis for chorein was performed with the financial support of the Neuroacanthocytosis Advocacy and the EMINA consortium (BMBF 01GM1003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bejjani BP, 1998, MOVEMENT DISORD, V13, P969, DOI 10.1002/mds.870130618; Biolsi B, 2008, J NEUROSURG, V109, P130, DOI 10.3171/JNS/2008/109/7/0130; BURKE RE, 1985, NEUROLOGY, V35, P73, DOI 10.1212/WNL.35.1.73; Danek A, 2005, J NEUROL SCI, V229, P171, DOI 10.1016/j.jns.2004.11.024; Edwards TC, 2012, MOVEMENT DISORD, V27, P357, DOI 10.1002/mds.23967; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fujimoto Y, 1997, Rinsho Shinkeigaku, V37, P891; Gan JJ, 2011, NEUROLOGY, V76, pA590; Ruiz PJG, 2009, MOVEMENT DISORD, V24, P1546, DOI 10.1002/mds.22592; Guehl D, 2007, NEUROLOGY, V68, P160, DOI 10.1212/01.wnl.0000250536.81426.1a; Guridi J, 2012, PARKINSONISM RELAT D, V18, P765, DOI 10.1016/j.parkreldis.2012.03.014; Isaias IU, 2009, ARCH NEUROL-CHICAGO, V66, P465, DOI 10.1001/archneurol.2009.20; Jung HH, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-68; Kang GA, 2011, J NEUROL NEUROSUR PS, V82, P272, DOI 10.1136/jnnp.2009.202903; Kefalopoulou Z, 2013, J NEUROL, V260, P303, DOI 10.1007/s00415-012-6714-0; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; Koss AM, 2005, ANN NEUROL, V58, P168, DOI 10.1002/ana.20525; Li P, 2012, NEUROL SCI, V33, P269, DOI 10.1007/s10072-011-0741-y; Lim BC, 2012, EUR J NEUROL, V19, P556, DOI 10.1111/j.1468-1331.2011.03589.x; Lim TT, 2013, NEUROSURGERY, V73, pE184, DOI 10.1227/01.neu.0000429852.45073.73; Lyons MK, 2011, MAYO CLIN PROC, V86, P662, DOI 10.4065/mcp.2011.0045; Moro E, 2004, ANN NEUROL, V56, P290, DOI 10.1002/ana.20183; Moro E, 2002, NEUROLOGY, V59, P706, DOI 10.1212/WNL.59.5.706; Odekerken VJJ, 2013, LANCET NEUROL, V12, P37, DOI 10.1016/S1474-4422(12)70264-8; Rodriguez-Oroz MC, 2005, BRAIN, V128, P2240, DOI 10.1093/brain/awh571; Schaltenbrand G., 1977, ATLAS STEREOTAXY HUM; Schneider SA, 2010, MOVEMENT DISORD, V25, P1487, DOI 10.1002/mds.23052; Shin H, 2012, STEREOT FUNCT NEUROS, V90, P273, DOI 10.1159/000338216; Sibon I, 2004, MOVEMENT DISORD, V19, P856, DOI 10.1002/mds.20091; Timmermann L, 2010, BRAIN, V133, P701, DOI 10.1093/brain/awq022; Vidailhet M, 2007, LANCET NEUROL, V6, P223, DOI 10.1016/S1474-4422(07)70035-2; Vidailhet M, 2009, LANCET NEUROL, V8, P709, DOI 10.1016/S1474-4422(09)70151-6; Vitek JL, 2010, MOVEMENT DISORD, V25, P1530, DOI 10.1002/mds.23151; Volkmann J, 2012, LANCET NEUROL, V11, P1029, DOI 10.1016/S1474-4422(12)70257-0; Walker RH, 2012, MOVEMENT DISORD, V27, P539, DOI 10.1002/mds.24020; Walterfang M, 2011, PSYCHIAT RES-NEUROIM, V192, P29, DOI 10.1016/j.pscychresns.2010.10.006; Wihl G, 2001, MOVEMENT DISORD, V16, P572, DOI 10.1002/mds.1109; Yelnik J, 2000, NEUROSCIENCE, V101, P77, DOI 10.1016/S0306-4522(00)00364-X; Yokochi F, 2008, NEUROACANTHOCYTOSIS SYNDROMES II, P255, DOI 10.1007/978-3-540-71693-8_22; Yokochi F, 2011, MOVEMENT DISORD, V26, pS96	40	35	38	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79241	10.1371/journal.pone.0079241	http://dx.doi.org/10.1371/journal.pone.0079241			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223913	Green Published, gold			2022-12-27	WOS:000326597400054
J	Pettay, DT; LaJeunesse, TC				Pettay, D. Tye; LaJeunesse, Todd C.			Long-Range Dispersal and High-Latitude Environments Influence the Population Structure of a "Stress-Tolerant" Dinoflagellate Endosymbiont	PLOS ONE			English	Article							CORAL POCILLOPORA-DAMICORNIS; SOUTHERN OSCILLATION EVENT; GREAT-BARRIER-REEF; GULF-OF-CALIFORNIA; EASTERN PACIFIC; GENETIC DIVERSITY; MICROSATELLITE LOCI; INDO-PACIFIC; SEA FAN; PATTERNS	The migration and dispersal of stress-tolerant symbiotic dinoflagellates (genus Symbiodinium) may influence the response of symbiotic reef-building corals to a warming climate. We analyzed the genetic structure of the stress-tolerant endosymbiont, Symbiodinium glynni nomen nudum (ITS2 - D1), obtained from Pocillopora colonies that dominate eastern Pacific coral communities. Eleven microsatellite loci identified genotypically diverse populations with minimal genetic subdivision throughout the Eastern Tropical Pacific, encompassing 1000's of square kilometers from mainland Mexico to the Galapagos Islands. The lack of population differentiation over these distances corresponds with extensive regional host connectivity and indicates that Pocillopora larvae, which maternally inherit their symbionts, aid in the dispersal of this symbiont. In contrast to its host, however, subtropical populations of S. glynni in the Gulf of California (Sea of Cortez) were strongly differentiated from populations in tropical eastern Pacific. Selection pressures related to large seasonal fluctuations in temperature and irradiance likely explain this abrupt genetic discontinuity. We infer that S. glynni genotypes harbored by host larvae arriving from more southern locations are rapidly replaced by genotypes adapted to more temperate environments. The strong population structure of S. glynni corresponds with fluctuating environmental conditions and suggests that these genetically diverse populations have the potential to evolve rapidly to changing environments and reveals the importance of environmental extremes in driving microbial eukaryote (e. g., plankton) speciation in marine ecosystems.	[Pettay, D. Tye; LaJeunesse, Todd C.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Pettay, D. Tye] Univ Delaware, Coll Earth Ocean & Environm, Lewes, DE 19958 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Delaware	Pettay, DT (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	tpettay@udel.edu	LaJeunesse, Todd/B-1720-2009	LaJeunesse, Todd/0000-0001-7607-9358	Florida International University; The Pennsylvania State University; National Science Foundation [IOB 544854, OCE-09287664]; DHHS/NIH/NIEHS [ES11181]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [S11ES011181] Funding Source: NIH RePORTER	Florida International University; The Pennsylvania State University; National Science Foundation(National Science Foundation (NSF)); DHHS/NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was funded in part by Florida International University, The Pennsylvania State University, the National Science Foundation (IOB 544854 and OCE-09287664) and DHHS/NIH/NIEHS (ES11181). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andras JP, 2011, MOL ECOL, V20, P2525, DOI 10.1111/j.1365-294X.2011.05115.x; Arnaud-Haond S, 2007, MOL ECOL, V16, P5115, DOI 10.1111/j.1365-294X.2007.03535.x; Ayre DJ, 1997, MAR ECOL PROG SER, V159, P175, DOI 10.3354/meps159175; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Byler KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059596; Casteleyn G, 2010, P NATL ACAD SCI USA, V107, P12952, DOI 10.1073/pnas.1001380107; Castro R, 2000, CIENC MAR, V26, P561; Chavez-Romo H, 2007, CIENC MAR, V33, P495, DOI 10.7773/cm.v33i4.1141; Chavez-Romo HE, 2008, P 11 INT COR REEF S, P429; Combosch DJ, 2008, MOL ECOL, V17, P1304, DOI 10.1111/j.1365-294X.2007.03672.x; Corander J, 2004, BIOINFORMATICS, V20, P2363, DOI 10.1093/bioinformatics/bth250; Darling KF, 2004, P NATL ACAD SCI USA, V101, P7657, DOI 10.1073/pnas.0402401101; Earl DA, 2009, STRUCTURE HARVESTER; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; FIEDLER PC, 1992, DEEP-SEA RES, V39, P199, DOI 10.1016/0198-0149(92)90105-3; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; FITT WK, 1983, NEW PHYTOL, V94, P421, DOI 10.1111/j.1469-8137.1983.tb03456.x; Foissner W, 2006, ACTA PROTOZOOL, V45, P111; Frade PR, 2008, MOL ECOL, V17, P691, DOI 10.1111/j.1365-294X.2007.03612.x; GLYNN PW, 1991, MAR BIOL, V109, P355, DOI 10.1007/BF01313501; Glynn PW, 1996, CORAL REEFS, V15, P71; Glynn PW, 2000, CORAL REEFS, V19, P1, DOI 10.1007/s003380050220; Glynn PW, 2001, B MAR SCI, V69, P79; Goulet TL, 2003, MAR ECOL PROG SER, V250, P117, DOI 10.3354/meps250117; Goulet TL, 2003, MAR BIOL, V142, P233, DOI 10.1007/s00227-002-0936-0; Hirose M, 2000, BIOL BULL, V199, P68, DOI 10.2307/1542708; Howells EJ, 2009, CORAL REEFS, V28, P215, DOI 10.1007/s00338-008-0450-z; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hurtado LA, 2007, MAR BIOL, V151, P1863, DOI 10.1007/s00227-007-0620-5; Jones RJ, 1997, PHILOS T ROY SOC B, V352, P457, DOI 10.1098/rstb.1997.0033; Kirk NL, 2009, MAR BIOL, V156, P1609, DOI 10.1007/s00227-009-1196-z; LaJeunesse TC, 2008, LIMNOL OCEANOGR, V53, P719, DOI 10.4319/lo.2008.53.2.0719; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P570, DOI 10.1093/molbev/msi042; LaJeunesse TC, 2004, MAR ECOL PROG SER, V284, P147, DOI 10.3354/meps284147; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; LaJeunesse TC, 2010, P ROY SOC B-BIOL SCI, V277, P2925, DOI 10.1098/rspb.2010.0385; LaJeunesse TC, 2010, J BIOGEOGR, V37, P785, DOI 10.1111/j.1365-2699.2010.02273.x; Lopez-Perez RA, 2005, EARTH-SCI REV, V72, P67, DOI 10.1016/j.earscirev.2005.04.002; Magalon H, 2006, MAR BIOL, V148, P913, DOI 10.1007/s00227-005-0133-z; Nagai S, 2009, MOL ECOL, V18, P2337, DOI 10.1111/j.1365-294X.2009.04193.x; Nagai S, 2007, J PHYCOL, V43, P43, DOI 10.1111/j.1529-8817.2006.00304.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pettay DT, 2007, MOL ECOL NOTES, V7, P1271, DOI 10.1111/j.1471-8286.2007.01852.x; Pettay DT, 2011, MOL ECOL, V20, P5197, DOI 10.1111/j.1365-294X.2011.05357.x; Pettay DT, 2009, MOL ECOL RESOUR, V9, P1022, DOI 10.1111/j.1755-0998.2009.02561.x; Pinzon JH, 2011, MOL ECOL, V20, P311, DOI 10.1111/j.1365-294X.2010.04939.x; Pinzon JH, 2011, CONSERV GENET RESOUR, V3, P45, DOI 10.1007/s12686-010-9283-5; RICHMOND RH, 1987, MAR BIOL, V93, P527, DOI 10.1007/BF00392790; Ridgway T, 2008, MAR ECOL PROG SER, V354, P161, DOI 10.3354/meps07245; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Rynearson TA, 2004, J PHYCOL, V40, P34, DOI 10.1046/j.1529-8817.2004.03089.x; Sampayo EM, 2009, MOL ECOL, V18, P500, DOI 10.1111/j.1365-294X.2008.04037.x; Santos SR, 2003, MAR BIOL, V143, P111, DOI 10.1007/s00227-003-1065-0; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Shankle AM, 2004, J PHYCOL, V40, P239, DOI 10.1111/j.1529-8817.2004.03021.x; Thornhill DJ, 2007, MOL ECOL, V16, P5326, DOI 10.1111/j.1365-294X.2007.03576.x; Thornhill DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006262; Victor BC, 2001, B MAR SCI, V69, P279; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Wham DC, 2011, CONSERV GENET RESOUR, V3, P541, DOI 10.1007/s12686-011-9399-2; Wintzingerode F., 1997, MICROBIOLOGY REV, V21, P213, DOI DOI 10.1111/J.1574-6976.1997.TB00351.X.PUBMED:9451814	65	33	33	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79208	10.1371/journal.pone.0079208	http://dx.doi.org/10.1371/journal.pone.0079208			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223906	Green Published, gold			2022-12-27	WOS:000326597400052
J	Coursey, TG; Gandhi, NB; Volpe, EA; Pflugfelder, SC; de Paiva, CS				Coursey, Terry G.; Gandhi, Niral B.; Volpe, Eugene A.; Pflugfelder, Stephen C.; de Paiva, Cintia S.			Chemokine Receptors CCR6 and CXCR3 Are Necessary for CD4(+) T Cell Mediated Ocular Surface Disease in Experimental Dry Eye Disease	PLOS ONE			English	Article							TH17 CELLS; PREVALENCE; EXPRESSION; INFLAMMATION; DISTINCT; MIGRATION; CYTOKINES; RESPONSES; SUBSETS; LINEAGE	CD4(+) T cells are essential to pathogenesis of ocular surface disease in dry eye. Two subtypes of CD4(+) T cells, Th1 and Th17 cells, function concurrently in dry eye to mediate disease. This occurs in spite of the cross-regulation of IFN-gamma and IL-17A, the prototypical cytokines Th1 and Th17 cells, respectively. Essential to an effective immune response are chemokines that direct and summon lymphocytes to specific tissues. T cell trafficking has been extensively studied in other models, but this is the first study to examine the role of chemokine receptors in ocular immune responses. Here, we demonstrate that the chemokine receptors, CCR6 and CXCR3, which are expressed on Th17 and Th1 cells, respectively, are required for the pathogenesis of dry eye disease, as CCR6KO and CXCR3KO mice do not develop disease under desiccating stress. CD4(+) T cells from CCR6KO and CXCR3KO mice exposed to desiccating stress (DS) do not migrate to the ocular surface, but remain in the superficial cervical lymph nodes. In agreement with this, CD4(+) T cells from CCR6 and CXCR3 deficient donors exposed to DS, when adoptively transferred to T cell deficient recipients manifest minimal signs of dry eye disease, including significantly less T cell infiltration, goblet cell loss, and expression of inflammatory cytokine and matrix metalloproteinase expression compared to wild-type donors. These findings highlight the important interaction of chemokine receptors on T cells and chemokine ligand expression on epithelial cells of the cornea and conjunctiva in dry eye pathogenesis and reveal potential new therapeutic targets for dry eye disease.	[Coursey, Terry G.; Gandhi, Niral B.; Volpe, Eugene A.; Pflugfelder, Stephen C.; de Paiva, Cintia S.] Baylor Coll Med, Cullen Eye Inst, Dept Ophthalmol, Ocular Surface Ctr, Houston, TX 77030 USA	Baylor College of Medicine	de Paiva, CS (corresponding author), Baylor Coll Med, Cullen Eye Inst, Dept Ophthalmol, Ocular Surface Ctr, Houston, TX 77030 USA.	cintiadp@bcm.edu	Volpe, Eugene A./D-2000-2012; De Paiva, Cintia/AAH-8354-2021	Volpe, Eugene A./0000-0002-9128-754X; De Paiva, Cintia/0000-0002-9057-5494	NIH [EY018888, EY11915, EY018090, EY002520, EY020799]; Research to Prevent Blindness; Oshman Foundation; William Stamps Farish Fund; Hamill Foundation; Cytometry and Cell Sorting Core at Baylor College of Medicine; NIH (NIAID) [P30AI036211]; NIH (NCI) [P30CA125123]; NIH (NCRR) [S10RR024574];  [2 T32 EY 7001-36]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018090, P30EY020799, R21EY018888, R01EY011915, P30EY002520, T32EY007001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Oshman Foundation; William Stamps Farish Fund; Hamill Foundation; Cytometry and Cell Sorting Core at Baylor College of Medicine; NIH (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Training Grant- 2 T32 EY 7001-36 (TGC), NIH Grant EY018888 (CSDP), EY11915 (SCP), EY018090 (SCP), NIH Core Grants EY002520 & EY020799, Research to Prevent Blindness, the Oshman Foundation, William Stamps Farish Fund, the Hamill Foundation and by the Cytometry and Cell Sorting Core at Baylor College of Medicine which is funded by the NIH (NIAID P30AI036211, NCI P30CA125123, and NCRR S10RR024574). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Bowman EP, 2000, J EXP MED, V191, P1303, DOI 10.1084/jem.191.8.1303; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Cook DN, 2000, IMMUNITY, V12, P495, DOI 10.1016/S1074-7613(00)80201-0; De Paiva CS, 2011, MUCOSAL IMMUNOL, V4, P397, DOI 10.1038/mi.2010.82; De Paiva CS, 2009, MUCOSAL IMMUNOL, V2, P243, DOI 10.1038/mi.2009.5; De Paiva CS, 2007, INVEST OPHTH VIS SCI, V48, P2553, DOI 10.1167/iovs.07-0069; Dohlman TH, 2013, INVEST OPHTH VIS SCI, V54, P4081, DOI 10.1167/iovs.12-11216; Dursun D, 2002, INVEST OPHTH VIS SCI, V43, P632; Dursun D, 2002, ADV EXP MED BIOL, V506, P647; El Annan J, 2009, INVEST OPHTH VIS SCI, V50, P3802, DOI 10.1167/iovs.08-2417; Elhofy A, 2009, J NEUROIMMUNOL, V213, P91, DOI 10.1016/j.jneuroim.2009.05.011; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Harper EG, 2009, J INVEST DERMATOL, V129, P2175, DOI 10.1038/jid.2009.65; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hedrick MN, 2010, EXPERT OPIN THER TAR, V14, P911, DOI 10.1517/14728222.2010.504716; Kallal LE, 2010, EUR J IMMUNOL, V40, P1042, DOI 10.1002/eji.200939778; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kim CH, 2002, BLOOD, V100, P11, DOI 10.1182/blood-2001-12-0196; Lacotte S, 2009, ANN NY ACAD SCI, V1173, P310, DOI 10.1111/j.1749-6632.2009.04813.x; Liston A, 2009, J IMMUNOL, V182, P3121, DOI 10.4049/jimmunol.0713169; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Luo LH, 2004, INVEST OPHTH VIS SCI, V45, P4293, DOI 10.1167/iovs.03-1145; McCarty CA, 1998, OPHTHALMOLOGY, V105, P1114, DOI 10.1016/S0161-6420(98)96016-X; Moss SE, 2000, ARCH OPHTHALMOL-CHIC, V118, P1264; Moss SE, 2004, ARCH OPHTHALMOL-CHIC, V122, P369, DOI 10.1001/archopht.122.3.369; Niederkorn JY, 2006, J IMMUNOL, V176, P3950, DOI 10.4049/jimmunol.176.7.3950; O'Connor RA, 2008, J IMMUNOL, V181, P3750, DOI 10.4049/jimmunol.181.6.3750; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Schaumberg DA, 2003, AM J OPHTHALMOL, V136, P318, DOI 10.1016/S0002-9394(03)00218-6; Schaumberg DA, 2009, ARCH OPHTHALMOL-CHIC, V127, P763, DOI 10.1001/archophthalmol.2009.103; Schaumburg CS, 2011, J IMMUNOL, V187, P3653, DOI 10.4049/jimmunol.1101442; Schein OD, 1997, AM J OPHTHALMOL, V124, P723, DOI 10.1016/S0002-9394(14)71688-5; Schiffman RM, 2003, OPHTHALMOLOGY, V110, P1412, DOI 10.1016/S0161-6420(03)00462-7; Shimmura S, 1999, CORNEA, V18, P408, DOI 10.1097/00003226-199907000-00003; Song XJ, 2003, INVEST OPHTH VIS SCI, V44, P4223, DOI 10.1167/iovs.02-1319; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391; Yoon KC, 2007, INVEST OPHTH VIS SCI, V48, P2561, DOI 10.1167/iovs.07-0002; Yoon KC, 2010, INVEST OPHTH VIS SCI, V51, P643, DOI 10.1167/iovs.09-3425; Zhang XB, 2011, AM J PATHOL, V179, P1807, DOI 10.1016/j.ajpath.2011.06.030; Zheng XF, 2010, J CELL PHYSIOL, V222, P95, DOI 10.1002/jcp.21926	42	39	44	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78508	10.1371/journal.pone.0078508	http://dx.doi.org/10.1371/journal.pone.0078508			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223818	Green Published, gold, Green Submitted			2022-12-27	WOS:000326503400070
J	Peltonen, HM; Haapasalo, A; Hiltunen, M; Kataja, V; Kosma, VM; Mannermaa, A				Peltonen, Hanna M.; Haapasalo, Annakaisa; Hiltunen, Mikko; Kataja, Vesa; Kosma, Veli-Matti; Mannermaa, Arto			Upsilon-Secretase Components as Predictors of Breast Cancer Outcome	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE; ESTROGEN-RECEPTOR; PRESENILIN/GAMMA-SECRETASE; TUMOR-SUPPRESSOR; BETA-CATENIN; SIGNALING PATHWAY; COMPLEX-FORMATION; GENE-EXPRESSION; APH-1 INTERACTS	Upsilon-secretase is a large ubiquitously expressed protease complex composed of four core subunits: presenilin, Aph1, PEN-2, and nicastrin. The function of Upsilon-secretase in the cells is to proteolytically cleave various proteins within their transmembrane domains. Presenilin and Aph1 occur as alternative variants belonging to mutually exclusive Upsilon-secretase complexes and providing the complexes with heterogeneous biochemical and physiological properties.Upsilon-secretase is proposed to have a role in the development and progression of cancer and Upsilon-secretase inhibitors are intensively studied for their probable anti-tumor effects in various types of cancer models. Here, we for the first time determined mRNA expression levels of presenilin-1, presenilin-2, Aph1a, Aph1b, PEN-2, and nicastrin in a set of breast cancer tissue samples (N = 55) by quantitative real-time PCR in order to clarify the clinical significance of the expression of different Upsilon-secretase complex components in breast cancer. We found a high positive correlation between the subunit expression levels implying a common regulation of transcription. Our univariate Kaplan-Meier survival analyses established low expression level of Upsilon-secretase complex as a risk factor for breast cancer specific mortality. The tumors expressing low levels of Upsilon-secretase complex were characterized by high histopathological tumor grade, low or no expression of estrogen and progesterone receptors and consequently high probability to fall into the class of triple negative breast cancer tumors. These results may provide novel tools to further categorize breast cancer tumors, especially the highly aggressive and poorly treatable breast cancer type of triple negative cases, and suggest a significant role for Upsilon-secretase in breast cancer.	[Peltonen, Hanna M.; Kosma, Veli-Matti; Mannermaa, Arto] Univ Eastern Finland, Inst Clin Med Pathol & Forens Med, Kuopio, Finland; [Peltonen, Hanna M.; Kosma, Veli-Matti; Mannermaa, Arto] Univ Eastern Finland, Bioctr Kuopio, Kuopio, Finland; [Peltonen, Hanna M.; Kosma, Veli-Matti; Mannermaa, Arto] Univ Eastern Finland, Canc Ctr Eastern Finland, Kuopio, Finland; [Peltonen, Hanna M.; Kosma, Veli-Matti; Mannermaa, Arto] Kuopio Univ Hosp, Imaging Ctr, SF-70210 Kuopio, Finland; [Haapasalo, Annakaisa; Hiltunen, Mikko] Univ Eastern Finland, Inst Clin Med Neurol, Kuopio, Finland; [Kataja, Vesa] Univ Eastern Finland, Inst Clin Med, Kuopio, Finland; [Kataja, Vesa] Kuopio Univ Hosp, Ctr Canc, SF-70210 Kuopio, Finland	University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Peltonen, HM (corresponding author), Univ Eastern Finland, Inst Clin Med Pathol & Forens Med, Kuopio, Finland.	hanna.peltonen@uef.fi		Haapasalo, Annakaisa/0000-0003-0959-2957; Kataja, Vesa/0000-0003-4846-4843	Special Government Funding (EVO) of Kuopio University Hospital; Cancer Fund of Northern Savo; Finnish Cancer Organisations; Sigrid Juselius Foundation; Health Research Council of the Academy of Finland; (UEF-Brain and Cancer Center of Eastern Finland)	Special Government Funding (EVO) of Kuopio University Hospital; Cancer Fund of Northern Savo; Finnish Cancer Organisations; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Health Research Council of the Academy of Finland(Academy of Finland); (UEF-Brain and Cancer Center of Eastern Finland)	This study was supported by grants from Special Government Funding (EVO) of Kuopio University Hospital (www.psshp.fi), the Cancer Fund of Northern Savo (www.pohjois-savonsyopayhdistys.fi), the Finnish Cancer Organisations (www.cancer.fi), Sigrid Juselius Foundation (www.sigridjuselius.fi), Health Research Council of the Academy of Finland (www.aka.fi), and the strategic funding of the University of Eastern Finland (UEF-Brain and Cancer Center of Eastern Finland; www.uef.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hussaini H, 2011, MOL CANCER THER, V10, P9, DOI 10.1158/1535-7163.MCT-10-0677; Auvinen P, 2005, HISTOPATHOLOGY, V47, P420, DOI 10.1111/j.1365-2559.2005.02220.x; Bao JY, 2007, MOL CELL BIOL, V27, P1321, DOI 10.1128/MCB.01280-06; Beher D, 2003, BIOCHEMISTRY-US, V42, P8133, DOI 10.1021/bi034045z; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Boulton ME, 2008, J CELL MOL MED, V12, P781, DOI 10.1111/j.1582-4934.2008.00274.x; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Checler F, 2012, NEURODEGENER DIS, V10, P52, DOI 10.1159/000332935; Chen FS, 2003, J BIOL CHEM, V278, P19974, DOI 10.1074/jbc.M210049200; Chen JQ, 2009, BBA-REV CANCER, V1796, P162, DOI 10.1016/j.bbcan.2009.06.003; Coolen MW, 2006, MOL PSYCHIATR, V11, P787, DOI 10.1038/sj.mp.4001846; Coolen MW, 2005, FASEB J, V19, P175, DOI 10.1096/fj.05-4337fje; Coolen MW, 2005, NEURON, V45, P497, DOI 10.1016/j.neuron.2004.12.054; Culvenor JG, 2000, EXP CELL RES, V255, P192, DOI 10.1006/excr.1999.4791; de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Debeb BG, 2012, BREAST CANCER RES TR, V134, P495, DOI 10.1007/s10549-012-2075-8; Edbauer D, 2002, P NATL ACAD SCI USA, V99, P8666, DOI 10.1073/pnas.132277899; Efferson CL, 2010, CANCER RES, V70, P2476, DOI 10.1158/0008-5472.CAN-09-3114; Filipovic A, 2011, BREAST CANCER RES TR, V125, P43, DOI 10.1007/s10549-010-0823-1; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Griffiths Carrie L, 2012, J Pharm Pract, V25, P319, DOI 10.1177/0897190012442062; Groth C, 2012, SEMIN CELL DEV BIOL, V23, P465, DOI 10.1016/j.semcdb.2012.01.016; Gu YJ, 2003, J BIOL CHEM, V278, P7374, DOI 10.1074/jbc.M209499200; Guo SC, 2011, BBA-REV CANCER, V1815, P197, DOI 10.1016/j.bbcan.2010.12.002; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Han JX, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2347; Harrison H, 2010, CANCER RES, V70, P709, DOI 10.1158/0008-5472.CAN-09-1681; Hartikainen JM, 2005, CANCER EPIDEM BIOMAR, V14, P75; Haughian JM, 2012, P NATL ACAD SCI USA, V109, P2742, DOI 10.1073/pnas.1106509108; Hebert SS, 2004, NEUROBIOL DIS, V17, P260, DOI 10.1016/j.nbd.2004.08.002; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Howard EM, 2005, J CANCER RES CLIN, V131, P14, DOI 10.1007/s00432-004-0618-z; Ilaya NT, 2004, J NEUROCHEM, V91, P230, DOI 10.1111/j.1471-4159.2004.02718.x; Jayadev S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015743; Jeschke U, 2007, ANTICANCER RES, V27, P1969; Junttila TT, 2005, CANCER RES, V65, P1384, DOI 10.1158/0008-5472.CAN-04-3150; Kang DE, 2002, CELL, V110, P751, DOI 10.1016/S0092-8674(02)00970-4; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kondratyev M, 2012, ONCOGENE, V31, P93, DOI 10.1038/onc.2011.212; Lai MT, 2003, J BIOL CHEM, V278, P22475, DOI 10.1074/jbc.M300974200; Lee CW, 2008, CANCER RES, V68, P5273, DOI 10.1158/0008-5472.CAN-07-6673; Lee CW, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2200; Lee MK, 1996, J NEUROSCI, V16, P7513, DOI 10.1523/jneurosci.16-23-07513.1996; Lee SF, 2002, J BIOL CHEM, V277, P45013, DOI 10.1074/jbc.M208164200; Leong KG, 2006, BLOOD, V107, P2223, DOI 10.1182/blood-2005-08-3329; Li T, 2007, J BIOL CHEM, V282, P32264, DOI 10.1074/jbc.M703649200; Li T, 2007, J NEUROSCI, V27, P10849, DOI 10.1523/JNEUROSCI.2152-07.2007; Lleo A, 2003, J BIOL CHEM, V278, P47370, DOI 10.1074/jbc.M308480200; Ma GJ, 2005, J NEUROSCI, V25, P192, DOI 10.1523/JNEUROSCI.3814-04.2005; Madsen LB, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-72; Mannisto S, 1996, INT J CANCER, V68, P8, DOI 10.1002/(SICI)1097-0215(19960927)68:1<8::AID-IJC2>3.0.CO;2-V; Mitrunen K, 2000, CANCER EPIDEM BIOMAR, V9, P1343; Mittal S, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-128; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Nykopp TK, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-143; O'Neill CF, 2007, AM J PATHOL, V171, P1023, DOI 10.2353/ajpath.2007.061029; Pellikainen MJ, 2003, J CLIN PATHOL, V56, P214, DOI 10.1136/jcp.56.3.214; Placanica L, 2009, J BIOL CHEM, V284, P2967, DOI 10.1074/jbc.M807269200; Proweller A, 2006, CANCER RES, V66, P7438, DOI 10.1158/0008-5472.CAN-06-0793; Purow B, 2012, ADV EXP MED BIOL, V727, P305, DOI 10.1007/978-1-4614-0899-4_23; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Rasul S, 2009, BRIT J CANCER, V100, P1879, DOI 10.1038/sj.bjc.6605034; Reedijk M, 2005, CANCER RES, V65, P8530, DOI 10.1158/0008-5472.CAN-05-1069; Reedijk M, 2008, BREAST CANCER RES TR, V111, P439, DOI 10.1007/s10549-007-9805-3; Rizzo P, 2008, CANCER RES, V68, P5226, DOI 10.1158/0008-5472.CAN-07-5744; Rizzo P, 2009, ADV ENZYME REGUL, V49, P134, DOI 10.1016/j.advenzreg.2009.01.008; Rocher-Ros V, 2010, ONCOGENE, V29, P2950, DOI 10.1038/onc.2010.57; Saito S, 2005, BIOCHEM BIOPH RES CO, V327, P18, DOI 10.1016/j.bbrc.2004.11.130; Saura CA, 1999, J BIOL CHEM, V274, P13818, DOI 10.1074/jbc.274.20.13818; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Seo SJ, 2007, NEUROCHEM RES, V32, P1016, DOI 10.1007/s11064-006-9262-0; Serneels L, 2005, P NATL ACAD SCI USA, V102, P1719, DOI 10.1073/pnas.0408901102; Serneels L, 2009, SCIENCE, V324, P639, DOI 10.1126/science.1171176; Seveno C, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3214; Shih IM, 2007, CANCER RES, V67, P1879, DOI 10.1158/0008-5472.CAN-06-3958; Shirotani K, 2004, J BIOL CHEM, V279, P41340, DOI 10.1074/jbc.M405768200; Steiner H, 2002, J BIOL CHEM, V277, P39062, DOI 10.1074/jbc.C200469200; Stylianou S, 2006, CANCER RES, V66, P1517, DOI 10.1158/0008-5472.CAN-05-3054; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Thelu Jacques, 2002, BMC Dermatol, V2, P7, DOI 10.1186/1471-5945-2-7; Thor AD, 2009, AM J PATHOL, V175, P1802, DOI 10.2353/ajpath.2009.090204; Xia XF, 2001, P NATL ACAD SCI USA, V98, P10863, DOI 10.1073/pnas.191284198; Yamaguchi N, 2008, CANCER RES, V68, P1881, DOI 10.1158/0008-5472.CAN-07-1597; Yu G, 1998, J BIOL CHEM, V273, P16470, DOI 10.1074/jbc.273.26.16470; Zardawi SJ, 2010, HISTOPATHOLOGY, V56, P286, DOI 10.1111/j.1365-2559.2009.03475.x; Zhang CC, 2012, CLIN CANCER RES, V18, P5008, DOI 10.1158/1078-0432.CCR-12-1379; Zhang YW, 2007, P NATL ACAD SCI USA, V104, P10613, DOI 10.1073/pnas.0703903104; Zhang YW, 2005, J BIOL CHEM, V280, P17020, DOI 10.1074/jbc.M409467200	91	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79249	10.1371/journal.pone.0079249	http://dx.doi.org/10.1371/journal.pone.0079249			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223915	Green Published, gold, Green Submitted			2022-12-27	WOS:000326499300069
J	Winck, FV; Arvidsson, S; Riano-Pachon, DM; Hempel, S; Koseska, A; Nikoloski, Z; Gomez, DAU; Rupprecht, J; Mueller-Roeber, B				Winck, Flavia Vischi; Arvidsson, Samuel; Mauricio Riano-Pachon, Diego; Hempel, Sabrina; Koseska, Aneta; Nikoloski, Zoran; Urbina Gomez, David Alejandro; Rupprecht, Jens; Mueller-Roeber, Bernd			Genome-Wide Identification of Regulatory Elements and Reconstruction of Gene Regulatory Networks of the Green Alga Chlamydomonas reinhardtii under Carbon Deprivation	PLOS ONE			English	Article							CONCENTRATING MECHANISM; TRANSCRIPTION FACTOR; HEAT-SHOCK; CO2-CONCENTRATING MECHANISM; BINDING PROTEINS; EXPRESSION; CHROMATIN; CO2; ACTIVATION; ANHYDRASE	The unicellular green alga Chlamydomonas reinhardtii is a long-established model organism for studies on photosynthesis and carbon metabolism-related physiology. Under conditions of air-level carbon dioxide concentration [CO2], a carbon concentrating mechanism (CCM) is induced to facilitate cellular carbon uptake. CCM increases the availability of carbon dioxide at the site of cellular carbon fixation. To improve our understanding of the transcriptional control of the CCM, we employed FAIRE-seq (formaldehyde-assisted Isolation of Regulatory Elements, followed by deep sequencing) to determine nucleosome-depleted chromatin regions of algal cells subjected to carbon deprivation. Our FAIRE data recapitulated the positions of known regulatory elements in the promoter of the periplasmic carbonic anhydrase (Cah1) gene, which is upregulated during CCM induction, and revealed new candidate regulatory elements at a genome-wide scale. In addition, time series expression patterns of 130 transcription factor (TF) and transcription regulator (TR) genes were obtained for cells cultured under photoautotrophic condition and subjected to a shift from high to low [CO2]. Groups of co-expressed genes were identified and a putative directed gene-regulatory network underlying the CCM was reconstructed from the gene expression data using the recently developed IOTA (inner composition alignment) method. Among the candidate regulatory genes, two members of the MYB-related TF family, Lcr1 (Low-CO2 response regulator 1) and Lcr2 (Low-CO2 response regulator 2), may play an important role in down-regulating the expression of a particular set of TF and TR genes in response to low [CO2]. The results obtained provide new insights into the transcriptional control of the CCM and revealed more than 60 new candidate regulatory genes. Deep sequencing of nucleosome-depleted genomic regions indicated the presence of new, previously unknown regulatory elements in the C. reinhardtii genome. Our work can serve as a basis for future functional studies of transcriptional regulator genes and genomic regulatory elements in Chlamydomonas.	[Winck, Flavia Vischi; Nikoloski, Zoran; Mueller-Roeber, Bernd] Univ Potsdam, GoFORSYS Res Unit Syst Biol, Inst Biochem & Biol, Potsdam, Germany; [Winck, Flavia Vischi; Arvidsson, Samuel; Rupprecht, Jens; Mueller-Roeber, Bernd] Max Planck Inst Mol Plant Physiol, GoFORSYS Res Unit Syst Biol, Potsdam, Germany; [Mauricio Riano-Pachon, Diego; Urbina Gomez, David Alejandro] Univ Los Andes, Dept Biol Sci, Grp Computat & Evolutionary Biol, Bogota, Colombia; [Hempel, Sabrina; Koseska, Aneta] Univ Potsdam, Inst Phys, Potsdam, Germany; [Nikoloski, Zoran] Max Planck Inst Mol Plant Physiol, Syst Biol & Math Modeling Grp, Potsdam, Germany; [Hempel, Sabrina] Potsdam Inst Climate Impact Res PIK, Potsdam, Germany; [Hempel, Sabrina] Humboldt Univ, Dept Phys, Berlin, Germany	University of Potsdam; Max Planck Society; Universidad de los Andes (Colombia); University of Potsdam; Max Planck Society; Potsdam Institut fur Klimafolgenforschung; Humboldt University of Berlin	Mueller-Roeber, B (corresponding author), Univ Potsdam, GoFORSYS Res Unit Syst Biol, Inst Biochem & Biol, Potsdam, Germany.	bmr@uni-potsdam.de	Riaño-Pachón, Diego M/A-1755-2010; Riaño-Pachón, Diego Mauricio/B-4891-2014; Hempel, Sabrina/AAO-7482-2020; Winck, Flavia V/K-5568-2014; Mueller-Roeber, Bernd/Z-4052-2019; Winck, Flavia Vischi/AAC-2949-2021	Riaño-Pachón, Diego M/0000-0001-9803-3465; Riaño-Pachón, Diego Mauricio/0000-0001-9803-3465; Hempel, Sabrina/0000-0002-8398-4820; Winck, Flavia V/0000-0002-8399-4156; Urbina-Gomez, David/0000-0003-3678-6327; Nikoloski, Zoran/0000-0003-2671-6763	Federal Ministry of Education and Research (BMBF), Germany [FKZ 0313924]	Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF))	The research was funded by the Federal Ministry of Education and Research (BMBF), Germany, within the frame of the GoFORSYS Research Unit for Systems Biology (FKZ 0313924). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akai Y, 2010, P NATL ACAD SCI USA, V107, P8153, DOI 10.1073/pnas.0912509107; Alexeev A, 2003, NAT STRUCT BIOL, V10, P182, DOI 10.1038/nsb901; Arvidsson S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-465; BADGER MR, 1980, PLANT PHYSIOL, V66, P407, DOI 10.1104/pp.66.3.407; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Brueggeman AJ, 2012, PLANT CELL, V24, P1860, DOI 10.1105/tpc.111.093435; Caldana C, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-7; Chen JH, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12224; DIONISIOSESE ML, 1990, PLANT PHYSIOL, V94, P1103, DOI 10.1104/pp.94.3.1103; Erkine AM, 2003, J BIOL CHEM, V278, P7755, DOI 10.1074/jbc.M211703200; Fang W, 2012, PLANT CELL, V24, P1876, DOI 10.1105/tpc.112.097949; Fukuzawa H, 2001, P NATL ACAD SCI USA, V98, P5347, DOI 10.1073/pnas.081593498; Gerhart LM, 2010, NEW PHYTOL, V188, P674, DOI 10.1111/j.1469-8137.2010.03441.x; Giresi PG, 2009, METHODS, V48, P233, DOI 10.1016/j.ymeth.2009.03.003; Graumann PL, 1998, TRENDS BIOCHEM SCI, V23, P286, DOI 10.1016/S0968-0004(98)01255-9; Hempel S, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.054101; Hempel S, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-31111-8; Heyer LJ, 1999, GENOME RES, V9, P1106, DOI 10.1101/gr.9.11.1106; Hogan GJ, 2006, PLOS GENET, V2, P1433, DOI 10.1371/journal.pgen.0020158; Jiang WN, 1997, J BIOL CHEM, V272, P196; Joint I, 2011, ISME J, V5, P1, DOI 10.1038/ismej.2010.79; Kaplan A, 1999, ANNU REV PLANT PHYS, V50, P539, DOI 10.1146/annurev.arplant.50.1.539; Karlson D, 2003, PLANT PHYSIOL, V131, P12, DOI 10.1104/pp.014472; Kim JS, 2007, NUCLEIC ACIDS RES, V35, P506, DOI 10.1093/nar/gkl1076; Klutstein M, 2008, GENETICS, V178, P2389, DOI 10.1534/genetics.108.086777; Kucho K, 1999, PLANT PHYSIOL, V121, P1329, DOI 10.1104/pp.121.4.1329; Kucho K, 2003, PLANT PHYSIOL, V133, P783, DOI 10.1104/pp.103.026492; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Louwers M, 2009, PLANT CELL, V21, P832, DOI 10.1105/tpc.108.064329; Mar JC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-110; Martin C, 1997, TRENDS GENET, V13, P67, DOI 10.1016/S0168-9525(96)10049-4; MARUSHIGE K, 1976, P NATL ACAD SCI USA, V73, P3937, DOI 10.1073/pnas.73.11.3937; Mazin AV, 2010, DNA REPAIR, V9, P286, DOI 10.1016/j.dnarep.2009.12.006; McGinn PJ, 2003, PLANT PHYSIOL, V132, P218, DOI 10.1104/pp.102.019349; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Miller G, 2006, ANN BOT-LONDON, V98, P279, DOI 10.1093/aob/mcl107; Miura K, 2004, PLANT PHYSIOL, V135, P1595, DOI 10.1104/pp.104.041400; Moroney JV, 2007, EUKARYOT CELL, V6, P1251, DOI 10.1128/EC.00064-07; Moseley JL, 2009, GENETICS, V181, P889, DOI 10.1534/genetics.108.099382; Nagy PL, 2003, P NATL ACAD SCI USA, V100, P6364, DOI 10.1073/pnas.1131966100; Nilsson L, 2007, PLANT CELL ENVIRON, V30, P1499, DOI 10.1111/j.1365-3040.2007.01734.x; Perez-Rodriguez P, 2010, NUCLEIC ACIDS RES, V38, pD822, DOI 10.1093/nar/gkp805; Pollock SV, 2004, PLANT MOL BIOL, V56, P125, DOI 10.1007/s11103-004-2650-4; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Riano-Pachon DM, 2008, GENETICS, V179, P31, DOI 10.1534/genetics.107.086090; Riano-Pachon DM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-42; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schulz-Raffelt M, 2007, PLANT J, V52, P286, DOI 10.1111/j.1365-313X.2007.03228.x; Spijkerman E, 2008, PHYSIOL PLANTARUM, V133, P41, DOI 10.1111/j.1399-3054.2008.01062.x; Spijkerman E, 2011, PHOTOSYNTH RES, V109, P179, DOI 10.1007/s11120-010-9607-z; Strenkert D, 2011, PLANT CELL, V23, P2285, DOI 10.1105/tpc.111.085266; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Yamano T, 2008, PLANT PHYSIOL, V147, P340, DOI 10.1104/pp.107.114652; Yamano T, 2009, J BASIC MICROB, V49, P42, DOI 10.1002/jobm.200800352; Yoshioka S, 2004, PLANT CELL, V16, P1466, DOI 10.1105/tpc.021162; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	56	15	15	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79909	10.1371/journal.pone.0079909	http://dx.doi.org/10.1371/journal.pone.0079909			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24224019	Green Published, Green Submitted, gold			2022-12-27	WOS:000326499300095
J	Lauters, P; Vercauteren, M; Bolotsky, YL; Godefroit, P				Lauters, Pascaline; Vercauteren, Martine; Bolotsky, Yuri L.; Godefroit, Pascal			Cranial Endocast of the Lambeosaurine Hadrosaurid Amurosaurus riabinini from the Amur Region, Russia	PLOS ONE			English	Article							GROWTH-HORMONE; ENDOCRANIAL CAVITY; NEOCORTEX SIZE; BRAIN SIZE; DINOSAUR; ANATOMY; ORNITHISCHIA; CROCODILES; PHYLOGENY; GIGANTISM	Information on the structure of the brain of the lambeosaurine hadrosaurid dinosaur Amurosaurus riabinini, from the Late Maastrichtian of Blagoveschensk, Far Eastern Russia, is presented based on endocranial casts. The endocasts are compared with physical and digital endocasts of other dinosaurs. The olfactory tract was large. The cerebral hemispheres are enlarged and round, illustrating the important development of this part of the brain in hadrosaurids. The pituitary body is enlarged as well, perhaps prefiguring the large size attained by hadrosaurids. The EQ of Amurosaurus was similar to that of the lambeosaurine dinosaur Hypacrosaurus altispinus and was relatively larger than in most extant non- avian reptiles, including sauropod and ceratopsian dinosaurs. However, it was apparently relatively smaller than those of most theropod dinosaurs. The relatively large size of the cerebrum is consistent with the range and complexity of social behaviors inferred for lambeosaurine dinosaurs.	[Lauters, Pascaline; Godefroit, Pascal] Royal Belgian Inst Nat Sci, Dept Palaeontol, Brussels, Belgium; [Lauters, Pascaline; Vercauteren, Martine] Univ Libre Bruxelles, Serv Anthropol & Genet Humaine, Brussels, Belgium; [Bolotsky, Yuri L.] Russian Acad Sci, Geol & Nat Explorat Inst, Far Eastern Branch, Blagoveshchensk, Russia	Royal Belgian Institute of Natural Sciences; Universite Libre de Bruxelles; Institute of Geology & Nature Management FEB RAS; Russian Academy of Sciences	Lauters, P (corresponding author), Royal Belgian Inst Nat Sci, Dept Palaeontol, Brussels, Belgium.	plauters@ulb.ac.be	Lauters, Pascaline/AAJ-8493-2020		Fonds pour la formation a la Recherche dans l'Industrie et l'Agriculture	Fonds pour la formation a la Recherche dans l'Industrie et l'Agriculture(Fonds de la Recherche Scientifique - FNRS)	This study was realized through the execution of S&T bilateral cooperation agreements on behalf of the Belgian State, Federal Scientific Policy. It constitutes part of a Ph.D. thesis by PL at the Universite Libre de Bruxelles, thanks to a grant from the Fonds pour la formation a la Recherche dans l'Industrie et l'Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambler G, 2002, BEST PRACT RES CL EN, V16, P519, DOI 10.1053/beem.2002.0207; ANDERSON JF, 1985, J ZOOL, V207, P53, DOI 10.1111/j.1469-7998.1985.tb04915.x; Bolotsky Y.L., 1991, GEOLOGY PACIFIC OCEA, P94; Bolotsky YL, 2004, J VERTEBR PALEONTOL, V24, P351, DOI 10.1671/1110; Boulenger G. A., 1881, B ACAD ROYALE BELGIQ, V1, P1; Campione NE, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-60; Chatterjee S, 2002, ZOOL J LINN SOC-LOND, V136, P145, DOI 10.1046/j.1096-3642.2002.00037.x; Chatterjee S, 2005, LIFE O PAST, P199; COPE E. D., 1869, T AM PHILOS SOC, V14, P1, DOI DOI 10.2307/1005355; Dechaseaux C, 1962, CERVEAUX DANIMAUX DI; DODSON P, 1975, SYST ZOOL, V24, P37, DOI 10.2307/2412696; Dunbar RIM, 1998, ETHOLOGY, V104, P695, DOI 10.1111/j.1439-0310.1998.tb00103.x; Dunbar RIM, 1998, EVOL ANTHROPOL, V6, P178, DOI 10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.0.CO;2-8; DUNBAR RIM, 1992, J HUM EVOL, V22, P469, DOI 10.1016/0047-2484(92)90081-J; Edinger T, 1942, Q REV BIOL, V17, P31, DOI 10.1086/394644; Edinger T, 1964, PROG BRAIN RES, V6, P147, DOI [10.1016/S0079-6123(08)63721-8, DOI 10.1016/S0079-6123(08)63721-8]; Erickson GM, 2012, SCIENCE, V338, P98, DOI 10.1126/science.1224495; Evans DC, 2007, J VERTEBR PALEONTOL, V27, P373, DOI 10.1671/0272-4634(2007)27[373:AAROLM]2.0.CO;2; Evans DC, 2010, ZOOL J LINN SOC-LOND, V159, P398, DOI 10.1111/j.1096-3642.2009.00611.x; Evans DC, 2009, ANAT REC, V292, P1315, DOI 10.1002/ar.20984; Evans DC, 2006, PALEOBIOLOGY, V32, P109, DOI 10.1666/0094-8373(2006)032[0109:NCHACC]2.0.CO;2; Evans DC, 2005, ACTA PALAEONTOL POL, V50, P617; Evans H. M., 1933, Memoirs of the University of California, V11, P1; FLEISHMAN LJ, 1988, J COMP PHYSIOL A, V163, P441, DOI 10.1007/BF00604898; Forster C.A., 1997, ENCY DINOSAURS, P293; Franzosa J.W., 2004, THESIS U TEXAS AUSTI; Galton P.M., 1989, Geologica et Palaeontologica, V23, P217; GELBER SJ, 1992, J PEDIATR-US, V120, P931, DOI 10.1016/S0022-3476(05)81966-3; Giffin E.B., 1989, Journal of Vertebrate Paleontology, V9, P67; Godefroit P, 2004, ACTA PALAEONTOL POL, V49, P585; Godefroit P, 2000, CR ACAD SCI II A, V330, P875, DOI 10.1016/S1251-8050(00)00214-7; Godefroit P, 2003, C R PALEVOL, V2, P143, DOI 10.1016/S1631-0683(03)00017-4; Godefroit P, 2009, ACT 4 JORN INT PAL D, P91; Godefroit P, 2012, BERNISSART DINOSAURE, P353; GODEFROIT P, 2001, SCI TERRE, V71, P119; Godefroit P, 2008, ACTA PALAEONTOL POL, V53, P47, DOI 10.4202/app.2008.0103; Hooley R. W., 1925, Quarterly Journal of the Geological Society of London, V81, P1; Hopson J.A., 1979, P39; HOPSON J A, 1975, Paleobiology, V1, P21; HOPSON JA, 1977, ANNU REV ECOL SYST, V8, P429, DOI 10.1146/annurev.es.08.110177.002241; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Hurlburt G.R, 1996, THESIS U TORONTO TOR; Ines Serrano-Branas Claudia, 2006, BULLETIN OF THE NEW MEXICO MUSEUM OF NATURAL HISTORY AND SCIENCE, P317; Jerison Harry J., 2001, Journal of Vertebrate Paleontology, V21, p65A; JERISON HJ, 1969, AM NAT, V103, P575, DOI 10.1086/282627; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Kilbourne BM, 2010, J ANAT, V217, P135, DOI 10.1111/j.1469-7580.2010.01253.x; Larsson Hans C.E., 2001, P19; Larsson HCE, 2000, J VERTEBR PALEONTOL, V20, P615, DOI 10.1671/0272-4634(2000)020[0615:FEANTD]2.0.CO;2; Lauters P, 2012, BERNISSART DINOSAURS, P227; Lauters P, 2008, PALAIOS, V23, P153, DOI 10.2110/palo.2006.p06-031r; LOPIS S, 1968, J CLIN ENDOCR METAB, V28, P393, DOI 10.1210/jcem-28-3-393; Lull R. S., 1942, Geological Society of America Special Paper, V40, P1; Marsh O.C., 1881, AM J SCI 3, V23, P81, DOI DOI 10.2475/AJS.S3-23.133.81; Nopsca F. von., 1917, CENTRALBLATT MINERAL, V1917, P332; Osmolska H, 2004, ACTA PALAEONTOL POL, V49, P321; OSTROM JOHN H., 1961, BULL AMER MUS NAT HIST, V122, P33; Owen R., 1842, 11 M BRIT ASS ADV SC, P66; PARKS WA, 1923, U TORONTO STUDIES GE, V15, P5; Perez-Barberia FJ, 2005, OECOLOGIA, V145, P41, DOI 10.1007/s00442-005-0067-7; Prieto-Marquez A, 2010, ZOOL J LINN SOC-LOND, V159, P435, DOI 10.1111/j.1096-3642.2009.00617.x; Rogers SW, 1999, ANAT RECORD, V257, P162; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Saveliev SV, 2012, PALEONTOL J+, V46, P79, DOI 10.1134/S003103011201011X; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Senter P, 2002, PALEOBIOLOGY, V28, P544, DOI 10.1666/0094-8373(2002)028<0544:LOAPSI>2.0.CO;2; Sereno PC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001230; SERENO PC, 1986, NATL GEOGR RES, V2, P234; Shultz S, 2010, P NATL ACAD SCI USA, V107, P21582, DOI 10.1073/pnas.1005246107; Stephan H., 1960, Zeitschrift fuer Wissenschaftliche Zoologie, V164, P143; Taquet Philippe, 1999, Annales de Paleontologie, V85, P85, DOI 10.1016/S0753-3969(99)80009-3; Walker SM, 2004, CROCODILES; WEISHAMPEL DB, 1981, PALEOBIOLOGY, V7, P252, DOI 10.1017/S0094837300004036; Witmer LM, 2008, ANATOMICAL IMAGING: TOWARDS A NEW MORPHOLOGY, P67, DOI 10.1007/978-4-431-76933-0_6; Zhou Chang-Fu, 2007, Palaeoworld, V16, P285, DOI 10.1016/j.palwor.2007.07.002; ZIMMERMAN D, 1993, J CLIN ENDOCR METAB, V76, P216, DOI 10.1210/jc.76.1.216	76	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78899	10.1371/journal.pone.0078899	http://dx.doi.org/10.1371/journal.pone.0078899			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236064	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700061
J	Li, K; Nataraj, R; Marquardt, TL; Li, ZM				Li, Ke; Nataraj, Raviraj; Marquardt, Tamara L.; Li, Zong-Ming			Directional Coordination of Thumb and Finger Forces during Precision Pinch	PLOS ONE			English	Article							MUSCLES; GRIP; OBJECT; ACTIVATION; SYNERGIES; RESPONSES; MODEL	The human opposable thumb enables the hand to perform dexterous manipulation of objects, which requires well-coordinated digit force vectors. This study investigated the directional coordination of force vectors generated by the thumb and index finger during precision pinch. Fourteen right-handed, healthy subjects were instructed to exert pinch force on an externally stabilized apparatus with the pulps of the thumb and index finger. Subjects applied forces to follow a force-ramp profile that linearly increased from 0 to 12 N and then decreased to 0 N, at a rate of +/- 3 N/s. Directional relationships between the thumb and index finger force vectors were quantified using the coordination angle (CA) between the force vectors. Individual force vectors were further analyzed according to their projection angles (PAs) with respect to the pinch surface planes and the shear angles (SAs) within those planes. Results demonstrated that fingertip force directions were dependent on pinch force magnitude, especially at forces below 2 N. Hysteresis was observed in the force-CA relationship for increasing and decreasing forces and fitted with exponential models. The fitted asymptotic values were 156.0 +/- 6.6 degrees and 150.8 +/- 9.3 degrees for increasing and decreasing force ramps, respectively. The PA of the thumb force vector deviated further from the direction perpendicular to the pinching surface planes than that of the index finger. The SA showed that the index finger force vector deviated in the ulnar-proximal direction, whereas the thumb switched its force between the ulnar-proximal and radial-proximal directions. The findings shed light on the effects of anatomical composition, biomechanical function, and neuromuscular control in coordinating digit forces during precision pinch, and provided insight into the magnitude-dependent force directional control which potentially affects a range of dexterous manipulations.	[Li, Zong-Ming] Cleveland Clin, Dept Biomed Engn, Dept Orthopaed Surg, Hand Res Lab, Cleveland, OH 44106 USA; Cleveland Clin, Dept Phys Med & Rehabil, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Li, ZM (corresponding author), Cleveland Clin, Dept Biomed Engn, Dept Orthopaed Surg, Hand Res Lab, Cleveland, OH 44106 USA.	liz4@ccf.org	Li, Weiming/D-9615-2013; Nataraj, Raviraj/G-4535-2010	Li, Weiming/0000-0001-5437-1518; Nataraj, Raviraj/0000-0002-5261-3031; Li, Ke/0000-0002-8660-0116	NIAMS/NIH [R01AR056964]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056964] Funding Source: NIH RePORTER	NIAMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The project described was supported by Grant Number R01AR056964 from NIAMS/NIH. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIAMS or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre T, 2009, J NEUROSCI METH, V179, P224, DOI 10.1016/j.jneumeth.2009.01.031; Birznieks I, 2001, J NEUROSCI, V21, P8222, DOI 10.1523/JNEUROSCI.21-20-08222.2001; BRAND PW, 1981, J HAND SURG-AM, V6, P209, DOI 10.1016/S0363-5023(81)80072-X; Cole KJ, 2006, EXP BRAIN RES, V175, P285, DOI 10.1007/s00221-006-0553-0; Dun SC, 2005, IEEE T INSTRUM MEAS, V54, P2336, DOI 10.1109/TIM.2005.858123; EDIN BB, 1992, J PHYSIOL-LONDON, V450, P547, DOI 10.1113/jphysiol.1992.sp019142; Flanagan JR, 2006, CURR OPIN NEUROBIOL, V16, P650, DOI 10.1016/j.conb.2006.10.005; Fu QS, 2010, J NEUROSCI, V30, P9117, DOI 10.1523/JNEUROSCI.4159-09.2010; Honeycutt CF, 2009, J NEUROPHYSIOL, V101, P2751, DOI 10.1152/jn.91040.2008; Jenmalm P, 1997, J NEUROSCI, V17, P4486; Johanson ME, 2001, J HAND SURG-AM, V26A, P698, DOI 10.1053/jhsu.2001.26188; Johansson RS, 2004, NAT NEUROSCI, V7, P170, DOI 10.1038/nn1177; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; Latash ML, 2008, SYNERGY; Li ZM, 2004, MED ENG PHYS, V26, P663, DOI 10.1016/j.medengphy.2004.03.004; Li ZM, 2003, CLIN BIOMECH, V18, P908, DOI 10.1016/S0268-0033(03)00178-5; Li ZM, 1998, EXP BRAIN RES, V119, P276, DOI 10.1007/s002210050343; Li ZM, 2002, ERGONOMICS, V45, P425, DOI 10.1080/00140130210129673; Marquardt TL, 2013, J MECH MED BIOL, V13, DOI 10.1142/S0219519413500474; Milner TE, 2002, EXP BRAIN RES, V146, P197, DOI 10.1007/s00221-002-1177-7; Moerchen VA, 2007, EXP BRAIN RES, V180, P367, DOI 10.1007/s00221-007-0864-9; Napier J. R., 1993, HANDS; Parikh PJ, 2012, J APPL PHYSIOL, V112, P1095, DOI 10.1152/japplphysiol.01385.2011; Pearlman JL, 2004, J ORTHOP RES, V22, P306, DOI 10.1016/j.orthres.2003.08.001; Schieber MH, 2004, J APPL PHYSIOL, V96, P2293, DOI 10.1152/japplphysiol.01063.2003; Seo NJ, 2010, EXP BRAIN RES, V202, P891, DOI 10.1007/s00221-010-2193-7; Serina ER, 1998, J BIOMECH, V31, P639, DOI 10.1016/S0021-9290(98)00067-0; Shim JK, 2005, EXP BRAIN RES, V164, P260, DOI 10.1007/s00221-005-2248-3; Singh T, 2012, HUM MOVEMENT SCI, V31, P1379, DOI 10.1016/j.humov.2012.06.008; Smutz WP, 1998, J BIOMECH, V31, P565, DOI 10.1016/S0021-9290(98)00043-8; Valero-Cuevas FJ, 2000, J NEUROPHYSIOL, V83, P1469, DOI 10.1152/jn.2000.83.3.1469; WESTLING G, 1987, EXP BRAIN RES, V66, P128	32	11	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79400	10.1371/journal.pone.0079400	http://dx.doi.org/10.1371/journal.pone.0079400			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236128	Green Submitted, Green Published, gold			2022-12-27	WOS:000327254700127
J	Michl, RK; Hentschel, J; Fischer, C; Beck, JF; Mainz, JG				Michl, Ruth K.; Hentschel, Julia; Fischer, Christiane; Beck, James F.; Mainz, Jochen G.			Reduced Nasal Nitric Oxide Production in Cystic Fibrosis Patients with Elevated Systemic Inflammation Markers	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; PARANASAL SINUSES; INFECTION; CHILDREN; COLONIZATION; BRONCHIECTASIS; GENOTYPE; DISEASES	Background: Nitric oxide (NO) is produced within the respiratory tract and can be detected in exhaled bronchial and nasal air. The concentration varies in specific diseases, being elevated in patients with asthma and bronchiectasis, but decreased in primary ciliary dyskinesia. In cystic fibrosis (CF), conflicting data exist on NO levels, which are reported unexplained as either decreased or normal. Functionally, NO production in the paranasal sinuses is considered as a location-specific first-line defence mechanism. The aim of this study was to investigate the correlation between upper and lower airway NO levels and blood inflammatory parameters, CF-pathogen colonisation, and clinical data. Methods and Findings: Nasal and bronchial NO concentrations from 57 CF patients were determined using an electrochemical analyser and correlated to pathogen colonisation of the upper and lower airways which were microbiologically assessed from nasal lavage and sputum samples. Statistical analyses were performed with respect to clinical parameters (lung function, BMI), laboratory findings (CRP, leucocytes, total-IgG, fibrinogen), and anti-inflammatory and antibiotic therapy. There were significant correlations between nasal and bronchial NO levels (rho = 0.48, p<0.001), but no correlation between NO levels and specific pathogen colonisation. In patients receiving azithromycin, significantly reduced bronchial NO and a tendency to reduced nasal NO could be found. Interestingly, a significant inverse correlation of nasal NO to CRP (rho = -0.28, p = 0.04) and to leucocytes (rho = -0.41, p = 0.003) was observed. In contrast, bronchial NO levels showed no correlation to clinical or inflammatory parameters. Conclusion: Given that NO in the paranasal sinuses is part of the first-line defence mechanism against pathogens, our finding of reduced nasal NO in CF patients with elevated systemic inflammatory markers indicates impaired upper airway defence. This may facilitate further pathogen acquisition in the sinonasal area, with consequences for lung colonisation and the overall outcome in CF.	[Michl, Ruth K.; Hentschel, Julia; Fischer, Christiane; Beck, James F.; Mainz, Jochen G.] Jena Univ Hosp, Dept Paediat, Jena, Germany	Friedrich Schiller University of Jena	Michl, RK (corresponding author), Jena Univ Hosp, Dept Paediat, Jena, Germany.	Ruth.Michl@med.uni-jena.de	Mainz, Jochen G/AFO-0929-2022	Mainz, Jochen G./0000-0003-3780-7759				Aanaes K, 2013, RHINOLOGY, V51, P222, DOI [10.4193/Rhino12.207, 10.4193/Rhin12.207]; Aanaes K, 2013, AM J RHINOL ALLERGY, V27, pE1, DOI 10.2500/ajra.2013.27.3829; Aanaes K, 2013, J CYST FIBROS, V12, P81, DOI 10.1016/j.jcf.2012.07.001; American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; [Anonymous], 2006, BMI CLASSIFICATION G; BalfourLynn IM, 1996, ARCH DIS CHILD, V75, P319, DOI 10.1136/adc.75.4.319; Bartley J, 1999, AM J RHINOL, V13, P401, DOI 10.2500/105065899781367528; Beiersdorf N, 2012, J CYST FIBROS; Bergoin Cyrille, 2002, J Cyst Fibros, V1, P110, DOI 10.1016/S1569-1993(02)00072-3; Boon M, 2012, EUR J PEDIAT; Corbelli R, 2004, CHEST, V126, P1054, DOI 10.1378/chest.126.4.1054; Elizur A, 2008, CHEST, V133, P489, DOI 10.1378/chest.07-1631; Elphick HE, 2001, THORAX, V56, P151, DOI 10.1136/thorax.56.2.151; Grasemann H, 2005, EUR RESPIR J, V25, P62, DOI 10.1183/09031936.04.00086104; Grasemann H, 1997, PEDIATR PULM, V24, P173, DOI 10.1002/(SICI)1099-0496(199709)24:3<173::AID-PPUL2>3.0.CO;2-O; Grasemann H, 1998, ARCH DIS CHILD, V78, P49, DOI 10.1136/adc.78.1.49; Hansen SK, 2012, ISME J, V6, P31, DOI 10.1038/ismej.2011.83; Ho LP, 1998, EUR RESPIR J, V12, P1290, DOI 10.1183/09031936.98.12061290; Jaffe A, 2005, PROG INFLAM RES, P167; Jobsis Q, 2000, EUR RESPIR J, V16, P95, DOI 10.1034/j.1399-3003.2000.16a17.x; Johansen HK, 2012, J CYST FIBROS, V11, P525, DOI 10.1016/j.jcf.2012.04.011; Kappler M, 2006, THORAX, V61, P684, DOI 10.1136/thx.2005.049536; Keen C, 2007, CHEST, V131, P1857, DOI 10.1378/chest.06-2635; KHARITONOV SA, 1995, AM J RESP CRIT CARE, V151, P1889, DOI 10.1164/ajrccm.151.6.7767536; Lee Tim W R, 2003, J Cyst Fibros, V2, P29, DOI 10.1016/S1569-1993(02)00141-8; Lundberg JON, 1996, ARCH DIS CHILD, V75, P323, DOI 10.1136/adc.75.4.323; Lundberg JON, 1999, THORAX, V54, P947, DOI 10.1136/thx.54.10.947; Mainz JG, 2011, AM J RESP CRIT CARE, V184, P1089, DOI 10.1164/ajrccm.184.9.1089; Mainz JG, 2009, THORAX, V64, P535, DOI 10.1136/thx.2008.104711; Maniscalco M, 2007, INFLAMM RES, V56, P58, DOI 10.1007/s00011-006-6111-1; Meng QH, 1998, J PATHOL, V184, P323, DOI 10.1002/(SICI)1096-9896(199803)184:3<323::AID-PATH2>3.0.CO;2-2; Palm JP, 2000, EUR RESPIR J, V16, P236, DOI 10.1034/j.1399-3003.2000.16b09.x; Pitrez PMC, 2005, RESPIROLOGY, V10, P177, DOI 10.1111/j.1440-1843.2005.00649.x; POLGAR G, 1979, AM REV RESPIR DIS, V120, P625; Ratjen F, 2012, CHEST; ROBBINS RA, 1994, BIOCHEM BIOPH RES CO, V203, P209, DOI 10.1006/bbrc.1994.2169; Southern KW, 2004, EUR RESPIR J, V24, P834, DOI 10.1183/09031936.04.00084304; Thomas SR, 2000, CHEST, V117, P1085, DOI 10.1378/chest.117.4.1085; WARREN JB, 1990, BIOCHEM J, V266, P921; Zapletal A, 1987, LUNG FUNCTION CHILDR; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	41	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79141	10.1371/journal.pone.0079141	http://dx.doi.org/10.1371/journal.pone.0079141			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236100	Green Submitted, gold, Green Published			2022-12-27	WOS:000327254700098
J	Oliva, CF; Damiens, D; Vreysen, MJB; Lempeiere, G; Gilles, J				Oliva, Clelia F.; Damiens, David; Vreysen, Marc J. B.; Lemperiere, Guy; Gilles, Jeremie			Reproductive Strategies of Aedes albopictus (Diptera: Culicidae) and Implications for the Sterile Insect Technique	PLOS ONE			English	Article							MEDITERRANEAN FRUIT-FLIES; DENGUE VECTOR MOSQUITO; SEMINAL FLUID PROTEINS; MALE MATING SUCCESS; SPERM COMPETITION; SEXUAL RECEPTIVITY; AEGYPTI LINNAEUS; FEMALE MONOGAMY; GLAND PROTEINS; SIZE	Male insects are expected to optimize their reproductive strategy according to the availability of sperm or other ejaculatory materials, and to the availability and reproductive status of females. Here, we investigated the reproductive strategy and sperm management of male and virgin female Aedes albopictus, a mosquito vector of chikungunya and dengue viruses. The dynamics of semen transfer to the female bursa inseminalis and spermathecae were observed. Double-mating experiments were conducted to study the effect of time lapsed or an oviposition event between two copulations on the likelihood of a female double-insemination and the use of sperm for egg fertilization; untreated fertile males and radio-sterilised males were used for this purpose. Multiple inseminations and therefore the possibility of sperm competition were limited to matings closely spaced in time. When two males consecutively mated the same female within a 40 min interval, in ca. 15% of the cases did both males sire progeny. When the intervals between the copulations were longer, all progeny over several gonotrophic cycles were offspring of the first male. The mating behavior of males was examined during a rapid sequence of copulations. Male Ae. albopictus were parceling sperm allocation over several matings; however they would also attempt to copulate with females irrespective of the available sperm supply or accessory gland secretion material. During each mating, they transferred large quantities of sperm that was not stored for egg fertilization, and they attempted to copulate with mated females with a low probability of transferring their genes to the next generation. The outcomes of this study provided in addition some essential insights with respect to the sterile insect technique (SIT) as a vector control method.	[Oliva, Clelia F.; Damiens, David; Vreysen, Marc J. B.; Gilles, Jeremie] IAEA, Joint FAO IAEA Div Nucl Techn Food, Insect Pest Control Lab, A-1400 Vienna, Austria; [Oliva, Clelia F.; Lemperiere, Guy] CNRS, MIVEGEC, Inst Rech Dev, IRD UM1 UM2 224 5290, Montpellier, France; [Oliva, Clelia F.; Lemperiere, Guy] Ctr Rech & Veille Malad Emergentes Ocean Indien, La Reunion, France	International Atomic Energy Agency; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Oliva, CF (corresponding author), Polo Innovaz Genom Genet Biol SCaRL, 4 Piano Polo Unico Med Santa Maria Misericordia, Perugia, Italy.	cleliaoliva@gmail.com		Oliva, Clelia/0000-0001-7728-1654	Reunion Region Council; European Social Funds; Joint FAO/IAEA Division; French Ministry of Health; European Regional Development Fund (ERDF)	Reunion Region Council; European Social Funds(European Social Fund (ESF)); Joint FAO/IAEA Division; French Ministry of Health; European Regional Development Fund (ERDF)(European Commission)	This study was supported by the Reunion Region Council and the European Social Funds through a PhD grant to C.F.O. This work was supported by the Joint FAO/IAEA Division, and was also part of the "SIT feasibility programme" in Reunion, jointly funded by the French Ministry of Health and the European Regional Development Fund (ERDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823; Balestrino F, 2010, J MED ENTOMOL, V47, P581, DOI 10.1603/ME09272; Benedict MQ, 2009, J INSECT PHYSIOL, V55, P197, DOI 10.1016/j.jinsphys.2008.11.003; Boivin G, 2005, OECOLOGIA, V143, P198, DOI 10.1007/s00442-004-1800-3; Bonduriansky R, 2001, BIOL REV, V76, P305, DOI 10.1017/S1464793101005693; Boyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042040; CRAIG GB, 1967, SCIENCE, V156, P1499, DOI 10.1126/science.156.3781.1499; Damiens D, 2006, BEHAV ECOL, V17, P138, DOI 10.1093/beheco/arj009; Damiens D, 2005, PHYSIOL ENTOMOL, V30, P241, DOI 10.1111/j.1365-3032.2005.00453.x; Damiens D, 2013, J MED ENTOMOL, V50, P336, DOI 10.1603/ME12212; DAPPLES C C, 1974, International Journal of Insect Morphology and Embryology, V3, P279, DOI 10.1016/0020-7322(74)90023-3; DEWSBURY DA, 1982, AM NAT, V119, P601, DOI 10.1086/283938; Dottorini T, 2013, FASEB J, V27, P86, DOI 10.1096/fj.12-219444; FOSTER W A, 1975, Journal of Insect Physiology, V21, P1085, DOI 10.1016/0022-1910(75)90120-1; Gavriel S, 2009, J INSECT PHYSIOL, V55, P637, DOI 10.1016/j.jinsphys.2009.04.002; GERBER GH, 1970, CAN ENTOMOL, V102, P358, DOI 10.4039/Ent102358-3; Giglioli M. E. C., 1964, Rivista di Malariologia Rome, V43, P265; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; GUBLER DJ, 1972, MOSQ NEWS, V32, P219; GWADZ RW, 1970, MOSQ NEWS, V30, P355; HAYNES JW, 1977, J ECON ENTOMOL, V70, P411, DOI 10.1093/jee/70.4.411; Helinski MEH, 2008, J MED ENTOMOL, V45, P698, DOI 10.1603/0022-2585(2008)45[698:MCOMAA]2.0.CO;2; Helinski MEH, 2012, J INSECT PHYSIOL, V58, P1307, DOI 10.1016/j.jinsphys.2012.07.003; Helinski MEH, 2012, AM J TROP MED HYG, V86, P635, DOI 10.4269/ajtmh.2012.11-0225; Helinski MEH, 2011, J MED ENTOMOL, V48, P202, DOI 10.1603/ME10071; Helinski MEH, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-9; Howell PI, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S8; JONES JC, 1973, J INSECT PHYSIOL, V19, P435, DOI 10.1016/0022-1910(73)90118-2; JONES JC, 1967, BIOL BULL, V132, P23, DOI 10.2307/1539874; JONES JC, 1965, J MORPHOL, V117, P401, DOI 10.1002/jmor.1051170306; JONES JC, 1965, BIOL BULL, V129, P134, DOI 10.2307/1539773; JONES JC, 1965, BIOL BULL, V129, P532, DOI 10.2307/1539731; JONES JC, 1968, SCI AM, V218, P108, DOI 10.1038/scientificamerican0468-108; Jones TM, 2001, J INSECT BEHAV, V14, P385, DOI 10.1023/A:1011127514317; Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x; King BH, 2000, GREAT LAKES ENTOMOL, V33, P117; Klowden MJ, 2006, J INSECT PHYSIOL, V52, P679, DOI 10.1016/j.jinsphys.2006.03.006; Koudelova J, 2001, FLA ENTOMOL, V84, P172, DOI 10.2307/3496164; LACHANCE LE, 1979, ANN ENTOMOL SOC AM, V72, P343, DOI 10.1093/aesa/72.3.343; Landa V., 1960, Acta Societatis Entomologicae Cechoslovenicae, V57, P297; LEAHY M. G., 1965, MOSQUITO NEWS, V25, P448; Lupold S, 2011, BEHAV ECOL, V22, P184, DOI 10.1093/beheco/arq193; LUM PATRICK T. M., 1961, ANN ENT SOC AMER, V54, P430; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; MAHMOOD F, 1982, J MED ENTOMOL, V19, P573, DOI 10.1093/jmedent/19.5.573; Mossinson S, 2003, J INSECT PHYSIOL, V49, P561, DOI 10.1016/S0022-1910(03)00027-1; NADEL H, 1985, ANN ENTOMOL SOC AM, V78, P410, DOI 10.1093/aesa/78.3.410; NORTH DT, 1975, J ECON ENTOMOL, V68, P595, DOI 10.1093/jee/68.5.595; Oliva CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049414; PARKER GA, 1982, J THEOR BIOL, V96, P281, DOI 10.1016/0022-5193(82)90225-9; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Parker GA, 1998, J THEOR BIOL, V96, P281; Parker GA, 2010, BIOL REV, V85, P897, DOI 10.1111/j.1469-185X.2010.00140.x; Perez-Staples D, 2013, ENTOMOL EXP APPL, V146, P66, DOI 10.1111/j.1570-7458.2012.01312.x; Ponlawat A, 2007, J MED ENTOMOL, V44, P422, DOI 10.1603/0022-2585(2007)44[422:AABSIM]2.0.CO;2; Ponlawat A, 2009, AM J TROP MED HYG, V80, P395, DOI 10.4269/ajtmh.2009.80.395; PROSHOLD FI, 1993, J ECON ENTOMOL, V86, P1104, DOI 10.1093/jee/86.4.1104; PROVERBS MD, 1969, ANNU REV ENTOMOL, V14, P81, DOI 10.1146/annurev.en.14.010169.000501; R Development Core Team, 2008, R LANG ENV STAT COMP; Radhakrishnan P, 2009, ANIM BEHAV, V78, P839, DOI 10.1016/j.anbehav.2009.07.002; Ramadan MM, 1991, BIOL CONTROL, V1, P248, DOI 10.1016/1049-9644(91)90074-A; Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853; Rogers DW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000272; Rogers DW, 2008, P NATL ACAD SCI USA, V105, P19390, DOI 10.1073/pnas.0809723105; ROTH LM, 1948, AM MIDL NAT, V40, P265, DOI 10.2307/2421604; Sella G, 2003, BIOL J LINN SOC, V78, P149, DOI 10.1046/j.1095-8312.2003.00167.x; Shutt B, 2010, MED VET ENTOMOL, V24, P91, DOI 10.1111/j.1365-2915.2009.00849.x; Simmons LW, 2002, EVOLUTION, V56, P1622, DOI 10.1111/j.0014-3820.2002.tb01474.x; Sirot LK, 2008, INSECT BIOCHEM MOLEC, V38, P176, DOI 10.1016/j.ibmb.2007.10.007; SPIELMAN A, 1964, BIOL BULL, V127, P324, DOI 10.2307/1539230; SPIELMAN A, 1967, BIOL BULL-US, V132, P404, DOI 10.2307/1539644; VANVOORHIES WA, 1992, NATURE, V360, P456, DOI 10.1038/360456a0; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8; Weidhaas DE, 1963, MOSQ NEWS, V23	74	56	58	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78884	10.1371/journal.pone.0078884	http://dx.doi.org/10.1371/journal.pone.0078884			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236062	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700059
J	Roodveldt, C; Labrador-Garrido, A; Gonzalez-Rey, E; Lachaud, CC; Guilliams, T; Fernandez-Montesinos, R; Benitez-Rondan, A; Robledo, G; Hmadcha, A; Delgado, M; Dobson, CM; Pozo, D				Roodveldt, Cintia; Labrador-Garrido, Adahir; Gonzalez-Rey, Elena; Lachaud, Christian C.; Guilliams, Tim; Fernandez-Montesinos, Rafael; Benitez-Rondan, Alicia; Robledo, Gema; Hmadcha, Abdelkrim; Delgado, Mario; Dobson, Christopher M.; Pozo, David			Preconditioning of Microglia by alpha-Synuclein Strongly Affects the Response Induced by Toll-like Receptor (TLR) Stimulation	PLOS ONE			English	Article							PARKINSONS-DISEASE; DOPAMINERGIC-NEURONS; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; SUBSTANTIA-NIGRA; LEWY BODIES; ACTIVATION; INFLAMMATION; INNATE; EXPRESSION	In recent years, it has become accepted that alpha-synuclein (alpha Syn) has a key role in the microglia-mediated neuroinflammation, which accompanies the development of Parkinson's disease and other related disorders, such as Dementia with Lewy Bodies and Alzheimer's disease. Nevertheless, the cellular and molecular mechanisms underlying its pathological actions, especially in the sporadic forms of the diseases, are not completely understood. Intriguingly, several epidemiological and animal model studies have revealed a link between certain microbial infections and the onset or progression of sporadic forms of these neurodegenerative disorders. In this work, we have characterized the effect of toll-like receptor (TLR) stimulation on primary murine microglial cultures and analysed the impact of priming cells with extracellular wild-type (Wt) alpha Syn on the subsequent TLR stimulation of cells with a set of TLR ligands. By assaying key interleukins and chemokines we report that specific stimuli, in particular Pam3Csk4 (Pam3) and single-stranded RNA40 (ssRNA), can differentially affect the TLR2/1- and TLR7-mediated responses of microglia when pre-conditioned with alpha Syn by augmenting IL-6, MCP-1/CCL2 or IP-10/CXCL10 secretion levels. Furthermore, we report a skewing of alpha Syn-primed microglia stimulated with ssRNA (TLR7) or Pam3 (TLR2/1) towards intermediate but at the same time differential, M1/M2 phenotypes. Finally, we show that the levels and intracellular location of activated caspase-3 protein change significantly in alpha Syn-primed microglia after stimulation with these particular TLR agonists. Overall, we report a remarkable impact of non-aggregated alpha Syn pre-sensitization of microglia on TLR-mediated immunity, a phenomenon that could contribute to triggering the onset of sporadic alpha-synuclein-related neuropathologies.	[Roodveldt, Cintia; Labrador-Garrido, Adahir; Lachaud, Christian C.; Fernandez-Montesinos, Rafael; Benitez-Rondan, Alicia; Hmadcha, Abdelkrim; Pozo, David] Andalusian Ctr Mol Biol & Regenerat Med, CABIMER, Seville, Spain; [Labrador-Garrido, Adahir; Fernandez-Montesinos, Rafael; Pozo, David] Univ Seville, Sch Med, Dept Med Biochem Mol Biol & Immunol, Seville, Spain; [Gonzalez-Rey, Elena; Robledo, Gema; Delgado, Mario] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Guilliams, Tim; Dobson, Christopher M.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); University of Cambridge	Pozo, D (corresponding author), Andalusian Ctr Mol Biol & Regenerat Med, CABIMER, Seville, Spain.	david.pozo@cabimer.es	Roodveldt, Cintia/I-9118-2014; Delgado, Mario/P-1524-2016; GONZALEZ-REY, ELENA/L-3296-2014; Lachaud, Christian Claude/C-2036-2017; Pozo, David/C-2149-2017; Hmadcha, Abdelkrim/T-1173-2019; Fernández-Montesinos, Rafael/ABG-1691-2021	Roodveldt, Cintia/0000-0003-4124-8769; Delgado, Mario/0000-0003-1893-5982; GONZALEZ-REY, ELENA/0000-0003-3917-9020; Lachaud, Christian Claude/0000-0001-8698-4589; Pozo, David/0000-0002-3732-4960; Hmadcha, Abdelkrim/0000-0002-4105-3702; Fernandez, Rafael/0000-0002-5062-4239; Labrador-Garrido, Adahir/0000-0001-5098-9601	Spanish Ministry of Science and Innovation-Carlos III Institute of Health [PS09-2252, CP10/00527]; FEDER funds; Andalusian Ministry of Health, Economy, Science and Innovation [PI-2010-0824, P10-CTS-6928, P11-CTS-8161]; PAIDI Program from the Andalusian Government [CTS-677]; FPU Predoctoral Fellowship from the Spanish Ministry of Education [AP-2009/3816]; Wellcome Trust; UK Medical and Biotechnological and Biological Sciences Research Council; Parkinson's UK; Parkinson&quot;s UK [H-0903] Funding Source: researchfish	Spanish Ministry of Science and Innovation-Carlos III Institute of Health; FEDER funds(European Commission); Andalusian Ministry of Health, Economy, Science and Innovation; PAIDI Program from the Andalusian Government; FPU Predoctoral Fellowship from the Spanish Ministry of Education; Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical and Biotechnological and Biological Sciences Research Council; Parkinson's UK(Parkinson's UK); Parkinson&quot;s UK(Parkinson&apos;s UK)	Financial support was provided by the Spanish Ministry of Science and Innovation-Carlos III Institute of Health according to the 'Plan Nacional de I+D+i 2008-2011' (PS09-2252 to DP, and CP10/00527 to CR) with co-funding by FEDER funds, the Andalusian Ministry of Health (PI-2010-0824 to DP), Economy, Science and Innovation (P10-CTS-6928 and P11-CTS-8161 to DP) and the PAIDI Program from the Andalusian Government (CTS-677 to DP). ALG holds a FPU Predoctoral Fellowship from the Spanish Ministry of Education (AP-2009/3816). The work of CMD is supported by the Wellcome Trust and the UK Medical and Biotechnological and Biological Sciences Research Council. TG is supported by Parkinson's UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Applequist SE, 2002, INT IMMUNOL, V14, P1065, DOI 10.1093/intimm/dxf069; Balin BJ, 2008, J ALZHEIMERS DIS, V13, P371; Beraud Dawn, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS17, DOI 10.1016/S1353-8020(11)70008-6; Beraud D, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00080; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Borghi R, 2000, NEUROSCI LETT, V287, P65, DOI 10.1016/S0304-3940(00)01153-8; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Carty M, 2011, BIOCHEM PHARMACOL, V81, P825, DOI 10.1016/j.bcp.2011.01.003; Castillo PM, 2008, NANOMEDICINE-UK, V3, P627, DOI 10.2217/17435889.3.5.627; Charlett A, 1999, ACTA NEUROL SCAND, V99, P26; Chen ZH, 2012, J NEUROSCI, V32, P11706, DOI 10.1523/JNEUROSCI.0730-12.2012; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Colton CA, 2010, CNS NEUROL DISORD-DR, V9, P174, DOI 10.2174/187152710791012053; Cookson MR, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-9; Couch Y, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-166; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Croisier E, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-14; Dobbs SM, 2010, HELICOBACTER, V15, P279, DOI 10.1111/j.1523-5378.2010.00768.x; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Emmanouilidou E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022225; Fellner L, 2013, MOL NEUROBIOL, V47, P575, DOI 10.1007/s12035-012-8340-3; Fellner L, 2011, ACTA NEUROPATHOL, V121, P675, DOI 10.1007/s00401-011-0833-z; Galimberti D, 2006, ARCH NEUROL-CHICAGO, V63, P538, DOI 10.1001/archneur.63.4.538; Gao HM, 2008, J NEUROSCI, V28, P7687, DOI 10.1523/JNEUROSCI.0143-07.2008; Hakansson A, 2005, MOVEMENT DISORD, V20, P569, DOI 10.1002/mds.20378; Hamilton RL, 2000, BRAIN PATHOL, V10, P378; Hammond CJ, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-121; Hartmann A, 2000, P NATL ACAD SCI USA, V97, P2875, DOI 10.1073/pnas.040556597; Jang H, 2009, BBA-MOL BASIS DIS, V1792, P714, DOI 10.1016/j.bbadis.2008.08.001; Jellinger KA, 2009, J NEURAL TRANSM, V116, P1111, DOI 10.1007/s00702-009-0240-y; Kalia LV, 2013, ANN NEUROL, V73, P155, DOI 10.1002/ana.23746; Kim YS, 2006, EXP MOL MED, V38, P333, DOI 10.1038/emm.2006.40; Krstic D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-151; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Lee DC, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-56; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee SJ, 2008, J MOL NEUROSCI, V34, P17, DOI 10.1007/s12031-007-0012-9; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Letiembre M, 2009, NEUROBIOL AGING, V30, P759, DOI 10.1016/j.neurobiolaging.2007.08.018; Long-Smith CM, 2009, PROG NEUROBIOL, V89, P277, DOI 10.1016/j.pneurobio.2009.08.001; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Marinova-Mutafchieva L, 2009, J NEUROCHEM, V110, P966, DOI 10.1111/j.1471-4159.2009.06189.x; Marques O, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.94; McKimmie CS, 2006, J NEUROIMMUNOL, V175, P128, DOI 10.1016/j.jneuroim.2006.03.012; Miman O, 2010, NEUROSCI LETT, V475, P129, DOI 10.1016/j.neulet.2010.03.057; Mollenhauer B, 2008, EXP NEUROL, V213, P315, DOI 10.1016/j.expneurol.2008.06.004; Mollenhauer B, 2013, NEUROSCI LETT, V532, P44, DOI 10.1016/j.neulet.2012.11.004; Mollenhauer B, 2011, LANCET NEUROL, V10, P230, DOI 10.1016/S1474-4422(11)70014-X; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Morrison BE, 2012, J IMMUNOL, V189, P5498, DOI 10.4049/jimmunol.1102150; Neher JJ, 2011, J IMMUNOL, V186, P4973, DOI 10.4049/jimmunol.1003600; Park JY, 2008, GLIA, V56, P1215, DOI 10.1002/glia.20691; Perry VH, 2007, NAT REV IMMUNOL, V7, P161, DOI 10.1038/nri2015; Ponomarev ED, 2013, GLIA, V61, P91, DOI 10.1002/glia.22363; Reale M, 2009, BRAIN BEHAV IMMUN, V23, P55, DOI 10.1016/j.bbi.2008.07.003; Roodveldt C., 2011, INTECH, P57; Roodveldt C, 2012, BIOCHEMISTRY-US, V51, P8771, DOI 10.1021/bi300558q; Roodveldt C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013481; Rostene W, 2007, NAT REV NEUROSCI, V8, P895, DOI 10.1038/nrn2255; Scalzo P, 2011, NEUROIMMUNOMODULAT, V18, P240, DOI 10.1159/000323779; Schwartz M, 2010, BRAIN BEHAV IMMUN, V24, P1054, DOI 10.1016/j.bbi.2010.01.010; Shechter R, 2013, J PATHOL, V229, P332, DOI 10.1002/path.4106; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Stefanova N, 2007, MOVEMENT DISORD, V22, P2196, DOI 10.1002/mds.21671; Takahashi M, 1999, JPN J INFECT DIS, V52, P89; Tatton NA, 2000, EXP NEUROL, V166, P29, DOI 10.1006/exnr.2000.7489; Tokuda T, 2010, NEUROLOGY, V75, P1766, DOI 10.1212/WNL.0b013e3181fd613b; Tokuda T, 2006, BIOCHEM BIOPH RES CO, V349, P162, DOI 10.1016/j.bbrc.2006.08.024; Tsui JKC, 1999, CAN J PUBLIC HEALTH, V90, P334, DOI 10.1007/BF03404523; Watson MB, 2012, EXP NEUROL, V237, P318, DOI 10.1016/j.expneurol.2012.06.025; Weller C, 2005, FEMS IMMUNOL MED MIC, V44, P129, DOI 10.1016/j.femsim.2005.01.011; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com; Zhang WB, 2009, AM J PATHOL, V175, P891, DOI 10.2353/ajpath.2009.081115; Zheng TS, 1998, P NATL ACAD SCI USA, V95, P13618, DOI 10.1073/pnas.95.23.13618	76	69	69	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79160	10.1371/journal.pone.0079160	http://dx.doi.org/10.1371/journal.pone.0079160			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236103	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700101
J	Schaefer, SM; Boylan, JM; van Reekum, CM; Lapate, RC; Norris, CJ; Ryff, CD; Davidson, RJ				Schaefer, Stacey M.; Boylan, Jennifer Morozink; van Reekum, Carien M.; Lapate, Regina C.; Norris, Catherine J.; Ryff, Carol D.; Davidson, Richard J.			Purpose in Life Predicts Better Emotional Recovery from Negative Stimuli	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; ALZHEIMER-DISEASE; AFFECTIVE STYLE; STARTLE REFLEX; INFORMATION; RESILIENCE; DEPRESSION; RISK; MODULATION; AMYGDALA	Purpose in life predicts both health and longevity suggesting that the ability to find meaning from life's experiences, especially when confronting life's challenges, may be a mechanism underlying resilience. Having purpose in life may motivate reframing stressful situations to deal with them more productively, thereby facilitating recovery from stress and trauma. In turn, enhanced ability to recover from negative events may allow a person to achieve or maintain a feeling of greater purpose in life over time. In a large sample of adults (aged 36-84 years) from the MIDUS study (Midlife in the U. S., http://www.midus.wisc.edu/), we tested whether purpose in life was associated with better emotional recovery following exposure to negative picture stimuli indexed by the magnitude of the eyeblink startle reflex (EBR), a measure sensitive to emotional state. We differentiated between initial emotional reactivity (during stimulus presentation) and emotional recovery (occurring after stimulus offset). Greater purpose in life, assessed over two years prior, predicted better recovery from negative stimuli indexed by a smaller eyeblink after negative pictures offset, even after controlling for initial reactivity to the stimuli during the picture presentation, gender, age, trait affect, and other well-being dimensions. These data suggest a proximal mechanism by which purpose in life may afford protection from negative events and confer resilience is through enhanced automatic emotion regulation after negative emotional provocation.	[Schaefer, Stacey M.; Lapate, Regina C.; Ryff, Carol D.] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; [Schaefer, Stacey M.; Lapate, Regina C.; Davidson, Richard J.] Univ Wisconsin, Waisman Lab Brain Imaging & Behav, Madison, WI 53706 USA; [Schaefer, Stacey M.; Lapate, Regina C.; Davidson, Richard J.] Univ Wisconsin, Ctr Investigating Healthy Minds, Madison, WI 53706 USA; [Boylan, Jennifer Morozink] Univ Wisconsin, Ctr Womens Hlth & Hlth Dispar Res, Madison, WI 53706 USA; [Ryff, Carol D.] Univ Wisconsin, Inst Aging, Madison, WI 53706 USA; [van Reekum, Carien M.] Univ Reading, Sch Psychol & Clin Language Sci, Ctr Integrat Neurosci & Neurodynam, Reading, Berks, England; [Norris, Catherine J.] Swarthmore Coll, Dept Psychol, Swarthmore, PA 19081 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Reading; Swarthmore College	Schaefer, SM (corresponding author), Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA.	smschaefer2@wisc.edu	Boylan, Jennifer/B-9288-2016	Norris, Catherine/0000-0003-3710-7998; Davidson, Richard/0000-0002-8506-4964; van Reekum, Carien M./0000-0002-1516-1101; Boylan, Jennifer/0000-0003-2597-1367	National Institute on Aging [PO1-AG020166]; National Institute on Mental Health [R01 MH043454]; Waisman Intellectual and Developmental Disabilities Research Center (Waisman IDDRC) [P30HD03352]; National Institute of Mental Health [T32MH018931-22]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD049302, P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH018931, R01MH043454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG020166] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Waisman Intellectual and Developmental Disabilities Research Center (Waisman IDDRC); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the National Institute on Aging (PO1-AG020166), the National Institute on Mental Health (R01 MH043454), and the Waisman Intellectual and Developmental Disabilities Research Center (Waisman IDDRC), P30HD03352. J. Morozink Boylan was supported by the National Institute of Mental Health (T32MH018931-22). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Mental Health or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alim TN, 2008, AM J PSYCHIAT, V165, P1566, DOI 10.1176/appi.ajp.2008.07121939; Angrilli A, 1996, BRAIN, V119, P1991, DOI 10.1093/brain/119.6.1991; Boyle PA, 2012, ARCH GEN PSYCHIAT, V69, P499, DOI 10.1001/archgenpsychiatry.2011.1487; Boyle PA, 2010, AM J GERIAT PSYCHIAT, V18, P1093, DOI 10.1097/JGP.0b013e3181d6c259; Boyle PA, 2010, ARCH GEN PSYCHIAT, V67, P304, DOI 10.1001/archgenpsychiatry.2009.208; Boyle PA, 2009, PSYCHOSOM MED, V71, P574, DOI 10.1097/PSY.0b013e3181a5a7c0; Bradley MM, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P581, DOI 10.1017/CBO9780511546396.025; BRADLEY MM, 1993, PSYCHOPHYSIOLOGY, V30, P541, DOI 10.1111/j.1469-8986.1993.tb02079.x; Brim OG, 2004, MAC FDN MEN, P1; Buchanan TW, 2004, BEHAV NEUROSCI, V118, P429, DOI 10.1037/0735-7044.118.2.429; Campbell-Sills L, 2006, BEHAV RES THER, V44, P1251, DOI 10.1016/j.brat.2005.10.001; Davidson RJ, 1998, COGNITION EMOTION, V12, P307, DOI 10.1080/026999398379628; Davidson RJ, 2000, AM PSYCHOL, V55, P1196, DOI 10.1037/0003-066X.55.11.1196; Davis M., 1999, STARTLE MODIFICATION, P95; Davis M, 2006, AM PSYCHOL, V61, P741, DOI 10.1037/0003-066X.61.8.741; Ehring T, 2008, PERS INDIV DIFFER, V44, P1574, DOI 10.1016/j.paid.2008.01.013; Feder A, 2013, J AFFECT DISORDERS, V147, P156, DOI 10.1016/j.jad.2012.10.027; Filion DL, 1998, BIOL PSYCHOL, V47, P1, DOI 10.1016/S0301-0511(97)00020-3; Friedman EM, 2007, HEALTH PSYCHOL, V26, P305, DOI 10.1037/0278-6133.26.3.305; Gard MG, 2007, EMOTION, V7, P429, DOI 10.1037/1528-3542.7.2.429; Gotlib IH, 2010, ANNU REV CLIN PSYCHO, V6, P285, DOI 10.1146/annurev.clinpsy.121208.131305; Grillon C, 1998, INT J PSYCHOPHYSIOL, V28, P223, DOI 10.1016/S0167-8760(97)00072-X; Gross JJ, 1997, J ABNORM PSYCHOL, V106, P95, DOI 10.1037/0021-843X.106.1.95; Gross JJ., 1998, REV GEN PSYCHOL, V2, P271, DOI 10.1037/1089-2680.2.3.271; Jackson DC, 2003, PSYCHOL SCI, V14, P612, DOI 10.1046/j.0956-7976.2003.psci_1473.x; Johnstone T, 2007, J NEUROSCI, V27, P8877, DOI 10.1523/JNEUROSCI.2063-07.2007; Koster EHW, 2011, CLIN PSYCHOL REV, V31, P138, DOI 10.1016/j.cpr.2010.08.005; Lang P.J., 2008, INT AFFECTIVE PICTUR; LANG PJ, 1995, AM PSYCHOL, V50, P372, DOI 10.1037/0003-066X.50.5.372; Lewis GJ, 2014, SOC COGN AFFECT NEUR, V9, P615, DOI 10.1093/scan/nst032; McCullough ME, 2002, J PERS SOC PSYCHOL, V82, P112, DOI 10.1037//0022-3514.82.1.112; Morozink JA, 2010, HEALTH PSYCHOL, V29, P626, DOI 10.1037/a0021360; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Nierenberg AA, 2010, CNS NEUROSCI THER, V16, P208, DOI 10.1111/j.1755-5949.2009.00108.x; Nolen-Hoeksema S, 2008, PERSPECT PSYCHOL SCI, V3, P400, DOI 10.1111/j.1745-6924.2008.00088.x; PAVOT W, 1993, PSYCHOL ASSESSMENT, V5, P164, DOI DOI 10.1037/1040-3590.5.2.164; Roberts NA, 2008, INT J PSYCHOPHYSIOL, V70, P82, DOI 10.1016/j.ijpsycho.2008.06.003; Ryff C, 2012, SOC PERSONAL PSYCHOL, V6, P792, DOI 10.1111/j.1751-9004.2012.00462.x; Ryff CD, 2012, ANNU REV GERONTOL GE, V32, P73, DOI 10.1891/0198-8794.32.73; RYFF CD, 1995, J PERS SOC PSYCHOL, V69, P719; RYFF CD, 1994, PSYCHOL AGING, V9, P195, DOI 10.1037/0882-7974.9.2.195; RYFF CD, 1989, J PERS SOC PSYCHOL, V57, P1069, DOI 10.1037/0022-3514.57.6.1069; Ryff CD, 2004, PHILOS T R SOC B, V359, P1383, DOI 10.1098/rstb.2004.1521; Siegle GJ, 2003, COGNITIVE THER RES, V27, P365, DOI 10.1023/A:1023974602357; Siegle GJ, 2002, BIOL PSYCHIAT, V51, P693, DOI 10.1016/S0006-3223(02)01314-8; Siegle GJ, 2001, BIOL PSYCHIAT, V49, P624, DOI 10.1016/S0006-3223(00)01024-6; Sprengelmeyer R, 2011, J AFFECT DISORDERS, V133, P120, DOI 10.1016/j.jad.2011.04.004; Tassinary LG, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P267, DOI 10.1017/CBO9780511546396.012; Taubitz LE, 2013, INT J PSYCHOPHYSIOL, V87, P124, DOI 10.1016/j.ijpsycho.2012.11.002; van Reekum CM, 2007, J COGNITIVE NEUROSCI, V19, P237, DOI 10.1162/jocn.2007.19.2.237; van Reekum CM, 2011, SOC COGN AFFECT NEUR, V6, P177, DOI 10.1093/scan/nsq031; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wood AM, 2010, J AFFECT DISORDERS, V122, P213, DOI 10.1016/j.jad.2009.06.032	53	87	88	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80329	10.1371/journal.pone.0080329	http://dx.doi.org/10.1371/journal.pone.0080329			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236176	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000327254700177
J	Tong, F; Fu, T				Tong, Fang; Fu, Tong			Meta-Analysis of Fluid Intelligence Tests of Children from the Chinese Mainland with Learning Difficulties	PLOS ONE			English	Article							PROGRESSIVE MATRICES	Objective: To evaluate the differences in fluid intelligence tests between normal children and children with learning difficulties in China. Method: PubMed, MD Consult, and other Chinese Journal Database were searched from their establishment to November 2012. After finding comparative studies of Raven measurements of normal children and children with learning difficulties, full Intelligent Quotation (FIQ) values and the original values of the sub-measurement were extracted. The corresponding effect model was selected based on the results of heterogeneity and parallel sub-group analysis was performed. Results: Twelve documents were included in the meta-analysis, and the studies were all performed in mainland of China. Among these, two studies were performed at child health clinics, the other ten sites were schools and control children were schoolmates or classmates. FIQ was evaluated using a random effects model. WMD was -13.18 (95% CI: -16.50--9.85). Children with learning difficulties showed significantly lower FIQ scores than controls (P<0.00001); Type of learning difficulty and gender differences were evaluated using a fixed-effects model (I-2 = 0%). The sites and purposes of the studies evaluated here were taken into account, but the reasons of heterogeneity could not be eliminated; The sum IQ of all the subgroups showed considerable heterogeneity (I-2 = 76.5%). The sub-measurement score of document A showed moderate heterogeneity among all documents, and AB, B, and E showed considerable heterogeneity, which was used in a random effect model. Individuals with learning difficulties showed heterogeneity as well. There was a moderate delay in the first three items (-0.5 to -0.9), and a much more pronounced delay in the latter three items (-1.4 to -1.6). Conclusion: In the Chinese mainland, the level of fluid intelligence of children with learning difficulties was lower than that of normal children. Delayed development in sub-items of C, D, and E was more obvious.	[Tong, Fang] Capital Inst Pediat, Beijing, Peoples R China; [Fu, Tong] Beijing Informat Sci & Technol Univ, Beijing, Peoples R China	Capital Institute of Pediatrics (CIP); Beijing Information Science & Technology University	Tong, F (corresponding author), Capital Inst Pediat, Beijing, Peoples R China.	tongfang371@163.com						Blinkhorn S, 2005, NATURE, V438, P31, DOI 10.1038/438031a; Brewin CR, 2002, BEHAV RES THER, V40, P923, DOI 10.1016/S0005-7967(01)00127-9; Cai ZY, 2000, CHINA J HLTH PSYCHOL, V8, P503; Fajgelj S, 2010, COLLEGIUM ANTROPOL, V34, P1015; Fang YH, 1998, CHINESE MENTAL HLTH, V12, P86; Flynn J R, 2000, Novartis Found Symp, V233, P202, DOI 10.1002/0470870850.ch13; Geake JG, 2010, NEUROIMAGE, V49, P3489, DOI 10.1016/j.neuroimage.2009.09.008; Gow AJ, 2008, GERONTOLOGY, V54, P177, DOI 10.1159/000118098; JENSEN AR, 1993, J BIOSOC SCI, V25, P397, DOI 10.1017/S0021932000020721; Jing J, 1996, CHINESE MENTAL HLTH, V10, P131; Li D, 1989, CHINESE BANKING ASIA, P1; Li J, 2006, CHINESE J SCH HLTH, V27, P662; Liang JL, 2000, CHINESE MENTAL HLTH, V14, P193; [梁小红 LIANG Xiaohong], 2006, [中国地方病学杂志, Chinese Journal of Endemiology], V25, P300; Lynn R, 2005, J BIOSOC SCI, V37, P107, DOI 10.1017/S0021932003006497; Lynn R, 2011, J BIOSOC SCI, V43, P469, DOI 10.1017/S0021932010000611; Sun CQ, 2000, CHINA J BIRTH HLTH H, V8, p[98, 92]; [童方 Tong Fang], 2012, [中国循证儿科杂志, Chinese Journal of Evidence Based Pediatrics], V7, P364; [童方 TONG Fang], 2006, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V14, P578; Wang D, 1997, CHINA TIMES     1117, P1; [王恩国 WANG EnGuo], 2008, [中国心理卫生杂志, Chinese Mental Health Journal], V22, P801; Wang Z, 2010, PRACTICAL PREVENTIVE, V17, P854; Xu SJ, 2005, CHINESE J SCH HLTH, V26, P376; Yang ZZ, 2000, CHINESE J BEHAV MED, V9, P64; Zatorre RJ, 2008, PHILOS T R SOC B, V363, P1087, DOI 10.1098/rstb.2007.2161; Zhang FR, 2002, CHINESE J CHILD HLTH, V10, P238; Zhang HC., 1985, RAVEN STANDARD INTEL, P1	27	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78311	10.1371/journal.pone.0078311	http://dx.doi.org/10.1371/journal.pone.0078311			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236016	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700013
J	Boynak, NY; Rojas, F; D'Alessio, C; Larrea, SCV; Rodriguez, V; Ghiringhelli, PD; Tellez-Inon, MT				Boynak, Natalia Y.; Rojas, Federico; D'Alessio, Cecilia; Larrea, Salome C. Vilchez; Rodriguez, Vanina; Ghiringhelli, Pablo D.; Tellez-Inon, Maria T.			Identification of a Wee1-Like Kinase Gene Essential for Procyclic Trypanosoma brucei Survival	PLOS ONE			English	Article							INDUCIBLE EXPRESSION SYSTEM; CELL-CYCLE REGULATION; PROTEIN-KINASE; TYROSINE PHOSPHORYLATION; NEGATIVE REGULATION; CHECKPOINT KINASE; FISSION YEAST; WEE1; MITOSIS; CYTOKINESIS	Regulation of eukaryotic cell cycle progression requires sequential activation and inactivation of cyclin-dependent kinases (CDKs). Activation of the cyclin B-cdc2 kinase complex is a pivotal step in mitotic initiation and the tyrosine kinase Wee1 is a key regulator of cell cycle sequence during G2/M transition and inhibits mitotic entry by phosphorylating the inhibitory tyrosine 15 on the cdc2 M-phase-inducing kinase. Wee1 degradation is essential for the exit from the G2 phase. In trypanosomatids, little is known about the genes that regulate cyclin B-cdc2 complexes at the G2/M transition of their cell cycle. Although canonical tyrosine kinases are absent in the genome of trypanosomatids, phosphorylation on protein tyrosine residues has been reported in Trypanosoma brucei. Here, we characterized a Wee1-like protein kinase gene from T. brucei. Expression of TbWee1 in a Schizosaccharomyces pombe strain null for Wee1 inhibited cell division and caused cell elongation. This demonstrates the lengthening of G2, which provided cells with extra time to grow before dividing. The Wee1-like protein kinase was expressed in the procyclic and bloodstream proliferative slender forms of T. brucei and the role of Wee1 in cell cycle progression was analyzed by generating RNA interference cell lines. In the procyclic form of T. brucei, the knock-down of TbWee1 expression by RNAi led to inhibition of parasite growth. Abnormal phenotypes showing an increase in the percentage of cells with 1N0K, 0N1K and 2N1K were observed in these RNAi cell lines. Using parasites with a synchronized cell cycle, we demonstrated that TbWee1 is linked to the G2/M phase. We also showed that TbWee1 is an essential gene necessary for proper cell cycle progression and parasite growth in T. brucei. Our results provide evidence for the existence of a functional Wee1 in T. brucei with a potential role in cell division at G2/M.	[Boynak, Natalia Y.; Rojas, Federico; Larrea, Salome C. Vilchez; Tellez-Inon, Maria T.] Consejo Nacl Invest Cient & Tecn, INGEBI, Inst Invest Ingn Genet Biol Mol Dr Hector N Torre, RA-1033 Buenos Aires, DF, Argentina; [D'Alessio, Cecilia] Consejo Nacl Invest Cient & Tecn, Fdn Inst Leloir, Lab Glycobiol, RA-1033 Buenos Aires, DF, Argentina; [Rodriguez, Vanina; Ghiringhelli, Pablo D.] Univ Nacl Quilmes, Dept Sci & Technol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute	Tellez-Inon, MT (corresponding author), Consejo Nacl Invest Cient & Tecn, INGEBI, Inst Invest Ingn Genet Biol Mol Dr Hector N Torre, RA-1033 Buenos Aires, DF, Argentina.	mtellez@dna.uba.ar	Ghiringhelli, Pablo D/N-8073-2017; Rojas, Federico/AAG-6220-2020	Ghiringhelli, Pablo D/0000-0002-2003-0106; Rojas, Federico/0000-0002-7018-2861; D'Alessio, Cecilia/0000-0001-7371-5080; Vilchez Larrea, Salome/0000-0001-8302-1509	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), Argentina(ANPCyT)	This work was funded by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) and Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), Argentina. NYB, FR, VR, SV were Fellows and DG, CD and MTTI are Career Investigators of CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aligue R, 1997, J BIOL CHEM, V272, P13320, DOI 10.1074/jbc.272.20.13320; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; BOOHER RN, 1993, EMBO J, V12, P3417, DOI 10.1002/j.1460-2075.1993.tb06016.x; Borup MT, 2006, CELL CYCLE, V5, P2138, DOI 10.4161/cc.5.18.3206; CAMPBELL SD, 1995, MOL BIOL CELL, V6, P1333, DOI 10.1091/mbc.6.10.1333; Charlesworth A, 2000, DEV BIOL, V227, P706, DOI 10.1006/dbio.2000.9922; Chowdhury AR, 2008, EUKARYOT CELL, V7, P425, DOI 10.1128/EC.00369-07; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Cools T, 2011, PLANT CELL, V23, P1435, DOI 10.1105/tpc.110.082768; De Schutter K, 2007, PLANT CELL, V19, P211, DOI 10.1105/tpc.106.045047; Dunphy William G., 1994, Trends in Cell Biology, V4, P202; Enders GH, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-12; FERRELL JE, 1991, METHOD ENZYMOL, V200, P430; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; Gomez EB, 1998, MOL BIOCHEM PARASIT, V91, P337, DOI 10.1016/S0166-6851(97)00218-1; Gonzalez N, 2004, PLANT MOL BIOL, V56, P849, DOI 10.1007/s11103-004-5110-2; Hamer PCD, 2011, CLIN CANCER RES, V17, P4200, DOI 10.1158/1078-0432.CCR-10-2537; Hammarton TC, 2007, MOL BIOCHEM PARASIT, V153, P1, DOI 10.1016/j.molbiopara.2007.01.017; Hammarton TC, 2005, MOL MICROBIOL, V56, P104, DOI 10.1111/j.1365-2958.2005.04542.x; Hammarton TC, 2004, J BIOL CHEM, V279, P24757, DOI 10.1074/jbc.M401276200; Hammarton TC, 2003, J BIOL CHEM, V278, P22877, DOI 10.1074/jbc.M300813200; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Harvey SL, 2003, CURR BIOL, V13, P264, DOI 10.1016/S0960-9822(03)00049-6; HONDA R, 1995, CHROMOSOME RES, V3, P300, DOI 10.1007/BF00713068; IGARASHI M, 1991, NATURE, V353, P80, DOI 10.1038/353080a0; KUMAGAI A, 1991, CELL, V64, P903, DOI 10.1016/0092-8674(91)90315-P; Li Y, 2003, MOL MICROBIOL, V49, P251, DOI 10.1046/j.1365-2958.2003.03575.x; Li ZY, 2003, J BIOL CHEM, V278, P20652, DOI 10.1074/jbc.M301635200; Lim HH, 2003, MOL CELL, V11, P845, DOI 10.1016/S1097-2765(03)00149-7; MacIntosh GC, 1996, PLANT PHYSIOL, V112, P1541, DOI 10.1104/pp.112.4.1541; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; MCGOWAN CH, 1993, EMBO J, V12, P75, DOI 10.1002/j.1460-2075.1993.tb05633.x; McKean PG, 2003, CURR OPIN MICROBIOL, V6, P600, DOI 10.1016/j.mib.2003.10.010; Michael WM, 1998, SCIENCE, V282, P1886, DOI 10.1126/science.282.5395.1886; Monnerat S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067327; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MOTTRAM JC, 1995, GENE, V162, P147, DOI 10.1016/0378-1119(95)00350-F; Mueller Paul R, 2005, Methods Mol Biol, V296, P299; MUELLER PR, 1995, MOL BIOL CELL, V6, P119, DOI 10.1091/mbc.6.1.119; Murakami MS, 2011, GENE DEV, V13, P620; Murrow LM, 2010, BREAST CANCER RES TR, V122, P347, DOI 10.1007/s10549-009-0571-2; Nett IRE, 2009, MOL CELL PROTEOMICS, V8, P1527, DOI 10.1074/mcp.M800556-MCP200; Nett IRE, 2009, EUKARYOT CELL, V8, P617, DOI 10.1128/EC.00366-08; Nurse P, 2002, CHEMBIOCHEM, V3, P596, DOI 10.1002/1439-7633(20020703)3:7<596::AID-CBIC596>3.0.CO;2-U; NURSE P, 1975, NATURE, V256, P547, DOI 10.1038/256547a0; Okamoto K, 2007, P NATL ACAD SCI USA, V104, P3753, DOI 10.1073/pnas.0607357104; PARKER LL, 1991, EMBO J, V10, P1255, DOI 10.1002/j.1460-2075.1991.tb08067.x; PARKER LL, 1992, P NATL ACAD SCI USA, V89, P2917, DOI 10.1073/pnas.89.7.2917; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; Parsons M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-127; PARSONS M, 1991, MOL BIOCHEM PARASIT, V45, P241, DOI 10.1016/0166-6851(91)90091-J; Perry JA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-12; Ploubidou A, 1999, J CELL SCI, V112, P4641; Potapova TA, 2011, MOL BIOL CELL, V22, P1191, DOI 10.1091/mbc.E10-07-0599; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; Sorrell DA, 2002, PLANTA, V215, P518, DOI 10.1007/s00425-002-0815-4; Squire CJ, 2005, STRUCTURE, V13, P541, DOI 10.1016/j.str.2004.12.017; Sreenivasan A, 1999, MOL CELL BIOL, V19, P7983; Sun YJ, 1999, P NATL ACAD SCI USA, V96, P4180, DOI 10.1073/pnas.96.7.4180; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TANG ZH, 1993, EMBO J, V12, P3427, DOI 10.1002/j.1460-2075.1993.tb06017.x; Tu XM, 2004, J BIOL CHEM, V279, P20519, DOI 10.1074/jbc.M312862200; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VICKERMAN K, 1985, BRIT MED BULL, V41, P105, DOI 10.1093/oxfordjournals.bmb.a072036; Watanabe N, 2005, P NATL ACAD SCI USA, V102, P11663, DOI 10.1073/pnas.0500410102; WATANABE N, 1995, EMBO J, V14, P1878, DOI 10.1002/j.1460-2075.1995.tb07180.x; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; WOODWARD R, 1990, J CELL SCI, V95, P49	72	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79364	10.1371/journal.pone.0079364	http://dx.doi.org/10.1371/journal.pone.0079364			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223931	gold, Green Published, Green Submitted			2022-12-27	WOS:000326597400062
J	Darbari, DS; Wang, ZY; Kwak, MJ; Hildesheim, M; Nichols, J; Allen, D; Seamon, C; Peters-Lawrence, M; Conrey, A; Hall, MK; Kato, GJ; Taylor, JG				Darbari, Deepika S.; Wang, Zhengyuan; Kwak, Minjung; Hildesheim, Mariana; Nichols, James; Allen, Darlene; Seamon, Catherine; Peters-Lawrence, Marlene; Conrey, Anna; Hall, Mary K.; Kato, Gregory J.; Taylor, James G.			Severe Painful Vaso-Occlusive Crises and Mortality in a Contemporary Adult Sickle Cell Anemia Cohort Study	PLOS ONE			English	Article							ACUTE CHEST SYNDROME; PULMONARY-HYPERTENSION; DISEASE; CHILDREN; RISK; HYDROXYUREA; PREVENTION; STROKE; DEATH; CARE	Background: Frequent painful vaso-occlusive crises (VOCs) were associated with mortality in the Cooperative Study of Sickle Cell Disease (CSSCD) over twenty years ago. Modern therapies for sickle cell anemia (SCA) like hydroxyurea are believed to have improved overall patient survival. The current study sought to determine the relevance of the association between more frequent VOCs and death and its relative impact upon overall mortality compared to other known risk factors in a contemporary adult SCA cohort. Methods: Two hundred sixty four SCA adults were assigned into two groups based on patient reported outcomes for emergency department (ED) visits or hospitalizations for painful VOC treatment during the 12 months prior to evaluation. Results: Higher baseline hematocrit (p = 0.0008), ferritin (p = 0.005), and HDL cholesterol (p = 0.01) were independently associated with 1 or more painful VOCs requiring an ED visit or hospitalization for acute pain. During a median follow-up of 5 years, mortality was higher in the ED visit/hospitalization group (relative risk [RR] 2.68, 95% CI 1.1-6.5, p = 0.03). Higher tricuspid regurgitatant jet velocity (TRV) (RR 2.41, 95% CI 1.5-3.9, p < 0.0001), elevated ferritin (RR 4.00, 95% CI 1.8-9.0, p = 0.001) and lower glomerular filtration rate (RR=2.73, 95% CI 1.6-4.6, p < 0.0001) were also independent risk factors for mortality. Conclusions: Severe painful VOCs remain a marker for SCA disease severity and premature mortality in a modern cohort along with other known risk factors for death including high TRV, high ferritin and lower renal function. The number of patient reported pain crises requiring healthcare utilization is an easily obtained outcome that could help to identify high risk patients for disease modifying therapies.	[Darbari, Deepika S.] Childrens Natl Med Ctr, Ctr Canc & Blood Disorders, Washington, DC 20010 USA; [Darbari, Deepika S.; Wang, Zhengyuan; Taylor, James G.] NHLBI, NIH, Hematol Branch, Genom Med Sect, Bethesda, MD 20892 USA; [Kwak, Minjung] Natl Heart Lung & Blood Inst, NIH, Off Biostat Res, Bethesda, MD USA; [Hildesheim, Mariana; Nichols, James; Allen, Darlene; Seamon, Catherine; Peters-Lawrence, Marlene; Conrey, Anna; Kato, Gregory J.] Natl Heart Lung & Blood Inst, NIH, Hematol Branch, Sickle Cell Dis Vasc Sect, Bethesda, MD USA; [Hall, Mary K.] NIH, Ctr Clin, Bethesda, MD 20892 USA	Children's National Health System; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Taylor, JG (corresponding author), NHLBI, NIH, Hematol Branch, Genom Med Sect, Bethesda, MD 20892 USA.	jamesta@mail.nih.gov	Kato, Gregory J/I-7615-2014; wang, zhengyuan/HGA-0435-2022; Wang, Zhengyuan/GWV-6069-2022; Taylor, James G./AAH-4782-2021	Kato, Gregory J/0000-0003-4465-3217; wang, zhengyuan/0000-0002-8447-9674; Taylor, James G./0000-0002-4421-1809	Division of Intramural Research, National Heart, Lung and Blood Institute [1ZIAHL006012-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006012] Funding Source: NIH RePORTER	Division of Intramural Research, National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the Division of Intramural Research, National Heart, Lung and Blood Institute (project 1ZIAHL006012-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RJ, 1998, NEW ENGL J MED, V339, P5, DOI 10.1056/NEJM199807023390102; BALLAS SK, 1988, BLOOD, V72, P1216; Bean CJ, 2012, BLOOD, V120, P3822, DOI 10.1182/blood-2011-06-361642; BILLETT HH, 1986, BLOOD, V68, P301; Brousseau DC, 2010, JAMA-J AM MED ASSOC, V303, P1288, DOI 10.1001/jama.2010.378; Castro O, 2003, BLOOD, V101, P1257, DOI 10.1182/blood-2002-03-0948; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; Charache S, 1995, CONTROL CLIN TRIALS, V16, P432, DOI 10.1016/S0197-2456(95)00098-4; GASTON MH, 1986, NEW ENGL J MED, V314, P1593, DOI 10.1056/NEJM198606193142501; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Hoots WK, 2012, PEDIATR BLOOD CANCER, V59, P353, DOI 10.1002/pbc.24180; Kauf TL, 2009, AM J HEMATOL, V84, P323, DOI 10.1002/ajh.21408; LETTRE G, 2012, COLD SPRING HARBOR P, V2; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Liu YT, 2000, BRIT J HAEMATOL, V108, P295; Machado RF, 2011, BLOOD, V118, P855, DOI 10.1182/blood-2010-09-306167; Miller ST, 2001, J PEDIATR-US, V139, P785, DOI 10.1067/mpd.2001.119593; Minniti CP, 2009, BRIT J HAEMATOL, V147, P737, DOI 10.1111/j.1365-2141.2009.07906.x; Nagel RL, 2003, BLOOD REV, V17, P167, DOI 10.1016/S0268-960X(03)00003-1; Parent F, 2011, NEW ENGL J MED, V365, P44, DOI 10.1056/NEJMoa1005565; PLATT OS, 1991, NEW ENGL J MED, V325, P11, DOI 10.1056/NEJM199107043250103; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Powars DR, 2005, MEDICINE, V84, P363, DOI 10.1097/01.md.0000189089.45003.52; SASAKI J, 1983, CLIN LAB HAEMATOL, V5, P35; Shalev H, 2007, AM J HEMATOL, V82, P199, DOI 10.1002/ajh.20804; Smith WR, 2008, ANN INTERN MED, V148, P94, DOI 10.7326/0003-4819-148-2-200801150-00004; Steinberg MH, 2010, AM J HEMATOL, V85, P403, DOI 10.1002/ajh.21699; Steinberg MH, 1999, NEW ENGL J MED, V340, P1021, DOI 10.1056/NEJM199904013401307; Taylor JG, 2008, AM J HEMATOL, V83, P6, DOI 10.1002/ajh.21035; Taylor JG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002095; Zorca S, 2010, BRIT J HAEMATOL, V149, P436, DOI 10.1111/j.1365-2141.2010.08109.x	31	70	72	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79923	10.1371/journal.pone.0079923	http://dx.doi.org/10.1371/journal.pone.0079923			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224021	Green Published, gold, Green Submitted			2022-12-27	WOS:000326597400095
J	Kato, H; Kira, S; Kawamukai, M				Kato, Hiroaki; Kira, Shintaro; Kawamukai, Makoto			The Transcription Factors Atf1 and Pcr1 Are Essential for Transcriptional Induction of the Extracellular Maltase Agl1 in Fission Yeast	PLOS ONE			English	Article							SCHIZOSACCHAROMYCES-POMBE; GENE; KINASE; MEDIATOR; PROTEIN; DISTINCT; ACTIVATION; EXPRESSION; ENCODES; BINDING	The fission yeast Schizosaccharomyces pombe secretes the extracellular maltase Agl1, which hydrolyzes maltose into glucose, thereby utilizing maltose as a carbon source. Whether other maltases contribute to efficient utilization of maltose and how Agl1 expression is regulated in response to switching of carbon sources are unknown. In this study, we show that three other possible maltases and the maltose transporter Sut1 are not required for efficient utilization of maltose. Transcription of agl1 was induced when the carbon source was changed from glucose to maltose. This was dependent on Atf1 and Pcr1, which are highly conserved transcription factors that regulate stress-responsive genes in various stress conditions. Atf1 and Pcr1 generally bind the TGACGT motif as a heterodimer. The agl1 gene lacks the exact motif, but has many degenerate TGACGT motifs in its promoter and coding region. When the carbon source was switched from glucose to maltose, Atf1 and Pcr1 associated with the promoters and coding regions of agl1, fbp1, and gpx1, indicating that the Atf1-Pcr1 heteromer binds a variety of regions in its target genes to induce their transcription. In addition, the association of Mediator with these genes was dependent on Atf1 and Pcr1. These data indicate that Atf1 and Pcr1 induce the transcription of agl1, which allows efficient utilization of extracellular maltose.	[Kato, Hiroaki; Kira, Shintaro; Kawamukai, Makoto] Shimane Univ, Fac Life & Environm Sci, Dept Life Sci & Biotechnol, Matsue, Shimane, Japan; [Kato, Hiroaki] Shimane Univ, Sch Med, Dept Biochem, Izumo, Shimane, Japan; [Kato, Hiroaki] Japan Sci & Technol Agcy JST, PRESTO, Saitama, Japan	Shimane University; Shimane University; Japan Science & Technology Agency (JST)	Kawamukai, M (corresponding author), Shimane Univ, Fac Life & Environm Sci, Dept Life Sci & Biotechnol, Matsue, Shimane, Japan.	kawamuka@life.shimane-u.ac.jp	Kawamukai, Makoto/AET-1038-2022; Kato, Hiroaki/T-1674-2017	Kawamukai, Makoto/0000-0003-2929-8798; Kato, Hiroaki/0000-0001-9591-1875	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24380056]; JSPS KAKENHI [24710229]; JST PRESTO program; Grants-in-Aid for Scientific Research [25660059] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JST PRESTO program; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid (#24380056) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan to Makoto Kawamukai, by JSPS KAKENHI Number 24710229, and by a grant from the JST PRESTO program to Hiroaki Kato. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins MW, 2007, MOL CELL BIOL, V27, P6372, DOI 10.1128/MCB.00981-07; Andrau JC, 2006, MOL CELL, V22, P179, DOI 10.1016/j.molcel.2006.03.023; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bell O, 2011, NAT REV GENET, V12, P554, DOI 10.1038/nrg3017; Bjorklund S, 2005, TRENDS BIOCHEM SCI, V30, P240, DOI 10.1016/j.tibs.2005.03.008; Casamassimi A, 2007, BIOCHIMIE, V89, P1439, DOI 10.1016/j.biochi.2007.08.002; Chi ZM, 2008, MYCOL RES, V112, P983, DOI 10.1016/j.mycres.2008.01.024; Eshaghi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011620; Hirota K, 2008, NATURE, V456, P130, DOI 10.1038/nature07348; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Horak J, 2013, CURR GENET, V59, P1, DOI 10.1007/s00294-013-0388-8; Jansen MLA, 2006, FEMS YEAST RES, V6, P888, DOI 10.1111/j.1567-1364.2006.00091.x; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Kato H, 2005, SCIENCE, V309, P467, DOI 10.1126/science.1114955; Krawchuk MD, 1999, YEAST, V15, P1419, DOI 10.1002/(SICI)1097-0061(19990930)15:13<1419::AID-YEA466>3.0.CO;2-Q; Kristjuhan A, 2004, EMBO J, V23, P4243, DOI 10.1038/sj.emboj.7600433; Lantermann AB, 2010, NAT STRUCT MOL BIOL, V17, P251, DOI 10.1038/nsmb.1741; Lawrence CL, 2007, J BIOL CHEM, V282, P5160, DOI 10.1074/jbc.M608526200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luu-The V, 2005, BIOTECHNIQUES, V38, P287, DOI 10.2144/05382RR05; Madrid M, 2004, J BIOL CHEM, V279, P41594, DOI 10.1074/jbc.M405509200; Mehta SV, 1998, J BACTERIOL, V180, P674, DOI 10.1128/JB.180.3.674-679.1998; MILLAR JBA, 1995, GENE DEV, V9, P2117, DOI 10.1101/gad.9.17.2117; Neely LA, 2000, MOL CELL BIOL, V20, P6426, DOI 10.1128/MCB.20.17.6426-6434.2000; Noguchi Chiaki, 2008, Biotechnology Journal, V3, P1280, DOI 10.1002/biot.200800140; Okuyama M, 2001, EUR J BIOCHEM, V268, P2270, DOI 10.1046/j.1432-1327.2001.02104.x; Reinders A, 2001, MOL MICROBIOL, V39, P445, DOI 10.1046/j.1365-2958.2001.02237.x; Reiter W, 2008, J BIOL CHEM, V283, P9945, DOI 10.1074/jbc.M710428200; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; Sanso M, 2008, EUKARYOT CELL, V7, P826, DOI 10.1128/EC.00465-07; Sato M, 2005, YEAST, V22, P583, DOI 10.1002/yea.1233; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Shiozaki K, 1996, GENE DEV, V10, P2276, DOI 10.1101/gad.10.18.2276; Steiner WW, 2005, GENETICS, V169, P1973, DOI 10.1534/genetics.104.039230; Takada H, 2007, MOL BIOL CELL, V18, P4794, DOI 10.1091/mbc.E07-03-0282; Takagi Y, 2006, J BIOL CHEM, V281, P80, DOI 10.1074/jbc.M508253200; Takeda T, 1995, EMBO J, V14, P6193, DOI 10.1002/j.1460-2075.1995.tb00310.x; WAHLS WP, 1994, GENE DEV, V8, P1693, DOI 10.1101/gad.8.14.1693; Watanabe Y, 1996, MOL CELL BIOL, V16, P704; Wilkinson MG, 1996, GENE DEV, V10, P2289, DOI 10.1101/gad.10.18.2289; Zhu XF, 2006, MOL CELL, V22, P169, DOI 10.1016/j.molcel.2006.03.032	41	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80572	10.1371/journal.pone.0080572	http://dx.doi.org/10.1371/journal.pone.0080572			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224056	Green Published, gold, Green Submitted			2022-12-27	WOS:000326597400120
J	Owen, EL; Bale, JS; Hayward, SAL				Owen, Emily L.; Bale, Jeffrey S.; Hayward, Scott A. L.			Can Winter-Active Bumblebees Survive the Cold? Assessing the Cold Tolerance of Bombus terrestris audax and the Effects of Pollen Feeding	PLOS ONE			English	Article							HYMENOPTERA APIDAE; L. HYMENOPTERA; HARDINESS; COLONIES; LIFE; FOOD; THERMOREGULATION; POLLINATOR; BEHAVIORS; DIAPAUSE	There is now considerable evidence that climate change is disrupting the phenology of key pollinator species. The recently reported UK winter activity of the bumblebee Bombus terrestris brings a novel set of thermal challenges to bumblebee workers that would typically only be exposed to summer conditions. Here we assess the ability of workers to survive acute and chronic cold stress (via lower lethal temperatures and lower lethal times at 0 degrees C), the capacity for rapid cold hardening (RCH) and the influence of diet (pollen versus nectar consumption) on supercooling points (SCP). Comparisons are made with chronic cold stress indices and SCPs in queen bumblebees. Results showed worker bees were able to survive acute temperatures likely to be experienced in a mild winter, with queens significantly more tolerant to chronic cold temperature stress. The first evidence of RCH in any Hymenoptera is shown. In addition, dietary manipulation indicated the consumption of pollen significantly increased SCP temperature. These results are discussed in the light of winter active bumblebees and climate change.	[Owen, Emily L.; Bale, Jeffrey S.; Hayward, Scott A. L.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England	University of Birmingham	Owen, EL (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	exo763@bham.ac.uk		Hayward, Scott/0000-0002-1899-6630	Biotechnology and Biological Sciences Research Council (BBSRC)	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by a PhD studentship awarded to ELO by the Biotechnology and Biological Sciences Research Council (BBSRC, www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFORD DV, 1969, J ANIM ECOL, V38, P149, DOI 10.2307/2743; Alford DV, 1975, BUMBLEBEES; [Anonymous], 2010, LOW TEMPERATURE BIOL; Bale JS, 2010, J EXP BIOL, V213, P980, DOI 10.1242/jeb.037911; Bale JS, 1996, EUR J ENTOMOL, V93, P369; BALE JS, 1989, CRYOBIOLOGY, V26, P285, DOI 10.1016/0011-2240(89)90024-2; Beekman M, 1999, ENTOMOL EXP APPL, V93, P69, DOI 10.1023/A:1003886710659; Buttermore RE, 1997, AUST J ENTOMOL, V36, P251, DOI 10.1111/j.1440-6055.1997.tb01463.x; Cattiaux J, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044613; Cornelissen T, 2011, NEOTROP ENTOMOL, V40, P155, DOI 10.1590/S1519-566X2011000200001; COULSON SJ, 1990, J INSECT PHYSIOL, V36, P207, DOI 10.1016/0022-1910(90)90124-X; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Diehl K, 2001, ATMOS RES, V58, P75, DOI 10.1016/S0169-8095(01)00091-6; DUMAN JG, 1978, COMP BIOCHEM PHYS A, V59, P69, DOI 10.1016/0300-9629(78)90308-0; Estoup A, 1996, MOL ECOL, V5, P19, DOI 10.1111/j.1365-294X.1996.tb00288.x; Everatt MJ, 2012, J INSECT PHYSIOL, V58, P1104, DOI 10.1016/j.jinsphys.2012.05.009; Finney D.J., 1971, PROBIT ANAL; FREE J. B., 1955, INSECTES SOCIAUX, V2, P303, DOI 10.1007/BF02331508; Goulson D, 2009, BUMBLEBEES BEHAV ECO; Gurel F, 2008, INSECT SOC, V55, P123, DOI 10.1007/s00040-008-0984-7; Hahn DA, 2007, J INSECT PHYSIOL, V53, P760, DOI 10.1016/j.jinsphys.2007.03.018; Hillstrom ML, 2008, INSECT CONSERV DIVER, V1, P233, DOI 10.1111/j.1752-4598.2008.00031.x; Hughes GE, 2009, BIOCONTROL, V54, P785, DOI 10.1007/s10526-009-9230-0; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kodra E, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047103; Kostal V, 2007, COMP BIOCHEM PHYS A, V147, P231, DOI 10.1016/j.cbpa.2006.12.033; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; Krunic MD, 2006, B ENTOMOL RES, V96, P323, DOI 10.1079/BER2006423; KRUNIC MD, 1971, CAN J ZOOLOG, V49, P863, DOI 10.1139/z71-129; LEE RE, 1989, BIOSCIENCE, V39, P308, DOI 10.2307/1311113; LEE RE, 1987, SCIENCE, V238, P1415, DOI 10.1126/science.238.4832.1415; Lee RE, 2006, J EXP BIOL, V209, P399, DOI 10.1242/jeb.02001; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Met Office, 2010, DEC 2010; Moret Y, 2000, SCIENCE, V290, P1166, DOI 10.1126/science.290.5494.1166; Musolin DL, 2003, ECOL ENTOMOL, V28, P694, DOI 10.1111/j.1365-2311.2003.00559.x; Osborne JL, 2008, J APPL ECOL, V45, P784, DOI 10.1111/j.1365-2664.2007.01359.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Rasmont P, 2005, J ECON ENTOMOL, V98, P656, DOI 10.1603/0022-0493-98.3.656; Rinehart JP, 2006, P NATL ACAD SCI USA, V103, P14223, DOI 10.1073/pnas.0606840103; Roberts Stuart P.M., 2011, BioRisk, V6, P1; Sadd BM, 2011, EVOLUTION, V65, P2995, DOI 10.1111/j.1558-5646.2011.01345.x; Sheffield CS, 2008, J KANSAS ENTOMOL SOC, V81, P276, DOI 10.2317/JKES-710.23.1; Shreve SM, 2004, J EXP BIOL, V207, P1797, DOI 10.1242/jeb.00951; Spaethe J, 2002, INSECT SOC, V49, P142, DOI 10.1007/s00040-002-8293-z; Stelzer RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009559; TASEI JN, 1994, ENTOMOL EXP APPL, V72, P273, DOI 10.1007/BF02383815; Velthuis HHW, 2006, APIDOLOGIE, V37, P421, DOI 10.1051/apido:2006019; Velthuis HHW, 2004, INT WORKSH SOL BEES; VOGT FD, 1986, PHYSIOL ZOOL, V59, P55, DOI 10.1086/physzool.59.1.30156090; VOGT FD, 1986, PHYSIOL ZOOL, V59, P60, DOI 10.1086/physzool.59.1.30156091; Weidenmuller A, 2002, ANIM BEHAV, V63, P1065, DOI 10.1006/anbe.2002.3020; Worland MR, 2001, FUNCT ECOL, V15, P515, DOI 10.1046/j.0269-8463.2001.00547.x; ZACHARIASSEN KE, 1982, COMP BIOCHEM PHYS A, V73, P557, DOI 10.1016/0300-9629(82)90262-6	55	33	34	5	133	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80061	10.1371/journal.pone.0080061	http://dx.doi.org/10.1371/journal.pone.0080061			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224036	Green Submitted, Green Published, gold			2022-12-27	WOS:000326597400108
J	Palagi, E; Norscia, I				Palagi, Elisabetta; Norscia, Ivan			Bonobos Protect and Console Friends and Kin	PLOS ONE			English	Article							CAPTIVE CHIMPANZEES; PAN-TROGLODYTES; RECONCILIATION; EMPATHY; AFFILIATION; BEHAVIOR; 3RD-PARTY; HIERARCHY; COGNITION; PLAY	Post-conflict third-party affiliation has been reported to have different functional meanings, one of them being consolation. Here, we tested the main hypotheses that have been put forth to explain the presence of this phenomenon at a functional level in the bonobo: Self-Protection Hypothesis, Victim-Protection Hypothesis, Relationship-Repair or Substitute for Reconciliation Hypothesis, and Consolation Hypothesis. By analyzing the data collected over 10 years, we investigated what factors affected the distribution of both spontaneous third party affiliation (initiated by the bystander) and solicited third party affiliation (initiated by the victim). We considered factors related to the individual features (sex, rank, age) of victim and bystander, their relationship quality (kinship, affiliation), and the effect that third party affiliation had on the victim (such as protection against further attacks and anxiety reduction). Both spontaneous and solicited third party affiliation reduced the probability of further aggression by group members on the victim (Victim-Protection Hypothesis supported). Yet, only spontaneous affiliation reduced victim anxiety (measured via self-scratching), thus suggesting that the spontaneous gesture - more than the protection itself - works in calming the distressed subject. The victim may perceive the motivational autonomy of the bystander, who does not require an invitation to provide post-conflict affiliative contact. Moreover, spontaneous - but not solicited - third party affiliation was affected by the bond between consoler and victim, being the relationship between consoler and aggressor irrelevant to the phenomenon distribution (Consolation Hypothesis supported). Spontaneous affiliation followed the empathic gradient described for humans, being mostly offered to kin, then friends, then acquaintances. Overall, our findings do not only indicate the consolatory function of spontaneous third-party affiliation but they also suggest that consolation in the bonobo may be an empathy-based phenomenon.	[Palagi, Elisabetta; Norscia, Ivan] Univ Pisa, Museo Storia Nat & Terr, Calci Pisa, Italy; [Palagi, Elisabetta] CNR, Ist Sci & Tecnol Cogniz, Unita Primatol Cognit, Rome, Italy	University of Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR)	Palagi, E (corresponding author), Univ Pisa, Museo Storia Nat & Terr, Calci Pisa, Italy.	elisabetta.palagi@unipi.it	Norscia, Ivan/J-3321-2015	Norscia, Ivan/0000-0002-1618-7717				ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Aureli F, 1997, AM J PRIMATOL, V41, P213, DOI 10.1002/(SICI)1098-2345(1997)41:3<213::AID-AJP4>3.0.CO;2-#; Baker KC, 1997, BEHAVIOUR, V134, P1031, DOI 10.1163/156853997X00386; BURLESON BR, 1983, HUM COMMUN RES, V10, P295, DOI 10.1111/j.1468-2958.1983.tb00019.x; Call J, 2002, ANIM BEHAV, V63, P209, DOI 10.1006/anbe.2001.1908; CHENEY DL, 1989, BEHAVIOUR, V110, P258, DOI 10.1163/156853989X00501; Clay Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055206; Cordoni G, 2006, INT J PRIMATOL, V27, P1365, DOI 10.1007/s10764-006-9078-4; Darwin C, 1859, ORIGIN SPECIES MEANS; Davidov M, 2013, CHILD DEV PERSPECT, V7, P126, DOI 10.1111/cdep.12028; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; de Waal FBM, 2012, SO NEUROSCI SER, P87; De Waal Frans B. M., 1996, P80; Decety J, 2010, DEV NEUROSCI-BASEL, V32, P257, DOI 10.1159/000317771; Demuru E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049613; DEWAAL FBM, 1981, BEHAVIOUR, V77, P164, DOI 10.1163/156853981X00211; DEWAAL FBM, 1987, NATL GEOGR RES, V3, P318; DEWAAL FBM, 1979, BEHAV ECOL SOCIOBIOL, V5, P55, DOI 10.1007/BF00302695; DEWAAL FBM, 1983, BEHAVIOUR, V85, P224, DOI 10.1163/156853983X00237; Eisenberg N., 1992, THE CARING CHILD; Elsenberg N, 2009, SOCIAL NEUROSCIENCE OF EMPATHY, P71; Erlandsson K, 2007, BIRTH-ISS PERINAT C, V34, P105, DOI 10.1111/j.1523-536X.2007.00162.x; Fraser ON, 2008, AM J PRIMATOL, V70, P1114, DOI 10.1002/ajp.20608; Fraser ON, 2008, P NATL ACAD SCI USA, V105, P8557, DOI 10.1073/pnas.0804141105; Fraser Orlaith N, 2009, Commun Integr Biol, V2, P285; Frith U., 1989, AUTISM EXPLAINING EN, V6th; Fruth B, 2002, BEHAVIOURAL DIVERSITY IN CHIMPANZEES AND BONOBOS, P231, DOI 10.1017/CBO9780511606397.023; Fujisawa KK, 2006, J COMP PSYCHOL, V120, P48, DOI 10.1037/0735-7036.120.1.48; Furuichi T, 2011, EVOL ANTHROPOL, V20, P131, DOI 10.1002/evan.20308; Ganda AJ, 2011, CLIN PEDIATR, V50, P753, DOI 10.1177/0009922811405516; Goleman D, 2020, EMOTIONAL INTELLIGEN, V25th; Guggisberg AG, 2010, NEUROSCI BIOBEHAV R, V34, P1267, DOI 10.1016/j.neubiorev.2010.03.008; Hare B, 2012, ANIM BEHAV, V83, P573, DOI 10.1016/j.anbehav.2011.12.007; Iacoboni M., 2012, PRIMATE MIND BUILT C, P32; Jaeggi AV, 2010, AM J PHYS ANTHROPOL, V143, P41, DOI 10.1002/ajpa.21288; Jahromi LB, 2007, INFANCY, V11, P255, DOI 10.1111/j.1532-7078.2007.tb00226.x; Kano T., 1992, LAST APE; KAPPELER PM, 1992, ETHOLOGY, V92, P51; Koski SE, 2007, ANIM BEHAV, V73, P133, DOI 10.1016/j.anbehav.2006.04.009; Koski SE, 2009, AM J PRIMATOL, V71, P409, DOI 10.1002/ajp.20668; Kutsukake N, 2004, PRIMATES, V45, P157, DOI 10.1007/s10329-004-0082-z; Light S, 2012, SO NEUROSCI SER, P109; Lombardo MV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000883; MAESTRIPIERI D, 1992, ANIM BEHAV, V44, P967, DOI 10.1016/S0003-3472(05)80592-5; Mallavarapu S, 2006, AM J PRIMATOL, V68, P789, DOI 10.1002/ajp.20279; Mancini G, 2013, SCI REP-UK, V3, DOI 10.1038/srep01527; Manly BFJ, 1997, RANDOMIZATION BOOTST; Mundry R, 1998, ANIM BEHAV, V56, P256, DOI 10.1006/anbe.1998.0756; Norscia I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028472; Palagi E, 2006, AM J PHYS ANTHROPOL, V129, P418, DOI 10.1002/ajpa.20289; Palagi E, 2006, AM J PHYS ANTHROPOL, V129, P105, DOI 10.1002/ajpa.20242; Palagi E, 2004, AM J PRIMATOL, V62, P15, DOI 10.1002/ajp.20000; Palagi E, 2006, INT J PRIMATOL, V27, P1257, DOI 10.1007/s10764-006-9071-y; Palagi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052767; Palagi E, 2011, STRESS, V14, P93, DOI 10.3109/10253890.2010.505272; Paoli T, 2006, AM J PHYS ANTHROPOL, V130, P116, DOI 10.1002/ajpa.20345; Paoli T, 2008, DEV PRIMATOL-PROG PR, P39, DOI 10.1007/978-0-387-74787-3_3; Paoli T, 2007, ANN ZOOL FENN, V44, P81; Platek SM, 2003, COGNITIVE BRAIN RES, V17, P223, DOI 10.1016/S0926-6410(03)00109-5; Platek SM, 2005, COGNITIVE BRAIN RES, V23, P448, DOI 10.1016/j.cogbrainres.2004.11.011; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Rilling JK, 2011, SCAN, DOI [10.1093/scan/nsr017, DOI 10.1093/SCAN/NSR017)]; Romero T, 2010, J COMP PSYCHOL, V124, P278, DOI 10.1037/a0019144; Romero T, 2010, P NATL ACAD SCI USA, V107, P12110, DOI 10.1073/pnas.1006991107; Schino G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038936; Sclafani V, 2012, PRIMATES, V53, P247, DOI 10.1007/s10329-012-0294-6; Senju A, 2007, BIOLOGY LETT, V3, P706, DOI 10.1098/rsbl.2007.0337; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Singer T, 2006, NEUROSCI BIOBEHAV R, V30, P855, DOI 10.1016/j.neubiorev.2006.06.011; Tan JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051922; Troisi A, 2002, STRESS, V5, P46, DOI 10.1080/10253890290012378; VEENEMA HC, 1994, BEHAV PROCESS, V31, P29, DOI 10.1016/0376-6357(94)90035-3; Watts David P., 2000, P281; Wittig RM, 2003, BEHAVIOUR, V140, P1527, DOI 10.1163/156853903771980701; Wittig RM, 2007, P R SOC B, V274, P1109, DOI 10.1098/rspb.2006.0203; Wittig RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013995; Wobber V, 2010, CURR BIOL, V20, P226, DOI 10.1016/j.cub.2009.11.070; Zahavi D, 2012, SO NEUROSCI SER, P3; ZAHNWAXLER C, 1990, MOTIV EMOTION, V14, P107, DOI 10.1007/BF00991639	79	39	39	0	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79290	10.1371/journal.pone.0079290	http://dx.doi.org/10.1371/journal.pone.0079290			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223924	Green Published, Green Submitted, gold			2022-12-27	WOS:000326597400060
J	Hsieh, YT; Lin, MH; Ho, HY; Chen, LC; Chen, CC; Shu, JC				Hsieh, Yi-Ting; Lin, Mei-Hui; Ho, Hung-Yao; Chen, Lei-Chin; Chen, Chien-Cheng; Shu, Jwu-Ching			Glucose-6-Phosphate Dehydrogenase (G6PD)-Deficient Epithelial Cells Are Less Tolerant to Infection by Staphylococcus aureus	PLOS ONE			English	Article							G6PD DEFICIENCY; APOPTOSIS; BACTERIAL; HEMOLYSIS; DNA	Glucose-6-phosphate dehydrogenase (G6PD) is a key enzyme in the pentose phosphate pathway and provides reducing energy to all cells by maintaining redox balance. The most common clinical manifestations in patients with G6PD deficiency are neonatal jaundice and acute hemolytic anemia. The effects of microbial infection in patients with G6PD deficiency primarily relate to the hemolytic anemia caused by Plasmodium or viral infections and the subsequent medication that is required. We are interested in studying the impact of bacterial infection in G6PD-deficient cells. G6PD knock down A549 lung carcinoma cells, together with the common pathogen Staphylococcus aureus, were employed in our cell infection model. Here, we demonstrate that a lower cell viability was observed among G6PD-deficient cells when compared to scramble controls upon bacterial infection using the MTT assay. A significant increase in the intracellular ROS was detected among S. aureus-infected G6PD-deficient cells by observing dichlorofluorescein (DCF) intensity within cells under a fluorescence microscope and quantifying this signal using flow cytometry. The impairment of ROS removal is predicted to enhance apoptotic activity in G6PD-deficient cells, and this enhanced apoptosis was observed by annexin V/PI staining under a confocal fluorescence microscope and quantified by flow cytometry. A higher expression level of the intrinsic apoptotic initiator caspase-9, as well as the downstream effector caspase-3, was detected by Western blotting analysis of G6PD-deficient cells following bacterial infection. In conclusion, we propose that bacterial infection, perhaps the secreted S. aureus a-hemolysin in this case, promotes the accumulation of intracellular ROS in G6PD-deficient cells. This would trigger a stronger apoptotic activity through the intrinsic pathway thereby reducing cell viability when compared to wild type cells.	[Hsieh, Yi-Ting; Lin, Mei-Hui; Ho, Hung-Yao; Shu, Jwu-Ching] Chang Gung Univ, Coll Med, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan; [Lin, Mei-Hui; Shu, Jwu-Ching] Chang Gung Univ, Res Ctr Pathogen Bacteria, Taoyuan, Taiwan; [Ho, Hung-Yao] Chang Gung Univ, Hlth Aging Res Ctr, Taoyuan, Taiwan; [Chen, Lei-Chin] I Shou Univ, Dept Nutr, Kaohsiung, Taiwan; [Chen, Chien-Cheng] Natl Kaohsiung Normal Univ, Dept Biotechnol, Kaohsiung, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; I Shou University; National Kaohsiung Normal University	Chen, CC (corresponding author), Natl Kaohsiung Normal Univ, Dept Biotechnol, Kaohsiung, Taiwan.	cheng@nknu.edu.tw; shujc@mail.cgu.edu.tw		Lin, Mei-Hui/0000-0002-3498-9377; Shu, Jwu-Ching/0000-0003-4862-6056	Research Program for Chang Gung Memorial Hospital, Taoyuan, Taiwan [CMRPD1B0081similar to2]	Research Program for Chang Gung Memorial Hospital, Taoyuan, Taiwan	This work was supported by the Research Program for Chang Gung Memorial Hospital (contract no. CMRPD1B0081 similar to 2), Taoyuan, Taiwan (http://www.cgmh.org.tw/eng2002/index.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriantsitohaina R, 2012, CLIN SCI, V123, P173, DOI 10.1042/CS20110643; Au WY, 2011, ANN HEMATOL, V90, P1237, DOI 10.1007/s00277-011-1167-6; Becker K, 1998, J CLIN MICROBIOL, V36, P2548, DOI 10.1128/JCM.36.9.2548-2553.1998; BOGOMOLSKIYAHALOM V, 1995, BLOOD REV, V9, P183, DOI 10.1016/0268-960X(95)90024-1; Bonnefont CMD, 2012, PHYSIOL GENOMICS, V44, P403, DOI 10.1152/physiolgenomics.00155.2011; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; Chakraborty SP, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/942123; Chao YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001557; Chen HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024472; Cheng ML, 2004, FREE RADICAL BIO MED, V36, P580, DOI 10.1016/j.freeradbiomed.2003.11.031; CLARK M, 1979, YALE J BIOL MED, V52, P169; Dong J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002869; *DRUGS TMCGO, 2011, PLOS MED, V8, P402; EFFERTH T, 1995, J MOL MED-JMM, V73, P47, DOI 10.1007/BF00203619; Fico A, 2004, CELL DEATH DIFFER, V11, P823, DOI 10.1038/sj.cdd.4401420; Garrabou G, 2012, J INFECT DIS, V205, P392, DOI 10.1093/infdis/jir764; Ho HY, 2008, J GEN VIROL, V89, P2080, DOI 10.1099/vir.0.2008/001404-0; Hsu CY, 2011, FEMS IMMUNOL MED MIC, V63, P236, DOI 10.1111/j.1574-695X.2011.00846.x; Ikeda R, 2008, RES MICROBIOL, V159, P628, DOI 10.1016/j.resmic.2008.07.006; Krzyminska S, 2011, J MED MICROBIOL, V60, P889, DOI 10.1099/jmm.0.030833-0; Kuranaga E, 2012, GENES CELLS, V17, P83, DOI 10.1111/j.1365-2443.2011.01579.x; Liang XD, 2007, CELL MICROBIOL, V9, P1809, DOI 10.1111/j.1462-5822.2007.00917.x; Lodha A, 2008, J PERINATOL, V28, P77, DOI 10.1038/sj.jp.7211853; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nkhoma ET, 2009, BLOOD CELL MOL DIS, V42, P267, DOI 10.1016/j.bcmd.2008.12.005; Paek DS, 2009, J EMERG MED, V37, P273, DOI 10.1016/j.jemermed.2007.10.049; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; Siddiqui T, 1998, MIL MED, V163, P434, DOI 10.1093/milmed/163.6.434; Sun GP, 2008, INFECT IMMUN, V76, P4405, DOI 10.1128/IAI.00575-08; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Wilmanski J, 2007, CRIT CARE MED, V35, P510, DOI 10.1097/01.CCM.0000254337.50361.2E; Wolach B, 2004, PEDIATR RES, V55, P807, DOI 10.1203/01.PDR.0000120680.47846.47; Wu YH, 2008, J INFECT DIS, V197, P812, DOI 10.1086/528377; Yang CH, 1997, J INFECTION, V35, P316, DOI 10.1016/S0163-4453(97)93574-X; Youngster I, 2010, DRUG SAFETY, V33, P713, DOI 10.2165/11536520-000000000-00000	37	15	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79566	10.1371/journal.pone.0079566	http://dx.doi.org/10.1371/journal.pone.0079566			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223971	Green Submitted, Green Published, gold			2022-12-27	WOS:000326503400126
J	Rocha, M; Banuls, C; Bellod, L; Rovira-Llopis, S; Morillas, C; Sola, E; Victor, VM; Hernandez-Mijares, A				Rocha, Milagros; Banuls, Celia; Bellod, Lorena; Rovira-Llopis, Susana; Morillas, Carlos; Sola, Eva; Victor, Victor M.; Hernandez-Mijares, Antonio			Association of Serum Retinol Binding Protein 4 with Atherogenic Dyslipidemia in Morbid Obese Patients	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; INSULIN-RESISTANCE; METABOLIC SYNDROME; CARDIOVASCULAR RISK; VISCERAL ADIPOSITY; RETINOL-BINDING-PROTEIN-4; CHOLESTEROL; FENRETINIDE; TAMOXIFEN; WOMEN	Retinol binding protein 4 (RBP4) is an adipokine that may contribute to the development of insulin resistance. However, how this adipokine is affected and its possible involvement in lipid metabolism in obese patients with varying degrees of insulin resistance is yet to be determined. A total of 299 middle-aged morbid obese patients (BMI>40 kg/m(2)) were divided in euglycemic, metabolic syndrome or type 2 diabetic. Anthropometric measurements, biochemical variables and systemic RBP4 levels were determined. RBP4 levels were significantly higher in patients with metabolic syndrome and type 2 diabetes than in euglycemic subjects (42.9 +/- 14.6; 42.3 +/- 17.0 and 37.4 +/- 11.7 mu g/ml, respectively) and correlated with triglycerides but not with those of HOMA-IR in the whole population. The multivariate regression model revealed that triglycerides were the strongest predictor of systemic RBP4 levels. Analysis of lipoprotein subfractions in a subpopulation of 80 subjects showed an altered profile of insulin resistant states characterized by higher VLDL, sdLDL and small HDL percentages and lower large HDL percentage. Although RBP4 levels correlated significantly with LDL particle size and small HDL percentage, the latter parameter was independently associated only with RBP4. Our study reveals that systemic RBP4 levels could play an important role in lipid metabolism in morbid obesity, increasing triglyceride levels and contributing to the formation of small HDL.	[Rocha, Milagros; Banuls, Celia; Bellod, Lorena; Rovira-Llopis, Susana; Morillas, Carlos; Sola, Eva; Victor, Victor M.; Hernandez-Mijares, Antonio] Univ Hosp Dr Peset, Serv Endocrinol, Valencia, Spain; [Rocha, Milagros; Bellod, Lorena; Rovira-Llopis, Susana; Morillas, Carlos; Sola, Eva; Victor, Victor M.; Hernandez-Mijares, Antonio] Fdn Promot Healthcare & Biomed Res Valencian Comm, Valencia, Spain; [Rocha, Milagros; Victor, Victor M.] Univ Valencia, Fac Med, CIBER Hepat & Digest Dis, CIBER Res Group CB06 04 0071, Valencia, Spain; [Rocha, Milagros; Banuls, Celia; Bellod, Lorena; Morillas, Carlos; Sola, Eva; Victor, Victor M.; Hernandez-Mijares, Antonio] Inst Hlth Res INCLIVA, Valencia, Spain; [Banuls, Celia; Morillas, Carlos; Sola, Eva; Hernandez-Mijares, Antonio] Univ Valencia, Fac Med, Dept Med, Valencia, Spain; [Victor, Victor M.] Univ Valencia, Fac Med, Dept Physiol, Valencia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Valencia; University of Valencia; University of Valencia	Rocha, M (corresponding author), Univ Hosp Dr Peset, Serv Endocrinol, Valencia, Spain.	milagros.rocha@uv.es	BaÃuls, Celia/H-7359-2017; VICTOR, VICTOR M/I-3270-2015; Rovira-Llopis, Susana/AAX-8666-2021; Rocha, Milagros/ABE-4931-2020; Cerviño, Alejandro/L-5853-2014; Mijares, Antonio Hernandez/D-3411-2011; victor, victor/Q-4843-2019; Rocha, Milagros/I-4987-2015; Morillas, Carlos/ABF-3504-2020; Hernandez Mijares, Antonio/D-3411-2011	BaÃuls, Celia/0000-0001-8077-7642; Rovira-Llopis, Susana/0000-0002-8476-5128; Rocha, Milagros/0000-0003-2923-6546; Cerviño, Alejandro/0000-0001-8014-3279; Mijares, Antonio Hernandez/0000-0003-2197-0607; Rocha, Milagros/0000-0003-2923-6546; Morillas, Carlos/0000-0002-3745-4423; VICTOR, VICTOR/0000-0002-3027-3945; Hernandez Mijares, Antonio/0000-0003-4099-1905	FIS [PI10/1195, PS12/01984]; European Regional Development Fund of the European Union (FEDER); Regional Ministry of Education of Valencian Community [ACOMP/2013/061]; FIS contract [CP10/00360]	FIS(Instituto de Salud Carlos III); European Regional Development Fund of the European Union (FEDER); Regional Ministry of Education of Valencian Community; FIS contract	This work was supported by grants PI10/1195 and PS12/01984 from FIS and co-funded by the European Regional Development Fund of the European Union (FEDER) and and ACOMP/2013/061 from the Regional Ministry of Education of Valencian Community. Milagros Rocha is a recipient of a FIS contract (CP10/00360). Victor M. Victor is a recipient of Valencian Regional Ministry of Health and Carlos III Health Institute contract. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkharfy KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048612; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Cabre A, 2010, NUTR METAB CARDIOVAS, V20, P243, DOI 10.1016/j.numecd.2009.04.003; Chiba M, 2010, ENDOCR J, V57, P811, DOI 10.1507/endocrj.K10E-054; Cho YM, 2006, DIABETES CARE, V29, P2457, DOI 10.2337/dc06-0360; Farjo KM, 2012, MOL CELL BIOL, V32, P5103, DOI 10.1128/MCB.00820-12; Gavi S, 2007, J CLIN ENDOCR METAB, V92, P1886, DOI 10.1210/jc.2006-1815; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hermsdorff HHM, 2011, INFLAMMATION, V34, P161, DOI 10.1007/s10753-010-9219-y; Hoefner DM, 2001, CLIN CHEM, V47, P266; Janke J, 2006, DIABETES, V55, P2805, DOI 10.2337/db06-0616; Jia WP, 2007, J CLIN ENDOCR METAB, V92, P3224, DOI 10.1210/jc.2007-0209; Johansson H, 2008, CANCER RES, V68, P9512, DOI 10.1158/0008-5472.CAN-08-0553; Kloeting N, 2007, CELL METAB, V6, P79, DOI 10.1016/j.cmet.2007.06.002; Klop B, 2013, NUTRIENTS, V5, P1218, DOI 10.3390/nu5041218; Koba Shinji, 2008, J Atheroscler Thromb, V15, P250; Kontush A, 2006, NAT CLIN PRACT CARD, V3, P144, DOI 10.1038/ncpcardio0500; Lazzeroni M, 2008, ECANCERMEDICALSCIENC, V2, DOI 10.3332/ecancer.2008.67; Lee JW, 2007, OBESITY, V15, P2225, DOI 10.1038/oby.2007.264; Lim S, 2010, OBESITY, V18, P826, DOI 10.1038/oby.2009.232; Lin CJ, 2013, CLIN PEDIATR, V52, P16, DOI 10.1177/0009922812459948; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Makino S, 2009, HORM METAB RES, V41, P221, DOI 10.1055/s-0028-1100411; Moon JY, 2007, CARDIOLOGY, V108, P282, DOI 10.1159/000099097; Musunuru K, 2010, LIPIDS, V45, P907, DOI 10.1007/s11745-010-3408-1; Packard CJ, 2006, CURR OPIN LIPIDOL, V17, P412, DOI 10.1097/01.mol.0000236367.42755.c1; Packard CJ, 2003, BIOCHEM SOC T, V31, P1066; Promintzer M, 2007, J CLIN ENDOCR METAB, V92, P4306, DOI 10.1210/jc.2006-2522; Qi QB, 2007, J CLIN ENDOCR METAB, V92, P4827, DOI 10.1210/jc.2007-1219; Saad MF, 1997, J CLIN ENDOCR METAB, V82, P579, DOI 10.1210/jc.82.2.579; Smith JD, 2010, J CLIN LIPIDOL, V4, P382, DOI 10.1016/j.jacl.2010.08.007; Staels B, 2001, J AM ACAD DERMATOL, V45, pS158, DOI 10.1067/mjd.2001.113718; Stefan N, 2007, DIABETES CARE, V30, P1173, DOI 10.2337/dc06-2342; Takashima N, 2006, NEW ENGL J MED, V355, P1392; Takebayashi K, 2007, J CLIN ENDOCR METAB, V92, P2712, DOI 10.1210/jc.2006-1249; Uelgen Fatma, 2010, Archives of Physiology and Biochemistry, V116, P57, DOI 10.3109/13813451003631421; Usui S, 2009, CLIN CHIM ACTA, V399, P45, DOI 10.1016/j.cca.2008.08.017; van der Westhuyzen DR, 2007, CURR OPIN LIPIDOL, V18, P147, DOI 10.1097/MOL.0b013e328051b4fe; Verges B, 2012, ARTERIOSCL THROM VAS, V32, P3050, DOI 10.1161/ATVBAHA.112.255190; von Eynatten M, 2007, DIABETOLOGIA, V50, P1930, DOI 10.1007/s00125-007-0743-8; Wu J, 2012, CLIN BIOCHEM, V45, P619, DOI 10.1016/j.clinbiochem.2012.02.022; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yu ZJ, 2012, EUR J CLIN INVEST, V42, P1100, DOI 10.1111/j.1365-2362.2012.02702.x; Zujewski J, 1999, BREAST CANCER RES TR, V57, P277, DOI 10.1023/A:1006216409688	46	43	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78670	10.1371/journal.pone.0078670	http://dx.doi.org/10.1371/journal.pone.0078670			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223837	Green Published, Green Submitted, gold			2022-12-27	WOS:000326503400080
J	Gaspar, MJ; Velasco, T; Feito, I; Alia, R; Majada, J				Gaspar, Maria Joao; Velasco, Tania; Feito, Isabel; Alia, Ricardo; Majada, Juan			Genetic Variation of Drought Tolerance in Pinus pinaster at Three Hierarchical Levels: A Comparison of Induced Osmotic Stress and Field Testing	PLOS ONE			English	Article							CLIMATE-CHANGE; PHENOTYPIC PLASTICITY; GAS-EXCHANGE; GROWTH; WATER; PROVENANCES; POPULATIONS; ADJUSTMENT; RESISTANCE; DELTA-C-13	Understanding the survival capacity of forest trees to periods of severe water stress could improve knowledge of the adaptive potential of different species under future climatic scenarios. In long lived organisms, like forest trees, the combination of induced osmotic stress treatments and field testing can elucidate the role of drought tolerance during the early stages of establishment, the most critical in the life of the species. We performed a Polyethylene glycol-osmotic induced stress experiment and evaluated two common garden experiments (xeric and mesic sites) to test for survival and growth of a wide range clonal collection of Maritime pine. This study demonstrates the importance of additive vs non additive effects for drought tolerance traits in Pinus pinaster, and shows differences in parameters determining the adaptive trajectories of populations and family and clones within populations. The results show that osmotic adjustment plays an important role in population variation, while biomass allocation and hydric content greatly influence survival at population level. Survival in the induced osmotic stress experiment presented significant correlations with survival in the xeric site, and height growth at the mesic site, at population level, indicating constraints of adaptation for those traits, while at the within population level no significant correlation existed. These results demonstrate that population differentiation and within population genetic variation for drought tolerance follow different patterns.	[Gaspar, Maria Joao] Univ Tras Os Montes & Alto Douro, Dept Genet & Biotecnol, Vila Real, Portugal; [Gaspar, Maria Joao] ULisboa, Inst Super Agron, Ctr Estudos Florestais, Lisbon, Portugal; [Velasco, Tania; Feito, Isabel; Majada, Juan] Finca Expt La Mata, SERIDA, Secc Forestal, Principado De Asturias, Spain; [Alia, Ricardo] Forest Res Ctr, INIA, Dept Forest Ecol & Genet, Madrid, Spain; [Alia, Ricardo] Univ Valladolid, INIA, Sustainable Forest Management Res Inst, Palencia, Spain; [Majada, Juan] Finca Expt La Mata, CETEMAS, Secc Forestal, Principado De Asturias, Spain	University of Tras-os-Montes & Alto Douro; Universidade de Lisboa; Servicio Regional Investigacion Desarrollo Agroalimentario - SERIDA; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Universidad de Valladolid; Servicio Regional Investigacion Desarrollo Agroalimentario - SERIDA	Majada, J (corresponding author), Finca Expt La Mata, SERIDA, Secc Forestal, Principado De Asturias, Spain.	jmajada@cetemas.es	Majada, Juan/AAZ-2999-2021; Gaspar, Maria João M/C-5166-2009; Feito, Isabel/ABG-8379-2020; Alia, Ricardo/B-5160-2011	Gaspar, Maria João M/0000-0002-2082-4205; Feito, Isabel/0000-0002-1379-1898; Alia, Ricardo/0000-0002-9426-0967	European Project Novel Tree Breeding Strategies [FP7-211868]; INIA Project "Heterogeneidad ambiental y adaptabilidad en respuesta a la sequia en colecciones clonales de Pinus pinaster" [RTA-2007-00084-00-00]	European Project Novel Tree Breeding Strategies; INIA Project "Heterogeneidad ambiental y adaptabilidad en respuesta a la sequia en colecciones clonales de Pinus pinaster"	This study was supported by funding from the European Project Novel Tree Breeding Strategies. FP7-211868 and INIA Project "Heterogeneidad ambiental y adaptabilidad en respuesta a la sequia en colecciones clonales de Pinus pinaster," RTA-2007-00084-00-00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; Alberto FJ, 2013, GLOBAL CHANGE BIOL, V19, P1645, DOI 10.1111/gcb.12181; Ramirez-Valiente JA, 2011, TREE GENET GENOMES, V7, P285, DOI 10.1007/s11295-010-0331-9; Alia R., 1996, Investigacion Agraria, Sistemas y Recursos Forestales, V5, P57; Alia R., 1991, Investigacion Agraria, Sistemas y Recursos Forestales, P11; ALIA R, 1995, SILVAE GENET, V44, P75; Alia R, 1997, CAN J FOREST RES, V27, P1548, DOI 10.1139/cjfr-27-10-1548; Aranda I, 2010, TREE GENET GENOMES, V6, P169, DOI 10.1007/s11295-009-0238-5; CARPITA N, 1979, SCIENCE, V205, P1144, DOI 10.1126/science.205.4411.1144; Chambers PGS, 1996, SILVAE GENET, V45, P107; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Corcuera L, 2012, TREE PHYSIOL, V32, P1442, DOI 10.1093/treephys/tps103; Corcuera L, 2011, TREES-STRUCT FUNCT, V25, P1033, DOI 10.1007/s00468-011-0578-2; Corcuera L, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2010048; Correia I, 2008, TREE PHYSIOL, V28, P1545, DOI 10.1093/treephys/28.10.1545; Cregg BM, 2001, FOREST ECOL MANAG, V154, P131, DOI 10.1016/S0378-1127(00)00626-5; Danjon F, 2009, PHENOTYPIC PLASTICIT; Eveno E, 2008, MOL BIOL EVOL, V25, P417, DOI 10.1093/molbev/msm272; Falconer D. S., 1996, INTRO QUANTITATIVE G; Fan SH, 1997, TREES-STRUCT FUNCT, V11, P342, DOI 10.1007/s004680050094; Fernandez M, 2000, ANN FOR SCI, V57, P9; Fernandez M, 2006, NEW FOREST, V31, P321, DOI 10.1007/s11056-005-8196-8; Gaspar MJ, 2009, FOREST ECOL MANAG, V258, P115, DOI 10.1016/j.foreco.2009.03.046; Gezan, 2005, OPTIMAL DESIGN ANAL; Gilmour AR, 1998, ASREML USERS MANUAL; Gonzalez-Martinez SC, 2006, MOL ECOL, V15, P4577, DOI 10.1111/j.1365-294X.2006.03118.x; Granda V, 2011, J PLANT PHYSIOL, V168, P661, DOI 10.1016/j.jplph.2010.09.015; GUYON JP, 1982, CAN J FOREST RES, V12, P936, DOI 10.1139/x82-136; Harfouche A, 2003, ANN FOREST SCI, V60, P539, DOI 10.1051/forest:2003047; HARFOUCHE A, 1995, ANN SCI FOREST, V52, P307, DOI 10.1051/forest:19950402; Institute Inc SAS, 2003, SAS STAT US GUID VER; Jenks M.A, 2007, ADV MOL BREEDING DRO; Gaspar MJ, 2009, TREE GENET GENOMES, V5, P609, DOI 10.1007/s11295-009-0213-1; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Lamy JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023476; Leck M.A., 2008, SEEDLING ECOLOGY EVO; Lindner M, 2010, FOREST ECOL MANAG, V259, P698, DOI 10.1016/j.foreco.2009.09.023; Lopez R, 2009, INVEST AGRAR-SIST R, V18, P159; Majada J, 2011, NEW FOREST, V41, P399, DOI 10.1007/s11056-010-9232-x; Martinez-Vilalta J, 2009, NEW PHYTOL, V184, P353, DOI 10.1111/j.1469-8137.2009.02954.x; Neale DB, 2011, NAT REV GENET, V12, P111, DOI 10.1038/nrg2931; NGUYEN A, 1989, TREE PHYSIOL, V5, P123, DOI 10.1093/treephys/5.1.123; Nguyen-Queyrens A, 2003, TREE PHYSIOL, V23, P397, DOI 10.1093/treephys/23.6.397; Nguyen-Queyrens A, 1998, CAN J FOREST RES, V28, P766, DOI 10.1139/cjfr-28-5-766; Parry M., CLIMATE CHANGE 2007; Picon C, 1996, PLANT CELL ENVIRON, V19, P182, DOI 10.1111/j.1365-3040.1996.tb00239.x; Richter S, 2012, OECOLOGIA, V169, P269, DOI 10.1007/s00442-011-2191-x; Sambatti JBM, 2007, NEW PHYTOL, V175, P70, DOI 10.1111/j.1469-8137.2007.02067.x; Sanchez-Gomez D, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2010007; Sanchez-Salguero R, 2012, CLIMATIC CHANGE, V113, P767, DOI 10.1007/s10584-011-0372-6; Sgro CM, 2004, HEREDITY, V93, P241, DOI 10.1038/sj.hdy.6800532; Soto A, 2010, MOL ECOL, V19, P1396, DOI 10.1111/j.1365-294X.2010.04571.x; Teulat B, 2003, THEOR APPL GENET, V108, P181, DOI 10.1007/s00122-003-1417-7; Valladares F, 2007, NEW PHYTOL, V176, P749, DOI 10.1111/j.1469-8137.2007.02275.x; Verslues PE, 1998, PLANT PHYSIOL, V116, P1403, DOI 10.1104/pp.116.4.1403; VIA S, 1985, EVOLUTION, V39, P505, DOI [10.2307/2408649, 10.1111/j.1558-5646.1985.tb00391.x]; White T. L., 2007, FOREST GENETICS	57	33	33	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79094	10.1371/journal.pone.0079094	http://dx.doi.org/10.1371/journal.pone.0079094			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223885	gold, Green Published, Green Submitted			2022-12-27	WOS:000326499300054
J	Streja, E; Wu, CS; Uldall, P; Grove, J; Arah, O; Olsen, J				Streja, Elani; Wu, Chunsen; Uldall, Peter; Grove, Jakob; Arah, Onyebuchi; Olsen, Jorn			Congenital Cerebral Palsy, Child Sex and Parent Cardiovascular Risk	PLOS ONE			English	Article							ISCHEMIC-HEART-DISEASE; PREGNANCY COMPLICATIONS; PRIMARY CAREGIVERS; BIRTH-WEIGHT; LATER LIFE; MOTHERS; STROKE; WOMEN; AGE; PREECLAMPSIA	Objective: Genes associated with cardiovascular disease may also be risk factors for congenital cerebral palsy (CP) and these associations may be modified by sex, since there is an increased risk of CP in male children. We investigated the association between CP of the child with cardiovascular disease in parents, taking sex of the child into consideration. Methods: All parents of non-adopted singletons born in Denmark between 1973 and 2003 were included. Parents of a child with CP, confirmed by the Danish National CP registry, were considered exposed. Cox proportional hazards regressions were used to model risk of cardiovascular outcomes for exposed parents compared to all other parents beginning at the child's 10th birthday. Results: We identified 733,730 mothers and 666,652 fathers among whom 1,592 and 1,484, respectively, had a child with CP. The mean age for mothers at end of follow up was 50 +/- 8 years. After adjustment for maternal age, parental education, child's sex, child's residence, child being small for gestational age and maternal hypertensive disorder during pregnancy, mothers of CP male children had an excess risk of cardiovascular disease (HR: 1.52, 95% CI: 1.16-2.00), attributable mostly to an increased incidence of hypertension and cerebrovascular disease. After additional adjustment for preterm birth, the association was markedly attenuated for cardiovascular disease (1.34, 95% CI: 1.02 - 1.76), became nonsignificant for hypertension, but remained significant for cerebrovascular disease (HR: 2.73, 95% CI: 1.45-5.12). There was no increased risk of cardiovascular events in mothers of female CP children, or fathers of CP children of any sex. Conclusions: Women that have a male child with CP are at increased risk for premature cardiovascular disease. Part of this association may be related to risk factors for preterm births.	[Streja, Elani; Arah, Onyebuchi; Olsen, Jorn] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA; [Wu, Chunsen; Olsen, Jorn] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark; [Uldall, Peter] Southern Univ, Natl Inst Publ Hlth, Danish Cerebral Registry, Odense, Denmark; [Uldall, Peter] Univ Copenhagen, Rigshosp, Dept Pediat, DK-2100 Copenhagen, Denmark; [Grove, Jakob] Univ Aarhus, Inst Biomed, Aarhus, Denmark; [Grove, Jakob] Univ Aarhus, Bioinformat Res Ctr, Aarhus, Denmark	University of California System; University of California Los Angeles; Aarhus University; University of Southern Denmark; Rigshospitalet; University of Copenhagen; Aarhus University; Aarhus University	Streja, E (corresponding author), Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA.	elani@ucla.edu	; Grove, Jakob/K-8112-2015	Arah, Onyebuchi/0000-0002-9067-1697; Grove, Jakob/0000-0003-2284-5744				Andersen TF, 1999, DAN MED BULL, V46, P263; [Anonymous], 2002, SAS 9 2; Arah OA, 2008, ANN EPIDEMIOL, V18, P637, DOI 10.1016/j.annepidem.2008.04.003; Arnadottir GA, 2005, BJOG-INT J OBSTET GY, V112, P286, DOI 10.1111/j.1471-0528.2004.00396.x; Bella GP, 2011, PSYCHONEUROENDOCRINO, V36, P834, DOI 10.1016/j.psyneuen.2010.11.005; Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; Brehaut Jamie C, 2004, Pediatrics, V114, pe182, DOI 10.1542/peds.114.2.e182; Brey RL, 2005, J THROMB THROMBOLYS, V20, P105, DOI 10.1007/s11239-005-3204-6; Brown AS, 1997, EPIDEMIOLOGY, V8, P55, DOI 10.1097/00001648-199701000-00009; Catov JM, 2007, EPIDEMIOLOGY, V18, P733, DOI 10.1097/EDE.0b013e3181567f96; Fraser A, 2012, CIRCULATION, V125, P1367, DOI 10.1161/CIRCULATIONAHA.111.044784; Gu L, 2013, AM J MED SCI, V345, P227, DOI 10.1097/MAJ.0b013e31825f92da; Hallas J, 2001, PHARMACOEPIDEM DR S, V10, P619, DOI 10.1002/pds.638; He S, 1999, THROMB HAEMOSTASIS, V81, P538; Hjern A, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-49; Hubel CA, 2008, HYPERTENSION, V51, P1499, DOI 10.1161/HYPERTENSIONAHA.108.109934; Jarvis S, 2003, LANCET, V362, P1106, DOI 10.1016/S0140-6736(03)14466-2; Jorgensen FS, 1999, ACTA OBSTET GYN SCAN, V78, P305, DOI 10.1034/j.1600-0412.1999.780406.x; Khashan AS, 2011, J PSYCHIATR RES, V45, P879, DOI 10.1016/j.jpsychires.2010.12.005; Knudsen LB, 1998, DAN MED BULL, V45, P320; Krageloh-Mann I, 2009, BRAIN DEV-JPN, V31, P537, DOI 10.1016/j.braindev.2009.03.009; Lee S, 2003, AM J PREV MED, V24, P113, DOI 10.1016/S0749-3797(02)00582-2; Li JO, 2010, EUR CHILD ADOLES PSY, V19, P747, DOI 10.1007/s00787-010-0113-9; Li J, 2009, PSYCHOSOM MED, V71, P615, DOI 10.1097/PSY.0b013e3181a56ca1; Li ZH, 2003, STROKE, V34, P2085, DOI 10.1161/01.STR.0000086753.00555.0D; Libby G, 2007, DIABETOLOGIA, V50, P523, DOI 10.1007/s00125-006-0558-z; Lindqvist PG, 2005, ULTRASOUND OBST GYN, V25, P258, DOI 10.1002/uog.1806; Lu M, 2008, CEREBROVASC DIS, V25, P517, DOI 10.1159/000131669; Lykke JA, 2010, PAEDIATR PERINAT EP, V24, P323, DOI 10.1111/j.1365-3016.2010.01120.x; Magnussen EB, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.02.016; Mann JR, 2011, PAEDIATR PERINAT EP, V25, P100, DOI 10.1111/j.1365-3016.2010.01157.x; Manso H, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-40; Mekinian A, 2013, ANN RHEUM DIS, V72, P217, DOI 10.1136/annrheumdis-2011-201167; Melamed N, 2010, J MATERN-FETAL NEO M, V23, P338, DOI 10.3109/14767050903300969; Mosca L, 2011, J AM COLL CARDIOL, V57, P1404, DOI [10.1016/j.jacc.2011.02.005, 10.1161/CIR.0b013e31820faaf8]; Nilsson PM, 2009, ACTA PAEDIATR, V98, P985, DOI 10.1111/j.1651-2227.2009.01261.x; Palmer CGS, 2008, SCHIZOPHR RES, V104, P135, DOI 10.1016/j.schres.2008.06.022; POLANI PE, 1958, BMJ-BRIT MED J, V2, P1497, DOI 10.1136/bmj.2.5111.1497; Rana SA, 2012, HORM BEHAV, V62, P228, DOI 10.1016/j.yhbeh.2012.03.015; Ravn SH, 2010, EUR J PAEDIATR NEURO, V14, P214, DOI 10.1016/j.ejpn.2009.06.001; Ross G, 2003, ARCH PEDIAT ADOL MED, V157, P397, DOI 10.1001/archpedi.157.4.397; Schaefer GB, 2008, SEMIN PEDIATR NEUROL, V15, P21, DOI 10.1016/j.spen.2008.01.004; Sie MPS, 2006, STROKE, V37, P2667, DOI 10.1161/01.STR.0000244779.30070.1a; Smith GCS, 2001, LANCET, V357, P2002, DOI 10.1016/S0140-6736(00)05112-6; Smith GD, 2005, EPIDEMIOLOGY, V16, P563, DOI 10.1097/01.ede.0000164790.96316.c0; Streja E, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.06.023; Thompson C, 2001, BRIT J PSYCHIAT, V179, P450, DOI 10.1192/bjp.179.5.450; Thorngren-Jerneck K, 2006, OBSTET GYNECOL, V108, P1499, DOI 10.1097/01.AOG.0000247174.27979.6b; Uldall P, 2001, DAN MED BULL, V48, P161; Wang H-Y, 2004, KAOHSIUNG J MED SCI, V20, P334, DOI [10.1016/S1607-551X(09)70167-6, DOI 10.1016/S1607-551X(09)70167-6]; Wikstrom AK, 2005, BJOG-INT J OBSTET GY, V112, P1486, DOI 10.1111/j.1471-0528.2005.00733.x; Wilson BJ, 2003, BRIT MED J, V326, P845, DOI 10.1136/bmj.326.7394.845; Wu YW, 2006, PEDIATRICS, V118, P690, DOI 10.1542/peds.2006-0278; Zetterstrom K, 2008, BJOG-INT J OBSTET GY, V115, P1436, DOI 10.1111/j.1471-0528.2008.01844.x	54	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79071	10.1371/journal.pone.0079071	http://dx.doi.org/10.1371/journal.pone.0079071			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223882	Green Published, gold			2022-12-27	WOS:000326499300052
J	Ewing, L; Pellicano, E; Rhodes, G				Ewing, Louise; Pellicano, Elizabeth; Rhodes, Gillian			Using Effort to Measure Reward Value of Faces in Children with Autism	PLOS ONE			English	Article							SPECTRUM DISORDERS; SOCIAL MOTIVATION; ATTRACTIVENESS; RECOGNITION; DEFICITS; MECHANISMS; BEAUTY; GAZE	According to one influential account, face processing atypicalities in autism reflect reduced reward value of faces, which results in limited attention to faces during development and a consequent failure to acquire face expertise. Surprisingly, however, there is a paucity of work directly investigating the reward value of faces for individuals with autism and the evidence for diminished face rewards in this population remains equivocal. In the current study, we measured how hard children with autism would work to view faces, using an effortful key-press sequence, and whether they were sensitive to the differential reward value of attractive and unattractive faces. Contrary to expectations, cognitively able children with autism did not differ from typically developing children of similar age and ability in their willingness to work to view faces. Moreover, the effort expended was strongly positively correlated with facial attractiveness ratings in both groups of children. There was also no evidence of atypical reward values for other, less social categories (cars and inverted faces) in the children with autism. These results speak against the possibility that face recognition difficulties in autism are explained by atypical reward value of faces.	[Ewing, Louise; Pellicano, Elizabeth; Rhodes, Gillian] Univ Western Australia, Sch Psychol, Ctr Excellence Cognit & its Disorders, Australian Res Council, Perth, WA 6009, Australia; [Pellicano, Elizabeth] Univ London, Inst Educ, Ctr Res Autism & Educ, London WC1N 1AZ, England	University of Western Australia; University of London; University College London; UCL Institute of Education	Ewing, L (corresponding author), Univ Western Australia, Sch Psychol, Ctr Excellence Cognit & its Disorders, Australian Res Council, Perth, WA 6009, Australia.	louise.ewing@uwa.edu.au	Jeffery, Linda/H-5127-2014; Ewing, Louise/H-9158-2014; Pellicano, Liz/I-5749-2019	Jeffery, Linda/0000-0002-3980-5864; Pellicano, Liz/0000-0002-7246-8003; Ewing, Louise/0000-0001-5263-1267; Rhodes, Gillian/0000-0002-3631-8518	Australian Research Council Centre of Excellence in Cognition and its Disorders [CE110001021]; Australian Research Council Professorial Fellowship [DP0877379]; University of Western Australia; Australian Federation of University Women; Clothworkers' Foundation; Pears Foundation; MRC [MR/J013145/1] Funding Source: UKRI; Medical Research Council [MR/J013145/1] Funding Source: researchfish	Australian Research Council Centre of Excellence in Cognition and its Disorders(Australian Research Council); Australian Research Council Professorial Fellowship(Australian Research Council); University of Western Australia; Australian Federation of University Women; Clothworkers' Foundation; Pears Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Australian Research Council Centre of Excellence in Cognition and its Disorders (project number CE110001021) and an Australian Research Council Professorial Fellowship to G.R (project number DP0877379). It was also supported by awards to L.E. from the University of Western Australia and the Australian Federation of University Women. Research at the Centre for Research in Autism and Education (CRAE) is supported by The Clothworkers' Foundation and Pears Foundation (E.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; BARLOW JD, 1970, PERCEPT MOTOR SKILL, V31, P331, DOI 10.2466/pms.1970.31.1.331; Chevallier C, 2012, TRENDS COGN SCI, V16, P231, DOI 10.1016/j.tics.2012.02.007; Cooper PA, 2006, DEVELOPMENTAL SCI, V9, P530, DOI 10.1111/j.1467-7687.2006.00520.x; Da Fonseca D, 2011, RES AUTISM SPECT DIS, V5, P299, DOI 10.1016/j.rasd.2010.04.012; Dawson G, 2002, CHILD DEV, V73, P700, DOI 10.1111/1467-8624.00433; Dawson G, 2005, DEV NEUROPSYCHOL, V27, P403, DOI 10.1207/s15326942dn2703_6; Dawson G, 1998, J AUTISM DEV DISORD, V28, P479, DOI 10.1023/A:1026043926488; Delmonte S, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-7; Dennett HW, 2012, BEHAV RES METHODS, V44, P587, DOI 10.3758/s13428-011-0160-2; Dichter GS, 2012, J AUTISM DEV DISORD, V42, P147, DOI 10.1007/s10803-011-1221-1; Duchaine BC, 2006, CURR OPIN NEUROBIOL, V16, P166, DOI 10.1016/j.conb.2006.03.003; Eisenthal Y, 2006, NEURAL COMPUT, V18, P119, DOI 10.1162/089976606774841602; Ewing L, 2013, J EXP CHILD PSYCHOL, V115, P342, DOI 10.1016/j.jecp.2013.01.009; Fournier KA, 2010, J AUTISM DEV DISORD, V40, P1227, DOI 10.1007/s10803-010-0981-3; Grelotti DJ, 2002, DEV PSYCHOBIOL, V40, P213, DOI 10.1002/dev.10028; Happe F, 2006, J AUTISM DEV DISORD, V36, P5, DOI 10.1007/s10803-005-0039-0; Hayden BY, 2007, P R SOC B, V274, P1751, DOI 10.1098/rspb.2007.0368; Hietanen JK, 2008, NEUROPSYCHOLOGIA, V46, P2423, DOI 10.1016/j.neuropsychologia.2008.02.029; Kampe KKW, 2001, NATURE, V413, P589, DOI 10.1038/35098149; Kohls G, 2012, SOCIAL COGNITIVE AFF; Kohls G, 2011, J AUTISM DEV DISORD, V41, P1523, DOI 10.1007/s10803-011-1177-1; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; OSTERLING J, 1994, J AUTISM DEV DISORD, V24, P247, DOI 10.1007/BF02172225; Palomo R, 2006, J DEV BEHAV PEDIATR, V27, pS59, DOI 10.1097/00004703-200604002-00003; Pellicano E, 2013, CAMBRIDGE FACE MEMOR; Philip RCM, 2010, PSYCHOL MED, V40, P1919, DOI 10.1017/S0033291709992364; Rhodes G, 2005, P ROY SOC B-BIOL SCI, V272, P1379, DOI 10.1098/rspb.2005.3093; Rutter M., 2003, SOCIAL COMMUNICATION; Santos IM, 2008, PERCEPTION, V37, P1061, DOI 10.1068/p5278; Schultz RT, 2005, INT J DEV NEUROSCI, V23, P125, DOI 10.1016/j.ijdevneu.2004.12.012; Scott-Van Zeeland AA, 2010, AUTISM RES, V3, P53, DOI 10.1002/aur.122; Senju A, 2009, NEUROSCI BIOBEHAV R, V33, P1204, DOI 10.1016/j.neubiorev.2009.06.001; Sepeta L, 2012, J NEURODEVELOPMENTAL, V4, P19; Skinner B. F., 1971, FREEDOM DIGNITY; Slater A, 2000, DEVELOPMENTAL SCI, V3, P181, DOI 10.1111/1467-7687.00111; Voos AC, 2013, J AUTISM DEV DISORD, V43, P1, DOI 10.1007/s10803-012-1683-9; Webb S. J., 2011, OXFORD HDB FACE PERC, P839; Weigelt S, 2012, NEUROSCI BIOBEHAV R, V36, P1060, DOI 10.1016/j.neubiorev.2011.12.008; White S, 2006, BRAIN COGNITION, V61, P69, DOI 10.1016/j.bandc.2005.12.007	42	28	28	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79493	10.1371/journal.pone.0079493	http://dx.doi.org/10.1371/journal.pone.0079493			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236140	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000327254700139
J	Golovliov, I; Twine, SM; Shen, H; Sjostedt, A; Conlan, W				Golovliov, Igor; Twine, Susan M.; Shen, Hua; Sjostedt, Anders; Conlan, Wayne			A Delta clpB Mutant of Francisella tularensis Subspecies holarctica Strain, FSC200, Is a More Effective Live Vaccine than F. tularensis LVS in a Mouse Respiratory Challenge Model of Tularemia	PLOS ONE			English	Article							LETHAL INHALATIONAL INFECTION; SCHU S4; VIRULENCE; IMMUNITY; AEROSOL; MICE; ESTABLISHMENT; IMMUNIZATION; PROTECTION; PROTEIN	Francisella tularensis subsp. tularensis is a highly virulent pathogen for humans especially if inhaled. Consequently, it is considered to be a potential biothreat agent. An experimental vaccine, F. tularensis live vaccine strain, derived from the less virulent subsp. holarctica, was developed more than 50 years ago, but remains unlicensed. Previously, we developed a novel live vaccine strain, by deleting the chaperonin clpB gene from F. tularensis subsp. tularensis strain, SCHU S4. SCHU S4 Delta clpB was less virulent for mice than LVS and a more effective vaccine against respiratory challenge with wild type SCHU S4. In the current study, we were interested to determine whether a similar mutant on the less virulent subsp. holarctica background would also outperform LVS in terms of safety and efficacy. To this end, clpB was deleted from clinical holarctica strain, FSC200. FSC200 Delta clpB had a significantly higher intranasal LD50 than LVS for BALB/c mice, but replicated to higher numbers at foci of infection after dermal inoculation. Moreover, FSC200 Delta clpB killed SCID mice more rapidly than LVS. However, dermal vaccination of BALB/c mice with the former versus the latter induced greater protection against respiratory challenge with SCHU S4. This increased efficacy was associated with enhanced production of pulmonary IL-17 after SCHU S4 challenge.	[Twine, Susan M.; Shen, Hua; Conlan, Wayne] Natl Res Council Canada, Ottawa, ON, Canada; [Golovliov, Igor; Sjostedt, Anders] Umea Univ, Dept Clin Microbiol Clin Bacteriol, Umea, Sweden	National Research Council Canada; Umea University	Conlan, W (corresponding author), Natl Res Council Canada, Ottawa, ON, Canada.	wayne.conlan@nrc-cnrc.ca	Sjöstedt, Anders/AAC-6575-2020	Sjöstedt, Anders/0000-0002-0768-8405	National Research Council Canada	National Research Council Canada	This study was funded by the National Research Council Canada (http://www.nrc-cnrc.gc.ca/eng/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Conlan JW, 2011, FUTURE MICROBIOL, V6, P391, DOI [10.2217/FMB.11.22, 10.2217/fmb.11.22]; Conlan JW, 2010, VACCINE, V28, P1824, DOI 10.1016/j.vaccine.2009.12.001; Conlan JW, 2003, MICROB PATHOGENESIS, V34, P239, DOI 10.1016/S0882-4010(03)00046-9; Cowley SC, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00026; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; EIGELSBACH H, 1961, P SOC EXP BIOL MED, V108, P732, DOI 10.3181/00379727-108-27049; EIGELSBACH H, 1961, J IMMUNOL, V87, P415; El Sahly HM, 2009, VACCINE, V27, P4905, DOI 10.1016/j.vaccine.2009.06.036; Eneslatt K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032367; Eneslatt K, 2011, EUR J IMMUNOL, V41, P974, DOI 10.1002/eji.201040923; Golovliov I, 2003, FEMS MICROBIOL LETT, V222, P273, DOI 10.1016/S0378-1097(03)00313-6; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; HORNICK RB, 1966, BACTERIOL REV, V30, P532, DOI 10.1128/MMBR.30.3.532-538.1966; Ireland PM, 2011, MICROBIOL-SGM, V157, P3172, DOI 10.1099/mic.0.052902-0; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Lin JS, 2011, J IMMUNOL, V186, P1675, DOI 10.4049/jimmunol.1003303; Lindgren H, 2009, INFECT IMMUN, V77, P4429, DOI 10.1128/IAI.00702-09; MCCRUMB FR, 1961, BACTERIOL REV, V25, P262, DOI 10.1128/MMBR.25.3.262-267.1961; Meibom KL, 2008, MOL MICROBIOL, V67, P1384, DOI 10.1111/j.1365-2958.2008.06139.x; Moffitt KL, 2011, CELL HOST MICROBE, V9, P158, DOI 10.1016/j.chom.2011.01.007; Nelson M, 2010, J MED MICROBIOL, V59, P1107, DOI 10.1099/jmm.0.020669-0; Nelson M, 2009, INT J EXP PATHOL, V90, P109, DOI 10.1111/j.1365-2613.2008.00631.x; Pasetti MF, 2008, VACCINE, V26, P1773, DOI 10.1016/j.vaccine.2008.01.005; Priebe GP, 2008, J IMMUNOL, V181, P4965, DOI 10.4049/jimmunol.181.7.4965; Qin AP, 2009, INFECT IMMUN, V77, P152, DOI 10.1128/IAI.01113-08; Rockx-Brouwer D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037752; Ryden P, 2013, MOL IMMUNOL, V54, P58, DOI 10.1016/j.molimm.2012.10.043; Salomonsson E, 2009, INFECT IMMUN, V77, P3424, DOI 10.1128/IAI.00196-09; SASLAW S, 1961, ARCH INTERN MED, V107, P702, DOI 10.1001/archinte.1961.03620050068007; SASLAW S, 1961, AM J MED SCI, V241, P689, DOI 10.1097/00000441-196106000-00001; Shen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013349; Sjostedt A, 2007, ANN NY ACAD SCI, V1105, P1, DOI 10.1196/annals.1409.009; TIGERTT WD, 1962, BACTERIOL REV, V26, P354, DOI 10.1128/MMBR.26.3.354-373.1962; Twenhafel NA, 2009, VET PATHOL, V46, P698, DOI 10.1354/vp.08-VP-0302-T-AM; Twine S, 2005, INFECT IMMUN, V73, P8345, DOI 10.1128/IAI.73.12.8345-8352.2005; Twine S, 2012, VACCINE, V30, P3634, DOI 10.1016/j.vaccine.2012.03.036	36	21	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78671	10.1371/journal.pone.0078671	http://dx.doi.org/10.1371/journal.pone.0078671			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236032	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700029
J	Jakobsdottir, G; Xu, J; Molin, G; Ahrne, S; Nyman, M				Jakobsdottir, Greta; Xu, Jie; Molin, Goran; Ahrne, Siv; Nyman, Margareta			High-Fat Diet Reduces the Formation of Butyrate, but Increases Succinate, Inflammation, Liver Fat and Cholesterol in Rats, while Dietary Fibre Counteracts These Effects	PLOS ONE			English	Article							GUT MICROBIOTA; ULCERATIVE-COLITIS; METABOLIC SYNDROME; RESISTANT STARCH; GAS-CHROMATOGRAPHY; GLUCOSE-METABOLISM; INSULIN-RESISTANCE; COLONIC-MUCOSA; ACID FORMATION; OBESITY	Introduction: Obesity is linked to type 2 diabetes and risk factors associated to the metabolic syndrome. Consumption of dietary fibres has been shown to have positive metabolic health effects, such as by increasing satiety, lowering blood glucose and cholesterol levels. These effects may be associated with short-chain fatty acids (SCFAs), particularly propionic and butyric acids, formed by microbial degradation of dietary fibres in colon, and by their capacity to reduce low-grade inflammation. Objective: To investigate whether dietary fibres, giving rise to different SCFAs, would affect metabolic risk markers in low-fat and high-fat diets using a model with conventional rats for 2, 4 and 6 weeks. Material and Methods: Conventional rats were administered low-fat or high-fat diets, for 2, 4 or 6 weeks, supplemented with fermentable dietary fibres, giving rise to different SCFA patterns (pectin - acetic acid; guar gum - propionic acid; or a mixture - butyric acid). At the end of each experimental period, liver fat, cholesterol and triglycerides, serum and caecal SCFAs, plasma cholesterol, and inflammatory cytokines were analysed. The caecal microbiota was analysed after 6 weeks. Results and Discussion: Fermentable dietary fibre decreased weight gain, liver fat, cholesterol and triglyceride content, and changed the formation of SCFAs. The high-fat diet primarily reduced formation of SCFAs but, after a longer experimental period, the formation of propionic and acetic acids recovered. The concentration of succinic acid in the rats increased in high-fat diets with time, indicating harmful effect of high-fat consumption. The dietary fibre partly counteracted these harmful effects and reduced inflammation. Furthermore, the number of Bacteroides was higher with guar gum, while noticeably that of Akkermansia was highest with the fibre-free diet.	[Jakobsdottir, Greta; Xu, Jie; Molin, Goran; Ahrne, Siv; Nyman, Margareta] Lund Univ, Dept Appl Nutr & Food Chem, Lund, Sweden	Lund University	Jakobsdottir, G (corresponding author), Lund Univ, Dept Appl Nutr & Food Chem, Lund, Sweden.	Greta.Jakobsdottir@appliednutrition.lth.se	Nyman, Margareta/AAY-9466-2020	Nyman, Margareta/0000-0003-3660-2364; Xu, Jie/0000-0002-9707-502X; Jakobsdottir, Greta/0000-0002-0109-6871	Antidiabetic Food Centre; VINNOVA VINN Excellence Center at Lund University; Sparbanksstiftelsen Fars & Frosta and Skanelandska Gastronomiska Akademien	Antidiabetic Food Centre; VINNOVA VINN Excellence Center at Lund University; Sparbanksstiftelsen Fars & Frosta and Skanelandska Gastronomiska Akademien	This study was supported by the Antidiabetic Food Centre, a VINNOVA VINN Excellence Center at Lund University (http://www.ffsc.lu.se/afc), and Sparbanksstiftelsen Fars & Frosta and Skanelandska Gastronomiska Akademien. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JW, 2009, NUTR REV, V67, P188, DOI 10.1111/j.1753-4887.2009.00189.x; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2011, ANN NUTR METAB, V58, P44, DOI 10.1159/000328042; Becker W, 1999, KOSTVANOR NARINGSINT; Berggren A, 1996, THESIS LUND U LUND; BERGGREN AM, 1995, EUR J CLIN NUTR, V49, pS233; Berggren AM, 1996, BRIT J NUTR, V76, P287, DOI 10.1079/BJN19960032; BJORCK I, 1987, J CEREAL SCI, V6, P159; Branning C, 2009, BR J NUTR, V101, P1; BREUER RI, 1991, DIGEST DIS SCI, V36, P185, DOI 10.1007/BF01300754; Bugianesi E, 2004, DIGEST LIVER DIS, V36, P165, DOI 10.1016/j.dld.2003.12.008; Casas JA, 2000, J SCI FOOD AGR, V80, P1722, DOI 10.1002/1097-0010(20000915)80:12<1722::AID-JSFA708>3.3.CO;2-O; Cherbut C, 2003, P NUTR SOC, V62, P95, DOI 10.1079/PNS2002213; Cook SI, 1998, ALIMENT PHARM THER, V12, P499, DOI 10.1046/j.1365-2036.1998.00337.x; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Dandona P, 2006, DRUG DEVELOP RES, V67, P619, DOI 10.1002/ddr.20137; Danisco, 2010, 201011 DAN; Delzenne NM, 2011, NAT REV ENDOCRINOL, V7, P639, DOI 10.1038/nrendo.2011.126; Delzenne NM, 2002, BRIT J NUTR, V87, pS255, DOI 10.1079/BJN/2002545; Everard A., 2013, P NATL ACAD SCI US; Fava F, 2013, INT J OBESITY, V37, P216, DOI 10.1038/ijo.2012.33; Galisteo M, 2008, J NUTR BIOCHEM, V19, P71, DOI 10.1016/j.jnutbio.2007.02.009; Ganesh BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074963; Hallert C, 2003, INFLAMM BOWEL DIS, V9, P116, DOI 10.1097/00054725-200303000-00005; Hara H, 1999, J NUTR, V129, P942, DOI 10.1093/jn/129.5.942; HEATON KW, 1973, LANCET, V2, P1418; Henningsson AM, 2003, BRIT J NUTR, V89, P319, DOI 10.1079/BJN2003782; Henningsson AM, 2002, J NUTR, V132, P3098, DOI 10.1093/jn/131.10.3098; Immerstrand T, 2010, BRIT J NUTR, V104, P364, DOI 10.1017/S0007114510000553; Inagaki A, 2007, J NUTR SCI VITAMINOL, V53, P377, DOI 10.3177/jnsv.53.377; Jakobsdottir G., 2013, BEETLES RUSSIA W EUR, V26, P1; Johansson EV, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-46; Johnson AR, 2012, IMMUNOL REV, V249, P218, DOI 10.1111/j.1600-065X.2012.01151.x; Karlsson CLJ, 2011, BRIT J NUTR, V106, P887, DOI 10.1017/S0007114511001036; Kotronen A, 2008, ARTERIOSCL THROM VAS, V28, P27, DOI 10.1161/ATVBAHA.107.147538; Krebs C.J., 2014, ECOLOGICAL METHODOLO; KRITCHEVSKY D, 1974, J NUTR, V104, P458, DOI 10.1093/jn/104.4.458; Langen MACLV, 2009, INFLAMM BOWEL DIS, V15, P454, DOI 10.1002/ibd.20737; LEVRAT MA, 1994, J NUTR, V124, P531, DOI 10.1093/jn/124.4.531; Luhrs H, 2002, SCAND J GASTROENTERO, V37, P458, DOI 10.1080/003655202317316105; Macfarlane GT, 2012, J AOAC INT, V95, P50, DOI 10.5740/jaoacint.SGE_Macfarlane; Mahady SE, 2012, CLIN LIVER DIS, V16, P631, DOI 10.1016/j.cld.2012.05.003; Marcil V, 2003, J NUTR, V133, P2180, DOI 10.1093/jn/133.7.2180; Marcil VR, 2002, AM J PHYSIOL-GASTR L, V283, pG340, DOI 10.1152/ajpgi.00440.2001; Moshfegh A., 2005, WHAT WE EAT AM NHANE; Nilsson U, 2005, BRIT J NUTR, V94, P705, DOI 10.1079/BJN20051531; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Schulze MB, 2007, ARCH INTERN MED, V167, P956, DOI 10.1001/archinte.167.9.956; Seppala-Lindroos A, 2002, J CLIN ENDOCR METAB, V87, P3023, DOI 10.1210/jc.87.7.3023; Siegmund B, 2001, J PHARMACOL EXP THER, V296, P99; Slavin J, 2004, NUTR RES REV, V17, P99, DOI 10.1079/NRR200374; Slavin JL, 2005, NUTRITION, V21, P411, DOI 10.1016/j.nut.2004.08.018; Tedelind S, 2007, WORLD J GASTROENTERO, V13, P2826, DOI 10.3748/wjg.v13.i20.2826; Thakur BR, 1997, CRIT REV FOOD SCI, V37, P47, DOI 10.1080/10408399709527767; Thibault R, 2010, INFLAMM BOWEL DIS, V16, P684, DOI 10.1002/ibd.21108; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; VERNIA P, 1988, DIGEST DIS SCI, V33, P1353, DOI 10.1007/BF01536987; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; WILSON JN, 1984, ARTERIOSCLEROSIS, V4, P147, DOI 10.1161/01.ATV.4.2.147; World Health Organization, OB OV; Yan H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059581; Zhao GH, 2007, J CHROMATOGR B, V846, P202, DOI 10.1016/j.jchromb.2006.09.027; Zhao GH, 2006, BIOMED CHROMATOGR, V20, P674, DOI 10.1002/bmc.580; Zoran DL, 1997, J NUTR, V127, P2217, DOI 10.1093/jn/127.11.2217	66	201	211	13	161	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80476	10.1371/journal.pone.0080476	http://dx.doi.org/10.1371/journal.pone.0080476			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236183	Green Submitted, Green Published, gold			2022-12-27	WOS:000327254700184
J	Kuo, MC; Lin, SH; Lin, CH; Mao, IC; Chang, SJ; Hsieh, MC				Kuo, Ming-Chun; Lin, Sheng-Hao; Lin, Ching-Hsiung; Mao, I-Chieh; Chang, Shun-Jen; Hsieh, Ming-Chia			Type 2 Diabetes : An Independent Risk Factor for Tuberculosis: A Nationwide Population-Based Study	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; IMPACT	Objective: Tuberculosis continues to be a major global health problem. We wanted to investigate whether Type 2 diabetes was a risk factor for tuberculosis in an Asian population. Methods: From Taiwan's National Health Insurance Research Database, we collected data from 31,237 female patients with type 2 diabetes and 92,642 female controls and 32,493 male patients with type 2 diabetes and 96,977 male controls. Cox proportional hazard regression was performed to evaluate independent risk factors for tuberculosis in all patients and to identify risk factors in patients with type 2 diabetes. Results: During the study period, both female (standardized incidence ratio (SIR): 1.40, p<0.01) and male (SIR: 1.48, p<0.01) patients with type 2 diabetes were found to have a significantly higher rate of incident tuberculosis than the control group. Type 2 diabetes (HR: 1.31, 1.23-1.39, p<0.001) was significantly associated with tuberculosis after adjusting sex, age, bronchiectasis, asthma and chronic obstructive lung disease. Conclusions: Patients with type 2 diabetes have a higher risk of tuberculosis compared to control subjects after adjusting for confounding factors. The current diabetes epidemic may lead to a resurgence of tuberculosis in endemic regions. Therefore, preventive measures, including addressing the possibility that type 2 diabetes increase the individual's susceptibility for incident TB, should be taken to further reduce the incidence of tuberculosis.	[Kuo, Ming-Chun] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Kuo, Ming-Chun] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Lin, Sheng-Hao; Lin, Ching-Hsiung] Changhua Christian Hosp, Dept Internal Med, Div Chest Med, Changhua, Taiwan; [Lin, Sheng-Hao] Chang Jung Christian Univ, Coll Hlth Sci, Dept Resp Care, Tainan, Taiwan; [Lin, Ching-Hsiung] Chung Shan Med Univ, Taiwan Sch Med, Taichung, Taiwan; [Lin, Ching-Hsiung] Natl Chung Hsing Univ, Grad Inst Biomed Sci, Taichung 40227, Taiwan; [Mao, I-Chieh; Hsieh, Ming-Chia] Changhua Christian Hosp, Dept Internal Med, Div Endocrinol & Metab, Changhua, Taiwan; [Chang, Shun-Jen] Natl Univ Kaohsiung, Dept Kinesiol Hlth & Leisure Studies, Kaohsiung, Taiwan; [Hsieh, Ming-Chia] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Changhua Christian Hospital; Chang Jung Christian University; Chung Shan Medical University; National Chung Hsing University; Changhua Christian Hospital; National University Kaohsiung; China Medical University Taiwan	Chang, SJ (corresponding author), Natl Univ Kaohsiung, Dept Kinesiol Hlth & Leisure Studies, Kaohsiung, Taiwan.	changsj1104@gmail.com; mingchiah@gmail.com		Lin, Ching-Hsiung/0000-0001-9407-8578				Alisjahbana B, 2006, INT J TUBERC LUNG D, V10, P696; Baker MA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-81; Bashar M, 2001, CHEST, V120, P1514, DOI 10.1378/chest.120.5.1514; Department of Health, 2004, STOPP TUB ENGL ACT P; Dobler CC, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000666; Dyck RF, 2007, CAN J PUBLIC HEALTH, V98, P55, DOI 10.1007/BF03405386; Fisher-Hoch SP, 2008, SCAND J INFECT DIS, V40, P888, DOI 10.1080/00365540802342372; Greenland S, 2008, MODERN EPIDEMIOLOGY, P252; Hopewell PC, 2006, LANCET INFECT DIS, V6, P710, DOI 10.1016/S1473-3099(06)70628-4; International Diabetes Federation, 2011, IDF DIABETES ATLAS; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; John GT, 2001, KIDNEY INT, V60, P1148, DOI 10.1046/j.1523-1755.2001.0600031148.x; Kant L, 2003, IND J TUB, V50, P183; Kim SJ, 1995, TUBERCLE LUNG DIS, V76, P534, DOI 10.1016/0962-8479(95)90530-8; Kim SJ, 1995, TUBERCLE LUNG DIS, V76, P529, DOI 10.1016/0962-8479(95)90529-4; Last JM., 2001, DICT EPIDEMIOLOGY, V4th; Lee MC, 2013, PHARMACOEPIDEMIOL DR; Leung CC, 2008, AM J EPIDEMIOL, V167, P1486, DOI 10.1093/aje/kwn075; Lonnroth K, 2008, SEMIN RESP CRIT CARE, V29, P481, DOI 10.1055/s-0028-1085700; Martens GW, 2007, AM J RESP CELL MOL, V37, P518, DOI 10.1165/rcmb.2006-0478OC; Ponce-De-Leon A, 2004, DIABETES CARE, V27, P1584, DOI 10.2337/diacare.27.7.1584; Raviglione MC, 2006, LANCET, V367, P952, DOI 10.1016/S0140-6736(06)68392-X; Restrepo BI, 2007, EPIDEMIOL INFECT, V135, P483, DOI 10.1017/S0950268806006935; Restrepo BI, 2008, CLIN INFECT DIS, V47, P634, DOI 10.1086/590565; Singla R, 2006, INT J TUBERC LUNG D, V10, P74; Stevenson CR, 2007, CHRONIC ILLN, V3, P228, DOI 10.1177/1742395307081502; Stevenson CR, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-234; Tuberculosis Coalition for Technical Assistance, 2006, INT STAND TUB CAR IS; Vallerskog T, 2010, J IMMUNOL, V184, P6275, DOI 10.4049/jimmunol.1000304; WHO, 2012, GLOB TUB CUL REP 201; WHO Global Tuberculosis Control Report, 2010, CENT EUR J PUBL HEAL, V18, P237	31	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78924	10.1371/journal.pone.0078924	http://dx.doi.org/10.1371/journal.pone.0078924			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236069	Green Submitted, Green Published, gold			2022-12-27	WOS:000327254700066
J	Le Tallec, T; Perret, M; Thery, M				Le Tallec, Thomas; Perret, Martine; Thery, Marc			Light Pollution Modifies the Expression of Daily Rhythms and Behavior Patterns in a Nocturnal Primate	PLOS ONE			English	Article							LOCOMOTOR-ACTIVITY; MICROCEBUS-MURINUS; DEER MICE; DIM LIGHT; FOOD; ILLUMINATION; EVOLUTION; RESPONSES; EXPOSURE; TIME	Among anthropogenic pressures, light pollution altering light/dark cycles and changing the nocturnal component of the environment constitutes a threat for biodiversity. Light pollution is widely spread across the world and continuously growing. However, despite the efforts realized to describe and understand the effects of artificial lighting on fauna, few studies have documented its consequences on biological rhythms, behavioral and physiological functions in nocturnal mammals. To determine the impacts of light pollution on nocturnal mammals an experimental study was conducted on a nocturnal primate, the grey mouse lemur Microcebus murinus. Male mouse lemurs (N = 8) were exposed 14 nights to moonlight treatment and then exposed 14 nights to light pollution treatment. For both treatments, chronobiological parameters related to locomotor activity and core temperature were recorded using telemetric transmitters. In addition, at the end of each treatment, the 14th night, nocturnal and feeding behaviors were explored using an infrared camera. Finally, throughout the study, body mass and daily caloric food intake were recorded. For the first time in a nocturnal primate, light pollution was demonstrated to modify daily rhythms of locomotor activity and core temperature especially through phase delays and increases in core temperature. Moreover, nocturnal activity and feeding behaviors patterns were modified negatively. This study suggests that light pollution induces daily desynchronization of biological rhythms and could lead to seasonal desynchronization with potential deleterious consequences for animals in terms of adaptation and anticipation of environmental changes.	[Le Tallec, Thomas; Perret, Martine; Thery, Marc] Museum Natl Hist Nat, CNRS, UMR 7179, Brunoy, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN)	Thery, M (corresponding author), Museum Natl Hist Nat, CNRS, UMR 7179, Brunoy, France.	thery@mnhn.fr			Ministere de l'Enseignement Superieur et de la Recherche	Ministere de l'Enseignement Superieur et de la Recherche	Thomas Le Tallec was funded by a PhD grant from the Ministere de l'Enseignement Superieur et de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlettaz R, 2000, BIOL CONSERV, V93, P55, DOI 10.1016/S0006-3207(99)00112-3; ASCHOFF J, 1960, COLD SPRING HARB SYM, V25, P11, DOI 10.1101/SQB.1960.025.01.004; Bedrosian TA, 2011, BIOL LETTERS, V7, P468, DOI 10.1098/rsbl.2010.1108; BEIER P, 1995, J WILDLIFE MANAGE, V59, P228, DOI 10.2307/3808935; Beier Paul, 2006, P19; Bird BL, 2004, CONSERV BIOL, V18, P1435, DOI 10.1111/j.1523-1739.2004.00349.x; Boldogh S, 2007, ACTA CHIROPTEROL, V9, P527, DOI 10.3161/1733-5329(2007)9[527:TEOTIO]2.0.CO;2; Bradshaw WE, 2007, ANNU REV ECOL EVOL S, V38, P1, DOI 10.1146/annurev.ecolsys.37.091305.110115; Bradshaw WE, 2010, ANNU REV PHYSIOL, V72, P147, DOI 10.1146/annurev-physiol-021909-135837; BRILLHART DB, 1991, J MAMMAL, V72, P764, DOI 10.2307/1381840; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cinzano P., 2000, Memorie della Societa Astronomica Italiana, V71, P159; Cinzano P, 2001, MON NOT R ASTRON SOC, V328, P689, DOI 10.1046/j.1365-8711.2001.04882.x; Cinzano P, 2001, EARTH MOON PLANETS, V85-6, P517; DAAN S, 1975, OECOLOGIA, V18, P269, DOI 10.1007/BF00345851; Dacke M, 2011, PHILOS T R SOC B, V366, P697, DOI 10.1098/rstb.2010.0191; DECOURSEY PJ, 1986, J COMP PHYSIOL A, V159, P161, DOI 10.1007/BF00612299; DUTRILLAUX B, 1979, HUM GENET, V48, P251, DOI 10.1007/BF00272830; Eisenbeis Gerhard, 2006, P281; Elvidge CD, 2010, SENSORS-BASEL, V10, P3961, DOI 10.3390/s100403961; Evans JA, 2007, J BIOL RHYTHM, V22, P356, DOI 10.1177/0748730407301988; Falkenberg JC, 1998, J MAMMAL, V79, P558, DOI 10.2307/1382986; Fonken LK, 2010, P NATL ACAD SCI USA, V107, P18664, DOI 10.1073/pnas.1008734107; Frank Kenneth D., 2006, P305; Gauthreaux Sidney A. Jr., 2006, P67; Genin F, 2003, COMP BIOCHEM PHYS B, V136, P71, DOI 10.1016/S1096-4959(03)00172-6; Giroud S, 2008, AM J PHYSIOL-REG I, V294, pR1958, DOI 10.1152/ajpregu.00794.2007; Giroud S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008823; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Haim A, 2005, CHRONOBIOL INT, V22, P59, DOI 10.1081/CBI-200038144; Holker F, 2010, ECOL SOC, V15; Holker F, 2010, TRENDS ECOL EVOL, V25, P681, DOI 10.1016/j.tree.2010.09.007; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kramer KM, 2001, J MAMMAL, V82, P535, DOI 10.1644/1545-1542(2001)082<0535:EOLIOA>2.0.CO;2; Kronfeld-Schor Noga, 2013, Proceedings of the Royal Society Biological Sciences Series B, V280, P1; Kumlien H. F., 1888, AUK, V5, P325; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Longcore T, 2004, FRONT ECOL ENVIRON, V2, P191, DOI 10.2307/3868314; Longcore T., 2006, ECOLOGICAL CONSEQUEN, P413; Montevecchi William A., 2006, P94; Nilsson DE, 2009, PHILOS T R SOC B, V364, P2833, DOI 10.1098/rstb.2009.0083; Perret M, 2001, AM J PHYSIOL-REG I, V281, pR1925, DOI 10.1152/ajpregu.2001.281.6.R1925; Perret M, 2000, PRIMATOLOGIE, P45; Polak T, 2011, J ZOOL, V285, P21, DOI 10.1111/j.1469-7998.2011.00808.x; Rich C., 2006, ECOLOGICAL CONSEQUEN, P1; Rocher P, 2010, EPHEMERIDES 2012 PAR, P1; Rotics S, 2011, J MAMMAL, V92, P159, DOI 10.1644/10-MAMM-A-112.1; Rotics S, 2011, CHRONOBIOL INT, V28, P70, DOI 10.3109/07420528.2010.525674; Salmon Michael, 2006, P141; Shuboni D, 2010, NEUROSCIENCE, V170, P1172, DOI 10.1016/j.neuroscience.2010.08.009; Smith F.G., 1979, IAU T A, VXVIIA, P218; Somanathan H, 2008, CURR BIOL, V18, pR996, DOI 10.1016/j.cub.2008.08.023; Stone EL, 2012, GLOBAL CHANGE BIOL, V18, P2458, DOI 10.1111/j.1365-2486.2012.02705.x; Stone EL, 2009, CURR BIOL, V19, P1123, DOI 10.1016/j.cub.2009.05.058; Terrien J, 2009, CHRONOBIOL INT, V26, P838, DOI 10.1080/07420520903044281; VASQUEZ RA, 1994, BEHAV ECOL SOCIOBIOL, V34, P375, DOI 10.1007/BF00197008; Zubidat AE, 2007, CHRONOBIOL INT, V24, P269, DOI 10.1080/07420520701284675; Zuur Alain F., 2009, P1	59	43	43	4	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79250	10.1371/journal.pone.0079250	http://dx.doi.org/10.1371/journal.pone.0079250			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236115	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700114
J	Saghizadeh, M; Winkler, MA; Kramerov, AA; Hemmati, DM; Ghiam, CA; Dimitrijevich, SD; Sareen, D; Ornelas, L; Ghiasi, H; Brunken, WJ; Maguen, E; Rabinowitz, YS; Svendsen, CN; Jirsova, K; Ljubimov, AV				Saghizadeh, Mehrnoosh; Winkler, Michael A.; Kramerov, Andrei A.; Hemmati, David M.; Ghiam, Chantelle A.; Dimitrijevich, Slobodan D.; Sareen, Dhruv; Ornelas, Loren; Ghiasi, Homayon; Brunken, William J.; Maguen, Ezra; Rabinowitz, Yaron S.; Svendsen, Clive N.; Jirsova, Katerina; Ljubimov, Alexander V.			A Simple Alkaline Method for Decellularizing Human Amniotic Membrane for Cell Culture	PLOS ONE			English	Article							EX-VIVO EXPANSION; LIMBAL EPITHELIAL TRANSPLANTATION; HUMAN DIABETIC CORNEAS; BASEMENT-MEMBRANE; STEM-CELLS; IV COLLAGEN; INTACT; DIFFERENTIATION; PROLIFERATION; COMPONENTS	Human amniotic membrane is a standard substratum used to culture limbal epithelial stem cells for transplantation to patients with limbal stem cell deficiency. Various methods were developed to decellularize amniotic membrane, because denuded membrane is poorly immunogenic and better supports repopulation by dissociated limbal epithelial cells. Amniotic membrane denuding usually involves treatment with EDTA and/or proteolytic enzymes; in many cases additional mechanical scraping is required. Although ensuring limbal cell proliferation, these methods are not standardized, require relatively long treatment times and can result in membrane damage. We propose to use 0.5 M NaOH to reliably remove amniotic cells from the membrane. This method was used before to lyse cells for DNA isolation and radioactivity counting. Gently rubbing a cotton swab soaked in NaOH over the epithelial side of amniotic membrane leads to nearly complete and easy removal of adherent cells in less than a minute. The denuded membrane is subsequently washed in a neutral buffer. Cell removal was more thorough and uniform than with EDTA, or EDTA plus mechanical scraping with an electric toothbrush, or n-heptanol plus EDTA treatment. NaOH-denuded amniotic membrane did not show any perforations compared with mechanical or thermolysin denuding, and showed excellent preservation of immunoreactivity for major basement membrane components including laminin alpha 2, gamma 1-gamma 3 chains, alpha 1/alpha 2 and alpha 6 type IV collagen chains, fibronectin, nidogen-2, and perlecan. Sodium hydroxide treatment was efficient with fresh or cryopreserved (10% dimethyl sulfoxide or 50% glycerol) amniotic membrane. The latter method is a common way of membrane storage for subsequent grafting in the European Union. NaOH-denuded amniotic membrane supported growth of human limbal epithelial cells, immortalized corneal epithelial cells, and induced pluripotent stem cells. This simple, fast and reliable method can be used to standardize decellularized amniotic membrane preparations for expansion of limbal stem cells in vitro before transplantation to patients.	[Saghizadeh, Mehrnoosh; Winkler, Michael A.; Kramerov, Andrei A.; Hemmati, David M.; Ghiam, Chantelle A.; Rabinowitz, Yaron S.; Ljubimov, Alexander V.] Cedars Sinai Med Ctr, Eye Program, Los Angeles, CA 90048 USA; [Saghizadeh, Mehrnoosh; Winkler, Michael A.; Kramerov, Andrei A.; Sareen, Dhruv; Ornelas, Loren; Rabinowitz, Yaron S.; Svendsen, Clive N.; Ljubimov, Alexander V.] Cedars Sinai Med Ctr, Regenerat Med Inst, Los Angeles, CA 90048 USA; [Saghizadeh, Mehrnoosh; Winkler, Michael A.; Kramerov, Andrei A.; Ghiasi, Homayon; Maguen, Ezra; Rabinowitz, Yaron S.; Svendsen, Clive N.; Ljubimov, Alexander V.] Cedars Sinai Med Ctr, Dept Biomed Sci, Dept Surg, Los Angeles, CA 90048 USA; [Saghizadeh, Mehrnoosh; Winkler, Michael A.; Kramerov, Andrei A.; Ghiasi, Homayon; Maguen, Ezra; Rabinowitz, Yaron S.; Svendsen, Clive N.; Ljubimov, Alexander V.] Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA; [Hemmati, David M.; Ghiam, Chantelle A.; Svendsen, Clive N.; Ljubimov, Alexander V.] Univ Calif Los Angeles, Los Angeles, CA USA; [Dimitrijevich, Slobodan D.] Univ N Texas, Hlth Sci Ctr, Dept Integrat Physiol, Ft Worth, TX USA; [Brunken, William J.] Suny Downstate Med Ctr, Dept Ophthalmol, New York, NY USA; [Brunken, William J.] Suny Downstate Med Ctr, Dept Cell Biol, New York, NY USA; [Maguen, Ezra] Amer Eye Inst, Los Angeles, CA USA; [Jirsova, Katerina] Charles Univ Prague, Fac Med 1, Inst Inherited Metab Disorders, Lab Biol & Pathol Eye, Prague, Czech Republic; [Jirsova, Katerina] Charles Univ Prague, Gen Teaching Hosp, Prague, Czech Republic	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of North Texas System; University of North Texas Health Science Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Charles University Prague; Charles University Prague; General University Hospital Prague	Ljubimov, AV (corresponding author), Cedars Sinai Med Ctr, Eye Program, Los Angeles, CA 90048 USA.	ljubimov@cshs.org	Ljubimov, Alexander V/E-5883-2013; Jirsova, Katerina/B-8301-2012; Ljubimov, Alexander/CAE-9130-2022	Jirsova, Katerina/0000-0002-4625-6701; Brunken, William J/0000-0001-7330-1814; Ljubimov, Alexander/0000-0003-2398-5319	NIH [EY13431, EY023429]; CTSI grant [UL 1RR033176]; Cedars-Sinai Regenerative Medicine Institute grants; Charles University, Prague [PRVOUK-P24/LF1/3]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033176] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY023429, R01EY013431] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CTSI grant; Cedars-Sinai Regenerative Medicine Institute grants; Charles University, Prague; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	NIH EY13431, EY023429, CTSI grant UL 1RR033176, Cedars-Sinai Regenerative Medicine Institute grants, and PRVOUK-P24/LF1/3 Institutional support program of the Charles University, Prague. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2010, DRUG DISCOV TODAY, V15, P306, DOI 10.1016/j.drudis.2010.02.001; ALLEN TD, 1988, SCANNING MICROSCOPY, V2, P2067; Baharvand H, 2007, MOL VIS, V13, P1711; Baradaran-rafii A., 2007, IRAN J OPHTHALMIC RE, V2, P58; Baradaran-Rafii A, 2011, OCUL SURF, V9, P163, DOI 10.1016/S1542-0124(11)70026-X; Baylis O, 2011, J CELL BIOCHEM, V112, P993, DOI 10.1002/jcb.23028; Biber Joseph M, 2010, Int Ophthalmol Clin, V50, P25, DOI 10.1097/IIO.0b013e3181e20d64; Blazejewska EA, 2009, STEM CELLS, V27, P642, DOI 10.1634/stemcells.2008-0721; Chen B, 2010, TISSUE ENG PT A, V16, P2721, DOI 10.1089/ten.tea.2009.0711; Connon CJ, 2010, BRIT J OPHTHALMOL, V94, P1057, DOI 10.1136/bjo.2008.153064; COUCHMAN JR, 1989, MATRIX, V9, P311, DOI 10.1016/S0934-8832(89)80007-1; DAVIS GE, 1987, SCIENCE, V236, P1106, DOI 10.1126/science.3576223; Melo Gustavo Barreto de, 2007, Arq. Bras. Oftalmol., V70, P407, DOI 10.1590/S0004-27492007000300005; Dietrich-Ntoukas T, 2012, CORNEA, V31, P564, DOI 10.1097/ICO.0b013e3182254b78; Dimitrijevich SD, 2008, INVEST OPHTHALMOL VI, V49; Fatima A, 2006, J POSTGRAD MED, V52, P257; Fukuda K, 1999, CORNEA, V18, P73, DOI 10.1097/00003226-199901000-00013; Gedrange T, 2008, J PHYSIOL PHARMACOL, V59, P87; Gomes Jose A P, 2005, Curr Opin Ophthalmol, V16, P233, DOI 10.1097/01.icu.0000172827.31985.3a; Grueterich M, 2003, SURV OPHTHALMOL, V48, P631, DOI 10.1016/j.survophthal.2003.08.003; Grueterich M, 2003, INVEST OPHTH VIS SCI, V44, P4230, DOI 10.1167/iovs.02-0943; HENDRIX MJC, 1985, CLIN EXP METASTAS, V3, P221, DOI 10.1007/BF01585078; Higa K, 2007, INVEST OPHTH VIS SCI, V48, P597, DOI 10.1167/iovs.06-0664; Hopkinson A, 2008, TISSUE ENG PART C-ME, V14, P371, DOI 10.1089/ten.tec.2008.0315; INGBER DE, 1986, AM J PATHOL, V122, P129; Kabosova A, 2007, INVEST OPHTH VIS SCI, V48, P4989, DOI 10.1167/iovs.07-0654; KENYON KR, 1989, OPHTHALMOLOGY, V96, P709; Kim J C, 1995, Korean J Ophthalmol, V9, P32; Koizumi N, 2000, CORNEA, V19, P65, DOI 10.1097/00003226-200001000-00013; Kolli S, 2008, REGEN MED, V3, P329, DOI 10.2217/17460751.3.3.329; Kruse FE, 2000, GRAEF ARCH CLIN EXP, V238, P68, DOI 10.1007/s004170050012; Kubo M, 2001, INVEST OPHTH VIS SCI, V42, P1539; Kumar PRV, 2009, MUTAT RES-GEN TOX EN, V678, P65, DOI 10.1016/j.mrgentox.2009.06.007; Li W, 2007, INVEST OPHTH VIS SCI, V48, P605, DOI 10.1167/iovs.06-0514; Liu JB, 2010, EXPERT REV OPHTHALMO, V5, P645, DOI 10.1586/EOP.10.63; LJUBIMOV AV, 1985, EXP CELL RES, V156, P311, DOI 10.1016/0014-4827(85)90540-3; LJUBIMOV AV, 1995, LAB INVEST, V72, P461; Mariappan I, 2010, NAT PROTOC, V5, P1470, DOI 10.1038/nprot.2010.115; Martin R, 2007, CLIN EXP OPTOM, V90, P26, DOI 10.1111/j.1444-0938.2006.00083.x; Mason SL, 2011, REGEN MED, V6, P767, DOI [10.2217/rme.11.94, 10.2217/RME.11.94]; Nakatsu MN, 2011, INVEST OPHTH VIS SCI, V52, P4734, DOI 10.1167/iovs.10-6486; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Ordonez P, 2012, STEM CELLS, V30, P100, DOI 10.1002/stem.794; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Riau AK, 2010, BIOMATERIALS, V31, P216, DOI 10.1016/j.biomaterials.2009.09.034; Saghizadeh M, 2011, MOL VIS, V17, P2177; Saghizadeh M, 2010, INVEST OPHTH VIS SCI, V51, P1970, DOI 10.1167/iovs.09-4569; Sangwan VS, 2011, BRIT J OPHTHALMOL, V95, P1525, DOI 10.1136/bjophthalmol-2011-300352; Schlotzer-Schrehardt U, 2007, EXP EYE RES, V85, P845, DOI 10.1016/j.exer.2007.08.020; Schulze U, 2012, HISTOCHEM CELL BIOL, V138, P243, DOI 10.1007/s00418-012-0943-2; Sejpal K, 2013, JAMA OPHTHALMOL, V131, P731, DOI 10.1001/jamaophthalmol.2013.2308; Shimazaki J, 2002, OPHTHALMOLOGY, V109, P1285, DOI 10.1016/S0161-6420(02)01089-8; Shortt AJ, 2008, OPHTHALMOLOGY, V115, P1989, DOI 10.1016/j.ophtha.2008.04.039; Shortt AJ, 2009, BIOMATERIALS, V30, P1056, DOI 10.1016/j.biomaterials.2008.10.048; SHUKLA I M, 1962, J All India Ophthalmol Soc, V10, P55; Sudha B, 2008, INDIAN J MED RES, V128, P149; Tamhane A, 2005, OPHTHALMOLOGY, V112, P1963, DOI 10.1016/j.ophtha.2005.05.022; Tseng SCG, 2010, CURR MOL MED, V10, P841; Wilshaw SP, 2006, TISSUE ENG, V12, P2117, DOI 10.1089/ten.2006.12.2117; Xiang HY, 2005, AM J IND MED, V48, P57, DOI 10.1002/ajim.20179; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zakaria N, 2010, TISSUE ENG PART C-ME, V16, P921, DOI [10.1089/ten.tec.2009.0634, 10.1089/ten.TEC.2009.0634]; Zhang T, 2013, INVEST OPHTH VIS SCI, V54, P3072, DOI 10.1167/iovs.12-10805	63	44	46	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79632	10.1371/journal.pone.0079632	http://dx.doi.org/10.1371/journal.pone.0079632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236148	Green Submitted, gold, Green Published			2022-12-27	WOS:000327254700147
J	Yamazaki, A; Liu, P; Cheng, WC; Badano, A				Yamazaki, Asumi; Liu, Peter; Cheng, Wei-Chung; Badano, Aldo			Image Quality Characteristics of Handheld Display Devices for Medical Imaging	PLOS ONE			English	Article							RADIOLOGY; RESOLUTION; SYSTEMS; NOISE; IPAD; CT	Handheld devices such as mobile phones and tablet computers have become widespread with thousands of available software applications. Recently, handhelds are being proposed as part of medical imaging solutions, especially in emergency medicine, where immediate consultation is required. However, handheld devices differ significantly from medical workstation displays in terms of display characteristics. Moreover, the characteristics vary significantly among device types. We investigate the image quality characteristics of various handheld devices with respect to luminance response, spatial resolution, spatial noise, and reflectance. We show that the luminance characteristics of the handheld displays are different from those of workstation displays complying with grayscale standard target response suggesting that luminance calibration might be needed. Our results also demonstrate that the spatial characteristics of handhelds can surpass those of medical workstation displays particularly for recent generation devices. While a 5 mega-pixel monochrome workstation display has horizontal and vertical modulation transfer factors of 0.52 and 0.47 at the Nyquist frequency, the handheld displays released after 2011 can have values higher than 0.63 at the respective Nyquist frequencies. The noise power spectra for workstation displays are higher than 1.2x10(-5) mm(2) at 1 mm(-1), while handheld displays have values lower than 3.7x10(-6) mm(2). Reflectance measurements on some of the handheld displays are consistent with measurements for workstation displays with, in some cases, low specular and diffuse reflectance coefficients. The variability of the characterization results among devices due to the different technological features indicates that image quality varies greatly among handheld display devices.	[Yamazaki, Asumi; Liu, Peter; Cheng, Wei-Chung; Badano, Aldo] US FDA, Ctr Devices & Radiol Hlth, Silver Spring, MD USA; [Yamazaki, Asumi] Nagoya Univ, Grad Sch Med Sci, Nagoya, Aichi 4648601, Japan	US Food & Drug Administration (FDA); Nagoya University	Badano, A (corresponding author), US FDA, Ctr Devices & Radiol Hlth, Silver Spring, MD USA.	aldo.badano@fda.hhs.gov	Cheng, Wei-Chung/E-6240-2014; Badano, Aldo/G-7786-2012	Badano, Aldo/0000-0003-3712-6670	appointments to the Research Participation Program at the CDRH; Oak Ridge Institute for Science and Education	appointments to the Research Participation Program at the CDRH; Oak Ridge Institute for Science and Education(General Electric)	AY and PL acknowledge funding by appointments to the Research Participation Program at the CDRH administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. DOE and the U.S. FDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badano A, 2004, MED PHYS, V31, P715, DOI 10.1118/1.1656529; Breslauer DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006320; Choudhri AF, 2012, J DIGIT IMAGING, V25, P492, DOI 10.1007/s10278-011-9431-9; Christopher M, 2012, RETINA-J RET VIT DIS, V32, P1629, DOI 10.1097/IAE.0b013e3182483361; Flanders AE, 2003, RADIOGRAPHICS, V23, P1035, DOI 10.1148/rg.234035011; Goost H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043402; Ichikawa K, 2006, J SOC INF DISPLAY, V14, P831, DOI 10.1889/1.2372416; Ichikawa K, 2008, RADIOL PHYS TECHNOL, V1, P201, DOI 10.1007/s12194-008-0029-y; John S, 2012, J DIGIT IMAGING, V25, P628, DOI 10.1007/s10278-012-9485-3; Johnson PT, 2012, EMERG RADIOL, V19, P323, DOI 10.1007/s10140-012-1037-0; Lee JH, 2008, OPT EXPRESS, V16, P21184, DOI 10.1364/OE.16.021184; Mc Laughlin P, 2012, EMERG RADIOL, V19, P127, DOI 10.1007/s10140-011-1011-2; McCarthy MA, 2011, SCIENCE, V332, P570, DOI 10.1126/science.1203052; McNulty JP, 2012, ACAD RADIOL, V19, P1023, DOI 10.1016/j.acra.2012.02.021; Park JB, 2013, J DIGITAL IMAGING; Samei E, 2005, MED PHYS, V32, P1205, DOI 10.1118/1.1861159; Saunders RS, 2006, MED PHYS, V33, P308, DOI 10.1118/1.2150777; Toomey RJ, 2010, AM J ROENTGENOL, V194, P469, DOI 10.2214/AJR.09.3418; Tuijn CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028348; Vogel R, 2007, J SOC INF DISPLAY, V15, P357, DOI 10.1889/1.2749321; Zafar F, 2012, J SOC INF DISPLAY, V20, P124, DOI 10.1889/JSID20.3.124	21	12	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79243	10.1371/journal.pone.0079243	http://dx.doi.org/10.1371/journal.pone.0079243			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236113	gold, Green Submitted, Green Published			2022-12-27	WOS:000327254700112
J	Khalki, L; M'hamed, SB; Sokar, Z; Bennis, M; Vinay, L; Bras, H; Viemari, JC				Khalki, Loubna; M'hamed, Saadia Ba; Sokar, Zahra; Bennis, Mohamed; Vinay, Laurent; Bras, Helene; Viemari, Jean-Charles			Prenatal Exposure to Fenugreek Impairs Sensorimotor Development and the Operation of Spinal Cord Networks in Mice	PLOS ONE			English	Article							KCL COTRANSPORTER KCC2; GRAECUM SEED POWDER; GAIT ANALYSIS; LUMBAR MOTONEURONS; RAT; LOCOMOTION; SEROTONIN; TRANSECTION; POTENTIALS; TISSUES	Fenugreek is a medicinal plant whose seeds are widely used in traditional medicine, mainly for its laxative, galactagogue and antidiabetic effects. However, consumption of fenugreek seeds during pregnancy has been associated with a range of congenital malformations, including hydrocephalus, anencephaly and spina bifida in humans. The present study was conducted to evaluate the effects of prenatal treatment of fenugreek seeds on the development of sensorimotor functions from birth to young adults. Pregnant mice were treated by gavage with 1g/kg/day of lyophilized fenugreek seeds aqueous extract (FSAE) or distilled water during the gestational period. Behavioral tests revealed in prenatally treated mice a significant delay in righting, cliff avoidance, negative geotaxis responses and the swimming development. In addition, extracellular recording of motor output in spinal cord isolated from neonatal mice showed that the frequency of spontaneous activity and fictive locomotion was reduced in FSAE-exposed mice. On the other hand, the cross-correlation coefficient in control mice was significantly more negative than in treated animals indicating that alternating patterns are deteriorated in FSAE-treated animals. At advanced age, prenatally treated mice displayed altered locomotor coordination in the rotarod test and also changes in static and dynamic parameters assessed by the CatWalk automated gait analysis system. We conclude that FSAE impairs sensorimotor and coordination functions not only in neonates but also in adult mice. Moreover, spinal neuronal networks are less excitable in prenatally FSAE-exposed mice suggesting that modifications within the central nervous system are responsible, at least in part, for the motor impairments.	[Khalki, Loubna; M'hamed, Saadia Ba; Sokar, Zahra; Bennis, Mohamed] Cadi Ayyad Univ, Ctr Natl Rech Sci & Tech URAC 37, Lab Pharmacol Neurobiol & Comportement, Marrakech, Morocco; [Khalki, Loubna; Vinay, Laurent; Bras, Helene; Viemari, Jean-Charles] Aix Marseille Univ, CNRS, Team P3M, Inst Neurosci Timone, Marseille, France	Cadi Ayyad University of Marrakech; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Viemari, JC (corresponding author), Aix Marseille Univ, CNRS, Team P3M, Inst Neurosci Timone, Marseille, France.	jean-charles.viemari@univ-amu.fr	Bras, Helene/L-8915-2018	Viemari, Jean-Charles/0000-0001-6614-1461; sokar, zahra/0000-0002-8646-4660	Groupement De Recherche International en Neuroscience GDRI-Neuro (CNRS/CNRST/INSERM); NEUROMED project	Groupement De Recherche International en Neuroscience GDRI-Neuro (CNRS/CNRST/INSERM); NEUROMED project	The authors acknowledge support from the Groupement De Recherche International en Neuroscience GDRI-Neuro (CNRS/CNRST/INSERM) and the NEUROMED project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, GUIDANCE IND ESTIMAT; Aruga J, 1998, J NEUROSCI, V18, P284; ATSUTA Y, 1990, J NEUROPHYSIOL, V64, P727, DOI 10.1152/jn.1990.64.3.727; Bellakhdar J, 1997, EDITIONS FENNEC; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; Bin-Hafeez B, 2003, INT IMMUNOPHARMACOL, V3, P257, DOI 10.1016/S1567-5769(02)00292-8; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; Boulenguez P, 2010, NAT MED, V16, P302, DOI 10.1038/nm.2107; Brocard F, 1999, DEV BRAIN RES, V117, P81, DOI 10.1016/S0165-3806(99)00101-7; CAZALETS JR, 1990, BEHAV BRAIN RES, V40, P215, DOI 10.1016/0166-4328(90)90078-S; CAZALETS JR, 1992, J PHYSIOL-LONDON, V455, P187, DOI 10.1113/jphysiol.1992.sp019296; Cheng HR, 1997, EXP NEUROL, V148, P544, DOI 10.1006/exnr.1997.6708; Clarac F, 1998, BRAIN RES REV, V28, P35, DOI 10.1016/S0165-0173(98)00024-1; Deumens R, 2007, J NEUROSCI METH, V164, P120, DOI 10.1016/j.jneumeth.2007.04.009; Fellippa-Marques S, 2000, EUR J NEUROSCI, V12, P155, DOI 10.1046/j.1460-9568.2000.00895.x; FOX WM, 1965, ANIM BEHAV, V13, P234, DOI 10.1016/0003-3472(65)90041-2; Geisler Hildegard C., 1993, Acta Neurobiologiae Experimentalis (Warsaw), V53, P517; Hamers FPT, 2006, J NEUROTRAUM, V23, P537, DOI 10.1089/neu.2006.23.537; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hanson MG, 2006, J NEUROSCI, V26, P12769, DOI 10.1523/JNEUROSCI.4170-06.2006; Huberman AD, 2006, NEURON, V52, P247, DOI 10.1016/j.neuron.2006.07.028; Jean-Xavier C, 2006, J NEUROPHYSIOL, V96, P2274, DOI 10.1152/jn.00328.2006; Jones TA, 2000, J NEUROPHYSIOL, V83, P1452, DOI 10.1152/jn.2000.83.3.1452; Jordan LM, 2008, BRAIN RES REV, V57, P183, DOI 10.1016/j.brainresrev.2007.07.019; KALLMAN, 1994, ASSESSMENT MOTORIC E, P103; KAMAL R, 1993, PHYTOTHER RES, V7, P134, DOI 10.1002/ptr.2650070208; Kassem A, 2006, CONTRACEPTION, V73, P301, DOI 10.1016/j.contraception.2005.08.020; Khalki L, 2012, J ETHNOPHARMACOL, V139, P672, DOI 10.1016/j.jep.2011.12.011; Khalki L, 2010, J ETHNOPHARMACOL, V131, P321, DOI 10.1016/j.jep.2010.06.033; Koopmans GC, 2007, PHYSIOL BEHAV, V92, P993, DOI 10.1016/j.physbeh.2007.07.018; Kumar P, 2012, EUR REV MED PHARMACO, V16, P18; Liu J, 2005, J NEUROPHYSIOL, V94, P1392, DOI 10.1152/jn.00136.2005; Myers CP, 2005, NEURON, V46, P37, DOI 10.1016/j.neuron.2005.02.022; Neumann M, 2009, J NEUROSCI METH, V176, P34, DOI 10.1016/j.jneumeth.2008.08.026; O'Donovan MJ, 1999, CURR OPIN NEUROBIOL, V9, P94, DOI 10.1016/S0959-4388(99)80012-9; Pearlstein E, 2005, EUR J NEUROSCI, V21, P1338, DOI 10.1111/j.1460-9568.2005.03971.x; Pflieger JF, 2002, J NEUROSCI, V22, P5108, DOI 10.1523/JNEUROSCI.22-12-05108.2002; Raju J, 2001, MOL CELL BIOCHEM, V224, P45, DOI 10.1023/A:1011974630828; REICHLING DB, 1994, J PHYSIOL-LONDON, V476, P411, DOI 10.1113/jphysiol.1994.sp020142; Sabiri N., 2013, J PEDIAT PUERICULT, V26, P198, DOI DOI 10.1016/J.JPP.2013.05.001; Sadlaoud K, 2010, J NEUROSCI, V30, P3358, DOI 10.1523/JNEUROSCI.6310-09.2010; Santillan ME, 2010, NUTRITION, V26, P423, DOI 10.1016/j.nut.2009.06.005; Secher T, 2006, NEUROSCIENCE, V141, P1289, DOI 10.1016/j.neuroscience.2006.04.059; Skalli S., 2006, B INFORM PHARMACOVIG, V3; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Spitzer NC, 2012, NAT REV NEUROSCI, V13, P94, DOI 10.1038/nrn3154; Stil A, 2011, EUR J NEUROSCI, V33, P1212, DOI 10.1111/j.1460-9568.2010.07592.x; Thakran S, 2004, MOL CELL BIOCHEM, V266, P151, DOI 10.1023/B:MCBI.0000049153.14295.0d; Vinay L, 2000, BRAIN RES BULL, V53, P635, DOI 10.1016/S0361-9230(00)00397-X; WESTERGA J, 1993, EARLY HUM DEV, V34, P89, DOI 10.1016/0378-3782(93)90044-U; Whelan P, 2000, J NEUROPHYSIOL, V84, P2821, DOI 10.1152/jn.2000.84.6.2821; Yakovenko S, 2005, J NEUROPHYSIOL, V94, P1057, DOI 10.1152/jn.00991.2004; Ziskind-Conhaim L, 1998, PERSPECT DEV NEUROBI, V5, P279	54	11	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80013	10.1371/journal.pone.0080013	http://dx.doi.org/10.1371/journal.pone.0080013			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224030	Green Published, Green Submitted, gold			2022-12-27	WOS:000326597400103
J	Qin, ZX; Kaufman, RS; Khoury, RN; Khoury, MK; Aswad, DW				Qin, Zhenxia; Kaufman, Rachel S.; Khoury, Rana N.; Khoury, Mitri K.; Aswad, Dana W.			Isoaspartate Accumulation in Mouse Brain Is Associated with Altered Patterns of Protein Phosphorylation and Acetylation, Some of Which Are Highly Sex-Dependent	PLOS ONE			English	Article							SYNAPSIN-I; CARBOXYL METHYLTRANSFERASE; O-METHYLTRANSFERASE; SYNAPTIC-TRANSMISSION; DEFICIENT MICE; REPAIR ENZYME; ASPARAGINE RESIDUES; ASPARTYL RESIDUES; DAMAGED PROTEINS; DEAMIDATION	Isoaspartate (isoAsp) formation is a major source of protein damage that is kept in check by the repair function of protein L-isoaspartyl methyltransferase (PIMT). Mice deficient in PIMT accumulate isoAsp-containing proteins, resulting in cognitive deficits, abnormal neuronal physiology and cytoarchitecture, and fatal epileptic seizures 30-60 days after birth. Synapsins I and II, dynamin-1, collapsin response mediator protein 2 (CRMP2), and alpha/beta-tubulin are major targets of PIMT in brain. To investigate links between isoAsp accumulation and the neurological phenotype of the KO mice, we used Western blotting to compare patterns of in vivo phosphorylation or acetylation of the major PIMT targets listed above. Phosphorylations of synapsins I and II at Ser-9 were increased in female KO vs. WT mice, and acetylation of tubulin at Lys-40 was decreased in male KO vs. WT mice. Average levels of dynamin-1 phosphorylation at Ser-778 and Ser-795 were higher in male KO vs. WT mice, but the statistical significance (P>0.1) was low. No changes in phosphorylation were found in synapsins I and II at Ser-603, in CRMP2 at Ser-522 or Thr-514, in DARPP-32 at Thr-34, or in PDK1 at Ser-241. General levels of phosphorylation assessed with Pro-Q Diamond stain, or an anti-phosphotyrosine antibody, appeared similar in the WT and KO mice. We conclude that isoAsp accumulation is associated with altered functional status of several neuronal proteins that are highly susceptible to this type of damage. We also uncovered unexpected differences in how male and female mice respond to isoAsp accumulation in the brain.	[Qin, Zhenxia; Kaufman, Rachel S.; Khoury, Rana N.; Khoury, Mitri K.; Aswad, Dana W.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA	University of California System; University of California Irvine	Aswad, DW (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA.	dwaswad@uci.edu			National Institutes of Health [NS-17269]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017269] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was funded solely by National Institutes of Health grant NS-17269. http://grants.nih.gov/grants/oer.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASWAD DW, 1984, J BIOL CHEM, V259, P714; BENFENATI F, 1989, J CELL BIOL, V108, P1851, DOI 10.1083/jcb.108.5.1851; Bidinosti M, 2010, J BIOL CHEM, V285, P19402, DOI 10.1074/jbc.M110.120774; Bidinosti M, 2010, MOL CELL, V37, P797, DOI 10.1016/j.molcel.2010.02.022; BOIVIN D, 1995, BIOCHEM J, V309, P993, DOI 10.1042/bj3090993; BRENNAN TV, 1994, J BIOL CHEM, V269, P24586; Cahill L, 2012, ENDOCRINOLOGY, V153, P2541, DOI 10.1210/en.2011-2167; Carter WG, 2008, BIOCHEMISTRY-US, V47, P10757, DOI 10.1021/bi8013467; Cesca F, 2010, PROG NEUROBIOL, V91, P313, DOI 10.1016/j.pneurobio.2010.04.006; Cheetham JJ, 2001, BIOCHEM J, V354, P57, DOI 10.1042/0264-6021:3540057; Clarke S, 2003, AGEING RES REV, V2, P263, DOI 10.1016/S1568-1637(03)00011-4; Corradi A, 2008, J CELL SCI, V121, P3042, DOI 10.1242/jcs.035063; Desrosiers Richard R, 2011, Curr Aging Sci, V4, P8; DILIBERTO EJ, 1976, J NEUROCHEM, V26, P1159, DOI 10.1111/j.1471-4159.1976.tb07001.x; Farrar C, 2005, AGING CELL, V4, P1, DOI 10.1111/j.1474-9728.2004.00136.x; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; GALLETTI P, 1988, BIOCHEMISTRY-US, V27, P1752, DOI 10.1021/bi00405a055; GEIGER T, 1987, J BIOL CHEM, V262, P785; Gitler D, 2004, J NEUROSCI, V24, P11368, DOI 10.1523/JNEUROSCI.3795-04.2004; Hensley K, 2011, MOL NEUROBIOL, V43, P180, DOI 10.1007/s12035-011-8166-4; Hosaka M, 1999, NEURON, V24, P377, DOI 10.1016/S0896-6273(00)80851-X; Ikegaya Y, 2001, HIPPOCAMPUS, V11, P287, DOI 10.1002/hipo.1043; Iwata SI, 1996, J PHARMACOL EXP THER, V278, P1428; Jazin E, 2010, NAT REV NEUROSCI, V11, P9, DOI 10.1038/nrn2754; JOHNSON BA, 1987, J BIOL CHEM, V262, P12283; JOHNSON BA, 1993, J BIOL CHEM, V268, P6174; JOHNSON BA, 1987, J BIOL CHEM, V262, P5622; JOHNSON BA, 1985, BIOCHEMISTRY-US, V24, P2581, DOI 10.1021/bi00331a028; Khoury MK, 2010, ANAL BIOCHEM, V397, P129, DOI 10.1016/j.ab.2009.09.041; Kim E, 1997, P NATL ACAD SCI USA, V94, P6132, DOI 10.1073/pnas.94.12.6132; Kim E, 1999, J BIOL CHEM, V274, P20671, DOI 10.1074/jbc.274.29.20671; Kosugi S, 2008, BIOCHEM BIOPH RES CO, V371, P22, DOI 10.1016/j.bbrc.2008.03.109; Le Novere N, 2008, CELL MOL LIFE SCI, V65, P2125, DOI 10.1007/s00018-008-8150-y; LI L, 1995, P NATL ACAD SCI USA, V92, P9235, DOI 10.1073/pnas.92.20.9235; Lindner H, 2001, EXP GERONTOL, V36, P1551, DOI 10.1016/S0531-5565(01)00140-1; MCFADDEN PN, 1987, P NATL ACAD SCI USA, V84, P2595, DOI 10.1073/pnas.84.9.2595; MURRAY ED, 1984, J BIOL CHEM, V259, P722; Najbauer J, 1996, BIOCHEMISTRY-US, V35, P5183, DOI 10.1021/bi953063g; OHTA K, 1987, BIOCHIMIE, V69, P1227, DOI 10.1016/0300-9084(87)90150-7; Perdiz D, 2011, CELL SIGNAL, V23, P763, DOI 10.1016/j.cellsig.2010.10.014; Reissner KJ, 2006, J BIOL CHEM, V281, P8389, DOI 10.1074/jbc.M510716200; Reissner KJ, 2003, CELL MOL LIFE SCI, V60, P1281, DOI 10.1007/s00018-003-2287-5; Robinson NE, 2004, J PEPT RES, V63, P426, DOI 10.1111/j.1399-3011.2004.00151.x; Sharma SK, 2002, ANAL BIOCHEM, V307, P187, DOI 10.1016/S0003-2697(02)00008-8; Shimizu T, 2005, BIOL PHARM BULL, V28, P1590, DOI 10.1248/bpb.28.1590; Stefani G, 1997, J PHYSIOL-LONDON, V504, P501, DOI 10.1111/j.1469-7793.1997.501bd.x; STROMBOM U, 1979, P NATL ACAD SCI USA, V76, P4687, DOI 10.1073/pnas.76.9.4687; TYLERCROSS R, 1991, J BIOL CHEM, V266, P22549; Vitali R, 2004, BEHAV BRAIN RES, V153, P129, DOI 10.1016/j.bbr.2003.11.007; Volkin DB, 1997, MOL BIOTECHNOL, V8, P105, DOI 10.1007/BF02752255; YAMAGATA Y, 1995, NEUROSCIENCE, V64, P1, DOI 10.1016/0306-4522(94)00492-N; Yamamoto A, 1998, J NEUROSCI, V18, P2063; Young AL, 2001, J BIOL CHEM, V276, P37161, DOI 10.1074/jbc.M106682200; Zhu JX, 2006, J BIOL CHEM, V281, P33802, DOI 10.1074/jbc.M606958200	54	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80758	10.1371/journal.pone.0080758	http://dx.doi.org/10.1371/journal.pone.0080758			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224061	Green Published, gold			2022-12-27	WOS:000326597400124
J	Ramsay, H; Kelleher, I; Flannery, P; Clarke, MC; Lynch, F; Harley, M; Connor, D; Fitzpatrick, C; Morris, DW; Cannon, M				Ramsay, Hugh; Kelleher, Ian; Flannery, Padraig; Clarke, Mary C.; Lynch, Fionnuala; Harley, Michelle; Connor, Dearbhla; Fitzpatrick, Carol; Morris, Derek W.; Cannon, Mary			Relationship between the COMT-Val158Met and BDNF-Val66Met Polymorphisms, Childhood Trauma and Psychotic Experiences in an Adolescent General Population Sample	PLOS ONE			English	Article							CATECHOL-O-METHYLTRANSFERASE; COMT VAL(158)MET MODERATION; HYPERACTIVITY DISORDER ADHD; DELUSIONAL-LIKE EXPERIENCES; ENVIRONMENT INTERACTIONS; ENZYME-ACTIVITY; MENTAL-HEALTH; CANNABIS USE; RISK-FACTOR; SYMPTOMS	Objective: Psychotic experiences occur at a much greater prevalence in the population than psychotic disorders. There has been little research to date, however, on genetic risk for this extended psychosis phenotype. We examined whether COMT or BDNF genotypes were associated with psychotic experiences or interacted with childhood trauma in predicting psychotic experiences. Method: Psychiatric interviews and genotyping for COMT-Val158Met and BDNF-Val66Met were carried out on two population-based samples of 237 individuals aged 11-15 years. Logistic regression was used to examine for main effects by genotype and childhood trauma, controlling for important covariates. This was then compared to a model with a term for interaction between genotype and childhood trauma. Where a possible interaction was detected, this was further explored in stratified analyses. Results: While childhood trauma showed a borderline association with psychotic experiences, COMT-Val158Met and BDNF-Val66Met genotypes were not directly associated with psychotic experiences in the population. Testing for gene x environment interaction was borderline significant in the case of COMT-Val158Met with individuals with the COMT-Val158Met Val-Val genotype, who had been exposed to childhood trauma borderline significantly more likely to report psychotic experiences than those with Val-Met or Met-Met genotypes. There was no similar interaction by BDNF-Val66Met genotype. Conclusion: The COMT-Val158Met Val-Val genotype may be a genetic moderator of risk for psychotic experiences in individuals exposed to childhood traumatic experiences.	[Ramsay, Hugh; Kelleher, Ian; Flannery, Padraig; Clarke, Mary C.; Harley, Michelle; Connor, Dearbhla; Cannon, Mary] Beaumont Hosp, Royal Coll Surg Ireland, Dept Psychiat, Dublin 9, Ireland; [Kelleher, Ian] Karolinska Inst, Natl Ctr Suicide Res & Prevent Mental Hlth 3, Stockholm, Sweden; [Lynch, Fionnuala] Lucena Clin, Dublin, Ireland; [Harley, Michelle] St Vincents Hosp, Dept Child & Adolescent Psychiat, Dublin 4, Ireland; [Fitzpatrick, Carol] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland; [Morris, Derek W.] Trinity Coll Dublin, Dept Psychiat, Neuropsychiat Genet Res Grp, Dublin, Ireland; [Morris, Derek W.] Trinity Coll Dublin, Inst Mol Med, Dublin, Ireland	Royal College of Surgeons - Ireland; Karolinska Institutet; University College Dublin; Trinity College Dublin; Trinity College Dublin	Ramsay, H (corresponding author), Beaumont Hosp, Royal Coll Surg Ireland, Dept Psychiat, Dublin 9, Ireland.	drhughramsay@gmail.com	Flannery, Padraig/HCI-9510-2022; Cannon, Mary/D-8227-2012; Morris, Derek/AAW-8343-2021	Cannon, Mary/0000-0002-0910-299X; Morris, Derek/0000-0002-3413-570X; Kelleher, Ian/0000-0003-1484-651X	European Communities Seventh Framework Programme [HEALTH-F2-2010-241909]; Health Research Board (Ireland) [CSA/2004/1]; Friends of the Children's University Hospital (Dublin); American Foundation for Suicide Prevention; HSE Northern Area; Mater Misericordiae University Hospital	European Communities Seventh Framework Programme(European Commission); Health Research Board (Ireland); Friends of the Children's University Hospital (Dublin); American Foundation for Suicide Prevention; HSE Northern Area; Mater Misericordiae University Hospital	The research leading to these results has received funding from the European Communities Seventh Framework Programme under grant agreement HEALTH-F2-2010-241909 (Project EU-GEI); EU-GEI is the acronym of the project European Network of National Schizophrenia Networks Studying Gene-Environment Interactions. This work was supported by a Clinician Scientist Award to Dr Cannon (CSA/2004/1) from the Health Research Board (Ireland). The original Challenging Times study was funded by Friends of the Children's University Hospital (Dublin), the American Foundation for Suicide Prevention, HSE Northern Area and the Mater Misericordiae University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera M, 2009, PSYCHOL MED, V39, P1425, DOI 10.1017/S0033291709005248; Alemany S, 2011, BRIT J PSYCHIAT, V199, P38, DOI 10.1192/bjp.bp.110.083808; Bebbington PE, 2004, BRIT J PSYCHIAT, V185, P220, DOI 10.1192/bjp.185.3.220; Bendall S, 2008, SCHIZOPHRENIA BULL, V34, P568, DOI 10.1093/schbul/sbm121; Binbay T, 2012, SCHIZOPHRENIA BULL, V38, P992, DOI 10.1093/schbul/sbr003; Caspi A, 2005, BIOL PSYCHIAT, V57, P1117, DOI 10.1016/j.biopsych.2005.01.026; Caspi A, 2008, ARCH GEN PSYCHIAT, V65, P203, DOI 10.1001/archgenpsychiatry.2007.24; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Eisenberg J, 1999, AM J MED GENET, V88, P497, DOI 10.1002/(SICI)1096-8628(19991015)88:5<497::AID-AJMG12>3.3.CO;2-6; Fisher HL, 2013, PSYCHOL MED, V43, P2077, DOI 10.1017/S0033291712003091; Gale CK, 2011, ACTA PSYCHIAT SCAND, V124, P205, DOI 10.1111/j.1600-0447.2011.01707.x; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Harley M, 2010, PSYCHOL MED, V40, P1627, DOI 10.1017/S0033291709991966; HARLEY M, 2013, IR J MED SC IN PRESS; Hawi Z, 2000, AM J MED GENET, V96, P282, DOI 10.1002/1096-8628(20000612)96:3<282::AID-AJMG9>3.0.CO;2-R; Henquet C, 2009, ACTA PSYCHIAT SCAND, V119, P156, DOI 10.1111/j.1600-0447.2008.01265.x; Janssen I, 2004, ACTA PSYCHIAT SCAND, V109, P38, DOI 10.1046/j.0001-690X.2003.00217.x; Karayiorgou M, 1997, P NATL ACAD SCI USA, V94, P4572, DOI 10.1073/pnas.94.9.4572; Kaufman J, 1996, SCHEDULE AFFECTIVE D; Kelleher I, 2012, PSYCHOL MED, V42, P1857, DOI 10.1017/S0033291711002960; Kelleher I, 2012, BRIT J PSYCHIAT, V201, P26, DOI 10.1192/bjp.bp.111.101543; Kelleher I, 2011, PSYCHOL MED, V41, P1, DOI 10.1017/S0033291710001005; Kelleher I, 2008, BRIT J PSYCHIAT, V193, P378, DOI 10.1192/bjp.bp.108.049536; Kelleher I, 2013, AM J PSYCHIAT, V170, P734, DOI 10.1176/appi.ajp.2012.12091169; Kelleher I, 2012, ARCH GEN PSYCHIAT, V69, P1277, DOI 10.1001/archgenpsychiatry.2012.164; Kelleher I, 2012, SCHIZOPHRENIA BULL, V38, P239, DOI 10.1093/schbul/sbr164; Kelleher I, 2010, BRIT J PSYCHIAT, V197, P167, DOI 10.1192/bjp.bp.109.076018; Kia-Keating BM, 2007, AM J MED GENET B, V144B, P1048, DOI 10.1002/ajmg.b.30551; Kirov G, 1998, MOL PSYCHIATR, V3, P342, DOI 10.1038/sj.mp.4000385; Klengel T, 2013, NAT NEUROSCI, V16, P33, DOI 10.1038/nn.3275; Kolassa IT, 2010, BIOL PSYCHIAT, V67, P304, DOI 10.1016/j.biopsych.2009.10.009; KOVACS M, 1985, PSYCHOPHARMACOL BULL, V21, P995; Kovacs M., 1992, CHILDRENS DEPRESSION; Lataster T, 2006, SOC PSYCH PSYCH EPID, V41, P423, DOI 10.1007/s00127-006-0060-4; Laurens KR, 2012, PSYCHOL MED, V42, P1495, DOI 10.1017/S0033291711002108; Linscott RJ, 2013, PSYCHOL MED, V43, P1133, DOI 10.1017/S0033291712001626; Lynch F, 2006, J ADOLESCENCE, V29, P555, DOI 10.1016/j.adolescence.2005.08.011; MANDELLI L, 2013, NEUROSCI BIOBEHAV R, P86513; Meira-Lima I, 2004, GENES BRAIN BEHAV, V3, P75, DOI 10.1046/j.1601-1848.2003.0042.x; Morgan C, 2007, SCHIZOPHRENIA BULL, V33, P3, DOI 10.1093/schbul/sbl053; Nishida A, 2010, ACTA PSYCHIAT SCAND, V121, P301, DOI 10.1111/j.1600-0447.2009.01439.x; Nurjono Milawaty, 2012, Clin Psychopharmacol Neurosci, V10, P61, DOI 10.9758/cpn.2012.10.2.61; Peerbooms O, 2012, ACTA PSYCHIAT SCAND, V125, P247, DOI 10.1111/j.1600-0447.2011.01806.x; Polanczyk G, 2010, ARCH GEN PSYCHIAT, V67, P328, DOI 10.1001/archgenpsychiatry.2010.14; Poulton R, 2000, ARCH GEN PSYCHIAT, V57, P1053, DOI 10.1001/archpsyc.57.11.1053; Read J, 2005, ACTA PSYCHIAT SCAND, V112, P330, DOI 10.1111/j.1600-0447.2005.00634.x; Saha S, 2011, SCHIZOPHR RES, V132, P197, DOI 10.1016/j.schres.2011.07.012; Savitz J, 2010, BEHAV GENET, V40, P415, DOI 10.1007/s10519-009-9323-7; Scott J, 2009, AM J PSYCHIAT, V166, P567, DOI 10.1176/appi.ajp.2008.08081182; Scott J, 2009, SCHIZOPHR RES, V107, P179, DOI 10.1016/j.schres.2008.11.002; Shoval G, 2005, EUR NEUROPSYCHOPHARM, V15, P319, DOI 10.1016/j.euroneuro.2004.12.005; Simons CJP, 2009, GENES BRAIN BEHAV, V8, P5, DOI 10.1111/j.1601-183X.2008.00434.x; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Spataro J, 2004, BRIT J PSYCHIAT, V184, P416, DOI 10.1192/bjp.184.5.416; Spauwen J, 2006, BRIT J PSYCHIAT, V188, P527, DOI 10.1192/bjp.bp.105.011346; Stefanis NC, 2007, PSYCHOL MED, V37, P1651, DOI 10.1017/S0033291707001080; Tunbridge EM, 2006, BIOL PSYCHIAT, V60, P141, DOI 10.1016/j.biopsych.2005.10.024; van Dam DS, 2012, PSYCHOL MED, V42, P2463, DOI 10.1017/S0033291712000360; van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814; Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050; Varghese D, 2013, ACTA PSYCHIAT SCAND, V127, P48, DOI 10.1111/j.1600-0447.2012.01905.x; VINKERS CH, 2013, SCHIZOPHR RES; Weinshilboum RM, 1999, ANNU REV PHARMACOL, V39, P19, DOI 10.1146/annurev.pharmtox.39.1.19; Welham J, 2009, PSYCHOL MED, V39, P625, DOI 10.1017/S0033291708003760; Werbeloff N, 2012, ARCH GEN PSYCHIAT, V69, P467, DOI 10.1001/archgenpsychiatry.2011.1580; Wigman JTW, 2012, ACTA PSYCHIAT SCAND, V126, P266, DOI 10.1111/j.1600-0447.2012.01857.x; Wigman JTW, 2012, SCHIZOPHRENIA BULL, V38, P247, DOI 10.1093/schbul/sbr196; Williams HJ, 2007, SCHIZOPHRENIA BULL, V33, P635, DOI 10.1093/schbul/sbm019; Zammit S, 2011, BRIT J PSYCHIAT, V199, P380, DOI 10.1192/bjp.bp.111.091421	70	26	26	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79741	10.1371/journal.pone.0079741	http://dx.doi.org/10.1371/journal.pone.0079741			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224001	gold, Green Submitted, Green Published			2022-12-27	WOS:000326597400084
J	Ellis, ECS; Nauglers, S; Parini, P; Mork, LM; Jorns, C; Zemack, H; Sandblom, AL; Bjorkhem, I; Ericzon, BG; Wilson, EM; Strom, SC; Grompe, M				Ellis, Ewa C. S.; Nauglers, Scott; Parini, Paolo; Mork, Lisa-Mari; Jorns, Carl; Zemack, Helen; Sandblom, Anita Lovgren; Bjorkhem, Ingemar; Ericzon, Bo-Goran; Wilson, Elizabeth M.; Strom, Stephen C.; Grompe, Markus			Mice with Chimeric Livers Are an Improved Model for Human Lipoprotein Metabolism	PLOS ONE			English	Article							BILE-ACID SYNTHESIS; CHOLESTEROL 7-ALPHA-HYDROXYLASE; HUMAN HEPATOCYTES; CONJUGATION; CULTURES; PLASMA; SIGNAL; RAT	Objective: Rodents are poor model for human hyperlipidemias because total cholesterol and low density lipoprotein levels are very low on a normal diet. Lipoprotein metabolism is primarily regulated by hepatocytes and we therefore assessed whether chimeric mice extensively repopulated with human cells can model human lipid and bile acid metabolism. Design: FRG [FahRag2(-/-)Il2rg(-/-)]) mice were repopulated with primary human hepatocytes. Serum lipoprotein lipid composition and distribution (VLDL, LDL, and HDL) was analyzed by size exclusion chromatography. Bile was analyzed by LC-MS or by GC-MS. RNA expression levels were measured by quantitative RT-PCR. Results: Chimeric mice displayed increased LDL and VLDL fractions and a lower HDL fraction compared to wild type, thus significantly shifting the ratio of LDL/HDL towards a human profile. Bile acid analysis revealed a human-like pattern with high amounts of cholic acid and deoxycholic acid (DCA). Control mice had only taurine-conjugated bile acids as expcted, but highly repopulated mice had glycine-conjugated cholic acid as found in human bile. RNA levels of human genes involved in bile acid synthesis including CYP7A1, and CYP27A1 were significantly upregulated as compared to human control liver. However, administration of recombinant hFGF19 restored human CYP7A1 levels to normal. Conclusion: Humanized-liver mice showed a typical human lipoprotein profile with LDL as the predominant lipoprotein fraction even on a normal diet. The bile acid profile confirmed presence of an intact enterohepatic circulation. Although bile acid synthesis was deregulated in this model, this could be fully normalized by FGF19 administration. Taken together these data indicate that chimeric FRG-mice are a useful new model for human lipoprotein and bile-acid metabolism.	[Ellis, Ewa C. S.; Mork, Lisa-Mari; Jorns, Carl; Zemack, Helen; Ericzon, Bo-Goran] Karolinska Univ, Huddinge Hosp, Dept Clin Sci Intervent & Technol CLINTEC, Div Transplantat Surg,Karolinska Inst, Stockholm, Sweden; [Nauglers, Scott; Grompe, Markus] Oregon Hlth & Sci Univ, Oregon Stem Cell Ctr, Pape Family Pediat Res Inst, Portland, OR USA; [Parini, Paolo; Sandblom, Anita Lovgren; Bjorkhem, Ingemar; Strom, Stephen C.] Karolinska Univ, Huddinge Hosp, Dept Lab Med, Stockholm, Sweden; [Wilson, Elizabeth M.] Yecuris Corp, Portland, OR USA	Karolinska Institutet; Karolinska University Hospital; Oregon Health & Science University; Karolinska Institutet; Karolinska University Hospital	Ellis, ECS (corresponding author), Karolinska Univ, Huddinge Hosp, Dept Clin Sci Intervent & Technol CLINTEC, Div Transplantat Surg,Karolinska Inst, Stockholm, Sweden.	Ewa.Ellis@ki.se	Ellis, Ewa C S/D-5370-2014; Jorns, Carl/AAE-6925-2021; Ericzon, Bo-Goran/AAH-5328-2020	Ellis, Ewa C S/0000-0002-3057-5337; Jorns, Carl/0000-0001-7727-8113; Bjorkhem, Ingemar/0000-0001-6087-9190; Bjorkhem, Ingemar/0000-0002-0575-9425; Grompe, Markus/0000-0002-6616-4345; Strom, Stephen/0000-0002-2889-3387	National Institute of Health [R01DK05192]; Swedish Research Council; Swedish Heart-Lung Foundation; Karolinska Institute	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Karolinska Institute(Karolinska Institutet)	Human hepatocytes were obtained from Pittsburgh, PA (to Stephen C. Strom), through the Liver Tissue and Cell Distribution system (N01-DK-7-0004/HHSN267200700004C). This work was supported by grants from the National Institute of Health to Markus Grompe (R01DK05192). The Swedish Research Council, the Swedish Heart-Lung Foundation, the Karolinska Institute to PP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Bjorkhem I, 1997, Subcell Biochem, V28, P23; BJORKHEM I, 1983, SCAND J CLIN LAB INV, V43, P163, DOI 10.3109/00365518309168239; Chen Z, 2011, J CARDIOVASC TRANSL, V4, P801, DOI 10.1007/s12265-011-9309-8; Chiang JYL, 2001, GENE, V262, P257, DOI 10.1016/S0378-1119(00)00518-7; de Vries-van der Weij J, 2009, ATHEROSCLEROSIS, V206, P153, DOI 10.1016/j.atherosclerosis.2009.02.038; EINARSSON K, 1985, NEW ENGL J MED, V313, P277, DOI 10.1056/NEJM198508013130501; Ellis E, 1998, HEPATOLOGY, V27, P615, DOI 10.1002/hep.510270241; Ellis E, 2003, HEPATOLOGY, V38, P930, DOI 10.1053/jhep.2003.50394; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Inoue Y, 2004, J BIOL CHEM, V279, P2480, DOI 10.1074/jbc.M311015200; Kamimura H, 2010, DRUG METAB PHARMACOK, V25, P223, DOI 10.2133/dmpk.25.223; Katoh M, 2008, TOXICOLOGY, V246, P9, DOI 10.1016/j.tox.2007.11.012; Lundasen T, 2006, J INTERN MED, V260, P530, DOI 10.1111/j.1365-2796.2006.01731.x; MATOBA N, 1986, J LIPID RES, V27, P1154; Miao J, 2009, GENE DEV, V23, P986, DOI 10.1101/gad.1773909; Parini P, 2006, EUR J CLIN INVEST, V36, P98, DOI 10.1111/j.1365-2362.2006.01597.x; PRINCEN HMG, 1988, BIOCHEM BIOPH RES CO, V154, P1114, DOI 10.1016/0006-291X(88)90256-2; RUSSELL DW, 1992, BIOCHEMISTRY-US, V31, P4737, DOI 10.1021/bi00135a001; Schwarz M, 1998, J LIPID RES, V39, P1833; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; SJOVALL J, 1959, P SOC EXP BIOL MED, V100, P676; Society TR, 2004, USE NONHUMAN ANIMALS; Song KH, 2009, HEPATOLOGY, V49, P297, DOI 10.1002/hep.22627; Strom SC, 2010, METHODS MOL BIOL, V640, P491, DOI 10.1007/978-1-60761-688-7_27; Tagliacozzi D, 2003, CLIN CHEM LAB MED, V41, P1633, DOI 10.1515/CCLM.2003.247; YOKOYAMA HO, 1953, CANCER RES, V13, P80; Zaragoza C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/497841	29	34	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78550	10.1371/journal.pone.0078550	http://dx.doi.org/10.1371/journal.pone.0078550			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223822	Green Published, Green Submitted, gold			2022-12-27	WOS:000326503400072
J	Leyrat, C; Renner, M; Harlos, K; Grimes, JM				Leyrat, Cedric; Renner, Max; Harlos, Karl; Grimes, Jonathan M.			Solution and Crystallographic Structures of the Central Region of the Phosphoprotein from Human Metapneumovirus	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; C-TERMINAL DOMAIN; BINDING DOMAIN; N-P; PROTEIN; NUCLEOPROTEIN; SCATTERING; DISORDER; IDENTIFICATION; PREDICTION	Human metapneumovirus (HMPV) of the family Paramyxoviridae is a major cause of respiratory illness worldwide. Phosphoproteins (P) from Paramyxoviridae are essential co-factors of the viral RNA polymerase that form tetramers and possess long intrinsically disordered regions (IDRs). We located the central region of HMPV P (P-ced) which is involved in tetramerization using disorder analysis and modeled its 3D structure ab initio using Rosetta fold-and-dock. We characterized the solution-structure of P-ced using small angle X-ray scattering (SAXS) and carried out direct fitting to the scattering data to filter out incorrect models. Molecular dynamics simulations (MDS) and ensemble optimization were employed to select correct models and capture the dynamic character of P-ced. Our analysis revealed that oligomerization involves a compact central core located between residues 169-194 (P-core), that is surrounded by flexible regions with a-helical propensity. We crystallized this fragment and solved its structure at 3.1 angstrom resolution by molecular replacement, using the folded core from our SAXS-validated ab initio model. The RMSD between modeled and experimental tetramers is as low as 0.9 angstrom, demonstrating the accuracy of the approach. A comparison of the structure of HMPV P to existing mononegavirales P-ced structures suggests that P-ced evolved under weak selective pressure. Finally, we discuss the advantages of using SAXS in combination with ab initio modeling and MDS to solve the structure of small, homo-oligomeric protein complexes.	[Leyrat, Cedric; Renner, Max; Harlos, Karl; Grimes, Jonathan M.] Univ Oxford, Div Struct Biol, Oxford, England; [Grimes, Jonathan M.] Diamond Light Source Ltd, Div Sci, Didcot, Oxon, England	University of Oxford; Diamond Light Source	Leyrat, C (corresponding author), Univ Oxford, Div Struct Biol, Oxford, England.	cedric@strubi.ox.ac.uk	LEYRAT, Cédric/G-5559-2017	Leyrat, Cedric/0000-0003-0189-0562; Grimes, Jonathan Mark/0000-0001-9698-0389; Renner, Max/0000-0001-9885-8256	European Union [260644]; Wellcome trust [099667/Z/12/Z, 090532/Z/09/Z, 075491/Z/04]	European Union(European Commission); Wellcome trust(Wellcome TrustEuropean Commission)	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under SILVER grant agreement no 260644. Max Renner was supported by a Wellcome trust fellowship (099667/Z/12/Z). This work was also supported by the Wellcome Trust Core award (090532/Z/09/Z). Administrative support was provided by the Wellcome Trust (Grant 075491/Z/04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrescia NGA, 2012, ANNU REV BIOCHEM, V81, P795, DOI 10.1146/annurev-biochem-060910-095130; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BERENDSEN HJC, 1984, MOL DYNAMICS SIMULAT, V135, P500; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Best RB, 2009, J PHYS CHEM B, V113, P9004, DOI 10.1021/jp901540t; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Blanchard L, 2004, VIROLOGY, V319, P201, DOI 10.1016/j.virol.2003.10.029; Boivin G, 2002, J INFECT DIS, V186, P1330, DOI 10.1086/344319; Buchholz UJ, 2005, J VIROL, V79, P6588, DOI 10.1128/JVI.79.11.6588-6597.2005; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Communie G, 2013, J VIROL, V87, P7166, DOI 10.1128/JVI.00487-13; Cox R, 2013, J VIROL, V87, P7558, DOI 10.1128/JVI.00653-13; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Das R, 2009, P NATL ACAD SCI USA, V106, P18978, DOI 10.1073/pnas.0904407106; Derdowski A, 2008, J GEN VIROL, V89, P2698, DOI 10.1099/vir.0.2008/004051-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Expert-Bezancon N, 2003, BIOPHYS CHEM, V100, P469, DOI 10.1016/S0301-4622(02)00299-5; Fearns R, 1999, J VIROL, V73, P5852, DOI 10.1128/JVI.73.7.5852-5864.1999; GarciaBarreno B, 1996, J VIROL, V70, P801; Gerard FCA, 2009, J MOL BIOL, V388, P978, DOI 10.1016/j.jmb.2009.03.061; Habchi J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011684; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Hyndman TH, 2012, INFECT GENET EVOL, V12, P1436, DOI 10.1016/j.meegid.2012.04.022; Jensen MR, 2010, PROTEIN PEPTIDE LETT, V17, P952; Johansson K, 2003, J BIOL CHEM, V278, P44567, DOI 10.1074/jbc.M308745200; Karlin D, 2003, J GEN VIROL, V84, P3239, DOI 10.1099/vir.0.19451-0; Khattar SK, 2001, J GEN VIROL, V82, P775, DOI 10.1099/0022-1317-82-4-775; Khattar SK, 2001, VIROLOGY, V285, P253, DOI 10.1006/viro.2001.0960; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leyrat C, 2012, J MOL BIOL, V423, P182, DOI 10.1016/j.jmb.2012.07.003; Leyrat C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002248; Leyrat C, 2011, PROTEIN SCI, V20, P542, DOI 10.1002/pro.587; Leyrat C, 2010, PROTEIN PEPTIDE LETT, V17, P979, DOI 10.2174/092986610791498939; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Llorente MT, 2008, PROTEINS, V72, P946, DOI 10.1002/prot.21988; Llorente MT, 2006, J GEN VIROL, V87, P159, DOI 10.1099/vir.0.81430-0; Longhi S, 2010, PROTEIN PEPTIDE LETT, V17, P961, DOI 10.2174/092986610791498894; Lu B, 2002, J VIROL, V76, P2871, DOI 10.1128/JVI.76.6.2871-2880.2002; Mallipeddi SK, 1996, J GEN VIROL, V77, P1019, DOI 10.1099/0022-1317-77-5-1019; Marriott AC, 1999, J VIROL, V73, P5162, DOI 10.1128/JVI.73.6.5162-5165.1999; Martinez N, 2013, J VIROL, V87, P9569, DOI 10.1128/JVI.00999-13; Mason SW, 2003, J VIROL, V77, P10670, DOI 10.1128/JVI.77.19.10670-10676.2003; Mavrakis M, 2004, J MOL BIOL, V343, P819, DOI 10.1016/j.jmb.2004.08.071; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Noel JK, 2010, NUCLEIC ACIDS RES, V38, pW657, DOI 10.1093/nar/gkq498; Pei JM, 2001, BIOINFORMATICS, V17, P700, DOI 10.1093/bioinformatics/17.8.700; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Pons C, 2010, J MOL BIOL, V403, P217, DOI 10.1016/j.jmb.2010.08.029; R_uhle V, 2008, PRESSURE COUPLING BA; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Retief J D, 2000, Methods Mol Biol, V132, P243; Ribeiro EA, 2008, J MOL BIOL, V382, P525, DOI 10.1016/j.jmb.2008.07.028; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Schneidman-Duhovny D, 2011, J STRUCT BIOL, V173, P461, DOI 10.1016/j.jsb.2010.09.023; Slack MS, 1998, VIRUS RES, V55, P167, DOI 10.1016/S0168-1702(98)00042-2; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Taly JF, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-6; Tarbouriech N, 2000, NAT STRUCT BIOL, V7, P777; van den Hoogen BG, 2007, CLIN INFECT DIS, V44, P1159, DOI 10.1086/513295; van den Hoogen BG, 2002, VIROLOGY, V295, P119, DOI 10.1006/viro.2001.1355; van den Hoogen BG, 2003, J INFECT DIS, V188, P1571, DOI 10.1086/379200; Walter TS, 2005, ACTA CRYSTALLOGR D, V61, P651, DOI 10.1107/S0907444905007808; WASSENAAR T, WENMR STRUCTURAL BIO, V10, P767; Whitford PC, 2009, PROTEINS, V75, P430, DOI 10.1002/prot.22253; Williams JV, 2004, NEW ENGL J MED, V350, P443, DOI 10.1056/NEJMoa025472; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Xepapadaki P, 2004, J CLIN VIROL, V30, P267, DOI 10.1016/j.jcv.2003.12.012; Zheng WJ, 2005, PROTEIN ENG DES SEL, V18, P209, DOI 10.1093/protein/gzi026; Zheng WJ, 2002, J MOL BIOL, V316, P173, DOI 10.1006/jmbi.2001.5324	76	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e80371	10.1371/journal.pone.0080371	http://dx.doi.org/10.1371/journal.pone.0080371			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24224051	gold, Green Published, Green Submitted			2022-12-27	WOS:000326503400155
J	Ohnesorge, H; Feng, ZY; Zitta, K; Steinfath, M; Albrecht, M; Bein, B				Ohnesorge, Henning; Feng, Zhiying; Zitta, Karina; Steinfath, Markus; Albrecht, Martin; Bein, Berthold			Influence of Clonidine and Ketamine on m-RNA Expression in a Model of Opioid-Induced Hyperalgesia in Mice	PLOS ONE			English	Article							ABNORMAL PAIN SENSITIVITY; LONG-LASTING HYPERALGESIA; MORPHINE ANALGESIA; BETA-ARRESTIN; MURINE MODEL; TOLERANCE; RECEPTOR; RATS; MECHANISMS; REMIFENTANIL	Background: We investigated the influence of morphine and ketamine or clonidine in mice on the expression of genes that may mediate pronociceptive opioid effects. Material and Methods: C57BL/6 mice received morphine injections thrice daily using increasing doses (5-20mg.kg(-1)) for 3 days (sub-acute, n=6) or 14 days (chronic, n=6) and additionally either s-ketamine (5mg.kg(-1), n=6) or clonidine (0.1mg.kg(-1), n=6). Tail flick test and the assessment of the mechanical withdrawal threshold of the hindpaw was performed during and 4 days after cessation of opioid treatment. Upon completion of the behavioural testing the mRNA-concentration of the NMDA receptor (NMDAR1) and beta-arrestin 2 (Arrb2) were measured by PCR. Results: Chronic opioid treatment resulted in a delay of the tail flick latency with a rapid on-and offset. Simultaneously the mice developed a static mechanical hyperalgesia with a delayed onset that that outlasted the morphine treatment. Sub-acute morphine administration resulted in a decrease of NMDAR1 and Arrb2 whereas during longer opioid treatment the expression NMDAR1 and Arrb2 mRNA increased again to baseline values. Coadministration of s-ketamine or clonidine resulted in a reversal of the mechanical hyperalgesia and inhibited the normalization of NMDAR1 mRNA expression but had no effect on the expression of Arrb2 mRNA. Conclusion: In the model of chronic morphine therapy the antinociceptive effects of morphine are represented by the thermal analgesia while the proniceptive effects are represented by the mechanical hyperalgesia. The results indicate that the regulation of the expression of NMDAR1 and Arrb2 may be associated to the development of OIH in mice. Perspective: The results indicate that co-administration of clonidine or ketamine may influence the underlying mechanisms of OIH.	[Ohnesorge, Henning; Zitta, Karina; Steinfath, Markus; Albrecht, Martin; Bein, Berthold] Univ Hosp Schleswig Holstein, Dept Anesthesiol & Intens Care Med, Kiel, Germany; [Feng, Zhiying] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Anesthesiol, Hangzhou 310003, Zhejiang, Peoples R China	University of Kiel; Schleswig Holstein University Hospital; Zhejiang University	Ohnesorge, H (corresponding author), Univ Hosp Schleswig Holstein, Dept Anesthesiol & Intens Care Med, Campus Kiel, Kiel, Germany.	ohnesorge@anaesthesie.uni-kiel.de	Albrecht, Martin/AAW-9303-2021	Albrecht, Martin/0000-0003-2580-768X	Department of Anesthesiology and Intensive Care Medicine, University Hospital Schleswig-Holstein, Campus Kiel, Germany; Christian-Albrecht-University, Kiel, Germany	Department of Anesthesiology and Intensive Care Medicine, University Hospital Schleswig-Holstein, Campus Kiel, Germany; Christian-Albrecht-University, Kiel, Germany	Work was supported by the Department of Anesthesiology and Intensive Care Medicine, University Hospital Schleswig-Holstein, Campus Kiel, Germany and the Christian-Albrecht-University, Kiel, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angst MS, 2006, ANESTHESIOLOGY, V104, P570, DOI 10.1097/00000542-200603000-00025; Angst MS, 2003, PAIN, V106, P49, DOI 10.1016/S0304-3959(03)00276-8; Appleyard SM, 1999, J BIOL CHEM, V274, P23802, DOI 10.1074/jbc.274.34.23802; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Bohn LM, 2002, J NEUROSCI, V22, P10494; Boudreau D, 2009, PHARMACOEPIDEM DR S, V18, P1166, DOI 10.1002/pds.1833; Celerier E, 2006, ANESTHESIOLOGY, V104, P546; Celerier E, 2000, ANESTHESIOLOGY, V92, P465, DOI 10.1097/00000542-200002000-00029; Celerier E, 1999, BRAIN RES, V847, P18, DOI 10.1016/S0006-8993(99)01998-8; CHANG SL, 1988, BIOCHEM BIOPH RES CO, V157, P698, DOI 10.1016/S0006-291X(88)80306-1; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen L, 2009, PAIN, V143, P65, DOI 10.1016/j.pain.2009.01.022; Chu LF, 2008, CLIN J PAIN, V24, P479, DOI 10.1097/AJP.0b013e31816b2f43; Chu LF, 2006, J PAIN, V7, P43, DOI 10.1016/j.jpain.2005.08.001; Crain SM, 2000, PAIN, V84, P121, DOI 10.1016/S0304-3959(99)00223-7; De Kock M, 2005, ANESTH ANALG, V101, P566, DOI 10.1213/01.ANE.0000157121.71808.04; Dupen A, 2007, PAIN MANAG NURS, V8, P113, DOI 10.1016/j.pmn.2007.02.004; Fairbanks CA, 1999, J PHARMACOL EXP THER, V288, P1107; Gowing LR, 2002, ADDICTION, V97, P49, DOI 10.1046/j.1360-0443.2002.00037.x; Himmelseher S, 2005, ANESTHESIOLOGY, V102, P211, DOI 10.1097/00000542-200501000-00030; Hong D, 2008, ANESTH ANALG, V107, P1384, DOI 10.1213/ane.0b013e3181823efb; Jiang BH, 2006, NEUROSCI LETT, V400, P150, DOI 10.1016/j.neulet.2006.02.071; Joly V, 2005, ANESTHESIOLOGY, V103, P147, DOI 10.1097/00000542-200507000-00022; Juni A, 2006, BRAIN RES, V1070, P35, DOI 10.1016/j.brainres.2005.11.054; Koch T, 2008, PHARMACOL THERAPEUT, V117, P199, DOI 10.1016/j.pharmthera.2007.10.003; Koppert W, 2003, ANESTHESIOLOGY, V99, P152, DOI 10.1097/00000542-200307000-00025; Koppert W, 2007, BEST PRACT RES-CLIN, V21, P65, DOI 10.1016/j.bpa.2006.12.004; Laulin JP, 1998, EUR J NEUROSCI, V10, P782, DOI 10.1046/j.1460-9568.1998.00083.x; Le Bars D, 2001, PHARMACOL REV, V53, P597; Li XH, 2001, J PHARMACOL EXP THER, V299, P939; Li XQ, 2001, ANESTH ANALG, V93, P204; Li XQ, 2001, MOL BRAIN RES, V86, P56, DOI 10.1016/S0169-328X(00)00260-6; LICHTMAN AH, 1993, PAIN, V55, P283, DOI 10.1016/0304-3959(93)90003-8; MAO J, 1994, J NEUROSCI, V14, P2301; Mao JR, 2002, PAIN, V100, P213, DOI 10.1016/S0304-3959(02)00422-0; Mao JR, 2002, J NEUROSCI, V22, P8312; Osikowicz M, 2008, PAIN, V139, P117, DOI 10.1016/j.pain.2008.03.017; Rivat C, 2002, ANESTHESIOLOGY, V96, P381, DOI 10.1097/00000542-200202000-00025; Rome JD, 2004, MAYO CLIN PROC, V79, P759; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; SOLOMON RL, 1974, PSYCHOL REV, V81, P119, DOI 10.1037/h0036128; Starowicz K, 2004, NEUROSCI LETT, V358, P79, DOI 10.1016/j.neulet.2003.12.096; Waxman AR, 2009, NEUROSCI LETT, V462, P68, DOI 10.1016/j.neulet.2009.06.061	43	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79567	10.1371/journal.pone.0079567	http://dx.doi.org/10.1371/journal.pone.0079567			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223972	Green Published, gold, Green Submitted			2022-12-27	WOS:000326499300090
J	Henriksen, C; Kjaer-Sorensen, K; Einholm, AP; Madsen, LB; Momeni, J; Bendixen, C; Oxvig, C; Vilsen, B; Larsen, K				Henriksen, Carina; Kjaer-Sorensen, Kasper; Einholm, Anja Pernille; Madsen, Lone Bruhn; Momeni, Jamal; Bendixen, Christian; Oxvig, Claus; Vilsen, Bente; Larsen, Knud			Molecular Cloning and Characterization of Porcine Na+/K+-ATPase Isoforms alpha 1, alpha 2, alpha 3 and the ATP1A3 Promoter	PLOS ONE			English	Article							ONSET DYSTONIA-PARKINSONISM; BETA-SUBUNIT GENES; 4TH TRANSMEMBRANE SEGMENT; DE-NOVO MUTATIONS; K+-ATPASE; ALTERNATING HEMIPLEGIA; CRYSTAL-STRUCTURE; NA,K-ATPASE; EXPRESSION; SODIUM	Na+/K+-ATPase maintains electrochemical gradients of Na+ and K+ essential for a variety of cellular functions including neuronal activity. The alpha-subunit of the Na+/K+-ATPase exists in four different isoforms (alpha 1-alpha 4) encoded by different genes. With a view to future use of pig as an animal model in studies of human diseases caused by Na+/K+-ATPase mutations, we have determined the porcine coding sequences of the alpha 1-alpha 3 genes, ATP1A1, ATP1A2, and ATP1A3, their chromosomal localization, and expression patterns. Our ATP1A1 sequence accords with the sequences from several species at five positions where the amino acid residue of the previously published porcine ATP1A1 sequence differs. These corrections include replacement of glutamine 841 with arginine. Analysis of the functional consequences of substitution of the arginine revealed its importance for Na+ binding, which can be explained by interaction of the arginine with the C-terminus, stabilizing one of the Na+ sites. Quantitative real-time PCR expression analyses of porcine ATP1A1, ATP1A2, and ATP1A3 mRNA showed that all three transcripts are expressed in the embryonic brain as early as 60 days of gestation. Expression of alpha 3 is confined to neuronal tissue. Generally, the expression patterns of ATP1A1, ATP1A2, and ATP1A3 transcripts were found similar to their human counterparts, except for lack of alpha 3 expression in porcine heart. These expression patterns were confirmed at the protein level. We also report the sequence of the porcine ATP1A3 promoter, which was found to be closely homologous to its human counterpart. The function and specificity of the porcine ATP1A3 promoter was analyzed in transgenic zebrafish, demonstrating that it is active and drives expression in embryonic brain and spinal cord. The results of the present study provide a sound basis for employing the ATP1A3 promoter in attempts to generate transgenic porcine models of neurological diseases caused by ATP1A3 mutations.	[Henriksen, Carina; Madsen, Lone Bruhn; Momeni, Jamal; Bendixen, Christian; Larsen, Knud] Aarhus Univ, Dept Mol Biol & Genet, Tjele, Denmark; [Henriksen, Carina; Einholm, Anja Pernille; Vilsen, Bente] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark; [Kjaer-Sorensen, Kasper; Oxvig, Claus] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University; Aarhus University	Larsen, K (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Tjele, Denmark.	Knud.Larsen@agrsci.dk	Kjaer-Sorensen, Kasper/AAF-1457-2020	Vilsen, Bente/0000-0002-4727-9382; Oxvig, Claus/0000-0002-4715-9719	Danish Medical Research Council; Novo Nordisk Foundation (Fabrikant Vilhelm Pedersen og Hustrus Legat); Lundbeck Foundation; Aarhus University, HEALTH; Lundbeck Foundation [R118-2012-11726, R48-2009-4638] Funding Source: researchfish	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation (Fabrikant Vilhelm Pedersen og Hustrus Legat)(Novo Nordisk Foundation); Lundbeck Foundation(Lundbeckfonden); Aarhus University, HEALTH; Lundbeck Foundation(Lundbeckfonden)	This work was supported in part by grants from the Danish Medical Research Council (to BV), the Novo Nordisk Foundation (Fabrikant Vilhelm Pedersen og Hustrus Legat) (to BV), and the Lundbeck Foundation (to BV and APE). CH is supported by a Ph.D. stipend from Aarhus University, HEALTH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; Al-Mashhadi RH, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004853; Antequera F, 2003, CELL MOL LIFE SCI, V60, P1647, DOI 10.1007/s00018-003-3088-6; BARLETBAS C, 1993, J BIOL CHEM, V268, P11512; Bendixen E, 2010, BRIEF FUNCT GENOMICS, V9, P208, DOI 10.1093/bfgp/elq004; Benfante R, 2005, BIOCHEM J, V386, P63, DOI 10.1042/BJ20041294; Bjerre D, 2006, BIOCHEM BIOPH RES CO, V347, P803, DOI 10.1016/j.bbrc.2006.06.167; Blanco G, 2005, SEMIN NEPHROL, V25, P292, DOI 10.1016/j.semnephrol.2005.03.004; Blanco-Arias P, 2009, HUM MOL GENET, V18, P2370, DOI 10.1093/hmg/ddp170; Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524; CAMERON R, 1994, MOL BRAIN RES, V21, P333, DOI 10.1016/0169-328X(94)90264-X; Canfield VA, 2002, MECH DEVELOP, V116, P51, DOI 10.1016/S0925-4773(02)00135-1; CANTLEY LC, 1978, J BIOL CHEM, V253, P7361; Chang CS, 1998, KIDNEY INT, V54, P457, DOI 10.1046/j.1523-1755.1998.00031.x; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; DOBYNS WB, 1993, NEUROLOGY, V43, P2596, DOI 10.1212/WNL.43.12.2596; Doganli C, 2012, J CELL SCI, V125, P6166, DOI 10.1242/jcs.115808; EHRLICH M, 1982, NUCLEIC ACIDS RES, V10, P2709, DOI 10.1093/nar/10.8.2709; Einholm AP, 2010, J BIOL CHEM, V285, P26245, DOI 10.1074/jbc.M110.123976; Fontanesi L, 1999, ANIM GENET, V30, P57, DOI 10.1046/j.1365-2052.1999.00407.x; GLYNN IM, 1993, J PHYSIOL-LONDON, V462, P1; Gritz SM, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-8; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Hakansson KO, 2003, J MOL BIOL, V332, P1175, DOI 10.1016/j.jmb.2003.07.012; Hansen O, 1998, ACTA PHYSIOL SCAND, V163, P201, DOI 10.1046/j.1365-201X.1998.00345.x; Hawken RJ, 1999, MAMM GENOME, V10, P824, DOI 10.1007/s003359901097; Heinzen EL, 2012, NAT GENET, V44, P1030, DOI 10.1038/ng.2358; HSU YM, 1989, BIOCHEMISTRY-US, V28, P569, DOI 10.1021/bi00428a023; Jimenez T, 2011, P NATL ACAD SCI USA, V108, P644, DOI 10.1073/pnas.1016902108; Kamm C, 2004, MOVEMENT DISORD, V19, P845, DOI 10.1002/mds.20095; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kramer PL, 1999, ANN NEUROL, V46, P176, DOI 10.1002/1531-8249(199908)46:2<176::AID-ANA6>3.0.CO;2-2; LAHBIBMANSAIS Y, 1993, GENOMICS, V15, P91, DOI 10.1006/geno.1993.1014; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Li H, 2011, BIOINFORMATICS, V27, P718, DOI 10.1093/bioinformatics/btq671; LINGREL JB, 1992, J BIOENERG BIOMEMBR, V24, P263; LUCCHESI PA, 1991, J BIOL CHEM, V266, P9327; MCGRAIL KM, 1991, J NEUROSCI, V11, P381, DOI 10.1523/jneurosci.11-02-00381.1991; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; PATHAK BG, 1990, GENOMICS, V8, P641, DOI 10.1016/0888-7543(90)90250-X; Petters RM, 1997, NAT BIOTECHNOL, V15, P965, DOI 10.1038/nbt1097-965; POST RL, 1972, J BIOL CHEM, V247, P6530; Rajarao SJR, 2001, GENOME RES, V11, P1211, DOI 10.1101/gr.186001; Rodacker V, 2006, J BIOL CHEM, V281, P18539, DOI 10.1074/jbc.M601780200; Rosewich H, 2012, LANCET NEUROL, V11, P764, DOI 10.1016/S1474-4422(12)70182-5; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Schack VR, 2008, J BIOL CHEM, V283, P27982, DOI 10.1074/jbc.M803506200; SCHNEIDER BG, 1991, J HISTOCHEM CYTOCHEM, V39, P507, DOI 10.1177/39.4.1848572; SHAMRAJ OI, 1994, P NATL ACAD SCI USA, V91, P12952, DOI 10.1073/pnas.91.26.12952; SHAMRAJ OI, 1991, BIOCHEM BIOPH RES CO, V179, P1434, DOI 10.1016/0006-291X(91)91733-S; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; SHULL GE, 1986, BIOCHEMISTRY-US, V25, P8125, DOI 10.1021/bi00373a001; SHYJAN AW, 1989, BIOCHEMISTRY-US, V28, P4531, DOI 10.1021/bi00437a002; SKOU JC, 1957, BIOCHIM BIOPHYS ACTA, V23, P394, DOI 10.1016/0006-3002(57)90343-8; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Suster Maximiliano L, 2009, Methods Mol Biol, V561, P41, DOI 10.1007/978-1-60327-019-9_3; SWEADNER KJ, 1994, CIRC RES, V74, P669, DOI 10.1161/01.RES.74.4.669; SWEADNER KJ, 1989, BIOCHIM BIOPHYS ACTA, V988, P185, DOI 10.1016/0304-4157(89)90019-1; Tokhtaeva E, 2009, BIOCHEMISTRY-US, V48, P11421, DOI 10.1021/bi901438z; Toustrup-Jensen M, 2001, BIOCHEMISTRY-US, V40, P5521, DOI 10.1021/bi002367m; Toustrup-Jensen MS, 2009, J BIOL CHEM, V284, P18715, DOI 10.1074/jbc.M109.015099; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; URAYAMA O, 1989, J BIOL CHEM, V264, P8271; VILSEN B, 1995, BIOCHEMISTRY-US, V34, P1455, DOI 10.1021/bi00004a041; VILSEN B, 1992, FEBS LETT, V314, P301, DOI 10.1016/0014-5793(92)81494-7; Vilsen B, 1997, BIOCHEMISTRY-US, V36, P13312, DOI 10.1021/bi971030q; Wang JN, 1996, J CLIN INVEST, V98, P1650, DOI 10.1172/JCI118960; YANG-FENG T L, 1988, Genomics, V2, P128, DOI 10.1016/0888-7543(88)90094-8; Yerle M, 1998, CYTOGENET CELL GENET, V82, P182, DOI 10.1159/000015095	70	23	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79127	10.1371/journal.pone.0079127	http://dx.doi.org/10.1371/journal.pone.0079127			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236096	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700094
J	Jing, HM; Xia, XM; Suzuki, K; Liu, HB				Jing, Hongmei; Xia, Xiaomin; Suzuki, Koji; Liu, Hongbin			Vertical Profiles of Bacteria in the Tropical and Subarctic Oceans Revealed by Pyrosequencing	PLOS ONE			English	Article							MICROBIAL DIVERSITY; SPATIAL-PATTERNS; COMMUNITIES; SEA; PHYTOPLANKTON; VARIABILITY; DYNAMICS; ECOLOGY; DEPTH	Community composition of Bacteria in the surface and deep water layers were examined at three oceanic sites in the Pacific Ocean separated by great distance, i.e., the South China Sea (SCS) in the western tropical Pacific, the Costa Rica Dome (CRD) in the eastern tropical Pacific and the western subarctic North Pacific (SNP), using high throughput DNA pyrosequencing of the 16S rRNA gene. Bioinformatic analysis rendered a total of 143600 high quality sequences with an average 11967 sequences per sample and mean read length of 449 bp. Phylogenetic analysis showed that Proteobacteria dominated in all shallow and deep waters, with Alphaproteobacteria and Gammaproteobacteria the two most abundant components, and SAR11 the most abundant group at family level in all regions. Cyanobacteria occurred mainly in the surface euphotic layer, and the majority of them in the tropical waters belonged to the GpIIa family including Prochlorococcus and Synechococcus, whilst those associated with Cryptophytes and diatoms were common in the subarctic waters. In general, species richness (Chao1) and diversity (Shannon index H') were higher for the bacterial communities in the intermediate water layers than for those in surface and deep waters. Both NMDS plot and UPGMA clustering demonstrated that bacterial community composition in the deep waters (500 m similar to 2000 m) of the three oceanic regions shared a high similarity and were distinct from those in the upper waters (5 m similar to 100 m). Our study indicates that bacterial community composition in the DOC-poor deep water in both tropical and subarctic regions were rather stable, contrasting to those in the surface water layers, which could be strongly affected by the fluctuations of environmental factors.	[Jing, Hongmei; Xia, Xiaomin; Liu, Hongbin] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China; [Jing, Hongmei] Chinese Acad Sci, Sanya Inst Deep Sea Sci & Engn, Sanya, Peoples R China; [Suzuki, Koji] Hokkaido Univ, Fac Environm Earth Sci, Sapporo, Hokkaido, Japan	Hong Kong University of Science & Technology; Chinese Academy of Sciences; Institute of Deep-Sea Science & Engineering, CAS; Hokkaido University	Liu, HB (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China.	liuhb@ust.hk	Liu, Hongbin/AAV-8862-2020; Suzuki, Koji/GVS-9807-2022; Suzuki, Koji/A-4349-2013; Suzuki, Koji/AAD-2630-2022	Suzuki, Koji/0000-0001-5354-1044; Suzuki, Koji/0000-0001-5354-1044; 	National Basic Research Program ("973" Program) of China [2009CB421203]; University Grants Committee of Hong Kong AoE project [AoE/P-04/04-4-II]; Research Grants Council of Hong Kong [661610, 661912, 661813]; Japan Society for the Promotion of Science [22310002]; Sanya Institute of Deep-sea Science and Engineering; Chinese Academy of Sciences [SIDSSE-BR-201301]; Grants-in-Aid for Scientific Research [22221001] Funding Source: KAKEN	National Basic Research Program ("973" Program) of China(National Basic Research Program of China); University Grants Committee of Hong Kong AoE project; Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Sanya Institute of Deep-sea Science and Engineering; Chinese Academy of Sciences(Chinese Academy of Sciences); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the following funding agencies: National Basic Research Program ("973" Program) of China through grant 2009CB421203, http://www.most.gov.cn/eng/programmes1/200610/t20061009_36223.htm; University Grants Committee of Hong Kong AoE project (AoE/P-04/04-4-II) http://www.ugc.edu.hk/eng/ugc/index.htm; Research Grants Council of Hong Kong (661610, 661912 and 661813) http://www.ugc.edu.hk/eng/rgc/about/about.htm; Grant-in-Aid for Scientific Research (B) of Japan Society for the Promotion of Science (22310002) http://www.jsps.go.jp/english/e-grants/index.html. In addition, the grant support from Sanya Institute of Deep-sea Science and Engineering. Chinese Academy of Sciences (SIDSSE-BR-201301) is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agogue H, 2011, MOL ECOL, V20, P258, DOI 10.1111/j.1365-294X.2010.04932.x; Andersson AF, 2010, ISME J, V4, P171, DOI 10.1038/ismej.2009.108; Aristegui J, 2009, LIMNOL OCEANOGR, V54, P1501, DOI 10.4319/lo.2009.54.5.1501; Baas-Becking L.G.M., 1934, GEOBIOLOGIE INLEIDIN, P263; Bhattacharya D, 2004, BIOESSAYS, V26, P50, DOI 10.1002/bies.10376; Bowman JS, 2012, ISME J, V6, P11, DOI 10.1038/ismej.2011.76; Brown MV, 2009, ISME J, V3, P1374, DOI 10.1038/ismej.2009.86; Bryant JA, 2012, ECOLOGY, V93, P1659, DOI 10.1890/11-1204.1; Clarke K., 2001, PRIMER VERSION 5 USE; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; COLE JJ, 1988, MAR ECOL PROG SER, V43, P1, DOI 10.3354/meps043001; de Wit R, 2006, ENVIRON MICROBIOL, V8, P755, DOI 10.1111/j.1462-2920.2006.01017.x; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Flombaum P, 2013, P NATL ACAD SCI USA, V110, P9824, DOI 10.1073/pnas.1307701110; Friedline C.J., 2012, BIOGEOSCI DISCUSS, V9, P109, DOI [10.5194/bgd-9-109-2012, DOI 10.5194/BGD-9-109-2012]; FUHRMAN JA, 1989, MAR ECOL PROG SER, V57, P207, DOI 10.3354/meps057207; Galand PE, 2012, FEMS MICROBIOL ECOL, V79, P203, DOI 10.1111/j.1574-6941.2011.01209.x; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Gallagher JM, 2004, FEMS MICROBIOL ECOL, V47, P249, DOI 10.1016/S0168-6496(03)00281-2; Ghiglione JF, 2008, BIOGEOSCIENCES, V5, P1751, DOI 10.5194/bg-5-1751-2008; Giovannoni SJ, 2005, NATURE, V437, P343, DOI 10.1038/nature04158; Hewson I, 2006, LIMNOL OCEANOGR, V51, P1274, DOI 10.4319/lo.2006.51.3.1274; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Jing HM, 2012, AQUAT MICROB ECOL, V65, P207, DOI 10.3354/ame01546; Kataoka T, 2009, J MARINE SYST, V77, P197, DOI 10.1016/j.jmarsys.2008.12.006; Kembel SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023214; Kirchman DL, 2010, ENVIRON MICROBIOL, V12, P1132, DOI 10.1111/j.1462-2920.2010.02154.x; Koskinen K, 2011, FEMS MICROBIOL ECOL, V75, P99, DOI 10.1111/j.1574-6941.2010.00987.x; Liu HB, 2007, DEEP-SEA RES PT II, V54, P1602, DOI 10.1016/j.dsr2.2007.05.004; Lo Giudice A, 2006, J APPL MICROBIOL, V101, P1039, DOI 10.1111/j.1365-2672.2006.03006.x; Lopez-Garcia P, 2001, FEMS MICROBIOL ECOL, V36, P193, DOI 10.1016/S0168-6496(01)00133-7; Ma Y, 2009, MICROBIOL RES, V164, P624, DOI 10.1016/j.micres.2008.01.001; Moeseneder MM, 2001, J MICROBIOL METH, V44, P159, DOI 10.1016/S0167-7012(00)00247-5; Partensky F., 1999, B I OCEANOGR MONACO, V19, P431; Paulmier A, 2009, PROG OCEANOGR, V80, P113, DOI 10.1016/j.pocean.2008.08.001; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; Pommier T, 2010, AQUAT MICROB ECOL, V61, P212, DOI 10.3354/ame01484; Quince C, 2008, ISME J, V2, P997, DOI 10.1038/ismej.2008.69; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stevens H, 2008, ENVIRON MICROBIOL, V10, P1244, DOI 10.1111/j.1462-2920.2007.01539.x; Suzuki K, 2011, DEEP-SEA RES PT I, V58, P575, DOI 10.1016/j.dsr.2011.03.003; Teeling H, 2012, SCIENCE, V336, P608, DOI 10.1126/science.1218344; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Worden AZ, 2006, TRENDS MICROBIOL, V14, P331, DOI 10.1016/j.tim.2006.06.008; Yan BQ, 2009, EXTREMOPHILES, V13, P725, DOI 10.1007/s00792-009-0263-1; Yu Y, 2005, BIOTECHNOL BIOENG, V89, P670, DOI 10.1002/bit.20347; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024570	48	36	37	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79423	10.1371/journal.pone.0079423	http://dx.doi.org/10.1371/journal.pone.0079423			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236132	Green Submitted, gold, Green Published			2022-12-27	WOS:000327254700131
J	Kornhuber, J; Zenses, EM; Lenz, B; Stoessel, C; Bouna-Pyrrou, P; Rehbein, F; Kliem, S; Mossie, T				Kornhuber, Johannes; Zenses, Eva-Maria; Lenz, Bernd; Stoessel, Christina; Bouna-Pyrrou, Polyxeni; Rehbein, Florian; Kliem, Soeren; Moessie, Thomas			Low 2D:4D Values Are Associated with Video Game Addiction	PLOS ONE			English	Article							DIGIT RATIO 2D/4D; FINGER LENGTH RATIO; PRENATAL ANDROGENS; SPATIAL ABILITY; RISK-FACTORS; ALCOHOL-USE; TESTOSTERONE; SEX; INTERNET; 2ND	Androgen-dependent signaling regulates the growth of the fingers on the human hand during embryogenesis. A higher androgen load results in lower 2D:4D (second digit to fourth digit) ratio values. Prenatal androgen exposure also impacts brain development. 2D:4D values are usually lower in males and are viewed as a proxy of male brain organization. Here, we quantified video gaming behavior in young males. We found lower mean 2D: 4D values in subjects who were classified according to the CSAS-II as having at-risk/addicted behavior (n = 27) compared with individuals with unproblematic video gaming behavior (n = 27). Thus, prenatal androgen exposure and a hyper-male brain organization, as represented by low 2D:4D values, are associated with problematic video gaming behavior. These results may be used to improve the diagnosis, prediction, and prevention of video game addiction.	[Kornhuber, Johannes; Lenz, Bernd; Stoessel, Christina; Bouna-Pyrrou, Polyxeni] Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, Erlangen, Germany; [Zenses, Eva-Maria; Rehbein, Florian; Kliem, Soeren; Moessie, Thomas] Criminol Res Inst Lower Saxony, Hannover, Germany	University of Erlangen Nuremberg	Kornhuber, J (corresponding author), Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, Erlangen, Germany.	Johannes.kornhuber@uk-erlangen.de	Kliem, Sören/AAB-5196-2020; Kornhuber, Johannes/B-9613-2014	Kliem, Sören/0000-0003-1788-9574; Kornhuber, Johannes/0000-0002-8096-3987; Lenz, Bernd/0000-0001-6086-0924	University Hospital of the Friedrich-Alexander-University of Erlangen-Nuremberg; Ministry for Science and Culture of Lower Saxony	University Hospital of the Friedrich-Alexander-University of Erlangen-Nuremberg; Ministry for Science and Culture of Lower Saxony	Funding for this study was provided by intramural grants from the University Hospital of the Friedrich-Alexander-University of Erlangen-Nuremberg and by the Ministry for Science and Culture of Lower Saxony. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey AA, 2005, BIOL PSYCHOL, V68, P215, DOI 10.1016/j.biopsycho.2004.05.001; Bowman AW, 2006, STAT MODEL, V6, P279, DOI 10.1177/1471082006071848; Bowman AW, 1997, APPL SMOOTHING TECHN; Branas-Garza P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060419; Branas-Garza P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029842; Breedlove SM, 2010, ENDOCRINOLOGY, V151, P4116, DOI 10.1210/en.2010-0041; Brookes H., 2007, J INDIVID DIFFER, V28, P55, DOI DOI 10.1027/1614-0001.28.2.55; Brosnan M, 2011, PERS INDIV DIFFER, V51, P371, DOI 10.1016/j.paid.2010.07.009; Chai XQJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032816; Chapman E, 2006, SOC NEUROSCI-UK, V1, P135, DOI 10.1080/17470910600992239; CLARKSON DB, 1993, ACM T MATH SOFTWARE, V19, P484, DOI 10.1145/168173.168412; Cohen J.E., 1988, STAT POWER ANAL BEHA; De Neys W, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0037; Derogatis L.R, 1993, BRIEF SYMPTOM INVENT; Gentile DA, 2011, PEDIATRICS, V127, pE319, DOI 10.1542/peds.2010-1353; Hahn A, 2010, PRAVENTION DIAGNOSTI, P185; Hahn A., 2001, ONLINE MARKTFORSCHUN, P211, DOI [10.1007/978-3-322-99429-5_15, DOI 10.1007/978-3-322-99429-5_15]; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hewig J, 2010, BIOL PSYCHIAT, V67, P781, DOI 10.1016/j.biopsych.2009.11.009; Honekopp J, 2007, PSYCHONEUROENDOCRINO, V32, P313, DOI 10.1016/j.psyneuen.2007.01.007; Honekopp J, 2012, AUTISM RES, V5, P221, DOI 10.1002/aur.1230; Honekopp J, 2006, HORM BEHAV, V49, P545, DOI 10.1016/j.yhbeh.2005.11.006; Honekopp J, 2006, PSYCHONEUROENDOCRINO, V31, P30, DOI 10.1016/j.psyneuen.2005.05.009; Honekopp J, 2010, AM J HUM BIOL, V22, P619, DOI 10.1002/ajhb.21054; Honekopp J, 2010, PERS INDIV DIFFER, V48, P4, DOI 10.1016/j.paid.2009.08.009; Hothorn T, 2013, LAB RECURSIVE PARTIT; Hothorn T., 2010, PARTY LAB RECURSIVE; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Hou HF, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/854524; Hussain Z, 2011, ADDICT RES THEORY, V20, P1; JACKSON CP, 1988, ALCOHOL ALCOHOLISM, V23, P305; Kempel P, 2005, INTELLIGENCE, V33, P215, DOI 10.1016/j.intell.2004.11.004; Kerridge BT, 2013, DRUG ALCOHOL DEPEN, V129, P60, DOI 10.1016/j.drugalcdep.2012.09.010; Kim KS, 2010, J KOREAN ACAD NURS, V40, P378, DOI 10.4040/jkan.2010.40.3.378; Kim SH, 2011, NEUROREPORT, V22, P407, DOI 10.1097/WNR.0b013e328346e16e; Ko CH, 2009, ARCH PEDIAT ADOL MED, V163, P937, DOI 10.1001/archpediatrics.2009.159; Kornhuber J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019332; Kuss DJ, 2012, BRAIN SCI, V2, P347, DOI 10.3390/brainsci2030347; Lenz B, 2012, PROG NEUROBIOL, V96, P136, DOI 10.1016/j.pneurobio.2011.11.001; LEX BW, 1991, HEALTH PSYCHOL, V10, P121, DOI 10.1037/0278-6133.10.2.121; Lin SSJ, 2013, COMPUT HUMAN BEHAV, V18, P411; Lombardo MV, 2012, BIOL PSYCHIAT, V72, P839, DOI 10.1016/j.biopsych.2012.05.027; Luxen MF, 2005, PERS INDIV DIFFER, V39, P959, DOI 10.1016/j.paid.2005.03.016; M/&beta;le T., 2013, SUCHT, V59, P153, DOI [DOI 10.1024/0939-5911.A000247, 10.1024/0939-5911.a000247]; Malas MA, 2006, EARLY HUM DEV, V82, P469, DOI 10.1016/j.earlhumdev.2005.12.002; Manning JT, 2008, AM J HUM BIOL, V20, P451, DOI 10.1002/ajhb.20767; Manning JT, 2010, AM J HUM BIOL, V22, P604, DOI 10.1002/ajhb.21051; Manning JT, 2002, MED HYPOTHESES, V59, P334, DOI 10.1016/S0306-9877(02)00181-0; Manning JT, 1998, HUM REPROD, V13, P3000, DOI 10.1093/humrep/13.11.3000; Martel MM, 2008, BEHAV NEUROSCI, V122, P273, DOI 10.1037/0735-7044.122.2.273; MEHTA CR, 1986, ACM T MATH SOFTWARE, V12, P154, DOI 10.1145/6497.214326; Millet K, 2006, BIOL PSYCHOL, V71, P111, DOI 10.1016/j.biopsycho.2005.06.001; Millet K, 2009, BRIT J PSYCHOL, V100, P151, DOI 10.1348/000712608X324359; MULLER R, 1994, STAT MED, V13, P2465, DOI 10.1002/sim.4780132310; Peters M, 2007, ARCH SEX BEHAV, V36, P251, DOI 10.1007/s10508-006-9166-8; Puts DA, 2008, ARCH SEX BEHAV, V37, P100, DOI 10.1007/s10508-007-9271-3; Rehbein F, 2013, NERVENARZT, V84, P569, DOI 10.1007/s00115-012-3721-4; Rehbein F, 2011, SUCHTTHERAPIE, V12, P64, DOI 10.1055/s-0031-1275313; Rehbein F, 2013, J MEDIA PSYCHOL-GER, V25, P118, DOI 10.1027/1864-1105/a000093; Rehbein F, 2010, CYBERPSYCH BEH SOC N, V13, P269, DOI 10.1089/cyber.2009.0227; Sanders G, 2005, CORTEX, V41, P789, DOI 10.1016/S0010-9452(08)70297-1; Schmidt A, 2010, ADHS E ADHS SCREENIN; Stevenson JC, 2007, AM J HUM BIOL, V19, P41, DOI 10.1002/ajhb.20571; STRASSER H, 1999, MATH METHODS STAT, V8, P220; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Teatero ML, 2013, J AUTISM DEV DISORD, V43, P2664, DOI 10.1007/s10803-013-1819-6; Von Horn A, 2010, SCAND J PSYCHOL, V51, P31, DOI 10.1111/j.1467-9450.2009.00725.x; Weinstein A, 2012, CURR PSYCHIAT REP, V14, P590, DOI 10.1007/s11920-012-0311-x; Wenzel HG, 2009, PSYCHOL REP, V105, P1237, DOI 10.2466/PR0.105.F.1237-1247; Wolfling K, 2008, PSYCHIAT PRAX, V35, P226, DOI 10.1055/s-2007-986238; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zheng ZG, 2011, P NATL ACAD SCI USA, V108, P16289, DOI 10.1073/pnas.1108312108	72	29	32	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79539	10.1371/journal.pone.0079539	http://dx.doi.org/10.1371/journal.pone.0079539			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236143	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700142
J	Liao, CK; Jeng, CJ; Wang, HS; Wang, SH; Wu, JC				Liao, Chih-Kai; Jeng, Chung-Jiuan; Wang, Hwai-Shi; Wang, Shu-Huei; Wu, Jiahn-Chun			Lipopolysaccharide Induces Degradation of Connexin43 in Rat Astrocytes via the Ubiquitin-Proteasome Proteolytic Pathway	PLOS ONE			English	Article							GAP-JUNCTION PROTEIN; N-TERMINAL KINASE; DOWN-REGULATION; KAPPA-B; INTERCELLULAR COMMUNICATION; ASTROGLIAL NETWORKS; UP-REGULATION; TNF-ALPHA; P38 MAPK; EXPRESSION	The astrocytic syncytium plays a critical role in maintaining the homeostasis of the brain through the regulation of gap junction intercellular communication (GJIC). Changes to GJIC in response to inflammatory stimuli in astrocytes may have serious effects on the brain. We have previously shown that lipopolysaccharide (LPS) reduces connexin43 (Cx43) expression and GJIC in cultured rat astrocytes via a toll-like receptor 4-mediated signaling pathway. In the present study, treatment of astrocytes with LPS resulted in a significant increase in levels of the phosphorylated forms of stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) -1, -2, and -3 for up to 18 h. An increase in nuclear transcription factor NF-kappa B levels was also observed after 8 h of LPS treatment and was sustained for up to 18 h. The LPS-induced decrease in Cx43 protein levels and inhibition of GJIC were blocked by the SAPK/JNK inhibitor SP600125, but not by the NF-kappa B inhibitor BAY11-7082. Following blockade of de novo protein synthesis by cycloheximide, LPS accelerated Cx43 degradation. Moreover, the LPS-induced downregulation of Cx43 was blocked following inhibition of 26S proteasome activity using the reversible proteasome inhibitor MG132 or the irreversible proteasome inhibitor lactacystin. Immunoprecipitation analyses revealed an increased association of Cx43 with both ubiquitin and E3 ubiquitin ligase Nedd4 in astrocytes after LPS stimulation for 6 h and this effect was prevented by SP600125. Taken together, these results suggest that LPS stimulation leads to downregulation of Cx43 expression and GJIC in rat astrocytes by activation of SAPK/JNK and the ubiquitin-proteasome proteolytic pathway.	[Liao, Chih-Kai; Wang, Shu-Huei] Natl Taiwan Univ, Coll Med, Dept Anat & Cell Biol, Taipei 10764, Taiwan; [Jeng, Chung-Jiuan; Wang, Hwai-Shi; Wu, Jiahn-Chun] Natl Yang Ming Univ, Sch Med, Inst Anat & Cell Biol, Taipei 112, Taiwan	National Taiwan University; National Yang Ming Chiao Tung University	Wu, JC (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Anat & Cell Biol, Taipei 112, Taiwan.	jcwu2@ym.edu.tw		WANG, SHU-HUEI/0000-0002-9208-3135	Taiwan National Science Council [NSC-98-2320-B010-030-MY3, NSC-102-2320-B010-011]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by the Taiwan National Science Council [grant numbers: NSC-98-2320-B010-030-MY3 and NSC-102-2320-B010-011]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2003, J BIOL CHEM, V278, P38360, DOI 10.1074/jbc.M306785200; Bellei B, 2008, EXP DERMATOL, V17, P115, DOI 10.1111/j.1600-0625.2007.00662.x; Brand-Schieber E, 2005, J NEUROSCI RES, V80, P798, DOI 10.1002/jnr.20474; Cameron SJ, 2003, J BIOL CHEM, V278, P18682, DOI 10.1074/jbc.M213283200; Carpentier PA, 2008, BRAIN BEHAV IMMUN, V22, P140, DOI 10.1016/j.bbi.2007.08.011; Carty M, 2011, BIOCHEM PHARMACOL, V81, P825, DOI 10.1016/j.bcp.2011.01.003; Chuang JY, 2008, MOL BIOL CELL, V19, P1139, DOI 10.1091/mbc.E07-09-0881; Chung TH, 2009, INT J BIOCHEM CELL B, V41, P2323, DOI 10.1016/j.biocel.2009.06.001; DERMIETZEL R, 1991, J NEUROSCI, V11, P1421; Dermietzel R, 2000, BRAIN RES REV, V32, P45, DOI 10.1016/S0165-0173(99)00067-3; Esen N, 2007, GLIA, V55, P104, DOI 10.1002/glia.20438; Esposito G, 2008, J CELL MOL MED, V12, P914, DOI 10.1111/j.1582-4934.2008.00159.x; FALLON RF, 1981, J CELL BIOL, V90, P521, DOI 10.1083/jcb.90.2.521; Giaume C, 2010, BRAIN RES REV, V63, P160, DOI 10.1016/j.brainresrev.2009.11.005; Giaume C, 2010, NAT REV NEUROSCI, V11, P87, DOI 10.1038/nrn2757; Girao H, 2009, EXP CELL RES, V315, P3587, DOI 10.1016/j.yexcr.2009.10.003; Gorina R, 2011, GLIA, V59, P242, DOI 10.1002/glia.21094; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Harris JE, 2007, J LEUKOCYTE BIOL, V81, P548, DOI 10.1189/jlb.0806512; Hsiao HJ, 2010, ARCH VIROL, V155, P1107, DOI 10.1007/s00705-010-0693-1; Kielian T, 2008, J NEUROCHEM, V106, P1000, DOI 10.1111/j.1471-4159.2008.05405.x; Kim HT, 2005, J NEUROVIROL, V11, P166, DOI 10.1080/13550280590922810; Kimura K, 2010, INVEST OPHTH VIS SCI, V51, P1943, DOI 10.1167/iovs.09-3573; Kjenseth A, 2010, CELL SIGNAL, V22, P1267, DOI 10.1016/j.cellsig.2010.03.005; LAING JG, 1995, J BIOL CHEM, V270, P26399, DOI 10.1074/jbc.270.44.26399; LAIRD DW, 1991, BIOCHEM J, V273, P67, DOI 10.1042/bj2730067; Leithe E, 2004, J BIOL CHEM, V279, P50089, DOI 10.1074/jbc.M402006200; Leithe E, 2004, J CELL SCI, V117, P1211, DOI 10.1242/jcs.00951; Liao CK, 2010, INT J BIOCHEM CELL B, V42, P762, DOI 10.1016/j.biocel.2010.01.016; Lutz SE, 2009, J NEUROSCI, V29, P7743, DOI 10.1523/JNEUROSCI.0341-09.2009; Orthmann-Murphy JL, 2009, BRAIN, V132, P426, DOI 10.1093/brain/awn328; Panaro MA, 2008, IMMUNOPHARM IMMUNOT, V30, P729, DOI [10.1080/08923970802278557, 10.1080/08923970802278557 ]; Pannasch U, 2011, P NATL ACAD SCI USA, V108, P8467, DOI 10.1073/pnas.1016650108; Petrich BG, 2002, CIRC RES, V91, P640, DOI 10.1161/01.RES.0000035854.11082.01; Roscoe WA, 2007, CELL COMMUN ADHES, V14, P57, DOI 10.1080/15419060701459569; Shi RX, 2007, MOL CANCER THER, V6, P1338, DOI 10.1158/1535-7163.MCT-06-0638; Srinivas H, 2005, MOL CELL BIOL, V25, P1054, DOI 10.1128/MCB.25.3.1054-1069.2005; Stanbouly S, 2008, J PHARMACOL EXP THER, V327, P105, DOI 10.1124/jpet.108.140228; Tacheau C, 2008, J CELL PHYSIOL, V216, P438, DOI 10.1002/jcp.21412; Tanahashi H, 2010, ARCH BIOCHEM BIOPHYS, V494, P94, DOI 10.1016/j.abb.2009.11.018; Wu CY, 2004, J NEUROCHEM, V90, P1477, DOI 10.1111/j.1471-4159.2004.02682.x; Zhang FF, 2013, J NEUROSCI RES, V91, P745, DOI 10.1002/jnr.23213; Zhang S, 2011, CELL MOL NEUROBIOL, V31, P111, DOI 10.1007/s10571-010-9560-6; Zhao Y, 2006, GLIA, V54, P775, DOI 10.1002/glia.20418	44	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79350	10.1371/journal.pone.0079350	http://dx.doi.org/10.1371/journal.pone.0079350			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236122	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700121
J	Lotem, J; Levanon, D; Negreanu, V; Leshkowitz, D; Friedlander, G; Groner, Y				Lotem, Joseph; Levanon, Ditsa; Negreanu, Varda; Leshkowitz, Dena; Friedlander, Gilgi; Groner, Yoram			Runx3-mediated Transcriptional Program in Cytotoxic Lymphocytes	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; HELPER TYPE-1 CELLS; ONLY PROTEIN FHL2; FACTORS T-BET; GENE-EXPRESSION; RUNX PROTEINS; CANCER CELLS; NK CELLS; B-CELLS; RECEPTOR	The transcription factor Runx3 is highly expressed in CD8(+) T and NK cytotoxic lymphocytes and is required for their effective activation and proliferation but molecular insights into the transcription program regulated by Runx3 in these cells are still missing. Using Runx3-ChIP-seq and transcriptome analysis of wild type vs. Runx3(-/-) primary cells we have now identified Runx3-regulated genes in the two cell types at both resting and IL-2-activated states. Runx3-bound genomic regions in both cell types were distantly located relative to gene transcription start sites and were enriched for RUNX and ETS motifs. Bound genomic regions significantly overlapped T-bet and p300-bound enhancer regions in Runx3-expressing Th1 helper cells. Compared to resting cells, IL-2-activated CD8(+) T and NK cells contain three times more Runx3-regulated genes that are common to both cell types. Functional annotation of shared CD8(+) T and NK Runx3-regulated genes revealed enrichment for immune-associated terms including lymphocyte activation, proliferation, cytotoxicity, migration and cytokine production, highlighting the role of Runx3 in CD8(+) T and NK activated cells.	[Lotem, Joseph; Levanon, Ditsa; Negreanu, Varda; Groner, Yoram] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Leshkowitz, Dena; Friedlander, Gilgi] Weizmann Inst Sci, Israel Natl Ctr, Personalized Med Bioinformat Unit, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Groner, Y (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	yoram.groner@weizmann.ac.il		Friedlander, Gerard/0000-0002-6854-4261	Israel Science Foundation	Israel Science Foundation(Israel Science Foundation)	This work was supported by grants from Israel Science Foundation individual grants to YG and D. Levanon. URL: http://isf.org.il/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcazar I, 2007, J EXP MED, V204, P2977, DOI 10.1084/jem.20070366; Arman M, 2009, MOL IMMUNOL, V46, P2226, DOI 10.1016/j.molimm.2009.04.018; Bai S, 2008, J BIOL CHEM, V283, P30861, DOI 10.1074/jbc.M802525200; Ben-Ami O, 2013, CELL REP, V4, P1131, DOI 10.1016/j.celrep.2013.08.020; Benson DM, 2009, BLOOD, V113, P2706, DOI 10.1182/blood-2008-05-159285; Bezman NA, 2012, NAT IMMUNOL, V13, P1000, DOI 10.1038/ni.2395; Bjorkstrom NK, 2012, BLOOD, V120, P3455, DOI 10.1182/blood-2012-03-416867; Bluman EM, 1996, BLOOD, V88, P3887, DOI 10.1182/blood.V88.10.3887.bloodjournal88103887; Brady G, 2009, J CELL PHYSIOL, V221, P283, DOI 10.1002/jcp.21880; Clements JL, 2006, J IMMUNOL, V177, P905, DOI 10.4049/jimmunol.177.2.905; Collins A, 2009, NAT REV IMMUNOL, V9, P106, DOI 10.1038/nri2489; Cruz-Guilloty F, 2009, J EXP MED, V206, P51, DOI 10.1084/jem.20081242; de Bruijn MFTR, 2004, ONCOGENE, V23, P4238, DOI 10.1038/sj.onc.1207763; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Dyson Jennifer M, 2012, Subcell Biochem, V58, P215, DOI 10.1007/978-94-007-3012-0_7; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Glimcher LH, 2004, NAT REV IMMUNOL, V4, P900, DOI 10.1038/nri1490; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Greig KT, 2008, SEMIN IMMUNOL, V20, P247, DOI 10.1016/j.smim.2008.05.003; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Grueter B, 2005, J IMMUNOL, V175, P1694, DOI 10.4049/jimmunol.175.3.1694; Gunther T, 2005, EMBO J, V24, P3049, DOI 10.1038/sj.emboj.7600773; Hendrix A, 2010, JNCI-J NATL CANCER I, V102, P866, DOI 10.1093/jnci/djq153; Hess J, 2001, J BIOL CHEM, V276, P20029, DOI 10.1074/jbc.M010601200; Hesslein DGT, 2011, ADV IMMUNOL, V109, P45, DOI 10.1016/B978-0-12-387664-5.00002-9; Hurlin PJ, 2004, INT REV CYTOL, V238, P183, DOI 10.1016/S0074-7696(04)38004-6; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ito Y, 2008, ADV CANCER RES, V99, P33, DOI 10.1016/S0065-230X(07)99002-8; Kohu K, 2009, J IMMUNOL, V183, P7817, DOI 10.4049/jimmunol.0802527; Kutlesa S, 2002, J CELL SCI, V115, P4505, DOI 10.1242/jcs.00142; Labalette C, 2008, J BIOL CHEM, V283, P15201, DOI 10.1074/jbc.M800708200; Lai CB, 2012, J BIOL CHEM, V287, P7324, DOI 10.1074/jbc.M111.306936; Levanon D, 2001, MECH DEVELOP, V109, P413, DOI 10.1016/S0925-4773(01)00537-8; Levanon D, 2004, ONCOGENE, V23, P4211, DOI 10.1038/sj.onc.1207670; Lichtinger M, 2012, EMBO J, V31, P4318, DOI 10.1038/emboj.2012.275; Little GH, 2012, NUCLEIC ACIDS RES, V40, P3538, DOI 10.1093/nar/gkr1219; Liu L, 2004, CANCER RES, V64, P3491, DOI 10.1158/0008-5472.CAN-03-2106; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Marusina AI, 2008, J IMMUNOL, V180, P409, DOI 10.4049/jimmunol.180.1.409; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Melero I, 2008, TRENDS PHARMACOL SCI, V29, P383, DOI 10.1016/j.tips.2008.05.005; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Modiano JF, 2008, IMMUNOL RES, V41, P137, DOI 10.1007/s12026-008-8017-1; Moretta L, 2001, TRANSPLANT P, V33, P60, DOI 10.1016/S0041-1345(00)02790-1; Morlon A, 2003, P NATL ACAD SCI USA, V100, P3977, DOI 10.1073/pnas.0735923100; Murray CM, 2005, NAT CHEM BIOL, V1, P371, DOI 10.1038/nchembio744; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; Naoe Y, 2007, J EXP MED, V204, P1749, DOI 10.1084/jem.20062456; Pekowska A, 2011, EMBO J, V30, P4198, DOI 10.1038/emboj.2011.295; Pencovich N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064248; Pencovich N, 2011, BLOOD, V117, pE1, DOI 10.1182/blood-2010-07-295113; Presnell SR, 2012, J IMMUNOL, V188, P4394, DOI 10.4049/jimmunol.1103352; Ramirez K, 2012, IMMUNITY, V36, P921, DOI 10.1016/j.immuni.2012.04.006; RINCON M, 1994, EMBO J, V13, P4370, DOI 10.1002/j.1460-2075.1994.tb06757.x; Rothenberg EV, 2010, IMMUNOL REV, V238, P150, DOI 10.1111/j.1600-065X.2010.00964.x; Schmitt TM, 2004, J EXP MED, V200, P469, DOI 10.1084/jem.20040394; Setoguchi R, 2008, SCIENCE, V319, P822, DOI 10.1126/science.1151844; Shen R, 2002, MOL CELL BIOL, V22, P3230, DOI 10.1128/MCB.22.10.3230-3236.2002; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Smid M, 2003, BIOINFORMATICS, V19, P2065, DOI 10.1093/bioinformatics/btg282; So T, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00139; Spender LC, 2005, ONCOGENE, V24, P1873, DOI 10.1038/sj.onc.1208404; Stein GS, 2004, ONCOGENE, V23, P4315, DOI 10.1038/sj.onc.1207676; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun JC, 2011, NAT REV IMMUNOL, V11, P645, DOI 10.1038/nri3044; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Tarrant JA, 2002, MOL CELL BIOL, V22, P5006, DOI 10.1128/MCB.22.14.5006-5018.2002; Tijssen MR, 2011, DEV CELL, V20, P597, DOI 10.1016/j.devcel.2011.04.008; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; Wai PY, 2006, J BIOL CHEM, V281, P18973, DOI 10.1074/jbc.M511962200; Wilcox RA, 2002, J IMMUNOL, V169, P4230, DOI 10.4049/jimmunol.169.8.4230; Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731, DOI 10.1073/pnas.1232420100; WOTTON D, 1994, MOL CELL BIOL, V14, P840, DOI 10.1128/MCB.14.1.840; Xiong YM, 2013, EUR J IMMUNOL, V43, P918, DOI 10.1002/eji.201242944; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Yarmus M, 2006, P NATL ACAD SCI USA, V103, P7384, DOI 10.1073/pnas.0602470103; Zamisch M, 2009, J EXP MED, V206, P2685, DOI 10.1084/jem.20092024; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	78	43	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80467	10.1371/journal.pone.0080467	http://dx.doi.org/10.1371/journal.pone.0080467			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236182	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700183
J	Miller, AJ; Matasci, N; Schwaninger, H; Aradhya, MK; Prins, B; Zhong, GY; Simon, C; Buckler, ES; Myles, S				Miller, Allison J.; Matasci, Naim; Schwaninger, Heidi; Aradhya, Mallikarjuna K.; Prins, Bernard; Zhong, Gan-Yuan; Simon, Charles; Buckler, Edward S.; Myles, Sean			Vitis Phylogenomics: Hybridization Intensities from a SNP Array Outperform Genotype Calls	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; NEXT-GENERATION; PHYLOGENETIC ANALYSIS; ARABIDOPSIS-THALIANA; MOLECULAR PHYLOGENY; ASCERTAINMENT BIAS; LINKAGE MAP; GENOME; ASSOCIATION; EVOLUTION	Understanding relationships among species is a fundamental goal of evolutionary biology. Single nucleotide polymorphisms (SNPs) identified through next generation sequencing and related technologies enable phylogeny reconstruction by providing unprecedented numbers of characters for analysis. One approach to SNP-based phylogeny reconstruction is to identify SNPs in a subset of individuals, and then to compile SNPs on an array that can be used to genotype additional samples at hundreds or thousands of sites simultaneously. Although powerful and efficient, this method is subject to ascertainment bias because applying variation discovered in a representative subset to a larger sample favors identification of SNPs with high minor allele frequencies and introduces bias against rare alleles. Here, we demonstrate that the use of hybridization intensity data, rather than genotype calls, reduces the effects of ascertainment bias. Whereas traditional SNP calls assess known variants based on diversity housed in the discovery panel, hybridization intensity data survey variation in the broader sample pool, regardless of whether those variants are present in the initial SNP discovery process. We apply SNP genotype and hybridization intensity data derived from the Vitis9kSNP array developed for grape to show the effects of ascertainment bias and to reconstruct evolutionary relationships among Vitis species. We demonstrate that phylogenies constructed using hybridization intensities suffer less from the distorting effects of ascertainment bias, and are thus more accurate than phylogenies based on genotype calls. Moreover, we reconstruct the phylogeny of the genus Vitis using hybridization data, show that North American subgenus Vitis species are monophyletic, and resolve several previously poorly known relationships among North American species. This study builds on earlier work that applied the Vitis9kSNP array to evolutionary questions within Vitis vinifera and has general implications for addressing ascertainment bias in array-enabled phylogeny reconstruction.	[Miller, Allison J.] St Louis Univ, Dept Biol, St Louis, MO 63103 USA; [Matasci, Naim] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Matasci, Naim] Univ Arizona, iPlant Collaborat, Tucson, AZ USA; [Schwaninger, Heidi; Zhong, Gan-Yuan; Simon, Charles] Cornell Univ, New York State Agr Expt Stn, USDA, ARS,Plant Genet Resources Unit, Geneva, NY 14456 USA; [Aradhya, Mallikarjuna K.; Prins, Bernard] Univ Calif Davis, USDA, ARS, Davis, CA 95616 USA; [Zhong, Gan-Yuan] Cornell Univ, New York Agr Expt Stn, USDA, ARS,Grape Genet Res Unit, Geneva, NY 14456 USA; [Buckler, Edward S.] Cornell Univ, Inst Genom Divers, Ithaca, NY USA; [Myles, Sean] Dalhousie Univ, Fac Agr, Truro, NS, Canada	Saint Louis University; University of Arizona; University of Arizona; Cornell University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); University of California System; University of California Davis; Cornell University; United States Department of Agriculture (USDA); Cornell University; Dalhousie University	Miller, AJ (corresponding author), St Louis Univ, Dept Biol, St Louis, MO 63103 USA.	amille75@slu.edu; sean.myles@dal.ca	Buckler, Edward/GPS-4932-2022; Buckler, Edward/L-7651-2019; Miller, Allison/F-2293-2019	Buckler, Edward/0000-0002-3100-371X; Miller, Allison/0000-0002-2722-9361; Matasci, Naim/0000-0003-4416-048X; Aradhya, Mallikarjuna/0000-0002-2118-7885; Myles, Sean/0000-0001-9754-5987	Canada Research Chairs program; National Sciences and Engineering Research Council of Canada; ARS [ARS-0424615] Funding Source: Federal RePORTER	Canada Research Chairs program(Canada Research Chairs); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This article was written, in part, thanks to funding from the Canada Research Chairs program and the National Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2010, P NATL ACAD SCI USA, V107, P1160, DOI 10.1073/pnas.0909918107; Albrechtsen A, 2010, MOL BIOL EVOL, V27, P2534, DOI 10.1093/molbev/msq148; Antanaviciute L, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-203; Aradhya M, 2013, PLANT SYST EVOL, V299, P317, DOI 10.1007/s00606-012-0723-4; Aradhya MK, 2003, GENET RES, V81, P179, DOI 10.1017/S0016672303006177; Arroyo-Garcia R, 2006, MOL ECOL, V15, P3707, DOI 10.1111/j.1365-294X.2006.03049.x; Borevitz JO, 2004, CURR OPIN PLANT BIOL, V7, P132, DOI 10.1016/j.pbi.2004.01.011; Bradbury IR, 2011, MOL ECOL RESOUR, V11, P218, DOI 10.1111/j.1755-0998.2010.02949.x; Cai DY, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-70; Carstens B, 2012, SYST BIOL, V61, P713, DOI 10.1093/sysbio/sys050; Chagne D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031745; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Coart E, 2006, MOL ECOL, V15, P2171, DOI 10.1111/j.1365-294X.2006.02924.x; Decker J, 2009, RESOLVING EVOLUTION, P1; Didion JP, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-34; Donoghue MJ, 2008, P NATL ACAD SCI USA, V105, P11549, DOI 10.1073/pnas.0801962105; Eckert AJ, 2010, MOL ECOL, V19, P3789, DOI 10.1111/j.1365-294X.2010.04698.x; Eckert AJ, 2009, GENETICS, V182, P1289, DOI 10.1534/genetics.109.102350; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Fu Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014178; Galbraith DW, 2010, BIOSCIENCE, V60, P337, DOI 10.1525/bio.2010.60.5.4; Galet P, 1979, PRACTICAL AMPELOGRAP; Ganal MW, 2012, J BIOSCIENCES, V37, P821, DOI 10.1007/s12038-012-9225-3; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Garvin MR, 2010, MOL ECOL RESOUR, V10, P915, DOI 10.1111/j.1755-0998.2010.02891.x; Gilad Y, 2006, CURR OPIN GENET DEV, V16, P553, DOI 10.1016/j.gde.2006.09.005; Golovnina KA, 2007, PLANT SYST EVOL, V264, P195, DOI 10.1007/s00606-006-0478-x; Harrison N, 2011, TAXON, V60, P1552, DOI 10.1002/tax.606002; Helyar SJ, 2011, MOL ECOL RESOUR, V11, P123, DOI 10.1111/j.1755-0998.2010.02943.x; Holliday JA, 2010, NEW PHYTOL, V188, P501, DOI 10.1111/j.1469-8137.2010.03380.x; Horton MW, 2012, NAT GENET, V44, P212, DOI 10.1038/ng.1042; Hu AYC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014578, 10.1371/journal.pone.0029229]; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Hyten DL, 2010, HIGH THROUGHPUT SNP, P1; Jones FC, 2012, CURR BIOL, V22, P83, DOI 10.1016/j.cub.2011.11.045; Keller SR, 2012, MOL BIOL EVOL, V29, P3143, DOI 10.1093/molbev/mss121; Kim S, 2006, GENETICS, V173, P1125, DOI 10.1534/genetics.105.052720; Lasky JR, 2012, MOL ECOL, V21, P5512, DOI 10.1111/j.1365-294X.2012.05709.x; Lo EYY, 2012, MOL PHYLOGENET EVOL, V63, P230, DOI 10.1016/j.ympev.2011.10.005; Malhi RS, 2011, AM J PRIMATOL, V73, P1031, DOI 10.1002/ajp.20969; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; McCouch SR, 2010, BREEDING SCI, V60, P524, DOI 10.1270/jsbbs.60.524; McCue ME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002451; Miller JM, 2012, MOL ECOL RESOUR, V12, P1145, DOI 10.1111/1755-0998.12017; MOORE M O, 1991, SIDA Contributions to Botany, V14, P339; Morrell PL, 2012, NAT REV GENET, V13, P85, DOI 10.1038/nrg3097; Mullins MG., 1992, BIOL GRAPEVINE BIOL; Myles S, 2011, P NATL ACAD SCI USA, V108, P3530, DOI 10.1073/pnas.1009363108; Myles S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008219; Neves LG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-189; Nielsen R, 2000, GEOCHEM GEOPHSY GEOS, P1; Ollitrault P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-13; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pavy N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-21; PENNY D, 1985, SYST ZOOL, V34, P75, DOI 10.2307/2413347; Peros JP, 2011, J BIOGEOGR, V38, P471, DOI 10.1111/j.1365-2699.2010.02410.x; Petit RJ, 2006, ANNU REV ECOL EVOL S, V37, P187, DOI 10.1146/annurev.ecolsys.37.091305.110215; Pindo M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-12; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ren H., 2007, FLORA CHINA, P210; Ren H, 2011, TAXON, V60, P629, DOI 10.1002/tax.603001; Sacks BN, 2008, MOL ECOL RESOUR, V8, P35, DOI 10.1111/j.1471-8286.2007.01830.x; Shiu SH, 2008, HEREDITY, V100, P141, DOI 10.1038/sj.hdy.6800916; Soejima A, 2006, AM J BOT, V93, P278, DOI 10.3732/ajb.93.2.278; Springer NM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000734; Stoneking M, 2011, NAT REV GENET, V12, P603, DOI 10.1038/nrg3029; Straub SCK, 2012, AM J BOT, V99, P349, DOI 10.3732/ajb.1100335; Terol J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-423; Thomson MJ, 2012, MOL BREEDING, V29, P875, DOI 10.1007/s11032-011-9663-x; Trondle D, 2010, AM J BOT, V97, P1168, DOI 10.3732/ajb.0900218; Verde I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035668; Vezzulli S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-128; Wada, 2008, SYST EV VIT; Wan YZ, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-141; Wang Y, 2012, MOL ECOL, V21, P974, DOI 10.1111/j.1365-294X.2011.05413.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wen J, 1999, ANNU REV ECOL SYST, V30, P421, DOI 10.1146/annurev.ecolsys.30.1.421; Wen J, 2007, CAN J BOT, V85, P731, DOI 10.1139/B07-071; Xiang QYJ, 2004, EVOLUTION, V58, P2175, DOI 10.1111/j.0014-3820.2004.tb01596.x; Zecca G, 2012, MOL PHYLOGENET EVOL, V62, P736, DOI 10.1016/j.ympev.2011.11.015	81	32	34	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78680	10.1371/journal.pone.0078680	http://dx.doi.org/10.1371/journal.pone.0078680			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236035	Green Submitted, gold, Green Published			2022-12-27	WOS:000327254700032
J	Noda, T; Kawabata, Y; Arai, N; Mitamura, H; Watanabe, S				Noda, Takuji; Kawabata, Yuuki; Arai, Nobuaki; Mitamura, Hiromichi; Watanabe, Shun			Monitoring Escape and Feeding Behaviours of Cruiser Fish by Inertial and Magnetic Sensors	PLOS ONE			English	Article							PREY CAPTURE; CHUM SALMON; ACCELERATION; PERFORMANCE; KINEMATICS; ANIMALS; SEALS; START; L.	A method was developed and applied for monitoring two types of fast-start locomotion (feeding and escape) of a cruiser fish, Japanese amberjacks Seriola quinqueradiata. A data logger, which incorporated a 3-axis gyroscope, a 3-axis accelerometer and a 3-axis magnetometer, was attached to the five fish. The escape, feeding and routine movements of the fish, which were triggered in tank experiments, were then recorded by the data logger and video cameras. The locomotor variables, calculated based on the high resolution measurements by the data logger (500 Hz), were investigated to accurately detect and classify the types of fast-track behaviour. The results show that fast-start locomotion can be detected with a high precision (0.97) and recall rate (0.96) from the routine movements. Two types of fast-start movements were classified with high accuracy (0.84). Accuracy was greater if the data were obtained from the data logger, which combined an accelerometer, a gyroscope and a magnetometer, than if only an accelerometer (0.80) or a gyroscope (0.66) was used.	[Noda, Takuji; Mitamura, Hiromichi] Kyoto Univ, Grad Sch Informat, Kyoto, Japan; [Kawabata, Yuuki; Watanabe, Shun] Nagasaki Univ, Inst East China Sea Res, Nagasaki 852, Japan; [Arai, Nobuaki] Kyoto Univ, Field Sci Educ & Res Ctr, Kyoto, Japan	Kyoto University; Nagasaki University; Kyoto University	Noda, T (corresponding author), Kyoto Univ, Grad Sch Informat, Kyoto, Japan.	noda@bre.soc.i.kyoto-u.ac.jp	Kawabata, Yuuki/H-4109-2019; Noda, Takuji/W-1420-2019		Japan Society for the Promotion of Science [10J06259]; Special Coordination Funds for Promoting Science and Technology; Japan Science and Technology Agency; Nakajima Foundation [23880023, 21688015]; GCOE program "Informatics Education and Research Centre for Knowledge-Circulating Society''	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Nakajima Foundation; GCOE program "Informatics Education and Research Centre for Knowledge-Circulating Society''	This research was partly supported by a Research Fellowship from the Japan Society for the Promotion of Science to TN (No. 10J06259), a grant from the Special Coordination Funds for Promoting Science and Technology, funded by The Japan Science and Technology Agency (http://www.jst.go.jp/shincho/), to YK, a Grant-in-Aid for Research Activity start-up to YK (No. 23880023), a Grant-in-Aid for Young Scientists to HM (No. 21688015), a fellowship from the Nakajima Foundation (http://www.nakajimafound.or.jp/) to HM, and the GCOE program "Informatics Education and Research Centre for Knowledge-Circulating Society'' (http://www.i.kyoto-u.ac.jp/gcoe/english.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAKE RW, 1995, J FISH BIOL, V46, P536, DOI 10.1111/j.1095-8649.1995.tb05994.x; Broell F, 2013, J EXP BIOL, V216, P1255, DOI 10.1242/jeb.077396; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; Davis RW, 1999, SCIENCE, V283, P993, DOI 10.1126/science.283.5404.993; DOMENICI P, 1991, J EXP BIOL, V156, P187; Domenici P, 2011, J EXP BIOL, V214, P2463, DOI 10.1242/jeb.029652; Domenici P, 2011, J EXP BIOL, V214, P2474, DOI 10.1242/jeb.053801; Fore M, 2011, COMPUT ELECTRON AGR, V76, P240, DOI 10.1016/j.compag.2011.02.003; Fourati H, 2011, BIOMED SIGNAL PROCES, V6, P94, DOI 10.1016/j.bspc.2010.06.004; Hale ME, 2002, J EXP BIOL, V205, P2005; Hall MA, 1998, AUST COMP S, V20, P181; HARPER DG, 1990, J EXP BIOL, V150, P321; HARPER DG, 1989, J EXP BIOL, V142, P465; Higham TE, 2007, INTEGR COMP BIOL, V47, P82, DOI 10.1093/icb/icm021; Johnson MP, 2003, IEEE J OCEANIC ENG, V28, P3, DOI 10.1109/JOE.2002.808212; Kawabe R, 2003, FISHERIES SCI, V69, P3, DOI 10.1046/j.1444-2906.2003.00581.x; Lefrancois C, 2006, MAR BIOL, V149, P969, DOI 10.1007/s00227-006-0261-0; Madgwick Sebastian O H, 2011, IEEE Int Conf Rehabil Robot, V2011, P5975346, DOI 10.1109/ICORR.2011.5975346; Makiguchi Y, 2012, J FISH BIOL, V80, P2345, DOI 10.1111/j.1095-8649.2012.03293.x; Murchie KJ, 2011, J EXP MAR BIOL ECOL, V396, P147, DOI 10.1016/j.jembe.2010.10.019; Noda T, 2012, AQUAT BIOL, V16, P265, DOI 10.3354/ab00448; OBRIEN WJ, 1990, AM SCI, V78, P152; Rutz C, 2009, BIOL LETTERS, V5, P289, DOI 10.1098/rsbl.2009.0089; Sato K, 2003, J EXP BIOL, V206, P1461, DOI 10.1242/jeb.00265; Shepard ELC, 2009, AQUAT BIOL, V4, P235, DOI 10.3354/ab00104; Tanaka H, 2001, J EXP BIOL, V204, P3895; Tsuda Y, 2006, ECOL FRESHW FISH, V15, P264, DOI 10.1111/j.1600-0633.2006.00147.x; Watanabe Y, 2004, MAR ECOL PROG SER, V279, P283, DOI 10.3354/meps279283; Watanabe YY, 2013, P NATL ACAD SCI USA, V110, P2199, DOI 10.1073/pnas.1216244110; WEBB PW, 1984, AM ZOOL, V24, P107; WEBB PW, 1981, COPEIA, P901; Whitney Nicholas M., 2010, Endangered Species Research, V10, P71, DOI 10.3354/esr00247; Wilson A, 2013, NATURE; Wilson Rory P., 2008, Endangered Species Research, V4, P123, DOI 10.3354/esr00064; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x	35	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79392	10.1371/journal.pone.0079392	http://dx.doi.org/10.1371/journal.pone.0079392			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236126	Green Submitted, Green Published, gold			2022-12-27	WOS:000327254700125
J	Pfaffinger, PJ				Pfaffinger, Paul J.			A Conserved Pre-Block Interaction Motif Regulates Potassium Channel Activation and N-Type Inactivation	PLOS ONE			English	Article							SHAKER-K+ CHANNEL; ALIGNMENT EDITOR; PROTEIN-KINASE; ION-CHANNEL; CURRENTS; GATE; INHIBITORS; PEPTIDES; RECEPTOR; BINDING	N-type inactivation occurs when the N-terminus of a potassium channel binds into the open pore of the channel. This study examined the relationship between activation and steady state inactivation for mutations affecting the N-type inactivation properties of the Aplysia potassium channel AKv1 expressed in Xenopus oocytes. The results show that the traditional singlestep model for N-type inactivation fails to properly account for the observed relationship between steady state channel activation and inactivation curves. We find that the midpoint of the steady state inactivation curve depends in part on a secondary interaction between the channel core and a region of the N-terminus just proximal to the pore blocking peptide that we call the Inactivation Proximal (IP) region. The IP interaction with the channel core produces a negative shift in the activation and inactivation curves, without blocking the pore. A tripeptide motif in the IP region was identified in a large number of different N-type inactivation domains most likely reflecting convergent evolution in addition to direct descent. Point mutating a conserved hydrophobic residue in this motif eliminates the gating voltage shift, accelerates recovery from inactivation and decreases the amount of pore block produced during inactivation. The IP interaction we have identified likely stabilizes the open state and positions the pore blocking region of the N-terminus at the internal opening to the transmembrane pore by forming a Pre-Block (P state) interaction with residues lining the side window vestibule of the channel.	Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Baylor College of Medicine	Pfaffinger, PJ (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	paulp@bcm.edu			United States National Institutes of Health [R01GM090029, P30HD024064]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090029] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by United States National Institutes of Health Grants R01GM090029 and P30HD024064. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich RW, 2001, NATURE, V411, P643, DOI 10.1038/35079705; Barros F, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00049; Beck EJ, 1998, J GEN PHYSIOL, V112, P71, DOI 10.1085/jgp.112.1.71; Camacho CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003342; Chen XR, 2010, P NATL ACAD SCI USA, V107, P11352, DOI 10.1073/pnas.1000142107; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; DEMO SD, 1991, NEURON, V7, P743, DOI 10.1016/0896-6273(91)90277-7; DRAIN P, 1994, NEURON, V12, P1097, DOI 10.1016/0896-6273(94)90317-4; Fineberg JD, 2012, J GEN PHYSIOL, V140, P513, DOI 10.1085/jgp.201210869; Gonzalez C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1446; Gonzalez-Perez V, 2012, NATURE, V485, P133, DOI 10.1038/nature10994; Hille, 2001, ION CHANNELS EXCITAB; Holmgren M, 1996, J GEN PHYSIOL, V108, P195, DOI 10.1085/jgp.108.3.195; Holmqvist MH, 2002, P NATL ACAD SCI USA, V99, P1035, DOI 10.1073/pnas.022509299; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; Jerng HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038205; Karplus PA, 1997, PROTEIN SCI, V6, P1302; Lee TE, 1996, J MEMBRANE BIOL, V151, P225, DOI 10.1007/s002329900073; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lu Q, 2008, BIOORGAN MED CHEM, V16, P3067, DOI 10.1016/j.bmc.2007.12.031; Milescu LS, 2005, BIOPHYS J, V88, P2494, DOI 10.1529/biophysj.104.053256; MURRELLLAGNADO RD, 1993, J GEN PHYSIOL, V102, P977, DOI 10.1085/jgp.102.6.977; MURRELLLAGNADO RD, 1993, J GEN PHYSIOL, V102, P949, DOI 10.1085/jgp.102.6.949; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PFAFFINGER PJ, 1991, J NEUROSCI, V11, P918; Prince A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062695; Prince-Carter A, 2009, J GEN PHYSIOL, V134, P15, DOI 10.1085/jgp.200910219; Rasmusson RL, 1998, CIRC RES, V82, P739, DOI 10.1161/01.RES.82.7.739; Roeper J, 1998, NATURE, V391, P390, DOI 10.1038/34916; RUPPERSBERG JP, 1991, NATURE, V352, P711, DOI 10.1038/352711a0; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; ZAGOTTA WN, 1990, J GEN PHYSIOL, V95, P29, DOI 10.1085/jgp.95.1.29; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; Zhang ZH, 2004, J BIOL CHEM, V279, P29226, DOI 10.1074/jbc.M403290200; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500	39	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79891	10.1371/journal.pone.0079891	http://dx.doi.org/10.1371/journal.pone.0079891			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236164	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700165
J	Li, P; Chen, Y; Mak, KK; Wong, CK; Wang, CC; Yuan, P				Li, Peng; Chen, Ying; Mak, Kinglun Kingston; Wong, Chun Kwok; Wang, Chi Chiu; Yuan, Ping			Functional Role of Mst1/Mst2 in Embryonic Stem Cell Differentiation	PLOS ONE			English	Article							HIPPO SIGNALING PATHWAY; PROMOTES APOPTOSIS; PROGENITOR CELLS; PRECURSOR CELLS; YAP ONCOPROTEIN; SIZE-CONTROL; CYCLE EXIT; ORGAN SIZE; PROLIFERATION; DROSOPHILA	The Hippo pathway is an evolutionary conserved pathway that involves cell proliferation, differentiation, apoptosis and organ size regulation. Mst1 and Mst2 are central components of this pathway that are essential for embryonic development, though their role in controlling embryonic stem cells (ES cells) has yet to be exploited. To further understand the Mst1/Mst2 function in ES cell pluripotency and differentiation, we derived Mst1/Mst2 double knockout (Mst-/-) ES cells to completely perturb Hippo signaling. We found that Mst-/- ES cells express higher level of Nanog than wild type ES cells and show differentiation resistance after LIF withdrawal. They also proliferate faster than wild type ES cells. Although Mst-/- ES cells can form embryoid bodies (EBs), their differentiation into tissues of three germ layers is distorted. Intriguingly, Mst-/- ES cells are unable to form teratoma. Mst-/- ES cells can differentiate into mesoderm lineage, but further differentiation to cardiac lineage cells is significantly affected. Microarray analysis revealed that ligands of non-canonical Wnt signaling, which is critical for cardiac progenitor specification, are significantly repressed in Mst-/- EBs. Taken together our results showed that Mst1/Mst2 are required for proper cardiac lineage cell development and teratoma formation.	[Li, Peng; Wong, Chun Kwok; Yuan, Ping] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China; [Chen, Ying; Wang, Chi Chiu; Yuan, Ping] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China; [Mak, Kinglun Kingston; Wang, Chi Chiu; Yuan, Ping] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Mak, Kinglun Kingston; Wong, Chun Kwok; Wang, Chi Chiu; Yuan, Ping] Chinese Univ Hong Kong, CUHK Shenzhen Res Inst, Shenzhen, Guangdong, Peoples R China; [Mak, Kinglun Kingston] Chinese Univ Hong Kong, Key Labs Regenerat Med, Minist Educ, Shatin, Hong Kong, Peoples R China; [Wang, Chi Chiu] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Obstet & Gynaecol, Fetal Med Unit, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen; Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital	Yuan, P (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China.	pyuan@cuhk.edu.hk	Wong, CK/H-3256-2016; Wang, Ronald/C-6541-2014	Wong, CK/0000-0002-5637-8331; Wang, Ronald/0000-0002-3928-7278; Yuan, Ping/0000-0001-7243-3487; Mak, Kingston King-Lun/0000-0002-4733-9146				Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chan SW, 2011, J CELL PHYSIOL, V226, P928, DOI 10.1002/jcp.22435; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Chen L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002571; Christoforou N, 2008, J CLIN INVEST, V118, P894, DOI 10.1172/JCI33942; Cohen ED, 2012, DEVELOPMENT, V139, P1931, DOI 10.1242/dev.069377; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dressel R, 2010, FASEB J, V24, P2164, DOI 10.1096/fj.09-134957; George NM, 2012, MOL CELL BIOL, V32, P5116, DOI 10.1128/MCB.01034-12; Gessert S, 2010, CIRC RES, V107, P186, DOI 10.1161/CIRCRESAHA.110.221531; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Lee KP, 2010, P NATL ACAD SCI USA, V107, P8248, DOI 10.1073/pnas.0912203107; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Liu AM, 2010, EXPERT OPIN THER TAR, V14, P855, DOI 10.1517/14728222.2010.499361; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Matallanas D, 2011, MOL CELL, V44, P893, DOI 10.1016/j.molcel.2011.10.016; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; O'Neill E, 2004, SCIENCE, V306, P2267, DOI 10.1126/science.1103233; Oh S, 2009, MOL CELL BIOL, V29, P6309, DOI 10.1128/MCB.00551-09; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; Onizuka T, 2012, J MOL CELL CARDIOL, V52, P650, DOI 10.1016/j.yjmcc.2011.11.010; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Pobbati AV, 2013, CANCER BIOL THER, V14, P390, DOI 10.4161/cbt.23788; Ramos A, 2012, TRENDS CELL BIOL, V22, P339, DOI 10.1016/j.tcb.2012.04.006; Rossant J, 2001, STEM CELLS, V19, P477, DOI 10.1634/stemcells.19-6-477; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Schleiffarth JR, 2007, PEDIATR RES, V61, P386, DOI 10.1203/pdr.0b013e3180323810; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Song JY, 2011, BIOCHEM BIOPH RES CO, V404, P728, DOI 10.1016/j.bbrc.2010.12.052; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tamm C, 2011, J CELL SCI, V124, P1136, DOI 10.1242/jcs.075796; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Tokuzawa Yoshimi, 2006, V329, P223; Vincent SD, 2010, CURR TOP DEV BIOL, V90, P1, DOI 10.1016/S0070-2153(10)90001-X; Wang H, 2007, J BIOL CHEM, V282, P782, DOI 10.1074/jbc.M606610200; Watt KI, 2010, BIOCHEM BIOPH RES CO, V393, P619, DOI 10.1016/j.bbrc.2010.02.034; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Yuan ZQ, 2009, J BIOL CHEM, V284, P11285, DOI 10.1074/jbc.M900461200; Zhang HY, 2011, P NATL ACAD SCI USA, V108, P2270, DOI 10.1073/pnas.1019603108; Zhang H, 2012, CELL SIGNAL, V24, P224, DOI 10.1016/j.cellsig.2011.09.004; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhao QS, 2011, STEM CELL REV REP, V7, P326, DOI 10.1007/s12015-010-9206-6; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108; Zhou DW, 2008, P NATL ACAD SCI USA, V105, P20321, DOI 10.1073/pnas.0810773105	54	30	31	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79867	10.1371/journal.pone.0079867	http://dx.doi.org/10.1371/journal.pone.0079867			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224013	gold, Green Published, Green Submitted			2022-12-27	WOS:000326597400092
J	Kulsantiwong, J; Prasopdee, S; Ruangsittichai, J; Ruangjirachuporn, W; Boonmars, T; Viyanant, V; Pierossi, P; Hebert, PDN; Tesana, S				Kulsantiwong, Jutharat; Prasopdee, Sattrachai; Ruangsittichai, Jiraporn; Ruangjirachuporn, Wipaporn; Boonmars, Thidarut; Viyanant, Vithoon; Pierossi, Paola; Hebert, Paul D. N.; Tesana, Smarn			DNA Barcode Identification of Freshwater Snails in the Family Bithyniidae from Thailand	PLOS ONE			English	Article							OPISTHORCHIS-VIVERRINI; BRAZILIAN BIOMPHALARIA; CHOLANGIOCARCINOMA; DIPTERA; CAENOGASTROPODA; VARIABILITY; MORPHOLOGY; GASTROPODA; INFECTION; IDENTIFY	Freshwater snails in the family Bithyniidae are the first intermediate host for Southeast Asian liver fluke (Opisthorchis viverrini), the causative agent of opisthorchiasis. Unfortunately, the subtle morphological characters that differentiate species in this group are not easily discerned by non-specialists. This is a serious matter because the identification of bithyniid species is a fundamental prerequisite for better understanding of the epidemiology of this disease. Because DNA barcoding, the analysis of sequence diversity in the 5' region of the mitochondrial COI gene, has shown strong performance in other taxonomic groups, we decided to test its capacity to resolve 10 species/subspecies of bithyniids from Thailand. Our analysis of 217 specimens indicated that COI sequences delivered species-level identification for 9 of 10 currently recognized species. The mean intraspecific divergence of COI was 2.3% (range 0-9.2 %), whereas sequence divergences between congeneric species averaged 8.7% (range 0-22.2 %). Although our results indicate that DNA barcoding can differentiate species of these medically-important snails, we also detected evidence for the presence of one overlooked species and one possible case of synonymy.	[Kulsantiwong, Jutharat; Prasopdee, Sattrachai; Ruangjirachuporn, Wipaporn; Boonmars, Thidarut; Tesana, Smarn] Khon Kaen Univ, Fac Med, Dept Parasitol, Food Borne Parasite Res Grp, Khon Kaen 40002, Thailand; [Ruangsittichai, Jiraporn] Mahidol Univ, Fac Trop Med, Dept Med Entomol, Bangkok, Thailand; [Viyanant, Vithoon] Thammasat Univ, Ctr Excellence Res Biomed Sci, Klongluang, Pathumthani, Thailand; [Viyanant, Vithoon] Thammasat Univ, Thailand Ctr Excellence Drug Discovery & Dev, Klongluang, Pathumthani, Thailand; [Pierossi, Paola; Hebert, Paul D. N.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada	Khon Kaen University; Mahidol University; Thammasat University; Thammasat University; University of Guelph	Tesana, S (corresponding author), Khon Kaen Univ, Fac Med, Dept Parasitol, Food Borne Parasite Res Grp, Khon Kaen 40002, Thailand.	smarn_te@kku.ac.th	Hebert, Paul DN/C-4161-2013	Hebert, Paul DN/0000-0002-3081-6700; Prasopdee, Sattrachai/0000-0003-0175-9679	Higher Education Research Promotion and National Research University Project (NRU) of Thailand; Office of the Higher Education Commission, Ministry of Education of Thailand and through the Health Cluster (SHeP-GMS), Khon Kaen University, Thailand; Office of the Higher Education Commission	Higher Education Research Promotion and National Research University Project (NRU) of Thailand; Office of the Higher Education Commission, Ministry of Education of Thailand and through the Health Cluster (SHeP-GMS), Khon Kaen University, Thailand; Office of the Higher Education Commission	The study was supported by the Higher Education Research Promotion and National Research University Project (NRU) of Thailand, and the Office of the Higher Education Commission, Ministry of Education of Thailand and through the Health Cluster (SHeP-GMS), Khon Kaen University, Thailand. Jutharat Kulsantiwong thanks the Office of the Higher Education Commission for supporting her PhD program (CHE) in the Department of Parasitology, Faculty of Medicine, Khon Kaen University, Thammasat University, and UdonThani Rajabhat University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, IARC Monogr Eval Carcinog Risks Hum, V61, P121; BRANDT R A M, 1974, Archiv fuer Molluskenkunde, V105, P1; Caldeira RL, 2009, ACTA TROP, V111, P1, DOI 10.1016/j.actatropica.2009.02.004; Canadian Centre for DNA Barcoding (CCDB), 2008, ADV SPEC ID DISC; Carvalho OS, 2001, PARASITOLOGY, V123, pS197, DOI 10.1017/S0031182001008058; Chitramvong Y.P., 1992, Malacological Review, V25, P21; Chitramvong Yaowaluk Prayoonhong, 1991, Walkerana, V5, P161; Davis GM, 1998, MALACOLOGIA, V40, P251; Delicado D, 2012, ZOOKEYS, P55, DOI 10.3897/zookeys.190.2555; Duangprompo W, 2007, THESIS KHON KAEN U K; Ferri E, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-1; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gibbs J, 2009, ZOOTAXA, P1; Hall T, 2008, BIOEDIT SEQUENCE ALI; HARINASUTA T, 1984, ARZNEIMITTEL-FORSCH, V34-2, P1167; HASWELLELKINS MR, 1992, PARASITOL TODAY, V8, P86, DOI 10.1016/0169-4758(92)90241-S; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Honjo S, 2005, INT J CANCER, V117, P854, DOI 10.1002/ijc.21146; Ivanova N, 2006, INCREASED DNA BARCOD; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Ivanova NV, 2005, PROTOCOLS HIGH VOLUM; Jones CS, 2001, PARASITOLOGY, V123, pS277, DOI 10.1017/S0031182001008381; Jorgensen A, 2007, ZOOL J LINN SOC-LOND, V151, P337, DOI 10.1111/j.1096-3642.2007.00330.x; Kiatsopit N, 2011, ACTA TROP, V118, P136, DOI 10.1016/j.actatropica.2011.02.002; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kodcharin P, 2006, THESIS KHON KAEN U K; LARKIN MA, 2007, BIOINFORMATICS, V23, P2947, DOI DOI 10.1093/BI0INF0RMATICS/BTM404; Linares MC, 2009, MOL PHYLOGENET EVOL, V50, P485, DOI 10.1016/j.ympev.2008.11.008; Locke SA, 2010, INT J PARASITOL, V40, P333, DOI 10.1016/j.ijpara.2009.08.012; Mairiang E, 2003, ACTA TROP, V88, P221, DOI 10.1016/j.actatropica.2003.03.001; McCarthy C, 2008, CHROMAS; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miller K, 2005, TLS-TIMES LIT SUPPL, P30; Osman M, 1998, DIGEST SURG, V15, P287, DOI 10.1159/000018640; Prayoonhong Chitramvong Y., 1990, Walkerana, V3, P179; Puillandre N, 2009, MOL ECOL RESOUR, V9, P1311, DOI 10.1111/j.1755-0998.2009.02576.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rojo S, 2006, EUR J ENTOMOL, V103, P443, DOI 10.14411/eje.2006.058; Rollinson D, 1998, MEM I OSWALDO CRUZ, V93, P111, DOI 10.1590/S0074-02761998000700015; Shufran KA, 2011, ANN ENTOMOL SOC AM, V104, P39, DOI 10.1603/AN10129; SITHITHAWORN P, 1994, INT J PARASITOL, V24, P833, DOI 10.1016/0020-7519(94)90009-4; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Sri-Aroon Pusadee, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P294; Sri-aroon Pusadee, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P653; Sripa B, 2007, PLOS MED, V4, P1148, DOI 10.1371/journal.pmed.0040201; Sripa B, 2005, WORLD J GASTROENTERO, V11, P3392, DOI 10.3748/wjg.v11.i22.3392; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THAMAVIT W, 1978, CANCER RES, V38, P4634; Tropmed Technical Group, 1986, Southeast Asian Journal of Tropical Medicine and Public Health, V17, P282; UPATHAM E S, 1983, Malacological Review, V16, P107; Vatanasapt V, 2000, LIVER CANC THAILAND, P3; Watanapa P, 2002, BRIT J SURG, V89, P962, DOI 10.1046/j.1365-2168.2002.02143.x; Whitworth TL, 2007, P ROY SOC B-BIOL SCI, V274, P1731, DOI 10.1098/rspb.2007.0062; Wilke T, 2000, ACTA TROP, V77, P215, DOI 10.1016/S0001-706X(00)00143-1; WINNEPENNINCKX B, 1993, TRENDS GENET, V9, P407; WYKOFF DE, 1965, J PARASITOL, V51, P207, DOI 10.2307/3276083	58	20	25	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79144	10.1371/journal.pone.0079144	http://dx.doi.org/10.1371/journal.pone.0079144			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223896	Green Published, gold			2022-12-27	WOS:000326503400099
J	Qiu, YW; Lv, XF; Su, HH; Jiang, GH; Tian, JZ; Zhuo, FZ; Han, LJ; Zhang, XL				Qiu, Yingwei; Lv, Xiaofei; Su, Huanhuan; Jiang, Guihua; Tian, Junzhang; Zhuo, Fuzhen; Han, Lujun; Zhang, Xuelin			Reduced Regional Homogeneity in Bilateral Frontostriatal System Relates to Higher Impulsivity Behavior in Codeine-Containing Cough Syrups Dependent Individuals	PLOS ONE			English	Article							STATE FUNCTIONAL MRI; MONKEY VISUAL-CORTEX; MAGNETIC-RESONANCE; ALZHEIMERS-DISEASE; ACTIVITY FLUCTUATIONS; PREFRONTAL CORTEX; NEURAL ACTIVITY; COCAINE USERS; HEROIN USERS; FMRI	Background: In the past twenty years, codeine-containing cough syrups (CCS) was recognized as a new type of addictive drugs. However, the exact neurobiologic mechanisms underlying CCS-dependence are still ill-defined. The aims of this study are to identify CCS-related modulations of neural activity during the resting-state in CCS-dependent individuals and to investigate whether these changes of neural activity can be related to duration of CCS use, the first age of CCS use and impulse control deficits in CCS-dependent individuals. We also want to observe the impact of gray matter deficits on these functional results. Methodology/Principal Findings: Thirty CCS-dependent individuals and 30 control subjects participated. Resting-state functional MRI was performed by using gradient-echo echo-planar imaging sequence. Regional homogeneity (ReHo) was calculated by using REST software. Voxel-based analysis of the ReHo maps between controls and CCS-dependent groups was performed using two-sample t tests (p<0.05, corrected for multiple comparisons). The Barratt Impulsiveness Scale 11 (BIS.11) was surveyed to assess participants' impulsivity trait soon after MR examination. Abnormal clusters revealed by group comparison were extracted and correlated with impulsivity, duration of CCS use, and age of first CCS use. ReHo was diminished in the bilateral medial orbitofrontal cortex (mOFC) and left dorsal striatum in CCS-dependent individuals. There were negative correlations between mean ReHo in the bilateral medial OFC, left dorsal striatum and duration of CCS use, BIS.11 total scores, and the subscale of attentional impulsivity in CCS-dependent individuals. There was a significantly positive correlation between mean ReHo in the left dorsal striatum and age of first CCS use in CCS-dependent individuals. Importantly, these results still remain significant after statistically controlling for the regional gray matter deficits. Conclusion: Resting-state abnormalities in CCS-dependent individuals revealed in the present study may further improve our understanding about the neural substrates of impulse control dysfunction in CCS-dependent individuals.	[Qiu, Yingwei; Lv, Xiaofei; Su, Huanhuan; Jiang, Guihua; Tian, Junzhang] Guangdong 2 Prov Peoples Hosp, Dept Med Imaging, Guangzhou, Guangdong, Peoples R China; [Lv, Xiaofei; Han, Lujun] Sun Yat Sen Univ, Ctr Canc, Dept Med Imaging, Guangzhou 510275, Guangdong, Peoples R China; [Lv, Xiaofei; Han, Lujun] Sun Yat Sen Univ, Ctr Canc, Dept Intervent Radiol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Xuelin] Southern Medial Univ, NanFang Hosp, Med Imaging Ctr, Guangzhou, Guangdong, Peoples R China; [Zhuo, Fuzhen] Guangdong 2 Prov Peoples Hosp, Addict Med Div, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Southern Medical University - China	Qiu, YW (corresponding author), Guangdong 2 Prov Peoples Hosp, Dept Med Imaging, Guangzhou, Guangdong, Peoples R China.	qiuyw1201@gmail.com; jiangguihua177@163.com; tianjz2010@163.com		Qiu, Yingwei/0000-0003-1298-8506; Tian, Junzhang/0000-0002-6212-1882	Natural Scientific Foundation of China [81201084]; Planned Science and Technology Project of Guangdong Province, China [2011B031800044]	Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Planned Science and Technology Project of Guangdong Province, China	This work was supported by the grants from the Natural Scientific Foundation of China [Grant No. 81201084 for Yingwei Qiu], and the Planned Science and Technology Project of Guangdong Province, China [Grant No. 2011B031800044 for Guihua Jiang]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asensio S, 2010, SYNAPSE, V64, P397, DOI 10.1002/syn.20741; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bokde ALW, 2001, ARCH NEUROL-CHICAGO, V58, P480, DOI 10.1001/archneur.58.3.480; Botelho MF, 2006, ANN NY ACAD SCI, V1074, P466, DOI 10.1196/annals.1369.047; Callicott JH, 2003, AM J PSYCHIAT, V160, P2209, DOI 10.1176/appi.ajp.160.12.2209; Cao QJ, 2006, NEUROREPORT, V17, P1033, DOI 10.1097/01.wnr.0000224769.92454.5d; Dai XJ, 2012, SLEEP MED, V13, P720, DOI 10.1016/j.sleep.2011.09.019; Ersche KD, 2011, BRAIN, V134, P2013, DOI 10.1093/brain/awr138; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Fu LP, 2008, NEUROSCI LETT, V438, P322, DOI 10.1016/j.neulet.2008.04.033; Garavan H, 2000, AM J PSYCHIAT, V157, P1789, DOI 10.1176/appi.ajp.157.11.1789; Goldstein RZ, 2007, AM J PSYCHIAT, V164, P43, DOI 10.1176/appi.ajp.164.1.43; Goncalves SI, 2006, NEUROIMAGE, V30, P203, DOI 10.1016/j.neuroimage.2005.09.062; Gu H, 2010, NEUROIMAGE, V53, P593, DOI 10.1016/j.neuroimage.2010.06.066; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Hou HF, 2011, DRUG ALCOHOL DEPEN, V118, P148, DOI 10.1016/j.drugalcdep.2011.03.011; Ibanez V, 1998, NEUROLOGY, V50, P1585, DOI 10.1212/WNL.50.6.1585; Jiang GH, 2011, NEUROIMAGE, V57, P149, DOI 10.1016/j.neuroimage.2011.04.004; Kaufman JN, 2003, J NEUROSCI, V23, P7839; Kelly C, 2011, BIOL PSYCHIAT, V69, P684, DOI 10.1016/j.biopsych.2010.11.022; Kendall M.G., 1990, RANK CORRELATION MET, V5th; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Lee TMC, 2005, NEUROSCI LETT, V382, P211, DOI 10.1016/j.neulet.2005.03.053; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Lui S, 2008, J MAGN RESON IMAGING, V27, P1214, DOI 10.1002/jmri.21370; Lui S, 2009, P NATL ACAD SCI USA, V106, P15412, DOI 10.1073/pnas.0812751106; Ma N, 2010, NEUROIMAGE, V49, P738, DOI 10.1016/j.neuroimage.2009.08.037; Maas LC, 1998, AM J PSYCHIAT, V155, P124, DOI 10.1176/ajp.155.1.124; Matsuo K, 2009, HUM BRAIN MAPP, V30, P1188, DOI 10.1002/hbm.20588; Mattoo SK, 1997, ADDICTION, V92, P1783, DOI 10.1111/j.1360-0443.1997.tb02898.x; Moeller FG, 2001, J SUBST ABUSE TREAT, V21, P193, DOI 10.1016/S0740-5472(01)00202-1; Nestor L, 2010, NEUROIMAGE, V49, P1133, DOI 10.1016/j.neuroimage.2009.07.022; Ojemann JG, 1997, NEUROIMAGE, V6, P156, DOI 10.1006/nimg.1997.0289; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Prvulovic D, 2002, NEUROIMAGE, V17, P1403, DOI 10.1006/nimg.2002.1271; Qiu YW, 2013, NEUROSCI LETT, V538, P43, DOI 10.1016/j.neulet.2013.01.019; Qiu YW, 2011, RADIOLOGY, V261, P551, DOI 10.1148/radiol.11102466; Remy F, 2005, NEUROIMAGE, V25, P253, DOI 10.1016/j.neuroimage.2004.10.045; Shek DTL, 2008, SOC BEHAV PERSONAL, V36, P135, DOI 10.2224/sbp.2008.36.1.135; Shek Daniel T L, 2006, Int J Adolesc Med Health, V18, P493; Shmuel A, 2008, HUM BRAIN MAPP, V29, P751, DOI 10.1002/hbm.20580; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Volkow ND, 2009, NEUROPHARMACOLOGY, V56, P3, DOI 10.1016/j.neuropharm.2008.05.022; Volkow ND, 2005, J NEUROSCI, V25, P3932, DOI 10.1523/JNEUROSCI.0433-05.2005; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; Vree TB, 2000, INT J CLIN PRACT, V54, P395; Wang LQ, 2011, NEUROSCI LETT, V488, P275, DOI 10.1016/j.neulet.2010.11.046; Wang XL, 2011, CHIN J SOC MED, V28, P190; Wexler BE, 2001, AM J PSYCHIAT, V158, P86, DOI 10.1176/appi.ajp.158.1.86; Wilson W, 2000, J ADDICT DIS, V19, P1, DOI 10.1300/J069v19n01_01; Xiao ZW, 2006, DRUG ALCOHOL DEPEN, V83, P157, DOI 10.1016/j.drugalcdep.2005.11.012; Yang Y, 2008, CHINESE J DRUG ABUSE, V14, P143; Yang Z, 2009, HUM BRAIN MAPP, V30, P766, DOI 10.1002/hbm.20542; Yao SQ, 2007, PERCEPT MOTOR SKILL, V104, P1169, DOI 10.2466/PMS.104.4.1169-1182; Yuan Y, 2009, BRAIN COGNITION, V71, P223, DOI 10.1016/j.bandc.2009.08.014; Zald DH, 2004, J NEUROSCI, V24, P4105, DOI 10.1523/JNEUROSCI.4643-03.2004; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030	60	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78738	10.1371/journal.pone.0078738	http://dx.doi.org/10.1371/journal.pone.0078738			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223847	gold, Green Published, Green Submitted			2022-12-27	WOS:000326503400087
J	Ferreira, JC; Icimoto, MY; Marcondes, MF; Oliveira, V; Nascimento, OR; Nantes, IL				Ferreira, Juliana C.; Icimoto, Marcelo Y.; Marcondes, Marcelo F.; Oliveira, Vitor; Nascimento, Otaciro R.; Nantes, Iseli L.			Recycling of the High Valence States of Heme Proteins by Cysteine Residues of Thimet-Oligopeptidase	PLOS ONE			English	Article							CYTOCHROME-C; EC 3.4.24.15; SELF-PEROXIDATION; HUMAN NEUROGLOBIN; ELECTRON-TRANSFER; PZ-PEPTIDASE; MYOGLOBIN; SPECIFICITY; RAT; METALLOENDOPEPTIDASE	The peptidolytic enzyme THIMET-oligopeptidase (TOP) is able to act as a reducing agent in the peroxidase cycle of myoglobin (Mb) and horseradish peroxidase (HRP). The TOP-promoted recycling of the high valence states of the peroxidases to the respective resting form was accompanied by a significant decrease in the thiol content of the peptidolytic enzyme. EPR (electron paramagnetic resonance) analysis using DBNBS spin trapping revealed that TOP also prevented the formation of tryptophanyl radical in Mb challenged by H2O2. The oxidation of TOP thiol groups by peroxidases did not promote the inactivating oligomerization observed in the oxidation promoted by the enzyme aging. These findings are discussed towards a possible occurrence of these reactions in cells.	[Ferreira, Juliana C.; Icimoto, Marcelo Y.; Marcondes, Marcelo F.; Oliveira, Vitor] Univ Fed Sao Paulo, Dept Biofis, Sao Paulo, Brazil; [Nascimento, Otaciro R.] Univ Sao Paulo, Inst Fis Sao Carlos, Sao Carlos, SP, Brazil; [Ferreira, Juliana C.; Nantes, Iseli L.] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Santo Andre, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade Federal do ABC (UFABC)	Nantes, IL (corresponding author), Univ Fed ABC, Ctr Ciencias Nat & Humanas, Santo Andre, SP, Brazil.	ilnantes@gmail.com	Oliveira, Vitor/L-3709-2013; Marcondes, Marcelo FM/I-2234-2013; Ferreira, Juliana/O-7542-2014; Icimoto, Marcelo Yudi/L-6275-2016; Nantes, Iseli Lourenço/B-9517-2012; Oliveira, Vitor/AAT-5981-2020	Oliveira, Vitor/0000-0002-4662-1377; Icimoto, Marcelo Yudi/0000-0002-0746-5279; Nantes, Iseli Lourenço/0000-0003-1434-3154; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/04948-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do ABC (UFABC); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do ABC (UFABC); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	We are grateful for financial support from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Projeto Tematico Proc. 2008/04948-0), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Universidade Federal de Sao Paulo (UNIFESP), Universidade Federal do ABC (UFABC) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnesano F, 2004, J BIOL CHEM, V279, P47998, DOI 10.1074/jbc.M406021200; BARRETT AJ, 1995, METHOD ENZYMOL, V248, P529; Camargo ACM, 1997, BIOCHEM J, V324, P517, DOI 10.1042/bj3240517; CAMARGO ACM, 1987, J NEUROCHEM, V48, P1258, DOI 10.1111/j.1471-4159.1987.tb05655.x; Carballal S, 2003, BIOCHEMISTRY-US, V42, P9906, DOI 10.1021/bi027434m; DAHMS P, 1992, EUR J BIOCHEM, V208, P145, DOI 10.1111/j.1432-1033.1992.tb17168.x; Demasi M, 2008, FREE RADICAL BIO MED, V44, P1180, DOI 10.1016/j.freeradbiomed.2007.12.012; Figueiredo KM, 2005, J PHOTOCH PHOTOBIO B, V79, P1, DOI 10.1016/j.jphotobiol.2004.11.011; GALARIS D, 1989, FREE RADICAL BIO MED, V6, P473, DOI 10.1016/0891-5849(89)90039-7; Getz EB, 1999, ANAL BIOCHEM, V273, P73, DOI 10.1006/abio.1999.4203; Goldsteins G, 2008, J BIOL CHEM, V283, P8446, DOI 10.1074/jbc.M706111200; GUNTHER MR, 1995, J BIOL CHEM, V270, P16075, DOI 10.1074/jbc.270.27.16075; Gunther MR, 1998, BIOCHEM J, V330, P1293; Gunther MR, 2003, CHEM RES TOXICOL, V16, P652, DOI 10.1021/tx0256580; HALLIWELL B, 1990, FREE RADICAL RES COM, V9, P1, DOI 10.3109/10715769009148569; Hardison RC, 1996, P NATL ACAD SCI USA, V93, P5675, DOI 10.1073/pnas.93.12.5675; Herold S, 2004, J BIOL CHEM, V279, P22841, DOI 10.1074/jbc.M313732200; HOLM L, 1993, FEBS LETT, V315, P301, DOI 10.1016/0014-5793(93)81183-Z; Hunter CL, 2003, P NATL ACAD SCI USA, V100, P3647, DOI 10.1073/pnas.0636702100; Kundu S, 2003, TRENDS PLANT SCI, V8, P387, DOI 10.1016/S1360-1385(03)00163-8; Lardinois OM, 2008, BIOCHEMISTRY-US, V47, P10440, DOI 10.1021/bi800771k; Lepeshkevich SV, 2009, BBA-PROTEINS PROTEOM, V1794, P103, DOI 10.1016/j.bbapap.2008.09.024; LEW RA, 1995, BIOCHEM BIOPH RES CO, V209, P788, DOI 10.1006/bbrc.1995.1569; LITTLE C, 1969, EUR J BIOCHEM, V10, P533, DOI 10.1111/j.1432-1033.1969.tb00721.x; Malvezzi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039408; Mano CM, 2009, FREE RADICAL BIO MED, V47, P841, DOI 10.1016/j.freeradbiomed.2009.06.028; Matsui T, 1999, J BIOL CHEM, V274, P2838, DOI 10.1074/jbc.274.5.2838; Matsui T, 1997, J BIOL CHEM, V272, P32735, DOI 10.1074/jbc.272.52.32735; MILLER VP, 1992, J BIOL CHEM, V267, P8936; Moran LK, 2001, CURR MED CHEM, V8, P763, DOI 10.2174/0929867013372904; Mugnol KCU, 2008, BIOPHYS J, V94, P4066, DOI 10.1529/biophysj.107.116483; Nantes IL, 2011, J BIOENERG BIOMEMBR, V43, P11, DOI 10.1007/s10863-011-9328-9; NAZHAT NB, 1990, BIOCHEM BIOPH RES CO, V166, P807, DOI 10.1016/0006-291X(90)90881-M; Oliveira V, 2001, BIOCHEMISTRY-US, V40, P4417, DOI 10.1021/bi002715k; OLLIKKA P, 1993, APPL ENVIRON MICROB, V59, P4010, DOI 10.1128/AEM.59.12.4010-4016.1993; ORLOWSKI M, 1983, EUR J BIOCHEM, V135, P81, DOI 10.1111/j.1432-1033.1983.tb07620.x; Pereverzev MO, 2003, BIOCHEM SOC T, V31, P1312; Pesce A, 2002, EMBO REP, V3, P1146, DOI 10.1093/embo-reports/kvf248; Pessoto FS, 2007, CHEM RES TOXICOL, V20, P1453, DOI 10.1021/tx700092r; Rodrigues T, 2007, J BIOL CHEM, V282, P25577, DOI 10.1074/jbc.M700009200; Saric T, 2001, J BIOL CHEM, V276, P36474, DOI 10.1074/jbc.M105517200; Shrimpton CN, 1997, J BIOL CHEM, V272, P17395, DOI 10.1074/jbc.272.28.17395; Silva CL, 1999, BIOCHEM BIOPH RES CO, V255, P591, DOI 10.1006/bbrc.1999.0250; Smith AI, 2000, BIOCHEM SOC T, V28, P430, DOI 10.1042/0300-5127:0280430; TISLJAR U, 1989, ARCH BIOCHEM BIOPHYS, V274, P138, DOI 10.1016/0003-9861(89)90424-4; TISLJAR U, 1990, BIOCHEM J, V267, P531, DOI 10.1042/bj2670531; Tullai JW, 2000, J BIOL CHEM, V275, P36514, DOI 10.1074/jbc.M001843200; Vincent B, 1997, EUR J PHARMACOL, V334, P49, DOI 10.1016/S0014-2999(97)01209-0; WELINDER KG, 1979, EUR J BIOCHEM, V96, P483, DOI 10.1111/j.1432-1033.1979.tb13061.x; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Wittenberg JB, 2003, J EXP BIOL, V206, P2011, DOI 10.1242/jeb.00243; Witting PK, 2000, J BIOL CHEM, V275, P20391, DOI 10.1074/jbc.M000373200; Yamin R, 1999, J BIOL CHEM, V274, P18777, DOI 10.1074/jbc.274.26.18777; Zhang H, 2005, J BIOL CHEM, V280, P40684, DOI 10.1074/jbc.M504503200; Zucchi MR, 2003, BIOCHEM J, V370, P671, DOI 10.1042/BJ20021521	55	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79102	10.1371/journal.pone.0079102	http://dx.doi.org/10.1371/journal.pone.0079102			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223886	Green Submitted, gold, Green Published			2022-12-27	WOS:000326499300055
J	Morgan, JP; Magee, H; Wong, A; Nelson, T; Koch, B; Cooper, JD; Weimer, JM				Morgan, Jeremy P.; Magee, Helen; Wong, Andrew; Nelson, Tarah; Koch, Bettina; Cooper, Jonathan D.; Weimer, Jill M.			A Murine Model of Variant Late Infantile Ceroid Lipofuscinosis Recapitulates Behavioral and Pathological Phenotypes of Human Disease	PLOS ONE			English	Article							SOUTH HAMPSHIRE SHEEP; THALAMOCORTICAL NEURON LOSS; LYSOSOMAL STORAGE DISEASE; BATTEN-DISEASE; MOUSE MODEL; GLIAL ACTIVATION; TRANSMEMBRANE PROTEIN; GENE-EXPRESSION; CLN6 MUTATIONS; DEFICIENT MICE	Neuronal ceroid lipofuscinoses (NCLs; also known collectively as Batten Disease) are a family of autosomal recessive lysosomal storage disorders. Mutations in as many as 13 genes give rise to similar to 10 variants of NCL, all with overlapping clinical symptomatology including visual impairment, motor and cognitive dysfunction, seizures, and premature death. Mutations in CLN6 result in both a variant late infantile onset neuronal ceroid lipofuscinosis (vLINCL) as well as an adult-onset form of the disease called Type A Kufs. CLN6 is a non-glycosylated membrane protein of unknown function localized to the endoplasmic reticulum (ER). In this study, we perform a detailed characterization of a naturally occurring Cln6 mutant (Cln6(nclf)) mouse line to validate its utility for translational research. We demonstrate that this Cln6(nclf) mutation leads to deficits in motor coordination, vision, memory, and learning. Pathologically, we demonstrate loss of neurons within specific subregions and lamina of the cortex that correlate to behavioral phenotypes. As in other NCL models, this model displays selective loss of GABAergic interneuron sub-populations in the cortex and the hippocampus with profound, early-onset glial activation. Finally, we demonstrate a novel deficit in memory and learning, including a dramatic reduction in dendritic spine density in the cerebral cortex, which suggests a reduction in synaptic strength following disruption in CLN6. Together, these findings highlight the behavioral and pathological similarities between the Cln6(nclf) mouse model and human NCL patients, validating this model as a reliable format for screening potential therapeutics.	[Morgan, Jeremy P.; Magee, Helen] Univ S Dakota, Sanford Sch Med, Div Basic Biomed Sci, Vermillion, SD 57069 USA; [Weimer, Jill M.] Univ S Dakota, Sanford Sch Med, Dept Pediat, Sioux Falls, SD 57105 USA; [Morgan, Jeremy P.; Magee, Helen; Nelson, Tarah; Weimer, Jill M.] Sanford Res USD, Childrens Hlth Res Ctr, Sioux Falls, SD USA; [Wong, Andrew; Cooper, Jonathan D.] Kings Coll London, James Black Ctr, Inst Psychiat, London WC2R 2LS, England; [Cooper, Jonathan D.] Kings Coll London, Dept Neurosci, London WC2R 2LS, England; [Koch, Bettina] Univ Med Ctr Hamburg Eppendorf, Childrens Hosp, Dept Biochem, Hamburg, Germany	University of South Dakota; University of South Dakota; Sanford Health; University of London; King's College London; University of London; King's College London; University of Hamburg; University Medical Center Hamburg-Eppendorf	Weimer, JM (corresponding author), Univ S Dakota, Sanford Sch Med, Dept Pediat, Sioux Falls, SD 57105 USA.	jill.weimer@sanfordhealth.org	Cooper, Jonathan/C-8117-2009; Cooper, Jonathan/V-9962-2019	Cooper, Jonathan/0000-0003-1339-4750; Cooper, Jonathan/0000-0003-1339-4750	Deutsche Forschungsgemeinshaft [FOR885]; Wellcome Trust [GR079491MA]; NIH-NINDS [NS41930]; Batten Disease Support and Research Association; Batten Disease Family Association; Natalie Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS041930] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinshaft(German Research Foundation (DFG)); Wellcome Trust(Wellcome TrustEuropean Commission); NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Batten Disease Support and Research Association; Batten Disease Family Association; Natalie Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by Deutsche Forschungsgemeinshaft (FOR885), Wellcome Trust Grant (GR079491MA), NIH-NINDS (NS41930), the Batten Disease Support and Research Association, Batten Disease Family Association, and The Natalie Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsov T, 2011, AM J HUM GENET, V88, P566, DOI 10.1016/j.ajhg.2011.04.004; Benedict JW, 2009, J NEUROSCI RES, V87, P2157, DOI 10.1002/jnr.22032; Bible E, 2004, NEUROBIOL DIS, V16, P346, DOI 10.1016/j.nbd.2004.02.010; Blom T, 2013, DIS MODEL MECH, V6, P342, DOI 10.1242/dmm.010140; Bouet V, 2007, EXP NEUROL, V203, P555, DOI 10.1016/j.expneurol.2006.09.006; BOUSTANY RMN, 1989, REV NEUROL, V145, P105; Bronson RT, 1998, AM J MED GENET, V77, P289, DOI 10.1002/(SICI)1096-8628(19980526)77:4<289::AID-AJMG8>3.0.CO;2-I; Broom MF, 1998, J MED GENET, V35, P717, DOI 10.1136/jmg.35.9.717; Buff H, 2007, GENETICS, V176, P209, DOI 10.1534/genetics.106.067983; Cannelli N, 2009, BIOCHEM BIOPH RES CO, V379, P892, DOI 10.1016/j.bbrc.2008.12.159; Chattopadhyay S, 2004, INVEST OPHTH VIS SCI, V45, P2893, DOI 10.1167/iovs.04-0143; Cook RW, 2002, AUST VET J, V80, P292, DOI 10.1111/j.1751-0813.2002.tb10847.x; Cooper JD, 2003, CURR OPIN NEUROL, V16, P121, DOI 10.1097/00019052-200304000-00001; Cooper JD, 1999, J NEUROSCI, V19, P2556; Cooper JD, 2006, BBA-MOL BASIS DIS, V1762, P873, DOI 10.1016/j.bbadis.2006.08.002; Cooper JD, 2010, BIOCHEM SOC T, V38, P1448, DOI 10.1042/BST0381448; Crawley JN, 1999, BRAIN RES, V835, P18, DOI 10.1016/S0006-8993(98)01258-X; Di Cristo G, 2007, CLIN GENET, V72, P1, DOI 10.1111/j.1399-0004.2007.00822.x; Freeman MR, 2006, CURR OPIN NEUROBIOL, V16, P119, DOI 10.1016/j.conb.2005.12.004; Gao HL, 2002, AM J HUM GENET, V70, P324, DOI 10.1086/338190; GOEBEL HH, 1995, J CHILD NEUROL, V10, P424, DOI 10.1177/088307389501000602; GOEBEL HH, 1992, AM J MED GENET, V42, P605, DOI 10.1002/ajmg.1320420435; GOEBEL HH, 1990, OPHTHALMIC PAED GEN, V11, P61, DOI 10.3109/13816819009012949; Guarneri R, 2004, BRAIN RES, V1014, P209, DOI 10.1016/j.brainres.2004.04.040; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Haltia M, 2003, J NEUROPATH EXP NEUR, V62, P1; Heine C, 2007, MOL MEMBR BIOL, V24, P74, DOI 10.1080/09687860600967317; Hutsler JJ, 2010, BRAIN RES, V1309, P83, DOI 10.1016/j.brainres.2009.09.120; Irwin SA, 2001, AM J MED GENET, V98, P161, DOI 10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B; Jalanko A, 2009, BBA-MOL CELL RES, V1793, P697, DOI 10.1016/j.bbamcr.2008.11.004; JOLLY RD, 1993, J INHERIT METAB DIS, V16, P280, DOI 10.1007/BF00710265; JOLLY RD, 1989, NEUROPATH APPL NEURO, V15, P371, DOI 10.1111/j.1365-2990.1989.tb01236.x; Kanninen KM, 2013, BIOL OPEN, V2, P635, DOI 10.1242/bio.20134804; Kanninen KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058644; Katz ML, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/198042; Kay C, 2011, CLIN GENET, V80, P505, DOI 10.1111/j.1399-0004.2011.01761.x; Kay GW, 2006, BRAIN PATHOL, V16, P110, DOI 10.1111/j.1750-3639.2006.00002.x; Kay GW, 2009, NEUROCHEM INT, V55, P783, DOI 10.1016/j.neuint.2009.07.012; Kielar C, 2007, NEUROBIOL DIS, V25, P150, DOI 10.1016/j.nbd.2006.09.001; Kielar C, 2009, HUM MOL GENET, V18, P4066, DOI 10.1093/hmg/ddp355; Korey CA, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-30; Kovacs AD, 2006, NEUROBIOL DIS, V22, P575, DOI 10.1016/j.nbd.2005.12.018; Kovacs AD, 2013, SCI REP-UK, V3, DOI 10.1038/srep02116; Kuronen M, 2012, NEUROBIOL DIS, V47, P444, DOI 10.1016/j.nbd.2012.04.018; Luebke JI, 2010, BRAIN STRUCT FUNCT, V214, P181, DOI 10.1007/s00429-010-0244-2; Matsuura K, 1997, J NEUROSCI METH, V73, P45, DOI 10.1016/S0165-0270(96)02211-X; Mitchison HM, 1999, NEUROBIOL DIS, V6, P321, DOI 10.1006/nbdi.1999.0267; Mole SE, 2005, NEUROGENETICS, V6, P107, DOI 10.1007/s10048-005-0218-3; Mole SE, 2004, EXP CELL RES, V298, P399, DOI 10.1016/j.yexcr.2004.04.042; Nagar S, 2009, NEUROSCIENCE, V160, P517, DOI 10.1016/j.neuroscience.2009.02.056; Narfstrom K, 2007, VET OPHTHALMOL, V10, P111, DOI 10.1111/j.1463-5224.2007.00527.x; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Oswald M J, 2001, Eur J Paediatr Neurol, V5 Suppl A, P135, DOI 10.1053/ejpn.2000.0450; Oswald MJ, 2008, NEUROBIOL DIS, V32, P50, DOI 10.1016/j.nbd.2008.06.004; Oswald MJ, 2005, NEUROBIOL DIS, V20, P49, DOI 10.1016/j.nbd.2005.01.025; Palmer DN, 2013, BBA-MOL BASIS DIS, V1832, P1882, DOI 10.1016/j.bbadis.2013.05.014; Palmer DN, 1997, NEUROPEDIATRICS, V28, P45, DOI 10.1055/s-2007-973666; Palmer DN, 2002, ARCH GERONTOL GERIAT, V34, P343, DOI 10.1016/S0167-4943(02)00011-0; Partanen S, 2008, J NEUROPATH EXP NEUR, V67, P16, DOI 10.1097/nen.0b013e31815f3899; Pears MR, 2007, J NEUROSCI RES, V85, P3494, DOI 10.1002/jnr.21343; Pontikis CC, 2005, NEUROBIOL DIS, V20, P823, DOI 10.1016/j.nbd.2005.05.018; Pontikis CC, 2004, BRAIN RES, V1023, P231, DOI 10.1016/j.brainres.2004.07.030; Pressey SNR, 2010, J NEUROPATH EXP NEUR, V69, P1228, DOI 10.1097/NEN.0b013e3181ffe742; Reynolds GP, 2001, BRAIN RES BULL, V55, P579, DOI 10.1016/S0361-9230(01)00526-3; Rider JA, 1999, MOL GENET METAB, V66, P231, DOI 10.1006/mgme.1999.2827; Rissman RA, 2007, J NEUROCHEM, V103, P1285, DOI 10.1111/j.1471-4159.2007.04832.x; Ros-Simo C, 2013, J NEUROCHEM, V125, P736, DOI 10.1111/jnc.12247; Sanders DN, 2010, MOL GENET METAB, V100, P349, DOI 10.1016/j.ymgme.2010.04.009; SANTAVUORI P, 1991, NEUROPEDIATRICS, V22, P92, DOI 10.1055/s-2008-1071423; Seigel GM, 2002, MOL CELL NEUROSCI, V19, P515, DOI 10.1006/mcne.2001.1099; Sharp JD, 2003, HUM MUTAT, V22, P35, DOI 10.1002/humu.10227; Siintola E, 2005, CLIN GENET, V68, P167, DOI 10.1111/j.1399-0004.2005.00471.x; Siintola E, 2006, BBA-MOL BASIS DIS, V1762, P857, DOI 10.1016/j.bbadis.2006.05.006; Sokol DK, 2011, NEUROLOGY, V76, P1344, DOI 10.1212/WNL.0b013e3182166dc7; Tammen I, 2001, Eur J Paediatr Neurol, V5 Suppl A, P37, DOI 10.1053/ejpn.2000.0432; Tammen I, 2006, BBA-MOL BASIS DIS, V1762, P898, DOI 10.1016/j.bbadis.2006.09.004; Teixeira C, 2003, J NEUROL, V250, P661, DOI 10.1007/s00415-003-1050-z; Teixeira CAF, 2006, BBA-MOL BASIS DIS, V1762, P637, DOI 10.1016/j.bbadis.2006.06.002; Teixeira CA, 2003, HUM MUTAT, V21, P502, DOI 10.1002/humu.10207; Thelen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035493; Tyynela J, 2004, BRAIN PATHOL, V14, P349; Tyynela J, 1997, J NEUROPATH EXP NEUR, V56, P369, DOI 10.1097/00005072-199704000-00005; Url A, 2001, ACTA NEUROPATHOL, V101, P410; van Spronsen M, 2010, CURR NEUROL NEUROSCI, V10, P207, DOI 10.1007/s11910-010-0104-8; von Schantz C, 2009, NEUROBIOL DIS, V34, P308, DOI 10.1016/j.nbd.2009.02.001; Weimer JM, 2007, BRAIN RES, V1162, P98, DOI 10.1016/j.brainres.2007.05.018; Weimer JM, 2009, DEVELOPMENT, V136, P2965, DOI 10.1242/dev.036616; Weimer JM, 2009, BRAIN RES, V1266, P93, DOI 10.1016/j.brainres.2009.02.009; Weimer JM, 2006, NEUROBIOL DIS, V22, P284, DOI 10.1016/j.nbd.2005.11.008; Weimer JM, 2005, ALTERATIONS ST UNPUB; Wheeler RB, 2002, AM J HUM GENET, V70, P537, DOI 10.1086/338708; WILLIAMS RS, 1977, ARCH NEUROL-CHICAGO, V34, P298, DOI 10.1001/archneur.1977.00500170052010	92	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78694	10.1371/journal.pone.0078694	http://dx.doi.org/10.1371/journal.pone.0078694			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223841	Green Published, Green Submitted, gold			2022-12-27	WOS:000326499300030
J	Tibbles, KL; Sarkar, S; Novak, B; Arumugam, P				Tibbles, Katherine Louise; Sarkar, Sourav; Novak, Bela; Arumugam, Prakash			CDK-Dependent Nuclear Localization of B-Cyclin Clb1 Promotes FEAR Activation during Meiosis I in Budding Yeast	PLOS ONE			English	Article							MITOTIC EXIT; SACCHAROMYCES-CEREVISIAE; CDC14 PHOSPHATASE; CHROMOSOME SEGREGATION; EARLY ANAPHASE; KINASE CDC5; RENT COMPLEX; CELL-CYCLE; PHOSPHORYLATION; REPLICATION	Cyclin-dependent kinases (CDK) are master regulators of the cell cycle in eukaryotes. CDK activity is regulated by the presence, post-translational modification and spatial localization of its regulatory subunit cyclin. In budding yeast, the B-cyclin Clb1 is phosphorylated and localizes to the nucleus during meiosis I. However the functional significance of Clb1's phosphorylation and nuclear localization and their mutual dependency is unknown. In this paper, we demonstrate that meiosis-specific phosphorylation of Clb1 requires its import to the nucleus but not vice versa. While Clb1 phosphorylation is dependent on activity of both CDK and polo-like kinase Cdc5, its nuclear localization requires CDK but not Cdc5 activity. Furthermore we show that increased nuclear localization of Clb1 during meiosis enhances activation of FEAR (Cdc Fourteen Early Anaphase Release) pathway. We discuss the significance of our results in relation to regulation of exit from meiosis I.	[Tibbles, Katherine Louise; Sarkar, Sourav; Arumugam, Prakash] Univ Warwick, Coventry CV4 7AL, W Midlands, England; [Novak, Bela] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Warwick; University of Oxford	Tibbles, KL (corresponding author), Univ Warwick, Coventry CV4 7AL, W Midlands, England.	katetibbles@yahoo.co.uk; prakash.arumugam@warwick.ac.uk	Novak, Bela/D-5365-2009; Arumugam, Prakash/AAZ-6422-2020	Novak, Bela/0000-0002-6961-1366; Arumugam, Prakash/0000-0001-6217-8128	BBSRC [BB/G00353X/1]; Biotechnology and Biological Sciences Research Council [BB/G00353X/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a BBSRC grant (BB/G00353X/1) awarded to PA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzam R, 2004, SCIENCE, V305, P516, DOI 10.1126/science.1099402; Benjamin KR, 2003, GENE DEV, V17, P1524, DOI 10.1101/gad.1101503; Bizzari F, 2011, J CELL BIOL, V193, P1213, DOI 10.1083/jcb.201103076; Carlile TM, 2008, CELL, V133, P280, DOI 10.1016/j.cell.2008.02.032; D'Amours D, 2004, CELL, V117, P455, DOI 10.1016/S0092-8674(04)00413-1; Diffley JFX, 1995, J CELL SCI, P67; GRANDIN N, 1993, MOL CELL BIOL, V13, P2113, DOI 10.1128/MCB.13.4.2113; Hu FH, 2001, CELL, V107, P655, DOI 10.1016/S0092-8674(01)00580-3; Jaspersen SL, 1998, MOL BIOL CELL, V9, P2803, DOI 10.1091/mbc.9.10.2803; Jensen S, 2002, CURR BIOL, V12, pR221, DOI 10.1016/S0960-9822(02)00756-X; Kamieniecki RJ, 2005, CELL CYCLE, V4, P1093; Kerr GW, 2011, J CELL BIOL, V193, P1157, DOI 10.1083/jcb.201103019; Kerr GW, 2012, CELL MOL LIFE SCI, V69, P3037, DOI 10.1007/s00018-012-0974-9; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Liang FS, 2009, MOL BIOL CELL, V20, P3671, DOI 10.1091/mbc.E08-10-1049; Marston AL, 2003, DEV CELL, V4, P711, DOI 10.1016/S1534-5807(03)00130-8; Mohl DA, 2009, J CELL BIOL, V184, P527, DOI 10.1083/jcb.200812022; Moore M, 2007, BIOCHEMISTRY-US, V46, P271, DOI 10.1021/bi061858p; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Porter ACG, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-3; Queralt E, 2008, J CELL BIOL, V182, P873, DOI 10.1083/jcb.200801054; Queralt E, 2006, CELL, V125, P719, DOI 10.1016/j.cell.2006.03.038; Sawarynski KE, 2007, BBA-MOL CELL RES, V1773, P450, DOI 10.1016/j.bbamcr.2006.10.003; Shin ME, 2010, MOL CELL BIOL, V30, P2996, DOI 10.1128/MCB.01682-09; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Shou WY, 2002, BMC MOL BIOL, V3, DOI 10.1186/1471-2199-3-3; Sourirajan A, 2008, GENE DEV, V22, P2627, DOI 10.1101/gad.1711408; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Stegmeier F, 2004, CURR BIOL, V14, P467, DOI 10.1016/j.cub.2004.03.009; Sullivan M, 2004, CELL, V117, P471, DOI 10.1016/S0092-8674(04)00415-5; Tomson BN, 2009, CURR BIOL, V19, P449, DOI 10.1016/j.cub.2009.02.024; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Yellman CM, 2006, MOL BIOL CELL, V17, P658, DOI 10.1091/mbc.E05-04-0336; Zhai YL, 2010, J CELL SCI, V123, P3933, DOI 10.1242/jcs.075366	35	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79001	10.1371/journal.pone.0079001	http://dx.doi.org/10.1371/journal.pone.0079001			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223874	Green Submitted, Green Published, gold			2022-12-27	WOS:000326499300046
J	Bagag, A; Jault, JM; Sidahmed-Adrar, N; Refregiers, M; Giuliani, A; Le Naour, F				Bagag, Aicha; Jault, Jean-Michel; Sidahmed-Adrar, Nazha; Refregiers, Matthieu; Giuliani, Alexandre; Le Naour, Francois			Characterization of Hydrophobic Peptides in the Presence of Detergent by Photoionization Mass Spectrometry	PLOS ONE			English	Article							ATMOSPHERIC-PRESSURE PHOTOIONIZATION; BINDING CASSETTE TRANSPORTER; INTEGRAL MEMBRANE-PROTEINS; BACILLUS-SUBTILIS; TETRASPANIN WEB; ABC TRANSPORTER; PROTEOMICS; IDENTIFICATION; IONIZATION; BMRA	The characterization of membrane proteins is still challenging. The major issue is the high hydrophobicity of membrane proteins that necessitates the use of detergents for their extraction and solubilization. The very poor compatibility of mass spectrometry with detergents remains a tremendous obstacle in studies of membrane proteins. Here, we investigated the potential of atmospheric pressure photoionization (APPI) for mass spectrometry study of membrane proteins. This work was focused on the tetraspanin CD9 and the multidrug transporter BmrA. A set of peptides from CD9, exhibiting a broad range of hydropathicity, was investigated using APPI as compared to electrospray ionization (ESI). Mass spectrometry experiments revealed that the most hydrophobic peptides were hardly ionized by ESI whereas all peptides, including the highly hydrophobic one that corresponds to the full sequence of the first transmembrane domain of CD9, were easily ionized by APPI. The native protein BmrA purified in the presence of the non-ionic detergent beta-D-dodecyl maltoside (DDM) was digested in-solution using trypsin. The resulting peptides were investigated by flow injection analysis of the mixture followed by mass spectrometry. Upon ESI, only detergent ions were detected and the ionic signals from the peptides were totally suppressed. In contrast, APPI allowed many peptides distributed along the sequence of the protein to be detected. Furthermore, the parent ion corresponding to the first transmembrane domain of the protein BmrA was detected under APPI conditions. Careful examination of the APPI mass spectrum revealed a-, b-, c-and y- fragment ions generated by in-source fragmentation. Those fragment ions allowed unambiguous structural characterization of the transmembrane domain. In conclusion, APPI-MS appears as a versatile method allowing the ionization and fragmentation of hydrophobic peptides in the presence of detergent.	[Bagag, Aicha; Sidahmed-Adrar, Nazha; Le Naour, Francois] INSERM, U785, Villejuif, France; [Bagag, Aicha; Sidahmed-Adrar, Nazha; Le Naour, Francois] Univ Paris 11, Inst Andre Lwoff, Villejuif, France; [Jault, Jean-Michel] Univ Grenoble 1, Inst Biol Struct, Grenoble, France; [Jault, Jean-Michel] CNRS, UMR 5075, Grenoble, France; [Jault, Jean-Michel] CEA, Inst Biol Struct, Grenoble, France; [Refregiers, Matthieu; Giuliani, Alexandre] Synchrotron SOLEIL, Gif Sur Yvette, France; [Giuliani, Alexandre] INRA, UAR CEPIA 1008, F-44026 Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); SOLEIL Synchrotron; INRAE	Le Naour, F (corresponding author), INSERM, U785, Villejuif, France.	francois.le-naour@inserm.fr	Réfrégiers, Matthieu/AAE-2075-2022; jault, jean-michel/G-2086-2012; ahmed, nazha sid/AAD-4538-2020; Giuliani, Alexandre/C-1476-2011; Réfrégiers, Matthieu/A-4249-2011	jault, jean-michel/0000-0003-1743-2777; Giuliani, Alexandre/0000-0003-1710-4933; Réfrégiers, Matthieu/0000-0002-3281-2308	PRES UniverSud Paris; Fondation pour la Recherche Medicale (FRM)	PRES UniverSud Paris; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	This work was supported by PRES UniverSud Paris and Fondation pour la Recherche Medicale (FRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre M, 2006, PROTEOMICS, V6, P1437, DOI 10.1002/pmic.200500180; Andre M, 2009, J PROTEOMICS, V73, P93, DOI 10.1016/j.jprot.2009.08.005; Arnold T., 2008, CURR PROTOC PROTEIN, DOI [10.1002/0471140864.ps0408s53, DOI 10.1002/0471140864.PS0408S53]; Bagag A, 2011, INT J MASS SPECTROM, V299, P1, DOI 10.1016/j.ijms.2010.08.010; Bagag A, 2012, INT J MASS SPECTROM, V328, P23, DOI 10.1016/j.ijms.2012.07.021; Bagag A, 2011, RAPID COMMUN MASS SP, V25, P3436, DOI 10.1002/rcm.5242; Bensalem N, 2007, J PROTEOME RES, V6, P1595, DOI 10.1021/pr0606272; BIEMANN K, 1992, ANNU REV BIOCHEM, V61, P977, DOI 10.1146/annurev.bi.61.070192.004553; Carroll J, 2007, P NATL ACAD SCI USA, V104, P14330, DOI 10.1073/pnas.0706817104; Chambrion C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011219; Cristoni S, 2002, RAPID COMMUN MASS SP, V16, P1686, DOI 10.1002/rcm.772; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Debois D, 2006, J MASS SPECTROM, V41, P1554, DOI 10.1002/jms.1122; Delobel A, 2003, ANAL CHEM, V75, P5961, DOI 10.1021/ac034532k; Do Cao MA, 2009, PROTEIN SCI, V18, P1507, DOI 10.1002/pro.141; Funk J, 2005, RAPID COMMUN MASS SP, V19, P2986, DOI 10.1002/rcm.2142; Galian C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019677; Gaudin M, 2012, J AM SOC MASS SPECTR, V23, P869, DOI 10.1007/s13361-012-0341-y; Gilmore JM, 2010, J PROTEOMICS, V73, P2078, DOI 10.1016/j.jprot.2010.08.005; Giuliani A, 2006, EUR J MASS SPECTROM, V12, P189, DOI 10.1255/ejms.803; Giuliani A, 2012, NUCL INSTRUM METH B, V279, P114, DOI 10.1016/j.nimb.2011.10.038; Giuliani A, 2009, J SYNCHROTRON RADIAT, V16, P835, DOI 10.1107/S0909049509034049; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Ilag LL, 2004, J AM CHEM SOC, V126, P14362, DOI 10.1021/ja0450307; Kauppila TJ, 2002, ANAL CHEM, V74, P5470, DOI 10.1021/ac025659x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Le Naour F, 2004, CANCER IMMUNOL IMMUN, V53, P148, DOI 10.1007/s00262-003-0477-5; Le Naour F, 2006, PROTEOMICS, V6, P6447, DOI 10.1002/pmic.200600282; Lin Y, 2010, ELECTROPHORESIS, V31, P2705, DOI 10.1002/elps.201000161; Linke D, 2009, METHOD ENZYMOL, V463, P603, DOI 10.1016/S0076-6879(09)63034-2; Lu BW, 2008, PROTEOMICS, V8, P3947, DOI 10.1002/pmic.200800120; Matar-Merheb R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018036; Orelle C, 2003, J BIOL CHEM, V278, P47002, DOI 10.1074/jbc.M308268200; Rabilloud T, 2010, J PROTEOMICS, V73, P2064, DOI 10.1016/j.jprot.2010.05.016; Rabilloud T, 2009, ELECTROPHORESIS, V30, pS174, DOI 10.1002/elps.200900050; Ravaud S, 2006, BIOCHEM J, V395, P345, DOI 10.1042/BJ20051719; Rey M, 2010, ANAL CHEM, V82, P5107, DOI 10.1021/ac100171m; Robb DB, 2000, ANAL CHEM, V72, P3653, DOI 10.1021/ac0001636; Santoni V, 2000, ELECTROPHORESIS, V21, P1054, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1054::AID-ELPS1054>3.3.CO;2-#; Savas JN, 2011, TRENDS BIOCHEM SCI, V36, P388, DOI 10.1016/j.tibs.2011.04.005; Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011; Speers AE, 2007, CHEM REV, V107, P3687, DOI 10.1021/cr068286z; Steinfels E, 2002, BBA-BIOMEMBRANES, V1565, P1, DOI 10.1016/S0005-2736(02)00515-1; Stevens TJ, 2000, PROTEINS, V39, P417, DOI 10.1002/(SICI)1097-0134(20000601)39:4<417::AID-PROT140>3.0.CO;2-Y; Syage JA, 2004, J AM SOC MASS SPECTR, V15, P1521, DOI 10.1016/j.jasms.2004.07.006; Tan S, 2008, PROTEOMICS, V8, P3924, DOI 10.1002/pmic.200800597; Wu CC, 2003, NAT BIOTECHNOL, V21, P262, DOI 10.1038/nbt0303-262	47	16	16	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79033	10.1371/journal.pone.0079033	http://dx.doi.org/10.1371/journal.pone.0079033			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236085	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700083
J	Santos, LEC; da Silveira, GA; Costa, VDC; Batista, AG; Madureira, AP; Rodrigues, AM; Scorza, CA; Amorim, HA; Arida, RM; Duarte, MA; Scorza, FA; Cavalheiro, EA; de Almeida, ACG				Canton Santos, Luiz Eduardo; da Silveira, Gilcelio Amaral; Cupertino Costa, Victor Diego; Batista, Aline Gisele; Madureira, Ana Paula; Rodrigues, Antonio Marcio; Scorza, Carla Alessandra; Amorim, Henrique Alves; Arida, Ricardo Mario; Duarte, Mario Antonio; Scorza, Fulvio Alexandre; Cavalheiro, Esper Abrao; de Almeida, Antonio-Carlos Guimaraes			Alcohol Abuse Promotes Changes in Non-Synaptic Epileptiform Activity with Concomitant Expression Changes in Cotransporters and Glial Cells	PLOS ONE			English	Article							CHRONIC ETHANOL-CONSUMPTION; UP-REGULATION; BRAIN-DAMAGE; SEIZURES; EXPOSURE; MODEL; NEURONS; STROKE; DEATH; NMDA	Non-synaptic mechanisms are being considered the common factor of brain damage in status epilepticus and alcohol intoxication. The present work reports the influence of the chronic use of ethanol on epileptic processes sustained by non-synaptic mechanisms. Adult male Wistar rats administered with ethanol (1, 2 e 3 g/kg/d) during 28 days were compared with Control. Non-synaptic epileptiform activities (NEAs) were induced by means of the zero-calcium and high-potassium model using hippocampal slices. The observed involvement of the dentate gyrus (DG) on the neurodegeneration promoted by ethanol motivated the monitoring of the electrophysiological activity in this region. The DG regions were analyzed for the presence of NKCC1, KCC2, GFAP and CD11b immunoreactivity and cell density. The treated groups showed extracellular potential measured at the granular layer with increased DC shift and population spikes (PS), which was remarkable for the group E1. The latencies to the NEAs onset were more prominent also for the treated groups, being correlated with the neuronal loss. In line with these findings were the predispositions of the treated slices for neuronal edema after NEAs induction, suggesting that restrict inter-cell space counteracts the neuronal loss and subsists the hyper-synchronism. The significant increase of the expressions of NKCC1 and CD11b for the treated groups confirms the existence of conditions favorable to the observed edematous necrosis. The data suggest that the ethanol consumption promotes changes on the non-synaptic mechanisms modulating the NEAs. For the lower ethanol dosage the neurophysiological changes were more effective suggesting to be due to the less intense neurodegenertation.	[Canton Santos, Luiz Eduardo; da Silveira, Gilcelio Amaral; Cupertino Costa, Victor Diego; Batista, Aline Gisele; Madureira, Ana Paula; Rodrigues, Antonio Marcio; Duarte, Mario Antonio; de Almeida, Antonio-Carlos Guimaraes] Univ Fed Sao Joao del Rei, Dept Engn Biossistemas, Lab Neurociencia Expt & Computac, Sao Joao Del Rei, MG, Brazil; [Scorza, Carla Alessandra; Scorza, Fulvio Alexandre; Cavalheiro, Esper Abrao] Univ Fed Sao Paulo, Escola Paulista Med, Disciplina Neurol Expt, Sao Paulo, Brazil; [Amorim, Henrique Alves] Univ Fed Sao Paulo, Dept Ciencia & Tecnol, Sao Jose Dos Campos, SP, Brazil; [Arida, Ricardo Mario] Univ Fed Sao Paulo, Escola Paulista Med, Disciplina Fisiol, Sao Paulo, Brazil	Universidade Federal de Sao Joao del-Rei; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	de Almeida, ACG (corresponding author), Univ Fed Sao Joao del Rei, Dept Engn Biossistemas, Lab Neurociencia Expt & Computac, Sao Joao Del Rei, MG, Brazil.	acga@ufsj.edu.br	ALMEIDA, ANTÔNIO-CARLOS GUIMARÃES/B-8028-2008; Cavalheiro, Esper A/I-3084-2016; Scorza, Carla A/AAV-2417-2020; Rodrigues, Antônio M/D-3953-2012; Arida, Ricardo M/E-2667-2013; Arida, Ricardo Mario/P-7408-2016; Cavalheiro, Esper A/F-4325-2014; Scorza, Fulvio/C-7048-2013; Santos, Luiz Eduardo Canton/AAY-8087-2020; Scorza, Carla Alessandra/C-4199-2013; Santos, Luiz Eduardo/E-9888-2018; Cavalheiro, Esper/N-3985-2019	ALMEIDA, ANTÔNIO-CARLOS GUIMARÃES/0000-0003-4893-338X; Cavalheiro, Esper A/0000-0002-0854-3582; Scorza, Carla A/0000-0001-7810-4748; Rodrigues, Antônio M/0000-0002-2678-9180; Arida, Ricardo M/0000-0002-0908-3274; Arida, Ricardo Mario/0000-0002-7771-6133; Cavalheiro, Esper A/0000-0002-0854-3582; Scorza, Fulvio/0000-0002-0694-8674; Scorza, Carla Alessandra/0000-0001-7810-4748; Santos, Luiz Eduardo/0000-0002-5465-2333; Cavalheiro, Esper/0000-0002-0854-3582; Amorim, Henrique/0000-0003-0611-1118	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); FAPEMIG; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; FAPESP/CNPq/MCT (Instituto Nacional de Neurociencia Translacional)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP/CNPq/MCT (Instituto Nacional de Neurociencia Translacional)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Brazilian agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), FAPEMIG, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior and FAPESP/CNPq/MCT (Instituto Nacional de Neurociencia Translacional). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHERN KV, 1994, NEUROSCI LETT, V165, P211; Almeida A.C.G., 2011, UNDERLING MECH EPILE, V1, P189; Almeida AC, 2008, EPILEPSIA, V49, P1; ANTON RF, 1987, ALCOHOL CLIN EXP RES, V11, P10, DOI 10.1111/j.1530-0277.1987.tb01251.x; Badan I, 2003, J CEREBR BLOOD F MET, V23, P845, DOI 10.1097/01.WCB.0000071883.63724.A7; Bartolomei F, 2006, EPILEPTIC DISORD, V8, pS72; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Bikson M, 1999, J NEUROPHYSIOL, V82, P2262, DOI 10.1152/jn.1999.82.5.2262; Casswell S, 2009, LANCET, V373, P2247, DOI 10.1016/S0140-6736(09)60745-5; Castilla-Guerra L, 2006, EPILEPSIA, V47, P1990, DOI 10.1111/j.1528-1167.2006.00861.x; CHANDLER LJ, 1993, J NEUROCHEM, V60, P1578, DOI 10.1111/j.1471-4159.1993.tb03326.x; COHEN SM, 1993, BRAIN RES, V601, P80, DOI 10.1016/0006-8993(93)91697-Q; Collins MA, 1998, FASEB J, V12, P221, DOI 10.1096/fasebj.12.2.221; Collins MA, 2013, NEUROTOX RES, V23, P105, DOI 10.1007/s12640-012-9360-5; DIAMOND I, 1994, WESTERN J MED, V161, P279; Diamond I, 1996, CECILS TXB MED, V20, P47; Fadda F, 1998, PROG NEUROBIOL, V56, P385, DOI 10.1016/S0301-0082(98)00032-X; Farr SA, 2005, ALCOHOL CLIN EXP RES, V29, P971, DOI 10.1097/01.ALC.0000171038.03371.56; Feigin VL, 2010, BEST PRACT RES-CLIN, V24, P485, DOI 10.1016/j.bpa.2010.10.006; Fox JE, 2004, J NEUROPHYSIOL, V92, P181, DOI 10.1152/jn.00123.2004; Freedland Eric S., 1993, Journal of Emergency Medicine, V11, P463, DOI 10.1016/0736-4679(93)90251-2; Fujikawa DG, 2000, NEUROSCIENCE, V98, P41, DOI 10.1016/S0306-4522(00)00085-3; FULLER TA, 1981, NEUROBEH TOXICOL TER, V3, P355; GONZALES RA, 1991, TRENDS PHARMACOL SCI, V12, P1, DOI 10.1016/0165-6147(91)90478-B; HAUSER WA, 1988, EPILEPSIA, V29, pS66, DOI 10.1111/j.1528-1157.1988.tb05800.x; Hughes JR, 2009, EPILEPSY BEHAV, V15, P92, DOI 10.1016/j.yebeh.2009.02.037; Ingolfsson HI, 2011, BIOPHYS J, V101, P847, DOI 10.1016/j.bpj.2011.07.013; Jin XM, 2005, J NEUROPHYSIOL, V93, P2117, DOI 10.1152/jn.00728.2004; Little HJ, 1999, PHARMACOL THERAPEUT, V84, P333, DOI 10.1016/S0163-7258(99)00040-6; LOVINGER DM, 1993, ALCOHOL CLIN EXP RES, V17, P19, DOI 10.1111/j.1530-0277.1993.tb00720.x; Lucocq John Milton, 2007, Proceedings Microscopy Conference 2007, P166, DOI 10.1017/S143192760708083X; Mandarim-De-Lacerda CA, 2003, AN ACAD BRAS CIENC, V75, P469, DOI 10.1590/S0001-37652003000400006; MELLO LEAM, 1993, EPILEPSIA, V34, P985, DOI 10.1111/j.1528-1157.1993.tb02123.x; Morales-Aza BM, 2004, NEUROBIOL DIS, V17, P62, DOI 10.1016/j.nbd.2004.05.010; Morris SA, 2010, ALCOHOL, V44, P89, DOI 10.1016/j.alcohol.2009.10.017; Obernier JA, 2002, ALCOHOL CLIN EXP RES, V26, P547, DOI 10.1097/00000374-200204000-00016; Obernier JA, 2001, PHARM BIOCH BEHAV, V72, P1; Okabe A, 2002, NEUROSCI RES, V44, P225, DOI 10.1016/S0168-0102(02)00093-7; OLNEY JW, 2002, ENCY HUMAN BRAIN, V1, P87; Palmer RHC, 2012, DRUG ALCOHOL DEPEN, V125, P179, DOI 10.1016/j.drugalcdep.2012.07.005; Pan EH, 1996, J NEUROPHYSIOL, V75, P124, DOI 10.1152/jn.1996.75.1.124; Patra J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-258; PorteraCailliau C, 1997, J COMP NEUROL, V378, P88, DOI 10.1002/(SICI)1096-9861(19970203)378:1<88::AID-CNE5>3.0.CO;2-G; ROPER SN, 1993, J NEUROPHYSIOL, V70, P857, DOI 10.1152/jn.1993.70.2.857; SATO N, 1991, AM J PHYSIOL, V260, pE946, DOI 10.1152/ajpendo.1991.260.6.E946; Scorza FA, 2003, NEUROSCI RES, V47, P323, DOI 10.1016/S0168-0102(03)00220-7; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; SIGGINS GR, 1980, PHARMACOL BIOCHEM BE, V13, P203, DOI 10.1016/S0091-3057(80)80032-3; Sripathirathan K, 2009, J NEUROTRAUM, V26, P261, DOI 10.1089/neu.2008.0682; Stanciu SG, 2008, ICTON MEDIT WIN CONF, P132, DOI 10.1109/ICTONMW.2008.4773118; Strahlendorf JC, 1999, NEUROSCI RES, V33, P155, DOI 10.1016/S0168-0102(98)00126-6; Sunkesula SRB, 2008, NEUROCHEM RES, V33, P1117, DOI 10.1007/s11064-007-9560-1; Syapin PJ, 2005, ALCOHOL CLIN EXP RES, V29, P1080, DOI 10.1097/01.ALC.0000167961.39176.E6; TAYLOR CP, 1982, SCIENCE, V218, P810, DOI 10.1126/science.7134978; Valles SL, 2004, BRAIN PATHOL, V14, P365; Watson RR, 1992, ALCOHOL NEUROBIOLOGY; Zador Z, 2009, ROLE AQUAPORINS NONS	57	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78854	10.1371/journal.pone.0078854	http://dx.doi.org/10.1371/journal.pone.0078854			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236060	gold, Green Published, Green Submitted			2022-12-27	WOS:000327254700057
J	Liu, WB; Shi, Y; Yao, LL; Zhou, Y; Ye, BC				Liu, Wei-Bing; Shi, Yang; Yao, Li-Li; Zhou, Ying; Ye, Bang-Ce			Prediction and Characterization of Small Non-Coding RNAs Related to Secondary Metabolites in Saccharopolyspora erythraea	PLOS ONE			English	Article							GENE IDENTIFICATION; ESCHERICHIA-COLI; EXPRESSION; REGULATORS; GENOME; TRANSCRIPTOME	Saccharopolyspora erythraea produces a large number of secondary metabolites with biological activities, including erythromycin. Elucidation of the mechanisms through which the production of these secondary metabolites is regulated may help to identify new strategies for improved biosynthesis of erythromycin. In this paper, we describe the systematic prediction and analysis of small non-coding RNAs (sRNAs) in S. erythraea, with the aim to elucidate sRNA-mediated regulation of secondary metabolite biosynthesis. In silico and deep-sequencing technologies were applied to predict sRNAs in S. erythraea. Six hundred and forty-seven potential sRNA loci were identified, of which 382 cis-encoded antisense RNA are complementary to protein-coding regions and 265 predicted transcripts are located in intergenic regions. Six candidate sRNAs (sernc292, sernc293, sernc350, sernc351, sernc361, and sernc389) belong to four gene clusters (tpc3, pke, pks6, and nrps5) that are involved in secondary metabolite biosynthesis. Deep-sequencing data showed that the expression of all sRNAs in the strain HL3168 E3 (E3) was higher than that in NRRL23338 (M), except for sernc292 and sernc361 expression. The relative expression of six sRNAs in strain M and E3 were validated by qRT-PCR at three different time points (24, 48, and 72 h). The results showed that, at each time point, the transcription levels of sernc293, sernc350, sernc351, and sernc389 were higher in E3 than in M, with the largest difference observed at 72 h, whereas no signals for sernc292 and sernc361 were detected. sernc293, sernc350, sernc351, and sernc389 probably regulate iron transport, terpene metabolism, geosmin synthesis, and polyketide biosynthesis, respectively. The major significance of this study is the successful prediction and identification of sRNAs in genomic regions close to the secondary metabolism-related genes in S. erythraea. A better understanding of the sRNA-target interaction would help to elucidate the complete range of functions of sRNAs in S. erythraea, including sRNA-mediated regulation of erythromycin biosynthesis.	[Liu, Wei-Bing; Shi, Yang; Yao, Li-Li; Zhou, Ying; Ye, Bang-Ce] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Lab Biosyst & Microanal, Shanghai 200237, Peoples R China	East China University of Science & Technology	Ye, BC (corresponding author), E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Lab Biosyst & Microanal, Shanghai 200237, Peoples R China.	bcye@ecust.edu.cn			China NSF [21276079]; SRFDP of the Chinese Ministry of Education [20120074110009]; Shanghai Postdoctoral Scientific Program; Fundamental Research Funds for the Central Universities	China NSF(National Natural Science Foundation of China (NSFC)); SRFDP of the Chinese Ministry of Education; Shanghai Postdoctoral Scientific Program; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The research work of this paper was jointly supported by the "China NSF (21276079)", "SRFDP (no. 20120074110009) of the Chinese Ministry of Education", "Shanghai Postdoctoral Scientific Program", and "the Fundamental Research Funds for the Central Universities". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2010, NUCLEIC ACIDS RES, V38, P868, DOI 10.1093/nar/gkp1032; Altuvia S, 2007, CURR OPIN MICROBIOL, V10, P257, DOI 10.1016/j.mib.2007.05.003; Axmann IM, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r73; Cane DE, 2012, ACCOUNTS CHEM RES, V45, P463, DOI 10.1021/ar200198d; D'Alia D, 2010, J BACTERIOL, V192, P1160, DOI 10.1128/JB.01374-09; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; De Lay N, 2012, MOL MICROBIOL, V86, P524, DOI 10.1111/j.1365-2958.2012.08209.x; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Eggenhofer F, 2011, NUCLEIC ACIDS RES, V39, pW149, DOI 10.1093/nar/gkr467; Gottesman S, 2006, COLD SPRING HARB SYM, V71, P1, DOI 10.1101/sqb.2006.71.016; Gottesman S, 2004, ANNU REV MICROBIOL, V58, P303, DOI 10.1146/annurev.micro.58.030603.123841; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Gruber AR, 2010, BIOCOMPUT-PAC SYM, P69; Herbig A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-40; Hershberg R, 2003, NUCLEIC ACIDS RES, V31, P1813, DOI 10.1093/nar/gkg297; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Huang HY, 2009, NUCLEIC ACIDS RES, V37, pD150, DOI 10.1093/nar/gkn852; Jager D, 2009, P NATL ACAD SCI USA, V106, P21878, DOI 10.1073/pnas.0909051106; Kang JY, 2006, ACTA CRYSTALLOGR F, V62, P1147, DOI 10.1107/S174430910604245X; Kawano M, 2005, NUCLEIC ACIDS RES, V33, P1040, DOI 10.1093/nar/gki256; LABEDA DP, 1987, INT J SYST BACTERIOL, V37, P19, DOI 10.1099/00207713-37-1-19; Livny J, 2005, NUCLEIC ACIDS RES, V33, P4096, DOI 10.1093/nar/gki715; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Majdalani N, 2005, CRIT REV BIOCHEM MOL, V40, P93, DOI 10.1080/10409230590918702; Marcellin E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-15; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Oliynyk M, 2007, NAT BIOTECHNOL, V25, P447, DOI 10.1038/nbt1297; Panek J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-217; Peano C, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-32; Peano C, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-37; Pichon C, 2005, P NATL ACAD SCI USA, V102, P14249, DOI 10.1073/pnas.0503838102; Pichon C, 2008, BIOINFORMATICS, V24, P2807, DOI 10.1093/bioinformatics/btn560; Romby P, 2006, CURR OPIN MICROBIOL, V9, P229, DOI 10.1016/j.mib.2006.02.005; Salvail H, 2012, WIRES RNA, V3, P26, DOI 10.1002/wrna.102; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Sharma CM, 2009, CURR OPIN MICROBIOL, V12, P536, DOI 10.1016/j.mib.2009.07.006; Silvaggi JM, 2006, J BACTERIOL, V188, P532, DOI 10.1128/JB.188.2.532-541.2006; Sorek R, 2010, NAT REV GENET, V11, P9, DOI 10.1038/nrg2695; Sridhar J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011970; Storz G, 2005, ANNU REV BIOCHEM, V74, P199, DOI 10.1146/annurev.biochem.74.082803.133136; Swiercz JP, 2008, NUCLEIC ACIDS RES, V36, P7240, DOI 10.1093/nar/gkn898; Tezuka T, 2009, J BACTERIOL, V191, P4896, DOI 10.1128/JB.00087-09; van Vliet AHM, 2010, FEMS MICROBIOL LETT, V302, P1, DOI 10.1111/j.1574-6968.2009.01767.x; Vockenhuber MP, 2011, RNA BIOL, V8, P468, DOI 10.4161/rna.8.3.14421; Vogel J, 2005, BIOL CHEM, V386, P1219, DOI 10.1515/BC.2005.140; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Weissman KJ, 2005, NAT REV MICROBIOL, V3, P925, DOI 10.1038/nrmicro1287; Yachie N, 2006, GENE, V372, P171, DOI 10.1016/j.gene.2005.12.034	52	5	5	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80676	10.1371/journal.pone.0080676	http://dx.doi.org/10.1371/journal.pone.0080676			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236194	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700197
J	San Segundo, D; Ballesteros, MA; Naranjo, S; Zurbano, F; Minambres, E; Lopez-Hoyos, M				San Segundo, David; Angeles Ballesteros, Maria; Naranjo, Sara; Zurbano, Felipe; Minambres, Eduardo; Lopez-Hoyos, Marcos			Increased Numbers of Circulating CD8 Effector Memory T Cells before Transplantation Enhance the Risk of Acute Rejection in Lung Transplant Recipients	PLOS ONE			English	Article							BRONCHIOLITIS OBLITERANS SYNDROME; RENAL-TRANSPLANT; INDUCTION; TOLERANCE; SUBSETS; IMPACT; HEART	The effector and regulatory T cell subpopulations involved in the development of acute rejection episodes in lung transplantation remain to be elucidated. Twenty-seven lung transplant candidates were prospectively monitored before transplantation and within the first year post-transplantation. Regulatory, Th17, memory and naive T cells were measured in peripheral blood of lung transplant recipients by flow cytometry. No association of acute rejection with number of peripheral regulatory T cells and Th17 cells was found. However, effector memory subsets in acute rejection patients were increased during the first two months post-transplant. Interestingly, patients waiting for lung transplant with levels of CD8(+) effector memory T cells over 185 cells/mm(3) had a significant increased risk of rejection [OR: 5.62 (95% CI: 1.08-29.37), p=0.04]. In multivariate analysis adjusted for age and gender the odds ratio for rejection was: OR: 5.89 (95% CI: 1.08-32.24), p=0.04. These data suggest a correlation between acute rejection and effector memory T cells in lung transplant recipients. The measurement of peripheral blood CD8(+) effector memory T cells prior to lung transplant may define patients at high risk of acute lung rejection.	[San Segundo, David; Lopez-Hoyos, Marcos] Marques Valdecilla Hosp, Serv Immunol, Santander, Spain; [Angeles Ballesteros, Maria; Minambres, Eduardo] Marques Valdecilla Hosp, Intens Care Unit, Santander, Spain; [Naranjo, Sara] Marques Valdecilla Hosp, Thorac Surg Unit, Santander, Spain; [Zurbano, Felipe] Marques Valdecilla Hosp, Serv Pneumol, Santander, Spain	Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV)	Lopez-Hoyos, M (corresponding author), Marques Valdecilla Hosp, Serv Immunol, Santander, Spain.	inmlhm@humv.es	San Segundo, David/O-9499-2016; López-Hoyos, Marcos/ABC-1024-2020; Miñambres, Eduardo/H-7761-2019	San Segundo, David/0000-0001-5745-9072; López-Hoyos, Marcos/0000-0003-0562-427X; Ballesteros, Maria A/0000-0002-4032-9973	Fundacion Marques de Valdecilla-IFIMAV [API-11/24, API-10/02]; Fondo de Investigaciones Sanitarias-ISCIII [PI080157, PI1100990]; RENDIREN [06/16]; Fundacion Mutua Madrilena	Fundacion Marques de Valdecilla-IFIMAV; Fondo de Investigaciones Sanitarias-ISCIII(Instituto de Salud Carlos III); RENDIREN; Fundacion Mutua Madrilena(Instituto de Salud Carlos III)	DSS received a grant from the Fundacion Marques de Valdecilla-IFIMAV (API-11/24). MAB received a grant from the Fundacion Marques de Valdecilla-IFIMAV (API-10/02.) MLH received grants from the Fondo de Investigaciones Sanitarias-ISCIII (PI080157, PI1100990), RENDIREN 06/16 and Fundacion Mutua Madrilena. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKBAR AN, 1990, CLIN EXP IMMUNOL, V81, P225; Bhorade SM, 2010, TRANSPLANTATION, V90, P540, DOI 10.1097/TP.0b013e3181e8dabe; Brook MO, 2006, TRANSPLANTATION, V82, P1, DOI 10.1097/01.tp.0000226082.17507.da; Burlingham WJ, 2007, J CLIN INVEST, V117, P3498, DOI 10.1172/JCI28031; Burton CM, 2009, J HEART LUNG TRANSPL, V28, P888, DOI 10.1016/j.healun.2009.04.022; Christie JD, 2012, J HEART LUNG TRANSPL, V31, P1073, DOI 10.1016/j.healun.2012.08.004; Furness PN, 2003, TRANSPLANTATION, V76, P969, DOI 10.1097/01.TP.0000082542.99416.11; Gregson AL, 2008, TRANSPLANTATION, V85, P1056, DOI 10.1097/TP.0b013e318169bd85; Gregson AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011354; Heidt S, 2010, CURR OPIN ORGAN TRAN, V15, P456, DOI 10.1097/MOT.0b013e32833b9bfb; Heng D, 1998, J HEART LUNG TRANSPL, V17, P1255; IBRAHIM S, 1993, AM J PATHOL, V142, P1794; Lakkis FG, 2003, J AM SOC NEPHROL, V14, P2402, DOI 10.1097/01.ASN.0000085020.78117.70; Lange CM, 2010, TRANSPL INT, V23, P266, DOI 10.1111/j.1432-2277.2009.00973.x; Lopez-Hoyos M, 2009, TRANSPLANTATION, V88, pS31, DOI 10.1097/TP.0b013e3181af7b99; Macedo C, 2012, TRANSPLANTATION, V93, P813, DOI 10.1097/TP.0b013e318247a717; Madsen CB, 2010, TRANSPL IMMUNOL, V24, P26, DOI 10.1016/j.trim.2010.06.011; Neujahr DC, 2009, TRANSPLANTATION, V88, P521, DOI 10.1097/TP.0b013e3181b0e719; Richards DM, 2003, J IMMUNOL, V171, P6919, DOI 10.4049/jimmunol.171.12.6919; Sagoo P, 2010, J CLIN INVEST, V120, P1848, DOI 10.1172/JCI39922; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Segundo DS, 2006, TRANSPLANTATION, V82, P550, DOI 10.1097/01.tp.0000229473.95202.50; Steger U, 2008, TRANSPLANTATION, V85, P1339, DOI 10.1097/TP.0b013e31816dd64a; Stewart S, 2007, J HEART LUNG TRANSPL, V26, P1229, DOI 10.1016/j.healun.2007.10.017; Sun YL, 2009, SCAND J CLIN LAB INV, V69, P789, DOI 10.3109/00365510903268818; Todd JL, 2011, CHEST, V140, P502, DOI 10.1378/chest.10-2838; Trzonkowski P, 2006, TRANSPLANTATION, V82, P1342, DOI 10.1097/01.tp.0000239268.64408.84; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; Yang J, 2007, P NATL ACAD SCI USA, V104, P19954, DOI 10.1073/pnas.0704397104; Yoshizawa A, 2005, TRANSPLANT P, V37, P37, DOI 10.1016/j.transproceed.2004.12.259	30	20	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80601	10.1371/journal.pone.0080601	http://dx.doi.org/10.1371/journal.pone.0080601			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236187	Green Submitted, Green Published, gold			2022-12-27	WOS:000327254700189
J	Shwetank; Date, OS; Kim, KS; Manjunath, R				Shwetank; Date, Onkar S.; Kim, Kwang S.; Manjunath, Ramanathapuram			Infection of Human Endothelial Cells by Japanese Encephalitis Virus: Increased Expression and Release of Soluble HLA-E	PLOS ONE			English	Article							WEST-NILE-VIRUS; TUMOR-NECROSIS-FACTOR; BLOOD-BRAIN-BARRIER; CLASS-I MOLECULES; NF-KAPPA-B; SIGNALING PATHWAYS; FLAVIVIRUS; INDUCTION; MATRIX-METALLOPROTEINASE-9; RESPONSES	Japanese encephalitis virus (JEV) is a single stranded RNA virus that infects the central nervous system leading to acute encephalitis in children. Alterations in brain endothelial cells have been shown to precede the entry of this flavivirus into the brain, but infection of endothelial cells by JEV and their consequences are still unclear. Productive JEV infection was established in human endothelial cells leading to IFN-beta and TNF-alpha production. The MHC genes for HLA-A, -B, -C and HLA-E antigens were upregulated in human brain microvascular endothelial cells, the endothelial-like cell line, ECV 304 and human foreskin fibroblasts upon JEV infection. We also report the release/shedding of soluble HLA-E (sHLA-E) from JEV infected human endothelial cells for the first time. This shedding of sHLA-E was blocked by an inhibitor of matrix metalloproteinases (MMP). In addition, MMP-9, a known mediator of HLA solubilisation was upregulated by JEV. In contrast, human fibroblasts showed only upregulation of cell-surface HLA-E. Addition of UV inactivated JEV-infected cell culture supernatants stimulated shedding of sHLA-E from uninfected ECV cells indicating a role for soluble factors/cytokines in the shedding process. Antibody mediated neutralization of TNF-alpha as well as IFNAR receptor together not only resulted in inhibition of sHLA-E shedding from uninfected cells, it also inhibited HLA-E and MMP-9 gene expression in JEV-infected cells. Shedding of sHLA-E was also observed with purified TNF-alpha and IFN-beta as well as the dsRNA analog, poly (I:C). Both IFN-beta and TNF-alpha further potentiated the shedding when added together. The role of soluble MHC antigens in JEV infection is hitherto unknown and therefore needs further investigation.	[Shwetank; Date, Onkar S.; Manjunath, Ramanathapuram] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Kim, Kwang S.] Johns Hopkins Univ, Sch Med, Dept Pediat Infect Dis, Baltimore, MD USA	Indian Institute of Science (IISC) - Bangalore; Johns Hopkins University	Manjunath, R (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	mjnhm@biochem.iisc.ernet.in	, Shwetank/I-6440-2019	, Shwetank/0000-0002-5069-603X	Council for Scientific and Industrial Research, Government of India (CSIR) [CSIR 37(1436)/10/EMR-II]; Department of Atomic Energy, Government of India (DAE) [2008/37/18/BRNS/1476]; Department of Biotechnology, Government of India (DBT), Government of India; CSIR, Government of India	Council for Scientific and Industrial Research, Government of India (CSIR); Department of Atomic Energy, Government of India (DAE); Department of Biotechnology, Government of India (DBT), Government of India; CSIR, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	Work done in the author's laboratory was funded by a grant from Council for Scientific and Industrial Research, Government of India (CSIR), grant number CSIR 37(1436)/10/EMR-II dtd 15-12-2010. Partial funding was received from Department of Atomic Energy, Government of India (DAE), grant number 2008/37/18/BRNS/1476 dtd 08-09-2008. Partial support was received from Department of Biotechnology, Government of India (DBT), Government of India as a part of the "Pathogen Biology Program". Shwetank was the recipient of a JRF and SRF fellowship from CSIR, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham S, 2010, J VIROL, V84, P5485, DOI 10.1128/JVI.02250-09; Allard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021118; Arnold SJ, 2004, VIROLOGY, V324, P286, DOI 10.1016/j.virol.2004.03.036; Barrett DM, 2004, MOL CELL BIOL, V24, P6194, DOI 10.1128/MCB.24.14.6194-6204.2004; Brown J, 2000, LAB INVEST, V80, P37, DOI 10.1038/labinvest.3780006; Chen LK, 1996, VIROLOGY, V217, P220, DOI 10.1006/viro.1996.0109; Cheng Y, 2004, J INFECT DIS, V189, P658, DOI 10.1086/381501; Cheng Y, 2004, VIROLOGY, V329, P361, DOI 10.1016/j.virol.2004.06.050; Contini P, 2005, J IMMUNOL, V175, P7244, DOI 10.4049/jimmunol.175.11.7244; Coupel S, 2007, BLOOD, V109, P2806, DOI 10.1182/blood-2006-06-030213; Dalrymple N, 2011, J VIROL, V85, P9478, DOI 10.1128/JVI.05008-11; Datema G, 1999, HUM IMMUNOL, V60, P435, DOI 10.1016/S0198-8859(99)00013-0; Demaria S, 1999, HUM IMMUNOL, V60, P1216, DOI 10.1016/S0198-8859(99)00113-5; Derre L, 2006, J IMMUNOL, V177, P3100, DOI 10.4049/jimmunol.177.5.3100; Doorbar J, 2005, J CLIN VIROL, V32, pS7, DOI 10.1016/j.jcv.2004.12.006; Ghosh D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000437; Gobin SJP, 2000, HUM IMMUNOL, V61, P1102, DOI 10.1016/S0198-8859(00)00198-1; Griffin DE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002004; Halstead Scott B, 2003, Adv Virus Res, V61, P103, DOI 10.1016/S0065-3527(03)61003-1; Heinz FX, 2000, ADV VIRUS RES, V55, P231, DOI 10.1016/S0065-3527(00)55005-2; Huang CC, 2006, PHYSIOL GENOMICS, V26, P125, DOI 10.1152/physiolgenomics.00002.2006; Kabilan Lalitha, 2004, Indian Journal of Pediatrics, V71, P609, DOI 10.1007/BF02724120; King NJC, 2007, IMMUNOL CELL BIOL, V85, P33, DOI 10.1038/sj.icb.7100012; KRANGEL MS, 1986, J EXP MED, V163, P1173, DOI 10.1084/jem.163.5.1173; Kurane I, 2002, CURR TOP MICROBIOL, V267, P91; Lai CY, 2012, J NEUROCHEM, V123, P250, DOI 10.1111/j.1471-4159.2012.07889.x; Larena M, 2011, FLAVIVIRUS ENCEPHALI, P317; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9; Liou ML, 1998, CELL TISSUE RES, V293, P389, DOI 10.1007/s004410051130; Liu TH, 2008, J NEUROVIROL, V14, P514, DOI 10.1080/13550280802339643; MANTOVANI A, 1992, FASEB J, V6, P2591, DOI 10.1096/fasebj.6.8.1592209; McMinn PC, 1996, VIROLOGY, V220, P414, DOI 10.1006/viro.1996.0329; Megret F, 2007, HUM IMMUNOL, V68, P294, DOI 10.1016/j.humimm.2006.12.003; Misra UK, 2010, PROG NEUROBIOL, V91, P108, DOI 10.1016/j.pneurobio.2010.01.008; Pejawar SS, 2005, J VIROL, V79, P7544, DOI 10.1128/JVI.79.12.7544-7557.2005; Ravi V, 1997, J MED VIROL, V51, P132, DOI 10.1002/(SICI)1096-9071(199702)51:2&lt;132::AID-JMV8&gt;3.0.CO;2-8; Sehgal A, 2003, INT J PARASITOL, V33, P1589, DOI 10.1016/S0020-7519(03)00267-4; SHEN J, 1995, VIROLOGY, V208, P437, DOI 10.1006/viro.1995.1174; Shen J, 1997, J VIROL, V71, P9323, DOI 10.1128/JVI.71.12.9323-9332.1997; Shwetank Abraham S, 2011, FLAVIVIRUS ENCEPHALI, P339; Solomon T, 2002, CURR TOP MICROBIOL, V267, P171; Stins MF, 2001, MICROB PATHOGENESIS, V30, P19, DOI 10.1006/mpat.2000.0406; Tabayoyong WB, 2007, LEUKEMIA RES, V31, P121, DOI 10.1016/j.leukres.2006.06.008; TAKAHASHI K, 1990, IN VITRO CELL DEV B, V26, P265; Tung WH, 2010, BRIT J PHARMACOL, V161, P1566, DOI 10.1111/j.1476-5381.2010.00982.x; Untucht C, 2011, MICROBIOL-SGM, V157, P2933, DOI 10.1099/mic.0.049106-0; van den Hurk AF, 2009, ANNU REV ENTOMOL, V54, P17, DOI 10.1146/annurev.ento.54.110807.090510; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Vashistha S, 2007, CYTOKINE, V37, P108, DOI 10.1016/j.cyto.2007.02.013; Verma S, 2009, VIROLOGY, V385, P425, DOI 10.1016/j.virol.2008.11.047; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Wilhelm I, 2011, ACTA NEUROBIOL EXP, V71, P113; YAMADA A, 1984, J GEN VIROL, V65, P973, DOI 10.1099/0022-1317-65-5-973; Yang CM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-12; Zhou JH, 2002, J VIROL, V76, P7374, DOI 10.1128/JVI.76.15.7374-7384.2002	56	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79197	10.1371/journal.pone.0079197	http://dx.doi.org/10.1371/journal.pone.0079197			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236107	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000327254700106
J	Singh, JA; Lewallen, DG				Singh, Jasvinder A.; Lewallen, David G.			Diabetes: A Risk Factor for Poor Functional Outcome after Total Knee Arthroplasty	PLOS ONE			English	Article							TOTAL JOINT ARTHROPLASTY; OLDER MEXICAN-AMERICANS; TOTAL HIP; SURVIVORSHIP ANALYSIS; MELLITUS; REPLACEMENT; PAIN; ASSOCIATION; POPULATION; PREDICTORS	Background: To assess the association of diabetes with postoperative limitation of activities of daily living (ADLs) after primary total knee arthroplasty (TKA). Methodology/Principal Findings: We used the prospectively collected data from the Mayo Clinic Total Joint Registry to assess the association of diabetes and diabetes with complications with moderate-severe ADL limitation 2- and 5-years after primary TKA. Multivariable logistic regression with general estimating equations adjusted for preoperative ADL limitation, comorbidity and demographic and clinical covariates. Odds ratio (OR) and 95% confidence interval (CI) are presented. 7,139 primary TKAs at 2-years and 4,234 at 5-years constituted the cohorts. In multivariable-adjusted analyses, diabetes was associated with higher odds of moderate-severe limitation at 2- and 5-years, 1.71 (95% CI: 1.26, 2.32; P = 0.001) and 1.66 (95% CI: 1.13, 2.46; P = 0.01). Respective ORs for patients with diabetes with complications were 2.73 (95% CI: 1.47, 5.07; P = 0.001) and 2.73 (95% CI: 1.21, 6.15; P = 0.016). Sensitivity analyses that adjusted for anxiety and depression or anxiety, depression and ipsilateral hip involvement showed minimal attenuation of magnitude of the association. Conclusions/Significance: In this large study of patients who underwent primary TKA, diabetes as well as its severity were independently associated with poorer functional outcome. Given the increasing rates of both diabetes as well as arthroplasty, more insight is needed into disease-related and treatment-related factors that underlie this higher risk of ADL limitation in patients with diabetes. Poor functional outcomes may be preventable by modifying the control of diabetes and associated comorbidity in pre- and post-arthroplasty periods.	[Singh, Jasvinder A.] VA Med Ctr, Med Serv, Birmingham, AL USA; [Singh, Jasvinder A.] VA Med Ctr, Ctr Surg Med Acute Care Res & Transit, Birmingham, AL USA; [Singh, Jasvinder A.] Univ Alabama Birmingham, Sch Med, Dept Med, Birmingham, AL USA; [Singh, Jasvinder A.] Univ Alabama Birmingham, Sch Publ Hlth, Div Epidemiol, Birmingham, AL 35294 USA; [Singh, Jasvinder A.; Lewallen, David G.] Mayo Clin, Coll Med, Dept Orthoped Surg, Rochester, MN USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Mayo Clinic	Singh, JA (corresponding author), VA Med Ctr, Med Serv, Birmingham, AL USA.	Jasvinder.md@gmail.com	Singh, Jasvinder/R-6172-2019; R, Manimegalai/D-7835-2016	Singh, Jasvinder/0000-0003-3485-0006; R, Manimegalai/0000-0001-6187-2652	National Institute of Aging, National Cancer Institute, Agency for Health Quality and Research Center for Education and Research on Therapeutics (CERTs); National Institute of Arthritis and Musculoskeletal and Skin Disease; Department of Veterans Affairs; DePuy; Stryker; Biomet; Zimmer	National Institute of Aging, National Cancer Institute, Agency for Health Quality and Research Center for Education and Research on Therapeutics (CERTs); National Institute of Arthritis and Musculoskeletal and Skin Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Department of Veterans Affairs(US Department of Veterans Affairs); DePuy; Stryker; Biomet; Zimmer	JAS is supported by research grants from National Institute of Aging, National Cancer Institute, Agency for Health Quality and Research Center for Education and Research on Therapeutics (CERTs), National Institute of Arthritis and Musculoskeletal and Skin Disease and the Department of Veterans Affairs (resources and the use of facilities at the Birmingham VA Medical Center, Alabama, USA). JAS has received research grants from Takeda and Savient and consultant fees from Savient, Takeda, Regeneron and Allergan. JAS is a member of the executive of OMERACT, an organization that develops outcome measures in rheumatology and receives arms-length funding from 36 companies; a member of the American College of Rheumatology's Guidelines Subcommittee of the Quality of Care Committee; and a member of the Veterans Affairs Rheumatology Field Advisory Committee. DGL has received royalties/speaker fees from Zimmer, Orthosonic and Osteotech, has been a paid consultant and owns stock in Pipeline Biomedical and his institution has received research funds from DePuy, Stryker, Biomet and Zimmer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agabiti N, 2007, INT J QUAL HEALTH C, V19, P37, DOI 10.1093/intqhc/mzl065; Al Snih S, 2005, J GERONTOL A-BIOL, V60, P1152, DOI 10.1093/gerona/60.9.1152; Asch DA, 1997, J CLIN EPIDEMIOL, V50, P1129, DOI 10.1016/S0895-4356(97)00126-1; Chiu FY, 2001, J BONE JOINT SURG BR, V83B, P691, DOI 10.1302/0301-620X.83B5.11737; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; ENGLAND SP, 1990, CLIN ORTHOP RELAT R, P130; Fisher DA, 2007, J ARTHROPLASTY, V22, P39, DOI 10.1016/j.arth.2007.04.011; GORDON SM, 1990, AM J EPIDEMIOL, V131, P905, DOI 10.1093/oxfordjournals.aje.a115580; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Iorio R, 2012, J ARTHROPLASTY, V27, P726, DOI 10.1016/j.arth.2011.09.013; Jones CA, 2001, ARCH INTERN MED, V161, P454, DOI 10.1001/archinte.161.3.454; Jones CA, 2003, PHYS THER, V83, P696, DOI 10.1093/ptj/83.8.696; Judge A, 2012, RHEUMATOLOGY, V51, P1804, DOI 10.1093/rheumatology/kes075; Lingard EA, 2004, J BONE JOINT SURG AM, V86A, P2179, DOI 10.2106/00004623-200410000-00008; Lingard EA, 2001, J BONE JOINT SURG AM, V83A, P1856, DOI 10.2106/00004623-200112000-00014; Mahomed NN, 2002, J RHEUMATOL, V29, P1273; Malinzak RA, 2009, J ARTHROPLASTY, V24, P84, DOI 10.1016/j.arth.2009.05.016; McGrory BJ, 1996, J ARTHROPLASTY, V11, P47, DOI 10.1016/S0883-5403(96)80160-4; Meding JB, 2003, CLIN ORTHOP RELAT R, P208, DOI 10.1097/01.blo.0000093002.90435.56; Moon HK, 2008, YONSEI MED J, V49, P129, DOI 10.3349/ymj.2008.49.1.129; Nieves-Plaza M, 2013, JCR-J CLIN RHEUMATOL, V19, P1, DOI 10.1097/RHU.0b013e31827cd578; OrthoInfo, 2011, TOT KNEE REPL; Papagelopoulos PJ, 1996, CLIN ORTHOP RELAT R, P124; Rajgopal V, 2008, J ARTHROPLASTY, V23, P795, DOI 10.1016/j.arth.2007.08.005; RAND JA, 1991, J BONE JOINT SURG AM, V73A, P397, DOI 10.2106/00004623-199173030-00011; Rand JA, 2003, J BONE JOINT SURG AM, V85A, P259, DOI 10.2106/00004623-200302000-00012; Santaguida PL, 2008, CAN J SURG, V51, P428; Schett G, 2013, DIABETES CARE, V36, P403, DOI 10.2337/dc12-0924; Singh JA, 2010, J BONE JOINT SURG BR, V92B, P799, DOI 10.1302/0301-620X.92B6.23114; Singh JA, 2010, OSTEOARTHR CARTILAGE, V18, P515, DOI 10.1016/j.joca.2009.12.001; Singh JA, 2008, CLIN ORTHOP RELAT R, V466, P2717, DOI 10.1007/s11999-008-0399-9; Singh JA, 2011, J ARTHROPLASTY, V26, P366, DOI 10.1016/j.arth.2010.02.006; Singh JA, 2010, J ARTHROPLASTY, V25, P1091, DOI 10.1016/j.arth.2009.07.020; *STROBE STAT, 2007, STRENGTH REP OBS STU; Tian WQ, 2010, AM J PHYS MED REHAB, V89, P905, DOI 10.1097/PHM.0b013e3181f1c6d8; Wasielewski RC, 1998, CLIN ORTHOP RELAT R, P85, DOI 10.1097/00003086-199811000-00014; Wright RJ, 2004, J BONE JOINT SURG AM, V86A, P2464, DOI 10.2106/00004623-200411000-00016; Wu JH, 2003, DIABETES CARE, V26, P314, DOI 10.2337/diacare.26.2.314; Yang K, 2001, J ARTHROPLASTY, V16, P102, DOI 10.1054/arth.2001.19159; Zeni JA, 2010, OSTEOARTHR CARTILAGE, V18, P510, DOI 10.1016/j.joca.2009.12.005	40	27	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78991	10.1371/journal.pone.0078991	http://dx.doi.org/10.1371/journal.pone.0078991			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236080	Green Submitted, Green Published, gold			2022-12-27	WOS:000327254700078
J	Frump, AL; Lowery, JW; Hamid, R; Austin, ED; de Caestecker, M				Frump, Andrea L.; Lowery, Jonathan W.; Hamid, Rizwan; Austin, Eric D.; de Caestecker, Mark			Abnormal Trafficking of Endogenously Expressed BMPR2 Mutant Allelic Products in Patients with Heritable Pulmonary Arterial Hypertension	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; II RECEPTOR; SODIUM 4-PHENYLBUTYRATE; ENDOPLASMIC-RETICULUM; CYSTIC-FIBROSIS; MUTATIONS; GENE; SUSCEPTIBILITY; SPECIFICITY; ENDOTHELIUM	More than 200 heterozygous mutations in the type 2 BMP receptor gene, BMPR2, have been identified in patients with Heritable Pulmonary Arterial Hypertension (HPAH). More severe clinical outcomes occur in patients with BMPR2 mutations by-passing nonsense-mediated mRNA decay (NMD negative mutations). These comprise 40% of HPAH mutations and are predicted to express BMPR2 mutant products. However expression of endogenous NMD negative BMPR2 mutant products and their effect on protein trafficking and signaling function have never been described. Here, we characterize the expression and trafficking of an HPAH-associated NMD negative BMPR2 mutation that results in an in-frame deletion of BMPR2 EXON2 (BMPR2.Ex2) in HPAH patient-derived lymphocytes and in pulmonary endothelial cells (PECs) from mice carrying the same in-frame deletion of Exon 2 (Bmpr2(Ex2/+) mice). The endogenous BMPR2 Delta Ex2 mutant product does not reach the cell surface and is retained in the endoplasmic reticulum. Moreover, chemical chaperones 4-PBA and TUDCA partially restore cell surface expression of Bmpr2.Ex2 in PECs, suggesting that the mutant product is mis-folded. We also show that PECs from Bmpr(2 Delta Ex2/+) mice have defects in the BMP-induced Smad1/5/8 and Id1 signaling axis, and that addition of chemical chaperones restores expression of the Smad1/5/8 target Id1. These data indicate that the endogenous NMD negative BMPR.Ex2 mutant product is expressed but has a folding defect resulting in ER retention. Partial correction of this folding defect and restoration of defective BMP signaling using chemical chaperones suggests that protein-folding agents could be used therapeutically in patients with these NMD negative BMPR2 mutations.	[Frump, Andrea L.; de Caestecker, Mark] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37203 USA; [Lowery, Jonathan W.] Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA; [Hamid, Rizwan] Vanderbilt Univ, Med Ctr, Dept Pediat, Div Mol Genet & Genom Med, Nashville, TN 37232 USA; [Austin, Eric D.] Vanderbilt Univ, Med Ctr, Dept Pediat, Div Pediat Pulm Med, Nashville, TN 37232 USA; [de Caestecker, Mark] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA	Vanderbilt University; Harvard University; Harvard School of Dental Medicine; Vanderbilt University; Vanderbilt University; Vanderbilt University	de Caestecker, M (corresponding author), Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37203 USA.	mark.de.caestecker@vanderbilt.edu	Frump, Andrea/W-5043-2019	Frump, Andrea/0000-0002-5972-5079	National Institutes of Health/NIH Heart, Lung and Blood Institute [HL093057, HL095797]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095797, R01HL102020, R01HL093057] Funding Source: NIH RePORTER	National Institutes of Health/NIH Heart, Lung and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by the National Institutes of Health/NIH Heart, Lung and Blood Institute grants HL093057 and HL095797, URL http://www.nhlbi.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson L, 2010, AM J PHYSIOL-REG I, V298, pR833, DOI 10.1152/ajpregu.00534.2009; Atkinson C, 2002, CIRCULATION, V105, P1672, DOI 10.1161/01.CIR.0000012754.72951.3D; Austin Eric D, 2011, Pulm Circ, V1, P389, DOI 10.4103/2045-8932.87308; Austin ED, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-87; Austin ED, 2009, SEMIN RESP CRIT CARE, V30, P386, DOI 10.1055/s-0029-1233308; Beppu H, 2004, AM J PHYSIOL-LUNG C, V287, pL1241, DOI 10.1152/ajplung.00239.2004; Bulleid NJ, 2012, COLD SPRING HARB PER, V4; Burton VJ, 2011, BLOOD, V117, P333, DOI 10.1182/blood-2010-05-285973; Cao SS, 2013, GASTROENTEROLOGY, V144, P989, DOI 10.1053/j.gastro.2013.01.023; Cogan JD, 2005, GENET MED, V7, P169, DOI 10.1097/01.GIM.0000156525.09595.E9; Cogan JD, 2006, AM J RESP CRIT CARE, V174, P590, DOI 10.1164/rccm.200602-165OC; da-Silva WS, 2011, FEBS LETT, V585, P539, DOI 10.1016/j.febslet.2010.12.044; Delot EC, 2003, DEVELOPMENT, V130, P209, DOI 10.1242/dev.00181; Drake KM, 2013, AM J RESP CELL MOL, V49, P403, DOI 10.1165/rcmb.2013-0100OC; Duricka DL, 2012, BIOCHEM J, V441, P685, DOI 10.1042/BJ20111004; Frank DB, 2008, AM J PHYSIOL-LUNG C, V294, pL98, DOI 10.1152/ajplung.00034.2007; Frank DB, 2005, CIRC RES, V97, P496, DOI 10.1161/01.RES.0000181152.65534.07; Freeze HH, 2008, CURR PROTOC IMMUNOL, P15; Hamid R, 2010, CLIN GENET, V77, P280, DOI 10.1111/j.1399-0004.2009.01311.x; Hamid R, 2009, HUM MUTAT, V30, P649, DOI 10.1002/humu.20922; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; Hong KH, 2008, CIRCULATION, V118, P722, DOI 10.1161/CIRCULATIONAHA.107.736801; Hua YA, 2010, J CARDIOVASC PHARM, V55, P49, DOI 10.1097/FJC.0b013e3181c37d86; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Lim M, 2004, AM J RESP CELL MOL, V31, P351, DOI 10.1165/rcmb.2002-0086OC; Liu D, 2007, BLOOD, V110, P1502, DOI 10.1182/blood-2006-11-058594; LODISH HF, 1988, J BIOL CHEM, V263, P2107; Long L, 2006, CIRC RES, V98, P818, DOI 10.1161/01.RES.0000215809.47923.fd; Long L, 2013, CIRC RES, V112, P1159, DOI 10.1161/CIRCRESAHA.111.300483; Lowery JW, 2010, AM J PHYSIOL-REG I, V299, pR1463, DOI 10.1152/ajpregu.00866.2009; Lowery JW, 2010, CYTOKINE GROWTH F R, V21, P287, DOI 10.1016/j.cytogfr.2010.06.001; Loyd James E, 2011, Proc Am Thorac Soc, V8, P154, DOI 10.1513/pats.201007-047MS; Machado RD, 2006, HUM MUTAT, V27, P121, DOI 10.1002/humu.20285; Machado RD, 2001, AM J HUM GENET, V68, P92, DOI 10.1086/316947; Miyazono K, 2002, SCI STKE, V2002, ppe40; Mueller TD, 2012, FEBS LETT, V586, P1846, DOI 10.1016/j.febslet.2012.02.043; Nishihara A, 2002, MOL BIOL CELL, V13, P3055, DOI 10.1091/mbc.E02-02-0063; Obici L, 2012, AMYLOID, V19, P34, DOI 10.3109/13506129.2012.678508; Pruliere-Escabasse V, 2007, J BIOL CHEM, V282, P34048, DOI 10.1074/jbc.M702384200; Ramos M, 2006, VASC PHARMACOL, V44, P50, DOI 10.1016/j.vph.2005.09.007; Roque T, 2008, J PHARMACOL EXP THER, V326, P949, DOI 10.1124/jpet.107.135186; Rubenstein RC, 1998, AM J RESP CRIT CARE, V157, P484, DOI 10.1164/ajrccm.157.2.9706088; Rudarakanchana N, 2002, HUM MOL GENET, V11, P1517, DOI 10.1093/hmg/11.13.1517; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Sobolewski A, 2008, HUM MOL GENET, V17, P3180, DOI 10.1093/hmg/ddn214; Song YL, 2008, AM J PHYSIOL-HEART C, V295, pH677, DOI 10.1152/ajpheart.91519.2007; Sorrenson B, 2013, J LIPID RES, V54, P55, DOI 10.1194/jlr.M027193; West J, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-45; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; Yeh LCC, 2012, BIOCHEMISTRY-US, V51, P6968, DOI 10.1021/bi3003023; Yin HR, 2008, J MOL BIOL, V378, P191, DOI 10.1016/j.jmb.2008.02.031; Zeitlin PL, 2002, MOL THER, V6, P119, DOI 10.1006/mthe.2002.0639	52	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80319	10.1371/journal.pone.0080319	http://dx.doi.org/10.1371/journal.pone.0080319			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224048	Green Published, Green Submitted, gold			2022-12-27	WOS:000326597400116
J	Hng, KI; Dormann, D				Hng, Keng Imm; Dormann, Dirk			ConfocalCheck - A Software Tool for the Automated Monitoring of Confocal Microscope Performance	PLOS ONE			English	Article							SLIDE-BASED SYSTEMS; FLUORESCENCE MICROSCOPY; QUALITY ASSESSMENT; IMAGE; CALIBRATION; ASSURANCE; LAYERS; FIELD	Laser scanning confocal microscopy has become an invaluable tool in biomedical research but regular quality testing is vital to maintain the system's performance for diagnostic and research purposes. Although many methods have been devised over the years to characterise specific aspects of a confocal microscope like measuring the optical point spread function or the field illumination, only very few analysis tools are available. Our aim was to develop a comprehensive quality assurance framework ranging from image acquisition to automated analysis and documentation. We created standardised test data to assess the performance of the lasers, the objective lenses and other key components required for optimum confocal operation. The ConfocalCheck software presented here analyses the data fully automatically. It creates numerous visual outputs indicating potential issues requiring further investigation. By storing results in a web browser compatible file format the software greatly simplifies record keeping allowing the operator to quickly compare old and new data and to spot developing trends. We demonstrate that the systematic monitoring of confocal performance is essential in a core facility environment and how the quantitative measurements obtained can be used for the detailed characterisation of system components as well as for comparisons across multiple instruments.	[Hng, Keng Imm; Dormann, Dirk] Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC Clin Sci Ctr, London, England	Imperial College London	Dormann, D (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC Clin Sci Ctr, London, England.	dirk.dormann@csc.mrc.ac.uk			Medical Research Council	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler J, 2003, J MICROSC-OXFORD, V210, P131, DOI 10.1046/j.1365-2818.2003.01160.x; Amos WB, 2003, BIOL CELL, V95, P335, DOI 10.1016/S0248-4900(03)00078-9; Brakenhoff GJ, 2005, J MICROSC-OXFORD, V219, P122, DOI 10.1111/j.1365-2818.2005.01504.x; Centonze V, 2006, HDB BIOL CONFOCAL MI, P627, DOI DOI 10.1007/978-0-387-45524-2_35; Cole RW, 2011, NAT PROTOC, V6, P1929, DOI 10.1038/nprot.2011.407; Dixon A, 2008, SPRINGER SERIES FLUO; Garsha K, 2008, SPRINGER SERIES FLUO; Gelman L, 2010, ROUTINE ASSESSMENT F; Hibbs AR, 2006, HDB BIOL CONFOCAL MI, P650; HIRAOKA Y, 1990, BIOPHYS J, V57, P325, DOI 10.1016/S0006-3495(90)82534-0; Hoffmann K, 2008, SPRINGER SERIES FLUO; Lerner JM, 2004, CYTOM PART A, V62A, P8, DOI 10.1002/cyto.a.20087; Linkert M, 2010, J CELL BIOL, V189, P777, DOI 10.1083/jcb.201004104; Matthews C, 2010, IMAGEJ US DEV C; McConnell G, 2012, CONFOCAL MICROSCOPY, P3; Model MA, 2008, J MICROSC-OXFORD, V229, P12, DOI 10.1111/j.1365-2818.2007.01880.x; Murray JM, 2007, J MICROSC-OXFORD, V228, P390, DOI 10.1111/j.1365-2818.2007.01861.x; Murray John M, 2011, Cold Spring Harb Protoc, V2011, P1399, DOI 10.1101/pdb.top066936; Pawley J, 2000, BIOTECHNIQUES, V28, P884, DOI 10.2144/00285bt01; Pawley J.B., 2006, HDB BIOL CONFOCAL MI, DOI [10.1007/978-0-387-45524-2_23, 10.1007/978-0-387-45524-2, DOI 10.1007/978-0-387-45524-2]; Resch-Genger U, 2005, J FLUORESC, V15, P337, DOI 10.1007/s10895-005-2630-3; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stack RF, 2011, MICROSC MICROANAL, V17, P598, DOI 10.1017/S1431927611000237; Swedlow JR, 2002, P NATL ACAD SCI USA, V99, P2014, DOI 10.1073/pnas.022554999; Vagh H, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2390626; Vischer N, 2013, SIPCHART PLUGIN IMAG; Zucker RM, 2005, MICROSC RES TECHNIQ, V68, P307, DOI 10.1002/jemt.20249; Zucker RM, 1999, METHODS, V18, P447, DOI 10.1006/meth.1999.0812; Zucker RM, 2001, CYTOMETRY, V44, P295, DOI 10.1002/1097-0320(20010801)44:4<295::AID-CYTO1121>3.0.CO;2-C; Zucker RM, 2001, CYTOMETRY, V44, P273, DOI 10.1002/1097-0320(20010801)44:4<273::AID-CYTO1120>3.0.CO;2-N; Zucker RM, 2010, CURR PROTOC CYTOM, V54, P2161; Zucker Robert M, 2006, Methods Mol Biol, V319, P77; Zucker RM, 2007, CYTOM PART A, V71A, P174, DOI 10.1002/cyto.a.20371; Zucker RM, 2006, CYTOM PART A, V69A, P930, DOI 10.1002/cyto.a.20315; Zucker RM, 2006, CYTOM PART A, V69A, P659, DOI 10.1002/cyto.a.20314; Zucker RM, 2006, CYTOM PART A, V69A, P677, DOI 10.1002/cyto.a.20313; Zwier JM, 2008, J MICROSC-OXFORD, V231, P59, DOI 10.1111/j.1365-2818.2008.02017.x	38	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79879	10.1371/journal.pone.0079879	http://dx.doi.org/10.1371/journal.pone.0079879			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224017	Green Published, Green Submitted, gold			2022-12-27	WOS:000326597400094
J	Mischke, M; Pruis, MGM; Boekschoten, MV; Groen, AK; Fitri, AR; van de Heijning, BJM; Verkade, HJ; Muller, M; Plosch, T; Steegenga, WT				Mischke, Mona; Pruis, Maurien G. M.; Boekschoten, Mark V.; Groen, Albert K.; Fitri, Aditia R.; van de Heijning, Bert J. M.; Verkade, Henkjan J.; Muller, Michael; Plosch, Torsten; Steegenga, Wilma T.			Maternal Western-Style High Fat Diet Induces Sex-Specific Physiological and Molecular Changes in Two-Week-Old Mouse Offspring	PLOS ONE			English	Article							HYPOTHALAMIC GENE-EXPRESSION; AORTIC VASCULAR FUNCTION; BETA-CATENIN; LIPID-METABOLISM; ESTROGEN-RECEPTOR; ECONOMIC BURDEN; C57BL/6 MICE; FOOD-INTAKE; X-RECEPTOR; LIVER	Maternal diet is associated with the development of metabolism-related and other non-communicable diseases in offspring. Underlying mechanisms, functional profiles, and molecular markers are only starting to be revealed. Here, we explored the physiological and molecular impact of maternal Western-style diet on the liver of male and female offspring. C57BL/6 dams were exposed to either a low fat/low cholesterol diet (LFD) or a Western-style high fat/high cholesterol diet (WSD) for six weeks before mating, as well as during gestation and lactation. Dams and offspring were sacrificed at postnatal day 14, and body, liver, and blood parameters were assessed. The impact of maternal WSD on the pups' liver gene expression was characterised by whole-transcriptome microarray analysis. Exclusively male offspring had significantly higher body weight upon maternal WSD. In offspring of both sexes of WSD dams, liver and blood parameters, as well as hepatic gene expression profiles were changed. In total, 686 and 604 genes were differentially expressed in liver (p <= 0.01) of males and females, respectively. Only 10% of these significantly changed genes overlapped in both sexes. In males, in particular alterations of gene expression with respect to developmental functions and processes were observed, such as Wnt/beta-catenin signalling. In females, mainly genes important for lipid metabolism, including cholesterol synthesis, were changed. We conclude that maternal WSD affects physiological parameters and induces substantial changes in the molecular profile of the liver in two-week-old pups. Remarkably, the observed biological responses of the offspring reveal pronounced sex-specificity.	[Mischke, Mona; Boekschoten, Mark V.; Fitri, Aditia R.; Muller, Michael; Steegenga, Wilma T.] Wageningen Univ, Div Human Nutr, Nutr Metab & Genom Grp, NL-6700 AP Wageningen, Netherlands; [Pruis, Maurien G. M.; Groen, Albert K.; Verkade, Henkjan J.; Plosch, Torsten] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Ctr Liver Digest & Metab Dis, NL-9700 AB Groningen, Netherlands; [Groen, Albert K.] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands; [van de Heijning, Bert J. M.] Danone Res, Ctr Specialised Nutr, Wageningen, Netherlands	Wageningen University & Research; University of Groningen; University of Groningen; Danone Nutricia	Steegenga, WT (corresponding author), Wageningen Univ, Div Human Nutr, Nutr Metab & Genom Grp, NL-6700 AP Wageningen, Netherlands.	wilma.steegenga@wur.nl	Muller, Michael/B-5795-2008; Plösch, Torsten/X-6808-2019; Muller, Michael/M-5724-2019; Boekschoten, Mark/AAS-4597-2021	Muller, Michael/0000-0002-5930-9905; Plösch, Torsten/0000-0002-9305-4045; Muller, Michael/0000-0002-5930-9905; Boekschoten, Mark/0000-0002-2139-0795; Verkade, Henkjan J/0000-0002-7034-2861	Dutch Technology Foundation STW , which is part of the Netherlands Organisation for Scientific Research (NWO); Ministry of Economic Affairs; CTMM, the Center for Translational Molecular Medicine, project PREDICCt [01C-104]; Dutch Heart Foundation; Dutch Diabetes Research Foundation; Dutch Kidney Foundation	Dutch Technology Foundation STW , which is part of the Netherlands Organisation for Scientific Research (NWO); Ministry of Economic Affairs; CTMM, the Center for Translational Molecular Medicine, project PREDICCt; Dutch Heart Foundation(Netherlands Heart Foundation); Dutch Diabetes Research Foundation; Dutch Kidney Foundation	This research is supported by the Dutch Technology Foundation STW (www.stw.nl), which is part of the Netherlands Organisation for Scientific Research (NWO), and which is partly funded by the Ministry of Economic Affairs. This research was performed within the framework of CTMM, the Center for Translational Molecular Medicine (www.ctmm.nl), project PREDICCt (grant 01C-104), and is supported by the Dutch Heart Foundation, Dutch Diabetes Research Foundation and Dutch Kidney Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander BT, 2009, AM J PHYSIOL-REG I, V296, pR1027, DOI 10.1152/ajpregu.00104.2009; Aounallah-Skhiri H, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-38; Apte U, 2007, AM J PHYSIOL-GASTR L, V292, pG1578, DOI 10.1152/ajpgi.00359.2006; Arnold AP, 2004, ENDOCRINOLOGY, V145, P1057, DOI 10.1210/en.2003-1491; Ashino NG, 2012, J NUTR BIOCHEM, V23, P341, DOI 10.1016/j.jnutbio.2010.12.011; Barker DJP, 1997, NUTRITION, V13, P807, DOI 10.1016/S0899-9007(97)00193-7; Bayol SA, 2010, ENDOCRINOLOGY, V151, P1451, DOI 10.1210/en.2009-1192; Behari J, 2010, EXPERT REV GASTROENT, V4, P745, DOI [10.1586/egh.10.74, 10.1586/EGH.10.74]; Behari J, 2010, AM J PATHOL, V176, P744, DOI 10.2353/ajpath.2010.090667; Bruce KD, 2009, HEPATOLOGY, V50, P1796, DOI 10.1002/hep.23205; Chafey P, 2009, PROTEOMICS, V9, P3889, DOI 10.1002/pmic.200800609; Chechi K, 2009, AM J PHYSIOL-REG I, V296, pR1029, DOI 10.1152/ajpregu.90932.2008; Cheng TO, 2003, J AM COLL CARDIOL, V42, P773, DOI 10.1016/S0735-1097(03)00792-7; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Connor KL, 2012, J PHYSIOL-LONDON, V590, P2167, DOI 10.1113/jphysiol.2011.223305; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dudley KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021662; Elahi MM, 2009, BRIT J NUTR, V102, P514, DOI 10.1017/S000711450820749X; Fung TT, 2001, AM J CLIN NUTR, V73, P61; Gabory A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047986; Giraudo SQ, 2010, PHARMACOL BIOCHEM BE, V97, P121, DOI 10.1016/j.pbb.2010.04.017; Godfrey KM, 2011, DIABETES, V60, P1528, DOI 10.2337/db10-0979; Guthrie JF, 2002, J NUTR EDUC BEHAV, V34, P140, DOI 10.1016/S1499-4046(06)60083-3; Howie GJ, 2009, J PHYSIOL-LONDON, V587, P905, DOI 10.1113/jphysiol.2008.163477; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jenkins TG, 2012, REPRODUCTION, V143, P727, DOI 10.1530/REP-11-0450; Jimenez-Chillaron JC, 2012, BIOCHIMIE, V94, P2242, DOI 10.1016/j.biochi.2012.06.012; KELLER H, 1995, MOL ENDOCRINOL, V9, P794, DOI 10.1210/me.9.7.794; Koletzko B, 2012, P NUTR SOC, V71, P371, DOI 10.1017/S0029665112000596; Leuenberger N, 2009, J CLIN INVEST, V119, P3138, DOI 10.1172/JCI39019; Lin K, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-160; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; McCarthy MM, 2011, NAT NEUROSCI, V14, P677, DOI 10.1038/nn.2834; McMillen IC, 2008, BASIC CLIN PHARMACOL, V102, P82, DOI 10.1111/j.1742-7843.2007.00188.x; Micsenyi A, 2004, GASTROENTEROLOGY, V126, P1134, DOI 10.1053/j.gastro.2003.12.047; Mittendorfer B, 2005, J NUTR, V135, P681, DOI 10.1093/jn/135.4.681; Monga SPS, 2011, INT J BIOCHEM CELL B, V43, P1021, DOI 10.1016/j.biocel.2009.09.001; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Muller-Riemenschneider F, 2008, EUR J EPIDEMIOL, V23, P499, DOI 10.1007/s10654-008-9239-1; Odegaard AO, 2012, CIRCULATION, V126, P182, DOI 10.1161/CIRCULATIONAHA.111.084004; Page KC, 2009, AM J PHYSIOL-REG I, V297, pR1049, DOI 10.1152/ajpregu.90585.2008; Popkin BM, 2001, J NUTR, V131, p871S, DOI 10.1093/jn/131.3.871S; Pruis M, 2011, J DEV ORIG HLTH DIS, V2, pS35; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sartor MA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-538; Seaborn T, 2010, TRENDS ENDOCRIN MET, V21, P729, DOI 10.1016/j.tem.2010.09.001; Silverman BL, 1998, DIABETES CARE, V21, pB142; Staal FJT, 2010, J CELL BIOCHEM, V109, P844, DOI 10.1002/jcb.22467; Strakovsky RS, 2011, J PHYSIOL-LONDON, V589, P2707, DOI 10.1113/jphysiol.2010.203950; Tracey R, 2013, REPROD TOXICOL, V36, P104, DOI 10.1016/j.reprotox.2012.11.011; van Straten EME, 2010, AM J PHYSIOL-REG I, V298, pR275, DOI 10.1152/ajpregu.00413.2009; Wang HH, 2006, J LIPID RES, V47, P778, DOI 10.1194/jlr.M500454-JLR200; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Waterland RA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001252; Waxman DJ, 2006, MOL ENDOCRINOL, V20, P2613, DOI 10.1210/me.2006-0007; Zhang JL, 2005, AM J PHYSIOL-REG I, V288, pR112, DOI 10.1152/ajpregu.00351.2004; Zhang XY, 2011, J NUTR, V141, P1254, DOI 10.3945/jn.111.139576	59	40	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78623	10.1371/journal.pone.0078623	http://dx.doi.org/10.1371/journal.pone.0078623			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223833	gold, Green Published, Green Submitted			2022-12-27	WOS:000326597400037
J	Nuss, AM; Adnan, F; Weber, L; Berghoff, BA; Glaeser, J; Klug, G				Nuss, Aaron M.; Adnan, Fazal; Weber, Lennart; Berghoff, Bork A.; Glaeser, Jens; Klug, Gabriele			DegS and RseP Homologous Proteases Are Involved in Singlet Oxygen Dependent Activation of RpoE in Rhodobacter sphaeroides	PLOS ONE			English	Article							ESCHERICHIA-COLI SIGMA(E); ENVELOPE STRESS-RESPONSE; PHOTOOXIDATIVE STRESS; TRANSCRIPTIONAL RESPONSE; CRYSTAL-STRUCTURE; SIGNALS; CAROTENOIDS; PROTEOLYSIS; EXPRESSION; RESISTANCE	Singlet oxygen (O-1(2)) is the main agent of photooxidative stress and is generated by photosensitizers as (bacterio) chlorophylls. It leads to the damage of cellular macromolecules and therefore photosynthetic organisms have to mount an adaptive response to O-1(2) formation. A major player of the photooxidative stress response in Rhodobacter sphaeroides is the alternative sigma factor RpoE, which is inactivated under non-stress conditions by its cognate anti-sigma factor ChrR. By using random mutagenesis we identified RSP_1090 to be required for full activation of the RpoE response under O-1(2) stress, but not under organic peroxide stress. In this study we show that both RSP_1090 and RSP_1091 are required for full resistance towards O-1(2). Moreover, we revealed that the DegS and RseP homologs RSP_3242 and RSP_2710 contribute to O-1(2) resistance and promote ChrR proteolysis. The RpoE signaling pathway in R. sphaeroides is therefore highly similar to that of Escherichia coli, although very different anti-sigma factors control RpoE activity. Based on the acquired results, the current model for RpoE activation in response to O-1(2) exposure in R. sphaeroides was extended.	[Nuss, Aaron M.; Adnan, Fazal; Weber, Lennart; Berghoff, Bork A.; Glaeser, Jens; Klug, Gabriele] Univ Giessen, Inst Microbiol & Mol Biol, D-35390 Giessen, Germany; [Nuss, Aaron M.] Helmholtz Ctr Infect Res, Dept Mol Infect Biol, Braunschweig, Germany; [Berghoff, Bork A.] Uppsala Univ, Biomed Ctr, Dept Cell & Mol Biol, Uppsala, Sweden	Justus Liebig University Giessen; Helmholtz Association; Helmholtz-Center for Infection Research; Uppsala University	Klug, G (corresponding author), Univ Giessen, Inst Microbiol & Mol Biol, D-35390 Giessen, Germany.	Gabriele.Klug@mikro.bio.uni-giessen.de; jens.glaeser@mikro.bio.uni-giessen.de	Klug, Gabriele/K-5322-2014	Klug, Gabriele/0000-0002-3527-5093	Deutsche Forschungsgemeinschaft [Kl 563/ 20-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This project was funded by the Deutsche Forschungsgemeinschaft grant Kl 563/ 20-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba BM, 2004, MOL MICROBIOL, V52, P613, DOI 10.1111/j.1365-2958.2003.03982.x; Anthony JR, 2005, P NATL ACAD SCI USA, V102, P6502, DOI 10.1073/pnas.0502225102; Anthony JR, 2004, J MOL BIOL, V341, P345, DOI 10.1016/j.jmb.2004.06.018; Anthony JR, 2003, METHOD ENZYMOL, V370, P54; Berghoff BA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003576; Berghoff BA, 2011, MOL MICROBIOL, V80, P1479, DOI 10.1111/j.1365-2958.2011.07658.x; Berghoff BA, 2011, ENVIRON MICROBIOL, V13, P775, DOI 10.1111/j.1462-2920.2010.02381.x; Braatsch S, 2002, MOL MICROBIOL, V45, P827, DOI 10.1046/j.1365-2958.2002.03058.x; Campbell EA, 2003, MOL CELL, V11, P1067, DOI 10.1016/S1097-2765(03)00148-5; Campbell EA, 2007, MOL CELL, V27, P793, DOI 10.1016/j.molcel.2007.07.009; Cezairliyan BO, 2007, P NATL ACAD SCI USA, V104, P3771, DOI 10.1073/pnas.0611567104; Chaba R, 2007, GENE DEV, V21, P124, DOI 10.1101/gad.1496707; Cogdell RJ, 2000, PHILOS T ROY SOC B, V355, P1345, DOI 10.1098/rstb.2000.0696; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; Davies MJ, 2004, PHOTOCH PHOTOBIO SCI, V3, P17, DOI 10.1039/b307576c; DeLasPenas A, 1997, MOL MICROBIOL, V24, P373, DOI 10.1046/j.1365-2958.1997.3611718.x; Drews G, 1983, MIKROBIOLOGISCHES PR; Dufour YS, 2008, J MOL BIOL, V383, P713, DOI 10.1016/j.jmb.2008.08.017; Flynn JM, 2004, GENE DEV, V18, P2292, DOI 10.1101/gad.1240104; Glaeser J, 2005, MICROBIOL-SGM, V151, P1927, DOI 10.1099/mic.0.27789-0; Glaeser J, 2011, ADV MICROB PHYSIOL, V58, P141, DOI 10.1016/B978-0-12-381043-4.00004-0; Gomelsky M, 2002, TRENDS BIOCHEM SCI, V27, P497, DOI 10.1016/S0968-0004(02)02181-3; Greenwell R, 2011, J MOL BIOL, V407, P477, DOI 10.1016/j.jmb.2011.01.055; Grigorova IL, 2004, GENE DEV, V18, P2686, DOI 10.1101/gad.1238604; Hendrischk AK, 2007, MICROBIOL-SGM, V153, P1842, DOI 10.1099/mic.0.2006/004390-0; Ho TD, 2012, CURR OPIN MICROBIOL, V15, P182, DOI 10.1016/j.mib.2012.01.001; HUBNER P, 1991, J BACTERIOL, V173, P2993; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Kim DY, 2007, P NATL ACAD SCI USA, V104, P8779, DOI 10.1073/pnas.0703117104; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lima S, 2013, SCIENCE, V340, P837, DOI 10.1126/science.1235358; Lourenco RF, 2009, MOL MICROBIOL, V72, P1159, DOI 10.1111/j.1365-2958.2009.06714.x; Nam TW, 2013, MBIO, V4, DOI 10.1128/mBio.00541-12; Nuss AM, 2009, J BACTERIOL, V191, P220, DOI 10.1128/JB.00925-08; Ogilby PR, 2010, CHEM SOC REV, V39, P3181, DOI 10.1039/b926014p; Raivio TL, 2001, ANNU REV MICROBIOL, V55, P591, DOI 10.1146/annurev.micro.55.1.591; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; SCHILKE BA, 1995, J BACTERIOL, V177, P1929, DOI 10.1128/jb.177.8.1929-1937.1995; SIMON R, 1986, METHOD ENZYMOL, V118, P640; van Niel CB, 1944, BACTERIOL REV, V8, P1; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; WILKINSON F, 1995, J PHYS CHEM REF DATA, V24, P663, DOI 10.1063/1.555965; Ziegelhoffer EC, 2009, NAT REV MICROBIOL, V7, P856, DOI 10.1038/nrmicro2237	44	18	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79520	10.1371/journal.pone.0079520	http://dx.doi.org/10.1371/journal.pone.0079520			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223961	Green Published, Green Submitted, gold			2022-12-27	WOS:000326597400070
J	Zhuchkova, E; Remme, MWH; Schreiber, S				Zhuchkova, Ekaterina; Remme, Michiel W. H.; Schreiber, Susanne			Somatic versus Dendritic Resonance: Differential Filtering of Inputs through Non-Uniform Distributions of Active Conductances	PLOS ONE			English	Article							CA1 PYRAMIDAL NEURONS; CORTEX LAYER-II; SUBTHRESHOLD MEMBRANE RESONANCE; MEDIAL ENTORHINAL CORTEX; RAT HIPPOCAMPAL-NEURONS; SQUID GIANT AXON; STELLATE CELLS; H-CURRENT; IN-VITRO; POTENTIAL OSCILLATIONS	Synaptic inputs to neurons are processed in a frequency-dependent manner, with either low-pass or resonant response characteristics. These types of filtering play a key role in the frequency-specific information flow in neuronal networks. While the generation of resonance by specific ionic conductances is well investigated, less attention has been paid to the spatial distribution of the resonance-generating conductances across a neuron. In pyramidal neurons - one of the major excitatory cell-types in the mammalian brain - a steep gradient of resonance-generating h-conductances with a 60-fold increase towards distal dendrites has been demonstrated experimentally. Because the dendritic trees of these cells are large, spatial compartmentalization of resonant properties can be expected. Here, we use mathematical descriptions of spatially extended neurons to investigate the consequences of such a distal, dendritic localization of h-conductances for signal processing. While neurons with short dendrites do not exhibit a pronounced compartmentalization of resonance, i.e. the filter properties of dendrites and soma are similar, we find that neurons with longer dendrites (similar to 1 space constant) can show distinct filtering of dendritic and somatic inputs due to electrotonic segregation. Moreover, we show that for such neurons, experimental classification as resonant versus nonresonant can be misleading when based on somatic recordings, because for these morphologies a dendritic resonance could easily be undetectable when using somatic input. Nevertheless, noise-driven membrane-potential oscillations caused by dendritic resonance can propagate to the soma where they can be recorded, hence contrasting with the low-pass filtering at the soma. We conclude that non-uniform distributions of active conductances can underlie differential filtering of synaptic input in neurons with spatially extended dendrites, like pyramidal neurons, bearing relevance for the localization-dependent targeting of synaptic input pathways to these cells.	[Zhuchkova, Ekaterina; Remme, Michiel W. H.; Schreiber, Susanne] Humboldt Univ, Inst Theoret Biol, D-10099 Berlin, Germany	Humboldt University of Berlin	Schreiber, S (corresponding author), Humboldt Univ, Inst Theoret Biol, D-10099 Berlin, Germany.	s.schreiber@hu-berlin.de		Remme, Michiel/0000-0003-0400-6074	German Federal Ministry of Education and Research [01GQ0901, 01GQ1001A, 01GQ0972]; Deutsche Forschungsgemeinschaft [SFB 618/B1, GK1589]; Einstein Foundation Berlin	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Einstein Foundation Berlin	This work was funded by the German Federal Ministry of Education and Research (01GQ0901, 01GQ1001A, 01GQ0972), Deutsche Forschungsgemeinschaft (SFB 618/B1 and GK1589), and the Einstein Foundation Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO A, 1989, NATURE, V342, P175, DOI 10.1038/342175a0; Angelo K, 2007, J NEUROSCI, V27, P8643, DOI 10.1523/JNEUROSCI.5284-06.2007; Berger T, 2001, J NEUROPHYSIOL, V85, P855, DOI 10.1152/jn.2001.85.2.855; BERNANDER O, 1994, J NEUROPHYSIOL, V72, P2743, DOI 10.1152/jn.1994.72.6.2743; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chapman CA, 1999, J NEUROPHYSIOL, V81, P1296, DOI 10.1152/jn.1999.81.3.1296; Coombes S, 2007, BIOL CYBERN, V97, P137, DOI 10.1007/s00422-007-0161-5; Dorval AD, 2005, J NEUROSCI, V25, P10025, DOI 10.1523/JNEUROSCI.3557-05.2005; Dudman JT, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000290; Engel TA, 2008, J NEUROPHYSIOL, V100, P1576, DOI 10.1152/jn.01282.2007; Erchova I, 2004, J PHYSIOL-LONDON, V560, P89, DOI 10.1113/jphysiol.2004.069930; Fernandez FR, 2008, J NEUROSCI, V28, P3790, DOI 10.1523/JNEUROSCI.5658-07.2008; Gastrein P, 2011, J PHYSIOL-LONDON, V589, P3753, DOI 10.1113/jphysiol.2011.209148; Golding NL, 2005, J PHYSIOL-LONDON, V568, P69, DOI 10.1113/jphysiol.2005.086793; Heys JG, 2010, J NEUROPHYSIOL, V104, P258, DOI 10.1152/jn.00492.2009; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hu H, 2002, J PHYSIOL-LONDON, V545, P783, DOI 10.1113/jphysiol.2002.029249; Hu H, 2009, J NEUROSCI, V29, P14472, DOI 10.1523/JNEUROSCI.0187-09.2009; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; Hutcheon B, 1996, J NEUROPHYSIOL, V76, P683, DOI 10.1152/jn.1996.76.2.683; Hutcheon B, 1996, J NEUROPHYSIOL, V76, P698, DOI 10.1152/jn.1996.76.2.698; Izhikevich EM, 2001, NEURAL NETWORKS, V14, P883, DOI 10.1016/S0893-6080(01)00078-8; Jack J.J.B., 1975, ELECT CURRENT FLOW E; KLINK R, 1993, J NEUROPHYSIOL, V70, P144, DOI 10.1152/jn.1993.70.1.144; KOCH C, 1984, BIOL CYBERN, V50, P15, DOI 10.1007/BF00317936; KOCH C, 1982, PHILOS T R SOC B, V298, P227, DOI 10.1098/rstb.1982.0084; LEUNG LWS, 1991, BRAIN RES, V553, P261, DOI 10.1016/0006-8993(91)90834-I; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Magee JC, 1998, J NEUROSCI, V18, P7613; Mainen ZF, 1996, J NEUROPHYSIOL, V76, P1904, DOI 10.1152/jn.1996.76.3.1904; MAURO A, 1970, J GEN PHYSIOL, V55, P497, DOI 10.1085/jgp.55.4.497; Narayanan R, 2007, NEURON, V56, P1061, DOI 10.1016/j.neuron.2007.10.033; Nolan MF, 2007, J NEUROSCI, V27, P12440, DOI 10.1523/JNEUROSCI.2358-07.2007; Nolan MF, 2004, CELL, V119, P719, DOI 10.1016/S0092-8674(04)01055-4; Nusser Z, 2009, TRENDS NEUROSCI, V32, P267, DOI 10.1016/j.tins.2009.01.003; Pike FG, 2000, J PHYSIOL-LONDON, V529, P205, DOI 10.1111/j.1469-7793.2000.00205.x; Rall W, 1964, NEURAL THEORY MODELI, P73; Remme MWH, 2011, J COMPUT NEUROSCI, V31, P13, DOI 10.1007/s10827-010-0295-7; Richardson MJE, 2003, J NEUROPHYSIOL, V89, P2538, DOI 10.1152/jn.00955.2002; Romand S, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00005; Roth A, 2001, J PHYSIOL-LONDON, V535, P445, DOI 10.1111/j.1469-7793.2001.00445.x; Rotstein HG, 2005, J NEUROPHYSIOL, V94, P1509, DOI 10.1152/jn.00957.2004; SABAH NH, 1969, BIOPHYS J, V9, P1206, DOI 10.1016/S0006-3495(69)86446-5; Schreiber S, 2004, J NEUROPHYSIOL, V92, P408, DOI 10.1152/jn.01116.2003; Schreiber S, 2009, J NEUROPHYSIOL, V101, P2239, DOI 10.1152/jn.90711.2008; SPAIN WJ, 1987, J NEUROPHYSIOL, V57, P1555, DOI 10.1152/jn.1987.57.5.1555; Stuart G, 1998, J NEUROSCI, V18, P3501; Ulrich D, 2002, J NEUROPHYSIOL, V87, P2753, DOI 10.1152/jn.2002.87.6.2753; Wahl-Schott C, 2009, CELL MOL LIFE SCI, V66, P470, DOI 10.1007/s00018-008-8525-0; Wang WT, 2006, NEUROSCIENCE, V140, P45, DOI 10.1016/j.neuroscience.2006.01.033; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; Williams SR, 2004, NAT NEUROSCI, V7, P961, DOI 10.1038/nn1305; Zemankovics R, 2010, J PHYSIOL-LONDON, V588, P2109, DOI 10.1113/jphysiol.2009.185975; Zhuchkova E, 2014, COMPUTING DENDRITE	54	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78908	10.1371/journal.pone.0078908	http://dx.doi.org/10.1371/journal.pone.0078908			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223864	Green Submitted, Green Published, gold			2022-12-27	WOS:000326597400042
J	Zou, RY; Zhou, K; Stephanopoulos, G; Too, HP				Zou, Ruiyang; Zhou, Kang; Stephanopoulos, Gregory; Heng Phon Too			Combinatorial Engineering of 1-Deoxy-D-Xylulose 5-Phosphate Pathway Using Cross-Lapping In Vitro Assembly (CLIVA) Method	PLOS ONE			English	Article							LIGATION-INDEPENDENT CLONING; REACTION-AMPLIFIED DNA; ESCHERICHIA-COLI; CHEMICAL-SYNTHESIS; SYNTHETIC BIOLOGY; OXIDATIVE STRESS; NATURAL-PRODUCTS; 2-C-METHYL-D-ERYTHRITOL-2,4-CYCLOPYROPHOSPHATE; BIOSYNTHESIS; ARTEMISININ	The ability to assemble multiple fragments of DNA into a plasmid in a single step is invaluable to studies in metabolic engineering and synthetic biology. Using phosphorothioate chemistry for high efficiency and site specific cleavage of sequences, a novel ligase independent cloning method (cross-lapping in vitro assembly, CLIVA) was systematically and rationally optimized in E. coli. A series of 16 constructs combinatorially expressing genes encoding enzymes in the 1-deoxy-D-xylulose 5-phosphate (DXP) pathway were assembled using multiple DNA modules. A plasmid (21.6 kb) containing 16 pathway genes, was successfully assembled from 7 modules with high efficiency (2.0 x 10(3) cfu/ mu g input DNA) within 2 days. Overexpressions of these constructs revealed the unanticipated inhibitory effects of certain combinations of genes on the production of amorphadiene. Interestingly, the inhibitory effects were correlated to the increase in the accumulation of intracellular methylerythritol cyclodiphosphate (MEC), an intermediate metabolite in the DXP pathway. The overexpression of the iron sulfur cluster operon was found to modestly increase the production of amorphadiene. This study demonstrated the utility of CLIVA in the assembly of multiple fragments of DNA into a plasmid which enabled the rapid exploration of biological pathways.	[Zou, Ruiyang; Zhou, Kang; Stephanopoulos, Gregory; Heng Phon Too] Singapore MIT Alliance, Singapore, Singapore; [Heng Phon Too] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore; [Stephanopoulos, Gregory] MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Singapore-MIT Alliance for Research & Technology Centre (SMART); National University of Singapore; Massachusetts Institute of Technology (MIT)	Too, HP (corresponding author), Singapore MIT Alliance, Singapore, Singapore.	heng-phon_too@nuhs.edu.sg	Zhou, Kang/AAI-9969-2021; Zhou, Kang/AAQ-5730-2021	Zhou, Kang/0000-0003-0606-7030	Singapore-MIT Alliance [CPE program grant]	Singapore-MIT Alliance [CPE program grant](Singapore-MIT Alliance for Research & Technology Centre (SMART))	Funding provided by Singapore-MIT Alliance http://web.mit.edu/sma/ [CPE program grant]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Barras F, 2011, METALLOMICS, V3, P1130, DOI 10.1039/c1mt00099c; Blanusa M, 2010, ANAL BIOCHEM, V406, P141, DOI 10.1016/j.ab.2010.07.011; BLOCH K, 1965, SCIENCE, V150, P19, DOI 10.1126/science.150.3692.19; Carlsen S, 2013, APPL MICROBIOL BIOT, V97, P5753, DOI 10.1007/s00253-013-4877-y; Coco WM, 2001, NAT BIOTECHNOL, V19, P354, DOI 10.1038/86744; CUNNINGHAM FX, 1994, PLANT CELL, V6, P1107, DOI 10.1105/tpc.6.8.1107; Dugar D, 2011, NAT BIOTECHNOL, V29, P1074, DOI 10.1038/nbt.2055; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Gibson DG, 2010, NAT METHODS, V7, P901, DOI 10.1038/nmeth.1515; Gibson DG, 2009, NUCLEIC ACIDS RES, V37, P6984, DOI 10.1093/nar/gkp687; GISH G, 1988, SCIENCE, V240, P1520, DOI 10.1126/science.2453926; Grey BN, 2001, APPL ENVIRON MICROB, V67, P5325, DOI 10.1128/AEM.67.11.5325-5327.2001; Hiraga K, 2003, J MOL BIOL, V330, P287, DOI 10.1016/S0022-2836(03)00590-4; Huang M, 2012, EXPERT OPIN INV DRUG, V21, P1801, DOI 10.1517/13543784.2012.727395; KALUZ S, 1992, NUCLEIC ACIDS RES, V20, P4369, DOI 10.1093/nar/20.16.4369; Keasling JD, 2012, METAB ENG, V14, P189, DOI 10.1016/j.ymben.2012.01.004; Kim SW, 2001, BIOTECHNOL BIOENG, V72, P408, DOI 10.1002/1097-0290(20000220)72:4<408::AID-BIT1003>3.0.CO;2-H; Lang BE, 2007, BIOPHYS CHEM, V131, P96, DOI 10.1016/j.bpc.2007.09.007; Li CA, 1997, NUCLEIC ACIDS RES, V25, P4165, DOI 10.1093/nar/25.20.4165; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Liu CZ, 2006, APPL MICROBIOL BIOT, V72, P11, DOI 10.1007/s00253-006-0452-0; Liu XP, 2010, PROTEIN SCI, V19, P967, DOI 10.1002/pro.374; Lutz S, 2001, P NATL ACAD SCI USA, V98, P11248, DOI 10.1073/pnas.201413698; Marienhagen J., 2012, BIOTECHNIQUES, P1, DOI [10.2144/000113865, DOI 10.2144/000113865]; Merryman C, 2012, METAB ENG, V14, P196, DOI 10.1016/j.ymben.2012.02.005; NAKAMAYE KL, 1988, NUCLEIC ACIDS RES, V16, P9947, DOI 10.1093/nar/16.21.9947; Nisson P E, 1991, PCR Methods Appl, V1, P120; Ogrel' O D, 1996, Biokhimiia, V61, P1294; Ogrel OD, 1996, CURR MICROBIOL, V32, P225, DOI 10.1007/s002849900040; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; Ostrovsky D, 1998, ARCH MICROBIOL, V171, P69, DOI 10.1007/s002030050680; Owczarzy R, 2008, BIOCHEMISTRY-US, V47, P5336, DOI 10.1021/bi702363u; Py B, 2011, CURR OPIN MICROBIOL, V14, P218, DOI 10.1016/j.mib.2011.01.004; Py B, 2010, NAT REV MICROBIOL, V8, P436, DOI 10.1038/nrmicro2356; Rabinowitz JD, 2007, ANAL CHEM, V79, P6167, DOI 10.1021/ac070470c; RASHTCHIAN A, 1992, ANAL BIOCHEM, V206, P91, DOI 10.1016/S0003-2697(05)80015-6; Rodriguez-Villalon A, 2008, J BIOTECHNOL, V135, P78, DOI 10.1016/j.jbiotec.2008.02.023; Rohmer M, 1999, NAT PROD REP, V16, P565, DOI 10.1039/a709175c; Shao ZY, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn991; Tsuruta H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004489; Tyo KEJ, 2009, NAT BIOTECHNOL, V27, P760, DOI 10.1038/nbt.1555; Villiers BRM, 2010, PROTEIN ENG DES SEL, V23, P1, DOI 10.1093/protein/gzp063; Xiao YM, 2012, CELL, V149, P1525, DOI 10.1016/j.cell.2012.04.038; Yadav VG, 2012, METAB ENG, V14, P233, DOI 10.1016/j.ymben.2012.02.001; Zhou K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047513; ZHOU MX, 1995, NUCLEIC ACIDS RES, V23, P1089, DOI 10.1093/nar/23.6.1089	48	43	48	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79557	10.1371/journal.pone.0079557	http://dx.doi.org/10.1371/journal.pone.0079557			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223968	Green Published, Green Submitted, gold			2022-12-27	WOS:000326597400072
J	Cushman, JD; Aharoni, DB; Willers, B; Ravassard, P; Kees, A; Vuong, C; Popeney, B; Arisaka, K; Mehta, MR				Cushman, Jesse D.; Aharoni, Daniel B.; Willers, Bernard; Ravassard, Pascal; Kees, Ashley; Vuong, Cliff; Popeney, Briana; Arisaka, Katsushi; Mehta, Mayank R.			Multisensory Control of Multimodal Behavior: Do the Legs Know What the Tongue Is Doing?	PLOS ONE			English	Article							HIPPOCAMPAL PLACE CELLS; VIRTUAL-NAVIGATION; PATH-INTEGRATION; SPATIAL MEMORY; MAZE PROCEDURE; RATS; SIGNALS; FIELDS; BRAIN; TASK	Understanding of adaptive behavior requires the precisely controlled presentation of multisensory stimuli combined with simultaneous measurement of multiple behavioral modalities. Hence, we developed a virtual reality apparatus that allows for simultaneous measurement of reward checking, a commonly used measure in associative learning paradigms, and navigational behavior, along with precisely controlled presentation of visual, auditory and reward stimuli. Rats performed a virtual spatial navigation task analogous to the Morris maze where only distal visual or auditory cues provided spatial information. Spatial navigation and reward checking maps showed experience-dependent learning and were in register for distal visual cues. However, they showed a dissociation, whereby distal auditory cues failed to support spatial navigation but did support spatially localized reward checking. These findings indicate that rats can navigate in virtual space with only distal visual cues, without significant vestibular or other sensory inputs. Furthermore, they reveal the simultaneous dissociation between two reward-driven behaviors.	[Cushman, Jesse D.; Aharoni, Daniel B.; Willers, Bernard; Ravassard, Pascal; Kees, Ashley; Vuong, Cliff; Popeney, Briana; Arisaka, Katsushi; Mehta, Mayank R.] Univ Calif Los Angeles, WM Keck Ctr Neurophys, Los Angeles, CA 90095 USA; [Cushman, Jesse D.; Aharoni, Daniel B.; Willers, Bernard; Ravassard, Pascal; Kees, Ashley; Arisaka, Katsushi; Mehta, Mayank R.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA USA; [Cushman, Jesse D.; Aharoni, Daniel B.; Willers, Bernard; Ravassard, Pascal; Kees, Ashley; Mehta, Mayank R.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Cushman, Jesse D.; Aharoni, Daniel B.; Willers, Bernard; Ravassard, Pascal; Kees, Ashley; Mehta, Mayank R.] Univ Calif Los Angeles, Integrat Ctr Learning & Memory, Los Angeles, CA 90024 USA; [Mehta, Mayank R.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Mehta, Mayank R.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Mehta, MR (corresponding author), Univ Calif Los Angeles, WM Keck Ctr Neurophys, Los Angeles, CA 90095 USA.	MayankMehta@ucla.edu		Mehta, Mayank/0000-0003-2005-2468; Kees, Ashley/0000-0002-1611-2803; Aharoni, Daniel/0000-0003-4931-8514; Ravassard, Pascal/0000-0002-7500-3623	National Science Foundation (NSF) [0969034]; NIH/CRCNS [1-R01-MH-092925-01]; Whitehall foundation; W. M. Keck foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092925] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); NIH/CRCNS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehall foundation; W. M. Keck foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants to MRM from the National Science Foundation (NSF) Career #0969034 (www.nsf.gov), NIH/CRCNS #1-R01-MH-092925-01 (www.nih.gov), Whitehall foundation (www.whitehall.org) and the W. M. Keck foundation (www.wmkeck.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astur RS, 1998, BEHAV BRAIN RES, V93, P185, DOI 10.1016/S0166-4328(98)00019-9; Balsam PD, 2010, COMP COGN BEHAV REV, V5, P1, DOI 10.3819/ccbr.2010.50001; Bohbot VD, 2007, J NEUROSCI, V27, P10078, DOI 10.1523/JNEUROSCI.1763-07.2007; Chen GF, 2013, P NATL ACAD SCI USA, V110, P378, DOI 10.1073/pnas.1215834110; CHENG K, 1986, COGNITION, V23, P149, DOI 10.1016/0010-0277(86)90041-7; Doeller CF, 2008, P NATL ACAD SCI USA, V105, P5915, DOI 10.1073/pnas.0801489105; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Dupret D, 2010, NAT NEUROSCI, V13, P995, DOI 10.1038/nn.2599; Eichenbaum H, 2000, CURR BIOL, V10, pR785, DOI 10.1016/S0960-9822(00)00763-6; EICHENBAUM H, 1990, J NEUROSCI, V10, P3531; Ekstrom AD, 2007, LEARN MEMORY, V14, P645, DOI 10.1101/lm.575107; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Fanselow MS, 2000, BEHAV BRAIN RES, V110, P73, DOI 10.1016/S0166-4328(99)00186-2; Gallistel C. R., 1990, ORG LEARNING; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; HEFFNER RS, 1992, J COMP NEUROL, V317, P219, DOI 10.1002/cne.903170302; Hollup SA, 2001, EUR J NEUROSCI, V13, P1197, DOI 10.1046/j.0953-816x.2001.01487.x; Holscher C, 2005, J EXP BIOL, V208, P561, DOI 10.1242/jeb.01371; Howard I. P., 1966, HUMAN SPATIAL ORIENT; Ito R, 2006, EUR J NEUROSCI, V23, P3071, DOI 10.1111/j.1460-9568.2006.04883.x; Jacobs WJ, 1997, LEARN MOTIV, V28, P521, DOI 10.1006/lmot.1997.0977; Keller GB, 2012, NEURON, V74, P809, DOI 10.1016/j.neuron.2012.03.040; MACKINTOSH NJ, 1976, ANIM LEARN BEHAV, V4, P186, DOI 10.3758/BF03214033; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; Mehta MR, 1997, EXPANSION SHIFT HIPP; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Muller RU, 1999, HIPPOCAMPUS, V9, P413, DOI 10.1002/(SICI)1098-1063(1999)9:4<413::AID-HIPO7>3.0.CO;2-#; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Pan WX, 2013, NAT NEUROSCI, V16, P71, DOI 10.1038/nn.3283; Pearce JM, 2002, ANIM LEARN BEHAV, V30, P73, DOI 10.3758/BF03192911; PETERSON GB, 1972, SCIENCE, V177, P1009, DOI 10.1126/science.177.4053.1009; Ravassard P KA, 2013, SCIENCE IN PRESS; Rossier J, 2000, BEHAV BRAIN RES, V117, P209, DOI 10.1016/S0166-4328(00)00293-X; RUDY JW, 1989, BEHAV BRAIN RES, V34, P97, DOI 10.1016/S0166-4328(89)80093-2; SCHULTZ W, 1992, J NEUROSCI, V12, P4595, DOI 10.1523/jneurosci.12-12-04595.1992; SUTHERLAND RJ, 1984, CAN J PSYCHOL, V38, P322, DOI 10.1037/h0080832; Talsma D, 2010, TRENDS COGN SCI, V14, P400, DOI 10.1016/j.tics.2010.06.008; WELCH RB, 1980, PSYCHOL BULL, V88, P638, DOI 10.1037/0033-2909.88.3.638; White NM, 2002, NEUROBIOL LEARN MEM, V77, P125, DOI 10.1006/nlme.2001.4008; Youngstrom IA, 2012, LEARN MEMORY, V19, P84, DOI 10.1101/lm.023523.111	44	28	28	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e80465	10.1371/journal.pone.0080465	http://dx.doi.org/10.1371/journal.pone.0080465			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	245ZC	24224054	Green Published, gold			2022-12-27	WOS:000326503400156
J	Murakoshi, M; Saiki, K; Urayama, K; Sato, TN				Murakoshi, Motoaki; Saiki, Kyohei; Urayama, Kyoji; Sato, Thomas N.			An Anthelmintic Drug, Pyrvinium Pamoate, Thwarts Fibrosis and Ameliorates Myocardial Contractile Dysfunction in a Mouse Model of Myocardial Infarction	PLOS ONE			English	Article							FUMARATE REDUCTASE; ANTITUMOR-ACTIVITY; CARDIAC FIBROSIS; ANGIOTENSIN; INHIBITION; METABOLISM; ACTIVATION; TARGETS; GROWTH; CELLS	Metabolic adaptation to limited supplies of oxygen and nutrients plays a pivotal role in health and disease. Heart attack results from insufficient delivery of oxygen and nutrients to the heart, where cardiomyocytes die and cardiac fibroblasts proliferate - the latter causing scar formation, which impedes regeneration and impairs contractility of the heart. We postulated that cardiac fibroblasts survive metabolic stress by adapting their intracellular metabolism to low oxygen and nutrients, and impeding this metabolic adaptation would thwart their survival and facilitate the repair of scarred heart. Herein, we show that an anthelmintic drug, Pyrvinium pamoate, which has been previously shown to compromise cancer cell survival under glucose starvation condition, also disables cardiac fibroblast survival specifically under glucose deficient condition. Furthermore, Pyrvinium pamoate reduces scar formation and improves cardiac contractility in a mouse model of myocardial infarction. As Pyrvinium pamoate is an FDA-approved drug, our results suggest a therapeutic use of this or other related drugs to repair scarred heart and possibly other organs.	[Murakoshi, Motoaki; Saiki, Kyohei; Urayama, Kyoji; Sato, Thomas N.] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan; [Sato, Thomas N.] Cornell Univ, Dept Biomed Engn, Ithaca, NY USA; [Sato, Thomas N.] Centenary Inst, Sydney, NSW, Australia	Nara Institute of Science & Technology; Cornell University; University of Sydney; Centenary Institute	Sato, TN (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan.	island1005@bs.naist.jp			JSPS [22229007, 24790758]; Takeda Science Foundation; Grants-in-Aid for Scientific Research [24790758] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI S Grant Number 22229007 (T.N.S.), Takeda Science Foundation (T.N.S.), JSPS KAKENHI Young Scientists (B) Grant Number 24790758 (K.U.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chun MGH, 2013, NAT BIOTECHNOL, V31, P505, DOI 10.1038/nbt.2611; De Mello WC, 2006, J RENIN-ANGIO-ALDO S, V7, P201, DOI 10.3317/jraas.2006.038; Deng L, 2013, DROSOPHILA INF SERV, V4, pe614; Esumi H, 2004, CANCER SCI, V95, P685, DOI 10.1111/j.1349-7006.2004.tb03330.x; Harada Y, 2012, CANCER LETT, V319, P83, DOI 10.1016/j.canlet.2011.12.034; Hu J, 2013, NAT BIOTECHNOL, V31, P522, DOI 10.1038/nbt.2530; Ikeda Y, 2005, J BIOL CHEM, V280, P29661, DOI 10.1074/jbc.M411694200; Ishii I, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00137; Jones JO, 2008, ACS CHEM BIOL, V3, P412, DOI 10.1021/cb800054w; Jones JO, 2009, P NATL ACAD SCI USA, V106, P7233, DOI 10.1073/pnas.0807282106; Kobayashi K, 2009, NAT CELL BIOL, V11, P46, DOI 10.1038/ncb1811; Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737; Ma L, 2013, CELL, V152, P599, DOI 10.1016/j.cell.2012.12.028; Sakai C, 2012, BBA-GEN SUBJECTS, V1820, P643, DOI 10.1016/j.bbagen.2011.12.013; Saraswati S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015521; Shibasaki Y, 2005, HYPERTENS RES, V28, P787, DOI 10.1291/hypres.28.787; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; Tomitsuka E, 2012, J BIOCHEM, V152, P171, DOI 10.1093/jb/mvs041; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; Visconti RP, 2002, P NATL ACAD SCI USA, V99, P8219, DOI 10.1073/pnas.122109599; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Yu DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003951	22	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79374	10.1371/journal.pone.0079374	http://dx.doi.org/10.1371/journal.pone.0079374			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223934	gold, Green Published, Green Submitted			2022-12-27	WOS:000326503400108
J	Ryan, MA; Whisson, DA; Holland, GJ; Arnould, JPY				Ryan, Michelle A.; Whisson, Desley A.; Holland, Greg J.; Arnould, John P. Y.			Activity Patterns of Free-Ranging Koalas (Phascolarctos cinereus) Revealed by Accelerometry	PLOS ONE			English	Article							METABOLIC-RATE; BEHAVIOR; CAPTIVITY; GOLDFUSS; TIME; ACCELERATION; POPULATIONS; CONSUMPTION; WATER; SIZE	An understanding of koala activity patterns is important for measuring the behavioral response of this species to environmental change, but to date has been limited by the logistical challenges of traditional field methodologies. We addressed this knowledge gap by using tri-axial accelerometer data loggers attached to VHF radio collars to examine activity patterns of adult male and female koalas in a high-density population at Cape Otway, Victoria, Australia. Data were obtained from 27 adult koalas over two 7-d periods during the breeding season: 12 in the early-breeding season in November 2010, and 15 in the late-breeding season in January 2011. Multiple 15 minute observation blocks on each animal were used for validation of activity patterns determined from the accelerometer data loggers. Accelerometry was effective in distinguishing between inactive (sleeping, resting) and active (grooming, feeding and moving) behaviors. Koalas were more active during the early-breeding season with a higher index of movement (overall dynamic body acceleration [ODBA]) for both males and females. Koalas showed a distinct temporal pattern of behavior, with most activity occurring from mid-afternoon to early morning. Accelerometry has potential for examining fine-scale behavior of a wide range of arboreal and terrestrial species.	[Ryan, Michelle A.; Whisson, Desley A.; Holland, Greg J.; Arnould, John P. Y.] Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Burwood, Vic, Australia	Deakin University	Whisson, DA (corresponding author), Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Burwood, Vic, Australia.	desley.whisson@deakin.edu.au	Whisson, Desley/V-9422-2019; Holland, Greg/K-9303-2013; Whisson, Desley A/H-9578-2013	Whisson, Desley/0000-0002-4221-0706; Whisson, Desley A/0000-0002-4221-0706				Benesch AR, 2010, BIOL RHYTHM RES, V41, P289, DOI 10.1080/09291010903018164; Charlton BD, 2012, ANIM COGN, V15, P999, DOI 10.1007/s10071-012-0527-5; Comport SS, 1996, WILDLIFE RES, V23, P401, DOI 10.1071/WR9960401; Cooper AR, 2010, AM J PREV MED, V38, P178, DOI 10.1016/j.amepre.2009.10.036; Core R Team, 2012, R LANG ENV STAT COMP; CORK SJ, 1983, J COMP PHYSIOL, V153, P181, DOI 10.1007/BF00689622; DEGABRIELE R, 1979, J COMP PHYSIOL, V134, P293, DOI 10.1007/BF00709996; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Ellis W, 2011, BEHAV ECOL, V22, P372, DOI 10.1093/beheco/arq216; Ellis W., 2010, Australian Zoologist, V35, P369; Halsey LG, 2009, PHYSIOL BIOCHEM ZOOL, V82, P396, DOI 10.1086/589815; Halsey LG, 2009, COMP BIOCHEM PHYS A, V152, P197, DOI 10.1016/j.cbpa.2008.09.021; HINDELL MA, 1985, AUST WILDLIFE RES, V12, P137; Jackson S., 1994, KOALA PHASCOLARCTOS; Jacobi D, 2009, EUR J EPIDEMIOL, V24, P171, DOI 10.1007/s10654-009-9329-8; Johansson HP, 2006, BRIT J NUTR, V95, P631, DOI 10.1079/BJN20051527; Kokubun N, 2011, J EXP BIOL, V214, P3760, DOI 10.1242/jeb.058263; Kotler BP, 2010, P ROY SOC B-BIOL SCI, V277, P1469, DOI 10.1098/rspb.2009.2036; Kronfeld-Schor N, 2003, ANNU REV ECOL EVOL S, V34, P153, DOI 10.1146/annurev.ecolsys.34.011802.132435; Larrucea ES, 2009, J MAMMAL, V90, P1176, DOI 10.1644/08-MAMM-A-272.1; Logan M, 2003, AUST J ZOOL, V51, P415, DOI 10.1071/ZO03017; Logan M, 2002, AUST J ZOOL, V50, P281, DOI 10.1071/ZO01022; Marsh KJ, 2007, OECOLOGIA, V154, P283, DOI 10.1007/s00442-007-0828-6; McLean N, 2006, AUST J ZOOL, V54, P385, DOI 10.1071/ZO06015; Melzer A, 2000, CONSERV BIOL, V14, P619, DOI 10.1046/j.1523-1739.2000.99383.x; Mitchell P., 1990, P151; Moore BD, 2005, BIOL LETT-UK, V1, P64, DOI 10.1098/rsbl.2004.0255; NAGY KA, 1985, AUST J ZOOL, V33, P655, DOI 10.1071/ZO9850655; Papailiou A, 2008, AM J PRIMATOL, V70, P185, DOI 10.1002/ajp.20476; SMITH M, 1980, AUST WILDLIFE RES, V7, P41; SMITH M, 1979, AUST WILDLIFE RES, V6, P117; SMITH M, 1979, AUST WILDLIFE RES, V6, P131; SMITH M, 1980, AUST WILDLIFE RES, V7, P13; SMITH M, 1980, AUST WILDLIFE RES, V7, P35; Stephens D.W., 1986, pi; Taborsky M, 2010, ETHOLOGY, V116, P185, DOI 10.1111/j.1439-0310.2010.01751.x; Takahashi M, 2009, ZOO BIOL, V28, P59, DOI 10.1002/zoo.20212; ULLREY DE, 1981, AUST J ZOOL, V29, P847, DOI 10.1071/ZO9810847; Weimerskirch H, 2005, P ROY SOC B-BIOL SCI, V272, P53, DOI 10.1098/rspb.2004.2918; Whisson DA, 2010, J MAMMAL, V91, P1160, DOI 10.1644/09-MAMM-A-384.1; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zuur Alain F., 2009, P1	43	20	20	5	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e80366	10.1371/journal.pone.0080366	http://dx.doi.org/10.1371/journal.pone.0080366			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24224050	Green Published, gold, Green Submitted			2022-12-27	WOS:000326503400154
J	Xu, CH; Wang, M; Zhou, L; Quan, TY; Xia, GM				Xu, Chunhui; Wang, Meng; Zhou, Li; Quan, Taiyong; Xia, Guangmin			Heterologous Expression of the Wheat Aquaporin Gene TaTIP2;2 Compromises the Abiotic Stress Tolerance of Arabidopsis thaliana	PLOS ONE			English	Article							PLASMA-MEMBRANE AQUAPORINS; INTRINSIC PROTEINS MIPS; ABSCISIC-ACID; SALT TOLERANCE; FUNCTIONAL-ANALYSIS; PLANT AQUAPORINS; RESPONSIVE GENE; CROSS-TALK; DROUGHT; FAMILY	Aquaporins are channel proteins which transport water across cell membranes. We show that the bread wheat aquaporin gene TaTIP2;2 maps to the long arm of chromosome 7b and that its product localizes to the endomembrane system. The gene is expressed constitutively in both the root and the leaf, and is down-regulated by salinity and drought stress. Salinity stress induced an increased level of C-methylation within the CNG trinucleotides in the TaTIP2; 2 promoter region. The heterologous expression of TaTIP2; 2 in Arabidopsis thaliana compromised its drought and salinity tolerance, suggesting that TaTIP2; 2 may be a negative regulator of abiotic stress. The proline content of transgenic A. thaliana plants fell, consistent with the down-regulation of P5CS1, while the expression of SOS1, SOS2, SOS3, CBF3 and DREB2A, which are all stress tolerance-related genes acting in an ABA-independent fashion, was also down-regulated. The supply of exogenous ABA had little effect either on TaTIP2; 2 expression in wheat or on the phenotype of transgenic A. thaliana. The expression level of the ABA signalling genes ABI1, ABI2 and ABF3 remained unaltered in the transgenic A. thaliana plants. Thus TaTIP2; 2 probably regulates the response to stress via an ABA-independent pathway(s).	[Xu, Chunhui; Wang, Meng; Zhou, Li; Quan, Taiyong; Xia, Guangmin] Shandong Univ, Sch Life Sci, Key Lab Plant Cell Engn & Germplasm Innovat, Minist Educ, Jinan, Shandong, Peoples R China	Shandong University	Xia, GM (corresponding author), Shandong Univ, Sch Life Sci, Key Lab Plant Cell Engn & Germplasm Innovat, Minist Educ, Jinan, Shandong, Peoples R China.	xiagm@sdu.edu.cn			National Transgenic Project of China [20011ZX08002-002]; National Basic Research 973 Program of China [2012CB114200]; Natural Science Foundation of China [30530480]; National Science Foundation of China [91117006]	National Transgenic Project of China; National Basic Research 973 Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Transgenic Project (20011ZX08002-002) of China, National Basic Research 973 Program of China (2012CB114200), the funds of the Major Program of the Natural Science Foundation of China (no. 30530480), and National Science Foundation of China (grant no. 91117006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon R, 2003, PLANT CELL, V15, P439, DOI 10.1105/tpc.009225; Aroca R, 2006, ANN BOT-LONDON, V98, P1301, DOI 10.1093/aob/mcl219; Ayadi M, 2011, PLANT PHYSIOL BIOCH, V49, P1029, DOI 10.1016/j.plaphy.2011.06.002; Barrieu F, 1998, PLANT PHYSIOL, V117, P1153, DOI 10.1104/pp.117.4.1153; Beebo A, 2009, PLANT MOL BIOL, V70, P193, DOI 10.1007/s11103-009-9465-2; Bienert GP, 2007, J BIOL CHEM, V282, P1183, DOI 10.1074/jbc.M603761200; Boudsocq M, 2005, PLANT PHYSIOL, V138, P1185, DOI 10.1104/pp.105.061275; Boursiac Y, 2005, PLANT PHYSIOL, V139, P790, DOI 10.1104/pp.105.065029; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chaumont F, 2000, PLANT PHYSIOL, V122, P1025, DOI 10.1104/pp.122.4.1025; Chaumont F, 2001, PLANT PHYSIOL, V125, P1206, DOI 10.1104/pp.125.3.1206; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Danielson JAH, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-45; De Amicis F, 2007, TRANSGENIC RES, V16, P731, DOI 10.1007/s11248-006-9063-x; Forrest KL, 2008, FUNCT INTEGR GENOMIC, V8, P115, DOI 10.1007/s10142-007-0065-4; Forrest KL, 2007, FUNCT INTEGR GENOMIC, V7, P263, DOI 10.1007/s10142-007-0049-4; Gao YP, 1999, PLANT MOL BIOL, V40, P635, DOI 10.1023/A:1006212216876; Gao ZX, 2010, PLANT CELL PHYSIOL, V51, P767, DOI 10.1093/pcp/pcq036; Gattolin S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-133; Gosti F, 1999, PLANT CELL, V11, P1897, DOI 10.1105/tpc.11.10.1897; Halfter U, 2000, P NATL ACAD SCI USA, V97, P3735, DOI 10.1073/pnas.040577697; Heymann JB, 1999, NEWS PHYSIOL SCI, V14, P187; Hoagland DR, 1938, WATER CULTURE METHOD, P7; Hu W, 2012, PLANT CELL PHYSIOL, V53, P2127, DOI 10.1093/pcp/pcs154; Jahn TP, 2004, FEBS LETT, V574, P31, DOI 10.1016/j.febslet.2004.08.004; Jakab G, 2005, PLANT PHYSIOL, V139, P267, DOI 10.1104/pp.105.065698; Jang JY, 2004, PLANT MOL BIOL, V54, P713, DOI 10.1023/B:PLAN.0000040900.61345.a6; Kaldenhoff R, 2006, BBA-BIOMEMBRANES, V1758, P1134, DOI 10.1016/j.bbamem.2006.03.012; Kang JY, 2002, PLANT CELL, V14, P343, DOI 10.1105/tpc.010362; Kawaura Kanako, 2006, Functional & Integrative Genomics, V6, P132, DOI 10.1007/s10142-005-0010-3; LANG V, 1992, PLANT MOL BIOL, V20, P951, DOI 10.1007/BF00027165; Li CL, 2010, PLANT PHYSIOL, V154, P211, DOI 10.1104/pp.110.161182; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li SO, 2010, PLANT CELL ENVIRON, V33, P117, DOI 10.1111/j.1365-3040.2009.02063.x; Lian HL, 2004, PLANT CELL PHYSIOL, V45, P481, DOI 10.1093/pcp/pch058; Lian HL, 2006, CELL RES, V16, P651, DOI 10.1038/sj.cr.7310068; Liu C, 2012, PLANT MOL BIOL, V78, P159, DOI 10.1007/s11103-011-9854-1; Liu JP, 1997, P NATL ACAD SCI USA, V94, P14960, DOI 10.1073/pnas.94.26.14960; Mariaux JB, 1998, PLANT MOL BIOL, V38, P1089, DOI 10.1023/A:1006013130681; Maurel C, 2007, FEBS LETT, V581, P2227, DOI 10.1016/j.febslet.2007.03.021; Merlot S, 2001, PLANT J, V25, P295, DOI 10.1046/j.1365-313x.2001.00965.x; Nongpiur R, 2012, PLANT SIGNAL BEHAV, V7, P1230, DOI 10.4161/psb.21516; Oh SJ, 2005, PLANT PHYSIOL, V138, P341, DOI 10.1104/pp.104.059147; Peng YH, 2007, PLANTA, V226, P729, DOI 10.1007/s00425-007-0520-4; Peng ZY, 2009, MOL CELL PROTEOMICS, V8, P2676, DOI 10.1074/mcp.M900052-MCP200; Sade N, 2009, NEW PHYTOL, V181, P651, DOI 10.1111/j.1469-8137.2008.02689.x; Sakuma Y, 2006, PLANT CELL, V18, P1292, DOI 10.1105/tpc.105.035881; Sakurai J, 2005, PLANT CELL PHYSIOL, V46, P1568, DOI 10.1093/pcp/pci172; Schussler MD, 2008, PLANT J, V56, P756, DOI 10.1111/j.1365-313X.2008.03632.x; Sears E.R., 1954, MISSOURI AGR EXP STA, V572, P1; Shi HZ, 2000, P NATL ACAD SCI USA, V97, P6896, DOI 10.1073/pnas.120170197; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; STEINITZSEARS LM, 1957, GENETICS, V42, P623; Suga S, 2002, PLANT CELL PHYSIOL, V43, P1229, DOI 10.1093/pcp/pcf148; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; TROLL W, 1955, J BIOL CHEM, V215, P655; Tyerman SD, 2002, PLANT CELL ENVIRON, V25, P173, DOI 10.1046/j.0016-8025.2001.00791.x; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; Wu SJ, 1996, PLANT CELL, V8, P617, DOI 10.1105/tpc.8.4.617; Xia GM, 2003, THEOR APPL GENET, V107, P299, DOI 10.1007/s00122-003-1247-7; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang J, 2006, FIELD CROPS RES, V97, P9; Zhang J, 2013, ACTA BIOCH BIOPH SIN, V45, P104, DOI 10.1093/abbs/gms096; Zhou SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052439; Zhu CF, 2005, J EXP BOT, V56, P2971, DOI 10.1093/jxb/eri294; Zhu JK, 2000, PLANT PHYSIOL, V124, P941, DOI 10.1104/pp.124.3.941; Zhu JK, 1998, PLANT CELL, V10, P1181, DOI 10.1105/tpc.10.7.1181	68	44	50	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79618	10.1371/journal.pone.0079618	http://dx.doi.org/10.1371/journal.pone.0079618			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223981	Green Submitted, Green Published, gold			2022-12-27	WOS:000326503400131
J	Chen, W; Wang, W; Zhu, BB; Guo, H; Sun, Y; Ming, J; Shen, N; Li, Z; Wang, ZL; Liu, LF; Cai, BX; Duan, JY; Li, JY; Liu, C; Zhong, R; Hu, WG; Huang, T; Miao, XP				Chen, Wei; Wang, Wei; Zhu, Beibei; Guo, Hui; Sun, Yu; Ming, Jie; Shen, Na; Li, Zhi; Wang, Zhenling; Liu, Lifeng; Cai, Bingxi; Duan, Jiayu; Li, Jiaoyuan; Liu, Cheng; Zhong, Rong; Hu, Weiguo; Huang, Tao; Miao, Xiaoping			A Functional Variant rs1820453 in YAP1 and Breast Cancer Risk in Chinese Population	PLOS ONE			English	Article							YES-ASSOCIATED PROTEIN; TUMOR-SUPPRESSOR; P73; HETEROZYGOSITY; SUSCEPTIBILITY	Background: To investigate the association between rs1820453 which located in the promoter region of yes-associated protein 1 (YAP1) gene and breast cancer (BC) risk. Method and Findings: We conducted a hospital-based case-control study including a total of 480 BC cases and 545 cancer-free controls in Chinese population. Then the expression quantitative trait locus (e-QTL) analysis was performed to explore the possible function of rs1820453 to the YAP1 gene expression. The association between rs1820453 and BC risk was significantly identified with the odds ratio (OR) was 1.27 (95 % confidence interval (CI)=1.03-1.57) under allelic model when adjusted by age and menopausal status. In addition, the correlation analysis of rs1820453 and YAP1 expression level found that this variant was significantly associated with the gene expression in Chinese population. When compared with level of mRNA expression of the AA genotype (6.011 +/- 0.046), the mRNA expression level in CC genotype (5.903 +/- 0.026) was statistically lower (P=0.024). Conclusion: The results from this study suggested that rs1820453 A>C change may affect the gene expression and contribute to the risk of developing BC in Chinese population though larger sample-size studies along with functional experiments were anticipated to warrant the results.	[Chen, Wei; Zhu, Beibei; Sun, Yu; Shen, Na; Wang, Zhenling; Liu, Lifeng; Cai, Bingxi; Duan, Jiayu; Li, Jiaoyuan; Liu, Cheng; Zhong, Rong; Miao, Xiaoping] Huazhong Univ Sci & Technol, Minist Environm Protect, Minist Educ,Key Lab Environm & Hlth, State Key Lab Environm Hlth Incubat,Key Lab Envir, Wuhan 430074, Peoples R China; [Chen, Wei; Zhu, Beibei; Sun, Yu; Shen, Na; Wang, Zhenling; Liu, Lifeng; Cai, Bingxi; Duan, Jiayu; Li, Jiaoyuan; Liu, Cheng; Zhong, Rong; Miao, Xiaoping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China; [Wang, Wei; Guo, Hui; Ming, Jie; Li, Zhi; Huang, Tao] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Breast & Thyroid Surg, Wuhan 430074, Peoples R China; [Wang, Wei] Hubei Canc Hosp, Dept Breast Surg, Wuhan, Peoples R China; [Hu, Weiguo] Wuhan Univ, Renmin Hosp, Dept Oncol, Wuhan 430072, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Wuhan University	Miao, XP (corresponding author), Huazhong Univ Sci & Technol, Minist Environm Protect, Minist Educ,Key Lab Environm & Hlth, State Key Lab Environm Hlth Incubat,Key Lab Envir, Wuhan 430074, Peoples R China.	huangtaowh@163.com; miaoxp@mail.hust.edu.cn	Duan, Jiayu/HCI-7247-2022; 李, 娇元/GVS-6952-2022; miao, xiaoping/C-4336-2011; Zhong, Rong/Q-1813-2019	miao, xiaoping/0000-0002-6818-9722; Duan, Jiayu/0000-0001-6311-5938	National Natural Science Foundation of China [81001171, 81202094]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grants 81001171 and 81202094). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniou AC, 2006, ONCOGENE, V25, P5898, DOI 10.1038/sj.onc.1209879; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; CARTER SL, 1994, CANCER RES, V54, P6270; Chen W, 2012, BREAST CANCER RES TR, V136, P847, DOI 10.1007/s10549-012-2309-9; Danovi SA, 2008, CELL DEATH DIFFER, V15, P217, DOI 10.1038/sj.cdd.4402226; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Espanel X, 2001, J BIOL CHEM, V276, P14514, DOI 10.1074/jbc.M008568200; Holm K, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-600; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Lapi E, 2008, MOL CELL, V32, P803, DOI 10.1016/j.molcel.2008.11.019; Levy D, 2007, CELL DEATH DIFFER, V14, P743, DOI 10.1038/sj.cdd.4402063; Liu L, 2011, BREAST CANCER RES TR, V125, P479, DOI 10.1007/s10549-010-0959-z; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; Ponder BAJ, 2000, BRIT J CANCER, V83, P1301; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Strano S, 2005, MOL CELL, V18, P447, DOI 10.1016/j.molcel.2005.04.008; Strano S, 2001, J BIOL CHEM, V276, P15164, DOI 10.1074/jbc.M010484200; TOMLINSON IPM, 1995, J CLIN PATHOL, V48, P424, DOI 10.1136/jcp.48.5.424; Wu C, 2010, CANCER RES, V70, P9721, DOI 10.1158/0008-5472.CAN-10-1493; Yuan M, 2008, CELL DEATH DIFFER, V15, P1752, DOI 10.1038/cdd.2008.108	20	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79056	10.1371/journal.pone.0079056	http://dx.doi.org/10.1371/journal.pone.0079056			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223879	gold, Green Submitted, Green Published			2022-12-27	WOS:000326499300049
J	Novick, PA; Ortiz, OF; Poelman, J; Abdulhay, AY; Pande, VS				Novick, Paul A.; Ortiz, Oscar F.; Poelman, Jared; Abdulhay, Amir Y.; Pande, Vijay S.			SWEETLEAD: an In Silico Database of Approved Drugs, Regulated Chemicals, and Herbal Isolates for Computer-Aided Drug Discovery	PLOS ONE			English	Article							THALIDOMIDE; INTEGRATION; DESIGN	In the face of drastically rising drug discovery costs, strategies promising to reduce development timelines and expenditures are being pursued. Computer-aided virtual screening and repurposing approved drugs are two such strategies that have shown recent success. Herein, we report the creation of a highly-curated in silico database of chemical structures representing approved drugs, chemical isolates from traditional medicinal herbs, and regulated chemicals, termed the SWEETLEAD database. The motivation for SWEETLEAD stems from the observance of conflicting information in publicly available chemical databases and the lack of a highly curated database of chemical structures for the globally approved drugs. A consensus building scheme surveying information from several publicly accessible databases was employed to identify the correct structure for each chemical. Resulting structures are filtered for the active pharmaceutical ingredient, standardized, and differing formulations of the same drug were combined in the final database. The publically available release of SWEETLEAD (https://simtk.org/home/sweetlead) provides an important tool to enable the successful completion of computer-aided repurposing and drug discovery campaigns.	[Novick, Paul A.; Ortiz, Oscar F.; Pande, Vijay S.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Poelman, Jared] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Abdulhay, Amir Y.] Ithaca Coll, Dept Biol, Ithaca, NY 14850 USA; [Pande, Vijay S.] Stanford Univ, Biophys Program, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Novick, PA (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	pnovick@stanford.edu	Pande, Vijay/ABE-8145-2020		Simbios via the NIH Roadmap for Medical Research Grant [U54 GM072970]; SPARK Translational Research Program; National Center for Research Resources; National Center for Advancing Translational Sciences, National Institutes of Health [UL1 TR000093, UL1 RR025744]; Center for Molecular Analysis and Design (CMAD), Stanford University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000093] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM072970] Funding Source: NIH RePORTER	Simbios via the NIH Roadmap for Medical Research Grant; SPARK Translational Research Program; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Center for Molecular Analysis and Design (CMAD), Stanford University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank the following funding sources: 1) Simbios via the NIH Roadmap for Medical Research Grant U54 GM072970; 2) SPARK Translational Research Program. http://sparkmed.stanford.edu/; 3) National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through UL1 TR000093 (formerly UL1 RR025744); and, 4) PAN was supported by the Center for Molecular Analysis and Design (CMAD), Stanford University, https://chemistry.stanford.edu/CMAD_%20symposium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu M, 2007, J OBSTET GYNAECOL, V27, P438, DOI 10.1080/01443610701359621; Bolton EE, 2010, ANN REP COMP CHEM, V4, P217, DOI 10.1016/S1574-1400(08)00012-1; Boolell M, 1996, Int J Impot Res, V8, P47; Degtyarenko K, 2008, NUCLEIC ACIDS RES, V36, pD344, DOI 10.1093/nar/gkm791; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Dudley JT, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002648; Dudley JT, 2011, BRIEF BIOINFORM, V12, P303, DOI 10.1093/bib/bbr013; Girke T, 2005, PLANT PHYSIOL, V138, P573, DOI 10.1104/pp.105.062687; Guido RVC, 2008, CURR MED CHEM, V15, P37; Hewett M, 2002, NUCLEIC ACIDS RES, V30, P163, DOI 10.1093/nar/30.1.163; Huang RL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001862; Hurle MR, 2013, CLIN PHARMACOL THER, V93, P335, DOI 10.1038/clpt.2013.1; IYER CGS, 1971, B WORLD HEALTH ORGAN, V45, P719; Kanehisa M, 1997, TRENDS GENET, V13, P375, DOI 10.1016/S0168-9525(97)01223-7; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Knox C, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P145; Liu Z, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-172; Lounkine E, 2012, NATURE, V486, P361, DOI 10.1038/nature11159; McGann M, 2012, J COMPUT AID MOL DES, V26, P897, DOI 10.1007/s10822-012-9584-8; Morgan S, 2011, HEALTH POLICY, V100, P4, DOI 10.1016/j.healthpol.2010.12.002; Moriaud F, 2011, BRIEF BIOINFORM, V12, P336, DOI 10.1093/bib/bbr017; Oda A, 2006, J CHEM INF MODEL, V46, P380, DOI 10.1021/ci050283k; Paul S, 2010, NAT REV DRUG DISCOV, V12; Paul T, 2006, 2006 IEEE C EV COMP, P8; Pence HE, 2010, J CHEM EDUC, V87, P1123, DOI 10.1021/ed100697w; Schneider G, 2005, NAT REV DRUG DISCOV, V4, P649, DOI 10.1038/nrd1799; Shen ZX, 1997, BLOOD, V89, P3354, DOI 10.1182/blood.V89.9.3354; Singhal S, 1999, NEW ENGL J MED, V341, P1565, DOI 10.1056/NEJM199911183412102; Sundar S, 2007, NEW ENGL J MED, V356, P2571, DOI 10.1056/NEJMoa066536; Teachey DT, 2009, BRIT J HAEMATOL, V145, P101, DOI 10.1111/j.1365-2141.2009.07595.x; Wall ME, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002284; Walters WP, 1998, DRUG DISCOV TODAY, V3, P160, DOI 10.1016/S1359-6446(97)01163-X; Warren GL, 2012, DRUG DISCOV TODAY, V17, P1270, DOI 10.1016/j.drudis.2012.06.011; Wikipedia contributors, 2013, LIST DRUGS; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Xu K, 2011, BRIEF BIOINFORM, V12, P341, DOI 10.1093/bib/bbr006	36	59	59	5	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79568	10.1371/journal.pone.0079568	http://dx.doi.org/10.1371/journal.pone.0079568			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223973	gold, Green Published, Green Submitted			2022-12-27	WOS:000326499300091
J	Robert, MC; Furlan, G; Rosso, N; Gambaro, SE; Apitsionak, F; Vianello, E; Tiribelli, C; Gazzin, S				Robert, Maria Celeste; Furlan, Giulia; Rosso, Natalia; Gambaro, Sabrina Eliana; Apitsionak, Faina; Vianello, Eleonora; Tiribelli, Claudio; Gazzin, Silvia			Alterations in the Cell Cycle in the Cerebellum of Hyperbilirubinemic Gunn Rat: A Possible Link with Apoptosis?	PLOS ONE			English	Article							BILIRUBIN INDUCES APOPTOSIS; POLY(ADP-RIBOSE) POLYMERASE; PROTEOLYTIC CLEAVAGE; CORTICAL-NEURONS; NERVOUS-SYSTEM; ANIMAL-MODEL; HYPOPLASIA; TOXICITY; ENCEPHALOPATHY; KERNICTERUS	Severe hyperbilirubinemia causes neurological damage both in humans and rodents. The hyperbilirubinemic Gunn rat shows a marked cerebellar hypoplasia. More recently bilirubin ability to arrest the cell cycle progression in vascular smooth muscle, tumour cells, and, more importantly, cultured neurons has been demonstrated. However, the involvement of cell cycle perturbation in the development of cerebellar hypoplasia was never investigated before. We explored the effect of sustained spontaneous hyperbilirubinemia on cell cycle progression and apoptosis in whole cerebella dissected from 9 day old Gunn rat by Real Time PCR, Western blot and FACS analysis. The cerebellum of the hyperbilirubinemic Gunn rats exhibits an increased cell cycle arrest in the late G0/G1 phase (p < 0.001), characterized by a decrease in the protein expression of cyclin D1 (15%, p < 0.05), cyclin A/A1 (20 and 30%, p < 0.05 and 0.01, respectively) and cyclin dependent kinases2 (25%, p < 0.001). This was associated with a marked increase in the 18 kDa fragment of cyclin E (67%, p < 0.001) which amplifies the apoptotic pathway. In line with this was the increase of the cleaved form of Poly (ADP-ribose) polymerase (54%, p < 0.01) and active Caspase3 (two fold, p < 0.01). These data indicate that the characteristic cerebellar alteration in this developing brain structure of the hyperbilirubinemic Gunn rat may be partly due to cell cycle perturbation and apoptosis related to the high bilirubin concentration in cerebellar tissue mainly affecting granular cells. These two phenomena might be intimately connected.	[Robert, Maria Celeste; Furlan, Giulia; Rosso, Natalia; Gambaro, Sabrina Eliana; Apitsionak, Faina; Vianello, Eleonora; Tiribelli, Claudio; Gazzin, Silvia] Fdn Italiana Fegato, Ctr Studi Fegato, Trieste, Italy; [Tiribelli, Claudio] Univ Trieste, Dept Med Sci, Trieste, Italy	University of Trieste	Gazzin, S (corresponding author), Fdn Italiana Fegato, Ctr Studi Fegato, Trieste, Italy.	silvia.gazzin@csf.units.it	Rosso, Natalia/K-9035-2016; Tiribelli, Claudio/A-4716-2014; Vianello, Eleonora/Y-2458-2018	Rosso, Natalia/0000-0002-4251-3547; Tiribelli, Claudio/0000-0001-6596-7595; Vianello, Eleonora/0000-0003-0342-4055	Italian Ministry of Foreign Affairs, Rome, Italy; Italian Liver Foundation; Regione Friuli Venezia Giulia [Fondo Regionale FVG LR26/2005]; Telethon [GGP10051]	Italian Ministry of Foreign Affairs, Rome, Italy; Italian Liver Foundation; Regione Friuli Venezia Giulia(Regione Friuli Venezia Giulia); Telethon(Fondazione Telethon)	MCR and SEG were supported by a PhD fellowship from the Italian Ministry of Foreign Affairs, Rome, Italy. SG, NR were supported by a in house grant of the Italian Liver Foundation. The work was supported by grants from Regione Friuli Venezia Giulia [Fondo Regionale FVG LR26/2005] and from Telethon (GGP10051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHDABBARMADA M, 1984, J NEUROPATH EXP NEUR, V43, P45, DOI 10.1097/00005072-198401000-00004; Ahlfors CE, 2000, ANAL BIOCHEM, V279, P130, DOI 10.1006/abio.2000.4485; Ahlfors CE, 2001, BIOL NEONATE, V80, P158, DOI 10.1159/000047136; BOOHER J, 1972, Neurobiology (Copenhagen), V2, P97; Boon AC, 2012, FREE RADICAL BIO MED, V52, P2120, DOI 10.1016/j.freeradbiomed.2012.03.002; Brito MA, 2004, BRAIN RES, V1026, P33, DOI 10.1016/j.brainres.2004.07.063; Brito MA, 2012, J CHILD NEUROL, V27, P615, DOI 10.1177/0883073811423975; Bulmer AC, 2013, PROG LIPID RES, V52, P193, DOI 10.1016/j.plipres.2012.11.001; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Calligaris R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-543; Calligaris S, 2006, FEBS LETT, V580, P1355, DOI 10.1016/j.febslet.2006.01.056; Calligaris SD, 2007, PEDIATR RES, V62, P576, DOI 10.1203/PDR.0b013e3181568c94; CHOWDHURY JR, 1993, ADV VET SCI COMP MED, V37, P149; Clarke DJ, 1997, CLIN CHIM ACTA, V266, P63, DOI 10.1016/S0009-8981(97)00167-8; Conlee JW, 1997, ACTA NEUROPATHOL, V93, P450, DOI 10.1007/s004010050639; Daood MJ, 2006, PEDIATR RES, V60, P44, DOI 10.1203/01.pdr.0000219561.07550.04; Deganuto M, 2010, PROTEOMICS, V10, P1645, DOI 10.1002/pmic.200900579; EHRLICH P, 1883, CENTR KLIN MED, V4, P721; Falcao AS, 2007, J NEUROSCI RES, V85, P1229, DOI 10.1002/jnr.21227; Falcao AS, 2006, ACTA NEUROPATHOL, V112, P95, DOI 10.1007/s00401-006-0078-4; Falcao AS, 2013, NEUROCHEM RES, V38, P644, DOI 10.1007/s11064-012-0963-2; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; GAZZIN S, 2012, PEDIAT RES UNPUB; Gazzin S, 2008, J COMP NEUROL, V510, P497, DOI 10.1002/cne.21808; Gazzin S, 2012, PEDIATR RES, V71, P653, DOI 10.1038/pr.2012.23; Gazzin S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016165; Geng Y, 1999, CELL, V97, P767, DOI 10.1016/S0092-8674(00)80788-6; Giraudi PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029078; Grojean S, 2000, EXP NEUROL, V166, P334, DOI 10.1006/exnr.2000.7518; Gunn CH, 1938, J HERED, V29, P137, DOI 10.1093/oxfordjournals.jhered.a104478; Heinlein C., 2011, CURR PROTOC CYTOM, V7, DOI DOI 10.1002/0471142956.CY0739S56.PUBMED:21455969; Heinlein C, 2010, CELL CYCLE, V9, P3584, DOI 10.4161/cc.9.17.12831; HUANG PWH, 1970, ARCH PATHOL, V90, P536; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Lee YK, 2009, PEDIATR INT, V51, P795, DOI 10.1111/j.1442-200X.2009.02878.x; Mazumder S, 2002, MOL CELL BIOL, V22, P2398, DOI 10.1128/MCB.22.7.2398-2409.2002; Mazumder S, 2007, CELL CYCLE, V6, P1437; Mazumder S, 2007, MOL CELL BIOL, V27, P3511, DOI 10.1128/MCB.01448-06; McDonald JW, 1998, EXP NEUROL, V150, P21, DOI 10.1006/exnr.1997.6762; MIKOSHIBA K, 1982, J NEUROCHEM, V39, P1028, DOI 10.1111/j.1471-4159.1982.tb11492.x; MIKOSHIBA K, 1980, J NEUROCHEM, V35, P1309, DOI 10.1111/j.1471-4159.1980.tb09003.x; Mitchell PJ, 2007, J NEUROSCI METH, V164, P350, DOI 10.1016/j.jneumeth.2007.04.021; Ollinger R, 2007, CELL CYCLE, V6, P3078, DOI 10.4161/cc.6.24.5022; Ollinger R, 2007, CELL CYCLE, V6, P39, DOI 10.4161/cc.6.1.3700; Ollinger R, 2005, CIRCULATION, V112, P1030, DOI 10.1161/CIRCULATIONAHA.104.528802; Ostrow JD, 2007, TRANSL RES, V149, P37, DOI 10.1016/j.trsl.2006.07.006; Ostrow JD, 2003, PEDIATR RES, V54, P926, DOI 10.1203/01.PDR.0000103388.01854.91; Peyton KJ, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00048; Plesca D, 2008, J BIOL CHEM, V283, P30796, DOI 10.1074/jbc.M804642200; Porter DC, 2001, MOL CELL BIOL, V21, P6254, DOI 10.1128/MCB.21.18.6254-6269.2001; Rao P, 2006, BIOCHEM BIOPH RES CO, V342, P1279, DOI 10.1016/j.bbrc.2006.02.074; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Roca L, 2006, PEDIATR RES, V60, P724, DOI 10.1203/01.pdr.0000245992.89965.94; Rodrigues CMP, 2002, J LIPID RES, V43, P885; Rodrigues CMP, 2002, HEPATOLOGY, V35, P1186, DOI 10.1053/jhep.2002.32967; Rodrigues CMP, 2002, PEDIATR RES, V51, P112, DOI 10.1203/00006450-200201000-00020; SAWASAKI Y, 1973, P JPN ACAD, V49, P840, DOI 10.2183/pjab1945.49.840; SAWASAKI Y, 1976, J NEUROCHEM, V27, P577, DOI 10.1111/j.1471-4159.1976.tb12285.x; SCHUTTA HS, 1967, J NEUROPATH EXP NEUR, V26, P377, DOI 10.1097/00005072-196707000-00003; Servedio V, 2005, HUM MUTAT, V25, DOI 10.1002/humu.9322; Shapiro SM, 2010, SEMIN FETAL NEONAT M, V15, P157, DOI 10.1016/j.siny.2009.12.004; Silva RFM, 2002, PEDIATR RES, V51, P535, DOI 10.1203/00006450-200204000-00022; Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968; Soldani C, 2001, EXP CELL RES, V269, P193, DOI 10.1006/excr.2001.5293; Stoeckius M, 2012, J BIOL CHEM, V287, P15418, DOI 10.1074/jbc.M111.266510; Tabarki B, 2002, PEDIATR NEUROL, V27, P234, DOI 10.1016/S0887-8994(02)00425-3; TAKAGISHI Y, 1989, BRAIN RES, V492, P116, DOI 10.1016/0006-8993(89)90894-9; Vance JE, 2005, SEMIN CELL DEV BIOL, V16, P193, DOI 10.1016/j.semcdb.2005.01.005; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vaz AR, 2010, J NEUROCHEM, V112, P56, DOI 10.1111/j.1471-4159.2009.06429.x; Volpe JJ, 2009, J CHILD NEUROL, V24, P1085, DOI 10.1177/0883073809338067; Wallner M, 2013, CLIN SCI, V125, P257, DOI 10.1042/CS20120661; Wingate H, 2003, CELL CYCLE, V2, P461, DOI 10.4161/cc.2.5.464; Yamamura H, 1993, Nagoya J Med Sci, V55, P11; YEARY RA, 1971, LAB ANIM SCI, V21, P362; Zelenka J, 2008, J CHROMATOGR B, V867, P37, DOI 10.1016/j.jchromb.2008.03.005	76	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79073	10.1371/journal.pone.0079073	http://dx.doi.org/10.1371/journal.pone.0079073			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223883	gold, Green Published, Green Submitted			2022-12-27	WOS:000326499300053
J	Sun, HW; Leng, TD; Zeng, Z; Gao, XR; Inoue, K; Xiong, ZG				Sun, Huawei; Leng, Tiandong; Zeng, Zhao; Gao, Xiuren; Inoue, Koichi; Xiong, Zhi-Gang			Role of TRPM7 Channels in Hyperglycemia-Mediated Injury of Vascular Endothelial Cells	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; HIGH GLUCOSE; OXIDATIVE STRESS; NEURONAL DEATH; SMOOTH-MUSCLE; KEY ROLE; DYSFUNCTION; EXPRESSION; DISEASE; KINASE	This study investigated the change of transient receptor potential melastatin 7 (TRPM7) expression by high glucose and its role in hyperglycemia induced injury of vascular endothelial cells. Human umbilical vein endothelial cells (HUVECs) were incubated in the presence or absence of high concentrations of D-glucose (HG) for 72h. RT-PCR, Real-time PCR, Western blotting, Immunofluorescence staining and whole-cell patch-clamp recordings showed that TRPM7 mRNA, TRPM7 protein expression and TRPM7-like currents were increased in HUVECs following exposure to HG. In contrast to D-glucose, exposure of HUVECs to high concentrations of L-glucose had no effect. HG increased reactive oxygen species (ROS) generation, cytotoxicity and decreased endothelial nitric oxide synthase protein expression, which could be attenuated by knockdown of TRPM7 with TRPM7 siRNA. The protective effect of silencing TRPM7 against HG induced endothelial injury was abolished by U0126, an inhibitor of the extracellular signal-regulated kinase signaling pathway. These observations suggest that TRPM7 channels play an important role in hyperglycemia-induced injury of vascular endothelial cells.	[Sun, Huawei; Gao, Xiuren] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou 510275, Guangdong, Peoples R China; [Sun, Huawei; Leng, Tiandong; Zeng, Zhao; Inoue, Koichi; Xiong, Zhi-Gang] Morehouse Sch Med, Inst Neurosci, Atlanta, GA 30310 USA	Sun Yat Sen University; Morehouse School of Medicine	Gao, XR (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou 510275, Guangdong, Peoples R China.	xiurengao@163.com; ZXiong@msm.edu			National Institute of Health [R01NS066027]; National Institute on Minority Health and Health Disparities [S21MD000101, U54RR026137]; American Heart Association [0840132N]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066027] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Health (R01NS066027), The National Institute on Minority Health and Health Disparities (S21MD000101, U54RR026137), and American Heart Association (0840132N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Ametov AS, 2012, TERAPEVT ARKH, V84, P91; Baldoli E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059891; Becerra A, 2011, CARDIOVASC RES, V91, P677, DOI 10.1093/cvr/cvr135; Beech DJ, 2005, CLIN EXP PHARMACOL P, V32, P597, DOI 10.1111/j.1440-1681.2005.04251.x; Brinkmann C, 2011, WIEN MED WOCHENSCHR, V161, P305, DOI 10.1007/s10354-011-0868-8; BUSCONI L, 1995, MOL PHARMACOL, V47, P655; Cheang WS, 2011, CARDIOVASC RES, V92, P267, DOI 10.1093/cvr/cvr233; Chen HC, 2012, BIOCHEM J, V445, P441, DOI 10.1042/BJ20120248; Dhar I, 2012, J PHARMACOL EXP THER, V342, P196, DOI 10.1124/jpet.112.192112; Dietrich A, 2006, PHARMACOL THERAPEUT, V112, P744, DOI 10.1016/j.pharmthera.2006.05.013; Fisslthaler B, 2008, CIRC RES, V102, P1520, DOI 10.1161/CIRCRESAHA.108.172072; Fulton D, 2008, CIRC RES, V102, P497, DOI 10.1161/CIRCRESAHA.107.162933; Ha HJ, 2000, KIDNEY INT, V58, pS19, DOI 10.1046/j.1523-1755.2000.07704.x; Hecquet CM, 2010, ADV EXP MED BIOL, V661, P155, DOI 10.1007/978-1-60761-500-2_10; Heikkinen M, 2007, EUR J VASC ENDOVASC, V33, P583, DOI 10.1016/j.ejvs.2007.01.012; Ho FM, 1999, J CELL BIOCHEM, V75, P258, DOI 10.1002/(SICI)1097-4644(19991101)75:2<258::AID-JCB8>3.0.CO;2-3; Ho FM, 2000, CIRCULATION, V101, P2618, DOI 10.1161/01.CIR.101.22.2618; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Inoue K, 2004, FEBS LETT, V564, P131, DOI 10.1016/S0014-5793(04)00328-X; Inoue K, 2004, GENES CELLS, V9, P59, DOI 10.1111/j.1356-9597.2004.00707.x; Inoue K, 2009, CARDIOVASC RES, V83, P547, DOI 10.1093/cvr/cvp153; Jiang J, 2007, CANCER RES, V67, P10929, DOI 10.1158/0008-5472.CAN-07-1121; Kwan HY, 2007, BBA-MOL BASIS DIS, V1772, P907, DOI 10.1016/j.bbadis.2007.02.013; Li MH, 2010, J PHYSIOL-LONDON, V588, P3883, DOI 10.1113/jphysiol.2010.192922; Lum H, 2001, AM J PHYSIOL-CELL PH, V280, pC719; Madonna R, 2011, VASC PHARMACOL, V54, P68, DOI 10.1016/j.vph.2011.03.005; Miller BA, 2011, ADV EXP MED BIOL, V704, P531, DOI 10.1007/978-94-007-0265-3_29; Noyman I, 2002, NITRIC OXIDE-BIOL CH, V7, P187, DOI 10.1016/S1089-8603(02)00106-4; Oancea E, 2006, CIRC RES, V98, P245, DOI 10.1161/01.RES.0000200179.29375.cc; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Sansbury BE, 2012, CIRC RES, V111, P1176, DOI [10.1161/circresaha.112.266395, 10.1161/CIRCRESAHA.112.266395]; Sasaki S, 2012, DIABETES METAB J, V36, P255, DOI 10.4093/dmj.2012.36.4.255; Shehata M, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-7; Su LT, 2010, J MOL BIOL, V396, P858, DOI 10.1016/j.jmb.2010.01.014; Sumi D, 2003, P NATL ACAD SCI USA, V100, P14451, DOI 10.1073/pnas.2235590100; Sun HS, 2009, NAT NEUROSCI, V12, P1300, DOI 10.1038/nn.2395; Sun JX, 2002, P NATL ACAD SCI USA, V99, P13108, DOI 10.1073/pnas.202260999; Tousoulis Dimitris, 2011, Recent Pat Cardiovasc Drug Discov, V6, P103; Wuensch T, 2010, DIABETES, V59, P844, DOI 10.2337/db09-1100; Yao XQ, 2005, CIRC RES, V97, P853, DOI 10.1161/01.RES.0000187473.85419.3e; Yuen DA, 2012, J AM SOC NEPHROL, V23, P1810, DOI 10.1681/ASN.2011121170; Zhu MM, 2012, ANESTH ANALG, V114, P303, DOI 10.1213/ANE.0b013e31823f0c42	43	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79540	10.1371/journal.pone.0079540	http://dx.doi.org/10.1371/journal.pone.0079540			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223965	Green Submitted, gold, Green Published			2022-12-27	WOS:000326499300088
J	Harcus, D; Dignard, D; Lepine, G; Askew, C; Raymond, M; Whiteway, M; Wu, CL				Harcus, Doreen; Dignard, Daniel; Lepine, Guylaine; Askew, Chris; Raymond, Martine; Whiteway, Malcolm; Wu, Cunle			Comparative Xylose Metabolism among the Ascomycetes C. albicans, S. stipitis and S. cerevisiae	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CANDIDA-ALBICANS; PICHIA-STIPITIS; GENE DISRUPTION; PENTOSE UTILIZATION; GLUCOSE REPRESSION; ETHANOL-PRODUCTION; FERMENTATION; REDUCTASE; STRAINS	The ascomycetes Candida albicans, Saccharomyces cerevisiae and Scheffersomyces stipitis metabolize the pentose sugar xylose very differently. S. cerevisiae fails to grow on xylose, while C. albicans can grow, and S. stipitis can both grow and ferment xylose to ethanol. However, all three species contain highly similar genes that encode potential xylose reductases and xylitol dehydrogenases required to convert xylose to xylulose, and xylulose supports the growth of all three fungi. We have created C. albicans strains deleted for the xylose reductase gene GRE3, the xylitol dehydrogenase gene XYL2, as well as the gre3 xyl2 double mutant. As expected, all the mutant strains cannot grow on xylose, while the single gre3 mutant can grow on xylitol. The gre3 and xyl2 mutants are efficiently complemented by the XYL1 and XYL2 from S. stipitis. Intriguingly, the S. cerevisiae GRE3 gene can complement the Cagre3 mutant, while the ScSOR1 gene can complement the Caxyl2 mutant, showing that S. cerevisiae contains the enzymatic capacity for converting xylose to xylulose. In addition, the gre3 xyl2 double mutant of C. albicans is effectively rescued by the xylose isomerase (XI) gene of either Piromyces or Orpinomyces, suggesting that the XI provides an alternative to the missing oxido-reductase functions in the mutant required for the xylose-xylulose conversion. Overall this work suggests that C. albicans strains engineered to lack essential steps for xylose metabolism can provide a platform for the analysis of xylose metabolism enzymes from a variety of species, and confirms that S. cerevisiae has the genetic potential to convert xylose to xylulose, although non-engineered strains cannot proliferate on xylose as the sole carbon source.	[Harcus, Doreen; Dignard, Daniel; Whiteway, Malcolm; Wu, Cunle] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada; [Lepine, Guylaine] Hop Maison Neuve Rosemont, Montreal, PQ H1T 2M4, Canada; [Askew, Chris; Whiteway, Malcolm] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Raymond, Martine] Univ Montreal, Inst Rech Immunol & Cancerol, Montreal, PQ, Canada; [Whiteway, Malcolm] Concordia Univ, Dept Biol, Montreal, PQ H3G 1M8, Canada; [Wu, Cunle] McGill Univ, Dept Med, Div Expt Med, Montreal, PQ, Canada	National Research Council Canada; Universite de Montreal; McGill University; Universite de Montreal; Concordia University - Canada; McGill University	Whiteway, M (corresponding author), Natl Res Council Canada, Biotechnol Res Inst, 6100 Royalmount Ave, Montreal, PQ H4P 2R2, Canada.	Malcolm.whiteway@concordia.ca; cunle.wu@cnrc-nrc.gc.ca			Canadian Institutes of Health Research (CIHR) [MOP42516, CTP79843]; Agricultural Bioproducts Innovation Program (ABIP)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Agricultural Bioproducts Innovation Program (ABIP)	This work was supported by grants from the Canadian Institutes of Health Research (CIHR) to MW (MOP42516) and MW and MR (CTP79843), and from the Agricultural Bioproducts Innovation Program (ABIP). This is NRC publication 49551. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askew C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000612; Bera AK, 2011, J IND MICROBIOL BIOT, V38, P617, DOI 10.1007/s10295-010-0806-6; Bettiga M, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-40; Brachmann CB, 1998, YEAST, V14, P115; Brat D, 2009, APPL ENVIRON MICROB, V75, P2304, DOI 10.1128/AEM.02522-08; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; DENG X X, 1990, Applied Biochemistry and Biotechnology, V24-25, P193, DOI 10.1007/BF02920245; Dignard D, 2006, EUKARYOT CELL, V5, P192, DOI 10.1128/EC.5.1.192-202.2006; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Ha SJ, 2011, P NATL ACAD SCI USA, V108, P504, DOI 10.1073/pnas.1010456108; Hahn-Hagerdal B, 2007, ADV BIOCHEM ENG BIOT, V108, P147, DOI 10.1007/10_2007_062; Jeffries TW, 2007, NAT BIOTECHNOL, V25, P319, DOI 10.1038/nbt1290; Jeffries TW, 2006, CURR OPIN BIOTECH, V17, P320, DOI 10.1016/j.copbio.2006.05.008; Jeffries TW, 2009, FEMS YEAST RES, V9, P793, DOI 10.1111/j.1567-1364.2009.00525.x; Kay J, 1987, KREBS CITRIC ACID CY; Laluce C, 2012, APPL BIOCHEM BIOTECH, V166, P1908, DOI 10.1007/s12010-012-9619-6; Leandro MJ, 2009, FEMS YEAST RES, V9, P511, DOI 10.1111/j.1567-1364.2009.00509.x; LELOIR LF, 1951, ARCH BIOCHEM BIOPHYS, V33, P186, DOI 10.1016/0003-9861(51)90096-3; Liang L, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-36; Nantel A, 2006, MICROARRAYS STUDYING; Noble SM, 2005, EUKARYOT CELL, V4, P298, DOI 10.1128/EC.4.2.298-309.2005; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Saha BC, 2003, J IND MICROBIOL BIOT, V30, P279, DOI 10.1007/s10295-003-0049-x; Saitoh S, 2011, APPL MICROBIOL BIOT, V91, P1553, DOI 10.1007/s00253-011-3357-5; Schwartz K, 2012, GENETICS, V191, P621, DOI 10.1534/genetics.112.140053; Tripathi G, 2002, EMBO J, V21, P5448, DOI 10.1093/emboj/cdf507; TRUMBLY RJ, 1992, MOL MICROBIOL, V6, P15, DOI 10.1111/j.1365-2958.1992.tb00832.x; van Maris AJA, 2007, ADV BIOCHEM ENG BIOT, V108, P179, DOI 10.1007/10_2007_057; van Maris AJA, 2006, ANTON LEEUW INT J G, V90, P391, DOI 10.1007/s10482-006-9085-7; Van Vleet JH, 2009, CURR OPIN BIOTECH, V20, P300, DOI 10.1016/j.copbio.2009.06.001; Verho R, 2003, APPL ENVIRON MICROB, V69, P5892, DOI 10.1128/AEM.69.10.5892-5897.2003; Walfridsson M, 1996, APPL ENVIRON MICROB, V62, P4648, DOI 10.1128/AEM.62.12.4648-4651.1996; Watanabe S, 2007, MICROBIOL-SGM, V153, P3044, DOI 10.1099/mic.0.2007/007856-0; Watanabe S, 2007, BIOSCI BIOTECH BIOCH, V71, P1365, DOI 10.1271/bbb.70104; Wenger JW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000942; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Wohlbach DJ, 2011, P NATL ACAD SCI USA, V108, P13212, DOI 10.1073/pnas.1103039108	38	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80733	10.1371/journal.pone.0080733	http://dx.doi.org/10.1371/journal.pone.0080733			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236198	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700201
J	Li, L; Yan, HF				Li, Lin; Yan, Haifei			A Remarkable New Species of Liparis (Orchidaceae) from China and Its Phylogenetic Implications	PLOS ONE			English	Article							EPIDENDROIDEAE; MALAXIDINAE; MORPHOLOGY; GENUS	In the present study, we formally describe Liparis pingxiangensis as a new species from Guangxi, China on the basis of morphological and molecular phylogenetic analyses. It is easily distinguished from closely related species by strongly curved column without column wings, and broadly rhombic-elliptic lip with 2 uncinate calli at the base. In particular, it differs most markedly from its congeners in possessing two pollinia attached by long and prominent caudicles (not stipes), to a distinct sticky disc. This type of pollinarium, as far as we know, is not found in any other species of Liparis, and is also unique among the orchids with waxy pollinia. We then proceeded to a phylogenetic analysis to ascertain the systematic position of this enigmatic species. Molecular study based on nuclear ribosomal ITS and plastid matK DNA sequence data supports L. pingxiangensis as a distinct species, which forms an independent lineage sister to L. nervosa and its allies (93% BS, 1.00 BPP). In the light of previous work, the findings have important implications for a better understanding of the well-supported pattern mainly based on vegetative features in Malaxideae.	[Li, Lin; Yan, Haifei] Chinese Acad Sci, Key Lab Plant Resources Conservat & Sustainable U, South China Bot Garden, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS	Yan, HF (corresponding author), Chinese Acad Sci, Key Lab Plant Resources Conservat & Sustainable U, South China Bot Garden, Guangzhou, Guangdong, Peoples R China.	yanhaifei@scbg.ac.cn	Li, Lin/J-6925-2019	Li, Lin/0000-0001-7091-9686	National Natural Science Foundation of China [31100149]; Doctoral Fund for Scientific Research of South China Botanical Garden, CAS [201007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund for Scientific Research of South China Botanical Garden, CAS	This study was financially supported by the National Natural Science Foundation of China (31100149) and Doctoral Fund for Scientific Research of South China Botanical Garden, CAS (201007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, ORCHIDEE; [Anonymous], 1992, ORCHIDS PENINSULAR M; Cameron KM, 2005, AM J BOT, V92, P1025, DOI 10.3732/ajb.92.6.1025; Chen S.C., 2009, FLORA CHINA, V25, P211; Comber J. B., 1990, ORCHIDS JAVA; Darlu P, 2002, MOL BIOL EVOL, V19, P432, DOI 10.1093/oxfordjournals.molbev.a004098; Doyle J. J., 1987, PHYTOCHEM B, P11; Dressler R.L., 1981, ORCHIDS NATURAL HIST; Dressler RL, 1993, PHYLOGENY CLASSIFICA; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Freudenstein JV, 1999, AM J BOT, V86, P225, DOI 10.2307/2656939; IUCN, 2012, IUCN RED LIST CATEGO, V2nd ed., P32; Jones DL, 2004, ORCHADIAN, V15, P33; Jones DL, 2004, ORCHADIAN SCI S, V14, P1; Liu ZJ, 2008, J SYST EVOL, V46, P622, DOI 10.3724/SP.J.1002.2008.08082; Margonska HB, 2001, ANN BOT FENN, V38, P77; Ohi-Toma Tetsuo, 2007, APG Acta Phytotaxonomica et Geobotanica, V58, P105; Pearce N R, 2002, FLORA BHUTAN 3, V3, P195; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pridgeon A.M., 2005, GENERA ORCHIDACEARUM, V4, P453; Pridgeon Alec M., 1997, Lindleyana, V12, P89; Pridgeon AM, 2001, AM J BOT, V88, P2286, DOI 10.2307/3558390; Rambaut A, 2007, SE AL SEQUENCE ALIGN; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SEIDENFADEN G, 1976, DAN BOT ARK, V31, P5; Singer Rodrigo B., 2008, Selbyana, V29, P6; SUN Y, 1994, THEOR APPL GENET, V89, P26, DOI 10.1007/BF00226978; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Szlachetko DL, 2008, ACTA SOC BOT POL, V77, P35; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsutsumi C, 2007, J PLANT RES, V120, P405, DOI 10.1007/s10265-007-0077-0; van den Berg C, 2005, AM J BOT, V92, P613, DOI 10.3732/ajb.92.4.613; Whitten WM, 2000, AM J BOT, V87, P1842, DOI 10.2307/2656837	34	19	20	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78112	10.1371/journal.pone.0078112	http://dx.doi.org/10.1371/journal.pone.0078112			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236013	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700010
J	Suzuki, H; Takaku, Y; Ohta, I; Ishii, D; Muranaka, Y; Shimomura, M; Hariyama, T				Suzuki, Hiroshi; Takaku, Yasuharu; Ohta, Isao; Ishii, Daisuke; Muranaka, Yoshinori; Shimomura, Masatsugu; Hariyama, Takahiko			In Situ Preparation of Biomimetic Thin Films and Their Surface-Shielding Effect for Organisms in High Vacuum	PLOS ONE			English	Article								Self-standing biocompatible films have yet to be prepared by physical or chemical vapor deposition assisted by plasma polymerization because gaseous monomers have thus far been used to create only polymer membranes. Using a nongaseous monomer, we previously found a simple fabrication method for a free-standing thin film prepared from solution by plasma polymerization, and a nano-suit made by polyoxyethylene (20) sorbitan monolaurate can render multicellular organisms highly tolerant to high vacuum. Here we report thin films prepared by plasma polymerization from various monomer solutions. The films had a flat surface at the irradiated site and were similar to films produced by vapor deposition of gaseous monomers. However, they also exhibited unique characteristics, such as a pinhole-free surface, transparency, solvent stability, flexibility, and a unique out-of-plane molecular density gradient from the irradiated to the unirradiated surface of the film. Additionally, covering mosquito larvae with the films protected the shape of the organism and kept them alive under the high vacuum conditions in a field emission-scanning electron microscope. Our method will be useful for numerous applications, particularly in the biological sciences.	[Suzuki, Hiroshi] Hamamatsu Univ, Sch Med, Dept Chem, Higashi Ku, Hamamatsu, Shizuoka 4312102, Japan; [Takaku, Yasuharu; Hariyama, Takahiko] Hamamatsu Univ, Sch Med, Dept Biol, Higashi Ku, Hamamatsu, Shizuoka 4312102, Japan; [Ohta, Isao; Muranaka, Yoshinori] Hamamatsu Univ, Sch Med, Res Equipment Ctr, Higashi Ku, Hamamatsu, Shizuoka 4312102, Japan; [Ishii, Daisuke] Nagoya Inst Technol, Ctr Fostering Young & Innovat Res, Showa Ku, Nagoya, Aichi, Japan; [Shimomura, Masatsugu] Tohoku Univ, World Premier Int Inst Mat Res, Aoba Ku, Sendai, Miyagi 980, Japan; [Shimomura, Masatsugu] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 980, Japan; [Takaku, Yasuharu; Ishii, Daisuke; Shimomura, Masatsugu; Hariyama, Takahiko] CREST, Japan Sci & Technol Agcy, Kawaguchi, Saitama, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Nagoya Institute of Technology; Tohoku University; Tohoku University; Japan Science & Technology Agency (JST)	Hariyama, T (corresponding author), Hamamatsu Univ, Sch Med, Dept Biol, Higashi Ku, Hamamatsu, Shizuoka 4312102, Japan.	hariyama@hama-med.ac.jp			Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency	Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST))	The authors gratefully acknowledge funding from the Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232; Decher G, 2011, MULTILAYER THIN FILM; Frank-Finney RJ, 2012, MACROMOLECULES, V45, P165, DOI 10.1021/ma202268J; FRIDMAN A, 2008, PLASMA CHEM; Friedrich J, 2011, PLASMA PROCESS POLYM, V8, P783, DOI 10.1002/ppap.201100038; Jiang CY, 2004, ADV MATER, V16, P157, DOI 10.1002/adma.200306010; Kumar C, 2010, FREE STANDING NANOFI; Kumar DS, 2003, J APPL POLYM SCI, V90, P1102, DOI 10.1002/app.12803; Kumar SA, 2010, BIOCOMPATIBLE NANOMA; Mitzi DB, 2004, NATURE, V428, P299, DOI 10.1038/nature02389; Orosco MM, 2009, NAT NANOTECHNOL, V4, P255, DOI [10.1038/nnano.2009.11, 10.1038/NNANO.2009.11]; Pierson H.O., 1999, HDB CHEM VAPOR DEPOS, Vsecond; Quinn JF, 2012, J AM CHEM SOC, V134, P19808, DOI 10.1021/ja308716v; Smith DL., 1995, THIN FILM DEPOSITION; Takaku Y, 2013, P NATL ACAD SCI USA, V110, P7631, DOI 10.1073/pnas.1221341110; YASUDA H, 1981, MACROMOL REV, V16, P199	16	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78563	10.1371/journal.pone.0078563	http://dx.doi.org/10.1371/journal.pone.0078563			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236023	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700020
J	Zhang, WH; Mi, ZQ; Yin, XY; Fan, H; An, XP; Zhang, ZY; Chen, JK; Tong, YG				Zhang, Wenhui; Mi, Zhiqiang; Yin, Xiuyun; Fan, Hang; An, Xiaoping; Zhang, Zhiyi; Chen, Jiankui; Tong, Yigang			Characterization of Enterococcus faecalis Phage IME-EF1 and Its Endolysin	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; STREPTOCOCCUS-PNEUMONIAE; BACTERIOPHAGE PHI-EF24C; DIABETIC FOOT; LYTIC ENZYMES; TRNASCAN-SE; CELL-WALL; INFECTIONS; VIRULENCE; RESISTANCE	Enterococcus faecalis is increasingly becoming an important nosocomial infection opportunistic pathogen. E. faecalis can easily obtain drug resistance, making it difficult to be controlled in clinical settings. Using bacteriophage as an alternative treatment to drug-resistant bacteria has been revitalized recently, especially for fighting drug-resistant bacteria. In this research, an E. faecalis bacteriophage named IME-EF1 was isolated from hospital sewage. Whole genomic sequence analysis demonstrated that the isolated IME-EF1 belong to the Siphoviridae family, and has a linear double-stranded DNA genome consisting of 57,081 nucleotides. The IME-EF1 genome has a 40.04% G+C content and contains 98 putative coding sequences. In addition, IME-EF1 has an isometric head with a width of 35 nm to 60 nm and length of 75 nm to 90 nm, as well as morphology resembling a tadpole. IME-EF1 can adsorb to its host cells within 9 min, with an absorbance rate more than 99% and a latent period time of 25 min. The endolysin of IME-EF1 contains a CHAP domain in its N-terminal and has a wider bactericidal spectrum than its parental bacteriophage, including 2 strains of vancomycin-resistant E. faecalis. When administrated intraperitoneally, one dose of IME-EF1 or its endolysin can reduce bacterial count in the blood and protected the mice from a lethal challenge of E. faecalis, with a survival rate of 60% or 80%, respectively. Although bacteriophage could rescue mice from bacterial challenge, to the best of our knowledge, this study further supports the potential function of bacteriophage in dealing with E. faecalis infection in vivo. The results also indicated that the newly isolated bacteriophage IME-EF1 enriched the arsenal library of lytic E. faecalis bacteriophages and presented another choice for phage therapy in the future.	[Zhang, Wenhui; Mi, Zhiqiang; Fan, Hang; An, Xiaoping; Zhang, Zhiyi; Tong, Yigang] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Yin, Xiuyun; Chen, Jiankui] Affiliated Hosp, Acad Mil Med Sci, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Academy of Military Medical Sciences - China	Chen, JK (corresponding author), Affiliated Hosp, Acad Mil Med Sci, Beijing, Peoples R China.	chenjiankui@hotmail.com; tong62035@gmail.com	Fan, Hang/AAA-8489-2022	Tong, Yigang/0000-0002-8503-8045; Fan, Hang/0000-0002-7927-1684	National Natural Science Foundation of China [81072350, 81072250]; China Mega-Project on Major Drug Development [2011ZX09401-023]; China Mega-Project on Infectious Disease Prevention [2011ZX10004-001]; State Key Laboratory of Pathogen and BioSecurity Program [SKLPBS1113]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Mega-Project on Major Drug Development; China Mega-Project on Infectious Disease Prevention; State Key Laboratory of Pathogen and BioSecurity Program	This research was supported by grants from the National Natural Science Foundation of China (No. 81072350, 81072250), the China Mega-Project on Major Drug Development (No. 2011ZX09401-023), the China Mega-Project on Infectious Disease Prevention (No. 2011ZX10004-001), and the State Key Laboratory of Pathogen and BioSecurity Program (No. SKLPBS1113). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MH, 1950, METHODS STUDY BACTER; Amyes SGB, 2007, INT J ANTIMICROB AG, V29, pS43, DOI 10.1016/S0924-8579(07)72177-5; Arias CA, 2010, CLIN MICROBIOL INFEC, V16, P555, DOI 10.1111/j.1469-0691.2010.03214.x; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bateman A, 2003, TRENDS BIOCHEM SCI, V28, P234, DOI 10.1016/S0968-0004(03)00061-6; Brede DA, 2011, J BACTERIOL, V193, P2377, DOI 10.1128/JB.00183-11; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; Carlton Richard M., 1999, Archivum Immunologiae et Therapiae Experimentalis, V47, P267; CHOW JW, 1993, ANTIMICROB AGENTS CH, V37, P2474, DOI 10.1128/AAC.37.11.2474; Courvalin P, 2006, CLIN INFECT DIS, V42, pS25, DOI 10.1086/491711; DIAZ E, 1990, P NATL ACAD SCI USA, V87, P8125, DOI 10.1073/pnas.87.20.8125; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Fard RMN, 2010, ARCH VIROL, V155, P1887, DOI 10.1007/s00705-010-0800-3; Fischetti VA, 2008, CURR OPIN MICROBIOL, V11, P393, DOI 10.1016/j.mib.2008.09.012; GARCIA P, 1990, GENE, V86, P81, DOI 10.1016/0378-1119(90)90116-9; GERMIDA JJ, 1983, APPL ENVIRON MICROB, V45, P1380, DOI 10.1128/AEM.45.4.1380-1388.1983; Giraffa G, 2003, INT J FOOD MICROBIOL, V88, P215, DOI 10.1016/S0168-1605(03)00183-1; Harper DR, 2011, THER DELIV, V2, P935, DOI 10.4155/TDE.11.64; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Horiuchi T, 2012, J VIROL, V86, P9538, DOI 10.1128/JVI.01424-12; HUYCKE MM, 1991, ANTIMICROB AGENTS CH, V35, P1626, DOI 10.1128/AAC.35.8.1626; IKE Y, 1984, INFECT IMMUN, V45, P528, DOI 10.1128/IAI.45.2.528-530.1984; JETT BD, 1994, CLIN MICROBIOL REV, V7, P462, DOI 10.1128/CMR.7.4.462-478.1994; JOHNSON AP, 1994, J ANTIMICROB CHEMOTH, V33, P1083, DOI 10.1093/jac/33.6.1083; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Lee YD, 2012, J VIROL, V86, P5402, DOI 10.1128/JVI.00321-12; Loeffler JM, 2001, SCIENCE, V294, P2170, DOI 10.1126/science.1066869; Loessner MJ, 2005, CURR OPIN MICROBIOL, V8, P480, DOI 10.1016/j.mib.2005.06.002; Lopez R, 2004, FEMS MICROBIOL REV, V28, P553, DOI 10.1016/j.femsre.2004.05.002; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; MURRAY BE, 1990, CLIN MICROBIOL REV, V3, P46, DOI 10.1128/CMR.3.1.46-65.1990; Pajunen M, 2000, J BACTERIOL, V182, P5114, DOI 10.1128/JB.182.18.5114-5120.2000; Perez-Dorado I, 2007, J BIOL CHEM, V282, P24990, DOI 10.1074/jbc.M704317200; Rao N, 2007, DRUGS, V67, P195, DOI 10.2165/00003495-200767020-00003; Sambrook J., 2002, MOL CLONING LAB MANU; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schuch R, 2002, NATURE, V418, P884, DOI 10.1038/nature01026; Son JS, 2010, J APPL MICROBIOL, V108, P1769, DOI 10.1111/j.1365-2672.2009.04576.x; Stevens RH, 2011, FEMS MICROBIOL LETT, V317, P9, DOI 10.1111/j.1574-6968.2010.02203.x; Stuart CH, 2006, J ENDODONT, V32, P93, DOI 10.1016/j.joen.2005.10.049; Uchiyama J, 2008, FEMS MICROBIOL LETT, V278, P200, DOI 10.1111/j.1574-6968.2007.00996.x; Uchiyama J, 2011, APPL ENVIRON MICROB, V77, P580, DOI 10.1128/AEM.01540-10; Vinodkumar CS, 2011, INDIAN J PATHOL MICR, V54, P90, DOI 10.4103/0377-4929.77333; Wilkins MR, 1999, METH MOL B, V112, P531; Yasmin A, 2010, J BACTERIOL, V192, P1122, DOI 10.1128/JB.01293-09; Yoong P, 2004, J BACTERIOL, V186, P4808, DOI 10.1128/JB.186.14.4808-4812.2004; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	48	32	36	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80435	10.1371/journal.pone.0080435	http://dx.doi.org/10.1371/journal.pone.0080435			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236180	gold, Green Published, Green Submitted			2022-12-27	WOS:000327254700181
J	Aboul-Enein, F; Seifert-Held, T; Mader, S; Kuenz, B; Lutterotti, A; Rauschka, H; Rommer, P; Leutmezer, F; Vass, K; Flamm-Horak, A; Stepansky, R; Lang, W; Fertl, E; Schlager, T; Heller, T; Eggers, C; Safoschnik, G; Fuchs, S; Kraus, J; Assar, H; Guggenberger, S; Reisz, M; Schnabl, P; Komposch, M; Simschitz, P; Skrobal, A; Moser, A; Jeschow, M; Stadlbauer, D; Freimuueller, M; Guger, M; Schmidegg, S; Franta, C; Weiser, V; Koppi, S; Niederkorn-Duft, M; Raber, B; Schmeissner, I; Jecel, J; Tinchon, A; Storch, MK; Reindl, M; Berger, T; Kristoferitsch, W				Aboul-Enein, Fahmy; Seifert-Held, Thomas; Mader, Simone; Kuenz, Bettina; Lutterotti, Andreas; Rauschka, Helmut; Rommer, Paulus; Leutmezer, Fritz; Vass, Karl; Flamm-Horak, Agathe; Stepansky, Robert; Lang, Wilfried; Fertl, Elisabeth; Schlager, Thomas; Heller, Thomas; Eggers, Christian; Safoschnik, Georg; Fuchs, Siegrid; Kraus, Joerg; Assar, Hamid; Guggenberger, Stefan; Reisz, Martin; Schnabl, Peter; Komposch, Martina; Simschitz, Philipp; Skrobal, Alena; Moser, Alexander; Jeschow, Mario; Stadlbauer, Dorothea; Freimueller, Manfred; Guger, Michael; Schmidegg, Susanne; Franta, Claudia; Weiser, Vera; Koppi, Stefan; Niederkorn-Duft, Margret; Raber, Bettina; Schmeissner, Iris; Jecel, Julia; Tinchon, Alexander; Storch, Maria K.; Reindl, Markus; Berger, Thomas; Kristoferitsch, Wolfgang			Neuromyelitis Optica in Austria in 2011: To Bridge the Gap between Neuroepidemiological Research and Practice in a Study Population of 8.4 Million People	PLOS ONE			English	Article							EXTENSIVE TRANSVERSE MYELITIS; MULTIPLE-SCLEROSIS; DIFFERENTIAL-DIAGNOSIS; CEREBROSPINAL-FLUID; MYASTHENIA-GRAVIS; CLINICAL-COURSE; ANTIBODY; MRI; MULTICENTER; AQUAPORIN-4	Background:In 2008 the Austrian Task Force for Neuromyelitis Optica (NMO) started a nation-wide network for information exchange and multi-centre collaboration. Their aim was to detect all patients with NMO or NMO spectrum disorders (NMO-SD) in Austria and to analyse their disease courses and response to treatment. Methods:(1) As of March 2008, 1957 serum samples (of 1557 patients) have been tested with an established cell based immunofluorescence aquaporin-4 antibody (AQP4-ab) assay with a high sensitivity and specificity (both >95%). All tests were performed in a single reference laboratory (Clinical Dept. of Neurology of the Innsbruck Medical University). (2) A nation-wide survey with several calls for participation (via email newsletters, articles in the official journal of the Austrian Society of Neurology, and workshops) was initiated in 2008. All collected data will be presented in a way that allows that every individual patient can be traced back in order to ensure transparency and to avoid any data distortion in future meta-analyses. The careful and detailed presentation allows the visualization and comparison of the different disease courses in real time span. Failure and response to treatment are made visible at one glance. Database closure was 31 December 2011. All co-operators were offered co-authorship. Results:All 71 NMO- or NMO-SD patients with AQP4-ab positivity (age range 12.3 to 79.6 years) were analysed in detail. Sex ratio (m:f = 1:7) and the proportion of patients without oligoclonal bands in cerebrospinal fluid (86.6%) were in line with previously published results. All identified patients were Caucasians. Conclusions:A nationwide collaboration amongst Austrian neurologists with good network communications made it possible to establish a database of 71 AQP4-ab positive patients with NMO/NMO-SD. This database is presented in detail and provides the basis for further studies and international cooperation in order to investigate this rare disease.	[Aboul-Enein, Fahmy; Rauschka, Helmut; Jecel, Julia; Kristoferitsch, Wolfgang] Donauspital, Sozial Med Zentrum Ost, Dept Neurol, Vienna, Austria; [Aboul-Enein, Fahmy; Rauschka, Helmut; Kristoferitsch, Wolfgang] Karl Landsteiner Inst Neuroimmunol & Neurodegener, Dept Neurol, Vienna, Austria; [Seifert-Held, Thomas; Fuchs, Siegrid; Storch, Maria K.] Med Univ Graz, Dept Neurol, Graz, Austria; [Mader, Simone; Kuenz, Bettina; Lutterotti, Andreas; Reindl, Markus; Berger, Thomas] Med Univ Innsbruck, Dept Clin Neurol, A-6020 Innsbruck, Austria; [Rommer, Paulus; Leutmezer, Fritz; Vass, Karl] Med Univ Vienna, Dept Neurol, Vienna, Austria; [Flamm-Horak, Agathe; Stepansky, Robert; Lang, Wilfried] Krankenhaus Barmherzigen Bruder, Dept Neurol, Vienna, Austria; [Fertl, Elisabeth; Schlager, Thomas; Heller, Thomas] Krankenanstalt Rudolfstiftung Wien, Dept Neurol, Vienna, Austria; [Eggers, Christian] Konventspital Barmherzige Bruder, Dept Neurol, Linz, Austria; [Safoschnik, Georg] Krankenhaus Hietzing, Neurologischem Zentrum Rosenhugel, Dept Neurol, Vienna, Austria; [Kraus, Joerg] Paracelsus Med Univ, Dept Neurol, Salzburg, Austria; [Assar, Hamid; Guggenberger, Stefan] Landes Nervenklin Wagner Jauregg, Dept Neurol, Linz, Austria; [Reisz, Martin] Landeskrankenhaus Steyr, Dept Neurol, Steyr, Austria; [Schnabl, Peter] Hosp Mariahilf, Humanomed Hosp, Private Hosp Mariahilf, Dept Neurol, Klagenfurt, Austria; [Komposch, Martina; Simschitz, Philipp] Klinikum Klagenfurt, Dept Neurol, Klagenfurt, Austria; [Skrobal, Alena] Landesklinikum Horn, Dept Neurol, Horn, Austria; [Moser, Alexander] Neurol Therapiezentrum Kapfenberg, Dept Neurol, Kapfenberg, Austria; [Jeschow, Mario; Stadlbauer, Dorothea] Krankenhaus Barmherzigen Schwestern Ried, Dept Neurol, Ried, Austria; [Freimueller, Manfred] Gailtal Klin Hermagor, Dept Neurol, Hermagor, Austria; [Guger, Michael; Schmidegg, Susanne] Allgemeines Krankenhaus Stadt Linz, Dept Neurol, Linz, Austria; [Franta, Claudia] Landesklinikum St Polten, Dept Neurol, St Polten, Austria; [Weiser, Vera; Koppi, Stefan] Landeskrankenhaus Rankweil, Dept Neurol, Rankweil, Austria; [Niederkorn-Duft, Margret; Raber, Bettina] Landeskrankenhaus Judenburg Knittelfeld, Dept Neurol, Knittelfeld, Austria; [Schmeissner, Iris] Landeskrankenhaus Vocklabruck, Dept Neurol, Vocklabruck, Austria; [Tinchon, Alexander] Sud Kaiser Franz Josef Spital, Sozialmed Zentrum, Dept Neurol, Vienna, Austria	Donauspital; Medical University of Graz; Medical University of Innsbruck; Medical University of Vienna; Konventhospital Der Barmherzigen Bruder; Rudolfstiftung Hospital; Konventhospital Der Barmherzigen Bruder; Hietzing Hospital; Paracelsus Private Medical University; Kepler University Hospital; Konventhospital Der Barmherzigen Bruder; Kepler University Hospital	Aboul-Enein, F (corresponding author), Donauspital, Sozial Med Zentrum Ost, Dept Neurol, Vienna, Austria.	fahmy.aboulenein@meduniwien.ac.at	Reindl, Markus/ABE-5880-2020	Mader, Simone/0000-0002-2844-9091; Berger, Thomas/0000-0001-5626-1144; Reindl, Markus/0000-0003-2817-1402; Tinchon, Alexander/0000-0001-6665-2990	Austrian Multiple Sclerosis Research Society	Austrian Multiple Sclerosis Research Society	This study was supported by research grants of the Austrian Multiple Sclerosis Research Society in 2010 and 2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboul-Enein F, 2010, AM J NEURORADIOL, V31, P76, DOI 10.3174/ajnr.A1791; About-Enein F, 2008, MULT SCLER, V14, pS268; ANDERSSON M, 1994, J NEUROL NEUROSUR PS, V57, P897, DOI 10.1136/jnnp.57.8.897; Asgari N, 2011, NEUROLOGY, V76, P1589, DOI 10.1212/WNL.0b013e3182190f74; Cabrera-Gomez JA, 2007, MULT SCLER, V13, P186, DOI 10.1177/1352458506070725; Cabrera-Gomez JA, 2009, J NEUROL, V256, P35, DOI 10.1007/s00415-009-0009-0; Collongues N, 2010, NEUROLOGY, V74, P736, DOI 10.1212/WNL.0b013e3181d31e35; Cossburn M, 2012, EUR J NEUROL, V19, P655, DOI 10.1111/j.1468-1331.2011.03529.x; Feigin V, 2009, NEUROEPIDEMIOLOGY, V33, P296, DOI 10.1159/000252942; Rivera JF, 2008, J NEUROL, V255, P710, DOI 10.1007/s00415-008-0781-2; Jarius S, 2008, BRAIN, V131, P3072, DOI 10.1093/brain/awn240; Jarius S, 2013, J NEUROL, V260, P663, DOI 10.1007/s00415-012-6755-4; Jarius S, 2012, MULT SCLER J, V18, P1135, DOI 10.1177/1352458511431728; Jarius S, 2011, J NEUROL SCI, V306, P82, DOI 10.1016/j.jns.2011.03.038; Jarius S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-14; Kawazoe T, 2012, INTERNAL MED, V51, P2625, DOI 10.2169/internalmedicine.51.7771; Kim W, 2013, MULT SCLER INT, V2012; Kitley JL, 2012, MULT SCLER J, V18, P271, DOI 10.1177/1352458511406165; Krampla W, 2009, EUR RADIOL, V19, P2535, DOI 10.1007/s00330-009-1425-3; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Mader S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-184; Mader S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010455; Matthews L, 2013, NEUROLOGY, V80, P1330, DOI 10.1212/WNL.0b013e3182887957; Mckeon A, 2009, MUSCLE NERVE, V39, P87, DOI 10.1002/mus.21197; Mealy MA, 2012, ARCH NEUROL-CHICAGO, V69, P1176, DOI 10.1001/archneurol.2012.314; Miller DH, 2008, MULT SCLER J, V14, P1157, DOI 10.1177/1352458508096878; Nakamura M, 2008, J NEUROL, V255, P163, DOI 10.1007/s00415-008-0545-z; ORiordan JI, 1996, J NEUROL NEUROSUR PS, V60, P382, DOI 10.1136/jnnp.60.4.382; Pittock SJ, 2008, ARCH NEUROL-CHICAGO, V65, P78, DOI 10.1001/archneurol.2007.17; Sellner J, 2010, EUR J NEUROL, V17, P1019, DOI 10.1111/j.1468-1331.2010.03066.x; Serbecic N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019843; Serbecic N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013877; Sinnecker T, 2012, NEUROLOGY, V79, P708, DOI 10.1212/WNL.0b013e3182648bc8; Trebst C, 2011, NAT REV NEUROL, V7, P688, DOI 10.1038/nrneurol.2011.176; Wingerchuk DM, 2007, NEUROLOGY, V68, P603, DOI 10.1212/01.wnl.0000254502.87233.9a; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 1999, NEUROLOGY, V53, P1107, DOI 10.1212/WNL.53.5.1107	37	46	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79649	10.1371/journal.pone.0079649	http://dx.doi.org/10.1371/journal.pone.0079649			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223985	gold, Green Published, Green Submitted			2022-12-27	WOS:000326597400078
J	Liu, K; Zhu, W; Shi, JG; Jia, LS; Shi, GD; Wang, Y; Liu, N				Liu, Kun; Zhu, Wei; Shi, Jiangang; Jia, Lianshun; Shi, Guodong; Wang, Yuan; Liu, Ning			Foot Drop Caused by Lumbar Degenerative Disease: Clinical Features, Prognostic Factors of Surgical Outcome and Clinical Stage	PLOS ONE			English	Article							PERONEAL NERVE; SURGERY; PATIENT	Objective: The purpose of this study was to analyze the clinical features and prognostic factors of surgical outcome of foot drop caused by lumbar degenerative disease and put forward the clinical stage. Methods: We retrospectively reviewed 135 patients with foot drop due to lumbar degenerative disease. The clinical features and mechanism were analyzed. Age, sex, duration of palsy, preoperative muscle strength of tibialis anterior (TA), sensation defect of affected lower limb, affected foot, diagnosis and compressed nerve roots were recorded and compared with surgical outcome. Results: Foot drop was observed in 8.1% of all inpatients of lumbar degenerative disease. L5 nerve root compression was observed in 126 of all 135 patients (93.3%). Single, double and triple roots compression was observed respectively in 43, 83, and 9 patients (31.9%, 61.5%, and 6.6%). But there was no significant relationship between preoperative muscle strength of TA and the number of compressed roots. The muscle strength of TA was improved in 113 (83.7%) patients after surgery, but it reached to >=4 in only 21 (15.6%) patients. Improvement of the muscle strength of TA was almost stable at the 6-month follow-up. At the last follow-up, the muscle strength of TA was 1, 2, 3, 4, 5 respectively in 28, 24, 62, 13, 8 patients. Multivariate logistic regression showed duration of palsy (p=0.0360, OR=2.543), preoperative muscle strength of TA (p=0.0064, OR=5.528) and age (p=0.0309, OR=3.208) were factors that influenced recovery following an operation. Conclusions: L5 nerve root was most frequently affected. The muscle strength of TA improved in most patients after surgery, but few patients can get a good recovery from foot drop. Patients of shorter duration of palsy, better preoperative muscle strength of TA and younger age showed a better surgical outcome.	[Liu, Kun] Second Artillery Gen Hosp, Dept Orthoped Surg, Beijing, Peoples R China; [Zhu, Wei; Shi, Jiangang; Jia, Lianshun; Shi, Guodong; Wang, Yuan; Liu, Ning] Second Mil Med Univ, Shanghai Chang Zheng Hosp, Dept Orthoped Surg, Shanghai, Peoples R China	Naval Medical University	Shi, JG (corresponding author), Second Mil Med Univ, Shanghai Chang Zheng Hosp, Dept Orthoped Surg, Shanghai, Peoples R China.	shijiangang616@163.com						Ahmad FU, 2006, INT J OBSTET ANESTH, V15, P233, DOI 10.1016/j.ijoa.2005.11.002; Aono H, 2007, SPINE, V32, pE262, DOI 10.1097/01.brs.0000259922.82413.72; Bobba RK, 2006, EUR J INTERN MED, V17, P572, DOI 10.1016/j.ejim.2006.07.010; Campbell WW, 2020, DEJONGS NEUROLOGIC E; Ferraresi S, 2010, J NEUROSURG-PEDIATR, V6, P506, DOI 10.3171/2010.8.PEDS10214; Ghahreman A, 2009, J CLIN NEUROSCI, V16, P1024, DOI 10.1016/j.jocn.2008.10.017; Girardi FP, 2002, J SPINAL DISORD TECH, V15, P490, DOI 10.1097/00024720-200212000-00010; Hans SS, 2011, J VASC SURG, V53, P407, DOI 10.1016/j.jvs.2010.08.084; Hoppenfeld S, 1976, PHYS EXAMINATION SPI; Iizuka Y, 2009, J NEUROSURG-SPINE, V10, P260, DOI 10.3171/2008.12.SPINE08500; Ji JH, 2007, KNEE, V14, P249, DOI 10.1016/j.knee.2007.01.003; Karaoglan A, 2009, TURK NEUROSURG, V19, P208; Masakado Yoshihisa, 2008, Keio Journal of Medicine, V57, P84, DOI 10.2302/kjm.57.84; MCCULLOCH JA, 1980, J BONE JOINT SURG BR, V62, P475, DOI 10.1302/0301-620X.62B4.7430228; Okuda S, 2006, J NEUROSURG-SPINE, V4, P304, DOI 10.3171/spi.2006.4.4.304; Stewart John D, 2008, Pract Neurol, V8, P158, DOI 10.1136/jnnp.2008.149393; Voermans NC, 2006, ACTA NEUROCHIR, V148, P809, DOI 10.1007/s00701-006-0754-0	17	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80375	10.1371/journal.pone.0080375	http://dx.doi.org/10.1371/journal.pone.0080375			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224052	Green Submitted, gold, Green Published			2022-12-27	WOS:000326597400118
J	Matos, LA; Hilf, ME; Chen, JC; Folimonova, SY				Matos, Luis A.; Hilf, Mark E.; Chen, Jianchi; Folimonova, Svetlana Y.			Validation of 'Variable Number of Tandem Repeat'-Based Approach for Examination of 'Candidatus Liberibacter asiaticus' Diversity and Its Applications for the Analysis of the Pathogen Populations in the Areas of Recent Introduction	PLOS ONE			English	Article							CITRUS SEED COATS; 1ST REPORT; SEQUENCE; BACTERIUM; DISEASE; TRANSMISSION; PCR	Citrus greening (Huanglongbing, HLB) is one of the most destructive diseases of citrus worldwide. In South Asia HLB has been known for more than a century, while in Americas the disease was found relatively recently. HLB is associated with three species of 'Candidatus Liberibacter' among which 'Ca. Liberibacter asiaticus' (CLas) has most wide distribution. Recently, a number of studies identified different regions in the CLas genome with variable number of tandem repeats (VNTRs) that could be used for examination of CLas diversity. One of the objectives of the work presented here was to further validate the VNTR analysis-based approach by assessing the stability of these repeats upon multiplication of the pathogen in a host over an extended period of time and upon its passaging from a host to a host using CLas populations from Florida. Our results showed that the numbers of tandem repeats in the four loci tested display very distinguishable "signature profiles" for the two Florida-type CLas haplotype groups. Remarkably, the profiles do not change upon passage of the pathogen in citrus and psyllid hosts as well as after its presence within a host over a period of five years, suggesting that VNTR analysis-based approach represents a valid methodology for examination of the pathogen populations in various geographical regions. Interestingly, an extended analysis of CLas populations in different locations throughout Florida and in several countries in the Caribbean and Central America regions and in Mexico where the pathogen has been introduced recently demonstrated the dispersion of the same haplotypes of CLas. On the other hand, these CLas populations appeared to differ significantly from those obtained from locations where the disease has been present for a much longer time.	[Matos, Luis A.; Folimonova, Svetlana Y.] Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA; [Matos, Luis A.] Inst Dominicano Invest Agr Forestales, Santo Domingo, Dominican Rep; [Hilf, Mark E.] USDA ARS, Ft Pierce, FL USA; [Chen, Jianchi] USDA ARS, San Joaquin Valley Agr Sci Ctr, Parlier, CA USA	State University System of Florida; University of Florida; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Folimonova, SY (corresponding author), Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA.	svetlana@ufl.edu	Folimonova, Svetlana/T-2592-2019; Matos, Luis/HDL-7321-2022					Bassanezi R. B, 2007, PLANT HLTH PROGR, V8, P1, DOI DOI 10.1094/PHP-2007-0906-01-RV; Bastianel C, 2005, APPL ENVIRON MICROB, V71, P6473, DOI 10.1128/AEM.71.11.6473-6478.2005; Bove JM, 2006, J PLANT PATHOL, V88, P7; Brown S. E., 2011, New Disease Reports, V24, P25; Chen J, 2010, PHYTOPATHOLOGY, V100, P567, DOI 10.1094/PHYTO-100-6-0567; Coil DA, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-218; Coletta HD, 2004, PLANT DIS, V88, P1382, DOI 10.1094/PDIS.2004.88.12.1382C; Da Graca J, 2004, DIS FRUITS VEGETABLE, VI, P229, DOI DOI 10.1007/1-4020-2606-4_4; DAGRACA JV, 1991, ANNU REV PHYTOPATHOL, V29, P109, DOI 10.1146/annurev.py.29.090191.000545; De Jensen CE, 2010, PHYTOPATHOLOGY, V100, pS34; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Folimonova SY, 2010, PHYTOPATHOLOGY, V100, P949, DOI 10.1094/PHYTO-100-9-0949; Folimonova SY, 2009, PHYTOPATHOLOGY, V99, P1346, DOI 10.1094/PHYTO-99-12-1346; Garnsey S. M., 2002, Proceedings of the Fifteenth Conference of the International Organization of Citrus Virologists, Paphos, Cyprus, 11-16 November 2001, P219; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Guichoux E, 2011, MOL ECOL RESOUR, V11, P591, DOI 10.1111/j.1755-0998.2011.03014.x; Halbert SE., 2005, PROC 2 INT CITRUS CA, pH3; Hilf ME, 2013, PHYTOPATHOLOGY, V103, P545, DOI 10.1094/PHYTO-09-12-0226-R; Hilf ME, 2011, PHYTOPATHOLOGY, V101, P1242, DOI 10.1094/PHYTO-11-10-0323; Irey M.S., 2006, P FLA STATE HORTIC S, V42, P17; Islam MS, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-39; JAGOUEIX S, 1994, INT J SYST BACTERIOL, V44, P379, DOI 10.1099/00207713-44-3-379; Johnson E, 2012, PHYTOPATHOLOGY, V102, P59; Katoh H, 2012, ANN APPL BIOL, V160, P291, DOI 10.1111/j.1744-7348.2012.00541.x; Katoh H, 2011, APPL ENVIRON MICROB, V77, P1910, DOI 10.1128/AEM.01571-10; Li WB, 2006, J MICROBIOL METH, V66, P104, DOI 10.1016/j.mimet.2005.10.018; Manjunath KL, 2008, PHYTOPATHOLOGY, V98, P387, DOI 10.1094/PHYTO-98-4-0387; Manjunath KL, 2010, PLANT DIS, V94, P781, DOI 10.1094/PDIS-94-6-0781A; Martinez Y, 2008, BS PLANT PATHOLOGY, V18, P7; Matos L, 2009, PLANT DIS, V93, P668, DOI 10.1094/PDIS-93-6-0668B; MATSUMOTO T., 1961, Proceedings of the Second Conference of the International Organization of Citrus Virologists., P121; MCCLEAN A. P. D., 1965, South African Journal of Agricultural Science, V8, P253; MIYAKAWA T, 1989, Annals of the Phytopathological Society of Japan, V55, P667, DOI 10.3186/jjphytopath.55.667; Miyata S, 2011, J GEN PLANT PATHOL, V77, P43, DOI 10.1007/s10327-010-0284-8; Oberholzer P. C. J., 1965, P 3 C IOCV, P213; OIRSA (Organismo Internacional Regional de Sanidad Agropecuaria), 2011, TALL SENS CERT PROD; Ramadugu C, 2010, PHYTOPATHOLOGY, V100, pS107; RAYCHAUDHURI S. P., 1969, Proceedings 1st int. Citrus Symp., Univ. California, Riverside 1968., V3, P1433; Tatineni S, 2008, PHYTOPATHOLOGY, V98, P592, DOI 10.1094/PHYTO-98-5-0592; Teixeira DC, 2008, INT J SYST EVOL MICR, V58, P1414, DOI 10.1099/ijs.0.65641-0; TIRTAWIDJAJA S, 1965, P AM SOC HORTIC SCI, V86, P235; Tomimura K, 2009, PHYTOPATHOLOGY, V99, P1062, DOI 10.1094/PHYTO-99-9-1062; Trujillo-Arriaga J, 2010, TALL INT HUANGL PSIL; van Belkum A, 1998, MICROBIOL MOL BIOL R, V62, P275, DOI 10.1128/MMBR.62.2.275-293.1998; Zhou LJ, 2011, APPL ENVIRON MICROB, V77, P6663, DOI 10.1128/AEM.05111-11	46	17	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78994	10.1371/journal.pone.0078994	http://dx.doi.org/10.1371/journal.pone.0078994			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223873	gold, Green Submitted, Green Published			2022-12-27	WOS:000326597400045
J	Mori, N; Ohwashi, M; Yoshinaga, K; Mitsuhashi, K; Tanaka, N; Teramura, M; Okada, M; Shiseki, M; Tanaka, J; Motoji, T				Mori, Naoki; Ohwashi, Mari; Yoshinaga, Kentaro; Mitsuhashi, Kenjiro; Tanaka, Norina; Teramura, Masanao; Okada, Michiko; Shiseki, Masayuki; Tanaka, Junji; Motoji, Toshiko			L265P Mutation of the MYD88 Gene Is Frequent in Waldenstrom's Macroglobulinemia and Its Absence in Myeloma	PLOS ONE			English	Article							SOMATIC MUTATIONS; KAPPA-B; LYMPHOMAS; CARCINOMA; TIME; BCR	L265P mutation in the MYD88 gene has recently been reported in Waldenstrom's macroglobulinemia; however the incidence has been different according to the methods used. To determine the relevance and compare the incidence by different methods, we analyzed the L265P mutation in bone marrow mononuclear cells from lymphoid neoplasms. We first performed cloning and sequencing in 10 patients: 8 Waldenstrm's macroglobulinemia; 1 non-IgM-secreting lymphoplasmacytic lymphoma; and 1 low grade B-cell lymphoma with monoclonal IgG protein. The L265P mutation was detected in only 1/8 Waldenstrm's macroglobulinemia patients (2 of 9 clones). To confirm these results, direct sequencing was performed in the 10 patients and an additional 17 Waldenstrm's macroglobulinemia patients and 1 lymphoplasmacytic lymphoma patient. Nine of 28 patients (7/25 Waldenstrm's macroglobulinemia, 1/2 lymphoplasmacytic lymphoma, and B-cell lymphoma) harbored the mutation. We next tested for the mutation with BSiE1 digestion and allele-specific polymerase chain reaction in the 28 patients and 38 patients with myeloma. Aberrant bands corresponding to the mutation were detected by BSiE1 digestion in 19/25 patients with Waldenstrm's macroglobulinemia (76%), 1/2 lymphoplasmacytic lymphoma and B-cell lymphoma, but not in the 38 myeloma patients. The L265P mutation was more frequent in patients with Waldenstrm's macroglobulinemia than in those with myeloma (p= 1.3x10(-10)). The mutation was detected by allele-specific polymerase chain reaction in 18/25 Waldenstrm's macroglobulinemia patients (72%). In the 25 Waldenstrm's macroglobulinemia patients, the L265P was more frequently detected by BSiE1 digestion than by direct sequencing (p= 5.3x10(-4)), and in males (15/16, 94%) than in females (4/9, 44%) (p= 1.2x10(-2)). No siginificant difference was observed in the incidence of the L265P mutation between BSiE1 digestion and allele-specific polymerase chain reaction (p= 0.32). These results suggest that the L265P mutation is involved in the majority of Waldenstrm's macroglobulinemia. BSiE1 digestion and allelespecific polymerase chain reaction may detect a small fraction of mutated cells in some cases.	[Mori, Naoki; Ohwashi, Mari; Yoshinaga, Kentaro; Mitsuhashi, Kenjiro; Tanaka, Norina; Teramura, Masanao; Okada, Michiko; Shiseki, Masayuki; Tanaka, Junji; Motoji, Toshiko] Tokyo Womens Med Univ, Dept Hematol, Tokyo, Japan	Tokyo Women's Medical University	Mori, N (corresponding author), Tokyo Womens Med Univ, Dept Hematol, Tokyo, Japan.	mori@dh.twmu.ac.jp		Mitsuhashi, Kenjiro/0000-0002-4103-7681				Angulo B, 2010, J MOL DIAGN, V12, P292, DOI 10.2353/jmoldx.2010.090139; Branford S, 2003, BLOOD, V102, P276, DOI 10.1182/blood-2002-09-2896; Cohen L, 1998, NATURE, V395, P292, DOI 10.1038/26254; Gachard N, 2013, LEUKEMIA, V27, P183, DOI 10.1038/leu.2012.257; James C, 2006, LEUKEMIA, V20, P350, DOI 10.1038/sj.leu.2404069; Johnson SA, 2006, BRIT J HAEMATOL, V132, P683, DOI 10.1111/j.1365-2141.2005.05948.x; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Lasho TL, 2006, BRIT J HAEMATOL, V135, P683, DOI 10.1111/j.1365-2141.2006.06348.x; Leleu X, 2008, BLOOD, V111, P5068, DOI 10.1182/blood-2007-09-115170; Li ZM, 2012, BRIT J HAEMATOL, V158, P662, DOI 10.1111/j.1365-2141.2012.09176.x; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Loiarro M, 2009, J BIOL CHEM, V284, P28093, DOI 10.1074/jbc.M109.004465; MORI N, 1990, ONCOGENE, V5, P1713; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Owen RG, 2003, SEMIN ONCOL, V30, P110, DOI 10.1053/sonc.2003.50082; Treon SP, 2012, NEW ENGL J MED, V367, P826, DOI 10.1056/NEJMoa1200710; Treon SP, 2009, BLOOD, V114, P2375, DOI 10.1182/blood-2009-05-174359; Varettoni M, 2013, BLOOD, V121, P2522, DOI 10.1182/blood-2012-09-457101; Watters TM, 2007, IMMUNOL CELL BIOL, V85, P411, DOI 10.1038/sj.icb.7100095; Xu L, 2013, BLOOD, V121, P2051, DOI 10.1182/blood-2012-09-454355; Yan QG, 2012, HAEMATOL-HEMATOL J, V97, P595, DOI 10.3324/haematol.2011.054080	22	25	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80088	10.1371/journal.pone.0080088	http://dx.doi.org/10.1371/journal.pone.0080088			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224040	gold, Green Submitted, Green Published			2022-12-27	WOS:000326597400112
J	Noszticzius, Z; Wittmann, M; Kaly-Kullai, K; Beregvari, Z; Kiss, I; Rosivall, L; Szegedi, J				Noszticzius, Zoltan; Wittmann, Maria; Kaly-Kullai, Kristof; Beregvari, Zoltan; Kiss, Istvan; Rosivall, Laszlo; Szegedi, Janos			Chlorine Dioxide Is a Size-Selective Antimicrobial Agent	PLOS ONE			English	Article							MYELOPEROXIDASE-DERIVED OXIDANTS; HYPOCHLOROUS ACID; GLUTATHIONE SULFONAMIDE; HYDROGEN-PEROXIDE; OXIDATION; DISINFECTANTS; MECHANISMS; TOXICITY; PROTEIN; ANTISEPTICS	Background / Aims: ClO2, the so-called "ideal biocide", could also be applied as an antiseptic if it was understood why the solution killing microbes rapidly does not cause any harm to humans or to animals. Our aim was to find the source of that selectivity by studying its reaction-diffusion mechanism both theoretically and experimentally. Methods: ClO2 permeation measurements through protein membranes were performed and the time delay of ClO2 transport due to reaction and diffusion was determined. To calculate ClO2 penetration depths and estimate bacterial killing times, approximate solutions of the reaction-diffusion equation were derived. In these calculations evaporation rates of ClO2 were also measured and taken into account. Results: The rate law of the reaction-diffusion model predicts that the killing time is proportional to the square of the characteristic size (e. g. diameter) of a body, thus, small ones will be killed extremely fast. For example, the killing time for a bacterium is on the order of milliseconds in a 300 ppm ClO2 solution. Thus, a few minutes of contact time (limited by the volatility of ClO2) is quite enough to kill all bacteria, but short enough to keep ClO2 penetration into the living tissues of a greater organism safely below 0.1 mm, minimizing cytotoxic effects when applying it as an antiseptic. Additional properties of ClO2, advantageous for an antiseptic, are also discussed. Most importantly, that bacteria are not able to develop resistance against ClO2 as it reacts with biological thiols which play a vital role in all living organisms. Conclusion: Selectivity of ClO2 between humans and bacteria is based not on their different biochemistry, but on their different size. We hope initiating clinical applications of this promising local antiseptic.	[Noszticzius, Zoltan; Wittmann, Maria; Kaly-Kullai, Kristof] Budapest Univ Technol & Econ, Dept Phys, Budapest, Hungary; [Beregvari, Zoltan; Szegedi, Janos] Josa Andras Hosp, Nyiregyhaza, Hungary; [Kiss, Istvan] St Imre Hosp, Budapest, Hungary; [Rosivall, Laszlo] Semmelweis Univ, H-1085 Budapest, Hungary	Budapest University of Technology & Economics; Semmelweis University	Wittmann, M (corresponding author), Budapest Univ Technol & Econ, Dept Phys, Budapest, Hungary.	wittmann@eik.bme.hu	Wittmann, Maria/AAN-5276-2021	Wittmann, Maria/0000-0003-4786-7712	OTKA [77908]	OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by OTKA Grant 77908. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amyes SGB, 2010, ANTIBACTERIAL CHEMOT; BARRETTE WC, 1989, BIOCHEMISTRY-US, V28, P9172, DOI 10.1021/bi00449a032; CADENAS E, 1989, ANNU REV BIOCHEM, V58, P79, DOI 10.1146/annurev.bi.58.070189.000455; Chesney JA, 1996, J BACTERIOL, V178, P2131, DOI 10.1128/jb.178.7.2131-2135.1996; Crank J., 1975, MATH DIFFUSION; Csikany Cs, 2009, DENT HIREK, P36; DANIEL FB, 1990, J AM WATER WORKS ASS, V82, P61; Das S, 2011, REV IND J DENT ADV, V3, P538; EASTOE JE, 1955, BIOCHEM J, V61, P589, DOI 10.1042/bj0610589; EPA Guidance Manual, ALT DIS OX 4 4 3 2 P; Evans BA, 2013, CURR PHARM DESIGN, V19, P223; Harris AG, 2002, MICROBIOL-SGM, V148, P3813, DOI 10.1099/00221287-148-12-3813; Harwood DT, 2006, BIOCHEM J, V399, P161, DOI 10.1042/BJ20060978; Herczegh A, 2013, ACTA MICROBIOL IMM H, V60, P63, DOI 10.1556/AMicr.60.2013.1.7; Ison A, 2006, INORG CHEM, V45, P8768, DOI 10.1021/ic0609554; Junli Huang, 1997, Water Research, V31, P455, DOI 10.1016/S0043-1354(96)00276-X; Koburger T, 2010, J ANTIMICROB CHEMOTH, V65, P1712, DOI 10.1093/jac/dkq212; Lansdown ABG, 2010, ISSUES TOXICOL, V6, P1; Loginova IV, 2008, CHEM NAT COMPD+, V44, P752, DOI 10.1007/s10600-009-9182-8; LUBBERS JR, 1982, ENVIRON HEALTH PERSP, V46, P57, DOI 10.2307/3429422; Luo GPS, 2012, PLOS ONE, V7, P46, DOI 10.1371/journal.pone.0029446; McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147, DOI 10.1128/CMR.12.1.147; Mehra P, 2000, J AM DENT ASSOC, V131, P67, DOI 10.14219/jada.archive.2000.0021; MEISTER A, 1988, J BIOL CHEM, V263, P17205; Muller G, 2006, DERMATOLOGY, V212, P91, DOI 10.1159/000090102; Muller G, 2007, GMS KRANKENHAUSHYG I, V2; Napolitano MJ, 2005, CHEM RES TOXICOL, V18, P501, DOI 10.1021/tx049697i; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Noszticzius Z, 2006, PERMEATION METHOD AP; Ogata N, 2007, BIOCHEMISTRY-US, V46, P4898, DOI 10.1021/bi061827u; Pattison DI, 2006, CURR MED CHEM, V13, P3271, DOI 10.2174/092986706778773095; Pattison DI, 2001, CHEM RES TOXICOL, V14, P1453, DOI 10.1021/tx0155451; Pullar JM, 2000, IUBMB LIFE, V50, P259, DOI 10.1080/15216540051080958; Pullar JM, 2001, J BIOL CHEM, V276, P22120, DOI 10.1074/jbc.M102088200; Robson M.C., 2007, J BURNS WOUNDS, V6, P80; Rosen H, 2009, P NATL ACAD SCI USA, V106, P18686, DOI 10.1073/pnas.0909464106; Sanekata T, 2010, BIOCONTROL SCI, V15, P45, DOI 10.4265/bio.15.45; Simpson GD, 1993, CORR 93 NEW ORL LA M; SMIT MJ, 1992, AGENTS ACTIONS, V36, P58, DOI 10.1007/BF01991229; Spellberg B., 2009, RISING PLAGUE GLOBAL; Stewart DJ, 2008, INORG CHEM, V47, P1639, DOI 10.1021/ic701761p; TANNER RS, 1989, J IND MICROBIOL, V4, P145, DOI 10.1007/BF01569799; Wang L., 2007, J BURNS WOUNDS, V6, P65	43	48	49	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79157	10.1371/journal.pone.0079157	http://dx.doi.org/10.1371/journal.pone.0079157			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223899	Green Submitted, Green Published, gold			2022-12-27	WOS:000326597400049
J	Singh, R; Avliyakulov, NK; Braga, M; Haykinson, MJ; Martinez, L; Singh, V; Parveen, M; Chaudhuri, G; Pervin, S				Singh, Rajan; Avliyakulov, Nuraly K.; Braga, Melissa; Haykinson, Michael J.; Martinez, Luis; Singh, Vikash; Parveen, Meher; Chaudhuri, Gautam; Pervin, Shehla			Proteomic Identification of Mitochondrial Targets of Arginase in Human Breast Cancer	PLOS ONE			English	Article							HYDROXY-L-ARGININE; NITRIC-OXIDE; MDA-MB-468 CELLS; SERINE HYDROXYMETHYLTRANSFERASE; MYOGENIC DIFFERENTIATION; INDUCED APOPTOSIS; POTENTIAL ROLE; COLON-CANCER; METABOLISM; INHIBITOR	We have previously reported arginase expression in human breast cancer cells and demonstrated that the inhibition of arginase by N-omega hydroxy L-arginine (NOHA) in MDA-MB-468 cells induces apoptosis. However, arginase expression and its possible molecular targets in human breast tumor samples and potential clinical implications have not been fully elucidated. Here, we demonstrate arginase expression in human breast tumor samples, and several established breast cancer cell lines, in which NOHA treatment selectively inhibits cell proliferation. The overexpression of Bcl2 in MDA-MB-468 cells abolished NOHA-induced apoptosis, suggesting that the mitochondria may be the main site of NOHA's action. We, therefore, undertook a proteomics approach to identify key mitochondrial targets of arginase in MDA-MB-468 cells. We identified 54 non-mitochondrial and 13 mitochondrial proteins that were differentially expressed in control and NOHA treated groups. Mitochondrial serine hydroxymethyltransferase (mSHMT) was identified as one of the most promising targets of arginase. Both arginase II (Arg II) and mSHMT expressions were higher in human breast tumor tissues compared to the matched normal and there was a strong correlation between Arg II and mSHMT protein expression. MDA-MB-468 xenografts had significant upregulation of Arg II expression that preceded the induction of mSHMT expression. Small inhibitory RNA (siRNA)-mediated inhibition of Arg II in MDA-MB-468 and HCC-1806 cells led to significant inhibition of both the mSHMT gene and protein expression. As mSHMT is a key player in folate metabolism, our data provides a novel link between arginine and folate metabolism in human breast cancer, both of which are critical for tumor cell proliferation.	[Singh, Rajan; Braga, Melissa; Martinez, Luis; Singh, Vikash; Parveen, Meher; Pervin, Shehla] Charles Drew Univ Med & Sci, Los Angeles, CA 90059 USA; [Singh, Rajan; Chaudhuri, Gautam; Pervin, Shehla] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA; [Singh, Rajan; Chaudhuri, Gautam; Pervin, Shehla] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Avliyakulov, Nuraly K.; Haykinson, Michael J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Chaudhuri, Gautam] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	Charles R. Drew University of Medicine & Science; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Singh, R (corresponding author), Charles Drew Univ Med & Sci, Los Angeles, CA 90059 USA.	rajansingh@mednet.ucla.edu			NIH [SC1 AG033407-01A1, 1SC1 CA165865-01A1]; CDU/UCLA Cancer Partnership [5U54CA143931]; NATIONAL CANCER INSTITUTE [U54CA143931, SC1CA165865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [SC1AG033407] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CDU/UCLA Cancer Partnership; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work was supported by NIH grants SC1 AG033407-01A1 (R. S.); 1SC1 CA165865-01A1 (S. P.) and in part by CDU/UCLA Cancer Partnership 5U54CA143931. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPLING DR, 1991, FASEB J, V5, P2645, DOI 10.1096/fasebj.5.12.1916088; Assaraf YG, 2007, CANCER METAST REV, V26, P153, DOI 10.1007/s10555-007-9049-z; Baggio R, 1999, J PHARMACOL EXP THER, V290, P1409; Braga M, 2012, MOL CELL ENDOCRINOL, V350, P39, DOI 10.1016/j.mce.2011.11.019; Buga GM, 1996, AM J PHYSIOL-HEART C, V271, pH1988, DOI 10.1152/ajpheart.1996.271.5.H1988; Chang CI, 2001, CANCER RES, V61, P1100; Chang WN, 2007, DRUG METAB DISPOS, V35, P2127, DOI 10.1124/dmd.107.016840; Collin SM, 2009, CANCER EPIDEM BIOMAR, V18, P2528, DOI 10.1158/1055-9965.EPI-09-0223; CYBULSKI RL, 1976, BIOCHEMISTRY-US, V15, P3183, DOI 10.1021/bi00660a004; De Koning TJ, 2003, BIOCHEM J, V371, P653, DOI 10.1042/BJ20021785; FARBER S, 1948, NEW ENGL J MED, V238, P787, DOI 10.1056/NEJM194806032382301; GARROW TA, 1993, J BIOL CHEM, V268, P11910; Jung EJ, 2007, PROTEOMICS, V7, P3906, DOI 10.1002/pmic.200700377; Komlosi V, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-525; Leamon CP, 2008, CANCER RES, V68, P9839, DOI 10.1158/0008-5472.CAN-08-2341; Low PS, 2009, CURR OPIN CHEM BIOL, V13, P256, DOI 10.1016/j.cbpa.2009.03.022; MALT RA, 1985, ADV ENZYME REGUL, V24, P93, DOI 10.1016/0065-2571(85)90071-8; Mayr M, 2009, J MOL CELL CARDIOL, V46, P268, DOI 10.1016/j.yjmcc.2008.10.008; Meulemans A, 2000, NEUROSCI LETT, V294, P125, DOI 10.1016/S0304-3940(00)01548-2; Mosessian S, 2009, J BIOL CHEM, V284, P30159, DOI 10.1074/jbc.M109.027995; Muller C, 2012, CURR PHARM DESIGN, V18, P1058, DOI 10.2174/138161212799315777; Murdoch C, 2004, BLOOD, V104, P2224, DOI 10.1182/blood-2004-03-1109; Nikiforov MA, 2002, MOL CELL BIOL, V22, P5793, DOI 10.1128/MCB.22.16.5793-5800.2002; Pervin S, 2013, BRIT J CANCER, V108, P848, DOI 10.1038/bjc.2013.40; Pervin S, 2003, CANCER RES, V63, P5470; Pervin S, 2001, P NATL ACAD SCI USA, V98, P3583, DOI 10.1073/pnas.041603998; Pervin S, 2001, CANCER RES, V61, P4701; Pervin S, 2008, NITRIC OXIDE-BIOL CH, V19, P103, DOI 10.1016/j.niox.2008.04.016; Pervin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053287; Polat MF, 2003, SURG TODAY, V33, P655, DOI 10.1007/s00595-002-2563-2; Porembska Z, 2003, CLIN CHIM ACTA, V328, P105, DOI 10.1016/S0009-8981(02)00391-1; Sanceau J, 2002, ONCOGENE, V21, P7700, DOI 10.1038/sj.onc.1205881; Shin H, 2004, J AM CHEM SOC, V126, P10278, DOI 10.1021/ja047788w; Singh R, 2006, J CELL BIOCHEM, V99, P146, DOI 10.1002/jcb.20908; Singh R, 2000, CANCER RES, V60, P3305; Singh R, 2002, J BIOL CHEM, V277, P37630, DOI 10.1074/jbc.M203648200; Singh R, 2001, CARCINOGENESIS, V22, P1863, DOI 10.1093/carcin/22.11.1863; Singh R, 2009, ENDOCRINOLOGY, V150, P1259, DOI 10.1210/en.2008-0858; SNELL K, 1988, BRIT J CANCER, V57, P87, DOI 10.1038/bjc.1988.15; SNELL K, 1989, CANCER LETT, V44, P217, DOI 10.1016/0304-3835(89)90064-5; STRAUS B, 1992, CLIN CHIM ACTA, V210, P5, DOI 10.1016/0009-8981(92)90040-W; Tenu JP, 1999, NITRIC OXIDE-BIOL CH, V3, P427, DOI 10.1006/niox.1999.0255; Vijayakrishnan J, 2010, HAEMATOL-HEMATOL J, V95, P1405, DOI 10.3324/haematol.2010.022095; Weigert A, 2008, NITRIC OXIDE-BIOL CH, V19, P95, DOI 10.1016/j.niox.2008.04.021; Xia W, 2010, J MED CHEM, V53, P6811, DOI 10.1021/jm100509v	45	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79242	10.1371/journal.pone.0079242	http://dx.doi.org/10.1371/journal.pone.0079242			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223914	Green Published, Green Submitted, gold			2022-12-27	WOS:000326597400055
J	Costa, ZB; Stefani, MMD; de Lima, YAR; de Souza, WV; de Siqueira, NT; Turchi, MD; Borges, WC; Gomes, C; Macedo, JV; Minuzzi, AL; Martelli, CMT				Costa, Zelma Bernardes; de Araujo Stefani, Mariane Martins; Ramos de Lima, Yanna Andressa; de Souza, Wayner Vieira; de Siqueira Filha, Noemia Teixeira; Turchi, Marilia Dalva; Borges, Walter Costa; Gomes Filho, Clidenor; Macedo Filho, Jose Vicente; Minuzzi, Ana Lucia; Turchi Martelli, Celina Maria			Estimated Incidence and Genotypes of HIV-1 among Pregnant Women in Central Brazil	PLOS ONE			English	Article							RIO-DE-JANEIRO; IMMUNODEFICIENCY-VIRUS-INFECTION; INJECTION-DRUG-USERS; SAO-PAULO; GENETIC DIVERSITY; TESTING CENTERS; ENZYME-IMMUNOASSAY; SUBTYPE-F; PREVALENCE; IDENTIFICATION	Objective: To estimate the incidence of HIV-1 infection among pregnant women from central-western Brazil. Design: Observational cross-sectional study. Methods: A total of 54,139 pregnant women received antenatal HIV screening from a network of public healthcare centers in 2011. The incidence of confirmed HIV-1 infection was estimated using the Serological Testing Algorithms for Recent HIV Seroconversion (STARHS) methodology and BED-capture enzyme immunoassay (BED-CEIA). The yearly incidence was calculated, and adjusted incidence rates were estimated. For a subgroup of patients, protease and partial reverse transcriptase regions were retrotranscribed from plasma HIV-1 RNA and sequenced after performing a nested polymerase chain reaction. Results: Of the participants, 20% had a pregnancy before the age of 18 and approximately 40% were experiencing their first pregnancy. Of the 54,139 pregnant women screened, 86 had a confirmed HIV-1 diagnosis, yielding an overall prevalence of 1.59 cases per 1000 women (95% CI 1.27-1.96). A higher prevalence was detected in the older age groups, reflecting cumulative exposure to the virus over time. Among the infected pregnant women, 20% were considered recently infected according to the BED-CEIA. The estimated incidence of HIV infection was 0.61 per 1000 person-years (95% CI 0.33-0.89); the corrected incidence was 0.47 per 1000 person-years (95% CI 0.26-0.68). In a subgroup of patients, HIV-1 subtype C (16.7%) was the second most prevalent form after subtype B (66.7%); BF1 recombinants (11.1%) and one case of subtype F1 (5.5%) were also detected. Conclusion: This study highlights the potential for deriving incidence estimates from a large antenatal screening program for HIV. The rate of recent HIV-1 infection among women in their early reproductive years is a public health warning to implement preventive measures.	[Costa, Zelma Bernardes; Borges, Walter Costa] Univ Fed Goias, Fac Med, Goiania, Go, Brazil; [de Araujo Stefani, Mariane Martins; Ramos de Lima, Yanna Andressa; Turchi, Marilia Dalva; Turchi Martelli, Celina Maria] Univ Fed Goias, Inst Trop Med & Publ Hlth, Goiania, Go, Brazil; [Gomes Filho, Clidenor] Hlth State Secretariat, Goiania, Go, Brazil; [Macedo Filho, Jose Vicente; Minuzzi, Ana Lucia] Assoc Pais & Amigos Excepcionais Goiania APAE, Goiania, Go, Brazil; [Turchi Martelli, Celina Maria] Univ Fed Pernambuco, Fac Med, Recife, PE, Brazil	Universidade Federal de Goias; Universidade Federal de Goias; Universidade Federal de Pernambuco	Martelli, CMT (corresponding author), Univ Fed Goias, Inst Trop Med & Publ Hlth, Goiania, Go, Brazil.	celina@pq.cnpq.br	Siqueira, Noemia/AGJ-3205-2022; Souza, Wayner V/H-3798-2013	Turchi Martelli, Celina Maria/0000-0002-2491-0688; Souza, Wayner/0000-0002-0939-9332	Fundacao de Apoio a Pesquisa do Estado de Goias [FAPEG 008/2009]; CNPq [306489/2010-4, 305947/2006-0, 306928/2010-8, 304869/2008-2]	Fundacao de Apoio a Pesquisa do Estado de Goias; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was sponsored by Fundacao de Apoio a Pesquisa do Estado de Goias (FAPEG 008/2009) and the authors' institutions. Martelli CMT, Souza WV, Turchi MD and Stefani MMA have received fellowship grants (CNPq# 306489/2010-4, # 305947/2006-0, # 306928/2010-8 and # 304869/2008-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara KC, 2012, J CLIN VIROL, V54, P15, DOI 10.1016/j.jcv.2012.01.011; Alencar CS, 2013, JAIDS-J ACQ IMM DEF, V63, P387, DOI 10.1097/QAI.0b013e31828ff979; Almeida C, 2000, INT J HEALTH SERV, V30, P129, DOI 10.2190/NDGW-C2DP-GNF8-HEW8; ANDERSON R M, 1991; [Anonymous], 2010, B EP AN 7; Barreto ML, 2011, LANCET, V377, P1877, DOI 10.1016/S0140-6736(11)60202-X; Bassichetto KC, 2009, BRAZ J INFECT DIS, V13, P9, DOI 10.1590/S1413-86702009000100004; Bastos FI, 2008, INT J EPIDEMIOL, V37, P729, DOI 10.1093/ije/dyn127; Batzing-Feigenbaum J, 2008, EUROSURVEILLANCE, V13; Bello G, 2007, INFECT GENET EVOL, V7, P263, DOI 10.1016/j.meegid.2006.11.002; Braunstein SL, 2009, AIDS REV, V11, P140; Brazil, 2010, REC PROF TRANSM VERT; Brazil, 2004, REC PROF TRANSM VERT; Brigido LFM, 2005, AIDS RES HUM RETROV, V21, P673, DOI 10.1089/aid.2005.21.673; Brookmeyer R, 2010, EPIDEMIOL REV, V32, P26, DOI 10.1093/epirev/mxq002; CDC, 2006, INT REC US BED CAPT; Cortes Martins H, 2008, EUROSURVEILLANCE, V13; Costa ZB, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-116; de Lima KO, 2012, J CLIN MICROBIOL, V50, P2145, DOI 10.1128/JCM.05107-11; De Sa DJ, 2006, AIDS RES HUM RETROV, V22, P1; Dobbs T, 2004, J CLIN MICROBIOL, V42, P2623, DOI 10.1128/JCM.42.6.2623-2628.2004; Dobbs T, 2011, J CLIN MICROBIOL, V49, P3470, DOI 10.1128/JCM.01122-11; Dourado I, 2006, REV SAUDE PUBL, V40, P9, DOI 10.1590/S0034-89102006000800003; Fiamma A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-137; Fl Bastos, 2008, PUBLIC HLTH ASPECTS, P629, DOI DOI 10.1007/978-0-387-72711-0_29; Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1; Gouws E, 2008, SEX TRANSM INFECT, V84, pI17, DOI 10.1136/sti.2008.030452; Graf T, 2013, VIROLOGY, V435, P170, DOI 10.1016/j.virol.2012.08.048; Guimaraes ML, 2008, AIDS, V22, P433, DOI 10.1097/QAD.0b013e3282f47ad0; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hargrove JW, 2008, AIDS, V22, P511, DOI 10.1097/QAD.0b013e3282f2a960; IBGE, 2010, DEM CENS 2010 CHAR P; Karita E, 2007, AIDS, V21, P403, DOI 10.1097/QAD.0b013e32801481b7; Le Vu S, 2008, EUROSURVEILLANCE, V13; Lee LM, 2007, PUBLIC HEALTH REP, V122, P72, DOI 10.1177/00333549071220S111; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lopes Fernanda, 2007, Rev. Saúde Pública, V41, P39; Malta Monica, 2010, BMC Public Health, V10, P317, DOI 10.1186/1471-2458-10-317; McDougal JS, 2006, AIDS RES HUM RETROV, V22, P945, DOI 10.1089/aid.2006.22.945; McDougal JS, 2005, AIDS, V19, pS25, DOI 10.1097/01.aids.0000172874.90133.7a; Mercon M, 2009, BRAZ J INFECT DIS, V13, P272, DOI 10.1590/S1413-86702009000400006; Morgado MG, 2011, CAD SAUDE PUBLICA, V27, pS7, DOI 10.1590/S0102-311X2011001300002; Nelson KE, 2002, AM J EPIDEMIOL, V156, P641, DOI 10.1093/aje/kwf086; Oliveira CAD, 2005, J CLIN MICROBIOL, V43, P1439, DOI 10.1128/JCM.43.3.1439-1442.2005; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Pereira G, 2011, PERSPECTIVAS CONTROL, P335; Porco TC, 2004, AIDS, V18, P81, DOI 10.1097/00002030-200401020-00010; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; SABINO EC, 1994, J VIROL, V68, P6340, DOI 10.1128/JVI.68.10.6340-6346.1994; Cavalcanti AMS, 2012, BRAZ J INFECT DIS, V16, P157, DOI [10.1590/S1413-86702012000200009, 10.1016/S1413-8670(12)70298-2]; Sanabani SS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-74; Semaille C, 2008, EURO SURVEILL, V13; Stefani MMA, 2007, J CLIN VIROL, V39, P205, DOI 10.1016/j.jcv.2007.04.012; Stefani MMA, 2000, J ACQ IMMUN DEF SYND, V23, P205; Szwarcwald CL, 2006, ESTIMATIVA PREVALENC, P11; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tebit DM, 2011, LANCET INFECT DIS, V11, P45, DOI 10.1016/S1473-3099(10)70186-9; Teixeira SLM, 2004, J CLIN VIROL, V31, P221, DOI 10.1016/j.jcv.2004.03.016; Turchi MD, 2002, J ACQ IMMUN DEF SYND, V30, P527, DOI 10.1097/00126334-200208150-00009; Tyndall MW, 2001, J ACQ IMMUN DEF SYND, V28, P351, DOI 10.1097/00126334-200112010-00008; UNAIDS, 2011, UNAIDS WORLDS AIDS D, P2011; UNAIDS, 2012, UNAIDS REP GLOB AIDS, P106; de Castro CAV, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-224; Veloso Valdiléa G, 2008, Rev. Saúde Pública, V42, P859, DOI 10.1590/S0034-89102008000500011; Walker N, 2004, LANCET, V363, P2180, DOI 10.1016/S0140-6736(04)16511-2	66	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79189	10.1371/journal.pone.0079189	http://dx.doi.org/10.1371/journal.pone.0079189			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223904	Green Published, gold, Green Submitted			2022-12-27	WOS:000326503400102
J	Sakakibara, M; Uenoyama, Y; Minabe, S; Watanabe, Y; Deura, C; Nakamura, S; Suzuki, G; Maeda, K; Tsukamura, H				Sakakibara, Mototsugu; Uenoyama, Yoshihisa; Minabe, Shiori; Watanabe, Youki; Deura, Chikaya; Nakamura, Sho; Suzuki, Genki; Maeda, Kei-ichiro; Tsukamura, Hiroko			Microarray Analysis of Perinatal-Estrogen-Induced Changes in Gene Expression Related to Brain Sexual Differentiation in Mice	PLOS ONE			English	Article							LUTEINIZING-HORMONE SURGE; FEMALE RATS; PREOPTIC AREA; NEONATAL TREATMENT; BEHAVIOR; NEURONS; ESTRADIOL; MOUSE; DIFFERENCE; FOREBRAIN	Sexual dimorphism of the behaviors or physiological functions in mammals is mainly due to the sex difference of the brain. A number of studies have suggested that the brain is masculinized or defeminized by estradiol converted from testicular androgens in perinatal period in rodents. However, the mechanisms of estrogen action resulting in masculinization/defeminization of the brain have not been clarified yet. The large-scale analysis with microarray in the present study is an attempt to obtain the candidate gene(s) mediating the perinatal estrogen effect causing the brain sexual differentiation. Female mice were injected with estradiol benzoate (EB) or vehicle on the day of birth, and the hypothalamus was collected at either 1, 3, 6, 12, or 24 h after the EB injection. More than one hundred genes down-regulated by the EB treatment in a biphasic manner peaked at 3 h and 12-24 h after the EB treatment, while forty to seventy genes were constantly up-regulated after it. Twelve genes, including Ptgds, Hcrt, Tmed2, Klc1, and Nedd4, whose mRNA expressions were down-regulated by the neonatal EB treatment, were chosen for further examination by semiquantitative RT-PCR in the hypothalamus of perinatal intact male and female mice. We selected the genes based on the known profiles of their potential roles in brain development. mRNA expression levels of Ptgds, Hcrt, Tmed2, and Nedd4 were significantly lower in male mice than females at the day of birth, suggesting that the genes are down-regulated by estrogen converted from testicular androgen in perinatal male mice. Some genes, such as Ptgds encoding prostaglandin D2 production enzyme and Hcrt encording orexin, have been reported to have a role in neuroprotection. Thus, Ptgds and Hcrt could be possible candidate genes, which may mediate the effect of perinatal estrogen responsible for brain sexual differentiation.	[Sakakibara, Mototsugu; Uenoyama, Yoshihisa; Minabe, Shiori; Watanabe, Youki; Deura, Chikaya; Tsukamura, Hiroko] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Sakakibara, Mototsugu] Mitsubishi Chem Medience Corp, Adv Med Sci Res Dept, Ibaraki, Japan; [Suzuki, Genki] Mitsubishi Chem Medience Corp, Mol Genet Res & Anal Dept, Tokyo, Japan; [Nakamura, Sho; Maeda, Kei-ichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Med Sci, Tokyo, Japan	Nagoya University; University of Tokyo	Tsukamura, H (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	htsukamura@nagoya-u.jp	Minabe, Shiori/AAJ-7486-2021; Tsukamura, Hiroko/AAC-5632-2022	Minabe, Shiori/0000-0001-7902-925X; Uenoyama, Yoshihisa/0000-0002-8272-2781	Japan Society for the Promotion Sciences (JSPS) [23380163, 23580402, 24380157]; Grants-in-Aid for Scientific Research [12J05310] Funding Source: KAKEN	Japan Society for the Promotion Sciences (JSPS); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by the Research Program on Innovative Technologies for Animal Breeding, Reproduction, and Vaccine Development to H. T., Grants-in Aid No. 23380163 to H. T., No. 23580402 to Y.U., and No. 24380157 to K. M. from the Japan Society for the Promotion Sciences (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S, 2007, J REPROD DEVELOP, V53, P367, DOI 10.1262/jrd.18146; Baxter KK, 2009, ASN NEURO, V1, DOI 10.1042/AN20090036; Berridge CW, 2010, BRAIN RES, V1314, P91, DOI 10.1016/j.brainres.2009.09.019; Cooke B, 1998, FRONT NEUROENDOCRIN, V19, P323, DOI 10.1006/frne.1998.0171; CORBIER P, 1983, PHYSIOL BEHAV, V30, P613, DOI 10.1016/0031-9384(83)90229-9; Davis EC, 1996, NEUROENDOCRINOLOGY, V63, P142, DOI 10.1159/000126950; Diao JK, 2010, THEOR CHEM ACC, V125, P397, DOI 10.1007/s00214-009-0677-y; DIAZ DR, 1995, DEV BRAIN RES, V86, P227; Forger NG, 2004, P NATL ACAD SCI USA, V101, P13666, DOI 10.1073/pnas.0404644101; GERALL AA, 1967, ANAT REC, V157, P97, DOI 10.1002/ar.1091570114; GORSKI RA, 1978, BRAIN RES, V148, P333, DOI 10.1016/0006-8993(78)90723-0; Gorski RA, 1971, FRONT NEUROENDOCRIN, P237; Hadjimarkou MM, 2008, EUR J NEUROSCI, V27, P1780, DOI 10.1111/j.1460-9568.2008.06142.x; Hajj GNM, 2007, J CELL SCI, V120, P1915, DOI 10.1242/jcs.03459; Hirokawa N, 2008, PHYSIOL REV, V88, P1089, DOI 10.1152/physrev.00023.2007; Homma T, 2009, BIOL REPROD, V81, P1216, DOI 10.1095/biolreprod.109.078311; Jerome-Majewska LA, 2010, DEV BIOL, V341, P154, DOI 10.1016/j.ydbio.2010.02.019; Kauffman AS, 2007, ENDOCRINOLOGY, V148, P1774, DOI 10.1210/en.2006-1540; Kauffman AS, 2009, PEPTIDES, V30, P83, DOI 10.1016/j.peptides.2008.06.014; Kinoshita M, 2005, ENDOCRINOLOGY, V146, P4431, DOI 10.1210/en.2005-0195; KONDO Y, 1986, PHYSIOL BEHAV, V37, P495, DOI 10.1016/0031-9384(86)90212-X; Kouki T, 2003, HORM BEHAV, V44, P140, DOI 10.1016/S0018-506X(03)00122-3; Kouki T, 2005, BRAIN RES BULL, V64, P449, DOI 10.1016/j.brainresbull.2004.10.002; Lenz KM, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00026; Liang XB, 2005, J NEUROCHEM, V92, P477, DOI 10.1111/j.1471-4159.2004.02870.x; Matsuda KI, 2012, REV ENDOCR METAB DIS, V13, P163, DOI 10.1007/s11154-012-9202-z; Mccarthy MM, 2008, PHYSIOL REV, V88, P91, DOI 10.1152/physrev.00010.2007; MCEWEN BS, 1977, HORM BEHAV, V9, P249, DOI 10.1016/0018-506X(77)90060-5; Mong JA, 2004, MOL PSYCHIATR, V9, P550, DOI 10.1038/sj.mp.4001493; Mong JA, 2003, P NATL ACAD SCI USA, V100, P318, DOI 10.1073/pnas.262663799; MULLINS RF, 1968, PHYSIOL BEHAV, V3, P333, DOI 10.1016/0031-9384(68)90110-8; PFAFF DW, 1971, NEUROENDOCRINOLOGY, V7, P129, DOI 10.1159/000121961; Poling MC, 2012, ENDOCRINOLOGY, V153, P782, DOI 10.1210/en.2011-1838; Rassart E, 2000, BBA-PROTEIN STRUCT M, V1482, P185, DOI 10.1016/S0167-4838(00)00162-X; Reik W, 2000, INT J DEV BIOL, V44, P145; Sakakibara M, 2013, J NEUROENDOCRINOL, V25, P251, DOI 10.1111/j.1365-2826.2012.02389.x; Smith JT, 2006, J NEUROSCI, V26, P6687, DOI 10.1523/JNEUROSCI.1618-06.2006; Smith JT, 2005, ENDOCRINOLOGY, V146, P3686, DOI 10.1210/en.2005-0488; Sokolowska P, 2012, NEUROSCI LETT, V506, P303, DOI 10.1016/j.neulet.2011.11.028; Takahashi K, 2008, J COMP NEUROL, V509, P180, DOI 10.1002/cne.21740; THOMAS CN, 1969, PSYCHON SCI, V16, P19; Tsukamura H, 2010, ANN NY ACAD SCI, V1200, P95, DOI 10.1111/j.1749-6632.2010.05645.x; Urade Y, 1999, BBA-MOL CELL BIOL L, V1436, P606, DOI 10.1016/S0005-2760(98)00163-5; VREEBURG JTM, 1977, J ENDOCRINOL, V74, P375, DOI 10.1677/joe.0.0740375; Wagner CK, 2001, J NEUROBIOL, V47, P176, DOI 10.1002/neu.1025; Waite MR, 2011, DEV DYNAM, V240, P333, DOI 10.1002/dvdy.22532; WHALEN RE, 1963, SCIENCE, V141, P273, DOI 10.1126/science.141.3577.273; Yang B, 2010, CELL DEATH DIFFER, V17, P68, DOI 10.1038/cdd.2009.84	48	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79437	10.1371/journal.pone.0079437	http://dx.doi.org/10.1371/journal.pone.0079437			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223949	gold, Green Published, Green Submitted			2022-12-27	WOS:000326503400114
J	De Clercq, S; Boucherie, C; Vandekerckhove, J; Gettemans, J; Guillabert, A				De Clercq, Sarah; Boucherie, Ciska; Vandekerckhove, Joel; Gettemans, Jan; Guillabert, Aude			L-Plastin Nanobodies Perturb Matrix Degradation, Podosome Formation, Stability and Lifetime in THP-1 Macrophages	PLOS ONE			English	Article							LEUKEMIA-CELL LINE; ENDOTHELIAL-CELLS; ACTIN; PROTEIN; GELSOLIN; INVADOPODIA; PHOSPHORYLATION; DOMAIN; PHAGOCYTOSIS; ORGANIZATION	Podosomes are cellular structures acting as degradation 'hot-spots' in monocytic cells. They appear as dot-like structures at the ventral cell surface, enriched in F-actin and actin regulators, including gelsolin and L-plastin. Gelsolin is an ubiquitous severing and capping protein, whereas L-plastin is a leukocyte-specific actin bundling protein. The presence of the capping protein CapG in podosomes has not yet been investigated. We used an innovative approach to investigate the role of these proteins in macrophage podosomes by means of nanobodies or Camelid single domain antibodies. Nanobodies directed against distinct domains of gelsolin, L-plastin or CapG were stably expressed in macrophage-like THP-1 cells. CapG was not enriched in podosomes. Gelsolin nanobodies had no effect on podosome formation or function but proved very effective in tracing distinct gelsolin populations. One gelsolin nanobody specifically targets actin-bound gelsolin and was effectively enriched in podosomes. A gelsolin nanobody that blocks gelsolin-G-actin interaction was not enriched in podosomes demonstrating that the calcium-activated and actin-bound conformation of gelsolin is a constituent of podosomes. THP-1 cells expressing inhibitory L-plastin nanobodies were hampered in their ability to form stable podosomes. Nanobodies did not perturb Ser5 phosphorylation of L-plastin although phosphorylated L-plastin was highly enriched in podosomes. Furthermore, nanobody-induced inhibition of L-plastin function gave rise to an irregular and unstable actin turnover of podosomes, resulting in diminished degradation of the underlying matrix. Altogether these results indicate that L-plastin is indispensable for podosome formation and function in macrophages.	[De Clercq, Sarah; Boucherie, Ciska; Vandekerckhove, Joel; Gettemans, Jan; Guillabert, Aude] Univ Ghent, Fac Med & Hlth Sci, Dept Biochem, B-9000 Ghent, Belgium	Ghent University	Gettemans, J (corresponding author), Univ Ghent, Fac Med & Hlth Sci, Dept Biochem, B-9000 Ghent, Belgium.	jan.gettemans@ugent.be			League against Cancer (Stichting tegen Kanker, Belgium); Ghent University (BOF-GOA); Research Foundation-Flanders (FWO-Vlaanderen); Interuniversity Attraction Poles Programme; Ghent University	League against Cancer (Stichting tegen Kanker, Belgium); Ghent University (BOF-GOA)(Ghent University); Research Foundation-Flanders (FWO-Vlaanderen)(FWO); Interuniversity Attraction Poles Programme(Belgian Federal Science Policy Office); Ghent University(Ghent University)	This work was supported by grants from the League against Cancer (Stichting tegen Kanker, Belgium), Ghent University (BOF-GOA), the Research Foundation-Flanders (FWO-Vlaanderen), and the Interuniversity Attraction Poles Programme initiated by the Belgian Science Policy Office. SDC was supported by Ghent University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRINK M, 1994, LEUKEMIA, V8, P1579; Al Tanoury Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009210; Alexander NR, 2008, CURR BIOL, V18, P1295, DOI 10.1016/j.cub.2008.07.090; AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; Babb SG, 1997, CELL MOTIL CYTOSKEL, V37, P308; Banon-Rodriguez I, 2011, EUR J CELL BIOL, V90, P213, DOI 10.1016/j.ejcb.2010.09.001; Bhuwania R, 2012, J CELL SCI, V125, P2300, DOI 10.1242/jcs.100032; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Burger KL, 2011, CYTOSKELETON, V68, P694, DOI 10.1002/cm.20545; Burns S, 2001, BLOOD, V98, P1142, DOI 10.1182/blood.V98.4.1142; Calle Y, 2006, EUR J CELL BIOL, V85, P151, DOI 10.1016/j.ejcb.2005.09.003; Chellaiah M, 2000, J CELL BIOL, V148, P665, DOI 10.1083/jcb.148.4.665; Chellaiah M, 1998, J BIOL CHEM, V273, P11908, DOI 10.1074/jbc.273.19.11908; Cooper JA, 2000, CURR OPIN CELL BIOL, V12, P97, DOI 10.1016/S0955-0674(99)00062-9; Cougoule C, 2010, BLOOD, V115, P1444, DOI 10.1182/blood-2009-04-218735; De Clercq S, 2013, CELL MOL LIFE SCI, V70, P909, DOI 10.1007/s00018-012-1169-0; De Corte V, 2002, EMBO J, V21, P6781, DOI 10.1093/emboj/cdf680; Delanote V, 2010, FASEB J, V24, P105, DOI 10.1096/fj.09-134304; Destaing O, 2003, MOL BIOL CELL, V14, P407, DOI 10.1091/mbc.E02-07-0389; Dreier R, 2004, EXP CELL RES, V297, P303, DOI 10.1016/j.yexcr.2004.02.027; Esparza J, 1999, BLOOD, V94, P2754, DOI 10.1182/blood.V94.8.2754.420k09_2754_2766; Evans JG, 2003, J CELL BIOL, V161, P697, DOI 10.1083/jcb.200212037; Gauvin TJ, 2009, BIOCHEMISTRY-US, V48, P9327, DOI 10.1021/bi901354z; Guiet R, 2012, J BIOL CHEM, V287, P13051, DOI 10.1074/jbc.M111.307124; Hai CM, 2002, EXP CELL RES, V280, P64, DOI 10.1006/excr.2002.5592; Hammarfjord O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021615; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Hmila I, 2010, FASEB J, V24, P3479, DOI 10.1096/fj.09-148213; Hultberg A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017665; Irobi J, 2004, NAT GENET, V36, P597, DOI 10.1038/ng1328; Janji B, 2006, J CELL SCI, V119, P1947, DOI 10.1242/jcs.02874; Jones SL, 1996, J BIOL CHEM, V271, P14623, DOI 10.1074/jbc.271.24.14623; KELLY T, 1994, J CELL PHYSIOL, V158, P299, DOI 10.1002/jcp.1041580212; Khurana S, 2008, FEBS LETT, V582, P2128, DOI 10.1016/j.febslet.2008.02.040; Labernadie A, 2010, P NATL ACAD SCI USA, V107, P21016, DOI 10.1073/pnas.1007835107; LEAVITT J, 1994, ELECTROPHORESIS, V15, P345, DOI 10.1002/elps.1150150154; Li A, 2010, CURR BIOL, V20, P339, DOI 10.1016/j.cub.2009.12.035; Linder S, 2005, J CELL SCI, V118, P2079, DOI 10.1242/jcs.02390; Linder S, 1999, P NATL ACAD SCI USA, V96, P9648, DOI 10.1073/pnas.96.17.9648; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Linder S, 2011, ANNU REV CELL DEV BI, V27, P185, DOI 10.1146/annurev-cellbio-092910-154216; Luxenburg C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000179; Luxenburg C, 2012, J CELL SCI, V125, P1666, DOI 10.1242/jcs.075903; Ma T, 2010, J BIOL CHEM, V285, P29911, DOI 10.1074/jbc.M109.099697; MESSIER JM, 1993, CELL MOTIL CYTOSKEL, V25, P223, DOI 10.1002/cm.970250303; Morley Sharon Celeste, 2012, Int J Cell Biol, V2012, P935173, DOI 10.1155/2012/935173; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; NAMBA Y, 1992, J BIOCHEM-TOKYO, V112, P503, DOI 10.1093/oxfordjournals.jbchem.a123929; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Ochs HD, 2001, CLIN REV ALLERG IMMU, V20, P61, DOI 10.1385/CRIAI:20:1:61; Osiak AE, 2005, EXP CELL RES, V307, P342, DOI 10.1016/j.yexcr.2005.03.035; Parikh SS, 2003, INFECT IMMUN, V71, P6582, DOI 10.1128/IAI.71.11.6582-6590.2003; PARK TS, 1994, CANCER RES, V54, P1775; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rizvi SA, 2009, CHEM BIOL, V16, P1158, DOI 10.1016/j.chembiol.2009.10.006; SHINOMIYA H, 1995, J IMMUNOL, V154, P3471; Silacci P, 2004, CELL MOL LIFE SCI, V61, P2614, DOI 10.1007/s00018-004-4225-6; SUN HQ, 1995, J CELL BIOL, V129, P147, DOI 10.1083/jcb.129.1.147; Tatin F, 2006, J CELL SCI, V119, P769, DOI 10.1242/jcs.02787; Tsuboi S, 2007, J IMMUNOL, V178, P2987, DOI 10.4049/jimmunol.178.5.2987; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Van Audenhove I, 2013, CYTOSKELETON, V70, P604, DOI 10.1002/cm.21122; Van Bockstaele F, 2009, CURR OPIN INVEST DR, V10, P1212; van den Abbeele A, 2007, CANCER LETT, V255, P57, DOI 10.1016/j.canlet.2007.03.023; Van den Abbeele A, 2010, CELL MOL LIFE SCI, V67, P1519, DOI 10.1007/s00018-010-0266-1; Varon C, 2006, MOL CELL BIOL, V26, P3582, DOI 10.1128/MCB.26.9.3582-3594.2006; Weaver AM, 2006, CLIN EXP METASTAS, V23, P97, DOI 10.1007/s10585-006-9014-1; Wernimont SA, 2008, EUR J CELL BIOL, V87, P507, DOI 10.1016/j.ejcb.2008.01.011; Witke W, 2001, J CELL BIOL, V154, P775, DOI 10.1083/jcb.200101113; Xiao HL, 2010, MOL CELL BIOL, V30, P5545, DOI 10.1128/MCB.00382-10; Yamaguchi H, 2006, EUR J CELL BIOL, V85, P213, DOI 10.1016/j.ejcb.2005.10.004; Yamakita Y, 2011, J IMMUNOL, V186, P2850, DOI 10.4049/jimmunol.1001667; YIN HL, 1979, NATURE, V281, P583, DOI 10.1038/281583a0; YIN HL, 1980, J BIOL CHEM, V255, P9490; YOUNG CL, 1990, BIOCHEMISTRY-US, V29, P2232, DOI 10.1021/bi00461a005; YU FX, 1990, SCIENCE, V250, P1413, DOI 10.1126/science.2255912	79	23	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78108	10.1371/journal.pone.0078108	http://dx.doi.org/10.1371/journal.pone.0078108			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236012	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700009
J	Eloot, S; Van Biesen, W; Glorieux, G; Neirynck, N; Dhondt, A; Vanholder, R				Eloot, Sunny; Van Biesen, Wim; Glorieux, Griet; Neirynck, Nathalie; Dhondt, Annemieke; Vanholder, Raymond			Does the Adequacy Parameter Kt/V-urea Reflect Uremic Toxin Concentrations in Hemodialysis Patients?	PLOS ONE			English	Article							RESIDUAL RENAL-FUNCTION; PROTEIN CATABOLIC RATE; GLYCATION END-PRODUCTS; HIGH-FLUX HEMODIALYSIS; CONVENTIONAL HEMODIALYSIS; P-CRESOL; BETA-2-MICROGLOBULIN LEVELS; METABOLIC PHENOTYPES; NUTRITIONAL-STATUS; RETENTION SOLUTES	Hemodialysis aims at removing uremic toxins thus decreasing their concentrations. The present study investigated whether Kt/V-urea, used as marker of dialysis adequacy, is correlated with these concentrations. Predialysis blood samples were taken before a midweek session in 71 chronic HD patients. Samples were analyzed by colorimetry, HPLC, or ELISA for a broad range of uremic solutes. Solute concentrations were divided into four groups according to quartiles of Kt/V-urea, and also of different other parameters with potential impact, such as age, body weight (BW), Protein equivalent of Nitrogen Appearance (PNA), Residual Renal Function (RRF), and dialysis vintage. Dichotomic concentration comparisons were performed for gender and Diabetes Mellitus (DM). Analysis of Variance in quartiles of Kt/V-urea did not show significant differences for any of the solute concentrations. For PNA, however, concentrations showed significant differences for urea (P<0.001), uric acid (UA), p-cresylsulfate (PCS), and free PCS (all P<0.01), and for creatinine (Crea) and hippuric acid (HA) (both P<0.05). For RRF, concentrations varied for beta(2)-microglobulin (P<0.001), HA, free HA, free indoxyl sulfate, and free indole acetic acid (all P<0.01), and for p-cresylglucuronide (PCG), 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid (CMPF), free PCS, and free PCG (all P<0.05). Gender and body weight only showed differences for Crea and UA, while age, vintage, and diabetes mellitus only showed differences for one solute concentration (UA, UA, and free PCS, respectively). Multifactor analyses indicated a predominant association of concentration with protein intake and residual renal function. In conclusion, predialysis concentrations of uremic toxins seem to be dependent on protein equivalent of nitrogen appearance and residual renal function, and not on dialysis adequacy as assessed by Kt/V-urea. Efforts to control intestinal load of uremic toxin precursors by dietary or other interventions, and preserving RRF seem important approaches to decrease uremic solute concentration and by extension their toxicity.	[Eloot, Sunny; Van Biesen, Wim; Glorieux, Griet; Neirynck, Nathalie; Dhondt, Annemieke; Vanholder, Raymond] Ghent Univ Hosp, Dept Internal Med, Nephrol Sect, Ghent, Belgium	Ghent University; Ghent University Hospital	Eloot, S (corresponding author), Ghent Univ Hosp, Dept Internal Med, Nephrol Sect, Ghent, Belgium.	sunny.eloot@ugent.be			Fresenius Medical Care; Baxter Healthcare; Gambro; Bellco	Fresenius Medical Care; Baxter Healthcare; Gambro; Bellco	Raymond Vanholder receives unrestricted research grants from Fresenius Medical Care, Baxter Healthcare, Gambro, and Bellco. The funding that Raymond Vanholder received is not related to the submitted study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	ACCHIARDO SR, 1983, KIDNEY INT S16, V24, P199; [Anonymous], 2002, NEPHROL DIAL TRAN S7, V17, P16; Aronov PA, 2011, J AM SOC NEPHROL, V22, P1769, DOI 10.1681/ASN.2010121220; Ayus JC, 2005, J AM SOC NEPHROL, V16, P2778, DOI 10.1681/ASN.2005040392; Azar AT, 2007, AM J NEPHROL, V27, P113, DOI 10.1159/000099836; Bammens B, 2004, AM J CLIN NUTR, V80, P1536, DOI 10.1093/ajcn/80.6.1536; Bammens B, 2003, KIDNEY INT, V64, P2238, DOI 10.1046/j.1523-1755.2003.00310.x; Bammens B, 2006, KIDNEY INT, V69, P1081, DOI 10.1038/sj.ki.5000115; Barreto FC, 2009, CLIN J AM SOC NEPHRO, V4, P1551, DOI 10.2215/CJN.03980609; Basile C, 2011, NEPHROL DIAL TRANSPL, V26, P1296, DOI 10.1093/ndt/gfq543; BERGSTROM J, 1995, J AM SOC NEPHROL, V6, P1329; BOUMENDILPODEVIN EF, 1975, J CLIN INVEST, V55, P1142, DOI 10.1172/JCI108031; Chertow GM, 2010, NEW ENGL J MED, V363, P2287, DOI 10.1056/NEJMoa1001593; Cheung AK, 2008, CLIN J AM SOC NEPHRO, V3, P69, DOI 10.2215/CJN.02340607; Cheung AK, 2006, J AM SOC NEPHROL, V17, P546, DOI 10.1681/ASN.2005020132; Culleton BF, 2007, JAMA-J AM MED ASSOC, V298, P1291, DOI 10.1001/jama.298.11.1291; Daugirdas JT, 2010, KIDNEY INT, V77, P637, DOI 10.1038/ki.2009.525; DAUGIRDAS JT, 1993, J AM SOC NEPHROL, V4, P1205; Daugirdas JT, 1997, KIDNEY INT, V51, P1270, DOI 10.1038/ki.1997.173; Duranton F, 2012, J AM SOC NEPHROL, V23, P1258, DOI 10.1681/ASN.2011121175; Eloot S, 2008, KIDNEY INT, V73, P765, DOI 10.1038/sj.ki.5002750; Eloot S, 2005, KIDNEY INT, V67, P1566, DOI 10.1111/j.1523-1755.2005.00238.x; Eloot S, 2007, AM J KIDNEY DIS, V50, P279, DOI 10.1053/j.ajkd.2007.05.009; Eloot S, 2011, CLIN J AM SOC NEPHRO, V6, P1266, DOI 10.2215/CJN.09981110; Eloot S, 2009, NEPHROL DIAL TRANSPL, V24, P2225, DOI 10.1093/ndt/gfp059; Evenepoel P, 2006, KIDNEY INT, V70, P794, DOI 10.1038/sj.ki.5001640; Evenepoel P, 2009, KIDNEY INT, V76, pS12, DOI 10.1038/ki.2009.402; Fagugli RM, 2002, AM J KIDNEY DIS, V40, P339, DOI 10.1053/ajkd.2002.34518; Fagugli RM, 2001, INT J ARTIF ORGANS, V24, P256, DOI 10.1177/039139880102400503; Fouque D, 2007, NEPHROL DIAL TRANSPL, V22, P45, DOI 10.1093/ndt/gfm020; Fry AC, 2007, BLOOD PURIFICAT, V25, P295, DOI 10.1159/000104870; Fujita T, 2012, J PHARMACOL EXP THER, V341, P626, DOI 10.1124/jpet.111.187732; GOTCH FA, 1985, KIDNEY INT, V28, P526, DOI 10.1038/ki.1985.160; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Heinzmann SS, 2012, J PROTEOME RES, V11, P643, DOI 10.1021/pr2005764; Herzog CA, 2002, NEPHROL DIAL TRANSPL, V17, P7, DOI 10.1093/ndt/17.1.7; Kalantar-Zadeh K, 2004, J AM SOC NEPHROL, V15, P442, DOI 10.1097/01.ASN.0000107564.60018.51; Kielstein JT, 2004, CIRCULATION, V109, P172, DOI 10.1161/01.CIR.0000105764.22626.B1; Kloppenburg WD, 1999, KIDNEY INT, V55, P1961, DOI 10.1046/j.1523-1755.1999.00412.x; Krediet RT, 2006, NEPHROL DIAL TRANSPL, V21, pii42; Kusumoto M, 2011, CLIN EXP NEPHROL, V15, P820, DOI 10.1007/s10157-011-0524-z; LAIRD NM, 1983, KIDNEY INT, pS101; Liabeuf S, 2010, NEPHROL DIAL TRANSPL, V25, P1183, DOI 10.1093/ndt/gfp592; LINDSAY RM, 1989, AM J KIDNEY DIS, V13, P382, DOI 10.1016/S0272-6386(89)80021-6; Locatelli F, 2009, J AM SOC NEPHROL, V20, P645, DOI 10.1681/ASN.2008060590; LOPOT F, 1995, ARTIF ORGANS, V19, P832, DOI 10.1111/j.1525-1594.1995.tb02436.x; Marcen R, 1997, NEPHROL DIAL TRANSPL, V12, P2324, DOI 10.1093/ndt/12.11.2324; Marquez IO, 2011, CLIN J AM SOC NEPHRO, V6, P290, DOI 10.2215/CJN.06100710; McGregor DO, 2001, BLOOD PURIFICAT, V19, P293, DOI 10.1159/000046957; Meijers BKI, 2008, KIDNEY INT, V73, P1174, DOI 10.1038/ki.2008.31; Meijers BKI, 2009, AM J KIDNEY DIS, V54, P891, DOI 10.1053/j.ajkd.2009.04.022; Meyer TW, 2007, NEW ENGL J MED, V357, P1316, DOI 10.1056/NEJMra071313; Meyer TW, 2011, SEMIN DIALYSIS, V24, P471, DOI 10.1111/j.1525-139X.2011.00979.x; *NAT KIDN FDN, 2000, AM J KIDNEY DIS S, V35, pS1, DOI DOI 10.1053/KD.2000.6671; Neirynck N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044201; Penne EL, 2010, CLIN J AM SOC NEPHRO, V5, P80, DOI 10.2215/CJN.03340509; Port FK, 2004, AM J KIDNEY DIS, V43, P1014, DOI 10.1053/j.ajkd.2004.02.014; Port FK, 2004, BLOOD PURIFICAT, V22, P175, DOI 10.1159/000074938; Rocco MV, 2011, KIDNEY INT, V80, P1080, DOI 10.1038/ki.2011.213; Rocco MV, 2004, KIDNEY INT, V65, P2321, DOI 10.1111/j.1523-1755.2004.00647.x; Santoro A, 2008, AM J KIDNEY DIS, V52, P507, DOI 10.1053/j.ajkd.2008.05.011; Saran Rajiv, 2004, Am J Kidney Dis, V44, P47, DOI 10.1053/j.ajkd.2004.08.011; Schepers E, 2010, BLOOD PURIFICAT, V29, P130, DOI 10.1159/000245639; Schulman G, 2004, SEMIN DIALYSIS, V17, P479, DOI 10.1111/j.0894-0959.2004.17609.x; Schwedler SB, 2002, KIDNEY INT, V62, P301, DOI 10.1046/j.1523-1755.2002.00423.x; Sirich TL, 2012, NEPHROL DIAL TRANSPL, V27, P1574, DOI 10.1093/ndt/gfr691; Spoto B, 2007, J NEPHROL, V20, P554; STEGEMAN CA, 1995, AM J KIDNEY DIS, V25, P887, DOI 10.1016/0272-6386(95)90571-5; Suda T, 2000, NEPHROL DIAL TRANSPL, V15, P396, DOI 10.1093/ndt/15.3.396; Suliman ME, 2004, AM J KIDNEY DIS, V44, P455, DOI 10.1053/j.ajkd.2004.04.049; Suliman M, 2007, NEPHROL DIAL TRANSPL, V22, P209, DOI 10.1093/ndt/gfl510; Swann JR, 2011, J PROTEOME RES, V10, P3590, DOI 10.1021/pr200243t; Tattersall JE, 1996, KIDNEY INT, V50, P2094, DOI 10.1038/ki.1996.534; VANHOLDER R, 1992, KIDNEY INT, V41, P1707, DOI 10.1038/ki.1992.244; Vanholder R, 2006, BLOOD PURIFICAT, V24, P33, DOI 10.1159/000089434; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Vanholder R, 2008, J AM SOC NEPHROL, V19, P863, DOI 10.1681/ASN.2007121377; Vanholder R, 2012, J AM SOC NEPHROL, V23, P1291, DOI 10.1681/ASN.2011111094; Vanholder R, 2012, SEMIN DIALYSIS, V25, P9, DOI 10.1111/j.1525-139X.2011.01003.x; VAZIRI ND, 1995, J AM SOC NEPHROL, V6, P1313; Viaene L, 2012, NEPHROL DIAL TRANSPL, V27, P2017, DOI 10.1093/ndt/gfr596; Walsh M, 2010, HEMODIAL INT, V14, P174, DOI 10.1111/j.1542-4758.2009.00418.x; Yilmaz MI, 2008, J AM SOC NEPHROL, V19, P388, DOI 10.1681/ASN.2007040461; Yu MA, 2010, J HYPERTENS, V28, P1234, DOI 10.1097/HJH.0b013e328337da1d; Zoccali C, 2006, J AM SOC NEPHROL, V17, P1466, DOI 10.1681/ASN.2005090949	85	57	58	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e76838	10.1371/journal.pone.0076838	http://dx.doi.org/10.1371/journal.pone.0076838			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236005	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700001
J	Laeyendecker, O; Kulich, M; Donnell, D; Komarek, A; Omelka, M; Mullis, CE; Szekeres, G; Piwowar-Manning, E; Fiamma, A; Gray, RH; Lutalo, T; Morrison, CS; Salata, RA; Chipato, T; Celum, C; Kahle, EM; Taha, TE; Kumwenda, NI; Karim, QA; Naranbhai, V; Lingappa, JR; Sweat, MD; Coates, T; Eshleman, SH				Laeyendecker, Oliver; Kulich, Michal; Donnell, Deborah; Komarek, Arnost; Omelka, Marek; Mullis, Caroline E.; Szekeres, Greg; Piwowar-Manning, Estelle; Fiamma, Agnes; Gray, Ronald H.; Lutalo, Tom; Morrison, Charles S.; Salata, Robert A.; Chipato, Tsungai; Celum, Connie; Kahle, Erin M.; Taha, Taha E.; Kumwenda, Newton I.; Karim, Quarraisha Abdool; Naranbhai, Vivek; Lingappa, Jairam R.; Sweat, Michael D.; Coates, Thomas; Eshleman, Susan H.			Development of Methods for Cross-Sectional HIV Incidence Estimation in a Large, Community Randomized Trial	PLOS ONE			English	Article							ENZYME-IMMUNOASSAY; PROJECT ACCEPT; RAKAI DISTRICT; UNITED-STATES; PREVENTION; TRANSMISSION; SPECIFICITY; ACYCLOVIR; INFECTION; UGANDA	Background: Accurate methods of HIV incidence determination are critically needed to monitor the epidemic and determine the population level impact of prevention trials. One such trial, Project Accept, a Phase III, community-randomized trial, evaluated the impact of enhanced, community-based voluntary counseling and testing on population-level HIV incidence. The primary endpoint of the trial was based on a single, cross-sectional, post-intervention HIV incidence assessment. Methods and Findings: Test performance of HIV incidence determination was evaluated for 403 multi-assay algorithms [MAAs] that included the BED capture immunoassay [BED-CEIA] alone, an avidity assay alone, and combinations of these assays at different cutoff values with and without CD4 and viral load testing on samples from seven African cohorts (5,325 samples from 3,436 individuals with known duration of HIV infection [1 month to >10 years]). The mean window period (average time individuals appear positive for a given algorithm) and performance in estimating an incidence estimate (in terms of bias and variance) of these MAAs were evaluated in three simulated epidemic scenarios (stable, emerging and waning). The power of different test methods to detect a 35% reduction in incidence in the matched communities of Project Accept was also assessed. A MAA was identified that included BED-CEIA, the avidity assay, CD4 cell count, and viral load that had a window period of 259 days, accurately estimated HIV incidence in all three epidemic settings and provided sufficient power to detect an intervention effect in Project Accept. Conclusions: In a Southern African setting, HIV incidence estimates and intervention effects can be accurately estimated from cross-sectional surveys using a MAA. The improved accuracy in cross-sectional incidence testing that a MAA provides is a powerful tool for HIV surveillance and program evaluation.	[Laeyendecker, Oliver] NIAID, NIH, Bethesda, MD 20892 USA; [Laeyendecker, Oliver; Mullis, Caroline E.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Kulich, Michal; Komarek, Arnost; Omelka, Marek] Charles Univ Prague, Fac Math & Phys, Dept Probabil & Stat, Prague, Czech Republic; [Donnell, Deborah] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98104 USA; [Szekeres, Greg; Fiamma, Agnes; Coates, Thomas] Univ Calif Los Angeles, UCLA Program Global Hlth, Los Angeles, CA USA; [Piwowar-Manning, Estelle; Eshleman, Susan H.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Gray, Ronald H.; Taha, Taha E.; Kumwenda, Newton I.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Gray, Ronald H.; Lutalo, Tom] Rakai Hlth Sci Program, Entebbe, Uganda; [Morrison, Charles S.] Family Hlth Int, Clin Sci, Durham, NC USA; [Salata, Robert A.] Case Western Reserve Univ, Div Infect Dis & HIV Med, Cleveland, OH 44106 USA; [Salata, Robert A.] Univ Hosp Cleveland, Case Med Ctr, Cleveland, OH 44106 USA; [Chipato, Tsungai] Univ Zimbabwe, Harare, Zimbabwe; [Celum, Connie] Univ Washington, Dept Global Hlth Med & Epidemiol, Seattle, WA 98195 USA; [Kahle, Erin M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Karim, Quarraisha Abdool] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Naranbhai, Vivek] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, Ctr AIDS Programme Res South Africa CAPRISA, Congella, South Africa; [Lingappa, Jairam R.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Lingappa, Jairam R.] Univ Washington, Dept Med & Pediat, Seattle, WA 98195 USA; [Sweat, Michael D.] Med Univ S Carolina, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Charles University Prague; Fred Hutchinson Cancer Center; University of California System; University of California Los Angeles; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Rakai Health Sciences Program; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; University of Zimbabwe; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Columbia University; University of Kwazulu Natal; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Medical University of South Carolina	Laeyendecker, O (corresponding author), NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	olaeyen1@jhmi.edu	Komarek, Arnost/A-5534-2012; Omelka, Marek/AAG-9535-2019; Kulich, Michal/B-1483-2013; Lingappa, Jairam/N-7760-2017; Omelka, Marek/I-2447-2014; Kumwenda, Newton/ADL-6890-2022; Abdool Karim, Quarraisha/GVS-1160-2022	Komarek, Arnost/0000-0001-8778-3762; Kulich, Michal/0000-0002-2812-8968; Omelka, Marek/0000-0002-0396-9373; Abdool Karim, Quarraisha/0000-0002-0985-477X; , Erin/0000-0001-6060-9852; Donnell, Deborah/0000-0002-0587-7480; Kumwenda, Newton/0000-0003-2622-4339; Laeyendecker, Oliver/0000-0002-6429-4760; Taha, Taha/0000-0001-9814-4894; Naranbhai, Vivek/0000-0003-4281-8882	U.S. National Institute of Mental Health [U01MH066687, U01MH066688, U01MH066701, U01MH066702]; HPTN Network Laboratory [U01AI068613/UM1AI068613]; SCHARP [U01AI068617/UM1AI068617]; HIV Prevention Trials Network of the Division of AIDS of the U.S. National Institute of Allergy and Infectious Diseases [U01AI068619/UM1AI068619]; Office of AIDS Research of the U.S. National Institutes of Health; Division of Intramural Research, NIAID, NIH [R01-AI095068]; PEPI [U50 PS022061-05, U50/CC0222061]; U.S. Centers for Disease Control and Prevention; Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH; Bill and Melinda Gates Foundation [26469]; US National Institutes of Health [P30 A127757, P01 057005, K08 AI0744248]; NIAID [R01 A134826, K22 AI092150-01, R01 A134265]; NICHD [RO1 HD 050180]; World Bank STI Project, Uganda; Henry M. Jackson Foundation; Fogarty Foundation [5D43TW00010]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD003310, R01HD050180] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW000010] Funding Source: NIH RePORTER; NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION [U50PS022061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068617, K22AI092150, R01AI095068, U01AI068613, U01AI052054, U01AI046749, ZIAAI000361, U01AI068619] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH066687, U01MH066702, U01MH066688, U01MH066701] Funding Source: NIH RePORTER	U.S. National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); HPTN Network Laboratory; SCHARP; HIV Prevention Trials Network of the Division of AIDS of the U.S. National Institute of Allergy and Infectious Diseases; Office of AIDS Research of the U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PEPI; U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); World Bank STI Project, Uganda; Henry M. Jackson Foundation; Fogarty Foundation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Primary sources of support: This research was sponsored by the U.S. National Institute of Mental Health as a cooperative agreement, through contracts U01MH066687 Johns Hopkins University - David Celentano, PI); U01MH066688 Medical University of South Carolina - Michael Sweat, PI); U01MH066701 University of California, Los Angeles - Thomas J. Coates, PI); and U01MH066702 University of California, San Francisco - Stephen F. Morin, PI). In addition, this work was supported as HPTN Protocol 043 through contracts U01AI068613/UM1AI068613 HPTN Network Laboratory - Susan Eshleman, PI); U01AI068617/UM1AI068617 SCHARP - Deborah Donnell, PI); and U01AI068619/UM1AI068619 HIV Prevention Trials Network - Sten Vermund/Wafaa El-Sadr, PIs) of the Division of AIDS of the U.S. National Institute of Allergy and Infectious Diseases; and by the Office of AIDS Research of the U. S. National Institutes of Health. Views expressed are those of the authors, and not necessarily those of sponsoring agencies. Additional support was provided by the Division of Intramural Research, NIAID, NIH and from R01-AI095068 Susan Eshleman/Ron Brookmeyer, PIs). Support for studies that provided samples and data for this work: 1) PEPI- Malawi Study: Cooperative Agreement U50 PS022061-05; Award # U50/CC0222061) from the U.S. Centers for Disease Control and Prevention and the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH. 2) Partners in Prevention HSV/HIV Transmission Study funded by the Bill and Melinda Gates Foundation grant 26469) with support from the US National Institutes of Health P30 A127757 to the University of Washington Center for AIDS Research, P01 057005, and K08 AI0744248). 3) Rakai Health Sciences Program was funded by NIAID grants R01 A134826, K22 AI092150-01, and R01 A134265); NICHD grant RO1 HD 050180); the World Bank STI Project, Uganda; the Henry M. Jackson Foundation; the Fogarty Foundation grant 5D43TW00010).	ABDOOL KQ, 2010, SCIENCE, V329, P1168, DOI DOI 10.1126/SCIENCE.1193748; Arroyo MA, 2006, JAIDS-J ACQ IMM DEF, V43, P440, DOI 10.1097/01.qai.0000243053.80945.f0; Brookmeyer R, 2010, JAIDS-J ACQ IMM DEF, V54, P406, DOI 10.1097/QAI.0b013e3181dc6d2c; Brookmeyer R, 2010, EPIDEMIOL REV, V32, P26, DOI 10.1093/epirev/mxq002; Brookmeyer R, 2009, AIDS, V23, P485, DOI 10.1097/QAD.0b013e3283269e28; Busch MP, 2010, AIDS, V24, P2763, DOI 10.1097/QAD.0b013e32833f1142; Campbell MS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016986, 10.1371/journal.pone.0018283]; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; Chang LW, 2013, LANCET INFECT DIS, V13, P65, DOI 10.1016/S1473-3099(12)70273-6; Conroy SA, 2010, AIDS RES HUM RETROV, V26, P1087, DOI 10.1089/aid.2010.0054; Dobbs T, 2004, J CLIN MICROBIOL, V42, P2623, DOI 10.1128/JCM.42.6.2623-2628.2004; Eshleman SH, 2013, J INFECT DIS, V207, P223, DOI 10.1093/infdis/jis658; Hallett TB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005720; Hayashida T, 2008, AIDS RES HUM RETROV, V24, P495, DOI 10.1089/aid.2007.0150; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Kulich M, 2013, EVALUATION MUL UNPUB; Kumwenda NI, 2008, NEW ENGL J MED, V359, P119, DOI 10.1056/NEJMoa0801941; Laeyendecker O, 2013, 043 HIV PREV TRIALS; Laeyendecker O, 2013, 20 C RETR OPP INF AT; Laeyendecker O, 2008, JAIDS-J ACQ IMM DEF, V48, P211, DOI 10.1097/QAI.0b013e3181743980; Laeyendecker O, 2012, AIDS RES HUM RETROV, V28, P1177, DOI 10.1089/aid.2011.0341; Laeyendecker O, 2013, J INFECT DIS, V207, P232, DOI 10.1093/infdis/jis659; Marinda ET, 2010, JAIDS-J ACQ IMM DEF, V53, P496, DOI 10.1097/QAI.0b013e3181b61938; Masciotra S, 2010, 17 C RETR OPP INF SA; Mastro TD, 2012, J INFECT DIS; Morrison CS, 2011, JAIDS-J ACQ IMM DEF, V57, P157, DOI 10.1097/QAI.0b013e318214ba4a; Mullis CE, 2012, 18 C RETR OPP INF SE; Padian NS, 2011, LANCET, V378, P269, DOI 10.1016/S0140-6736(11)60877-5; Parekh BS, 2011, AIDS RES HUM RETROV, V27, P265, DOI 10.1089/aid.2010.0159; Piwowar-Manning E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-251; Sweat M, 2011, LANCET INFECT DIS, V11, P525, DOI 10.1016/S1473-3099(11)70060-3; UNAIDS Reference Group on Estimates MaP, 2006, WEEKLY EPIDEMIOLOGIC, V81, P33; Valley-Omar Z, 2012, J INFECT DIS, V206, P35, DOI 10.1093/infdis/jis305; Wawer MJ, 1999, LANCET, V353, P525, DOI 10.1016/S0140-6736(98)06439-3; Young CL, 2003, AIDS RES HUM RETROV, V19, P481, DOI 10.1089/088922203766774522	36	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78818	10.1371/journal.pone.0078818	http://dx.doi.org/10.1371/journal.pone.0078818			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236054	Green Submitted, Green Published, gold			2022-12-27	WOS:000327254700051
J	Maliphol, AB; Garth, DJ; Medler, KF				Maliphol, Amanda B.; Garth, Deborah J.; Medler, Kathryn F.			Diet-Induced Obesity Reduces the Responsiveness of the Peripheral Taste Receptor Cells	PLOS ONE			English	Article							CHORDA TYMPANI RESPONSES; DIABETIC DB/DB MOUSE; SWEET TASTE; BITTER TASTE; ENHANCED RESPONSES; ACESULFAME-K; BODY-WEIGHT; MICE; SENSITIVITY; LEPTIN	Introduction: Obesity is a growing epidemic that causes many serious health related complications. While the causes of obesity are complex, there is conclusive evidence that overconsumption coupled with a sedentary lifestyle is the primary cause of this medical condition. Dietary consumption is controlled by appetite which is in turn regulated by multiple neuronal systems, including the taste system. However, the relationship between taste and obesity has not been well defined. Growing evidence suggests that taste perception in the brain is altered in obese animals and humans, however no studies have determined if there are altered taste responses in the peripheral taste receptor cells, which is the initiation site for the detection and perception of taste stimuli. Methodology/Principal Findings: In this study, we used C57Bl/6 mice which readily become obese when placed on a high fat diet. After ten weeks on the high fat diet, we used calcium imaging to measure how taste-evoked calcium signals were affected in the obese mice. We found that significantly fewer taste receptor cells were responsive to some appetitive taste stimuli while the numbers of taste cells that were sensitive to aversive taste stimuli did not change. Properties of the taste-evoked calcium signals were also significantly altered in the obese mice. Behavioral analyses found that mice on the high fat diet had reduced ability to detect some taste stimuli compared to their littermate controls. Conclusions/Significance: Our findings demonstrate that diet-induced obesity significantly influences peripheral taste receptor cell signals which likely leads to changes in the central taste system and may cause altered taste perception.	[Maliphol, Amanda B.; Garth, Deborah J.; Medler, Kathryn F.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Medler, KF (corresponding author), SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA.	kmedler@buffalo.edu		Medler, Kathryn/0000-0001-9664-3606	National Science Foundation [0917893, 1256950]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation [Grants #0917893 and #1256950] to KM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackroff K, 2007, PHYSIOL BEHAV, V92, P468, DOI 10.1016/j.physbeh.2007.04.021; Ackroff K, 2012, PHYSIOL BEHAV, V107, P207, DOI 10.1016/j.physbeh.2012.06.022; ANDERSON GH, 1995, AM J CLIN NUTR, V62, p195S, DOI 10.1093/ajcn/62.1.195S; Bachmanov AA, 2001, CHEM SENSES, V26, P905, DOI 10.1093/chemse/26.7.905; Bartoshuk LM, 2006, PHILOS T R SOC B, V361, P1137, DOI 10.1098/rstb.2006.1853; Bi S, 2007, AM J PHYSIOL-REG I, V293, pR55, DOI 10.1152/ajpregu.00002.2007; Boughter JD, 2002, CHEM SENSES, V27, P133, DOI 10.1093/chemse/27.2.133; Chen K, 2010, BRAIN RES, V1325, P53, DOI 10.1016/j.brainres.2010.02.026; Chevrot M., 2013, J LIPID RES; DeSimone JA, 2012, J NEUROPHYSIOL, V108, P3221, DOI 10.1152/jn.00129.2012; DeSimone JA, 2012, J NEUROPHYSIOL, V108, P3206, DOI 10.1152/jn.00916.2011; Donaldson LF, 2009, AM J CLIN NUTR, V90, p800S, DOI 10.3945/ajcn.2009.27462Q; Duffy VB, 2007, CURR OPIN GASTROEN, V23, P171, DOI 10.1097/MOG.0b013e3280147d50; GRINKER J, 1978, AM J CLIN NUTR, V31, P1078, DOI 10.1093/ajcn/31.6.1078; Hacker K, 2008, J NEUROPHYSIOL, V99, P1503, DOI 10.1152/jn.00892.2007; Hajnal A, 2005, AM J PHYSIOL-REG I, V289, pR1675, DOI 10.1152/ajpregu.00412.2005; Hajnal A, 2005, PHYSIOL BEHAV, V84, P363, DOI 10.1016/j.physbeh.2004.12.014; Hajnal A, 2010, AM J PHYSIOL-GASTR L, V299, pG967, DOI 10.1152/ajpgi.00070.2010; Hellstrom PM, 2004, BRIT J NUTR, V92, pS47, DOI 10.1079/BJN20041142; Hill JO, 2005, PSYCHIAT CLIN N AM, V28, P1, DOI 10.1016/j.psc.2004.09.010; Horio N, 2010, J PHARMACOL SCI, V112, P8, DOI 10.1254/jphs.09R07FM; Horne J, 2002, CHEM SENSES, V27, P31, DOI 10.1093/chemse/27.1.31; Huang YJA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030662; Kawai K, 2000, P NATL ACAD SCI USA, V97, P11044, DOI 10.1073/pnas.190066697; Kovacs P, 2008, J NEUROPHYSIOL, V100, P2145, DOI 10.1152/jn.01359.2007; Kuhn C, 2004, J NEUROSCI, V24, P10260, DOI 10.1523/JNEUROSCI.1225-04.2004; Lindemann B, 1996, PHYSIOL REV, V76, P719, DOI 10.1152/physrev.1996.76.3.719; Martin B, 2010, DIABETES; Martin B, 2010, DIABETES, V59, P1143, DOI 10.2337/db09-0807; Martin B, 2009, ANN NY ACAD SCI, V1170, P98, DOI 10.1111/j.1749-6632.2009.03920.x; Medler KF, 2003, J NEUROSCI, V23, P2608; Mennella JA, 2005, PEDIATRICS, V115, pE216, DOI 10.1542/peds.2004-1582; Ninomiya Y, 1998, AM J PHYSIOL-REG I, V274, pR1324, DOI 10.1152/ajpregu.1998.274.5.R1324; NINOMIYA Y, 1995, AM J PHYSIOL-REG I, V269, pR930, DOI 10.1152/ajpregu.1995.269.4.R930; Ninomiya Y, 2002, VITAM HORM, V64, P221, DOI 10.1016/S0083-6729(02)64007-5; Norgren R, 2006, PHYSIOL BEHAV, V89, P531, DOI 10.1016/j.physbeh.2006.05.024; Ohta R, 2003, NEUROBIOL LEARN MEM, V80, P105, DOI 10.1016/S1074-7427(03)00046-7; Overberg J, 2012, ARCH DIS CHILD, V97, P1048, DOI 10.1136/archdischild-2011-301189; Pepino MY, 2010, OBESITY, V18, P959, DOI 10.1038/oby.2009.493; Preacher K.J., 2001, CALCULATION CHI SQUA; Rebello MR, 2010, EUR J NEUROSCI, V32, P1825, DOI 10.1111/j.1460-9568.2010.07463.x; Sanematsu K, 2009, ANN NY ACAD SCI, V1170, P102, DOI 10.1111/j.1749-6632.2009.03893.x; SCHIFFMAN SS, 1979, PHYSIOL BEHAV, V23, P1, DOI 10.1016/0031-9384(79)90113-6; Shigemura N, 2004, ENDOCRINOLOGY, V145, P839, DOI 10.1210/en.2003-0602; Shimizu Y, 2003, J NEUROPHYSIOL, V90, P128, DOI 10.1152/jn.01170.2002; Shin YK, 2008, J NEUROCHEM, V106, P455, DOI 10.1111/j.1471-4159.2008.05397.x; Simchen U, 2006, EUR J CLIN NUTR, V60, P698, DOI 10.1038/sj.ejcn.1602371; Vandenbeuch A, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-77; Yamada K, 1999, PHYSIOL BEHAV, V66, P863, DOI 10.1016/S0031-9384(99)00032-3; Yee CL, 2001, J COMP NEUROL, V440, P97, DOI 10.1002/cne.1372; Yoshida R, 2010, P NATL ACAD SCI USA, V107, P935, DOI 10.1073/pnas.0912048107; Zukerman S, 2011, AM J PHYSIOL-REG I, V301, pR1635, DOI 10.1152/ajpregu.00425.2011; Zukerman S, 2009, AM J PHYSIOL-REG I, V296, pR866, DOI 10.1152/ajpregu.90870.2008	53	49	49	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79403	10.1371/journal.pone.0079403	http://dx.doi.org/10.1371/journal.pone.0079403			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236129	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700128
J	Mameli, G; Madeddu, G; Mei, A; Uleri, E; Poddighe, L; Delogu, LG; Maida, I; Babudieri, S; Serra, C; Manetti, R; Mura, MS; Dolei, A				Mameli, Giuseppe; Madeddu, Giordano; Mei, Alessandra; Uleri, Elena; Poddighe, Luciana; Delogu, Lucia G.; Maida, Ivana; Babudieri, Sergio; Serra, Caterina; Manetti, Roberto; Mura, Maria S.; Dolei, Antonina			Activation of MSRV-Type Endogenous Retroviruses during Infectious Mononucleosis and Epstein-Barr Virus Latency: The Missing Link with Multiple Sclerosis?	PLOS ONE			English	Article							B-CELLS; BRAIN; EXPRESSION; RISK; TRANSCRIPTION; ASSOCIATION; MODULATION; UNIVERSITY; DEATH; BLOOD	The etiology of multiple sclerosis (MS) is still unclear. The immuno-pathogenic phenomena leading to neurodegeneration are thought to be triggered by environmental (viral?) factors operating on predisposing genetic backgrounds. Among the proposed co-factors are the Epstein Barr virus (EBV), and the potentially neuropathogenic HERV-W/MSRV/Syncytin-1 endogenous retroviruses. The ascertained links between EBV and MS are history of late primary infection, possibly leading to infectious mononucleosis (IM), and high titers of pre-onset IgG against EBV nuclear antigens (anti-EBNA IgG). During MS, there is no evidence of MS-specific EBV expression, while a continuous expression of HERV-Ws occurs, paralleling disease behaviour. We found repeatedly extracellular HERV-W/MSRV and MSRV-specific mRNA sequences in MS patients (in blood, spinal fluid, and brain samples), and MRSV presence/load strikingly paralleled MS stages and active/remission phases. Aim of the study was to verify whether HERV-W might be activated in vivo, in hospitalized young adults with IM symptoms, that were analyzed with respect to expression of HERV-W/MSRV transcripts and proteins. Healthy controls were either EBV-negative or latently EBV-infected with/without high titers of anti-EBNA-1 IgG. The results show that activation of HERV-W/MSRV occurs in blood mononuclear cells of IM patients (2Log10 increase of MSRV-type env mRNA accumulation with respect to EBV-negative controls). When healthy controls are stratified for previous EBV infection (high and low, or no anti-EBNA-1 IgG titers), a direct correlation occurs with MSRV mRNA accumulation. Flow cytometry data show increased percentages of cells exposing surface HERV-Wenv protein, that occur differently in specific cell subsets, and in acute disease and past infection. Thus, the data indicate that the two main links between EBV and MS (IM and high anti-EBNA-1-IgG titers) are paralleled by activation of the potentially neuropathogenic HERV-W/MSRV. These novel findings suggest HERV-W/MSRV activation as the missing link between EBV and MS, and may open new avenues of intervention.	[Mameli, Giuseppe; Mei, Alessandra; Uleri, Elena; Poddighe, Luciana; Serra, Caterina; Dolei, Antonina] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy; [Madeddu, Giordano; Maida, Ivana; Babudieri, Sergio; Manetti, Roberto; Mura, Maria S.] Univ Sassari, Dept Clin & Expt Med, I-07100 Sassari, Italy; [Delogu, Lucia G.] Univ Sassari, Dept Chem & Pharm, I-07100 Sassari, Italy	University of Sassari; University of Sassari; University of Sassari	Dolei, A (corresponding author), Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy.	doleivir@uniss.it	MADEDDU, Giordano/AAP-4342-2020	MADEDDU, Giordano/0000-0001-6099-2273; Delogu, Lucia Gemma/0000-0002-2329-7260; mameli, giuseppe/0000-0002-0286-5433; MAIDA, Ivana/0000-0003-4895-7576; BABUDIERI, SERGIO/0000-0001-7291-8687; Uleri, Elena/0000-0003-1014-0042	Fondazione Italiana Sclerosi Multipla onlus [2010/R/16]; Regione Sardegna; Fondazione Banco di Sardegna	Fondazione Italiana Sclerosi Multipla onlus(Fondazione Italiana Sclerosi Multipla (FISM)); Regione Sardegna(Regione Sardegna); Fondazione Banco di Sardegna(Fondazione Banco di Sardegna)	This work was supported in part by Fondazione Italiana Sclerosi Multipla onlus grant 2010/R/16 (AD), by Regione Sardegna (grant 2010, AD), by Fondazione Banco di Sardegna (grant 2011, CS, and a research fellowship 2011 to support GM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almohmeed YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061110; Antony JM, 2004, NAT NEUROSCI, V7, P1088, DOI 10.1038/nn1319; Antony JM, 2011, BBA-MOL BASIS DIS, V1812, P162, DOI 10.1016/j.bbadis.2010.07.016; Arru Giannina, 2007, Int J Biomed Sci, V3, P292; Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Ascherio A, 2010, J NEUROIMMUNE PHARM, V5, P271, DOI 10.1007/s11481-010-9201-3; Balfour HH, 2013, J INFECT DIS, V207, P80, DOI 10.1093/infdis/jis646; Banwell B, 2007, LANCET NEUROL, V6, P773, DOI 10.1016/S1474-4422(07)70196-5; Bhat RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019176; Borkosky SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032160; Brudek T, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-104; Castillo-Trivino T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066308; Christensen T, 2010, J NEUROIMMUNE PHARM, V5, P326, DOI 10.1007/s11481-010-9214-y; Chung BK, 2013, BLOOD; Coppotelli G, 2013, NUCLEIC ACIDS RES, V41, P2950, DOI 10.1093/nar/gkt032; Cusick MF, 2013, CURR OPIN RHEUMATOL, V25, P496, DOI 10.1097/BOR.0b013e328362004d; DeLorenze GN, 2006, ARCH NEUROL-CHICAGO, V63, P839, DOI 10.1001/archneur.63.6.noc50328; Disanto G, 2012, NEUROLOGY, V78, P823, DOI 10.1212/WNL.0b013e318249f6f0; Dolei A, 2002, NEUROLOGY, V58, P471, DOI 10.1212/WNL.58.3.471; Dolei Antonina, 2006, Expert Rev Clin Immunol, V2, P149, DOI 10.1586/1744666X.2.1.149; Dolei A, 2009, J NEUROVIROL, V15, P4, DOI 10.1080/13550280802448451; Dresang LR, 2009, J VIROL, V83, P2930, DOI 10.1128/JVI.01974-08; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; Firouzi R, 2003, J NEUROVIROL, V9, P79, DOI 10.1080/13550280390173328; Goldacre MJ, 2004, J EPIDEMIOL COMMUN H, V58, P1032, DOI 10.1136/jech.2003.018366; Handel AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012496; Kakalacheva K, 2011, BBA-MOL BASIS DIS, V1812, P132, DOI 10.1016/j.bbadis.2010.06.012; Kim DY, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-25; Komijani M, 2011, INT J NEUROSCI, V121, P437, DOI 10.3109/00207454.2011.569039; Lassmann H, 2011, BRAIN, V134, P2772, DOI 10.1093/brain/awr197; Levin LI, 2010, ANN NEUROL, V67, P824, DOI 10.1002/ana.21978; Lucas RM, 2011, J NEUROL NEUROSUR PS, V82, P1142, DOI 10.1136/jnnp-2011-300174; Lunemann JD, 2010, ANN NEUROL, V67, P159, DOI 10.1002/ana.21886; Mameli G, 2008, J NEUROVIROL, V14, P73, DOI 10.1080/13550280701801107; Mameli G, 2007, J GEN VIROL, V88, P264, DOI 10.1099/vir.0.81890-0; Mameli G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044991; Mameli G, 2009, J VIROL METHODS, V161, P98, DOI 10.1016/j.jviromet.2009.05.024; McQualter JL, 2007, J NEUROCHEM, V100, P295, DOI 10.1111/j.1471-4159.2006.04232.x; Meier UC, 2012, CLIN EXP IMMUNOL, V167, P1, DOI 10.1111/j.1365-2249.2011.04446.x; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Munger KL, 2011, MULT SCLER J, V17, P1185, DOI 10.1177/1352458511408991; Nielsen TR, 2009, MULT SCLER J, V15, P431, DOI 10.1177/1352458508100037; Owens GP, 2012, MULT SCLER J, V18, P1204, DOI 10.1177/1352458512448109; Pakpoor J, 2013, EXPERT REV NEUROTHER, V13, P287, DOI [10.1586/ERN.13.6, 10.1586/ern.13.6]; Pakpoor J, 2013, MULT SCLER J, V19, P162, DOI 10.1177/1352458512449682; Perron H, 1997, P NATL ACAD SCI USA, V94, P7583, DOI 10.1073/pnas.94.14.7583; Perron H, 2005, J NEUROVIROL, V11, P23, DOI 10.1080/13550280590901741; Perron H, 2012, MULT SCLER J, V18, P1721, DOI 10.1177/1352458512441381; Perron H, 2010, CLIN REV ALLERG IMMU, V39, P51, DOI 10.1007/s12016-009-8170-x; Petersen T, 2009, J NEUROIMMUNOL, V215, P108, DOI 10.1016/j.jneuroim.2009.08.015; Pfeiffer F, 2011, ACTA NEUROPATHOL, V122, P601, DOI 10.1007/s00401-011-0883-2; Rawji KS, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/948976; Santiago O, 2010, EUR J CLIN MICROBIOL, V29, P857, DOI 10.1007/s10096-010-0940-0; Serra C, 2003, J NEUROVIROL, V9, P637, DOI 10.1080/714044485; Sotgiu S, 2006, MULT SCLER J, V12, P698, DOI 10.1177/1352458506070773; Sotgiu S, 2006, MULT SCLER J, V12, P357, DOI 10.1191/135248506ms1303sr; Sotgiu S, 2002, NEUROLOGY, V59, P1071, DOI 10.1212/WNL.59.7.1071; Sotgiu S, 2010, MULT SCLER, V16, P1248, DOI 10.1177/1352458510376956; Tselis A, 2012, CURR OPIN RHEUMATOL, V24, P424, DOI 10.1097/BOR.0b013e3283542cf8; Wood VHJ, 2007, ONCOGENE, V26, P4135, DOI 10.1038/sj.onc.1210496	60	54	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78474	10.1371/journal.pone.0078474	http://dx.doi.org/10.1371/journal.pone.0078474			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236019	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700016
J	Parmigiani, A; Alcaide, ML; Freguja, R; Pallikkuth, S; Frasca, D; Fischl, MA; Pahwa, S				Parmigiani, Anita; Alcaide, Maria L.; Freguja, Ricardo; Pallikkuth, Suresh; Frasca, Daniela; Fischl, Margaret A.; Pahwa, Savita			Impaired Antibody Response to Influenza Vaccine in HIV-Infected and Uninfected Aging Women Is Associated with Immune Activation and Inflammation	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ALPHA TNF-ALPHA; CD4 T-CELLS; B-CELLS; REPLICATIVE SENESCENCE; ANTIRETROVIRAL THERAPY; DISEASE; VIRUS; AIDS; PROGRESSION	Background: Aging and HIV infection are independently associated with excessive immune activation and impaired immune responses to vaccines, but their relationships have not been examined. Methods: For selecting an aging population we enrolled 28 post-menopausal women including 12 healthy volunteers and 16 HIV-infected women on antiretroviral treatment with <100 HIV RNA copies/ml. Antibody titers to trivalent influenza vaccination given during the 2011-2012 season were determined before and 4 weeks after vaccination. Results: Seroprotective influenza antibody titers (>= 1: 40) were observed in 31% HIV+ and 58% HIV-uninfected women pre-vaccination. Following vaccination, magnitude of antibody responses and frequency of seroprotection were lower in HIV+(75%) than in HIV-(91%) women. Plasma IL-21, the signature cytokine of T follicular helper cells (Tfh), and CD4 T cell IL-21R were upregulated with seroconversion (>= 4 fold increase in antibody titer). Post-vaccine antibody responses were inversely correlated with pre-vaccination plasma TNF alpha levels and with activated CD4 T cells, including activated peripheral (p) Tfh. Plasma TNFa levels were correlated with activated pTfh cells (r=0.48, p=0.02), and inversely with the post-vaccination levels of plasma IL-21 (r=-0.53, p=0.02). In vitro TNFa blockade improved the ability of CD4 T cells to produce IL-21 and of B cells to secrete immunoglobulins, and addition of exogenous IL-21 to cell cultures enhanced B cell function. Higher frequencies of activated and exhausted CD8 T and B cells were noted in HIV+ women, but these markers did not show a correlation with antibody responses. Conclusions: In aging HIV-infected and uninfected women, activated CD4 and pTfh cells may compromise influenza vaccine-induced antibody response, for which a mechanism of TNF alpha-mediated impairment of pTfh-induced IL-21 secretion is postulated. Interventions aimed at reducing chronic inflammation and immune activation in aging, HIV-infected patients may improve their response to vaccines.	[Parmigiani, Anita; Pallikkuth, Suresh; Frasca, Daniela; Pahwa, Savita] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA; [Alcaide, Maria L.] Univ Miami, Miller Sch Med, Div Infect Dis, Miami, FL 33136 USA; [Freguja, Ricardo] Univ Padua, Unit Viral Oncol, Oncol & Immunol Sect, Dept Surg Oncol & Gastroenterol, Padua, Italy; [Freguja, Ricardo] Univ Padua, AIDS Reference Ctr, Padua, Italy; [Fischl, Margaret A.] Univ Miami, Miller Sch Med, Div Infect Dis, UM AIDS Clin Res Unit, Miami, FL 33136 USA	University of Miami; University of Miami; University of Padua; University of Padua; University of Miami	Pahwa, S (corresponding author), Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA.	Spahwa@med.miami.edu	Pahwa, Savita/AAA-4900-2019	Pahwa, Savita/0000-0002-4470-4216; Alcaide, Maria/0000-0003-4648-0145	University of Miami Center for AIDS Research (CFAR) (National Institute of Health) [P30AI073961]; NIAID [R01 AI108472]; OAR (Office of AIDS Research); NIAID; NCI; NICHD; NHLBI; NIDA; NIMH; NIA; FIC (Fogarty International Center); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI108472, P30AI073961] Funding Source: NIH RePORTER	University of Miami Center for AIDS Research (CFAR) (National Institute of Health); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OAR (Office of AIDS Research); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); FIC (Fogarty International Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the University of Miami Center for AIDS Research (CFAR) via a CFAR developmental award to MLA and AP (National Institute of Health, P30AI073961) and NIAID (R01 AI108472). The CFAR program at the NIH includes the following co-funding and participating Institutes and Centers: NIAID, NCI, NICHD, NHLBI, NIDA, NIMH, NIA, FIC (Fogarty International Center), and OAR (Office of AIDS Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063804; ALCAIDE ML, 2013, IMMUNE ACTIVATION HI; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Aukrust P, 1999, J INFECT DIS, V179, P74, DOI 10.1086/314572; AUKRUST P, 1994, J INFECT DIS, V169, P420, DOI 10.1093/infdis/169.2.420; Bender BS, 2003, IMMUNOL ALLERGY CLIN, V23, P57, DOI 10.1016/S0889-8561(02)00078-4; Bose F, 2011, CLIN IMMUNOL, V139, P164, DOI 10.1016/j.clim.2011.01.015; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Bruunsgaard H, 2000, CLIN EXP IMMUNOL, V121, P255, DOI 10.1046/j.1365-2249.2000.01281.x; Bruunsgaard H, 1999, J GERONTOL A-BIOL, V54, pM357, DOI 10.1093/gerona/54.7.M357; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Chevalier N, 2011, J IMMUNOL, V186, P5556, DOI 10.4049/jimmunol.1002828; Cohen C, 2012, CLIN INFECT DIS, V55, P996, DOI 10.1093/cid/cis549; Cope AP, 1997, J EXP MED, V185, P1573, DOI 10.1084/jem.185.9.1573; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Deeks SG, 2012, CURR OPIN IMMUNOL, V24, P501, DOI 10.1016/j.coi.2012.05.004; Desai Seema, 2010, Curr HIV/AIDS Rep, V7, P4, DOI 10.1007/s11904-009-0038-4; Douek Daniel, 2007, Top HIV Med, V15, P114; Effros RB, 1996, AIDS, V10, pF17, DOI 10.1097/00002030-199607000-00001; Ettinger R, 2005, J IMMUNOL, V175, P7867, DOI 10.4049/jimmunol.175.12.7867; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; FRASCA D, 2013, VACCINE; Frasca D, 2012, INT IMMUNOL, V24, P175, DOI 10.1093/intimm/dxr123; Frasca D, 2012, J IMMUNOL, V188, P279, DOI 10.4049/jimmunol.1003964; Frasca D, 2011, J CLIN IMMUNOL, V31, P430, DOI 10.1007/s10875-010-9501-7; Frasca D, 2010, VACCINE, V28, P8077, DOI 10.1016/j.vaccine.2010.10.023; GARDNER ID, 1980, REV INFECT DIS, V2, P801; Gardner P, 2004, EMERG INFECT DIS, V10, P1990; GODFRIED MH, 1994, J INFECT DIS, V169, P739, DOI 10.1093/infdis/169.4.739; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Goronzy JJ, 2001, J VIROL, V75, P12182, DOI 10.1128/JVI.75.24.12182-12187.2001; Gruver AL, 2007, J PATHOL, V211, P144, DOI 10.1002/path.2104; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; High KP, 2012, JAIDS-J ACQ IMM DEF, V60, pS1, DOI 10.1097/QAI.0b013e31825a3668; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Hsiung G.D., 1994, HSIUNGS DIAGNOSTIC V, P404; Hunt PW, 2011, J INFECT DIS, V203, P1474, DOI 10.1093/infdis/jir060; Isomaki P, 2001, J IMMUNOL, V166, P5495, DOI 10.4049/jimmunol.166.9.5495; Jackson LA, 2012, J INFECT DIS, V206, P811, DOI 10.1093/infdis/jis427; Klatt NR, 2013, TRENDS MICROBIOL, V21, P6, DOI 10.1016/j.tim.2012.09.001; Kogut I, 2012, SEMIN IMMUNOL, V24, P342, DOI 10.1016/j.smim.2012.04.004; LAHDEVIRTA J, 1988, AM J MED, V85, P289, DOI 10.1016/0002-9343(88)90576-1; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; Lang PO, 2011, AGEING RES REV, V10, P389, DOI 10.1016/j.arr.2010.09.005; LEVACHER M, 1992, CLIN EXP IMMUNOL, V90, P376; Liu ZY, 1997, J ACQ IMMUN DEF SYND, V16, P83, DOI 10.1097/00042560-199710010-00003; Maecker HT, 2006, CYTOM PART A, V69A, P1037, DOI 10.1002/cyto.a.20333; Malaspina A, 2005, J INFECT DIS, V191, P1442, DOI 10.1086/429298; Mayer KH, 2011, CLIN INFECT DIS, V52, pS205, DOI 10.1093/cid/ciq043; Mocroft A, 1997, J ACQ IMMUN DEF SYND, V14, P158, DOI 10.1097/00042560-199702010-00009; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Moir S, 2008, J INFECT DIS, V197, P572, DOI 10.1086/526789; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Murasko DM, 2002, EXP GERONTOL, V37, P427, DOI 10.1016/S0531-5565(01)00210-8; Ozaki K, 2004, J IMMUNOL, V173, P5361, DOI 10.4049/jimmunol.173.9.5361; Pallikkuth S, 2012, BLOOD, V120, P985, DOI 10.1182/blood-2011-12-396648; Pallikkuth S, 2011, J IMMUNOL, V186, P6173, DOI 10.4049/jimmunol.1100264; Paolisso G, 1998, AM J PHYSIOL-ENDOC M, V275, pE294, DOI 10.1152/ajpendo.1998.275.2.E294; Perfetto SP, 2006, NAT PROTOC, V1, P1522, DOI 10.1038/nprot.2006.250; SalazarGonzalez JF, 1997, CLIN IMMUNOL IMMUNOP, V84, P36, DOI 10.1006/clin.1997.4364; Sheth Anandi N, 2011, Curr HIV/AIDS Rep, V8, P181, DOI 10.1007/s11904-011-0086-4; Skowronski DM, 2008, J INFECT DIS, V197, P490, DOI 10.1086/524146; Tebas P, 2010, AIDS, V24, P2187, DOI 10.1097/QAD.0b013e32833c6d5c; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Trzonkowski P, 2003, VACCINE, V21, P3826, DOI 10.1016/S0264-410X(03)00309-8; Weinberger B, 2008, CLIN INFECT DIS, V46, P1078, DOI 10.1086/529197; Weng NP, 2009, TRENDS IMMUNOL, V30, P306, DOI 10.1016/j.it.2009.03.013; YAO ZQ, 2013, ARCH IMMUNOL THER EX; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	70	79	80	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79816	10.1371/journal.pone.0079816	http://dx.doi.org/10.1371/journal.pone.0079816			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236161	gold, Green Submitted, Green Published			2022-12-27	WOS:000327254700161
J	Scarpa, A; Sikora, K; Fassan, M; Rachiglio, AM; Cappellesso, R; Antonello, D; Amato, E; Mafficini, A; Lambiase, M; Esposito, C; Bria, E; Simonato, F; Scardoni, M; Turri, G; Chilosi, M; Tortora, G; Fassina, A; Normanno, N				Scarpa, Aldo; Sikora, Katarzyna; Fassan, Matteo; Rachiglio, Anna Maria; Cappellesso, Rocco; Antonello, Davide; Amato, Eliana; Mafficini, Andrea; lambiase, MatilDe; Esposito, Claudia; Bria, Emilio; Simonato, Francesca; Scardoni, Maria; Turri, Giona; Chilosi, Marco; Tortora, Giampaolo; Fassina, Ambrogio; Normanno, Nicola			Molecular Typing of Lung Adenocarcinoma on Cytological Samples Using a Multigene Next Generation Sequencing Panel	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; FINE-NEEDLE-ASPIRATION; TARGETED THERAPIES; MUTATION STATUS; CANCER; EGFR; GEFITINIB; CLASSIFICATION; DIAGNOSTICS; RESISTANCE	Identification of driver mutations in lung adenocarcinoma has led to development of targeted agents that are already approved for clinical use or are in clinical trials. Therefore, the number of biomarkers that will be needed to assess is expected to rapidly increase. This calls for the implementation of methods probing the mutational status of multiple genes for inoperable cases, for which limited cytological or bioptic material is available. Cytology specimens from 38 lung adenocarcinomas were subjected to the simultaneous assessment of 504 mutational hotspots of 22 lung cancer-associated genes using 10 nanograms of DNA and Ion Torrent PGM next-generation sequencing. Thirty-six cases were successfully sequenced (95%). In 24/36 cases (67%) at least one mutated gene was observed, including EGFR, KRAS, PIK3CA, BRAF, TP53, PTEN, MET, SMAD4, FGFR3, STK11, MAP2K1. EGFR and KRAS mutations, respectively found in 6/36 (16%) and 10/36 (28%) cases, were mutually exclusive. Nine samples (25%) showed concurrent alterations in different genes. The next-generation sequencing test used is superior to current standard methodologies, as it interrogates multiple genes and requires limited amounts of DNA. Its applicability to routine cytology samples might allow a significant increase in the fraction of lung cancer patients eligible for personalized therapy.	[Scarpa, Aldo; Sikora, Katarzyna; Fassan, Matteo; Amato, Eliana; Mafficini, Andrea] Univ Verona, ARC NET Res Ctr, I-37100 Verona, Italy; [Scarpa, Aldo; Fassan, Matteo; Antonello, Davide; Scardoni, Maria; Turri, Giona; Chilosi, Marco] Univ Verona, Dept Pathol & Diagnost, I-37100 Verona, Italy; [Rachiglio, Anna Maria; lambiase, MatilDe; Esposito, Claudia] INT Fdn Pascale, Ctr Ric Oncol Mercogliano, Pharmacogen Lab, Mercogliano, Italy; [Simonato, Francesca; Fassina, Ambrogio] Univ Padua, Dept Med, Padua, Italy; [Tortora, Giampaolo] Univ Verona, Dept Med, Oncol Unit, I-37100 Verona, Italy; [Normanno, Nicola] INT Fdn Pascale, Cell Biol & Biotherapy Unit, Naples, Italy	University of Verona; University of Verona; IRCCS Fondazione Pascale; University of Padua; University of Verona; IRCCS Fondazione Pascale	Fassan, M (corresponding author), Univ Verona, ARC NET Res Ctr, I-37100 Verona, Italy.	matteo.fassan@gmail.com	Bria, Emilio/A-8574-2019; Normanno, Nicola/AAT-1107-2021; Lambiase, Matilde/AAB-8356-2022; Cappellesso, Rocco/L-5463-2016; Rachiglio, Anna Maria/AAA-5208-2019; Tortora, Giampaolo/HGB-6261-2022; CHILOSI, MARCO/ABB-8028-2021; Fassan, Matteo/F-5152-2012; Tortora, Giampaolo/AAA-1252-2019; scarpa, aldo/K-6832-2016; Mafficini, Andrea/AAK-8158-2020	Bria, Emilio/0000-0002-2333-704X; Lambiase, Matilde/0000-0002-4478-8042; Cappellesso, Rocco/0000-0002-0480-3412; Rachiglio, Anna Maria/0000-0002-4144-7066; Fassan, Matteo/0000-0001-6515-5482; scarpa, aldo/0000-0003-1678-739X; Mafficini, Andrea/0000-0002-7471-3121; Normanno, Nicola/0000-0002-7158-2605; Tortora, Giampaolo/0000-0002-1378-4962	Italian Cancer Genome Project [FIRB RBAP10AHJB]; Associazione Italiana Ricerca Cancro (AIRC) [12182]	Italian Cancer Genome Project; Associazione Italiana Ricerca Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Italian Cancer Genome Project (FIRB RBAP10AHJB) and Associazione Italiana Ricerca Cancro (AIRC 5 per mille grant n. 12182). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040109; Buttitta F, 2013, CLIN CANCER RES, V19, P691, DOI 10.1158/1078-0432.CCR-12-1958; Cheng L, 2012, MODERN PATHOL, V25, P347, DOI 10.1038/modpathol.2011.215; Chilosi M, 2010, ARCH PATHOL LAB MED, V134, P55, DOI 10.1043/1543-2165-134.1.55; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Daniels M, 2012, J THORAC DIS, V4, P155, DOI 10.3978/j.issn.2072-1439.2012.02.01; De Luca A, 2010, CURR DRUG TARGETS, V11, P851, DOI 10.2174/138945010791320773; Douillard JY, 2010, J CLIN ONCOL, V28, P744, DOI 10.1200/JCO.2009.24.3030; Ellis LM, 2009, CLIN CANCER RES, V15, P7471, DOI 10.1158/1078-0432.CCR-09-1070; Fassina A, 2012, CYTOPATHOLOGY, V23, P213, DOI 10.1111/j.1365-2303.2012.01005.x; Fassina A, 2011, CYTOPATHOLOGY, V22, P306, DOI 10.1111/j.1365-2303.2010.00802.x; Fassina A, 2009, J CLIN PATHOL, V62, P1096, DOI 10.1136/jcp.2009.067587; Fassina A, 2011, CHEST, V140, P1305, DOI 10.1378/chest.11-0708; Gao YJ, 2011, PROTEIN CELL, V2, P99, DOI 10.1007/s13238-011-1021-6; Gazziero A, 2009, J CLIN PATHOL, V62, P429, DOI 10.1136/jcp.2008.059808; Geurts-Giele WRR, 2013, VIRCHOWS ARCH, V462, P249, DOI 10.1007/s00428-012-1346-4; Goto K, 2012, ANN ONCOL, V23, P2914, DOI 10.1093/annonc/mds121; Hammerman PS, 2011, CANCER DISCOV, V1, P78, DOI 10.1158/2159-8274.CD-11-0005; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Herbst RS, 2007, NEW ENGL J MED, V356, P76, DOI 10.1056/NEJMe068218; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Janne PA, 2013, LANCET ONCOL, V14, P38, DOI 10.1016/S1470-2045(12)70489-8; Kawano O, 2006, LUNG CANCER, V54, P209, DOI 10.1016/j.lungcan.2006.07.006; Kris MG, 2011, J CLIN ONCOL, V29, P7506; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; Marcheti A, 2010, PATHOLOGICA, V102, P119; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Normanno N, 2013, J CELL BIOCHEM, V114, P514, DOI 10.1002/jcb.24401; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pao W, 2012, NAT MED, V18, P349, DOI 10.1038/nm.2697; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Peled N, 2012, J THORAC ONCOL, V7, pE14, DOI 10.1097/JTO.0b013e3182614ab5; Pirker R, 2012, J THORAC ONCOL, V5, P1706; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rossi A, 2013, CANCER TREAT REV, V39, P489, DOI 10.1016/j.ctrv.2012.09.001; Sanchez-Cespedes M, 2011, FAM CANCER, V10, P447, DOI 10.1007/s10689-011-9443-0; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sorio C, 2004, VIRCHOWS ARCH, V444, P269, DOI 10.1007/s00428-003-0936-6; Sun YH, 2010, J CLIN ONCOL, V28, P4616, DOI 10.1200/JCO.2010.29.6038; Thomas A, 2013, ANN ONCOL, V24, P577, DOI 10.1093/annonc/mds478; Travis WD., 2004, TRAVIS WB WHO CLASSI; Vivanco I, 2010, P NATL ACAD SCI USA, V107, P6459, DOI 10.1073/pnas.0911188107; Ware Kathryn E, 2010, PLoS One, V5, pe14117, DOI 10.1371/journal.pone.0014117; Zhou Q, 2011, J CLIN ONCOL, V29, P3316, DOI 10.1200/JCO.2010.33.3757	45	70	70	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80478	10.1371/journal.pone.0080478	http://dx.doi.org/10.1371/journal.pone.0080478			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236184	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700185
J	Stalvey, MS; Clines, KL; Havasi, V; McKibbin, CR; Dunn, LK; Chung, WJ; Clines, GA				Stalvey, Michael S.; Clines, Katrina L.; Havasi, Viktoria; McKibbin, Christopher R.; Dunn, Lauren K.; Chung, W. Joon; Clines, Gregory A.			Osteoblast CFTR Inactivation Reduces Differentiation and Osteoprotegerin Expression in a Mouse Model of Cystic Fibrosis-Related Bone Disease	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; PARATHYROID-HORMONE; OSTEOCLAST DIFFERENTIATION; ANIMAL-MODEL; MURINE MODEL; RECEPTOR; MICE; OSTEOPENIA; DENSITY; PROTEIN	Low bone mass and increased fracture risk are recognized complications of cystic fibrosis (CF). CF-related bone disease (CFBD) is characterized by uncoupled bone turnover-impaired osteoblastic bone formation and enhanced osteoclastic bone resorption. Intestinal malabsorption, vitamin D deficiency and inflammatory cytokines contribute to CFBD. However, epidemiological investigations and animal models also support a direct causal link between inactivation of skeletal cystic fibrosis transmembrane regulator (CFTR), the gene that when mutated causes CF, and CFBD. The objective of this study was to examine the direct actions of CFTR on bone. Expression analyses revealed that CFTR mRNA and protein were expressed in murine osteoblasts, but not in osteoclasts. Functional studies were then performed to investigate the direct actions of CFTR on osteoblasts using a CFTR knockout (Cftr-/-) mouse model. In the murine calvarial organ culture assay, Cftr-/- calvariae displayed significantly less bone formation and osteoblast numbers than calvariae harvested from wildtype (Cftr+/+) littermates. CFTR inactivation also reduced alkaline phosphatase expression in cultured murine calvarial osteoblasts. Although CFTR was not expressed in murine osteoclasts, significantly more osteoclasts formed in Cftr-/- compared to Cftr+/+ bone marrow cultures. Indirect regulation of osteoclastogenesis by the osteoblast through RANK/RANKL/OPG signaling was next examined. Although no difference in receptor activator of NF-kappa B ligand (Rankl) mRNA was detected, significantly less osteoprotegerin (Opg) was expressed in Cftr-/- compared to Cftr+/+ osteoblasts. Together, the Rankl: Opg ratio was significantly higher in Cftr-/- murine calvarial osteoblasts contributing to a higher osteoclastogenesis potential. The combined findings of reduced osteoblast differentiation and lower Opg expression suggested a possible defect in canonical Wnt signaling. In fact, Wnt3a and PTH-stimulated canonical Wnt signaling was defective in Cftr-/- murine calvarial osteoblasts. These results support that genetic inactivation of CFTR in osteoblasts contributes to low bone mass and that targeting osteoblasts may represent an effective strategy to treat CFBD.	[Stalvey, Michael S.; Havasi, Viktoria] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 USA; [Clines, Katrina L.; Clines, Gregory A.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [McKibbin, Christopher R.; Dunn, Lauren K.] Univ Virginia, Dept Med, Charlottesville, VA USA; [Chung, W. Joon] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; [Clines, Gregory A.] Vet Adm Med Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Virginia; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Clines, GA (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.	clines@uab.edu	Havasi, Viktoria/B-1309-2009	Stalvey, Michael/0000-0003-4257-5710	American Society for Bone and Mineral Research (GAC); NIH [K08DK094784, R21AR056826]; UAB CMBD Bone Histomorphometry Core [P30AR046031]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR046031, R21AR056826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK094784, P30DK027651] Funding Source: NIH RePORTER	American Society for Bone and Mineral Research (GAC); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UAB CMBD Bone Histomorphometry Core; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a Career Enhancement Award from the American Society for Bone and Mineral Research (GAC), NIH K08DK094784 (MSS), NIH R21AR056826 (GAC) and the UAB CMBD Bone Histomorphometry Core (P30AR046031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Aris RM, 2005, J CLIN ENDOCR METAB, V90, P1888, DOI 10.1210/jc.2004-1629; Aris RM, 2002, OSTEOPOROSIS INT, V13, P151, DOI 10.1007/s001980200007; Aris RM, 1998, ANN INTERN MED, V128, P186, DOI 10.7326/0003-4819-128-3-199802010-00004; Bakker A, 2003, METH MOLEC MED, V80, P19; Baron R, 2007, ENDOCRINOLOGY, V148, P2635, DOI 10.1210/en.2007-0270; Baroncelli GI, 1997, PEDIATR RES, V41, P397, DOI 10.1203/00006450-199703000-00016; Black DM, 2003, NEW ENGL J MED, V349, P1207, DOI 10.1056/NEJMoa031975; Bronckers A, 2010, BONE, V46, P1188, DOI 10.1016/j.bone.2009.12.002; CLARKE LL, 1994, P NATL ACAD SCI USA, V91, P479, DOI 10.1073/pnas.91.2.479; Clines GA, 2007, MOL ENDOCRINOL, V21, P486, DOI 10.1210/me.2006-0346; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Dif F, 2004, BONE, V35, P595, DOI 10.1016/j.bone.2004.05.021; Divangahi M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000586; Elkin SL, 2001, OSTEOPOROSIS INT, V12, P366, DOI 10.1007/s001980170104; Foundation CF, 2011, PATIENT REGISTRY ANN; Fu Q, 2002, J BIOL CHEM, V277, P48868, DOI 10.1074/jbc.M208494200; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; HAHN TJ, 1979, J PEDIATR-US, V94, P38, DOI 10.1016/S0022-3476(79)80346-7; Haston CK, 2008, AM J RESP CRIT CARE, V177, P309, DOI 10.1164/rccm.200705-659OC; Hodges CA, 2008, GENESIS, V46, P546, DOI 10.1002/dvg.20433; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Kent G, 1997, J CLIN INVEST, V100, P3060, DOI 10.1172/JCI119861; King SJ, 2005, EUR RESPIR J, V25, P54, DOI 10.1183/09031936.04.00050204; KOLLER BH, 1991, P NATL ACAD SCI USA, V88, P10730, DOI 10.1073/pnas.88.23.10730; Kondo H, 2002, J BONE MINER RES, V17, P1667, DOI 10.1359/jbmr.2002.17.9.1667; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lamhonwah AM, 2010, ANN NEUROL, V67, P802, DOI 10.1002/ana.21982; Le Henaff C, 2012, AM J PATHOL, V180, P2068, DOI 10.1016/j.ajpath.2012.01.039; Le Heron L, 2010, J CYST FIBROS, V9, P69, DOI 10.1016/j.jcf.2009.11.005; Liang HT, 2010, CLIN EXP PHARMACOL P, V37, P506, DOI 10.1111/j.1440-1681.2009.05319.x; MISCHLER EH, 1979, AM J DIS CHILD, V133, P632, DOI 10.1001/archpedi.1979.02130060072016; Mohammad Khalid S., 2008, V455, P37, DOI 10.1007/978-1-59745-104-8_3; Naren AP, 2003, P NATL ACAD SCI USA, V100, P342, DOI 10.1073/pnas.0135434100; Pashuck TD, 2009, PEDIATR RES, V65, P311, DOI 10.1203/PDR.0b013e3181961e80; Pietrement C, 2008, J BIOL CHEM, V283, P2986, DOI 10.1074/jbc.M704678200; Qiang YW, 2008, BLOOD, V112, P196, DOI 10.1182/blood-2008-01-132134; Shapiro B J, 1999, Curr Opin Pulm Med, V5, P365, DOI 10.1097/00063198-199911000-00008; Shead EF, 2007, THORAX, V62, P650, DOI 10.1136/thx.2006.075887; Shead EF, 2010, J CYST FIBROS, V9, P93, DOI 10.1016/j.jcf.2009.11.007; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; SNOUWAERT JN, 1995, AM J RESP CRIT CARE, V151, pS59, DOI 10.1164/ajrccm/151.3_Pt_2.S59; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; Suzuki A, 2008, J CELL BIOCHEM, V104, P304, DOI 10.1002/jcb.21626; Wang B, 2007, J BIOL CHEM, V282, P36214, DOI 10.1074/jbc.M707263200; Yasuda H, 1998, ENDOCRINOLOGY, V139, P1329, DOI 10.1210/en.139.3.1329	46	41	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80098	10.1371/journal.pone.0080098	http://dx.doi.org/10.1371/journal.pone.0080098			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236172	gold, Green Published, Green Submitted			2022-12-27	WOS:000327254700173
J	Zou, MY; Li, XZ; Zhao, J; Qu, YB				Zou, Mouyong; Li, Xuezhi; Zhao, Jian; Qu, Yinbo			Characteristics of Polygalacturonate Lyase C from Bacillus subtilis 7-3-3 and Its Synergistic Action with PelA in Enzymatic Degumming	PLOS ONE			English	Article							ALKALINE	An alkaline polygalacturonate lyase (PGL) from Bacillus subtilis 7-3-3, PelC, with diverse depolymerization abilities for different pectin substrates was found. The PGL activity of PelC decreased with increasing degree of methyl esterification of the substrate. PelA and PelC displayed notable synergistic effects in the enzymatic degumming of ramie fibers. Gum loss rates increased by 62% when PelC was used to replace up to three-eighths of the PelA dose (PelC, 60 U g(-1) ramie fibers). To the best of our knowledge, this study is the first to report the synergistic action of members of polysaccharide lyase families 1 and 3, represented by PelA and PelC, respectively. The present paper provides new insights into the improvement and production of enzymes used in enzymatic degumming.	[Zou, Mouyong; Li, Xuezhi; Zhao, Jian; Qu, Yinbo] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Shandong, Peoples R China	Shandong University	Zhao, J (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Shandong, Peoples R China.	zhaojian@sdu.edu.cn			National High Technology Research and Development Program of China [2012AA022203B]; National Natural Sciences Foundation of China [31170107]; Natural Sciences Foundation of Shandong Province [ZR2010CM023]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Sciences Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This study was supported by grants from the National High Technology Research and Development Program of China (No. 2012AA022203B)(http://www.863.gov.cn/), the National Natural Sciences Foundation of China (31170107)(http://www.nsfc.gov.cn/Portal0/default152.htm), and the Natural Sciences Foundation of Shandong Province (ZR2010CM023)(http://www.sdnsf.gov.cn/portal/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita M, 2001, ACTA CRYSTALLOGR D, V57, P1786, DOI 10.1107/S0907444901014482; Basu S, 2009, J IND MICROBIOL BIOT, V36, P239, DOI 10.1007/s10295-008-0490-y; Bin Z, 2008, BIOCHEM ENG J, V40, P92, DOI 10.1016/j.bej.2007.11.018; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruhlmann F, 2000, J BIOTECHNOL, V76, P43, DOI 10.1016/S0168-1656(99)00175-3; Guo FF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/212315; Hoondal GS, 2002, APPL MICROBIOL BIOT, V59, P409, DOI 10.1007/s00253-002-1061-1; Kapoor M, 2001, PROCESS BIOCHEM, V36, P803, DOI 10.1016/S0032-9592(00)00282-X; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Soriano M, 2006, MICROBIOL-SGM, V152, P617, DOI 10.1099/mic.0.28562-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Yadav S, 2009, PROCESS BIOCHEM, V44, P1, DOI 10.1016/j.procbio.2008.09.012; Zheng LS, 2001, BIORESOURCE TECHNOL, V78, P89, DOI 10.1016/S0960-8524(00)00154-1; Zou M, 2013, PROCESS BIOCH	16	16	16	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79357	10.1371/journal.pone.0079357	http://dx.doi.org/10.1371/journal.pone.0079357			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236123	Green Submitted, gold, Green Published			2022-12-27	WOS:000327254700122
J	Bodewes, R; Garcia, AR; Wiersma, LCM; Getu, S; Beukers, M; Schapendonk, CME; van Run, PRWA; van de Bildt, MWG; Poen, MJ; Osinga, N; Contreras, GJS; Kuiken, T; Smits, SL; Osterhaus, ADME				Bodewes, Rogier; Garcia, Ana Rubio; Wiersma, Lidewij C. M.; Getu, Sarah; Beukers, Martijn; Schapendonk, Claudia M. E.; van Run, Peter R. W. A.; van de Bildt, Marco W. G.; Poen, Marjolein J.; Osinga, Nynke; Contreras, Guillermo J. Sanchez; Kuiken, Thijs; Smits, Saskia L.; Osterhaus, Albert D. M. E.			Novel B19-Like Parvovirus in the Brain of a Harbor Seal	PLOS ONE			English	Article							CYNOMOLGUS MONKEYS; PHOCA-VITULINA; B19 PARVOVIRUS; IDENTIFICATION; INFECTION; VIRUS; MENINGOENCEPHALITIS; COINFECTION; DISEASE; ANEMIA	Using random PCR in combination with next-generation sequencing, a novel parvovirus was detected in the brain of a young harbor seal (Phoca vitulina) with chronic non-suppurative meningo-encephalitis that was rehabilitated at the Seal Rehabilitation and Research Centre (SRRC) in the Netherlands. In addition, two novel viruses belonging to the family Anelloviridae were detected in the lungs of this animal. Phylogenetic analysis of the coding sequence of the novel parvovirus, tentatively called Seal parvovirus, indicated that this virus belonged to the genus Erythrovirus, to which human parvovirus B19 also belongs. Although no other seals with similar signs were rehabilitated in SRRC in recent years, a prevalence study of tissues of seals from the same area collected in the period 2008-2012 indicated that the Seal parvovirus has circulated in the harbor seal population at least since 2008. The presence of the Seal parvovirus in the brain was confirmed by real-time PCR and in vitro replication. Using in situ hybridization, we showed for the first time that a parvovirus of the genus Erythrovirus was present in the Virchow-Robin space and in cerebral parenchyma adjacent to the meninges. These findings showed that a parvovirus of the genus Erythrovirus can be involved in central nervous system infection and inflammation, as has also been suspected but not proven for human parvovirus B19 infection.	[Bodewes, Rogier; Wiersma, Lidewij C. M.; Getu, Sarah; Schapendonk, Claudia M. E.; van Run, Peter R. W. A.; van de Bildt, Marco W. G.; Poen, Marjolein J.; Kuiken, Thijs; Smits, Saskia L.; Osterhaus, Albert D. M. E.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Garcia, Ana Rubio; Osinga, Nynke; Contreras, Guillermo J. Sanchez] Seal Rehabil & Res Ctr, Pieterburen, Netherlands; [Beukers, Martijn] Univ Utrecht, Fac Vet Med, Div Diagnost Imaging, Utrecht, Netherlands; [Smits, Saskia L.; Osterhaus, Albert D. M. E.] Viroclin Biosci BV, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Utrecht University	Bodewes, R (corresponding author), Erasmus MC, Dept Virosci, Rotterdam, Netherlands.	r.bodewes@erasmusmc.nl	Smits, Saskia/A-2953-2014	Bodewes, Rogier/0000-0002-0689-7889; Sanchez Contreras, Guillermo J./0000-0002-7664-2531; Kuiken, Thijs/0000-0001-5501-9049	European Community [223498]; Dutch Virgo Consortium	European Community(European Commission); Dutch Virgo Consortium	This work was supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under the project European Management Platform for Emerging and Re-emerging Infectious Disease Entities (EMPERIE; EC grant agreement number 223498) and the Dutch Virgo Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2001, P NATL ACAD SCI USA, V98, P11609, DOI 10.1073/pnas.211424698; Anthony SJ, 2012, MBIO, V3, DOI 10.1128/mBio.00166-12; BARRETT T, 1993, VIROLOGY, V193, P1010, DOI 10.1006/viro.1993.1217; Bodewes R, 2013, VIROLOGY, V440, P84, DOI 10.1016/j.virol.2013.02.011; Bodewes R, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.2; Bonvicini F, 2008, CLIN INFECT DIS, V47, P385, DOI 10.1086/589863; BORST GHA, 1986, J WILDLIFE DIS, V22, P1; Burns K, 2007, FIELDS VIROLOGY, P2437; Coskun O, 2008, CLIN MICROBIOL INFEC, V14, P1188, DOI 10.1111/j.1469-0691.2008.02110.x; Das Neves C, 2011, HERPESVIRUS INFECT M; Di Guardo G, 2005, J VET MED A, V52, P88, DOI 10.1111/j.1439-0442.2005.00693.x; Douvoyiannis M, 2009, CLIN INFECT DIS, V48, P1713, DOI 10.1086/599042; Green SW, 2000, VIROLOGY, V269, P105, DOI 10.1006/viro.2000.0215; Greer LL, 2001, CRC HANDBOOK OF MARINE MAMMAL MEDICINE, SECOND EDITION, P729, DOI 10.1201/9781420041637.ch32; Hino S, 2007, REV MED VIROL, V17, P45, DOI 10.1002/rmv.524; Hoelzer K, 2010, VET RES, V41, DOI 10.1051/vetres/2010011; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; ICTV, 2012, VIRUS TAXONOMY; Jones MS, 2005, J VIROL, V79, P8230, DOI 10.1128/JVI.79.13.8230-8236.2005; Kapoor A, 2008, J VIROL, V82, P311, DOI 10.1128/JVI.01240-07; Koraka P, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002682; Maggi F, 2010, REV MED VIROL, V20, P392, DOI 10.1002/rmv.668; Maness HTD, 2011, VET MICROBIOL, V149, P23, DOI 10.1016/j.vetmic.2010.09.035; Morinet F, 2011, STEM CELLS, V29, P1656, DOI 10.1002/stem.725; Ng TFF, 2011, J GEN VIROL, V92, P1318, DOI 10.1099/vir.0.029678-0; Nolan RC, 2003, CLIN INFECT DIS, V36, P1191, DOI 10.1086/374603; Osinga N, 2012, J COMP PATHOL, V147, P550, DOI 10.1016/j.jcpa.2012.04.001; Osinga Nynke, 2010, NAMMCO Scientific Publications, V8, P355; OSTERHAUS ADME, 1988, NATURE, V335, P403, DOI 10.1038/335403a0; OSullivan MG, 1997, J VIROL, V71, P4517, DOI 10.1128/JVI.71.6.4517-4521.1997; OSULLIVAN MG, 1994, J CLIN INVEST, V93, P1571, DOI 10.1172/JCI117136; OZAWA K, 1987, BLOOD, V70, P384, DOI 10.1182/blood.V70.2.384.384; Phan TG, 2012, J VIROL, V86, P11024, DOI 10.1128/JVI.01427-12; Rohayem J, 2001, J CLIN MICROBIOL, V39, P4585, DOI 10.1128/JCM.39.12.4585-4587.2001; Rommel SA, 2001, CRC HANDBOOK OF MARINE MAMMAL MEDICINE, SECOND EDITION, P129; Servant-Delmas A, 2010, J VIROL, V84, P9658, DOI 10.1128/JVI.00684-10; Servey JT, 2007, AM FAM PHYSICIAN, V75, P373; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Toan NL, 2006, J HEPATOL, V45, P361, DOI 10.1016/j.jhep.2006.03.013; Toan NL, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-375; van den Brand JMA, 2012, J VIROL, V86, P2360, DOI 10.1128/JVI.06373-11; van Leeuwen M, 2010, J CLIN MICROBIOL, V48, P1787, DOI 10.1128/JCM.02452-09; VanDevanter DR, 1996, J CLIN MICROBIOL, V34, P1666, DOI 10.1128/JCM.34.7.1666-1671.1996; WILSON TM, 1972, J AM VET MED ASSOC, V161, P611; Yoo BC, 1999, VIROLOGY, V253, P250, DOI 10.1006/viro.1998.9518	45	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79259	10.1371/journal.pone.0079259	http://dx.doi.org/10.1371/journal.pone.0079259			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223918	gold, Green Published, Green Submitted			2022-12-27	WOS:000326597400056
J	Chan, R; Leung, J; Woo, J				Chan, Ruth; Leung, Jason; Woo, Jean			A Prospective Cohort Study Examining the Associations of Dietary Calcium Intake with All-Cause and Cardiovascular Mortality in Older Chinese Community-Dwelling People	PLOS ONE			English	Article							HEART-DISEASE MORTALITY; HONG-KONG; RISK; WOMEN; SUPPLEMENTATION; MAGNESIUM; STROKE; MEN	Background: Most epidemiological studies of calcium intake and mortality risk have been conducted in populations with moderate to high calcium intake, and limited studies have focused on populations with low habitual calcium intake (i.e., mean dietary calcium intake <700 mg/d). Objective: This study investigated the association between dietary calcium intake and death from all causes and cardiovascular disease in Chinese population with low habitual calcium intake. Design: Data from 3,139 Chinese men and women in a population-based prospective cohort study, aged >= 65 years and free of heart diseases or stroke at baseline, were analyzed. Primary outcome measures, identified from the death registry, were death from all causes and cardiovascular disease. Dietary calcium intake assessed using a validated food frequency questionnaire was categorized into sex-specific quartiles. Data on use of supplemental calcium (yes or no) including individual calcium supplements and other calcium containing supplement were collected. Cox regression models adjusted for demographic and lifestyle variables were used to estimate hazard ratios (HRs) and 95% confidence intervals (CI). Results: During a median of 9.1 years of follow-up, 529 all-cause deaths (344 men, 185 women) and 114 (74 men, 40 women) deaths from cardiovascular disease were identified. An inverse trend between dietary calcium intake and mortality was observed. Compared with the lowest quartile (< 458 mg/d for men, < 417 mg/d for women), the highest quartile of dietary calcium intake (> 762 mg/d for men, > 688 mg/d for women) had a significantly reduced risk of all-cause mortality (multivariate HR=0.63, 95% CI= 0.49-0.81, P-trend<0.001) but an insignificant decreased risk of cardiovascular mortality (multivariate HR= 0.70, 95% CI= 0.41-1.21, P-trend=0.228). Similar inverse association was observed when the analyses were stratified on calcium supplemental use. Conclusions: Higher intake of dietary calcium was associated with reduced risk of all-cause mortality and possibly cardiovascular mortality in Chinese older people with low habitual calcium intake.	[Chan, Ruth; Woo, Jean] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Leung, Jason] Chinese Univ Hong Kong, Jockey Club Ctr Osteoporosis Care & Control, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Chan, R (corresponding author), Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China.	ruthchansm@cuhk.edu.hk	Chan, Ruth/K-4995-2014; Woo, Jean/K-2625-2014	Woo, Jean/0000-0001-7593-3081; Chan, Ruth/0000-0002-5725-4066	Research Grants Council of Hong Kong [CUHK 4101/02M]; Hong Kong Jockey Club Charities Trust; SH Ho Centre for Gerontology and Geriatric; Centre for Nutritional Studies; Chinese University of Hong Kong	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Hong Kong Jockey Club Charities Trust; SH Ho Centre for Gerontology and Geriatric; Centre for Nutritional Studies; Chinese University of Hong Kong(Chinese University of Hong Kong)	The work was supported by grants from the Research Grants Council of Hong Kong, CUHK 4101/02M; the Hong Kong Jockey Club Charities Trust; the SH Ho Centre for Gerontology and Geriatric; and the Centre for Nutritional Studies, The Chinese University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnlov J, 2013, KIDNEY INT, V83, P160, DOI 10.1038/ki.2012.327; Bolland MJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3691; Bostick RM, 1999, AM J EPIDEMIOL, V149, P151, DOI 10.1093/oxfordjournals.aje.a009781; CHAN R, 2013, JAMA INTERN IN PRESS; Dalal M, 2011, EUR J ENDOCRINOL, V165, P797, DOI 10.1530/EJE-11-0577; Jakobsen MU, 2009, AM J CLIN NUTR, V89, P1425, DOI 10.3945/ajcn.2008.27124; Kaluza J, 2010, AM J EPIDEMIOL, V171, P801, DOI 10.1093/aje/kwp467; Larsson SC, 2013, AM J CLIN NUTR, V97, P951, DOI 10.3945/ajcn.112.052449; Li KR, 2012, HEART, V98, P920, DOI 10.1136/heartjnl-2011-301345; Michaelsson K, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f228; Paul A.A., 1978, MCCANCE WIDDOWSONS C; Reid IR, 2011, OSTEOPOROSIS INT, V22, P1649, DOI 10.1007/s00198-011-1599-9; Reid IR, 2012, HEART, V98, P895, DOI 10.1136/heartjnl-2012-301904; Sacks FM, 1998, HYPERTENSION, V31, P131, DOI 10.1161/01.HYP.31.1.131; Torres MRSG, 2012, CLINICS, V67, P839, DOI 10.6061/clinics/2012(07)22; VANDERVIJVER LPL, 1992, INT J EPIDEMIOL, V21, P36, DOI 10.1093/ije/21.1.36; Vervloet MG, 2011, CLIN J AM SOC NEPHRO, V6, P383, DOI 10.2215/CJN.04730510; Wang L, 2012, AM J CARDIOVASC DRUG, V12, P105, DOI 10.2165/11595400-000000000-00000; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Wong SYS, 2005, OSTEOPOROSIS INT, V16, P1933, DOI 10.1007/s00198-005-1968-3; Woo J, 1997, NUTR RES, V17, P1633, DOI 10.1016/S0271-5317(97)00170-X; Xiao Q, 2013, JAMA INTERN MED, V173, P639, DOI 10.1001/jamainternmed.2013.3283; Yang Y., 2002, CHINA FOOD COMPOSITI, V2002nd ed.	24	22	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80895	10.1371/journal.pone.0080895	http://dx.doi.org/10.1371/journal.pone.0080895			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224062	Green Submitted, Green Published, gold			2022-12-27	WOS:000326597400125
J	Sanderson, TH; Mahapatra, G; Pecina, P; Ji, QQ; Yu, KB; Sinkler, C; Varughese, A; Kumar, R; Bukowski, MJ; Tousignant, RN; Salomon, AR; Lee, I; Huttemann, M				Sanderson, Thomas H.; Mahapatra, Gargi; Pecina, Petr; Ji, Qinqin; Yu, Kebing; Sinkler, Christopher; Varughese, Ashwathy; Kumar, Rita; Bukowski, Melissa J.; Tousignant, Renee N.; Salomon, Arthur R.; Lee, Icksoo; Huttemann, Maik			Cytochrome c Is Tyrosine 97 Phosphorylated by Neuroprotective Insulin Treatment	PLOS ONE			English	Article							ISCHEMIC BRAIN-DAMAGE; CEREBRAL-ISCHEMIA; FOREBRAIN ISCHEMIA; APOPTOSIS; RELEASE; CARDIOLIPIN; DEATH; CELL; RESPIRATION; MECHANISMS	Recent advancements in isolation techniques for cytochrome c (Cytc) have allowed us to discover post-translational modifications of this protein. We previously identified two distinct tyrosine phosphorylated residues on Cytc in mammalian liver and heart that alter its electron transfer kinetics and the ability to induce apoptosis. Here we investigated the phosphorylation status of Cytc in ischemic brain and sought to determine if insulin-induced neuroprotection and inhibition of Cytc release was associated with phosphorylation of Cytc. Using an animal model of global brain ischemia, we found a similar to 50% decrease in neuronal death in the CA1 hippocampal region with post-ischemic insulin administration. This insulin-mediated increase in neuronal survival was associated with inhibition of Cytc release at 24 hours of reperfusion. To investigate possible changes in the phosphorylation state of Cytc we first isolated the protein from ischemic pig brain and brain that was treated with insulin. Ischemic brains demonstrated no detectable tyrosine phosphorylation. In contrast Cytc isolated from brains treated with insulin showed robust phosphorylation of Cytc, and the phosphorylation site was unambiguously identified as Tyr97 by immobilized metal affinity chromatography/nano-liquid chromatography/electrospray ionization mass spectrometry. We next confirmed these results in rats by in vivo application of insulin in the absence or presence of global brain ischemia and determined that Cytc Tyr97-phosphorylation is strongly induced under both conditions but cannot be detected in untreated controls. These data suggest a mechanism whereby Cytc is targeted for phosphorylation by insulin signaling, which may prevent its release from the mitochondria and the induction of apoptosis.	[Sanderson, Thomas H.; Kumar, Rita; Bukowski, Melissa J.; Tousignant, Renee N.] Wayne State Univ, Sch Med, Dept Emergency Med, Detroit, MI USA; [Sanderson, Thomas H.; Kumar, Rita; Bukowski, Melissa J.; Huttemann, Maik] Wayne State Univ, Sch Med, Cardiovasc Res Inst, Detroit, MI 48202 USA; [Mahapatra, Gargi; Pecina, Petr; Sinkler, Christopher; Varughese, Ashwathy; Huttemann, Maik] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI USA; [Mahapatra, Gargi; Huttemann, Maik] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI USA; [Pecina, Petr] Acad Sci Czech Republ, Inst Physiol, Prague, Czech Republic; [Pecina, Petr] Acad Sci Czech Republ, Ctr Appl Genom, Prague, Czech Republic; [Ji, Qinqin; Yu, Kebing; Salomon, Arthur R.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Lee, Icksoo] Dankook Univ, Coll Med, Cheonan Si, Chungcheongnam, South Korea	Wayne State University; Wayne State University; Wayne State University; Wayne State University; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Czech Academy of Sciences; Brown University; Dankook University	Huttemann, M (corresponding author), Wayne State Univ, Sch Med, Cardiovasc Res Inst, Detroit, MI 48202 USA.	mhuttema@med.wayne.edu	Pecina, Petr/A-9396-2010; Yu, Kebing/D-4585-2014; Sanderson, Thomas H/K-6656-2012; Mahapatra, Gargi/ABC-9107-2020	Pecina, Petr/0000-0003-0641-2834; Sanderson, Thomas H/0000-0003-0112-8164; Mahapatra, Gargi/0000-0003-2363-4092; Huttemann, Maik/0000-0001-6310-7081; Kumar, Rita/0000-0002-9573-7667	National Institutes of Health [GM089900, NS076715, AI083636, AI083908]; Cardiovascular Research Institute; Department of Emergency Medicine; Center for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083636, R21AI083908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076715] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cardiovascular Research Institute; Department of Emergency Medicine; Center for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Research described in this article was supported by grants GM089900 (MH), NS076715 (THS, RK), AI083636, and AI083908 (ARS) from the National Institutes of Health, the Cardiovascular Research Institute (MH, THS), the Department of Emergency Medicine, and the Center for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao GD, 2004, J NEUROSCI, V24, P6189, DOI 10.1523/JNEUROSCI.1426-04.2004; Endo H, 2006, J NEUROSCI, V26, P7974, DOI 10.1523/JNEUROSCI.0897-06.2006; Fernandez MG, 2002, CELL GROWTH DIFFER, V13, P449; Ficarro SB, 2005, RAPID COMMUN MASS SP, V19, P57, DOI 10.1002/rcm.1746; Fujimura M, 1998, J CEREBR BLOOD F MET, V18, P1239, DOI 10.1097/00004647-199811000-00010; Gonzalvez F, 2007, APOPTOSIS, V12, P877, DOI 10.1007/s10495-007-0718-8; Green DR, 2000, CELL, V102, P1, DOI 10.1016/S0092-8674(00)00003-9; Hetz C, 2005, J BIOL CHEM, V280, P42960, DOI 10.1074/jbc.M505843200; Huttemann M, 2011, MITOCHONDRION, V11, P369, DOI 10.1016/j.mito.2011.01.010; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Lebesgue D, 2009, STEROIDS, V74, P555, DOI 10.1016/j.steroids.2009.01.003; Lee I, 2006, BIOCHEMISTRY-US, V45, P9121, DOI 10.1021/bi060585v; Liu SS, 1999, J BIOENERG BIOMEMBR, V31, P367; Matapurkar A, 2006, CELL DEATH DIFFER, V13, P2062, DOI 10.1038/sj.cdd.4401968; Ouyang YB, 1999, J CEREBR BLOOD F MET, V19, P1126, DOI 10.1097/00004647-199910000-00009; Pecina P, 2010, BIOCHEMISTRY-US, V49, P6705, DOI 10.1021/bi100486s; Putcha GV, 2002, J CELL BIOL, V157, P441, DOI 10.1083/jcb.200110108; Rizk NN, 2005, BRAIN RES, V1053, P1, DOI 10.1016/j.brainres.2005.05.036; Rodriguez-Roldan V, 2008, BIOCHEMISTRY-US, V47, P12371, DOI [10.1021/bi801329s, 10.1021/bi800910v]; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Sanderson TH, 2008, J NEUROCHEM, V106, P1248, DOI 10.1111/j.1471-4159.2008.05473.x; Sanderson TH, 2013, JOVE-J VIS EXP, DOI 10.3791/50173; Sanderson TH, 2013, MOL NEUROBIOL, V47, P9, DOI 10.1007/s12035-012-8344-z; Sanderson TH, 2009, NEUROL RES, V31, P947, DOI 10.1179/174313209X382449; SMITH ML, 1984, ACTA NEUROL SCAND, V69, P385, DOI 10.1111/j.1600-0404.1984.tb07822.x; Sugawara T, 1999, J NEUROSCI, V19, part. no.; Traub ML, 2009, J NEUROENDOCRINOL, V21, P1038, DOI 10.1111/j.1365-2826.2009.01927.x; VOLL CL, 1989, STROKE, V20, P646, DOI 10.1161/01.STR.20.5.646; VOLL CL, 1988, ANN NEUROL, V24, P638, DOI 10.1002/ana.410240508; VOLL CL, 1991, J CEREBR BLOOD F MET, V11, P1006, DOI 10.1038/jcbfm.1991.168; Yu H, 2008, BBA-BIOENERGETICS, V1777, P1066, DOI 10.1016/j.bbabio.2008.04.023; Zhao X, 2010, MOL CELL PROTEOMICS	32	40	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78627	10.1371/journal.pone.0078627	http://dx.doi.org/10.1371/journal.pone.0078627			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223835	Green Published, gold, Green Submitted			2022-12-27	WOS:000326597400038
J	Chen, R; Feng, LQ; Ruan, M; Liu, XH; Adriouch, S; Liao, H				Chen, Rong; Feng, Liqiang; Ruan, Mo; Liu, Xinghui; Adriouch, Sahil; Liao, Hua			Mechanical-Stretch of C2C12 Myoblasts Inhibits Expression of Toll-Like Receptor 3 (TLR3) and of Autoantigens Associated with Inflammatory Myopathies	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; MUSCLE SATELLITE CELLS; SKELETAL-MUSCLE; NITRIC-OXIDE; INDUCED ACTIVATION; REGENERATING MUSCLE; P38 MAPK; MYOSITIS; DIFFERENTIATION; DERMATOMYOSITIS	Recent studies in patients suffering from inflammatory autoimmune myopathies suggested that moderate exercise training improves or at least stabilizes muscle strength and function without inducing disease flares. However, the precise mechanisms involved in this beneficial effect have not been extensively studied. Here we used a model of in vitro stretched C2C12 myoblasts to investigate whether mechanical stretch could influence myoblast proliferation or the expression of proinflammatory genes. Our results demonstrated that cyclic mechanical stretch stimulated C2C12 cell cycling and early up-regulation of the molecules related to mechanical-stretch pathway in muscle (calmodulin, nNOS, MMP-2, HGF and c-Met). Unexpectedly, mechanical stretch also reduced the expression of TLR3 and of proteins known to represent autoantigens in inflammatory autoimmune myopathies (Mi-2, HRS, DNA-PKcs, U1-70). Interestingly, stimulation or inhibition of calmodulin, NOS, HGF or c-Met molecules in vitro affected the expression of autoantigens and TLR3 proteins confirming their role in the inhibition of autoantigens and TLR3 during mechanical stretch. Overall, this study demonstrates for the first time that mechanical stretch could be beneficial by reducing expression of muscle autoantigens and of pro-inflammatory TLR3 and may provide new insight to understand how resistance training can reduce the symptoms associated with myositis.	[Chen, Rong; Liu, Xinghui; Liao, Hua] Southern Med Univ, Dept Anat, Guangzhou, Guangdong, Peoples R China; [Feng, Liqiang] NingXia Med Univ, Dept Anat, Ningxia, Peoples R China; [Ruan, Mo] KunMing Gen Hosp ChengDu Mil Command, Affiliated Orthoped Hosp, Kunming, Peoples R China; [Adriouch, Sahil] Univ Rouen, Inst Res & Innovat Biomed, INSERM, U905, Normandy, France	Southern Medical University - China; Ningxia Medical University; Kunming General Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie	Liao, H (corresponding author), Southern Med Univ, Dept Anat, Guangzhou, Guangdong, Peoples R China.	hua-liao@163.com	ADRIOUCH, Sahil/G-8999-2012	ADRIOUCH, Sahil/0000-0002-0265-7773	National Natural Science Foundation of China [81171724, 81371924]; National Basic Research Program of China [2012CB619104]; Guang Dong Provincial Science and Technology Program [2012B031800146]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Guang Dong Provincial Science and Technology Program	This study has been supported by grants from the National Natural Science Foundation of China (81171724) and (81371924), National Basic Research Program of China (Grant No. 2012CB619104), and Guang Dong Provincial Science and Technology Program (2012B031800146). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Alexanderson H, 2007, ARTHRIT RHEUM-ARTHR, V57, P768, DOI 10.1002/art.22780; Anderson JE, 2000, MOL BIOL CELL, V11, P1859, DOI 10.1091/mbc.11.5.1859; Betteridge ZE, 2009, CURR OPIN RHEUMATOL, V21, P604, DOI 10.1097/BOR.0b013e328331638a; Casciola-Rosen L, 2005, J EXP MED, V201, P591, DOI 10.1084/jem.20041367; Fluck M, 2000, J APPL PHYSIOL, V88, P352, DOI 10.1152/jappl.2000.88.1.352; Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011; Gong RJ, 2004, J AM SOC NEPHROL, V15, P2868, DOI 10.1097/01.ASN.0000141962.44300.3A; Hengstman GJD, 2001, CURR OPIN RHEUMATOL, V13, P476, DOI 10.1097/00002281-200111000-00004; Kook SH, 2008, MOL CELLS, V25, P479; Kook SH, 2008, MOL CELL BIOCHEM, V309, P133, DOI 10.1007/s11010-007-9651-y; Kuroiwa T, 2001, J CLIN INVEST, V107, P1365, DOI 10.1172/JCI11808; Li CH, 2007, CELL SIGNAL, V19, P881, DOI 10.1016/j.cellsig.2007.01.004; Mammen AL, 2009, ARTHRITIS RHEUM, V60, P3784, DOI 10.1002/art.24977; Nader GA, 2010, MOL MED, V16, P455, DOI 10.2119/molmed.2010.00016; Nguyen HX, 2003, J PHYSIOL-LONDON, V550, P347, DOI 10.1113/jphysiol.2003.040907; Okunishi K, 2005, J IMMUNOL, V175, P4745, DOI 10.4049/jimmunol.175.7.4745; Okunishi K, 2007, J IMMUNOL, V179, P5504, DOI 10.4049/jimmunol.179.8.5504; SCHULTZ E, 1994, REV PHYSIOL BIOCH P, V123, P213, DOI 10.1007/BFb0030904; Tatsumi R., 2002, Animal Science Journal, V73, P235, DOI 10.1046/j.1344-3941.2002.00033.x; Tatsumi R, 2002, MOL BIOL CELL, V13, P2909, DOI 10.1091/mbc.E02-01-0062; Tatsumi R, 2004, MUSCLE NERVE, V30, P654, DOI 10.1002/mus.20114; Tatsumi R, 2010, ANIM SCI J, V81, P11, DOI 10.1111/j.1740-0929.2009.00712.x; Tatsumi R, 2009, AM J PHYSIOL-CELL PH, V296, pC922, DOI 10.1152/ajpcell.00471.2008; Tournadre A, 2010, ARTHRITIS RHEUM-US, V62, P2144, DOI 10.1002/art.27465; VazquezAbad D, 1996, ARTHRITIS RHEUM, V39, P292, DOI 10.1002/art.1780390218; Wozniak AC, 2005, MUSCLE NERVE, V31, P283, DOI 10.1002/mus.20263; Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163; Yamada M, 2008, INT J BIOCHEM CELL B, V40, P2183, DOI 10.1016/j.biocel.2008.02.017; Zhan M, 2007, J CELL SCI, V120, P692, DOI 10.1242/jcs.03372	29	12	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79930	10.1371/journal.pone.0079930	http://dx.doi.org/10.1371/journal.pone.0079930			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24224022	gold, Green Published, Green Submitted			2022-12-27	WOS:000326503400148
J	Ge, HT; Yin, XT; Xu, JH; Tang, YC; Han, Y; Xu, WJ; Pang, ZC; Meng, HW; Liu, SW				Ge, Haitao; Yin, Xuntao; Xu, Junhai; Tang, Yuchun; Han, Yan; Xu, Wenjian; Pang, Zengchang; Meng, Haiwei; Liu, Shuwei			Fiber Pathways of Attention Subnetworks Revealed with Tract-Based Spatial Statistics (TBSS) and Probabilistic Tractography	PLOS ONE			English	Article							WORKING-MEMORY; VISUOSPATIAL ATTENTION; EXECUTIVE ATTENTION; CORTICAL THICKNESS; PREFRONTAL CORTEX; BRAIN; NETWORKS; INDEPENDENCE; CEREBELLUM; MATURATION	It has been widely accepted that attention can be divided into three subnetworks - alerting, orienting and executive control (EC), and the subnetworks of attention are linked to distinct brain regions. However, the association between specific white matter fibers and the subnetworks of attention is not clear enough. Using diffusion tensor imaging (DTI), the white matter connectivity related to the performance of attention was assessed by attention network test (ANT) in 85 healthy adolescents. Tract-based spatial statistics (TBSS) and probabilistic diffusion tractography analysis demonstrated that cerebellothalamic tract was involved in alerting, while orienting depended upon the superior longitudinal fasciculus (SLF). In addition, EC was under the control of anterior corona radiata (ACR). Our findings suggest that different fiber pathways are involved in the three distinct subnetworks of attention. The current study will yield more precise information about the structural substrates of attention function and may aid the efforts to understand the neurophysiology of several attention disorders.	[Ge, Haitao; Yin, Xuntao; Xu, Junhai; Tang, Yuchun; Meng, Haiwei; Liu, Shuwei] Shandong Univ, Sch Med, Res Ctr Sect & Imaging Anat, Jinan, Shandong, Peoples R China; [Han, Yan; Xu, Wenjian] Qingdao Univ, Coll Med, Affiliated Hosp, Dept Radiol, Qingdao, Shandong, Peoples R China; [Pang, Zengchang] Qingdao Municipal Ctr Dis Control & Prevent, Dept Epidemiol, Qingdao, Shandong, Peoples R China	Shandong University; Qingdao University	Liu, SW (corresponding author), Shandong Univ, Sch Med, Res Ctr Sect & Imaging Anat, Jinan, Shandong, Peoples R China.	liusw@sdu.edu.cn		Yin, Xuntao/0000-0002-8228-6908; Xu, Junhai/0000-0002-4289-647X	National Natural Science Foundation of China [30871305, 81371533]; Graduate Independent Innovation Foundation of Shandong University [yzc12151]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Graduate Independent Innovation Foundation of Shandong University	This study was supported by National Natural Science Foundation of China (No. 30871305, 81371533) and the Graduate Independent Innovation Foundation of Shandong University (No. yzc12151). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastian AJ, 2011, CURR OPIN NEUROBIOL, V21, P596, DOI 10.1016/j.conb.2011.06.007; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Callejas A, 2004, BRAIN COGNITION, V54, P225, DOI 10.1016/j.bandc.2004.02.012; Charlton RA, 2010, CORTEX, V46, P474, DOI 10.1016/j.cortex.2009.07.005; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2011, ANNU REV NEUROSCI, V34, P569, DOI 10.1146/annurev-neuro-061010-113731; Coull JT, 2001, CEREB CORTEX, V11, P73, DOI 10.1093/cercor/11.1.73; Fan J, 2003, P NATL ACAD SCI USA, V100, P7406, DOI 10.1073/pnas.0732088100; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Fan J, 2007, J NEUROSCI, V27, P2272, DOI 10.1523/JNEUROSCI.3470-06.2007; Gallay MN, 2008, BRAIN STRUCT FUNCT, V212, P443, DOI 10.1007/s00429-007-0170-0; Golla H, 2005, BRAIN, V128, P1525, DOI 10.1093/brain/awh523; Hatta T, 2004, APPL NEUROPSYCHOL, V11, P153, DOI 10.1207/s15324826an1103_3; HEILMAN KM, 1980, NEUROLOGY, V30, P327, DOI 10.1212/WNL.30.3.327; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Jokisch D, 2005, EUR J NEUROSCI, V21, P3439, DOI 10.1111/j.1460-9568.2005.04145.x; Klarborg B, 2012, HUM BRAIN MAPP; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Mahoney JR, 2010, J INT NEUROPSYCH SOC, V16, P877, DOI 10.1017/S1355617710000767; Mamah D, 2010, PSYCHIAT RES-NEUROIM, V183, P144, DOI 10.1016/j.pscychresns.2010.04.013; Nestor PG, 2007, SCHIZOPHR RES, V90, P308, DOI 10.1016/j.schres.2006.10.005; Niogi S, 2010, FRONT NEUROANAT, V4, DOI [10.3389/neuro.05.002.2010, 10.3389/fneur.2010.00149]; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; Penke L., 2012, MOL PSYCHIAT; Petrides M, 2006, J COMP NEUROL, V498, P227, DOI 10.1002/cne.21048; Posner MI, 2008, ANN NY ACAD SCI, V1129, P193, DOI 10.1196/annals.1417.011; Posner MI, 2006, NEURAL NETWORKS, V19, P1422, DOI 10.1016/j.neunet.2006.08.004; Raz A, 2006, NAT REV NEUROSCI, V7, P367, DOI 10.1038/nrn1903; SAKAI ST, 1993, J COMP NEUROL, V330, P183, DOI 10.1002/cne.903300204; Schmahmann JD, 2006, FIBER PATHWAYS BRAIN, DOI DOI 10.1093/ACPROF:OSO/9780195104233.003.0014; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Schmahmann JD, 2010, NEUROPSYCHOL REV, V20, P236, DOI 10.1007/s11065-010-9142-x; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Suchan J, 2013, HUM BRAIN MAPP, DOI 10.1002/hbm.22232; Takahashi M, 2010, NEUROSCI LETT, V477, P72, DOI 10.1016/j.neulet.2010.04.031; Takeuchi H, 2011, HUM BRAIN MAPP; Takeuchi H, 2010, J NEUROSCI, V30, P3297, DOI 10.1523/JNEUROSCI.4611-09.2010; Tamnes CK, 2010, CEREB CORTEX, V20, P534, DOI 10.1093/cercor/bhp118; Tang YY, 2010, P NATL ACAD SCI USA, V107, P15649, DOI 10.1073/pnas.1011043107; Thiebaut de Schotten M, 2005, SCIENCE, V309, P2226, DOI 10.1126/science.1116251; Thiebaut de Schotten M, 2011, NAT NEUROSCI, V14, P1245, DOI 10.1038/nn.2905; Thiel CM, 2004, NEUROIMAGE, V21, P318, DOI 10.1016/j.neuroimage.2003.08.044; Thimm M, 2011, PSYCHOL MED, V41, P1551, DOI 10.1017/S0033291710002217; Thimm M, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-54; Troster AI, 2002, EUR J NEUROL, V9, P143; Umarova RM, 2010, CEREB CORTEX, V20, P121, DOI 10.1093/cercor/bhp086; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Westlye LT, 2011, CEREB CORTEX, V21, P345, DOI 10.1093/cercor/bhq101; Yin XT, 2013, HUM BRAIN MAPP, V34, P796, DOI 10.1002/hbm.21477	60	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78831	10.1371/journal.pone.0078831	http://dx.doi.org/10.1371/journal.pone.0078831			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223852	Green Published, gold, Green Submitted			2022-12-27	WOS:000326503400090
J	Streijger, F; Plunet, WT; Lee, JHT; Liu, J; Lam, CK; Park, S; Hilton, BJ; Fransen, BL; Matheson, KAJ; Assinck, P; Kwon, BK; Tetzlaff, W				Streijger, Femke; Plunet, Ward T.; Lee, Jae H. T.; Liu, Jie; Lam, Clarrie K.; Park, Soeyun; Hilton, Brett J.; Fransen, Bas L.; Matheson, Keely A. J.; Assinck, Peggy; Kwon, Brian K.; Tetzlaff, Wolfram			Ketogenic Diet Improves Forelimb Motor Function after Spinal Cord Injury in Rodents	PLOS ONE			English	Article							MONOCARBOXYLATE TRANSPORTER MCT1; ACTIVATED PROTEIN-KINASE; BETA-HYDROXYBUTYRATE; RAT-BRAIN; NEURONAL DAMAGE; STAIRCASE TEST; SYNAPTIC PLASTICITY; MOUSE-BRAIN; LEPTIN; ADULT	High fat, low carbohydrate ketogenic diets (KD) are validated non-pharmacological treatments for some forms of drug-resistant epilepsy. Ketones reduce neuronal excitation and promote neuroprotection. Here, we investigated the efficacy of KD as a treatment for acute cervical spinal cord injury (SCI) in rats. Starting 4 hours following C5 hemi-contusion injury animals were fed either a standard carbohydrate based diet or a KD formulation with lipid to carbohydrate plus protein ratio of 3: 1. The forelimb functional recovery was evaluated for 14 weeks, followed by quantitative histopathology. Post-injury 3: 1 KD treatment resulted in increased usage and range of motion of the affected forepaw. Furthermore, KD improved pellet retrieval with recovery of wrist and digit movements. Importantly, after returning to a standard diet after 12 weeks of KD treatment, the improved forelimb function remained stable. Histologically, the spinal cords of KD treated animals displayed smaller lesion areas and more grey matter sparing. In addition, KD treatment increased the number of glucose transporter-1 positive blood vessels in the lesion penumbra and monocarboxylate transporter-1 (MCT1) expression. Pharmacological inhibition of MCTs with 4-CIN (alpha-cyano-4-hydroxycinnamate) prevented the KD-induced neuroprotection after SCI, In conclusion, post-injury KD effectively promotes functional recovery and is neuroprotective after cervical SCI. These beneficial effects require the function of monocarboxylate transporters responsible for ketone uptake and link the observed neuroprotection directly to the function of ketones, which are known to exert neuroprotection by multiple mechanisms. Our data suggest that current clinical nutritional guidelines, which include relatively high carbohydrate contents, should be revisited.	[Streijger, Femke; Plunet, Ward T.; Lee, Jae H. T.; Liu, Jie; Lam, Clarrie K.; Park, Soeyun; Hilton, Brett J.; Fransen, Bas L.; Matheson, Keely A. J.; Assinck, Peggy; Kwon, Brian K.; Tetzlaff, Wolfram] Blusson Spinal Cord Ctr, Int Collaborat Repair Discoveries ICORD, Vancouver, BC, Canada; [Kwon, Brian K.; Tetzlaff, Wolfram] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Kwon, Brian K.] Univ British Columbia, Dept Orthopaed, Combined Neurosurg & Orthopaed Spine Program, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Tetzlaff, W (corresponding author), Blusson Spinal Cord Ctr, Int Collaborat Repair Discoveries ICORD, Vancouver, BC, Canada.	tetzlaff@icord.org	Hilton, Brett/N-9290-2019; Tetzlaff, Wolfram/AAY-4430-2020; Fransen, Bas/AAC-1020-2020; Assinck, Peggy/ABA-9634-2020; Assinck, Peggy/ABD-5333-2020	Hilton, Brett/0000-0003-2813-2294; Assinck, Peggy/0000-0001-6085-8162; Assinck, Peggy/0000-0001-6085-8162; Fransen, Bas/0000-0001-8865-8656	Craig Neilsen Foundation; Christopher and Dana Reeve Foundation; Canadian Institutes for Health Research; Rick Hansen Foundation	Craig Neilsen Foundation; Christopher and Dana Reeve Foundation; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Rick Hansen Foundation	This research was supported by The Craig Neilsen Foundation (to WT; www.chnfoundation.org), The Christopher and Dana Reeve Foundation (to FS; www.christopherreeve.org), and the Canadian Institutes for Health Research (to WT; www.cihr-irsc.gc.ca). WT holds the Edie Ehlers Chair in Spinal Cord Research funded by the Rick Hansen Foundation (www.rickhansen.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Ben-Shachar D, 2004, INT REV NEUROBIOL, V59, P273; Blazquez C, 1999, J NEUROCHEM, V73, P1674, DOI 10.1046/j.1471-4159.1999.731674.x; Bough KJ, 2006, ANN NEUROL, V60, P223, DOI 10.1002/ana.20899; Chen DF, 1997, NATURE, V385, P434, DOI 10.1038/385434a0; Chiry O, 2006, BRAIN RES, V1070, P65, DOI 10.1016/j.brainres.2005.11.064; *CNS, 2002, NEUROSURGERY, V50, DOI DOI 10.1097/00006123-200203001-00015.PUBMED:12431291; Cruse JM, 2000, EXP MOL PATHOL, V68, P38, DOI 10.1006/exmp.1999.2292; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Davis LM, 2008, J NEUROSCI RES, V86, P1812, DOI 10.1002/jnr.21628; Duelli R, 1999, BRAIN RES, V831, P254, DOI 10.1016/S0006-8993(99)01463-8; Duelli R, 2001, NEWS PHYSIOL SCI, V16, P71; DUIJVESTIJN AM, 1992, LAB INVEST, V66, P459; ELWOOD JC, 1960, J BIOL CHEM, V235, P573; Enerson BE, 2003, J PHARM SCI-US, V92, P1531, DOI 10.1002/jps.10389; Genovese T, 2005, J PINEAL RES, V38, P198, DOI 10.1111/j.1600-079X.2004.00194.x; Genovese T, 2007, NEUROSCI LETT, V423, P41, DOI 10.1016/j.neulet.2007.05.058; Genovese T, 2006, SHOCK, V25, P608, DOI 10.1097/01.shk.0000209560.54328.69; Gensel JC, 2006, J NEUROTRAUM, V23, P36, DOI 10.1089/neu.2006.23.36; Girgis J, 2007, BRAIN, V130, P2993, DOI 10.1093/brain/awm245; Guzman M, 2004, PROSTAG LEUKOTR ESS, V70, P287, DOI 10.1016/j.plefa.2003.05.001; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; Harvey J, 2006, PROG LIPID RES, V45, P369, DOI 10.1016/j.plipres.2006.03.001; HAWKINS RA, 1971, BIOCHEM J, V122, P13, DOI 10.1042/bj1220013; Hillard VH, 2004, J NEUROTRAUM, V21, P1405, DOI 10.1089/neu.2004.21.1405; Imamura K, 2006, J NEUROSCI RES, V84, P1376, DOI 10.1002/jnr.21021; Irving AJ, 2006, NEUROSCIENCE, V138, P1137, DOI 10.1016/j.neuroscience.2005.11.042; ITOH T, 1970, BIOCHEM J, V116, P641, DOI 10.1042/bj1160641; Jaerve A, 2012, INT J BIOCHEM CELL B, V44, P452, DOI 10.1016/j.biocel.2011.11.023; Jeong MA, 2011, J NEUROTRAUM, V28, P479, DOI 10.1089/neu.2010.1609; Jiao JW, 2005, EMBO J, V24, P1068, DOI 10.1038/sj.emboj.7600589; Kashiwaya Y, 2000, P NATL ACAD SCI USA, V97, P5440, DOI 10.1073/pnas.97.10.5440; Kim DY, 2008, CURR OPIN CLIN NUTR, V11, P113, DOI 10.1097/MCO.0b013e3282f44c06; Kim HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004987; Kleman AM, 2008, J NEUROSCI METH, V167, P292, DOI 10.1016/j.jneumeth.2007.08.028; Kloth V, 2006, BRAIN RES BULL, V70, P68, DOI 10.1016/j.brainresbull.2006.04.006; Kweon GR, 2004, J BIOL CHEM, V279, P51783, DOI 10.1074/jbc.M407336200; KWON BK, 2011, J NEUROTRAUMA; Leaver SG, 2006, EUR J NEUROSCI, V24, P3323, DOI 10.1111/j.1460-9568.2006.05230.x; Lee JHT, 2012, JOVE-J VIS EXP, DOI 10.3791/3313; Lee JHT, 2010, EXP NEUROL, V225, P219, DOI 10.1016/j.expneurol.2010.06.018; Leino RL, 2001, NEUROCHEM INT, V38, P519, DOI 10.1016/S0197-0186(00)00102-9; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Liu D, 1999, NEUROSCIENCE, V93, P1383, DOI 10.1016/S0306-4522(99)00278-X; Liu Y, 1999, J NEUROSCI, V19, P4370; Lutas A, 2013, TRENDS NEUROSCI, V36, P32, DOI 10.1016/j.tins.2012.11.005; Maalouf M, 2007, NEUROSCIENCE, V145, P256, DOI 10.1016/j.neuroscience.2006.11.065; Madri JA, 2009, J PHYSIOL PHARMACOL, V60, P95; Makuc J, 2004, FEMS YEAST RES, V4, P795, DOI 10.1016/j.femsyr.2004.06.003; Massieu L, 2003, NEUROSCIENCE, V120, P365, DOI 10.1016/S0306-4522(03)00266-5; Mattson MP, 2003, BIOCHEM BIOPH RES CO, V304, P539, DOI 10.1016/S0006-291X(03)00627-2; Mejia-Toiber J, 2006, NEUROCHEM RES, V31, P1399, DOI 10.1007/s11064-006-9189-5; Melo TM, 2006, NEUROCHEM INT, V48, P498, DOI 10.1016/j.neuint.2005.12.037; Metz GAS, 2000, BEHAV BRAIN RES, V116, P111, DOI 10.1016/S0166-4328(00)00245-X; MONTOYA CP, 1991, J NEUROSCI METH, V36, P219, DOI 10.1016/0165-0270(91)90048-5; Morris AAM, 2005, J INHERIT METAB DIS, V28, P109, DOI 10.1007/s10545-005-5518-0; Nikkhah G, 1998, BEHAV BRAIN RES, V92, P85, DOI 10.1016/S0166-4328(97)00128-9; Noh HS, 2006, J NEUROSCI RES, V84, P1829, DOI 10.1002/jnr.21057; Noh HS, 2004, MOL BRAIN RES, V129, P80, DOI 10.1016/j.molbrainres.2004.06.020; O'Malley D, 2007, MOL CELL NEUROSCI, V35, P559, DOI 10.1016/j.mcn.2007.05.001; Oomura Y, 2006, PEPTIDES, V27, P2738, DOI 10.1016/j.peptides.2006.07.001; Pan JW, 2002, J CEREBR BLOOD F MET, V22, P890, DOI 10.1097/00004647-200207000-00014; Pellerin L, 1998, P NATL ACAD SCI USA, V95, P3990, DOI 10.1073/pnas.95.7.3990; Pierre K, 2000, NEUROSCIENCE, V100, P617, DOI 10.1016/S0306-4522(00)00294-3; Plunet WT, 2008, EXP NEUROL, V213, P28, DOI 10.1016/j.expneurol.2008.04.011; Plunet WT, 2010, ANN NY ACAD SCI, V1198, pE1, DOI 10.1111/j.1749-6632.2010.05564.x; Prins ML, 2005, J NEUROSCI RES, V82, P413, DOI 10.1002/jnr.20633; Puchowicz MA, 2007, AM J PHYSIOL-ENDOC M, V292, pE1607, DOI 10.1152/ajpendo.00512.2006; Puchowicz MA, 2008, J CEREBR BLOOD F MET, V28, P1907, DOI 10.1038/jcbfm.2008.79; RILEY KO, 2001, NEUROLOGICAL INJURY; RODRIGUEZ DJ, 1999, NUTR SUPPORT; ROSEN GD, 1990, J NEUROSCI METH, V35, P115, DOI 10.1016/0165-0270(90)90101-K; Sacrey LAR, 2009, BEHAV BRAIN RES, V204, P153, DOI 10.1016/j.bbr.2009.05.035; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schultke E, 2003, J NEUROTRAUM, V20, P583, DOI 10.1089/089771503767168500; Schurr A, 2001, BRAIN RES, V895, P268, DOI 10.1016/S0006-8993(01)02082-0; Shanley LJ, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-24-j0001.2001; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Streijger F, 2013, J NEUROTRAUM, V30, P869, DOI 10.1089/neu.2012.2405; Sullivan PG, 2004, ANN NEUROL, V55, P576, DOI 10.1002/ana.20062; Suzuki M, 2002, JPN J PHARMACOL, V89, P36, DOI 10.1254/jjp.89.36; Tai KK, 2008, J NEURAL TRANSM, V115, P1011, DOI 10.1007/s00702-008-0050-7; Tai KK, 2007, NEUROSCI LETT, V425, P34, DOI 10.1016/j.neulet.2007.08.007; Taub E, 1976, Exerc Sport Sci Rev, V4, P335; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; Thio LL, 2006, PEDIATR RES, V60, P413, DOI 10.1203/01.pdr.0000238244.54610.27; Tieu K, 2003, J CLIN INVEST, V112, P892, DOI 10.1172/JCI200318797; Tysseling VM, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-16; Valerio A, 2006, J BIOL CHEM, V281, P12950, DOI 10.1074/jbc.M508691200; Van der Auwera Ingrid, 2005, Nutr Metab (Lond), V2, P28, DOI 10.1186/1743-7075-2-28; VanItallie TB, 2005, NEUROLOGY, V64, P728, DOI 10.1212/01.WNL.0000152046.11390.45; Vavrek R, 2006, BRAIN, V129, P1534, DOI 10.1093/brain/awl087; Veech RL, 2004, PROSTAG LEUKOTR ESS, V70, P309, DOI 10.1016/j.plefa.2003.09.007; Whetstone WD, 2003, J NEUROSCI RES, V74, P227, DOI 10.1002/jnr.10759; WHISHAW IQ, 1994, BEHAV BRAIN RES, V61, P65, DOI 10.1016/0166-4328(94)90009-4; Xiaowei H, 2006, SPINAL CORD, V44, P35, DOI 10.1038/sj.sc.3101813; Yudkoff M, 2007, ANNU REV NUTR, V27, P415, DOI 10.1146/annurev.nutr.27.061406.093722	98	67	74	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78765	10.1371/journal.pone.0078765	http://dx.doi.org/10.1371/journal.pone.0078765			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223849	gold, Green Published, Green Submitted			2022-12-27	WOS:000326503400088
J	Baez-Saldana, R; Lopez-Arteaga, Y; Bizarron-Muro, A; Ferreira-Guerrero, E; Ferreyra-Reyes, L; Delgado-Sanchez, G; Cruz-Hervert, LP; Mongua-Rodriguez, N; Garcia-Garcia, L				Baez-Saldana, Renata; Lopez-Arteaga, Yesenia; Bizarron-Muro, Alma; Ferreira-Guerrero, Elizabeth; Ferreyra-Reyes, Leticia; Delgado-Sanchez, Guadalupe; Pablo Cruz-Hervert, Luis; Mongua-Rodriguez, Norma; Garcia-Garcia, Lourdes			A Novel Scoring System to Measure Radiographic Abnormalities and Related Spirometric Values in Cured Pulmonary Tuberculosis	PLOS ONE			English	Article							DISEASE; BURDEN; STANDARDIZATION; PREVALENCE; RISK; COPD	Background: Despite chemotherapy, patients with cured pulmonary tuberculosis may result in lung functional impairment. Objective: To evaluate a novel scoring system based on the degree of radiographic abnormalities and related spirometric values in patients with cured pulmonary tuberculosis. Methods: One hundred and twenty seven patients with cured pulmonary tuberculosis were prospectively enrolled in a referral hospital specializing in respiratory diseases. Spirometry was performed and the extent of radiographic abnormalities was evaluated twice by each of two readers to generate a novel quantitative score. Scoring reproducibility was analyzed by the intra-class correlation coefficient (ICC) and the Bland-Altman method. Multiple linear regression models were performed to assess the association of the extent of radiographic abnormalities with spirometric values. Results: The intra-observer agreement for scoring of radiographic abnormalities (SRA) showed an ICC of 0.81 (CI: 95%, 0.67-0.95) and 0.78 (CI: 95%, 0.65-0.92), for reader 1 and 2, respectively. Inter-observer reproducibility for the first measurement was 0.83 (CI: 95%, 0.71-0.95), and for the second measurement was 0.74 (CI: 95%, 0.58-0.90). The Bland-Altman analysis of the intra-observer agreement showed a mean bias of 0.87% and -0.55% and an inter-observer agreement of -0.35% and -1.78%, indicating a minor average systematic variability. After adjustment for age, gender, height, smoking status, pack-years of smoking, and degree of dyspnea, the scoring degree of radiographic abnormalities was significantly and negatively associated with absolute and percent predicted values of FVC: -0.07 (CI: 95%, -0.01 to -0.04); -2.48 (CI: 95%, -3.45 to -1.50); and FEV1-0.07 (CI: 95%, -0.10 to -0.05); -2.92 (CI: 95%, -3.87 to -1.97) respectively, in the patients studied. Conclusion: The extent of radiographic abnormalities, as evaluated through our novel scoring system, was inversely associated with spirometric values, and exhibited good reliability and reproducibility. As intra-observer and inter-observer agreement of the SRA varied from good to excellent, the use of SRA in this setting appears acceptable.	[Baez-Saldana, Renata; Lopez-Arteaga, Yesenia; Bizarron-Muro, Alma] INER, Mexico City, DF, Mexico; [Baez-Saldana, Renata; Ferreira-Guerrero, Elizabeth; Ferreyra-Reyes, Leticia; Delgado-Sanchez, Guadalupe; Pablo Cruz-Hervert, Luis; Mongua-Rodriguez, Norma; Garcia-Garcia, Lourdes] INSP, Cuernavaca, Morelos, Mexico		Baez-Saldana, R (corresponding author), INER, Mexico City, DF, Mexico.	baezrd@unam.mx	Cruz-Hervert, Luis Pablo/AEI-4595-2022; García, Maria de Lourdes/I-2724-2019	Cruz-Hervert, Luis Pablo/0000-0002-6094-958X; García, Maria de Lourdes/0000-0001-5262-1157	Instituto Nacional de Enfermedades Respiratorias, Secretaria de Salud, Mexico City	Instituto Nacional de Enfermedades Respiratorias, Secretaria de Salud, Mexico City	The study was sponsored by the Instituto Nacional de Enfermedades Respiratorias, Secretaria de Salud, Mexico City. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society, 1991, AM REV RESPIR DIS, V144, P1201; [Anonymous], 2009, PLAT UN INF MOD TUB; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Caballero A, 2008, CHEST, V133, P343, DOI 10.1378/chest.07-1361; Dheda K, 2005, J INFECT DIS, V192, P1201, DOI 10.1086/444545; Ehrlich RI, 2011, INT J TUBERC LUNG D, V15, P886, DOI 10.5588/ijtld.10.0526; Eisner MD, 2010, AM J RESP CRIT CARE, V182, P693, DOI 10.1164/rccm.200811-1757ST; ENRIGHT PL, 1991, AM REV RESPIR DIS, V143, P1215, DOI 10.1164/ajrccm/143.6.1215; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; Hnizdo E, 2000, THORAX, V55, P32, DOI 10.1136/thorax.55.1.32; JIMÉNEZ P PATRICIO, 2006, Rev. chil. enferm. respir., V22, P98; Kim SJ, 2006, INT J TUBERC LUNG D, V10, P1393; Lee SW, 2011, J KOREAN MED SCI, V26, P268, DOI 10.3346/jkms.2011.26.2.268; Long R, 1998, CHEST, V113, P933, DOI 10.1378/chest.113.4.933; Maguire GP, 2009, INT J TUBERC LUNG D, V13, P1500; Menezes AMB, 2007, EUR RESPIR J, V30, P1180, DOI 10.1183/09031936.00083507; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Oficial Norma Mexicana, 1993, NOM006SSA21993 OF NO; Organization WH, GLOB TUB REP 2012; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Perez Rafael L, 2003, Semin Respir Infect, V18, P23, DOI 10.1053/srin.2003.50005; Perez-Padilla JR, 2001, SALUD PUBLICA MEXICO, V43, P113; Plit ML, 1998, EUR RESPIR J, V12, P351, DOI 10.1183/09031936.98.12020351; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Ramos Lucia Maria Macedo, 2006, J. bras. pneumol., V32, P43, DOI 10.1590/S1806-37132006000100010; Vecino Mauricio, 2011, J Infect Public Health, V4, P244, DOI 10.1016/j.jiph.2011.08.005; WILLCOX PA, 1989, RESP MED, V83, P195, DOI 10.1016/S0954-6111(89)80031-9	27	21	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78926	10.1371/journal.pone.0078926	http://dx.doi.org/10.1371/journal.pone.0078926			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223865	Green Published, Green Submitted, gold			2022-12-27	WOS:000326499300042
J	Dias-Lopes, C; Neshich, IAP; Neshich, G; Ortega, JM; Granier, C; Chavez-Olortegui, C; Molina, F; Felicori, L				Dias-Lopes, Camila; Neshich, Izabella A. P.; Neshich, Goran; Ortega, Jose Miguel; Granier, Claude; Chavez-Olortegui, Carlos; Molina, Franck; Felicori, Liza			Identification of New Sphingomyelinases D in Pathogenic Fungi and Other Pathogenic Organisms	PLOS ONE			English	Article							WEB-BASED APPLICATION; DERMONECROTIC TOXIN; ARCANOBACTERIUM-HAEMOLYTICUM; LOXOSCELES-INTERMEDIA; PROTEIN-STRUCTURE; GENE FAMILY; SPIDER; SEQUENCE; VENOM; VIRULENCE	Sphingomyelinases D (SMases D) or dermonecrotic toxins are well characterized in Loxosceles spider venoms and have been described in some strains of pathogenic microorganisms, such as Corynebacterium sp. After spider bites, the SMase D molecules cause skin necrosis and occasional severe systemic manifestations, such as acute renal failure. In this paper, we identified new SMase D amino acid sequences from various organisms belonging to 24 distinct genera, of which, 19 are new. These SMases D share a conserved active site and a C-terminal motif. We suggest that the C-terminal tail is responsible for stabilizing the entire internal structure of the SMase D Tim barrel and that it can be considered an SMase D hallmark in combination with the amino acid residues from the active site. Most of these enzyme sequences were discovered from fungi and the SMase D activity was experimentally confirmed in the fungus Aspergillus flavus. Because most of these novel SMases D are from organisms that are endowed with pathogenic properties similar to those evoked by these enzymes alone, they might be associated with their pathogenic mechanisms.	[Dias-Lopes, Camila; Ortega, Jose Miguel; Chavez-Olortegui, Carlos; Felicori, Liza] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim Imunol, Belo Horizonte, MG, Brazil; [Neshich, Izabella A. P.] Univ Estadual Campinas UNICAMP, Ctr Biol Mol & Engn Genet, Campinas, SP, Brazil; [Neshich, Goran] Embrapa Informat Technol, Campinas, SP, Brazil; [Granier, Claude; Molina, Franck] BioRad, CNRS, SysDiag UMR 3145, Montpellier, France	Universidade Federal de Minas Gerais; Universidade Estadual de Campinas; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Centre National de la Recherche Scientifique (CNRS)	Felicori, L (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim Imunol, Belo Horizonte, MG, Brazil.	liza@icb.ufmg.br	Ortega, J Miguel/E-8272-2011; Felicori, Liza F/I-6683-2013; Pena, Izabella/P-6345-2017; Chavez-Olortegui, Carlos/F-9227-2019	Ortega, J Miguel/0000-0002-8047-9191; Pena, Izabella/0000-0001-5242-3724; Chavez-Olortegui, Carlos/0000-0001-9390-7207	INCTTOX PROGRAM of Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Centre national de la recherche scientifique (CNRS) [2474]; Coodernacao de aperfeicoamento de pessoal de nivel superior, Brazil - CAPES [23038000825/2011-63]; FAPESP [12/00235-5, 2009/16376-4]	INCTTOX PROGRAM of Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Centre national de la recherche scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Coodernacao de aperfeicoamento de pessoal de nivel superior, Brazil - CAPES; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by INCTTOX PROGRAM of Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Centre national de la recherche scientifique (CNRS) - Projet International de Cooperation Scientifique [PICS no. 2474] and Coodernacao de aperfeicoamento de pessoal de nivel superior, Brazil - CAPES (Toxinologia no. 23038000825/2011-63). Izabella Pena Neshich received a PhD fellowship from FAPESP- 12/00235-5 and Goran Neshich received support from FAPESP (research project number 2009/16376-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon-Chaidez FJ, 2009, PARASITE IMMUNOL, V31, P210, DOI 10.1111/j.1365-3024.2009.01095.x; Albermann S, 2013, APPL MICROBIOL BIOT, V97, P2979, DOI 10.1007/s00253-012-4377-5; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ameen M, 2010, CLIN EXP DERMATOL, V35, P576, DOI 10.1111/j.1365-2230.2009.03647.x; Ampel Neil M, 2010, Proc Am Thorac Soc, V7, P181, DOI 10.1513/pats.200907-080AL; Bagagli E, 2006, INFECT GENET EVOL, V6, P344, DOI 10.1016/j.meegid.2005.12.002; Barthelmes J, 2007, NUCLEIC ACIDS RES, V35, pD511, DOI 10.1093/nar/gkl972; Bazzini S, 2011, APPL MICROBIOL BIOT, V92, P887, DOI 10.1007/s00253-011-3616-5; Binford GJ, 2009, MOL BIOL EVOL, V26, P547, DOI 10.1093/molbev/msn274; Bramwell PA, 1998, LETT APPL MICROBIOL, V27, P255, DOI 10.1046/j.1472-765X.1998.00439.x; Chaim OM, 2006, TOXICOL APPL PHARM, V211, P64, DOI 10.1016/j.taap.2005.05.015; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cordes MHJ, 2006, BIOINFORMATICS, V22, P264, DOI 10.1093/bioinformatics/bti811; Cox GM, 2001, MOL MICROBIOL, V39, P166, DOI 10.1046/j.1365-2958.2001.02236.x; Dighe NS, 2009, ARLING S DIS REV, V1, P88; Edwards KT, 2011, VET PARASITOL, V183, P1, DOI 10.1016/j.vetpar.2011.09.038; Fernandes JH, 2003, BIOCHEM BIOPH RES CO, V308, P533; Fry BG, 2009, ANNU REV GENOM HUM G, V10, P483, DOI 10.1146/annurev.genom.9.081307.164356; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Health TC for FS and P Biologics I for IC in A, 2005, DERMATOPHYTOSIS, P1; Health TC for FS and P Biologics I for IC in A, 2009, REV REP ACT SUBST MA, P1; Hedayati MT, 2007, MICROBIOL-SGM, V153, P1677, DOI 10.1099/mic.0.2007/007641-0; Horta CCR, 2013, J INVEST DERMATOL, V133, P1682, DOI 10.1038/jid.2013.40; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jurgenson JE, 2002, APPL ENVIRON MICROB, V68, P1972, DOI 10.1128/AEM.68.4.1972-1979.2002; Kiss T, 2012, VET PARASITOL, V187, P357, DOI 10.1016/j.vetpar.2012.02.010; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Korbsrisate S, 2007, MICROBIOL-SGM, V153, P1907, DOI 10.1099/mic.0.2006/003004-0; Krieger E, 2002, BIOINFORMATICS, V18, P315, DOI 10.1093/bioinformatics/18.2.315; Kusma J, 2008, BIOCHIMIE, V90, P1722, DOI 10.1016/j.biochi.2008.07.011; Lee S, 2005, BIOCHEM J, V391, P317, DOI 10.1042/BJ20050043; Li XP, 2012, INFECT IMMUN, V80, P429, DOI 10.1128/IAI.05830-11; Lucas EA, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-270; Mancini AL, 2004, BIOINFORMATICS, V20, P2145, DOI 10.1093/bioinformatics/bth203; Marcellino LH, 1996, FEBS LETT, V385, P154, DOI 10.1016/0014-5793(96)00375-4; MCNAMARA PJ, 1995, GENE, V156, P113, DOI 10.1016/0378-1119(95)00002-N; Murakami MT, 2005, J BIOL CHEM, V280, P13658, DOI 10.1074/jbc.M412437200; Neshich G, 2006, GENET MOL RES, V5, P717; Neshich G, 2004, NUCLEIC ACIDS RES, V32, pW595, DOI 10.1093/nar/gkh480; Neshich G, 2005, NUCLEIC ACIDS RES, V33, pD269, DOI 10.1093/nar/gki111; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Ribeiro C, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-36; Selvy PE, 2011, CHEM REV, V111, P6064, DOI 10.1021/cr200296t; Sitkiewicz I, 2006, P NATL ACAD SCI USA, V103, P16009, DOI 10.1073/pnas.0607669103; Tambourgi DV, 2007, MOL IMMUNOL, V44, P576, DOI 10.1016/j.molimm.2006.02.002; Tambourgi DV, 1998, BIOCHEM BIOPH RES CO, V251, P366, DOI 10.1006/bbrc.1998.9474; Tambourgi DV, 2004, MOL IMMUNOL, V41, P831, DOI 10.1016/j.molimm.2004.03.027; Tambourgi DV, 2000, BLOOD, V95, P683, DOI 10.1182/blood.V95.2.683; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomma BPHJ, 2005, MOL PLANT PATHOL, V6, P379, DOI 10.1111/J.1364-3703.2005.00292.X; van Meeteren LA, 2004, J BIOL CHEM, V279, P10833, DOI 10.1074/jbc.C300563200; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290	54	19	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79240	10.1371/journal.pone.0079240	http://dx.doi.org/10.1371/journal.pone.0079240			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223912	Green Published, gold, Green Submitted			2022-12-27	WOS:000326499300068
J	Jonas, JB; Holbach, L; Panda-Jonas, S				Jonas, Jost B.; Holbach, Leonard; Panda-Jonas, Songhomitra			Peripapillary Arterial Circle of Zinn-Haller: Location and Spatial Relationships with Myopia	PLOS ONE			English	Article							INDOCYANINE GREEN ANGIOGRAPHY; OPTIC-NERVE HEAD; FUNDUS FLUORESCEIN ANGIOGRAPHY; ANGLE-CLOSURE GLAUCOMA; BEIJING EYE; COHERENCE TOMOGRAPHY; LAMINA-CRIBROSA; IN-VIVO; VASCULATURE; RING	Purpose: To measure histomorphometrically the location of the peripapillary arterial circle of Zinn-Haller (ZHAC) and assess its associations with axial length. Methods: Using a light microscope, we measured the distance from the ZHAC to the peripapillary ring (optic disc border), the merging point of the dura mater with the posterior sclera ("dura-sclera point"), and the inner scleral surface. In the parapapillary region, we differentiated between beta zone (presence of Bruch's membrane, absence of retinal pigment epithelium) and gamma zone (absence of Bruch's membrane). The peripapillary scleral flange as roof of the orbital cerebrospinal fluid space was the connection between the end of the lamina cribrosa and the posterior full-thickness sclera starting at the dura-sclera point. Results: The study included 101 human globes (101 patients) with a mean axial length of 26.7 +/- 3.7 mm (range: 20.0-39.0 mm). The distance between the ZHAC and the peripapillary ring increased significantly with longer axial length (P<0.001; correlation coefficient r=0.49), longer parapapillary gamma zone (P<0.001; r=0.85), longer (P<0.001; r=0.73) land thinner (P<0.001; r=-0.45) peripapillary scleral flange, and thinner sclera posterior to the equator (P<0.001). ZHAC distance to the peripapillary ring was not significantly associated with length of parapapillary beta zone (P=0.33). Including only non-highly myopic eyes (axial length <26.5 mm), the ZHAC distance to the disc border was not related with axial length (P=0.84). In non-highly myopic eyes, the ZHAC was located close to the dura-sclera point. With increasing axial length and decreasing thickness of the peripapillary scleral flange, the ZHAC was located closer to the inner scleral surface. Conclusions: The distance between the ZHAC and the optic disc border is markedly enlarged in highly myopic eyes. Since the ZHAC is the main arterial source for the lamina cribrosa blood supply, the finding may be of interest for the pathogenesis of the increased glaucoma susceptibility in highly myopic eyes.	[Jonas, Jost B.; Panda-Jonas, Songhomitra] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany; [Holbach, Leonard] Univ Erlangen Nurnberg, Dept Ophthalmol, Erlangen, Germany	Ruprecht Karls University Heidelberg; University of Erlangen Nuremberg	Jonas, JB (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany.	Jost.Jonas@medma.uni-heidelberg.de						ANDERSON DR, 1976, AM J OPHTHALMOL, V82, P165, DOI 10.1016/0002-9394(76)90414-1; Haller A, 1754, A HALLERS PHYSL; HAYREH SS, 1969, BRIT J OPHTHALMOL, V53, P721, DOI 10.1136/bjo.53.11.721; HAYREH SS, 1985, DOC OPHTHALMOL, V59, P217, DOI 10.1007/BF00159262; HAYREH SS, 1974, T AM ACAD OPHTHALMOL, V78, P240; HENKIND P, 1969, AM J OPHTHALMOL, V68, P979, DOI 10.1016/0002-9394(69)93437-0; Hollo G, 1998, BRIT J OPHTHALMOL, V82, P332; Jonas JB, 2005, AM J OPHTHALMOL, V139, P346, DOI 10.1016/j.ajo.2004.07.047; Jonas JB, 2003, INVEST OPHTH VIS SCI, V44, P5189, DOI 10.1167/iovs.03-0174; JONAS JB, 1992, GRAEF ARCH CLIN EXP, V230, P134, DOI 10.1007/BF00164651; Jonas JB, 2012, PLOS ONE, V7; Jonas JB, 2010, ACTA OPHTHALMOL, V88, pe317, DOI 10.1111/j.1755-3768.2010.02022.x; Ko MK, 1999, BRIT J OPHTHALMOL, V83, P862, DOI 10.1136/bjo.83.7.862; Ko MK, 1997, BRIT J OPHTHALMOL, V81, P663, DOI 10.1136/bjo.81.8.663; LEVITZKY M, 1969, AM J OPHTHALMOL, V68, P986, DOI 10.1016/0002-9394(69)93438-2; LIEBERMAN MF, 1976, AM J OPHTHALMOL, V82, P405, DOI 10.1016/0002-9394(76)90489-X; Liu HH, 2010, OPHTHALMOLOGY, V117, P1763, DOI 10.1016/j.ophtha.2010.01.020; Morgan WH, 2012, INVEST OPHTH VIS SCI, V53, P4676, DOI 10.1167/iovs.12-9837; Morrison JC, 1999, INVEST OPHTH VIS SCI, V40, P1702; Nangia V, 2010, OPHTHALMOLOGY, V117, P1360, DOI 10.1016/j.ophtha.2009.11.040; Ohno-Matsui K, 1998, BRIT J OPHTHALMOL, V82, P1357, DOI 10.1136/bjo.82.12.1357; Ohno-Matsui K, 2013, AM J OPHTHALMOL, V155, P920, DOI 10.1016/j.ajo.2012.12.010; OhnoMatsui K, 1997, AM J OPHTHALMOL, V123, P494, DOI 10.1016/S0002-9394(14)70175-8; OLVER JM, 1994, INVEST OPHTH VIS SCI, V35, P3858; ONDA E, 1995, AM J OPHTHALMOL, V120, P92, DOI 10.1016/S0002-9394(14)73763-8; Park KH, 1996, AM J OPHTHALMOL, V122, P905, DOI 10.1016/S0002-9394(14)70398-8; Povazay B, 2009, INVEST OPHTH VIS SCI, V50, P1856, DOI 10.1167/iovs.08-2869; QUIGLEY HA, 1977, AM J OPHTHALMOL, V84, P358, DOI 10.1016/0002-9394(77)90680-8; Vurgese S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029692; Wang Y, 2006, BRIT J OPHTHALMOL, V90, P353, DOI 10.1136/bjo.2005.081521; Xu LA, 2007, OPHTHALMOLOGY, V114, P216, DOI 10.1016/j.ophtha.2006.06.050; Xu LA, 2010, ACTA OPHTHALMOL, V88, pe350, DOI 10.1111/j.1755-3768.2009.01770.x; Yasuzumi K, 2003, BRIT J OPHTHALMOL, V87, P1088, DOI 10.1136/bjo.87.9.1088; ZHAO Y, 1987, JPN J OPHTHALMOL, V31, P147; Zinn J, 1755, DESCRIPTIO ANATOMICA	35	14	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78867	10.1371/journal.pone.0078867	http://dx.doi.org/10.1371/journal.pone.0078867			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223862	Green Submitted, Green Published, gold			2022-12-27	WOS:000326499300040
J	Lee, HK; Tang, JWT; Kong, DHL; Loh, TP; Chiang, DKL; Lam, TTY; Koay, ESC				Lee, Hong Kai; Tang, Julian Wei-Tze; Kong, Debra Han-Lin; Loh, Tze Ping; Chiang, Donald Kok-Leong; Lam, Tommy Tsan-Yuk; Koay, Evelyn Siew-Chuan			Comparison of Mutation Patterns in Full-Genome A/H3N2 Influenza Sequences Obtained Directly from Clinical Samples and the Same Samples after a Single MDCK Passage	PLOS ONE			English	Article							RECEPTOR-BINDING PROPERTIES; NEURAMINIDASE INHIBITORS; MEMBRANE-FUSION; VIRUS ENTRY; HEMAGGLUTININ; RESISTANCE; A(H3N2); OSELTAMIVIR; VARIANTS; CELLS	Human influenza viruses can be isolated efficiently from clinical samples using Madin-Darby canine kidney (MDCK) cells. However, this process is known to induce mutations in the virus as it adapts to this non-human cell-line. We performed a systematic study to record the pattern of MDCK-induced mutations observed across the whole influenza A/H3N2 genome. Seventy-seven clinical samples collected from 2009-2011 were included in the study. Two full influenza genomes were obtained for each sample: one from virus obtained directly from the clinical sample and one from the matching isolate cultured in MDCK cells. Comparison of the full-genome sequences obtained from each of these sources showed that 42% of the 77 isolates had acquired at least one MDCK-induced mutation. The presence or absence of these mutations was independent of viral load or sample origin (in-patients versus out-patients). Notably, all the five hemagglutinin missense mutations were observed at the hemaggutinin 1 domain only, particularly within or proximal to the receptor binding sites and antigenic site of the virus. Furthermore, 23% of the 77 isolates had undergone a MDCK-induced missense mutation, D151G/N, in the neuraminidase segment. This mutation has been found to be associated with reduced drug sensitivity towards the neuraminidase inhibitors and increased viral receptor binding efficiency to host cells. In contrast, none of the neuraminidase sequences obtained directly from the clinical samples contained the D151G/N mutation, suggesting that this mutation may be an indicator of MDCK culture-induced changes. These D151 mutations can confound the interpretation of the hemagglutination inhibition assay and neuraminidase inhibitor resistance results when these are based on MDCK isolates. Such isolates are currently in routine use in the WHO influenza vaccine and drug-resistance surveillance programs. Potential data interpretation miscalls can therefore be avoided by careful exclusion of such D151 mutants after further sequence analysis.	[Lee, Hong Kai; Koay, Evelyn Siew-Chuan] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pathol, Singapore 117595, Singapore; [Lee, Hong Kai; Kong, Debra Han-Lin; Loh, Tze Ping; Chiang, Donald Kok-Leong; Koay, Evelyn Siew-Chuan] Natl Univ Hlth Syst, Natl Univ Hosp, Dept Lab Med, Singapore, Singapore; [Tang, Julian Wei-Tze] Univ Alberta Hosp, Alberta Prov Lab Publ Hlth, Edmonton, AB T6G 2B7, Canada; [Tang, Julian Wei-Tze] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [Lam, Tommy Tsan-Yuk] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	National University of Singapore; National University of Singapore; University of Alberta; University of Alberta; University of Oxford	Tang, JWT (corresponding author), Univ Alberta Hosp, Alberta Prov Lab Publ Hlth, Edmonton, AB T6G 2B7, Canada.	julian.tang@albertahealthservices.ca; evelyn_koay@nuhs.edu.sg	, Julian W Tang/H-2348-2014; Lam, Tsan Yuk/D-4837-2012	Lam, Tsan Yuk/0000-0002-9769-1527; Tang, Julian/0000-0002-4963-1028; Loh, Tze Ping/0000-0002-4272-0001	National Medical Research Council [NMRC/1247/2010]	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the National Medical Research Council grant funding (ref number: NMRC/1247/2010 to JWT and ESK; http://www.nmrc.gov.sg/content/nmrc_internet/home.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baz M, 2006, CLIN INFECT DIS, V43, P1555, DOI 10.1086/508777; Bush RM, 2000, P NATL ACAD SCI USA, V97, P6974, DOI 10.1073/pnas.97.13.6974; Ciappi S, 1997, RES VIROLOGY, V148, P427, DOI 10.1016/S0923-2516(97)83632-1; Clarke LM, 2006, VIRAL CULTURE; Cohen-Daniel L, 2009, J CLIN VIROL, V44, P138, DOI 10.1016/j.jcv.2008.11.014; DANIELS RS, 1987, EMBO J, V6, P1459, DOI 10.1002/j.1460-2075.1987.tb02387.x; Deyde VM, 2009, ANTIVIR RES, V81, P16, DOI 10.1016/j.antiviral.2008.08.008; Ghate AA, 1998, EUR J BIOCHEM, V258, P320, DOI 10.1046/j.1432-1327.1998.2580320.x; Giria MT, 2012, J CLIN VIROL, V53, P140, DOI 10.1016/j.jcv.2011.11.002; Hurt AC, 2009, J VIROL, V83, P10366, DOI 10.1128/JVI.01200-09; KATZ JM, 1987, VIROLOGY, V156, P386, DOI 10.1016/0042-6822(87)90418-1; Klimov AI, 2012, VACCINE, V30, P6461, DOI 10.1016/j.vaccine.2012.07.089; Kumari K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-42; Lam TTY, 2013, INFECT GENET EVOL, V18, P367, DOI 10.1016/j.meegid.2013.03.015; Lee C, 2011, HAEMOPHILIA, V17, P1, DOI 10.1111/j.1365-2516.2010.02478.x; Lee HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064785; Lee HK, 2012, J MED VIROL, V84, P1646, DOI 10.1002/jmv.23375; Lee HK, 2010, J MOL DIAGN, V12, P636, DOI 10.2353/jmoldx.2010.100010; Li D, 2009, J CLIN MICROBIOL, V47, P466, DOI 10.1128/JCM.00892-08; Lin YP, 2012, P NATL ACAD SCI USA, V109, P21474, DOI 10.1073/pnas.1218841110; Lin YP, 2010, J VIROL, V84, P6769, DOI 10.1128/JVI.00458-10; Matrosovich MN, 2004, J VIROL, V78, P12665, DOI 10.1128/JVI.78.22.12665-12667.2004; McKimm-Breschkin J, 2003, ANTIMICROB AGENTS CH, V47, P2264, DOI 10.1128/AAC.47.7.2264-2272.2003; McKimm-Breschkin JL, 2000, ANTIVIR RES, V47, P1, DOI 10.1016/S0166-3542(00)00103-0; MEGURO H, 1979, J CLIN MICROBIOL, V9, P175; Mochalova L, 2003, VIROLOGY, V313, P473, DOI 10.1016/S0042-6822(03)00377-5; Narasaraju T, 2009, MICROBES INFECT, V11, P2, DOI 10.1016/j.micinf.2008.09.013; Okomo-Adhiambo M, 2010, VIRUSES-BASEL, V2, P2269, DOI 10.3390/v2102269; Okomo-Adhiambo M, 2010, ANTIMICROB AGENTS CH, V54, P1834, DOI 10.1128/AAC.01608-09; Okomo-Adhiambo M, 2010, ANTIVIR RES, V85, P381, DOI 10.1016/j.antiviral.2009.11.005; Petric M, 2006, J INFECT DIS, V194, pS98, DOI 10.1086/507554; Richard M, 2011, ANTIMICROB AGENTS CH, V55, P2942, DOI 10.1128/AAC.01699-10; Roedig JV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027989; Sheu TG, 2008, ANTIMICROB AGENTS CH, V52, P3284, DOI 10.1128/AAC.00555-08; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Stevens J, 2010, J VIROL, V84, P8287, DOI 10.1128/JVI.00058-10; Su B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008495; Vanderlinden E, 2010, J VIROL, V84, P4277, DOI 10.1128/JVI.02325-09; VARGHESE JN, 1991, J MOL BIOL, V221, P473, DOI 10.1016/0022-2836(91)80068-6; VERHOEYEN M, 1980, NATURE, V286, P771, DOI 10.1038/286771a0; W.H.O, 2012, WKLY EPIDEMIOL REC, V87, P83; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; Zhirnov OP, 2009, J CLIN VIROL, V45, P322, DOI 10.1016/j.jcv.2009.05.030; Zhu XY, 2012, J VIROL, V86, P13371, DOI 10.1128/JVI.01426-12	44	25	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79252	10.1371/journal.pone.0079252	http://dx.doi.org/10.1371/journal.pone.0079252			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223916	gold, Green Published, Green Submitted			2022-12-27	WOS:000326499300070
J	Mahande, MJ; Daltveit, AK; Mmbaga, BT; Masenga, G; Obure, J; Manongi, R; Lie, RT				Mahande, Michael J.; Daltveit, Anne K.; Mmbaga, Blandina T.; Masenga, Gileard; Obure, Joseph; Manongi, Rachel; Lie, Rolv T.			Recurrence of Preeclampsia in Northern Tanzania: A Registry-Based Cohort Study	PLOS ONE			English	Article							SUBSEQUENT PREGNANCY; 2ND PREGNANCY; RISK-FACTORS; WOMEN; 1ST; OUTCOMES; COMPLICATIONS	Objective: Preeclampsia occurs in about 4 per cent of pregnancies worldwide, and may have particularly serious consequences for women in Africa. Studies in western countries have shown that women with preeclampsia in one pregnancy have a substantially increased risk of preeclampsia in subsequent pregnancies. We estimate the recurrence risks of preeclampsia in data from Northern Tanzania. Methods: A prospective cohort study was designed using 19,811 women who delivered singleton infants at a hospital in Northern Tanzania between 2000 and 2008. A total of 3,909 women were recorded with subsequent deliveries in the hospital with follow up through 2010. Adjusted recurrence risks of preeclampsia were computed using regression models. Results: The absolute recurrence risk of preeclampsia was 25%, which was 9.2-fold (95% CI: 6.4 - 13.2) compared with the risk for women without prior preeclampsia. When there were signs that the preeclampsia in a previous pregnancy had been serious either because the baby was delivered preterm or had died in the perinatal period, the recurrence risk of preeclampsia was even higher. Women who had preeclampsia had increased risk of a series of adverse pregnancy outcomes in future pregnancies. These include perinatal death (RR = 4.3), a baby with low birth weight (RR = 3.5), or a preterm birth (RR = 2.5). These risks were only partly explained by recurrence of preeclampsia. Conclusions: Preeclampsia in one pregnancy is a strong predictor for preeclampsia and other adverse pregnancy outcomes in subsequent pregnancies in Tanzania. Women with previous preeclampsia may benefit from close follow-up during their pregnancies.	[Mahande, Michael J.; Obure, Joseph; Manongi, Rachel] Kilimanjaro Christian Med Univ Coll, Moshi, Tanzania; [Mahande, Michael J.; Daltveit, Anne K.; Mmbaga, Blandina T.; Lie, Rolv T.] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Mahande, Michael J.; Mmbaga, Blandina T.] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Daltveit, Anne K.; Lie, Rolv T.] Norwegian Inst Publ Hlth, Oslo, Norway; [Masenga, Gileard; Obure, Joseph] Kilimanjaro Christian Med Ctr, Dept Obstet & Gynaecol, Moshi, Tanzania; [Mmbaga, Blandina T.] Kilimanjaro Christian Med Ctr, Dept Pediat, Moshi, Tanzania	University of Bergen; University of Bergen; Norwegian Institute of Public Health (NIPH); Kilimanjaro Christian Medical Centre; Kilimanjaro Christian Medical Centre	Mahande, MJ (corresponding author), Kilimanjaro Christian Med Univ Coll, Moshi, Tanzania.	jmmahande@yahoo.com	Mahande, Michael Johnson J/I-6359-2015; Mmbaga, Blandina Theophil/AAR-8707-2021	Mahande, Michael Johnson J/0000-0002-7750-7657; Mmbaga, Blandina Theophil/0000-0002-5550-1916	Norwegian Council for Higher Education; Quota scholarship scheme	Norwegian Council for Higher Education; Quota scholarship scheme	The birth registry was supported by the Norwegian Council for Higher Education's Program for Development Research or Nasjonalt program for Utvikling, Forskning og Utdanning (NUFU) and Quota scholarship scheme as part of MJM PhD training. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton JR, 2008, OBSTET GYNECOL, V112, P359, DOI 10.1097/AOG.0b013e3181801d56; Bhattacharya S, 2009, OBSTET GYNECOL SURV, V64, P577, DOI 10.1097/01.ogx.0000358026.53650.5a; Bramham K, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.02.014; Brown MA, 2007, BJOG-INT J OBSTET GY, V114, P984, DOI 10.1111/j.1471-0528.2007.01376.x; Chappell LC, 2008, HYPERTENSION, V51, P1002, DOI 10.1161/HYPERTENSIONAHA.107.107565; Dildy GA, 2007, SEMIN PERINATOL, V31, P135, DOI 10.1053/j.semperi.2007.03.005; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Hernandez-Diaz Sonia, 2009, BMJ, V338, pb2255, DOI 10.1136/bmj.b2255; Lie RT, 1998, BRIT MED J, V316, P1343, DOI 10.1136/bmj.316.7141.1343; Lykke JA, 2009, OBSTET GYNECOL, V113, P1217, DOI 10.1097/AOG.0b013e3181a66f2d; Macdonald-Wallis C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022115; Mahomed K, 1998, PAEDIATR PERINAT EP, V12, P253, DOI 10.1046/j.1365-3016.1998.00116.x; Mahomed K., 1998, Journal of Obstetrics and Gynaecology (Abingdon), V18, P218; Majoko F, 2005, TROP DOCT, V35, P195, DOI 10.1258/004947505774938710; Makkonen N, 2000, HYPERTENS PREGNANCY, V19, P173, DOI 10.1081/PRG-100100133; Mbah AK, 2011, EUR J OBSTET GYN R B, V156, P23, DOI 10.1016/j.ejogrb.2010.12.036; Melamed N, 2012, J MATERN-FETAL NEO M, V25, P2248, DOI 10.3109/14767058.2012.684174; Mmbaga BT, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-68; Obed Sa, 2007, Ghana Med J, V41, P139; Osungbade KO, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/481095; van Rijn BB, 2006, AM J OBSTET GYNECOL, V195, P723, DOI 10.1016/j.ajog.2006.06.044; Wang A, 2009, PHYSIOLOGY, V24, P147, DOI 10.1152/physiol.00043.2008; Williams D, 2011, SEMIN NEPHROL, V31, P111, DOI 10.1016/j.semnephrol.2010.10.010	23	10	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79116	10.1371/journal.pone.0079116	http://dx.doi.org/10.1371/journal.pone.0079116			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223889	Green Published, gold, Green Submitted			2022-12-27	WOS:000326499300058
J	Kuribayashi, N; Uchida, D; Kinouchi, M; Takamaru, N; Tamatani, T; Nagai, H; Miyamoto, Y				Kuribayashi, Nobuyuki; Uchida, Daisuke; Kinouchi, Makoto; Takamaru, Natsumi; Tamatani, Tetsuya; Nagai, Hirokazu; Miyamoto, Youji			The Role of Metabotropic Glutamate Receptor 5 on the Stromal Cell-Derived Factor-1/CXCR4 System in Oral Cancer	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; ENDOGENOUS ACTIVATION; PROGENITOR CELLS; CNS DISORDERS; EXPRESSION; CARCINOMA; CXCR4; PROLIFERATION; PROTEIN; ANTAGONISTS	We have demonstrated that blocking CXCR4 may be a potent anti-metastatic therapy for CXCR4-related oral cancer. However, as CXCR4 antagonists are currently in clinical use to induce the mobilization of hematopoietic stem cells, continuous administration as an inhibitor for the metastasis may lead to persistent leukocytosis. In this study, we investigated the novel therapeutic downstream target(s) of the SDF-1/CXCR4 system, using B88-SDF-1 cells, which have an autocrine SDF-1/CXCR4 system and exhibit distant metastatic potential in vivo. Microarray analysis revealed that 418 genes were upregulated in B88-SDF-1 cells. We identified a gene that is highly upregulated in B88-SDF-1 cells, metabotropic glutamate receptor 5 (mGluR5), which was downregulated following treatment with 1,1'-[1,4-Phenylenebis(methylene)]bis-1,4,8,11-tetraazacyclotetradecane octahydrochloride (AMD3100), a CXCR4 antagonist. The upregulation of mGluR5 mRNA in the SDF-1/CXCR4 system was predominately regulated by the Ras-extracellular signal-regulated kinase (ERK)1/2 pathway. Additionally, the growth of B88-SDF-1 cells was not affected by the mGluR5 agonist (S)-3,5-DHPG (DHPG) or the mGluR5 antagonists 2-Methyl-6-(phenylethynyl)pyridine (MPEP) and 3-((2-Methyl-1,3-thiazol-4-yl)ethynyl)pyridine (MTEP). However, we observed that DHPG promoted B88-SDF-1 cell migration, whereas both MPEP and MTEP inhibited B88-SDF-1 cell migration. To assess drug toxicity, the antagonists were intraperitoneally injected into immunocompetent mice for 4 weeks. Mice injected with MPEP (5 mg/kg) and MTEP (5 mg/kg) did not exhibit any side effects, such as hematotoxicity, allergic reactions or weight loss. The administration of antagonists significantly inhibited the metastasis of B88-SDF-1 cells to the lungs of nude mice. These results suggest that blocking mGluR5 with antagonists such as MPEP and MTEP could prevent metastasis in CXCR4-related oral cancer without causing side effects.	[Kuribayashi, Nobuyuki; Uchida, Daisuke; Kinouchi, Makoto; Takamaru, Natsumi; Tamatani, Tetsuya; Nagai, Hirokazu; Miyamoto, Youji] Univ Tokushima, Grad Sch, Inst Hlth Biosci,Subdiv Mol Oral Med, Div Integrated Sci Translat Res,Dept Oral Surg, Kuramoto, Tokushima, Japan	Tokushima University	Uchida, D (corresponding author), Univ Tokushima, Grad Sch, Inst Hlth Biosci,Subdiv Mol Oral Med, Div Integrated Sci Translat Res,Dept Oral Surg, Kuramoto, Tokushima, Japan.	daisuke@tokushima-u.ac.jp			 [24792225]; Grants-in-Aid for Scientific Research [24792225] Funding Source: KAKEN	; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Young Scientists (B; 24792225; http://www.jsps.go.jp/english/e-grants/grants01.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almofti A, 2004, INT J ONCOL, V25, P65; Bathe OF, 2011, CANCER EPIDEM BIOMAR, V20, P140, DOI 10.1158/1055-9965.EPI-10-0712; Beraldo FH, 2011, FASEB J, V25, P265, DOI 10.1096/fj.10-161653; Brauner-Osborne H, 2000, J MED CHEM, V43, P2609, DOI 10.1021/jm000007r; Cappuccio I, 2005, NEUROPHARMACOLOGY, V49, P196, DOI 10.1016/j.neuropharm.2005.05.014; Carroll FI, 2008, ANN NY ACAD SCI, V1141, P221, DOI 10.1196/annals.1441.015; Cleva RM, 2011, MOLECULES, V16, P2097, DOI 10.3390/molecules16032097; Corti C, 2003, J BIOL CHEM, V278, P33105, DOI 10.1074/jbc.M212380200; De Clercq E, 2003, NAT REV DRUG DISCOV, V2, P581, DOI 10.1038/nrd1134; De Groot JF, 2008, J NEURO-ONCOL, V88, P121, DOI 10.1007/s11060-008-9552-2; Di Giorgi-Gerevini V, 2005, CELL DEATH DIFFER, V12, P1124, DOI 10.1038/sj.cdd.4401639; Fukunaga S, 2006, ONCOLOGY-BASEL, V71, P204, DOI 10.1159/000106070; Genzyme, 2009, PLER INJ INV BROCH V; Hinoi E, 2004, EUR J BIOCHEM, V271, P1, DOI 10.1046/j.1432-1033.2003.03907.x; Kuzmiski JB, 2010, J NEUROENDOCRINOL, V22, P785, DOI 10.1111/j.1365-2826.2010.02020.x; Lea PM, 2006, CNS DRUG REV, V12, P149, DOI 10.1111/j.1527-3458.2006.00149.x; Libura J, 2002, BLOOD, V100, P2597, DOI 10.1182/blood-2002-01-0031; Luo YQ, 2005, J NEUROCHEM, V93, P452, DOI 10.1111/j.1471-4159.2005.03049.x; Luyt K, 2004, BIOCHEM BIOPH RES CO, V319, P120, DOI 10.1016/j.bbrc.2004.04.158; Lyons SA, 2007, CANCER RES, V67, P9463, DOI 10.1158/0008-5472.CAN-07-2034; Onoue T, 2006, INT J ONCOL, V29, P1133; Park SY, 2007, ONCOL REP, V17, P81; Piao YJ, 2009, NEURO-ONCOLOGY, V11, P260, DOI 10.1215/15228517-2008-094; Pilla M, 2010, BIOORG MED CHEM LETT, V20, P7521, DOI 10.1016/j.bmcl.2010.09.120; Pissimissis N, 2009, ANTICANCER RES, V29, P371; Salcedo R, 2003, MICROCIRCULATION, V10, P359, DOI 10.1038/sj.mn.7800200; Scotton CJ, 2002, CANCER RES, V62, P5930; Seidlitz EP, 2009, CLIN EXP METASTAS, V26, P781, DOI 10.1007/s10585-009-9277-4; Shah A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-52; Sharma MK, 2010, BIOCHEM BIOPH RES CO, V391, P91, DOI 10.1016/j.bbrc.2009.10.168; Skerry TM, 2001, TRENDS PHARMACOL SCI, V22, P174, DOI 10.1016/S0165-6147(00)01642-4; Spooren W, 2003, BEHAV PHARMACOL, V14, P257, DOI 10.1097/01.fbp.0000081783.35927.8f; Stepulak A, 2009, HISTOCHEM CELL BIOL, V132, P435, DOI 10.1007/s00418-009-0613-1; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Uchida D, 2003, EXP CELL RES, V290, P289, DOI 10.1016/S0014-4827(03)00344-6; Uchida D, 2007, MOL CANCER RES, V5, P1, DOI DOI 10.1158/1541-7786.MCR-06-0208.PUBMED:17259342; Uchida D, 2013, CLIN EXP METASTAS, V30, P133, DOI 10.1007/s10585-012-9518-9; Uchida D, 2011, EUR J CANCER, V47, P452, DOI 10.1016/j.ejca.2010.09.028; Uchida DE, 2004, LAB INVEST, V84, P1538, DOI 10.1038/labinvest.3700190; Vahle AK, 2012, CANCER LETT, V317, P199, DOI 10.1016/j.canlet.2011.11.027; Vanhoutte N, 2008, FEBS LETT, V582, P1847, DOI 10.1016/j.febslet.2008.04.053; Wisniewski K, 2012, DRUG RES, V8, P101; Ye ZC, 1999, CANCER RES, V59, P4383; Zeelenberg IS, 2003, CANCER RES, V63, P3833; Zhao L, 2011, NEUROSCIENCE, V192, P185, DOI 10.1016/j.neuroscience.2011.06.044; Zijlstra A, 2002, CANCER RES, V62, P7083	46	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80773	10.1371/journal.pone.0080773	http://dx.doi.org/10.1371/journal.pone.0080773			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236200	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700203
J	Lundmark, K; Shariatpanahi, AV; Westermark, GT				Lundmark, Katarzyna; Shariatpanahi, Aida Vahdat; Westermark, Gunilla T.			Depletion of Spleen Macrophages Delays AA Amyloid Development: A Study Performed in the Rapid Mouse Model of AA Amyloidosis	PLOS ONE			English	Article							FIBRIL PROTEIN; MARGINAL ZONE; DEPOSITION; LIPOSOMES; PHASE; CELLS; SAA; AMYLOIDOGENESIS; MEMBRANE; MONOCYTE	AA amyloidosis is a systemic disease that develops secondary to chronic inflammatory diseases Macrophages are often found in the vicinity of amyloid deposits and considered to play a role in both formation and degradation of amyloid fibrils. In spleen reside at least three types of macrophages, red pulp macrophages (RPM), marginal zone macrophages (MZM), metallophilic marginal zone macrophages (MMZM). MMZM and MZM are located in the marginal zone and express a unique collection of scavenger receptors that are involved in the uptake of blood-born particles. The murine AA amyloid model that resembles the human form of the disease has been used to study amyloid effects on different macrophage populations. Amyloid was induced by intravenous injection of amyloid enhancing factor and subcutaneous injections of silver nitrate and macrophages were identified with specific antibodies. We show that MZMs are highly sensitive to amyloid and decrease in number progressively with increasing amyloid load. Total area of MMZMs is unaffected by amyloid but cells are activated and migrate into the white pulp. In a group of mice spleen macrophages were depleted by an intravenous injection of clodronate filled liposomes. Subsequent injections of AEF and silver nitrate showed a sustained amyloid development. RPMs that constitute the majority of macrophages in spleen, appear insensitive to amyloid and do not participate in amyloid formation.	[Lundmark, Katarzyna; Shariatpanahi, Aida Vahdat] Linkoping Univ, Fac Hlth Sci, Div Expt Pathol, Dept Clin & Expt Med, Linkoping, Sweden; [Lundmark, Katarzyna; Shariatpanahi, Aida Vahdat] Cty Council Ostergotland, Pathol Clin, Linkoping, Sweden; [Westermark, Gunilla T.] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden	Linkoping University; City Council Ostergotland; Uppsala University	Westermark, GT (corresponding author), Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden.	Gunilla.westermark@mcb.uu.se			Swedish Research Council [GTW5343]; County Council of Ostergotland Magnus Bergvalls research foundation; Ingrid Svenssons research foundation; Broderna Karlssons research foundation; Hildur Pettersons research foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); County Council of Ostergotland Magnus Bergvalls research foundation; Ingrid Svenssons research foundation; Broderna Karlssons research foundation; Hildur Pettersons research foundation	Funding provided by Swedish Research Council (GTW5343), County Council of Ostergotland Magnus Bergvalls research foundation, Ingrid Svenssons research foundation, Broderna Karlssons research foundation and Hildur Pettersons research foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; BENDITT EP, 1979, P NATL ACAD SCI USA, V76, P4092, DOI 10.1073/pnas.76.8.4092; Bodin K, 2010, NATURE, V468, P93, DOI 10.1038/nature09494; Boissonneault V, 2009, BRAIN, V132, P1078, DOI 10.1093/brain/awn331; Buiting AMJ, 1996, J IMMUNOL METHODS, V192, P55, DOI 10.1016/0022-1759(96)00034-8; CHRONOPOULOS S, 1994, J PATHOL, V173, P361, DOI 10.1002/path.1711730412; EIN D, 1972, J BIOL CHEM, V247, P5653; Engel MFM, 2008, P NATL ACAD SCI USA, V105, P6033, DOI 10.1073/pnas.0708354105; GANOWIAK K, 1994, BIOCHEM BIOPH RES CO, V199, P306, DOI 10.1006/bbrc.1994.1229; Geijtenbeek TBH, 2002, BLOOD, V100, P2908, DOI 10.1182/blood-2002-04-1044; Giurleo JT, 2008, J MOL BIOL, V381, P1332, DOI 10.1016/j.jmb.2008.06.043; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; GROOM AC, 1991, SCANNING MICROSCOPY, V5, P159; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Jablonska J, 2007, INFECT IMMUN, V75, P462, DOI 10.1128/IAI.00443-06; Kang YS, 2004, P NATL ACAD SCI USA, V101, P215, DOI 10.1073/pnas.0307124101; KISILEVSKY R, 1983, LAB INVEST, V48, P53; Kisilevsky Robert, 2004, V299, P237; Kluve-Beckerman B, 2002, ARTHRITIS RHEUM-US, V46, P1905, DOI 10.1002/art.10335; KRAAL G, 1986, IMMUNOLOGY, V58, P665; KRAAL G, 1992, INT REV CYTOL, V132, P31, DOI 10.1016/S0074-7696(08)62453-5; Lundmark K, 2002, P NATL ACAD SCI USA, V99, P6979, DOI 10.1073/pnas.092205999; Magy N, 2007, AMYLOID, V14, P51, DOI 10.1080/13506120601116575; MALLE E, 1993, ATHEROSCLEROSIS, V102, P131, DOI 10.1016/0021-9150(93)90155-N; Mambule C, 2000, BBA-GEN SUBJECTS, V1474, P331, DOI 10.1016/S0304-4165(00)00032-5; Milanesi L, 2012, P NATL ACAD SCI USA, V109, P20455, DOI 10.1073/pnas.1206325109; Mishra R, 2007, J MOL BIOL, V366, P1029, DOI 10.1016/j.jmb.2006.11.084; NIEWOLD TA, 1993, SCAND J IMMUNOL, V37, P29, DOI 10.1111/j.1365-3083.1993.tb01660.x; Nystrom SN, 2012, AMYLOID, V19, P138, DOI 10.3109/13506129.2012.711391; Olsen KE, 1999, AMYLOID, V6, P89, DOI 10.3109/13506129909007308; PUCHTLER H, 1965, J HISTOCHEM CYTOCHEM, V13, P693, DOI 10.1177/13.8.693; Rogers Maurice, 2011, Scottish Forestry, V65, P34; SHIRAHAMA T, 1971, AM J PATHOL, V63, P463; Sipe JD, 2012, AMYLOID, V19, P167, DOI 10.3109/13506129.2012.734345; Solomon A, 2007, P NATL ACAD SCI USA, V104, P10998, DOI 10.1073/pnas.0700848104; Sorby R, 2008, AMYLOID, V15, P20, DOI 10.1080/13506120701815332; Sponarova J, 2013, AM J PATHOL, V182, P1297, DOI 10.1016/j.ajpath.2012.12.035; STEEL DM, 1993, BIOCHEM J, V291, P701, DOI 10.1042/bj2910701; Steiniger B., 2000, ADV ANAT EMBRYOL, DOI [10.1007/978-3-642-57088-9, DOI 10.1007/978-3-642-57088-9]; TAKAHASHI M, 1989, VIRCHOWS ARCH A, V415, P411, DOI 10.1007/BF00747742; VANROOIJEN N, 1992, RES IMMUNOL, V143, P177; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; WESTERMARK GT, 1987, LAB INVEST, V57, P57; Westermark P, 2012, UPSALA J MED SCI, V117, P244, DOI 10.3109/03009734.2012.654861	44	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79104	10.1371/journal.pone.0079104	http://dx.doi.org/10.1371/journal.pone.0079104			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236094	gold, Green Published, Green Submitted			2022-12-27	WOS:000327254700092
J	Nord, KH; Nilsson, J; Arbajian, E; von Steyern, FV; Brosjo, O; Cleton-Jansen, AM; Szuhai, K; Hogendoorn, PCW				Nord, Karolin H.; Nilsson, Jenny; Arbajian, Elsa; von Steyern, Fredrik Vult; Brosjo, Otte; Cleton-Jansen, Anne-Marie; Szuhai, Karoly; Hogendoorn, Pancras C. W.			Recurrent Chromosome 22 Deletions in Osteoblastoma Affect Inhibitors of the Wnt/Beta-Catenin Signaling Pathway	PLOS ONE			English	Article							MENINGIOMA 1; SUPPRESSOR; BONE; DIFFERENTIATION; MEMBRANE; GROWTH; GENE	Osteoblastoma is a bone forming tumor with histological features highly similar to osteoid osteoma; the discrimination between the tumor types is based on size and growth pattern. The vast majority of osteoblastomas are benign but there is a group of so-called aggressive osteoblastomas that can be diagnostically challenging at the histopathological level. The genetic aberrations required for osteoblastoma development are not known and no genetic difference between conventional and aggressive osteoblastoma has been reported. In order to identify recurrent genomic aberrations of importance for tumor development we applied cytogenetic and/or SNP array analyses on nine conventional and two aggressive osteoblastomas. The conventional osteoblastomas showed few or no acquired genetic aberrations while the aggressive tumors displayed heavily rearranged genomes. In one of the aggressive osteoblastomas, three neighboring regions in chromosome band 22q12 were homozygously deleted. Hemizygous deletions of these regions were found in two additional cases, one aggressive and one conventional. In total, 10 genes were recurrently and homozygously lost in osteoblastoma. Four of them are functionally involved in regulating osteogenesis and/or tumorigenesis. MN1 and NF2 have previously been implicated in the development of leukemia and solid tumors, and ZNRF3 and KREMEN1 are inhibitors of the Wnt/beta-catenin signaling pathway. In line with deletions of the latter two genes, high beta-catenin protein expression has previously been reported in osteoblastoma and aberrations affecting the Wnt/beta-catenin pathway have been found in other bone lesions, including osteoma and osteosarcoma.	[Nord, Karolin H.; Nilsson, Jenny; Arbajian, Elsa] Lund Univ, Skane Univ Hosp, Univ & Reg Labs, Dept Clin Genet, Lund, Sweden; [von Steyern, Fredrik Vult] Skane Univ Hosp, Dept Orthoped, Lund, Sweden; [Brosjo, Otte] Karolinska Hosp, Dept Orthoped, S-10401 Stockholm, Sweden; [Cleton-Jansen, Anne-Marie; Hogendoorn, Pancras C. W.] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands; [Szuhai, Karoly] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands	Lund University; Skane University Hospital; Lund University; Skane University Hospital; Karolinska Institutet; Karolinska University Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Nord, KH (corresponding author), Lund Univ, Skane Univ Hosp, Univ & Reg Labs, Dept Clin Genet, Lund, Sweden.	Karolin.Hansen_Nord@med.lu.se	Hogendoorn, Pancras C.W./H-5859-2015; Arbajian, Elsa/AAW-9123-2021; Szuhai, Karoly/A-1100-2008; Hogendoorn, Pancras/O-6494-2019	Hogendoorn, Pancras C.W./0000-0002-1513-8104; Arbajian, Elsa/0000-0002-1484-0073; Szuhai, Karoly/0000-0002-1228-4245; Hogendoorn, Pancras/0000-0002-1513-8104; Hansen Nord, Karolin/0000-0002-2397-2254	Magnus Bergvall Foundation; Royal Physiographic Society (Lund, Sweden); Swedish Cancer Society	Magnus Bergvall Foundation; Royal Physiographic Society (Lund, Sweden); Swedish Cancer Society(Swedish Cancer Society)	This work was supported by the Magnus Bergvall Foundation, the Royal Physiographic Society (Lund, Sweden) and the Swedish Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baruffi MR, 2001, CANCER GENET CYTOGEN, V124, P127, DOI 10.1016/S0165-4608(00)00327-7; Cai YP, 2010, J PATHOL, V220, P24, DOI 10.1002/path.2628; Cleton-Jansen AM, 2009, BRIT J CANCER, V101, P1909, DOI 10.1038/sj.bjc.6605405; Davidson TB, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-19; Ellwanger K, 2008, MOL CELL BIOL, V28, P4875, DOI 10.1128/MCB.00222-08; Fletcher C., 2013, IARC WHO CLASSIFICAT, V5; Fujimori S, 2010, DEV BIOL, V348, P97, DOI 10.1016/j.ydbio.2010.09.009; Garcia EBG, 2009, LANCET ONCOL, V10, P727, DOI 10.1016/S1470-2045(09)70167-6; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Hogendoorn PCW, 2013, WHO CLASSIFICATION T, V4th, P277; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Lee HW, 2009, STEM CELLS, V27, P2254, DOI 10.1002/stem.144; Lee YC, 2011, CANCER RES, V71, P5194, DOI 10.1158/0008-5472.CAN-10-4374; Lowy AM, 2006, CANCER RES, V66, P4734, DOI 10.1158/0008-5472.CAN-05-4268; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; MERTENS F, 1993, INT J CANCER, V55, P44, DOI 10.1002/ijc.2910550109; Mertens F., 2013, WHO CLASSIFICATION T, P282; Mitelman F, 2013, MITELMAN DATABASE CH; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Nord KH, 2010, P NATL ACAD SCI USA, V107, P21122, DOI 10.1073/pnas.1013512107; Nunez F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018562; Radig K, 1998, PATHOL RES PRACT, V194, P669, DOI 10.1016/S0344-0338(98)80125-8; Schiller A., 2013, WHO CLASSIFICATION T, P279, DOI [10.1097/PAT.0000000000000050, DOI 10.1097/PAT.0000000000000050]; Shaffer LG, 2009, ISCN 2013 INT SYSTEM; Tamamura Y, 2005, J BIOL CHEM, V280, P19185, DOI 10.1074/jbc.M414275200; Zhang XX, 2009, J BIOL CHEM, V284, P18174, DOI 10.1074/jbc.M109.001354; Zhang Y, 2012, BONE, V50, pS146, DOI 10.1016/j.bone.2012.02.453; Zhou L, 2012, FEBS LETT, V586, P1403, DOI 10.1016/j.febslet.2012.03.016	30	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80725	10.1371/journal.pone.0080725	http://dx.doi.org/10.1371/journal.pone.0080725			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236197	gold, Green Published, Green Submitted			2022-12-27	WOS:000327254700200
J	Onasoga-Jarvis, AA; Leiderman, K; Fogelson, AL; Wang, M; Manco-Johnson, MJ; Di Paola, JA; Neeves, KB				Onasoga-Jarvis, Abimbola A.; Leiderman, Karin; Fogelson, Aaron L.; Wang, Michael; Manco-Johnson, Marilyn J.; Di Paola, Jorge A.; Neeves, Keith B.			The Effect of Factor VIII Deficiencies and Replacement and Bypass Therapies on Thrombus Formation under Venous Flow Conditions in Microfluidic and Computational Models	PLOS ONE			English	Article							RECOMBINANT FACTOR-VIIA; TISSUE FACTOR; BLOOD-COAGULATION; HEMOPHILIA-A; SHEAR RATES; ACTIVATION; DEPOSITION; PLATELETS; MOUSE; CLOTS	Clinical evidence suggests that individuals with factor VIII (FVIII) deficiency (hemophilia A) are protected against venous thrombosis, but treatment with recombinant proteins can increase their risk for thrombosis. In this study we examined the dynamics of thrombus formation in individuals with hemophilia A and their response to replacement and bypass therapies under venous flow conditions. Fibrin and platelet accumulation were measured in microfluidic flow assays on a TF-rich surface at a shear rate of 100 s(-1). Thrombin generation was calculated with a computational spatial-temporal model of thrombus formation. Mild FVIII deficiencies (5-30% normal levels) could support fibrin fiber formation, while severe (<1%) and moderate (1-5%) deficiencies could not. Based on these experimental observations, computational calculations estimate an average thrombin concentration of similar to 10 nM is necessary to support fibrin formation under flow. There was no difference in fibrin formation between severe and moderate deficiencies, but platelet aggregate size was significantly larger for moderate deficiencies. Computational calculations estimate that the local thrombin concentration in moderate deficiencies is high enough to induce platelet activation (>1 nM), but too low to support fibrin formation (, 10 nM). In the absence of platelets, fibrin formation was not supported even at normal FVIII levels, suggesting platelet adhesion is necessary for fibrin formation. Individuals treated by replacement therapy, recombinant FVIII, showed normalized fibrin formation. Individuals treated with bypass therapy, recombinant FVIIa, had a reduced lag time in fibrin formation, as well as elevated fibrin accumulation compared to healthy controls. Treatment of rFVIIa, but not rFVIII, resulted in significant changes in fibrin dynamics that could lead to a prothrombotic state.	[Onasoga-Jarvis, Abimbola A.; Neeves, Keith B.] Colorado Sch Mines, Dept Chem & Biol Engn, Golden, CO 80401 USA; [Leiderman, Karin] Univ Calif Merced, Sch Nat Sci, Appl Math Unit, Merced, CA USA; [Fogelson, Aaron L.] Univ Utah, Dept Math, Salt Lake City, UT 84112 USA; [Fogelson, Aaron L.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Wang, Michael; Manco-Johnson, Marilyn J.; Di Paola, Jorge A.; Neeves, Keith B.] Univ Colorado Denver, Hemophilia & Thrombosis Ctr, Dept Pediat, Aurora, CO USA	Colorado School of Mines; University of California System; University of California Merced; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Neeves, KB (corresponding author), Colorado Sch Mines, Dept Chem & Biol Engn, Golden, CO 80401 USA.	kneeves@mines.edu	Neeves, Keith/J-9494-2019	Neeves, Keith/0000-0001-7546-4588	American Heart Association; National Heart, Lung, and Blood Institute [HL100333]; Postle Family Chair; Colorado Office of Economic Development and International Trade; Bayer Hemophilia Awards Program; Boettcher Foundation's Webb-Waring Biomedical Research Award; Direct For Mathematical & Physical Scien [1148230] Funding Source: National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL100333] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Postle Family Chair; Colorado Office of Economic Development and International Trade; Bayer Hemophilia Awards Program; Boettcher Foundation's Webb-Waring Biomedical Research Award; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a Scientist Development Grant (to KBN) from the American Heart Association, the National Heart, Lung, and Blood Institute (HL100333), the Postle Family Chair (to JDP), the Colorado Office of Economic Development and International Trade, the Bayer Hemophilia Awards Program and the Boettcher Foundation's Webb-Waring Biomedical Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS R, 1993, CVGIP-GRAPH MODEL IM, V55, P325, DOI 10.1006/cgip.1993.1024; Aledort LM, 2004, J THROMB HAEMOST, V2, P1700, DOI 10.1111/j.1538-7836.2004.00944.x; Cawthern KM, 1998, BLOOD, V91, P4581, DOI 10.1182/blood.V91.12.4581.412k12_4581_4592; Chauhan AK, 2007, BLOOD, V109, P2424, DOI 10.1182/blood-2006-06-028241; Danforth CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030385; Duchemin J, 2008, THROMB HAEMOSTASIS, V99, P767, DOI 10.1160/TH07-09-0581; Flamm MH, 2012, BLOOD, V120, P190, DOI 10.1182/blood-2011-10-388140; FRESSINAUD E, 1992, BLOOD, V80, P988; GEMMELL CH, 1988, BLOOD, V72, P1404; Girolami A, 2006, J THROMB THROMBOLYS, V21, P279, DOI 10.1007/s11239-006-6556-7; Haynes LM, 2011, BIOPHYS J, V100, P765, DOI 10.1016/j.bpj.2010.12.3720; JONES PK, 1991, ANN INTERN MED, V114, P641, DOI 10.7326/0003-4819-114-8-641; Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042; Leiderman K, 2011, MATH MED BIOL, V28, P47, DOI 10.1093/imammb/dqq005; Lisman T, 2005, J THROMB HAEMOST, V3, P742, DOI 10.1111/j.1538-7836.2005.01227.x; Mann KG, 2012, J THROMB HAEMOST, V10, P1463, DOI 10.1111/j.1538-7836.2012.04799.x; Monroe DM, 1997, BRIT J HAEMATOL, V99, P542, DOI 10.1046/j.1365-2141.1997.4463256.x; Neeves KB, 2010, BIOPHYS J, V98, P1344, DOI 10.1016/j.bpj.2009.12.4275; Neeves KB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054680; Neyman M, 2008, BLOOD, V112, P1101, DOI 10.1182/blood-2008-04-152959; Ogawa S, 2012, HAEMOPHILIA, V18, P926, DOI 10.1111/j.1365-2516.2012.02867.x; Okorie UM, 2008, BLOOD, V111, P3507, DOI 10.1182/blood-2007-08-106229; Reininger AJ, 2010, J AM COLL CARDIOL, V55, P1147, DOI 10.1016/j.jacc.2009.11.051; Smith S, 2004, J THROMB HAEMOST; Sugita C, 2009, THROMB RES, V124, P601, DOI 10.1016/j.thromres.2009.06.035; von Bruhl ML, 2012, J EXP MED, V209, P819, DOI 10.1084/jem.20112322; WEISS HJ, 1984, BLOOD, V63, P1004, DOI 10.1182/blood.V63.5.1004.1004; Welsh JD, 2012, J THROMB HAEMOST, V10, P2344, DOI 10.1111/j.1538-7836.2012.04928.x; Xu ZL, 2010, BIOPHYS J, V98, P1723, DOI 10.1016/j.bpj.2009.12.4331	29	44	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78732	10.1371/journal.pone.0078732	http://dx.doi.org/10.1371/journal.pone.0078732			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236042	Green Published, gold, Green Submitted			2022-12-27	WOS:000327254700039
J	Wilcox, CL; Terry, NA; May, CL				Wilcox, Crystal L.; Terry, Natalie A.; May, Catherine Lee			Arx Polyalanine Expansion in Mice Leads to Reduced Pancreatic alpha-Cell Specification and Increased alpha-Cell Death	PLOS ONE			English	Article							LINKED MENTAL-RETARDATION; INFANTILE SPASMS; ABNORMAL GENITALIA; HOMEOBOX GENE; MUTATIONS; DISORDERS; EPILEPSY	ARX/Arx is a homeodomain-containing transcription factor necessary for the specification and early maintenance of pancreatic endocrine alpha-cells. Many transcription factors important to pancreas development, including ARX/Arx, are also crucial for proper brain development. Although null mutations of ARX in human patients result in the severe neurologic syndrome XLAG (X-linked lissencephaly associated with abnormal genitalia), the most common mutation is the expansion of the first polyalanine tract of ARX, which results primarily in the clinical syndrome ISSX (infantile spasms). Mouse models of XLAG, ISSX and other human ARX mutations demonstrate a direct genotype-phenotype correlation in ARX-related neurologic disorders. Furthermore, mouse models utilizing a polyalanine tract expansion mutation have illustrated critical developmental differences between null mutations and expansion mutations in the brain, revealing context-specific defects. Although Arx is known to be required for the specification and early maintenance of pancreatic glucagon-producing alpha-cells, the consequences of the Arx polyalanine expansion on pancreas development remain unknown. Here we report that mice with an expansion mutation in the first polyalanine tract of Arx exhibit impaired alpha-cell specification and maintenance, with gradual alpha-cell loss due to apoptosis. This is in contrast to the re-specification of alpha-cells into beta- and delta-cells that occurs in mice null for Arx. Overall, our analysis of an Arx polyalanine expansion mutation on pancreatic development suggests that impaired alpha-cell function might also occur in ISSX patients.	[Wilcox, Crystal L.; May, Catherine Lee] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Terry, Natalie A.] Childrens Hosp Philadelphia, Dept Pediat, Div Gastroenterol, Philadelphia, PA 19104 USA; [May, Catherine Lee] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	May, CL (corresponding author), Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	catheril@mail.med.upenn.edu			Center for Molecular Studies in Digestive and Liver Disease [P30-DK050306]; Penn Institute for Diabetes, Obesity, and Metabolism (DERC) [P30-DK19525]; NIH/NIDDK [T32-DK007066, NIH-5K12HD043245]; CHOP Foerderer Award;  [NIHDK078606];  [NIH-DK019525];  [JDRF2-2007-730]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043245] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007066, P30DK019525, R56DK078606, P30DK050306, R01DK078606] Funding Source: NIH RePORTER	Center for Molecular Studies in Digestive and Liver Disease; Penn Institute for Diabetes, Obesity, and Metabolism (DERC); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); CHOP Foerderer Award; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Part of these studies were supported by the Center for Molecular Studies in Digestive and Liver Disease (P30-DK050306) and Penn Institute for Diabetes, Obesity, and Metabolism (DERC: P30-DK19525). CLM is supported by NIHDK078606, NIH-DK019525 and JDRF2-2007-730. NAT is supported by NIH/NIDDK T32-DK007066 and NIH-5K12HD043245. These studies were also supported by the CHOP Foerderer Award. www2.niddk.nih.gov/. http://jdrf.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bienvenu T, 2002, HUM MOL GENET, V11, P981, DOI 10.1093/hmg/11.8.981; Colasante G, 2008, J NEUROSCI, V28, P10674, DOI 10.1523/JNEUROSCI.1283-08.2008; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Collombat P, 2006, MECH DEVELOP, V123, P501, DOI 10.1016/j.mod.2006.05.006; Depienne C, 2012, GENES INFANTILE EPIL; Friocourt G, 2006, EUR J NEUROSCI, V23, P869, DOI 10.1111/j.1460-9568.2006.04629.x; Gecz J, 2006, CURR OPIN GENET DEV, V16, P308, DOI 10.1016/j.gde.2006.04.003; Guerrini R, 2007, NEUROLOGY, V69, P427, DOI 10.1212/01.wnl.0000266594.16202.c1; Hancock AS, 2010, MOL ENDOCRINOL, V24, P1605, DOI 10.1210/me.2010-0120; Itoh M, 2010, DIFFERENTIATION, V80, P118, DOI 10.1016/j.diff.2010.05.003; Kato M, 2004, HUM MUTAT, V23, P147, DOI 10.1002/humu.10310; Kitamura K, 2002, NAT GENET, V32, P359, DOI 10.1038/ng1009; Kitamura K, 2009, HUM MOL GENET, V18, P3708, DOI 10.1093/hmg/ddp318; McKenzie O, 2007, NEUROSCIENCE, V146, P236, DOI 10.1016/j.neuroscience.2007.01.038; Nasrallah MP, 2011, HUM MOL GENET; Ohira R, 2002, MOL GENET METAB, V77, P179, DOI 10.1016/S1096-7192(02)00126-9; Olivetti PR, 2012, CURR OPIN NEUROBIOL, V22, P859, DOI 10.1016/j.conb.2012.04.006; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; Prado CL, 2004, P NATL ACAD SCI USA, V101, P2924, DOI 10.1073/pnas.0308604100; Price MG, 2009, J NEUROSCI, V29, P8752, DOI 10.1523/JNEUROSCI.0915-09.2009; Shoubridge C, 2010, HUM MUTAT, V31, P889, DOI 10.1002/humu.21288; Stromme P, 2002, NAT GENET, V30, P441, DOI 10.1038/ng862; Uyanik G, 2003, NEUROLOGY, V61, P232, DOI 10.1212/01.WNL.0000079371.19562.BA; Wilcox CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066214	24	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78741	10.1371/journal.pone.0078741	http://dx.doi.org/10.1371/journal.pone.0078741			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236044	Green Submitted, Green Published, gold			2022-12-27	WOS:000327254700041
J	Wongkajornsilp, A; Wamanuttajinda, V; Kasetsinsombat, K; Duangsa-ard, S; Sa-ngiamsuntorn, K; Hongeng, S; Maneechotesuwan, K				Wongkajornsilp, Adisak; Wamanuttajinda, Valla; Kasetsinsombat, Kanda; Duangsa-ard, Sunisa; Sa-ngiamsuntorn, Khanit; Hongeng, Suradej; Maneechotesuwan, Kittipong			Sunitinib Indirectly Enhanced Anti-Tumor Cytotoxicity of Cytokine-Induced Killer Cells and CD3(+) CD56(+) Subset through the Co-Culturing Dendritic Cells	PLOS ONE			English	Article							REGULATORY T-CELLS; TYROSINE KINASE INHIBITOR; CARCINOMA PATIENTS; CANCER-PATIENTS; INDOLEAMINE 2,3-DIOXYGENASE; IMMUNE SUPPRESSION; LUNG-CANCER; SORAFENIB; PROLIFERATION; POPULATION	Cytokine-induced killer (CIK) cells have reached clinical trials for leukemia and solid tumors. Their anti-tumor cytotoxicity had earlier been shown to be intensified after the co-culture with dendritic cells (DCs). We observed markedly enhanced antitumor cytotoxicity activity of CIK cells after the co-culture with sunitinib-pretreated DCs over that of untreated DCs. This cytotoxicity was reliant upon DC modulation by sunitinib because the direct exposure of CIK cells to sunitinib had no significant effect. Sunitinib promoted Th1-inducing and pro-inflammatory phenotypes (IL-12, IFN-gamma and IL-6) in DCs at the expense of Th2 inducing phenotype (IL-13) and regulatory phenotype (PD-L1, IDO). Sunitinib-treated DCs subsequently induced the upregulation of Th1 phenotypic markers (IFN-gamma and T-bet) and the downregulation of the Th2 signature (GATA-3) and the Th17 marker (RORC) on the CD3(+) CD56(+) subset of CIK cells. It concluded that sunitinib-pretreated DCs drove the CD3(+) CD56(+) subset toward Th1 phenotype with increased anti-tumor cytotoxicity.	[Wongkajornsilp, Adisak; Wamanuttajinda, Valla; Kasetsinsombat, Kanda; Duangsa-ard, Sunisa; Sa-ngiamsuntorn, Khanit] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Pharmacol, Bangkok 10700, Thailand; [Maneechotesuwan, Kittipong] Mahidol Univ, Dept Med, Fac Med, Siriraj Hosp, Bangkok 10700, Thailand; [Hongeng, Suradej] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Pediat, Bangkok 10400, Thailand; [Sa-ngiamsuntorn, Khanit] Mahidol Univ, Fac Pharm, Dept Biochem, Bangkok 10700, Thailand	Mahidol University; Mahidol University; Mahidol University; Mahidol University	Maneechotesuwan, K (corresponding author), Mahidol Univ, Dept Med, Fac Med, Siriraj Hosp, Bangkok 10700, Thailand.	kittipong.man@mahidol.ac.th	Wongkajornsilp, Adisak/AAH-7668-2019	Wongkajornsilp, Adisak/0000-0002-3965-0997; Sa-ngiamsuntorn, Khanit/0000-0001-7010-345X	Thailand Research Fund; Mahidol University; Chalermphrakiat Grant at the Faculty of Medicine Siriraj Hospital, Mahidol University	Thailand Research Fund(Thailand Research Fund (TRF)); Mahidol University; Chalermphrakiat Grant at the Faculty of Medicine Siriraj Hospital, Mahidol University	This work was supported by research grants from Thailand Research Fund and Mahidol University (to AW). AW and KM are recipients of Chalermphrakiat Grant at the Faculty of Medicine Siriraj Hospital, Mahidol University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adotevi O, 2010, J IMMUNOTHER, V33, P991, DOI 10.1097/CJI.0b013e3181f4c208; Alfaro C, 2009, BRIT J CANCER, V100, P1111, DOI 10.1038/sj.bjc.6604965; Amsen D, 2009, CURR OPIN IMMUNOL, V21, P153, DOI 10.1016/j.coi.2009.03.010; Barbi J, 2013, IMMUNOL REV, V252, P52, DOI 10.1111/imr.12029; Bose A, 2011, INT J CANCER, V129, P2158, DOI 10.1002/ijc.25863; Brenk M, 2009, J IMMUNOL, V183, P145, DOI 10.4049/jimmunol.0803277; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Erhardt M, 2006, ARCH IMMUNOL THER EX, V54, P403, DOI 10.1007/s00005-006-0048-5; Finke JH, 2008, CLIN CANCER RES, V14, P6674, DOI 10.1158/1078-0432.CCR-07-5212; Friberg M, 2002, INT J CANCER, V101, P151, DOI 10.1002/ijc.10645; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; Frumento Guido, 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P223, DOI 10.2174/187153006778250019; Heine A, 2011, LEUKEMIA, V25, P899, DOI 10.1038/leu.2011.24; Hipp MM, 2008, BLOOD, V111, P5610, DOI 10.1182/blood-2007-02-075945; Houk BE, 2009, CLIN CANCER RES, V15, P2497, DOI 10.1158/1078-0432.CCR-08-1893; Kao J, 2011, CRIT REV ONCOL HEMAT, V77, P13, DOI 10.1016/j.critrevonc.2010.02.004; Ko JS, 2010, CANCER RES, V70, P3526, DOI 10.1158/0008-5472.CAN-09-3278; Ko JS, 2009, CLIN CANCER RES, V15, P2148, DOI 10.1158/1078-0432.CCR-08-1332; Kobayashi M, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0556-1; Krusch M, 2009, J IMMUNOL, V183, P8286, DOI 10.4049/jimmunol.0902404; Kujawski M, 2010, CANCER RES, V70, P9599, DOI 10.1158/0008-5472.CAN-10-1293; Li H, 2007, J CLIN IMMUNOL, V27, P317, DOI 10.1007/s10875-007-9076-0; Li H, 2009, CYTOTHERAPY, V11, P1076, DOI 10.3109/14653240903121252; Lindau D, 2013, IMMUNOLOGY, V138, P105, DOI 10.1111/imm.12036; LU PH, 1994, J IMMUNOL, V153, P1687; Marten A, 2001, J IMMUNOTHER, V24, P502, DOI 10.1097/00002371-200111000-00007; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Morse MA, 2009, EXPERT OPIN BIOL TH, V9, P331, DOI 10.1517/14712590802715756 ; Nishioka Y, 2011, IMMUNOTHERAPY-UK, V3, P107, DOI [10.2217/imt.10.79, 10.2217/IMT.10.79]; Ozao-Choy J, 2009, CANCER RES, V69, P2514, DOI 10.1158/0008-5472.CAN-08-4709; Schmidt J, 2004, CANCER IMMUNOL IMMUN, V53, P1018, DOI 10.1007/s00262-004-0554-4; SchmidtWolf GD, 1997, ANN HEMATOL, V74, P51, DOI 10.1007/s002770050257; Terness P, 2002, J EXP MED, V196, P447, DOI 10.1084/jem.20020052; van Cruijsen H, 2008, CLIN CANCER RES, V14, P5884, DOI 10.1158/1078-0432.CCR-08-0656; Wongkajornsilp A, 2005, J ORTHOP RES, V23, P1460, DOI 10.1016/j.orthres.2005.03.009; Wongkajornsilp A, 2009, CANCER INVEST, V27, P140, DOI 10.1080/07357900802189832; Zhang H, 2013, BLOOD, V122, P1105, DOI 10.1182/blood-2012-08-449413; Zheng Rena, 2010, Genes Cancer, V1, P1178, DOI 10.1177/1947601911404223	38	20	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78980	10.1371/journal.pone.0078980	http://dx.doi.org/10.1371/journal.pone.0078980			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24232460	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700076
J	Adler, NRL; Dean, RE; Saint, RJ; Stevens, MP; Prior, JL; Atkins, TP; Galyov, EE				Adler, Natalie R. Lazar; Dean, Rachel E.; Saint, Richard J.; Stevens, Mark P.; Prior, Joann L.; Atkins, Timothy P.; Galyov, Edouard E.			Identification of a Predicted Trimeric Autotransporter Adhesin Required for Biofilm Formation of Burkholderia pseudomallei	PLOS ONE			English	Article							PROTEIN SECRETION; STRESS TOLERANCE; VIRULENCE; MELIOIDOSIS; KNOCKOUT; MOTILITY; INSIGHTS; VECTORS; OPERON; MUTANT	The autotransporters are a large and diverse family of bacterial secreted and outer membrane proteins, which are present in many Gram-negative bacterial pathogens and play a role in numerous environmental and virulence-associated interactions. As part of a larger systematic study on the autotransporters of Burkholderia pseudomallei, the causative agent of the severe tropical disease melioidosis, we have constructed an insertion mutant in the bpss1439 gene encoding an unstudied predicted trimeric autotransporter adhesin. The bpss1439 mutant demonstrated a significant reduction in biofilm formation at 48 hours in comparison to its parent 10276 wild-type strain. This phenotype was complemented to wild-type levels by the introduction of a full-length copy of the bpss1439 gene in trans. Examination of the wild-type and bpss1439 mutant strains under biofilm-inducing conditions by microscopy after 48 hours confirmed that the bpss1439 mutant produced less biofilm compared to wild-type. Additionally, it was observed that this phenotype was due to low levels of bacterial adhesion to the abiotic surface as well as reduced microcolony formation. In a murine melioidosis model, the bpss1439 mutant strain demonstrated a moderate attenuation for virulence compared to the wild-type strain. This attenuation was abrogated by in trans complementation, suggesting that bpss1439 plays a subtle role in the pathogenesis of B. pseudomallei. Taken together, these studies indicate that BPSS1439 is a novel predicted autotransporter involved in biofilm formation of B. pseudomallei; hence, this factor was named BbfA, Burkholderia biofilm factor A.	[Adler, Natalie R. Lazar; Galyov, Edouard E.] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Stevens, Mark P.] Def Sci & Technol Lab, Porton Down, England; [Stevens, Mark P.] Univ Edinburgh, Roslin Inst, Royal Dick Sch Vet Studies, Easter Bush, England; [Atkins, Timothy P.] Univ Exeter, Sch Biosci, Exeter, Devon, England	University of Leicester; Defence Science & Technology Laboratory; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Exeter	Galyov, EE (corresponding author), Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England.	eg98@leicester.ac.uk	Lazar Adler, Natalie/I-2099-2014	Lazar Adler, Natalie/0000-0001-5775-7627; Galyov, Edouard/0000-0003-2609-0748; Stevens, Mark/0000-0003-2174-5039	Wellcome Trust Research [085972]; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001116, BB/E021212/1, BBS/E/D/20231761] Funding Source: researchfish; BBSRC [BB/E021212/1, BBS/E/D/20231761] Funding Source: UKRI	Wellcome Trust Research(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded by the Wellcome Trust Research Grant #085972 (http://www.wellcome.ac.uk/Funding/Biomedical-science/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NRL, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00151; Adler NRL, 2009, FEMS MICROBIOL REV, V33, P1079, DOI 10.1111/j.1574-6976.2009.00189.x; Alexeyev MF, 1999, BIOTECHNIQUES, V26, P824, DOI 10.2144/99265bm05; Atkins T, 2002, J MED MICROBIOL, V51, P539, DOI 10.1099/0022-1317-51-7-539; Balder R, 2010, BMC MICROBIOL, V10, DOI [10.1186/1471-2180-1110-1250, DOI 10.1186/1471-2180-1110-1250]; Chanchamroen S, 2009, INFECT IMMUN, V77, P456, DOI 10.1128/IAI.00503-08; Cotter SE, 2005, TRENDS MICROBIOL, V13, P199, DOI 10.1016/j.tim.2005.03.004; Currie BJ, 2001, AM J TROP MED HYG, V65, P177, DOI 10.4269/ajtmh.2001.65.177; Dautin N, 2007, ANNU REV MICROBIOL, V61, P89, DOI 10.1146/annurev.micro.61.080706.093233; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; Gamage AM, 2011, MICROBIOL-SGM, V157, P1176, DOI 10.1099/mic.0.046540-0; Heeb S, 2000, MOL PLANT MICROBE IN, V13, P232, DOI 10.1094/MPMI.2000.13.2.232; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Henderson IR, 2001, INFECT IMMUN, V69, P1231, DOI 10.1128/IAI.69.3.1231-1243.2001; Kamjumphol W, 2013, SE ASIAN J TROP MED, V44, P72; Korbsrisate S, 2005, FEMS MICROBIOL LETT, V252, P243, DOI 10.1016/j.femsle.2005.09.002; Lazar Adler NR, 2011, FRONTIERS MICROBIOLO, P2; Lee HS, 2010, INFECT IMMUN, V78, P1832, DOI 10.1128/IAI.00446-09; Mack K, 1996, ANAL BIOCHEM, V242, P73, DOI 10.1006/abio.1996.0430; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Mil-Homens D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041747; Muller NF, 2011, INFECT IMMUN, V79, P2544, DOI 10.1128/IAI.01309-10; Nandi T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000845; Pibalpakdee P, 2012, INT J ANTIMICROB AG, V39, P356, DOI 10.1016/j.ijantimicag.2011.12.010; Ramli NSK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044104; Sawasdidoln C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009196; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Songsri J, 2012, SE ASIAN J TROP MED, V43, P124; Taweechaisupapong S, 2005, MICROB PATHOGENESIS, V39, P77, DOI 10.1016/j.micpath.2005.06.001; Thongboonkerd V, 2007, J PROTEOME RES, V6, P1334, DOI 10.1021/pr060457t; Tiyawisutsri R, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-19; Tunpiboonsak S, 2010, J MICROBIOL, V48, P63, DOI 10.1007/s12275-010-9138-5; Vorachit M, 1995, J TROP MED HYG, V98, P379; VORACHIT M, 1993, ANTIMICROB AGENTS CH, V37, P2000, DOI 10.1128/AAC.37.9.2000; Wilhelm S, 2007, J BACTERIOL, V189, P6695, DOI 10.1128/JB.00023-07; Yuen CW, 2012, J MICROBIOL BIOTECHN, V22, P1336, DOI 10.4014/jmb.1203.03059	36	18	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79461	10.1371/journal.pone.0079461	http://dx.doi.org/10.1371/journal.pone.0079461			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223950	Green Submitted, Green Published, gold			2022-12-27	WOS:000326597400067
J	Cheng, KC; Pratt, J; Maki, BE				Cheng, Kenneth C.; Pratt, Jay; Maki, Brian E.			Do Aging and Dual-Tasking Impair the Capacity to Store and Retrieve Visuospatial Information Needed to Guide Perturbation-Evoked Reach-To-Grasp Reactions?	PLOS ONE			English	Article							ONLINE VISUAL CONTROL; AGE-RELATED-CHANGES; BALANCE-RECOVERY; WORKING-MEMORY; POSTURAL STABILITY; SPATIAL-MEMORY; ATTENTIONAL DEMANDS; STEPPING REACTIONS; COGNITIVE DEMANDS; NORMATIVE DATA	A recent study involving young adults showed that rapid perturbation-evoked reach-to-grasp balance-recovery reactions can be guided successfully with visuospatial-information (VSI) retained in memory despite: 1) a reduction in endpoint accuracy due to recall-delay (time between visual occlusion and perturbation-onset, PO) and 2) slowing of the reaction when performing a concurrent cognitive task during the recall-delay interval. The present study aimed to determine whether this capacity is compromised by effects of aging. Ten healthy older adults were tested with the previous protocol and compared with the previously-tested young adults. Reactions to recover balance by grasping a small handhold were evoked by unpredictable antero-posterior platform-translation (barriers deterred stepping reactions), while using liquid-crystal goggles to occlude vision post-PO and for varying recall-delay times (0-10s) prior to PO (the handhold was moved unpredictably to one of four locations 2s prior to vision-occlusion). Subjects also performed a spatial-or non-spatial-memory cognitive task during the delay-time in a subset of trials. Results showed that older adults had slower reactions than the young across all experimental conditions. Both age groups showed similar reduction in medio-lateral end-point accuracy when recall-delay was longest (10s), but differed in the effect of recall delay on vertical hand elevation. For both age groups, engaging in either the non-spatial or spatial-memory task had similar (slowing) effects on the arm reactions; however, the older adults also showed a dual-task interference effect (poorer cognitive-task performance) that was specific to the spatial-memory task. This provides new evidence that spatial working memory plays a role in the control of perturbation-evoked balance-recovery reactions. The delays in completing the reaction that occurred when performing either cognitive task suggest that such dual-task situations in daily life could increase risk of falling in seniors, particularly when combined with the general age-related slowing that was observed across all experimental conditions.	[Cheng, Kenneth C.; Pratt, Jay; Maki, Brian E.] Toronto Rehabil Inst, Univ Hlth Network, Toronto, ON, Canada; [Cheng, Kenneth C.; Maki, Brian E.] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Cheng, Kenneth C.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Pratt, Jay] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Maki, Brian E.] Univ Toronto, Inst Biomaterials & Biomed Engn, Toronto, ON, Canada; [Maki, Brian E.] Univ Toronto, Dept Surg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Maki, BE (corresponding author), Toronto Rehabil Inst, Univ Hlth Network, Toronto, ON, Canada.	brian.maki@uhn.ca		Pratt, Jay/0000-0002-4902-5095	Canadian Institutes of Health Research (CIHR) [MOP-13355]; CIHR; Ontario Neurotrauma Foundation; Vision Science Research Program; Ontario Graduate Scholarship Program	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Ontario Neurotrauma Foundation; Vision Science Research Program; Ontario Graduate Scholarship Program(Ontario Graduate Scholarship)	The work was upported by grant #MOP-13355 from the Canadian Institutes of Health Research (CIHR) and by scholarships from CIHR, the Ontario Neurotrauma Foundation, the Vision Science Research Program and the Ontario Graduate Scholarship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKRITAS MG, 1994, J AM STAT ASSOC, V89, P336, DOI 10.2307/2291230; Bradshaw MF, 2002, NEUROPSYCHOLOGIA, V40, P1766, DOI 10.1016/S0028-3932(02)00039-8; Brauer SG, 2002, GAIT POSTURE, V15, P83, DOI 10.1016/S0966-6362(01)00163-1; Brown LA, 1999, J GERONTOL A-BIOL, V54, pM165, DOI 10.1093/gerona/54.4.M165; Brown LA, 2002, J GERONTOL A-BIOL, V57, pM785, DOI 10.1093/gerona/57.12.M785; Carrozzo M, 1999, EXP BRAIN RES, V129, P201, DOI 10.1007/s002210050890; Chen HC, 1996, J GERONTOL A-BIOL, V51, pM116, DOI 10.1093/gerona/51A.3.M116; Cheng KC, 2013, HUM MOVEMENT SCI, V32, P328, DOI 10.1016/j.humov.2012.11.001; Cheng KC, 2012, J GERONTOL A-BIOL, V67, P1238, DOI 10.1093/gerona/gls116; Cheng KC, 2012, EXP BRAIN RES, V218, P589, DOI 10.1007/s00221-012-3051-6; Cheng KC, 2009, GAIT POSTURE, V29, P339, DOI 10.1016/j.gaitpost.2008.08.011; CHERRY KE, 1993, EXP AGING RES, V19, P333, DOI 10.1080/03610739308253942; CHERRY KE, 1989, J GERONTOL, V44, pP16, DOI 10.1093/geronj/44.1.P16; Chieffi S, 1999, NEUROPSYCHOLOGIA, V37, P495, DOI 10.1016/S0028-3932(98)00082-7; Christopoulos VN, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000538; Christou EA, 2003, J APPL PHYSIOL, V95, P373, DOI 10.1152/japplphysiol.00060.2003; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; Desrocher M, 1998, BRAIN COGNITION, V37, P91; Doumas M, 2008, EXP BRAIN RES, V187, P275, DOI 10.1007/s00221-008-1302-3; Edwards JD, 2006, ARCH CLIN NEUROPSYCH, V21, P275, DOI 10.1016/j.acn.2006.03.001; ELLIOTT D, 1988, CAN J PSYCHOL, V42, P57, DOI 10.1037/h0084172; ELLIOTT D, 1987, Q J EXP PSYCHOL-A, V39, P541, DOI 10.1080/14640748708401802; Enoka RM, 2003, J ELECTROMYOGR KINES, V13, P1, DOI 10.1016/S1050-6411(02)00084-6; FLICKER C, 1984, NEUROBIOL AGING, V5, P275, DOI 10.1016/0197-4580(84)90003-4; Fougnie D, 2009, ATTEN PERCEPT PSYCHO, V71, P1831, DOI 10.3758/APP.71.8.1831; Fougnie D, 2009, VIS COGN, V17, P48, DOI 10.1080/13506280802281337; Gage WH, 2007, EXP BRAIN RES, V181, P627, DOI 10.1007/s00221-007-0959-3; Ghafouri M, 2004, EXP BRAIN RES, V155, P532, DOI 10.1007/s00221-004-1855-8; GITTINGS NS, 1986, EXP GERONTOL, V21, P423, DOI 10.1016/0531-5565(86)90047-1; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Hesse C, 2009, NEUROPSYCHOLOGIA, V47, P1532, DOI 10.1016/j.neuropsychologia.2008.08.012; Hu Y, 1999, EXP BRAIN RES, V126, P109, DOI 10.1007/s002210050720; Huang H J, 2001, Pediatr Phys Ther, V13, P133, DOI 10.1097/00001577-200110000-00005; KERR B, 1985, J EXP PSYCHOL HUMAN, V11, P617, DOI 10.1037/0096-1523.11.5.617; Khan MA, 2003, MOTOR CONTROL, V7, P290, DOI 10.1123/mcj.7.3.290; Khan MA, 2006, NEUROSCI BIOBEHAV R, V30, P1106, DOI 10.1016/j.neubiorev.2006.05.002; King EC, 2009, J OPTOM, V2, P119, DOI [10.3921/joptom.2009.119, DOI 10.3921/J0PT0M.2009.119]; King EC, 2011, HUM MOVEMENT SCI, V30, P368, DOI 10.1016/j.humov.2010.07.005; King EC, 2010, EXP BRAIN RES, V207, P105, DOI 10.1007/s00221-010-2434-9; Korsnes MS, 1996, ACTA PSYCHOL, V94, P133, DOI 10.1016/0001-6918(95)00056-9; Lemay M, 2004, EXP AGING RES, V30, P391, DOI 10.1080/03610730490484443; Lemay M, 2002, J MOTOR BEHAV, V34, P11, DOI 10.1080/00222890209601927; Lemay M, 2001, EXP BRAIN RES, V140, P357, DOI 10.1007/s002210100834; LOGIE RH, 1994, MEM COGNITION, V22, P395, DOI 10.3758/BF03200866; Lord SR, 2000, GERONTOLOGY, V46, P306, DOI 10.1159/000022182; Lustig C, 2001, J EXP PSYCHOL GEN, V130, P199, DOI 10.1037//0096-3445.130.2.199; Maki B, 2001, CONTROL POSTURE GAIT, P126; Maki BE, 2007, J NEURAL TRANSM, V114, P1279, DOI 10.1007/s00702-007-0764-y; Maki BE, 1996, J BIOMECH, V29, P343, DOI 10.1016/0021-9290(95)00053-4; Maki BE, 2001, NEUROREPORT, V12, P3583, DOI 10.1097/00001756-200111160-00042; Maki BE, 2000, J GERONTOL A-BIOL, V55, pM270, DOI 10.1093/gerona/55.5.M270; Maki BE, 2006, AGE AGEING, V35, P12, DOI 10.1093/ageing/afl078; Mansfield A, 2009, J BIOMECH, V42, P1023, DOI 10.1016/j.jbiomech.2009.02.007; Maylor EA, 1996, J GERONTOL B-PSYCHOL, V51, pP143, DOI 10.1093/geronb/51B.3.P143; McIlroy WE, 1996, J GERONTOL A-BIOL, V51, pM289, DOI 10.1093/gerona/51A.6.M289; MCILROY WE, 1993, BRAIN RES, V631, P203, DOI 10.1016/0006-8993(93)91536-2; NAVON D, 1979, PSYCHOL REV, V86, P214, DOI 10.1037/0033-295X.86.3.214; Norrie RG, 2002, EXP BRAIN RES, V146, P315, DOI 10.1007/s00221-002-1172-z; Oberauer K, 2002, J EXP PSYCHOL LEARN, V28, P411, DOI 10.1037//0278-7393.28.3.411; PATLA AE, 1996, CHANGES SENSORY MOTO, P257; QUANT S, 2000, PHYSIOTHERAPY CANA S, V52, P98; Rankin JK, 2000, J GERONTOL A-BIOL, V55, pM112, DOI 10.1093/gerona/55.3.M112; Rapp MA, 2006, AM J GERIAT PSYCHIAT, V14, P52, DOI 10.1097/01.JGP.0000192490.43179.e7; Redfern MS, 2002, J GERONTOL A-BIOL, V57, pB298, DOI 10.1093/gerona/57.8.B298; Sarlegna F, 2004, EXP BRAIN RES, V157, P468, DOI 10.1007/s00221-004-1860-y; Sarlegna F, 2003, EXP BRAIN RES, V151, P524, DOI 10.1007/s00221-003-1504-7; Schlicht EJ, 2007, EXP BRAIN RES, V182, P47, DOI 10.1007/s00221-007-0970-8; Scovil CY, 2008, NEUROSCI LETT, V445, P108, DOI 10.1016/j.neulet.2008.08.062; ShumwayCook A, 1997, J GERONTOL A-BIOL, V52, pM232, DOI 10.1093/gerona/52A.4.M232; TEASDALE N, 1993, EXP AGING RES, V19, P1, DOI 10.1080/03610739308253919; THOMPSON GL, 1991, J AM STAT ASSOC, V86, P410, DOI 10.2307/2290586; THOMPSON GL, 1991, BIOMETRIKA, V78, P697; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Tombaugh TN, 1996, PSYCHOL ASSESSMENT, V8, P48, DOI 10.1037/1040-3590.8.1.48; WATANABE K, 1994, INT CONGR SER, V1070, P195; Westwood DA, 2003, J MOTOR BEHAV, V35, P127, DOI 10.1080/00222890309602128; Westwood DA, 2001, CAN J EXP PSYCHOL, V55, P304, DOI 10.1037/h0087377; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Zettel JL, 2005, EXP BRAIN RES, V165, P392, DOI 10.1007/s00221-005-2310-1; Zettel JL, 2008, J GERONTOL A-BIOL, V63, P1370, DOI 10.1093/gerona/63.12.1370	80	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79401	10.1371/journal.pone.0079401	http://dx.doi.org/10.1371/journal.pone.0079401			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	247EE	24223942	Green Published, gold			2022-12-27	WOS:000326597400063
J	Kim, EC; Morgan, IG; Kakizaki, H; Kang, S; Jee, D				Kim, Eun Chul; Morgan, Ian G.; Kakizaki, Hirohiko; Kang, Seungbum; Jee, Donghyun			Prevalence and Risk Factors for Refractive Errors: Korean National Health and Nutrition Examination Survey 2008-2011	PLOS ONE			English	Article							OUTDOOR ACTIVITY; UNITED-STATES; MYOPIA; SINGAPORE; EYE; CHILDREN; POPULATION; CHINESE; ASSOCIATION; EDUCATION	Purpose: To examine the prevalence and risk factors of refractive errors in a representative Korean population aged 20 years old or older. Methods: A total of 23,392 people aged 20(+) years were selected for the Korean National Health and Nutrition Survey 2008-2011, using stratified, multistage, clustered sampling. Refractive error was measured by autorefraction without cycloplegia, and interviews were performed regarding associated risk factors including gender, age, height, education level, parent's education level, economic status, light exposure time, and current smoking history. Results: Of 23,392 participants, refractive errors were examined in 22,562 persons, including 21,356 subjects with phakic eyes. The overall prevalences of myopia (< -0.5 D), high myopia (< -6.0 D), and hyperopia (> 0.5 D) were 48.1% (95% confidence interval [CI], 47.4-48.8), 4.0% (CI, 3.7-4.3), and 24.2% (CI, 23.6-24.8), respectively. The prevalence of myopia sharply decreased from 78.9% (CI, 77.4-80.4) in 20-29 year olds to 16.1% (CI, 14.9-17.3) in 60-69 year olds. In multivariable logistic regression analyses restricted to subjects aged 40(+) years, myopia was associated with younger age (odds ratio [OR], 0.94; 95% Confidence Interval [CI], 0.93-0.94, p < 0.001), education level of university or higher (OR, 2.31; CI, 1.97-2.71, p < 0.001), and shorter sunlight exposure time (OR, 0.84; CI, 0.76-0.93, p = 0.002). Conclusions: This study provides the first representative population-based data on refractive error for Korean adults. The prevalence of myopia in Korean adults in 40+ years (34.7%) was comparable to that in other Asian countries. These results show that the younger generations in Korea are much more myopic than previous generations, and that important factors associated with this increase are increased education levels and reduced sunlight exposures.	[Kim, Eun Chul] Catholic Univ Korea, Coll Med, Buchon St Marys Hosp, Dept Ophthalmol & Visual Sci, Suwon, South Korea; [Morgan, Ian G.] Australian Natl Univ, ARC Ctr Excellence Vis Sci, Res Sch Biol, Canberra, ACT, Australia; [Kakizaki, Hirohiko] Aichi Med Univ, Dept Ophthalmol, Nagakute, Aichi 48011, Japan; [Kang, Seungbum] Catholic Univ Korea, Coll Med, Daejon St Marys Hosp, Dept Ophthalmol & Visual Sci, Suwon, South Korea; [Jee, Donghyun] Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Ophthalmol & Visual Sci, Suwon, South Korea	Catholic University of Korea; Australian National University; Aichi Medical University; Catholic University of Korea; Catholic University of Korea	Jee, D (corresponding author), Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Ophthalmol & Visual Sci, Suwon, South Korea.	donghyunjee@catholic.ac.kr	Morgan, Ian G/D-1190-2009	Morgan, Ian G/0000-0002-4548-3574				Attebo K, 1999, OPHTHALMOLOGY, V106, P1066, DOI 10.1016/S0161-6420(99)90251-8; Choo V, 2003, LANCET, V361, P1622, DOI 10.1016/S0140-6736(03)13315-6; Dirani M, 2009, BRIT J OPHTHALMOL, V93, P997, DOI 10.1136/bjo.2008.150979; Fotouhi A, 2012, ACTA OPHTHALMOL, V90, P380, DOI 10.1111/j.1755-3768.2010.01983.x; He MG, 2004, INVEST OPHTH VIS SCI, V45, P793, DOI 10.1167/iovs.03-1051; He MG, 2009, INVEST OPHTH VIS SCI, V50, P5130, DOI 10.1167/iovs.09-3455; HOLT D, 1991, J R STAT SOC D-STAT, V40, P333; Ip JM, 2008, INVEST OPHTH VIS SCI, V49, P2903, DOI 10.1167/iovs.07-0804; Jung SK, 2012, INVEST OPHTH VIS SCI, V53, P5579, DOI 10.1167/iovs.12-10106; KATZ B, 1993, AM J OPHTHALMOL, V116, P754, DOI 10.1016/S0002-9394(14)73477-4; Kempen AH, 2004, ARCH OPHTHALMOL-CHIC, V122, P495; Krishnaiah S, 2009, CLIN OPHTHALMOL, V3, P17; LEE DA, 1984, ARCH OPHTHALMOL-CHIC, V102, P46; LEE JH, 2013, INVEST OPHTHALMOL VI; LESKE MC, 1991, ARCH OPHTHALMOL-CHIC, V109, P244, DOI 10.1001/archopht.1991.01080020090051; Liang YB, 2009, OPHTHALMOLOGY, V116, P2119, DOI 10.1016/j.ophtha.2009.04.040; Lim MCC, 2009, EYE, V23, P1086, DOI 10.1038/eye.2008.225; Lin LLK, 2004, ANN ACAD MED SINGAP, V33, P27; Low W, 2010, BRIT J OPHTHALMOL, V94, P1012, DOI 10.1136/bjo.2009.173187; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Pan CW, 2012, OPHTHAL PHYSL OPT, V32, P3, DOI 10.1111/j.1475-1313.2011.00884.x; Pan CW, 2011, INVEST OPHTH VIS SCI, V52, P3166, DOI 10.1167/iovs.10-6210; RICHLER A, 1980, ACTA OPHTHALMOL, V58, P468; Rose KA, 2008, OPHTHALMOLOGY, V115, P1279, DOI 10.1016/j.ophtha.2007.12.019; Saw SM, 2008, OPHTHALMOLOGY, V115, P1713, DOI 10.1016/j.ophtha.2008.03.016; Saw SM, 2007, OPHTHAL PHYSL OPT, V27, P126, DOI 10.1111/j.1475-1313.2006.00455.x; Saw SM, 1996, EPIDEMIOL REV, V18, P175, DOI 10.1093/oxfordjournals.epirev.a017924; Sawada A, 2008, OPHTHALMOLOGY, V115, P363, DOI 10.1016/j.ophtha.2007.03.075; Sherwin JC, 2012, INVEST OPHTH VIS SCI, V53, P4363, DOI 10.1167/iovs.11-8677; SO CH, 2007, KOREA KNOWLEDGE EC E, P5; SORSBY A, 1960, BRIT MED J, V1, P1394, DOI 10.1136/bmj.1.5183.1394; Tarczy-Hornoch K, 2006, INVEST OPHTH VIS SCI, V47, P1845, DOI 10.1167/iovs.05-1153; Vitale S, 2008, ARCH OPHTHALMOL-CHIC, V126, P1111, DOI 10.1001/archopht.126.8.1111; Vitale S, 2009, ARCH OPHTHALMOL-CHIC, V127, P1632, DOI 10.1001/archophthalmol.2009.303; WANG Q, 1994, INVEST OPHTH VIS SCI, V35, P4344; Wensor M, 1999, ARCH OPHTHALMOL-CHIC, V117, P658; Wickremasinghe S, 2004, INVEST OPHTH VIS SCI, V45, P776, DOI 10.1167/iovs.03-0456; Wong TY, 2000, INVEST OPHTH VIS SCI, V41, P2486; Wu HM, 2001, OPTOMETRY VISION SCI, V78, P234, DOI 10.1097/00006324-200104000-00012	39	52	54	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80361	10.1371/journal.pone.0080361	http://dx.doi.org/10.1371/journal.pone.0080361			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224049	Green Published, gold, Green Submitted			2022-12-27	WOS:000326597400117
J	Olivier, M; Foret, B; Le Vern, Y; Kerboeuf, D; Guilloteau, LA				Olivier, Michel; Foret, Benjamin; Le Vern, Yves; Kerboeuf, Dominique; Guilloteau, Laurence A.			Plasticity of Migrating CD1b(+) and CD1b(-) Lymph Dendritic Cells in the Promotion of Th1, Th2 and Th17 in Response to Salmonella and Helminth Secretions	PLOS ONE			English	Article							DELTA-T-CELLS; IMMUNE-RESPONSE; INFECTION; POLARIZATION	Dendritic cells (DCs) are pivotal in the development of specific T-cell responses to control pathogens, as they govern both the initiation and the polarization of adaptive immunity. To investigate the capacities of migrating DCs to respond to pathogens, we used physiologically generated lymph DCs (L-DCs). The flexible polarization of L-DCs was analysed in response to Salmonella or helminth secretions known to induce different T cell responses. Mature conventional CD1b(+) L-DCs showed a predisposition to promote pro-inflammatory (IL-6), pro-Th1 (IL-12p40) and anti-inflammatory (IL-10) responses which were amplified by Salmonella, and limited to only IL-6 induction by helminth secretions. The other major population of L-DCs did not express the CD1b molecule and displayed phenotypic features of immaturity compared to CD1b(+) L-DCs. Salmonella infection reduced the constitutive expression of TNF-alpha and IL-4 mRNA in CD1b(-) L-DCs, whereas this expression was not affected by helminth secretions. The cytokine response of T cells promoted by L-DCs was analysed in T cell subsets after co-culture with Salmonella or helminth secretion-driven CD1b(+) or CD1b(-) L-DCs. T cells preferentially expressed the IL-17 gene, and to a lesser extent the IFN-gamma and IL-10 genes, in response to Salmonella-driven CD1b(+) L-DCs, whereas a preferential IL-10, IFN-gamma and IL-17 gene expression was observed in response to Salmonella-driven CD1b(-) L-DCs. In contrast, a predominant IL-4 and IL-13 gene expression by CD4(+) and CD8(+) T cells was observed after stimulation of CD1b(+) and CD1b(-) L-DCs with helminth secretions. These results show that mature conventional CD1b(+) L-DCs maintain a flexible capacity to respond differently to pathogens, that the predisposition of CD1b(-) L-DCs to promote a Th2 response can be oriented towards other Th responses, and finally that the modulation of migrating L-DCs responses is controlled more by the pathogen encountered than the L-DC subsets.	[Olivier, Michel; Foret, Benjamin; Kerboeuf, Dominique; Guilloteau, Laurence A.] INRA, Infectiol & Sante Publ UR1282, Nouzilly, France; [Le Vern, Yves] INRA, Lab Cytometrie, F-37380 Nouzilly, France	INRAE; INRAE	Guilloteau, LA (corresponding author), INRA, Infectiol & Sante Publ UR1282, Nouzilly, France.	Laurence.Guilloteau@tours.inra.fr			Institut National de la Recherche Agronomique (INRA)	Institut National de la Recherche Agronomique (INRA)	This work was funded by the Institut National de la Recherche Agronomique (INRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsen D, 2009, CURR OPIN IMMUNOL, V21, P153, DOI 10.1016/j.coi.2009.03.010; Bonneau M, 2006, J LEUKOCYTE BIOL, V79, P268, DOI 10.1189/jlb.0605288; Brunner E, 2002, NONPARAMETRIC ANAL W; BUJDOSO R, 1990, International Reviews of Immunology, V6, P177, DOI 10.3109/08830189009056628; Contreras V, 2010, J IMMUNOL, V185, P3313, DOI 10.4049/jimmunol.1000824; Dascher CC, 2003, TRENDS IMMUNOL, V24, P412, DOI 10.1016/S1471-4906(03)00179-0; Everts B, 2010, EUR J IMMUNOL, V40, P1525, DOI 10.1002/eji.200940109; Ferret-Bernard S, 2008, PROTEOMICS, V8, P980, DOI 10.1002/pmic.200700538; Gohin I, 1997, VET IMMUNOL IMMUNOP, V60, P111, DOI 10.1016/S0165-2427(97)00090-1; Hegde VL, 2008, J LEUKOCYTE BIOL, V84, P134, DOI 10.1189/jlb.1107752; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Hwang YY, 2013, ADV EXP MED BIOL, V785, P9, DOI 10.1007/978-1-4614-6217-0_2; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Knight JS, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-51; Liotta F, 2008, J ALLERGY CLIN IMMUN, V121, P1000, DOI 10.1016/j.jaci.2008.01.004; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; MacDonald AS, 2008, J EXP MED, V205, P13, DOI 10.1084/jem.20072665; Mastroeni Pietro, 2002, Current Molecular Medicine (Hilversum), V2, P393, DOI 10.2174/1566524023362492; Mittrucker HW, 2000, J LEUKOCYTE BIOL, V67, P457, DOI 10.1002/jlb.67.4.457; Nanton MR, 2012, J IMMUNOL, V189, P5503, DOI 10.4049/jimmunol.1201413; O'Brien RL, 2009, EUR J IMMUNOL, V39, P662, DOI 10.1002/eji.200839120; Olivier M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030430; Pascale F, 2008, J IMMUNOL, V180, P5963, DOI 10.4049/jimmunol.180.9.5963; Pearce EJ, 2004, IMMUNOL REV, V201, P117, DOI 10.1111/j.0105-2896.2004.00187.x; Rengarajan J, 2000, IMMUNOL TODAY, V21, P479, DOI 10.1016/S0167-5699(00)01712-6; Ryan S, 2000, J VIROL, V74, P10096, DOI 10.1128/JVI.74.21.10096-10103.2000; Schulz SM, 2008, INT IMMUNOL, V20, P1129, DOI 10.1093/intimm/dxn069; Segura E, 2012, J EXP MED, V209, P653, DOI 10.1084/jem.20111457; Segura E, 2009, CURR OPIN IMMUNOL, V21, P105, DOI 10.1016/j.coi.2009.03.011	30	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79537	10.1371/journal.pone.0079537	http://dx.doi.org/10.1371/journal.pone.0079537			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223964	Green Published, Green Submitted, gold			2022-12-27	WOS:000326597400071
J	Zhao, JL; Solis-Montero, L; Lou, A; Vallejo-Marin, M				Zhao, Jiali; Solis-Montero, Lislie; Lou, Anru; Vallejo-Marin, Mario			Population Structure and Genetic Diversity of Native and Invasive Populations of Solanum rostratum (Solanaceae)	PLOS ONE			English	Article							PLANT; INFERENCE; BIOLOGY	Aims: We investigate native and introduced populations of Solanum rostratum, an annual, self-compatible plant that has been introduced around the globe. This study is the first to compare the genetic diversity of Solanum rostratum between native and introduced populations. We aim to (1) determine the level of genetic diversity across the studied regions; (2) explore the likely origins of invasive populations in China; and (3) investigate whether there is the evidence of multiple introductions into China. Methods: We genotyped 329 individuals at 10 microsatellite loci to determine the levels of genetic diversity and to investigate population structure of native and introduced populations of S. rostratum. We studied five populations in each of three regions across two continents: Mexico, the U.S.A. and China. Important Findings: We found the highest genetic diversity among Mexican populations of S. rostratum. Genetic diversity was significantly lower in Chinese and U.S.A. populations, but we found no regional difference in inbreeding coefficients (F-IS) or population differentiation (F-ST). Population structure analyses indicate that Chinese and U.S.A. populations are more closely related to each other than to sampled Mexican populations, revealing that introduced populations in China share an origin with the sampled U.S.A. populations. The distinctiveness between some introduced populations indicates multiple introductions of S. rostratum into China.	[Zhao, Jiali; Lou, Anru] Beijing Normal Univ, Coll Life Sci, State Key Lab Earth Surface Proc & Resource, Beijing 100875, Peoples R China; [Solis-Montero, Lislie; Vallejo-Marin, Mario] Univ Stirling, Sch Nat Sci, Stirling FK9 4LA, Scotland	Beijing Normal University; University of Stirling	Lou, A (corresponding author), Beijing Normal Univ, Coll Life Sci, State Key Lab Earth Surface Proc & Resource, Beijing 100875, Peoples R China.	louanru@bnu.edu.cn; mario.vallejo@stir.ac.uk	Solis-Montero, Lislie/N-2556-2014; Vallejo-Marin, Mario/G-4186-2011	Solis-Montero, Lislie/0000-0002-5793-3376; Vallejo-Marin, Mario/0000-0002-5663-8025	Royal Society of Edinburgh-Chinese National Science Foundation; National Natural Science Foundation of China [31070374]; Royal Society of London [RG2010R1]; University of Stirling	Royal Society of Edinburgh-Chinese National Science Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Royal Society of London(Royal Society of London); University of Stirling	Support for this study was provided by a Royal Society of Edinburgh-Chinese National Science Foundation Joint Project to MVM and AL, a grant by the National Natural Science Foundation of China (Project 31070374) to AL, a Royal Society of London research grant (RG2010R1) to MVM, and a Horizon Ph.D. fellowship from the University of Stirling to LSM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, TFPGA TOOLS POPULATI; Baker H. G., 1975, Annual Review of Ecology and Systematics, V5, P1, DOI 10.1146/annurev.es.05.110174.000245; BAKER HG, 1955, EVOLUTION, V9, P347, DOI 10.2307/2405656; BARRELL J, 1975, RED HILLS KANSAS CRO; Barrett SCH, 2011, FIFTY YEARS OF INVASION ECOLOGY: THE LEGACY OF CHARLES ELTON, P195; BASSETT IJ, 1986, CAN J PLANT SCI, V66, P977, DOI 10.4141/cjps86-120; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; Cho Young-Ho, 1997, Korean Journal of Plant Taxonomy, V27, P277; Dyer RJ, 2004, MOL ECOL, V13, P1713, DOI 10.1111/j.1365-294X.2004.02177.x; Dyer RJ, 2010, MOL ECOL, V19, P3746, DOI 10.1111/j.1365-294X.2010.04748.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Facon B, 2006, TRENDS ECOL EVOL, V21, P130, DOI 10.1016/j.tree.2005.10.012; Friedman J, 2008, ANN BOT-LONDON, V101, P1303, DOI 10.1093/aob/mcn039; [高芳 Gao Fang], 2005, [北京师范大学学报. 自然科学版, Journal of Beijing Normal University], V41, P420; Gao H, 2007, GENETICS, V176, P1635, DOI 10.1534/genetics.107.072371; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GUAN G, 1984, PLANT QUAR, V4, P25; Henry P, 2009, MOL ECOL, V18, P2819, DOI 10.1111/j.1365-294X.2009.04237.x; Hollingsworth ML, 2000, BOT J LINN SOC, V133, P463, DOI 10.1111/j.1095-8339.2000.tb01589.x; Lafuma L, 2007, OIKOS, V116, P201, DOI 10.1111/j.0030-1299.2007.15220.x; Langella O, 1999, POPULATIONS 1 2 30; Lin Y, 2007, ACTA PHYTOTAXON SIN, V45, P675, DOI 10.1360/aps07010; Lowry DB, 2008, EVOLUTION, V62, P2196, DOI 10.1111/j.1558-5646.2008.00457.x; NOVAK SJ, 1993, HEREDITY, V71, P167, DOI 10.1038/hdy.1993.121; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Prentis PJ, 2008, TRENDS PLANT SCI, V13, P288, DOI 10.1016/j.tplants.2008.03.004; Pritchard JK, 2000, GENETICS, V155, P945; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Stern SR, 2010, SYST BOT, V35, P885, DOI 10.1600/036364410X539934; Tower W.L., 1906, INVESTIGATION EVOLUT, V2, P13; USDA NRCS, 2012, PLANTS DAT; Vallejo-Marin M, 2013, PLANT BIOLOGY, V15, P948, DOI 10.1111/j.1438-8677.2012.00715.x; Vallejo-Marin M, 2009, J EVOLUTION BIOL, V22, P828, DOI 10.1111/j.1420-9101.2009.01693.x; Vallejo-Marin M, 2011, AM J BOT, V98, pE296, DOI 10.3732/ajb.1100159; Voss N, 2012, ANN BOT-LONDON, V110, P585, DOI 10.1093/aob/mcs117; Wang WS, 2005, PLANTS QUARANTINE, V19, P247; Whalen MD, 1979, GENTES HERBARIUM, V11, P359; WHITLOCK MC, 1990, EVOLUTION, V44, P1717, DOI [10.2307/2409501, 10.1111/j.1558-5646.1990.tb05243.x]; Willi Y, 2006, ANNU REV ECOL EVOL S, V37, P433, DOI 10.1146/annurev.ecolsys.37.091305.110145; Zhang S. M., 1997, J LIAONING NORMAL U, V20, P323; Zhang YY, 2010, MOL ECOL, V19, P1774, DOI 10.1111/j.1365-294X.2010.04609.x; [赵晓英 ZHAO Xiaoying], 2007, [地球科学进展, Advance in Earth Sciences], V22, P167; Zhong Gen-ping, 2009, Shengtaixue Zazhi, V28, P162	45	26	28	5	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79807	10.1371/journal.pone.0079807	http://dx.doi.org/10.1371/journal.pone.0079807			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24224008	Green Published, Green Submitted, gold			2022-12-27	WOS:000326597400089
J	Jia, PY; Zhao, Y; Wu, SP; Wu, JH; Gao, S; Tong, Y; Wang, YX				Jia, Peiyuan; Zhao, Yu; Wu, Shaoping; Wu, Junhua; Gao, Shan; Tong, Ying; Wang, Yuxia			The Novel Fusion Proteins, GnRH-p53 and GnRHIII-p53, Expression and Their Anti-Tumor Effect	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; LH-RH RECEPTORS; ANALOGS; CANCERS; BREAST; CELLS; P53; DERIVATIVES; PROSTATE; THERAPY	p53, one of the most well studied tumor suppressor factor, is responsible to a variety of damage owing to the induction of apoptosis and cell cycle arrest in the tumor cells. More than 50% of human tumors contain mutation or deletion of p53. Gonadotrophin-releasing hormone (GnRH), as the ligand of Gonadotrophin-releasing hormone receptor (GnRH-R), was used to deliver p53 into tumor cells. The p53 fusion proteins GnRH-p53 and GnRH iii-p53 were expressed and their targeted anti-tumor effects were determined. GnRH mediates its fusion proteins transformation into cancer cells. The intracellular delivery of p53 fusion proteins exerted the inhibition of the growth of H1299 cells in vitro and the reduction of tumor volume in vivo. Their anti-tumor effect was functioned by the apoptosis and cell cycle arrest induced by p53. Hence, the fusion protein could be a novel protein drug for anti-tumor therapy.	[Jia, Peiyuan; Zhao, Yu; Wu, Junhua; Wang, Yuxia] Beijing Inst Pharmacol & Toxicol, Beijing, Peoples R China; [Wu, Shaoping; Gao, Shan; Tong, Ying] Beijing Ctr Dis Prevent & Control, Beijing, Peoples R China	Academy of Military Medical Sciences - China	Wang, YX (corresponding author), Beijing Inst Pharmacol & Toxicol, Beijing, Peoples R China.	wangyuxia1962@hotmail.com		Zhao, Yu/0000-0002-4919-1341	National Natural Science Foundation of China [30973562]; National Basic Research Program of China [2010CB933904]; Ministry of Science and Technology of China [2009ZX09103-614]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by a grant from the National Natural Science Foundation of China (No. 30973562), the National Basic Research Program of China (No. 2010CB933904) and the Ministry of Science and Technology of China (No. 2009ZX09103-614). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	FRIESS H, 1991, INT J PANCREATOL, V10, P151; Gho YS, 1999, MOL CELLS, V9, P31; Gunthert AR, 2005, EUR J ENDOCRINOL, V153, P613, DOI 10.1530/eje.1.01996; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; HAZUM E, 1985, CELL TISSUE RES, V239, P3, DOI 10.1007/BF00214895; Ji TH, 1998, J BIOL CHEM, V273, P17299, DOI 10.1074/jbc.273.28.17299; Kovacs M, 2007, PEPTIDES, V28, P821, DOI 10.1016/j.peptides.2007.01.003; KUERBITZ SJ, 1992, P NATL ACAD SCI USA, V89, P7491, DOI 10.1073/pnas.89.16.7491; Lovas S, 1998, J PEPT RES, V52, P384; Mezo G, 2007, PEPTIDES, V28, P806, DOI 10.1016/j.peptides.2006.12.014; Mezo G, 2010, EXPERT OPIN DRUG DEL, V7, P79, DOI 10.1517/17425240903418410; Mezo G, 2008, CURR MED CHEM, V15, P2366, DOI 10.2174/092986708785909157; Nagy A, 2005, BIOL REPROD, V73, P851, DOI 10.1095/biolreprod.105.043489; Nakatani T, 2001, JPN J CANCER RES, V92, P249, DOI 10.1111/j.1349-7006.2001.tb01089.x; Nechushtan A, 1997, J BIOL CHEM, V272, P11597; Orban E, 2011, AMINO ACIDS, V41, P469, DOI 10.1007/s00726-010-0766-1; PINSKI J, 1995, INT J PEPT PROT RES, V45, P410; Saad M, 2008, J CONTROL RELEASE, V130, P107, DOI 10.1016/j.jconrel.2008.05.024; Sapan CV, 1999, BIOTECHNOL APPL BIOC, V29, P99; Schally AV, 2004, TRENDS ENDOCRIN MET, V15, P300, DOI 10.1016/j.tem.2004.07.002; SOWER SA, 1993, ENDOCRINOLOGY, V132, P1125, DOI 10.1210/en.132.3.1125; Szepeshazi K, 2007, INT J ONCOL, V30, P1485; Wu SP, 2006, BIOCHEM BIOPH RES CO, V346, P1, DOI 10.1016/j.bbrc.2006.03.247; Zhao Y, 2011, CANCER BIOL THER, V11, P95, DOI 10.4161/cbt.11.1.13960; Zhao Y, 2009, CANCER LETT, V279, P101, DOI 10.1016/j.canlet.2009.01.030	25	2	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79384	10.1371/journal.pone.0079384	http://dx.doi.org/10.1371/journal.pone.0079384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223939	Green Submitted, gold, Green Published			2022-12-27	WOS:000326503400112
J	Ozdemir, B; Abd-Almageed, W; Roessler, S; Wang, XW				Ozdemir, Bahadir; Abd-Almageed, Wael; Roessler, Stephanie; Wang, Xin Wei			iSubgraph: Integrative Genomics for Subgroup Discovery in Hepatocellular Carcinoma Using Graph Mining and Mixture Models	PLOS ONE			English	Article							REGULATORY MODULES; MICRORNA; PREDICTION; IDENTIFICATION; CLASSIFICATION; GENES	The high tumor heterogeneity makes it very challenging to identify key tumorigenic pathways as therapeutic targets. The integration of multiple omics data is a promising approach to identify driving regulatory networks in patient subgroups. Here, we propose a novel conceptual framework to discover patterns of miRNA-gene networks, observed frequently up-or down-regulated in a group of patients and to use such networks for patient stratification in hepatocellular carcinoma (HCC). We developed an integrative subgraph mining approach, called iSubgraph, and identified altered regulatory networks frequently observed in HCC patients. The miRNA and gene expression profiles were jointly analyzed in a graph structure. We defined a method to transform microarray data into graph representation that encodes miRNA and gene expression levels and the interactions between them as well. The iSubgraph algorithm was capable to detect cooperative regulation of miRNAs and genes even if it occurred only in some patients. Next, the miRNA-mRNA modules were used in an unsupervised class prediction model to discover HCC subgroups via patient clustering by mixture models. The robustness analysis of the mixture model showed that the class predictions are highly stable. Moreover, the Kaplan-Meier survival analysis revealed that the HCC subgroups identified by the algorithm have different survival characteristics. The pathway analyses of the miRNA-mRNA co-modules identified by the algorithm demonstrate key roles of Myc, E2F1, let-7, TGFB1, TNF and EGFR in HCC subgroups. Thus, our method can integrate various omics data derived from different platforms and with different dynamic scales to better define molecular tumor subtypes. iSubgraph is available as MATLAB code at http://www.cs.umd.edu/similar to ozdemir/isubgraph/.	[Ozdemir, Bahadir] Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA; [Ozdemir, Bahadir; Roessler, Stephanie; Wang, Xin Wei] Natl Canc Inst, Ctr Canc Res, Human Carcinogenesis Lab, Liver Carcinogenesis Sect, Bethesda, MD USA; [Abd-Almageed, Wael] Univ Maryland, Inst Adv Comp Studies, College Pk, MD 20742 USA; [Roessler, Stephanie] Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Germany	University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland College Park; Ruprecht Karls University Heidelberg	Roessler, S (corresponding author), Natl Canc Inst, Ctr Canc Res, Human Carcinogenesis Lab, Liver Carcinogenesis Sect, Bethesda, MD USA.	stephanie.roessler@med.uni-heidelberg.de; xw3u@nih.gov	Wang, Xin Wei/B-6162-2009; Roessler, Stephanie/J-8432-2019	Wang, Xin Wei/0000-0001-9735-606X; Roessler, Stephanie/0000-0002-5333-5942	UMD-NCI Partnership for Cancer Technology; Intramural Research Program of the Center for Cancer Research, the National Cancer Institute [Z01-BC 010313]; NATIONAL CANCER INSTITUTE [ZIABC010313] Funding Source: NIH RePORTER	UMD-NCI Partnership for Cancer Technology; Intramural Research Program of the Center for Cancer Research, the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	B.O. was supported by the UMD-NCI Partnership for Cancer Technology. This work was supported in part by grants (Z01-BC 010313) from the Intramural Research Program of the Center for Cancer Research, the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bishop C. M, 2006, PATTERN RECOGNITION; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Burchard J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.58; Burrage K, 2006, BRIEF BIOINFORM, V7, P390, DOI 10.1093/bib/bbl033; Cook DJ, 2006, MINING GRAPH DATA; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Fiedler M., 2007, P IEEE INT WORKSH MI, P399; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Harrington D, 2005, LINEAR RANK TESTS SU; Hood Leroy, 2008, Briefings in Functional Genomics & Proteomics, V7, P239, DOI 10.1093/bfgp/eln027; Huang JC, 2006, LECT NOTES COMPUT SC, V3909, P114; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; HUGHES GF, 1968, IEEE T INFORM THEORY, V14, P55, DOI 10.1109/TIT.1968.1054102; Joung JG, 2007, BIOINFORMATICS, V23, P1141, DOI 10.1093/bioinformatics/btm045; Kim SJ, 2010, ESEM 10 P 2010 ACM I, P1; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Lee JS, 2004, HEPATOLOGY, V40, P667, DOI 10.1002/hep.20375; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu AM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000825; Liu B, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-408; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Pekalska E, 2005, DISSIMILARITY REPRES; Peng XX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-373; Riesen K, 2009, IEEE T SYST MAN CY B, V39, P1472, DOI 10.1109/TSMCB.2009.2019264; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Saint-Jean C, 2000, LECT NOTES COMPUT SC, V1876, P872; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Tran DH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S5; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Villanueva A, 2011, GASTROENTEROLOGY, V140, P1501, DOI 10.1053/j.gastro.2011.02.006; Wang XW, 2012, GASTROENTEROLOGY, V142, P1431, DOI 10.1053/j.gastro.2012.04.007; Woo HG, 2011, GASTROENTEROLOGY, V140, P1063, DOI 10.1053/j.gastro.2010.11.034; Yan X., 2003, P 9 ACM SIGKDD INT C, P286, DOI [DOI 10.1145/956750.956784, 10.1145/956750.956784]; Yoon SR, 2005, BIOINFORMATICS, V21, P93, DOI 10.1093/bioinformatics/bti1116; Zhang SH, 2011, BIOINFORMATICS, V27, pI401, DOI 10.1093/bioinformatics/btr206	40	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78624	10.1371/journal.pone.0078624	http://dx.doi.org/10.1371/journal.pone.0078624			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223834	Green Submitted, Green Published, gold			2022-12-27	WOS:000326503400079
J	Zhi, XF; Zhou, XY; Wang, WZ; Xu, ZK				Zhi, Xiaofei; Zhou, Xiaoying; Wang, Weizhi; Xu, Zekuan			Practical Role of Mutation Analysis for Imatinib Treatment in Patients With Advanced Gastrointestinal Stromal Tumors: A Meta-Analysis	PLOS ONE			English	Article							BONE-SARCOMA-GROUP; EORTC-SOFT-TISSUE; KINASE MUTATIONS; KIT MUTATIONS; RANDOMIZED-TRIAL; KOREAN PATIENTS; BRAF MUTATIONS; PHASE-II; MESYLATE; EFFICACY	Background: Imatinib has become the standard first line treatment of gastrointestinal stromal tumors (GIST) in the advanced phase and adjuvant setting. We carried out an up-to-date meta-analysis to determine the practical role of mutation analysis for imatinib treatment in patients with advanced GIST. Methods: Eligible studies were limited to imatinib treatment for patients with advanced GIST and reported on mutation analysis. Statistical analyses were conducted to calculate the odds ratio (OR), hazard ratio (HR) and 95% confidence interval (CI) using fixed-effects and random-effects models. Results: A total of 2834 patients from 3 randomized controlled trials and 12 cohort studies were included. The ORs of response rates in KIT exon 11-mutant GISTs were 3.504 (95% CI 2.549-4.816, p<0.001) and 3.521 (95% CI 1.731-7.165, p=0.001) compared with KIT exon 9-mutant and wild type GISTs, respectively. The HRs of progression-free survival in KIT exon 11-mutant GISTs were 0.365 (95% CI 0.301-0.444, p<0.001) and 0.375 (95% CI 0.270-0.519, p<0.001) compared with KIT exon 9-mutant and wild type GISTs. The HRs of overall survival in KIT exon 11-mutant GISTs were 0.388 (95% CI 0.293-0.515, p<0.001) and 0.400 (95% CI 0.297-0.538, p<0.001) compared with KIT exon 9-mutant and wild type GISTs. No statistical significant differences were found between KIT exon 9-mutant and wild type. The overall response rate in KIT-exon 11-mutant GISTs were 70.5% (65%-75.9%) compared with 57.1% (51%-63.2%) in KIT-positive GISTs. No evidence of publication bias was observed. Conclusion: Patients with advanced GIST harboring a KIT exon 11 mutation have the best response rate and long-term survival with imatinib treatment. Mutation analysis would be more helpful than KIT expression analysis to decide appropriate therapy for a specific patient.	[Zhi, Xiaofei; Wang, Weizhi; Xu, Zekuan] Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China; [Zhou, Xiaoying] Nanjing Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Xu, ZK (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China.	xuzekuan@njmu.edu.cn			National Natural Science Foundation of China [81272712, 81072031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (81272712, 81072031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaram NP, 2008, GENE CHROMOSOME CANC, V47, P853, DOI 10.1002/gcc.20589; Bachet JB, 2013, EUR J CANCER; Blanke CD, 2008, J CLIN ONCOL, V26, P626, DOI 10.1200/JCO.2007.13.4452; Chen P, 2010, WORLD J GASTROENTERO, V16, P4227, DOI 10.3748/wjg.v16.i33.4227; Debiec-Rychter M, 2004, J PATHOL, V202, P430, DOI 10.1002/path.1546; Debiec-Rychter M, 2004, EUR J CANCER, V40, P689, DOI 10.1016/j.ejca.2003.11.025; Debiec-Rychter M, 2006, EUR J CANCER, V42, P1093, DOI 10.1016/j.ejca.2006.01.030; Demetri GD, 2004, J CLIN ONCOL, V22, p195S; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Falchook GS, 2012, LANCET, V379, P1893, DOI 10.1016/S0140-6736(12)60398-5; Gao J, 2012, MED ONCOL, V29, P3039, DOI 10.1007/s12032-012-0308-7; Gounder MM, 2011, CANCER CHEMOTH PHARM, V67, P25, DOI 10.1007/s00280-010-1526-3; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Heinrich MC, 2012, CLIN CANCER RES, V18, P4375, DOI 10.1158/1078-0432.CCR-12-0625; Heinrich MC, 2008, J CLIN ONCOL, V26, P5360, DOI 10.1200/JCO.2008.17.4284; Joensuu H, 2013, LANCET IN PRESS; Joensuu H, 2012, JAMA-J AM MED ASSOC, V307, P1265, DOI 10.1001/jama.2012.347; Kang HJ, 2012, ACTA ONCOL, V51, P528, DOI 10.3109/0284186X.2011.636753; Kim TW, 2009, ONCOLOGIST, V14, P540, DOI 10.1634/theoncologist.2008-0145; Maki Robert G, 2007, Curr Oncol Rep, V9, P165, DOI 10.1007/s11912-007-0017-0; Medeiros F, 2004, AM J SURG PATHOL, V28, P889, DOI 10.1097/00000478-200407000-00007; Miettinen M, 2000, MODERN PATHOL, V13, P1134, DOI 10.1038/modpathol.3880210; Miettinen M, 2013, GASTROENTEROL CLIN N, V42, P399, DOI 10.1016/j.gtc.2013.01.001; Miranda C, 2012, CLIN CANCER RES, V18, P1769, DOI 10.1158/1078-0432.CCR-11-2230; Rubin BP, 2001, CANCER RES, V61, P8118; Rutkowski P, 2007, J CANCER RES CLIN, V133, P589, DOI 10.1007/s00432-007-0202-4; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; van Oosterom AT, 2001, LANCET, V358, P1421, DOI 10.1016/S0140-6736(01)06535-7; Verweij J, 2003, EUR J CANCER, V39, P2006, DOI 10.1016/S0959-8049(02)00836-5; Verweij J, 2004, LANCET, V364, P1127, DOI 10.1016/S0140-6736(04)17098-0; Wardelmann E, 2006, CLIN CANCER RES, V12, P1743, DOI 10.1158/1078-0432.CCR-05-1211; Yantiss RK, 2005, MODERN PATHOL, V18, P475, DOI 10.1038/modpathol.3800334; Yeh CN, 2007, ANN SURG ONCOL, V14, P1123, DOI 10.1245/s10434-006-9288-1	34	9	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79275	10.1371/journal.pone.0079275	http://dx.doi.org/10.1371/journal.pone.0079275			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223922	Green Published, Green Submitted, gold			2022-12-27	WOS:000326503400105
J	Jaffre, M; Beaugrand, G; Goberville, E; Jiguet, F; Kjellen, N; Troost, G; Dubois, PJ; Lepretre, A; Luczak, C				Jaffre, Mikael; Beaugrand, Gregory; Goberville, Eric; Jiguet, Frederic; Kjellen, Nils; Troost, Gerard; Dubois, Philippe J.; Lepretre, Alain; Luczak, Christophe			Long-Term Phenological Shifts in Raptor Migration and Climate	PLOS ONE			English	Article							ARRIVAL; REPRODUCTION; SELECTION; PATTERNS; MIGRANTS; PLANKTON; IMPACT; BIRDS; DATES	Climate change is having a discernible effect on many biological and ecological processes. Among observed changes, modifications in bird phenology have been widely documented. However, most studies have interpreted phenological shifts as gradual biological adjustments in response to the alteration of the thermal regime. Here we analysed a long-term dataset (1980-2010) of short-distance migratory raptors in five European regions. We revealed that the responses of these birds to climate-induced changes in autumn temperatures are abrupt and synchronous at a continental scale. We found that when the temperatures increased, birds delayed their mean passage date of autumn migration. Such delay, in addition to an earlier spring migration, suggests that a significant warming may induce an extension of the breeding-area residence time of migratory raptors, which may eventually lead to residency.	[Jaffre, Mikael; Beaugrand, Gregory; Goberville, Eric; Luczak, Christophe] Univ Lille 1, Stn Marine Wimereux, CNRS, Lab Oceanol & Geosci,LOG,UMR 8187, Wimereux, France; [Jiguet, Frederic] UPMC, MNHN, Ctr Rech Biol Populat Oiseaux, CNRS,UMR 7204, Paris, France; [Kjellen, Nils] Lund Univ, Dept Biol, Lund, Sweden; [Dubois, Philippe J.] Trektellen Org, SOVON Dutch Ctr Field Ornithol, Nijmegen, Netherlands; [Dubois, Philippe J.] Ligue Protect Oiseaux, Rochefort, France; [Lepretre, Alain] Univ Lille 1, UPRES, EA 4515, F-59655 Villeneuve Dascq, France; [Luczak, Christophe] Univ Artois, IUFM, Gravelines, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Lund University; Universite de Lille - ISITE; Universite de Lille; Universite d'Artois; Universite de Bretagne Occidentale	Jaffre, M (corresponding author), Univ Lille 1, Stn Marine Wimereux, CNRS, Lab Oceanol & Geosci,LOG,UMR 8187, Wimereux, France.	mikael.jaffre@univ-lille1.fr	Goberville, Eric/A-2621-2017	Goberville, Eric/0000-0002-1843-7855; BEAUGRAND, GREGORY/0000-0002-0712-5223	Region Ile de France/LPO - PICRI (LPO/Universite Lille research fund) [SASS9045]	Region Ile de France/LPO - PICRI (LPO/Universite Lille research fund)(Region Ile-de-France)	This research was partly supported by a grant from Region Ile de France/LPO - PICRI project to M. Jaffre (LPO/Universite Lille 1 research fund SASS9045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	[Anonymous], 2006, ENTOMOL REV, DOI DOI 10.1134/S0013873806100058; Beaugrand G, 2000, MAR ECOL PROG SER, V200, P93, DOI 10.3354/meps200093; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; BERTHOLD P, 1994, P ROY SOC B-BIOL SCI, V257, P311, DOI 10.1098/rspb.1994.0131; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Coppack T, 2002, ARDEA, V90, P369; Cotton PA, 2003, P NATL ACAD SCI USA, V100, P12219, DOI 10.1073/pnas.1930548100; Devictor V, 2012, NAT CLIM CHANGE, V2, P121, DOI 10.1038/NCLIMATE1347; DOLEDEC S, 1994, FRESHWATER BIOL, V31, P277, DOI 10.1111/j.1365-2427.1994.tb01741.x; Filippi-Codaccioni O, 2010, J ORNITHOL, V151, P687, DOI 10.1007/s10336-010-0500-5; Goberville E, 2010, MAR ECOL PROG SER, V408, P129, DOI 10.3354/meps08564; Gwinner E, 1996, IBIS, V138, P47, DOI 10.1111/j.1474-919X.1996.tb04312.x; Hohn ME, 1993, COMPUTERS GEOLOGY 25, P181; Huppop O, 2003, P ROY SOC B-BIOL SCI, V270, P233, DOI 10.1098/rspb.2002.2236; Hussell David J.T., 2005, North American Bird Bander, V30, P6; Jenni L, 2003, P ROY SOC B-BIOL SCI, V270, P1467, DOI 10.1098/rspb.2003.2394; Jonzen N, 2006, SCIENCE, V312, P1959, DOI 10.1126/science.1126119; La Sorte FA, 2007, ECOLOGY, V88, P1803, DOI 10.1890/06-1072.1; Lehikoinen A, 2009, OIKOS, V118, P829, DOI 10.1111/j.1600-0706.2008.17440.x; Lehikoinen E, 2004, ADV ECOL RES, V35, P1, DOI 10.1016/S0065-2504(04)35001-4; Louchart A, 2008, NATURWISSENSCHAFTEN, V95, P1109, DOI 10.1007/s00114-008-0435-3; Luczak C, 2011, BIOL LETTERS, V7, P702, DOI 10.1098/rsbl.2011.0225; Mihoub JB, 2012, J AVIAN BIOL, V43, P472, DOI 10.1111/j.1600-048X.2012.05529.x; Mills AM, 2005, IBIS, V147, P259, DOI 10.1111/j.1474-919X.2005.00380.x; Moussus JP, 2010, METHODS ECOL EVOL, V1, P140, DOI 10.1111/j.2041-210X.2010.00020.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Peron G, 2007, CLIM RES, V35, P147, DOI 10.3354/cr00721; Porter R.F., 1985, International Council for Bird Preservation Technical Publication, P237; Pulido F, 1996, P NATL ACAD SCI USA, V93, P14642, DOI 10.1073/pnas.93.25.14642; Pulido F, 2010, P NATL ACAD SCI USA, V107, P7341, DOI 10.1073/pnas.0910361107; Rodionov SN, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025904; Rodionov SN, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019448; Sergio F, 2003, J AVIAN BIOL, V34, P144, DOI 10.1034/j.1600-048X.2003.03104.x; Sparks TH, 2002, INT J CLIMATOL, V22, P1715, DOI 10.1002/joc.821; Strandberg R, 2008, ARDEA, V96, P159, DOI 10.5253/078.096.0202; Thorup K, 2007, OECOLOGIA, V151, P697, DOI 10.1007/s00442-006-0608-8	37	23	23	4	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79112	10.1371/journal.pone.0079112	http://dx.doi.org/10.1371/journal.pone.0079112			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223888	Green Published, gold			2022-12-27	WOS:000326499300057
J	Hunter, JC; Yang, JE; Crawley, AW; Biesiadecki, L; Aragon, TJ				Hunter, Jennifer C.; Yang, Jane E.; Crawley, Adam W.; Biesiadecki, Laura; Aragon, Tomas J.			Public Health Response Systems In-Action: Learning from Local Health Departments' Experiences with Acute and Emergency Incidents	PLOS ONE			English	Article							DELIVERY-SYSTEMS; PREPAREDNESS	As part of their core mission, public health agencies attend to a wide range of disease and health threats, including those that require routine, acute, and emergency responses. While each incident is unique, the number and type of response activities are finite; therefore, through comparative analysis, we can learn about commonalities in the response patterns that could improve predictions and expectations regarding the resources and capabilities required to respond to future acute events. In this study, we interviewed representatives from more than 120 local health departments regarding their recent experiences with real-world acute public health incidents, such as infectious disease outbreaks, severe weather events, chemical spills, and bioterrorism threats. We collected highly structured data on key aspects of the incident and the public health response, particularly focusing on the public health activities initiated and community partners engaged in the response efforts. As a result, we are able to make comparisons across event types, create response profiles, and identify functional and structural response patterns that have import for future public health preparedness and response. Our study contributes to clarifying the complexity of public health response systems and our analysis reveals the ways in which these systems are adaptive to the character of the threat, resulting in differential activation of functions and partners based on the type of incident. Continued and rigorous examination of the experiences of health departments throughout the nation will refine our very understanding of what the public health response system is, will enable the identification of organizational and event inputs to performance, and will allow for the construction of rich, relevant, and practical models of response operations that can be employed to strengthen public health systems.	[Hunter, Jennifer C.; Yang, Jane E.; Aragon, Tomas J.] Univ Calif Berkeley, Sch Publ Hlth, Ctr Infect Dis & Emergency Readiness, Berkeley, CA 94720 USA; [Crawley, Adam W.] San Mateo Cty Hlth Syst, Div Publ Hlth Policy & Planning, San Mateo, CA USA; [Biesiadecki, Laura] Natl Assoc Cty & City Hlth Officials, Washington, DC USA; [Aragon, Tomas J.] San Francisco Dept Publ Hlth, San Francisco, CA USA	University of California System; University of California Berkeley; San Francisco Department of Public Health	Hunter, JC (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Ctr Infect Dis & Emergency Readiness, Berkeley, CA 94720 USA.	jhunter@berkeley.edu		Aragon, Tomas/0000-0002-2058-0423	Preparedness and Emergency Response Research Center (PERRC) grant from the Centers for Disease Control and Prevention under FOA [RFA-TP-08-001, 5P01TP000295]	Preparedness and Emergency Response Research Center (PERRC) grant from the Centers for Disease Control and Prevention under FOA	This study was supported by a Preparedness and Emergency Response Research Center (PERRC) grant from the Centers for Disease Control and Prevention, under FOA RFA-TP-08-001, to the University of California at Berkeley (grant number 5P01TP000295). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control & Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta J., 2009, NATL AGENDA PUBLIC H; Altevogt BM, 2008, RES PRIORITIES EMERG; [Anonymous], 2006, HOMELAND SECURITY AF; Asch SM, 2005, PUBLIC HEALTH REP, V120, P532, DOI 10.1177/003335490512000508; Bovaird T, 2008, PUBLIC MANAG REV, V10, P319, DOI 10.1080/14719030802002741; Burke DS, 2013, J PUBLIC HEALTH MAN, V19, pS12, DOI 10.1097/PHH.0b013e31828a842f; Centers for Disease Control and Prevention (US), 2011, PUBL HLTH PREP CAP N; Dato V, 2004, PUBLIC HEALTH REP, V119, P464, DOI 10.1016/j.phr.2004.07.003; Harris JK, 2007, PUBLIC HEALTH REP, V122, P488, DOI 10.1177/003335490712200410; Hunter JC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-680; Larson RC, 2006, INTERFACES, V36, P486, DOI 10.1287/inte.1060.0250; Lurie N, 2006, HEALTH AFFAIR, V25, P935, DOI 10.1377/hlthaff.25.4.935; March JG, 1991, ORGAN SCI, V2, P1, DOI 10.1287/orsc.2.1.1; Mays GP, 2010, MILBANK Q, V88, P81, DOI 10.1111/j.1468-0009.2010.00590.x; Mays GP, 2009, AM J PREV MED, V36, P256, DOI 10.1016/j.amepre.2008.11.008; Mays GR, 2004, AM J PUBLIC HEALTH, V94, P1019, DOI 10.2105/AJPH.94.6.1019; *NACCHO, 2012, LHD BUDG CUTS JOB LO; *NACCHO, 2010, NAT PROF LOC HLTH DE; *NAT BIOD SCIENC B, 2011, CALL ACT INCL SCI IN; *NAT WEATH SERV, 2012, US STAT TERR; NELSON C, 2007, ASSESSING PUBLIC HLT, DOI DOI 10.1146/ANNUREV.PUBLHEALTH.28.021406.144054; Nelson Christopher, 2007, Am J Public Health, V97 Suppl 1, pS9, DOI 10.2105/AJPH.2007.114496; Nelson CD, 2010, HEALTH AFFAIR, V29, P2286, DOI 10.1377/hlthaff.2010.0189; Pisati M., 2007, SPMAP STATA MODULE V; ROCHLIN GI, 1987, NAVAL WAR COLL REV; Savoia E, 2012, INT J ENV RES PUB HE, V9, P2949, DOI 10.3390/ijerph9082949; STOTO M, 2013, FRONTIERS PUBLIC HLT, V2; STOTO M, 2005, LEARNING EXPERIENCE; Stoto M, 2013, J PUBLIC HEALTH MAN, V19, pS16, DOI 10.1097/PHH.0b013e318294b0e3; Thompson J.D., 2003, ORG ACTION SOCIAL SC; *US CDCP, CDC EM PREP RESP SIT	31	7	7	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79457	10.1371/journal.pone.0079457	http://dx.doi.org/10.1371/journal.pone.0079457			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236137	Green Published, gold			2022-12-27	WOS:000327254700136
J	Park, B; Park, J; Jun, JK				Park, Boyoung; Park, Jonghan; Jun, Jae Kwan			Cognitive Impairment, Depression, Comorbidity of the Two and Associated Factors among the Early Sixties in a Rural Korean Community	PLOS ONE			English	Article							MENTAL-STATE-EXAMINATION; LATE-LIFE DEPRESSION; RISK-FACTORS; GERIATRIC DEPRESSION; NONWESTERN SOCIETY; GENDER-DIFFERENCES; OLDER-ADULTS; FOLLOW-UP; SYMPTOMS; HEALTH	This study was conducted to investigate the prevalence of cognitive impairment, depression, and comorbidity of the two conditions and related factors in subjects aged in early 60s. This cross-sectional study included 3,174 inhabitants aged 60-64 years old in a rural area of Korea. Cognitive function was evaluated by the Korean version of the Mini-Mental State Examination (MMSE-K), and depression was measured using the short form of the Geriatric Depression Scale (GDS-15). The overall prevalence of cognitive impairment (MMSE-K <= 24) was 17.4%, that of depression was 26.0% (GDS-15 >= 8), and the comorbidity was 7.1%. Female gender, living with one housemate, and high GDS-15 score were significantly associated with increased cognitive impairment. Employment status and more years of schooling were associated with a decreased probability of cognitive impairment. Increased depression was significantly associated with bereavement and receiving benefits from the Medical Aid Program. Employed status, more years of schooling, and higher MMSE-K scores were significantly associated with decreased depression. The risk of comorbidity was associated with bereavement and receipt of Medical Aid benefits (odds ratio[OR], 1.85; 95% confidence interval[CI], 1.26-2.71; OR, 5.02; 95% CI, 2.37-10.63; respectively). Employment and more years of schooling were associated with a lower risk of comorbidity (OR, 0.46; 95% CI, 0.34-0.62, P-trend <0.01). The correlated factors for cognitive impairment, depression, and comorbidity of the two conditions were similar, and employment status and years of schooling were associated with all three conditions.	[Park, Boyoung; Jun, Jae Kwan] Natl Canc Ctr, Natl Canc Control Inst, Goyang, South Korea; [Park, Jonghan] Catholic Univ Daegu, Dept Psychiat, Taegu, South Korea	National Cancer Center - Korea (NCC); Catholic University of Daegu	Park, B (corresponding author), Natl Canc Ctr, Natl Canc Control Inst, Goyang, South Korea.	hayejine@ncc.re.kr						Anstey KJ, 2008, DEMENT GERIATR COGN, V26, P226, DOI 10.1159/000154646; Appenzeller S, 2009, ARTHRIT RHEUM-ARTHR, V61, P680, DOI 10.1002/art.24346; Azad NA, 2007, GENDER MED, V4, P120, DOI 10.1016/S1550-8579(07)80026-X; Bac JN, 2004, J PSYCHOSOM RES, V57, P297, DOI 10.1016/j.jpsychores.2004.01.004; Burns A, 2001, BRIT MED J, V322, P789, DOI 10.1136/bmj.322.7289.789; Chang-Quan H, 2010, INT J PSYCHIAT MED, V40, P109, DOI 10.2190/PM.40.1.i; Cherbuin N, 2009, DEMENT GERIATR COGN, V28, P47, DOI 10.1159/000229025; Cho M. J., 1999, J KOREAN NEUROPSYCHI, V38, P48; Cho MJ, 2011, J KOREAN MED SCI, V26, P1, DOI 10.3346/jkms.2011.26.1.1; Cole MG, 2003, AM J PSYCHIAT, V160, P1147, DOI 10.1176/appi.ajp.160.6.1147; Dening T, 2004, J BR MENOPAUSE SOC, V10, P64; Dening Tom, 2004, J Br Menopause Soc, V10, P49, DOI 10.1258/136218004774202346; Everson-Rose SA, 2003, AM J EPIDEMIOL, V158, P1083, DOI 10.1093/aje/kwg263; Fratiglioni L, 2007, J ALZHEIMERS DIS, V12, P11; Ganguli M, 1999, INT J GERIATR PSYCH, V14, P807, DOI 10.1002/(SICI)1099-1166(199910)14:10<807::AID-GPS31>3.0.CO;2-#; Glei DA, 2005, INT J EPIDEMIOL, V34, P864, DOI 10.1093/ije/dyi049; Ho SC, 2001, INT J EPIDEMIOL, V30, P1389, DOI 10.1093/ije/30.6.1389; Hohman TJ, 2011, J AM GERIATR SOC, V59, P1908, DOI 10.1111/j.1532-5415.2011.03589.x; Jeon GS, 2007, J GERONTOL B-PSYCHOL, V62, pS323, DOI 10.1093/geronb/62.5.S323; Kumar R, 2005, DEMENT GERIATR COGN, V19, P67, DOI 10.1159/000082351; Kumar R, 2006, INT PSYCHOGERIATR, V18, P471, DOI 10.1017/S1041610205003005; Lee Y, 2005, INT J GERIATR PSYCH, V20, P576, DOI 10.1002/gps.1313; Millan-Calenti JC, 2011, INT J GERIATR PSYCH, V26, P1071, DOI 10.1002/gps.2646; Panza F, 2010, AM J GERIAT PSYCHIAT, V18, P98, DOI 10.1097/JGP.0b013e3181b0fa13; PARK JH, 1990, INT J GERIATR PSYCH, V5, P381, DOI 10.1002/gps.930050606; PARK JH, 1991, INT J GERIATR PSYCH, V6, P875, DOI 10.1002/gps.930061208; Qiu CX, 2007, CURR OPIN PSYCHIATR, V20, P380, DOI 10.1097/YCO.0b013e32816ebc7b; Raji MA, 2007, J GERIATR PSYCH NEUR, V20, P145, DOI 10.1177/0891988707303604; Rautio N, INT J SOC PSYCHIAT; REIFLER BV, 1982, AM J PSYCHIAT, V139, P623; Shin Hee-Young, 2005, J Prev Med Public Health, V38, P351; St John PD, 2006, INT J GERIATR PSYCH, V21, P1175, DOI 10.1002/gps.1637; Steffens DC, 2008, PSYCHOL MED, V38, P163, DOI 10.1017/S003329170700102X; Stewart R, 2003, INT PSYCHOGERIATR, V15, P27, DOI 10.1017/S1041610203008731; Vinkers DJ, 2004, BRIT MED J, V329, P881, DOI 10.1136/bmj.38216.604664.DE; Whooley MA, 2002, ARCH INTERN MED, V162, P2614, DOI 10.1001/archinte.162.22.2614	36	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79460	10.1371/journal.pone.0079460	http://dx.doi.org/10.1371/journal.pone.0079460			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24236138	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700137
J	Anchala, R; Di Angelantonio, E; Prabhakaran, D; Franco, OH				Anchala, Raghupathy; Di Angelantonio, Emanuele; Prabhakaran, Dorairaj; Franco, Oscar H.			Development and Validation of a Clinical and Computerised Decision Support System for Management of Hypertension (DSS-HTN) at a Primary Health Care (PHC) Setting	PLOS ONE			English	Article							PREVENTION; DISEASE; BURDEN	Background: Hypertension remains the top global cause of disease burden. Decision support systems (DSS) could provide an adequate and cost-effective means to improve the management of hypertension at a primary health care (PHC) level in a developing country, nevertheless evidence on this regard is rather limited. Methods: Development of DSS software was based on an algorithmic approach for (a) evaluation of a hypertensive patient, (b) risk stratification (c) drug management and (d) lifestyle interventions, based on Indian guidelines for hypertension II (2007). The beta testing of DSS software involved a feedback from the end users of the system on the contents of the user interface. Software validation and piloting was done in field, wherein the virtual recommendations and advice given by the DSS were compared with two independent experts (government doctors from the non-participating PHC centers). Results: The overall percent agreement between the DSS and independent experts among 60 hypertensives on drug management was 85% (95% CI: 83.61 - 85.25). The kappa statistic for overall agreement for drug management was 0.659 (95% CI: 0.457 - 0.862) indicating a substantial degree of agreement beyond chance at an alpha fixed at 0.05 with 80% power. Receiver operator curve (ROC) showed a good accuracy for the DSS, wherein, the area under curve (AUC) was 0.848 (95% CI: 0.741 - 0.948). Sensitivity and specificity of the DSS were 83.33 and 85.71% respectively when compared with independent experts. Conclusion: A point of care, pilot tested and validated DSS for management of hypertension has been developed in a resource constrained low and middle income setting and could contribute to improved management of hypertension at a primary health care level.	[Anchala, Raghupathy; Di Angelantonio, Emanuele] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Anchala, Raghupathy; Prabhakaran, Dorairaj] Publ Hlth Fdn India, New Delhi, India; [Prabhakaran, Dorairaj] Ctr Chron Dis Control, New Delhi, India; [Franco, Oscar H.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands	University of Cambridge; Public Health Foundation of India; Erasmus University Rotterdam; Erasmus MC	Anchala, R (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England.	ra391@medschl.cam.ac.uk	DiAngelantonio, Emanuele/ABE-6852-2020; Anchala, Raghupathy/AGD-8723-2022; Prabhakaran, Dorairaj/B-4147-2011; Franco, Óscar H/ABE-2305-2020	Anchala, Raghupathy/0000-0003-4733-211X; Prabhakaran, Dorairaj/0000-0002-3172-834X; Franco, Óscar H/0000-0002-4606-4929; Di Angelantonio, Emanuele/0000-0001-8776-6719	Wellcome Trust; consortium of UK universities; MRC [MR/L003120/1] Funding Source: UKRI; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [MR/L003120/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10165] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); consortium of UK universities; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by a Wellcome Trust Capacity Strengthening Strategic Award to the Public Health Foundation of India and a consortium of UK universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anchala R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-393; Anderson JA, 2010, CIN-COMPUT INFORM NU, V28, P353, DOI 10.1097/NCN.0b013e3181f69c5b; CAMPBELL JR, 2003, SAGE GUIDELINE MODEL; CHAEA YM, 2003, CLIN DECISION SUPPOR; Das Shyamal Kumar, 2005, Int J Med Sci, V2, P70; Friedman C.P., 1997, EVALUATION METHODS M, P41; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; Goldstein MK, 2008, CURR HYPERTENS REP, V10, P201, DOI 10.1007/s11906-008-0038-6; Goldstein MK, 2000, J AM MED INFORM ASSN, P300; Gupta R, 2004, J HUM HYPERTENS, V18, P73, DOI 10.1038/sj.jhh.1001633; Indrayan A, 1997, Indian Heart J, V49, P337; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kim HY, 2010, STUD HEALTH TECHNOL, V160, P1140, DOI 10.3233/978-1-60750-588-4-1140; Leeder SR, 2004, CHALLENGE CARDIOVASC; LIN D, 2012, ICSICT DIG TECH PAPE, P1, DOI DOI 10.1109/VETECS.2012.6239914; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mackay J, 2004, ATLAS HEART DIS STRO; Martins S B, 2006, AMIA Annu Symp Proc, P539; Miller RA, 1996, J AM MED INFORM ASSN, V3, P429, DOI 10.1136/jamia.1996.97084516; Persson M, 2000, J INTERN MED, V247, P87, DOI 10.1046/j.1365-2796.2000.00581.x; Reddy KS, 2005, LANCET, V366, P1744, DOI [10.1016/s0140-6736(05)67343-6, 10.1016/S0140-6736(05)67343-6]; Ru SW, 2007, J AM MED INFORM ASSN, V14, P589, DOI 10.1197/jamia.M2399; Seroussi B, 2004, STUD HEALTH TECHNOL, V101, P142; Shojania KG, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001096.pub2; Thankappan K R, 2006, Indian Heart J, V58, P28; 2007, IND HYP GUID 2	26	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79638	10.1371/journal.pone.0079638	http://dx.doi.org/10.1371/journal.pone.0079638			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223984	Green Published, gold, Green Submitted			2022-12-27	WOS:000326597400077
J	Simon, O; Williams, T; Cerutti, M; Caballero, P; Lopez-Ferber, M				Simon, Oihane; Williams, Trevor; Cerutti, Martine; Caballero, Primitivo; Lopez-Ferber, Miguel			Expression of a Peroral Infection Factor Determines Pathogenicity and Population Structure in an Insect Virus	PLOS ONE			English	Article							JUVENILE-HORMONE ESTERASE; PER-OS INFECTIVITY; RECOMBINANT BACULOVIRUS; GENETIC-STRUCTURE; P10 PROTEIN; NUCLEOPOLYHEDROVIRUS; GENOTYPES; DELETION; PIF; PROMOTER	A Nicaraguan isolate of Spodoptera frugiperda multiple nucleopolyhedrovirus is being studied as a possible biological insecticide. This virus exists as a mixture of complete and deletion genotypes; the latter depend on the former for the production of an essential per os transmission factor (pif1) in coinfected cells. We hypothesized that the virus population was structured to account for the prevalence of pif1 defector genotypes, so that increasing the abundance of pif1 produced by a cooperator genotype in infected cells would favor an increased prevalence of the defector genotype. We tested this hypothesis using recombinant viruses with pif1 expression reprogrammed at its native locus using two exogenous promoters (egt, p10) in the pif2/pif1 intergenic region. Reprogrammed viruses killed their hosts markedly faster than the wild-type and rescue viruses, possibly due to an earlier onset of systemic infection. Group success (transmission) depended on expression of pif1, but overexpression was prejudicial to group-specific transmissibility, both in terms of reduced pathogenicity and reduced production of virus progeny from each infected insect. The presence of pif1-overproducing genotypes in the population was predicted to favor a shift in the prevalence of defector genotypes lacking pif1-expressing capabilities, to compensate for the modification in pif1 availability at the population level. As a result, defectors increased the overall pathogenicity of the virus population by diluting pif1 produced by overexpressing genotypes. These results offer a new and unexpected perspective on cooperative behavior between viral genomes in response to the abundance of an essential public good that is detrimental in excess.	[Simon, Oihane; Caballero, Primitivo] Consejo Super Invest Cient Gobierno Navarra, Inst Agrobiotecnol, Navarra, Spain; [Williams, Trevor] Inst Ecol AC, Xalapa, Veracruz, Mexico; [Cerutti, Martine] CNRS, Lab Baculovirus & Therapie, St Christol Les Ales, France; [Caballero, Primitivo] Univ Publ Navarra, Dept Agr Prod, Pamplona, Spain; [Lopez-Ferber, Miguel] Ecole Mines Ales, Lab Genie Environm Ind, Ales, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-GN-UPNA - Instituto de Agrobiotecnologia (IDAB); Instituto de Ecologia - Mexico; Centre National de la Recherche Scientifique (CNRS); Universidad Publica de Navarra; IMT - Institut Mines-Telecom; IMT Mines Ales	Lopez-Ferber, M (corresponding author), Ecole Mines Ales, Lab Genie Environm Ind, Ales, France.	miguel.lopez-ferber@mines-ales.fr	Simon, Oihane/G-5703-2014; Lopez-Ferber, Miguel/F-5465-2012; Williams, Trevor/ABG-3961-2020; Caballero, Primitivo/D-5063-2009; Williams, Trevor/F-1447-2011; GUO, Zhaoyu/AAS-5699-2020; Williams, Trevor/J-4239-2013	Simon, Oihane/0000-0003-1239-1486; Lopez-Ferber, Miguel/0000-0002-3850-1703; Caballero, Primitivo/0000-0003-0065-9625; Williams, Trevor/0000-0003-3414-3440; Williams, Trevor/0000-0003-3414-3440	Spanish Ministry for Science and Technology [AGL2005-07909-CO3-01, AGL2008-05456-CO3-01/AGR]; Jose Castillejo grant for postdoctoral mobility	Spanish Ministry for Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Jose Castillejo grant for postdoctoral mobility	This study received financial support from the Spanish Ministry for Science and Technology projects AGL2005-07909-CO3-01 and AGL2008-05456-CO3-01/AGR. O.S. received a Jose Castillejo grant for postdoctoral mobility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BONNING BC, 1995, ARCH INSECT BIOCHEM, V30, P177, DOI 10.1002/arch.940300208; BONNING BC, 1994, J GEN VIROL, V75, P1551, DOI 10.1099/0022-1317-75-7-1551; Bull JC, 2001, APPL ENVIRON MICROB, V67, P5204, DOI 10.1128/AEM.67.11.5204-5209.2001; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caballero P, 2009, REV COLOMB ENTOMOL, V35, P105; Clavijo G, 2010, P ROY SOC B-BIOL SCI, V277, P943, DOI 10.1098/rspb.2009.1838; Clavijo G, 2009, J VIROL, V83, P5127, DOI 10.1128/JVI.02020-08; Cory JS, 2005, J INVERTEBR PATHOL, V89, P101, DOI 10.1016/j.jip.2005.03.008; Crawley M.J., 1993, GLIM ECOLOGISTS; Evans OP, 1999, J GEN VIROL, V80, P485, DOI 10.1099/0022-1317-80-2-485; Frank SA, 2010, J EVOLUTION BIOL, V23, P1245, DOI 10.1111/j.1420-9101.2010.01986.x; Gore J, 2009, NATURE, V459, P253, DOI 10.1038/nature07921; GREENE GL, 1976, J ECON ENTOMOL, V69, P487, DOI 10.1093/jee/69.4.487; Gutierrez S, 2005, J BIOTECHNOL, V116, P135, DOI 10.1016/j.jbiotec.2004.10.007; Gutierrez S, 2004, J GEN VIROL, V85, P331, DOI 10.1099/vir.0.19623-0; HAMMOCK BD, 1990, NATURE, V344, P458, DOI 10.1038/344458a0; Hauert C, 2006, P R SOC B, V273, P2565, DOI 10.1098/rspb.2006.3600; Hernandez-Crespo P, 2001, APPL ENVIRON MICROB, V67, P1140, DOI 10.1128/AEM.67.3.1140-1146.2001; Hodgson DJ, 2004, J EVOLUTION BIOL, V17, P1018, DOI 10.1111/j.1420-9101.2004.00750.x; Hodgson DJ, 2001, EVOL ECOL RES, V3, P687; Hodgson JJ, 2007, J GEN VIROL, V88, P2479, DOI 10.1099/vir.0.82863-0; HORTON HM, 1993, J VIROL, V67, P1860, DOI 10.1128/JVI.67.4.1860-1868.1993; Hughes PR, 1987, BIOL BACULOVIRUSES, P1; IJkel WFJ, 1999, J GEN VIROL, V80, P3289, DOI 10.1099/0022-1317-80-12-3289; Kikhno I, 2002, J GEN VIROL, V83, P3013, DOI 10.1099/0022-1317-83-12-3013; KnebelMorsdorf D, 1996, J GEN VIROL, V77, P815, DOI 10.1099/0022-1317-77-5-815; LeOra Software, 1987, POL PC US GUID PROB; Lopez-Ferber M, 2003, P ROY SOC B-BIOL SCI, V270, P2249, DOI 10.1098/rspb.2003.2498; LYNN DE, 1992, BIOTECHNIQUES, V13, P282; MacLean RC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000486; MAEDA S, 1989, ANNU REV ENTOMOL, V34, P351, DOI 10.1146/annurev.en.34.010189.002031; McNeil J, 2010, J GEN VIROL, V91, P1590, DOI 10.1099/vir.0.018952-0; Moscardi F, 1999, ANNU REV ENTOMOL, V44, P257, DOI 10.1146/annurev.ento.44.1.257; Ohkawa T, 2005, J VIROL, V79, P15258, DOI 10.1128/JVI.79.24.15258-15264.2005; OREILLY DR, 1990, J VIROL, V64, P1321, DOI 10.1128/JVI.64.3.1321-1328.1990; OREILLY DR, 1991, BIO-TECHNOL, V9, P1086, DOI 10.1038/nbt1191-1086; Peng K, 2012, J VIROL, V86, P4981, DOI 10.1128/JVI.06801-11; Peng K, 2010, J VIROL, V84, P9497, DOI 10.1128/JVI.00812-10; Simon O, 2006, P ROY SOC B-BIOL SCI, V273, P783, DOI 10.1098/rspb.2005.3394; Simon O, 2005, APPL ENVIRON MICROB, V71, P4254, DOI 10.1128/AEM.71.8.4254-4262.2005; Simon O, 2004, APPL ENVIRON MICROB, V70, P5579, DOI 10.1128/AEM.70.9.5579-5588.2004; Simon O, 2008, BIOL CONTROL, V44, P321, DOI 10.1016/j.biocontrol.2007.12.005; Simon O, 2011, J INVERTEBR PATHOL, V107, P33, DOI 10.1016/j.jip.2011.01.002; STEWART LMD, 1991, NATURE, V352, P85, DOI 10.1038/352085a0; TOMALSKI MD, 1991, NATURE, V352, P82, DOI 10.1038/352082a0; VANOERS MM, 1993, J GEN VIROL, V74, P563, DOI 10.1099/0022-1317-74-4-563; Washburn JO, 2003, J VIROL, V77, P280, DOI 10.1128/JVI.77.1.280-290.2003; Washburn JO, 1999, J VIROL, V73, P411, DOI 10.1128/JVI.73.1.411-416.1999; WEYER U, 1989, J GEN VIROL, V70, P203, DOI 10.1099/0022-1317-70-1-203	51	18	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78834	10.1371/journal.pone.0078834	http://dx.doi.org/10.1371/journal.pone.0078834			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24223853	gold, Green Published, Green Submitted			2022-12-27	WOS:000326597400040
J	Connes, P; Lamarre, Y; Hardy-Dessources, MD; Lemonne, N; Waltz, X; Mougenel, D; Mukisi-Mukaza, M; Lalanne-Mistrih, ML; Tarer, V; Tressieres, B; Etienne-Julan, M; Romana, M				Connes, Philippe; Lamarre, Yann; Hardy-Dessources, Marie-Dominique; Lemonne, Nathalie; Waltz, Xavier; Mougenel, Daniele; Mukisi-Mukaza, Martin; Lalanne-Mistrih, Marie-Laure; Tarer, Vanessa; Tressieres, Benoit; Etienne-Julan, Maryse; Romana, Marc			Decreased Hematocrit-To-Viscosity Ratio and Increased Lactate Dehydrogenase Level in Patients with Sickle Cell Anemia and Recurrent Leg Ulcers	PLOS ONE			English	Article							CLINICAL-MANIFESTATIONS; BLOOD RHEOLOGY; HEMOLYSIS; DISEASE; TRANSFUSION; RISK	Leg ulcer is a disabling complication in patients with sickle cell anemia (SCA) but the exact pathophysiological mechanisms are unknown. The aim of this study was to identify the hematological and hemorheological alterations associated with recurrent leg ulcers. Sixty-two SCA patients who never experienced leg ulcers (ULC-) and 13 SCA patients with a positive history of recurrent leg ulcers (ULC+) - but with no leg ulcers at the time of the study - were recruited. All patients were in steady state condition. Blood was sampled to perform hematological, biochemical (hemolytic markers) and hemorheological analyses (blood viscosity, red blood cell deformability and aggregation properties). The hematocrit-to-viscosity ratio (HVR), which reflects the red blood cell oxygen transport efficiency, was calculated for each subject. Patients from the ULC+ group were older than patients from the ULC- group. Anemia (red blood cell count, hematocrit and hemoglobin levels) was more pronounced in the ULC+ group. Lactate dehydrogenase level was higher in the ULC+ group than in the ULC-group. Neither blood viscosity, nor RBC aggregation properties differed between the two groups. HVR was lower and RBC deformability tended to be reduced in the ULC+ group. Our study confirmed increased hemolytic rate and anemia in SCA patients with leg ulcers recurrence. Furthermore, our data suggest that although systemic blood viscosity is not a major factor involved in the pathophysiology of this complication, decreased red blood cell oxygen transport efficiency (i.e., low hematocrit/viscosity ratio) may play a role.	[Connes, Philippe; Lamarre, Yann; Hardy-Dessources, Marie-Dominique; Waltz, Xavier; Lalanne-Mistrih, Marie-Laure; Romana, Marc] Univ Antilles Guyane, UMR Inserm 665, Pointe A Pitre, Guadeloupe, France; [Connes, Philippe; Lamarre, Yann; Hardy-Dessources, Marie-Dominique; Waltz, Xavier; Romana, Marc] PRES Sorbonne Paris Cite, Lab Excellence GR Ex Red Cell Genesis Death, Paris, France; [Connes, Philippe] Univ Antilles Guyane, Dept Physiol, Lab ACTES, EA 3596, Pointe A Pitre, Guadeloupe, France; [Lemonne, Nathalie; Mougenel, Daniele; Mukisi-Mukaza, Martin; Etienne-Julan, Maryse] Ctr Hosp, Unite Transversale Drepanocytose, Pointe A Pitre, Guadeloupe, France; [Lemonne, Nathalie; Mougenel, Daniele; Mukisi-Mukaza, Martin; Tarer, Vanessa; Etienne-Julan, Maryse] Univ Pointe A Pitre, Pointe A Pitre, Guadeloupe, France; [Lalanne-Mistrih, Marie-Laure; Tressieres, Benoit] Ctr Hosp Univ Pointe A Pitre, INSERM, CICEC 802, Pointe A Pitre, Guadeloupe, France; [Tarer, Vanessa; Etienne-Julan, Maryse] Ctr Hosp, Ctr Refrence Malad Rares Drepanocytose Antilles G, Pointe A Pitre, Guadeloupe, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite des Antilles; Universite des Antilles; CHU Guadeloupe; CHU Guadeloupe; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Guadeloupe	Connes, P (corresponding author), Univ Antilles Guyane, UMR Inserm 665, Pointe A Pitre, Guadeloupe, France.	pconnes@yahoo.fr	Romana, Marc/K-6442-2017; , Hardy-dessources/K-9189-2017; Lamarre, Yann/ABC-2074-2020; WALTZ, Xavier/M-3606-2016; Connes, Philippe/J-7835-2019; TRESSIERES, Benoit/ABH-1085-2020	Romana, Marc/0000-0002-8715-9836; , Hardy-dessources/0000-0003-0861-3648; WALTZ, Xavier/0000-0002-0838-290X; Connes, Philippe/0000-0002-9232-0268; ETIENNE-JULAN, Maryse/0000-0003-1339-6545; Lamarre, Yann/0000-0003-0669-793X; Philippe, Connes/0000-0001-8449-7998				Alexy T, 2006, TRANSFUSION, V46, P912, DOI 10.1111/j.1537-2995.2006.00823.x; BALLAS SK, 1989, AM J HEMATOL, V32, P104, DOI 10.1002/ajh.2830320206; Bartolucci P, 2012, BLOOD, V120, P3136, DOI 10.1182/blood-2012-04-424184; Baskurt OK, 2013, CLIN HEMORHEOL MICRO, V53, P23, DOI 10.3233/CH-2012-1573; Baskurt OK, 2009, CLIN HEMORHEOL MICRO, V42, P75, DOI 10.3233/CH-2009-1202; Baskurt OK, 2003, SEMIN THROMB HEMOST, V29, P435; Bowers AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068929; Cumming V, 2008, BRIT J HAEMATOL, V142, P119, DOI 10.1111/j.1365-2141.2008.07115.x; Delaney KMH, 2013, HEMOGLOBIN, V37, P325, DOI 10.3109/03630269.2013.789968; Detterich J, 2013, TRANSFUSION, V53, P297, DOI 10.1111/j.1537-2995.2012.03822.x; DUPUYFONS C, 1995, CLIN HEMORHEOL, V15, P191; Eckman JR, 1996, HEMATOL ONCOL CLIN N, V10, P1333, DOI 10.1016/S0889-8588(05)70404-4; Giraldi S, 2003, PEDIATR DERMATOL, V20, P427, DOI 10.1046/j.1525-1470.2003.20512.x; GUERI M, 1970, TROP GEOGR MED, V22, P155; Kato GJ, 2007, BLOOD REV, V21, P37, DOI 10.1016/j.blre.2006.07.001; KOSHY M, 1989, BLOOD, V74, P1403; LAMARRE Y, 2013, CLIN HEMORHEOL MICRO, P4554; Lamarre Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066004; Lemonne N, 2013, BLOOD, V121, P3054, DOI 10.1182/blood-2013-01-480277; Minniti CP, 2014, AM J HEMATOL, V89, P1, DOI 10.1002/ajh.23571; Minniti CP, 2011, AM J HEMATOL, V86, P705, DOI 10.1002/ajh.22065; Minniti Caterina P, 2010, Am J Hematol, V85, P831, DOI 10.1002/ajh.21838; Nolan VG, 2006, BRIT J HAEMATOL, V133, P570, DOI 10.1111/j.1365-2141.2006.06074.x; Nourale M, 2013, HAEMATOLOGICA, V98, P464, DOI 10.3324/haematol.2012.068965; Tan ASC, 2001, BLOOD, V98, P250, DOI 10.1182/blood.V98.1.250; Tarer V, 2006, EUR J HAEMATOL, V76, P193, DOI 10.1111/j.1600-0609.2005.00590.x; Taylor JG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002095; WALTZ X, 2013, CLIN HEMORHEOL MICRO; Wang LM, 2009, J LIPID RES, V50, P204, DOI 10.1194/jlr.M700505-JLR200	29	41	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79680	10.1371/journal.pone.0079680	http://dx.doi.org/10.1371/journal.pone.0079680			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223994	Green Published, gold			2022-12-27	WOS:000326503400138
J	Harada, K; Itoh, H; Kawazoe, Y; Miyazaki, S; Doi, K; Kubo, T; Akagawa, Y; Shiba, T				Harada, Kana; Itoh, Hiromichi; Kawazoe, Yumi; Miyazaki, Shuichi; Doi, Kazuya; Kubo, Takayasu; Akagawa, Yasumasa; Shiba, Toshikazu			Polyphosphate-Mediated Inhibition of Tartrate-Resistant Acid Phosphatase and Suppression of Bone Resorption of Osteoclasts	PLOS ONE			English	Article							INORGANIC POLYPHOSPHATE; IN-VITRO; CELLS; EXOPOLYPHOSPHATASE; ACIDOCALCISOMES; REGENERATION; RECOMBINANT; MODULATION; ACTIVATION; INDUCTION	Inorganic polyphosphate (poly(P)) has recently been found to play an important role in bone formation. In this study, we found that tartrate-resistant acid phosphatase (TRAP), which is abundantly expressed in osteoclasts, has polyphosphatase activity that degrades poly(P) and yields Pi as well as shorter poly(P) chains. Since the TRAP protein that coprecipitated with anti-TRAP monoclonal antibodies exhibited both polyphosphatase and the original phosphatase activity, poly(P) degradation activity is dependent on TRAP and not on other contaminating enzymes. The ferrous chelator alpha, alpha'-bipyridyl, which inhibits the TRAP-mediated production of reactive oxygen species (ROS), had no effect on such poly(P) degradation, suggesting that the degradation is not dependent on ROS. In addition, shorter chain length poly(P) molecules were better substrates than longer chains for TRAP, and poly(P) inhibited the phosphatase activity of TRAP depending on its chain length. The IC50 of poly(P) against the original phosphatase activity of TRAP was 9.8 mu M with an average chain length more than 300 phosphate residues, whereas the IC50 of poly(P) with a shorter average chain length of 15 phosphate residues was 8.3 mM. Finally, the pit formation activity of cultured rat osteoclasts differentiated by RANKL and M-CSF were markedly inhibited by poly(P), while no obvious decrease in cell number or differentiation efficiency was observed for poly(P). In particular, the inhibition of pit formation by long chain poly(P) with 300 phosphate residues was stronger than that of shorter chain poly(P). Thus, poly(P) may play an important regulatory role in osteoclastic bone resorption by inhibiting TRAP activity, which is dependent on its chain length.	[Harada, Kana; Doi, Kazuya; Kubo, Takayasu; Akagawa, Yasumasa] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Adv Prosthodont, Hiroshima, Japan; [Itoh, Hiromichi; Kawazoe, Yumi; Shiba, Toshikazu] Regenetiss Inc, Koganei, Tokyo, Japan; [Miyazaki, Shuichi] YAMASA Corp, Diagnost Dept, Choshi, Chiba, Japan; [Shiba, Toshikazu] Kitasato Univ, Kitasato Inst, Kitasato Inst Life Sci, Tokyo, Japan	Hiroshima University; Kitasato University	Shiba, T (corresponding author), Regenetiss Inc, Koganei, Tokyo, Japan.	shiba@regenetiss.com	Doi, Kazuya/J-6554-2016	Doi, Kazuya/0000-0001-9452-4750	Regenetiss Inc.	Regenetiss Inc.	This work was supported by basic research fund of Regenetiss Inc. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel NZ, 2000, J BONE MINER RES, V15, P103, DOI 10.1359/jbmr.2000.15.1.103; [Anonymous], J BIOL CHEM, V274, P22907; Choi SH, 2011, BLOOD, V118, P6963, DOI 10.1182/blood-2011-07-368811; Ek-Rylander B, 2010, EXP CELL RES, V316, P443, DOI 10.1016/j.yexcr.2009.10.019; EKRYLANDER B, 1994, J BIOL CHEM, V269, P14853; Halleen JM, 2003, J BONE MINER RES, V18, P1908, DOI 10.1359/jbmr.2003.18.10.1908; Halleen JM, 1999, PLOS ONE; Hayman AR, 1996, DEVELOPMENT, V122, P3151; HAYMAN AR, 1994, J BIOL CHEM, V269, P1294; Itoh H, 2006, J MICROBIOL METH, V64, P241, DOI 10.1016/j.mimet.2005.05.003; Janckila AJ, 2009, CALCIFIED TISSUE INT, V85, P465, DOI 10.1007/s00223-009-9309-8; Kawazoe Y, 2004, J DENT RES, V83, P613, DOI 10.1177/154405910408300806; Kawazoe Y, 2008, INT J BIOL SCI, V4, P37, DOI 10.7150/ijbs.4.37; Kumble KD, 1996, J BIOL CHEM, V271, P27146, DOI 10.1074/jbc.271.43.27146; LING P, 1993, J BIOL CHEM, V268, P6896; Ljusberg J, 2005, J BIOL CHEM, V280, P28370, DOI 10.1074/jbc.M502469200; Lorenz B, 2001, BBA-PROTEIN STRUCT M, V1547, P254, DOI 10.1016/S0167-4838(01)00193-5; Lorenz B, 1997, BBA-GEN SUBJECTS, V1335, P51, DOI 10.1016/S0304-4165(96)00121-3; McInerney P, 2006, MOL MICROBIOL, V60, P438, DOI 10.1111/j.1365-2958.2006.05103.x; Miyazaki S, 2001, METHOD FIND EXP CLIN, V23, P433, DOI 10.1358/mf.2001.23.8.662130; MOONGA BS, 1990, J PHYSIOL-LONDON, V429, P29, DOI 10.1113/jphysiol.1990.sp018242; Moreno-Sanchez D, 2012, J BIOL CHEM, V287, P28435, DOI 10.1074/jbc.M112.385823; Morita K, 2010, ACTA BIOMATER, V6, P2808, DOI 10.1016/j.actbio.2009.12.055; Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001; Omelon S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005634; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; Rashid MH, 2000, J BACTERIOL, V182, P225, DOI 10.1128/JB.182.1.225-227.2000; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P9636, DOI 10.1073/pnas.170283397; REINHOLT FP, 1990, J BONE MINER RES, V5, P1055; Ruiz FA, 2004, J BIOL CHEM, V279, P44250, DOI 10.1074/jbc.M406261200; Schroder HC, 2000, BIOCHEMISTRY-MOSCOW+, V65, P296; Shiba T, 2003, J BIOL CHEM, V278, P26788, DOI 10.1074/jbc.M303468200; Shiba T, 2000, BIOCHEMISTRY-MOSCOW+, V65, P315; Smith SA, 2006, P NATL ACAD SCI USA, V103, P903, DOI 10.1073/pnas.0507195103; Smith SA, 2008, BLOOD, V112, P2810, DOI 10.1182/blood-2008-03-145755; Sun PL, 2008, P NATL ACAD SCI USA, V105, P16590, DOI 10.1073/pnas.0807472105; Tammenkoski M, 2008, BIOCHEMISTRY-US, V47, P9707, DOI 10.1021/bi8010847; WURST H, 1995, J BACTERIOL, V177, P898, DOI 10.1128/jb.177.4.898-906.1995; Yuan Q, 2009, ACTA BIOMATER, V5, P1716, DOI 10.1016/j.actbio.2009.01.034; ZAIDI M, 1989, BIOCHEM BIOPH RES CO, V159, P68, DOI 10.1016/0006-291X(89)92405-4	40	30	30	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78612	10.1371/journal.pone.0078612	http://dx.doi.org/10.1371/journal.pone.0078612			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223830	Green Submitted, gold, Green Published			2022-12-27	WOS:000326503400078
J	Yu, S; Yu, YY; Zhao, NQ; Cui, JL; Li, W; Liu, TS				Yu, Shan; Yu, Yiyi; Zhao, Naiqing; Cui, Jianlan; Li, Wei; Liu, Tianshu			c-Met as a Prognostic Marker in Gastric Cancer: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							HEPATOCYTE GROWTH-FACTOR; FACTOR-RECEPTOR; E-CADHERIN; POOR-PROGNOSIS; EXPRESSION; AMPLIFICATION; OVEREXPRESSION; GENE; CARCINOMAS; ACTIVATION	Background: c-Met has been recognized as an important therapeutic target in gastric cancer, but the prognostic property of the c-Met status is still unclear. We aimed to characterize the prognostic effect of c-Met by systematic review and meta-analysis. Methods: We identified 15 studies assessing survival in gastric cancer by c-Met status. Effect measure of interest was hazard ratio (HR) for survival. Meta-regression was performed to estimate the relationship between HR and disease stage. Random-effects meta-analyses were used to account for heterogeneity. Results: 15 eligible studies provided outcome data stratified by c-Met status in 2210 patients. Meta-analysis of the HRs indicated a significantly poorer Os in patients with high c-Met expression (average HR=2.112, 95% CI: 1.622-2.748). Subgroup analysis showed the prognostic effect of c-Met was identical in protein-level and gene-level based methodology. The same effect was also seen in Asian and Western ethnicity subgroup analysis. Meta-regression showed HR was not associated with disease stage. Conclusions: Patients with tumors that harbor high c-Met expression are more likely to have a worse Os, with this prognostic effect independent of disease stage. c-Met status should be evaluated in clinical prognosis.	[Yu, Shan; Yu, Yiyi; Li, Wei; Liu, Tianshu] Fudan Univ, Zhongshan Hosp, Dept Med Oncol, Shanghai 200433, Peoples R China; [Zhao, Naiqing; Cui, Jianlan] Fudan Univ, Dept Biostat, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Liu, TS (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Med Oncol, Shanghai 200433, Peoples R China.	liutianshu1969@126.com			National Natural Science Foundation of China [30972551, 81273187]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is supported by the projects 30972551 and 81273187 from National Natural Science Foundation of China.(www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajani Jaffer A, 2008, J Natl Compr Canc Netw, V6, P813; Amemiya H, 2002, ONCOLOGY-BASEL, V63, P286, DOI 10.1159/000065477; Catenacci DVT, 2011, CANCER BIOL THER, V12, P9, DOI 10.4161/cbt.12.1.15747; Conrotto P, 2005, BLOOD, V105, P4321, DOI 10.1182/blood-2004-07-2885; Drebber U, 2008, ONCOL REP, V19, P1477; Gill S, 2003, J CLIN ONCOL, V21, P2070, DOI 10.1200/JCO.2003.11.054; Goscinski MA, 2009, SCAND J SURG, V98, P214, DOI 10.1177/145749690909800404; Graziano F, 2011, J CLIN ONCOL, V29, P4789, DOI 10.1200/JCO.2011.36.7706; Han SU, 2005, ANN SURG, V242, P676, DOI 10.1097/01.sla.0000186171.85804.fe; Hofmann M, 2008, HISTOPATHOLOGY, V52, P797, DOI 10.1111/j.1365-2559.2008.03028.x; Huang TJ, 2001, ACTA ONCOL, V40, P638; Inoue T, 2004, CANCER SCI, V95, P803, DOI 10.1111/j.1349-7006.2004.tb02185.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim J, 2010, ANN ONCOL, V21, P152, DOI 10.1093/annonc/mdp290; Kubicka S, 2002, DIGEST DIS SCI, V47, P114, DOI 10.1023/A:1013275706401; KUNIYASU H, 1992, BIOCHEM BIOPH RES CO, V189, P227, DOI 10.1016/0006-291X(92)91548-5; Lee HE, 2012, BRIT J CANCER, V107, P325, DOI 10.1038/bjc.2012.237; Lee J, 2011, ONCOL REP, V25, P1517, DOI 10.3892/or.2011.1219; Lennerz JK, 2011, J CLIN ONCOL, V29, P4803, DOI 10.1200/JCO.2011.35.4928; Li Y, 2012, J SURG ONCOL, V106, P304, DOI 10.1002/jso.23008; Nakajima M, 1999, CANCER, V85, P1894; Oliner KS, 2012, J CLIN ONCOL, V30; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Retterspitz MF, 2010, ANTICANCER RES, V30, P4635; Shi J, 2012, INT J MOL SCI, V13, P4714, DOI 10.3390/ijms13044714; Tang ZB, 2004, ONCOL REP, V11, P333; Taniguchi K, 1998, CANCER, V82, P2112, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2112::AID-CNCR5>3.3.CO;2-U; Toiyama Y, 2012, INT J CANCER, V130, P2912, DOI 10.1002/ijc.26330; Tsugawa K, 1998, ONCOLOGY-BASEL, V55, P475, DOI 10.1159/000011898; Wu CW, 1998, ONCOL REP, V5, P817; Yi S, 2000, NEOPLASIA, V2, P226, DOI 10.1038/sj.neo.7900080; Yonemura Y, 1997, ONCOL REP, V4, P743; Zhao J, 2011, HISTOL HISTOPATHOL, V26, P1111, DOI 10.14670/HH-26.1111	33	61	63	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e79137	10.1371/journal.pone.0079137	http://dx.doi.org/10.1371/journal.pone.0079137			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24223894	gold, Green Submitted, Green Published			2022-12-27	WOS:000326503400098
J	Adams, RI; Miletto, M; Taylor, JW; Bruns, TD				Adams, Rachel I.; Miletto, Marzia; Taylor, John W.; Bruns, Thomas D.			The Diversity and Distribution of Fungi on Residential Surfaces	PLOS ONE			English	Article							QUANTITATIVE PCR; BACTERIAL; AIRBORNE; COMMUNITY; WORLD; DUST	The predominant hypothesis regarding the composition of microbial assemblages in indoor environments is that fungal assemblages are structured by outdoor air with a moderate contribution by surface growth, whereas indoor bacterial assemblages represent a mixture of bacteria entered from outdoor air, shed by building inhabitants, and grown on surfaces. To test the fungal aspect of this hypothesis, we sampled fungi from three surface types likely to support growth and therefore possible contributors of fungi to indoor air: drains in kitchens and bathrooms, sills beneath condensation-prone windows, and skin of human inhabitants. Sampling was done in replicated units of a university-housing complex without reported mold problems, and sequences were analyzed using both QIIME and the new UPARSE approach to OTU-binning, to the same result. Surfaces demonstrated a mycological profile similar to that of outdoor air from the same locality, and assemblages clustered by surface type. "Weedy" genera typical of indoor air, such as Cladosporium and Cryptococcus, were abundant on sills, as were a diverse set of fungi of likely outdoor origin. Drains supported more depauperate assemblages than the other surfaces and contained thermotolerant genera such as Exophiala, Candida, and Fusarium. Most surprising was the composition detected on residents' foreheads. In addition to harboring Malassezia, a known human commensal, skin also possessed a surprising richness of non-resident fungi, including plant pathogens such as ergot (Claviceps purperea). Overall, fungal richness across indoor surfaces was high, but based on known autecologies, most of these fungi were unlikely to be growing on surfaces. We conclude that while some endogenous fungal growth on typical household surfaces does occur, particularly on drains and skin, all residential surfaces appear - to varying degrees - to be passive collectors of airborne fungi of putative outdoor origin, a view of the origins of the indoor microbiome quite different from bacteria.	[Adams, Rachel I.; Miletto, Marzia; Taylor, John W.; Bruns, Thomas D.] Univ Calif Berkeley, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Adams, RI (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.	adamsri@berkeley.edu		Adams, Rachel/0000-0003-4499-5743	Alfred P. Sloan Foundation [2010-10-03]	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	This work was funded with a grant from the Alfred P. Sloan Foundation (http://www.sloan.org), grant number 2010-10-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Abe N, 2011, BIOCONTROL SCI, V16, P139, DOI 10.4265/bio.16.139; Adams Rachel I, 2013, Microb Ecol, V66, P735, DOI 10.1007/s00248-013-0266-4; Adams RI, 2013, ISME J, V7, P1262, DOI 10.1038/ismej.2013.28; Akbari H, 2009, CLIMATIC CHANGE, V94, P275, DOI 10.1007/s10584-008-9515-9; Amend AS, 2010, P NATL ACAD SCI USA, V107, P13748, DOI 10.1073/pnas.1000454107; Anaissie EJ, 2003, BLOOD, V101, P2542, DOI 10.1182/blood-2002-02-0530; Andersen B, 2011, APPL ENVIRON MICROB, V77, P4180, DOI 10.1128/AEM.02513-10; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Ara Katsutoshi, 2004, Allergology International, V53, P369, DOI 10.1111/j.1440-1592.2004.00356.x; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Breitenbach M, 2008, INT ARCH ALLERGY IMM, V145, P58, DOI 10.1159/000107578; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chang DC, 2006, JAMA-J AM MED ASSOC, V296, P953, DOI 10.1001/jama.296.8.953; Dunn RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064133; Edgar RC, 2013, NAT METHODS ADV; Edgar RC, 2013, UPARSE PIPELINE; Fierer N, 2008, APPL ENVIRON MICROB, V74, P200, DOI 10.1128/AEM.01467-07; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Fisher AJ, 2007, PLANT DIS, V91, P380, DOI 10.1094/PDIS-91-4-0380; Flores GE, 2013, ENVIRON MICROBIOL, V15, P588, DOI 10.1111/1462-2920.12036; Flores GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028132; Fujimura KE, 2010, J ALLERGY CLIN IMMUN, V126, DOI 10.1016/j.jaci.2010.05.042; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Hamada N, 2010, BIOCONTROL SCI, V15, P51, DOI 10.4265/bio.15.51; Hamada N, 2009, MYCOSCIENCE, V50, P421, DOI 10.1007/s10267-009-0500-6; Hewitt KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037849; Horner WE, 2004, APPL ENVIRON MICROB, V70, P6394, DOI 10.1128/AEM.70.11.6394-6400.2004; Hospodsky D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034867; Huffnagle GB, 2013, TRENDS MICROBIOL, V21, P334, DOI 10.1016/j.tim.2013.04.002; Karvala K, 2010, INT ARCH OCC ENV HEA, V83, P855, DOI 10.1007/s00420-010-0507-5; Klepeis NE, 2001, J EXPO ANAL ENV EPID, V11, P231, DOI 10.1038/sj.jea.7500165; Kuczynski J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-210; Kuhn DM, 2003, CLIN MICROBIOL REV, V16, P144, DOI 10.1128/CMR.16.1.144-172.2003; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; McManus CJ, 2005, J APPL MICROBIOL, V99, P502, DOI 10.1111/j.1365-2672.2005.02651.x; Meadow JF, 2014, INDOOR AIR, V24, P41, DOI 10.1111/ina.12047; Nonnenmann MW, 2012, J ENVIRON MONITOR, V14, P2038, DOI 10.1039/c2em30229b; OKSANEN J, 2012, R PACKAGE VERSION, V2, P1, DOI DOI 10.3856/V0L41-ISSUEL-FULLTEXT-11; Pitkaranta M, 2008, APPL ENVIRON MICROB, V74, P233, DOI 10.1128/AEM.00692-07; R Development Core Team, 2012, R LANG ENV STAT COMP; Rintala H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-56; SAMSON RA, 2001, MICROORGANISMS HOME, P287, DOI DOI 10.1201/9780203302934; Shelton BG, 2002, APPL ENVIRON MICROB, V68, P1743, DOI 10.1128/AEM.68.4.1743-1753.2002; Short DPG, 2011, J CLIN MICROBIOL, V49, P4264, DOI 10.1128/JCM.05468-11; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Zalar P, 2011, FUNGAL BIOL-UK, V115, P997, DOI 10.1016/j.funbio.2011.04.007; Zhang ES, 2011, MICROBIOL IMMUNOL, V55, P625, DOI 10.1111/j.1348-0421.2011.00364.x; Zhou G, 2000, MOL CELL PROBE, V14, P339, DOI 10.1006/mcpr.2000.0324	52	107	108	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78866	10.1371/journal.pone.0078866	http://dx.doi.org/10.1371/journal.pone.0078866			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	23936296	Green Published, Green Submitted, gold			2022-12-27	WOS:000326499300039
J	Yeh, CB; Hsieh, MJ; Lin, CW; Chiou, HL; Lin, PY; Chen, TY; Yang, SF				Yeh, Chao-Bin; Hsieh, Ming-Ju; Lin, Chiao-Wen; Chiou, Hui-Ling; Lin, Pen-Yuan; Chen, Tzy-Yen; Yang, Shun-Fa			The Antimetastatic Effects of Resveratrol on Hepatocellular Carcinoma through the Downregulation of a Metastasis-Associated Protease by SP-1 Modulation	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR; ORAL-CANCER; SIGNALING PATHWAY; KAPPA-B; EXPRESSION; INVASION; CELLS; INHIBITION; ANGIOGENESIS; APOPTOSIS	Background: The mortality and morbidity rates from cancer metastasis have not declined in Taiwan, especially because of hepatocellular carcinoma (HCC). Resveratrol has been shown to have benefits such as cardioprotection, providing antioxidative, anti-inflammatory, anti-cancer properties in previous studies. Therefore, HCC cells were subjected to treatment with resveratrol and then analyzed to determine the effects of resveratrol on the migration and invasion. Methodology and Principal Findings: Modified Boyden chamber assays revealed that resveratrol treatment significantly inhibited cell migration and invasion capacities of Huh7 cell lines that have low cytotoxicity in vitro, even at a high concentration of 100 mu M. The results of casein zymography and western blotting revealed that the activities and protein levels of the urokinase-type plasminogen activator (u-PA) were inhibited by resveratrol. Western blot analysis also showed that resveratrol inhibits phosphorylation of JNK1/2. Tests of the mRNA level, real-time PCR, and promoter assays evaluated the inhibitory effects of resveratrol on u-PA expression in HCC cells. The chromatin immunoprecipitation (ChIP) assay showed that reactive in transcription protein of nuclear factor SP-1 was inhibited by resveratrol. Conclusions: Resveratrol inhibits u-PA expression and the metastasis of HCC cells and is a powerful chemopreventive agent. The inhibitory effects were associated with the downregulation of the transcription factors of SP-1 signaling pathways.	[Yeh, Chao-Bin; Chen, Tzy-Yen] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Yeh, Chao-Bin] Chung Shan Med Univ, Dept Emergency Med, Taichung, Taiwan; [Yeh, Chao-Bin] Chung Shan Med Univ Hosp, Dept Emergency Med, Taichung, Taiwan; [Hsieh, Ming-Ju; Chiou, Hui-Ling] Chung Shan Med Univ, Sch Med Lab & Biotechnol, Taichung, Taiwan; [Lin, Chiao-Wen] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan; [Lin, Pen-Yuan] Taipei Med Univ, Sch Pharm, Taipei, Taiwan; [Chen, Tzy-Yen] Chung Shan Med Univ Hosp, Dept Internal Med, Taichung, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Taipei Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Chen, TY (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.	cshy042@csh.org.tw; ysf@csmu.edu.tw	Yang, Shun-Fa/AAN-1519-2020; Hsieh, Ming-Ju/GQB-3025-2022	Yang, Shun-Fa/0000-0002-0365-7927; Yeh, Chao-Bin/0000-0002-3978-5576; Ryu, Soojin/0000-0002-7059-0160; Hsieh, Ming-Ju/0000-0001-9726-3234	Chung Shan Medical University Hospital, Taiwan [CSH-2012-C-006]	Chung Shan Medical University Hospital, Taiwan	This study was supported by a research grant from Chung Shan Medical University Hospital, Taiwan (CSH-2012-C-006). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athar M, 2009, ARCH BIOCHEM BIOPHYS, V486, P95, DOI 10.1016/j.abb.2009.01.018; Bae S, 2011, MOL CELLS, V32, P243, DOI 10.1007/s10059-011-1037-z; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chan CF, 2004, CLIN CANCER RES, V10, P4140, DOI 10.1158/1078-0432.CCR-03-0574; Chen TY, 2011, ANN SURG ONCOL, V18, P2348, DOI 10.1245/s10434-011-1574-x; Chien MH, 2012, FOOD CHEM TOXICOL, V50, P558, DOI 10.1016/j.fct.2011.12.016; Fabre KM, 2011, CANCER BIOL THER, V12, P915, DOI 10.4161/cbt.12.10.17714; Freeman MR, 2011, CANCER BIOL THER, V12, P966, DOI 10.4161/cbt.12.11.18136; Gupta SC, 2010, CANCER METAST REV, V29, P405, DOI 10.1007/s10555-010-9235-2; Hsu WH, 2012, J CELL PHYSIOL, V227, P697, DOI 10.1002/jcp.22777; Johnson WD, 2011, FOOD CHEM TOXICOL, V49, P3319, DOI 10.1016/j.fct.2011.08.023; Kundu JK, 2008, CANCER LETT, V269, P243, DOI 10.1016/j.canlet.2008.03.057; Kunimasa K, 2011, MOL NUTR FOOD RES, V55, P1730, DOI 10.1002/mnfr.201100098; Lee MF, 2011, J AGR FOOD CHEM, V59, P11853, DOI 10.1021/jf202426k; Liu M, 2011, COMMUN INTEGR BIOL, P4382; Mohapatra P, 2011, ONCOL RES, V19, P311, DOI 10.3727/096504011X13079697132844; Nam EH, 2012, CARCINOGENESIS, V33, P563, DOI 10.1093/carcin/bgs005; Piotrowska H., 2011, MUTAT RES, V750, P60; Previdi S, 2010, GYNECOL ONCOL, V118, P182, DOI 10.1016/j.ygyno.2010.03.020; Reddy KB, 2003, CANCER METAST REV, V22, P395, DOI 10.1023/A:1023781114568; Roy S, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/703676; Ryu J, 2011, ANTICANCER RES, V31, P4223; Scarlatti F, 2003, FASEB J, V17, P2339, DOI 10.1096/fj.03-0292fje; Szekeres T, 2011, ANN NY ACAD SCI, V1215, P89, DOI 10.1111/j.1749-6632.2010.05864.x; Szekeres T, 2010, PHARM RES-DORDR, V27, P1042, DOI 10.1007/s11095-010-0090-1; Thummarati P, 2012, WORLD J GASTROENTERO, V18, P244, DOI 10.3748/wjg.v18.i3.244; VONDERAHE D, 1988, NUCLEIC ACIDS RES, V16, P7527, DOI 10.1093/nar/16.15.7527; Weng CJ, 2012, CANCER TREAT REV, V38, P76, DOI 10.1016/j.ctrv.2011.03.001; Weng CJ, 2010, ANN SURG ONCOL, V17, P3394, DOI 10.1245/s10434-010-1124-y; Weng CJ, 2009, J AGR FOOD CHEM, V57, P5235, DOI 10.1021/jf900531m; Woo JH, 2004, ONCOGENE, V23, P1845, DOI 10.1038/sj.onc.1207307; Yang SF, 2008, J DENT RES, V87, P401, DOI 10.1177/154405910808700413; Yang SF, 2007, J ETHNOPHARMACOL, V110, P483, DOI 10.1016/j.jep.2006.10.010; Yang SF, 2010, J BIOL CHEM, V285, P29808, DOI 10.1074/jbc.M110.108183; Yang SF, 2010, FOOD CHEM TOXICOL, V48, P1052, DOI 10.1016/j.fct.2010.01.019; Yeh CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031055	36	51	53	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56661	10.1371/journal.pone.0056661	http://dx.doi.org/10.1371/journal.pone.0056661			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	24223943	Green Published, gold			2022-12-27	WOS:000315184200133
J	Brewer, MS; Swafford, L; Spruill, CL; Bond, JE				Brewer, Michael S.; Swafford, Lynn; Spruill, Chad L.; Bond, Jason E.			Arthropod Phylogenetics in Light of Three Novel Millipede (Myriapoda: Diplopoda) Mitochondrial Genomes with Comments on the Appropriateness of Mitochondrial Genome Sequence Data for Inferring Deep Level Relationships	PLOS ONE			English	Article							NUCLEOTIDE COMPOSITION; GENE ORDER; MODEL; EVOLUTION; XYSTODESMIDAE; MITOGENOMICS; POLYDESMIDA; SYMPHYLA; SYNOPSIS; RESOLVE	Background: Arthropods are the most diverse group of eukaryotic organisms, but their phylogenetic relationships are poorly understood. Herein, we describe three mitochondrial genomes representing orders of millipedes for which complete genomes had not been characterized. Newly sequenced genomes are combined with existing data to characterize the protein coding regions of myriapods and to attempt to reconstruct the evolutionary relationships within the Myriapoda and Arthropoda. Results: The newly sequenced genomes are similar to previously characterized millipede sequences in terms of synteny and length. Unique translocations occurred within the newly sequenced taxa, including one half of the Appalachioria falcifera genome, which is inverted with respect to other millipede genomes. Across myriapods, amino acid conservation levels are highly dependent on the gene region. Additionally, individual loci varied in the level of amino acid conservation. Overall, most gene regions showed low levels of conservation at many sites. Attempts to reconstruct the evolutionary relationships suffered from questionable relationships and low support values. Analyses of phylogenetic informativeness show the lack of signal deep in the trees (i.e., genes evolve too quickly). As a result, the myriapod tree resembles previously published results but lacks convincing support, and, within the arthropod tree, well established groups were recovered as polyphyletic. Conclusions: The novel genome sequences described herein provide useful genomic information concerning millipede groups that had not been investigated. Taken together with existing sequences, the variety of compositions and evolution of myriapod mitochondrial genomes are shown to be more complex than previously thought. Unfortunately, the use of mitochondrial protein-coding regions in deep arthropod phylogenetics appears problematic, a result consistent with previously published studies. Lack of phylogenetic signal renders the resulting tree topologies as suspect. As such, these data are likely inappropriate for investigating such ancient relationships.	[Brewer, Michael S.; Swafford, Lynn; Spruill, Chad L.] E Carolina Univ, Dept Biol, Greenville, NC 27858 USA; [Brewer, Michael S.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Brewer, Michael S.] Univ Calif Berkeley, Essig Museum Entomol, Berkeley, CA 94720 USA; [Bond, Jason E.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Bond, Jason E.] Auburn Univ, Museum Nat Hist, Auburn, AL 36849 USA	University of North Carolina; East Carolina University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Auburn University System; Auburn University; Auburn University System; Auburn University	Brewer, MS (corresponding author), E Carolina Univ, Dept Biol, Greenville, NC 27858 USA.	michaelsbrewer@gmail.com	Bond, Jason E./P-1501-2017	Bond, Jason E./0000-0001-6373-3875	National Science Foundation [DEB 05-29715]	National Science Foundation(National Science Foundation (NSF))	This study was supported by the National Science Foundation, DEB 05-29715 (nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Blanquart S, 2008, MOL BIOL EVOL, V25, P842, DOI 10.1093/molbev/msn018; Bond JE, 2002, EVOLUTION, V56, P1123; Boore JL, 1998, CURR OPIN GENET DEV, V8, P668, DOI 10.1016/S0959-437X(98)80035-X; Braband A, 2010, MOL PHYLOGENET EVOL, V57, P285, DOI 10.1016/j.ympev.2010.05.011; Brewer MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037240; Brinkmann H, 2005, SYST BIOL, V54, P743, DOI 10.1080/10635150500234609; Cameron SL, 2004, CLADISTICS, V20, P534, DOI 10.1111/j.1096-0031.2004.00040.x; Chen WJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-246; Curole JP, 1999, TRENDS ECOL EVOL, V14, P394, DOI 10.1016/S0169-5347(99)01660-2; Delsuc F, 2003, SCIENCE, V301, P1482; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Foster PG, 1997, J MOL EVOL, V44, P282, DOI 10.1007/PL00006145; Gai YH, 2008, MOL PHYLOGENET EVOL, V49, P574, DOI 10.1016/j.ympev.2008.08.010; Gibson A, 2005, MOL BIOL EVOL, V22, P251, DOI 10.1093/molbev/msi012; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Hamilton AJ, 2010, AM NAT, V176, P90, DOI 10.1086/652998; Helfenbein KG, 2001, MOL BIOL EVOL, V18, P1734, DOI 10.1093/oxfordjournals.molbev.a003961; Hoffman R.L., 2002, P505; Hwang UW, 2001, NATURE, V413, P154, DOI 10.1038/35093090; Hwang UW, 2001, MOL PHYLOGENET EVOL, V19, P345, DOI 10.1006/mpev.2001.0940; Jones M, 2007, MOL PHYLOGENET EVOL, V43, P583, DOI 10.1016/j.ympev.2006.11.017; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Klimov PB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-598; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lavrov DV, 2000, P NATL ACAD SCI USA, V97, P13738, DOI 10.1073/pnas.250402997; Lavrov DV, 2002, MOL BIOL EVOL, V19, P163, DOI 10.1093/oxfordjournals.molbev.a004068; Lopez-Giraldez F, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-152; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Marek P, 2011, CURR BIOL, V21, pR680, DOI 10.1016/j.cub.2011.08.012; Marek PE, 2007, ZOOTAXA, P27; Marek PE, 2006, MOL PHYLOGENET EVOL, V41, P704, DOI 10.1016/j.ympev.2006.05.043; Marek PE, 2009, P NATL ACAD SCI USA, V106, P9755, DOI 10.1073/pnas.0810408106; Masta SE, 2009, MOL PHYLOGENET EVOL, V50, P117, DOI 10.1016/j.ympev.2008.10.010; Meusemann K, 2010, MOL BIOL EVOL, V27, P2451, DOI 10.1093/molbev/msq130; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Negrisolo E, 2004, MOL BIOL EVOL, V21, P770, DOI 10.1093/molbev/msh078; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Perseke M, 2010, MOL PHYLOGENET EVOL, V56, P201, DOI 10.1016/j.ympev.2010.01.035; Pitz KM, 2010, CLADISTICS, V26, P497, DOI 10.1111/j.1096-0031.2009.00303.x; Podsiadlowski L, 2007, MOL PHYLOGENET EVOL, V45, P251, DOI 10.1016/j.ympev.2007.07.017; Regier JC, 2005, MOL PHYLOGENET EVOL, V34, P147, DOI 10.1016/j.ympev.2004.09.005; Regier JC, 2001, ZOOL J LINN SOC-LOND, V132, P469, DOI 10.1006/zjls.2000.0277; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Regier JC, 2008, SYST BIOL, V57, P920, DOI 10.1080/10635150802570791; Rehm P, 2011, MOL PHYLOGENET EVOL, V61, P880, DOI 10.1016/j.ympev.2011.09.003; Rota-Stabelli O, 2008, MOL PHYLOGENET EVOL, V48, P103, DOI 10.1016/j.ympev.2008.03.033; Rota-Stabelli O, 2011, P ROY SOC B-BIOL SCI, V278, P298, DOI 10.1098/rspb.2010.0590; Rota-Stabelli O, 2010, GENOME BIOL EVOL, V2, P425, DOI 10.1093/gbe/evq030; Saccone C, 2002, GENE, V286, P3, DOI 10.1016/S0378-1119(01)00807-1; Shear William, 2011, Zootaxa, V3148, P159; SHELLEY RM, 1984, CAN J ZOOL, V62, P980, DOI 10.1139/z84-137; Shelley Rowland M., 2005, Fragmenta Faunistica (Warsaw), V48, P137; Sierwald P, 2003, J ZOOL SYST EVOL RES, V41, P87, DOI 10.1046/j.1439-0469.2003.00202.x; Sierwald P, 2007, ANNU REV ENTOMOL, V52, P401, DOI 10.1146/annurev.ento.52.111805.090210; Silvestre D, 2008, GENET MOL BIOL, V31, P451, DOI 10.1590/S1415-47572008000300010; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Spelda J, 2011, ZOOKEYS, P123, DOI 10.3897/zookeys.156.2176; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swafford L, 2009, INVERTEBR SYST, V23, P445, DOI 10.1071/IS09036; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Team RCD, 2009, R LANG ENV STAT COMP; Walker MJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-25; Wesener T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028035; White TR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-295; Woo HJ, 2007, MOL CELLS, V23, P182; Zhang P, 2008, MOL PHYLOGENET EVOL, V49, P586, DOI 10.1016/j.ympev.2008.08.020; Zhang P, 2009, MOL PHYLOGENET EVOL, V53, P492, DOI 10.1016/j.ympev.2009.07.010	71	33	34	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e68005	10.1371/journal.pone.0068005	http://dx.doi.org/10.1371/journal.pone.0068005			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23869209	gold, Green Published, Green Submitted			2022-12-27	WOS:000323110600008
J	Zhou, XY; Barsky, LW; Adams, GB				Zhou, Xiaoying; Barsky, Lora W.; Adams, Gregor B.			Placental Growth Factor Expression Is Required for Bone Marrow Endothelial Cell Support of Primitive Murine Hematopoietic Cells	PLOS ONE			English	Article							STEM-CELL; PROGENITOR CELLS; VASCULAR NICHE; IN-VIVO; THERAPEUTIC NEOVASCULARIZATION; SELF-RENEWAL; TRANSPLANTATION; RECONSTITUTION; TISSUE; MOUSE	Two distinct microenvironmental niches that regulate hematopoietic stem/progenitor cell physiology in the adult bone marrow have been proposed; the endosteal and the vascular niche. While extensive studies have been performed relating to molecular interactions in the endosteal niche, the mechanisms that regulate hematopoietic stem/progenitor cell interaction with bone marrow endothelial cells are less well defined. Here we demonstrate that endothelial cells derived from the bone marrow supported hematopoietic stem/progenitor cells to a higher degree than other endothelial or stromal cell populations. This support was dependant upon placental growth factor expression, as genetic knockdown of mRNA levels reduced the ability of endothelial cells to support hematopoietic stem/progenitor cells in vitro. Furthermore, using an in vivo model of recovery from radiation induced myelosuppression, we demonstrate that bone marrow endothelial cells were able to augment the recovery of the hematopoietic stem/progenitor cells. However, this effect was diminished when the same cells with reduced placental growth factor expression were administered, possibly owing to a reduced homing of the cells to the bone marrow vasculature. Our data suggest that placental growth factor elaborated from bone marrow endothelial cells mediates the regulatory effects of the vascular niche on hematopoietic stem/progenitor cell physiology.	[Zhou, Xiaoying; Barsky, Lora W.; Adams, Gregor B.] Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA	University of Southern California	Adams, GB (corresponding author), Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA.	gregorad@med.usc.edu		Adams, Rachel/0000-0003-4499-5743	California Institute for Regenerative Medicine	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine)	This work was supported by the California Institute for Regenerative Medicine (XZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Benten D, 2005, HEPATOLOGY, V42, P140, DOI 10.1002/hep.20746; Butler JM, 2012, BLOOD, V120, P1344, DOI 10.1182/blood-2011-12-398115; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Cho HJ, 2007, J EXP MED, V204, P3257, DOI 10.1084/jem.20070166; Corada M, 1999, P NATL ACAD SCI USA, V96, P9815, DOI 10.1073/pnas.96.17.9815; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; DUMONT DJ, 1992, ONCOGENE, V7, P1471; Ewing P, 2003, J IMMUNOL METHODS, V283, P307, DOI 10.1016/j.jim.2003.08.004; Feng YM, 2009, BLOOD, V113, P755, DOI 10.1182/blood-2008-06-161794; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; Follenzi A, 2008, J CLIN INVEST, V118, P935, DOI 10.1172/JCI32748; Gerber HP, 2003, J MOL MED, V81, P20, DOI 10.1007/s00109-002-0397-4; Gerber HP, 2002, NATURE, V417, P954, DOI 10.1038/nature00821; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Grassinger J, 2012, CYTOKINE, V58, P218, DOI 10.1016/j.cyto.2012.01.014; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Hattori K, 2002, NAT MED, V8, P841, DOI 10.1038/nm740; Hattori K, 2001, J EXP MED, V193, P1005, DOI 10.1084/jem.193.9.1005; Haylock DN, 2007, STEM CELLS, V25, P1062, DOI 10.1634/stemcells.2006-0528; Himburg HA, 2012, CELL REP, V2, P964, DOI 10.1016/j.celrep.2012.09.002; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kawamoto A, 2001, CIRCULATION, V103, P634; Kawamoto A, 2006, CIRCULATION, V114, P2163, DOI 10.1161/CIRCULATIONAHA.106.644518; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kwon KR, 2010, STEM CELLS, V28, P268, DOI 10.1002/stem.285; LAMBERTSEN RH, 1984, BLOOD, V63, P287; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lammert E, 2003, MECH DEVELOP, V120, P59, DOI 10.1016/S0925-4773(02)00332-5; Larrivee B, 2006, EXP HEMATOL, V34, P1741, DOI 10.1016/j.exphem.2006.08.006; Li WM, 2004, EXP HEMATOL, V32, P1226, DOI 10.1016/j.exphem.2004.09.001; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Marelli-Berg FM, 2000, J IMMUNOL METHODS, V244, P205, DOI 10.1016/S0022-1759(00)00258-1; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Miyamoto Y, 2007, J MOL CELL CARDIOL, V43, P627, DOI 10.1016/j.yjmcc.2007.08.001; Murohara T, 2000, J CLIN INVEST, V105, P1527, DOI 10.1172/JCI8296; PLOEMACHER RE, 1991, BLOOD, V78, P2527; RICKARD DJ, 1994, DEV BIOL, V161, P218, DOI 10.1006/dbio.1994.1022; Salter AB, 2009, BLOOD, V113, P2104, DOI 10.1182/blood-2008-06-162941; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; SPANGRUDE GJ, 1993, BLOOD, V82, P3327; Taichman RS, 1998, STEM CELLS, V16, P7, DOI 10.1002/stem.160007; Timmermans F, 2009, J CELL MOL MED, V13, P87, DOI 10.1111/j.1582-4934.2008.00598.x; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Yan Z, 2013, TRANSPL P, V45, P427, DOI 10.1016/j.transproceed.2012.03.064; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	53	107	108	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e67861	10.1371/journal.pone.0067861	http://dx.doi.org/10.1371/journal.pone.0067861			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	23936296	Green Published, Green Submitted, gold			2022-12-27	WOS:000324545800001
J	Chen, H; Wu, N; Wang, YF; Zhu, D; Zhu, QA; Yang, G; Gao, YH; Fang, XQ; Wang, X; Peng, CH				Chen, Huai; Wu, Ning; Wang, Yanfen; Zhu, Dan; Zhu, Qiu'an; Yang, Gang; Gao, Yongheng; Fang, Xiuqin; Wang, Xu; Peng, Changhui			Inter-Annual Variations of Methane Emission from an Open Fen on the Qinghai-Tibetan Plateau: A Three-Year Study	PLOS ONE			English	Article							NITROUS-OXIDE; EXPERIMENTAL DROUGHT; CARBON-DIOXIDE; SOIL EMISSIONS; ALPINE WETLAND; NITRIC-OXIDE; RICE FIELDS; FLUXES; CLIMATE; CHINA	The study aimed to understand the inter-annual variations of methane (CH4) emissions from an open fen on the Qinghai-Tibetan Plateau (QTP) from 2005 to 2007. The weighted mean CH4 emission rate was 8.37 +/- 11.32 mg CH4 m(-2) h(-1) during the summers from 2005 to 2007, falling in the range of CH4 fluxes reported by other studies, with significant inter-annual and spatial variations. The CH4 emissions of the year of 2006 (2.11 +/- 3.48 mg CH4 m(-2) h(-1)) were 82% lower than the mean value of the years 2005 and 2007 (13.91 +/- 17.80 mg CH4 m(-2) h(-1) and 9.44 +/- 14.32 mg CH4 m(-2) h(-1), respectively), responding to the inter-annual changes of standing water depths during the growing season of the three years. Significant drawdown of standing water depth is believed to cause such significant reduction in CH4 emissions from wetlands in the year 2006, probably through changing the methanogen composition and decreasing its community size as well as activating methanotrophs to enhance CH4 oxidation. Our results are helpful to understand the inter-annual variations of CH4 emission and provide a more reasonable regional budget of CH4 emission from wetlands on the QTP and even for world-wide natural wetlands under climate change.	[Chen, Huai; Wu, Ning; Zhu, Dan] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Peoples R China; [Chen, Huai; Zhu, Qiu'an; Yang, Gang; Peng, Changhui] NW A&F Univ, Lab Ecol Forecasting & Global Change, Coll Forestry, Yangling, Peoples R China; [Wang, Yanfen] Univ Chinese Acad Sci, Beijing, Peoples R China; [Gao, Yongheng] Chinese Acad Sci, Inst Mt Hazards & Environm, Chengdu, Peoples R China; [Fang, Xiuqin; Peng, Changhui] Univ Quebec Montreal, Inst Environm Sci, Montreal, PQ, Canada; [Wang, Xu] Chinese Acad Forestry, Res Inst Trop Forestry, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Northwest A&F University - China; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Mountain Hazards & Environment, CAS; University of Quebec; University of Quebec Montreal; Chinese Academy of Forestry; Research Institute of Tropical Forestry, CAF	Chen, H (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Peoples R China.	chenhuai81@gmail.com; wuning@cib.ac.cn	Chen, Huai/AAI-1024-2020; Wang, Yanfen/C-6889-2013; Furnham, Adrian/ABB-2072-2020; yang, gang/F-9553-2013; Chen, Huai/A-7418-2015; Wang, Yuesi/AAF-3317-2019; Chen, Huai/A-7418-2015	Chen, Huai/0000-0001-7650-289X; Chen, Huai/0000-0001-7650-289X; Chen, Huai/0000-0001-6208-1481; wang, yan fen/0000-0001-5666-9289; Yang, Gang/0000-0003-2576-013X	National Natural Science Foundation of China [31100348]; Natural Science Foundation Project of CQ CSTC [2009BB7182]; Natural Sciences and Engineering Research Council of Canada (NSERC); China QianRen programme	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of CQ CSTC(Natural Science Foundation Project of CQ CSTC); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); China QianRen programme	This study was supported by the National Natural Science Foundation of China (No. 31100348), Natural Science Foundation Project of CQ CSTC (2009BB7182), Natural Sciences and Engineering Research Council of Canada (NSERC) discovery grant, and the China QianRen programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai ZC, 2000, J GEOPHYS RES-ATMOS, V105, P17231, DOI 10.1029/2000JD900014; Chen H, 2009, SCI TOTAL ENVIRON, V407, P1097, DOI 10.1016/j.scitotenv.2008.10.038; Chen H, 2010, ENVIRON MONIT ASSESS, V164, P21, DOI 10.1007/s10661-009-0871-3; Chen H, 2009, ATMOS ENVIRON, V43, P4995, DOI 10.1016/j.atmosenv.2009.07.001; Chen H, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD012410; Chen H, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2006JD008072; Chen YH, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006058; Davidson EA, 2004, GLOBAL CHANGE BIOL, V10, P718, DOI 10.1111/j.1365-2486.2004.00762.x; Davidson EA, 2008, GLOBAL CHANGE BIOL, V14, P2582, DOI 10.1111/j.1365-2486.2008.01694.x; Denman KL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P499; Ding WX, 2004, ATMOS ENVIRON, V38, P751, DOI 10.1016/j.atmosenv.2003.10.016; Ding WX, 2002, ATMOS ENVIRON, V36, P5149, DOI 10.1016/S1352-2310(02)00647-7; Dowrick DJ, 2006, GEODERMA, V132, P384, DOI 10.1016/j.geoderma.2005.06.003; Estop-Aragones C, 2012, SOIL BIOL BIOCHEM, V47, P1, DOI 10.1016/j.soilbio.2011.12.008; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; FREEMAN C, 1993, BIOGEOCHEMISTRY, V19, P51; Freeman C, 2002, SOIL BIOL BIOCHEM, V34, P61, DOI 10.1016/S0038-0717(01)00154-7; Hirota M, 2005, ATMOS ENVIRON, V39, P5255, DOI 10.1016/j.atmosenv.2005.05.036; Hirota M, 2004, SOIL BIOL BIOCHEM, V36, P737, DOI 10.1016/j.soilbio.2003.12.009; HUTCHINSON GL, 1981, SOIL SCI SOC AM J, V45, P311, DOI 10.2136/sssaj1981.03615995004500020017x; Jin HJ, 1999, CHINESE SCI BULL, V44, P2282, DOI 10.1007/BF02885940; Kang SC, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/015101; Kato T, 2011, ATMOS ENVIRON, V45, P5632, DOI 10.1016/j.atmosenv.2011.03.010; Kim SY, 2008, SOIL BIOL BIOCHEM, V40, P2874, DOI 10.1016/j.soilbio.2008.08.004; Knorr KH, 2008, SOIL BIOL BIOCHEM, V40, P1781, DOI 10.1016/j.soilbio.2008.03.019; Knorr KH, 2009, SOIL BIOL BIOCHEM, V41, P1187, DOI 10.1016/j.soilbio.2009.02.030; Li L, 2010, ARCT ANTARCT ALP RES, V42, P449, DOI 10.1657/1938-4246-42.4.449; Middelburg JJ, 2002, BIOGEOCHEMISTRY, V59, P95, DOI 10.1023/A:1015515130419; MOSIER A, 1991, NATURE, V350, P330, DOI 10.1038/350330a0; Ringeval B, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2008GB003354; SHANNON RD, 1994, BIOGEOCHEMISTRY, V27, P35, DOI 10.1007/BF00002570; Singh S.N., 2000, CHEMOSPHERE GLOB CHA, V2, DOI [10.1016/S1465- 9972(99)00046-X, DOI 10.1016/S1465-9972(99)00046-X]; Tian JQ, 2012, EUROPEAN J SOIL BIOL, DOI [10.1016/j.ej-sobi.2012.1007.1003, DOI 10.1016/J.EJSOBI.2012.1007.1003]; [王德宣 Wang Dexuan], 2002, [地球科学进展, Advance in Earth Sciences], V17, P877; Wang MH, 1987, SCI GEOGRAPHICA SINI, V18, P145; Wu N, 1997, ERDE, V128, P67; Wu QB, 2010, GLOBAL PLANET CHANGE, V72, P32, DOI 10.1016/j.gloplacha.2010.03.001; Xiang SA, 2009, ECOL ENG, V35, P553, DOI 10.1016/j.ecoleng.2008.02.016; Xu BQ, 2001, SCI CHINA SER D, V44, P689, DOI 10.1007/BF02907198; Xu ZX, 2008, HYDROL PROCESS, V22, P3056, DOI 10.1002/hyp.6892; Yan XY, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003182; Zhang Y, 2011, ENVIRON MONIT ASSESS, V180, P189, DOI 10.1007/s10661-010-1781-0	42	72	78	3	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53878	10.1371/journal.pone.0053878	http://dx.doi.org/10.1371/journal.pone.0053878			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23342029	gold, Green Published			2022-12-27	WOS:000314759400093
J	Di, L; Zhang, H; Gu, WJ; Liu, YQ; Zhang, MG				Liu, Di; Zhang, Hong; Gu, Wenjuan; Liu, Yuqin; Zhang, Mengren			Neuroprotective Effects of Ginsenoside Rb1 on High Glucose-Induced Neurotoxicity in Primary Cultured Rat Hippocampal Neurons	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; CELL-PROLIFERATION; PYRAMIDAL NEURONS; OXIDATIVE STRESS; DIABETIC-RATS; NADPH OXIDASE; ER STRESS; APOPTOSIS; MICE	Ginsenoside Rb1 is one of the main active principles in traditional herb ginseng and has been reported to have a wide variety of neuroprotective effects. Endoplasmic reticulum (ER) stress has been implicated in neurodegenerative diseases, so the present study aimed to observe the effects of ginsenoside Rb1 on ER stress signaling pathways in high glucose-treated hippocampal neurons. The results from MTT, TUNEL labeling and Annexin V-FITC/PI/Hoechst assays showed that incubating neurons with 50 mM high glucose for 72h decreased cell viability and increased the number of apoptotic cells whereas treating neurons with 1 mu M Rb1 for 72h protected the neurons against high glucose-induced cell damage. Further molecular mechanism study demonstrated that Rb1 suppressed the activation of ER stress-associated proteins including protein kinase RNA (PKR)-like ER kinase (PERK) and C/EBP homology protein (CHOP) and downregulation of Bcl-2 induced by high glucose. Moreover, Rb1 inhibited both the elevation of intracellular reactive oxygen species (ROS) and the disruption of mitochondrial membrane potential induced by high glucose. In addition, the high glucose-induced cell apoptosis, activation of ER stress, ROS accumulation and mitochondrial dysfunction can also be attenuated by the inhibitor of ER stress 4-phenylbutyric acid (4-PBA) and anti-oxidant N-acetylcysteine(NAC). In conclusion, these results suggest that Rb1 may protect neurons against high glucose-induced cell injury through inhibiting CHOP signaling pathway as well as oxidative stress and mitochondrial dysfunction.	[Liu, Di; Gu, Wenjuan; Zhang, Mengren] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Tradit Chinese Med, Beijing 100021, Peoples R China; [Liu, Di; Zhang, Hong; Gu, Wenjuan; Liu, Yuqin; Zhang, Mengren] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Zhang, Hong; Liu, Yuqin] Peking Union Med Coll, Inst Basic Med Sci, Dept Cell Resource Ctr, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Zhang, MG (corresponding author), Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Tradit Chinese Med, Beijing 100021, Peoples R China.	xh02742@163.com	Vieira, Fernando/L-6246-2013	Vieira, Fernando/0000-0003-2996-6418	NIAID NIH HHS [K02-AI-060701, K02 AI060701] Funding Source: Medline; NIA NIH HHS [P30 AG013846, AG013846] Funding Source: Medline; BLRD VA [I01 BX001428] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); BLRD VA		Allagnat F, 2011, CELL DEATH DIFFER, V18, P328, DOI 10.1038/cdd.2010.105; Arduino DM, 2009, NEUROCHEM INT, V55, P341, DOI 10.1016/j.neuint.2009.04.004; Bravo R, 2012, INT J BIOCHEM CELL B, V44, P16, DOI 10.1016/j.biocel.2011.10.012; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; Chen ZY, 2010, NEUROSCI LETT, V482, P264, DOI 10.1016/j.neulet.2010.07.052; Cukierman T, 2005, DIABETOLOGIA, V48, P2460, DOI 10.1007/s00125-005-0023-4; Gaspar JM, 2010, NEUROSCIENCE, V171, P981, DOI 10.1016/j.neuroscience.2010.10.019; Gold SM, 2007, DIABETOLOGIA, V50, P711, DOI 10.1007/s00125-007-0602-7; Guo J, 2010, NEUROSCI RES, V68, P329, DOI 10.1016/j.neures.2010.08.012; Hashimoto R, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/693717; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hou Y, 2012, NEUROSCIENCE, V200, P120, DOI 10.1016/j.neuroscience.2011.10.030; Jackson-Guilford J, 2000, NEUROSCI LETT, V293, P91, DOI 10.1016/S0304-3940(00)01502-0; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Li G, 2010, J CELL BIOL, V191, P1113, DOI 10.1083/jcb.201006121; Li ZG, 2002, BRAIN RES, V946, P221, DOI 10.1016/S0006-8993(02)02887-1; Liu D, 2013, INT J NEUROSCI, V123, P155, DOI 10.3109/00207454.2012.746974; Liu L, 2011, BRAIN RES, V1382, P147, DOI 10.1016/j.brainres.2011.01.051; Lu J, 2011, BRAIN BEHAV IMMUN, V25, P1658, DOI 10.1016/j.bbi.2011.06.009; Lu J, 2011, BRAIN, V134, P783, DOI 10.1093/brain/awq376; Luo FC, 2012, NEUROTOXICOLOGY, V33, P290, DOI 10.1016/j.neuro.2012.02.004; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; McCrimmon RJ, 2012, LANCET, V379, P2291, DOI 10.1016/S0140-6736(12)60360-2; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Mook-Jung I, 2001, J NEUROSCI RES, V63, P509, DOI 10.1002/jnr.1045; Revsin Y, 2005, BRAIN RES, V1038, P22, DOI 10.1016/j.brainres.2004.12.032; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Russell JW, 1999, NEUROBIOL DIS, V6, P347, DOI 10.1006/nbdi.1999.0254; Santos CXC, 2009, ANTIOXID REDOX SIGN, V11, P2409, DOI 10.1089/ARS.2009.2625; Sims-Robinson C, 2012, DIABETOLOGIA, V55, P2276, DOI 10.1007/s00125-012-2573-6; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Srinivasan K, 2011, BEHAV BRAIN RES, V225, P110, DOI 10.1016/j.bbr.2011.07.004; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tekkok S, 1999, NEUROSCIENCE, V91, P185, DOI 10.1016/S0306-4522(98)00662-9; Timmins JM, 2009, J CLIN INVEST, V119, P2925, DOI 10.1172/JCI38857; Vannuvel K, 2013, J CELL PHYSIOL, V228, P1802, DOI 10.1002/jcp.24360; Verkhratsky A, 2008, CELL CALCIUM, V44, P112, DOI 10.1016/j.ceca.2007.11.010; Wang SH, 2009, TOXICOL SCI, V111, P72, DOI 10.1093/toxsci/kfp126; Wang WW, 2013, BRAIN INJURY, V27, P924, DOI 10.3109/02699052.2013.793397; Xue JF, 2006, BRAIN RES, V1106, P91, DOI 10.1016/j.brainres.2006.05.106; Yang W, 2009, EXP NEUROL, V219, P376, DOI 10.1016/j.expneurol.2009.07.009; Ye L, 2011, BRAIN RES, V1411, P57, DOI 10.1016/j.brainres.2011.07.011; Yi SS, 2011, NEUROCHEM RES, V36, P117, DOI 10.1007/s11064-010-0280-6; Yoshikawa T, 2008, J PHARMACOL SCI, V107, P32, DOI 10.1254/jphs.FP0071297; Zhang XM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/924327; Zhao CH, 2012, BRAIN RES, V1457, P33, DOI 10.1016/j.brainres.2012.03.067	46	56	63	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79399	10.1371/journal.pone.0079399	http://dx.doi.org/10.1371/journal.pone.0079399			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24223941	Green Published, Green Submitted, gold			2022-12-27	WOS:000326499300081
J	Hodgson, AB; Randell, RK; Jeukendrup, AE				Hodgson, Adrian B.; Randell, Rebecca K.; Jeukendrup, Asker E.			The Metabolic and Performance Effects of Caffeine Compared to Coffee during Endurance Exercise	PLOS ONE			English	Article							SKELETAL-MUSCLE; INTERMITTENT EXERCISE; PERCEIVED EXERTION; PROLONGED EXERCISE; FAT-METABOLISM; INGESTION; RESPONSES; HUMANS; CARBOHYDRATE; METAANALYSIS	There is consistent evidence supporting the ergogenic effects of caffeine for endurance based exercise. However, whether caffeine ingested through coffee has the same effects is still subject to debate. The primary aim of the study was to investigate the performance enhancing effects of caffeine and coffee using a time trial performance test, while also investigating the metabolic effects of caffeine and coffee. In a single-blind, crossover, randomised counter-balanced study design, eight trained male cyclists/triathletes (Mean +/- SD: Age 41 +/- 7y, Height 1.80 +/- 0.04 m, Weight 78.9 +/- 4.1 kg, VO2 max 58 +/- 3 ml.kg(-1).min(-1)) completed 30 min of steady-state (SS) cycling at approximately 55% VO(2)max followed by a 45 min energy based target time trial (TT). One hour prior to exercise each athlete consumed drinks consisting of caffeine (5 mg CAF/kg BW), instant coffee (5 mg CAF/kg BW), instant decaffeinated coffee or placebo. The set workloads produced similar relative exercise intensities during the SS for all drinks, with no observed difference in carbohydrate or fat oxidation. Performance times during the TT were significantly faster (similar to 5.0%) for both caffeine and coffee when compared to placebo and decaf (38.35 +/- 1.53, 38.27 +/- 1.80, 40.23 +/- 1.98, 40.31 +/- 1.22 min respectively, p<0.05). The significantly faster performance times were similar for both caffeine and coffee. Average power for caffeine and coffee during the TT was significantly greater when compared to placebo and decaf (294 +/- 21 W, 291 +/- 22 W, 277 +/- 14 W, 276 +/- 23 W respectively, p<0.05). No significant differences were observed between placebo and decaf during the TT. The present study illustrates that both caffeine (5 mg/kg/BW) and coffee (5 mg/kg/BW) consumed 1 h prior to exercise can improve endurance exercise performance.	[Hodgson, Adrian B.; Randell, Rebecca K.; Jeukendrup, Asker E.] Univ Birmingham, Human Performance Lab, Sch Sport & Exercise Sci, Birmingham, W Midlands, England; [Jeukendrup, Asker E.] PepsiCo, Gatorade Sport Sci Inst, Barrington, IL USA	University of Birmingham; PepsiCo	Jeukendrup, AE (corresponding author), Univ Birmingham, Human Performance Lab, Sch Sport & Exercise Sci, Birmingham, W Midlands, England.	a.e.jeukendrup@bham.ac.uk		Hodgson, Amanda/0000-0002-9479-3018; Kelly, Nat/0000-0002-9664-354X				Beaudoin Marie-Soleil, 2011, Handb Exp Pharmacol, P509, DOI 10.1007/978-3-642-13443-2_21; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; BUTTS NK, 1985, RES Q EXERCISE SPORT, V56, P301, DOI 10.1080/02701367.1985.10605333; Chesley A, 1998, AM J PHYSIOL-REG I, V275, pR596, DOI 10.1152/ajpregu.1998.275.2.R596; COSTILL DL, 1978, MED SCI SPORT EXER, V10, P155; Cox GR, 2002, J APPL PHYSIOL, V93, P990, DOI 10.1152/japplphysiol.00249.2002; Crozier TWM, 2012, FOOD FUNCT, V3, P30, DOI 10.1039/c1fo10240k; Currell K, 2008, SPORTS MED, V38, P297, DOI 10.2165/00007256-200838040-00003; de Paulis T, 2002, EUR J PHARMACOL, V442, P215, DOI 10.1016/S0014-2999(02)01540-6; Desbrow B, 2006, INT J SPORT NUTR EXE, V16, P545, DOI 10.1123/ijsnem.16.5.545; Desbrow B, 2012, J SPORT SCI, V30, P115, DOI 10.1080/02640414.2011.632431; Doherty M, 2005, SCAND J MED SCI SPOR, V15, P69, DOI 10.1111/j.1600-0838.2005.00445.x; Doherty M, 2004, INT J SPORT NUTR EXE, V14, P626, DOI 10.1123/ijsnem.14.6.626; Ganio MS, 2009, J STRENGTH COND RES, V23, P315, DOI 10.1519/JSC.0b013e31818b979a; Graham TE, 1998, J APPL PHYSIOL, V85, P883, DOI 10.1152/jappl.1998.85.3.883; GRAHAM TE, 1995, J APPL PHYSIOL, V78, P867, DOI 10.1152/jappl.1995.78.3.867; GRAHAM TE, 1991, J APPL PHYSIOL, V71, P2292, DOI 10.1152/jappl.1991.71.6.2292; Graham TE, 2000, J PHYSIOL-LONDON, V529, P837, DOI 10.1111/j.1469-7793.2000.00837.x; Graham TE, 2008, APPL PHYSIOL NUTR ME, V33, P1311, DOI 10.1139/H08-129; Irwin C, 2011, J SPORT SCI, V29, P509, DOI 10.1080/02640414.2010.541480; Jenkins NT, 2008, INT J SPORT NUTR EXE, V18, P328, DOI 10.1123/ijsnem.18.3.328; Jeukendrup A, 1996, MED SCI SPORT EXER, V28, P266, DOI 10.1097/00005768-199602000-00017; Jeukendrup AE, 2005, INT J SPORTS MED, V26, pS28, DOI 10.1055/s-2004-830512; KATHER H, 1985, J CLIN INVEST, V76, P1559, DOI 10.1172/JCI112137; Lamina S, 2009, AFR HEALTH SCI, V9, P270; McLellan TM, 2004, INT J SPORT NUTR EXE, V14, P698, DOI 10.1123/ijsnem.14.6.698; Mohr M, 2011, J APPL PHYSIOL, V111, P1372, DOI 10.1152/japplphysiol.01028.2010; Mohr T, 1998, J APPL PHYSIOL, V85, P979, DOI 10.1152/jappl.1998.85.3.979; Ong KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032718; Raguso CA, 1996, METABOLISM, V45, P1153, DOI 10.1016/S0026-0495(96)90016-5; SPRIET LL, 1992, AM J PHYSIOL, V262, pE891, DOI 10.1152/ajpendo.1992.262.6.E891; Stalmach A, 2012, COFFEE EMERGING HLTH; Tallis J, 2012, J APPL PHYSIOL, V112, P64, DOI 10.1152/japplphysiol.00801.2011; Tarnopolsky M, 2000, J APPL PHYSIOL, V89, P1719, DOI 10.1152/jappl.2000.89.5.1719; Tarnopolsky MA, 2008, APPL PHYSIOL NUTR ME, V33, P1284, DOI 10.1139/H08-121; TRICE I, 1995, INT J SPORT NUTR, V5, P37, DOI 10.1123/ijsn.5.1.37; TSE SYH, 1992, J PHARM SCI, V81, P449, DOI 10.1002/jps.2600810512; Tsuda S, 2012, J NUTR BIOCH; vanSoeren M, 1996, J APPL PHYSIOL, V80, P999, DOI 10.1152/jappl.1996.80.3.999; VERGAUWEN L, 1994, J CLIN INVEST, V93, P974, DOI 10.1172/JCI117104; WAHLBERG G, 1992, SCAND J CLIN LAB INV, V52, P547, DOI 10.3109/00365519209090132; Wiles J D, 1992, Br J Sports Med, V26, P116	42	195	202	2	171	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2013	8	4							e59561	10.1371/journal.pone.0059561	http://dx.doi.org/10.1371/journal.pone.0059561			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143BA	23573201	gold, Green Published, Green Submitted			2022-12-27	WOS:000318840100020
J	Chauhan, JS; Rao, A; Raghava, GPS				Chauhan, Jagat Singh; Rao, Alka; Raghava, Gajendra P. S.			In silico Platform for Prediction of N-, O- and C-Glycosites in Eukaryotic Protein Sequences	PLOS ONE			English	Article							GLYCOSYLATION SITES; DATABASE	Glycosylation is one of the most abundant and an important post-translational modification of proteins. Glycosylated proteins (glycoproteins) are involved in various cellular biological functions like protein folding, cell-cell interactions, cell recognition and host-pathogen interactions. A large number of eukaryotic glycoproteins also have therapeutic and potential technology applications. Therefore, characterization and analysis of glycosites (glycosylated residues) in these proteins is of great interest to biologists. In order to cater these needs a number of in silico tools have been developed over the years, however, a need to get even better prediction tools remains. Therefore, in this study we have developed a new webserver GlycoEP for more accurate prediction of N-linked, O-linked and C-linked glycosites in eukaryotic glycoproteins using two larger datasets, namely, standard and advanced datasets. In case of standard datasets no two glycosylated proteins are more similar than 40%; advanced datasets are highly non-redundant where no two glycosites' patterns (as defined in methods) have more than 60% similarity. Further, based on our results with several algorihtms developed using different machine-learning techniques, we found Support Vector Machine (SVM) as optimum tool to develop glycosite prediction models. Accordingly, using our more stringent and non-redundant advanced datasets, the SVM based models developed in this study achieved a prediction accuracy of 84.26%, 86.87% and 91.43% with corresponding MCC of 0.54, 0.20 and 0.78, for N-, O- and C-linked glycosites, respectively. The best performing models trained on advanced datasets were then implemented as a user-friendly web server GlycoEP (http://www.imtech.res.in/raghava/glycoep/). Additionally, this server provides prediction models developed on standard datasets and allows users to scan sequons in input protein sequences.	[Chauhan, Jagat Singh; Raghava, Gajendra P. S.] Inst Microbial Technol, Bioinformat Ctr, Chandigarh, India; [Rao, Alka] Inst Microbial Technol, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Raghava, GPS (corresponding author), Inst Microbial Technol, Bioinformat Ctr, Chandigarh, India.	raghava@imtech.res.in	Raghava, Gajendra/B-1717-2009; Raghava, Gajendra P.S./AAA-2413-2022; Rao, Alka/F-9826-2010; Brown, Wendy J/G-2201-2010; matthews, charles/E-8073-2015	Raghava, Gajendra P.S./0000-0002-8902-2876; Grunseit, Anne/0000-0003-1250-3265; Chau, Josephine/0000-0001-6261-2545; van der Ploeg, Hidde/0000-0002-3719-5249; Brown, Wendy J/0000-0001-9093-4509; matthews, charles/0000-0001-8037-3103	CSIR; DBT, government of India	CSIR(Council of Scientific & Industrial Research (CSIR) - India); DBT, government of India(Department of Biotechnology (DBT) India)	This piece of work was financially supported by CSIR and DBT, government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhat AH, 2012, NUCLEIC ACIDS RES, V40, pD388, DOI 10.1093/nar/gkr911; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Caragea C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-438; Chauhan JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040155; Chauhan JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-301; Christlet THT, 2001, BIOPHYS J, V80, P952, DOI 10.1016/S0006-3495(01)76074-2; Dell A, 2010, INT J MICROBIOL, V2010, P148; Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069; Garg A, 2005, PROTEINS, V61, P318, DOI 10.1002/prot.20630; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; Gupta R, 1999, NUCLEIC ACIDS RES, V27, P370, DOI 10.1093/nar/27.1.370; Gupta Ramneek, 2002, Pac Symp Biocomput, P310; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Hamby SE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-500; Hansen JE, 1998, GLYCOCONJUGATE J, V15, P115, DOI 10.1023/A:1006960004440; Hart Gerald W., 1992, Current Opinion in Cell Biology, V4, P1017, DOI 10.1016/0955-0674(92)90134-X; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Joachims T, 1999, ADVANCES IN KERNEL METHODS, P169; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Krieg J, 1998, MOL BIOL CELL, V9, P301, DOI 10.1091/mbc.9.2.301; Kumar M, 2008, PROTEINS, V71, P189, DOI 10.1002/prot.21677; LEHLE L, 1978, EUR J BIOCHEM, V83, P563, DOI 10.1111/j.1432-1033.1978.tb12124.x; Li SJ, 2006, COMPUT BIOL CHEM, V30, P203, DOI 10.1016/j.compbiolchem.2006.02.002; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Miyamoto S, 2006, CURR OPIN MOL THER, V8, P507; Pandhal J, 2010, BIOTECHNOL LETT, V32, P1189, DOI 10.1007/s10529-010-0289-6; Schwartz D, 2012, ESSAYS BIOCHEM, V52, P165, DOI [10.1042/bse0520165, 10.1042/BSE0520165]; Schwartz D, 2009, MOL CELL PROTEOMICS, V8, P365, DOI 10.1074/mcp.M800332-MCP200; Vapnik V., 2013, NATURE STAT LAERNING; von der Lieth CW, 2004, BRIEF BIOINFORM, V5, P164, DOI 10.1093/bib/5.2.164; WILSON IBH, 1991, BIOCHEM J, V275, P529, DOI 10.1042/bj2750529	33	360	368	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67008	10.1371/journal.pone.0067008	http://dx.doi.org/10.1371/journal.pone.0067008			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840574	gold, Green Published, Green Submitted			2022-12-27	WOS:000321148400028
J	Chen, X; Zhang, Z; Visser, RGF; Broekgaarden, C; Vosman, B				Chen, Xi; Zhang, Zhao; Visser, Richard G. F.; Broekgaarden, Colette; Vosman, Ben			Overexpression of IRM1 Enhances Resistance to Aphids in Arabidopsis thaliana	PLOS ONE			English	Article							GREEN PEACH APHID; INSECT-RESISTANCE; DEFENSE RESPONSES; XYLEM INGESTION; MYZUS-PERSICAE; PLANT DEFENSE; ACTIVATION; PENETRATION; GENE; PATHOGEN	Aphids are insects that cause direct damage to crops by the removal of phloem sap, but more importantly they spread devastating viruses. Aphids use their sophisticated mouthpart (i.e. stylet) to feed from the phloem sieve elements of the host plant. To identify genes that affect host plant resistance to aphids, we previously screened an Arabidopsis thaliana activation tag mutant collection. In such mutants, tagged genes are overexpressed by a strong 35S enhancer adjacent to the natural promoter, resulting in a dominant gain-of-function phenotype. We previously identified several of these mutants on which the aphid Myzus persicae showed a reduced population development compared with wild type. In the present study we show that the gene responsible for the phenotype of one of the mutants is At5g65040 and named this gene Increased Resistance to Myzus persicae 1 (IRM1). Overexpression of the cloned IRM1 gene conferred a phenotype identical to that of the original mutant. Conversely, an IRM1 knockout mutant promoted aphid population development compared to the wild type. We performed Electrical Penetration Graph analysis to investigate how probing and feeding behaviour of aphids was affected on plants that either overexpressed IRM1 or contained a knockout mutation in this gene. The EPG results indicated that the aphids encounter resistance factors while reaching for the phloem on the overexpressing line. This resistance mechanism also affected other aphid species and is suggested to be of mechanical nature. Interestingly, genetic variation for IRM1 expression in response to aphid attack was observed. Upon aphid attack the expression of IRM1 was initially (after 6 hours) induced in ecotype Wassilewskija followed by suppression. In Columbia-0, IRM1 expression was already suppressed six hours after the start of the infestation. The resistance conferred by the overexpression of IRM1 in A. thaliana trades off with plant growth.	[Chen, Xi; Visser, Richard G. F.; Broekgaarden, Colette; Vosman, Ben] Wageningen Univ, Wageningen UR Plant Breeding, NL-6700 AP Wageningen, Netherlands; [Zhang, Zhao] Wageningen Univ, Phytopathol Lab, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Broekgaarden, C (corresponding author), Wageningen Univ, Wageningen UR Plant Breeding, NL-6700 AP Wageningen, Netherlands.	colette.broekgaarden@wur.nl	Zhang, Zhao/J-1615-2019; Vosman, Ben/C-5494-2013; Visser, Richard GF/B-3423-2012; Wang, Cheng/O-7206-2016	Zhang, Zhao/0000-0002-7323-5500; Vosman, Ben/0000-0003-4942-8342; Visser, Richard GF/0000-0002-0213-4016; Zhang, Chunni/0000-0002-7329-7162; Wang, Cheng/0000-0002-1834-2119	Chinese scholarship council; Wageningen UR Plant Breeding	Chinese scholarship council(China Scholarship Council); Wageningen UR Plant Breeding	The work was financially supported by the Chinese scholarship council (http://en.csc.edu.cn/). The work was additionally funded by Wageningen UR Plant Breeding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2011, PLANT CELL ENVIRON, V34, P1191, DOI 10.1111/j.1365-3040.2011.02317.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Beneteau J, 2010, PLANT PHYSIOL, V153, P1345, DOI 10.1104/pp.110.153882; Bostock RM, 2005, ANNU REV PHYTOPATHOL, V43, P545, DOI 10.1146/annurev.phyto.41.052002.095505; Broekgaarden C, 2011, PLANT BIOTECHNOL J, V9, P819, DOI 10.1111/j.1467-7652.2011.00635.x; Chen X, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-33; Civolani S, 2010, B INSECTOL, V63, P265; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Couldridge C, 2007, B ENTOMOL RES, V97, P523, DOI 10.1017/S0007485307005160; De Vos M, 2005, MOL PLANT MICROBE IN, V18, P923, DOI 10.1094/MPMI-18-0923; De Vos M, 2009, PLANT CELL ENVIRON, V32, P1548, DOI 10.1111/j.1365-3040.2009.02019.x; Divol F, 2007, PLANT CELL ENVIRON, V30, P187, DOI 10.1111/j.1365-3040.2006.01618.x; Ellis C, 2002, PLANT CELL, V14, P1557, DOI 10.1105/tpc.002022; Firdaus S, 2011, PLANT BREEDING, V130, P708, DOI 10.1111/j.1439-0523.2011.01894.x; Halarewicz A, 2012, B INSECTOL, V65, P77; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Ichikawa T, 2003, PLANT J, V36, P421, DOI 10.1046/j.1365-313X.2003.01876.x; Iven T, 2012, MOL PLANT, V5, P1389, DOI 10.1093/mp/sss044; Karam GN, 2005, ANN BOT-LONDON, V95, P1179, DOI 10.1093/aob/mci130; Kusnierczyk A, 2008, PLANT CELL ENVIRON, V31, P1097, DOI 10.1111/j.1365-3040.2008.01823.x; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Levy M, 2005, PLANT J, V43, P79, DOI 10.1111/j.1365-313X.2005.02435.x; Marsch-Martinez N, 2002, PLANT PHYSIOL, V129, P1544, DOI 10.1104/pp.003327; Nalam VJ, 2012, PLANT CELL, V24, P1643, DOI 10.1105/tpc.111.094110; Pegadaraju V, 2007, PLANT J, V52, P332, DOI 10.1111/j.1365-313X.2007.03241.x; Powell G, 2002, ENTOMOL EXP APPL, V104, P103, DOI 10.1023/A:1021234412475; Scholl RL, 2000, PLANT PHYSIOL, V124, P1477, DOI 10.1104/pp.124.4.1477; Shimada TL, 2010, PLANT J, V61, P519, DOI 10.1111/j.1365-313X.2009.04060.x; Simmons AT, 2005, EUPHYTICA, V144, P313, DOI 10.1007/s10681-005-8002-x; SPILLER NJ, 1990, ENTOMOL EXP APPL, V55, P101, DOI 10.1007/BF00352570; Stafford Candice A., 2012, Communicative & Integrative Biology, V5, P43; Thompson GA, 2006, J EXP BOT, V57, P755, DOI 10.1093/jxb/erj135; Tjallingii W.F., 1990, P89; Tjallingii WF, 2010, ENTOMOL EXP APPL, V135, P193, DOI 10.1111/j.1570-7458.2010.00983.x; Tjallingii WF, 2006, J EXP BOT, V57, P739, DOI 10.1093/jxb/erj088; TJALLINGII WF, 1985, ENTOMOL EXP APPL, V38, P187, DOI 10.1007/BF00361931; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vasconcelos IM, 2004, TOXICON, V44, P385, DOI 10.1016/j.toxicon.2004.05.005; Wagner GJ, 2004, ANN BOT-LONDON, V93, P3, DOI 10.1093/aob/mch011; Walling LL, 2008, PLANT PHYSIOL, V146, P859, DOI 10.1104/pp.107.113142; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; Will T, 2006, J EXP BOT, V57, P729, DOI 10.1093/jxb/erj089; Zavala JA, 2006, PLANT CELL ENVIRON, V29, P1751, DOI 10.1111/j.1365-3040.2006.01551.x; Zhang ZY, 2006, PLANT CELL, V18, P1524, DOI 10.1105/tpc.105.039602; Zhu LC, 2011, J ECON ENTOMOL, V104, P2068, DOI 10.1603/EC11203	47	43	48	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e70914	10.1371/journal.pone.0070914	http://dx.doi.org/10.1371/journal.pone.0070914			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23951039	Green Published, Green Submitted, gold			2022-12-27	WOS:000323097300067
J	Feng, XW; Liang, N; Zhu, DX; Gao, Q; Peng, L; Dong, HM; Yue, QW; Liu, HL; Bao, LH; Zhang, J; Hao, J; Gao, YM; Yu, XJ; Sun, JH				Feng, Xiaowen; Liang, Nan; Zhu, Dexiao; Gao, Qing; Peng, Lei; Dong, Haiman; Yue, Qingwei; Liu, Haili; Bao, Lihua; Zhang, Jing; Hao, Jing; Gao, Yingmao; Yu, Xuejie; Sun, Jinhao			Resveratrol Inhibits beta-Amyloid-Induced Neuronal Apoptosis through Regulation of SIRT1-ROCK1 Signaling Pathway	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; PC12 CELLS; LIFE-SPAN; CALORIE RESTRICTION; HYDROGEN-PEROXIDE; OXIDATIVE INJURY; SIRT1 ACTIVATION; TOXICITY; DEATH; PREVENTION	Alzheimer's disease (AD) is characterized by the accumulation of beta-amyloid peptide (Ab) and loss of neurons. Recently, a growing body of evidences have indicated that as a herbal compound naturally derived from grapes, resveratrol modulates the pathophysiology of AD, however, with a largely unclear mechanism. Therefore, we aimed to investigate the protection of resveratrol against the neurotoxicity of beta-amyloid peptide 25-35 (A beta(25-35)) and further explore its underlying mechanism in the present study. PC12 cells were injuried by A beta(25-35), and resveratrol at different concentrations was added into the culture medium. We observed that resveratrol increased cell viability through the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and lactate dehydrogenase (LDH) colorimetric assays. Flow cytometry indicated the reduction of cell apoptosis by resveratrol. Moreover, resveratrol also stabilized the intercellular Ca2+ homeostasis and attenuated A beta(25-35) neurotoxicity. Additionally, A beta(25-35)-suppressed silent information regulator 1 (SIRT1) activity was significantly reversed by resveratrol, resulting in the downregulation of Rho-associated kinase 1 (ROCK1). Our results clearly revealed that resveratrol significantly protected PC12 cells and inhibited the beta-amyloid-induced cell apoptosis through the upregulation of SIRT1. Moreover, as a downstream signal molecule, ROCK1 was negatively regulated by SIRT1. Taken together, our study demonstrated that SIRT1-ROCK1 pathway played a critical role in the pathomechanism of AD.	[Feng, Xiaowen; Zhu, Dexiao; Peng, Lei; Dong, Haiman; Yue, Qingwei; Liu, Haili; Bao, Lihua; Zhang, Jing; Sun, Jinhao] Shandong Univ, Key Lab, Minist Educ Expt Teratol, Sch Med, Jinan 250100, Shandong, Peoples R China; [Feng, Xiaowen; Zhu, Dexiao; Peng, Lei; Dong, Haiman; Yue, Qingwei; Liu, Haili; Bao, Lihua; Zhang, Jing; Sun, Jinhao] Shandong Univ, Dept Anat, Sch Med, Jinan 250100, Shandong, Peoples R China; [Liang, Nan] Shandong Univ, Prov Hosp, Dept Neurosurg, Jinan 250100, Shandong, Peoples R China; [Gao, Qing; Hao, Jing; Gao, Yingmao] Shandong Univ, Sch Med, Dept Histol & Embryol, Jinan 250100, Shandong, Peoples R China; [Yu, Xuejie] Shandong Univ, Sch Publ Hlth, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University; Shandong University	Sun, JH (corresponding author), Shandong Univ, Key Lab, Minist Educ Expt Teratol, Sch Med, Jinan 250100, Shandong, Peoples R China.	sunjinhao@sdu.edu.cn	SUN, JIN/GPX-9641-2022; Yu, Xuejie/AAP-9246-2021		National Natural Science Foundation of China [81071081]; Natural Science Foundation of Shandong Province [ZR2010HM051, ZR2012HM026]; Shandong Provincial Science and Technology Development Plan [2011GSF11810]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Shandong Provincial Science and Technology Development Plan	This work was financially supported by grants of National Natural Science Foundation of China (No. 81071081), Natural Science Foundation of Shandong Province (ZR2010HM051 and ZR2012HM026), and a grant of Shandong Provincial Science and Technology Development Plan (2011GSF11810). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvira D, 2007, NEUROSCIENCE, V147, P746, DOI 10.1016/j.neuroscience.2007.04.029; Anekonda TS, 2006, BRAIN RES REV, V52, P316, DOI 10.1016/j.brainresrev.2006.04.004; Anekonda TS, 2006, J NEUROCHEM, V96, P305, DOI 10.1111/j.1471-4159.2005.03492.x; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Bournival J, 2009, CELL MOL NEUROBIOL, V29, P1169, DOI 10.1007/s10571-009-9411-5; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Conte A, 2003, BRAIN RES BULL, V62, P29, DOI 10.1016/j.brainresbull.2003.08.001; Dong J, 2007, P NATL ACAD SCI USA, V104, P13313, DOI 10.1073/pnas.0702669104; Feng Y, 2009, NEUROTOXICOLOGY, V30, P986, DOI 10.1016/j.neuro.2009.08.013; Ferreiro E, 2004, J NEUROSCI RES, V76, P872, DOI 10.1002/jnr.20135; Frankel D, 1999, EXP NEUROL, V160, P376, DOI 10.1006/exnr.1999.7214; Furuya TK, 2012, NEUROCHEM INT, V61, P973, DOI 10.1016/j.neuint.2012.07.014; Guarente L, 2000, GENE DEV, V14, P1021; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Howes MJR, 2003, PHYTOTHER RES, V17, P1, DOI 10.1002/ptr.1280; Huang TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029102; Hung LW, 2012, FUTURE MED CHEM, V4, P955, DOI [10.4155/FMC.12.32, 10.4155/fmc.12.32]; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Ji ZN, 2006, J ETHNOPHARMACOL, V107, P48, DOI 10.1016/j.jep.2006.02.004; Jia LQ, 2012, J ETHNOPHARMACOL, V143, P100, DOI 10.1016/j.jep.2012.06.007; Julien C, 2009, J NEUROPATH EXP NEUR, V68, P48, DOI 10.1097/NEN.0b013e3181922348; Lamming DW, 2004, MOL MICROBIOL, V53, P1003, DOI 10.1111/j.1365-2958.2004.04209.x; Limpeanchob N, 2008, J ETHNOPHARMACOL, V120, P112, DOI 10.1016/j.jep.2008.07.039; Minase T, 2010, EUR J PHARMACOL, V648, P67, DOI 10.1016/j.ejphar.2010.09.007; Olofsson Maria Haegg, 2008, BMC Chemical Biology, V8, P2, DOI 10.1186/1472-6769-8-2; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Parker JA, 2005, NAT GENET, V37, P349, DOI 10.1038/ng1534; Pasinetti GM, 2011, EXP NEUROL, V232, P1, DOI 10.1016/j.expneurol.2011.08.014; Pervaiz S, 2003, FASEB J, V17, P1975, DOI 10.1096/fj.03-0168rev; Porcu M, 2005, TRENDS PHARMACOL SCI, V26, P94, DOI 10.1016/j.tips.2004.12.009; Qin WP, 2006, J ALZHEIMERS DIS, V10, P417; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; Raskin I, 2002, TRENDS BIOTECHNOL, V20, P522, DOI 10.1016/S0167-7799(02)02080-2; Rasola A, 2011, CELL CALCIUM, V50, P222, DOI 10.1016/j.ceca.2011.04.007; Roy SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025166; Scalbert A, 2005, CRIT REV FOOD SCI, V45, P287, DOI 10.1080/1040869059096; Sharma M, 2002, LIFE SCI, V71, P2489, DOI 10.1016/S0024-3205(02)02083-0; Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019; Surh YJ, 1999, MUTAT RES-FUND MOL M, V428, P305, DOI 10.1016/S1383-5742(99)00057-5; Tang BL, 2005, BIOCHEM BIOPH RES CO, V331, P375, DOI 10.1016/j.bbrc.2005.03.074; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang J, 2008, J NEUROSCI, V28, P6388, DOI 10.1523/JNEUROSCI.0364-08.2008; Xi YD, 2011, J BIOENERG BIOMEMBR, V43, P399, DOI 10.1007/s10863-011-9362-7; Xiao QA, 2010, EUR J PHARMACOL, V647, P48, DOI 10.1016/j.ejphar.2010.08.002; Xie XH, 2012, INFLAMMATION, V35, P1392, DOI 10.1007/s10753-012-9452-7; Yang SH, 2011, J ETHNOPHARMACOL, V137, P1095, DOI 10.1016/j.jep.2011.07.014	48	117	122	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59888	10.1371/journal.pone.0059888	http://dx.doi.org/10.1371/journal.pone.0059888			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	24223855	gold, Green Published, Green Submitted			2022-12-27	WOS:000317262200055
J	Cheng, HL; Furnham, A				Cheng, Helen; Furnham, Adrian			Correlates of Adult Binge Drinking: Evidence from a British Cohort	PLOS ONE			English	Article							HEALTH-RELATED BEHAVIORS; ALCOHOL-CONSUMPTION; PERSONALITY; INTELLIGENCE; CHILDHOOD; ANXIETY	Objective: To investigate whether parental social class and cognitive ability in childhood, as well as social and psychological factors, particularly personality traits, are independently associated with binge drinking in 50 year old adults assessed in a longitudinal birth cohort study. Method: 17,415 babies born in Great Britain in 1958 and followed up at 11, 33, and 50 years of age. Their binge drinking alcohol abuse at aged 50 was the outcome measure. Results: 6,478 participants with data on parental social class, childhood cognitive ability, educational qualifications at age 33, personality traits, psychological distress, occupational levels, and alcohol consumption (all measured at age 50) were included in the study. Using logistic regression analyses, results showed that parental social class, childhood intelligence, educational qualifications, occupational levels, personality traits (Extraversion and Disagreeableness), as well as psychological distress, were all significantly and independently associated with adult excessive alcohol use. Men tended to binge drink more than women (22% in men and 9.8% in women). Conclusion: Both social and psychological factors influence adult excessive alcohol consumption. Personality traits play a more important role than previously understood. There appears to be a distinction between the frequency and dose level of alcohol consumption.	[Cheng, Helen; Furnham, Adrian] UCL, Dept Psychol, London, England; [Furnham, Adrian] BI Norwegian Business Sch, Oslo, Norway	University of London; University College London; BI Norwegian Business School	Furnham, A (corresponding author), UCL, Dept Psychol, London, England.	a.furnham@ucl.ac.uk	Chen, Huai/AAI-1024-2020; Wang, Yanfen/C-6889-2013; Furnham, Adrian/ABB-2072-2020; yang, gang/F-9553-2013; Chen, Huai/A-7418-2015; Wang, Yuesi/AAF-3317-2019; Chen, Huai/A-7418-2015	Chen, Huai/0000-0001-7650-289X; Chen, Huai/0000-0001-7650-289X; Chen, Huai/0000-0001-6208-1481; wang, yan fen/0000-0001-5666-9289; Yang, Gang/0000-0003-2576-013X				Batty GD, 2007, ANN EPIDEMIOL, V17, P278, DOI 10.1016/j.annepidem.2006.07.010; Batty GD, 2008, AM J PUBLIC HEALTH, V98, P2237, DOI 10.2105/AJPH.2007.109488; Batty GD, 2004, BMJ-BRIT MED J, V329, P585, DOI 10.1136/bmj.329.7466.585; Bogg T, 2004, PSYCHOL BULL, V130, P887, DOI 10.1037/0033-2909.130.6.887; Chambless DL, 1987, J ANXIETY DIORD, V1, P29; Ciarrochi J, 2012, INTELLIGENCE, V40, P317, DOI 10.1016/j.intell.2012.03.003; Cook M, 1998, PERS INDIV DIFFER, V24, P641, DOI 10.1016/S0191-8869(97)00214-6; Davie R, 1972, BIRTH 7; Douglas James W.B, 1964, HOME SCH; Ferri E., 2003, CHANGING BRITAIN CHA; Fogelman K., 1976, BRITAINS 16 YEAR OLD; Friedman HS, 2008, BRAIN BEHAV IMMUN, V22, P668, DOI 10.1016/j.bbi.2007.09.004; FRIEDMAN HS, 1993, J PERS SOC PSYCHOL, V65, P176, DOI 10.1037/0022-3514.65.1.176; Furnham A, 2003, BINGE DRINKING; Furnham A., 2008, PERSONALITY INTELLIG; George SM, 2010, PERS INDIV DIFFER, V49, P204, DOI 10.1016/j.paid.2010.03.036; Goldberg L.R., 1999, PERSONALITY PSYCHOL, V7, P7, DOI DOI 10.1016/J.JRP.2014.05.003; Gratzer D, 2004, J AFFECT DISORDERS, V79, P209, DOI 10.1016/S0165-0327(02)00355-5; Gunn RL, 2013, ADDICT BEHAV, V38, P2352, DOI 10.1016/j.addbeh.2013.02.009; Kanazawa S, 2012, INTELLIGENCE PARADOX; Kanazawa S, 2010, REV GEN PSYCHOL, V14, P382, DOI 10.1037/a0021526; Leete R, 1977, POPULATION TRENDS, V8, P1; Leino J, 2011, SCAND J PUBLIC HEALT, V39, P749, DOI 10.1177/1403494811421056; Leon DA, 2009, INTELLIGENCE, V37, P520, DOI 10.1016/j.intell.2008.11.004; MARSH C, 1986, KEY VARIABLES SOCIAL; MARTIN NG, 1989, BEHAV GENET, V19, P97, DOI 10.1007/BF01065886; Plewis I, 2004, NATL CHILD DEV STUDY; Ronksley Paul E, 2011, BMJ, V342, pd671, DOI 10.1136/bmj.d671; Rutter M, 1976, CYCLES DISADVANTAGE; Swendsen JD, 1998, COMPR PSYCHIAT, V39, P176, DOI 10.1016/S0010-440X(98)90058-X; Terracciano A, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-22; Wilkinson R., 2003, Social determinants of health: the solid facts	32	72	78	3	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e78838	10.1371/journal.pone.0078838	http://dx.doi.org/10.1371/journal.pone.0078838			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	23342029	Green Submitted, Green Published, gold			2022-12-27	WOS:000327254700054
J	Li, M; Zhang, YM; Zhang, ZY; Ji, XH; Zhang, R; Liu, DL; Gao, LP; Zhang, J; Wang, BA; Wu, YS; Wu, SJ; Chen, XL; Feng, SQ; Chen, XS				Li, Min; Zhang, Yanmin; Zhang, Zongying; Ji, Xiaohao; Zhang, Rui; Liu, Daliang; Gao, Liping; Zhang, Jing; Wang, Biao; Wu, Yusen; Wu, Shujing; Chen, Xiaoliu; Feng, Shouqian; Chen, Xuesen			Hypersensitive Ethylene Signaling and ZMdPG1 Expression Lead to Fruit Softening and Dehiscence	PLOS ONE			English	Article							DNA-BINDING PROTEINS; GOLDEN-DELICIOUS APPLES; GCC-BOX; TOMATO FRUIT; ARABIDOPSIS-THALIANA; RESPONSIVE ELEMENT; PLANT DEVELOPMENT; GENE-EXPRESSION; MESSENGER-RNA; CIS-ELEMENTS	Taishanzaoxia' fruit rapid softening and dehiscence during ripening stage and this process is very sensitive to endogenous ethylene. In this study, we cloned five ethylene signal transcription factors (ZMdEIL1, ZMdEIL2, ZMdEIL3, ZMdERF1 and ZMdERF2) and one functional gene, ZMdPG1, encoding polygalacturonase that could loose the cell connection which associated with fruit firmness decrease and fruit dehiscence to illustrate the reasons for this specific fruit phenotypic and physiological changes. Expression analysis showed that ZMdERF1 and ZMdEIL2 transcription were more abundant in 'Taishanzaoxia' softening fruit and dehiscent fruit and their expression was inhibited by an ethylene inhibitor 1-methylcyclopropene. Therefore, ZMdERF1 and ZMdEIL2 expression were responses to endogenous ethylene and associated with fruit softening and dehiscence. ZMdPG1 expression was induced when fruit softening and dehiscence but this induction can be blocked by 1-MCP, indicating that ZMdPG1 was essential for fruit softening and dehiscence and its expression was mediated by the endogenously occurred ethylene. ZMdPG1 overexpression in Arabidopsis led to silique early dehiscence while suppressing ZMdPG1 expression by antisense ZMdPG1 prevented silique naturally opening. The result also suggested that ZMdPG1 related with the connection between cells that contributed to fruit softening and dehiscence. ZMdERF1 was more closely related with ethylene signaling but it was not directly regulated the ZMdPG1, which might be regulated by the synergic pattern of ethylene transcription factors because of both the ZMdERF1 and ZMdERF2 could interact with ZMdEIL2.	[Li, Min; Zhang, Zongying; Ji, Xiaohao; Zhang, Rui; Liu, Daliang; Gao, Liping; Zhang, Jing; Wu, Yusen; Wu, Shujing; Chen, Xiaoliu; Feng, Shouqian; Chen, Xuesen] Shandong Agr Univ, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Zhang, Yanmin] Shandong Agr Univ, Coll Life Sci, Tai An, Shandong, Peoples R China; [Wang, Biao] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Shandong Agricultural University; Shandong Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Chen, XS (corresponding author), Shandong Agr Univ, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	chenxs@sdau.edu.cn	Li, Rachel Wei/T-2261-2019; zhang, qiu/GXG-5600-2022; Wang, Shaolin/M-2282-2013	Li, Rachel Wei/0000-0001-7053-7928; Wang, Shaolin/0000-0003-0866-4584; Li, Min/0000-0002-6059-7756	National Key Basic Research Program of China [2011CB100606]; National Natural Science Foundation of China [31171932, 31272132]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Key Basic Research Program of China (2011CB100606 and the National Natural Science Foundation of China (31171932 and 31272132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MD, 1998, EMBO J, V17, P5484, DOI 10.1093/emboj/17.18.5484; Atkinson R.G., 2008, New Zealand Patent, Patent No. [NZ570886, 570886]; ATKINSON RG, 1994, PLANT PHYSIOL, V105, P1437, DOI 10.1104/pp.105.4.1437; Atkinson RG, 2002, PLANT PHYSIOL, V129, P122, DOI 10.1104/pp.010986; Bapat VA, 2010, BIOTECHNOL ADV, V28, P94, DOI 10.1016/j.biotechadv.2009.10.002; Brummell DA, 2001, PLANT MOL BIOL, V47, P311, DOI 10.1023/A:1010656104304; Buttner M, 1997, P NATL ACAD SCI USA, V94, P5961, DOI 10.1073/pnas.94.11.5961; Camps C, 2005, J TEXTURE STUD, V36, P387, DOI 10.1111/j.1745-4603.2005.00023.x; Cara B, 2008, PLANT SCI, V175, P106, DOI 10.1016/j.plantsci.2008.03.021; Chakravarthy S, 2003, PLANT CELL, V15, P3033, DOI 10.1105/tpc.017574; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Chen SB, 2009, PLANT PHYSIOL, V150, P1111, DOI 10.1104/pp.109.137125; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DELLAPENNA D, 1986, P NATL ACAD SCI USA, V83, P6420, DOI 10.1073/pnas.83.17.6420; DELLAPENNA D, 1989, PLANT PHYSIOL, V90, P1372, DOI 10.1104/pp.90.4.1372; Hiwasa K, 2004, J EXP BOT, V55, P2281, DOI 10.1093/jxb/erh250; Huang SZ, 2010, PLANT SCI, V178, P251, DOI 10.1016/j.plantsci.2010.01.005; Jiang CZ, 2008, J EXP BOT, V59, P973, DOI 10.1093/jxb/ern023; Kendrick MD, 2008, CURR OPIN PLANT BIOL, V11, P479, DOI 10.1016/j.pbi.2008.06.011; Li YC, 2007, PLANT CELL REP, V26, P1999, DOI 10.1007/s00299-007-0394-8; Liu ChaoChao, 2011, Acta Horticulturae Sinica, V38, P133; Liu MeiYan, 2012, Acta Horticulturae Sinica, V39, P845; Liu YG, 2007, BIOTECHNIQUES, V43, P649, DOI 10.2144/000112601; Mir NA, 2001, J AM SOC HORTIC SCI, V126, P618, DOI 10.21273/JASHS.126.5.618; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Ogawa M, 2009, PLANT CELL, V21, P216, DOI 10.1105/tpc.108.063768; OHMETAKAGI M, 1995, PLANT CELL, V7, P173, DOI 10.1105/tpc.7.2.173; Okamuro JK, 1997, P NATL ACAD SCI USA, V94, P7076, DOI 10.1073/pnas.94.13.7076; Patterson SE, 2004, PLANT PHYSIOL, V134, P194, DOI 10.1104/pp.103.028027; Peace CP, 2005, MOL BREEDING, V16, P21, DOI 10.1007/s11032-005-0828-3; Pirrello J, 2006, PLANT CELL PHYSIOL, V47, P1195, DOI 10.1093/pcp/pcj084; Rieu I, 2003, J EXP BOT, V54, P2239, DOI 10.1093/jxb/erg240; Roeder Adrienne H K, 2006, Arabidopsis Book, V4, pe0075, DOI 10.1199/tab.0075; Saftner RA, 2003, J AM SOC HORTIC SCI, V128, P120, DOI 10.21273/JASHS.128.1.0120; Sawada K, 2000, J NEUROCHEM, V74, P1731, DOI 10.1046/j.1471-4159.2000.0741731.x; Schupp JR, 2004, HORTSCIENCE, V39, P1030, DOI 10.21273/HORTSCI.39.5.1030; Sieburth LE, 1997, PLANT CELL, V9, P355, DOI 10.1105/tpc.9.3.355; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Song SJ, 2011, J MECH SCI TECHNOL, V25, P3; SPEIRS J, 1990, J PLANT PHYSIOL, V135, P576, DOI 10.1016/S0176-1617(11)80639-5; Tacken E, 2010, PLANT PHYSIOL, V153, P294, DOI 10.1104/pp.109.151092; Tieman DM, 2001, PLANT J, V26, P47, DOI 10.1046/j.1365-313x.2001.01006.x; TIEMAN DM, 1994, PLANT PHYSIOL, V106, P429, DOI 10.1104/pp.106.2.429; Toivonen PMA, 2005, J HORTIC SCI BIOTECH, V80, P439, DOI 10.1080/14620316.2005.11511957; Tournier B, 2003, FEBS LETT, V550, P149, DOI 10.1016/S0014-5793(03)00757-9; Wakasa Y, 2006, POSTHARVEST BIOL TEC, V39, P193, DOI 10.1016/j.postharvbio.2005.10.005; Wang AD, 2009, POSTHARVEST BIOL TEC, V52, P38, DOI 10.1016/j.postharvbio.2008.09.001; Wang A, 2007, J EXP BOT, V58, P3743, DOI 10.1093/jxb/erm224; Wang ZY, 2000, PLANT MOL BIOL, V42, P317, DOI 10.1023/A:1006309529922; Wei JM, 2010, POSTHARVEST BIOL TEC, V56, P147, DOI 10.1016/j.postharvbio.2009.12.003; Weinthal D, 2009, TRENDS PLANT SCI, V14, P59, DOI 10.1016/j.tplants.2008.11.002; Yin XR, 2008, J EXP BOT, V59, P2097, DOI 10.1093/jxb/ern067; Yin XR, 2010, PLANT PHYSIOL, V153, P1280, DOI 10.1104/pp.110.157081; Yin XueRen, 2009, Acta Horticulturae Sinica, V36, P133; Yokotani N, 2003, J EXP BOT, V54, P2775, DOI 10.1093/jxb/erg308; Yuan RC, 2007, HORTSCIENCE, V42, P101, DOI 10.21273/HORTSCI.42.1.101	57	68	78	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58745	10.1371/journal.pone.0058745	http://dx.doi.org/10.1371/journal.pone.0058745			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527016	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562600038
J	Li, M; Zhang, QP; Liu, LN; Lu, WP; Wei, H; Li, RW; Lu, S				Li, Mei; Zhang, Qiuping; Liu, Lina; Lu, Weipeng; Wei, Hong; Li, Rachel W.; Lu, Shen			Expression of the Mismatch Repair Gene hMLH1 Is Enhanced in Non-Small Cell Lung Cancer with EGFR Mutations	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITORS; CLINICAL-SIGNIFICANCE; ACQUIRED-RESISTANCE; SOMATIC MUTATIONS; SIGNALING PATHWAY; KRAS MUTATIONS; CARCINOMAS; PROTEINS; HMSH2	Mismatch repair (MMR) plays a pivotal role in keeping the genome stable. MMR dysfunction can lead to carcinogenesis by gene mutation accumulation. HMSH2 and hMLH1 are two key components of MMR. High or low expression of them often mark the status of MMR function. Mutations (EGFR, KRAS, etc) are common in non-small cell lung cancer (NSCLC). However, it is not clear what role MMR plays in NSCLC gene mutations. The expression of MMR proteins hMSH2 and hMLH1, and the proliferation markers PCNA and Ki67 were measured by immunohistochemistry in 181 NSCLCs. EGFR and KRAS mutations were identified by high resolution melting analysis. Stronger hMLH1 expression correlated to a higher frequency of EGFR mutations in exon 19 and 21 (p<0.0005). Overexpression of hMLH1 and the adenocarcinoma subtype were both independent factors that related to EGFR mutations in NSCLCs (p=0.013 and p<0.0005). The expression of hMLH1, hMSH2 and PCNA increased, while Ki67 expression significantly decreased (p=0.030) in NSCLCs with EGFR mutations. Overexpression of hMLH1 could be a new molecular marker to predict the response to EGFR-TKIs in NSCLCs. Furthermore, EGFR mutations might be an early event of NSCLC that occur before MMR dysfunction.	[Li, Mei; Lu, Weipeng; Wei, Hong; Lu, Shen] Dalian Med Univ, Hosp 2, Cent Lab, Dalian, Peoples R China; [Zhang, Qiuping] Dalian Med Univ, Hosp 1, Dept Pathol, Dalian, Peoples R China; [Liu, Lina] Dalian Med Univ, Hosp 1, Dept Internal Med, Dalian, Peoples R China; [Li, Rachel W.] Australian Med Univ, Sch Med, Canberra, ACT, Australia	Dalian Medical University; Dalian Medical University; Dalian Medical University	Lu, S (corresponding author), Dalian Med Univ, Hosp 2, Cent Lab, Dalian, Peoples R China.	lvshen1956@126.com	Li, Rachel Wei/T-2261-2019; zhang, qiu/GXG-5600-2022; Wang, Shaolin/M-2282-2013	Li, Rachel Wei/0000-0001-7053-7928; Wang, Shaolin/0000-0003-0866-4584; Li, Min/0000-0002-6059-7756	National Nature Science Funds in China [81071805]; Dalian Merricon Gene Diagnosis Technology Co., Ltd.	National Nature Science Funds in China; Dalian Merricon Gene Diagnosis Technology Co., Ltd.	This work was supported by the National Nature Science Funds in China (Fund No. 81071805; URL: http://isisn.nsfc.gov.cn/egrantweb/), and Dalian Merricon Gene Diagnosis Technology Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Y, 2008, LUNG CANCER, V59, P164, DOI 10.1016/j.lungcan.2007.08.003; Balak MN, 2006, CLIN CANCER RES, V12, P6494, DOI 10.1158/1078-0432.CCR-06-1570; Betz BL, 2011, AM J CLIN PATHOL, V136, P564, DOI 10.1309/AJCP84TUTQOSUONG; Bischoff J, 2012, CLIN EXP METASTAS, V29, P889, DOI 10.1007/s10585-012-9478-0; Chung H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003463; Donehower LA, 2013, J PATHOL, V229, P99, DOI 10.1002/path.4087; Kawaguchi M, 2009, INT J ONCOL, V34, P1541, DOI 10.3892/ijo_00000283; Kouso H, 2008, J SURG ONCOL, V98, P377, DOI 10.1002/jso.21108; Lee SY, 2010, J THORAC ONCOL, V5, P1734, DOI 10.1097/JTO.0b013e3181f0beca; Li M, 2011, NEOPLASMA, V58, P74, DOI 10.4149/neo_2011_01_74; Li M, 2008, ONCOL REP, V19, P401; Li M, 2009, ONCOL REP, V22, P1013, DOI 10.3892/or_00000529; Lo FY, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-235; Luchtenborg M, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-160; Lujan SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003016; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Massarelli E, 2007, CLIN CANCER RES, V13, P2890, DOI 10.1158/1078-0432.CCR-06-3043; Nielsen FC, 2004, ONCOGENE, V23, P1457, DOI 10.1038/sj.onc.1207265; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Poulogiannis G, 2010, HISTOPATHOLOGY, V56, P167, DOI 10.1111/j.1365-2559.2009.03392.x; Pu X, 2011, LUNG CANCER, V71, P82, DOI 10.1016/j.lungcan.2010.04.008; Romeo F, 2011, INT J BIOCHEM CELL B, V43, P1754, DOI 10.1016/j.biocel.2011.08.011; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Saletta F, 2007, CANCER RES, V67, P7088, DOI 10.1158/0008-5472.CAN-06-4420; Sasaki H, 2006, LUNG CANCER, V54, P103, DOI 10.1016/j.lungcan.2006.06.003; Scartozzi M, 2006, LUNG CANCER, V53, P103, DOI 10.1016/j.lungcan.2006.03.008; Schmid K, 2009, CLIN CANCER RES, V15, P4554, DOI 10.1158/1078-0432.CCR-09-0089; Shah SN, 2010, CANCER RES, V70, P431, DOI 10.1158/0008-5472.CAN-09-3049; Shigematsu H, 2006, INT J CANCER, V118, P257, DOI 10.1002/ijc.21496; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Shih CM, 2010, INT J MOL MED, V25, P165, DOI 10.3892/ijmm_00000327; Sholl LM, 2010, AM J CLIN PATHOL, V133, P922, DOI 10.1309/AJCPST1CTHZS3PSZ; Stoehr C, 2012, PATHOBIOLOGY, V79, P162, DOI 10.1159/000335642; Stubbert LJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-207; Tada T, 2006, JNCI-J NATL CANCER I, V98, P396, DOI 10.1093/jnci/djj093; Takahashi Y, 2005, MOL CARCINOGEN, V42, P150, DOI 10.1002/mc.20073; Tol J, 2010, EUR J CANCER, V46, P1997, DOI 10.1016/j.ejca.2010.03.036; Vageli D, 2009, LUNG CANCER, V64, P282, DOI 10.1016/j.lungcan.2008.09.018; Vageli DP, 2012, INT J BIOL MARKER, V27, pE400, DOI 10.5301/JBM.2012.9420; van Puijenbroek M, 2008, FAM CANCER, V7, P319, DOI 10.1007/s10689-008-9194-8; Vogelsang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036962; Wang Y, 2000, GENE DEV, V14, P927; Wang YC, 2003, J CLIN INVEST, V111, P887, DOI 10.1172/JCI200315475; Wu CC, 2008, CANCER, V113, P3199, DOI 10.1002/cncr.23925; Xinarianos G, 2000, CANCER RES, V60, P4216; Yamaguchi F, 2012, LUNG CANCER, V78, P201, DOI 10.1016/j.lungcan.2012.08.014	47	68	78	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78500	10.1371/journal.pone.0078500	http://dx.doi.org/10.1371/journal.pone.0078500			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	23527016	Green Published, gold, Green Submitted			2022-12-27	WOS:000326152300065
